false2022FY000156341100015634112022-01-012022-12-310001563411dei:OtherAddressMember2022-01-012022-12-310001563411dei:BusinessContactMember2022-01-012022-12-3100015634112022-12-31xbrli:sharesiso4217:EUR00015634112021-01-012021-12-3100015634112020-01-012020-12-31iso4217:EURxbrli:shares00015634112021-12-310001563411ifrs-full:IssuedCapitalMember2021-12-310001563411ifrs-full:SharePremiumMember2021-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2021-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2021-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310001563411ifrs-full:OtherReservesMember2021-12-310001563411ifrs-full:RetainedEarningsMember2021-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2021-12-310001563411ifrs-full:NoncontrollingInterestsMember2021-12-310001563411ifrs-full:RetainedEarningsMember2022-01-012022-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2022-01-012022-12-310001563411ifrs-full:NoncontrollingInterestsMember2022-01-012022-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2022-01-012022-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2022-01-012022-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-01-012022-12-310001563411ifrs-full:OtherReservesMember2022-01-012022-12-310001563411ifrs-full:IssuedCapitalMember2022-12-310001563411ifrs-full:SharePremiumMember2022-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2022-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2022-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-12-310001563411ifrs-full:OtherReservesMember2022-12-310001563411ifrs-full:RetainedEarningsMember2022-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2022-12-310001563411ifrs-full:NoncontrollingInterestsMember2022-12-310001563411ifrs-full:IssuedCapitalMember2020-12-310001563411ifrs-full:SharePremiumMember2020-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2020-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2020-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310001563411ifrs-full:OtherReservesMember2020-12-310001563411ifrs-full:RetainedEarningsMember2020-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2020-12-310001563411ifrs-full:NoncontrollingInterestsMember2020-12-3100015634112020-12-310001563411ifrs-full:RetainedEarningsMember2021-01-012021-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2021-01-012021-12-310001563411ifrs-full:NoncontrollingInterestsMember2021-01-012021-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2021-01-012021-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2021-01-012021-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-01-012021-12-310001563411ifrs-full:OtherReservesMember2021-01-012021-12-310001563411ifrs-full:IssuedCapitalMember2019-12-310001563411ifrs-full:SharePremiumMember2019-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2019-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2019-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2019-12-310001563411ifrs-full:OtherReservesMember2019-12-310001563411ifrs-full:RetainedEarningsMember2019-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2019-12-310001563411ifrs-full:NoncontrollingInterestsMember2019-12-3100015634112019-12-310001563411ifrs-full:RetainedEarningsMember2020-01-012020-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2020-01-012020-12-310001563411ifrs-full:NoncontrollingInterestsMember2020-01-012020-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2020-01-012020-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2020-01-012020-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-01-012020-12-310001563411ifrs-full:OtherReservesMember2020-01-012020-12-31cstm:facilitycstm:centercstm:sitecstm:employee0001563411currency:USD2022-01-012022-12-31xbrli:pure0001563411currency:USD2021-01-012021-12-310001563411currency:USD2020-01-012020-12-310001563411currency:USD2022-12-310001563411currency:USD2021-12-310001563411currency:USD2020-12-310001563411currency:CHF2022-01-012022-12-310001563411currency:CHF2021-01-012021-12-310001563411currency:CHF2020-01-012020-12-310001563411currency:CHF2022-12-310001563411currency:CHF2021-12-310001563411currency:CHF2020-12-310001563411currency:CZK2022-01-012022-12-310001563411currency:CZK2021-01-012021-12-310001563411currency:CZK2020-01-012020-12-310001563411currency:CZK2022-12-310001563411currency:CZK2021-12-310001563411currency:CZK2020-12-310001563411ifrs-full:BuildingsMemberifrs-full:BottomOfRangeMember2022-01-012022-12-310001563411ifrs-full:BuildingsMemberifrs-full:TopOfRangeMember2022-01-012022-12-310001563411ifrs-full:BottomOfRangeMembercstm:MachineryAndEquipment1Member2022-01-012022-12-310001563411ifrs-full:TopOfRangeMembercstm:MachineryAndEquipment1Member2022-01-012022-12-310001563411ifrs-full:BottomOfRangeMemberifrs-full:VehiclesMember2022-01-012022-12-310001563411ifrs-full:TopOfRangeMemberifrs-full:VehiclesMember2022-01-012022-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2022-01-012022-12-310001563411cstm:CustomerRelationships1Member2022-01-012022-12-310001563411ifrs-full:ComputerSoftwareMemberifrs-full:BottomOfRangeMember2022-01-012022-12-310001563411ifrs-full:TopOfRangeMemberifrs-full:ComputerSoftwareMember2022-01-012022-12-310001563411cstm:PackagingRolledProductsMember2022-01-012022-12-310001563411cstm:PackagingRolledProductsMember2021-01-012021-12-310001563411cstm:PackagingRolledProductsMember2020-01-012020-12-310001563411cstm:AutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:AutomotiveRolledProductsMember2021-01-012021-12-310001563411cstm:AutomotiveRolledProductsMember2020-01-012020-12-310001563411cstm:SpecialtyAndOtherThinrolledProductsMember2022-01-012022-12-310001563411cstm:SpecialtyAndOtherThinrolledProductsMember2021-01-012021-12-310001563411cstm:SpecialtyAndOtherThinrolledProductsMember2020-01-012020-12-310001563411cstm:AerospaceRolledProductsMember2022-01-012022-12-310001563411cstm:AerospaceRolledProductsMember2021-01-012021-12-310001563411cstm:AerospaceRolledProductsMember2020-01-012020-12-310001563411cstm:TransportationIndustryAndOtherRolledProductsMember2022-01-012022-12-310001563411cstm:TransportationIndustryAndOtherRolledProductsMember2021-01-012021-12-310001563411cstm:TransportationIndustryAndOtherRolledProductsMember2020-01-012020-12-310001563411cstm:AutomotiveExtrudedProductsMember2022-01-012022-12-310001563411cstm:AutomotiveExtrudedProductsMember2021-01-012021-12-310001563411cstm:AutomotiveExtrudedProductsMember2020-01-012020-12-310001563411cstm:OtherExtrudedProductsMember2022-01-012022-12-310001563411cstm:OtherExtrudedProductsMember2021-01-012021-12-310001563411cstm:OtherExtrudedProductsMember2020-01-012020-12-310001563411country:DE2022-01-012022-12-310001563411country:DE2021-01-012021-12-310001563411country:DE2020-01-012020-12-310001563411country:FR2022-01-012022-12-310001563411country:FR2021-01-012021-12-310001563411country:FR2020-01-012020-12-310001563411country:GB2022-01-012022-12-310001563411country:GB2021-01-012021-12-310001563411country:GB2020-01-012020-12-310001563411country:CH2022-01-012022-12-310001563411country:CH2021-01-012021-12-310001563411country:CH2020-01-012020-12-310001563411country:ES2022-01-012022-12-310001563411country:ES2021-01-012021-12-310001563411country:ES2020-01-012020-12-310001563411country:CZ2022-01-012022-12-310001563411country:CZ2021-01-012021-12-310001563411country:CZ2020-01-012020-12-310001563411cstm:OtherEuropeMember2022-01-012022-12-310001563411cstm:OtherEuropeMember2021-01-012021-12-310001563411cstm:OtherEuropeMember2020-01-012020-12-310001563411srt:EuropeMember2022-01-012022-12-310001563411srt:EuropeMember2021-01-012021-12-310001563411srt:EuropeMember2020-01-012020-12-310001563411country:US2022-01-012022-12-310001563411country:US2021-01-012021-12-310001563411country:US2020-01-012020-12-310001563411cstm:AsiaAndOtherPacificMember2022-01-012022-12-310001563411cstm:AsiaAndOtherPacificMember2021-01-012021-12-310001563411cstm:AsiaAndOtherPacificMember2020-01-012020-12-310001563411cstm:OtherCountriesMember2022-01-012022-12-310001563411cstm:OtherCountriesMember2021-01-012021-12-310001563411cstm:OtherCountriesMember2020-01-012020-12-310001563411ifrs-full:GoodsOrServicesTransferredOverTimeMember2022-01-012022-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2022-12-31cstm:country0001563411cstm:AerospaceAndTransportationMember2022-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMemberifrs-full:EliminationOfIntersegmentAmountsMember2022-01-012022-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2021-01-012021-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMemberifrs-full:EliminationOfIntersegmentAmountsMember2021-01-012021-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2021-01-012021-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMemberifrs-full:EliminationOfIntersegmentAmountsMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2022-01-012022-12-310001563411cstm:AerospaceAndTransportationMemberifrs-full:EliminationOfIntersegmentAmountsMember2022-01-012022-12-310001563411cstm:AerospaceAndTransportationMember2022-01-012022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2021-01-012021-12-310001563411cstm:AerospaceAndTransportationMemberifrs-full:EliminationOfIntersegmentAmountsMember2021-01-012021-12-310001563411cstm:AerospaceAndTransportationMember2021-01-012021-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:AerospaceAndTransportationMemberifrs-full:EliminationOfIntersegmentAmountsMember2020-01-012020-12-310001563411cstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMemberifrs-full:EliminationOfIntersegmentAmountsMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2021-01-012021-12-310001563411cstm:AutomotiveStructuresAndIndustryMemberifrs-full:EliminationOfIntersegmentAmountsMember2021-01-012021-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2021-01-012021-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMemberifrs-full:EliminationOfIntersegmentAmountsMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMember2022-01-012022-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMember2022-01-012022-12-310001563411ifrs-full:OperatingSegmentsMember2021-01-012021-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMember2021-01-012021-12-310001563411ifrs-full:OperatingSegmentsMember2020-01-012020-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMember2021-01-012021-12-310001563411cstm:HoldingsAndCorporateMember2020-01-012020-12-3100015634112022-10-012022-10-310001563411cstm:OtherPostEmploymentBenefitMember2021-01-012021-12-310001563411cstm:COVID19PandemicMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2021-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2021-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2021-12-310001563411ifrs-full:OperatingSegmentsMembercstm:HoldingsAndCorporateMember2022-12-310001563411ifrs-full:OperatingSegmentsMembercstm:HoldingsAndCorporateMember2021-12-310001563411ifrs-full:OperatingSegmentsMember2022-12-310001563411ifrs-full:OperatingSegmentsMember2021-12-310001563411ifrs-full:UnallocatedAmountsMember2022-12-310001563411ifrs-full:UnallocatedAmountsMember2021-12-310001563411cstm:OneLargestCustomerMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:OneLargestCustomerMembercstm:PackagingAndAutomotiveRolledProductsMember2021-01-012021-12-310001563411cstm:OneLargestCustomerMembercstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411country:US2022-12-310001563411country:US2021-12-310001563411country:FR2022-12-310001563411country:FR2021-12-310001563411country:DE2022-12-310001563411country:DE2021-12-310001563411country:CZ2022-12-310001563411country:CZ2021-12-310001563411cstm:OtherCountriesMember2022-12-310001563411cstm:OtherCountriesMember2021-12-310001563411cstm:TotalOperatingExpensesMember2022-01-012022-12-310001563411cstm:TotalOperatingExpensesMember2021-01-012021-12-310001563411cstm:TotalOperatingExpensesMember2020-01-012020-12-310001563411cstm:AerospaceAndTransportationAndAutomotiveStructuresAndIndustryMembercstm:COVID19PandemicMember2020-01-012020-12-310001563411cstm:RevenueFromContractWithCustomersMember2022-01-012022-12-310001563411cstm:RevenueFromContractWithCustomersMember2021-01-012021-12-310001563411cstm:RevenueFromContractWithCustomersMember2020-01-012020-12-310001563411cstm:CostOfSales1Member2022-01-012022-12-310001563411cstm:CostOfSales1Member2021-01-012021-12-310001563411cstm:CostOfSales1Member2020-01-012020-12-310001563411cstm:OtherGainsAndLossesNetMember2022-01-012022-12-310001563411cstm:OtherGainsAndLossesNetMember2021-01-012021-12-310001563411cstm:OtherGainsAndLossesNetMember2020-01-012020-12-31iso4217:USD0001563411cstm:ConstelliumSESeniorNotesMember2022-01-012022-12-310001563411cstm:ConstelliumSESeniorNotesMember2021-01-012021-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMember2021-02-012021-02-280001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMember2021-06-012021-06-300001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2021-11-012021-11-300001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2021-11-300001563411cstm:SubsidiariesInCapitalControlRestrictionsCountriesMember2022-12-310001563411ifrs-full:GrossCarryingAmountMember2022-12-310001563411ifrs-full:GrossCarryingAmountMember2021-12-310001563411ifrs-full:AccumulatedImpairmentMember2022-12-310001563411ifrs-full:AccumulatedImpairmentMember2021-12-310001563411cstm:UnbilledToolingCostsMember2022-12-310001563411cstm:UnbilledToolingCostsMember2021-12-310001563411ifrs-full:CurrentMember2022-12-310001563411ifrs-full:CurrentMember2021-12-310001563411cstm:PastDueOneToThirtyDaysMember2022-12-310001563411cstm:PastDueOneToThirtyDaysMember2021-12-310001563411ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2022-12-310001563411ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2021-12-310001563411currency:EUR2022-12-310001563411currency:EUR2021-12-310001563411cstm:OtherCurrenciesMember2022-12-310001563411cstm:OtherCurrenciesMember2021-12-310001563411ifrs-full:FactoringOfReceivablesMembercountry:UScstm:MuscleShoalsFactoringFacilityMember2022-01-012022-12-310001563411ifrs-full:FactoringOfReceivablesMembercstm:ConstelliumAutomotiveMembercountry:US2022-01-012022-12-310001563411country:FRifrs-full:FactoringOfReceivablesMember2022-01-012022-12-310001563411cstm:FactoringReceivableRecourseLineMembercountry:FR2022-01-012022-12-310001563411ifrs-full:FactoringOfReceivablesMembercstm:GermanySwitzerlandAndCzechRepublicMember2022-01-012022-12-310001563411cstm:LandAndPropertyRightsMember2021-12-310001563411ifrs-full:BuildingsMember2021-12-310001563411cstm:MachineryAndEquipment1Member2021-12-310001563411ifrs-full:ConstructionInProgressMember2021-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2021-12-310001563411cstm:LandAndPropertyRightsMember2022-01-012022-12-310001563411ifrs-full:BuildingsMember2022-01-012022-12-310001563411cstm:MachineryAndEquipment1Member2022-01-012022-12-310001563411ifrs-full:ConstructionInProgressMember2022-01-012022-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2022-01-012022-12-310001563411cstm:LandAndPropertyRightsMember2022-12-310001563411ifrs-full:BuildingsMember2022-12-310001563411cstm:MachineryAndEquipment1Member2022-12-310001563411ifrs-full:ConstructionInProgressMember2022-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2022-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:LandAndPropertyRightsMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2022-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:MachineryAndEquipment1Member2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:OtherPropertyPlantAndEquipmentMember2022-12-310001563411cstm:LandAndPropertyRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:BuildingsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:MachineryAndEquipment1Member2022-12-310001563411ifrs-full:ConstructionInProgressMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411cstm:LandAndPropertyRightsMember2020-12-310001563411ifrs-full:BuildingsMember2020-12-310001563411cstm:MachineryAndEquipment1Member2020-12-310001563411ifrs-full:ConstructionInProgressMember2020-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2020-12-310001563411cstm:LandAndPropertyRightsMember2021-01-012021-12-310001563411ifrs-full:BuildingsMember2021-01-012021-12-310001563411cstm:MachineryAndEquipment1Member2021-01-012021-12-310001563411ifrs-full:ConstructionInProgressMember2021-01-012021-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2021-01-012021-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:LandAndPropertyRightsMember2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2021-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:MachineryAndEquipment1Member2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:OtherPropertyPlantAndEquipmentMember2021-12-310001563411cstm:LandAndPropertyRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:BuildingsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:MachineryAndEquipment1Member2021-12-310001563411ifrs-full:ConstructionInProgressMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2021-12-310001563411ifrs-full:RightofuseAssetsMembercstm:MachineryAndEquipment1Member2021-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2021-12-310001563411ifrs-full:RightofuseAssetsMember2021-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2022-01-012022-12-310001563411ifrs-full:RightofuseAssetsMembercstm:MachineryAndEquipment1Member2022-01-012022-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2022-01-012022-12-310001563411ifrs-full:RightofuseAssetsMember2022-01-012022-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2022-12-310001563411ifrs-full:RightofuseAssetsMembercstm:MachineryAndEquipment1Member2022-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2022-12-310001563411ifrs-full:RightofuseAssetsMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMembercstm:MachineryAndEquipment1Member2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2022-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:MachineryAndEquipment1Member2022-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2020-12-310001563411ifrs-full:RightofuseAssetsMembercstm:MachineryAndEquipment1Member2020-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2020-12-310001563411ifrs-full:RightofuseAssetsMember2020-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2021-01-012021-12-310001563411ifrs-full:RightofuseAssetsMembercstm:MachineryAndEquipment1Member2021-01-012021-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2021-01-012021-12-310001563411ifrs-full:RightofuseAssetsMember2021-01-012021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMembercstm:MachineryAndEquipment1Member2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:RightofuseAssetsMember2021-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:MachineryAndEquipment1Member2021-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411cstm:SellingAndAdministrativeExpenses1Member2022-01-012022-12-310001563411cstm:SellingAndAdministrativeExpenses1Member2021-01-012021-12-310001563411cstm:SellingAndAdministrativeExpenses1Member2020-01-012020-12-310001563411cstm:ResearchAndDevelopmentExpensesMember2022-01-012022-12-310001563411cstm:ResearchAndDevelopmentExpensesMember2021-01-012021-12-310001563411cstm:ResearchAndDevelopmentExpensesMember2020-01-012020-12-310001563411cstm:AerospaceAndTransportationMember2020-12-31cstm:cash_generating_unit0001563411cstm:AerospaceAndTransportationMembercstm:MontreuilJuignMember2020-01-012020-12-310001563411cstm:UsselMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2020-12-310001563411cstm:NanjingPlantMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:WhiteGeorgiaMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:WhiteGeorgiaMember2020-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2021-12-310001563411ifrs-full:ComputerSoftwareMember2021-12-310001563411cstm:CustomerRelationships1Member2021-12-310001563411cstm:WorkInProgressMember2021-12-310001563411ifrs-full:OtherIntangibleAssetsMember2021-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2022-01-012022-12-310001563411ifrs-full:ComputerSoftwareMember2022-01-012022-12-310001563411cstm:CustomerRelationships1Member2022-01-012022-12-310001563411cstm:WorkInProgressMember2022-01-012022-12-310001563411ifrs-full:OtherIntangibleAssetsMember2022-01-012022-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2022-12-310001563411ifrs-full:ComputerSoftwareMember2022-12-310001563411cstm:CustomerRelationships1Member2022-12-310001563411cstm:WorkInProgressMember2022-12-310001563411ifrs-full:OtherIntangibleAssetsMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:TechnologybasedIntangibleAssetsMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2022-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:CustomerRelationships1Member2022-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:WorkInProgressMember2022-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:OtherIntangibleAssetsMember2022-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411cstm:CustomerRelationships1Memberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:WorkInProgressMember2022-12-310001563411ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2020-12-310001563411ifrs-full:ComputerSoftwareMember2020-12-310001563411cstm:CustomerRelationships1Member2020-12-310001563411cstm:WorkInProgressMember2020-12-310001563411ifrs-full:OtherIntangibleAssetsMember2020-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2021-01-012021-12-310001563411ifrs-full:ComputerSoftwareMember2021-01-012021-12-310001563411cstm:CustomerRelationships1Member2021-01-012021-12-310001563411cstm:WorkInProgressMember2021-01-012021-12-310001563411ifrs-full:OtherIntangibleAssetsMember2021-01-012021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:TechnologybasedIntangibleAssetsMember2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2021-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:CustomerRelationships1Member2021-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:WorkInProgressMember2021-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:OtherIntangibleAssetsMember2021-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411cstm:CustomerRelationships1Memberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:WorkInProgressMember2021-12-310001563411ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2021-12-310001563411ifrs-full:TopOfRangeMembercstm:PackagingAndAutomotiveRolledProductsMember2022-12-310001563411ifrs-full:BottomOfRangeMembercstm:PackagingAndAutomotiveRolledProductsMember2022-12-310001563411cstm:LongTermAssetsMember2021-12-310001563411cstm:LongTermAssetsMember2022-01-012022-12-310001563411cstm:LongTermAssetsMember2022-12-310001563411cstm:InventoryMember2021-12-310001563411cstm:InventoryMember2022-01-012022-12-310001563411cstm:InventoryMember2022-12-310001563411cstm:PensionsMember2021-12-310001563411cstm:PensionsMember2022-01-012022-12-310001563411cstm:PensionsMember2022-12-310001563411cstm:DerivativeValuationMember2021-12-310001563411cstm:DerivativeValuationMember2022-01-012022-12-310001563411cstm:DerivativeValuationMember2022-12-310001563411cstm:TaxLossesCarriedForwardMember2021-12-310001563411cstm:TaxLossesCarriedForwardMember2022-01-012022-12-310001563411cstm:TaxLossesCarriedForwardMember2022-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2021-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2022-01-012022-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2022-12-310001563411cstm:LongTermAssetsMember2020-12-310001563411cstm:LongTermAssetsMember2021-01-012021-12-310001563411cstm:InventoryMember2020-12-310001563411cstm:InventoryMember2021-01-012021-12-310001563411cstm:PensionsMember2020-12-310001563411cstm:PensionsMember2021-01-012021-12-310001563411cstm:DerivativeValuationMember2020-12-310001563411cstm:DerivativeValuationMember2021-01-012021-12-310001563411cstm:TaxLossesCarriedForwardMember2020-12-310001563411cstm:TaxLossesCarriedForwardMember2021-01-012021-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2020-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2021-01-012021-12-310001563411ifrs-full:UnusedTaxLossesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001563411ifrs-full:UnusedTaxLossesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001563411ifrs-full:UnusedTaxLossesMembercstm:LaterThanFiveYearsAndLimitedMember2022-12-310001563411ifrs-full:UnusedTaxLossesMembercstm:LaterThanFiveYearsAndLimitedMember2021-12-310001563411ifrs-full:UnusedTaxLossesMembercstm:UnlimitedMember2022-12-310001563411ifrs-full:UnusedTaxLossesMembercstm:UnlimitedMember2021-12-310001563411ifrs-full:UnusedTaxLossesMember2022-12-310001563411ifrs-full:UnusedTaxLossesMember2021-12-310001563411cstm:LongTermAssetsMember2022-12-310001563411cstm:LongTermAssetsMember2021-12-310001563411cstm:PensionsMember2022-12-310001563411cstm:PensionsMember2021-12-310001563411ifrs-full:OtherTemporaryDifferencesMember2022-12-310001563411ifrs-full:OtherTemporaryDifferencesMember2021-12-310001563411ifrs-full:TemporaryDifferenceMember2022-12-310001563411ifrs-full:TemporaryDifferenceMember2021-12-310001563411ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember2022-12-310001563411cstm:DeferredToolingRevenueMember2022-12-310001563411cstm:DeferredToolingRevenueMember2021-12-310001563411cstm:AdvancePaymentFromCustomersMember2022-12-310001563411cstm:AdvancePaymentFromCustomersMember2021-12-310001563411cstm:UnrecognizedVariableConsiderationMember2022-12-310001563411cstm:UnrecognizedVariableConsiderationMember2021-12-310001563411cstm:OtherContractLiabilitiesMember2022-12-310001563411cstm:OtherContractLiabilitiesMember2021-12-310001563411cstm:SecuredPanUSABLMember2022-12-310001563411cstm:SecuredPanUSABLMember2021-12-310001563411cstm:FrenchPGEMember2022-12-310001563411cstm:FrenchPGEMember2021-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2022-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2022-01-012022-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2021-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember2022-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember2022-01-012022-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember2021-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2022-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2022-01-012022-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2021-12-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Member2022-12-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Member2022-01-012022-12-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Member2021-12-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedJune2021DueJune2029Member2022-12-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedJune2021DueJune2029Member2022-01-012022-12-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedJune2021DueJune2029Member2021-12-310001563411cstm:UnsecuredCreditFacilitySwitzerlandMember2022-12-31iso4217:CHF0001563411cstm:UnsecuredCreditFacilitySwitzerlandMember2022-01-012022-12-310001563411cstm:UnsecuredCreditFacilitySwitzerlandMember2021-12-310001563411cstm:OtherLoansMember2022-12-310001563411cstm:OtherLoansMember2021-12-310001563411cstm:SecuredPanUSABLMember2022-06-300001563411cstm:FrenchPGEMember2021-05-012021-05-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Member2021-02-280001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedJune2021DueJune2029Member2021-06-30cstm:target0001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Membercstm:BorrowingCovenantPeriodOneMember2021-02-012021-02-280001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Membercstm:BorrowingCovenantPeriodTwoMember2021-02-012021-02-280001563411cstm:FinancingArrangementsMember2022-12-310001563411cstm:SecuredInventoryFacilityMember2022-12-310001563411cstm:MoneyMarketFacilityMember2022-12-310001563411cstm:SecuredPanUSABLMember2022-01-012022-12-3100015634112021-01-012021-06-300001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Member2021-02-012021-02-280001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedJune2021DueJune2029Member2021-06-012021-06-300001563411ifrs-full:FinancialAssetsAtAmortisedCostMembercstm:CashandCashEquivalentsMember2022-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembercstm:CashandCashEquivalentsMember2022-12-310001563411cstm:CashandCashEquivalentsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2022-12-310001563411cstm:CashandCashEquivalentsMember2022-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMembercstm:CashandCashEquivalentsMember2021-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembercstm:CashandCashEquivalentsMember2021-12-310001563411cstm:CashandCashEquivalentsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-12-310001563411cstm:CashandCashEquivalentsMember2021-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2022-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2022-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2022-12-310001563411ifrs-full:TradeReceivablesMember2022-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2021-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-12-310001563411ifrs-full:TradeReceivablesMember2021-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2022-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2022-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2022-12-310001563411cstm:OtherFinancialAssetsMember2022-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2021-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-12-310001563411cstm:OtherFinancialAssetsMember2021-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMember2022-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2022-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2022-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMember2021-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2021-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:TradePayablesMember2022-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:TradePayablesMember2022-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:TradePayablesMember2022-12-310001563411cstm:TradePayablesMember2022-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:TradePayablesMember2021-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:TradePayablesMember2021-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:TradePayablesMember2021-12-310001563411cstm:TradePayablesMember2021-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:Borrowings1Member2022-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:Borrowings1Member2022-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:Borrowings1Member2022-12-310001563411cstm:Borrowings1Member2022-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:Borrowings1Member2021-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:Borrowings1Member2021-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:Borrowings1Member2021-12-310001563411cstm:Borrowings1Member2021-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:OtherFinancialLiabilitiesMember2022-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:OtherFinancialLiabilitiesMember2022-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:OtherFinancialLiabilitiesMember2022-12-310001563411cstm:OtherFinancialLiabilitiesMember2022-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:OtherFinancialLiabilitiesMember2021-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:OtherFinancialLiabilitiesMember2021-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:OtherFinancialLiabilitiesMember2021-12-310001563411cstm:OtherFinancialLiabilitiesMember2021-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMember2022-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2022-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2022-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMember2021-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2021-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-12-310001563411ifrs-full:AtFairValueMembercstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMemberifrs-full:Level1OfFairValueHierarchyMember2022-12-310001563411ifrs-full:AtFairValueMembercstm:ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMemberifrs-full:Level1OfFairValueHierarchyMember2022-12-310001563411ifrs-full:AtFairValueMembercstm:ConstelliumSEEURandUSDseniorunsecurednotesissuedNovembertwothousandseventeenDueTwoThousandTwentySixMemberifrs-full:Level1OfFairValueHierarchyMember2022-12-310001563411ifrs-full:AtFairValueMemberifrs-full:Level1OfFairValueHierarchyMembercstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2022-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2022-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2021-12-310001563411cstm:EnergyFutureContractMember2022-12-310001563411cstm:EnergyFutureContractMember2021-12-310001563411cstm:OtherCommodityDerivativesMember2022-12-310001563411cstm:OtherCommodityDerivativesMember2021-12-310001563411cstm:CurrencyCommercialContractsMember2022-12-310001563411cstm:CurrencyCommercialContractsMember2021-12-310001563411cstm:CurrencyNetDebtDerivativesMember2022-12-310001563411cstm:CurrencyNetDebtDerivativesMember2021-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2022-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2021-12-310001563411cstm:EnergyFutureContractMember2022-12-310001563411cstm:EnergyFutureContractMember2021-12-310001563411cstm:OtherCommodityDerivativesMember2022-12-310001563411cstm:OtherCommodityDerivativesMember2021-12-310001563411cstm:CurrencyCommercialContractsMember2022-12-310001563411cstm:CurrencyCommercialContractsMember2021-12-310001563411cstm:CurrencyNetDebtDerivativesMembercstm:ForwardPurchaseContractsVersusEuroMember2021-12-310001563411cstm:CurrencyNetDebtDerivativesMembercstm:ForwardPurchaseContractsVersusEuroMember2021-01-012021-12-310001563411ifrs-full:Level1OfFairValueHierarchyMember2022-12-310001563411ifrs-full:Level2OfFairValueHierarchyMember2022-12-310001563411ifrs-full:Level3OfFairValueHierarchyMember2022-12-310001563411ifrs-full:Level1OfFairValueHierarchyMember2021-12-310001563411ifrs-full:Level2OfFairValueHierarchyMember2021-12-310001563411ifrs-full:Level3OfFairValueHierarchyMember2021-12-310001563411ifrs-full:CurrencyRiskMember2022-01-012022-12-310001563411cstm:UsdEurForwardDerivativesSalesMemberifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMember2022-12-31cstm:EUR_0001563411cstm:UsdEurForwardDerivativesSalesMemberifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMember2022-12-310001563411cstm:EurChfForwardDerivativesSalesMemberifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMember2022-12-310001563411cstm:EurChfForwardDerivativesSalesMemberifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:EURCZKForwardDerivativesSalesMemberifrs-full:CurrencyRiskMember2022-12-310001563411cstm:EURCZKForwardDerivativesSalesMemberifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMember2022-12-310001563411cstm:OtherCurrenciesForwardDerivativesSalesMemberifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMember2022-12-310001563411cstm:OtherCurrenciesForwardDerivativesSalesMemberifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:UsdEurForwardDerivativesPurchasesMember2022-12-310001563411ifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMembercstm:UsdEurForwardDerivativesPurchasesMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:EurChfForwardDerivativesPurchasesMemberifrs-full:CurrencyRiskMember2022-12-310001563411cstm:EurChfForwardDerivativesPurchasesMemberifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMember2022-12-310001563411cstm:ForwardDerivativesPurchasesEurCzkMemberifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMember2022-12-310001563411cstm:ForwardDerivativesPurchasesEurCzkMemberifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:OtherCurrenciesForwardDerivativesPurchasesMember2022-12-310001563411ifrs-full:CurrencyRiskMemberifrs-full:LaterThanOneYearMembercstm:OtherCurrenciesForwardDerivativesPurchasesMember2022-12-310001563411cstm:DerivativeClassifiedAsCashFlowHedgeMember2022-12-310001563411cstm:DerivativeClassifiedAsCashFlowHedgeMember2021-12-310001563411cstm:NonqualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2022-01-012022-12-310001563411cstm:NonqualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2021-01-012021-12-310001563411cstm:NonqualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2020-01-012020-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2022-01-012022-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2021-01-012021-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-01-012020-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembercstm:QualifyingHedgesMember2022-01-012022-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembercstm:QualifyingHedgesMember2021-01-012021-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembercstm:QualifyingHedgesMember2020-01-012020-12-310001563411cstm:ForeignExchangeForwardContractsMembercstm:ForwardPurchaseContractsVersusEuroMember2022-01-012022-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CurrencyRiskMember2022-01-012022-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CurrencyRiskMember2021-01-012021-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:CurrencyRiskMember2020-01-012020-12-310001563411cstm:OtherCurrenciesMember2022-01-012022-12-310001563411ifrs-full:TradeReceivablesMembercstm:TenPercentageStrengtheningUsDollarEuroMember2022-01-012022-12-310001563411cstm:TradePayablesMembercstm:TenPercentageStrengtheningUsDollarEuroMember2022-01-012022-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:DerivativesOnCommercialTransactionMember2022-01-012022-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:CommercialTransactionExposureMember2022-01-012022-12-310001563411cstm:CashInBankAndIntercompanyLoansMembercstm:TenPercentageStrengtheningUsDollarEuroMember2022-01-012022-12-310001563411cstm:Borrowings1Membercstm:TenPercentageStrengtheningUsDollarEuroMember2022-01-012022-12-310001563411cstm:DerivativesOnFinancingTransactionMembercstm:TenPercentageStrengtheningUsDollarEuroMember2022-01-012022-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:FinancingTransactionExposureMember2022-01-012022-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMember2022-01-012022-12-310001563411ifrs-full:CommodityPriceRiskMember2022-01-012022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:AluminiumMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:LaterThanOneYearMembercstm:AluminiumMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:PremiumsMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:LaterThanOneYearMembercstm:PremiumsMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:CopperMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411cstm:CopperMemberifrs-full:LaterThanOneYearMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:SilverMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:LaterThanOneYearMembercstm:SilverMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NaturalGasMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:LaterThanOneYearMembercstm:NaturalGasMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:ZincMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:LaterThanOneYearMembercstm:ZincMemberifrs-full:CommodityPriceRiskMember2022-12-310001563411ifrs-full:CommodityPriceRiskMember2021-01-012021-12-310001563411ifrs-full:CommodityPriceRiskMember2020-01-012020-12-310001563411cstm:TenPercentageIncreaseOrDecreaseInTheMarketPriceMembercstm:AluminiumMember2022-01-012022-12-310001563411ifrs-full:TopOfRangeMembercstm:FiftyBasisPointIncreaseOrDecreaseInTheLiborOrEuriborInterestRatesMember2022-01-012022-12-310001563411ifrs-full:TopOfRangeMembercstm:FiftyBasisPointIncreaseOrDecreaseInTheLiborOrEuriborInterestRatesMember2021-01-012021-12-310001563411cstm:RatedAaOrBetterMember2022-12-31cstm:counterparty0001563411cstm:RatedAaOrBetterMember2021-12-310001563411cstm:RatedAMember2022-12-310001563411cstm:RatedAMember2021-12-310001563411cstm:RatedBaaMember2022-12-310001563411cstm:RatedBaaMember2021-12-310001563411ifrs-full:CurrencyRiskMember2021-01-012021-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2022-12-310001563411cstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2021-12-310001563411cstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2021-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:NotLaterThanOneYearMember2022-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:LaterThanFiveYearsMember2022-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:NotLaterThanOneYearMember2021-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:LaterThanFiveYearsMember2021-12-310001563411ifrs-full:NotLaterThanOneYearMember2022-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001563411ifrs-full:LaterThanFiveYearsMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMember2021-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001563411ifrs-full:LaterThanFiveYearsMember2021-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:Borrowings1Member2022-12-310001563411cstm:Borrowings1Memberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:Borrowings1Member2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:Borrowings1Member2021-12-310001563411cstm:Borrowings1Memberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:Borrowings1Member2021-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:InterestsMember2022-12-310001563411cstm:InterestsMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:InterestsMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:InterestsMember2021-12-310001563411cstm:InterestsMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:InterestsMember2021-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:NotLaterThanOneYearMember2022-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanFiveYearsMember2022-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:NotLaterThanOneYearMember2021-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanFiveYearsMember2021-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:TradePayablesAndOtherFixedAssetPayabalesMember2022-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMembercstm:TradePayablesAndOtherFixedAssetPayabalesMember2022-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:TradePayablesAndOtherFixedAssetPayabalesMember2022-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:TradePayablesAndOtherFixedAssetPayabalesMember2021-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMembercstm:TradePayablesAndOtherFixedAssetPayabalesMember2021-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:TradePayablesAndOtherFixedAssetPayabalesMember2021-12-310001563411ifrs-full:ActuarialAssumptionOfDiscountRatesMember2022-01-012022-12-310001563411ifrs-full:ActuarialAssumptionOfDiscountRatesMember2022-12-310001563411country:FRifrs-full:ActuarialAssumptionOfDiscountRatesMember2022-12-310001563411country:DEifrs-full:ActuarialAssumptionOfDiscountRatesMember2022-12-310001563411ifrs-full:ActuarialAssumptionOfDiscountRatesMembercountry:CH2022-12-310001563411ifrs-full:ActuarialAssumptionOfDiscountRatesMembercountry:US2022-12-310001563411country:CH2022-12-310001563411country:CH2021-12-310001563411cstm:HourlyPensionMembercountry:US2022-12-310001563411cstm:HourlyPensionMembercountry:USifrs-full:BottomOfRangeMember2022-12-310001563411ifrs-full:TopOfRangeMembercstm:HourlyPensionMembercountry:US2022-12-310001563411cstm:HourlyPensionMembercountry:US2021-12-310001563411cstm:HourlyPensionMembercountry:USifrs-full:BottomOfRangeMember2021-12-310001563411ifrs-full:TopOfRangeMembercstm:HourlyPensionMembercountry:US2021-12-310001563411cstm:SalariedPensionMembercountry:US2022-12-310001563411cstm:SalariedPensionMembercountry:US2021-12-310001563411cstm:OtherPostEmploymentBenefitMembercountry:US2022-12-310001563411cstm:OtherPostEmploymentBenefitMembercountry:USifrs-full:BottomOfRangeMember2022-12-310001563411ifrs-full:TopOfRangeMembercstm:OtherPostEmploymentBenefitMembercountry:US2022-12-310001563411cstm:OtherPostEmploymentBenefitMembercountry:US2021-12-310001563411cstm:OtherPostEmploymentBenefitMembercountry:USifrs-full:BottomOfRangeMember2021-12-310001563411ifrs-full:TopOfRangeMembercstm:OtherPostEmploymentBenefitMembercountry:US2021-12-310001563411country:UScstm:OtherEmployeeBenefitsMember2022-12-310001563411country:USifrs-full:BottomOfRangeMembercstm:OtherEmployeeBenefitsMember2022-12-310001563411ifrs-full:TopOfRangeMembercountry:UScstm:OtherEmployeeBenefitsMember2022-12-310001563411country:UScstm:OtherEmployeeBenefitsMember2021-12-310001563411country:USifrs-full:BottomOfRangeMembercstm:OtherEmployeeBenefitsMember2021-12-310001563411ifrs-full:TopOfRangeMembercountry:UScstm:OtherEmployeeBenefitsMember2021-12-310001563411country:FRifrs-full:BottomOfRangeMember2022-12-310001563411country:FRifrs-full:BottomOfRangeMember2021-12-310001563411country:FRifrs-full:TopOfRangeMember2021-12-310001563411country:FRcstm:RetirementBenefitsMember2022-12-310001563411country:FRcstm:RetirementBenefitsMember2021-12-310001563411country:FRcstm:OtherPostRetirementBenefitsMember2022-12-310001563411country:FRcstm:OtherPostRetirementBenefitsMember2021-12-310001563411cstm:OtherPostEmploymentBenefitMembercstm:TwoThousandTwentyMembercstm:PreSixtyFiveMember2022-12-310001563411cstm:TwoThousandTwentyNineMembercstm:OtherPostEmploymentBenefitMembercstm:PreSixtyFiveMember2022-12-310001563411cstm:OtherPostEmploymentBenefitMembercstm:TwoThousandTwentyMembercstm:PostSixtyFiveMember2022-12-310001563411cstm:TwoThousandTwentyNineMembercstm:OtherPostEmploymentBenefitMembercstm:PostSixtyFiveMember2022-12-310001563411ifrs-full:PensionDefinedBenefitPlansMember2022-12-310001563411cstm:OtherBenefitPlansMember2022-12-310001563411ifrs-full:PensionDefinedBenefitPlansMember2021-12-310001563411cstm:OtherBenefitPlansMember2021-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2021-12-310001563411cstm:OtherBenefitPlansMemberifrs-full:PresentValueOfDefinedBenefitObligationMember2021-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2021-12-310001563411ifrs-full:PlanAssetsMember2021-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2022-01-012022-12-310001563411cstm:OtherBenefitPlansMemberifrs-full:PresentValueOfDefinedBenefitObligationMember2022-01-012022-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2022-01-012022-12-310001563411ifrs-full:PlanAssetsMember2022-01-012022-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2022-12-310001563411cstm:OtherBenefitPlansMemberifrs-full:PresentValueOfDefinedBenefitObligationMember2022-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2022-12-310001563411ifrs-full:PlanAssetsMember2022-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310001563411cstm:OtherBenefitPlansMemberifrs-full:PresentValueOfDefinedBenefitObligationMember2020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2020-12-310001563411ifrs-full:PlanAssetsMember2020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2021-01-012021-12-310001563411cstm:OtherBenefitPlansMemberifrs-full:PresentValueOfDefinedBenefitObligationMember2021-01-012021-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2021-01-012021-12-310001563411ifrs-full:PlanAssetsMember2021-01-012021-12-310001563411cstm:OtherPostEmploymentBenefitMember2022-01-012022-12-310001563411cstm:OtherBenefitPlansMember2018-01-012018-12-310001563411country:FR2022-12-310001563411country:FR2021-12-310001563411country:DE2022-12-310001563411country:DE2021-12-310001563411country:CH2022-12-310001563411country:CH2021-12-310001563411country:US2022-12-310001563411country:US2021-12-310001563411cstm:PlanAssetCategoriesQuotedInAnActiveMarketMember2022-12-310001563411cstm:PlanAssetCategoriesNotQuotedInAnActiveMarketMember2022-12-310001563411cstm:PlanAssetCategoriesQuotedInAnActiveMarketMember2021-12-310001563411cstm:PlanAssetCategoriesNotQuotedInAnActiveMarketMember2021-12-310001563411ifrs-full:PensionDefinedBenefitPlansMember2022-01-012022-12-310001563411cstm:OtherBenefitPlansMember2022-01-012022-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2021-12-310001563411ifrs-full:RestructuringProvisionMember2021-12-310001563411ifrs-full:LegalProceedingsProvisionMember2021-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2022-01-012022-12-310001563411ifrs-full:RestructuringProvisionMember2022-01-012022-12-310001563411ifrs-full:LegalProceedingsProvisionMember2022-01-012022-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2022-12-310001563411ifrs-full:RestructuringProvisionMember2022-12-310001563411ifrs-full:LegalProceedingsProvisionMember2022-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2020-12-310001563411ifrs-full:RestructuringProvisionMember2020-12-310001563411ifrs-full:LegalProceedingsProvisionMember2020-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2021-01-012021-12-310001563411ifrs-full:RestructuringProvisionMember2021-01-012021-12-310001563411ifrs-full:LegalProceedingsProvisionMember2021-01-012021-12-310001563411ifrs-full:BottomOfRangeMemberifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMember2022-01-012022-12-310001563411ifrs-full:TopOfRangeMemberifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMember2022-01-012022-12-310001563411ifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMember2022-01-012022-12-31cstm:claim0001563411ifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMember2021-01-012021-12-310001563411ifrs-full:TopOfRangeMemberifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMember2021-01-012021-12-310001563411ifrs-full:OrdinarySharesMember2022-12-31cstm:vote0001563411ifrs-full:OrdinarySharesMember2021-12-310001563411ifrs-full:OrdinarySharesMembercstm:EmployeesMember2022-01-012022-12-310001563411ifrs-full:IssuedCapitalMember2022-01-012022-12-310001563411ifrs-full:SharePremiumMember2022-01-012022-12-310001563411ifrs-full:PropertyPlantAndEquipmentMember2022-12-310001563411ifrs-full:PropertyPlantAndEquipmentMember2021-12-310001563411cstm:FrenchGovernmentMembercstm:FrenchPGEMember2020-05-130001563411ifrs-full:SubsidiariesMembercstm:FrenchGovernmentMembercstm:FrenchPGEMember2020-05-130001563411cstm:PerformanceShareUnitsMember2022-01-012022-12-310001563411cstm:PerformanceShareUnitsMemberifrs-full:BottomOfRangeMember2022-01-012022-12-310001563411ifrs-full:TopOfRangeMembercstm:PerformanceShareUnitsMember2022-01-012022-12-310001563411cstm:PerformanceShareUnitsMember2017-07-012017-07-310001563411cstm:PerformanceShareUnitsMember2020-07-012020-07-310001563411cstm:PerformanceShareUnitsMember2018-05-012018-05-310001563411cstm:PerformanceShareUnitsMember2020-05-012020-05-310001563411cstm:PerformanceShareUnitsMember2019-04-012019-04-300001563411cstm:PerformanceShareUnitsMember2022-04-012022-04-300001563411cstm:PerformanceShareUnitsMember2021-01-012021-12-310001563411cstm:RestrictedStockUnitsMembercstm:CertainEmployeesAndChiefFinancialOfficerMember2022-01-012022-12-310001563411ifrs-full:KeyManagementPersonnelOfEntityOrParentMembercstm:RestrictedStockUnitsMember2019-01-012019-12-310001563411ifrs-full:KeyManagementPersonnelOfEntityOrParentMembercstm:RestrictedStockUnitsMember2020-01-012020-12-310001563411ifrs-full:KeyManagementPersonnelOfEntityOrParentMembercstm:RestrictedStockUnitsMember2022-01-012022-12-310001563411ifrs-full:KeyManagementPersonnelOfEntityOrParentMembercstm:RestrictedStockUnitsMember2021-01-012021-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2020-12-310001563411cstm:RestrictedStockUnitsMember2020-12-310001563411cstm:EquityAwardsPlanMember2020-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2021-01-012021-12-310001563411cstm:RestrictedStockUnitsMember2021-01-012021-12-310001563411cstm:EquityAwardsPlanMember2021-01-012021-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2021-12-310001563411cstm:RestrictedStockUnitsMember2021-12-310001563411cstm:EquityAwardsPlanMember2021-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2022-01-012022-12-310001563411cstm:RestrictedStockUnitsMember2022-01-012022-12-310001563411cstm:EquityAwardsPlanMember2022-01-012022-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2022-12-310001563411cstm:RestrictedStockUnitsMember2022-12-310001563411cstm:EquityAwardsPlanMember2022-12-310001563411cstm:CrossOperatingSegmentMembercstm:ConstelliumSingenGmbHMember2022-01-012022-12-310001563411cstm:ConstelliumValaisSAMembercstm:CrossOperatingSegmentMember2022-01-012022-12-310001563411cstm:ConstelliumAutomotiveUSALLCMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:ConstelliumEngleyChangchunAutomotiveStructuresCoLtdMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:ConstelliumExtrusionsDecinSroMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:ConstelliumExtrusionsDeutschlandGmbHMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumExtrusionsLandauGmbHMember2022-01-012022-12-310001563411cstm:ConstelliumExtrusionsBurgGmbHMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:ConstelliumExtrusionsFranceSASMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumExtrusionsLeviceSroMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveMexicoSDERLDECVMember2022-01-012022-12-310001563411cstm:ConstelliumAutomotiveMexicoTradingSDERLDECVMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:AstrexIncMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveZilinaSroMember2022-01-012022-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveNanjingCoLtdMember2022-01-012022-12-310001563411cstm:ConstelliumAutomotiveSpainSLMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:ConstelliumUKLimitedMembercstm:AutomotiveStructuresAndIndustryMember2022-01-012022-12-310001563411cstm:ConstelliumIssoireSASMembercstm:AerospaceAndTransportationMember2022-01-012022-12-310001563411cstm:AerospaceAndTransportationMembercstm:ConstelliumMontreuilJuigneMember2022-01-012022-12-310001563411cstm:ConstelliumChinaCoLtdMembercstm:AerospaceAndTransportationMember2022-01-012022-12-310001563411cstm:AerospaceAndTransportationMembercstm:ConstelliumJapanKKMember2022-01-012022-12-310001563411cstm:AerospaceAndTransportationMembercstm:ConstelliumRolledProductsRavenswoodLLCMember2022-01-012022-12-310001563411cstm:AerospaceAndTransportationMembercstm:ConstelliumUsselSASMember2022-01-012022-12-310001563411cstm:AerospaceAndTransportationMembercstm:AluinfraServicesSAMember2022-01-012022-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumDeutschlandGmbHMember2022-01-012022-12-310001563411cstm:ConstelliumRolledProductsSingenGmbHKGMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumNeufBrisachMember2022-01-012022-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumMuscleShoalsLLCMember2022-01-012022-12-310001563411cstm:ConstelliumHoldingMuscleShoalsLLCMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:ConstelliumMuscleShoalsFundingTwoLLCMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:ConstelliumMuscleShoalsFundingIIILLCMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:ConstelliumMetalProcurementLLCMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:ConstelliumUACJABSLLCMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:RhenarollSaMembercstm:PackagingAndAutomotiveRolledProductsMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:CtecConstelliumTechnologyCenterSASMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumFinanceSASMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumFranceIIISASMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumFranceHoldcoSASMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumInternationalSASMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumParisSASMember2022-01-012022-12-310001563411cstm:ConstelliumGermanyHoldcoGmbHAndCoKGMembercstm:HoldingsAndCorporateMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumGermanyVerwaltungsGmbhMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumUSHoldingsILLCMember2022-01-012022-12-310001563411cstm:ConstelliumUSIntermediateHoldingsLLCMembercstm:HoldingsAndCorporateMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumSwitzerlandAGMember2022-01-012022-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumTreuhandUGMember2022-01-012022-12-310001563411cstm:EngineeredProductsInternationalSASMembercstm:HoldingsAndCorporateMember2022-01-012022-12-310001563411ifrs-full:DisposalOfMajorSubsidiaryMember2023-02-022023-02-02


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________________________________________________
FORM 20-F
__________________________________________________________________________
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-35931
__________________________________________________________________________
Constellium SE
(Exact Name of Registrant as Specified in its Charter)
__________________________________________________________________________
Constellium SE
(Translation of Registrant’s name into English)
__________________________________________________________________________
France
(Jurisdiction of incorporation or organization)
__________________________________________________________________________
Washington Plaza,300 East Lombard Street
40-44 rue WashingtonSuite 1710
75008 Paris
Baltimore, MD, 21202
FranceUnited States
(Head Office)
(Address of principal executive offices)
Rina E. Teran
Chief Securities Counsel
300 East Lombard Street, Suite 1710, Baltimore, MD, 21202
United States
Tel: (443) 420-7861
E-mail: rina.teran@constellium.com
(Name, telephone, e-mail and/or facsimile number and address of company contact person)
__________________________________________________________________________
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each classTrading SymbolName of each exchange on which registered
Ordinary SharesCSTMNew York Stock Exchange
Securities registered or to be registered pursuant to Section 12(g) of the Act:
None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
None
_____________________________
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report:
144,301,592 Ordinary Shares, Nominal Value €0.02 per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   x  Yes ☐  No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.     ☐  Yes     x  No
Note—Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ☐  No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
x   Yes     ☐   No



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer”, "accelerated filer", and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  x            Accelerated filer  ☐            Non-accelerated filer  ☐            Emerging growth company  
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
U.S. GAAP   ☐International Financial Reporting StandardsOther   ☐
as issued by the International Accounting Standards Board   x
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:    Item 17  ☐        Item 18  ☐
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   ☐   Yes   x   No
PCAOB ID:Auditor Name:Auditor Location:
1347PricewaterhouseCoopers AuditNeuilly-sur-Seine, France



TABLE OF CONTENTS
Page
Item 12. Description of Securities Other than Equity Securities
F-1

-i-


SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS
This annual report on Form 20-F (this “Annual Report”) of Constellium SE (“Constellium SE” or “the Company”, and when referred to together with its subsidiaries, "the Group" or "Constellium") contains “forward-looking statements” with respect to our business, results of operations and financial condition, and our expectations or beliefs concerning future events and conditions. You can identify certain forward-looking statements because they contain words such as, but not limited to, “believes,” “expects,” “may,” “should,” “approximately,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “likely,” “will,” “would,” “could” and similar expressions (or the negative of these terminologies or expressions). All forward-looking statements involve risks and uncertainties. Many risks and uncertainties are inherent in our industry and markets. Others are more specific to our business and operations. The occurrence of the events described and the achievement of the expected results depend on many events, some or all of which are not predictable or within our control. Actual results may differ materially from the forward-looking statements contained in this Annual Report.
Important factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements are disclosed under “Item 3. Key Information—D. Risk Factors” and elsewhere in this Annual Report, including, without limitation, in conjunction with the forward-looking statements included in this Annual Report. All forward-looking statements in this Annual Report and subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. Some of the factors that we believe could materially affect our results include:
We may not be able to compete successfully in the highly competitive markets in which we operate, and new competitors could emerge, which could negatively impact our share of industry sales, sales volumes and selling prices.
Aluminium may become less competitive with alternative materials, which could reduce our sales volumes, or lower our selling prices.
A significant portion of our revenue is derived from international operations, which exposes us to certain risks inherent in doing business globally.
The price volatility of energy costs may adversely affect our profitability.
If we are unable to substantially pass through to our customers the cost of price increases of our raw materials, which may be subject to volatility, our profitability could be adversely affected.
Widespread public health pandemics, including COVID-19, or any major disruption, could have a material and adverse effect on our business, financial condition and results of operations.
The cyclical and seasonal nature of the metals industry, our end-use markets and our customers’ industries could adversely affect our financial condition and results of operations.
We may be unable to execute and timely complete our expected capital investments, or may be unable to achieve the anticipated benefits of such investments.
We may be affected by global climate change or by legal, regulatory, or market responses to such change, and our efforts to meet ESG targets or standards or to enhance the sustainability of our businesses may not meet the expectations of our stakeholders or regulators.
Disruptions or failures in our IT systems, or failure to protect our IT systems against cyber-attacks or information security breaches, could have a material adverse effect on our business and financial results.
Our failure to meet customer manufacturing and quality requirements, standards and demand, or changing market conditions could have a material adverse impact on our business, reputation and financial results.
We are dependent on a limited number of customers for a substantial portion of our sales and a failure to successfully renew or renegotiate our agreements with such customers may adversely affect our results of operations, financial condition and cash flows.
We are dependent on a limited number of suppliers for a substantial portion of our aluminium supply and a failure to successfully renew or renegotiate our agreements with our suppliers, or supply interruptions, may adversely affect our results of operations, financial condition and cash flows.
The loss of certain members of our senior management team or other key employees may have a material adverse effect on our operating results.
Our level of indebtedness could limit cash flow available for our operations and capital expenditures and could adversely affect our net income, our ability to service our debt or obtain additional financing, and our business relationships.
We are a foreign private issuer under the U.S. securities laws and within the meaning of the New York Stock Exchange (“NYSE”) rules. As a result, we qualify for and rely on exemptions from certain corporate governance requirements and may rely on other exemptions available to us in the future.
-ii-


Any inability of the Company to continue to benefit from French provisions applicable to registered intermediaries (“intermédiaires inscrits”) could adversely affect the rights of shareholders.
The other factors presented under “Item 3. Key Information-D. Risk Factors.”
We caution you that the foregoing list may not contain all of the factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this Annual Report may not in fact occur. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by law.

-iii-


PART I
Item 1. Identity of Directors, Senior Management and Advisers
Not applicable.
Item 2. Offer Statistics and Expected Timetable
Not applicable.
Item 3. Key Information
A.Selected Financial Data
Reserved.
B.Capitalization and Indebtedness
Not applicable.
C.Reasons for the Offer and Use of Proceeds
Not applicable.
D.
Risk Factors
You should carefully consider the risks and uncertainties described below and the other information in this Annual Report. Our business, financial condition or results of operations could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our outstanding securities could decline. This Annual Report also contains forward-looking statements that involve risks and uncertainties. See “Special Note About Forward-Looking Statements.” Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain factors.
BUSINESS AND OPERATIONAL RISKS
We may not be able to compete successfully in the highly competitive markets in which we operate, and new competitors could emerge, which could negatively impact our market share, sales volumes and selling prices.
We are engaged in a highly competitive industry and compete in the production and sale of rolled and extruded aluminium products with a number of other producers, some of which are larger and have greater financial and technical resources than we do. As a result, these competitors may have an advantage over us in their abilities to research and develop technology, pursue acquisitions, investments and other business opportunities, market and sell their products and services, capitalize on market opportunities, enter new markets and withstand business interruptions, pricing reductions, or adverse industry or economic conditions. In addition, producers with a lower cost basis may, in certain circumstances, have a competitive advantage. Further, a current or new competitor may add or build new capacity, which could increase competitive pressure in our markets. New competitors could emerge within aluminium, steel or other materials, that may seek to compete in our industry. Emerging or transitioning markets in regions with abundant natural resources, low-cost labor and energy, and lower environmental and other standards may pose a significant competitive threat to our business. Moreover, technological innovation is important to our customers who require us to lead or keep pace with new innovations to address their needs. If we do not compete successfully, our market share, sales volumes and financial position may be negatively impacted.
Aluminium may become less competitive with alternative materials, which could reduce our sales volumes, or lower our selling prices.
Our offerings compete with products made from other materials, such as steel, glass, plastics and composite materials, for various applications. Higher aluminium prices relative to alternative materials tend to make aluminium products less competitive. Environmental and other regulations may also make our products less competitive as compared to materials that
-1-


are subject to fewer regulations. Customers in our end-markets use and continue to evaluate the further use of alternative materials to aluminium in order to reduce the weight and increase the efficiency of their products. The willingness of customers to accept substitutions for aluminium, or the ability of large customers to exert leverage in the market to reduce the pricing for our aluminium products, could materially adversely affect our financial position, results of operations and cash flows.
A significant portion of our revenue is derived from international operations, which exposes us to certain risks inherent in doing business globally.
We are a global company with our head office in Paris, France, with operations in France, the United States, Germany, Switzerland, the Czech Republic, Slovakia, China, Spain, Canada and Mexico, and we sell our products primarily across Europe, North America and Asia. Economic downturns in regional and global economies, or a prolonged recession in our principal industry segments, have had a negative impact on our operations in the past by reducing overall demand of our products, and could have a negative impact on our future financial condition or results of operations. Similarly, geopolitical conditions including wars, such as the Russian war on Ukraine, terrorist acts and tensions between states can affect the normal and peaceful course of international relations, and can have an adverse impact on the economy and our financial condition.
We generally are subject to financial, political, economic, regulatory and business risks in connection with our global operations, including:
changes in international governmental regulations, trade restrictions and laws, including those relating to taxes, employment and repatriation of earnings;
compliance with sanction regimes and export control laws of multiple jurisdictions;
currency restrictions, currency exchange rate and interest rate fluctuations;
the potential for nationalization of enterprises or government policies favoring local production;
renegotiation or nullification of existing agreements;
high rates of, excessive, or sustained inflation;
differing protections for intellectual property and their enforcement;
divergent environmental laws and regulations;
significant supply/demand imbalances impacting our industry;
public health crises, epidemics and pandemics, such as COVID-19;
uncertain social, political, regulatory, or trade conditions (e.g. U.K. Brexit; U.S. duties, tariffs, sanctions and trade negotiations) and potential retaliatory measures by any negatively impacted countries;
international conflict, terrorist attacks, armed conflict and wars; and
sustained economic downturns regionally and globally.
The occurrence of any of these events could cause our costs to rise, limit growth opportunities, have a negative effect on our operations and financial results, as well as on our ability to plan for future periods. Similarly, if any of our customers or suppliers are similarly impacted, we could be indirectly impacted and our operations and financial results could be adversely affected. In addition, any of the above events may be heightened due to the ongoing Russian war on Ukraine and resulting armed and international conflict. The duration and consequences of such conflict and war are uncertain and unpredictable, and we may not be able to adequately foresee events that could disrupt, and have a negative impact on our operations. Moreover, the continuation of this armed conflict is likely to contribute to further instability in the global economy, financial markets and supply chains.
The price volatility of energy costs may adversely affect our profitability.
Our operations use natural gas and electricity, which represent the fourth largest component of our cost of sales, after metal, labor costs, and depreciation. We typically purchase the majority of our natural gas and electricity requirements on a forward basis under fixed price commitments or long-term contracts with suppliers which provides increased visibility on costs. However, the volatility in costs of fuel, principally natural gas, and other utility services used by our manufacturing facilities affects operating costs. Fuel and utility prices are affected by factors outside our control, such as supply and demand in both local and regional markets as well as governmental regulation, imposition of taxes on energy and costs associated with CO2 emissions, which costs could be significantly impacted during times of economic and political instability. The price exposure of our energy requirements has been negatively impacted since late 2021 when the energy crisis in Europe began, has been further affected by the Russian war on Ukraine and related reductions in natural gas flows from Russia to Europe, and is expected to continue in the future. As a significant purchaser of energy, existing and future regulations relating to the emissions by our
-2-


energy suppliers could result in materially increased energy costs for our operations, which we may be unable to pass-through to our customers. Although we have secured a good part of our natural gas and electricity supply under fixed price commitments or annual or multi-year contracts with suppliers, future increases in fuel and utility prices, or disruptions in energy supply, as we have experienced, may have an adverse effect on our financial position, results of operations and cash flows.
If we are unable to substantially pass through to our customers the cost of price increases of our raw materials, which may be subject to volatility, our profitability could be adversely affected.
Prices for the raw materials we require are subject to continuous volatility and may increase from time to time, as we are currently experiencing. The overall price of primary aluminium consists of several components: (1) the underlying base metal component, which is typically based on quoted prices from the London Metal Exchange (“LME”); (2) the regional premium, which represents an incremental price over the base LME component that is associated with the physical delivery of metal to a particular region (e.g., the Midwest premium for metal sold in the United States or the Rotterdam premium for metal sold in Europe); and (3) the product premium, which represents a separate incremental price for receiving physical metal in a particular shape (e.g., billet, slab, rod, etc.), alloy, or purity. Each of these three components has its own drivers of variability. The LME price is typically driven by macroeconomic factors, including the global supply and demand of aluminium. Regional premiums tend to vary based on the supply and demand for metal in a particular region, changes in tariffs and associated warehousing and transportation costs. Product premiums generally are a function of supply and demand as well as production and raw material costs for a given primary aluminium shape and alloy combination in a particular region. Raw materials used in our products include alloying elements, such as magnesium, manganese, silicon, zinc or copper. Prices for these alloying elements are subject to constant volatility and, as we continued to experience in 2022, may increase significantly from time to time.
Sustained high raw material prices, increases in raw material prices, the inability to meaningfully hedge our exposure to such prices, or the inability to pass-through any fluctuation in regional premiums, product premiums or other raw material costs to our customers, could have a material adverse effect on our business, financial condition, and results of operations and cash flow. In addition, although our sales are generally made on a “margin over metal (aluminium) price” basis, if aluminium prices increase, we may not be able to pass on the entire increase to our customers. There could also be a time lag between when changes in metal prices under our purchase contracts are effective and the point when we can implement corresponding changes under our sales contracts with our customers. As a result, we may be exposed to the effects of fluctuations in raw material prices, including aluminium, due to time lag. Further, although most of our contracts allow us to substantially pass-through aluminium prices to our customers, we have certain contracts that are based on fixed pricing, where pass-through is not available. Similarly, in certain contracts we may have ineffective pass through mechanisms related to regional premium fluctuation and fluctuations in raw material cost, such as alloying elements. We attempt to mitigate these risks through hedging and by improving the pass-through mechanisms, but we may not be able to successfully reduce or eliminate all of the resulting impact, including higher operating costs, which could have a material adverse effect on our financial results and cash flows.
Widespread public health pandemics, including COVID-19, or any major disruption, could have a material and adverse effect on our business, financial condition and results of operations.
Any public health pandemic and other disease outbreak in countries where we, our customers or our suppliers operate could have a material and adverse effect on our business, financial conditions and results of operations. COVID-19 affected our operations globally. As a result of this pandemic and resulting disruptions in production and operations at both our facilities and those of our customers, our sales and operating margins were negatively affected, which adversely impacted our revenues and operating margins. In response to the COVID-19 pandemic and remaining impact, we adjusted operating levels at our manufacturing sites, including implementing temporary workforce reductions and other cost cutting measures, to match the demand from our customers. Our operating results and financial condition may also be materially adversely affected by laws, regulations, orders or other governmental or regulatory actions addressing the COVID-19 pandemic, or any future outbreaks or resurgence, that place restrictions on, or require us to make changes to, our operations.
With respect to our suppliers, disruptions resulting from the COVID-19 pandemic resulted in cancellations or delays and increased transport times for delivery of materials to our facilities, which affected our ability to timely manufacture and ship our products to customers. If such difficulties were to resurface and continue, we may need to seek alternate suppliers, which may be more expensive, may not be available or may result in delays in shipments to us and subsequently to our customers. Alternatively, suppliers may require that we take metal in excess of our needs based on our reduced operating rates, which could negatively affect our financial position. Decreases in our operating levels may also have implications for our hedging strategy which could adversely impact our financial results.
The nature and extent of COVID-19’s continuing impact on the global economy, our business, financial condition and results of operations is beyond our control, and depends on various uncertain factors, including the duration and severity of
-3-


continued outbreaks, the possibility of new outbreaks, vaccination levels, the success of vaccines, other preventative measures or treatments, and the actions to contain or treat its impact, including any quarantine orders, business restrictions and closures and other similar restrictions and limitations. The foregoing and other continued disruptions to our business as a result of the COVID-19 pandemic, as well as any global recession resulting from the impact of COVID-19, could materially adversely affect our business, financial condition and results of operations. In addition, if there are gaps in our management systems designed to effectively respond to the COVID-19 pandemic, or any major disruptions such as future pandemics or other business and operational interruptions, including those relating to natural disasters, severe weather conditions, supply or logistics disruptions and shortages, excessive inflation, increasing costs for energy, temporary plant and/or power outages, information technology systems and network disruptions and cyber-security breaches, terrorist attacks, armed conflict, war, fires, floods or other catastrophic events, our operations or those of our customers and suppliers, and our financial performance could be adversely impacted.
The cyclical and seasonal nature of the metals industry, our end-use markets and our customers’ industries could adversely affect our financial condition and results of operations.
Our end markets are cyclical and tend to directly correlate with changes in general and local economic conditions. These conditions include the level of economic growth, affordable energy sources, employment levels, the availability of financing, interest rates, consumer confidence and housing demand. We are particularly sensitive to cyclicality in the aerospace, automotive, defense, industrial and transportation end-markets. During recessions or periods of low growth, these industries typically experience major cutbacks in production, resulting in decreased demand for aluminium products. This leads to significant fluctuations in demand and pricing for our products and services. Because our operations are capital intensive and we generally have high fixed costs and may not be able to reduce costs and production capacity on a sufficiently rapid basis, our near-term profitability may be significantly affected by decreased processing volumes. Customer demand is also affected by holiday seasons, seasonal slowdowns, weather conditions, economic downturns and other factors beyond our control. Accordingly, cyclical fluctuations and seasonality, reduced demand and pricing pressures may significantly reduce our profitability and materially adversely affect our financial condition, results of operations and cash flows.
We may be unable to execute and timely complete our expected capital investments, or may be unable to achieve the anticipated benefits of such investments.
Our operations are capital intensive. We may not generate sufficient operating cash flows and our external financing sources may not be available in sufficient amounts to enable us to make anticipated capital expenditures, or to complete them on a timely basis. If we are unable to, or determine not to, complete our expected investments, or such investments are delayed, we will not realize the anticipated benefits of such investments. In addition, if we are unable to make investments for upgrades and repairs or purchase new plants and equipment, our financial condition and results of operations could be materially adversely affected by higher maintenance costs, lower sales volumes due to the impact of reduced product quality, operational disruptions, reduced production capacity, and other competitive factors. Customer demand for our products produced on new investments may be slow to materialize, and new equipment may not perform to our expectations. These factors could adversely affect our results of operations.
 We may fail to implement or execute our business strategy, successfully develop and implement new technology initiatives and other strategic investments.
Our future financial performance and success depend in large part on our ability to successfully implement and execute our business strategy, including investing in high-return opportunities in our core markets, focusing on higher-margin, technologically advanced products, differentiating our products, expanding our strategic relationships with customers, containing our costs, and executing on our manufacturing productivity improvement programs. Any inability to execute on our strategy could reduce our expected earnings and could adversely affect our operations overall.
In addition, being at the forefront of technological development is important to remain competitive. We have invested in, and are involved with, a number of technology and process initiatives. Several technical aspects of certain of these initiatives are still unproven and the eventual commercial outcomes and feasibility cannot be assessed with any certainty. Even if we are successful with these initiatives, we may not be able to bring them to market as planned before our competitors or at all, and the initiatives may end up costing more than expected. As a result, the costs and benefits from our investments in new technologies and the impact on our financial results may vary from present expectations. Further, we have undertaken and may continue to undertake strategic growth, streamlining and productivity initiatives and investments to improve performance. We cannot assure you that these initiatives will be completed or that they will have their intended benefits. Capital investments in debottlenecking or other organic growth initiatives may not produce the returns we anticipate.
-4-


We may be affected by global climate change or by legal, regulatory, or market responses to such change, and our efforts to meet ESG targets or standards or to enhance the sustainability of our businesses may not meet the expectations of our stakeholders or regulators.
Climate change has become a focus globally and has led to new and proposed legislative and regulatory initiatives. New or revised laws and regulations in this area could directly and indirectly affect us, our customers and suppliers, including by increasing the costs of production or impacting demand for certain products, which could result in an adverse effect on our financial condition, results of operations and cash flows. Compliance with any new or more stringent laws or regulations or stricter interpretations of existing laws, could require additional expenditures by us or our customers or suppliers. We rely on natural gas, electricity, fuel oil and transport fuel to operate our facilities. We are also subject to environmental reviews, investigations and remediation by relevant governmental authorities from time to time. Any scrutiny or increased costs of these energy sources in response to new laws and regulatory requirements could be passed through to us, our customers and suppliers, which could also have a negative impact on our financial condition and profitability.
In addition, some of our shareholders, investors, customers, or those considering such a relationship with us, may evaluate our business or other practices according to a variety of environmental, social, and governance (“ESG”) targets and standards and expectations. Further, we define our own corporate purpose, in part, by the sustainability of our practices and our impact on all our stakeholders. As a result, our efforts to conduct our business in accordance with some or all these expectations may involve trade-offs, and may not satisfy all stakeholders. Our policies and processes to evaluate and manage ESG targets and standards in coordination with other business priorities may not prove completely effective. As a result, we may face adverse regulatory, investor, media, or public scrutiny that may adversely affect our business, our results of operations, or our financial condition.
Disruptions or failures in our IT systems, or failure to protect our IT systems against cyber-attacks or information security breaches, could have a material adverse effect on our business and financial results.
We rely on our IT systems to effectively manage and operate our business, including such processes as data collection, accounting, financial reporting, communications, supply chain, order entry and fulfillment, other business processes, and in operating our equipment. The failure of our IT systems to perform efficiently could disrupt our business and could result in transaction errors, processing inefficiencies, limited equipment utilization, and the loss of sales and customers, causing our business and financial results to suffer. A failure in, or breach of, our IT systems as a result of cyber-attacks or information security breaches could disrupt our business, result in the disclosure or misuse of confidential or proprietary information, damage our reputation, increase our costs or cause losses. As cyber threats continue to evolve, we are expending additional resources to continue to enhance our information security measures and be able to investigate and promptly remediate any information security vulnerabilities. Information security risks have grown in recent years because of the proliferation of new technologies and the sophistication and high level of activity of perpetrators of cyber-attacks, particularly during periods of domestic and international conflict. Moreover, with increased remote working since the start of the COVID-19 pandemic, we have greater dependency on remote equipment and connectivity infrastructure to access critical business systems that may be subject to failure, disruption or unavailability, and increases our exposure to security breaches. Any of these events could negatively impact our operations. We did not have any significant security incidents or intrusions in 2022 that adversely impacted our systems or business.
We continuously evaluate our IT systems and security processes, including conducting third party security assessments. We continue to make investments and adopt measures designed to enhance our protection, detection, response, and recovery capabilities, and to mitigate potential risks to our technology, products, services and operations from potential cyber-attacks. However, given the unpredictability, nature and scope of cyber-attacks, it is possible that potential vulnerabilities could go undetected for an extended period. We, and our suppliers, could potentially be subject to operational disruption to our respective information systems, which could cause production downtime, operational delays or outages, other adverse impacts on our operations or ability to provide products and services to our customers, the compromise of confidential or otherwise protected information, misappropriation, destruction or corruption of data (including customer and order data), security breaches, other manipulation or improper use of our or third-party systems, networks or products. We are also facing supply chain issues with IT equipment due to the global chip shortage and general logistics issues which started with COVID-19. We are well stocked with backup and spare equipment, but there is increased risk that in the event of a critical network switch break down as an example, we may not have adequate or timely replacements. Any of the aforementioned events could lead to financial losses from remedial actions, loss of business or potential liability, and/or damage our reputation, which could have a material adverse effect on our competitive position, results of operations, cash flows or financial condition.
-5-


Our failure to meet customer manufacturing and quality requirements, standards and demand, or changing market conditions could have a material adverse impact on our business, reputation and financial results.
Product manufacturing in our business is a highly complex process. Our customers specify quality, performance and reliability standards that we must meet. If our products do not meet these standards or are defective, we may be required to replace or rework the products. We have experienced product quality, performance or reliability problems and defects from time to time and similar defects or failures may occur in the future.
Some additional factors that could adversely impact our ability to meet our customer requirements and demand, or changing market conditions include:
making substantial capital investments to repair, maintain, upgrade, and expand our facilities and equipment. Notwithstanding our ongoing plans and investments to increase our capacity, we may not be able to expand our production capacity quickly enough to meet our customer requirements;
unplanned business interruptions caused by events such as explosions, fires, inclement weather, natural disasters, pandemics, economic and political instability and unrest, wars, accidents, equipment failure and breakdown, IT systems and process failures, electrical blackouts or outages, transportation and, global and regional supply interruptions. Any such disruption at one or more of our manufacturing facilities could cause substantial losses or delays in our production capacity, increase our operating costs and have a negative financial impact on the Company and our customers. Business and operational interruptions may also harm our reputation among actual and potential customers, and the reputation of our customers;
qualification of our products by our customers which can be lengthy and unpredictable as many of these customers have extensive sourcing and qualification processes, and require substantial time and financial resources, with no certainty of success or recovery of our related expenses and investments. Failure to qualify or re-qualify our products may result in us losing such customers or customer contracts; and
implementing manufacturing processes in new locations, or for new equipment or newly introduced products, may experience difficulties, including operational and manufacturing disruptions, delays or other complications, which could adversely affect our ability to timely launch or ramp-up productions and serve our customers.
If these or any other similar manufacturing or quality failures occur, they could result in losses or product recalls, customer penalties, contract cancellation and product liability exposure. Further, they could adversely affect product demand, result in negative publicity, damage our reputation and could lead to loss of customer confidence in our products, which could have a material adverse impact on our business, financial position and results of operations.
We are dependent on a limited number of customers for a substantial portion of our sales and a failure to successfully renew or renegotiate our agreements with such customers may adversely affect our results of operations, financial condition and cash flows.
Our business is exposed to customer concentration risk. A significant downturn in the business, credit or financial condition of our largest customers could expose us to the risk of default on contractual agreements.
Some of our customer contracts and related arrangements are subject to renewal, renegotiation or re-pricing at periodic intervals or upon changes in competitive and regulatory supply conditions, provide termination rights to our customers, or may have provisions that may become less favorable to us over time. If we fail to successfully renew or renegotiate these contracts or arrangements, negotiate improved terms, or if we are not successful in replacing business lost from such customers, then our results of operations, financial condition and cash flows could be materially adversely affected. Similarly, any material deterioration in, or termination of, these customer relationships could result in a reduction or loss in sales volume or revenue which could materially adversely affect our results of operations, financial condition and cash flows.
Relatedly, we have dedicated facilities serving certain of our customers which subjects us to the inherent risk of increased dependence on such customers with respect to these facilities. In such cases, the loss of such a customer, or the reduction of that customer’s business at these facilities, or the deterioration of such customer’s credit or financial condition, could materially adversely affect our financial condition and results of operations, and we may be unable to timely replace, or replace at all, lost order volumes and revenue.
Customers in our end-markets, including the packaging, automotive, and aerospace sectors, may consolidate and grow in a manner that could affect their relationships with us. For example, if our customers become larger and more concentrated, they could exert financial pressure on all suppliers, including us. Accordingly, our ability to maintain or raise prices in the future may be limited, including during periods of raw material and other cost increases. If we are forced to reduce prices or maintain
-6-


prices or reduce volumes of production during periods of increased costs, or if we lose customers because of consolidation, pricing or other methods of competition, our financial position, results of operations and cash flows may be adversely affected. If as a result of consolidation in our industry, our competitors are able to exert financial pressure on suppliers, obtain more favorable terms or otherwise take actions that could increase their competitive strengths, our competitive position may be materially adversely affected.
We are dependent on a limited number of suppliers for a substantial portion of our aluminium supply and a failure to successfully renew or renegotiate our agreements with our suppliers, or supply interruptions, may adversely affect our results of operations, financial condition and cash flows.
Our ability to produce competitively priced aluminium products depends on our ability to procure competitively priced aluminium in a timely manner and in sufficient quantities to meet our production needs. We have supply arrangements with a limited number of suppliers for aluminium. Increasing aluminium demand levels and reduced availability have caused regional supply constraints in the industry, and further increases in demand and capacity limitations could exacerbate these issues, particularly during periods of economic and political instability. We maintain annual and multi-year contracts for a majority of our supply requirements and depend on annual and spot purchases for the remainder of such requirements. There can be no assurance that we will be able to renew, or obtain replacements for such contracts when they expire on favorable terms, or at all. Additionally, if any of our key suppliers is unable to deliver sufficient quantities on a timely basis, our production may be disrupted, and we could be forced to purchase primary metal or other raw materials from alternative sources, which may not be available in sufficient quantities or may only be available on terms that are less favorable to us, and could also impact our overall sustainability targets. An interruption in key supplies required for our operations could have a material adverse effect on our ability to produce and deliver products on a timely or cost-efficient basis and therefore on our financial condition, results of operations and cash flows. Moreover, a significant downturn in the business or financial condition of our significant suppliers exposes us to the risk of default by the supplier on our contractual agreements.
We depend on aluminium scrap for our operations and acquire our scrap inventory from numerous sources. Our suppliers generally are not bound by long-term contracts and have no obligation to sell aluminium scrap to us. As an example, a decrease in the supply of used beverage containers (UBCs) could negatively impact our supply of aluminium. In addition, when using recycled material, we benefit from the difference between the price of primary aluminium and aluminium scrap. Consequently, if this difference narrows for a considerable period of time or if an adequate supply of aluminium scrap is not available to us, we would be unable to recycle metals at desired volumes and our results of operations, financial condition and cash flows could be materially adversely affected.
In addition, we depend on certain alloying elements for our operations and the production of such alloying elements is highly concentrated in certain countries. The suppliers of alloying elements are not bound by long-term contracts and have no obligation to sell products to us. The availability and price exposure of alloying elements has been negatively impacted since late 2020 and this could continue in the future. This is also driven by government policy changes in countries like China, for example, where these alloying elements are produced. Consequently, if prices increase for a considerable period of time or if an adequate supply of alloying elements is not available to us, we would be unable to produce aluminium at desired volumes and our results of operations, financial condition and cash flows could be materially adversely affected.
We may be exposed to fraud, misconduct, corruption or other illegal activity which could harm our reputation and our financial results.
We may be exposed to fraud, misconduct, corruption or other illegal activity by our employees, independent contractors, consultants, commercial partners, and vendors. Despite the internal controls and the policies and procedures we have developed and implemented to ensure strict compliance with anti-bribery, anti-money laundering, anti-corruption and other laws, violations or misconduct by these parties could include intentional, reckless and negligent conduct, which can be difficult to detect and such policies and procedures may not be effective in all instances to prevent these actions. In addition, regulators and enforcement agencies continue to devote greater resources to the enforcement of the Foreign Corrupt Practices Act, Loi Sapin II, and other anti-money laundering laws and anti-corruption laws.
Any determination of fraud or violation of laws in any jurisdictions in which we do business, could subject us to, among other things, civil and criminal penalties, material fines, profit disgorgement, injunctions, securities litigation and reputational damage, any of which could adversely affect our business, financial position or results of operations.
-7-


The loss of certain members of our senior management team or other key employees may have a material adverse effect on our operating results.
Our success depends, in part, on the efforts of our senior management and other key employees. These individuals, including our Chief Executive Officer and Chief Financial Officer, possess sales, marketing, engineering, technical, manufacturing, financial and administrative skills that are critical to the operation of our business. If we lose or suffer an extended interruption in the services of one or more of our senior officers or other key employees, or the cost of labor significantly increases, our ability to operate and expand our business, improve our operations, develop new products, and, as a result, our financial condition and results of operations, may be adversely affected. Moreover, the hiring of qualified individuals is highly competitive in our industry, which is exacerbated by continuing labor shortages, and we may not be able to attract and retain qualified personnel to replace or succeed members of our senior management or other key employees. Further, the failure to retain or provide adequate succession plans for key personnel could adversely affect our operations and competitiveness.
We could experience labor disputes and work stoppages, or be unable to renegotiate collective bargaining agreements, which could disrupt our business and have a negative impact on our financial condition and results of operations.
A significant number of our employees are represented by unions or equivalent bodies or are covered by collective bargaining or similar agreements that are subject to periodic renegotiation. Although we believe that we will be able to successfully negotiate new collective bargaining agreements when the current agreements expire, these negotiations may not prove successful, and may result in a significant increase in the cost of labor, or may break down and result in the disruption or cessation of our operations. In addition, from time to time, we may experience labor disputes and work stoppages at our facilities generally, and at times in connection with collective bargaining agreement negotiations. Reasons for stoppages include disapproval of governmental measures, solidarity with a dismissed employee, wage claims, protests against working conditions and/or strikes. These disruptions can have a duration ranging from hours to weeks. Existing collective bargaining agreements may not prevent a strike or work stoppage at our facilities. Any such stoppages or disturbances may adversely affect our financial condition and results of operations by limiting plant production, sales volumes, profitability and operating costs.
We could be required to make unexpected contributions to our defined benefit pension plans as a result of adverse changes in interest rates and the capital markets.
We have substantial pension and other post-employment benefit obligations. Most of our pension obligations relate to defined benefit pension plans for our employees in the United States, Switzerland, France and Germany, and lump sum indemnities payable to our employees in France and Germany upon retirement or termination. Our estimates of liabilities and expenses for pensions and other post-retirement benefits incorporate a number of assumptions, including interest rates used to discount future benefits. Our liquidity or shareholders’ equity in a particular period could be materially adversely affected by capital market returns that are less than their assumed long-term rate of return or a decline in the rate used to discount future benefits. Our pension plan assets consist primarily of funds invested in diversified portfolios. If the assets of our pension plans do not achieve assumed investment returns for any period, such deficiency could result in one or more charges against shareholders’ equity for that period. In addition, changing economic conditions, poor pension investment returns or other factors may require us to make unexpected cash contributions to the pension plans in the future, preventing the use of such cash for other purposes.
In addition, one of our facilities in the United States participates in various “multi-employer” pension plans administered by labor unions representing some of our employees. In the ordinary course of our renegotiation of collective bargaining agreements with labor unions that maintain these plans, we could decide to discontinue participation in a plan, and potentially be faced with significant withdrawal liability. Further, if any of the other plan sponsors were to fail to meet their obligations, we could be exposed to increased liability. Any of these potential increased liabilities could have an adverse effect on our results of operations or financial condition.

-8-


FINANCIAL RISKS
Our level of indebtedness could limit cash flow available for our operations and capital expenditures and could adversely affect our net income, our ability to service our debt or obtain additional financing, and our business relationships.
We have a significant amount of indebtedness. To service such debt, we require a significant amount of cash. We believe that the cash provided by our operations will be sufficient to provide for our cash requirements for the foreseeable future. However, our ability to satisfy our obligations depends on our future operating performance and financial results, which are subject, in part, to factors beyond our control, including interest rates and general economic, financial and business conditions. We cannot assure you that our business will generate sufficient cash flow from operations or that future borrowings will be available to us in an amount sufficient to enable us to pay our indebtedness or to fund our other liquidity needs.
In addition, our level of indebtedness could adversely affect our operations by:
reducing the availability of our cash flow to fund working capital, capital expenditures, research and development efforts and other general corporate purposes;
adversely affect the terms under which suppliers provide goods and services to us;
limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we compete, including limiting our ability to make strategic acquisitions; and
place us at a competitive disadvantage compared to our competitors that have less debt.
If we are unable to meet our debt service obligations and pay our expenses, we may be forced to reduce or delay business activities and capital expenditures, sell assets, obtain additional debt or equity capital, restructure or refinance all or a portion of our debt before maturity or take other measures. Such measures may materially adversely affect our business. If these alternative measures are unsuccessful, we could default on our obligations, which could result in the acceleration of our outstanding debt obligations and could have a material adverse effect on our business, results of operations and financial condition.
A failure to comply with our debt covenants could result in an event of default. If we default under our indebtedness, we may not be able to borrow additional amounts, and our lenders could elect to declare all outstanding borrowings, plus accrued and unpaid interest and fees, to be due and payable, or take other remedial actions. Our indebtedness also contains cross-default provisions, which means that if an event of default occurs under certain material indebtedness, such event of default could trigger an event of default under our other indebtedness. If our debt payments were to be accelerated, we cannot assure you that our assets would be sufficient to repay such debt in full and our lenders could consequently foreclose on our pledged assets.
In addition, a deterioration in our financial position or a downgrade of our credit ratings could adversely affect our financing levels, limit access to the capital or credit markets or our liquidity facilities, or otherwise adversely affect the availability of other new financing on favorable terms or at all, result in more restrictive covenants in agreements governing the terms of any future indebtedness that we incur, increase our borrowing costs, or otherwise impair our business, financial condition and results of operations. Such deterioration or downgrade of our credit ratings could also have an adverse effect on our business relationships with customers, suppliers and hedging counterparties.
 Our results of operations, cash flows and liquidity could be adversely affected if we are unable to execute on our hedging policy, if counterparties to our derivative instruments fail to honor their agreements or if we are unable to enter into certain derivative instruments.
We purchase and sell forwards, futures and, from time to time, options contracts as part of our efforts to reduce our exposure to changes in currency exchange rates, aluminium prices and other raw materials and energy prices. If we are unable to enter into such derivative instruments to manage those risks due to the cost or availability of such instruments or other factors, or if we are not successful in passing through the costs of our risk management activities, our results of operations, cash flows and liquidity could be adversely affected. Our ability to realize the benefit of our hedging program is dependent upon many factors, including factors that are beyond our control. For example, our foreign exchange hedges are scheduled to mature on the expected payment date by the customer; therefore, if the customer fails to pay an invoice on time and does not warn us in advance, we may be unable to reschedule the maturity date of the foreign exchange hedge, which could result in an outflow of foreign currency that will not be offset until the customer makes the payment. We may realize a gain or a loss in unwinding such hedges. In addition, our metal-price hedging program depends on our ability to match our monthly exposure to sold and purchased metal, which can be made difficult by seasonal variations in metal demand, unplanned changes in metal delivery
-9-


dates by either us, our suppliers, or by our customers and other disruptions to our inventories. We may also be exposed to losses if the counterparties to our derivative instruments fail to honor their agreements.
With the exception of hedges on certain long-term aerospace contracts, we do not apply hedge accounting to our forwards, futures or option contracts. Unrealized gains and losses on our derivative financial instruments that do not qualify for hedge accounting are reported in our consolidated results of operations, or in the case of hedges relating to our indebtedness, in Finance cost - net. The inclusion of such unrealized gains and losses in earnings may produce significant period-over-period earnings volatility that is not necessarily reflective of our underlying operating performance. In addition, in certain scenarios when market price movements result in a decline in value of our current derivatives position, our mark-to-market expense may exceed our credit line and counterparties may request the posting of cash collateral which, in turn, can be a significant demand on our liquidity.
At certain times, hedging instruments may simply be unavailable or not available on terms acceptable to us. In addition, current legislation increases the regulatory oversight of over-the-counter derivatives markets and derivative transactions. The companies and transactions that are subject to these regulations may change. If future regulations subject us to additional capital or margin requirements or other restrictions on our trading and commodity positions, this could have an adverse effect on our financial condition and results of operations.
Changes in income tax rates or income tax laws, additional income tax liabilities due to unfavorable resolution of tax audits, and challenges to our tax position could have a material adverse impact on our financial results.
We operate in multiple tax jurisdictions and believe that we file our tax returns in compliance with the tax laws and regulations of these jurisdictions. Various factors determine our effective tax rate and/or the amount we are required to pay, including changes in or interpretations of tax laws and regulations in any given jurisdiction or global- and EU-based initiatives. Some such tax laws and regulations aim, among other things, to address tax avoidance by multinational companies, changes in geographical allocation of income and expense, the ability to use net operating loss and other tax attributes, and the evaluation of deferred tax assets that requires significant judgment. Any resulting changes to our effective tax rate could materially adversely affect our financial position, liquidity, results of operations and cash flows.
In addition, due to the size and nature of our business, we are subject to ongoing reviews by tax authorities on various tax matters, including challenges to positions we assert on our income tax and withholding tax returns. We accrue income tax liabilities and tax contingencies based upon our best estimate of the taxes ultimately expected to be paid after considering our knowledge of all relevant facts and circumstances, existing tax laws and regulations and how the tax authorities and courts view certain issues. Such amounts are included in income taxes payable or deferred income tax liabilities, as appropriate, and updated over time. Any material adverse review could impact our financial position and results of operations.

LEGAL, GOVERNANCE AND COMPLIANCE RISKS
Significant legal proceedings and investigations, proprietary claims, regulatory and compliance costs, including on environmental matters, could increase our operating costs and adversely affect our financial condition and results of operations.
We may from time-to-time be involved in, or be the subject of, disputes, proceedings and investigations with respect to a variety of matters, including matters related to personal injury, product liability and warranty claims, intellectual property rights or defending claims of infringement, employees, taxes, contracts, anti-competitive or anti-corruption practices as well as other disputes and proceedings that arise in the ordinary course of our business. It could be costly to address these claims or any related investigations, whether meritorious or not, and if found liable, we could be required to pay substantial monetary damages. Legal proceedings and investigations could also divert management’s attention as well as operational resources, adversely affecting our financial position, results of operations, cash flows, and reputation.
We believe that our intellectual property has significant value and is important to the marketing of our products and maintaining our competitive advantage. Although we attempt to protect our intellectual property rights through a combination of patent, trademark, trade secret and copyright laws, as well as through confidentiality and nondisclosure agreements and other measures, these measures may not be adequate to fully protect our rights. For example, we have a presence in China, which historically has afforded less protection to intellectual property rights than the United States or Europe. Our failure to obtain or maintain adequate protection of our intellectual property rights for any reason could have a material adverse effect on our business, results of operations and financial condition, we therefore may incur significant costs protecting such rights.
-10-


Our operations are subject to international, national, state and local laws and regulations in the jurisdictions where we do business, which govern, among other things, air emissions, wastewater discharges, the handling, storage and disposal of hazardous substances and wastes, the remediation of contaminated sites, and employee health and safety. At December 31, 2022, we had close down and environmental remediation costs provisions of €86 million. Future environmental regulations, requirements or more aggressive enforcement of existing regulations could impose stricter compliance requirements on us and on the industries in which we operate, such as legislative efforts to limit greenhouse gas emissions, including carbon dioxide. If we are unable to comply with these laws and regulations, we could incur substantial costs, including fines and civil or criminal sanctions, or costs associated with upgrades to our facilities or changes in our manufacturing processes in order to achieve and maintain compliance.  
We are a foreign private issuer under the U.S. securities laws and within the meaning of the New York Stock Exchange (“NYSE”) rules. As a result, we qualify for and rely on exemptions from certain corporate governance requirements and may rely on other exemptions available to us in the future.
As a “foreign private issuer,” as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”), we are permitted to follow our home country practice in lieu of certain corporate governance requirements of the NYSE. Foreign private issuers are also exempt from certain U.S. securities law requirements applicable to U.S. domestic issuers, including the requirement to file quarterly reports on Form 10-Q, requirements relating to the solicitation of proxies for shareholder meetings under Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 16 filings.
So long as we qualify as a foreign private issuer, you may not have the same protections applicable to companies that are subject to all of the NYSE corporate governance requirements.
If we were to lose or relinquish our status as a foreign private issuer, our regulatory and compliance costs could be significantly more than the costs we currently incur. We would be required to file periodic reports and registration statements on U.S. domestic issuer forms with the U.S. Securities and Exchange Commission (the “SEC”), including proxy statements pursuant to Section 14 of the Exchange Act, which are more detailed and extensive than the forms available to a foreign private issuer, and on a more abbreviated timetable than is applicable to our current SEC filings. In addition, our directors and executive officers would become subject to insider short-swing profit disclosure and recovery rules under Section 16 of the Exchange Act and we would lose our ability to rely upon exemptions from certain NYSE corporate governance requirements as described above. Any of these changes would likely increase our regulatory and compliance costs and expenses, which could have a material adverse effect on our business, financial condition and results of operations.
Any shareholder acquiring 30% or more of our voting rights may be required to make a mandatory takeover bid or be subject to claims for damages.
According to the Company’s Articles of Association, any person, acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, who comes into possession, other than following a voluntary takeover bid, directly or indirectly, of more than 30% of the capital or voting rights of the Company, shall launch a takeover bid on all the shares and securities granting access to the shares or voting rights, and on terms that comply with applicable U.S. securities laws, and SEC and NYSE rules and regulations. The same requirement applies to persons, acting alone or in concert, who directly or indirectly own a number between 30% and half of the total number of equity securities or voting rights of the Company and who, in less than twelve consecutive months, increase the holding, in capital or voting rights, by at least 1% of the total number of equity securities or voting rights of the Company.
The rights of our shareholders may be different from the rights of shareholders of U.S. companies and provisions of our organizational documents and applicable law may impede or discourage a takeover, which could deprive our investors of the opportunity to receive a premium for their ordinary shares or to make changes in our Board.
Our corporate affairs are governed by the Company’s Articles of Association and by the laws governing companies incorporated in France. The rights of shareholders and the responsibilities of members of our Board may be different from the rights and obligations of shareholders in companies governed by the laws of U.S. jurisdictions. In the performance of its duties, our Board is required by French law to consider the interests of the Company, its shareholders, its employees and other stakeholders, in all cases with due consideration to the principles of reasonableness and fairness. It is possible that some of these parties could have interests that are different from, or in addition to, your interests as a shareholder.
-11-


If a third party is liable to a French company, under French law, shareholders generally do not have the right to bring a derivative action on behalf of a company or to bring an action on their own behalf to recover damages sustained as a result of a decrease in value, or loss of an increase in value, of their stock. Only in the event that the cause of liability of such third party to the company also constitutes a tortious act directly against such shareholder causing him direct, personal and definite harm, may such shareholder have an individual right of action against such third party on its own behalf to recover damages.
The French Consumer Code provides for the possibility to initiate class actions (actions en représentation conjointe); however, such class action is not applicable to acts which can affect the rights of shareholders. Approved associations of shareholders or investors are allowed to bring claims in respect of wrongful acts harming the “collective interest” of the investors or of certain categories of investors. Such associations may request that the court orders the responsible person to comply with the legal provisions to end the irregularity or eliminate its effects. They may seek indemnification in the name of individual investors who have suffered individual damages if mandated by at least two such investors.
The provisions of French corporate law and the Articles of Association have the effect of concentrating control over certain corporate decisions and transactions in the hands of our Board. As a result, holders of our shares may have more difficulty in protecting their interests in the face of actions by members of the Board than if we were incorporated in the United States.
In addition, several provisions of the Articles of Association and the laws of France may discourage, delay or prevent a merger, consolidation or acquisition that shareholders may consider favorable, such as the obligation to disclose the crossing of ownership thresholds or the possibility for our Board to issue equity securities, including during a takeover bid. Under French law, our general meeting of shareholders may empower our Board to issue shares, or warrants to subscribe new shares, and restrict or exclude preemptive rights on those shares. These provisions could impede the ability of our shareholders to benefit from a change in control and, as a result, may materially adversely affect the market price of our ordinary shares and your ability to realize any potential change of control premium. French law does not grant appraisal rights to a company’s shareholders who wish to challenge the consideration to be paid upon a domestic legal merger or demerger of a company.
United States civil liabilities may not be enforceable against the Company.
We are incorporated under the laws of France and a substantial portion of our assets are located, and a majority of our directors and officers reside, outside the United States. As a result, it may be difficult for investors to effect service of process within the United States upon the Company or other persons residing outside the United States. It may also be difficult to enforce judgments obtained against persons in U.S. courts in any action, including under the civil liability provisions of U.S. federal securities laws, outside the United States or to enforce rights under U.S. federal securities laws in foreign courts.
There is no treaty between the United States and France for the mutual recognition and enforcement of judgments (other than arbitration awards) in civil and commercial matters. Therefore, a final judgment for the payment of money rendered by any U.S. court based on civil liability would not be enforceable in France unless recognized by French courts. Moreover, an SEC decision ordering the payment of a fine would not be enforceable in France.
If a U.S. judgment is not recognized in France, the parties would have to re-litigate their dispute before a French court, provided such court has jurisdiction over the dispute. Accordingly, there can be no assurance that U.S. investors will be able to enforce any civil judgments obtained in U.S. courts, including under U.S. federal securities laws, against the Company or our directors, our officers or certain experts who are residents of France or other foreign countries. In addition, there is doubt as to whether a French court would impose civil liability on the Company, our directors, our officers or certain of our experts in an action based on U.S. federal securities laws even if brought in a French court of competent jurisdiction.
Any inability of the Company to continue to benefit from French provisions applicable to registered intermediaries (“intermédiaires inscrits”) could adversely affect the rights of shareholders.
Article 198 of the Pacte Act, that came into full force and effect on June 10, 2019, amended the French Commercial Code in a way that allows us to maintain our current shareholder ownership structure in the United States. The French Commercial Code (as amended by the Pacte Act) allows an intermediary to be registered for the account of holders of shares of companies which are admitted to trading solely on a market in a non-EU country that is considered equivalent to a regulated market pursuant to paragraph (a) of Article 25(4) of Directive EC2014/65/EU (which, pursuant to the European Commission decision dated December 13, 2017, includes the NYSE).
-12-


We use a French registered intermediary for the account of our beneficial owners (the “French Intermediary”). If the French Intermediary fails to comply with the French provisions applicable to registered intermediaries (intermédiaires inscrits), and if we are unable to find an appropriate substitute, or if the European Commission no longer considered the NYSE as equivalent to a regulated market as described above, we might not be able to comply with existing French laws regarding the holding of shares in the “au porteur” (bearer) form, and shares would have to be held in “au nominatif” (registered) form. In such case, the Company would need to maintain at all times a register with the name of (and number of shares held by) each shareholder, which could adversely affect the rights of our shareholders, including potentially the right to exercise their voting rights as Company shareholders as only shareholders registered on such register would be entitled to vote.
Transactions in our ordinary shares could be subject to the European financial transaction tax, if adopted.
On February 14, 2013, the European Commission adopted a proposal for a directive on a common financial transaction tax (the “FTT”) to be implemented under the enhanced cooperation procedure by several EU Member States (Austria, Belgium, France, Germany, Greece, Italy, Portugal, Slovenia, Slovakia and Spain).
Following the lack of consensus in the negotiations on the directive proposal of 2013, these Member States have agreed to continue the negotiations under a new proposal (the “European FTT”) based on the French financial transaction tax, which would concern the listed shares of European companies whose stock market capitalization exceeds €1 billion as at December 1 of the year preceding the taxation year. According to this new proposal, the applicable tax rate would be a minimum of 0.2%, and primary market transactions would be exempt. This new proposal may be amended before its adoption, the timing of which remains uncertain. Other EU Member States may decide to participate in, and any of the EU Member States mentioned above may decide to withdraw from, this new proposal.
The European FTT could, if introduced in its current form, apply to certain dealings in our ordinary shares (including secondary market transactions) in certain circumstances. The mechanism by which the tax would be applied and collected is not yet known, but if the proposed European FTT or any similar tax is adopted, transactions in our ordinary shares would be subject to higher costs, and the liquidity of the market for our ordinary shares may be diminished.
If dividends were paid by our Company, it is uncertain whether our shareholders would actually obtain the elimination or reduction of the French and/or Dutch domestic dividend withholding tax to which they would be entitled.
General comments on the French and Dutch withholding tax treatment of dividends paid on our ordinary shares are set out under section “Item 10. Additional Information - E - Taxation — Material French Tax Consequences -French dividend withholding tax” and “-Certain Material Dutch Tax Consequences Dutch dividend withholding tax” herein. In accordance with domestic or double tax treaty provisions, shareholders may be entitled to an elimination or reduction of the default French withholding tax, and/or Dutch withholding tax on dividends distributed by the Company (i.e., 15%, 25% respectively, or 75% in the case where the dividends are paid in non-cooperative States or territories within the meaning of article 238-0 A 1, 2 and 2 bis-1° of the French tax code), subject to the French paying agent of the dividends being provided with the required information and documentation relating to the tax status of the shareholders. Numerous intermediaries would be involved in the process of transmitting the relevant information and documentation from our shareholders to the French paying agent in case of distribution of dividends by the Company. As a result, this process may potentially jeopardize the ability for our shareholders to obtain the elimination or reduction of the French or Dutch withholding tax to which they are entitled.
The French Ruling could be revoked if the description and legal analysis of the holding structure of the shares of the Company after the completion of its transfer from the Netherlands to France was inaccurate.
The various confirmations obtained from the French tax authorities on October 11, 2019 (the “French Ruling”) (set forth under section “Item 10. Additional Information - E - Taxation” below) are based on the description and legal analysis of the holding structure of the shares of the Company made by the Company to the French tax authorities in its ruling request. If the French tax authorities were to consider that the description or legal analysis in the ruling request with regards to the holding structure of the shares of the Company is inaccurate, notably to the extent that such description and analysis are based on U.S. securities law notions that are foreign to French law, the French tax authorities could decide to revoke the French ruling and such decision could have adverse tax consequences to our shareholders.
-13-


Purchases of our ordinary shares could be subject to the French financial transaction tax, if the NYSE were to be formally recognized as a foreign regulated market by the French Financial Market Authority or the applicable provisions of the French tax code were amended.
Pursuant to Article 235 ter ZD of the French tax code, purchases of equity instruments or similar securities of a French company listed on a regulated market of the EU or on a foreign regulated market formally recognized as such by the French Financial Market Authority (the “AMF”) are subject to a 0.3% French tax on financial transactions provided that the issuer’s market capitalization exceeds 1 billion euros as of December 1 of the year preceding the taxation year (See “Item 10. Additional Information - E - Taxation - French Financial Transaction Tax and Registration Duties on Disposition of our Shares”). On the date hereof, the NYSE is not formally recognized as a foreign regulated market by the AMF.
If the NYSE were to be formally recognized as a foreign regulated market by the AMF in the future, or if Article 235 ter ZD of the French tax code were amended to include the NYSE as a foreign regulated market, the French financial transaction tax could be due on purchases of ordinary shares of the Company.

Item 4. Information on the Company
A.History and Development of the Company
Constellium Holdco B.V. (formerly known as Omega Holdco B.V.) was incorporated as a Dutch private limited liability company on May 14, 2010 (incorporated and governed under the Dutch Civil Code). Constellium Holdco B.V. was formed to serve as the holding company for various entities comprising Alcan’s Engineered Aluminum Product business unit, which Constellium acquired from affiliates of Rio Tinto on January 4, 2011 (the “Acquisition”). On May 21, 2013, Constellium Holdco B.V. was converted into a Dutch public limited liability company and renamed Constellium N.V. On May 29, 2013, we completed our initial public offering and began trading our shares as Constellium N.V., a Dutch company, on the New York Stock Exchange (the “NYSE”) under the symbol “CSTM”.
On June 28, 2019, Constellium N.V. converted its corporate form from a Dutch public limited liability company (Naamloze Vennootschap) into a Societas Europaea (SE) and changed its name to Constellium SE, with its head office remaining in Amsterdam, the Netherlands (the “Conversion”).
On December 12, 2019, Constellium SE completed its re-domicile and the relocation of its head office to Paris, France (the “Transfer”). The Conversion and the Transfer were each approved by the Company’s shareholders. Effective as of December 12, 2019, the Company’s existing Articles of Association were amended by means of a deed of amendment to reflect the Company’s re-domicile to Paris, France (as further amended from time to time, the “Articles of Association”).
As of the effectiveness of the Transfer, each outstanding Class A ordinary share of Constellium SE with its head office in Amsterdam, the Netherlands, automatically became an ordinary share of Constellium SE with its head office in Paris, France. The Company’s ordinary shares continue to be listed on the NYSE under the symbol “CSTM” and began trading under Constellium SE, a French company, on December 13, 2019.
Since the Transfer, any references to French law and the Articles of Association herein are references to French law and the Articles of Association of the Company, respectively, following the Conversion and Transfer.
The business address (head office) of Constellium SE is Washington Plaza, 40-44 rue Washington, 75008 Paris, France, and our telephone number is +33 1 73 01 46 20. The address for our agent for service of process in the United States is Corporation Service Company, 80 State Street, Albany, New York 12207-2543, and its telephone number is + 1(302) 636-5400.
For information on our historical capital expenditures and capital expenditures currently in progress, see “Item 5. Operating and Financial Review and Prospects—Cash Flows—Historical Capital Expenditures” and “—D. Property, Plants and Equipment.” We expect to finance our capital expenditures currently in process with a combination of internal and external financing sources.
-14-


The SEC maintains an Internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that site is www.sec.gov. We also make available on our website, free of charge, our annual reports on Form 20-F and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is www.constellium.com. The information contained on our website is not incorporated by reference in this document.
B.
Business Overview
The Company
Overview
We are a global leader in the design and manufacture of a broad range of innovative rolled and extruded aluminium products, serving primarily the packaging, aerospace, automotive as well as defense and other transportation and industry end-markets. Our business model is to add value by converting aluminium into semi-fabricated and in some instances fabricated products. We supply numerous blue-chip customers with value-added products for performance-critical applications. Our product portfolio generally commands higher margins as compared to less differentiated, more commoditized fabricated aluminium products, such as common alloy coils, paintstock, foilstock and soft alloys for construction and distribution.
As of December 31, 2022, we operated 29 manufacturing facilities, 3 R&D centers and 3 administrative centers in Baltimore, Maryland, Paris, France and Zürich, Switzerland. We believe our portfolio of flexible, integrated and strategically located facilities is among the most technologically advanced in the industry and that the significant growth investments we have made now position us well to capture expected demand growth in each of our end markets. It is our view that our established presence in Europe, North America and China combined with more than 50 years of manufacturing experience, quality and innovation, strategically position us to be a leading supplier to our global customer base. The Company had approximately 12,500 employees as of December 31, 2022.
We seek to sell to end-markets that have attractive characteristics for aluminium, including (i) stability through economic cycles as seen in our North American and European packaging businesses, (ii) rigorous and complex technical requirements as seen in our global aerospace and automotive businesses, and (iii) favorable growth fundamentals seen in the packaging, automotive, and transportation markets generally.
We have invested capital not only to maintain the condition of our assets, but also to take advantage of a number of attractive growth opportunities including: (i) Auto Body Sheet capabilities in Muscle Shoals, Alabama, in Bowling Green, Kentucky, in Neuf-Brisach, France, and in Singen, Germany (ii) new Automotive Structures operations in San Luis Potosi, Mexico, in White, Georgia, in Vigo, Spain, and in Zilina, Slovakia and Automotive Structures facility expansions in Gottmadingen and Dahenfeld, Germany and in Van Buren, Michigan (iii) additional extrusion capability in Děčín, Czech Republic and in Singen, Germany, (iv) a new casthouse in Děčín, Czech Republic, (v) a new recycling center in Neuf-Brisach, France, that is currently under construction, and (vi) a number of other incremental growth initiatives across our operations.
Our unique platform has enabled us to develop a diversified customer base and to enjoy long-standing relationships with our largest customers. Our customer base includes market leading firms in packaging, aerospace, and automotive, such as AB InBev, Ball Corporation, Crown Holdings, Inc., Airbus, Boeing, and many premium automotive OEMs, including BMW AG, Mercedes-Benz Group AG, Ford Motor Company and Volkswagen Group. We believe that we are a critical supplier to many of our customers due to our technological and R&D capabilities as well as the long and complex qualification process required for many of our products. Our core products require close collaboration and, in many instances, joint development with our customers. We believe that this integrated collaboration with our customers for high value-added products reduces substitution risk, supports our competitive position and is difficult to replicate.

-15-


For the years ended December 31, 2022, 2021 and 2020, the Company’s key operational and financial metrics were as follows:
For the years ended December 31,
(in millions of euros, unless otherwise noted)202220212020
Shipments (kt)1,5801,571 1,431 
Revenue8,120 6,152 4,883 
Net income / (loss)308 262 (17)
Adjusted EBITDA673 581 465 
Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
References to “tons” throughout this Annual Report are to metric tons.
For information on our Revenue by geographic market, see Note 3 to the Consolidated Financial Statements.
Our Strategy
Our mission is to meet customers’ and society’s need for lightweight, strong and sustainable aluminium products while generating attractive returns for our shareholders.
We aim to achieve our mission by expanding our leading position as an innovative, go-to-supplier of technologically advanced and responsible fabricated aluminium solutions. We are committed to building a safe and sustainable company and becoming the most exciting company in our industry. This means developing, manufacturing and promoting products that are sustainable for the benefit of our customers and end consumers, reducing our emissions and our waste, investing in our people, supporting our communities, adhering to sound governance principles, and creating shareholder value.
To achieve these objectives, we have built a business strategy centered around six core principles:
(i)Focus on High Value-added and Responsible Products
We are primarily focused on our three strategic end-markets—packaging, aerospace and automotive—in which we have leading positions and established relationships with many of the main manufacturers. These are also markets where we believe that we can differentiate ourselves through our high value-added and specialty products which make up the majority of our product portfolio. We have made substantial investments to develop unique R&D and technological capabilities and to increase our recycling capacity, which we believe give us a competitive advantage in quality, design, innovation and sustainability. We leverage aluminium’s inherent sustainability characteristics — lightweight, durable, and infinitely recyclable – to produce environmentally responsible products. We believe our differentiated products provide significant benefits to our customers in many areas such as weight reduction, higher strength and better formability, and contribute to their objective of reducing carbon emissions. In addition, these products typically command higher margins than more commoditized products, and are supplied to end-markets that we believe have highly attractive characteristics and long-term growth trends. We intend to continue to invest in our R&D and technological capabilities to develop a high value-added and responsible product portfolio.
(ii)Increase Customer Connectivity
We regard our relationships with our customers as partnerships in which we work closely together to leverage our unique knowledge of the attributes of aluminium, our industry leading R&D and technological capabilities, and our integrated industrial platform to develop customized solutions. Our diverse teams globally aim to deepen our ties with our customers by consistently providing best-in-class quality, sustainable products and services and joint product development projects.
In addition, through market leading supply chain integration we are able to better anticipate customer demands, optimize supply and more efficiently manage our working capital needs. We also seek to strengthen customer connectivity through customer technical support and closed-loop scrap recycling programs. We will aim to continue to further foster and enhance the relationships with our customers and position our company as a preferred supplier to our customers.
-16-


(iii)Optimize Margins and Asset Utilization Through Rigorous Product Portfolio Management
We are highly focused on maximizing the throughput of our facilities to increase the tons per machine hour and profitability per machine hour. We believe there are significant opportunities to do so through rigorous focus on the products we choose to make and optimizing the throughput of these products in our facilities. For example, given our manufacturing configurations, there are certain products that our facilities are better equipped to manufacture. As a consequence, we not only manufacture them more efficiently and at a lower cost, but we also reduce our energy consumption and improve our environmental footprint. This rigor encompasses both the existing portfolio as well as new product development. In addition, we strive to increase our throughput through our investments in asset integrity, and through continuous improvements in our operations such as debottlenecking and optimizing equipment uptime, recovery and mill speed. Finally, we intend to complement these efforts with increased recycling which will strengthen our margins, reduce our dependence on external slab and billet suppliers and enhance the sustainability of our products.
(iv)Strictly Control Cost, Continuously Improve and Manage Resources Responsibly
We believe that there are significant opportunities to reduce our operating costs and improve our operations by implementing manufacturing excellence initiatives, metal management programs and other cost, energy reduction, waste and water management initiatives. We aim to establish best-in-class operations and achieve cost reductions by standardizing manufacturing processes and reducing waste, while still allowing the flexibility to respond to local market demands. An important part of this continuous improvement plan is our focus on responsible resource management, including minimizing energy and water usage, maximizing scrap input and efficiently managing other resources used by the Company, including capital.
(v)Manage Capital Through a Disciplined Approach and Increase Financial Flexibility
We have invested capital in a number of attractive growth opportunities to advance our production capabilities, product offering and sustainability profile. One example of this is our light weight solutions for the automotive market. We are highly focused on realizing attractive returns on the capital we invest to grow our business and, as a result, very discriminating on where we invest capital. We will remain disciplined with respect to future capital deployment and to capital allocation decisions more generally.
In addition, we are highly focused on increasing our financial flexibility through earnings growth and free cash flow conversion which will enable us to reduce our debt. This includes strict cost control but also working capital management and disciplined capital spending. We believe having increased financial flexibility is critical to achieving our long-term objective of investing in our operations and in our people such that we are the supplier-of-choice for high value-added, specialized, technologically-advanced products.
(vi)Commit to Our People and Communities
We believe our people are among the best in the industry; this is a competitive strength which allows us to be a leader in our industry. This is why we continuously provide training opportunities to our employees, expanding their skills and competencies as they grow with us. We strive to promote a safe and inclusive environment where everyone is valued, can contribute, and thrive. Lastly, we strive to be socially responsible operators in our communities.
Recent Developments
On February 2, 2023 we completed the divestment of the Ussel plant to French Investment Holding Noe Industries (as indicated in Note 32 of the audited Consolidated Financial Statements).
On February 16, 2023, the Company announced that following Peter Matt’s decision to leave the Company to pursue another career opportunity, Jack Guo will be appointed Chief Financial Officer, effective April 1, 2023.
Our Operating Segments
Our business is organized into three operating segments:
(i) Packaging & Automotive Rolled Products (P&ARP) includes the production of rolled aluminium products in our European and North American facilities. We supply the packaging market with canstock and closure stock for the beverage and
-17-


food industry, as well as foil stock for the flexible packaging market. In addition, we supply the automotive market with a number of technically sophisticated applications such as Auto Body Sheet ("ABS") and heat exchanger materials.
(ii) Aerospace & Transportation (A&T) includes the production of rolled aluminium products and very limited volumes of extruded products in our European and North American facilities. We supply rolled aluminium products in plate and sheet form for the aerospace market and for transportation, industry and defense end-uses.
(iii) Automotive Structures & Industry (AS&I) includes the production of extruded aluminium products and aluminium structural components. We supply technologically advanced structural components for the automotive industry including crash-management systems, body structures, side impact beams and battery enclosures in our European, North American and Chinese facilities. In addition, we fabricate hard and soft aluminium alloy extruded profiles in a number of our other European facilities for a range of high demand industry applications in the automotive, engineering, rail and other transportation end markets.
Table: Overview of Operating Segments (as of December 31, 2022)
Packaging & Automotive
Rolled Products
Aerospace &
Transportation
Automotive Structures &
Industry
Manufacturing Facilities
• 4 (France, Germany, U.S.)
• 6 (France, Switzerland, U.S.)
• 19 (Canada, China, Czech Republic, France, Germany, Mexico, Slovakia, Spain, Switzerland, U.S.)
Employees
4,100
3,5004,500
Key Products
• Can stock
• Foilstock
• Closure stock
• Auto Body Sheet
• Rolled products for heat exchangers
• Specialty reflective sheet (Bright)
• Aerospace plates, sheets and extrusions
• Aerospace wing skins
• Plate and sheet for transportation, industry and defense applications
• Automotive extruded products
• Other extruded products including:
Soft alloys
Hard alloys
Large profiles
Key Customers
Packaging: AB InBev, Amcor, Ardagh Group, Ball Corporation, Can-Pack, Coca-Cola, Crown Holdings
Automotive: Audi, BMW AG, Mercedes-Benz Group AG, Stellantis, Volkswagen Group

Aerospace: Airbus, Boeing, Bombardier, Dassault
Transportation, Industry, Defense and Distribution: Amari, Nexter Systems, Ryerson, ThyssenKrupp

Automotive: Audi, BMW AG, Mercedes-Benz Group AG, Ford Motor Company, Porsche, Stellantis
Rail: CAF, Hitachi, Stadler
Select Key Facilities
• Bowling Green (Kentucky, U.S.)
• Neuf-Brisach (France)
• Singen (Germany)
• Muscle Shoals (Alabama, U.S.)
• Issoire (France)
• Ravenswood (West Virginia, U.S.)
• Sierre (Switzerland)
• Děčín (Czech Republic)
• Gottmadingen (Germany)
• Singen (Germany)
• Van Buren (Michigan, U.S.)
% of total Revenue
(for the twelve months ended December 31, 2022)
57%
21%
22%
% of Adjusted EBITDA2
(for the twelve months ended December 31, 2022)
49%
32%
22%
1Our 29 manufacturing facilities are located in 27 sites, two of which are shared between two operating segments.
2The difference between the sum of Adjusted EBITDA for our three segments and the Company’s Adjusted EBITDA is attributable to Holdings and Corporate.

-18-


The following table presents our shipments by product lines:
(in thousand metric tons)For the year ended December 31,
202220212020
Packaging rolled products809 833 785 
Automotive rolled products245 228 207 
Specialty and other thin-rolled products35 43 27 
Aerospace rolled products76 53 78 
Transportation, industry, and other rolled products147 153 105 
Automotive extruded products117 115 108 
Other extruded products151 146 121 
Total shipments1,580 1,571 1,431 
Packaging & Automotive Rolled Products Operating Segment
In our Packaging & Automotive Rolled Products operating segment, we develop and produce customized aluminium sheet solutions. For the year ended December 31, 2022, approximately 74% of operating segment volume was in packaging rolled products, which primarily includes beverage and food canstock as well as closure stock and foil stock, approximately 23% of operating segment volume was in automotive rolled products, and approximately 3% of operating segment volume was in specialty and other thin-rolled products.
We are a leading European and North American supplier of canstock and the leading worldwide supplier of closure stock. We are also a major player in automotive rolled products for ABS in both Europe and North America, and for heat exchangers in Europe. These products are subject to the exacting requirements and qualification processes of our customers which we believe provides us with a competitive advantage and represents a barrier to entry for new competitors. We have a diverse customer base, consisting of many of the world’s largest beverage and food can manufacturers, specialty packaging producers, leading automotive OEMs and global industrial companies. Our customers include AB InBev, Amcor Ltd., Ardagh Group S.A, Ball Corporation, BMW AG, Can-Pack S.A., Coca-Cola, Crown Holdings, Inc., Mercedes-Benz Group AG, Ford Motor Company, Stellantis and Volkswagen Group. Our customer contracts in packaging usually have a duration of three to five years. Our customer contracts in automotive are usually valid for the lifetime of a model, which is typically five to seven years.
We have two integrated rolling operations located in Europe and one in the U.S. Neuf-Brisach, our facility in France, is a fully integrated aluminium recycling, rolling and finishing facility producing both canstock and ABS. Singen, our facility located in Germany, is a rolling and finishing facility specialized in high-margin niche applications. Our Muscle Shoals, Alabama facility is a fully integrated aluminium recycling, rolling and finishing operation producing both canstock and ABS. We also operate a finishing line for ABS in Bowling Green, Kentucky.
The following table summarizes our volume, revenue and Adjusted EBITDA for our Packaging & Automotive Rolled Products operating segment for the periods presented:
For the year ended December 31,
(in millions of euros, unless otherwise noted)202220212020
Packaging & Automotive Rolled Products:
Segment Shipments (kt)1,089 1,104 1,019 
Segment Revenue4,664 3,698 2,734 
Segment Revenue (€/ton)4,281 3,350 2,683 
Segment Adjusted EBITDA(1)
326 344 291 
Segment Adjusted EBITDA(€/ton)299 312 286 
Segment Adjusted EBITDA margin%%11 %
__________________
(1)Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
-19-


Aerospace & Transportation Operating Segment
Our Aerospace & Transportation operating segment has market leadership positions in technologically advanced aluminium and specialty material products with wide applications across the global aerospace, transportation, industry and defense sectors. Approximately 34% of the segment volume for the year ended December 31, 2022 was in aerospace rolled products and approximately 66% was in transportation, industry, defense and other rolled product applications.
We offer a wide range of products including plate, sheet and extrusions products which allow us to offer tailored solutions to our customers. We seek to differentiate our products and act as a key partner to our customers through our advanced R&D capabilities, extensive recycling capabilities, broad product range, supply-chain solutions and a portfolio of plants across Europe and North America. Our customers are diverse and range from Airbus and Boeing in aerospace to Ryerson, ThyssenKrupp and Nexter Systems in transportation, industry and defense.
We have two integrated rolling operations located in Issoire, France and Ravenswood, West Virginia. These integrated facilities have extensive capabilities that enable us to produce value added products like wide and very thick gauge plates required for certain civil and commercial aerospace programs and a range of transportation, industry and defense applications. In addition, we operate two other sites located in Sierre, Switzerland and Montreuil-Juigné, France. We completed the sale of our Ussel, France operation in February 2023.
Downstream aluminium products for the aerospace market require relatively high levels of R&D investment and advanced technological capabilities, and therefore tend to command higher margins compared to more commoditized products. We work in close collaboration with our customers to develop highly engineered solutions to fulfill their specific requirements. For example, we developed Airware®, a lightweight specialty aluminium-lithium alloy, for our aerospace customers to address increasing demand for lighter and more fuel-efficient aircraft.
Additionally, aerospace products are generally subject to long qualification periods. Aerospace production sites are regularly audited by external certification organizations including the National Aerospace and Defense Contractors Accreditation Program (“NADCAP”) and/or the International Organization for Standardization. NADCAP is a cooperative organization of a number of aerospace OEMs that defines industry-wide manufacturing standards. NADCAP appoints private auditors who grant suppliers like Constellium a NADCAP certification, which customers tend to require. New products or alloys are separately certified by the OEM that uses the product. Our sites have been qualified by external certification organizations and our products have been qualified by our customers. We are typically able to obtain qualification within 6 months to one year mainly because: (i) we have an existing range of qualifications including in excess of 100 specifications regarding alloy, temper or shape, due to our long history of working with the main aircraft OEMs, which we can build on to obtain new product qualifications; and (ii) we have invested in a number of capital intensive equipment and R&D programs to be able to qualify to the current industry norms and standards.
The majority of our contracts with our largest aerospace customers have a term of three to ten years, which provides visibility on volumes and profitability. We expect demand for our aerospace products to directly correlate with aircraft backlogs and build rates. As of December 31, 2022, the backlog reported by Airbus and Boeing for commercial aircraft reached 11,817 units on a combined basis.
We also serve the transportation, industry and defense end markets. Our product portfolio in these segments include both specialty products as well as standard products. Specialty products are differentiated products, which are engineered to meet specific customer needs and as such have specific properties (e.g., mechanical properties, dimensions, surface aspect, etc.). Standard products typically face higher levels of competition in the regions that we serve. The majority of our contracts in the transportation and defense industry typically last between one to three years.
-20-


The following table summarizes our volume, revenue and Adjusted EBITDA for our Aerospace & Transportation operating segment for the periods presented:
For the year ended December 31,
(in millions of Euros, unless otherwise noted)202220212020
Aerospace & Transportation:
Segment Shipments (kt)223 206 183 
Segment Revenue1,700 1,142 1,025 
Segment Revenue (€/ton)7,619 5,548 5,601 
Segment Adjusted EBITDA(1)
217 111 106 
Segment Adjusted EBITDA(€/ton)976 539 580 
Segment Adjusted EBITDA margin13 %10 %10 %
__________________
(1)Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
Automotive Structures & Industry Operating Segment
Our Automotive Structures & Industry operating segment produces (i) technologically advanced structures for the automotive industry including crash management systems, body structures, side impact beams and battery enclosure components and (ii) soft and hard alloy extrusions for automotive, transportation, energy and building and construction applications and iii) large profiles for rail and industrial applications. We complement our products with a comprehensive offering of downstream technology and services, which include pre-machining, surface treatment, R&D and technical support services. Approximately 44% of the segment volume for the year ended December 31, 2022 was in automotive extruded products and approximately 56% was in other extruded product applications.
In our automotive structures business, a series of aluminium extrusions are consolidated into a system for specific automotive applications. Due to the unique combination of strength and weight, aluminium extrusions are increasingly favored by our automotive customers. We manufacture automotive structural products for some of the largest European and North American car manufacturers supplying the global market, including Mercedes-Benz Group AG, BMW AG, Volkswagen Group, Stellantis and Ford Motor Company. We believe that we are one of the largest providers of aluminium automotive crash management systems globally. Our automotive structures contracts are typically five to seven years in duration, which usually represents a lifetime of a model.
In our Industry businesses, we serve a broad range of customers across a number of industries including automotive, rail, industrial and other transportation markets in Europe. Our Industry business is tied to contracts that typically last up to one year on average.
We manufacture products for our AS&I segment in 19 facilities located in Canada, China, Czech Republic, France, Germany, Mexico, Slovakia, Spain, Switzerland and U.S. We believe our local presence, downstream services and industry leading cycle times help to ensure that we respond to our customer demands in a timely and consistent fashion. Our two integrated remelt and casting centers in Switzerland and the Czech Republic utilize significant amounts of recycled aluminium and help provide security of metal supply. We also produce soft alloy extrusions for customers primarily in Germany and France, with customized solutions for a diverse number of end markets.
We operate a joint venture, Astrex Inc., which produces automotive extruded profiles in Ontario, Canada, for our North American operations, and a joint venture, Engley Automotive Structures Co., Ltd., which produces aluminium crash management systems in China.
We believe that we have strong market positions in our AS&I segment given our R&D and manufacturing capabilities. Led by our partnership with Brunel University, London, United Kingdom, we have developed proprietary alloys and manufacturing technology which enable us to deliver high quality, cost effective products to our extrusion customers and differentiated design, engineering and manufacturing capabilities which accelerate time to market for our automotive customers, and to accelerate time to market.
-21-


The following table summarizes our volume, revenue and Adjusted EBITDA for our Automotive Structures & Industry operating segment for the periods presented:
For the year ended December 31,
(in millions of Euros, unless otherwise noted)202220212020
Automotive Structures & Industry:
Segment Shipments (kt)268 261 229 
Segment Revenue1,861 1,383 1,167 
Segment Revenue (€/ton)6,947 5,292 5,096 
Segment Adjusted EBITDA(1)
149 142 88 
Segment Adjusted EBITDA(€/ton)557 545 382 
Segment Adjusted EBITDA margin%10 %%
__________________
(1)Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
Our Industry
Aluminium Sector Value Chain
The global aluminium industry consists of (i) mining companies that produce bauxite, the ore from which aluminium is ultimately derived, (ii) primary aluminium producers that refine bauxite into alumina and smelt alumina into aluminium, (iii) aluminium semi-fabricated products manufacturers, including aluminium casters, extruders and rollers, (iv) aluminium recyclers and remelters and (v) integrated companies that are present across multiple stages of the aluminium production chain.
Our business is primarily focused on rolling and extruding semi-fabricated products for a variety of value added end markets. We recycle aluminium, both for our own use and as a service to our customers. We do not participate in upstream activities such as mining, refining bauxite or smelting alumina into aluminium.
Constellium’s Position in the Aluminium Sector Value Chain
Aluminium value chain
cstm-20221231_g1.jpg
Rolled and extruded aluminium product prices are based generally on the price of aluminium (which is based on the LME quoted price plus a regional premium) plus a conversion margin (i.e., the margin to convert the aluminium into a semi-finished product). The price of aluminium is not a significant driver of our financial performance because we typically pass through the cost of aluminium either to our customers or the financial market. Instead, the financial performance of producers of rolled and
-22-


extruded aluminium products, such as Constellium, is driven by the dynamics in the end markets that they serve, their relative positioning in those markets and the efficiency of their industrial operations.
The aluminium rolled products industry is characterized by economies of scale as significant capital investments are required to achieve and maintain technological capabilities and demanding customer qualification standards. The service and efficiency demands of large customers have encouraged consolidation among suppliers of aluminium rolled products.
The aluminium extruded products industry is relatively fragmented and generally more regional. The business also requires significant capital investments in order to achieve and maintain technological capabilities and meet demanding customer qualification standards.
The supply of aluminium rolled and extruded products has historically been affected by production capacity, alternative technology substitution and trade flows between regions. The demand for these products has historically been affected by economic growth, substitution trends, cyclicality and seasonality and aluminium rolled products in particular by down-gauging.
There are two main sources of input aluminium metal for our rolled or extruded products:
Slabs or billets we cast from a combination of primary and recycled aluminium. The primary aluminium is typically in the form of standard ingots. The recycled aluminium comes either from scrap from fabrication processes, or from recycled end products in their end of life phase, such as used beverage cans.
Slabs or billets purchased from smelters or metal trading companies.
Primary aluminium, sheet ingot and extrusion billets can generally be purchased at prices set on the LME plus a premium that varies by geographic region on delivery, alloying material, form (ingot or molten metal) and purity.
Recycled aluminium is also tied to LME pricing (typically sold at a discount to LME price and regional premium). Aluminium is infinitely recyclable and recycling aluminium requires only approximately 5% of the energy required to produce primary aluminium. As a result, in regions where aluminium is widely used, manufacturers and customers are active in setting up collection processes in which used beverage cans and other end-of-life aluminium products are collected for remelting at purpose-built plants. Manufacturers may also enter into agreements with customers who sell them recycled process material, which is then re-melted and rolled into the same product again.
Aluminium Rolled Products Overview
The rolling process consists of passing aluminium through a hot-rolling mill and then transferring it to a cold-rolling mill, which gradually reduces the thickness of the metal down to approximately 6 mm for plates and to approximately 0.2-6 mm for sheet.
Aluminium rolled products, including sheet, plate and foil, are semi-finished products that provide the raw material for the manufacture of finished goods ranging from packaging to automotive body panels to fuselage sheet to aircraft wing parts. The packaging industry is a major consumer of sheet and foil for making beverage cans, foil containers and foil wrapping. Sheet is also used extensively in transportation applications for airframes, automobiles, trucks and rail vehicles, in marine applications, including offshore platforms, and the hulls of boats and in building applications for roofing and siding. Plate is used for airframes, military vehicles, ships and other large vessels, bridges, and as tooling plate for the production of plastic products. Foil applications outside packaging include electrical equipment, insulation for buildings and foil for heat exchangers.
The following chart illustrates expected global demand for aluminium rolled products according to CRU International Limited (“CRU”). The compound annual growth rate (“CAGR”) between 2022 and 2027 for the flat rolled products market is expected to be 3.8% according to CRU.
-23-


Projected Aluminium Flat Rolled Products Demand (in kt)
cstm-20221231_g2.jpg
Source: CRU International Ltd., Aluminium Rolled Products Market Outlook November 2022
(Asia Pacific includes Japan, China, India, South Korea, Australia, Middle East and other Asia. Other includes Central and South America, and Africa)
Aluminium Extrusions and Automotive Structures Overview
Aluminium extrusion is a technique used to transform aluminium billets into objects with a defined cross-sectional profile for a wide range of uses. In the extrusion process, a heated aluminium billet is forced through a die. Extrusions can be manufactured in many sizes and in almost any shape. The extrusion process makes the most of aluminium’s unique combination of physical characteristics. Its malleability allows it to be easily cast and machined. Aluminium is one-third the density of steel but has the same stiffness, so the resulting products offer strength and stability, particularly when alloyed with other metals.
Extruded profiles can be produced in solid or hollow form and additional complexities can be applied using advanced die designs. After the extrusion process, a variety of options are available to adjust the color, texture and brightness of the aluminium’s finish. This may include aluminium anodizing or painting.
Today, aluminium extrusions are used for a wide range of purposes, including building, transportation and industrial markets. Virtually every type of vehicle contains aluminium extrusions, including cars, boats, bicycles and trains. Home appliances and tools take advantage of aluminium’s excellent strength-to-weight ratio. The increased focus on green building is also leading contractors and architects to use more extruded aluminium products, as aluminium extrusions are corrosion-resistant and offer design flexibility. These diverse applications are possible due to the advantageous attributes of aluminium, including its particular blend of strength and ductility, its conductivity, its non-magnetic properties and its ability to be recycled repeatedly without loss of integrity. We believe that all of these capabilities make aluminium extrusions a viable and adaptable solution for a growing number of manufacturing needs.
Our Key End-markets
We have a significant presence in (i) the packaging end-markets, which have historically been relatively stable and recession-resilient and are now growing with the increased demand for sustainable packaging, (ii) the automotive end market which, despite the recent below normal levels of development due to semiconductor shortage and supply chain issues, has exhibited steady growth based on the light weight and strength attributes of aluminium, (iii) the aerospace end-markets, which are continuing to recover and remain to have attractive longer term growth prospects and (iv) a number of niche specialty end markets including transportation, industry, defense and other products that diversify our exposure to economic trends.
-24-


Packaging
Our Packaging & Automotive Rolled Products operating segment serves the packaging market which has historically been relatively resilient during periods of economic downturn and has had relatively limited exposure to economic cycles and periods of financial instability.
Aluminium beverage cans represented approximately 23% of the total European aluminium flat rolled demand by volume and 38% of total North American flat rolled demand in 2022. According to CRU, aluminium demand for the canstock market in Europe and North America is expected to grow by 3.6% and 4.0% per year between 2022 and 2027, respectively.
Aluminium is a preferred material for beverage packaging as it allows drinks to chill faster, can be stacked for transportation and stored more densely than competing formats (such as glass bottles), is highly formable for unique or differentiated branding, and offers the environmental advantage of easy, cost- and energy-efficient recycling. As a result of these benefits, aluminium is displacing tinplate, glass and plastics as the preferred packaging material in most markets. In both Europe and North America, aluminium is increasingly the beverage packaging container of choice and is experiencing increased demand. We are benefiting from increased can consumption, including growing specialty product categories given the attributes of aluminium packaging.
Total European Rolled Products Consumption
Can Stock (kt)
Total North American Rolled Products
Consumption Can Stock (kt)
cstm-20221231_g3.jpg
cstm-20221231_g4.jpg
Source: CRU International Ltd., Aluminium Rolled Products Market Outlook November 2022Source: CRU International Ltd., Aluminium Products Market Outlook November 2022

-25-


Automotive
We supply the automotive sector with rolled products out of our Packaging & Automotive Rolled Products operating segment and extruded and fabricated products out of our Automotive Structures & Industry operating segment. Our automotive products are predominantly used in premium models, light trucks and sport utility vehicles manufactured by the European and North American OEMs.
In our view, the main drivers of automotive sales are overall economic growth, credit availability, consumer prices and consumer confidence. According to CRU, light vehicle production is expected to grow in Europe and North America by approximately 6.3% per annum from 2022 to 2027.

Vehicle Production(1)
cstm-20221231_g5.jpg
Source: CRU International Ltd, Global & Economic Outlook December 2022
(1) Represents both car and commercial vehicle production, including light trucks, heavy trucks and, except in the U.S. and Canada, coaches
Within the automotive sector, the demand for aluminium has been increasing faster than the underlying demand for light vehicles due to recent growth in the use of aluminium products in automotive applications. We believe the main reasons for this are aluminium’s high strength-to-weight ratio in comparison to steel and a need for increased energy efficiency. This lightweighting facilitates better fuel economy, improves emissions performance and enhances vehicle safety. As a result, manufacturers are seeking additional applications where aluminium can be used in place of steel and an increased number of cars are being manufactured with aluminium panels and crash management systems.
We believe that the vehicle lightweighting trend will continue as increasingly stringent EU and U.S. regulations relating to reductions in carbon emissions will force the automotive industry to increase its use of aluminium to “lightweight” vehicles. In Europe, EU legislation has set mandatory emission reduction targets for new cars such that by 2030, the fleet average to be achieved by all new cars is 37.5% lower compared to the limits in 2021 of 95 grams of CO2 emissions per kilometer (g/km). In the United States, we expect that U.S. regulations requiring reductions in carbon emissions and fuel efficiency, as well as fluctuating fuel prices, will continue to drive aluminium demand in the automotive industry.
As electric vehicles become more widespread, we believe the demand for aluminium in the automotive industry will increase due to the greater importance of lightweighting to maximize range. Aluminium thermal conductivity is a significant inherent advantage for battery boxes in electric vehicles and aluminium also has superior energy absorption as compared to steel. Whereas growth in aluminium use in vehicles has historically been driven by increased use of aluminium castings, we anticipate that future growth will be primarily in the kinds of extruded and rolled products that we supply to the OEMs.
-26-


According to CRU, the consumption of ABS between 2022 and 2027 will grow 10.1% per annum in Europe and 8.5% per annum in North America.

Total European Automotive Body Sheet Flat Rolled Products Consumption (kt)Total North American Automotive Body Sheet Flat Rolled Products Consumption (kt)
cstm-20221231_g6.jpg
cstm-20221231_g7.jpg
Source: CRU International Ltd., Aluminium Products Market Outlook November 2022Source: CRU International Ltd., Aluminium Products Market Outlook November 2022

Aerospace
Demand for aerospace plate and sheet is primarily driven by the build rate of commercial aircraft, which we believe will be supported for the foreseeable future by (i) the ongoing recovery from the low demand caused by the COVID-19 pandemic and (ii) necessary replacement of aging fleets by airline operators, particularly in the United States and Western Europe, and (iii) increasing global passenger air traffic, particularly in China. While the pace of fleet replacement and passenger traffic growth have been impacted due to the global pandemic caused by COVID-19, over the longer term, the fundamentals driving aerospace demand growth remain intact. Between 2022 and 2041, Boeing predicts approximately 41,170 new aircraft across all categories of large commercial aircraft with 42% of sales of new airplanes to Asia Pacific, 44% to Europe and North America and the remaining 14% to the Middle East, Latin America and and Africa, excluding Russia.
According to CRU, aluminium demand for the aerospace rolled products markets in North America and Europe is expected to increase by 11.0% per annum from 2022 to 2027 due to significant recovery from the COVID-19 led downturn.
-27-


World’s Commercial Aircraft Fleet (thousands) Fleet Development Driven by Passenger Demand and Aging Fleet (units) 
cstm-20221231_g8.jpg
cstm-20221231_g9.jpg
Source: Boeing 2022 current market outlookSource: Boeing 2022 current market outlook, excluding Freighters

Aerospace Flat Rolled Products Consumption (kt)
cstm-20221231_g10.jpg
Source: CRU International Ltd., Aluminium Rolled Products Market Outlook November 2022

-28-


Our Business Operations
Our business model is to add value by converting aluminium into semi-fabricated products. It is our policy not to speculate on metal price movements.
Managing Our Metal Price Exposure
For all contracts, we seek to minimize the impact of aluminium price fluctuations in order to protect our cash flows against variations in the LME price, regional and other premiums that we buy and sell, with the following methods:
In cases where we are able to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to our customers, we enter into back-to-back arrangements with our customers.
When we are unable to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to our customers, we enter into derivative financial instruments to pass through the exposure to financial institutions at the time the price is set.
For a small portion of our volumes, the aluminium we process is owned by our customers and we bear no aluminium price risk.
Sales and Marketing
Our sales force is based in Europe (France, Germany, Czech Republic, United Kingdom and Switzerland), the U.S. and Asia (Seoul and Shanghai). We primarily serve our customers directly and in some cases through distributors.
Raw Materials and Supplies
Approximately 68% of our rolling slab demand and approximately 63% of our extrusion billet demand are produced in our own internal cast-houses. In addition, our external rolling slab and extrusion billet supplies are secured through long-term contracts with several upstream companies. All of our top 10 overall metal suppliers (covering rolling slabs, extrusion billets, primary, high purity, scrap and hardeners) have been long-standing suppliers to our plants (in many cases for more than 10 years) and, in aggregate, accounted for approximately 53% of our total metal purchases (in terms of volumes) for the year ended December 31, 2022. We typically enter into annual or multi-year contracts with these metal suppliers pursuant to which we purchase various types of metal, including:
Primary metal from smelters or metal traders in the form of ingots, rolling slabs or extrusion billets.
Remelted metal in the form of rolling slabs or extrusion billets from external cast-houses, as an addition to our own internal cast-houses.
Production scrap from customers and scrap traders.
End-of-life scrap (e.g., used beverage cans) from customers, collectors and scrap traders.
Specific alloying elements and primary ingots from producers and metal traders.
Our operations use natural gas and electricity, which represents the fourth largest component of our cost of sales, after metal, labor costs and depreciation. We purchase natural gas and electricity from the market and typically we secure a large part of our natural gas and electricity needs pursuant to fixed-price commitments. To reduce the risks associated with our natural gas and electricity requirements, we use forward contracts or financial futures with our suppliers - and, to a lesser extent, the financial markets - to fix the commodity component of the energy costs. Furthermore, in our longer-term sales contracts, we try to include indexation clauses on energy prices. From time to time, we can experience fluctuations and periods of volatility in the pricing of raw materials.
Our Customers
Our customer base includes some of the leading manufacturers in the packaging, aerospace and automotive end-markets. We have a relatively diverse customer base with our 10 largest customers representing approximately 50% of our revenue for the year ended December 31, 2022. We generally have long-term relationships with our significant customers, many of which span decades.
A substantial portion of our volume is sold under multi-year contracts, as we generally have three- to five-year terms in contracts with our packaging customers, five- to ten-year terms in contracts with our largest aerospace customers, and five- to seven-year terms in our “life of a car platform/car model” contracts with our automotive customers. This provides us with a certain visibility into our future volumes and earnings.
-29-


We collaborate with our customers to complete a rigorous process for qualifying our products in each of our end-markets, which requires substantial time and investment and creates high switching costs, resulting in longer-term, mutually beneficial relationships. We see our relationships with our customers as partnerships where we work together to find customized solutions to meet their evolving requirements.
Our product portfolio is predominantly focused on high value-added products, which tend to require close collaboration with our customers to develop tailored solutions. The significant effort and investment to adhere to rigorous qualification procedures enables us to foster long-term relationships with our customers.
Competition
The worldwide rolled and extruded aluminium industry is highly competitive, and we expect this dynamic to continue for the foreseeable future. We believe the most important competitive factors in our industry are: product quality, price, timeliness of delivery and customer service, geographic coverage and product innovation. Aluminium competes with other materials such as steel, plastic, composite materials and glass for various applications. Our key competitors in our Packaging & Automotive Rolled Products operating segment are Arconic Corporation, Kaiser Aluminum Corporation, Novelis Inc., Speira GmbH and Tri-Arrows Aluminum Inc. Our key competitors in our Aerospace & Transportation operating segment are Arconic Corporation, AMAG Austria Metall AG, Commonwealth Rolled Products, Inc., Kaiser Aluminum Corporation, Novelis Inc. and Universal Alloy Corporation. Our key competitors in our Automotive Structures & Industry operating segment are Benteler International AG, Commonwealth Rolled Products, Inc., Gestamp Automoción, S.A., Magna International Inc., Martinrea International Inc., Metra Aluminum Inc., Nemak, S.A.B. de C.V., Norsk Hydro ASA, Otto Fuchs KG, Sankyo Tateyama, Inc. and UACJ Automotive Whitehall Industries, Inc.
Seasonality
Customer demand in the aluminium industry is seasonal due to a variety of factors, including holiday seasons, weather conditions, economic and other factors beyond our control. Our volumes are impacted by the timing of the holiday seasons in particular, with the lowest volumes typically delivered in August and December and highest volumes delivered in January to June. Our business is also impacted by seasonal slowdowns and upturns in certain of our customers’ industries. Historically, the can industry is strongest in the spring and summer seasons and the automotive and aerospace sectors encounter slowdowns in both the third and fourth quarters of the calendar year.
Research and Development (“R&D”)
We believe that our research and development capabilities coupled with our integrated, longstanding customer relationships create a distinctive competitive advantage versus our competition. Our three R&D centers are based in Voreppe, France, Brunel University, London, United Kingdom and Plymouth, Michigan.
We invested €48 million in R&D in the year ended December 31, 2022 and €39 million in R&D in each of the years ended December 31, 2021 and 2020.
C-TEC, our R&D center based in Voreppe, France provides services and support to all of our facilities, focusing on product and process development, providing technical assistance to our plants and working with our customers to develop new products. In developing new products, we focus on increased performance that aims to lower the total cost of ownership for the end users of our products, for example, by developing materials that decrease maintenance costs of aircraft or increase fuel efficiency in cars. At the Voreppe facility, we also work on the development, improvement, and testing of processes used in our plants such as melting, casting, rolling, extruding, finishing and recycling. In addition, we develop and test technologies used by our customers, such as friction stir welding, and provide technological support to our customers.
Our R&D center in the U.S. located in Plymouth, Michigan provides support primarily to our North American automotive customers by addressing specific market requirements related to our aluminium based lightweighting solutions.
Additionally, in the Constellium University Technology Center at Brunel University London, United Kingdom, a dedicated team of R&D engineers and project managers translate technology from the lab to new customer programs and to our plants for production. The facility features industrial scale casting and extrusion equipment, forming technology and extensive joining methods, enabling us to leverage our proprietary alloys and strong manufacturing innovation capabilities to develop engineered solutions adapted to customer needs, and accelerate time to market.
-30-


As of December 31, 2022, C-TEC, our main R&D center located in Voreppe, France and its hub in Plymouth, Michigan, employed 284 people, approximately 75% of whom were scientists and technicians. Our R&D center in Brunel, England, employed 51 Constellium scientists, in addition to 14 PhD studentships and postdoctoral research fellows from Brunel University and other academic partners.
Trademarks, Patents, Licenses and IT
We actively review intellectual property arising from our operations and our research and development activities and, when appropriate, apply for patents in the appropriate jurisdictions. We currently hold more than 200 active patent families and regularly apply for new ones. While these patents and patent applications are important to the business on an aggregate basis, we do not believe any single patent family or patent application is critical to the business.
We are from time to time involved in opposition and re-examination proceedings that we consider to be part of the ordinary course of our business, in particular at the European Patent Office and the U.S. Patent and Trademark Office. We believe that the outcome of existing proceedings would not have a material adverse effect on our financial position, results of operations or cash flows.
In connection with our collaborations with universities and other third parties, we occasionally obtain royalty-bearing licenses for the use of third-party technologies in the ordinary course of business.
Insurance
We have implemented a corporate-wide insurance program consisting of both master policies with worldwide coverage and local policies where required by applicable regulations. Our insurance coverage includes: (i) property damage and business interruption; (ii) general liability including operation, professional, product and environment liability; (iii) aviation product liability; (iv) marine cargo (transport); (v) business travel and personal accident; (vi) construction all risk; (vii) automobile liability; (viii) trade credit; (ix) cyber risk; (x) workers’ compensation in the U.S.; and (xi) other specific coverages for executive and special risks.
We believe that our insurance coverage terms and conditions are customary for a business such as Constellium and are sufficient to protect us against catastrophic losses.
We also purchase and maintain insurance on behalf of our directors and officers.
Governmental Regulations and Environmental, Health and Safety Matters
Our operations are subject to a number of international, national, state and local regulations relating to the protection of the environment and to workplace health and safety. Our operations involve the use, handling, storage, transportation and disposal of hazardous substances, and accordingly we are subject to extensive laws and regulations governing emissions to air, discharges to water emissions, the generation, storage, transportation, treatment or disposal of hazardous materials or wastes and employee health and safety matters. In addition, prior operations at certain of our properties have resulted in contamination of soil and groundwater which we are required to investigate and remediate pursuant to applicable environmental, health and safety (“EHS”) laws and regulations. Environmental compliance at our key facilities is supervised by the Direction Régionale de l’Environnement de l’Aménagement et du Logement in France, the Umweltbundesamt in Germany, the Service de la Protection de l’Environnement du Canton du Valais in Switzerland, the United States Environmental Protection Agency, West Virginia Department of Environmental Protection, the Alabama Department of Environmental Management, the Kentucky Department for Environmental Protection, Georgia Environmental Protection Division and Michigan Department of Environment, Great Lakes and Energy in the United States, the Regional Authority of the Usti Region in the Czech Republic, the Slovenká Insvpekcia zvivotného prostredia in Slovakia, Secretaria de Medio Ambiente y Recursos Naturales in Mexico, the Environmental Monitoring Agency in China, Consellería de Medioambiente, Territorio y Vivienda in Spain and Enforcement Branch Ontario region in Canada. Violations of EHS laws and regulations, and remediation obligations arising under such laws and regulations, may result in restrictions being imposed on our operating activities as well as fines, penalties, damages or other costs. Accordingly, we have implemented EHS policies and procedures to protect the environment and ensure compliance with these laws, and incorporate EHS considerations into our planning for new projects. We perform regular risk assessments and EHS reviews. We closely and systematically monitor and manage situations of noncompliance with EHS laws and regulations and cooperate with authorities to redress any noncompliance issues. We believe that we have made adequate reserves with respect to our remediation and compliance obligations. Nevertheless, new regulations or other unforeseen increases in the number of our non-compliant situations may impose costs on us that may have a material adverse effect on our financial condition, results of operations or liquidity.
-31-


Our operations also result in the emission of substantial quantities of carbon dioxide, a greenhouse gas that is regulated under the EU’s Emissions Trading System (“ETS”). Although compliance with ETS to date has not resulted in material costs to our business, compliance with ETS requirements currently being developed for the 2021-2030 period, and increased energy costs due to ETS requirements imposed on our energy suppliers, could have a material adverse effect on our business, financial condition or results of operations. We may also be liable for personal injury claims or workers’ compensation claims relating to exposure to hazardous substances. In addition, we are, from time to time, subject to environmental reviews and investigations by relevant governmental authorities.
E.U. Directive 2010/75 titled “Industrial Emissions” regulates some of our European activities as recycling or melting/casting. With the revision of the Best Available Technics Reference of Non Ferrous Metals in 2016, which defines associated emissions limits values for these activities applicable in 2020 at the latest, staying in compliance with the law requires significant expenditures to tune our processes or implement abatement installations.
Additionally, some of the chemicals we use in our fabrication processes are subject to REACH in the EU. Under REACH, we are required to register some of the substances contained in our products with the European Chemicals Agency, and this process could cause significant delays or costs. We are currently compliant with REACH, and expect to stay in compliance, but if the nature of the regulation changes in the future, or if the perimeter of REACH is changing (e.g. Brexit) or if substances we use currently in our process, considered as Substances of Very High Concern, fall under need of authorization for use, we may be required to make significant expenditures to reformulate the chemicals that we use in our products and materials or incur costs to register such chemicals to gain and/or regain compliance. Future noncompliance could also subject us to significant fines or other civil and criminal penalties. Obtaining regulatory approvals for chemical products used in our facilities is an important part of our operations.
We accrue for costs associated with environmental investigations and remedial efforts when it becomes probable that we are liable and the associated costs can be reasonably estimated. The aggregate close down and environmental remediation costs provisions at December 31, 2022 were €86 million. All accrued amounts have been recorded without giving effect to any possible future recoveries. With respect to ongoing environmental compliance costs, including maintenance and monitoring, we expense the costs when incurred.
We have incurred, and in the future will continue to incur, operating expenses related to environmental compliance. As part of our general capital expenditure plan, we expect to incur capital expenditures for other capital projects that may, in addition to improving operations, reduce certain environmental impacts as energy consumption, air emissions, water releases, waste streams optimization.
Litigation and Legal Proceedings
The Company is involved, and may become involved, in various lawsuits, claims and proceedings relating to customer claims, product liability, employee and retiree benefit matters, and other commercial matters. The Company records provisions for pending litigation matters when it determines that it is probable that an outflow of resources will be required to settle the obligation, and such amounts can be reasonably estimated. In some proceedings, the issues raised are or can be highly complex and subject to significant uncertainties and amounts claimed are and can be substantial. As a result, the probability of loss and an estimation of damages are and can be difficult to ascertain. From time to time, asbestos-related claims are also filed against us, relating to historic asbestos exposure in our production process. We have made reserves for potential occupational disease claims for a total of €10 million as of December 31, 2022. It is not anticipated that any of our currently pending litigation and proceedings will have a material effect on the future results of the Company.
-32-


C.Organizational Structure
The following diagram reflects our simplified corporate legal entity structure as of March 10, 2023. Percentages reflect ownership interest where ownership interest is less than 100%. The country listed for each legal entity below depicts such entity’s jurisdiction of incorporation.
cstm-20221231_g11.jpg

-33-


D.Property, Plants and Equipment
At December 31, 2022, we operated 29 manufacturing facilities serving both global and local customers and three R&D centers, two in Europe and one in the United States. Among our production sites, we have seven major facilities (Muscle Shoals, Alabama, Neuf-Brisach, France, Issoire, France, Ravenswood, West Virginia, Singen, Germany, Déčín, Czech Republic and Sierre, Switzerland) catering to the needs of our Packaging & Automotive Rolled Products, Aerospace & Transportation and Automotive Structures & Industry operating segments:
The Muscle Shoals, Alabama facility is an integrated recycling, casting, rolling and finishing plant. It operates one of the largest and most efficient can reclamation facilities in the world. In addition, the facility utilizes multi-station electromagnetic casting, houses the widest hot line in North America and has the fastest can end stock coating line in the world. Production capabilities include body stock, tab stock, and end stock. In addition, we are producing cold coils for ABS. The capital expenditures invested in the facility were €134 million in the three-year period ended December 31, 2022.
The Neuf-Brisach, France plant is an integrated recycling, casting, rolling and finishing facility. The plant is one of the biggest recyclers of aluminium in Europe, capable of producing sheets for the beverage and food can industries, with high levels of recycled content. With its state-of-the-art automotive finishing capabilities, the plant is well positioned as a major supplier of aluminium ABS. The plant also enjoys a strong position in heat exchanger material for the automotive market. The capital expenditures invested in the facility were €107 million in the three-year period ended December 31, 2022.
The Issoire, France facility is one of the world’s two leading integrated aerospace plate mills based on volume. The plant operates two Airware® industrial casthouses and currently uses recycling capabilities to take back scrap along the entire fabrication chain. Issoire also produces high-technology materials for the space market. Issoire works as an integrated platform with Ravenswood, West Virginia and Sierre, Switzerland, providing a significant competitive advantage for us as a global supplier to the aerospace industry. Issoire also produces sheet and plate products for the transportation, industry and defense markets with significant capabilities. The capital expenditures invested in the facility were €82 million in the three-year period ended December 31, 2022.
The Ravenswood, West Virginia facility is an integrated plant which has significant capability to produce plate and sheet products for the aerospace, transportation, industry and defense markets. The facility has stretchers and wide-coil capabilities that make it one of the few facilities in the world capable of producing plates of a size needed for the largest commercial aircraft. The capital expenditures invested in the facility were €73 million in the three-year period ended December 31, 2022.
The Singen, Germany rolling and extrusions plant has capabilities to make sheet and extruded products for the automotive, packaging, rail and other markets. The rolling operations are an integrated producer of aluminium sheet products primarily for specialty end markets. The extrusion operations have one of the largest extrusion presses in Europe and advanced extrusion presses that support the demand for automotive extrusions. In 2022, we invested to further improve our rolling capabilities and product quality. The capital expenditures invested in the facility were €102 million in the three-year period ended December 31, 2022.
The Děčín, Czech Republic facility is a large integrated extrusion facility, mainly focusing on hard alloy extrusions for automotive and industrial applications, with significant recycling capabilities. It is located near the German border, strategically positioning it to supply the German, Czech and French Tier 1 suppliers and OEMs. Its integrated casthouse allows it to offer high value-add customized hard alloys to our customers. The capital expenditures invested in the facility were €15 million in the three-year period ended December 31, 2022.
The Sierre, Switzerland facility is dedicated to precision plates for general engineering, aerospace plates and slabs and is a leading supplier of extruded products for high-speed train railway manufacturers and a wide range of applications. The Sierre facility includes the Steg casthouse that produces automotive, general engineering and aerospace slabs and the Chippis casthouse that has the capacity to produce non-standard billets for a wide range of extrusions. Its qualification to produce aerospace grade slabs and plate products increases the flexibility of our aerospace capabilities. The capital expenditures invested in the facility were €37 million in the three-year period ended December 31, 2022.
-34-


Our manufacturing facilities as of December 31, 2022 are listed below by operating segment:
LocationCountryOwned/
Leased
Packaging & Automotive Rolled Products
Biesheim, Neuf-BrisachFranceOwned
SingenGermanyOwned
Muscle Shoals, ALUnited StatesOwned
Bowling Green, KYUnited StatesOwned
Aerospace & Transportation
Ravenswood, WVUnited StatesOwned
IssoireFranceOwned
Montreuil-JuignéFranceOwned
Ussel(1)
FranceOwned
StegSwitzerlandOwned
SierreSwitzerlandOwned
Automotive Structures & Industry
Van Buren, MIUnited StatesLeased
Changchun, Jilin Province (JV)(2)
ChinaLeased
DěčínCzech RepublicOwned
Nuits-Saint-GeorgesFranceOwned
BurgGermanyOwned
CrailsheimGermanyOwned
NeckarsulmGermanyOwned
GottmadingenGermanyOwned
Landau/PfalzGermanyOwned
SingenGermanyOwned
LeviceSlovakiaOwned
ChippisSwitzerlandOwned
SierreSwitzerlandOwned
White, GAUnited StatesLeased
Lakeshore, Ontario (JV)(3)
CanadaLeased
San Luis PotosiMexicoLeased
ZilinaSlovakiaLeased
VigoSpainLeased
NanjingChinaLeased
(1)Our facility in Ussel was sold in February 2023.
(2)Constellium Engley (Changchun) Automotive Structures Co Ltd is a Constellium joint venture with Changchun Engley Auto Parts Co. Ltd.
(3)Astrex Inc. is a Constellium joint venture with Can Art Aluminium Extrusions Inc.

-35-


The production capacity for our main plants as of December 31, 2022 is listed below. In 2022, the estimated utilization rate for these plants ranged from 70% to 99%.
PlantCapacity
Neuf-Brisach450 kt
Muscle Shoals
500-550 kt
Issoire110 kt
Ravenswood175 kt
Děčín106 kt
Singen
300-320 kt
Sierre
70-75 kt
Production capacity is an estimate based on a theoretical output capacity assuming the plant operates with currently operating equipment and current staffing levels and product mix.
For information concerning the material plans to construct, expand or improve facilities, see “Item 5. Operating and Financial Review and Prospects—Liquidity and Capital Resources.”
Item 4A. Unresolved Staff Comments
None.
Item 5. Operating and Financial Review and Prospects
The following discussion and analysis is based principally on our audited Consolidated Financial Statements as of December 31, 2022 and 2021 and for the three years in the period ended December 31, 2022 included elsewhere in this Annual Report and is provided to supplement the audited Consolidated Financial Statements and the related notes to help provide an understanding of our financial condition, changes in financial condition, results of our operations, and liquidity. The following discussion is to be read in conjunction with Selected Financial Data and our audited Consolidated Financial Statements and the notes thereto which are included elsewhere in this Annual Report.
The following discussion and analysis includes forward-looking statements. These forward-looking statements are subject to risks, uncertainties and other factors that could cause our actual results to differ materially from those expressed or implied by our forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, those discussed below and elsewhere in this Annual Report. See in particular “Special Note about Forward-Looking Statements” and “Item 3. Key Information—D. Risk Factors.”
Overview
We are a global leader in the development, manufacture and sale of a broad range of highly engineered, value-added specialty rolled and extruded aluminium products to the packaging, aerospace, automotive, other transportation and industrial end-markets. As of December 31, 2022, we had approximately 12,500 employees, 29 production facilities, 3 R&D centers, and 3 administrative centers.
We serve a diverse set of customers across a broad range of end-markets with very different product needs, specifications and requirements. As a result, we have organized our business into three segments to better serve our customer base:
Our Packaging & Automotive Rolled Products segment produces aluminium sheet and coils, which primarily includes beverage and food can stock, closure stock, foil stock and automotive rolled products.
Our Aerospace & Transportation segment produces technologically advanced aluminium products, including plate, sheet and other fabricated products with applications across the aerospace, defense, transportation, and industrial sectors.
Our Automotive Structures & Industry segment produces technologically advanced structures for the automotive industry (including crash-management systems, body structures, side impact beams and battery enclosures), soft and hard alloy extrusions and large extruded profiles for automotive, rail, energy, building and industrial applications.
-36-


For the year ended December 31, 2022, our segments represented the following percentages of total Revenue and total Adjusted EBITDA:
Year ended December 31, 2022
(as a % of total)RevenueAdjusted EBITDA
P&ARP57 %49 %
A&T21 %32 %
AS&I22 %22 %
Holdings and Corporate— %(3)%
Total100 %100 %
Management Review of 2022 and Outlook
Review
Constellium delivered strong results in 2022 despite lingering effects from the COVID-19 crisis and the war in Ukraine, including significant inflationary pressures and continuing supply chain disruptions. Shipments were stable at 1.6 million metric tons. We reported revenue of €8.1 billion and net income of €308 million. We achieved record Adjusted EBITDA of €673 million, including record results in both A&T and AS&I. We generated strong cash flows from operating activities and reduced our net debt leverage to 2.8x Adjusted EBITDA.
Outlook
Looking forward to 2023, Constellium expects aerospace demand to remain strong as the path of recovery continues and automotive demand to improve, but to remain below pre-COVID levels. In packaging, we are experiencing weakness as we begin the year, but, as customer excess inventory is depleted, we expect demand to return to trend growth rates underpinned by strong consumer demand for infinitely recyclable aluminium cans.
We are expecting inflationary cost pressures to continue at an elevated level throughout 2023 across our business including energy, labor and alloying metal costs. However, we expect to be able to offset a substantial portion of the impact with improved pricing and our relentless focus on cost control.
To prepare for our long-term growth, we are planning to invest, more than we have in the past, in activities where we see the most potential, particularly in additional recycling capacity. Our products are at the core of the circular economy of tomorrow, and we remain confident in our ability to navigate through the challenging market environment.
Key Factors Influencing Constellium’s Financial Condition and Results from Operations
Russian War on Ukraine
Although we do not have operations in Russia or Ukraine, the conflict and the related sanctions imposed on Russian institutions, companies and individuals continue to generate volatility and disruption in the global economy, including issues with supply chains and increased commodity and energy prices. It is difficult at this time to predict the length and impact of this crisis on the global economy and on the price and availability of metal and energy. We are monitoring the situation closely and continue to develop contingency plans and counter-measures as necessary to address adverse effects or disruptions to our operations as they develop. However, the broader consequences of this conflict and its impact on our business and results of operations as well as the global economy cannot be predicted.
Economic Conditions and Markets
We are directly impacted by the economic conditions that affect our customers and the markets in which they operate. General economic conditions such as the level of disposable income, the level of inflation, the rate of economic growth, the rate of unemployment, interest rates, exchange rates and currency devaluation or revaluation influence consumer confidence and consumer purchasing power. These factors, in turn, influence the demand for our products in terms of total volumes and prices
-37-


that can be charged. We attempt to respond to the variability of economic conditions through the terms of our contracts with our customers and cost control.
In addition, although a number of our end-markets are cyclical in nature, we believe that the diversity of our portfolio and the secular growth trends we are experiencing in many of our core packaging, automotive and aerospace end markets will help the Company weather these economic cycles.
Can packaging tends not to be highly correlated to the general economic cycle. In addition, we believe can sheet has an attractive long-term growth outlook due to increased consumer preference for cans as a package and the sustainable attributes of aluminium.
The automotive markets continue to be impacted globally by the semi-conductor shortages and other supply chain challenges. However, longer term demand for aluminium has been increasing in recent years triggered by a light-weighting trend for new car models, which increases fuel efficiency, reduces emissions and increases vehicle safety. We expect this to continue and be enhanced by increased demand for electric vehicles.
While aerospace demand had been adversely impacted following the COVID crisis, it has more recently significantly recovered. We continue to believe the longer term trends including increasing passenger traffic and fleet replacements with newer and more fuel efficient aircraft support a positive long term demand trend.
Aluminium Consumption
The aluminium industry is cyclical and is affected by global economic conditions, industry competition and product development. Aluminium is increasingly seen as the material of choice in a number of applications, including packaging, automotive and aerospace given its lightweight high strength-to-weight ratio, corrosion resistance and infinite recyclability. Due to these qualities, the penetration of aluminium in a wide variety of applications continues to increase. We believe that long-term growth in aluminium consumption generally, and demand for those products we produce specifically, will be supported by factors that include growing populations, greater purchasing power and increasing focus on sustainability and environmental issues, globally.
Aluminium Prices
Raw materials and consumables, where aluminium is the largest component by a wide margin, represented 74%, 71% and 64% of our cost of sales in the years ended December 31, 2022, 2021 and 2020, respectively. Aluminium prices are determined by worldwide forces of supply and demand and are volatile. We operate a pass–through model and therefore, to the extent possible, avoid taking aluminium price risk. In case of significant sustained increases in the price of aluminium, the demand for our products may be affected over time.
The price we pay for aluminium includes regional premiums, such as the Rotterdam premium for metal purchased in Europe or the Midwest premium for metal purchased in the U.S. The regional premiums have been volatile in recent years. Like LME prices, we seek to pass-through this regional premium price risk to our customers or to hedge it in the financial markets. However, in certain instances, we are not able to pass through or hedge this cost.
We believe our cash flows are largely protected from variations in LME prices due to the fact that we hedge the majority of our sales based on their replacement cost, by matching the price paid for our aluminium purchases with the price received from our aluminium sales, at a given time, using hedges when necessary. As a result, when LME prices increase, we have limited additional cash requirements to finance the increased replacement cost of our inventory.
The average LME transaction price, Rotterdam Premium and Midwest Premium per ton of primary aluminium in the years ended December 31, 2022, 2021 and 2020 are presented below.
-38-


Year ended December 31,Percent changes
(Euros per ton)2022202120202022 vs 20212021 vs 2020
Average LME transaction price
2,560 2,099 1,491 22 %41 %
Average Rotterdam Premium (ECDP)445 231 111 93 %108 %
Average all-in aluminium price Europe
3,005 2,330 1,602 29 %45 %
Average LME transaction price
2,560 2,099 1,491 22 %41 %
Average Midwest Premium622 491 238 27 %106 %
Average all-in aluminium price U.S.
3,182 2,590 1,729 23 %50 %
Product Price and Margin
Our products are typically priced based on three components: (i) the LME price, (ii) a regional premium and (iii) a conversion margin.
Our risk management practices aim to reduce, but do not entirely eliminate, our exposure to changing primary aluminium and regional premium prices. Moreover, while we limit our exposure to unfavorable price changes, we also limit our ability to benefit from favorable price changes. We do not apply hedge accounting for the derivative instruments entered into to hedge our exposure to changes in metal prices and the mark-to-market movements for these instruments are recognized in Other gains and losses—net.
Our results are also impacted by changes in the difference between the prices of primary and scrap aluminium. As we price our products using the prevailing price of primary aluminium but purchase large amounts of scrap aluminium to manufacture our products, we benefit when primary aluminium price increases exceed scrap price increases. Conversely, when scrap price increases exceed primary aluminium price increases, our results are negatively impacted. The difference between the price of primary aluminium and scrap price is referred to as the “scrap spread” and is impacted by the effectiveness of our scrap purchasing activities, the supply of scrap available and movements in the terminal commodity markets.
Volumes
The profitability of our businesses is determined, in part, by the volume of tons processed and sold. Increased production volumes will generally result in lower per unit costs. Higher volumes sold will generally result in additional revenue and associated margins.
Personnel Costs
Our operations are labor intensive. Our personnel costs were €1,110 million, €967 million and €902 million, and represented 14%, 17% and 19% of our cost of sales, selling and administrative expenses and R&D expenses for the years ended December 31, 2022, 2021, and 2020, respectively. Personnel costs include the salaries, wages and benefits of our employees, as well as costs related to temporary labor. During our seasonal peaks and especially during the summer months, we have historically increased our temporary workforce to compensate for staff on vacation and increased volume of activity.
Personnel costs generally increase and decrease with the expansion or contraction in production levels of operating facilities. Personnel costs also generally increase in periods of higher inflation.
Energy
Our operations require substantial amounts of energy to run, primarily electricity and natural gas. Energy costs were €274 million, €149 million, €141 million, and represented 4%, 3% and 3% of our cost of sales in the years ended December 31, 2022, 2021 and 2020, respectively.
The direction of energy costs depends on the energy supply demand relationships in the regions we operate and will likely continue being impacted by the effects of the war in Ukraine and related sanctions. The current geopolitical instability resulting from the war in Ukraine is also exposing us to the risk of energy supply disruptions. In addition, sustainability trends are expected to put upward pressure on energy costs over time. A significant increase in energy costs or disruption of energy supply could have a material adverse effect on financial position, results of operations, and cash flows.
-39-


Currency
We are a global company with operations in France, the United States, Germany, Switzerland, the Czech Republic, Slovakia, Spain, Mexico, Canada and China. As a result, our revenue and earnings have exposure to a number of currencies, primarily the euro, the U.S. dollar and the Swiss franc. As our presentation currency is the euro, and the functional currencies of the businesses located outside of the Eurozone are primarily the U.S. dollar and the Swiss franc, the results of the businesses located outside of the Eurozone must be translated each period to euros. Accordingly, fluctuations in the exchange rate of the functional currencies of our businesses located outside of the Eurozone against the euro have a translation impact on our results of operations.
In addition, transaction impacts arise when our businesses transact in a currency other than their own functional currency. As a result, we are exposed to foreign exchange risk on payments and receipts in multiple currencies. In Europe, a portion of our revenue is denominated in U.S. dollars while the majority of our costs incurred are denominated in local currencies.
We engage in hedging activities to attempt to mitigate the effects of foreign currency transactions on our cash flows, notably, where we have multiple-year sales agreements in U.S. dollars by euro-functional currency entities, we have entered into derivative contracts to forward sell U.S. dollars to match these future sales. With the exception of certain derivative instruments entered into to hedge the foreign currency risk associated with the cash flows of certain highly probable forecasted sales, which we have designated for hedge accounting, hedge accounting is not applied to such ongoing commercial transactions and therefore the mark-to-market impact is recorded in Other gains and losses —net.

Results of Operations
For the years ended December 31,
(in millions of Euros and as a % of revenue)202220212020
Revenue8,120 100 %6,152 100 %4,883 100 %
Cost of sales(7,448)92 %(5,488)89 %(4,393)90 %
Gross profit672 8 %664 11 %490 10 %
Selling and administrative expenses(282)%(258)%(237)%
Research and development expenses(48)%(39)%(39)%
Other gains and losses - net(8)— %117 %(89)%
Income from operations334 4 %484 8 %125 3 %
Finance costs - net(131)%(167)%(159)%
Income before tax203 3 %317 5 %(34)1 %
Income tax benefit / (expense)105 %(55)%17 — %
Net income308 4 %262 4 %(17) %
Shipment volumes (in kt)1,580 n/a1,571 n/a1,431 n/a
Revenue per ton (€ per ton)5,138 n/a3,916 n/a3,412 n/a
Results of Operations for the years ended December 31, 2022 and 2021
Revenue
For the year ended December 31, 2022, revenue increased by 32% to €8,120 million from €6,152 million for the year ended December 31, 2021. This increase reflected stable shipments and higher revenue per ton.
For the year ended December 31, 2022, sales volumes were relatively stable with a 1% increase to 1,580 kt from 1,571 kt for the year ended December 31, 2021. This increase reflected an 8% increase in volumes for A&T, a 2% increase in volumes for AS&I, partially offset by a 1% decrease in volumes for P&ARP. For the year ended December 31, 2022, revenue per ton increased by 31% to €5,138 from €3,916 for the year ended December 31, 2021 reflecting higher metal prices and a stronger mix.
Our revenue is discussed in more detail in the “Segment Results” section.
-40-


Cost of Sales
For the year ended December 31, 2022, cost of sales increased by 36% to €7,448 million from €5,488 million for the year ended December 31, 2021. This increase in cost of sales was primarily driven by an increase of €1,660 million, or 43%, in raw materials and consumables used due to higher metal prices, a €127 million, or 17%, increase in labor costs and a €124 million, or 84%, increase in energy costs.
Selling and Administrative Expenses
For the year ended December 31, 2022, selling and administrative expenses increased by 9% to €282 million from €258 million for the year ended December 31, 2021. This increase was primarily due to a €12 million increase in labor costs and an €8 million increase in professional fees.
Research and Development Expenses
For the year ended December 31, 2022, research and development expenses increased by €9 million to €48 million from €39 million for the year ended December 31, 2021. Research and development expenses are presented net of €9 million of research and development tax credits received in France for each of the years ended December 31, 2022 and 2021. In the year ended December 31, 2022, research and development expenses, excluding tax credits received were €25 million, €16 million, €14 million and €2 million for the P&ARP, A&T, AS&I and Holding & Corporate segments, respectively. In the year ended December 31, 2021, research and development expenses, excluding tax credits received were €22 million, €13 million, €12 million and €1 million for the P&ARP, A&T, AS&I and Holding & Corporate segments, respectively.
Other Gains and Losses, net
For the years ended December 31,
(in millions of Euros)20222021
Realized (losses) / gains on derivatives(6)113 
Unrealized (losses) / gains on derivatives at fair value through profit and loss—net(47)39 
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities—net(1)
Restructuring costs(1)(3)
Gains / (losses) on pension plan amendments47 (32)
Losses on disposal(4)(3)
Other
Total other gains and losses, net(8)117 
The following table provides an analysis of the realized and unrealized gains and losses by nature of exposure:
For the years ended December 31,
(in millions of Euros)20222021
Realized gains on foreign currency derivatives— 
Realized (losses) / gains on commodity derivatives(6)112 
Realized (losses) / gains on derivatives(6)113 
Unrealized gains on foreign currency derivatives15 
Unrealized (losses) / gains on commodity derivatives(53)24 
Unrealized (losses) / gains on derivatives at fair value through profit and loss—net(47)39 
Realized gains or losses relate to financial derivatives used by the group to hedge underlying commercial transactions. Realized gains and losses on these derivatives are recognized in Other Gains and Losses, net and are offset by the commercial transactions accounted for in revenue and cost of sales.
-41-


Unrealized gains or losses relate to financial derivatives used by the group to hedge forecasted commercial transactions for which hedge accounting is not applied. Unrealized gains or losses on these derivatives are recognized in Other Gains and Losses, net and are intended to offset the change in the value of forecasted transactions which are not yet accounted for.
Changes in realized and unrealized gains or losses on derivatives for the year ended December 31, 2022 as compared to the year ended December 31, 2021 primarily reflected the fluctuation in metal prices.
For the year ended December 31, 2022, restructuring costs were €1 million. For the year ended December 31, 2021, restructuring costs were €3 million and were primarily related to restructuring plans in the U.S. and in Europe in our A&T segment.
In October 2022, Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 entered into a new three-year collective bargaining agreement. The agreement included changes in OPEB and pension benefits that are accounted for as a plan amendment in the year ended December 31, 2022. The changes resulted in a reduction of the OPEB obligation recorded as a gain from negative past service cost for €49 million and an increase of the pension obligation recorded as an additional past service cost for €2 million. In 2021, the group recognized a loss of €31 million from past service cost following an adverse decision of the Fourth Circuit Court of Appeals in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network.
Finance Costs, net
For the year ended December 31, 2022, finance costs, net decreased by €36 million, to €131 million from €167 million for the year ended December 31, 2021. This decrease primarily reflects one-time costs incurred in 2021, which included €15 million of redemption fees and a €12 million write-off of unamortized debt issuance costs relating to the refinancing of our Senior Notes in February and June 2021 and partial repayment in November 2021 as well as lower interest costs in 2022.
Income Tax
For the years ended December 31, 2022 and 2021, income tax was a benefit of €105 million and an expense of €55 million, respectively.
For the year ended December 31, 2022, income tax was significantly impacted by the recognition of previously unrecognized deferred tax assets related to one of our main operating entities in the United States, which resulted in a €154 million tax benefit being recorded in the period. Excluding this impact, our effective tax rate was 24% of our income before income tax compared to a statutory tax rate of 25.8%. Our effective tax rate was lower than the statutory rate, primarily due to the favorable impact of the geographical mix of our pre-tax results.
For the year ended December 31, 2021, our effective tax rate was 17% of our income before income tax compared to a statutory rate of 28.4%. Our effective tax rate was lower than the statutory rate, primarily due to the favorable impact from the use of previously unrecognized deferred tax assets and the geographical mix of our pre-tax results.
The statutory tax rate decreased to 25.8% in the year ended December 31, 2022 from 28.4% in the year ended December 31, 2021 as a result of changes in the applicable tax rates in France.
Net Income / Loss
As a result of the foregoing factors, we recognized net income of €308 million in the year ended December 31, 2022 compared to net income of €262 million in the year ended December 31, 2021.
-42-


Results of Operations for the years ended December 31, 2021 and 2020
Revenue
For the year ended December 31, 2021, revenue increased by 26% to €6,152 million from €4,883 million for the year ended December 31, 2020. This increase reflected an increase in shipments and higher revenue per ton.
For the year ended December 31, 2021, sales volumes increased by 10% to 1,571 kt from 1,431 kt for the year ended December 31, 2020. This increase reflected an 8% increase in volumes for P&ARP, a 13% increase in volumes for A&T and a 14% increase in volumes for AS&I. For the year ended December 31, 2021, revenue per ton increased by 15% to €3,916 from €3,412 for the year ended December 31, 2020 reflecting higher metal prices partially offset by weaker mix.
Our revenue is discussed in more detail in the “Segment Results” section.
Cost of Sales
For the year ended December 31, 2021, cost of sales increased by 25% to €5,488 million from €4,393 million for the year ended December 31, 2020. This increase in cost of sales was primarily driven by an increase of €1,053 million, or 37%, in raw materials and consumables used due to higher volumes and higher metal prices and a €43 million, or 6%, increase in labor costs.
Selling and Administrative Expenses
For the year ended December 31, 2021, selling and administrative expenses increased by 9% to €258 million from €237 million for the year ended December 31, 2020. This increase was primarily due to a €24 million increase in labor costs, partially offset by a reduction of professional fees of €3 million.
Research and Development Expenses
For the year ended December 31, 2021, research and development expenses were stable at €39 million compared to the year ended December 31, 2020. Research and development expenses are presented net of €9 million and €10 million of research and development tax credits received in France for the years ended December 31, 2021 and 2020, respectively. In the year ended December 31, 2021, research and development expenses, excluding tax credits received were €22 million, €13 million, €12 million and €1 million for the P&ARP, A&T, AS&I and Holding & Corporate segments, respectively. In the year ended December 31, 2020, research and development expenses, excluding tax credits received were €19 million, €14 million, €13 million and €3 million for the P&ARP, A&T, AS&I and Holding & Corporate segments, respectively.
Other Gains and losses, net
For the years ended December 31,
(in millions of Euros)20212020
Realized gains / (losses) on derivatives113 (35)
Unrealized gains on derivatives at fair value through profit and loss—net39 16 
Losses reclassified from OCI as a result of hedge accounting discontinuation— (6)
Unrealized exchange gains from the remeasurement of monetary assets and liabilities—net
Impairment of assets— (43)
Restructuring costs(3)(13)
Losses on pension plan amendments(32)(2)
Losses on disposal(3)(4)
Other(3)
Total other gains and losses, net117 (89)
-43-


The following table provides an analysis of the realized and unrealized gains and losses by nature of exposure:
For the years ended December 31,
(in millions of Euros)20212020
Realized gains / (losses) on foreign currency derivatives(4)
Realized gains / (losses) on commodity derivatives112 (31)
Realized gains / (losses) on derivatives113 (35)
Unrealized gains / (losses) on foreign currency derivatives15 (9)
Unrealized gains on commodity derivatives24 25 
Unrealized gains on derivatives at fair value through profit and loss—net39 16 
Realized gains or losses relate to financial derivatives used by the group to hedge underlying commercial transactions. Realized gains and losses on these derivatives are recognized in Other Gains and Losses, net and are offset by the underlying commercial transactions accounted for in revenue and cost of sales.
Unrealized gains or losses relate to financial derivatives used by the group to hedge forecasted commercial transactions. Unrealized gains or losses on these derivatives are recognized in Other Gains and Losses, net and are offset by the change in the value of forecasted transactions which are not yet accounted for.
Changes in realized and unrealized gains / (losses) on derivatives for the year ended December 31, 2021 as compared to the year ended December 31, 2020 were primarily due to the increase in metal prices.
In 2020, we determined that a portion of the hedged forecasted sales for the remainder of 2020 and for 2021 to which hedge accounting was applied were no longer expected to occur. Consequently, the fair value of the related derivatives accumulated in equity was reclassified to the income statement, which resulted in a €6 million loss for the year ended December 31, 2020.
In 2020, impairment charges of €43 million were primarily comprised of a €9 million and a €7 million impairment related to long lived assets of our Montreuil-Juigné, France and Ussel, France operations, respectively, within our A&T segment and a €13 million and €12 million impairment related to long lived assets of our White, GA, U.S. and Nanjing, China operations, respectively, within the AS&I segment.
For the year ended December 31, 2021, restructuring costs were €3 million. For the year ended December 31, 2020, restructuring costs were €13 million and were primarily related to restructuring plans in the U.S. and in Europe tied to the impact of COVID-19.
In 2021, the group recognized a loss of €31 million from past service costs following an adverse decision of the Fourth Circuit Court of Appeals in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network.
Finance Costs, net
For the year ended December 31, 2021, finance costs, net increased by €8 million, to €167 million from €159 million for the year ended December 31, 2020. This increase primarily reflects one-time costs, which included €15 million of redemption fees and a €12 million write-off of unamortized debt issuance costs relating to the refinancing of our Senior Notes in February and June 2021 and partial repayment in November 2021, partially offset by lower interest costs.
Income Tax
For the year ended December 31, 2021 and 2020, income tax was an expense of €55 million and a benefit of €17 million, respectively.
-44-


For the year ended December 31, 2021, our effective tax rate was 17% of our income before income tax compared to a statutory tax rate of 28.4%. Our effective tax rate was lower than the statutory rate, primarily due to the favorable impact from the use of previously unrecognized deferred tax assets and the geographical mix of our pre-tax results.
For the year ended December 31, 2020, our effective tax rate was 49% of our loss before income tax compared to a statutory rate of 32.0%. Our effective tax rate was higher than the statutory rate, due to the geographical mix of our pre-tax results and the favorable impact of the CARES Act and certain clarifications of tax law in the U.S. which allowed for the recognition of additional deferred tax assets on prior year loss carryforwards.
The statutory tax rate decreased to 28.4% in the year ended December 31, 2021 from 32.0% in the year ended December 31, 2020 as a result of changes in the applicable tax rates in France.
Net Income / Loss
As a result of the foregoing factors, we reported net income of €262 million in the year ended December 31, 2021 compared to a net loss of €17 million in the year ended December 31, 2020.
Segment Results
Segment Revenue
The following table sets forth the revenue for our operating segments for the periods presented:
For the years ended December 31,
(in millions of Euros and
as a % of revenue)
202220212020
P&ARP4,664 57 %3,698 60 %2,734 56 %
A&T1,700 21 %1,142 18 %1,025 20 %
AS&I1,861 22 %1,383 22 %1,167 24 %
Inter-segment eliminations(105)n.m.(71)n.m.(43)n.m.
Total revenue8,120 100 %6,152 100 %4,883 100 %
n.m. not meaningful
P&ARP
For the year ended December 31, 2022, revenue in our P&ARP segment increased 26% to €4,664 million from €3,698 million for the year ended December 31, 2021, reflecting higher revenue per ton partially offset by lower shipments. P&ARP shipments were down 1% or 15 kt, due to lower shipments in packaging and specialty and other thin-rolled products largely offset by higher shipments in automotive rolled products. For the year ended December 31, 2022, revenue per ton increased by 28% to €4,281 per ton from €3,350 per ton for the year ended December 31, 2021, primarily driven by higher metal prices and improved price and mix.
For the year ended December 31, 2021, revenue in our P&ARP segment increased 35% to €3,698 million from €2,734 million for the year ended December 31, 2020, due to higher shipments and higher revenue per ton. P&ARP shipments were up 8% or 85 kt, due to higher shipments in packaging, automotive and specialty and other thin-rolled products. For the year ended December 31, 2021, revenue per ton increased by 25% to €3,350 per ton from €2,683 per ton for the year ended December 31, 2020, primarily driven by higher metal prices.
A&T
For the year ended December 31, 2022, revenue in our A&T segment increased 49% to €1,700 million from €1,142 million for the year ended December 31, 2021, due to higher shipments and higher revenue per ton. A&T shipments were up 8%, or 17 kt, reflecting higher aerospace rolled product shipments, partially offset by lower volumes of transportation, industry, defense and other rolled products. For the year ended December 31, 2022, revenue per ton increased by 37% to €7,619 per ton from €5,548 per ton for the year ended December 31, 2021, primarily reflecting a more favorable mix with higher aerospace product shipments, higher metal prices and a favorable impact from foreign exchange.
-45-


For the year ended December 31, 2021, revenue in our A&T segment increased 11% to €1,142 million from €1,025 million for the year ended December 31, 2020, due to higher shipments, partially offset by lower revenue per ton. A&T shipments were up 13%, or 23 kt, as higher transportation, industry, defense and other rolled product shipments more than offset lower volumes of aerospace rolled products as a result of continued challenging market conditions. For the year ended December 31, 2021, revenue per ton decreased by 1% to €5,548 per ton from €5,601 per ton for the year ended December 31, 2020, primarily reflecting a less favorable mix with lower aerospace product shipments and higher transportation, industry, defense and other rolled product shipments, offset by higher metal prices.
AS&I
For the year ended December 31, 2022, revenue in our AS&I segment increased 35% to €1,861 million from €1,383 million for the year ended December 31, 2021, due to higher shipments and higher revenue per ton. AS&I shipments were up 2%, or 7 kt, on higher shipments of automotive and other extruded products. For the year ended December 31, 2022, revenue per ton increased by 31% to €6,947 per ton from €5,292 per ton for the year ended December 31, 2021, primarily reflecting a more favorable mix with higher automotive extruded products and higher metal prices.
For the year ended December 31, 2021, revenue in our AS&I segment increased 19% to €1,383 million from €1,167 million for the year ended December 31, 2020, due to higher shipments and higher revenue per ton. AS&I shipments were up 14%, or 32 kt, on higher shipments of automotive and other extruded products. For the year ended December 31, 2021, revenue per ton increased by 4% to €5,292 per ton from €5,096 per ton for the year ended December 31, 2020, primarily reflecting higher metal prices partially offset by less favorable mix with a higher proportion of other extruded product shipments.
Segment Adjusted EBITDA
The following table sets forth the Adjusted EBITDA for our operating segments for the periods presented:
For the years ended December 31,
(in millions of Euros and as a % of revenue)202220212020
P&ARP326%344%291 11 %
A&T217 13 %111 10 %106 10 %
AS&I149 %142 10 %88 %
Holdings and Corporate(19)n.m.(16)n.m.(20)n.m.
Total Adjusted EBITDA673 8 %581 9 %465 10 %
n.m. not meaningful
Adjusted EBITDA is not a measure defined by IFRS. We believe the most directly comparable IFRS measure to Adjusted EBITDA is our net income or loss for the relevant period.
In considering the financial performance of the business, we analyze the primary financial performance measure of Adjusted EBITDA in all of our business segments. Our Chief Operating Decision Maker measures the profitability and financial performance of our operating segments based on Adjusted EBITDA. Adjusted EBITDA is defined as income/(loss) from continuing operations before income taxes, results from joint ventures, net finance costs, other expenses and depreciation and amortization as adjusted to exclude restructuring costs, impairment charges, unrealized gains or losses on derivatives and on foreign exchange differences on transactions that do not qualify for hedge accounting, metal price lag (as defined hereafter), share-based compensation expense, effects of certain purchase accounting adjustments, start-up and development costs or acquisition, integration and separation costs, certain incremental costs and other exceptional, unusual or generally non-recurring items.
We believe Adjusted EBITDA, as defined above, is useful to investors as it illustrates the underlying performance of continuing operations by excluding certain non-recurring and non-operating items. Similar concepts of adjusted EBITDA are frequently used by securities analysts, investors and other interested parties in their evaluation of our company and in comparison to other companies, many of which present an adjusted EBITDA-related performance measure when reporting their results.
-46-


Adjusted EBITDA has limitations as an analytical tool. It is not a measure defined by IFRS and therefore does not purport to be an alternative to operating profit or net income as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Adjusted EBITDA is not necessarily comparable to similarly titled measures used by other companies. As a result, you should not consider Adjusted EBITDA in isolation from, or as a substitute analysis for, our results prepared in accordance with IFRS.
The following table reconciles our net income / (loss) to our Adjusted EBITDA:
For the years ended December 31,
(in millions of Euros)202220212020
Net income / (loss)308 262 (17)
Income tax (benefit) / expense (105)55 (17)
Finance costs, net 131 167 159 
Depreciation and amortization 287 267 259 
Impairment of assets — — 43 
Restructuring costs (a)13 
Unrealized losses / (gains) on derivatives 46 (35)(16)
Unrealized exchange losses / (gains) from the remeasurement of monetary assets and liabilities – net (1)(1)
(Gains) / losses on pension plan amendments (b)(47)32 
Share-based compensation 18 15 15 
Metal price lag (c)29 (187)
Start-up and development costs (d)— — 
Losses on disposals
Other (e)— — 
Adjusted EBITDA673 581 465 
__________________
(a)For the years ended December 31, 2022 and 2021, restructuring costs amounted to €1million and €3 million, respectively. For the year ended December 31, 2020 restructuring costs amounted to €13 million and related to A&T headcount reductions in Europe and in the U.S.
(b)In the year ended December 31, 2022 the group recognized a net gain of €47 million from past service cost as a result from a new 3-year collective bargaining agreement between Constellium Rolled Products Ravenswood and the United Steelworkers Local Union 5668 entered in October 2022. The agreement resulted in changes in OPEB and pension benefits that were accounted for as a plan amendment in the year ended December 31, 2022. In the year ended December 31, 2021, the group recognized a loss of €31 million from past service cost following an adverse decision of the Fourth Circuit Court in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network.
(c)Metal price lag represents the financial impact of the timing difference between when aluminium prices included within Constellium's Revenue are established and when aluminium purchase prices included in Cost of sales are established. The Group accounts for inventory using a weighted average price basis and this adjustment aims to remove the effect of volatility in LME prices. The calculation of the Group metal price lag adjustment is based on an internal standardized methodology calculated at each of Constellium’s manufacturing sites and is primarily calculated as the average value of product recorded in inventory, which approximates the spot price in the market, less the average value transferred out of inventory, which is the weighted average of the metal element of cost of sales, based on the quantity sold in the year.
(d)Start-up and development costs, for the year ended December 31, 2020, was related to new projects in our AS&I operating segment.
(e)Other, for the year ended December 31, 2020, included €2 million of procurement penalties and termination fees incurred because of the Groups inability to fulfill certain commitments due to the COVID-19 pandemic and a €6 million loss resulting from the discontinuation of hedge accounting for certain forecasted sales that were determined to be no longer expected to occur in light of the COVID-19 pandemic effects.
-47-



The following table presents the primary drivers for changes in Adjusted EBITDA for each one of our three segments:
(in millions of Euros)P&ARPA&TAS&I
Adjusted EBITDA for the year ended December 31, 2020291 106 88 
Volume56 33 35 
Price and product mix(4)(55)18 
Costs29 
Foreign exchange and other(7)(2)— 
Adjusted EBITDA for the year ended December 31, 2021344 111 142 
Volume(11)28 10 
Price and product mix94 182 74 
Costs(123)(111)(79)
Foreign exchange and other22 
Adjusted EBITDA for the year ended December 31, 2022326 217 149 
P&ARP
For the year ended December 31, 2022, Adjusted EBITDA in our P&ARP segment decreased 5% to €326 million from €344 million for the year ended December 31, 2021, with higher operating costs mainly due to inflation and operating challenges at our Muscle Shoals facility which resulted in higher maintenance costs and slightly lower volumes, partially offset by improved price and mix, favorable metal costs and favorable foreign exchange translation. For the year ended December 31, 2022, Adjusted EBITDA per metric ton decreased by 4% to €299 from €312 for the year ended December 31, 2021.
For the year ended December 31, 2021, Adjusted EBITDA in our P&ARP segment increased 18% to €344 million from €291 million for the year ended December 31, 2020, primarily due to higher shipments, solid cost control and favorable metal costs, partially offset by weaker mix and unfavorable foreign exchange translation. For the year ended December 31, 2021, Adjusted EBITDA per metric ton increased by 9% to €312 from €286 for the year ended December 31, 2020.
A&T
For the year ended December 31, 2022, Adjusted EBITDA in our A&T segment increased 96% to €217 million from €111 million for the year ended December 31, 2021, primarily due to improved price and mix, higher shipments and favorable foreign exchange translation, partially offset by higher operating costs due to inflation and costs associated with the production ramp-up in aerospace. The year ended December 31, 2022 included €18 million in customer payments related to contractual volume commitments. For the year ended December 31, 2022, Adjusted EBITDA per metric ton increased by 81% to €976 from €539 for the year ended December 31, 2021.
For the year ended December 31, 2021, Adjusted EBITDA in our A&T segment increased 5% to €111 million from €106 million for the year ended December 31, 2020, primarily due to higher shipments and strong cost control, partially offset by weaker mix from lower aerospace shipments as a result of continued challenging aerospace market conditions. For the year ended December 31, 2021, Adjusted EBITDA per metric ton decreased by 7% to €539 from €580 for the year ended December 31, 2020.
AS&I
For the year ended December 31, 2022, Adjusted EBITDA in our AS&I segment increased 5% to €149 million from €142 million for the year ended December 31, 2021, primarily due to improved price and mix and higher shipments, partially offset by higher operating costs mainly due to inflation. For the year ended December 31, 2022, Adjusted EBITDA per metric ton increased 2% to €557 per ton from €545 per ton for the year ended December 31, 2021.
For the year ended December 31, 2021, Adjusted EBITDA in our AS&I segment increased 63% to €142 million from €88 million for the year ended December 31, 2020, primarily due to higher shipments, improved price and mix and solid cost
-48-


control. For the year ended December 31, 2021, Adjusted EBITDA per metric ton increased 43% to €545 per ton from €382 per ton for the year ended December 31, 2020.
Holdings & Corporate
Our Holdings and Corporate segment generated Adjusted EBITDA losses of €19 million, €16 million and €20 million for years ended December 31, 2022, 2021 and 2020, respectively.
Liquidity and capital resources
Our primary sources of cash flow have historically been cash flows from operating activities and funding or borrowings from external parties.
Based on our current and anticipated levels of operations, and the condition in our markets and industry, we believe that our cash flows from operations, cash on hand, new debt issuances or refinancing of existing debt facilities, and availability under our factoring and revolving credit facilities will enable us to meet our working capital, capital expenditures, debt service and other funding requirements for the short-term and long-term.
It is our policy to hedge all highly probable or committed foreign currency operating cash flows. As we have significant third party future receivables denominated in U.S. dollars in our euro functional currency entities, we generally enter into combinations of forward contracts with financial institutions, selling forward U.S. dollars against Euros.
When we are unable to align the price and quantity of physical aluminium purchases with that of physical aluminium sales, it is also our policy to enter into derivative financial instruments to pass through the exposure to metal price fluctuations to financial institutions at the time the price is set.
As the U.S. dollar appreciates against the euro or the LME price for aluminium falls, the derivative contracts related to transactional hedging entered into with financial institution counterparties will have a negative mark-to-market.
In addition, we borrow in a combination of euros and U.S. dollars. When the external currency mix of our debt does not match the mix of our assets, we use a combination of cross-currency interest rate swaps and cross-currency swaps to balance the risk.
Our financial institution counterparties may require margin calls should our negative mark-to-market exceed a pre-agreed contractual limit. In order to protect the Group from the potential margin calls for significant market movements, we maintain additional cash or availability under our various borrowing facilities, we enter into derivatives with a large number of financial counterparties and we monitor potential margin requirements on a daily basis for adverse movements in the U.S. dollar against the Euro and in aluminium prices. At December 31, 2022 and 2021, there was no margin requirement paid as collateral to counterparties related to foreign exchange hedges nor related to aluminium or any other commodity hedges. At December 31, 2020, the margin requirement paid as collateral to counterparties amounted to €3 million and was related to foreign exchange hedges.
At December 31, 2022, we had €709 million of total liquidity, comprised of €166 million in cash and cash equivalents, €380 million of undrawn availability under our Pan-U.S. ABL Facility, €100 million of undrawn availability under our French Inventory Facility and €63 million of availability under our factoring arrangements.
-49-


Cash Flows
The following table summarizes our operating, investing and financing activities for the years ended December 31, 2022, 2021 and 2020:
For the years ended December 31,
(in millions of Euros)202220212020
Net Cash Flows from / (used in)
Operating activities451 357 334 
Investing activities(270)(221)(176)
Financing activities(163)(435)101 
Net increase / (decrease) in cash and cash equivalents, excluding the effect of exchange rate changes18 (299)259 
Net cash Flows from Operating Activities
For the year ended December 31, 2022, net cash flows from operating activities were €451 million, a €94 million increase from €357 million in the year ended December 31, 2021. This change primarily reflects a €135 million decrease from the change in cash flows from operating activities before working capital and a €229 million increase in changes in working capital. In the year ended December 31, 2022, factored receivables under non-recourse arrangements increased by €23 million compared to a €53 million decrease for the year ended December 31, 2021.
For the year ended December 31, 2021, net cash flows from operating activities were €357 million, a €23 million increase from €334 million in the year ended December 31, 2020. This change primarily reflects a €335 million increase from the change in cash flows from operating activities before working capital and a €312 million decrease in changes in working capital. In the year ended December 31, 2021, factored receivables under non-recourse arrangements decreased by €53 million compared to a €65 million decrease for the year ended December 31, 2020.
Net Cash Flows used in Investing Activities
For the years ended December 31, 2022 and 2021, net cash flows used in investing activities were €270 million and €221 million, respectively. Capital expenditures were €273 million and €232 million, respectively and related primarily to recurring and optimization investments in our manufacturing facilities.
For the year ended December 31, 2020, net cash flows used in investing activities were €176 million. Capital expenditures were €182 million and related primarily to recurring investment in our manufacturing facilities and growth projects.
For further details on capital expenditures projects, see the “—Historical Capital Expenditures” section below.
Net Cash flows (used in) / from Financing Activities
For the year ended December 31, 2022, net cash flows used in financing activities were €163 million. In the year ended December 31, 2022, Constellium drew on the Pan-U.S. ABL due 2026 and used the proceeds and cash on the balance sheet to repay the French and Swiss COVID-19 State-guaranteed loans, which had been drawn in 2020 under the secured PGE French Facility and the unsecured Swiss Facility, for €180 million and CHF 15 million, respectively.
For the year ended December 31, 2021, net cash flows used in financing activities were €435 million. In the year ended December 31, 2021, Constellium (i) issued $500 million of 3.750% Sustainability-Linked Notes due 2029, using the proceeds and cash on hand to tender and redeem the $650 million 6.625% Senior Notes due 2025, (ii) issued €300 million of 3.125% Sustainability-Linked Notes due 2029, using the proceeds and cash on hand to redeem the $400 million 5.750% Senior Notes due 2024, and (iii) repaid $200 million out of the $500 million 5.875% Senior Notes due 2026.
For the year ended December 31, 2020, net cash flows from financing activities were €101 million. In the year ended December 31, 2020, Constellium issued $325 million of 5.625% Senior Notes due 2028, using a portion of the proceeds to redeem the remaining balance of the 4.625% Senior Notes due 2021 and repay amounts drawn under the Pan-U.S. ABL. In addition, Constellium entered into a €180 million loan partially guaranteed by the French State and drew CHF20 million on a facility partially guaranteed by the Swiss Government.
-50-


Historical Capital Expenditures
The following table provides a breakdown of the historical capital expenditures by segment for the periods indicated:
For the years ended December 31,
(in millions of Euros)202220212020
P&ARP(127)(94)(73)
A&T(78)(70)(45)
AS&I(62)(62)(61)
Holdings and Corporate(6)(6)(3)
Total capital expenditures(273)(232)(182)
Contractual obligations
At December 31, 2022, our estimated material short-term and long-term contractual cash obligations consist of our borrowings and lease commitments and related interest and are detailed by maturity in Note 22.5 and Note 28 of our audited Consolidated Financial Statements.
In addition, we have material pension and other post-employment obligations as we operate various pension plans for the benefit of our employees across a number of countries as detailed in Note 23 of our audited Consolidated Financial Statements.
Some of these plans are defined benefit plans and others are defined contribution plans. The largest of these plans are in the United States, Switzerland, Germany and France. Pension benefits are generally based on the employee’s length of service and highest average eligible compensation before retirement, and are periodically adjusted for cost of living increases, either by practice, collective agreement or statutory requirement. Finally, we also participate in various multi-employer pension plans in one of our facilities in the United States.
We also provide health and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents. These plans are predominantly in the United States.
The total amount recognized in the income statement in relation to all our pension and post-retirement benefits was a gain of €11 million and an expense of €73 million and an expense of €45 million for the years ended December 31, 2022, 2021 and 2020, respectively. These amounts included negative past service costs of €47 million, past service costs €32 million and €2 million, for the years ended December 31, 2022, 2021 and 2020, respectively. The fair value of the plans assets was €461 million and €544 million for the years ended December 31, 2022 and 2021, respectively. The present value of our obligations was €864 million and €1,143 million for the years ended December 31, 2022 and 2021, respectively. This resulted in aggregate plan deficits of €403 million and €599 million as of December 31, 2022 and 2021, respectively.
Our estimated funding for our funded pension plans and other post-retirement benefit plans is based on actuarial estimates using benefit assumptions for discount rates, rates of compensation increases, and health care cost trend rates. The deficit related to the funded pension plans was €153 million and €222 million as of December 31, 2022 and 2021, respectively. The present value of the unfunded obligations was €250 million and €377 million as of December 31, 2022 and 2021, respectively.
Contributions to pension and other benefit plans were €44 million, €43 million and €53 million for the years ended December 31, 2022, 2021 and 2020, respectively.
Contributions to our multi-employer plans were approximately €3 million, €2 million and €2 million for the years ended December 31, 2022, 2021 and 2020, respectively.
Covenant Compliance
The indentures governing our outstanding debt securities contain no maintenance covenants but contain customary affirmative and negative covenants that, among other things, restrict, subject to certain exceptions, our ability and the ability of our subsidiaries, to incur or guarantee indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations and make dividends and other restricted payments.
-51-


The Pan-U.S. ABL Facility contains a financial covenant that provides that at any time during which borrowing availability thereunder is below 10% of the aggregate commitments under the Pan-U.S. ABL Facility, we will be required to maintain a minimum fixed charge coverage ratio of 1.0 to 1.0 and a minimum Borrower EBITDA Contribution of 25%, in each case calculated on a trailing twelve-month basis. “Borrower EBITDA Contribution” means, for any period, the ratio of the combined EBITDA of the borrowers under the Pan-U.S. ABL Facility and their subsidiaries for such period, to the consolidated EBITDA of the Company and its subsidiaries for such period. The Pan-U.S. ABL Facility also contains customary negative covenants on liens, investments and restricted payments related to Ravenswood, Muscle Shoals, and Bowling Green.
The Muscle Shoals Factoring Facility contains customary covenants and the factors’ commitment to purchase the receivables is subject to the maintenance of certain credit rating levels.
The European Factoring Facilities contain customary covenants.
We were in compliance with our covenants as of and for the year ended December 31, 2022.
See “Item 10. Additional Information—C. Material Contracts” for a description of our significant financing arrangements.
Principal Accounting Policies, Critical Accounting Estimates and Key Judgments
Our principal accounting policies are set out in Note 2 to the audited Consolidated Financial Statements, which appear elsewhere in this Annual Report. New standards and interpretations not yet adopted are also disclosed in Note 2.3 to our audited Consolidated Financial Statements. Critical accounting estimates and key judgments are described in Note 2.7 to our audited Consolidated Financial Statements.

Item 6. Directors, Senior Management and Employees
A.Directors and Senior Management
According to the Articles of Association, our Board of Directors is composed of natural or legal persons between 3 and 18 in number, appointed by the shareholders at the general meeting.
The following table provides biographical information (by date of appointment, other than for our Chairman), of the members of our Board of Directors as of the date of this Annual Report (ages are given as of March 10, 2023). The business address of each of our directors listed below is c/o Constellium, Washington Plaza, 40-44 rue Washington, 75008 Paris, France.
NameAgePositionDate of AppointmentCurrent Term
Jean-Christophe Deslarzes59ChairmanMay 11, 20212021-2024
Michiel Brandjes68DirectorJune 11, 20142021-2023
John Ormerod74DirectorJune 11, 20142021-2023
Lori A. Walker65DirectorJune 11, 20142022-2025
Martha Brooks63DirectorJune 15, 20162022-2025
Jean-Marc Germain57
Director (also CEO)
June 15, 20162020-2023
Isabelle Boccon-Gibod54DirectorMay 11, 20212021-2024
Christine Browne62DirectorMay 11, 20212021-2024
Jean-Philippe Puig62DirectorMay 11, 20212021-2024
Jean-François Verdier59Employee DirectorDecember 1, 20212021-2024
Wiebke Weiler38Employee DirectorDecember 1, 20212021-2024
Emmanuel Blot37DirectorJune 10, 20222022-2025
Pursuant to an amended and restated shareholders agreement between the Company and Bpifrance Participations (f/k/a Fonds Stratégique d’Investissement) ("Bpifrance"), Mr. Blot was designated by Bpifrance to succeed Ms. Stéphanie Frachet as Bpifrance's nominee, and was thereafter appointed by the shareholders to serve as a director of the Company.
-52-


Jean-Christophe Deslarzes. Mr. Deslarzes has served as a non-executive director since May 2021 and as Chairman of our Board of Directors since June 2022. Mr. Deslarzes has been a member of the Board of Directors of Adecco Group AG since April 2015 and Chairman of the Board since April 2020, and also serves as Chairman of the Adecco Group Foundation. Mr. Deslarzes served as Chief Human Resources Officer and member of the Executive Committee of ABB Group, based in Zurich, Switzerland, from 2013 to 2019. Previously, he was Chief Human Resources and Organization Officer and a member of the Executive Board at Carrefour Group, based in Paris, France, from 2010 to 2013. From 1994 to 2010, he held various management positions at Rio Tinto and its predecessor companies, Alcan and Alusuisse, in Europe and Canada, including as Senior Vice President Human Resources and member of the Executive Committee of Alcan Group based in Montreal, Canada, as well as President and CEO, Downstream Aluminium Businesses, Rio Tinto. Mr. Deslarzes was Chairman of the Board of Directors of ABB India Limited from February 2018 to February 2021. Since January 2021, Mr. Deslarzes has been a Member of the Executive Faculty at the University of St. Gallen, Switzerland. A Swiss national, Mr. Deslarzes holds a master’s degree in Law from the University of Fribourg, Switzerland.
Michiel Brandjes. Mr. Brandjes has served as a non-executive director since June 2014. He served as Company Secretary and General Counsel Corporate of Royal Dutch Shell plc from 2005 to 2017. Mr. Brandjes formerly served as Company Secretary and General Counsel Corporate of Royal Dutch Petroleum Company. He served for 25 years in numerous legal and non-legal jobs in the Shell Group within the Netherlands and abroad, including as head of the legal department in Singapore and as head of the legal department for North East Asia based in Beijing and Hong Kong. Before he joined Shell, Mr. Brandjes worked at a law firm in Chicago. Mr. Brandjes serves in a number of advisory and director positions of charitable foundations and other organizations, including currently as legal advisor to Wassenaarse Energie Co-operatie UA, an energy transition/green electricity co-operative, and to small business startups. He has published a number of articles on legal and business topics and on corporate legal and governance topics. Mr. Brandjes graduated from law school at the University of Rotterdam and at Berkeley, California.
John Ormerod. Mr. Ormerod has served as a non-executive director since June 2014. Mr. Ormerod is a chartered accountant and worked for over 30 years in public accounting firms. He served for 32 years at Arthur Andersen, serving in various client service and management positions, with last positions held from 2001 to 2002 serving as Regional Managing Partner UK and Ireland, and Managing Partner (UK). From 2002 to 2004, he was Practice Senior Partner for London at Deloitte (UK) and was member of the UK executives and Board. Until May 2018, Mr. Ormerod served in the following director positions: since 2006, as a non-executive director, member of the Audit Committee (of which he also served as its Chairman until September 2017), and as member of the Compensation Committee of Gemalto N.V.; since 2008, as non-executive director of ITV plc, and as member of the Remuneration and Nominations Committees, and as Chairman of the Audit Committee since 2010. Until December 31, 2015, Mr. Ormerod served as a non-executive director of Tribal Group plc., as member of the Audit, Remuneration and Nominations Committees and as Chairman of the board. Mr. Ormerod served as non-executive director and Chairman of the Audit Committee of Computacenter plc., and as member of the Remuneration and Nominations Committees until April 1, 2015. Mr. Ormerod also served as a senior independent director of Misys plc. from 2006 to 2012, and as Chairman of the Audit Committee from 2005 to 2012. Mr. Ormerod is a Trustee and Chairman of Bloodwise, a UK charity. Mr. Ormerod is a graduate of Oxford University.
Lori A. Walker. Ms. Walker has served as a non-executive director since June 2014. Ms. Walker previously served as Chief Financial Officer and Senior Vice President of The Valspar Corporation from 2008 to 2013, where she led the Finance, IT and Communications teams. Prior to that position, Ms. Walker served as Valspar’s Vice President, Controller and Treasurer from 2004 to 2008, and as Vice President and Controller from 2001 to 2004. Prior to joining Valspar, Ms. Walker held a number of roles with progressively increasing responsibility at Honeywell Inc. during a 20-year tenure, with her last position there serving as director of Global Financial Risk Management. Ms. Walker currently serves as the Audit Committee Chair of Compass Minerals International, Inc. and is a member of its Nominating & Governance Committee. In addition, Ms. Walker became Chair of the Audit Committee for Hayward Industries in March 2021. She also serves as the Audit Committee Chair of Southwire Company, LLC, a private company, and is also a member of its Human Resources Committee. Ms. Walker holds a Bachelor of Science of Finance from Arizona State University and attended the Executive Institute Program and the Director’s College at Stanford University.
Martha Brooks. Ms. Brooks has served as a non-executive director since June 2016. Ms. Brooks was until her retirement in May 2009, President and Chief Operating Officer of Novelis Inc, where she held senior positions since 2005. From 2002 to 2005, she served as Corporate Senior Vice President and President and Chief Executive Officer of Alcan Rolled Products, Americas and Asia. Before she joined Alcan, Ms. Brooks served 16 years with Cummins, the global leader in diesel engine and power generation from 1986 to 2002, ultimately running the truck and bus engine business. She is currently a director at The Volvo Group (AB Volvo) where she serves as a member of the Audit Committee; a director at Jabil Circuit Inc., where she serves as a member of the Nominating and Governance Committee; and a director of CARE Enterprises Inc., a for profit subsidiary of CARE USA, where she served as board Co-Chair until 2021, and remains a director. She served as the Chair of
-53-


the Women Corporate Directors’ Compensation and Human Capital Committee Peer Group from June 2020 until June 2022, which devised and led programming for 250 director members. She has previously served as a director of Bombardier Inc., Harley Davidson and International Paper. Ms. Brooks holds a BA in Economics and Political Science and a Master’s in Public and Private Management from Yale University.
Jean-Marc Germain. Mr. Germain has served as an executive director since June 2016 and as our Chief Executive Officer since July 2016. Prior to joining Constellium, Mr. Germain was Chief Executive Officer of Algeco Scotsman, a Baltimore-based leading global business services provider focused on modular space and secure portable storages. Previously, Mr. Germain held numerous leadership positions in the aluminium industry, including senior executive roles in operations, sales & marketing, financial planning and strategy with Pechiney, Alcan and Novelis. His last position with Novelis from 2008 to 2012 was as President for North American operations. Earlier in his career, he held a number of international positions with Bain & Company and GE Capital. Mr. Germain became an independent, non-executive Director of Graftech International Ltd. in October 2021. Mr. Germain is a graduate of Ecole Polytechnique in Paris, France and a dual French and American citizen.
Isabelle Boccon-Gibod. Ms. Boccon-Gibod has served as a non-executive director since May 2021. Ms. Boccon-Gibod served as Executive Vice-President of the Sequana Group from 2009 to 2013 and was advisor to the deputy CEO of the Sequana Group from 2006 to 2009. She started her career with the International Paper Group, where she held various senior management positions in the U.S., in the United Kingdom and in France. Ms. Boccon-Gibod has served as a non-executive director on the Boards of Arkema S.A., as permanent representative of Fonds Stratégique de Participations, since 2014, Legrand S.A. since 2016, Fonds Adie since 2018 and served on the Gaztransport & Technigaz SA Board from 2020 to 2022. She is also on the Boards of two private companies Paprec since 2014 and Arc Holdings since 2019. A French citizen, Ms. Boccon-Gibod holds a Masters in Engineering from Ecole Centrale de Paris and a Master of Science in Industrial Engineering from Columbia University (NYC).
Christine Browne. Ms. Browne has served as a non-executive director since May 2021. Ms. Browne has extensive experience in the airline industry, including Iberia, First Choice Airways and TUI. At TUI, Ms. Browne was Managing Director of Thomson Airways from 2007 to 2014, and Managing Director of TUI Airlines from 2014 to 2015. More recently, Ms. Browne served as Chief Operating Officer of EasyJet from 2016 to 2019. Ms. Browne has been a non-executive director of Vistry Group PLC since 2014, and of Kier Group PLC since 2022. She also served on the Board of Norwegian Air Shuttle ASA from 2020 to 2022. A British national, Ms. Browne holds a Doctorate of Science (Honorary) for Leadership in Management from the University of Ulster and a Bachelors in Modern Languages from Queen’s University. Ms. Browne was awarded an OBE (Order of the British Empire) in 2013 for services to the aviation industry.
Jean-Philippe Puig. Mr. Jean-Philippe Puig has served as a non-executive director since May 2021. Mr. Puig has served as Chief Executive Officer of the Avril Group (oils and proteins industry) since 2012. Prior to joining the Avril Group, Mr. Puig was President of the Primary Metal Division for the EMEA region at Rio Tinto Alcan from 2008 to 2011. He started his career in the aluminium industry, holding various senior executive management positions with Pechiney, Alcan then Rio Tinto Alcan in France, Greece and Australia, accumulating over 28 years’ experience and gaining significant industrial expertise in the mineral extraction business. Mr. Puig has served as a Board member representing Financière Senior Cinqus at CEVA Santé animale (Animal healthcare) since 2020, as Chairman of the Supervisory Board representing Avril S.C.A. of AgroInvest (Development Fund) since 2014, and as Chairman of the Supervisory Board representing Avril S.C.A. of CapAgro SAS (Capital Risk Fund) since 2014. A French national, Mr. Puig holds a PhD with honors in Applied Chemistry from the Ecole Nationale Supérieure de Chimie de Paris.
Jean-François Verdier. Mr. Verdier has served as Employee Director since December 2021. Mr. Verdier has served as an Engineering Project Manager at Constellium’s Issoire, France facility since 2006. He was responsible for designing and building the Airware® casthouse and for introducing an innovative system on the Issoire plant’s rolling mill. He has also led engineering and Black Belt manufacturing missions for several of Constellium’s plants including Ussel and Montreuil-Juigné in France, and Sierre and Steg in Switzerland. Previously, he worked on industrialization programs in France and Canada, including Airware® casting and recycling projects. Mr. Verdier started working for Constellium in 1988 as a metallurgist in Issoire and has significant experience in the aluminium industry. A French national, Mr. Verdier graduated as an engineer from Polytech Clermont-Ferrand University (formerly CUST) in France.
Wiebke Weiler. Ms. Weiler has served as Employee Director since December 2021. Ms. Weiler has served as a Reliability Engineer at Constellium’s Singen, Germany facility since 2019. In her current position, she is responsible for the development and integration of maintenance strategies to prevent breakdowns of critical infrastructure equipment at the Singen site. Previously, she worked in a variety of positions in the aerospace and automotive industries with a strong focus on design engineering, manufacturing processes and maintenance, gaining significant experience in those industries. Before joining Constellium, Ms. Weiler served as Maintenance Manager and Manufacturing Engineer at Aerospace Transmission
-54-


Technologies, a joint venture of Liebherr-Aerospace and Rolls-Royce, from 2016 - 2019, after gaining extensive manufacturing process knowledge as a Tool & Fixture Design Engineer at the Liebherr-Aerospace facility in Friedrichshafen, Germany from 2013 - 2016. From 2008 - 2012, Ms. Weiler participated in a dual study program at Continental AG in Hannover, Germany.
Emmanuel Blot. Mr. Blot has served as a non-executive director since June 2022. Mr. Blot joined Bpifrance Investissement in 2012 and is currently Investment Director and Head of the Listed Investments Practice (Large Cap). In his current position at Bpifrance Investissement, Mr. Blot has led several investment processes in listed companies and has followed many investments, including Constellium SE, which he has been monitoring for ten years. He was previously a sell-side equity analyst at Kepler Cheuvreux (2007-2008), Bryan, Garnier & Co (2009-2010) and at Oddo BHF (2010-2012) covering first Aerospace & Defense stocks then the Capital Goods sector. Since May 2022, Mr. Blot has served as a non-executive director on the Board of Mersen SA, as a permanent representative of Bpifrance Participations. A French citizen, Mr. Blot graduated from ESSEC Business School in Paris in 2009.
The following persons are our executive officers as of the date of this Annual Report (ages are given as of March 10, 2023). The business address of each of our executive officers listed below is c/o Constellium, Washington Plaza, 40-44 rue Washington, 75008 Paris, France.
NameAgeTitle
Jean-Marc Germain57 Chief Executive Officer
Peter R. Matt60 Executive Vice President and Chief Financial Officer
Peter Basten47 President, Packaging and Automotive Rolled Products business unit
Ingrid Joerg53 President, Aerospace and Transportation business unit
Philippe Hoffmann57 President, Automotive Structures and Industry business unit
Ludovic Piquier50 Senior Vice President Manufacturing Excellence and Chief Technical Officer
Philip Ryan Jurkovic51 Senior Vice President and Chief Human Resources Officer
Nicolas Brun56 Senior Vice President, Public Affairs, Communications and Sustainability
Jeremy Leach61 Senior Vice President and Group General Counsel
Vittorio Rossetti58 Senior Vice President, Chief Information Officer and Chief Digital Officer
The following paragraphs set forth biographical information of our executive officers (other than Mr. Germain, whose biographical information is set forth above in the description of biographical information of our directors):
Peter R. Matt. Mr. Matt has served as our Executive Vice President and Chief Financial Officer since January 1, 2017. From November 2016 to December 2016 he served as our Chief Financial Officer Designate. Prior to joining Constellium, he spent 30 years in investment banking at Credit Suisse where he built leading metals and diversified industrials coverage practices. From 2010 to 2015, he was the Managing Director and Group Head at Credit Suisse responsible for managing the firm’s Global Industrials business in the Americas. Mr. Matt has served on the Board of Commercial Metals Corporation since June 2020. He is a graduate of Amherst College. Mr. Matt has decided to leave the Company to pursue another career opportunity and will continue to serve as our Executive Vice President and Chief Financial Officer until April 1, 2023.
Peter Basten. Mr. Basten has served as President of our Packaging and Automotive Rolled Products business unit since September 2017. He previously served as our Executive Vice President, Strategy, Business Development, Research & Development since 2016, and prior to that as our Vice President, Strategy and Business Planning, the Managing Director of Soft Alloys Europe at our Automotive Structures and Industry Business Unit and our Vice President Strategic Planning & Business Development. Mr. Basten joined Alcan in 2005 as the Director of Strategy and Business Planning at Alcan Specialty Sheet, and became Director of Sales and Marketing in 2008, responsible for the aluminium packaging applications markets. Prior to joining Alcan, Mr. Basten worked as a consultant at Monitor Group, a Strategy Consulting firm. His assignments ranged from developing marketing, corporate, pricing and competitive strategy to M&A and optimizing manufacturing operations. Mr. Basten holds degrees in Applied Physics (Delft University of Technology, Netherlands) and Economics & Corporate Management (ENSPM, France).
-55-


Ingrid Joerg. Ms. Joerg has served as President of our Aerospace and Transportation business unit since June 2015. Previously, Ms. Joerg served as Chief Executive Officer of Aleris Rolled Products Europe. Prior to joining Aleris, Ms. Joerg held leadership positions with Alcoa where she was President of its European and Latin American Mill Products business unit, and commercial positions with Amag Austria. Ms. Joerg joined the Board of voestalpine AG in July 2019. She also serves as the Chair of the European Aluminium Association (EA) since July 2021 and as Chair of the CVSA Advisory Board (Valais) since April 2021. She received a Master’s Degree in Business Administration from the University of Linz, Austria.
Philippe Hoffman. Mr. Hoffmann has served as President of our Automotive Structures and Industry business unit since October 2020. He previously held numerous leadership positions in the company, including Managing Director for Constellium’s Hard Alloys and Large Extrusion business, Vice President Rolled Products Europe for our Aerospace and Transportation business unit, and Vice President and Managing Director Automotive Structures. During his extensive career in the aluminium industry, Mr. Hoffmann held various manufacturing, strategic, and management roles, serving our automotive, industry, transportation and aerospace customers across Europe and North America. Mr. Hoffmann is a graduate of INSEAD Business School and of the École Nationale Supérieure des Mines with a Master in Physics and Material Science. He holds a Master of International Management from the International Master Program for Managers (IMPM), which includes studies at McGill (Canada), Lancaster University (UK), IIMB (India), KDI School (Korea), INSEAD (France) and JAIST (Japan).
Ludovic Piquier. Mr. Piquier has served as Senior Vice President Manufacturing Excellence and Chief Technical Officer since July 2021. Ludovic Piquier began his career at Constellium in 2014 as Plant Manager for our facility in Neuf-Brisach, France where he led the plant in its transition to the automotive market, including the ramp-up of the FT3 auto heat treat line. In September 2020, he became Director, Corporate Strategy and supported the execution of key business priorities. Previously, he held various senior positions at PSA Peugeot Citroёn, including Car Assembly Plant Manager in France and in the UK, and Project Manager in France and in Slovakia. Mr. Piquier is a French citizen and a graduate of École Nationale Supérieure des Arts et Métiers.
Philip Ryan Jurkovic. Mr. Jurkovic has served as our Senior Vice President and Chief Human Resources Officer since November 2016. Prior to joining Constellium, Mr. Jurkovic was Senior Vice President and Chief Human Resources Officer of Algeco Scotsman. He started his career as a financial analyst before taking on various HR leadership roles in Europe, Asia and the U.S. with United Technologies and Novelis. Mr. Jurkovic has a BS from Allegheny College and an MBA from Purdue University.
Nicolas Brun. Mr. Brun has served as our Senior Vice President, Public Affairs, Communications and Sustainability since January 2018, and was previously Senior Vice President, Public Affairs and Communications from September 2017 to January 2018, and Vice President, Communications from January 2011 to January 2017. He previously held the same role at Alcan Engineered Products since June 2008. From 2005 through June 2008, Mr. Brun served in the roles of Vice President, Communications for Thales Alenia Space and also as Head of Communications for Thales’ Space division. Prior to 2005, Mr. Brun held senior global communications positions as Vice President External Communications with Alcatel, Vice President Communications Framatome ANP/AREVA, and with the Carlson Wagonlit Travel Group. Mr. Brun currently serves as President of Constellium Neuf Brisach SAS since January 2015, and was appointed President of Constellium France Holdco on December 30, 2019 and President of Constellium Paris in April 2021. Mr. Brun attended University of Paris-La Sorbonne and received a degree in economics. He has a master’s degree in corporate communications from Ecole Française des Attachés de Presse and a certificate in marketing management for distribution networks from the Ecole Supérieure de Commerce in Paris.
Jeremy Leach. Mr. Leach has served as our Senior Vice President and Group General Counsel and Secretary to the Board of Constellium since January 2011 and previously was Vice President and General Counsel at Alcan Engineered Products. Mr. Leach joined Pechiney in 1991 from the international law firm Richards Butler (now Reed Smith). Prior to becoming General Counsel at Alcan Engineered Products, he was the General Counsel of Alcan Packaging and held various senior legal positions in Rio Tinto, Alcan and Pechiney. He has been admitted in a number of jurisdictions, holds a law degree from Oxford University (MA Jurisprudence) and an MBA from the London Business School.
Vittorio Rossetti. Mr. Rossetti joined Constellium in April 2012, and serves as Senior Vice President, Chief Information Officer and Chief Digital Officer since July 2021. Prior to that he worked 16 years for Johnson & Johnson, in Italy, the UK, Belgium and the US. He has led major transformation programs in the Consumer, Medical Devices and Pharmaceutical sectors. He has also set up and managed global outsourcing contracts. Prior to Johnson & Johnson he worked for Pirelli, for both the Tyre and Cables businesses. Mr. Rossetti holds a degree in Computer Science and a Masters in Industrial Technologies and Business Management from the Milano Polytechnic.
-56-


B.Compensation
Non-Executive Director Compensation
In 2022, the compensation structure for our non-executive directors was the same as in 2021. That is, it consisted of (i) Annual retainer fees, (ii) Committee membership fees, (iii) Committee Chair fees following a formulaic approach (200% of the Committee membership fee), and (iv) cash paid in lieu of the former annual RSU grant:
Annual Retainer
an annual fee of €65,000 for the Chairman of the Board and €70,000 for each other non-executive director
an additional annual fee of €65,000 for the Chairman of the Board
Audit Committee
an annual fee of €12,000 for members of the Audit Committee
an additional annual fee of €12,000 for the Chair of the Audit Committee
Human Resources Committee
an annual fee of €8,000 for members of the Human Resources Committee
an additional annual fee of €8,000 for the Chair of the Human Resources Committee
Nominating and Governance Committee
an annual fee of €6,000 for members of the Nominating and Governance Committee
an additional annual fee of €6,000 for the Chair of the Nominating and Governance Committee
Safety and Sustainability Committee
an annual fee of €6,000 for members of the Safety and Sustainability Committee
an additional annual fee of €6,000 for the Chair of the Safety and Sustainability Committee
Cash paid in lieu of the former annual RSU grant
annual cash of $95,000 for the Chairman of the Board
annual cash of $75,000 for our other non-executive directors
Upon the Transfer, the equivalent of the RSU grant that had been previously granted on an annual basis was replaced with quarterly cash payments, starting in the third quarter of 2020.
The non-executive directors of the Board have not entered into any service contracts with the Company that provide either for benefits upon termination of employment or pension-related benefits.
In December 2021, as required by French law, two employees joined the Board as non-executive directors representing the employees, one of whom is based in Germany as a Reliability Engineer (designated to the Board by the European Works Council) and the other one in France as an Engineering Project Manager (designated to the Board by the French Group Works Council).
-57-


The following table sets forth the remuneration paid during our 2022 fiscal year to our non-executive directors:
NameAnnual
Retainer
Fees
Chair FeesMembership Fees
Cash paid in lieu of the former RSU grant(1)
Total
Richard B. Evans(2)
45,179 49,349 9,730 59,909 164,167 
Werner P. Paschke(3)
48,654 — 8,341 47,296 104,291 
Michiel Brandjes70,000 6,000 12,000 69,758 157,758 
John Ormerod70,000 1,846 18,000 69,758 159,604 
Lori A. Walker70,000 12,000 18,000 69,758 169,758 
Martha Brooks70,000 8,000 18,154 69,758 165,912 
Stéphanie Frachet(4)
— — — — — 
Isabelle Boccon-Gibod70,000 — 9,693 69,758 149,451 
Christine Browne70,000 — 20,000 69,758 159,758 
Jean-Christophe Deslarzes68,462 20,000 14,000 75,799 178,261 
Jean-Philippe Puig70,000 — 8,462 69,758 148,220 
Jean-François Verdier(5)
— — — — — 
Wiebke Weiler(5)
— — — — — 
Emmanuel Blot(6)
— — — — — 
Total652,295 97,195 136,380 671,310 1,557,180 
__________________
(1)$23,750 (per quarter) for the Chairman and $18,750 (per quarter) for each other non-executive director converted in euros at the exchange rates of the date of each Board meeting.
(2)Mr. Evans’ term ended after the annual general meeting of shareholders on June 10, 2022. Compensation presented from January 1 through June 10, 2022.
(3)Mr. Paschke’s term ended after the annual general meeting of shareholders on June 10, 2022. Compensation presented from January 1 through June 10, 2022.
(4)Ms. Frachet’s term ended after the annual general meeting of shareholders on June 10, 2022. Ms. Frachet did not receive any fees for her services as a non-executive director.
(5)Both of the non-executive employee directors had and continue to have employee contracts with subsidiaries of the Company and are paid remuneration in line with market practices and in accordance with their positions as employees. They do not receive any fees for their services as non-executive employee directors.
(6)Mr. Blot was appointed at the annual general meeting of shareholders on June 10, 2022. Mr. Blot does not receive any fees for his services as a non-executive director.
Share Ownership Guidelines for Non-Executive Directors
In 2019, we adopted Share Ownership Guidelines (SOGs) for our non-executive directors to further encourage minimum levels of ownership and to foster additional alignment between the non-executive directors and shareholder interests (the SOGs do not apply to Mr. Verdier, Ms. Weiler and Mr. Blot, who do not receive compensation in respect of their services as non-executive directors). The non-executive directors are required to hold a fixed value in Constellium shares as follows:
$500,000        Chairman of the Board
$250,000        Other non-executive directors
-58-


The SOGs give the non-executive directors five years to achieve guideline levels of ownership. With the exception of our four non-executive directors appointed in 2021 (Ms. Boccon-Gibod, Ms. Browne, Mr. Deslarzes and Mr. Puig), all of our other non-executive directors met the SOGs in 2022.
Officer Compensation
The table below sets forth the remuneration paid during our 2022 fiscal year to certain of our executive officers. They include Jean-Marc Germain, our Chief Executive Officer, Peter Matt, our Executive Vice President and Chief Financial Officer, Peter Basten, our President Packaging & Automotive Rolled Products, Ingrid Joerg, our President Aerospace & Transportation, and Philippe Hoffmann, our President, Automotive Structures & Industry. The remuneration information for our executive officers other than our Chief Executive Officer Jean-Marc Germain and our Executive Vice President and Chief Financial Officer Peter Matt (namely, Peter Basten, Ingrid Joerg and Philippe Hoffmann) is presented on an aggregate basis in the row “Other Executive Officers” in the table below.
NameBase Salary
Paid
2021 Bonus (EPA)
Paid in 2022
Equity
Awards(1)
Retirement /Pension(2)
Other
Compensation(3)
Total(4)
Jean-Marc Germain1,061,298 1,910,337 5,151,478 26,128 158,980 8,308,221 
Peter Matt686,274 899,486 1,884,697 26,128 79,490 3,576,075 
Other Executive Officers1,798,183 2,197,436 2,713,953 211,025 40,036 6,960,633 
_________________
(1)The amount reported as Equity Awards represents the grant date fair value of the awards granted in 2022, computed in accordance with IFRS 2. Jean-Marc Germain was granted the following in March 2022: (a) 158,858 performance-based restricted stock units (“PSUs”) (which can become a maximum of 317,716 shares); and (b) 81,037 restricted stock units ("RSUs"). Peter Matt was granted the following in March 2022: (a) 58,119 PSUs (which can become a maximum of 116,238 shares); and (b) 29,648 RSUs. Our other executive officers listed were granted, in the aggregate, 83,691 PSUs (which can become a maximum of 167,382 shares) and 42,693 RSUs. The PSUs vest on the third anniversary of the date of grant, subject to continued service and certain market-related performance conditions being satisfied, and have a vesting range of 0-200%. RSUs vest 100% on the third anniversary of the date of grant, subject to continued service. See hereafter “2022 Long-Term Incentive Plan” for a description of market-related performance conditions. See also Note 30 to the Consolidated Financial Statements for more information.
(2)Retirement / Pension represents amounts contributed by the Group during the 2022 fiscal year in the US and Switzerland as part of the overall employer retirement / pension requirements apportioned to the base salary of these individuals.
(3)Other compensation for Mr. Germain and Mr. Matt include car allowance, parking, tax services and premiums for health, life and long-term disability insurance as well as non-qualified restoration contributions under the Constellium US Holdings I, LLC U.S. Non-qualified Deferred Compensation and Restoration Plan. Other compensation for Ms. Joerg as well as for Messrs. Basten and Hoffmann include car allowance, lunch allowance, tax and medical services and premiums for life and long-term disability insurance.
(4)The total compensation paid to such executive officers, including Messrs. Germain and Matt, during our 2022 fiscal year amounted to €9,094,801, consisting of (a) an aggregate base salary of €3,545,755, (b) aggregate short-term incentive compensation of €5,007,259, (c) aggregate contribution to the retirement / pensions for such executive officers of €263,281, and (d) aggregate other compensation in an amount equal to €278,506. All compensation amounts for the CEO, CFO and the U.S.-based executive officers were converted to euros using an exchange rate of 0.9518. All compensation amounts for the Swiss-based executive officers were converted to euros using an exchange rate of 0.9962.
Below is a brief description of the compensation and benefit plans as well as share ownership guidelines in which our executive officers participate.
-59-


Share Ownership Guidelines for Executive Officers
In 2018, we adopted Share Ownership Guidelines (SOGs) for our executive officers to further encourage minimum levels of ownership and to further foster alignment between the Executive Committee and shareholder interests. The SOGs are as follows:
400% of base salary    CEO
200% of base salary    CFO and Business Unit Presidents
100% of base salary    Other executive officers
The SOGs give the executive officers five years to achieve guideline percentages. All of our executive officers met the SOGs in 2022.
Non-qualified Deferred Compensation and Restoration Plan
A select group of highly compensated employees of Constellium US Holdings I, LLC and certain other subsidiaries and affiliates (including Messrs. Germain and Matt) is eligible to participate in the Constellium US Holdings I, LLC U.S. Non-qualified Deferred Compensation and Restoration Plan (“DCRP”). The DCRP allows such employees to defer up to 85% of their annual Employee Performance Award. The DCRP is also a non-qualified restoration plan for employer contributions that cannot be made to our 401(k) plan due to the Code Section 401(a)(17) annual limit on compensation paid under a qualified plan. The restoration contribution equals 9% of total eligible 2022 pay (base salary plus bonus award paid in 2022) in excess of this limit. The 9% consists of the 6% employer matching contribution and the 3% non-elective retirement contribution. Restoration contributions are 100% vested.
Distributions are made as a lump sum after separation from service, unless the participant elects to receive one to 10 annual payments beginning at least one year after separation from service.
Each participant directs investment of his or her individual account under the DCRP. The DCRP provides a broad range of market-based investments that may be changed daily. Benefits due under the DCRP are paid from our general assets, although we also maintain a rabbi trust that may be used to pay benefits. The trust and the funds held in it are Group assets. In the event of our bankruptcy, DCRP participants would be unsecured general creditors.
Say-On-Pay
As a foreign private issuer listed on the NYSE and a company not listed on a regulated French stock exchange, the Company is not subject to the Say-On-Pay regime for French listed companies.
2022 Employee Performance Award Plan
Each of our executive officers, among other selected employees, participates in the Employee Performance Award Plan (which we refer to as the “EPA”). The EPA is an annual cash bonus plan intended to provide performance-related award opportunities to employees contributing substantially to the success of Constellium. Under the EPA, participants are provided opportunities to earn cash bonuses (expressed as a percentage of base salary, and paid in the year following the performance period) based on the level of achievement of certain Financial and ESG Objectives as approved by our Human Resources Committee for the applicable annual performance period, as well as Individual Objectives established by the applicable participant’s supervisor (as described below).
The three components of bonuses awarded under the EPA for 2022 had the following weights:
Financial Objectives — 65%
ESG Objectives — 15%
Individual Objectives — 20%
The Financial Objectives are calculated on an annual basis and take into account two components as defined and reported by the Group’s corporate controller: Adjusted EBITDA (50%) and Free Cash Flow (15%). To promote synergies throughout the Group, the EPA is designed to encourage individual plants, business units and our corporate division to work closely together to achieve common strategic, operating and financial goals. Therefore, the Financial Objectives are defined, depending on the level of the employee, as a combination of the financial results of the Group and those of the business unit and / or operating unit/site. The threshold performance level for the Financial Objectives is set at 80% of the target level for Adjusted EBITDA
-60-


and 75 million below the target level for Free Cash Flow. If threshold performance is not achieved for a Financial Objective, there is no payout. Between threshold performance and target performance, payouts increase linearly from 0% to 100%. The maximum performance level is set at 120% of the target level for Adjusted EBITDA and 75 million above the target level for Free Cash Flow. Achieving maximum performance level for a Financial Objective results in a payout of 200%, with payouts increasing linearly from 100% to 200%.     
The ESG Objective is newly (since 2022) divided into EHS (5%), diversity (5%) and carbon emissions (5%) components. The EHS metric is measured quarterly at the Group, business unit or operating unit/site level, while diversity and carbon emission are measured annually at the Group level. Payout for ESG Objectives can range from 0% to 200%.
The Individual Objectives are evaluated annually via the Performance Management Program, and achievement against these objectives is used to determine the percentage attained of the Individual Objectives target. Employees were required to have at least one objective related to ESG. Payout for Individual Objectives can range from 0% to 200%.
The payout scale defines the performance levels and resulting payouts. Achieving target performance results in a payout at 100% of the target amount. Overall payout can range from 0% to 150% of the target amount.
The EPA 2022 was applicable to approximately 2,200 employees worldwide, including all of our executive officers. For its payout in 2023, the following results were earned by our employees:
Financial Objectives: The payouts ranged from 0% to 200%;
ESG Objectives: The payouts ranged from 50% to 200%;
Individual Objectives: The payouts ranged from 0% to 200%. The payout for Mr. Germain was 160%.

Constellium SE 2013 Equity Incentive Plan
Our share-based compensation plan is the Constellium SE 2013 Equity Incentive Plan (the “Plan”). The principal purposes of the Plan are to focus our officers and employees on business performance to help create shareholder value, to encourage innovative approaches to the business of the Group and to encourage ownership of our ordinary shares by officers and employees. The Plan is also intended to recognize and retain our key employees needed to sustain and ensure our future and business competitiveness.
The Plan provides for a variety of awards, including “incentive stock options” (within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) (“ISOs”), nonqualified stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), other stock-based awards or any combination of those awards. To date, we have only awarded RSUs and PSUs under the Plan.
The Plan provides that awards may be made under the Plan for 10 years following approval by the Company’s board of directors (the “Board of Directors”) of the Plan in 2013.
The Company’s shareholders previously authorized a total of 14,292,291 ordinary shares to be eligible for issue or delivery under the Plan. These authorizations were confirmed at the shareholders’ meeting held on November 25, 2019 to allow for awards to be made under the Plan following the Transfer. The number of ordinary shares so authorized and available was subject to adjustment in certain circumstances to prevent dilution. This shareholders’ authorization expired on January 24, 2022.
At the Company’s shareholders’ meeting held on May 11, 2021, the shareholders authorized an additional 6,800,000 ordinary shares to be eligible for issue or delivery under the Plan. This shareholders’ authorization is effective until July 10, 2024. The number of ordinary shares so authorized and available is subject to adjustment in certain circumstances to prevent dilution.
Awards made following the Transfer are subject to compliance with mandatory provisions of the French Commercial Code that now apply, as further described below.
-61-


Administration
The Plan is administered by the Human Resources Committee of our Board of Directors. The Board of Directors or the Human Resources Committee may delegate administration to one or more members of our Board of Directors. The Human Resources Committee has the power to interpret the Plan and to adopt rules for the administration, interpretation and application of the Plan according to its terms. The Board of Directors, acting on the recommendation of our Human Resources Committee, determines the number of our ordinary shares that will be subject to each award granted under the Plan and may take into account the recommendations of our senior management in determining the award recipients and the terms and conditions of such awards. Subject to certain exceptions as may be required pursuant to Rule 16b-3 under the Exchange Act, if applicable, our Board of Directors may, at any time and from time to time, exercise any and all rights and duties of the Human Resources Committee under the Plan.
Following the Transfer, in accordance with the French Commercial Code:
the Human Resources Committee no longer has the power to make awards of any type;
the Board of Directors has exclusive power to make awards that are to be settled with shares;
the Board of Directors has exclusive power to make awards to the Company’s CEO and to any deputy chief executive officer (Directeur Général Délégué), irrespective of the form of settlement; and
the Company’s senior management has exclusive power to make awards to officers and employees that are cash-settled (other than to the Company’s CEO and any deputy chief executive officer (Directeur Général Délégué)).
Eligibility
Officers and employees are eligible to be granted awards under the Plan. Our Human Resources Committee makes recommendations regarding:
which officers and employees are to be granted awards;
the type of award that is granted;
the number of our ordinary shares subject to the awards; and
the terms and conditions of such awards, consistent with the Plan.
Following the Transfer, the power to make new awards and set their terms are as described above under “Administration.” Furthermore, in accordance with the French Commercial Code, following the Transfer, the Company is no longer permitted to grant restricted stock, and only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share-settled awards. Except for the Chairman of the Board of Directors, non-executive members of the Board of Directors and consultants are no longer eligible to receive share-settled awards.
Stock Options
Subject to the terms and provisions of the Plan, stock options to purchase our ordinary shares may be granted to eligible individuals at any time and from time to time as determined by our Board of Directors. Stock options may be granted as ISOs, which are intended to qualify for favorable treatment to the recipient under U.S. federal tax law, or as nonqualified stock options, which do not qualify for this favorable tax treatment. Subject to the limits provided in the Plan, our Board of Directors has the authority to determine the number of stock options granted to each recipient. Each stock option award is evidenced by a stock option agreement that specifies the stock option exercise price, whether the stock options are intended to be incentive stock options or nonqualified stock options, the term of the stock options, the number of shares to which the stock options pertain, and such additional limitations, terms and conditions as our Board of Directors may determine.
Our Board of Directors determines the exercise price for each stock option granted, except that the stock option exercise price may not be less than 100% of the fair market value of an ordinary share on the date of grant. All stock options granted under the Plan expire no later than 10 years from the date of grant. Stock options are nontransferable except by will or by the laws of descent and distribution or, in the case of nonqualified stock options, as otherwise expressly permitted by our Board of Directors. The granting of a stock option does not accord the recipient the rights of a shareholder, and such rights accrue only after the exercise of a stock option and the registration of ordinary shares in the recipient’s name. Following the Transfer, stock options may only be granted if the Company’s shareholders specifically authorize the Board of Directors to make such grants. As of the date of this annual report, we have not requested such shareholders’ authorization, but may do so at a future date.
-62-


Stock Appreciation Rights
The Company’s senior management may grant SARs under the Plan. SARs may be “tandem SARs,” which are granted in conjunction with a stock option, or “free-standing SARs,” which are not granted in conjunction with a stock option. A SAR entitles the holder to receive from us, upon exercise, an amount equal to the excess, if any, of the aggregate fair market value of a specified number of our ordinary shares to which such SAR pertains over the aggregate exercise price for the underlying shares. The exercise price of a free-standing SAR may not be less than 100% of the fair market value of an ordinary share on the date of grant.
A tandem SAR may be granted at the grant date of the related stock option. A tandem SAR may be exercised only at such time or times and to the extent that the related stock option is exercisable and has the same exercise price as the related stock option. A tandem SAR terminates or is forfeited upon the exercise or forfeiture of the related stock option, and the related stock option terminates or is forfeited upon the exercise or forfeiture of the tandem SAR.
Each SAR is evidenced by an award agreement that specifies the exercise price, the number of ordinary shares to which the SAR pertains and such additional limitations, terms and conditions as the Company's senior management may determine. We may make payment of the amount to which the participant exercising the SARs is entitled by delivering ordinary shares, cash or a combination of stock and cash as set forth in the award agreement relating to the SARs. SARs are not transferable except by will or the laws of descent and distribution or, with respect to SARs that are not granted in “tandem” with a stock option, as expressly permitted by the Company’s senior management.
Following the Transfer, the power to make new grants of free-standing SARs and set the terms of free-standing SARs are as described above under “Administration” with respect to cash-settled awards. No tandem SARs may be granted unless the shareholders specifically authorize the Board of Directors to make grants of stock options, as described above under “Stock Options”.
Restricted Stock
The Plan provides for the award of ordinary shares that are subject to forfeiture and restrictions on transferability to the extent permitted by applicable law and as set forth in the Plan, the applicable award agreement and as may be otherwise determined by our Board of Directors. Except for these restrictions and any others imposed by our Board of Directors to the extent permitted by applicable law, upon the grant of restricted stock, the recipient will have rights of a shareholder with respect to the restricted stock, including the right to vote the restricted stock and to receive all dividends and other distributions paid or made with respect to the restricted stock on such terms as set forth in the applicable award agreement. During the restriction period set by our Board of Directors, the recipient is prohibited from selling, transferring, pledging, exchanging or otherwise encumbering the restricted stock to the extent permitted by applicable law.
Following the Transfer, under the terms of the French Commercial Code, the Company is no longer permitted to grant restricted stock.
Restricted Stock Units (RSUs)
The Plan authorizes our Board of Directors to grant RSUs. RSUs are not ordinary shares and do not entitle the recipient to the rights of a shareholder, although the award agreement may provide for rights with respect to dividend equivalents. The recipient may not sell, transfer, pledge or otherwise encumber RSUs granted under the Plan prior to their vesting. RSUs may be settled in cash, ordinary shares or a combination thereof as provided in the applicable award agreement, in an amount based on the fair market value of an ordinary share on the settlement date.
Following the Transfer, the Board of Directors has exclusive power to make new grants of RSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”.
Performance-Based Restricted Stock Units (PSUs)
The Plan authorizes the Board of Directors to grant PSUs. The value of a PSU is conditioned upon the achievement of performance goals set by our Board of Directors in granting the PSUs and may be paid in cash, ordinary shares, other property or a combination thereof. Each PSU award is evidenced by an award agreement, which may contain terms relating to the termination of a participant’s employment.
-63-


Following the Transfer, the Board of Directors has exclusive power to make new grants of PSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”.
Other Stock-Based Awards
The Plan provides for the award of ordinary shares and other awards that are valued by reference to our ordinary shares, including unrestricted stock, dividend equivalents and convertible debentures.
Following the Transfer, grants of other stock-based awards may only be made in accordance with the French Commercial Code.
Performance Goals
The Plan provides that performance goals may be established by our Board of Directors in connection with the grant of any award under the Plan.
Termination without Cause following a Change in Control
The Plan has a “double trigger” vesting provision in place for its awards. Upon a termination of employment by the Company without “cause” (as defined in the Plan) of a participant occurring upon or during the two years immediately following the date of a “change in control”, unless otherwise provided in the applicable award agreement, (i) all awards held by such participant will vest in full (in the case of any awards that are subject to performance goals, at target) and be free of restrictions, and (ii) any option or SAR held by the participant as of the date of the change in control that remains outstanding as of the date of such termination of employment may thereafter be exercised until (A) in the case of ISOs, the last date on which such ISOs would otherwise be exercisable or (B) in the case of nonqualified options and SARs, the later of (x) the last date on which such nonqualified option or SAR would otherwise be exercisable and (y) the earlier of (I) the second anniversary of such change in control and (II) the expiration of the term of such nonqualified option or SAR. With respect to new share-settled awards made following the Transfer, the Company’s ability to deliver shares is subject to the minimum vesting and, if applicable, holding period requirements set forth under the French Commercial Code, as described below.
Application of the French Commercial Code
Following the Transfer, the French Commercial Code applies to new share-settled awards and requires in particular that:
awards be made by the Board of Directors, pursuant to an authorization of the shareholders which may be valid for a maximum of up to 38 months;
the total number of shares subject to outstanding awards plus shares subject to a mandatory holding condition under French tax law (if any) may not exceed 10% of share capital, as measured on the relevant grant date;
only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share-settled awards (as described above under “Eligibility”); and
persons holding more than 10% of the Company’s share capital prior to grant or as a result of the award are ineligible.
Pursuant to the French Commercial Code, awards are subject to a two-year minimum vesting period, or a one-year minimum vesting period followed by a mandatory one-year holding period, subject in both cases to exceptions for death and disability. The foregoing requirement pursuant to the French Commercial Code is satisfied with respect to awards under the Plan, which are subject to a minimum 36-month vesting period.
Amendments
Our Board of Directors or our Human Resources Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation will be made that would materially impair the rights of a participant with respect to a previously granted award without such participant’s consent, unless such an amendment is made to comply with applicable law, including, without limitation, Section 409A of the Code, stock exchange rules or accounting rules. In addition, no such amendment will be made without the approval of the Company’s shareholders to the extent such approval is required by applicable law or the listing standards of the applicable stock exchange.
-64-


2022 Long-Term Incentive Plan
The 2022 Long-Term Incentive Plan (which we refer to as the “2022 LTIP”) had the same plan design as the previous year. For our executive officers, as well as for other selected employees, awards consisted of PSUs and RSUs. For other selected employees, awards consisted of RSUs only. These awards were granted on March 10, 2022, and are subject to a three-year cliff vesting period, subject to the participant’s continued service through the applicable vesting date, and for PSUs, certain market-related performance conditions being satisfied.
With regard to PSUs, for the purposes of computing the Constellium Total Shareholder Return (the “Constellium TSR”), (i) the stock price at the beginning of the performance period is deemed to be the average closing share price for the 20 trading days preceding the grant date, and (ii) the stock price at the end of the performance period is deemed to be the average closing share price for the 20 trading days preceding the third anniversary of the grant date. Constellium measures itself against a peer group consisting of the S&P MidCap 400 Materials Index and the S&P SmallCap 600 Materials Index (the “Comparator Group”), which represents approximately 60 constituents. The 20-day average starting point of a Constellium share for the March 10, 2022 grant date was $18.64. The level of achievement shall be determined by comparing the Constellium TSR to the average of the TSRs of the two indices indicated above as follows:
If the Constellium TSR is below the average of the two 25th percentile TSRs of the Comparator Group, no PSUs will vest
If the Constellium TSR is at the average of the two 25th percentile TSRs of the Comparator Group, 25% of the target PSUs will vest
If the Constellium TSR is at the average of the two median TSRs of the Comparator Group, 100% of the target PSUs will vest
If the Constellium TSR is between the average of the two 25th percentile TSRs and the average of the two median TSRs of the Comparator Group, then the number of PSUs will be determined by linear interpolation on a straight line basis (between 25% and 100%)
If the Constellium TSR is at or above the average of the two 75th percentile TSRs of the Comparator Group, 200% of the target PSUs will vest
If the Constellium TSR is between the average of the two median TSRs and the average of the two 75th percentile TSRs of the Comparator Group, then the number of PSUs will be determined by linear interpolation on a straight line basis (between 100% and 200%)
If the Constellium TSR is negative, the number of PSUs that vest will be capped at 100% of target

Consistent with the 2019 - 2021 Long-Term Incentive Plans, the 2022 LTIP contains a double trigger with respect to the vesting of RSUs and PSUs upon a change in control (i.e. shares do not automatically vest upon a change in control, as vesting requires two triggers: (i) change in control as well as (ii) termination of employment without cause or voluntary termination for good reason). In the event of such a double trigger being applied at any time prior to vesting, unvested RSUs and PSUs will be converted into cash-denominated rights that vest on the date of employment termination. For both RSUs and PSUs, the reference date for the share price will be the date immediately preceding the change in control. For PSUs, the rights will be based on the higher of (I) the base amount (i.e., at target) or (II) the measured TSR on the reference date.
For the 2022 LTIP, 603,023 PSUs at target (which can become 1,206,046 shares at maximum) and 556,360 RSUs were granted on March 10, 2022. Under the 2022 LTIP, 107 participants were granted both PSUs and RSUs and an additional 142 participants were granted RSUs only. On December 31, 2022, 601,947 PSUs at target (which can become 1,203,894 shares at maximum) and 550,258 RSUs were outstanding. 106 participants held both PSUs and RSUs and an additional 136 participants held RSUs only.
For the 2021 Long-Term Incentive Plan (the “2021 LTIP”), 614,555 PSUs at target (which can become 1,229,110 shares at maximum) and 534,499 RSUs were granted on May 11, 2021. Under the 2021 LTIP, 101 participants were granted both PSUs and RSUs and an additional 125 participants were granted RSUs only. On December 31, 2022, 606,078 PSUs at target (which can become 1,212,156 shares at maximum) and 507,429 RSUs were outstanding. 96 participants held both PSUs and RSUs and an additional 110 participants held RSUs only.
For the 2020 Long-Term Incentive Plan (the “2020 LTIP”), 1,049,839 PSUs at target (which can become 2,099,678 shares at maximum) and 910,047 RSUs were granted on April 7, 2020. Under the 2020 LTIP, 99 participants were granted both PSUs and RSUs and an additional 108 participants were granted RSUs only. On December 31, 2022, 977,809 PSUs at target
-65-


(which can become 1,955,618 shares at maximum) and 817,759 RSUs were outstanding. 86 participants held both PSUs and RSUs and an additional 90 participants held RSUs only.
Employment and Service Arrangements
Constellium is party to employment or services agreements with each of its officers. In general, Constellium may terminate its officers’ employment or services for “cause” upon advance written notice, without compensation, for certain acts of the officer. Each officer may terminate his or her employment at any time upon advance written notice to Constellium. In the event that the officer’s employment or services is terminated by Constellium without cause or, in the case of certain executives, by him for “good reason,” the officer is entitled to certain payments as provided by applicable laws or collective bargaining agreements or as otherwise provided under the applicable employment or services agreements. Except for the foregoing, our officers are not entitled to any severance payments upon the termination of their employment or services for any reason.
Under such employment and services agreements, each of the officers has also agreed not to engage or participate in any business activities that compete with Constellium or solicit its employees or customers for (depending on the officer) up to two years after the termination of the employment or services. The officers have further agreed not to use or disseminate any confidential information concerning Constellium as a result of performing their duties or using Constellium resources during their employment or services.
Contracts with certain of our executive officers are described below.
Employment Agreement with Jean-Marc Germain
Jean-Marc Germain’s employment agreement is dated April 25, 2016 and provides that his annual base salary will be subject to review on an annual basis by the Board of Directors. Mr. Germain’s annual base salary for 2022 was $1,115,000, and has not been raised since 2020. The employment agreement also provides for a target annual bonus, which was increased in 2022 from 120% to 130% of the annual base salary (equal to $1,449,500), and a maximum annual bonus of 195% of the annual base salary (equal to $2,174,250). In respect of his 2021 annual bonus, Mr. Germain received a payment of $2,007,000 in 2022. In addition, Mr. Germain may be granted equity compensation awards at the discretion of the Board of Directors. Mr. Germain was granted the following equity awards in March 2022: (1) 158,858 PSUs (which can become a maximum of 317,716 shares) and (2) 81,037 RSUs. The PSUs vest on the third anniversary of the grant date, subject to continued service and certain market-related performance conditions being satisfied, and have a vesting range of 0-200% of the granted (target) number. RSUs vest 100% on the third anniversary of the date of grant, subject to continued service.
If Mr. Germain is terminated without “cause” or he resigns for “good reason” (each as defined in the employment agreement), he will be entitled to receive, subject to his execution and non-revocation of a general release of claims, cash severance in an amount equal to the product of (1) one (two, if such termination occurs within the 12-month period following a “change in control” (as defined in the employment agreement)) multiplied by (2) the sum of his base salary and target annual bonus, which severance will be payable over the 12-month (24-month, in the case of a termination within the 12-month period following a change in control) period following his termination of employment. The employment agreement also includes a perpetual confidentiality covenant, a perpetual mutual non-disparagement covenant, and 12-month post-termination non-competition and non-solicitation covenants.
Employment Agreement with Peter Matt
Peter Matts employment agreement is dated as of October 26, 2016 and provides that his annual base salary will be subject to review on an annual basis by Constellium. The employment agreement with Mr. Matt provides for an annual base salary of $700,000 per year until March 31, 2022, which amount was raised to $728,000 per year as of April 1, 2022, a target bonus of 90% of base salary (equal to $655,200), and a maximum annual bonus of 135% (equal to $982,800) of base salary. In respect of his 2021 annual bonus, Mr. Matt received a payment of $945,000 in 2022. In addition, Mr. Matt may be granted equity compensation awards at the discretion of the Board of Directors. Mr. Matt was granted the following equity awards in March 2022: (1) 58,119 PSUs (which can become a maximum of 116,238 shares) and (2) 29,648 RSUs. The PSUs vest on the third anniversary of the grant date, subject to continued service and certain market-related performance conditions being satisfied, and have a vesting range of 0-200% of the granted (target) number. RSUs vest 100% on the third anniversary of the date of grant, subject to continued service.
If Mr. Matt is terminated without “cause” or he resigns for “good reason” (each as defined in the employment agreement), he will be entitled to receive, subject to his execution and non-revocation of a general release of claims, (1) cash severance in an amount equal to the sum of his annual base salary, target annual bonus and vacation pay (multiple of 1 year)
-66-


and (2) six months of continued welfare benefits. The employment agreement also includes a perpetual confidentiality covenant and 12-month post-termination non-competition and non-solicitation covenants. If Mr. Matt’s employment is terminated without “cause”, Mr. Matt will be offered an additional amount equal to 50% of the sum of his annual base salary, target annual bonus, and vacation pay (multiple of 1.5 years) in consideration for his agreeing to not compete.
C.Board Practices
Our Board of Directors currently consists of 12 directors, less than a majority of whom are citizens or residents of the United States. In 2021, the Board held seven meetings with approximately 90% director attendance at all meetings.
Upon the effectiveness of the Transfer on December 12, 2019, the Company ceased to be governed by the laws of the Netherlands but instead became governed by the laws of France and the Articles of Association that became effective upon the Transfer. The Transfer resulted in changes to the rights of shareholders and the governance of the Company.
Directors
In France, a company organized as a "Societas Europaea" can have a two-tier board structure: a management board comprising managing directors (Directoire) and a supervisory board comprising the non-executive directors (Conseil de Surveillance), or a single-tier board of directors (Conseil d’Administration). The single-tier board of directors of such French company will be comprised of non-executive directors and, if any, executive directors (see “Management” below).
Under French law, the board of directors supervises the management of the executive officers, sets the guidelines for the company’s activities and oversees their implementation. Subject to the powers expressly assigned by law to the shareholders’ meetings and within the limit of the corporate purpose, the board of directors hears any issue relevant to the company’s operation and, by means of its deliberations, settles the matters of concern to it, taking into consideration the social and environmental impact of the company’s activity. The board of directors proceeds with the controls and checks what it deems advisable. Moreover, the board of directors exercises the special powers conferred on it by law.
We currently have a single-tier Board of Directors consisting of one executive director (the CEO) and eleven non-executive directors, two of which are employee directors. For a listing of the current terms of service of our Directors, see “A. Directors and Senior Management” above.
Under French law, each director has a duty towards the company to properly perform his/her duties. Furthermore, each director has a duty to act in the corporate interest of the company.
The corporate interest extends to the interests of all corporate stakeholders, such as shareholders, creditors, employees, customers and suppliers.
The company is bound vis-à-vis third parties by the actions of its board of directors, even if such actions are not in line with the corporate purpose, unless it can be proven that the third party knew that the action exceeded that purpose or that the third party could not have been unaware of such excess in light of the circumstances; publication of the articles of association (which, under French law, include description of the corporate purpose) does not per se constitute such proof.
Any board resolution regarding a change in the company’s Articles of Association requires shareholders’ approval. The board of directors may decide in its sole discretion, within the confines of French law and the Articles of Association, to incur additional indebtedness subject to any contractual restrictions pursuant to existing financing arrangements.
Under French law, there is no obligation for directors to hold shares in the company unless required by the articles of association. According to our Articles of Association, there is no such obligation. However, the Company adopted internal Share Ownership Guidelines (SOGs) to encourage minimum levels of the Company’s share ownership by its executive director (CEO) and by those of its non-executive directors who receive compensation in such capacity. For further information on the SOGs, you may refer to “Item 6. Directors, Senior Management and Employees—B. Compensation”.
Management
Following the Transfer, our Board of Directors has maintained the separation of the functions of Chairman of the Board of Directors (Président du conseil d’administration) and Chief Executive Officer (Directeur Général).
-67-


The Chief Executive Officer is appointed by the board of directors and may (but is not required to) be a director. He or she is vested with the broadest powers to act in all circumstances in the company’s name. He or she exercises his or her powers within the scope of the corporate purpose and subject to those that the law expressly assigns to shareholders' meetings and the board of directors.
He or she represents the company in its relations with third parties. The company is bound vis-à-vis third parties by the actions of its Chief Executive Officer, even if such actions are not in line with the corporate purpose, unless it can be proven that the third party knew that the action exceeded that purpose or that the third party could not have been unaware of such excess in light of the circumstances; publication of the articles of association (which, under French law, include description of the corporate purpose) does not per se constitute such proof.
According to our Articles of Association, our Chief Executive Officer shall not be more than seventy (70) years of age. If our Chief Executive Officer reaches that age limit, he or she shall be considered to have resigned. However, his or her term of office shall be extended until the next meeting of the Board of Directors during which a new Chief Executive Officer shall be appointed.
On a proposal made by the Chief Executive Officer, the Board of Directors may appoint one or more natural persons to assist the Chief Executive Officer as Deputy Chief Executive Officer(s) (Directeur Général Délégué), who may (but are not required to) be Directors. The Chief Executive Officer and, if any, the Deputy Chief Executive Officer(s) would be the executive corporate officers ("mandataires sociaux dirigeants"), under French law.
In agreement with the Chief Executive Officer, the Board of Directors shall define the scope and duration of the powers conferred on the Deputy Chief Executive Officer(s). The Board of Directors shall define such Deputy Chief Executive Officer’s additional compensation. If a Deputy Chief Executive Officer is a director, his or her duties as Deputy Chief Executive Officer cannot outlast his or her directorship.
With regard to representation vis-à-vis third parties, Deputy Chief Executive Officers may have the same powers as the Chief Executive Officer. The number of Deputy Chief Executive Officers may not exceed five at the same time.
Director Terms and Remuneration
Under French law, a director of a company is appointed for a maximum term of six years. In practice, the articles of association set the directors’ precise term. According to our Articles of Association, the term of office of a Director is of three (3) years and can be renewed without limitation. Directors may be appointed for a shorter term so that the renewal of the Directors’ terms of office may be spread out over time. According to our Articles of Association, the number of Directors who are more than seventy-five (75) years old may not exceed one third of the directors in office and, if this limit is exceeded during the terms of office, the oldest director shall automatically be considered to have resigned at the close of the next general meeting.
The board of directors determines the remuneration of executive directors (i.e. the CEO (“Directeur Général”) and, if any, Deputy Chief Executive Officers (“Directeurs Généraux Délégués”), who may (but are not required to) be directors). French law does not provide for any specific rules on remuneration of executive directors for French companies not listed on a EU-regulated market. Executive directors may be granted free shares and stock options of the Company.
With respect to the remuneration of non-executive directors, the ordinary shareholders’ meeting votes an envelope of fixed annual fees to be allocated to directors for each year. The board of directors will then decide the allocation of these fees among directors. These fees include all cash remunerations granted to directors in such capacity. In addition to the fixed amount of fees approved at the shareholders meeting, the board of directors may grant fees to the chairman of the board in such capacity, and may also, exceptionally, grant additional fees to certain directors in remuneration for separate, specific missions or tasks assigned to them. Non-executive directors are not eligible to receive awards that are to be settled with shares. However, the board of directors may grant share-settled awards (such as free shares or stock options) to the chairman of the board in such capacity.
Removal of Directors
Under French law, directors may be removed from office, with or without cause, at any shareholders’ meeting without notice or justification, by a simple majority vote of shareholders.
Directors cannot be suspended or removed by the board of directors.
-68-


Under French law, an employee director may be removed from office only in case of a fault in the performance of the directorship, by decision of the president of a French court (Tribunal Judiciaire), at request of majority of directors.
An executive corporate officer appointed by the board of directors (CEO (Directeur Général) or, if any, deputy chief executive officer (Directeur Général Délégué)) can have his or her executive duties suspended at any time by the board of directors. If such executive corporate officer is also a director, he or she will remain non-executive director as his or her duties as a director can only be removed by a shareholders’ meeting.
Director Election and Vacancies
Under French law, new members of the board of directors of a company are appointed by the general meeting of shareholders by a simple majority. The board of directors which convenes the shareholders’ meeting proposes candidates; shareholders may also propose candidates under certain conditions. The shareholders at the meeting may vote for other candidates than those proposed on the agenda, by a simple majority.
Vacancies on the board of directors occurring between shareholders’ meetings may be filled at a board meeting by a majority of the remaining directors, subject to ratification at the next shareholders’ meeting.
According to our Articles of Association, the first employee director is appointed by the French Group Works Council and the second by the European Works Council. In the event of a vacancy in a seat of an employee director, the vacant seat is filled in by an employee designated in the same way as the replaced employee director.
Conflict of Interest Transactions
Pursuant to French law and the Articles of Association, any agreement between (directly or through an intermediary) a company and any of its directors, its executive corporate officers (“Directeur Général” or any “Directeur Général Délégué”), its shareholders holding more than 10% of its voting rights or companies controlling such shareholders, that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions, is subject to a prior authorization of the board of directors, excluding the participation and vote of the interested director. Such agreement is also subject to approval at the next ordinary shareholders’ meeting (by a simple majority), excluding the votes of any interested persons. The foregoing requirements also apply to agreements between the company and another entity if one of the company’s directors, or executive corporate officers (“Directeur Général” or any “Directeur Général Délégué”) is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the company’s directors, executive corporate officers (“Directeur Général” or any “Directeur Général Délégué”), shareholders holding more than 10% of its voting rights or companies controlling such shareholders has an indirect interest. If the transaction has not been pre-approved by the board of directors, it can be nullified if it has prejudicial consequences for the company. If an agreement is not then approved by the shareholders, the interested person may be held liable for any prejudicial consequences for the company of the unapproved transaction; such transaction will nevertheless remain valid unless it is nullified in case of fraud. Aside from the above rule, there are no specific provisions prohibiting conflicted directors to participate or vote at board meetings. However, as a general rule, directors must act in the interest of the company.
Action by Written Consent and Quorum Requirements
According to French law and the Articles of Association, certain decisions of the Board of Directors may be adopted in writing. These decisions include interim appointment of directors, authorization of certain security interests and guarantees, amendment of the articles of association to comply with legal provisions, convening of shareholder meetings and decisions to transfer the registered office within the same department. According to French law and our Articles of Association, a director may grant to another director a proxy to represent him or her at a meeting of the board of directors. No director can hold more than one proxy at any meeting.
According to French law and the Articles of Association, for the board’s deliberations to be valid, more than half of the board members must be present or represented. The board of directors’ decisions shall be taken by a majority vote; if the votes are tied, the chairman’s vote shall be decisive.
Board Composition and Diversity
According to Article L. 225-17 of the French Commercial Code, the appointment of members of the board of directors must seek to achieve a balanced representation of men and women. As of December 31, 2022, our Board of Directors is comprised of twelve members, five of whom are women.
-69-


Also, under French law, if the number of permanent employees of a company exceeds 1,000 (including its direct and indirect French subsidiaries) or 5,000 (including its direct and indirect subsidiaries worldwide) for two consecutive fiscal years, an amendment of the articles of association may be required for the board of directors to include at least two directors representing the employees (in companies having more than eight directors) or at least one director representing the employees (in companies having no more than eight directors). Following the amendment by the Company’s Annual General Meeting held on May 11, 2021 of our Articles of Association to allow for such appointment, two employees of the Group were appointed to our Board of Directors by, respectively, the French Group Works Council and the European Works Council.
Chairman of the Board
Pursuant to French law, companies with a single-tier board of directors can choose between the separation of functions of the chairman of the board of directors (Président du conseil d'administration) and chief executive officer (Directeur Général) of the company and the aggregation of such duties. According to our Articles of Association, our Board of Directors can decide to separate, or not separate, the functions of the Chairman of the Board of Directors and Chief Executive Officer.
Under French law, the board of directors elects a chairman among its members who must be a natural person. The board of directors determines the term of office of the chairman, which cannot exceed his or her tenure as director, and may revoke him or her at any time.
The chairman organizes and directs the work of the board of directors, on which he or she reports to the general shareholders’ meeting, and ensures the proper functioning of the corporate bodies and, in particular, that the directors are able to fulfill their mission.
According to our Articles of Association, our Chairman of the Board cannot be older than seventy-five (75) years. If our Chairman of the Board reaches this age limit during his or her term as Chairman, he or she is automatically deemed to have resigned from such position. His or her mandate would extend however, until the next meeting of the Board of Directors during which his or her successor is appointed. Subject to this provision, the Chairman of the Board is always eligible for re-election.
Director Independence
Under French law, there are no director independence requirements for French companies not listed on an EU-regulated market, so we defer to the NYSE requirements. As a foreign private issuer under the NYSE rules, we are not required to have independent Directors on our Board, except to the extent that our Audit Committee is required to consist of independent Directors. However, our Board has determined that, under current NYSE listing standards regarding independence (which we are not currently subject to), and taking into account applicable committee standards, as of December 31, 2022, Messrs. Brandjes, Deslarzes, Ormerod, Puig, and Blot and Mmes. Boccon-Gibod, Brooks, Browne, and Walker are deemed independent directors. Under these standards, Mr. Germain is not deemed independent as he serves as the CEO of the Company, and Mr. Verdier and Ms. Weiler are not deemed independent as they are employees of the Group.
Committees
Under French law, the board of directors may appoint from its members one or more special committees, for which the board sets the composition and powers and which carry out their activity under the board’s responsibility. Each committee shall report on its missions at the meetings of the board of directors. Our Board of Directors has currently four committees: the Audit Committee, the Human Resources Committee, the Nominating and Governance Committee and the Safety and Sustainability Committee.
Audit Committee
As of December 31, 2022, our Audit Committee consisted of four independent directors under the NYSE requirements: Lori Walker (Chair), Isabelle Boccon-Gibod, Christine Browne and John Ormerod. Our Board has determined that at least one member is an “audit committee financial expert” as defined by the SEC and also meets the additional criteria for independence of audit committee members set forth in Rule 10A-3(b)(1) under the Exchange Act. The Audit Committee held 8 meetings in 2022, with 100% director attendance at all meetings.
The principal duties and responsibilities of our Audit Committee are to oversee and monitor the following:
our financial reporting process and internal control system;
the integrity of our consolidated financial statements, and disclosure matters;
-70-


the independence, qualifications and performance of our independent auditors;
the performance of our internal audit function;
financial and other significant risk exposure; and
our compliance with legal, ethical and regulatory matters.
Human Resources Committee
As of December 31, 2022, our Human Resources Committee consisted of four directors: Martha Brooks (Chair), Christine Browne, Jean-Christophe Deslarzes, and Jean-Philippe Puig. The Human Resources Committee held 6 meetings in 2022, with 100% director attendance at all meetings.
The principal duties and responsibilities of our Human Resources Committee are:
to review and make recommendations to the Board with respect to our compensation philosophy, policies and structure and with respect to our annual incentive compensation and equity-based compensation plans;
to review the compensation of, and reimbursement policies for, members of the Board;
to review and approve the corporate goals, performance and compensation structure of our Chief Executive Officer;
to review and approve the compensation structure for all employees who report directly to our Chief Executive Officer;
to oversee our critical strategic or major human capital issues, including amongst other items, diversity and inclusion, employment engagement surveys and talent development programs; and
to oversee the selection of officers and management succession planning.
Nominating and Governance Committee
As of December 31, 2022, our Nominating and Governance Committee consisted of five directors: John Ormerod (Chair), Isabelle Boccon-Gibod, Michiel Brandjes, Jean-Christophe Deslarzes and Lori Walker. The Nominating and Governance Committee held 4 meetings in 2022, with almost 100% director attendance at all meetings, except for one director who did not attend one meeting.
The principal duties and responsibilities of the Nominating and Governance Committee are:
to establish criteria for Board and committee membership and recommend to our Board proposed nominees for election to the Board and for membership on committees of our Board;
to conduct succession planning for the Chair of the Board, and for the Chief Executive Officer;
to make recommendations to our Board regarding Board governance matters and practices;
to oversee the annual self-assessment of the Board and its committees; and
to review Board corporate governance matters, including conflicts of interest, related party matters and director independence.
Safety and Sustainability Committee
As of December 31, 2022, our Safety and Sustainability Committee consisted of four directors: Michiel Brandjes (Chair), Emmanuel Blot, Martha Brooks and Jean-Philippe Puig. The Safety and Sustainability Committee held four meetings in 2022, with approximately 90% director attendance at all meetings.
The principal duties and responsibilities of the Safety and Sustainability Committee are:
to review periodically the Company’s policies, practices and programs with respect to the overall management of safety and sustainability matters, including climate change and environmental matters;
to oversee the implementation and effectiveness of the Company’s employee safety risk-management procedures, policies, practices, programs and initiatives;
to review the Company’s record of compliance with laws, regulations and Company policies relating to safety and sustainability matters; and
to work with and advise the other Board committees in areas that come within the mandate of such committees and that also are part of the Company’s sustainability initiatives.
-71-


D.Employees
As of December 31, 2022, we employed approximately 12,500 employees, including approximately 600 fixed-term contractors as well as approximately 300 apprentices. In addition, we contracted with approximately 800 temporary workers. Approximately 90% of our employees were engaged in production and maintenance activities and approximately 10% were employed in support functions. Approximately 33% of our employees were employed in France, 25% in the United States, 22% in Germany, 6% in Switzerland, and 14% in Eastern Europe and other regions, which percentages are comparable to the distribution of employees geographically in 2021.
A vast majority of non-U.S. employees and approximately 50% of U.S. employees are covered by collective bargaining agreements. These agreements are negotiated on site, regionally or on a national level, and are of different durations.
E.Share Ownership
Information with respect to share ownership of members of our Board of Directors and our senior management is included in “Item 7. Major Shareholders and Related Party Transactions.”
Equity Incentive Plans
The Company has adopted the Constellium 2013 Equity Plan and the 2022 LTIP thereunder pursuant to which certain of our directors, executive officers and employees are currently eligible to receive equity awards. See “—Constellium SE 2013 Equity Incentive Plan” and “— 2022 Long-Term Incentive Plan” above.
F.
Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation
Not applicable.
Item 7. Major Shareholders and Related Party Transactions
A.Major Shareholders
The following table sets forth the major shareholders of Constellium SE as known by us or ascertained from public filings made by our major shareholders (each person or group of affiliated persons who is known to be the beneficial owner of more than 5% of ordinary shares) and the number and percentage of ordinary shares owned by each such shareholder, in each case as of March 10, 2023.
Under the rules of the SEC, a person is deemed to be a “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the voting of such security, or “investment power,” which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days. Under these rules, more than one person may be deemed to be a beneficial owner of such securities as to which such person has voting or investment power.
-72-


The beneficial ownership percentages in this table have been calculated on the basis of the total number of ordinary shares.
Name of beneficial owner
Number of
ordinary
shares
Beneficial
ownership
percentage
Caisse des Dépôts (f/k/a Caisse des Dépôts et Consignations),
Bpifrance Participations S.A., Bpifrance S.A. (f/k/a BPI-Groupe), EPIC Bpifrance (f/k/a EPIC BPI-Groupe)
16,393,903 (1)11.4 %
T. Rowe Price Investment Management, Inc. 14,604,987 (2)10.1 %
BlackRock, Inc.11,513,896 (3)8.0 %
FMR LLC11,167,375 (4)7.7 %
Janus Henderson Group plc10,407,176 (5)7.2 %
Directors and Senior Management
Michiel Brandjes52,000 (6)*
John Ormerod22,263 (7)*
Lori A. Walker35,044 (8)*
Martha Brooks144,641 (9)*
Isabelle Boccon-Gibod10,000 (10)*
Christine Browne5,000 (11)*
Jean-Christophe Deslarzes8,510 (12)*
Jean-Philippe Puig17,000 (13)*
Jean-François Verdier41 (14)*
Wiebke Weiler— (15)*
Emmanuel Blot— (16)
Jean-Marc Germain1,184,594 (17)*
Peter R. Matt536,180 (18)*
Ingrid Joerg214,496 (19)*
Peter Basten294,271 (20)*
Philippe Hoffmann85,163 (21)*
___________
*Represents beneficial ownership of less than 1%.
(1)This information is based on a Schedule 13D/A filed with the SEC on November 8, 2017, which share amount is reconfirmed in a Form 13F dated February 13, 2023. Bpifrance Participations S.A. (f/k/a Fonds Stratégique d’Investissement, “Bpifrance”) is a French public investment fund specializing in the business of equity financing via direct investments or fund and a wholly owned subsidiary of Bpifrance S.A., a French financial institution (“Bpifrance S.A.”). Caisse des Dépôts (“CDC”) and EPIC Bpifrance (“EPIC”) each hold 50% of the share capital of Bpifrance S.A. and jointly control Bpifrance S.A. CDC is principally engaged in the business of long-term investments. EPIC is principally engaged in the business of banking finance. Bpifrance holds directly 16,393,903 ordinary shares of the Company. As of the date hereof, neither Bpifrance S.A., CDC nor EPIC holds any ordinary shares directly. Bpifrance S.A. may be deemed to be the beneficial owner of 16,393,903 ordinary shares of the Company, indirectly through its sole ownership of Bpifrance. CDC and EPIC may be deemed to be the beneficial owners of 16,393,903 ordinary shares of the Company, indirectly through their joint ownership and control of Bpifrance S.A. The principal address for CDC is 56, rue de Lille, 75007 Paris, France and for Bpifrance, Bpifrance S.A. and EPIC is 27-31 avenue du Général Leclerc, 94700 Maisons-Alfort, France.
(2)This information is based on a Schedule 13G/A filed with the SEC on February 14, 2023 reporting beneficial ownership as of December 31, 2022. T. Rowe Price Investment Management, Inc. has sole dispositive power with respect to 14,604,987 ordinary shares and sole voting power with respect to 4,673,727 ordinary shares. The principal business address of T. Rowe Price Investment Management, Inc. is 100 E. Pratt Street, Baltimore, MD 21202.
-73-


(3)This information is based on a Schedule 13G/A filed with the SEC on February 3, 2023 reporting beneficial ownership as of December 31, 2022. BlackRock, Inc. has sole dispositive power with respect to 11,513,896 ordinary shares and sole voting power with respect to 11,101,161 ordinary shares. The principal business address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055.
(4)This information is based on a Schedule 13G filed with the SEC on February 9, 2023 reporting beneficial ownership as of December 31, 2022. FMR LLC has sole dispositive power with respect to 11,167,375 ordinary shares and sole voting power with respect to 11,166,374 ordinary shares. The principal business address of FMR LLC is 245 Summer Street, Boston, MA 02210.
(5)This information is based on a Schedule 13G/A filed with the SEC on February 10, 2023 reporting beneficial ownership as of December 31, 2022. Janus Henderson Group plc (“Janus Henderson”) has shared dispositive power with respect to 10,407,176 ordinary shares and shared voting power with respect to 10,407,176 ordinary shares. Janus Henderson has a 100% ownership stake in Janus Henderson Investors U.S. LLC (“JHIUS”), Janus Henderson Investors UK Limited (“JHIUKL”) and Janus Henderson Investors Australia Institutional Funds Management Limited (“JHIAIFML”), (each an “Asset Manager” and collectively as the “Asset Managers”). Due to the above ownership structure, holdings for the Asset Managers are aggregated for purposes of this filing. Each Asset Manager is an investment adviser registered or authorized in its relevant jurisdiction and each furnishing investment advice to various fund, individual and/or institutional clients (collectively referred to herein as “Managed Portfolios”). As a result of its role as investment adviser or sub-adviser to the Managed Portfolios, JHIUS may be deemed to be the beneficial owner of 10,407,176 ordinary shares or 7.3% of the shares outstanding of Constellium Ordinary Shares held by such Managed Portfolios. However, JHIUS does not have the right to receive any dividends from, or the proceeds from the sale of, the securities held in the Managed Portfolios and disclaims any ownership associated with such rights. Janus Henderson Contrarian Fund is an investment company registered under the Investment Company Act of 1940 and is one of the Managed Portfolios to which JHIUS provides investment advice. The principal business address of Janus Henderson Group plc is 201 Bishopsgate, EC2M 3AE, United Kingdom, and the principal business address of Janus Henderson Contrarian Fund is 151 Detroit Street, Denver, Colorado 80206.
(6)Consists of 52,000 ordinary shares held directly by Mr. Brandjes.
(7)Consists of 15,640 ordinary shares held directly by Mr. Ormerod, and 6,623 ordinary shares held indirectly in a self-employed pension trust.
(8)Consists of 35,044 ordinary shares held directly by Ms. Walker.
(9)Consists of 144,641 ordinary shares, including: (i) 42,641 shares held directly by Ms. Brooks, as well as 22,000 shares held indirectly by Ms. Brooks in her husband's brokerage account for which she is the beneficiary, and (ii) 80,000 ordinary shares indirectly held by Ms. Brooks through a family limited partnership for which she has shared voting power and shared dispositive power. Out of the 80,000 shares held by Ms. Brooks through the family limited partnership, Ms. Brooks has beneficial ownership of 14,480 of such shares and her husband has beneficial ownership of 1,920 shares for which she is the beneficiary, and she disclaims beneficial ownership of 63,600 shares because she does not have the right to receive proceeds from the sale of, or dividends with respect to such shares.
(10)Consists of 10,000 ordinary shares held directly by Ms. Boccon-Gibod.
(11)Consists of 5,000 ordinary shares held directly by Ms. Browne.
(12)Consists of 8,510 ordinary shares held directly by Mr. Deslarzes.
(13)Consists of 17,000 ordinary shares held directly by Mr. Puig.
(14)Consists of 41 ordinary shares held directly by Mr. Verdier and no RSUs or PSUs were granted in 2022.
(15)No ordinary shares are held by Ms. Weiler and no RSUs or PSUs were granted in 2022.
(16)No ordinary shares are held by Mr. Blot.
(17)Consists of 1,184,594 ordinary shares held by Mr. Germain, including 484,594 held directly, 350,000 ordinary shares held directly through the JMG Irrevocable Trust, and 350,000 ordinary shares held indirectly through the
-74-


FG Irrevocable Trust, for which he is a beneficiary. Excludes the remaining portions of previous grants: 312,481 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 159,404 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service; 175,540 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 11, 2024, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 89,547 ordinary shares underlying unvested RSUs that will vest on May 11, 2024, subject to continued service; 158,858 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on March 10, 2025, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 81,037 ordinary shares underlying unvested RSUs that will vest on March 10, 2025, subject to continued service.
(18)Consists of 536,180 ordinary shares held directly by Mr. Matt. Excludes the remaining portions of previous grants: 109,791 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 56,007 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service; 63,833 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 11, 2024, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 32,562 ordinary shares underlying unvested RSUs that will vest on May 11, 2024, subject to continued service; 58,119 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on March 10, 2025, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 29,648 ordinary shares underlying unvested RSUs that will vest on March 10, 2025, subject to continued service.
(19)Consists of 214,496 ordinary shares held directly by Ms. Joerg. Excludes the remaining portions of previous grants: 50,224 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 25,620 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service; 30,748 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 11, 2024, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 15,686 ordinary shares underlying unvested RSUs that will vest on
May 11, 2024, subject to continued service; 27,897 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on March 10, 2025, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 14,231 ordinary shares underlying unvested RSUs that will vest on March 10, 2025, subject to continued service.
(20)Consists of 294,271 ordinary shares held directly by Mr. Basten. Excludes the remaining portions of previous grants: 50,224 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 25,620 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service; 30,748 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 11, 2024, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 15,686 ordinary shares underlying unvested RSUs that will vest on
May 11, 2024, subject to continued service; 27,897 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on March 10, 2025, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 14,231 ordinary shares underlying unvested RSUs that will vest on March 10, 2025, subject to continued service.
(21)Consists of 85,163 ordinary shares held directly by Mr. Hoffmann. Excludes the remaining portions of previous grants: 14,292 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 13,540 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service; 30,748 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 11, 2024, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 15,686 ordinary shares underlying unvested RSUs that will vest on May 11, 2024, subject to continued service; 27,897 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on March 10, 2025, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 14,231 ordinary shares underlying unvested RSUs that will vest on March 10, 2025, subject to continued service.
-75-


None of our principal shareholders have voting rights different from those of our other shareholders.
The registrar and transfer agent for our Company reported that, as of December 31, 2022, 144,291,033 of our ordinary shares were held by 3 holders of record in the United States.
B.Related Party Transactions
Amended and Restated Shareholders Agreement and Related Transactions
The Company, Apollo Omega, Rio Tinto and Bpifrance entered into an amended and restated shareholders agreement on May 29, 2013 (the “Shareholders Agreement”). The Shareholders Agreement terminated with respect to Apollo Omega and Rio Tinto in connection with certain of their respective sales of our ordinary shares. The Shareholders Agreement provides for, among other things, piggyback registration rights and demand registration rights for Bpifrance for so long as Bpifrance owns any of our ordinary shares.
In addition, the Shareholders Agreement provides that, except as otherwise required by applicable law, Bpifrance will be entitled to designate for binding nomination one director to our Board of Directors so long as its percentage ownership interest is equal to or greater than 4% or it continues to hold all of the ordinary shares it subscribed for at the closing of the acquisition (such share number adjusted for the pro rata share issuance). Any such nominee director will be elected by our shareholders acting at a general meeting upon a binding nomination by the Board of Directors. Under the Shareholders Agreement, the Company also agreed to share financial and other information with Bpifrance to the extent reasonably required to comply with its tax, investor or regulatory obligations and with a view to keeping Bpifrance properly informed about the financial and business affairs of the Company. The Shareholders Agreement contains provisions to the effect that Bpifrance is obliged to treat all information provided to it as confidential, and to comply with all applicable rules and regulations in relation to the use and disclosure of such information. Pursuant to the Shareholders Agreement, Mr. Blot was designated by Bpifrance as a nominee, and was then appointed by the shareholders to serve as a director of the Company in June 2022. Mr. Blot joined Bpifrance Investissement in 2012, and is currently Investment Director and Head of the Listed Investments Practice - Large Cap.
Bpifrance Investissement is a subsidiary of Bpifrance, which is a wholly owned subsidiary of Bpifrance S.A. (f/k/a BPI Groupe), a French financial institution jointly owned and controlled by the Caisse des Dépôts, a French special public entity (établissement special) and EPIC Bpifrance (f/k/a EPIC BPI-Groupe), a French public institution of industrial and commercial nature. As of March 10, 2023, Bpifrance owns approximately 11.4% of the Company’s outstanding ordinary shares. On March 28, 2018, Bpifrance Financement, an affiliate of Bpifrance Investissement and of Bpifrance, entered into a revolving credit facility with Constellium Issoire (f/k/a Constellium France) for an aggregate amount of €10 million for the purpose of financing various investments, subject to a commitment fee of 1% per year. The maximum amount of authorized ceiling was set to be reduced each quarter by €833,333.33. Any amount drawn under this facility was set to bear interest at a rate equal to 3 months Euribor (with a floor of 0%) plus 2.5%. The facility could be drawn upon from time to time. On December 31, 2021, this facility expired in accordance with its contractual terms.
On May 13, 2020, one of our French entities, Constellium International S.A.S., entered into a fully committed term loan facility with a syndicate of banks (the “PGE French Facility”) for an aggregate amount of up to €180 million, of which 80% was guaranteed by the French State. Bpifrance Financement provided €30 million of the PGE French Facility. The PGE French Facility was repaid at its maturity in May 2022. For further information on the PGE French Facility, please refer to “Item 10. Additional Information—C. Material Contracts—PGE French Facility”.
C.Interests of Experts and Counsel
Not applicable.
Item 8. Financial Information
A.Consolidated Statements and Other Financial Information
Our Consolidated Financial Statements as of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020 are included in this Annual Report at “Item 18. Financial Statements.”
-76-


Legal Proceedings
Legal proceedings are disclosed in “Item 4. Information on the Company—B. Business Overview—Litigation and Legal Proceedings.”
Dividend Policy
Our Board of Directors periodically explores the potential adoption of a dividend program; however, no assurances can be made that any future dividends will be paid on the ordinary shares. Any proposal to declare and pay future dividends to holders of our ordinary shares will be at the discretion of our Board of Directors and will depend on many factors, including our financial condition, earnings, capital requirements, level of indebtedness, statutory future prospects and contractual restrictions applying to the payment of dividends and other considerations that our Board of Directors deems relevant.
Under French law, dividends are approved by the shareholders’ meeting. All calculations to determine the amounts available for dividends or other distributions will be based on our statutory financial statements which are, as a holding company, different from our consolidated financial statements and which are prepared in accordance with French GAAP because we are a French company. Dividends may only be paid by a French Societas Europaea out of “distributable profits,” plus any distributable reserves and “distributable premium” that the shareholders decide to make available for distribution, other than those reserves that are specifically required by law.
“Distributable profits” consist of the unconsolidated net profits of the relevant company for each fiscal year, as increased or reduced by any profit or loss carried forward from prior years.
“Distributable premium” refers to the contribution paid by the shareholders in addition to the par value of their shares for their subscription that the shareholders decide to make available for distribution.
Except in the case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the articles of association.
Dividends may be paid in cash or, if the shareholders’ meeting so decides, in kind, provided that all the shareholders receive a whole number of assets of the same nature paid in lieu of cash.
Our Articles of Association provide that each shareholder may be given the choice to receive his or her dividend in cash or in shares subject to a decision of the shareholders’ meeting taken by ordinary resolution.
Under French law, the board of directors may distribute interim dividends before the approval by the shareholders of the financial statements for the relevant fiscal year when the interim balance sheet, established during or at the close of such year and certified by the auditors, reflects that the company has earned distributable profits since the close of the previous fiscal year, after recognizing the necessary depreciation and provisions and after deducting prior losses, if any, and the sums to be allocated to reserves, as required by French law or articles of association, and including any retained earnings. The amount of such interim dividends may not exceed the amount of the profit so defined.
Generally, we rely on dividends paid to Constellium SE, or funds otherwise distributed or advanced to Constellium SE by its subsidiaries to fund the payment of dividends, if any, to our shareholders. In addition, restrictions contained in the agreements governing our outstanding indebtedness limit our ability to pay dividends on our ordinary shares and limit the ability of our subsidiaries to pay dividends to us. Future indebtedness that we may incur may contain similar restrictions. According to our Articles of Association, distributions payable in cash shall be approved in euros and paid (i) in euros for all the holders of shares under the French Register and (ii) in USD for all the holders of shares under the U.S. Register. For the purposes of the payment of the dividend in dollars, the general shareholders’ meeting or, as the case may be, our Board of Directors, shall set the reference date to be considered for the EUR/USD exchange rate.
Cash dividends and other distributions that have not been collected within five years after the date on which they became due and payable will revert to the French State.
We have historically not paid dividends to our shareholders since the time that we became a publicly listed company on the NYSE.
-77-


B.Significant Changes
Except as otherwise disclosed within this annual report, no significant change has occurred since the date of the Consolidated Financial Statements.

Item 9. The Offer and Listing
A.Offer and Listing Details
Our ordinary shares are listed on the NYSE under the symbol CSTM.
B.Plan of Distribution
Not applicable.
C.Markets
We began trading on the NYSE on May 23, 2013 and on the professional segment of Euronext Paris on May 27, 2013 through a public offering in the United States. Trading on the NYSE is under the symbol “CSTM.” In February 2018, we voluntarily delisted our ordinary shares from Euronext Paris to reduce costs and complexity associated with listing in multiple jurisdictions. We continue to be listed on the NYSE. For more information on our shares see “Item 10. Additional Information—B. Memorandum and Articles of Association.”
D.Selling Shareholders
Not applicable.
E.Dilution
Not applicable.
F.Expenses of the Issue
Not applicable.
Item 10. Additional Information
A.Share Capital
Not applicable.
B.Memorandum and Articles of Association
Pursuant to Instruction 1(b) to Item 10, the information called for by this Item is included in “Exhibit 2.1. Description of Securities Registered under Section 12 of the Exchange Act” filed with this Annual Report pursuant to Instruction 2(d) to Item 19.
-78-


C.Material Contracts
The following is a summary of each material contract, other than material contracts entered into in the ordinary course of business, to which we are a party, for the two years immediately preceding the date of this Annual Report:
Employment Agreements and Benefit Plans. See “Item 6. Directors, Senior Management and Employees—B. Compensation” for a description of the material terms of our employment agreements and benefits plans.
Amended and Restated Shareholders Agreement. See “Item 7. Major Shareholders and Related Party Transactions” for a description of material terms of this contract.
Notes, Pan-U.S. ABL Facility, PGE French Facility, Swiss Facilities, German Facilities, French Inventory Facility and Factoring Agreements. As disclosed below.

May 2014 Notes (Redeemed in June 2021)
On May 7, 2014, the Company completed a private offering of $400 million in aggregate principal amount of 5.750% Senior Notes due 2024 (the “2024 U.S. Dollar Notes”) and €300 million in aggregate principal amount of 4.625% Senior Notes due 2021 (the “2021 Euro Notes,” and together with the 2024 U.S. Dollar Notes, the “May 2014 Notes”) pursuant to indentures among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. A portion of the net proceeds of the May 2014 Notes were used to repay amounts outstanding under our senior secured term loan B facility, including related transaction fees, expenses, and prepayment premium thereon. We used the remaining net proceeds for general corporate purposes, including to put additional cash on our balance sheet.
Interest on the 2024 U.S. Dollar Notes accrued at a rate of 5.750% per annum and was payable semi-annually on May 15 and November 15 of each year, beginning November 15, 2014. Substantially concurrently with the launch of the June 2021 Notes Offering (as defined below), we issued a notice of redemption for all of the outstanding 2024 U.S. Dollar Notes (the “2024 Note Redemption”), at a redemption price equal to 100.958% of the principal amount of the 2024 U.S. Dollar Notes redeemed plus accrued and unpaid interest, if any, to the redemption date (the “2024 Note Redemption Price”). On June 16, 2021 (the “2024 Note Redemption Date”), the $400 million in aggregate principal amount of the 2024 U.S. Dollar Notes were redeemed in accordance with the indenture governing the 2024 U.S. Dollar Notes. Substantially concurrently with the issuance of the June 2021 Notes (as defined below), we satisfied and discharged (the “Satisfaction and Discharge”) the indenture governing the 2024 U.S. Dollar Notes by depositing with the trustee for the 2024 U.S. Dollar Notes an amount in cash sufficient to pay on the 2024 Note Redemption Date the 2024 Note Redemption Price for all 2024 U.S. Dollar Notes redeemed. We used the net proceeds from the June 2021 Notes Offering, together with cash on hand, to fund the 2024 Note Redemption and to pay related fees and expenses.
Prior to May 15, 2019, we were permitted to redeem some or all of the 2024 U.S. Dollar Notes at a price equal to 100% of the principal amount of the 2024 U.S. Dollar Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after May 15, 2019, we were permitted to redeem the 2024 U.S. Dollar Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.875% during the 12-month period commencing on May 15, 2019, 101.917% during the 12-month period commencing on May 15, 2020, 100.958% during the 12-month period commencing on May 15, 2021, and par on or after May 15, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to May 15, 2017, we were permitted to, within 90 days of a qualified equity offering, redeem the 2024 U.S. Dollar Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount of the 2024 U.S. Dollar Notes (after giving effect to any issuance of additional 2024 U.S. Dollar Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 5.750% for the 2024 U.S. Dollar Notes, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of 2024 U.S. Dollar Notes would remain outstanding immediately after giving effect to such redemption.
-79-


Within 30 days of the occurrence of specific kinds of changes of control, the Company was required to make an offer to purchase all outstanding 2024 U.S. Dollar Notes at a price in cash equal to 101% of the principal amount of the 2024 U.S. Dollar Notes, plus accrued and unpaid interest, if any, to the purchase date.
The 2024 U.S. Dollar Notes were senior unsecured obligations of Constellium and were guaranteed on a senior unsecured basis by Constellium International, Constellium France Holdco, Constellium Neuf Brisach, Constellium Issoire, Constellium Finance, Engineered Products International, Constellium Germany Holdco GmbH & Co. KG, Constellium Deutschland GmbH, Constellium Singen GmbH, Constellium Rolled Products Singen GmbH & Co. KG, Constellium Switzerland AG, Constellium US Holdings I, LLC, Constellium Rolled Products Ravenswood, LLC, Constellium Holdings Muscle Shoals LLC (f/k/a Wise Metal Group LLC), Constellium Muscle Shoals LLC (f/k/a Wise Alloys LLC), Constellium Bowling Green LLC, and Constellium Property and Equipment Company, LLC. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guaranteed certain indebtedness of Constellium (including the November 2017 Notes, the June 2020 Notes, and the February 2021 Notes) or certain indebtedness of any of the guarantors of the 2024 U.S. Dollar Notes was required to guarantee the 2024 U.S. Dollar Notes.
The indenture governing the 2024 U.S. Dollar Notes contained customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the 2024 U.S. Dollar Notes also contained customary events of default.
Interest on the 2021 Euro Notes accrued at a rate of 4.625% per annum and was payable semi-annually beginning November 15, 2014. The 2021 Euro Notes were scheduled to mature on May 15, 2021. On August 8, 2019, we redeemed €100 million plus accrued and unpaid interest. On July 16, 2020, all of the outstanding 2021 Euro Notes were redeemed in accordance with the terms of the indenture governing the 2021 Euro Notes.
Prior to May 15, 2017, we were permitted to redeem some or all of the 2021 Euro Notes at a price equal to 100% of the principal amount of the 2021 Euro Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after May 15, 2017, we were permitted to redeem the 2021 Euro Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.313% during the 12-month period commencing on May 15, 2017, 101.156% during the 12-month period commencing on May 15, 2018, and par on or after May 15, 2019, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to May 15, 2017, we were permitted to, within 90 days of a qualified equity offering, redeem the 2021 Euro Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount of the 2021 Euro Notes (after giving effect to any issuance of additional 2021 Euro Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 4.625%, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of 2021 Euro Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company was required to make an offer to purchase all outstanding 2021 Euro Notes at a price in cash equal to 101% of the principal amount of the 2021 Euro Notes, plus accrued and unpaid interest, if any, to the purchase date.
The 2021 Euro Notes were senior unsecured obligations of Constellium and were guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guaranteed the 2024 U.S. Dollar Notes. While the 2021 Euro Notes were outstanding, each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guaranteed certain indebtedness of Constellium or certain indebtedness of any of the guarantors of the 2021 Euro Notes was required to guarantee the 2021 Euro Notes.
The indenture governing the 2021 Euro Notes contained customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the 2021 Euro Notes also contained customary events of default.
-80-


February 2017 Notes (Redeemed in February 2021)
On February 16, 2017, the Company completed a private offering of $650 million in aggregate principal amount of 6.625% Senior Notes due 2025 (the “February 2017 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. The Company used the net proceeds from the offering, together with cash on hand, to retire all of the outstanding 8.75% Senior Secured Notes due 2018 and used the remaining net proceeds, if any, for general corporate purposes.
Interest on the February 2017 Notes accrued at rate of 6.625% per annum and was payable semi-annually beginning September 1, 2017. The February 2017 Notes were scheduled to mature on March 1, 2025. The February 2017 Notes were repurchased or redeemed in full in connection with the February 2021 Notes Offering.
Prior to March 1, 2020, we were permitted to redeem some or all of the February 2017 Notes at a price equal to 100% of the principal amount of the February 2017 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after March 1, 2020, we were permitted to redeem the February 2017 Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 103.313% during the 12-month period commencing on March 1, 2020, 101.656% during the 12-month period commencing on March 1, 2021, and par on or after March 1, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to March 1, 2020, we were permitted to, within 90 days of a qualified equity offering, redeem February 2017 Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount thereof (after giving effect to any issuance of additional February 2017 Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 6.625%, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of February 2017 Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company was required to make an offer to purchase all outstanding February 2017 Notes at a price in cash equal to 101% of the principal amount of the February 2017 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The February 2017 Notes were senior unsecured obligations of Constellium and were guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guaranteed the 2024 U.S. Dollar Notes. While the February 2017 Notes were outstanding, each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guaranteed certain indebtedness of Constellium or certain indebtedness of any of the guarantors of the February 2017 Notes was also required to guarantee the February 2017 Notes.
The indenture governing the February 2017 Notes contained customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the February 2017 Notes also contained customary events of default.
November 2017 Notes (Partially redeemed in November 2021)
On November 9, 2017, the Company completed a private offering (the “November 2017 Notes Offering”) of $500 million in aggregate principal amount of 5.875% Senior Notes due 2026 (the “2026 U.S. Dollar Notes”) and €400 million in aggregate principal amount of 4.250% Senior Notes due 2026 (the “2026 Euro Notes” and together with the 2026 U.S. Dollar Notes, the “November 2017 Notes”) pursuant to indentures among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. The Company used the net proceeds from an equity offering and the November 2017 Notes Offering, together with cash on hand, to fund the cash tender offers (the “2017 Tender Offers”) for any and all of the $400 million in aggregate principal amount of 8.00% Senior Notes due 2023 (the “2023 U.S. Dollar Notes”), €240 million in aggregate principal amount of 7.00% Senior Notes due 2023 (the “2023 Euro Notes,”), and $425 million in aggregate principal amount of 7.875% Senior Secured Notes due 2021 (the “Senior Secured Notes”, and together with the 2023 Euro Notes and the 2023 U.S. Dollar Notes, the “2017 Tender Offer Notes”) and the redemption (the “2017 Redemption”) of the 2017 Tender Offer Notes not purchased in the 2017 Tender Offers, with the remaining net proceeds being used for general corporate purposes.
-81-


Interest on the 2026 U.S. Dollar Notes and 2026 Euro Notes accrues at rates of 5.875% and 4.250% per annum, respectively, and is payable semi-annually on February 15 and August 15 of each year, beginning February 15, 2018. The November 2017 Notes mature on February 15, 2026.
On October 26, 2021, we issued a notice of redemption for an aggregate principal amount of $200 million of the 2026 U.S. Dollar Notes, at a redemption price equal to 101.469% of the principal amount of the 2026 U.S. Dollar Notes redeemed plus accrued and unpaid interest, if any, to the redemption date. On November 25, 2021, $200 million in aggregate principal amount of the 2026 U.S. Dollar Notes were redeemed in accordance with the indenture governing the 2026 U.S. Dollar Notes. The aggregate principal amount of the 2026 U.S. Dollar Notes now outstanding is $300 million.
Prior to November 15, 2020, we were permitted to redeem some or all of the 2026 U.S. Dollar Notes at a price equal to 100% of the principal amount of the 2026 U.S. Dollar Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after November 15, 2020, we may redeem the 2026 U.S. Dollar Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.938% during the 12-month period commencing on November 15, 2020, 101.469% during the 12-month period commencing on November 15, 2021, and par on or after November 15, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
Prior to November 15, 2020, we were permitted to redeem some or all of the 2026 Euro Notes at a price equal to 100% of the principal amount of the 2026 Euro Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after November 15, 2020, we may redeem the 2026 Euro Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.125% during the 12-month period commencing on November 15, 2020, 101.063% during the 12-month period commencing on November 15, 2021, and par on or after November 15, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to November 15, 2020, we were permitted to, within 90 days of a qualified equity offering, redeem November 2017 Notes of either series in an aggregate amount equal to up to 35% of the original aggregate principal amount of the November 2017 Notes of the applicable series (after giving effect to any issuance of additional November 2017 Notes of such series) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 5.875% for the 2026 U.S. Dollar Notes and 4.250% for the 2026 Euro Notes, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of November 2017 Notes of the series being redeemed would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding November 2017 Notes at a price in cash equal to 101% of the principal amount of the November 2017 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The November 2017 Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the June 2020 Notes, the February 2021 Notes, and the June 2021 Notes, including Constellium US Intermediate Holdings LLC. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantees certain indebtedness of Constellium (including the June 2020 Notes, the February 2021 Notes, and the June 2021 Notes) or certain indebtedness of any of the guarantors of the November 2017 Notes must also guarantee the November 2017 Notes.
The indentures governing the November 2017 Notes contain customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indentures governing the November 2017 Notes also contain customary events of default.
June 2020 Notes
On June 30, 2020, the Company completed a private offering (the “June 2020 Notes Offering”) of $325 million in aggregate principal amount of 5.625% Senior Notes due 2028 (the “June 2020 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. The Company used the net proceeds from the offering to retire all of the outstanding 2021 Euro Notes and used the remaining net proceeds, for general corporate purposes and to pay related fees and expenses.
-82-


Interest on the June 2020 Notes accrues at a rate of 5.625% per annum, and is payable semi-annually on June 15 and December 15 of each year, beginning December 15, 2020. The June 2020 Notes mature on June 15, 2028.
Prior to June 15, 2023, we may redeem some or all of the June 2020 Notes at a price equal to 100% of the principal amount of the June 2020 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after June 15, 2023, we may redeem the June 2020 Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.813% during the 12-month period commencing on June 15, 2023, 101.406% during the 12-month period commencing on June 15, 2024, and par on or after June 15, 2025, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to June 15, 2023, we may, within 90 days of a qualified equity offering, redeem the June 2020 Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount thereof (after giving effect to any issuance of additional June 2020 Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 5.625% plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of June 2020 Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding June 2020 Notes at a price in cash equal to 101% of the principal amount of the June 2020 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The June 2020 Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the November 2017 Notes, the February 2021 Notes, and the June 2021 Notes. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantee certain indebtedness of Constellium (including the November 2017 Notes, the February 2021 Notes, and the June 2021 Notes) or certain indebtedness of any of the guarantors of the June 2020 Notes must also guarantee the June 2020 Notes.
The indenture governing the June 2020 Notes contains customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the June 2020 Notes also contains customary events of default.
February 2021 Notes
On February 24, 2021, the Company completed a private offering (the “February 2021 Notes Offering”) of $500 million in aggregate principal amount of 3.750% Sustainability-Linked Senior Notes due 2029 (the “February 2021 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee (the “February 2021 Indenture”). The Company used the net proceeds from the offering, together with cash on hand, to repurchase the outstanding February 2017 Notes that were validly tendered and accepted for payment pursuant to a cash tender offer and to redeem the February 2017 Notes that were not validly tendered and accepted for payment in such cash tender offer, and to pay related fees and expenses.
Interest on the February 2021 Notes initially accrues at a rate of 3.750% per annum and is payable semi-annually on April 15 and October 15 of each year, beginning October 15, 2021. From and including April 15, 2026, the interest rate payable on the February 2021 Notes shall be increased by +0.125% to 3.875% per annum (the “Target 1 Step-Up”), unless the Company has notified the trustee of the February 2021 Notes in writing, at least 15 days prior to April 15, 2026, that it has determined that the Company has attained Sustainability Performance Target 1 (as defined in the February 2021 Indenture) and received an Assurance Letter (as defined in the February 2021 Indenture). From and including April 15, 2027, the interest rate payable on the February 2021 Notes shall be increased by +0.125% to (x) 4.000% per annum, if the Target 1 Step-Up took effect or (y) 3.875% per annum, if the Target 1 Step-Up did not take effect, in each case unless the Company has notified the trustee of the February 2021 Notes in writing, at least 15 days prior to April 15, 2027, that it has determined that the Company has attained Sustainability Performance Target 2 (as defined in the February 2021 Indenture) and received an Assurance Letter. The February 2021 Notes mature on April 15, 2029.
Prior to April 15, 2024, we may redeem some or all of the February 2021 Notes at a price equal to 100% of the principal amount of the February 2021 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-
-83-


whole” premium. On or after April 15, 2024, we may redeem the February 2021 Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102% during the 12-month period commencing on April 15, 2024, 101% during the 12-month period commencing on April 15, 2025, and par on or after April 15, 2026, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to April 15, 2024, we may, within 90 days of a qualified equity offering, redeem the February 2021 Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount thereof (after giving effect to any issuance of additional February 2021 Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 3.750%, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of February 2021 Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding February 2021 Notes at a price in cash equal to 101% of the principal amount of the February 2021 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The February 2021 Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the November 2017 Notes, the June 2020 Notes and the June 2021 Notes. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantee certain indebtedness of Constellium (including the November 2017 Notes, the June 2020 Notes and the June 2021 Notes) or certain indebtedness of any of the guarantors of the February 2021 Notes must also guarantee the February 2021 Notes.
The February 2021 Indenture contains customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The February 2021 Indenture also contains customary events of default.
June 2021 Notes
On June 2, 2021, the Company completed a private offering (the “June 2021 Notes Offering”) of €300 million in aggregate principal amount of 3.125% Sustainability-Linked Senior Notes due 2029 (the “June 2021 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee, Deutsche Bank AG, London Branch, as principal paying agent, and Deutsche Bank Luxembourg S.A., as registrar and transfer agent (the “June 2021 Indenture”). The net proceeds of the June 2021 Notes, together with cash on hand, were used to redeem the 2024 U.S. Dollar Notes.
Interest on the June 2021 Notes initially accrues at a rate of 3.125% per annum and is payable semi-annually on January 15 and July 15 of each year, beginning January 15, 2022. From and including July 15, 2026, the interest rate payable on the June 2021 Notes shall be increased by +0.125% to 3.250% per annum (the “Target 1 Step-Up”), unless the Company has notified the trustee of the June 2021 Notes in writing, at least 15 days prior to July 15, 2026, that it has determined that the Company has attained Sustainability Performance Target 1 (as defined in the June 2021 Indenture) and received an Assurance Letter (as defined in the June 2021 Indenture). From and including July 15, 2027, the interest rate payable on the June 2021 Notes shall be increased by +0.125% to (x) 3.375% per annum, if the Target 1 Step-Up took effect or (y) 3.250% per annum, if the Target 1 Step-Up did not take effect, in each case unless the Company has notified the trustee of the June 2021 Notes in writing, at least 15 days prior to July 15, 2027, that it has determined that the Company has attained Sustainability Performance Target 2 (as defined in the June 2021 Indenture) and received an Assurance Letter. The June 2021 Notes mature on July 15, 2029.
Prior to July 15, 2024, we may redeem some or all of the June 2021 Notes at a price equal to 100% of the principal amount of the June 2021 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after July 15, 2024, we may redeem the June 2021 Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 101.688% during the 12-month period commencing on July 15, 2024, 100.844% during the 12-month period commencing on July 15, 2025, and par on or after July 15, 2026, in each case plus accrued and unpaid interest, if any, to the redemption date.
-84-


In addition, at any time or from time to time prior to July 15, 2024, we may, within 90 days of a qualified equity offering, redeem the June 2021 Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount thereof (after giving effect to any issuance of additional June 2021 Notes) at a redemption price equal to 103.125% of the principal amount thereof, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of the February 2021 Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding June 2021 Notes at a price in cash equal to 100% of the principal amount of the June 2021 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The June 2021 Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the November 2017 Notes, the June 2020 Notes and the February 2021 Notes. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantee certain indebtedness of Constellium (including the November 2017 Notes, the June 2020 Notes and the February 2021 Notes) or certain indebtedness of any of the guarantors of the June 2021 Notes must also guarantee the June 2021 Notes.
The June 2021 Indenture contains customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The June 2021 Indenture also contains customary events of default.
Pan-U.S. ABL Facility
On June 21, 2017, Ravenswood and Constellium Muscle Shoals LLC (f/k/a Wise Alloys LLC) (“Muscle Shoals”), entered into a $300 million asset-based revolving credit facility (as amended, supplemented or otherwise modified as described below, the “Pan-U.S. ABL Facility”), with the lenders from time to time party thereto and Wells Fargo Bank, National Association as administrative agent (the “Administrative Agent”) and collateral agent. Concurrently with Ravenswood and Muscle Shoals’ entry into the Pan-U.S. ABL Facility, (i) the $100 million asset-based revolving credit facility entered into by Ravenswood on May 25, 2012 and (ii) the asset-based revolving credit facility entered into by Muscle Shoals, as borrower, and Constellium Holdings Muscle Shoals LLC (f/k/a Wise Metals Group LLC), Listerhill Total Maintenance Center, LLC, Wise Alloys Finance Corporation, and Alabama Electric Motor Services, LLC, as guarantors, dated December 11, 2013, were each terminated. On February 20, 2019, we amended and restated the Pan-U.S. ABL Facility to, among other things, (i) join Constellium Bowling Green LLC (“Bowling Green”) as an additional borrower and Constellium Property and Equipment Company, LLC as an additional guarantor, (ii) increase the available commitments thereunder to $350 million, and (iii) make certain changes to the covenants, terms, and conditions thereof. On May 10, 2019, we amended the Pan-U.S. ABL Facility to (i) increase the available commitments thereunder to $400 million and (ii) make certain other changes to the covenants, terms and/or conditions thereof.
The Pan-U.S. ABL Facility provides Ravenswood, Muscle Shoals, and Bowling Green (the “Borrowers”) a working capital facility for their respective operations. The Pan-U.S. ABL Facility has sublimits of $35 million for letters of credit and $35 million for swingline loans.
The Pan-U.S. ABL Facility matures on the earlier of (i) April 27, 2026 and (ii) 90 days prior to the maturity date of any indebtedness (other than loans under the Pan-U.S. ABL Facility) of any Borrower or any Borrower’s subsidiaries in an aggregate amount exceeding $50.0 million (but excluding for this purpose the indebtedness of Borrowers pursuant to their guarantees of the existing unsecured notes issued by Constellium SE) (the “Pan-U.S. ABL Maturity Date”).
On April 24, 2020, the Borrowers entered into an Amendment No. 2 (“Amendment No. 2”) to the Pan-U.S. ABL Facility, with certain of the Constellium SE’s subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent and collateral agent. Amendment No. 2, established a new fully-committed delayed draw term loan facility (the “Delayed Draw Term Loans”) that allowed the Borrowers to borrow an aggregate amount up to the lesser of $166.25 million and 50% of the net orderly liquidation value of eligible equipment, in up to three separate draws at any time until November 1, 2020 (the “Term Loan Commitment Expiration Date”), subject to quarterly amortization payments of principal (calculated on the basis of a seven year assumed life) commencing on January 1, 2021. If drawn, the proceeds of the Delayed Draw Term Loans would have been used for general corporate purposes. The Delayed Draw Term Loans (if drawn) was set to mature on the Pan-U.S. ABL Maturity Date. Interest payable on any drawn Delayed Draw Term Loans would have been
-85-


calculated, at the applicable Borrower’s election, based on either the LIBOR or base rate (as calculated by the Administrative Agent in accordance with the Pan-U.S. ABL Facility), plus a margin equal to 4.00% per annum in the case of LIBOR loans and 3.00% in the case of base rate loans. The Delayed Draw Term Loans was subject to substantially the same covenants as the Pan-U.S. ABL Facility. The Delayed Draw Term Loans replaced the committed $200 million incremental revolving facility that was available prior to the effectiveness of Amendment No. 2.
Amendment No. 2 also modified the interest rate that applies to any revolving loans under the Pan-U.S. ABL Facility to equal, at the applicable Borrower’s election, LIBOR plus a margin of 1.75%-2.25% or base rate plus a margin of 0.75%-1.25% (in each case, determined based on (i) a net leverage ratio until the Term Loan Commitment Expiration Date and the prepayment or repayment of outstanding Delayed Draw Term Loans and (ii) average quarterly excess availability thereafter). Until the Term Loan Commitment Expiration Date, the applicable margins for LIBOR and base rate loans will be 2.25% and 1.25%, respectively.
Borrowings under the Delayed Draw Term Loans could be repaid from time to time without premium or penalty, subject to customary “breakage” costs with respect to LIBOR loans and certain excess availability conditions.
On September 25, 2020, the Borrowers entered into an Amendment No. 3 (“Amendment No. 3”) to the Pan-U.S. ABL Facility with certain of Constellium SE’s subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent and collateral agent. Amendment No. 3, among other things, extended the Term Loan Commitment Expiration Date to May 1, 2021 and changed the date of the first quarterly amortization payment of principal with respect to the Delayed Draw Term Loans from January 1, 2021 to July 1, 2021.
On April 27, 2021, the Borrowers entered into an Amendment No. 4 (“Amendment No. 4”) to the Pan-U.S. ABL Facility with certain of Constellium SE’s subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent and collateral agent. Amendment No. 4, among other things, extended the facility maturity date to the fifth anniversary of the amendment effective date, reduced the interest rate to LIBOR plus a margin of 1.25%-1.75% or base rate plus a margin of 0.25%-0.75%, provided alternate reference currencies to replace LIBOR, terminated all Term Loan Commitments and deleted the financial maintenance covenant relating to the minimum Borrower EBITDA Contribution.
On December 3, 2021, the Borrowers entered into an Amendment No. 5 (“Amendment No. 5”) to the Pan-U.S. ABL Facility with certain of Constellium SE’s subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent and collateral agent. Amendment No. 5 made certain technical changes to the Pan-U.S. ABL Facility, including adding Constellium US Intermediate Holdings LLC as a “Constellium Holding Company” (as defined in the Pan-U.S. ABL Facility).
On June 23, 2022, the Borrowers entered into an Amendment No. 6 (“Amendment No. 6”) to the Pan-U.S. ABL Facility with certain of Constellium SE’s subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent and collateral agent. Amendment No. 6, among other things, (i) increased the available commitments thereunder to $500 million, (ii) included an accordion feature which if exercised in full, would allow the Borrowers to increase commitments by $100 million subject to additional lender commitments, borrowing base availability and certain other conditions and (iii) made certain technical changes to the Pan-U.S. ABL Facility, including amending certain definitions and other provisions to replace LIBOR-based benchmark rates applicable to loans outstanding under the Pan-U.S. ABL Facility with a secured overnight financing rate plus a credit spread adjustment of 0.10% (“Term SOFR”), in each case as specified in Amendment No. 6.
The Borrowers’ ability to borrow under the Pan-U.S. ABL Facility is limited to a borrowing base equal to the sum of (a) 85% of eligible accounts plus (b) up to the lesser of (i) 80% of the lesser of cost or market value of eligible inventory and (ii) 85% of the net orderly liquidation value of eligible inventory minus (c) applicable reserves, and is subject to other conditions, limitations and reserve requirements.
Interest for revolving facility loans under the Pan-U.S. ABL Facility is calculated, at the applicable Borrower’s election, based on either the Term SOFR or base rate (as calculated by the Administrative Agent in accordance with the Pan-U.S. ABL Facility), as further described below. The Borrowers are required to pay a commitment fee on the unused portion of the Pan-U.S. ABL Facility of 0.25% or 0.375% per annum (determined on a ratio of unutilized revolving credit commitments to available revolving credit commitments).
Subject to customary “breakage” costs with respect to Term SOFR loans, borrowings of revolving loans under the Pan-U.S. ABL Facility may be repaid from time to time without premium or penalty.
-86-


The Borrowers’ obligations under the Pan-U.S. ABL Facility are guaranteed by Constellium US Holdings I, LLC, Constellium Holdings Muscle Shoals LLC, Constellium US Intermediate Holdings LLC, and Constellium International (as successor to Constellium Holdco II B.V.). Obligations under the Pan-U.S. ABL Facility are, subject to certain exceptions, secured by substantially all assets of the Borrowers, Constellium US Holdings I, LLC, Constellium Holdings Muscle Shoals LLC, and Constellium US Intermediate Holdings LLC. The guarantee by Constellium International of the Pan-U.S. ABL Facility is unsecured.
The Pan-U.S. ABL Facility contains customary terms and conditions, including, among other things, negative covenants limiting the ability of the Borrowers and their respective material subsidiaries to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances (including to other Constellium group companies), make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The Pan-U.S. ABL Facility also contains a financial maintenance covenant that provides that at any time during which borrowing availability thereunder is below 10% of the aggregate commitments under the Pan-U.S. ABL Facility, the Borrowers will be required to maintain a minimum fixed charge coverage ratio with respect to the Company and its subsidiaries of 1.0 to 1.0, calculated on a trailing twelve-month basis. Previously, the Company would also need to maintain a minimum Borrower EBITDA Contribution of 25%, calculated on a trailing twelve-month basis. “Borrower EBITDA Contribution” means, for any period, the ratio of (x) the combined EBITDA of the Borrowers and their respective subsidiaries for such period, to (y) the consolidated EBITDA of the Company and its subsidiaries for such period. The financial maintenance covenant relating to the minimum Borrower EBITDA Contribution was removed from the Pan-U.S. ABL Facility in Amendment No. 4 (defined below).
The Pan-U.S. ABL Facility also contains customary events of default.
PGE French Facility (repaid in May 2022)
On May 13, 2020, Constellium International S.A.S. (the “French Borrower”) entered into a term facility agreement for a loan guaranteed by the French State (PGE Grande Entreprise) (the “PGE French Facility”) with BNP Paribas as coordinator, agent and security agent and BNP Paribas, Société Générale and Bpifrance Financement as original lenders. The PGE French Facility established a fully committed term loan (the “PGE Loan”) that allowed the French Borrower to borrow an aggregate amount of up to €180 million in one draw on May 20, 2020, which the French Borrower drew on such date. The proceeds of the PGE French Facility were destined to be used for financing the working capital and liquidity needs of the French Borrower and its subsidiaries in France.
The PGE Loan was set to mature no earlier than May 20, 2021, with the French Borrower having an option to extend for up to five years. In 2021, the French Borrower exercised the option to extend the PGE French Facility for one year until May 20, 2022.
The PGE French Facility was repaid in cash at its maturity in May 2022.
In accordance with French law no. 2020-289 dated March 23, 2020, related ministerial order (arrêté) dated March 23, 2020, as amended from time to time, and pursuant to ministerial order (arrêté) dated May 15, 2020 published on May 16, 2020, 80% of the principal outstanding amount of the PGE Loan benefited from a guarantee of the French State.
Interest payable on the drawn PGE Loan was calculated based on the EURIBOR plus a margin and the cost of the guarantee calculated in accordance with the PGE French Facility, with 1.30% per annum for the margin and 0.50% for the guarantee cost during the first year of the PGE Loan and 1.80% per annum for the margin and 1.00% for the guarantee cost during the second year.
The PGE French Facility contained financial covenants that provided that, on semi-annual testing dates: (i) the Leverage should not have exceeded a specified ratio, beginning at 6.5x for June 30, 2021 and (ii) the Interest Cover Ratio (calculated on a twelve-month basis) should have been at least equal to a specified ratio, beginning at 1.75x for June 30, 2021.
“Leverage” meant the ratio of total net debt on the relevant testing date to the consolidated EBITDA of Constellium SE (of which the French Borrower is a consolidated subsidiary). “Interest Cover Ratio” meant the ratio of the consolidated EBITDA of Constellium SE to the aggregate of (x) the consolidated net financial interest of Constellium SE for that period and (y) the aggregate amount of any other financial expenses invoiced or paid by Constellium SE during that period.
-87-


The PGE French Facility also contained customary terms and conditions, including, among other things, negative covenants limiting the ability of the French Borrower, Constellium France Holdco S.A.S., Constellium Issoire S.A.S. and Constellium Neuf Brisach S.A.S. (and, as the case may be, any other French subsidiary of the French Borrower designated by the French Borrower as a material subsidiary), inter alia, to incur debt, grant liens, sell assets, make acquisitions, merge, demerge, amalgamate or enter into corporate reconstruction, enter into joint ventures, make loans and advances (including, in specific events, to other members of the Constellium SE group of companies) and enter into certain derivative transactions.
By a letter dated May 12, 2021, the PGE French Facility was amended to extend the date after which, if Constellium SE were to make a debt capital markets issuance, it would be required to make a voluntary prepayment of the PGE Loan up to the amount of the net proceeds of such issuance (such date extended from May 20, 2021 to August 20, 2021).
Borrowings under the PGE Loan could be repaid from time to time without premium or penalty, subject to customary “breakage” costs and certain mandatory prepayment events as mentioned in the PGE French Facility.
The French Borrower’s obligations under the PGE French Facility were secured by pledges of (i) the shares of Constellium Issoire S.A.S. and Constellium Neuf Brisach S.A.S. owned by Constellium France Holdco S.A.S., and (ii) certain French bank accounts of the French Borrower, Constellium Issoire S.A.S. and Constellium Neuf Brisach S.A.S.
Swiss Facilities (repaid in June 2022)
On April 14, 2020, Constellium Valais SA entered into term facility agreements for loans with credit support from the Swiss Federal Government. These facilities allowed for the borrowing of a combined amount of CHF 20 million, which were uncommitted. The facilities were reduced on a half-year basis by CHF 2.4 million from June 30, 2021 onwards. The Swiss facilities were repaid in cash in June 2022.
German Facilities (expired in 2021)
On July 15, 2020, two of our German entities entered into two credit facilities for a total amount of €50 million, of which 80% was guaranteed by the German government. One of the German facilities had an interest coverage covenant applicable if the facility were drawn. In July 2021, the two German facilities were not drawn and consequently expired in accordance with their contractual terms.
French Inventory Facility
On April 21, 2017, Constellium Issoire and Constellium Neuf Brisach (the “French Borrowers”) entered into a €100 million asset-based revolving credit facility (the “French Inventory Facility”) with the lenders from time to time party thereto and Factofrance as agent. The French Inventory Facility was amended on June 13, 2017 to, among other things, make certain changes to the procedure for calculating the Turn Ratio (as defined below). The French Inventory Facility provides the French Borrowers a working capital facility for their operations. The French Inventory Facility was amended on March 29, 2018 to, among other things, make certain changes to the inventory included in the borrowing base. The French Inventory Facility was amended on March 15, 2019 to, among other things, extend the maturity to April 21, 2021, and further amended on February 16, 2021 to, among other things, extend the maturity to April 30, 2023.
The French Borrowers’ ability to borrow under the French Inventory Facility is limited to a borrowing base equal to the lesser of (i) the sum of (A) 90% of the net orderly liquidation value of eligible inventory of the applicable French Borrower pledged and in possession of an escrow agent (the “Inventory Pledged With Dispossession” by such French Borrower), plus (B) 70% of the net orderly liquidation value of eligible inventory of the applicable French Borrower pledged without possession by the escrow agent (the “Inventory Pledged Without Dispossession” by such French Borrower), and (ii) the product of 90% of the net orderly liquidation value of the Inventory Pledged With Dispossession by the applicable French Borrower, multiplied by four.
Notwithstanding the foregoing, if on any quarterly test date the ratio of a French Borrower’s aggregate sales for the previous 365 days to the average book value of the eligible inventory pledged by such French Borrower under the French Inventory Facility (the “Turn Ratio” for such French Borrower) is less than 3, in the case of Constellium Issoire, or 6, in the case of Constellium Neuf Brisach, the borrowing base for such French Borrower will equal 70% of the net orderly liquidation value of the Inventory Pledged With Dispossession by such French Borrower until the next quarterly test date on which such French Borrower’s Turn Ratio is greater than or equal to 3, in the case of Constellium Issoire, or 6, in the case of Constellium Neuf Brisach (such period, a “Borrowing Base Event”).
-88-


Loans not in excess of 90% of the net orderly liquidation value of the Inventory Pledged with Dispossession of the applicable French Borrower at the time of borrowing bear interest at a rate of EURIBOR plus 2% per annum (“Tranche A Loans”), and loans in excess of that amount at the time of borrowing bear (“Tranche B Loans”) interest at a rate of EURIBOR plus 2.75% per annum. The French Borrowers are also required to pay a commitment fee on the unused portion of the French Inventory Facility of 0.80% per annum. Borrowings of Tranche B Loans by a French Borrower are subject to a minimum EBITDA for such French Borrower, calculated on a trailing twelve months of €40 million in the case of Constellium Issoire, and €65 million in the case of Constellium Neuf Brisach.
Subject to customary “breakage” costs, borrowings under the French Inventory Facility are permitted to be repaid from time to time without premium or penalty.
The French Borrowers’ obligations under the French Inventory Facility are guaranteed by Constellium International and are secured by possessory and non-possessory pledges of the eligible inventory of the French Borrowers.
European Factoring Agreements
On January 4, 2011, certain of our French subsidiaries (the “French Sellers”) entered into a factoring agreement with GE Factofrance S.A.S., as factor (the “French Factor”), which was amended from time to time and fully restated on December 3, 2015 (the “French Factoring Agreement”). On December 16, 2010, certain of our German and Swiss subsidiaries (the “German/Swiss Sellers”) entered into factoring agreements with GE Capital Bank AG, as factor (the “German/Swiss Factor”), which was amended from time to time or replaced with a factoring agreement entered into on March 26, 2014 (the “Original German/Swiss Factoring Agreements”). On June 26, 2015, our Czech subsidiary (the “Czech Seller,” and together with the German/Swiss Sellers and the French Sellers, the “European Factoring Sellers”) entered into a factoring agreement with GE Capital Bank AG, as factor (the “Czech Factor,” and together with the German/Swiss Factor and the French Factor, the “European Factors”), as amended from time to time (the “Czech Factoring Agreement,” and together with the German/Swiss Factoring Agreements and the French Factoring Agreement, the “European Factoring Agreements”). On May 27, 2016, one of our German subsidiaries, Constellium Rolled Products Singen GmbH & Co. KG (another “German/Swiss Seller”), entered into a factoring agreement with the German/Swiss Factor (the “Additional German/Swiss Factoring Agreement” and, together with the Original German/Swiss Factoring Agreements, the “German/Swiss Factoring Agreements”) while certain of the Original German/Swiss Factoring Agreements were amended.
On July 20, 2016, the Banque Fédérative du Crédit Mutuel purchased the Equipment Finance and Receivable Finance businesses of GE. Pursuant to this transaction, GE Factofrance S.A.S. was renamed Factofrance and GE Capital Bank AG was renamed Targo Commercial Financing AG. On August 1, 2018, Targo Commercial Finance AG was merged into Targobank AG. Both transactions had no other impact on the European Factoring Agreements.
The French Factoring Agreement was amended and restated on April 19, 2017 to, among other things, extend the commitment period thereunder from December 2018 to October 2021.
On May 26, 2020, the French Factoring Agreement was amended to (a) extend the maturity to December 31, 2023, (b) add a €20 million recourse tranche to the facility to increase liquidity of the facility on the same asset base and subject to the same terms, and (c) change the interest rate margin (applicable on top of EURIBOR in the discount rate formula) for a range between 0.8% and 1.4% depending on Constellium SE’s credit rating.
On July 21, 2022, the French Factoring Agreement was amended and restated to (a) extend the maturity to December 31, 2027, or January 31, 2026 if on that date, the outstanding principal amount of the November 2017 Notes exceeds €50 million (b) increase the maximum financing amount to €250 million (recourse and non-recourse) with a sublimit of €20 million for the recourse tranche, (c) change the interest rate margin (applying on top of EURIBOR in the discount rate formula) for a range between 0.95% and 1.15% depending on Constellium SE’s credit rating and (d) reduce the fees.
The German/Swiss Factoring Agreements were amended on December 21, 2016 to, among other things, increase the maximum financing amount from €115 million to €150 million, extend the termination date from June 15, 2017 to October 29, 2021, and reduce the fees payable by the German/Swiss Sellers.
On April 30, 2020, the German/Swiss, and Czech Factoring Agreements were each extended to December 31, 2023. On June 30, 2022, the German/Swiss and Czech Factoring Agreements were amended to, among other things, increase the maximum aggregate financing amount to €200 million, extend the termination date to December 31, 2027 and reduce the fees payable by the German/Swiss and Czech Sellers.
-89-


The European Factoring Agreements provide for the sale by the European Factoring Sellers to the European Factors of receivables originated by the European Factoring Sellers, subject to a maximum aggregate financing amount of (i) €250 million available to the French Sellers under the French Factoring Agreement and (ii) €200 million available to the German/Swiss Sellers and the Czech Seller under the German/Swiss Factoring Agreements and the Czech Factoring Agreement. The funding made available to the European Factoring Sellers by the European Factors is used by the Sellers for general corporate purposes.
Receivables sold to the European Factors under the European Factoring Agreements are without recourse to the European Factoring Sellers in the event of a payment default by the relevant customer, with a €20 million recourse tranche available under the French Factoring Agreement. The European Factors are entitled to claim the repayment of any amount financed by them in respect of a receivable by withdrawing the financing provided against such assigned receivable or requiring the European Factoring Sellers to repurchase/unwind the purchase of such receivable under certain circumstances, including when (i) the nonpayment of that receivable arises from a dispute between a European Factoring Seller and the relevant customer or (ii) the receivable proves not to have satisfied the eligibility criteria set forth in the European Factoring Agreements. Constellium International (as successor to Constellium Holdco II B.V.) has provided a performance guaranty for the Sellers’ obligations under the European Factoring Agreements.
Subject to some exceptions, the European Factoring Sellers will collect the transferred receivables on behalf of the European Factors pursuant to a receivables collection mandate under the European Factoring Agreements. The receivables collection mandate may be terminated upon the occurrence of certain events. In the event that the receivables collection mandate is terminated, the European Factors will be entitled to notify the account debtors of the assignment of receivables and collect directly from the account debtors the assigned receivables.
The European Factoring Agreements contain customary fees, including (i) a financing fee on the outstanding amount financed in respect of the assigned receivables, (ii) a non-utilization fee on the portion of the facilities not utilized by the European Factors and (iii) a factoring fee on all assigned receivables in the case of the German/Swiss Factoring Agreements and sold receivables, which were approved by the French Factor in the case of the French Factoring Agreement. In addition, the European Factoring Sellers incur the cost of maintaining the necessary credit insurance (as stipulated in the European Factoring Agreements) on assigned receivables.
The European Factoring Agreements contain certain affirmative and negative covenants, including relating to the administration and collection of the assigned receivables, the terms of the invoices and the exchange of information, but do not contain restrictive financial covenants. As of and for the fiscal year ended December 31, 2022, the European Factoring Sellers were in compliance with all applicable covenants under the European Factoring Agreements.
Wise Factoring Facility (expired in 2021)
On March 16, 2016, Wise Alloys, since renamed Constellium Muscle Shoals LLC, entered into a Receivables Purchase Agreement (the “Wise Factoring Facility”) with Wise Alloys Funding II, LLC, since renamed Constellium Muscle Shoals Funding II LLC (“New RPA Seller”), Hitachi Capital America Corp. (“Hitachi”), and Greensill Capital Inc., as purchaser agent, providing for the sale of certain receivables of Wise Alloys to Hitachi. The Wise Factoring Facility was amended on November 22, 2016 to join Intesa Sanpaolo S.p.A., New York Branch (together with Hitachi, the “Wise Factoring Purchasers”) as a purchaser. As of December 31, 2017, the Wise Factoring Facility provides for the sale of receivables to the Wise Factoring Purchasers in an amount not to exceed $325 million in the aggregate outstanding at any time. Receivables under the Wise Factoring Facility are sold at a discount based on a rate equal to a LIBOR rate plus 2.00-2.50% (based on the credit rating of the account debtor) per annum. The New Wise RPA Seller is required to pay a commitment fee in the amount of $20,000 per annum plus 1% per annum of the total commitments under the Wise Factoring Facility.
Subject to certain customary exceptions, each purchase under the Wise Factoring Facility is made without recourse to the New Wise RPA Seller. The New Wise RPA Seller has no liability to the Wise Factoring Purchasers, and the Wise Factoring Purchasers are solely responsible for the account debtor’s failure to pay any purchased receivable when it is due and payable under the terms applicable thereto. Constellium International (as successor to Constellium Holdco II B.V.) has provided a guaranty for the New Wise RPA Seller’s and Wise Alloys’ performance obligations under the Wise Factoring Facility.
The Wise Factoring Facility contains customary covenants. The Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility is subject to certain conditions, including without limitation that certain changes of control shall not have occurred, that there shall not have occurred a material adverse change in the business condition, operations or performance of the New Wise RPA Seller, Wise Alloys, or Constellium International, and that Constellium’s corporate credit rating shall not have been withdrawn by either Standard & Poor’s or Moody’s or downgraded below B- by Standard & Poor’s and B3 by Moody’s.
-90-


On June 28, 2016, the Wise Factoring Facility was amended to, among other things, change the maximum commitments thereunder to $250 million in the aggregate outstanding at any time.
On January 25, 2017, the Wise Factoring Facility was amended to extend the date on which the Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility will terminate to January 24, 2018.
On May 12, 2017, the Wise Factoring Facility was amended to permit the sale of certain receivables with due dates up to 115 days after the invoice date (increased from 90 days).
On January 2, 2018, the Wise Factoring Facility was amended to, among other things, increase the commitments thereunder to $375 million in the aggregate outstanding at any time, reduce the discount at which receivables are sold to a rate equal to a LIBOR rate plus 1.75-2.25% (based on the credit rating of the account debtor) per annum, and extend the date on which the Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility will terminate to January 24, 2020.
On October 22, 2018, the Wise Factoring Facility was amended to make certain changes to the eligibility requirements for receivables sold pursuant to the Wise Factoring Facility.
On September 30, 2019, the Wise Factoring Facility was amended to, among other things, join Deutsche Bank Trust Company America as a Wise Factoring Purchaser, release Hitachi from its commitment and remove Hitachi as a purchaser under the facility, decrease the commitments thereunder to $300 million in the aggregate outstanding at any time, reduce the discount at which receivables are sold to a rate equal to a LIBOR rate plus 1.65% per annum, permit the sale of certain receivables with due dates up to 180 days after the invoice date (increased from 135 days) and extend the date on which the Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility would terminate to September 30, 2021.
The Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility terminated on September 30, 2021. The receivables purchased by the Wise Factoring Purchasers prior to September 30, 2021 shall be governed by the terms of the Wise Factoring Facility until such receivables have been paid off or are otherwise discharged.
Muscle Shoals Factoring Facility
On September 30, 2021, Constellium Muscle Shoals LLC (“Constellium Muscle Shoals”), entered into a Receivables Purchase Agreement (the “Muscle Shoals Factoring Facility”) with Constellium Muscle Shoals Funding III LLC (“Funding III RPA Seller”), Intesa Sanpaolo S.p.A., New York Branch (“Intesa”), as purchaser representative, and Intesa and Deutsche Bank Trust Company Americas (“DB”, together with Intesa, the “CSTM MS Factoring Purchasers”), as purchasers. Under the Muscle Shoals Factoring Facility, Constellium Muscle Shoals and Funding III RPA Seller may, from time to time, sell certain receivables of Constellium Muscle Shoals to the CSTM MS Factoring Purchasers. On December 21, 2021, the Muscle Shoals Facility was amended to permit Constellium Muscle Shoals and Funding III RPA Seller to begin selling receivables relating to a new account debtor. On June 28, 2022, the Muscle Shoals Facility was amended to reduce the size of the facility from $300 million to $200 million, adjust the applicable credit spreads of the account debtors and to transition the Muscle Shoals Facility from LIBOR to SOFR with a discount rate based on Term SOFR plus 1.675-2.05% per annum. Funding III RPA Seller is required to pay a commitment fee in an amount equal to the product of 0.56%, per annum, and the difference between the CSTM MS Factoring Purchasers’ total commitments and their aggregate purchase amounts of receivables purchased under the Muscle Shoals Factoring Facility.
Subject to certain customary exceptions, each purchase under the Muscle Shoals Factoring Facility is made without recourse to the Funding III RPA Seller. Funding III RPA Seller has no liability to the CSTM MS Factoring Purchasers, and the CSTM MS Factoring Purchasers are solely responsible for the account debtor’s failure to pay any purchased receivable when it is due and payable under the terms applicable thereto. Constellium International has provided a guaranty for Funding III RPA Seller’s and Constellium Muscle Shoals’ performance obligations under the Muscle Shoals Factoring Facility.
The Muscle Shoals Factoring Facility contains customary covenants. The CSTM MS Factoring Purchasers’ obligation to purchase receivables under the Muscle Shoals Factoring Facility is subject to certain conditions, including without limitation that certain changes of control shall not have occurred, that there shall not have occurred a material adverse change in the business condition, operations or performance of the Funding III RPA Seller, Constellium Muscle Shoals, or Constellium International, and that Constellium’s corporate credit rating shall not have been withdrawn by either Standard & Poor’s or Moody’s or downgraded below B- by Standard & Poor’s and B3 by Moody’s.
-91-


D.Exchange Controls
French exchange control regulations currently do not limit the amount of payments that we may remit to non-residents of France. Laws and regulations concerning foreign exchange controls do require, however, that all payments or transfers of funds made by a French resident to a non-resident be handled by an accredited intermediary.
E.Taxation

General
The following discussion contains a description of certain U.S. federal income tax, French tax and Dutch tax consequences of the acquisition, ownership and disposition of our ordinary shares, but it does not purport to be a comprehensive description of all the tax considerations that may be relevant to a decision to purchase ordinary shares. The discussion is not, and should not be construed as, tax advice. The discussion is based upon the federal income tax laws of the U.S. and regulations thereunder, the tax laws of France and regulations thereunder and the tax laws of the Netherlands and regulations thereunder, all as of the date hereof, which are subject to change and possibly with retroactive effect. Prospective investors should consult their own tax advisors.

Certain Material U.S. Federal Income Tax Consequences
The following discussion describes the material U.S. federal income tax consequences relating to acquiring, owning and disposing of our ordinary shares by a U.S. Holder (as defined below) that holds the ordinary shares as “capital assets” (generally, property held for investment) under the Code. This discussion is based upon existing U.S. federal income tax law, including the Code, U.S. Treasury regulations thereunder, rulings and court decisions, all of which are subject to differing interpretations or change, possibly with retroactive effect. No ruling from the Internal Revenue Service (the “IRS”) has been sought with respect to any U.S. federal income tax consequences described below, and there can be no assurance that the IRS or a court will not take a contrary position.
This discussion does not address all aspects of U.S. federal income taxation that may be relevant to particular investors in light of their individual circumstances, including investors subject to special tax rules (for example, financial institutions, insurance companies, regulated investment companies, real estate investment trusts, broker-dealers, traders in securities that elect mark-to-market treatment, any entity or arrangement treated as a partnership or pass-through entity for U.S. federal income tax purposes and their partners and investors, tax-exempt organizations (including private foundations), individual retirement and other tax-deferred accounts, U.S. expatriates, investors who are not U.S. Holders, U.S. Holders who at any time own or owned (directly, indirectly or constructively) 5% or more of our stock (by vote or value), U.S. Holders that acquire their ordinary shares pursuant to any employee share option or otherwise as compensation, U.S. Holders that will hold their ordinary shares as part of a straddle, hedge, conversion, wash sale, constructive sale or other integrated transaction for U.S. federal income tax purposes, U.S. Holders that have a functional currency other than the U.S. dollar or persons required to accelerate the recognition of any item of gross income with respect to our ordinary shares as a result of such income being recognized on an applicable financial statement, all of whom may be subject to tax rules that differ significantly from those summarized below). In addition, this discussion does not discuss any U.S. state or local tax, any U.S. federal tax (for example, federal estate or gift tax) other than the income tax, any U.S. alternative minimum tax consequences, any tax consequences of the Medicare tax on certain investment income pursuant to the Health Care and Education Reconciliation Act of 2010, any considerations with respect to FATCA (which for this purpose means Sections 1471 through 1474 of the Code, the Treasury regulations and administrative guidance promulgated thereunder, any intergovernmental agreement entered in connection therewith, and any non-U.S. laws, rules or directives implementing or relating to any of the foregoing), or any state, local or non-U.S. tax consequences. Each U.S. Holder is urged to consult its tax advisor regarding the U.S. federal, state, local and non-U.S. income and other tax considerations of an investment in our ordinary shares.
This discussion is for general information purposes only and is not tax advice or a complete description of all tax consequences relating to the acquisition, ownership and disposition of our ordinary shares. Prospective investors should consult their own tax advisors regarding the U.S. federal, state, local and non-U.S. tax considerations relating to the purchase, ownership and disposition of our ordinary shares in light of their particular circumstances.
-92-


General
For purposes of this discussion, a “U.S. Holder” is a beneficial owner of our ordinary shares that is, for U.S. federal income tax purposes, (i) an individual who is a citizen or resident of the United States, (ii) a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created in, or organized under the laws of, the United States, any state thereof or the District of Columbia, (iii) an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source, or (iv) a trust (A) the administration of which is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust or (B) that has otherwise validly elected to be treated as a U.S. person under the Code.
If an entity or arrangement treated as a partnership or pass-through entity for U.S. federal income tax purposes is a beneficial owner of our ordinary shares, the tax treatment of an investor therein will generally depend upon the status of such investor, the activities of the entity or arrangement and certain determinations made at the investor level or the level of the entity or arrangement. Such entities or arrangements, and investors therein, are urged to consult their own tax advisors regarding their investment in our ordinary shares.
Passive Foreign Investment Company Consequences
We believe that we will not be a “passive foreign investment company” for U.S. federal income tax purposes (“PFIC”) for the current taxable year and that we have not been a PFIC for prior taxable years and we expect that we will not become a PFIC in the foreseeable future, although there can be no assurance in this regard. Because PFIC status is a fact-intensive determination, no assurance can be given that we are not, have not been, or will not become, classified as a PFIC.
If we are a PFIC for any taxable year, U.S. Holders generally will be subject to special tax rules that could result in materially adverse U.S. federal income tax consequences. In such event, a U.S. Holder may be subject to U.S. federal income tax at the highest applicable ordinary income tax rates on (i) any “excess distribution” that we make to the U.S. Holder (which generally means any distribution paid during a taxable year to a U.S. Holder that is greater than 125% of the average annual distributions paid in the three preceding taxable years or, if shorter, the U.S. Holder’s holding period for the ordinary shares), or (ii) any gain realized on the disposition of our ordinary shares. In addition, a U.S. Holder may be subject to an interest charge on such tax. Furthermore, the favorable dividend tax rates that may apply to certain U.S. Holders on our dividends will not apply if we are a PFIC during the taxable year in which such dividend was paid, or the preceding taxable year.
As an alternative to the foregoing rules, if we are a PFIC for any taxable year, a U.S. Holder may make a mark-to-market election with respect to our ordinary shares, provided that the ordinary shares are regularly traded. Although no assurances may be given, we expect that our ordinary shares should qualify as being regularly traded. If a U.S. Holder makes a valid mark-to-market election, the U.S. Holder will generally (i) include as ordinary income for each taxable year that we are a PFIC the excess, if any, of the fair market value of our ordinary shares held at the end of the taxable year over the adjusted tax basis of such ordinary shares and (ii) deduct as an ordinary loss the excess, if any, of the adjusted tax basis of the ordinary shares over the fair market value of such ordinary shares held at the end of the taxable year, but only to the extent of the net amount previously included in income as a result of the mark-to-market election. The U.S. Holder’s tax basis in the ordinary shares would be adjusted to reflect any income or loss resulting from the mark-to-market election. Gain on the sale or other disposition of our ordinary shares would be treated as ordinary income, and loss on the sale or other disposition of our ordinary shares would be treated as an ordinary loss, but only to the extent of the amount previously included in income as a result of the mark-to-market election. If a U.S. Holder makes a mark-to-market election in respect of a corporation classified as a PFIC and such corporation ceases to be classified as a PFIC, the holder will not be required to take into account the gain or loss described above during any period that such corporation is not classified as a PFIC. Because a mark-to-market election cannot be made for any lower-tier PFICs that we may own, a U.S. Holder may continue to be subject to the PFIC rules with respect to such U.S. Holder’s indirect interest in any investment held by us that is treated as an equity interest in a PFIC for U.S. federal income tax purposes.
A “qualified electing fund” election (“QEF election”), in certain limited circumstances, could serve as a further alternative to the foregoing rules with respect to an investment in a PFIC. However, in order for a U.S. Holder to be able to make a QEF election, we would need to provide such U.S. Holder with certain information. Because we do not intend to provide U.S. Holders with the information they would need to make such an election, prospective investors should assume that the QEF election will not be available in respect of an investment in our ordinary shares.
Each U.S. Holder is advised to consult its tax advisor concerning the U.S. federal income tax consequences of acquiring, owning or disposing of our ordinary shares if we are or become classified as a PFIC, including the possibility of making a mark-to-market election.
-93-


The remainder of the discussion below assumes that we are not a PFIC, have not been a PFIC and will not become a PFIC in the future.
Distributions
The gross amount of distributions with respect to our ordinary shares (including the amount of any non-U.S. withholding taxes) will be taxable as dividends, to the extent paid out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Such distributions will be includable in a U.S. Holder’s gross income as ordinary dividend income on the day actually or constructively received by the U.S. Holder. Such dividends will not be eligible for the dividends-received deduction generally allowed to U.S. corporations in respect of dividends received from other U.S. corporations.
To the extent that the amount of the distribution exceeds our current and accumulated earnings and profits for a taxable year, as determined under U.S. federal income tax principles, the distribution will be treated first as a tax-free return of capital to the extent of the U.S. Holder’s tax basis in our ordinary shares, and to the extent the amount of the distribution exceeds the U.S. Holder’s tax basis, the excess will be taxed as capital gain recognized on a sale or exchange of such ordinary shares. Because we do not expect to determine our earnings and profits in accordance with U.S. federal income tax principles, U.S. Holders should expect that a distribution will generally be reported as a dividend for U.S. federal income tax purposes, even if that distribution would otherwise be treated as a tax-free return of capital or as capital gain under the rules described above.
With respect to non-corporate U.S. Holders, certain dividends received from a qualified foreign corporation may be subject to reduced rates of U.S. federal income taxation. A non-U.S. corporation is treated as a qualified foreign corporation with respect to dividends paid by that corporation on shares that are readily tradable on an established securities market in the United States. We believe our ordinary shares, which are listed on the NYSE, are considered to be readily tradable on an established securities market in the United States, although there can be no assurance that this will continue to be the case in the future. Non-corporate U.S. Holders that do not meet a minimum holding period requirement during which they are not protected from the risk of loss, or that elect to treat the dividend income as “investment income” pursuant to Section 163(d)(4) of the Code, will not be eligible for the reduced rates of taxation regardless of our status as a qualified foreign corporation. In addition, even if the minimum holding period requirement has been met, the rate reduction will not apply to dividends if the recipient of a dividend is obligated to make related payments with respect to positions in substantially similar or related property. You should consult your own tax advisors regarding the application of these rules given your particular circumstances.
In the event that a U.S. Holder is subject to non-U.S. withholding taxes on dividends paid to such U.S. Holder with respect to our ordinary shares, such U.S. Holder may be eligible, subject to certain conditions and limitations, to claim a foreign tax credit for such non-U.S. withholding taxes (imposed at the rate applicable to the U.S. Holder, taking into account the elimination or reduction of such non-U.S. withholding taxes under an applicable treaty) against the U.S. Holder’s U.S. federal income tax liability or alternatively deduct such non-U.S. withholding taxes in computing such U.S. Holder’s U.S. federal income tax liability. Dividends paid to a U.S. Holder with respect to our ordinary shares are expected to generally constitute “foreign source income” and to generally be treated as “passive category income,” for purposes of the foreign tax credit, except that a portion of such dividends may be treated as income from U.S. sources if (i) U.S. persons (as defined in the Code and applicable Treasury regulations) own, directly or indirectly, 50% or more of our ordinary shares (by vote or value) and (ii) we receive more than a de minimis amount of income from U.S. sources. The rules governing the foreign tax credit and ability to deduct such non-U.S. withholding taxes are complex and involve the application of rules that depend upon your particular circumstances. You are urged to consult your own tax advisors regarding the availability of, and any limits or conditions to, the foreign tax credit or deduction under your particular circumstances.
Sale, Exchange or Other Disposition
For U.S. federal income tax purposes, a U.S. Holder generally will recognize taxable gain or loss on any sale, exchange or other taxable disposition of our ordinary shares in an amount equal to the difference between the amount realized for our ordinary shares and the U.S. Holder’s tax basis in such ordinary shares. Such gain or loss will generally be capital gain or loss. Capital gains of individuals derived with respect to capital assets held for more than one year generally are eligible for reduced rates of U.S. federal income taxation. The deductibility of capital losses is subject to limitations. Any gain or loss recognized by a U.S. Holder will generally be treated as U.S. source gain or loss. You are urged to consult your tax advisors regarding the tax consequences if a non-U.S. tax is imposed on a sale, exchange or other disposition of our ordinary shares, if any, including the availability of the foreign tax credit or deduction under your particular circumstances.
Information Reporting and Backup Withholding
-94-


A U.S. Holder with interests in “specified foreign financial assets” (including, among other assets, our ordinary shares, unless such shares were held on such U.S. Holder’s behalf through certain financial institutions) may be required to file an information report with the IRS if the aggregate value of all such assets exceeds certain threshold amounts. You should consult your own tax advisor as to the possible obligation to file such information reports in light of your particular circumstances.
Moreover, information reporting generally will apply to dividends in respect of our ordinary shares and the proceeds from the sale, exchange or other disposition of our ordinary shares, in each case, that are paid to a U.S. Holder within the United States (and in certain cases, outside the United States or through certain U.S. intermediaries), unless the U.S. Holder is an exempt recipient. Backup withholding (currently at a rate of 24% for payments made before January 1, 2026) may also apply to such payments unless the U.S. Holder provides a correct taxpayer identification number, certifies as to no loss of exemption from backup withholding by providing a properly completed IRS Form W-9 and otherwise complies with applicable requirements of the backup withholding rules, or otherwise establishes an exemption. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or a credit against a U.S. Holder’s U.S. federal income tax liability provided the required information is timely furnished to the IRS. You should consult your tax advisors regarding the application of the U.S. information reporting and backup withholding rules to your particular circumstances.
Material French Tax Consequences
General
The information set out below is a summary of certain material French tax consequences in connection with the acquisition, ownership and disposition of our ordinary shares.
This summary does not purport to be a comprehensive description of all the French tax considerations that may be relevant to a particular holder of our ordinary shares. Holders may be subject to special tax treatment under any applicable law and this summary is not intended to be applicable in respect of all categories of holders of our ordinary shares.
This summary is based on the applicable tax laws of France as in effect on the date of this Annual Report and the guidelines issued by the French tax authorities within the Bulletin Officiel des Finances Publiques-Impôts (the “Guidelines”) in force as of the date of this Annual Report, as applied and interpreted by French courts. All of the foregoing is subject to change, which change could apply retroactively and could affect the continued validity of this summary.
Because it is a general summary, prospective holders of our ordinary shares should consult their own tax advisors as to the French or other tax consequences of the acquisition, holding and disposition of the ordinary shares including, in particular, the application to their particular situations of the tax considerations discussed below. This summary does not constitute legal or tax advice.
French dividend withholding tax
The comments below (i) relate exclusively to the situation of the shareholders holding ordinary shares of the Company registered on the register maintained by our transfer agent in the U.S., Computershare Trust Company, N.A. (the “U.S. Register”) that are eligible for listing (“DTC-eligible”) through The Depository Trust Company (“DTC”), and (ii) are notably based on the confirmation obtained from the French tax authorities on October 11, 2019 (the “French Ruling”). Any shareholder holding our ordinary shares in a different manner should seek advice from their tax advisor to determine the taxation mechanism applicable to them in connection with the shares of the Company.
In the case of a distribution of dividends by the Company, the French withholding tax treatment described below would apply subject to the French financial intermediary in its capacity as French paying agent of the dividends (such French paying agent and any of its successors acting in the same capacity, the “French Paying Agent”) being provided with the required information and documentation relating to the tax status of the shareholders. Failing that, the withholding tax would be levied at the “default” rate of 25% (except in the case where the dividends are paid in non-cooperative States or territories within the meaning of article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, in which case a 75% withholding tax would apply). Any tax to be withheld at source will be calculated on the amount in euros of the distribution attributable to the shareholder.
The list of non-cooperative States and territories within the meaning of article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code is published by ministerial order and normally updated annually. It was last updated by a ministerial order dated
-95-


February 3, 2023 (Official Journal dated February 5, 2023) and presently includes Anguilla, the Bahamas, the British Virgin Islands, Panama, Seychelles, Turks and Caicos Islands and Vanuatu.
Withholding tax on dividends paid to shareholders who are residents of France
French tax resident individuals
Personal income tax
The following would only apply to individual shareholders resident of France for tax purposes, holding their shares in the Company as part of their private estate, who do not hold their shares in the Company through an equity savings plan (plan d’épargne en actions or PEA), and who do not conduct stock market transactions under conditions similar to those which define an activity carried out by a person conducting such operations on a professional basis.
Under Article 117 quater of the French tax code, subject to certain exceptions mentioned below, dividends paid to individuals who are French tax residents are subject to a withholding tax equal to 12.8% of the gross amount distributed. This withholding tax would be levied by the French Paying Agent.
However, individuals belonging to a tax household whose reference fiscal income, as defined in 1° of IV of Article 1417 of the French Tax Code, for the second year preceding the year of payment of the dividends is less than €50,000 for taxpayers who are single, divorced or widowed, or €75,000 for couples filing jointly, may request an exemption from this withholding tax under the terms and conditions of Article 242 quater of the French Tax Code, i.e., by providing to the French Paying Agent, no later than November 30 of the year preceding the year of the payment of the dividends, a sworn statement that their reference fiscal income shown on their taxation notice (avis d’imposition) issued in respect of the second year preceding the year of payment was below the above-mentioned taxable income thresholds. Taxpayers who acquire new shares after the deadline for providing the aforementioned exemption request could provide such exemption request to the French Paying Agent upon acquisition of such new shares pursuant to paragraph 320 of the Guidelines BOI-RPPM-RCM-30-20-10-06/07/2021.
The 12.8% withholding constitutes an installment on account of the taxpayer’s final income tax and is creditable against the final personal income tax due by the taxpayer with respect to the year during which it is withheld, the surplus, if any, being refunded to the taxpayer.
The taxpayer is then subject to income tax at a flat rate of 12.8% on the dividends (except if he elects to be taxed at the progressive income tax rates). Because the rate of the withholding tax is aligned on the rate of the final personal income tax due by the recipient of the dividend (except if he elects to be taxed at the progressive income tax rates), the total amount of the personal income tax charge related to the dividend is in practice withheld at source.
Shareholders concerned should seek advice from their usual tax advisor to determine the taxation mechanism applicable to them in connection with dividends paid on the shares of the Company.
Moreover, regardless of the shareholder’s tax residence or place of residence, pursuant to Article 119 bis 2 of the French Tax Code, if dividends are paid outside France in a non-cooperative State or territory within the meaning of Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, a 75% withholding tax would be applicable on the gross dividend distributed unless the shareholder provides evidence that the distributions have neither the object nor the effect to enable, for tax evasion purpose, the location of income in such a State or territory.
Relevant shareholders are advised to consult their usual tax advisor to determine the method by which this withholding tax will be credited against the amount of their income tax.
Social contributions
Whether or not the 12.8% withholding tax described above is applicable, the gross amount of the dividends paid by the Company to French tax resident individuals would also be subject to social contributions at an overall rate of 17.2%, which breaks down as follows:
the contribution sociale généralisée at a rate of 9.2%;
the contribution pour le remboursement de la dette sociale at a rate of 0.5%; and
the prélèvement de solidarité at a rate of 7.5%.
-96-


The social contributions are levied in the same manner as the 12.8% withholding tax described above.
French tax resident entities that are subject to French corporate income tax under standard conditions
Dividends paid by the Company to legal entities that are French tax residents subject to French corporate income tax under standard conditions will not, in principle, be liable to any withholding tax.
However, if the dividends distributed by the Company are paid outside France in a non-cooperative State or jurisdiction within the meaning of Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, a 75% withholding tax will apply, unless the concerned shareholder provides evidence that the distributions have neither the object nor the effect to enable, for tax evasion purpose, the location of income in such a State or territory.
Shareholders are advised to consult their usual tax advisor to determine the tax regime that will apply to their own situation.
Other French tax residents
French tax resident shareholders who are in a different situation than those described above should seek professional advice from their usual tax advisor as to the tax treatment that will apply to their own situation.
Withholding tax on dividends paid to shareholders who are not resident of France
Under French law, dividends paid by a French corporation, such as the Company, to non-residents of France are generally subject to French withholding tax at a rate of (i) 12.8% for distributions made to individuals, (ii) 15% for distributions made to not-for-profit organizations with a head office in a Member State of the European Union or in another Member State of the European Economic Area Agreement that has concluded a tax treaty with France which includes an administrative assistance provision to address tax evasion and avoidance, that would be taxed in accordance with the provisions of Article 206, 5 of the French Tax Code had such holder had its registered office in France and that meet the criteria provided for by the Guidelines BOI-IS-CHAMP-10-50-10-40-25/03/2013, n° 580 et seq. and BOI-RPPM-RCM-30-30-10-70-24/12/2019, n° 130, and (iii) generally 25% in other cases.
The French dividend withholding tax also applies to any payment made by a person established or domiciled in France to a non-resident in the context of a temporary assignment or a similar transaction giving the right or obligation to return or resell the shares or other rights relating to these shares. In accordance with Article 119 bis A, 1 of the French Tax Code, such temporary or similar transaction must be carried out for a period of less than forty-five days, including the date on which a right to receive a dividend (or assimilated income) in respect of the assigned shares (or rights related thereto) arises. The withholding tax is assessed on the payment made to the assignor by the assignee, within the limit of the amount of the dividend (or assimilated income) which the assignee acquires the right to receive over the period of assignment. If the assignor provides proof that such payment relates to a transaction the principal object and effect of which is not to avoid the application of a withholding tax or to obtain the granting of a tax benefit, then such assignor will be able to obtain reimbursement of the withholding tax from the tax office of his domicile or registered office.
Pursuant to paragraph 2 of Article 187 of the French Tax Code, dividends paid by a French corporation, such as the Company, in non-cooperative States or territories, as defined by Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, will generally be subject to French withholding tax at a rate of 75%, irrespective of the tax residence of the beneficiary of the dividends, unless the concerned beneficiary provides evidence that the dividends have neither the object nor the effect to enable, for tax evasion purpose, the location of income in such a State or territory.
Shareholders that are legal entities having their place of effective management in a Member State of the European Union or, under certain conditions, in another Member State of the European Economic Area Agreement that has concluded with France a tax treaty including an administrative assistance provision to address tax evasion and avoidance, may benefit from a withholding tax exemption, if they hold at least 10% of the Company’s share capital, and otherwise meet all the conditions of Article 119 ter of the French Tax Code. This 10% threshold is decreased to 5% where such legal entities qualify as parent companies (sociétés mères) within the meaning of Article 145 of the French Tax Code and cannot use the withholding tax as a tax credit in the jurisdiction in which their tax residence is situated.
Moreover, under article 235 quater of the French Tax Code, legal entities (i) having their place of effective management in (a) a Member State of the European Union, (b) another Member State of the European Economic Area Agreement or (c) any third country that has concluded with France a tax treaty including an administrative assistance provision
-97-


to address tax evasion and avoidance and a treaty on mutual administrative assistance for recovery and which is not a non-cooperative State or territory, as defined by Article 238-0 A of the French Tax Code (provided that, in the latter case, the shareholding held by concerned legal entity in the distributing company does not enable it to effectively take part in its management or control) and (ii) being in a tax loss position may, under certain conditions, benefit from a temporary reimbursement of the withholding tax (taking the form of a tax deferral), such withholding tax having to be paid to the French treasury under certain circumstances, including, in particular, at the time they reach a profitable tax position.
The legal entities referred to in the preceding paragraph may benefit from a withholding tax exemption provided that they are (i) in a tax loss position and (ii) the subject of a liquidation under a bankruptcy proceeding at the time of the distribution.
Furthermore, Article 119 bis 2° of the French Tax Code provides that the withholding tax does not apply to dividends distributed to collective investment undertakings governed by foreign law, located in a Member State of the European Union or another State that has concluded with France a tax treaty including an administrative assistance provision to address tax evasion and avoidance and which satisfy the following two conditions:
raising capital from a certain number of investors with the purpose of investing it in a fiduciary capacity on behalf of such investors pursuant to a defined investment policy; and
having features similar to those required from collective undertakings governed by French law under section 1, paragraphs 1, 2, 3, 5 et 6 of sub-section 2, sub-section 3, or sub-section 4 of section 2 of Chapter IV of the 1st Title of Book II of the French Monetary and Financial Code.
The conditions for this exemption are set forth in detail in the Guidelines BOI-RPPM-RCM-30-30-20-70-06/10/2021.
In addition, Article 235 quinquies of the French Tax Code provides for a mechanism to refund the withholding tax up to the difference between this taxation and the taxation determined on a basis net of the acquisition and conservation expenses directly attached to the dividends received when the following conditions are met:
the beneficiary is a legal person or an entity whose results are not subject to income tax in the hands of a shareholder and whose registered seat or permanent establishment in the result of which the income is included is located in (a) a Member State of the European Union, (b) another Member State of the European Economic Area Agreement or (c) any third country that has concluded with France a tax treaty including an administrative assistance provision to address tax evasion and avoidance and a treaty on mutual administrative assistance for recovery and which is not a non-cooperative State or territory, as defined by Article 238-0 A of the French Tax Code (provided that, in the latter case, the shareholding held by concerned legal entity in the distributing company does not enable it to effectively take part in its management or control);
the acquisition and conservation expenses of such income would be deductible if the beneficiary were located in France; and
the taxation rules in the State of residence of the beneficiary do not allow it to offset the withholding tax.
Finally, double tax treaties entered into between France and the States of residence of shareholders may provide for an exemption or a reduction of the French dividend withholding tax, subject to (i) certain requirements set forth therein being met and (ii) the shareholders duly completing and providing the required information and documentation. The exemptions or reduced rates of withholding tax provided for in double tax treaties may be applied to the benefit of the shareholders of our Company, as effective beneficiaries of the income, provided that they are identified and are entitled to the benefits provided by the double tax treaty which they avail themselves.
Dividends paid to eligible shareholders may be subject to the reduced rates from the outset provided, as the case may be, by the applicable double tax treaties if the French Paying Agent has received before the date of payment of the dividend the required information and documentation.
Shareholders who failed to file the required information and documentation with the French Paying Agent prior to the payment of the dividend may claim to the French tax authorities or the French Paying Agent the refund of the excess withholding tax by filing such information and documentation before December 31 of the second calendar year following the year during which the dividend is paid.
-98-


French Financial Transaction Tax and Registration Duties on Disposition of our Shares
In its decision of 13 December 2017 on the equivalence of the legal and supervisory framework of the United States of America for national securities exchanges and alternative trading systems in accordance with Directive 2014/65/EU of the European Parliament and of the Council, the European Commission decided that for the purposes of Article 23, paragraph 1, of Regulation (EU) No 600/2014, the legal and supervisory framework of the United States applicable to the NYSE are considered equivalent to the requirements applicable to regulated markets, within the meaning of Directive 2014/65/EU, as they result from Regulation (EU) No 596/214, Title III of Directive 2014/65/EU, Title II of Regulation (EU) No 600/2014 and Directive 2004/109/EC, together with effective supervision and sanctions regime.
Article 198 of the Pacte Act came into force on June 10, 2019 and modified Article L. 228-1 paragraph 7 of the French Commercial Code to allow an intermediary to be registered as the “registered intermediary” (intermédiaire inscrit) on behalf of any holders of shares of companies which are admitted to trading solely on a market in a non-EU country considered equivalent to a regulated market pursuant to paragraph (a) of Article 25(4) of Directive EC2014/65/EU (which includes the NYSE).
However, the NYSE is not formally recognized as a foreign regulated market by the French Minister of the Economy.
French financial transaction tax
The comments below (i) relate exclusively to the book-entry transfers of our ordinary shares within DTC and (ii) are notably based on the French Ruling.
Pursuant to Article 235 ter ZD of the French Tax Code, purchases of equity instruments or similar securities (such as American Depositary Receipts) of a French company listed on a regulated market of the EU or on a foreign regulated market formally recognized as such by the French Minister of the Economy are subject to a 0.3% French tax on financial transactions provided that the issuer’s market capitalization exceeds 1 billion of euros as of December 1 of the year preceding the taxation year.
The French financial transaction tax will not be due on the purchases of ordinary shares of the Company as long as the NYSE is not a foreign regulated market formally recognized as such by the French Minister of the Economy and Article 235 ter ZD of the French Tax Code is not modified.
French registration duties
The comments below (i) relate exclusively to the book-entry transfers of our ordinary shares within DTC and (ii) are notably based on the French Ruling. Transfers of shares issued by a French corporation for consideration are generally subject to registration duties at the rate of 0.1% (i) when the French corporation is listed on a regulated market within the meaning of Article L 421-1 of the French Monetary Code, on a multilateral trading facility within the meaning of Article L 424-1 of the French Monetary Code, or on any foreign equivalent market operating under similar conditions, when the transfer is evidenced by a written agreement, and (ii) when the French corporation is not listed on any of the above mentioned markets, irrespective of whether the transfer is evidenced by a written agreement.
The NYSE has been considered equivalent to a regulated market pursuant to paragraph (a) of Article 25(4) of Directive EC2014/65/EU. Thus, we believe that the NYSE should be deemed to be a foreign market operating under similar conditions to regulated markets within the meaning of Article L 421-1 of the French Monetary Code or multilateral trading facilities within the meaning of Article L 424-1 of the French Monetary Code.
Therefore, the following transactions on ordinary shares of the Company should not give rise to the duty provided for in Article 726 of the French Tax Code:
transactions on shares of the Company realized on the NYSE;
over-the-counter sales of ordinary shares of the Company published on the market or communicated to the regulator in application of the MIF Directive or foreign provisions equivalent to the MIF Directive, provided that they are not evidenced by a written agreement; and
over-the-counter transactions carried out on ordinary shares of the Company in connection with transactions that are the subject of the same publishing or communication obligations, provided that they are not evidenced by a written agreement.
-99-


French withholding tax treatment of the sale or other disposition of the rights on our ordinary shares
French tax residents
No French withholding tax will apply on the sale, exchange, repurchase or redemption (other than redemption proceeds which may, under certain circumstances be partially or fully characterized as dividends under French domestic tax law or administrative guidelines) of their rights on the ordinary shares of the Company by French tax residents.
Non-French tax residents
A shareholder who is not a French resident for French tax purposes will not be subject to French tax on capital gain from the sale, exchange, repurchase or redemption (other than redemption proceeds which may, under certain circumstances be partially or fully characterized as dividends under French domestic tax law or administrative guidelines) of its rights on the ordinary shares of the Company, unless (i) the shareholder is domiciled, established or incorporated out of France in a non-cooperative State or territory as defined in Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, (ii) the rights on the shares of the Company form part of the property of a permanent establishment that the shareholder has in France or (iii) the shareholder has held, directly or indirectly, at any time during the five years preceding the date of disposal, and as relates to individuals together with their spouse, ascendants and descendants, rights to more than 25% of the profits of the Company (droits aux bénéfices sociaux).

Certain Material Dutch Tax Consequences Dutch dividend withholding tax
General
Since the Company was initially incorporated under Dutch law it is deemed to be resident of the Netherlands for Dutch dividend withholding tax purposes. Dividends paid on our ordinary shares following migration are therefore, based on Dutch domestic law, still subject to Dutch dividend withholding tax at a rate of 15%. However, since our corporate seat has been transferred to France as of December 12, 2019, our dividends paid on our ordinary shares generally should be subject to French dividend withholding tax and not to Dutch dividend withholding tax on the basis of the double tax treaty between the Netherlands and France. However, both French and Dutch dividend withholding tax may be required to be withheld from any such dividends paid, if and when paid to Dutch resident holders of our ordinary shares (and non-Dutch resident holders of our ordinary shares that have a permanent establishment in the Netherlands to which the ordinary shares are attributable). We have approached the Dutch Tax authorities (here after “Dutch Revenue”) to apply for a tax ruling confirming that no withholding of any Dutch dividend withholding tax is applicable to any dividends paid by us even if we are no longer a Dutch tax resident for treaty purposes. However, Dutch Revenue has not been willing to confirm this. We will approach the Dutch Revenue again in the course of 2023.
We will therefore be required to identify our shareholders in order to assess whether there are Dutch resident holders of our ordinary shares or non-Dutch resident holders of our ordinary shares with a permanent establishment in the Netherlands to which the ordinary shares are attributable in respect of which Dutch dividend withholding tax has to be withheld on dividends paid. Such identification may not always be possible in practice. According to Dutch Revenue, Dutch dividend withholding tax must also be withheld on dividends paid in as far as the identity of our shareholders cannot be assessed. Withholding of both French and Dutch dividend withholding tax may occur in certain scenarios. Once we anticipate distributing a dividend, identification of our shareholders (by ourselves or a paying agent) is typically required in order to effectuate such dividend payments and could limit the Dutch dividend withholding tax that may need to be withheld.
Generally, the Dutch dividend withholding tax will not be borne by us, but will be withheld from the gross dividends paid on our ordinary shares. A 15% Dutch dividend withholding tax will in principle be levied on the gross amount of dividend. The term “dividends” for Dutch dividend withholding tax purposes includes, but is not limited to:
distributions in cash or in kind, deemed and constructive distributions and repayments of paid-in capital not recognized for Dutch dividend withholding tax purposes;
liquidation proceeds, proceeds of redemption of ordinary shares or, generally, consideration for the repurchase of ordinary shares by us in excess of the average paid-in capital of those ordinary shares recognized for Dutch dividend withholding tax purposes;
-100-


the nominal value of ordinary shares issued to a shareholder or an increase of the nominal value of ordinary shares, as the case may be, to the extent that it does not appear that a contribution to the capital recognized for Dutch dividend withholding tax purposes was made or will be made; and
partial repayment of paid-in capital, recognized for Dutch dividend withholding tax purposes, if and to the extent that there are net profits (zuivere winst), within the meaning of the Dutch Dividend Withholding Tax Act 1965 (Wet op de dividendbelasting 1965), unless the general meeting of shareholders has resolved in advance to make such a repayment and provided that the nominal value of the ordinary shares concerned has been reduced by a corresponding amount by way of an amendment of our articles of association.
Notwithstanding the above, as part of the Multilateral Instrument of the Action Plan on Base Erosion and Profit Shifting of the OECD, a principal purpose test (“PPT”) should be applied alongside the double tax treaty between the Netherlands and France as of January 1, 2020. This PPT requires that the benefits of a tax treaty should not be available if it is reasonable to conclude, having regard to all relevant facts and circumstances, that obtaining that benefit was one of the principal purposes of any arrangement or transaction that resulted directly or indirectly in that benefit, unless it is established that granting that benefit in these circumstances would be in accordance with the object and purpose of the relevant provisions of that treaty.
In theory, the Dutch Revenue may take the position that one of the principal purposes of the transfer of the place of effective management of the Company to France was to obtain a tax benefit under the double tax treaty between the Netherlands and France, being the benefit that the Netherlands cannot levy a dividend withholding tax anymore (except for the cases as stated above). On this basis, they could argue that the PPT is met and, hence, that the treaty would effectively not apply and that the Netherlands would be allowed to levy Dutch dividend withholding tax on dividends distributed, irrespective of the shareholder. Considering the background of the Transfer it seems unlikely that the Dutch Revenue would be able to successfully take the position.
Conditional withholding tax
As of January 1, 2021, a withholding tax has been introduced on interest and royalty payments by a withholding agent established in the Netherlands (including withholding agents that were initially incorporated under Dutch law) to affiliated benefit beneficiaries in a low-tax jurisdiction and in case of abusive situations. Special rules apply to payments to (reverse) hybrid entities. The rate is linked to the highest Dutch corporate income tax rate (25.8% in 2022 and 25.8% in 2023).
A benefit beneficiary is an entity that is entitled to benefits in the form of interest and royalties. Benefit beneficiaries subject to the conditional withholding tax are those that:
1.judged on circumstances or according to local regulations are established in a low‑tax jurisdiction. If the benefit beneficiary is also established in a high-tax jurisdiction and certain conditions have been met, they will not be subject to tax;
2.are not established in a low-tax jurisdiction, but the benefits are allocated to a permanent establishment in that jurisdiction;
3.from a Dutch perspective are transparent and from the perspective of the country of the underlying participant are non-transparent (hybrid entity);
4.from a Dutch perspective are non-transparent and from the perspective of the country of establishment are transparent (reverse hybrid entity);
5.are not established in the Netherlands or a low-tax jurisdiction because there is an abuse situation. For there to be abuse, both the subjective test and the objective test must be met. The subjective test means that the main objective or one of the main objectives of the arrangement is to avoid withholding tax being imposed at another party. The objective test is met if there is an artificial arrangement or transaction (the arrangement is not set up based on valid business reasons that reflect economic reality).
Payments to affiliated entities entail payments to both parent/grandparent, subsidiary/ sub-subsidiary and sister companies. There is affiliation if:
1.the benefit beneficiary directly or indirectly holds a qualifying interest in the withholding agent;
2.the withholding agent directly or indirectly holds a qualifying interest in the benefit beneficiary;
3.a third party directly or indirectly holds a qualifying interest in the benefit beneficiary and in the withholding agent;
4.the benefit beneficiary together with other entities that belong to a cooperating group directly or indirectly hold a qualifying interest in the withholding agent;
5.the withholding agent together with other entities that belong to a cooperating group directly or indirectly hold a qualifying interest in the benefit beneficiary;
-101-


6.entities belonging to a cooperating group together directly or indirectly hold a qualifying interest in the benefit beneficiary and in the withholding agent.
A qualifying interest is an interest in an entity with which the decisions of that entity can be influenced in such a way that the activities of that entity can be determined. This is, in principle, the case if the interest represents more than 50% of the statutory voting rights.
Low-tax jurisdictions are countries included in the Regulation on Low-tax States and Non‑cooperative Jurisdictions for Tax Purposes. These countries either appear on the EU list of non-cooperative jurisdictions or have a statutory tax rate of less than 9%. An exhaustive list of states designated on the basis of the above criteria is drawn up each year. It is based on the rate applying on October 1 of the preceding calendar year or on the most recent EU blacklist for the preceding calendar year. For financial years commencing on or after January 1, 2022, the following states have been classified as designated states: American Samoa, Anguilla, the Bahamas, Bahrain, Barbados, Bermuda, the British Virgin Islands, the Cayman Islands, Fiji, Guam, Guernsey, the Isle of Man, Jersey, Palau, Panama, Samoa, Trinidad and Tobago, the Turks and Caicos Islands, Turkmenistan, the United Arab Emirates, the US Virgin Islands, and Vanuatu.
As of 2024, the tax base for this conditional withholding tax on interest and royalty payments will be expanded to also cover dividends. The term “dividends” for the conditional withholding tax will be equal to the term “dividends” for dividend withholding tax purposes.
Since the Company was initially incorporated under Dutch law it is deemed to be resident of the Netherlands for the conditional withholding tax and as such should qualify as a withholding agent. Dividends paid on our ordinary shares following migration may therefore, based on Dutch domestic law, still become subject to the Dutch conditional withholding tax as of 2024. However, as set out above, on the basis of the double tax treaty between the Netherlands and France, the conditional withholding tax may only be withheld from any such dividends paid, if and when paid to Dutch resident holders of our ordinary shares (and non-Dutch resident holders of our ordinary shares that have a permanent establishment in the Netherlands to which the ordinary shares are attributable). Given that no conditional withholding tax should be due on payment to Dutch tax residents, the conditional withholding tax may only become due to the extent that a dividend is paid to an affiliated benefit beneficiary that judged on circumstances or according to local regulations is established in a low‑tax jurisdiction and that has a permanent establishment in the Netherlands to which our ordinary shares are allocable.
F.Dividends and Paying Agents
Not applicable.
G.Statement of Experts
Not applicable.
H.Documents on Display
The SEC maintains an Internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that site is www.sec.gov.
We also make available on our website, free of charge, our annual reports on Form 20-F and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is www.constellium.com. The information contained on our website is not incorporated by reference in this document.
I.Subsidiary Information
Not applicable.
-102-


Item 11. Quantitative and Qualitative Disclosures About Market Risk
Refer to the information set forth under the Notes to the Consolidated Financial Statements at “Item 18. Financial Statements”:
Note 2 - Summary of Significant Accounting Policies—2.6— Principles governing the preparation of the Consolidated Financial Statements— Financial Instruments; and
Note 22 - Financial Risk Management.

Item 12. Description of Securities Other than Equity Securities
Not applicable.
PART II
Item 13. Defaults, Dividend Arrearages and Delinquencies
None.
Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds
A.Material Modifications to the Rights of Security Holders
Not applicable.
B.Use of Proceeds
None.
Item 15. Controls and Procedures
A.Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of the end of the period covered by this Form 20-F, have concluded that, as of such date, our disclosure controls and procedures were effective.
B.Management’s Annual Report on Internal Control over Financial Reporting
The management of the Company, including the Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in the Securities Exchange Act of 1934, as amended, Rule 13a-15(f).
The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and as endorsed by the European Union (EU).
The Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.
-103-


Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of the effectiveness of internal control to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Constellium’s management has assessed the effectiveness of the Company’s internal controls over financial reporting as of December 31, 2022 based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and, based on such criteria, Constellium’s management has concluded that, as of December 31, 2022, the Company´s internal control over financial reporting is effective.
C.Attestation Report of the Registered Public Accounting Firm
The effectiveness of the Company’s internal control over financial reporting as of December 31, 2022 has been audited by PricewaterhouseCoopers Audit, an independent registered public accounting firm, as stated in their report which appears herein.
D.Changes in Internal Control over Financial Reporting
During the period covered by this report, we have not made any change to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 16.
Item 16A. Audit Committee Financial Expert
Our Board of Directors has determined that the members of our Audit Committee, Mmes. Walker, Boccon-Gibod and Browne and Mr. Ormerod satisfy the “independence” requirements set forth in Rule 10A-3 under the Exchange Act. Our Board of Directors has also determined that each of Ms. Walker and Mr. Ormerod is an “audit committee financial expert” as defined in Item 16A of Form 20-F under the Exchange Act.
Item 16B. Code of Ethics
We have adopted a Worldwide Code of Employee and Business Conduct that applies to all our employees, officers and directors, including our principal executive, principal financial and principal accounting officers. Our Worldwide Code of Employee and Business Conduct addresses, among other things, competition and fair dealing, conflicts of interest, financial integrity, government relations, confidentiality and corporate opportunity requirements and the process for reporting violations of the Worldwide Code of Employee and Business Conduct, employee misconduct, conflicts of interest or other violations. Our Worldwide Code of Employee and Business Conduct is intended to meet the definition of “code of ethics” under Item 16B of Form 20-F under the Exchange Act.
A copy of our Worldwide Code of Employee and Business Conduct is available on our website at www.constellium.com. Any amendments to the Worldwide Code of Employee and Business Conduct, or any waivers of its requirements, will be disclosed on our website.
Item 16C. Principal Accountant Fees and Services
PricewaterhouseCoopers Audit has served as our independent registered public accounting firm for each of the fiscal years in the three-year period ended December 31, 2022.
-104-


The following table sets out the aggregate fees for professional services and other services rendered to us by PricewaterhouseCoopers in the years ended December 31, 2022 and 2021, and breaks down these amounts by category of service:
For the year ended December 31,
20222021
(€ in thousands)
Audit fees4,346 3,891 
Audit-related fees100 338 
Tax fees331 305 
All other fees78 
Total(1)
4,855 4,537 
__________________
(1) Including out-of-pocket expenses amounting to €185,000 and €103,000 for the years ended December 31, 2022 and 2021, respectively.
Audit Fees
Audit fees consist of fees related to the annual audit of our Consolidated Financial Statements, and our statutory financial statements, the audit of the statutory financial statements of our subsidiaries, other audit or interim review services provided in connection with statutory and regulatory filings or engagements.
Audit-Related Fees
Audit-related fees consist of fees rendered for assurance and related services that are reasonably related to the performance of the audit or review of the company’s financial statements, or that are traditionally performed by the independent auditor, and include consultations concerning financial accounting and reporting standards; advice and assistance in connection with local statutory accounting requirements and due diligence related to acquisitions or disposals.
Tax Fees
Tax fees relate to tax compliance, including the preparation of tax returns and assistance with tax audits.
Pre-Approval Policies and Procedures
The advance approval of the Audit Committee or members thereof, to whom approval authority has been delegated, is required for all audit and non-audit services provided by our auditors.
Item 16D. Exemptions from the Listing Standards for Audit Committees
None.
Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers
None.
Item 16F. Change in Registrant’s Certifying Accountant
None.
-105-


Item 16G. Corporate Governance
As a foreign private issuer listed on the NYSE, we are subject to NYSE corporate governance listing standards. However, NYSE rules permit a foreign private issuer like us to follow the corporate governance practices of its home country. Following the Transfer, we intend to rely on the NYSE Listed Company Manual with respect to our corporate governance to the extent possible under French law.
The following are the significant ways in which our corporate governance practices differ from those required for U.S. companies listed on the NYSE following the Transfer.
Audit Committee-The Board’s audit committee is responsible for selecting our statutory auditors and making a recommendation to our Board regarding the terms of their compensation. As required by French law, the actual appointment of the statutory auditors has to be made by the shareholders at a general meeting of the shareholders.
Committee Powers-While the NYSE Listed Company Manual empowers board committees with decision-making authority that can be delegated by a company’s board, under French law, committees of the Company recommend to the full Board, which will be the decision-making body (not its committees).
Executive Sessions/Communications with Independent Directors-French law does not require for our independent directors to meet regularly without management, nor does it require the independent directors to meet alone in executive session at least once a year, as required by the NYSE Listed Company Manual. However, if our independent directors decide to engage in either or both of these activities, they will be permitted to do so. In practice, our independent directors regularly meet among themselves for discussions, but we do not expect them to be under any requirement to do so under our Articles of Association or French law. In addition, French law does not require a method for interested parties to communicate with our independent directors.
Equity Compensation Plans-French law requires shareholder approval at a general meeting of the shareholders to adopt an equity compensation plan, which is consistent with the shareholder vote required by the NYSE Listed Company Manual. It is common practice after obtaining such shareholder approval for the shareholders of a French company to then delegate to such company’s board of directors the authority to decide on the specific terms of the granting of equity compensation, within the limits of the shareholders’ authorization. The shareholders of the Company at the extraordinary general meeting held on November 25, 2019 and at the annual general meeting held on May 11, 2021 approved such authorizations to delegate such authority to the Board of Directors.
Corporate Governance Guidelines-A Board Internal Charter is required by the NYSE Listed Company Manual for U.S. companies listed on the NYSE that would set forth certain corporate governance practices of a listed company’s board. Our Board Internal Charter after the Transfer covers all items required by the NYSE Listed Company Manual subject to certain differences set forth by French law, particularly with respect to Committee powers (as described above) and conflict of interest transactions (as described below).
Conflicts of Interest-Pursuant to French law and the Articles of Association, any agreement (directly or through an intermediary) between the Company and any director of the Company that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions will be subject to the prior authorization of the Board, excluding the participation and vote of the interested director. As required by French law, any such agreement will also be subject to approval at the next ordinary shareholders’ meeting (by a simple majority, excluding the vote of interested persons). If the transaction has not been pre-approved by the Board, it can be nullified if it has prejudicial consequences for the Company. If it is not approved by the shareholders, interested directors may be held liable for any prejudicial consequences for the Company of the unapproved transaction; such transaction will nevertheless remain valid, unless it is nullified in case of fraud. The foregoing requirements also apply to agreements between the Company and another entity if one of the Company’s directors is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the Company’s directors has an indirect interest. Aside from the foregoing requirements, there are no specific provisions prohibiting conflicted directors to participate or vote at a Board meeting. However, as a general rule under French law, directors must act in the interest of the Company.
In addition to the above differences, the following are corporate governance provisions applicable to the Company under French law and our Articles of Association:
-106-


Rights of Shareholders and Shareholders’ Meetings
Under French law and in general, each shareholder is entitled to one vote per share at any general shareholders’ meeting. A general shareholders’ meeting is held annually to, inter alia, approve the annual financial statements. General shareholders’ meetings (including annual meetings) can be ordinary and/or extraordinary, depending upon the resolutions submitted to the vote.
At an extraordinary general shareholders’ meeting (which votes upon any proposal to change the articles of association, including any change in the rights of shareholders), majority is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/4 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting. If the quorum at the second meeting is not reached, the second meeting can be postponed to a date no later than two months after the date on which the second meeting was convened. The quorum for such second or postponed meeting, as the case may be, to be validly held is 1/5 of the voting shares.
At an ordinary shareholders’ meeting (which votes upon any proposal within the competence of a general shareholders’ meeting other than an extraordinary shareholders meeting such as approval of annual financial statements or appointment of directors), majority is simple majority (more than 50%) of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/5 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting; no quorum is required for such second meeting.
Special meetings bring together the holders of shares of a specified class, should it be created, to decide on an amendment to the rights relating to the shares of this class. Majority at special meetings is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/3 of the voting shares, and, failing which, 1/5 for the meeting held on the date set by the second convening notice or in the case of postponement of the second meeting.
French law does not provide for cumulative voting. The right to participate in a shareholders’ meeting is granted to all the shareholders whose shares are fully paid up and for whom a right to attend shareholders’ meetings has been established by registration of their shares in their names or names of the authorized intermediary acting on their behalf on the second business day prior to the shareholders’ meeting at 0:00 (zero hour) (Paris time) (the “French Record Date”), either in the registered (“au nominatif”) shares accounts held by the company (or an agent acting on its behalf) or in the bearer (“au porteur”) shares accounts held by the authorized intermediary.
Shareholders holding shares registered on the U.S. Register (which include all shares which are listed on the NYSE, held through a DTC participant and shares directly recorded in the name of their holder with Computershare) vote through a process similar to the one that was in place before the Transfer with the following main differences:
their voting instructions will be transmitted to the Company via the French Intermediary, acting as intermediary for the account of all shareholders registered on the U.S. Register, in accordance with articles L. 228-1 et seq. of the French Commercial Code;
the French Record Date will be set;
an additional record date will be fixed for all shareholders registered on the U.S. Register, which date will be the 25th day before the meeting (the “U.S. Record Date”); and
shareholders who purchase shares between the U.S. Record Date and the French Record Date will be entitled to participate and vote at the shareholders’ meeting as long as they continue to be shareholders on the French Record Date. However, given the short time between the French Record Date and the shareholders’ meeting date, shareholders as of the French Record Date may not have received the notices and information received by shareholders holding shares registered on the U.S. Register as of the U.S. Record Date. To the extent that shareholders as of the U.S. Record Date have sent voting instructions and sold or otherwise transferred their shares as of the French Record Date, such voting instructions will be invalidated or modified by the Company, as the case may be, in accordance with articles R. 225-85 and R. 225-86 of the French Commercial Code.
-107-


Shareholder Proposals and Action by Written Consent
Pursuant to French law, the board of directors is required to convene an annual ordinary general meeting of shareholders for approval of the annual financial statements. This meeting must be held within six months after the end of each prior fiscal year.
The board of directors may also convene an ordinary or extraordinary meeting of shareholders upon proper notice at any time during the year. If the board of directors fails to convene a shareholders’ meeting, the auditors may call the meeting. In a bankruptcy, the liquidator or court-appointed agent may also call a shareholders’ meeting in some instances. Any of the following may request the court to appoint an agent:
one or several shareholders holding at least 5% of the share capital, or
 any interested party or the workers committee in cases of urgency.
Shareholders holding a majority of the capital or voting rights after a public take-over bid or exchange offer or the transfer of a controlling block of shares may also convene a shareholders’ meeting. In general, shareholders can only take action at shareholders’ meetings on matters listed on the agenda for the meeting. As an exception to this rule, shareholders may take action with respect to the dismissal and appointment of directors.
Additional draft resolutions to be submitted for approval by the shareholders at any shareholders’ meeting may be proposed to the board of directors within the legal time limit (which is no later than 20 days after the publication of the convening notice (avis de réunion) and in any event no sooner than 25 days prior to the date of the shareholders’ meeting) by one or several shareholders holding a specified percentage of shares. The convening notice (avis de réunion) must be published in France with the BALO at least 35 days prior to the date of the shareholders’ meeting and can be consulted at https://www.journal-officiel.gouv.fr/balo/. As the U.S. Record Date is fixed at the 25th day before the shareholders’ meeting, shareholders wishing to submit additional resolutions will need to submit them before receiving the meeting materials sent to them on or around the U.S. Record Date, otherwise their submissions will not be considered. The percentage of shares required to be held by one or several shareholders to be able to submit additional draft resolutions depends on the amount of the share capital of the Company; based on the Company’s issued share capital of €2,886,031.84 as of December 31, 2022, this percentage would be 2.89%.
Under French law, shareholders’ action by written consent is not permitted in a Societas Europaea.
Shareholder Suits
French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a company in the company’s interest if it fails to bring such legal action itself. If so, any damages awarded by the court are paid to the company and any legal fees relating to such action are borne by the relevant shareholder or the group of shareholders. The plaintiff must remain a shareholder throughout the duration of the legal action. There is no other case where shareholders may initiate a derivative action to enforce a right of a company.
A shareholder may alternatively or cumulatively bring an individual legal action against the directors, provided he or she has suffered distinct damages from those suffered by the company. In this case, any damages awarded by the court are paid to the relevant shareholder.
Repurchase of Shares; Pre-emptive Rights; Shareholder Vote on Certain Reorganizations
Under French law, a private company (which our Company is for French law purposes for so long as its shares are not listed on an EU-regulated market) may not subscribe for newly issued shares in its capital but may, however, acquire its own shares, subject to shareholders’ authorization, for the following purposes only:
With a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, restricted free share or share option plan, not to exceed 10% of the share capital;
In payment or in exchange for assets acquired by the company within two years of their repurchase, not to exceed 5% of the share capital;
To sell the relevant shares to any shareholders willing to purchase them as part of a process organized by the company within five years, not to exceed 10% of the share capital.
-108-


Shares acquired but not used in accordance with the above purposes must be cancelled. As of the date of this Annual Report, the Company does not have in place such shareholders’ authorization granted to the Board of Directors to purchase its own shares.
Also, under French law, a private company (which our Company is for French law purposes for so long as its shares are not listed on an EU-regulated market) may acquire its own shares, without shareholders’ authorization, with a view to distributing within one year of their repurchase the relevant shares to employees or managers under a restricted free share or share option plan, not to exceed 10% of the share capital.
The Company may also acquire its own shares to decrease its share capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction.
Under French law, in case of issuance of additional shares or other securities giving right, immediately or in the future, to new shares for cash or set-off against cash debts, the existing shareholders have preferential subscription rights to these securities on a pro rata basis unless such rights are waived by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the extraordinary meeting deciding or authorizing the capital increase. In case such rights are not waived by the extraordinary general meeting, each shareholder may individually either exercise, or assign or not exercise its preferential rights.
Generally, under French law, completion of a legal merger (fusion), demerger (scission), dissolution, sale, lease or exchange of all or substantially all of a company’s assets, requires:
 the approval of the board of directors; and
 the approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting, or in the case of a legal merger (fusion) with a non-EU company, approval of all the shareholders of the company.
Anti-Takeover Provisions and Shareholder Disclosure Thresholds
Anti-Takeover Provisions
French law does not contain provisions restricting or making difficult to change the composition of the board of directors following a change of control.
French law allows shareholders at general meetings to delegate the authority to the board of directors to issue shares or warrants to subscribe for shares, which may make it more difficult for a shareholder to obtain control over our general meeting of shareholders.
Crossing of Threshold Notifications
According to the Articles of Association, any natural persons or legal entities acting alone or in concert, who come to own, directly or indirectly, a number of shares equal to or greater than 5%, 10%, 15%, 20%, 25%, 30%, 33 1/3%, 50%, 66 2/3% or 90% of the total number of shares or voting rights must, within five (5) trading days after the shareholding threshold is crossed, upwards or downwards, notify the Company, by certified letter with acknowledgment of receipt, of the total number of shares or voting rights that they own alone, directly or indirectly, or in concert.
The notification includes information on (i) the number of securities held giving deferred rights to the shares to be issued and the corresponding voting rights, and (ii) the number of shares already issued or the voting rights they may acquire.
Furthermore, according to the Articles of Association, any persons or entities who hold a number of shares equal to or greater than 10%, 15%, 20% or 25% of the total number of shares or voting rights in the Company shall inform the Company of the objectives they intend to pursue over the six (6) months to come.
Following a period of six (6) months, any persons or entities who continue to hold a number of shares or voting rights equal to or greater than the fractions mentioned hereinabove, shall renew their statement of intent, in compliance with the aforementioned terms, for each new period of six (6) months.
-109-


This statement shall specify whether the shareholder is acting alone or in concert, if he plans to discontinue or continue his purchases, to acquire or not the control of the Company, to request his appointment or that of one or several persons as director.
The Company reserves the right to share with the public and shareholders either the objectives that it has been notified of, or the relevant person’s failure to comply with the aforementioned obligation.
For the application of the preceding subparagraphs, the shares or voting rights listed in paragraphs 1 to 8 of Article L. 233-9 I of the French Commercial Code shall be considered equivalent to the shares or voting rights held by a shareholder.
Mandatory Takeover Bid
According to the Articles of Association, any natural or legal persons, acting alone or in concert under Article L. 233-10 of the French Commercial Code, who comes into possession, otherwise than following a voluntary takeover bid, directly or indirectly, of more than 30% of the capital or voting rights of the Company, shall file a draft takeover bid on all the capital and securities granting access to the capital or voting rights, and on terms that comply with applicable United States securities law, rules of the SEC and NYSE rules.
The same requirement applies to natural or legal persons, acting alone or in concert, who directly or indirectly own a number between 30% and half of the total number of equity securities or voting rights of the company and who, in less than twelve consecutive months, increase the holding, in capital or voting rights, of at least 1% of the total number of equity securities or voting rights of the Company.
When a draft offer is submitted, the price proposed must be at least equal to the highest price paid by the offeror, acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, over a period of twelve (12) months preceding the event giving rise to the obligation to submit the draft offer.
In the event of a clear change in the characteristics of the Company, if the market for its securities so justifies or in the absence of a transaction by the offeror, acting alone or in concert, over the Company’s shares during the twelve-month period mentioned in the first paragraph, the price will be fixed by an expert appointed in accordance with Article 1592 of the French Civil Code and determined according to objective evaluation criteria usually used, the characteristics of the Company and the market of its securities, it being specified that the expert will be required to take into account, in its assessment, the criteria identified by the Commission des Opérations de Bourse, the AMF and the French courts.
The obligation to file a draft public offer does not apply if the person or persons concerned justify to the Company the fulfillment of one of the conditions listed in Articles 234-7 and 234-9 of the AMF General Regulations. In the event of disagreement between the parties, an expert will be appointed by the president of the commercial court, ruling in the form of interim relief, for the purpose of determining whether or not it is necessary to file a draft public offer, it being specified that the expert will be required to apply the relevant provisions of the AMF General Regulations as well as the criteria issued by the French Conseil des Marchés Financiers, the AMF and the French courts.
Any breach of the obligation to file a takeover bid as provided in the Articles of Association may give rise to claims for damages or, as the case may be, action for injunctive relief.
Item 16H. Mine Safety Disclosure
Not applicable.
Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.
-110-


PART III
Item 17. Financial Statements
See “Item 18. Financial Statements.”
Item 18. Financial Statements
The audited Consolidated Financial Statements as required under Item 18 are attached hereto starting on page F-1 of this Annual Report. The audit report of PricewaterhouseCoopers Audit, an independent registered public accounting firm, is included herein preceding the audited Consolidated Financial Statements.
Item 19. Exhibits
The following exhibits are filed as part of this Annual Report:
EXHIBIT INDEX
1.1
2.1
4.8
4.9
4.10
4.11
4.12
4.12.1
4.13
4.14
4.15
-111-


4.16
4.17
4.17.2
4.41
4.42
4.43
4.43.1
4.43.2
4.44
4.45
4.45.1
4.45.2
4.46
-112-


4.46.1
4.46.2
4.46.3
4.46.4
4.46.5
4.46.6
4.46.7
4.47
4.48
4.48.1
4.49
-113-


4.49.1
4.50
4.50.1
4.51
4.51.1
4.52
4.52.1
10.1
10.2
10.3
10.4
10.5
10.6
10.7
-114-


10.8
10.8.1
10.8.2
10.8.3
10.8.4
10.9
10.9.1
10.9.2
10.9.3
10.9.4
10.9.5
10.10
10.10.1
10.10.2
10.10.3
10.11
10.11.1
10.12
-115-


10.12.1
10.12.2
10.12.3
10.12.4
10.13
10.13.1
10.13.2
10.13.3
10.13.4
10.15
10.15.1
10.15.2
10.15.3
10.15.4
10.16
10.17
10.21
10.22
10.23
-116-


10.23.1
10.23.2
10.23.3
10.23.4
10.25

10.25.1

10.25.2
10.25.3
10.25.4
10.25.5
10.26
10.27
10.28
10.29.1
-117-


10.29.2
10.30.1
10.30.2
10.30.3
10.30.4
10.30.5
10.30.6
10.30.7
10.30.8
10.30.9
10.30.10
10.30.11
10.30.12
10.30.13
10.31
10.32
10.33
10.34
10.35
10.36
-118-


12.1
12.2
13.1
13.2
15.1
21.1
101.INSXBRL Instance Document**
101.SCHXBRL Taxonomy Extension Schema Document**
101.CALXBRL Taxonomy Extension Calculation Linkbase Document**
101.DEFXBRL Taxonomy Extension Definition Linkbase Document**
101.LABXBRL Taxonomy Extension Label Linkbase Document**
101.PREXBRL Taxonomy Extension Presentation Linkbase Document**
__________________
**    Filed herein.
+    Confidential treatment granted as to certain portions, which portions have been provided separately to the Securities and Exchange Commission.
‡    Translated in part.


-119-


SIGNATURES
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.
CONSTELLIUM SE
By:/s/ Jean-Marc Germain
Name: Jean-Marc Germain
Title:Chief Executive Officer
Date: March 14, 2023

-120-


INDEX TO FINANCIAL STATEMENTS
Constellium SE Audited Consolidated Financial Statements as of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020

F-1


Report of lndependent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Constellium SE
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated statement of financial position of Constellium SE and its subsidiaries (the "Company") as of December 31, 2022 and 2021, and the related consolidated income statement, statements of comprehensive income, of changes in equity and of cash flows for each of the three years in the period ended December 31, 2022, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control- Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board and in conformity with International Financial Reporting Standards as adopted by the European Union. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Annual Report on Internal Control over Financial Reporting, appearing under Item 15B. Our responsibility is to express opinions on the Company's consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
F-2


Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Recoverability of deferred tax assets of the US tax groups
As described in Notes 2 and 17 to the consolidated financial statements, the Company recognized net deferred income tax assets in relation to recoverable tax losses and temporary differences between the accounting base and the tax base of assets and liabilities amounting to €243 million as of December 31, 2022. Of this amount, €190 million is related to recoverable tax losses. Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available, against which the temporary differences can be utilized. The amount of deferred income tax assets were determined based on the expected future taxable income per tax jurisdiction, the applicable tax rates and local expiry periods of tax losses. Management exercised significant judgment in determining that, based on the expected taxable income of the entities, it is more likely than not that a total of €199 million of unused tax losses and deductible temporary differences, with a related tax impact of €48 million as of December 31, 2022, will not be used, and that it is more likely than not that a total of €243 million deferred tax assets will be recoverable.
The principal considerations for our determination that performing procedures relating to the recoverability of deferred income tax assets is a critical audit matter are (i) the significant management judgement involved in considering whether or not it is likely that deferred income tax assets will be utilized and (ii) a high degree of auditor judgment, subjectivity and effort in evaluating management's assessment of the relevant assumptions related to forecasts of taxable profit.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. These procedures, focused on recoverability of deferred tax assets at the Company's subsidiaries located in the United States, included, among others, understanding the controls relating to management's assessment of the recoverability of deferred income tax assets and testing their effectiveness, examining the deferred income tax assets by jurisdiction and agreeing the forecasted future taxable profits with approved underlying business plans, assessing whether the underlying trends and assumptions in the forecasts of taxable profit were consistent with those used in the impairment tests, and the past performance against the expected future tax profits in the business plans used by the Company. The procedures also included (i) evaluating management's relevant assumptions involved in the forecasted future taxable profits estimated by management, (ii) consideration of the historical taxable profits, applicable tax rates and local expiry periods of tax losses together with any applicable restrictions in recovery established by local legislation, (iii) evaluating the estimated reversal of the various temporary differences and (iv) assessing the adequacy of the Company's disclosures on deferred tax assets.

/s/ PricewaterhouseCoopers Audit

Neuilly-sur-Seine, France
March 14, 2023


We have served as the Company’s auditor since 2011.
F-3


CONSOLIDATED INCOME STATEMENT
Year ended December 31,
(in millions of Euros)Notes202220212020
Revenue38,1206,1524,883
Cost of sales(7,448)(5,488)(4,393)
Gross profit672664490
Selling and administrative expenses(282)(258)(237)
Research and development expenses(48)(39)(39)
Other gains and losses - net8(8)117(89)
Income from operations334484125
Finance costs - net10(131)(167)(159)
Income / (loss) before tax203317(34)
Income tax benefit / (expense)11105(55)17
Net income / (loss)308262(17)
Net income / (loss) attributable to:
Equity holders of Constellium301257(21)
Non-controlling interests754
Net income / (loss)308262(17)



Earnings per share attributable to the equity holders of Constellium (in Euros)
Basic2.101.82(0.15)
Diluted2.061.75(0.15)
Weighted average number of shares
Basic143,625,764140,995,106138,739,635
Diluted146,605,716147,169,971138,739,635
The accompanying notes are an integral part of these consolidated financial statements.

F-4


CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
Year ended December 31,
(in millions of Euros)Notes202220212020
Net income / (loss)308262(17)
Other comprehensive income / (loss)
Items that will not be reclassified subsequently to the consolidated income statement
Remeasurement on post-employment benefit obligations157114(20)
Income tax on remeasurement on post-employment benefit obligations(35)(16)5
Items that may be reclassified subsequently to the consolidated income statement
Cash flow hedges22(8)(17)26
Income tax on cash flow hedges1724(7)
Currency translation differences2134(18)
Other comprehensive income / (loss)137119(14)
Total comprehensive income / (loss)445381(31)
Attributable to:
Equity holders of Constellium439374(34)
Non-controlling interests673
Total comprehensive income / (loss)445381(31)
The accompanying notes are an integral part of these consolidated financial statements.

F-5


CONSOLIDATED STATEMENT OF FINANCIAL POSITION
At December 31,
(in millions of Euros)Notes20222021
Assets
Current assets
Cash and cash equivalents12166147
Trade receivables and other 13539683
Inventories141,3201,050
Other financial assets213158
2,0561,938
Non-current assets
Property, plant and equipment152,0171,948
Goodwill16478451
Intangible assets165458
Deferred tax assets17271162
Trade receivables and other 134355
Other financial assets21812
2,8712,686
Assets of disposal group classified as held for sale1814
Total Assets4,9414,624
Liabilities
Current liabilities
Trade payables and other 191,4671,377
Borrowings20148258
Other financial liabilities214125
Income tax payable1634
Provisions242120
1,6931,714
Non-current liabilities
Trade payables and other 194332
Borrowings201,9081,871
Other financial liabilities21146
Pension and other post-employment benefit obligations23403599
Provisions249097
Deferred tax liabilities172814
2,4862,619
Liabilities of disposal group classified as held for sale1810
Total Liabilities4,1894,333
Equity
Share capital2633
Share premium26420420
Retained earnings / (deficit) and other reserves308(149)
Equity attributable to equity holders of Constellium731274
Non-controlling interests2117
Total Equity752291
Total Equity and Liabilities4,9414,624
The accompanying notes are an integral part of these consolidated financial statements.
F-6


CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

(in millions of Euros)Share capitalShare premiumRe-
measurement
Cash flow hedgesForeign currency translation reserveOther reservesRetained (deficit) / earningsTotal Non-controlling interestsTotal equity
At January 1, 20223420(94)(4)1983(153)27417291
Net income3013017308
Other comprehensive income / (loss)
122(6)22138(1)137
Total comprehensive income / (loss)
122(6)223014396445
Share-based compensation181818
Transactions with non-controlling interests(2)(2)
At December 31, 2022342028(10)4110114873121752

(in millions of Euros)Share capitalShare premiumRe-
measurement
Cash flow hedgesForeign currency translation reserveOther reservesRetained deficitTotalNon-controlling interestsTotal equity
At January 1, 20213420(192)9(13)68(410)(115)14(101)
Net income2572575262
Other comprehensive income / (loss)98(13)321172119
Total comprehensive income / (loss)98(13)322573747381
Share-based compensation151515
Transactions with non-controlling interests(4)(4)
At December 31, 20213420(94)(4)1983(153)27417291

(in millions of Euros)Share capitalShare premiumRe-
measurement
Cash flow hedgesForeign currency translation reserveOther reservesRetained deficitTotalNon-controlling interestsTotal equity
at January 1, 20203420(177)(10)453(389)(96)11(85)
Net (loss) / income(21)(21)4(17)
Other comprehensive (loss) / income(15)19(17)(13)(1)(14)
Total comprehensive (loss) / income(15)19(17)(21)(34)3(31)
Share-based compensation151515
Transactions with non-controlling interests
At December 31, 20203420(192)9(13)68(410)(115)14(101)
The accompanying notes are an integral part of these consolidated financial statements.
F-7


CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31,
(in millions of Euros)Notes202220212020
Net income308262(17)
Adjustments
Depreciation and amortization15, 16287267259
Impairment of assets15, 1643
Pension and other post-employment benefits service costs23(22)6434
Finance costs - net10131167159
Income tax (benefit) / expense11(105)55(17)
Unrealized losses / (gains) on derivatives - net and from remeasurement of monetary assets and liabilities - net47(36)(18)
Losses on disposal434
Other - net171119
Change in working capital
Inventories(241)(435)63
Trade receivables 155(227)36
Trade payables 41396(38)
Other135(10)
Change in provisions(10)(7)1
Pension and other post-employment benefits paid23(44)(43)(53)
Interest paid(113)(128)(140)
Income tax (paid) / refunded(17)39
Net cash flows from operating activities451357334
Purchases of property, plant and equipment4(273)(232)(182)
Property, plant and equipment grants received4105
Proceeds from disposals, net of cash11
Other investing activities(1)
Net cash flows used in investing activities(270)(221)(176)
Proceeds from issuance of long-term borrowings20712472
Repayments of long-term borrowings20(192)(1,052)(209)
Net change in revolving credit facilities and short-term borrowings2072(5)(110)
Lease repayments20(37)(32)(35)
Payment of financing costs and redemption fees(1)(30)(9)
Transactions with non-controlling interests(2)(2)
Other financing activities(3)(26)(8)
Net cash flows (used in) / from financing activities(163)(435)101
Net increase / (decrease) in cash and cash equivalents18(299)259
Cash and cash equivalents - beginning of period147439184
Reclassification as assets of disposal group classified as held for sale (1)
Effect of exchange rate changes on cash and cash equivalents27(4)
Cash and cash equivalents - end of year12166147439
The accompanying notes are an integral part of these consolidated financial statements.
F-8


Notes to the Consolidated Financial Statements
NOTE 1 - GENERAL INFORMATION
Constellium is a global leader in the design and manufacture of a broad range of innovative specialty rolled and extruded aluminium products, serving primarily the packaging, aerospace and automotive end-markets. The Group has a strategic footprint of 29 manufacturing facilities located in North America, Europe and China, 3 R&D centers and 3 administrative centers. The Group has approximately 12,500 employees.
Constellium SE, a French Societas Europaea (SE), is the parent company of the Group. The business address (head office) of Constellium SE is located at Washington Plaza, 40-44 rue Washington, 75008 Paris, France.
Unless the context indicates otherwise, when we refer to “we”, “our”, “us”, “Constellium”, the “Group” and the “Company” in this document, we are referring to Constellium SE and its subsidiaries.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.1 Statement of compliance
The Consolidated Financial Statements of Constellium SE and its subsidiaries have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and as endorsed by the European Union (EU). The Group’s application of IFRS results in no difference between IFRS as issued by the IASB and IFRS as endorsed by the EU (https://ec.europa.eu/info/law/international-accounting-standards-regulation-ec-no-1606-2002_en).
The Consolidated Financial Statements were authorized for issue on March 9, 2023 by the Board of Directors.
2.2 New and amended standards and interpretations
Several amendments to IFRS standards and interpretations applied for the first time in 2022, but had no impact on the Consolidated Financial Statements of the Group.
Amendments to IAS 16: Property, Plant and Equipment: Proceeds before Intended Use
Amendments to IFRS 3: Reference to the Conceptual Framework
Amendments to IAS 37: Onerous Contracts – Costs of Fulfilling a Contract
Annual Improvements to IFRS Standards 2018-2020
IFRS 9 Financial Instruments: Fees in the ‘10 per cent’ test for derecognition of financial liabilities
2.3 New standards and interpretations not yet mandatorily applicable
The Group has not early adopted the following new standards, amendments and interpretations which have been issued, but are not yet effective. The Group plans to adopt these new standards, amendments and interpretations on their required effective dates and does not expect any material impact as a result of their adoption.
Amendments to IAS 1: Classification of Liabilities as Current or Non-current
Amendment to IAS 1 and IFRS Practice Statement 2: Disclosure of Accounting Policies
Amendment to IAS 8: Definition of Accounting Estimates
Amendment to IAS 12: Deferred Tax related to Assets and Liabilities arising from a Single Transaction
2.4 Basis of preparation
In accordance with IAS 1- Presentation of Financial Statements, the Consolidated Financial Statements are prepared on the assumption that Constellium is a going concern and will continue in operation for the foreseeable future.
The Group’s financial position, its cash flows, liquidity position and borrowing facilities are described in the Consolidated Financial Statements in NOTE 12 - Cash and Cash Equivalents, NOTE 20 - Borrowings and NOTE 22 - Financial Risk Management.
F-9


The Group’s forecasts and projections, taking account of reasonably possible changes in operating performance, including an assessment of the current macroeconomic environment, indicate that the Group should be able to operate within the level of its current facilities and related covenants.
Accordingly, the Group continues to adopt the going concern basis in preparing the Consolidated Financial Statements. This assessment was confirmed by the Board of Directors on March 9, 2023.
2.5 Presentation of the operating performance of each operating segment and of the Group
In accordance with IFRS 8 - Operating Segments, operating segments are based upon the product lines, markets and industries served, and are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The Chief Executive Officer, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the chief operating decision-maker.
The accounting principles used to prepare the Group’s operating segment information are the same as those used to prepare the Group’s Consolidated Financial Statements.
2.6 Principles governing the preparation of the Consolidated Financial Statements
Presentation of financial statements
The Consolidated Financial Statements are presented in millions of Euros, except as otherwise stated. Certain reclassifications may have been made to prior year amounts to conform to the current year presentation.
Basis of consolidation
These Consolidated Financial Statements include all the assets, liabilities, equity, revenues, expenses and cash flows of the Group's subsidiaries. All intercompany transactions and balances are eliminated.
Subsidiaries are entities over which the Group has control. The Group controls an entity when the Group has power over the entity, is exposed to, or has rights to variable returns from its involvement in the entity and has the ability to affect those returns through its power over the entity.
Subsidiaries are consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.
Investments over which the Group has joint control are accounted for either as joint ventures under the equity method or as joint arrangements in relation to its interest in the joint operation. Investments over which the Group has significant influence are accounted for under the equity method.
Joint venture investments are initially recorded at cost. They are subsequently increased or decreased by the Group’s share in the profit or loss, or by other movements reflected directly in the equity of the entity.
Business combinations
The Group applies the acquisition method to account for business combinations.
The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities assumed and the equity interests issued by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. The amount of non-controlling interests is determined for each business combination and is either based on the fair value (full goodwill method) or the present ownership instruments’ proportionate share in the recognized amounts of the acquiree’s identifiable net assets, resulting in recognition of only the share of goodwill attributable to equity holders of the parent (partial goodwill method).
Goodwill is initially measured as the excess of the aggregate of the consideration transferred and the amount of non-controlling interest over the net identifiable assets acquired and liabilities assumed. If this consideration is lower than the fair
F-10


value of the net assets of the subsidiary acquired, the difference is recognized as a gain in Other gains and losses - net in the Consolidated Income Statement.
At the acquisition date, the Group recognizes the identifiable acquired assets, liabilities and contingent liabilities (identifiable net assets) of the subsidiaries on the basis of fair value at the acquisition date. Recognized assets and liabilities may be adjusted during a maximum of 12 months from the acquisition date, depending on new information obtained about the facts and circumstances existing at the acquisition date.
Acquisition-related costs are expensed as incurred and are included in Other gains and losses - net in the Consolidated Income Statement.
Non-current Assets (and disposal groups) Held for Sale and Discontinued Operations
IFRS 5 “Non-current Assets Held For Sale and Discontinued Operations” defines a discontinued operation as a component of an entity that (i) generates cash flows that are largely independent from cash flows generated by other components, (ii) is held for sale or has been sold, and (iii) represents a separate major line of business or geographic areas of operations.
Assets and liabilities are classified as held for sale when their carrying amount will be recovered principally through a sale transaction rather than through continuing use. This condition is regarded as met only when the sale is highly probable and the non-current asset (or disposal group) is available for immediate sale in its present condition.
Assets and liabilities are stated at the lower of carrying amount and fair value less costs to sell if their carrying amount is to be recovered principally through a sale transaction rather than through continuing use.
Assets and liabilities held for sale are reflected in separate line items in the Consolidated Statement of Financial Position of the period during which the decision to sell is made.
The results of discontinued operations are shown separately in the Consolidated Income Statement.
Foreign currency transactions and foreign operations
Functional currency
Items included in the Consolidated Financial Statements of each of the entities and businesses of Constellium are measured using their functional currency, which is the currency of the primary economic environment in which they operate.
Foreign currency transactions
Transactions denominated in currencies other than the functional currency are recorded in the functional currency at the exchange rate in effect at the date of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the Consolidated Income Statement, except when deferred in Other Comprehensive Income ("OCI") as qualifying cash flow hedges or qualifying net investment hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in Finance costs - net. Realized foreign exchange gains and losses that relate to commercial transactions are presented in Cost of sales. All other foreign exchange gains and losses, including those that relate to foreign currency derivatives hedging commercial transactions where hedge accounting has not been applied, are presented within Other gains and losses - net.
Foreign operations: presentation currency and foreign currency translation
In the preparation of the Consolidated Financial Statements, the year-end balances of assets, liabilities and components of equity of Constellium’s entities and businesses are translated from their functional currencies into Euros, the presentation currency of the Group, at their respective year-end exchange rates. Revenue, expenses and cash flows of Constellium’s entities and businesses are translated from their functional currencies into Euros using their respective average exchange rates for the year. The net differences arising from exchange rate translation are recognized in OCI.
F-11


The following table summarizes the main exchange rates used for the preparation of the Consolidated Financial Statements:
Average ratesClosing rates
Foreign exchange rate for 1 EuroYear ended December 31,At December 31,
202220212020202220212020
U.S. DollarsUSD1.05071.18211.14051.06661.13261.2271
Swiss FrancsCHF1.00381.08081.07040.98471.03311.0802
Czech KorunaCZK24.563325.636626.433724.116024.858026.2420
Revenue from contracts with customers
Revenue is recognized in an amount that reflects the consideration to which the Group expects to be entitled in exchange for transferring goods or services to a customer.
The Group primarily contracts with customers for the sale of rolled or extruded aluminium products. For the majority of our business, performance obligations with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near-term. These purchase orders are short-term in nature, although they may be governed by multi-year frame agreements.
Revenue from product sales, measured at the fair value of the consideration received or receivable, is recognized at a point in time when control of the asset is transferred to the customer, generally upon delivery. In certain limited circumstances, the Group may be required to recognize revenue over time for products that have no alternative use and for which the Group has an enforceable right to payment for production completed to date.
Revenue from product sales, net of trade discounts, allowances and volume-based incentives, is recognized for the amount the Group expects to be entitled to, generally upon delivery, and provided that control has transferred.
Contract liabilities consist of expected volume discounts, rebates, incentives, refunds, penalties and price concessions. Contract liabilities are presented in Trade payables and other.
The Group applies the practical expedient for disclosures on performance obligations that are part of contracts that have an original duration of one year or less.
The Group elected the practical expedient on significant financing components when the period of transfer of the product and the payment is one year or less.
Research and development costs
Costs incurred on development projects are recognized as intangible assets when the following criteria are met:
It is technically feasible to complete the intangible asset so that it will be available for use;
Management intends to complete and use the intangible asset;
There is an ability to use the intangible asset;
It can be demonstrated how the intangible asset will generate probable future economic benefits;
Adequate technical, financial and other resources to complete the development and use or sell the intangible asset are available; and
The expenditure attributable to the intangible asset during its development can be reliably measured.
Development expenditures that do not meet these criteria are expensed as incurred. Development costs previously recognized as expenses cannot be recognized as an asset in a subsequent period.
Other gains and losses - net
Other gains and losses - net includes: (i) realized and unrealized gains and losses for commodity derivatives and foreign exchange derivatives contracted for commercial purposes to which hedge accounting is not applied (ii) unrealized exchange gains and losses from the remeasurement of monetary assets and liabilities, (iii) the ineffective portion of changes in the fair value of derivatives designated for hedge accounting and (iv) impairment charges on assets.
F-12


Other gains and losses - net also includes other unusual, infrequent or non-recurring items. Such items are disclosed by virtue of their size, nature or incidence. In determining whether an event or transaction is unusual, infrequent or non-recurring, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence.
Interest income and expense
Interest expense on short and long-term financing is recorded at the relevant rates on the various borrowing agreements using the effective interest rate method.
Borrowing costs, including interest, incurred for the construction of any qualifying asset are capitalized during the period of time required to complete and prepare the asset for its intended use.
Cash and cash equivalents
Cash and cash equivalents are comprised of cash in bank accounts and on hand, short-term deposits held on call with banks and other short-term highly liquid investments with original maturities of three months or less that are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value, less bank overdrafts that are repayable on demand, provided there is an offset right.
Trade account receivables
Recognition and measurement
Trade account receivables are recognized at fair value through OCI since they are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to factors. The group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables and contract assets.
Factoring arrangements
In factoring arrangements under which the Group has transferred substantially all the risks and rewards of ownership of the receivables, the receivables are derecognized from the Consolidated Statement of Financial Position. In determining whether the Group has transferred substantially all the risks and rewards of ownership, it considers credit risk, late-payment risk, dilution risk, foreign exchange risk and tax risk. Arrangements in which the Group derecognizes receivables result in changes in trade receivables, which are reflected as cash flows from operating activities. When trade account receivables are sold with limited recourse and substantially all the risks and rewards associated with these receivables are not transferred, receivables are not derecognized. Where the Group does not derecognize the receivables, the cash received from the factor is classified as a financing cash inflow, the settlement of the receivables as an operating cash inflow and the repayment to the factor as a financing cash outflow.
Inventories
Inventories are valued at the lower of cost and net realizable value, primarily on a weighted-average cost basis.
Weighted-average cost for raw materials, stores, work in progress and finished goods is calculated using the costs experienced in the current period based on normal operating capacity and includes the purchase price of materials, freight, duties and customs, and the costs of production, which includes labor, materials and other costs that are directly attributable to the production process and production overheads.
Financial Instruments
i.Classification and measurement
Financial assets
At initial recognition, financial assets are classified either: (a) at amortized cost, (b) at fair value through other comprehensive income (FVOCI), or (c) at fair value through profit or loss (FVPL). The classification depends on the financial asset’s contractual cash flow characteristics and the Group’s business model for managing the financial assets.
F-13


i.Assets at amortized cost are comprised of other receivables, non-current loans receivable and current loans receivable in the Consolidated Statement of Financial Position. The business model objective is to hold assets in order to collect contractual cash flows provided they give rise to cash flows that are ‘solely payments of principal and interest’ on the principal amount outstanding. They are carried at amortized cost using the effective interest rate method, less any impairment. They are classified as current or non-current assets based on their maturity date.
ii.Assets at fair value through OCI are comprised of trade receivables in the Consolidated Statement of Financial Position. The business model objective is to maintain liquidity for the Group, should the need arise, which leads to sales through factoring agreements that are more than infrequent and significant in value. Trade receivables are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to the factors. The portfolio of trade receivables is therefore classified as measured at fair value through OCI. Upon derecognition, the cumulative fair value change recognized in OCI is reclassified to profit or loss. Foreign exchange revaluation and impairment losses or reversals are recognized in profit or loss and computed in the same manner as for financial assets measured at amortized cost. The remaining fair value changes are recognized in OCI. These assets are classified as current or non-current assets based on their maturity date.
iii.Assets at fair value through profit or loss are comprised of derivatives except those designated as hedging instruments that qualify for hedge accounting in accordance with IAS 39 - Financial Instruments which are classified as assets at fair value through OCI. Financial assets carried at fair value through profit or loss are initially recognized at fair value and transaction costs are expensed in the Consolidated Income Statement.
Financial liabilities
Borrowings and other financial liabilities, excluding derivative liabilities, are recognized initially at fair value, net of transaction costs incurred and directly attributable to the issuance of the liability. These financial liabilities are subsequently measured at amortized cost using the effective interest rate method. Any difference between the amounts originally received, net of transaction costs, and the redemption value is recognized in the Consolidated Income Statement using the effective interest rate method.
ii.Impairment of financial assets
Financial assets subject to IFRS 9’s expected credit loss model are cash and cash equivalents, trade receivables and other and loans to joint ventures.
iii.Offsetting financial instruments
Financial assets and liabilities are offset and the net amount is reported in the Consolidated Statement of Financial Position when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously.
Derivative financial instruments
Derivatives
The Group uses derivative financial instruments, such as forward currency contracts, interest rate swaps and forward commodity contracts, to hedge its foreign currency risks, interest rate risks and commodity price risks, respectively.
Derivatives are carried as financial assets when the fair value is positive and as financial liabilities when the fair value is negative.
Fair value is the price expected to be received in selling an asset or paid in transferring a liability in an orderly transaction between market participants at the measurement date. Where available, relevant market prices are used to determine fair values. The Group periodically estimates the impact of credit risk on its derivative instruments aggregated by counterparties and takes this into account when estimating the fair value of its derivatives.
Credit Value Adjustments are calculated for asset derivatives based on the counterparties’ credit risk. Debit Value Adjustments are calculated for credit derivatives based on Constellium’s own credit risk. The fair value method used is based on the historical probability of default, provided by leading rating agencies.
F-14


Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently re-measured to their fair value at the end of each reporting period.
The accounting for subsequent changes in fair value depends on whether the derivative qualifies for hedge accounting treatment. For derivative instruments that do not qualify for hedge accounting, changes in the fair value are recognized immediately in profit or loss and are included in Other gains and losses - net or Finance costs, net depending on the nature of the underlying exposure. For derivatives that qualify for hedge accounting, changes in the fair value are recognized in OCI.
Hedge accounting
The Group did not adopt the disposition of IFRS 9 - Financial Instruments on hedging and will therefore continue to apply the provisions of IAS 39 - Financial Instruments. For derivative instruments that are designated for hedge accounting, at the inception of the hedging transaction, the group documents the relationship between hedging instruments and hedged items, the risk management objective and the strategy for undertaking the hedge transaction. The group also documents its assessment, both at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions have been and will continue to be highly effective in offsetting changes in cash flows of hedged items.
The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized in OCI and accumulated in equity. The gain or loss relating to the ineffective portion is recognized immediately in the Consolidated Income Statement in Other gains and losses - net.
Amounts accumulated in equity are reclassified to the Consolidated Income Statement when the hedged item affects the Consolidated Income Statement. The gain or loss relating to the effective portion of derivative instruments hedging forecasted cash flows under customer agreements is recognized in Revenue. When the forecasted transaction that is hedged results in the recognition of a non-financial asset, the gains and losses previously deferred in equity are reclassified from equity and included in the initial measurement of the cost of the asset. The deferred amounts would ultimately be recognized in the Consolidated Income Statement upon the sale, depreciation or impairment of the asset.
When a hedging instrument expires or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, any cumulative gain or loss existing in equity at that time remains in equity and is recognized when the forecasted transaction is ultimately recognized in the Consolidated Income Statement. When a forecasted transaction is no longer expected to occur, the cumulative gain or loss that was recognized in equity is immediately reclassified to the Consolidated Income Statement.
Property, plant and equipment
Recognition and measurement
Property, plant and equipment acquired by the Company are recorded at cost, which comprises the purchase price, including import duties and non-refundable purchase taxes, any costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management and the estimated close down and restoration costs associated with the asset. Borrowing costs, including interest, directly attributable to the acquisition or construction of property, plant and equipment are included in the cost. Subsequent to the initial recognition, Property, plant and equipment are measured at cost less accumulated depreciation and impairment, if any. Costs are capitalized into construction work-in-progress until projects are completed and the assets are available for use.
Subsequent costs
Enhancements and replacements are capitalized as additions to Property, plant and equipment only when it is probable that future economic benefits associated with them will flow to the Company and their cost can be measured with reliability. Ongoing regular maintenance costs related to Property, plant and equipment are expensed as incurred.
Depreciation
Land is not depreciated. Property, plant and equipment are depreciated over the estimated useful lives of the related assets using the straight-line method as follows:
Buildings: 1050 years;
Machinery and equipment: 340 years;
F-15


Vehicles: 58 years.
Government Grants
Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions are complied with.
Government grants relating to the purchase of property, plant and equipment reduce the carrying amount of the asset. They are credited to profit or loss on a straight-line basis over the expected useful lives of the related assets. Government grants relating to costs offset the corresponding expense and are deferred and recognized in profit or loss over the period necessary to match them with the costs that they are intended to compensate.
Intangible assets
Recognition and measurement
Technology and customer relationships acquired in a business combination are recognized at fair value at the acquisition date. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and impairment losses. The useful lives of the Group intangible assets are assessed to be finite.
Amortization
Intangible assets are amortized over the estimated useful lives of the related assets using the straight-line method as follows:
Technology: 20 years;
Customer relationships: 25 years;
Software: 35 years.
Goodwill
Goodwill arising from a business combination is carried at cost as established at the date of the business combination less accumulated impairment losses, if any.
Goodwill is allocated at the operating segment levels, which are the groups of cash-generating units that are expected to benefit from the synergies of the combination. The operating segments represent the lowest level within the Group at which goodwill is monitored for internal management purposes.
Gains and losses on the disposal of a cash-generating unit include the carrying amount of goodwill relating to the cash-generating unit sold.
Impairment
Impairment of property, plant and equipment and intangible assets
Property, plant and equipment and intangible assets subject to amortization are reviewed for impairment if there is any indication that the carrying amount of the asset, or cash-generating unit to which it belongs, may not be recoverable. The recoverable amount is based on the higher of fair value less cost of disposal and value in use, as determined using estimates of discounted future net cash flows of the asset or group of assets to which it belongs.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement.
Impairment of goodwill
Groups of cash-generating units to which goodwill is allocated are tested for impairment annually, or more frequently when there is an indication that allocated goodwill may be impaired.
The net carrying value of a group of cash-generating units is compared to their recoverable amounts, which is the higher of the value in use and the fair value less costs of disposal.
F-16


Value in use calculations use cash flow projections based on financial budgets approved by management and usually covering a 5-year period. Cash flows beyond this period are estimated using a perpetual long-term growth rate for the subsequent years.
The value in use is the sum of the discounted cash flows over the projected period and the terminal value. Discount rates are determined based on the weighted-average cost of capital of each operating segment.
The fair value is the price that would be received for the group of cash-generating units, in an orderly transaction, from a market participant. This value is estimated on the basis of available and relevant market data or a discounted cash flow model reflecting market participant assumptions.
An impairment loss is recognized for the amount by which the group of units carrying amount exceeds its recoverable amount.
Any impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the group of cash-generating units and then to the other assets of the group of units pro rata on the basis of the carrying amount of each asset in the group of units.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement. An impairment loss recognized for goodwill cannot be reversed in subsequent years.
Cash-generating units
The reporting units, which generally correspond to industrial sites, are the lowest level of independent cash flows and have been identified as cash-generating units.
Taxation
Income tax (expense) / benefit is calculated on the basis of the tax laws enacted or substantively enacted at the Consolidated Statement of Financial Position date in the countries where the Company and its subsidiaries operate and generate taxable income.
The Group is subject to income taxes in France, the United States, Germany and numerous other jurisdictions. Certain of Constellium’s businesses may be included in tax returns in some jurisdictions. In certain circumstances, these businesses may be jointly and severally liable with the entity filing the consolidated return, for additional taxes that may be assessed.
Deferred income tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the Consolidated Financial Statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income tax assets are also recognized for operating loss carryforwards and tax credit carryforwards.
Deferred income tax assets and liabilities are measured using tax rates that are expected to apply in the year when the asset is realized or the liability is settled. Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.
Trade payables
Trade payables are initially recorded at fair value and are subsequently measured at amortized cost. Trade payables are classified as current liabilities if payment is due in one year or less.
Leases
Right-of-use assets
The Group recognizes right-of-use assets at the commencement date of the lease. Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and are adjusted for remeasurement of lease liabilities resulting from a change in future lease payments arising from a change in an index or a rate, or a change in the assessment of whether the purchase, extension or termination options will be exercised.
F-17


The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are recorded in the asset category to which they relate in Property, plant and equipment. Unless the Group is reasonably certain to obtain ownership of the leased assets at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of their estimated useful life and the lease term. Right-of-use assets are subject to impairment.
Lease liabilities
At the commencement date of the lease, the Group recognizes a lease liability measured at the present value of lease payments to be made over the lease term.
In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension or termination option. Extension options or periods after termination options are only included in the lease term if the lease is reasonably certain to be extended or not terminated.
The lease payments include fixed payments less any lease incentive receivables, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating a lease, if the lease term reflects the Group exercising the option to terminate. Lease liabilities are presented within Borrowings. Variable lease payments that do not depend on an index or a rate are recognized as expense in the period in which the event or condition that triggers the payment occurs.
In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the implicit interest rate in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced by the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, or a change in the assessment to purchase the underlying asset.
Short-term leases and leases of low-value assets
The Group applies the short-term lease recognition exemption to leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option. The Group also applies the low-value asset recognition exemption to leases of assets with a value below €5,000. Lease payments on short-term leases and low-value asset leases are recognized as expense on a straight-line basis over the lease term.
The Group also applies the practical expedients for lease and non-lease components as a single component for vehicles.
Provisions
Provisions are recorded at the best estimate of expenditures required to settle liabilities of uncertain timing or amount when management determines that i) a legal or constructive obligation exists as a result of past events, ii) it is probable that an outflow of resources will be required to settle the obligation and iii) such amounts can be reasonably estimated. Provisions are measured at the present value of the expected expenditures required to settle the obligation.
The ultimate cost to settle such liabilities is uncertain, and cost estimates can vary in response to many factors. The settlement of these liabilities could materially differ from recorded amounts or the expected timing of expenditure could change. As a result, there could be significant adjustments to provisions, which could result in additional charges or recoveries.
Close down and restoration costs
Estimated close down and restoration costs are accounted for in the year when the legal or constructive obligation arising from the related disturbance occurs and it is probable that an outflow of resources will be required to settle the obligation. These costs are based on the net present value of estimated future costs. Provisions for close down and restoration costs do not include any additional obligations expected to arise from future disturbance. The costs are estimated on the basis of a closure plan including feasibility and engineering studies, are updated annually during the life of the operation to reflect known developments (e.g. revisions to cost estimates and to the estimated lives of operations) and are subject to formal review at regular intervals each year.
F-18


The initial closure provision together with subsequent movements in the provisions for close down and restoration costs, including those resulting from new disturbance, updated cost estimates, changes to the estimated lives of operations and revisions to discount rates, are capitalized in Property, plant and equipment. These costs are depreciated over the remaining useful lives of the related assets. The amortization or unwinding of the discount applied in establishing the net present value of the provisions is recorded in the Consolidated Income Statement as a finance cost.
Environmental remediation costs
Environmental remediation costs are accounted for based on the estimated present value of the costs of the Group’s environmental clean-up obligations. Changes in the environmental remediation provisions are recorded in Cost of sales.
Restructuring costs
Provisions for restructuring are recorded when Constellium’s management is demonstrably committed to the restructuring plan and the liabilities can be reasonably estimated. The Group recognizes liabilities that primarily include one-time termination benefits, severance, and contract termination costs, primarily related to equipment and facility lease obligations. These amounts are based on the remaining amounts due under various contractual agreements and are periodically adjusted for changes in circumstances that would reduce or increase these obligations.
Legal, tax and other potential claims
Provisions for legal claims are made when it is probable that liabilities will be incurred and when such liabilities can be reasonably estimated. For asserted claims and assessments, liabilities are recorded when an unfavorable outcome of a matter is deemed to be probable and the loss is reasonably estimable. Management determines the likelihood of an unfavorable outcome based on many factors such as the nature of the matter, available defenses and case strategy, progress of the matter, views and opinions of legal counsel and other advisors, applicability and success of appeals, process and outcomes of similar historical matters, amongst others. Once an unfavorable outcome is considered probable, management weighs the probability of possible outcomes and the most likely loss is recorded. Legal matters are reviewed on a regular basis to determine if there have been changes in management’s judgment regarding the likelihood of an unfavorable outcome or the estimate of a potential loss. Depending on their nature, these costs may be recorded in Cost of sales or Other gains and losses - net in the Consolidated Income Statement. Included in other potential claims are provisions for product warranties and guarantees to settle the net present value portion of any settlement costs for potential future legal actions, claims and other assertions that may be brought by Constellium’s customers or the end-users of products. Provisions for product warranty and guarantees are recorded in Cost of sales in the Consolidated Income Statement.
Management establishes tax reserves and accrues interest thereon, if deemed appropriate, in expectation that certain tax positions other than income tax may be challenged and that the Group might not succeed in defending such positions.
Pension, other post-employment plans and other long-term employee benefits
For defined contribution plans, the contribution paid in respect of service rendered over the service year is recognized in the Consolidated Income Statement. This expense is included in Income / (loss) from operations.
For defined benefit plans, the retirement benefit obligation recognized in the Consolidated Statement of Financial Position represents the present value of the defined benefit obligation less the fair value of plan assets. The defined benefit obligations are assessed using the projected unit credit method. The most significant assumption is the discount rate. The amount recorded in the Consolidated Income Statement in respect of these plans is included within Income / (loss) from operations except for net interest costs, which are included in Finance costs - net. The effects of changes in actuarial assumptions and experience adjustments are presented in the Consolidated Statement of Comprehensive Income.
Other post-employment benefit plans mainly relate to health and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents. Eligibility for coverage is dependent upon certain age and service criteria. These benefit plans are unfunded and are accounted for as defined benefit obligations, as described above.
Other long-term employee benefits mainly include jubilees and other long-term disability benefits. For these plans, actuarial gains and losses are recognized immediately in the Consolidated Income Statement.

F-19


Share capital
Ordinary shares are classified as equity. Costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Share-based payment arrangements
Equity-settled share-based payments to employees and Board members are measured at the fair value of the equity instruments at the grant date.
The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the Group’s estimate of equity instruments that will eventually vest, with a corresponding increase in equity. At the end of each reporting period, the Group revises its estimate of the number of equity instruments expected to vest.
2.7 Judgments in applying accounting policies and key sources of estimation uncertainty
The preparation of the Group’s consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures, and the disclosure of contingent liabilities. These judgments, estimates and assumptions are based on management’s best knowledge of the relevant facts and circumstances, giving consideration to previous experience. However, actual results may differ from the amounts included in the Consolidated Financial Statements. Key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year include the items presented below. The Group continuously reviews its significant assumptions and estimates in light of the uncertainty associated with the global geopolitical and macroeconomic conditions, including the ongoing armed conflict in Ukraine and the COVID-19 pandemic and their potential direct and indirect impacts on its business and its financial statements, as detailed in NOTE 4 - Operating Segment Information, NOTE 15 - Property, Plant and Equipment, NOTE 20 - Borrowings, NOTE 22 - Financial Risk Management, NOTE 24 - Provisions and NOTE 27 - COVID-19-related Government assistance. However, there remains significant uncertainty with respect to the duration and severity of these crises and their potential impacts on the global economy and our business, and there can be no guarantee that our assumptions will materialize or that actual results will not differ materially from estimates.
Impairment tests for goodwill, intangible assets and property, plant and equipment
The determination of fair value and value in use of cash-generating units or groups of cash-generating units depends on a number of assumptions, in particular market data, estimated future cash flows and discount rates.
The Group assesses where climate risks could have a significant impact, such as the introduction of emission-reduction legislation that may increase manufacturing costs. The Group constantly monitors the latest government legislation in relation to climate-related matters. At the current time, no legislation has been passed that will impact the Group. The Group will adjust the assumptions used in value-in-use calculations and sensitivity to changes in assumptions should a change be required.
These assumptions are subject to risk and uncertainty. Any material changes in these assumptions could result in a significant change in a cash-generating units’ recoverable value or in a goodwill impairment. Details of the key assumptions made and judgments applied are set out in NOTE 15 - Property, Plant and Equipment and in NOTE 16 - Intangible Assets and Goodwill.
Income Taxes
Significant judgment is sometimes required in determining the accrual for income taxes as there are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Group recognizes liabilities based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were recorded, such differences will impact the current and deferred income tax provisions, results of operations and possibly cash flows in the year in which such determination is made.
Significant judgment is also required to determine the extent to which deferred tax assets can be recognized. In assessing the recognition of deferred tax assets, management considers whether it is more likely than not that the deferred tax assets will be utilized. The deferred tax assets will be ultimately utilized to the extent that sufficient taxable profits will be available in the years in which the temporary differences become deductible. This assessment is conducted through a detailed review of deferred tax assets by jurisdiction and takes into account the scheduled reversals of taxable and deductible temporary
F-20


differences, past, current and expected future performance deriving from the budget, the business plan and tax planning strategies. Deferred tax assets are not recognized in the jurisdictions where it is less likely than not that sufficient taxable profits will be available against which the deductible temporary differences can be utilized. Details of the key assumptions made and judgments applied are set out in NOTE 17 - Deferred Income Taxes.
Provisions
Provisions have been recorded for: (i) close down and restoration costs; (ii) environmental remediation and monitoring costs; (iii) restructuring plans; (iv) legal and other potential claims including provisions for tax risks other than income tax, product warranty and guarantees. These provisions are recorded at amounts which represent management’s best estimates of the expenditure required to settle the obligation at the date of the Consolidated Statement of Financial Position. Expectations are revised each year until the actual liability is settled, with any difference accounted for in the Consolidated Income Statement in the year in which the revision is made. Details of the key assumptions made and judgments applied are described in NOTE 24 - Provisions.
Pension, other post-employment benefits and other long-term employee benefits
The present value of the defined benefit obligations depends on a number of factors that are determined on an actuarial basis using a number of assumptions and its determination requires the application of judgment. Assumptions used and judgments made in determining the defined benefit obligations and net pension costs include discount rates, rates of future compensation increase, and the criteria considered to determine when a plan amendment has occurred.
Any material changes in these assumptions could result in a significant change in Pensions and other post-employment benefit obligations and in employee benefit expenses recognized in the Consolidated Income Statement or actuarial gains and losses recognized in OCI. Details of the key assumptions made and judgments applied are set out in NOTE 23 - Pensions and Other Post-Employment Benefit Obligations.
F-21


NOTE 3 - REVENUE
Year ended December 31,
(in millions of Euros)202220212020
Packaging rolled products3,3262,6731,960
Automotive rolled products1,154854663
Specialty and other thin-rolled products175161102
Aerospace rolled products728389560
Transportation, industry, defense and other rolled products916713442
Automotive extruded products949735665
Other extruded products872627491
Total Revenue by product line8,1206,1524,883
Year ended December 31,
(in millions of Euros)202220212020
Germany2,0361,4811,014
France691466362
United Kingdom221179192
Switzerland876352
Spain302252185
Czech Republic237172119
Other Europe1,110809619
Total Europe4,6843,4222,543
United States2,8232,3351,941
Asia and Other Pacific252171211
All Other361224188
Total Revenue by destination of shipment8,1206,1524,883
Revenue is recognized at a point in time, except for certain products with no alternative use for which we have a right to payment, which represent less than 1% of total revenue.
F-22


NOTE 4 - OPERATING SEGMENT INFORMATION
Packaging and Automotive Rolled Products (P&ARP)
P&ARP supplies thin-gauge rolled aluminium products to the packaging market with canstock and closure stock for the beverage and food industry, foil stock for the flexible packaging market and to the automotive market with a number of technically sophisticated applications, such as automotive body sheet and heat exchanger materials. P&ARP operates four facilities in three countries and had approximately 4,100 employees at December 31, 2022.
Aerospace and Transportation (A&T)
A&T supplies thick-gauge rolled aluminium products and very limited volumes of extruded products to the aerospace market, as well as thick-gauge rolled products for transportation, industry and defense end-uses. A&T operates six facilities in three countries and had approximately 3,500 employees at December 31, 2022.
Automotive Structures and Industry (AS&I)
AS&I supplies hard and soft aluminium alloy extruded profiles for a range of high demand industry applications in the automotive, engineering, rail and other transportation end markets, and technologically advanced structural components to the automotive industry. AS&I operates nineteen facilities in ten countries and had approximately 4,500 employees at December 31, 2022.
Holdings & Corporate (H&C)
Holdings & Corporate includes the costs of our corporate support functions and our technology centers.
Intersegment elimination
Intersegment transactions are conducted on an arm’s length basis and reflect market prices.
4.1 Segment Revenue
Year ended December 31,
202220212020
(in millions of Euros)Segment revenueInter-segment eliminationExternal revenueSegment revenueInter-segment eliminationExternal revenueSegment revenueInter-segment eliminationExternal revenue
P&ARP4,664(9)4,6553,698(10)3,6882,734(9)2,725
A&T1,700(55)1,6451,142(40)1,1021,025(23)1,002
AS&I1,861(41)1,8201,383(21)1,3621,167(11)1,156
Total8,225(105)8,1206,223(71)6,1524,926(43)4,883
4.2 Segment Adjusted EBITDA and reconciliation of Adjusted EBITDA to Net Income
Constellium’s chief operating decision-maker measures the profitability and financial performance of its operating segments based on Adjusted EBITDA. Adjusted EBITDA is defined as income / (loss) from continuing operations before income taxes, results from joint ventures, net finance costs, other expenses and depreciation, amortization as adjusted to exclude restructuring costs, impairment charges, unrealized gains or losses on derivatives and on foreign exchange differences on transactions that do not qualify for hedge accounting, metal price lag, share-based compensation expense, effects of certain purchase accounting adjustments, start-up and development costs or acquisition, integration and separation costs, certain incremental costs and other exceptional, unusual or generally non-recurring items.
F-23


Year ended December 31,
(in millions of Euros)Notes202220212020
P&ARP 326344291
A&T 217111106
AS&I 14914288
H&C (19)(16)(20)
Adjusted EBITDA 673581465
Metal price lag (A)(29)187(8)
Start-up and development costs (B)(5)
Share based compensation costs 30(18)(15)(15)
Gains / (losses) on pension plan amendments (C)2347(32)(2)
Depreciation and amortization 15, 16(287)(267)(259)
Impairment of assets 15, 16(43)
Restructuring costs 8(1)(3)(13)
Unrealized (losses) / gains on derivatives (46)3516
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net 8(1)11
Losses on disposal 8(4)(3)(4)
Other (D)(8)
Income from operations334484125
Finance costs - net10(131)(167)(159)
Income / (loss) before tax203317(34)
Income tax benefit / (expense)11105(55)17
Net income / (loss)308262(17)
(A)Metal price lag represents the financial impact of the timing difference between when aluminium prices included within Constellium's Revenue are established and when aluminium purchase prices included in Cost of sales are established. The Group accounts for inventory using a weighted average price basis and this adjustment aims to remove the effect of volatility in LME prices. The calculation of the Group metal price lag adjustment is based on an internal standardized methodology calculated at each of Constellium’s manufacturing sites and is primarily calculated as the average value of product recorded in inventory, which approximates the spot price in the market, less the average value transferred out of inventory, which is the weighted average of the metal element of cost of sales, based on the quantity sold in the year.
(B)Start-up and development costs, for the year ended December 31, 2020, was related to new projects in our AS&I operating segment.
(C)In the year ended December 31, 2022 the group recognized a net gain of €47 million from past service cost as a result from a new 3-year collective bargaining agreement between Constellium Rolled Products Ravenswood and the United Steelworkers Local Union 5668 entered in October 2022. The agreement resulted in changes in OPEB and pension benefits that were accounted for as a plan amendment in the year ended December 31, 2022. (see Note 23.6 Ravenswood plan amendment).
In the year ended December 31, 2021, the group recognized a loss of €31 million from past service cost following an adverse decision of the Fourth Circuit Court in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network. (see Note 23.7 Ravenswood OPEB dispute).
(D)Other, for the year ended December 31, 2020, included €2 million of procurement penalties and termination fees incurred because of the Groups inability to fulfill certain commitments due to the COVID-19 pandemic and a €6 million loss resulting from the discontinuation of hedge accounting for certain forecasted sales that were determined to be no longer expected to occur in light of the COVID-19 pandemic effects.
F-24


4.3 Segment capital expenditures
Year ended December 31,
(in millions of Euros)202220212020
P&ARP(127)(94)(73)
A&T(78)(70)(45)
AS&I(62)(62)(61)
H&C(6)(6)(3)
Capital expenditures(273)(232)(182)
4.4 Segment assets
At December 31,
(in millions of Euros)20222021
P&ARP2,1872,108
A&T1,081948
AS&I727738
H&C456451
Segment assets4,4514,245
Deferred income tax assets271162
Cash and cash equivalents166147
Other financial assets3970
Assets of disposal group classified as held for sale14
Total Assets4,9414,624
4.5 Information about major customers
Revenue in the P&ARP segment from sales to the Group’s largest customer, which we serve through a number of contracts across our sites, was €839 million, €692 million and €492 million for the years ended December 31, 2022, 2021 and 2020, respectively. No other single customer contributed 10% or more to the Group’s revenue for 2022, 2021 and 2020.
NOTE 5 - INFORMATION BY GEOGRAPHIC AREA
Property, plant and equipment are reported based on the physical location of the assets:
At December 31,
(in millions of Euros)20222021
United States832811
France699653
Germany269266
Czech Republic9799
Other120119
Total2,0171,948
F-25


NOTE 6 - EXPENSES BY NATURE
Year ended December 31,
(in millions of Euros)202220212020
Raw materials and consumables used(5,545)(3,885)(2,832)
Employee benefit expenses(1,110)(967)(902)
Energy costs(274)(149)(141)
Sub-contractors(125)(102)(89)
Freight out costs(163)(143)(122)
Professional fees(81)(63)(73)
Lease expenses(15)(12)(11)
Depreciation and amortization(287)(267)(259)
Other operating expenses(178)(197)(240)
Other gains and losses - net(8)117(89)
Total operating expenses(7,786)(5,668)(4,758)
NOTE 7 - EMPLOYEE BENEFIT EXPENSES
Year ended December 31,
(in millions of Euros)Notes202220212020
Wages and salaries(1,067)(920)(855)
Pension costs - defined benefit plans23(22)(24)(23)
Other post-employment benefits23(3)(8)(9)
Share-based compensation30(18)(15)(15)
Total employee benefit expenses(1,110)(967)(902)
NOTE 8 - OTHER GAINS AND LOSSES - NET
Year ended December 31,
(in millions of Euros)Notes202220212020
Realized (losses) / gains on derivatives (A)(6)113(35)
Losses reclassified from OCI as a result of hedge accounting discontinuation (B)(6)
Unrealized (losses) / gains on derivatives at fair value through profit and loss - net (A)(47)3916
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net (1)11
Impairment of assets (C)15, 16(43)
Restructuring costs (D)24(1)(3)(13)
Gains / (losses) on pension plan amendments (E)2347(32)(2)
Losses on disposal (4)(3)(4)
Other 42(3)
Total other gains and losses - net (8)117(89)
(A)Realized and unrealized gains and losses are related to derivatives entered into with the purpose of mitigating exposure to volatility in foreign currencies and commodity prices and that do not qualify for hedge accounting.
(B)In the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for 2020 and 2021, to which hedge accounting was applied, were no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted in a €6 million loss.
F-26


(C)In the year ended December 31, 2020, an impairment charge of €43 million was recognized for certain A&T cash-generating units due to the downturn in the aerospace industry resulting from the COVID-19 pandemic and for certain AS&I cash-generating units as a result of the review of their long-term business perspectives.
(D)For the years ended December 31, 2021 and 2020, restructuring costs amounted to €3 million and €13 million, respectively, and related to headcount reductions in Europe and in the U.S.
(E)In the year ended December 31, 2022 the group recognized a net gain of €47 million from past service cost as a result from a new 3-year collective bargaining agreement between Constellium Rolled Products Ravenswood and the United Steelworkers Local Union 5668 entered in October 2022. The agreement resulted in changes in OPEB and pension benefits that were accounted for as a plan amendment in the year ended December 31, 2022 (see Note 23.6 Ravenswood plan amendment).
In the year ended December 31, 2021, the group recognized a loss of €31 million from past service cost following an adverse decision of the Fourth Circuit Court in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network (see Note 23.7 Ravenswood OPEB dispute).
NOTE 9 - CURRENCY GAINS / (LOSSES)
Year ended December 31,
(in millions of Euros)Notes202220212020
Included in Revenue22(8)(4)(6)
Included in Cost of sales21(2)
Included in Other gains and losses - net516(19)
Total(1)13(27)
Realized exchange losses on foreign currency derivatives - net22(8)(1)(11)
Losses reclassified from OCI as a result of hedge accounting discontinuation22(6)
Unrealized gains / (losses) on foreign currency derivatives - net22613(8)
Exchange gains / (losses) from the remeasurement of monetary assets and liabilities - net11(2)
Total(1)13(27)
See NOTE 21 - Financial Instruments and NOTE 22 - Financial Risk Management for further information regarding the Company’s foreign currency derivatives and hedging activities.
Foreign currency translation reserve
At December 31,
(in millions of Euros)20222021
Foreign currency translation reserve at January 1,19(13)
Effect of currency translation differences2232
Foreign currency translation reserve at December 31,4119
F-27


NOTE 10 - FINANCE COSTS - NET
Year ended December 31,
(in millions of Euros)202220212020
Interest expense on borrowings (A)(91)(103)(122)
Interest expense on leases (10)(14)(10)
Interest cost on pension and other benefits (11)(9)(11)
Expenses on factoring arrangements (15)(9)(10)
Net loss on settlement of debt (B)(27)
Realized and unrealized gains / (losses) on debt derivatives at fair value (C)110(32)
Realized and unrealized exchange (losses) / gains on financing activities - net (C)(1)(10)37
Other finance expenses (5)(6)(12)
Capitalized borrowing costs (D)111
Finance expenses (131)(167)(159)
Finance costs - net (131)(167)(159)
(A)For the year ended December 31, 2022, interest expense on borrowings included €79 million of interest and €4 million of amortization of arrangement fees related to Constellium SE Senior Notes. For the year ended December 31, 2021, it included €92 million of interest and €4 million of amortization of arrangement fees related to Constellium SE Senior Notes.
(B)In February 2021, Constellium SE tendered and redeemed its $650 million 6.625% Senior Notes due 2025. The net loss on the settlement of debt included redemption fees of €9 million and the write-off of the outstanding deferred arrangement fees at the date of redemption of €8 million.
In June 2021, Constellium SE redeemed its $400 million 5.750% Senior Notes due 2024. The net loss on the settlement of debt included redemption fees of €3 million and the write-off of the outstanding deferred arrangement fees at the date of redemption of €3 million.
In November 2021, Constellium SE redeemed $200 million of the $500 million outstanding aggregate principal amount of the 5.875% Senior Notes due 2026. The net loss on the settlement of debt included redemption fees of €3 million and the write-off of the deferred arrangement fees attributable to the portion redeemed at the date of redemption of €1 million.
(C)     The Group hedges the dollar exposure, relating to the principal of its Constellium SE U.S. Dollar Senior Notes, for the portion that has not been used to finance directly or indirectly U.S. Dollar functional currency entities. Changes in the fair value of these hedging derivatives are recognized within Finance costs – net in the Consolidated Income Statement.
(D)     Borrowing costs directly attributable to the construction of assets are capitalized. The capitalization rate was 5% for the years ended December 31, 2022 and 2021 and 6% for the year ended December 31, 2020.
NOTE 11 - INCOME TAX
Year ended December 31,
(in millions of Euros)202220212020
Current tax expense (22)(26)(14)
Deferred tax benefit / (expense) 127(29)31
Income tax benefit / (expense)105(55)17
F-28


The Group’s effective tax rate reconciliation is as follows:
Year ended December 31,
(in millions of Euros)202220212020
Income / (loss) before tax 203317(34)
Statutory tax rate applicable to the parent company 25.8%28.4%32.0%
Income tax (expense) / benefit calculated at statutory tax rate (52)(90)11
Effect of foreign tax rate (A)3152
Changes in recognized and unrecognized deferred tax assets (B)1542415
Other (4)(11)
Income tax benefit / (expense) 105(55)17
Effective income tax rate (52)%17%49%
(A)For the years ended December 31, 2022, 2021 and 2020, the Effect of foreign tax rate resulted from the geographical mix of our pre-tax results.
(B)For the year ended December 31, 2022, the changes in recognized and unrecognized deferred tax assets mainly related to the recognition of previously unrecognized deferred tax assets at one of our main operating entities in the United States for €154 million (see NOTE 17 - Deferred Income Taxes). For the year ended December 31, 2021, the changes mainly related to the recognition of deferred tax assets on temporary differences at one of our main operating entities in the United States. For the year ended December 31, 2020, the changes mainly related to recognized deferred tax assets on prior-year losses carried forward at one of our main operating entities in the United States, following some clarification on U.S. interest limitation rules and the CARES Act.
NOTE 12 - CASH AND CASH EQUIVALENTS
Cash at bank and on hand at December 31, 2022 amounted to €166 million and included €24 million held by subsidiaries that operate in countries where capital control restrictions prevent these balances from being immediately available for general use by the other entities within the Group. At December 31, 2021, the amount subject to these restrictions was €29 million.
NOTE 13 - TRADE RECEIVABLES AND OTHER
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Trade receivables - gross467607
Impairment(2)(4)
Total trade receivables - net465603
Income tax receivables14162420
Other tax receivables3840
Contract assets152192
Prepaid expenses1819
Other1310119
Total other receivables43745580
Total trade receivables and other4353955683
13.1 Contract assets
Contract assets included €4 million and €6 million of unbilled tooling costs at December 31, 2022 and 2021, respectively.
F-29


13.2 Aging
At December 31,
(in millions of Euros)20222021
Not past due453596
1 – 30 days past due106
31 – 60 days past due21
Total trade receivables - net465603
The maximum exposure to credit risk at the reporting date is the carrying value of each class of receivable shown above. The Group does not hold any collateral from its customers or debtors as security.
13.3 Currency concentration
At December 31,
(in millions of Euros)20222021
Euro225277
U.S. Dollar213305
Swiss franc84
Other currencies1917
Total trade receivables - net465603
13.4 Factoring arrangements
The Group factors trade receivables under committed factoring agreements in the United States, France, Germany, Switzerland and the Czech Republic:
In the United States, Constellium Muscle Shoals LLC is party to a factoring agreement with a capacity of $200 million and a maturity date in September 2023 and Constellium Automotive USA LLC is party to a factoring agreement with a maximum capacity of $25 million and a maturity date in December 2023.
The factoring agreement in place for our entities in France has a maximum capacity of €250 million (including a €20 million recourse line) and a maturity date in January 2026.
Factoring agreements in place for our entities in Germany, Switzerland and the Czech Republic have a combined maximum capacity of €200 million and maturity dates in December 2027.
In addition, the Group sells receivables from one of its German customers under an uncommitted factoring facility whereby receivables sold are confirmed by the customer.
These factoring agreements contain certain customary affirmative and negative covenants, including some relating to the administration and collection of the assigned receivables, the terms of the invoices and the exchange of information, but do not contain maintenance financial covenants. In addition, the commitment of the factor to buy receivables under the Muscle Shoals factoring agreement is subject to certain credit ratings being maintained. The Group was in compliance with all applicable covenants at and for the years ended December 31, 2022 and 2021.
Under the Group’s factoring agreements, most of the trade receivables are sold without recourse. Where the Group has transferred substantially all the risks and rewards of ownership of the receivables, the receivables are derecognized. Some remaining receivables do not qualify for derecognition, as the Group retains substantially all the associated risks and rewards. At December 31, 2022, the total carrying amount of the original assets factored was €574 million of which €368 million were derecognized. At December 31, 2021, the total carrying amount of the original assets factored was €639 million of which €345 million were derecognized.
The amounts due to the factors in respect to trade receivables sold were €6 million and zero at December 31, 2022 and 2021, respectively.
F-30


NOTE 14 - INVENTORIES
At December 31,
(in millions of Euros)20222021
Finished goods315225
Work in progress638551
Raw materials 308226
Stores and supplies11295
Inventories write down(53)(47)
Total inventories1,3201,050
NOTE 15 - PROPERTY, PLANT AND EQUIPMENT
(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2022213741,411127151,948
Additions14901885297
Disposals(4)(1)(5)
Depreciation expense(1)(32)(230)(2)(12)(277)
Transfer and other changes21876(103)7
Effect of changes in foreign exchange rates17441154
Net balance at December 31, 2022233811,387211152,017
Cost426372,957224633,923
Less accumulated depreciation and impairment(19)(256)(1,570)(13)(48)(1,906)
Net balance at December 31, 2022233811,387211152,017
(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2021203791,361132141,906
Additions6521696233
Disposals(1)(2)(1)(4)
Depreciation expense(1)(27)(210)(3)(12)(253)
Transfer and other changes15153(174)8(7)
Effect of changes in foreign exchange rates11257373
Net balance at December 31, 2021213741,411127151,948
Cost385902,750142573,577
Less accumulated depreciation and impairment(17)(216)(1,339)(15)(42)(1,629)
Net balance at December 31, 2021213741,411127151,948
Right-of-use assets
Right-of-use assets have been included in the same line item as that in which a corresponding owned asset would be presented.
F-31


(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2022108651174
Additions11718
Disposals(1)(1)
Depreciation expense(12)(20)(1)(33)
Effect of changes in foreign exchange rates33
Net balance at December 31, 202210754161
Cost1611461308
Less accumulated depreciation and impairment(54)(92)(1)(147)
Net balance at December 31, 202210754161
(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2021112722186
Additions5712
Depreciation expense(11)(16)(1)(28)
Transfer and other changes(1)(1)
Effect of changes in foreign exchange rates235
Net balance at December 31, 2021108651174
Cost1501443297
Less accumulated depreciation and impairment(42)(79)(2)(123)
Net balance at December 31, 2021108651174
The total expense relating to short-term leases, low value asset leases and variable lease payments that are still recognized as operating expenses was €15 million, €12 million and €11 million for the years ended December 31, 2022, 2021 and 2020 respectively.
Depreciation expense
Total depreciation expense relating to property, plant and equipment and intangible assets are presented in the Consolidated Income Statement as follows:
Year ended December 31,
(in millions of Euros)202220212020
Cost of sales(270)(245)(240)
Selling and administrative expenses(12)(17)(14)
Research and development expenses(5)(5)(5)
Total depreciation expense(287)(267)(259)
The amount of contractual commitments for the acquisition of property, plant and equipment is disclosed in NOTE 28 - Commitments.




F-32


Impairment tests for property, plant and equipment and intangibles assets
Impairment tests at December 31, 2022 and 2021
No triggering events were identified at December 31, 2022 and 2021 for our Cash Generating Units (“CGUs”).
Impairment tests at December 31, 2020
At December 31, 2020, the downturn in the aerospace industry resulting from the COVID-19 pandemic was identified as an indicator of impairment for all the CGUs in the A&T segment.
As a result, these CGUs were tested for impairment and their value in use was calculated using discounted cash flows based on a financial forecast for the period 2021-2025 prepared by management and reflecting its best estimates at the time. Based on this analysis, the conclusion to fully impair these two CGUs for €16 million (€9 million for the Montreuil-Juigné plant and €7 million for the Ussel plant) was reached in the year ended December 31, 2020.
The Group also tested the sensitivity of two other A&T CGUs to changes in cash flows, in discount rates, and in perpetuity growth rates, and determined that no impairment was appropriate.
At December 31, 2020, management also reviewed the CGUs in the AS&I segment and identified an indicator of impairment for two Automotive Structures plants - Nanjing, China and White, Georgia, U.S. The two CGUs were tested for impairment and their values in use were calculated using discounted cash flows and a discount rate of 9%. Based on this analysis, the conclusion to fully impair the Nanjing plant for €12 million was reached in the year ended December 31, 2020. The White Georgia plant was partially impaired for €13 million, leading to a carrying value of €11 million at December 31, 2020.
There were no other impairment indicators identified for our other CGUs at December 31, 2020.
NOTE 16 - INTANGIBLE ASSETS AND GOODWILL
(in millions of Euros)TechnologyComputer SoftwareCustomer relationshipsWork in ProgressOtherTotal Intangible AssetsGoodwill
Net balance at January 1, 20221821132458451
Additions33
Amortization expense(2)(7)(1)(10)
Transfer2(2)
Effect of changes in foreign exchange rates21327
Net balance at December 31, 20221816133454478
Cost92944244236478
Less accumulated depreciation and impairment(74)(78)(29)(1)(182)
Net balance at December 31, 20221816133454478
F-33


(in millions of Euros)TechnologyComputer SoftwareCustomer relationshipsWork in ProgressOtherTotal Intangible Assets Goodwill
Net balance at January 1, 202118151313261417
Additions44
Amortization expense(1)(12)(1)(14)
Transfer 17(15)24
Effect of changes in foreign exchange rates111334
Net balance at December 31, 20211821132458451
Cost86914034224451
Less accumulated depreciation and impairment(68)(70)(27)(1)(166)
Net balance at December 31, 20211821132458451
Impairment tests for goodwill
Goodwill in the amount of €478 million was allocated to our operating segments: €471 million to P&ARP, €5 million to A&T and €2 million to AS&I.
At December 31, 2022, the recoverable amount of our operating segments was determined based on value in use calculations, using discounted cash-flows.
The recoverable amount of the A&T and AS&I operating segments significantly exceeded their carrying value. No reasonable change in the assumptions used could have led to a potential impairment charge.
For the P&ARP operating segment, the analysis was based on forecasted cash flows that grow to management’s estimate of a normalized level by 2027 and then at a long term growth rate of 1.5% thereafter. The discount rate applied to the cash-flow projections was 9%. Based on this analysis, the carrying value of €1.6 billion remained below the recoverable value which was in excess of €2 billion at December 31, 2022 and therefore there was no goodwill impairment at the P&ARP operating segment.
With cash-flows 40% lower from 2023 to 2027 including the terminal year cash flow, the recoverable value still exceeded the carrying value.
F-34


NOTE 17 - DEFERRED INCOME TAXES
Recognized Deferred Tax Assets
At December 31,
(in millions of Euros)20222021
Deferred income tax assets 271162
Deferred income tax liabilities (28)(14)
Net deferred income tax assets 243148
At January 1, 2022Reclassified as held for saleRecognized inFXAt December 31, 2022
(in millions of Euros)Profit or lossOCI
Long-term assets (124)(2)31(7)(102)
Inventories 3(4)(1)(2)
Pensions 119(10)(35)478
Derivative valuation (6)824
Tax losses carried forward 117676190
Other (A)3935175
Net deferred income tax assets 148(2)127(33)3243
(A)At December 31, 2022, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.
At January 1, 2021Recognized inFXAt December 31,
2021
(in millions of Euros)Profit or lossOCI
Long-term assets (106)(10)(8)(124)
Inventories 5(2)3
Pensions 1265(17)5119
Derivative valuation (5)(5)4(6)
Tax losses carried forward 116(7)8117
Other (A)47(10)239
Net deferred income tax assets 183(29)(13)7148
(A)At December 31, 2021, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.









F-35



Unrecognized Deferred Tax Assets
Based on the expected taxable income of the entities, the Group believed that it was more likely than not that a total of €199 million and €805 million at December 31, 2022 and 2021, respectively, of unused tax losses and deductible temporary differences, would not be used. Consequently, the corresponding net deferred tax assets were not recognized. The related tax impact of €48 million and €191 million at December 31, 2022 and 2021, respectively, was attributable to the following:
At December 31,
(in millions of Euros)20222021
Expiring within 5 years (5)(3)
Expiring after 5 years and limited (5)(55)
Unlimited (21)(27)
Tax losses (31)(85)
Long-term assets (2)(65)
Pensions (3)(7)
Other (12)(34)
Deductible temporary differences (17)(106)
Total (48)(191)
Recognition of Deferred Tax Assets
Some deferred tax assets in respect of temporary differences and unused tax losses were recognized without being offset by deferred tax liabilities.
In accordance with the accounting policies described in note 2.6 of the Consolidated Financial Statements, a detailed assessment was performed on net deferred tax asset recovery at December 31, 2022, with specific focus on tax jurisdictions with unused tax losses carried forward.
At December 31, 2021, most of the the tax loss carryforwards as well as the deductible temporary differences on long-term assets and other differences resided at one of our main operating entities in the United States. An assessment was performed on the recoverability of the deferred tax assets associated with the deductible temporary differences and tax losses. Management concluded that it was more likely than not that the entity would not be able to use the tax benefits associated with the deductible temporary differences and tax losses. Consequently, the related deferred tax assets were not recognized.
In the year ended December 31, 2022, management determined that it is more likely than not that future earnings will be sufficient to realize these previously unrecognized deferred tax assets. In making this determination management considered all available positive and negative evidence including historical results as well as forecasted profitability supported by revised projections from the Group’s latest long-term plan. Accordingly, the Group recognized a deferred tax asset and a corresponding income tax benefit of €154 million in the year ended December 31, 2022.
Management considered that the tax losses related to the other tax jurisdictions that generated the deferred tax assets were not expected to be recurring and did not challenge the profitable long-term structure of its business model. In addition, tax planning opportunities are available to increase the taxable profit and the use the long-term limited and unlimited tax losses.
Management concluded that it was more likely than not that the net deferred tax asset balance of €243 million and €148 million at December 31, 2022 and 2021, respectively, would be recoverable.
NOTE 18 - DISPOSAL GROUPS CLASSIFIED AS HELD FOR SALE
In the quarter ended December 31, 2022, the Group determined that Constellium Ussel, one of the entities in the Aerospace and Transportation operating segment, met the criteria to be classified as a disposal group held for sale. As a result, the related assets and liabilities were presented as held for sale at December 31, 2022. The sale of this entity was completed in February 2023 (see NOTE 32 - Subsequent Events).
F-36


No impairment loss was recognized on the reclassification as held for sale.
At December 31,
(in millions of Euros)2022
Assets of disposal group classified as held for sale
Cash and cash equivalents1
Trade receivables and other6
Inventories5
Deferred tax assets2
Total assets of disposal group classified as held for sale14
Liabilities of disposal group classified as held for sale
Trade payables and other8
Pensions and other post-employment benefit obligations2
Total liabilities of disposal group classified as held for sale10
NOTE 19 - TRADE PAYABLES AND OTHER
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Trade payables1,1551,065
Fixed assets payables3622
Employees' entitlements195185
Taxes payable other than income tax1716
Contract liabilities and other liabilities to customers2055477
Other payables2392812
Total other4331232312
Total trade payables and other431,467321,377
Contract liabilities and other liabilities to customers
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Deferred tooling revenue193
Advance payment from customers67
Unrecognized variable consideration (A)149167
Other3
Total contract liabilities and other liabilities to customers2055477
(A)Unrecognized variable consideration consists of expected volume rebates, discounts, incentives, refunds penalties and price concessions.
Revenue of €58 million that related to contract liabilities at at January 1, 2022 was recognized in the year ended December 31, 2022. Revenue of €60 million generated in the year ended December 31, 2022 was deferred.
Revenue of €33 million that related to contract liabilities at January 1, 2021 was recognized in the year ended December 31, 2021. Revenue of €36 million generated in the year ended December 31, 2021 was deferred.
F-37


NOTE 20 - BORROWINGS
20.1 Analysis by nature
At December 31,
20222021
(in millions of Euros)Nominal Value in CurrencyNominal rateNominal Value in Euros(Arrange-ment fees) Accrued interestsCarrying valueCarrying
value
Secured Pan-U.S. ABL
(due 2026) (A)
$85 Floating80181
Secured PGE French Facility
(repaid in May 2022) (B)
180 Floating180
Senior Unsecured Notes (C)
Issued November 2017 anddue 2026 $300 5.875 %281(2)6285268
Issued November 2017 anddue 2026 400 4.250 %400(3)6403402
Issued June 2020 anddue 2028 $325 5.625 %305(5)1301284
Issued February 2021 anddue 2029 (D)$500 3.750 %469(6)4467438
Issued June 2021 anddue 2029 (D)300 3.125 %300(4)4300300
Unsecured Swiss Facility
(repaid in June 2022)
CHF15 1.175 %14
Lease liabilities 1671168183
Other loans (E)515160
Total Borrowings2,053(20)232,0562,129
Of which non-current1,9081,871
Of which current148258
(A)In June 2022, the Pan-U.S. ABL was amended to, among other things, increase the commitment to $500 million, provide an incremental revolving credit facility accordion of up to $100 million, and replace the LIBOR reference rate by the SOFR reference rate.
(B)The initial maturity date of the PGE was May 2021 with an option for Constellium to extend for up to 5 years. In May 2021, the maturity date was extended to May 2022. In May 2022, the PGE was repaid accordingly.
(C)The Senior Unsecured Notes were issued by Constellium SE and are guaranteed by certain subsidiaries.
(D)For the $500 million Sustainability-Linked Senior Notes issued in February 2021 and the €300 million Sustainability-Linked Senior Notes issued in June 2021, Constellium has established two sustainability performance targets (greenhouse gas emissions intensity and recycled metal input). If Constellium does not satisfy the first target for the year ended December 31, 2025, the interest rates for both Notes will be increased by 0.125% starting April 15, 2026 and July 15, 2026 respectively. If Constellium does not satisfy the second target for the year ended December 31, 2026, the interest rates will be increased by 0.125% starting April 15, 2027 and July 15, 2027, respectively (in addition to any increase arising from failure to meet the first target). At December 31, 2022, the Group expects to satisfy these targets.
(E)At December 31, 2022 Other loans included €36 million of financial liabilities relating to the sale and leaseback of assets that were considered to be financing arrangements in substance.
20.2 Undrawn credit facilities and overdraft arrangements
At December 31, 2022, the Group had a €100 million Secured Inventory facility in place. This committed asset-based credit facility matures in April 2023 and was undrawn at December 31, 2022. The Group also uses a €50 million Money Market facility, as well as overdraft agreements with its commercial banks for cash management purposes. These arrangements are uncommitted and were undrawn at December 31, 2022.


F-38


20.3 Securities against borrowings and covenants
Assets pledged as security
Constellium has pledged assets and financial instruments as collateral against certain of its borrowings.
Pan-U.S. ABL
Obligations under this facility are, subject to certain permitted liens, secured by substantially all assets of Ravenswood, Muscle Shoals, and Bowling Green.
French Inventory Facility
Obligations under the Secured Inventory Facility of Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S. (the “French Inventory Facility”) are secured by possessory and non-possessory pledges of the eligible inventory of Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S.
Lease liabilities
Lease liabilities are generally secured as the rights to the leased assets recognized in the financial statements revert to the lessor in the event of default.
Covenants
The Group was in compliance with all applicable debt covenants at and for the years ended December 31, 2022 and 2021.
Constellium SE Senior Notes
The indentures for our outstanding Senior Notes contain customary terms and conditions, including amongst other things, limitations on incurring or guaranteeing additional indebtedness, on paying dividends, on making other restricted payments, on creating restrictions on dividends and other payments to us from certain of our subsidiaries, on incurring certain liens, on selling assets and subsidiary stock, and on merging.
Pan-U.S. ABL
This facility contains a fixed charge coverage ratio covenant along with customary affirmative and negative covenants. Evaluation of compliance with the maintenance covenants is only required if the excess availability falls below 10% of the aggregate revolving loan commitment.
F-39


20.4 Movements in borrowings
(in millions of Euros)20222021
At January 1, 2,1292,391
Cash flows
Proceeds from issuance of long-term borrowings (A)712
Repayments of long-term borrowings (B)(192)(1,052)
Net change in revolving credit facilities and short-term borrowings (C)72(5)
Lease repayments(37)(32)
Payment of deferred financing costs(13)
Non-cash changes
Movement in accrued interest(1)(11)
Changes in leases and other loans1818
Deferred arrangement fees 316
Effects of changes in foreign exchange rates64105
At December 31,2,0562,129
(A)In February 2021, Constellium SE issued $500 million 3.750% Sustainability-Linked Senior Notes (€412 million converted at the issuance date exchange rate). In June 2021, Constellium SE issued €300 million 3.125% Sustainability-Linked Senior Notes.
(B)For the twelve months ended December 31, 2022, repayments of long-term borrowings included the repayment of the PGE.
In February 2021, Constellium SE tendered and redeemed the $650 million 6.625% Senior Notes due 2025 (€536 million converted at the redemption date exchange rate). In June 2021, Constellium SE redeemed the $400 million 5.750% Senior Notes due 2024 (€328 million converted at the redemption date exchange rate). In November 2021, Constellium SE partially redeemed $200 million ( €177 million converted at the repayment date exchange rate) of the $500 million outstanding aggregate principal amount of the 5.875% Senior Notes due 2026.
(C)For the twelve months ended December 31, 2022, the net change in revolving credit facilities and short-term borrowings included the net proceeds from the Pan-U.S. ABL and the repayment of the Swiss facility.
20.5 Currency concentration
At December 31,
(in millions of Euros)20222021
U.S. Dollar1,1881,055
Euro8611,048
Other currencies726
Total borrowings2,0562,129
F-40


NOTE 21 - FINANCIAL INSTRUMENTS
21.1 Financial assets and liabilities by categories
At December 31,
20222021
(in millions of Euros)NotesAt amortized costAt fair value through profit and lossAt fair value through OCITotalAt amortized costAt fair value through profit and lossAt fair value through OCITotal
Cash and cash equivalents12166166147147
Trade receivables 13465465603603
Other financial assets372397070
Total1663746767014770603820
At December 31,
20222021
(in millions of Euros)NotesAt amortized costAt fair value through profit and lossAt fair value through OCITotalAt amortized costAt fair value through profit and lossAt fair value through OCITotal
Trade payables and fixed asset payables191,1911,1911,0871,087
Borrowings202,0562,0562,1292,129
Other financial liabilities40155526531
Total3,24740153,3023,2162653,247
21.2 Fair values
The carrying value of the Group’s borrowings at maturity is the redemption value.
The fair value of Constellium SE Senior Notes issued in November 2017, June 2020, February 2021 and June 2021 account for 97%, 92%, 82% and 80% respectively of the nominal value and amount to €657 million, €282 million, €385 million and €239 million, respectively, at December 31, 2022.
All derivatives are presented at fair value in the Consolidated Statement of Financial Position. The fair values of trade receivables, other financial assets and liabilities approximate their carrying values, as a result of their liquidity or short maturity.
F-41


At December 31,
20222021
(in millions of Euros)Non-currentCurrentTotalNon-currentCurrentTotal
Aluminium and premium derivatives27993847
Energy derivatives325112
Other commodity derivatives2244
Currency commercial derivatives3202321416
Currency net debt derivatives11
Other financial assets - derivatives83139125870
Aluminium and premium derivatives19191414
Energy derivatives3710
Other commodity derivatives11
Currency commercial derivatives11142561117
Other financial liabilities - derivatives14415562531
In the year ended December 31, 2021, forward purchases of $565 million versus the Euro using cross currency basis swaps were not renewed when they reached their maturity or were bought out before their initial maturity in connection with the refinancing of the Senior Notes. This transaction generated a cash outflow of €32 million which is presented in Other financing activities within the Consolidated Statement of Cash Flows in the year ended December 31, 2021.
21.3 Valuation hierarchy
The following table provides an analysis of financial instruments measured at fair value, grouped into levels based on the degree to which the fair value is observable:
Level 1 is based on a quoted price (unadjusted) in active markets for identical financial instruments. Level 1 includes aluminium, copper and zinc futures that are traded on the LME.
Level 2 is based on inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly (i.e. prices) or indirectly (i.e. derived from prices). Level 2 includes foreign exchange derivatives and natural gas derivatives. The present value of future cash flows based on the forward or on the spot exchange rates at the balance sheet date is used to value foreign exchange derivatives.
Level 3 is based on inputs for the asset or liability that are not based on observable market data (unobservable inputs). Trade receivables are classified as a Level 3 measurement under the fair value hierarchy.
At December 31,
20222021
(in millions of Euros)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Other financial assets - derivatives63339412970
Other financial liabilities - derivatives173855131831
There was no material transfer of asset and liability categories into or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2022 and 2021.

F-42


NOTE 22 - FINANCIAL RISK MANAGEMENT
The Group’s financial risk management strategy focuses on minimizing the cash flow impacts of volatility in foreign currency exchange rates and metal prices, while maintaining the financial flexibility the Group requires in order to successfully execute its business strategy.
Due to Constellium’s capital structure and the nature of its operations, the Group is exposed to the following financial risks: (i) market risk including foreign exchange, commodity price and interest rate risks; (ii) credit risk and (iii) liquidity risk.
22.1 Foreign exchange risk
Foreign exchange risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates.
Net assets, earnings and cash flows are influenced by multiple currencies due to the geographic diversity of sales and the countries in which the Group operates.
Constellium has the following foreign exchange risk: i) transaction exposures, which include commercial transactions related to forecasted sales and purchases and on-balance sheet receivables/payables resulting from such transactions and financing transactions related to external and internal net debt, and ii) translation exposures, which relate to net investments in foreign entities that are converted in Euros in the Consolidated Financial Statements.
i. Commercial transaction exposures
The Group policy is to hedge committed and highly probable forecasted foreign currency operational transactions. The Group uses foreign exchange forwards and foreign exchange swaps for this purpose.
The following tables outline the nominal value (converted to millions of Euros at the closing rate) of forward derivatives for Constellium’s most significant foreign exchange exposures at December 31, 2022.
Sold currenciesMaturity YearLess than 1 yearOver 1 year
USD2023-2025409186
CHF2023-20268229
CZK20233
Other currencies202310
Purchased currenciesMaturity YearLess than 1 yearOver 1 year
USD2023-202610925
CHF2023-202513416
CZK2023-20247820
Other currencies20231
The Group has agreed to supply a major customer with fabricated metal products from a Euro functional currency entity and invoices in U.S. Dollars. The Group has entered into significant foreign exchange derivatives that matched related highly probable future conversion sales. The Group designates these derivatives for hedge accounting, with a total nominal amount of $248 million and $274 million at December 31, 2022 and December 31, 2021 respectively, with maturities ranging from 2023 to 2025.
F-43


The table below details the effect of foreign currency derivatives in the Consolidated Income Statement and the Consolidated Statement of Comprehensive Income:
Year ended December 31,
(in millions of Euros)Notes202220212020
Derivatives that do not qualify for hedge accounting
Included in Other gains and losses - net
Realized gains / (losses) on foreign currency derivatives - net91(4)
Unrealized gains / (losses) on foreign currency derivatives - net (A)9615(9)
Derivatives that qualify for hedge accounting
Included in Other comprehensive income
Unrealized (losses) / gains on foreign currency derivatives - net(16)(21)20
Gains reclassified from cash flow hedge reserve to the Consolidated Income Statement846
Included in Revenue (B)
Realized losses on foreign currency derivatives - net
9(8)(2)(7)
Unrealized (losses) / gains on foreign currency derivatives - net9(2)1
Derivatives discontinued from hedge accounting
Included in Other gains and losses - net
Losses reclassified from OCI as a result of hedge accounting discontinuation (C)9(6)
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized.
(B)Changes in fair value of derivatives that qualify for hedge accounting are included in Revenue when the related customer invoices are issued.
(C)In the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for 2020 and 2021, to which hedge accounting was applied, was no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted a €6 million loss.
ii. Financing transaction exposures
When the Group enters into intercompany loans and deposits, the financing is generally provided in the functional currency of the subsidiary. The foreign currency exposure of the Group’s external funding and liquid assets is systematically hedged either naturally through intercompany foreign currency loans and deposits or through foreign currency derivatives.
At December 31, 2022, the net hedged position related to long-term and short-term loans and deposits in U.S. dollars included a forward sale of $115 million versus the Euro using simple foreign exchange forward contracts.
Year ended December 31,
(in millions of Euros)202220212020
Derivatives
Included in Finance costs - net
Realized gains / (losses) on foreign currency derivatives - net2(36)7
Unrealized (losses) / gains on foreign currency derivatives - net(1)46(39)
Total110(32)
In accordance with the Group policy, total realized and unrealized gains or losses on foreign currency derivatives are expected to offset the net foreign exchange result related to financing activities, both included in Finance costs - net.
F-44


Net debt derivatives settled during the year are presented in Other financing activities in the Consolidated Statement of Cash Flows.
Foreign exchange sensitivity on commercial and financing transaction exposures
The largest exposures of the Group are related to the Euro/U.S. Dollar exchange rate. The table below summarizes the impact on income and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro for non U.S. Dollar functional currency entities.
(in millions of Euros)Effect on income before taxEffect on pretax equity
Trade receivables3
Trade payables(1)
Derivatives on commercial transactions (A)(25)(24)
Net commercial transaction exposure(23)(24)
Cash in Bank and intercompany loans105
Borrowings(117)
Derivatives on financing transactions12
Net financing transaction exposure
Total(23)(24)
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized. The impact on pretax equity of €24 million relates to derivatives hedging the future sales spread from 2023 to 2025 which are designated as cash flow hedges.
The amounts shown in the table above may not be indicative of future results since the balances of financial assets and liabilities may change.
iii. Translation exposures
Foreign exchange impacts related to the translation of net investments in foreign subsidiaries from functional currency to Euro, and of the related revenue and expenses, are not hedged as the Group operates in these various countries on permanent basis except as described below.
Foreign exchange sensitivity on translation exposures
The exposure relates to foreign currency translation of net investments in foreign subsidiaries and arises mainly from operations conducted by U.S. Dollar functional currency subsidiaries.
The table below summarizes the impact on income and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro (on average rate for income before tax and closing rate for pretax equity) for U.S. Dollar functional currency entities.
(in millions of Euros)Effect on income before taxEffect on pretax equity
10% strengthening U.S. Dollar/Euro23182
The amounts shown in the table above may not be indicative of future results since the balances of financial assets and liabilities may change.
22.2 Commodity price risk
The Group is subject to the effects of market fluctuations in the price of aluminium, which is the Group’s primary metal input and a significant component of its output. The Group is also exposed to variation in regional premiums and in the price of zinc, natural gas, silver and copper and other alloying metals but in a less significant way.
F-45


The Group policy is to minimize exposure to aluminium price volatility by passing through the aluminium price risk to customers and using derivatives where necessary. For most of its aluminium price exposure, sales and purchases of aluminium are converted to be on the same floating basis and then the same quantities are bought and sold at the same market price.
Temporary increases in inventory, to the extent material, are sold forward to the expected sales date to ensure the price paid for the metal will be redeemed when it is sold.
The Group also purchases fixed price copper, aluminium premium, silver and zinc derivatives to offset the commodity exposure where sales contracts have embedded fixed price agreements for these commodities.
In addition, the Group purchases natural gas fixed price derivatives to lock in energy costs where a fixed price purchase contract is not possible.
At December 31, 2022, the nominal amount of commodity derivatives is as follows:
(in millions of Euros)MaturityLess than 1 yearOver 1 year
Aluminium 2023-20242905
Premium 2023-2025185
Copper 202312
Silver 2023-202418
Natural gas2023-20263129
Zinc20238
The value of the contracts will fluctuate due to changes in market prices but our hedging strategy helps protect the Group’s margin on future conversion and fabrication activities. At December 31, 2022, these contracts were directly entered into with external counterparties.
The Group does not apply hedge accounting on commodity derivatives and therefore mark-to-market movements are recognized in Other gains and losses - net.
Year ended December 31,
(in millions of Euros)202220212020
Derivatives
Included in Other gains and losses - net
Realized (losses) / gains on commodity derivatives - net
(6)112(31)
Unrealized (losses) / gains on commodity derivatives - net(53)2425
Commodity price sensitivity: risks associated with derivatives
The net impact on earnings and equity of a 10% increase in the market price of aluminium, based on the aluminium derivatives held by the Group at December 31, 2022 (before tax), with all other variables held constant, was estimated to be a €28 million gain. The balances of these financial instruments may change in future years, and therefore these amounts may not be indicative of future results.
22.3 Interest rate risk
Interest rate risk is the risk that the fair value or future cash flows of financial instruments will fluctuate because of changes in market interest rates. The Group’s interest rate risk arises principally from borrowings. Borrowings issued at variable rates expose the Group to cash flow interest rate risk, which is partially offset by cash and cash equivalent deposits earning interest at variable interest rates. Borrowings issued at fixed rates expose the Group to fair value interest rate risk. At December 31, 2022, the Group’s borrowings were mainly at fixed rates.
F-46


Interest rate sensitivity: risks associated with variable-rate financial instruments
The impact on income before income tax of a 50 basis point increase or decrease in the LIBOR, EURIBOR or SOFR interest rates as applicable, based on the variable rate financial instruments held by the Group at December 31, 2022 and 2021, with all other variables held constant, was estimated to be approximately €3 million for the year ended December 31, 2022, and approximately €1 million for the year ended December 31, 2021. However, the balances of such financial instruments may not remain constant in future years, and therefore these amounts may not be indicative of future results.
22.4 Credit risk
Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Group is exposed to credit risk with financial institutions and other parties as a result of cash-in-bank, cash deposits, mark-to-market on derivative transactions and customer trade receivables arising from the Group’s operating activities. The maximum exposure to credit risk for the year ended December 31, 2022 is the carrying value of each class of financial asset as described in NOTE 21 - Financial Instruments. The Group does not generally hold any collateral as security.
i. Credit risk related to transactions with financial institutions
Credit risk with financial institutions is managed by the Group’s Treasury department in accordance with a Board approved policy. Management is not aware of any significant risks associated with financial institutions as a result of cash and cash equivalent deposits, including short-term investments and financial derivative transactions.
The number of financial counterparties tabulated below shows our exposure to the counterparty by rating type (Parent company ratings from Moody’s Investor Services):
At December 31,
20222021
Number of financial counterparties (A)Exposure (in millions of Euros)Number of financial counterparties (A)Exposure (in millions of Euros)
Rated Aa or better251354
Rated A61121398
Rated Baa13333
Total 916619185
(A)Financial counterparties for which the Group’s exposure is below €0.25 million have been excluded from the analysis.
ii. Credit risks related to customer trade receivables
The Group has a diverse customer base geographically and by industry. The responsibility for customer credit risk management rests with management. Payment terms vary and are set in accordance with practices in the different geographies and end-markets served. Credit limits are typically established based on internal or external rating criteria, which take into account such factors as the financial condition of the customers, their credit history and the risk associated with their industry segment.
Trade receivables are actively monitored and managed, at the business unit or site level. Business units report credit exposure information to Constellium management on a regular basis. Over 76% of the Group’s trade account receivables are insured by insurance companies rated A3 or better or sold to a factor on a non-recourse basis. In situations where collection risk is considered to be above acceptable levels, risk is mitigated through the use of advance payments, bank guarantees or letters of credit.
Historically, we have a very low level of customer default as a result of long history of dealing with our customer base and an active credit monitoring function. See NOTE 13 - Trade Receivables and Other for the aging of trade receivables.
F-47


22.5 Liquidity risk management
The Group’s capital structure includes shareholder’s equity, borrowings and various third-party financing arrangements. Constellium’s total capital is defined as total equity plus net debt. Net debt includes borrowings due to third parties less cash and cash equivalents.
Constellium’s overriding objectives when managing capital are to safeguard the business as a going concern, to maintain an optimal capital structure in order to minimize the weighted cost of capital, and to maximize returns for its owners.
All activities around cash funding, borrowings and financial instruments are centralized within Constellium’s Treasury department.
The liquidity requirements of the overall Company are funded by cash and drawings on available credit facilities, while the internal management of liquidity is optimized by means of cash pooling agreements and/or intercompany loans and deposits between the Company’s operating entities and central Treasury.
At December 31, 2022, the borrowing base for the Pan-U.S. ABL and the French Inventory Facility were €469 million and €100 million, respectively. After deduction of amounts drawn and letters of credit, the Group had €480 million outstanding availability under these revolving credit facilities.
At December 31, 2022, liquidity was €709 million, comprised of €166 million of cash and cash equivalents and €543 million of available undrawn facilities, including the €480 million described above.
At December 31, 2021, liquidity was €773 million, comprised of €147 million of cash and cash equivalents and €626 million of available undrawn facilities.
Margin calls
The Group’s financial institution counterparties may require margin calls should the mark-to-market of our derivatives hedging foreign exchange and commodity price risks exceed a pre-agreed contractual limit. In order to protect from potential margin calls for significant market movements, the Group enters into derivatives with a large number of financial counterparties and monitors margin requirements on a daily basis. In addition, the Group (i) ensures that financial counterparts hedging transactional exposure are also hedging foreign currency loan and deposit exposures and (ii) holds a significant liquidity buffer in cash or in availability under its various borrowing facilities.
At December 31, 2022 and 2021, there was no margin requirement paid as collateral to counterparties related to foreign exchange hedges nor related to aluminium or any other commodity hedges.
Undiscounted contractual financial assets and liabilities
The tables below show undiscounted contractual financial assets and financial liabilities values by relevant maturity groupings based on the remaining periods from December 31, 2022 and 2021, respectively, to the contractual maturity date.
At December 31,
20222021
(in millions of Euros)Less than 1 yearBetween 1- 5 yearsOver 5 yearsLess than 1 yearBetween 1 - 5 yearsOver 5 years
Financial assets
Net cash flows from derivative assets related to currencies and commodities3196012
Trade receivables 465603
Total496966312
F-48


At December 31,
20222021
(in millions of Euros)NotesLess than 1 yearBetween 1 - 5 yearsAfter 5 yearsLess than 1 yearBetween 1 - 5 YearsAfter 5 years
Financial liabilities
Borrowings56981,0871957101,046
Leases359886379985
Interest (A)78260547928596
Net cash flows from derivative liabilities related to currencies and commodities42192612
Trade payables and fixed asset payables191,1911,087
Total1,3511,0751,2271,4241,1061,227
(A)Interest disclosed is an undiscounted forecasted interest amount that excludes interest on leases.
NOTE 23 - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS
The Group has a number of pensions, other post-employment benefits and other long-term employee benefit plans. Some of these plans are defined contribution plans and some are defined benefit plans, with assets held in separate trustee-administered funds. Benefits paid through pension trusts are sufficiently funded to ensure the payment of benefits to retirees when they become due.
Actuarial valuations are reflected in the Consolidated Financial Statements as described in NOTE 2.6 - Principles governing the preparation of the Consolidated Financial Statements.
23.1 Description of the plans
Pension plans
Constellium’s pension obligations are in the U.S., Switzerland, Germany and France. Pension benefits are generally based on the employee’s service and highest average eligible compensation before retirement and are periodically adjusted for cost of living increases, either by company practice, collective agreement or statutory requirement. Benefit plans in the U.S., Switzerland and France are funded through long-term employee benefit funds.
Other post-employment benefits (OPEB)
The Group provides healthcare and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents, mainly in the U.S. Eligibility for coverage depends on certain age and service criteria. These benefit plans are unfunded.
Other long-term employee benefits
Other long-term employee benefits mainly include jubilees in France, Germany and Switzerland and other long-term disability benefits in the U.S. These benefit plans are unfunded.
23.2 Description of risks
The defined benefit obligations expose the Group to a number of risks, including longevity, inflation, interest rate, medical cost inflation, investment performance, and change in law governing the employee benefit obligations. These risks are mitigated when possible by applying an investment strategy for the funded schemes that aims to reduce the volatility of returns and achieve a matching of the underlying liabilities to minimize the long-term costs. This is achieved by investing in a diversified selection of asset classes.
F-49


Investment performance risk
Our pension plan assets consist primarily of funds invested in listed stocks and bonds.
The present value of funded defined benefit obligations is calculated using a discount rate determined by reference to high-quality corporate bond yields. If the return on plan assets is below this rate, it will increase the plan deficit.
Interest rate risk
A decrease in the discount rate will increase the defined benefit obligation. At December 31, 2022, impacts of the change on the defined benefit obligation of a 50 basis points increase / decrease in the discount rates are calculated by using a proxy based on the duration of each scheme:
(in millions of Euros)50 bp increase in
discount rates
50 bp decrease in
discount rates
France (6)7
Germany(5)5
Switzerland(16)17
United States(19)23
Total sensitivity on Defined Benefit Obligations(46)52
Longevity risk
The present value of the defined benefit obligation is calculated by reference to the best estimate of the mortality of plan participants. An increase in the life expectancy of the plan participants will increase the plan’s liability.
23.3 Actuarial assumptions
Pension and other post-employment benefit obligations were updated based on the discount rates applicable at December 31, 2022.
At December 31,
20222021
Rate of increase in salariesRate of increase in pensionsDiscount rateRate of increase in salariesRate of increase in pensionsDiscount rate
Switzerland1.75%2.05%1.50%0.15%
U.S.
Hourly pension3.00%
5.00% - 5.05%
2.20%
2.80% - 2.95%
Salaried pension%5.05%%2.85%
OPEB (A)4.00%
5.00% - 5.05%
3.80%
2.85% - 2.95%
Other benefits3.80%
4.95% - 5.00%
3.80%
2.60% - 2.85%
France
2.20%
2.00%
1.80% - 3.80%
2.00%
Retirements3.80%1.00%
Other benefits3.80%0.90%
Germany2.50%2.00%3.75%2.50%1.80%1.05%
(A)The other main financial assumptions used for the OPEB healthcare plans, which are predominantly in the U.S. were:
Medical trend rate: i) pre-65: 6.75% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards and ii) post-65: 6.00% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards,
Claims costs based on Company experience.
For both pension and healthcare plans, the post-employment mortality assumptions allow for future improvements in life expectancy.
F-50


23.4 Amounts recognized in the Consolidated Statement of Financial Position
At December 31,
20222021
(in millions of Euros)Pension BenefitsOther BenefitsTotalPension BenefitsOther BenefitsTotal
Present value of funded obligation614614766766
Fair value of plan assets(461)(461)(544)(544)
Deficit of funded plans153153222222
Present value of unfunded obligation96154250128249377
Net liability / (asset) arising from defined benefit obligation249154403350249599
23.5 Movement in net defined benefit obligations
Year ended December 31, 2022
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20228942491,143(544)599
Included in the Consolidated Income Statement
Current service cost2082828
Interest cost / (income)13720(9)11
Past service cost2(49)(47)(47)
Immediate recognition of gains arising over the year(5)(5)(5)
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets107107
—changes in financial assumptions(211)(43)(254)(254)
—changes in demographic assumptions(1)(1)(1)
—experience losses(3)(9)(12)(12)
Effects of changes in foreign exchange rates341650(30)20
Included in the Consolidated Statement of Cash Flows
Benefits paid(42)(21)(63)57(6)
Contributions by the Group(38)(38)
Contributions by the plan participants426(6)
Reclassification as liabilities of disposal group classified as held for sale (1)(1)(1)
At December 31, 2022710154864(461)403
F-51


Year ended December 31, 2021
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20219062161,122(458)664
Included the Consolidated Income Statement
Current service cost2283030
Interest cost / (income)10515(6)9
Past service cost1313232
Immediate recognition of gains arising over the year
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets(56)(56)
—changes in financial assumptions(29)(9)(38)(38)
—changes in demographic assumptions(13)(13)(13)
—experience losses(9)(2)(11)(11)
Effects of changes in foreign exchange rates381755(32)23
Included in the Consolidated Statement of Cash Flows
Benefits paid(36)(18)(54)32(22)
Contributions by the Group(21)(21)
Contributions by the plan participants415(5)
At December 31, 20218942491,143(544)599
Movements in net defined benefit obligations reported in Other Comprehensive Income in the years ended December 31, 2022 and 2021, primarily reflected the impact of changes in discount rates (see note 23.3), the difference between actual returns and interest on plan assets and the impact of changes in foreign exchanges rates.
23.6 Ravenswood plan amendment
In October 2022, Constellium Rolled Products Ravenswood and United Steelworkers Local Union 5668 entered into a new three-year collective bargaining agreement. The agreement included changes in OPEB and pension benefits that are accounted for as a plan amendment in the year ended December 31, 2022. The changes resulted in a reduction of the OPEB obligation recorded as a gain from negative past service cost for €49 million and an increase of the pension obligation recorded as an additional past service costs for €2 million.
23.7 Ravenswood OPEB dispute
In 2018, the Group announced a plan to transfer certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan (“the Plan”) from a company-sponsored program to a third-party health network providing similar benefits at a lower cost. The United Steelworkers Local Union 5668 (the “Union”) contested this change in benefits and filed a lawsuit against Constellium Rolled Products Ravenswood, LLC ("Ravenswood") in a federal district court in West Virginia (the “District Court”) seeking to enjoin the Plan changes and to compel arbitration. The District Court issued an order in December 2018, enjoining Ravenswood from implementing the Plan amendments pending resolution in arbitration. In September 2019, the arbitrator issued a decision ruling against Ravenswood and sustaining the Union’s grievance. Ravenswood filed a motion in the District Court to vacate this decision, which was denied in June 2020. In July 2020, Ravenswood appealed that denial to the Fourth Circuit Court of Appeals. In November 2021, the Fourth Circuit Court issued an opinion in favor of the Union, and the Group elected not to further pursue legal action on this matter.
The Group recognized a gain of €36 million from negative past service cost in the year ended December 31, 2018, reflecting its decision to amend the plan benefits and its determination at the time that it was probable that it would ultimately prevail in the dispute with the Union. This gain was partially reversed in the years ended December 31, 2019 and 2020, to reflect delays in the estimated implementation timetable as a result of the dispute with the Union. The Group recognized a loss
F-52


of €31 million from past service cost in the year ended December 31, 2021, following the Fourth Circuit Court's ruling in favor of the Union.
23.8 Net defined benefit obligations by country
At December 31,
20222021
(in millions of Euros)Defined benefit obligationsPlan assetsNet defined benefit liabilityDefined benefit obligationsPlan assetsNet defined benefit liability
France117(6)111158(5)153
Germany100(1)99134(2)132
Switzerland249(236)13306(268)38
United States398(218)180545(269)276
Total864(461)4031,143(544)599
23.9 Plan asset categories
At December 31,
20222021
(in millions of Euros)Quoted in an active marketNot quoted in an active marketTotalQuoted in an active marketNot quoted in an active marketTotal
Cash & cash equivalents4444
Equities873612311561176
Bonds14680226149110259
Property146074165571
Other34343434
Total fair value of plan assets251210461284260544
23.10 Cash flows
Expected contributions to pension and other benefit plans amount to €23 million and €16 million, respectively, for the year ending December 31, 2023.
Future benefit payments expected to be paid either by pension funds or directly by the Company to beneficiaries are as follows:
(in millions of Euros)Estimated benefits payments
Year ended December 31,
202356
202456
202557
202657
202760
2028 to 2032328
The weighted-average maturity of the defined benefit obligations was 11.2 and 14.2, respectively, for the years ended December 31, 2022 and 2021.
F-53


NOTE 24 - PROVISIONS
(in millions of Euros)Close down and environmental remediation costsRestructuring
 costs
Legal claims
and other costs
Total
At January 1, 202288227117
Allowance336
Amounts used(3)(2)(2)(7)
Unused amounts reversed(4)(4)
Unwinding of discounts and change in discount rates(5)(5)
Effects of changes in foreign exchange rates314
At December 31, 20228625111
Of which current12921
Of which non-current741690
Total provisions8625111
(in millions of Euros)Close down and environmental remediation costsRestructuring
 costs
Legal claims
and other costs
Total
At January 1, 202188627121
Allowance43411
Amounts used(1)(6)(2)(9)
Unused amounts reversed(2)(1)(6)(9)
Unwinding of discounts and change in discount rates(1)(1)
Effects of changes in foreign exchange rates44
Transfer(4)4
At December 31, 202188227117
Current711220
Non-Current8111597
Total Provisions88227117
Close down, environmental and remediation costs
The Group records provisions for the estimated present value of the costs of its environmental clean-up obligations and close down and restoration efforts based on the net present value of estimated future costs of the dismantling and demolition of infrastructure and the removal of residual material of disturbed areas.
These provisions are expected to be settled over the next 40 years depending on the nature of the disturbance and the technical remediation plans.
Legal claims and other costs
At December 31,
(in millions of Euros)20222021
Litigation1516
Disease claims (A)109
Other2
Total provisions for legal claims and other costs2527
(A)Since the early 1990s, certain activities of the Group’s businesses have been subject to claims and lawsuits in France relating to occupational diseases resulting from alleged asbestos exposure, such as mesothelioma and asbestosis. It is not uncommon for the investigation and resolution of such claims to go on over many years as the latency period for developing such diseases is typically
F-54


between 25 and 40 years. For any such claim, it is up to the social security authorities in each jurisdiction to determine if a claim qualifies as an occupational illness claim. If so determined, the Group must settle the case or defend its position in court. At December 31, 2022, six cases in which gross negligence is alleged (“faute inexcusable”) are outstanding (five at December 31, 2021), the average amount per claim being around €0.4 million. The average settlement amount per claim over the past five years was less than €0.5 million. It is not anticipated that the resolution of such litigation and proceedings will have a material effect on the future results from continuing operations, financial position, or cash flows of the Group.
Contingencies
The Group is involved, and may become involved, in various lawsuits, claims and proceedings relating to customer claims, product liability, employee and retiree benefit matters and other commercial matters. The Group records provisions for pending litigation matters when it determines that it is probable that an outflow of resources will be required to settle the obligation, and such amounts can be reasonably estimated. In some proceedings, the issues raised are or can be highly complex and subject to significant uncertainties and amounts claimed are and can be substantial. As a result, the probability of loss and an estimation of damages are and can be difficult to ascertain. In exceptional cases, when the Group considers that disclosures relating to provisions and contingencies may prejudice its position, disclosures are limited to the general nature of the dispute.
NOTE 25 - NON-CASH INVESTING AND FINANCING TRANSACTIONS
Property, plant and equipment acquired through leases or financed by third parties amounted to €18 million, €18 million and €66 million for the years ended December 31, 2022, 2021 and 2020, respectively. These leases and financings are excluded from the Statement of Cash Flow as they are non-cash investing transactions.
Fair values of vested Restricted Stock Units and Performance Stock Units amounted to €15 million for the years ended December 31, 2022 and 2021, and €14 million for the year ended December 31, 2020, respectively. They are excluded from the Statement of Cash flows as non-cash financing activities.
NOTE 26 - SHARE CAPITAL
Share capital amounted to €2,886,031.84 at December 31, 2022, divided into 144,301,592 ordinary shares, each with a nominal value of two cents and fully paid-up. All shares are of the same class and have the right to one vote.
(in millions of Euros)
Number of sharesShare capitalShare premium
At January 1, 2022141,677,3663420
New shares issued (A)2,624,226
At December 31, 2022144,301,5923420
(A)In the year ended December 31, 2022, Constellium SE issued and delivered 2,624,226 ordinary shares to certain employees and directors related to share-based compensation plans.
NOTE 27 - COVID-19-RELATED GOVERNMENT ASSISTANCE
In the year ended December 31, 2020, the Group received government assistance in various forms, including government-guaranteed credit facilities in France, Germany, and Switzerland (see NOTE 20 - Borrowings), as well as subsidies to compensate for the cost of employees furloughed as a result of the COVID-19 pandemic in various jurisdictions. These subsidies were recognized where there was reasonable assurance that they would be received and the Company was able to meet all of the associated conditions. For the year ended December 31, 2020, COVID-19-related subsidies in the amount of €22 million were accounted for as a deduction of employee benefit expenses.

F-55


NOTE 28 - COMMITMENTS
Non-cancellable lease commitments
Non-cancellable lease commitments relating to the future aggregate minimum lease payments under non-cancellable leases still recognized as expense are presented below:
At December 31,
(in millions of Euros)20222021
Less than 1 year33
1 to 5 years93
More than 5 years2
Total non-cancellable minimum lease payments128
Tangible and intangible asset commitments
Contractual commitments for the acquisition of Property, Plant and Equipment are presented below:
At December 31,
(in millions of Euros)20222021
Property, plant and equipment16665
Total tangible and intangible asset commitments16665
NOTE 29 - RELATED PARTIES
Subsidiaries and affiliates
A list of the principal companies controlled by the Group or over which the Group has significant influence is presented in NOTE 31 - Subsidiaries and Affiliates. Transactions between consolidated companies are eliminated when preparing the Consolidated Financial Statements.
Shareholders
One of our French entities entered into a fully committed term loan facility with a syndicate of banks (the “PGE French Facility”) on May 13, 2020 for an aggregate amount of up to €180 million, of which 80% is guaranteed by the French State. Bpifrance Financement, an affiliate of one of the shareholders of Constellium SE, Bpifrance Participations S.A., provided €30 million of the PGE French Facility. The initial maturity date of the PGE was May 2021 with an option for Constellium to extend for up to 5 years. In May 2021, the maturity date was extended to May 2022. In May 2022, the PGE was repaid accordingly.
Key management remuneration
The Group’s key management comprises the Board members and the Executive committee members effectively present in 2022.
Executive officers who are members of the Executive committee are those persons having authority and responsibility for planning, directing and controlling the activities of the Company, and typically directly reporting to the CEO.
The costs reported below are compensation and benefits for key management:
Short term employee benefits include their base salary plus bonus and other in-kind benefits;
Directors’ fees include annual retainers fees, committee membership fees, chair fees and cash paid in lieu of RSU grant for 2022;
Share-based compensation includes the portion of the IFRS 2 expense as allocated to key management;
Post-employment benefits mainly include pension costs;
Termination benefits include departure costs.
F-56


As a result, the aggregate compensation for the Group’s key management is comprised of the following:
Year ended December 31,
(in millions of Euros)202220212020
Short-term employee benefits1289
Directors' fees211
Share-based compensation10910
Post-employments benefits
Termination benefits
Employer social contribution211
Total261921
NOTE 30 - SHARE-BASED COMPENSATION
Description of the plans
Performance-Based Restricted Stock Units Award Agreements (equity-settled)
The Company has periodically granted Performance Stock Units (PSUs) to selected employees and to the CEO. These units vest after three years from the grant date if the following conditions are met:
A vesting condition under which the beneficiaries must be continuously employed by or at the service of the Company through the end of the vesting period; and
A performance condition, contingent on the TSR performance of Constellium shares over the vesting period compared to the TSR of specified indices. PSUs will ultimately vest based on a vesting multiplier which ranges from 0% to 200%.
The PSUs granted in July 2017 achieved a TSR performance of 186.8%. These PSUs vested in July 2020 and 1,458,985 shares were granted to beneficiaries.
The PSUs granted in May 2018 achieved a TSR performance of 182.9%. These PSUs vested in May 2021 and 1,161,718 shares were granted to beneficiaries.
The PSUs granted in April 2019 achieved a TSR performance of 200.0%. These PSUs vested in April 2022 and 1,849,268 shares were granted to beneficiaries.
In March 2022, the Company granted Performance Stock Units (PSUs) to selected employees and to the CEO. The following table lists the inputs to the valuation model used for the PSUs granted in 2022 and 2021:
March 2022 PSUsMay 2021 PSUs
Fair value at grant date (in euros)23.7021.84
Share price at grant date (in euros)17.1113.90
Dividend yield
Expected volatility (A)70%71%
Risk-free interest rate (US government bond yield)1.88%0.31%
Model usedMonte CarloMonte Carlo
(A)Volatilities for the Company and companies included in indices were estimated based on observed historical volatilities over a period equal to the PSU vesting period.
Restricted Stock Units Award Agreements (equity-settled)
During the year ended December 31, 2022, the Company granted Restricted Stock Units (RSUs) to a certain number of employees and to the CEO subject to the beneficiaries remaining continuously employed within or at the service of the Group
F-57


from the grant date through the end of the vesting period. The vesting period is three years. The fair value of the RSUs awarded is €17.11, being the euro equivalent of the quoted market price at grant date.
Equity Awards Plans (equity-settled)
In 2019, our non-executive Company Board members were granted two RSU awards. These RSUs vest in equal installments on the earlier of (i) the first anniversary or (ii) the date of the annual general meeting of shareholders of that year, and on the earlier of (i) the second anniversary or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service. The fair value of RSUs awarded under the plan was the the euro equivalent of the quoted market price at grant date.
In 2022, 2021 and 2020, no RSU awards were granted to our non-executive Company Board members.
Expense recognized during the year
In accordance with IFRS 2, share-based compensation is recognized as an expense over the vesting period. The estimate of this expense is based upon the fair value of a potential ordinary share at the grant date. The total share-based compensation for the year ended December 31, 2022, 2021 and 2020 amounted to €18 million, €15 million and €15 million, respectively.
Movement of potential shares
Performance-Based RSURestricted Stock UnitsEquity Award Plans
Potential SharesWeighted-Average Grant-Date Fair Value per Share Potential SharesWeighted-Average Grant-Date Fair Value per Share Potential SharesWeighted-Average Grant-Date Fair Value per Share
At January 1, 20212,594,32710.172,231,9116.8832,9128.39
Granted614,55521.84534,49913.90
Over-performance526,55115.31
Vested(1,161,718)15.31(520,064)10.27(32,912)8.39
Forfeited(47,188)10.29(97,347)7.17
At December 31, 20212,526,52711.712,148,9997.79
Granted (A)603,02323.70556,36017.11
Over-performance (B)924,63410.44
Vested(1,849,268)10.44(774,958)7.10
Forfeited (C)(19,082)11.65(54,955)9.04
At December 31, 20222,185,83415.561,875,44610.80
(A)For PSUs, the number of potential shares granted is presented using a vesting multiplier of 100%.
(B)When the achievement of TSR performance exceeds the vesting multiplier of 100%, the additional potential shares are presented as over-performance shares.
(C)For potential shares related to PSUs, 19,082 were forfeited following the departure of certain beneficiaries and none were forfeited in relation to the non-fulfilment of performance conditions.
Antidilutive potential ordinary shares
For the year ended December 31, 2020, there were 6,402,289 potential ordinary shares that could have had a dilutive impact but were considered antidilutive due to negative earnings.

F-58


NOTE 31 - SUBSIDIARIES AND AFFILIATES
The following Group’s affiliates are legal entities included in the Consolidated Financial Statements of the Group at December 31, 2022. All entities are consolidated except for Rhenaroll which is accounted for under the equity method.
EntityCountry% Group Interest
Cross Operating Segment
Constellium Singen GmbH (AS&I and P&ARP)Germany100%
Constellium Valais S.A. (AS&I and A&T)Switzerland100%
AS&I
Constellium Automotive USA, LLCU.S.100%
Constellium Engley (Changchun) Automotive Structures Co Ltd.China54%
Constellium Extrusions Decin S.r.o.Czech Republic100%
Constellium Extrusions Deutschland GmbHGermany100%
Constellium Extrusions Landau GmbHGermany100%
Constellium Extrusions Burg GmbHGermany100%
Constellium Extrusions France S.A.S.France100%
Constellium Extrusions Levice S.r.o.Slovakia100%
Constellium Automotive Mexico, S. DE R.L. DE C.V.Mexico100%
Constellium Automotive Mexico Trading, S. DE R.L. DE C.V.Mexico100%
Astrex IncCanada50%
Constellium Automotive Zilina S.r.o.Slovakia100%
Constellium Automotive (Nanjing) Co. Ltd.China100%
Constellium Automotive Spain SLSpain100%
Constellium UK LimitedUnited Kingdom100%
A&T
Constellium Issoire S.A.S.France100%
Constellium Montreuil Juigné S.A.S.France100%
Constellium China Co. Ltd.China100%
Constellium Japan KKJapan100%
Constellium Rolled Products Ravenswood, LLCU.S.100%
Constellium Ussel S.A.S.France100%
AluInfra Services SA (A)Switzerland50%
P&ARP
Constellium Deutschland GmbHGermany100%
Constellium Rolled Products Singen GmbH & Co. KGGermany100%
Constellium Neuf Brisach S.A.S.France100%
Constellium Muscle Shoals LLCU.S.100%
Constellium Holdings Muscle Shoals LLCU.S.100%
Constellium Muscle Shoals Funding II LLCU.S.100%
Constellium Muscle Shoals Funding III LLCU.S.100%
Constellium Metal Procurement LLCU.S.100%
Constellium Bowling Green LLCU.S.100%
Rhenaroll SAFrance50%
Holdings & Corporate
C-TEC Constellium Technology Center S.A.S.France100%
Constellium Finance S.A.S.France100%
F-59


Constellium France III S.A.S.France100%
Constellium France Holdco S.A.S.France100%
Constellium International S.A.S.France100%
Constellium Paris S.A.S.France100%
Constellium Germany Holdco GmbH & Co. KGGermany100%
Constellium Germany Verwaltungs GmbHGermany100%
Constellium US Holdings I, LLCU.S.100%
Constellium US Intermediate Holdings LLCU.S.100%
Constellium Switzerland AGSwitzerland100%
Constellium Treuhand UG (haftunsgbeschränkt)Germany100%
Engineered Products International S.A.S.France100%
(A)AluInfra Services SA, the joint venture created with Novelis in July 2018, is consolidated as a joint operation and is immaterial to the Group Consolidated Financial Statements.
NOTE 32 - SUBSEQUENT EVENTS
On February 2, 2023, the Group completed the sale of Constellium Ussel in exchange for cash consideration of €1.6 million.
F-60

TRANSLATION FROM FRENCH INTO ENGLISH (solely for convenience of English speaking users) CONSTELLIUM SE A European company with share capital of €2,886,031.84 Registered Office: Washington Plaza, 40-44 rue Washington, 75008 Paris Paris Trade and Companies Register n° 831 763 743 ARTICLES OF ASSOCIATION (as of April 4, 2022)


 
2 TITLE I FORM, NAME, OBJECT, REGISTERED OFFICE, AND DURATION OF THE COMPANY ARTICLE 1 – FORM The company shall be a European company. Created on May 14, 2010 in the form of a “besloten vennootschap met beperkte aansprakelijkheid” (B.V.) and transformed into " naamloze vennootschap " (N.V.) on May 21, 2013, it continues to exist among the owners of the shares composing its capital, after transformation into a European company pursuant to a general meeting dated June 27, 2019 and then transfer of its registered office to France pursuant to a general meeting dated November 25, 2019. It is governed by all applicable laws and regulations, as well as these Articles of Association. ARTICLE 2 – COMPANY NAME The company name is: CONSTELLIUM SE In all deeds and documents issued by the company and intended for third parties, the name shall always be immediately preceded or followed by the words: "société européenne" or the initials "SE" and the amount of share capital. ARTICLE 3 – COMPANY OBJECT The object of the company, directly or indirectly, in any form, in France and in all countries, is: • to incorporate, to participate in, to finance, to collaborate with, to manage, to supervise businesses, companies and other enterprises and provide advice and other services; • to acquire, use and/or assign industrial and intellectual property rights and real property; • to finance and/or acquire companies and any businesses; • to borrow, to lend and to raise funds, including through the issue of bonds, debt instruments or other securities or evidence of indebtedness as well as to enter into agreements in connection with the aforementioned activities; • to invest funds; • to provide guarantees and security for debts of legal persons or of other companies with which the Company is affiliated in a Group or for the debts of third parties; • to undertake all that which is connected to the foregoing or in furtherance thereof, all of the above being understood in the broadest sense of the words. ARTICLE 4 – REGISTERED OFFICE The company's registered office and central administration are located at: Washington Plaza, 40-44 rue Washington, 75008 Paris, France.


 
3 The registered office may be transferred to any other location within the French territory, either by decision of the ordinary general meeting or by decision of the Board of Directors, subject to such decision being ratified by the next ordinary general meeting. If a transfer is approved by the Board of Directors, the latter is authorised to amend the Articles of Association and to carry out the resulting publicity and filing formalities, provided the transfer is submitted for the ratification mentioned hereinabove. The Board of Directors may establish offices, agencies, or branches wherever it deems useful, and may also remove them. ARTICLE 5 – DURATION The company has a duration of ninety-nine (99) years as from its registration with the Paris Trade and Companies Register, except in cases of early dissolution or extension as approved by the extraordinary general meeting. TITLE II CAPITAL AND SHARES ARTICLE 6 – CAPITAL The capital amounts to two million, eight hundred and eighty-six thousand, thirty-one euros and eighty-four cents (€2,886,031.84). It is divided into one hundred and forty-four million, three hundred and one thousand, five hundred and ninety-two (144,301,592) ordinary shares, each with a nominal value of two euro cents (0.02), fully paid-up and all of the same category. ARTICLE 7 – FORM OF SHARES, SHAREHOLDING PROCEDURES Shares shall be either registered (“au nominatif”) or bearer (“au porteur”) shares, at the shareholder's discretion, in accordance with Article L. 228-1 of the French Commercial Code. Shares of the Company will be registered either on a register (the "U.S. Register") maintained in the United States of America by a registrar, or on accounts maintained by the Company (or its agent) or by authorized intermediaries in accordance with Article L. 211-3 of the French Monetary and Financial code (such accounts being collectively referred to as the "French Register"), at the shareholder’s discretion. Shares registered on the U.S. Register will either be in the name of Cede & co, acting on behalf of The Depository Trust Company ("DTC"), or in the name of holders who want to be directly recorded on the U.S. Register. The shares must be held through a participant in the system managed by DTC and registered on the U.S. Register in the name of Cede & co to be eligible for direct trading on the New York Stock Exchange. Shares registered on the U.S. Register will be in “au porteur” form; they shall be registered in France in the name of a single intermediary in the form of a collective account for the account of all owners of these shares, in accordance with Article L. 228-1, 7th subparagraph of the French Commercial Code.


 
4 Shares registered on the French Register may be in “au nominatif” form or in “au porteur” form, at the shareholder’s discretion, it being specified that these shares may not be traded in this form on the NYSE. On the effective date of the transfer of the registered office in France, all shares comprising the company's capital shall be entered in the U.S. Register. Any shareholder seeking to transfer its shares from one register to another will have to give proper instructions, at its own cost, to its broker or the Company, as the case may be. ARTICLE 8 – TRANSFERS Any transfer of shares shall be made pursuant to law and to these Articles of Association. Shares shall be transmitted by transfer between accounts, according to the procedures defined by the laws and regulations in force. Shares shall be freely transferable. ARTICLE 9 – THRESHOLD CROSSING Any natural person or legal entity acting alone or in concert, who comes to own, directly or indirectly, a number of shares equal to or greater than 5%, 10%, 15%, 20%, 25%, 30%, 33 1/3%, 50%, 66 2/3% or 90% of the total number of shares or voting rights must, within five (5) trading days after the shareholding threshold is crossed, notify the company, by certified letter with acknowledgement of receipt, of the total number of shares or voting rights that it owns alone, directly or indirectly, or in concert. Moreover, it shall also inform the company, in its threshold notification letter, (i) of the number of securities held giving deferred rights to the shares to be issued and the corresponding voting rights, and (ii) of the number of shares already issued or the voting rights it may acquire by virtue of agreements or financial instruments mentioned in Article L. 211-1 of the French Monetary and Financial Code. The same obligations apply if the participation in capital or voting rights falls below one of the thresholds stipulated hereinabove. Moreover, any person or entity who holds a number of shares equal to or greater than 10%, 15%, 20% or 25% of the total number of shares or voting rights in the company shall, within five (5) trading days after the shareholding threshold is crossed, inform the company of the objectives it intends to pursue over the six (6) months to come. Following a period of six (6) months, any person or entity who continues to hold a number of shares or voting rights equal to or greater than the fractions mentioned hereinabove, shall renew its statement of intent, in compliance with the aforementioned terms, for each new period of six (6) months. This statement shall specify whether the person or entity is acting alone or in concert, if it plans to discontinue or continue its purchases, to acquire or not the control of the company, to request its appointment or that of one or several persons as director. The company reserves the right to share with the public and shareholders either the objectives


 
5 that it has been notified of, or the relevant person's failure to comply with the aforementioned obligation. For the application of the preceding subparagraphs, the shares or voting rights listed in paragraphs 1 to 8 of Article L. 233-9 I of the French Commercial Code shall be considered equivalent to the shares or voting rights held by a person or an entity. Neither Cede & Co, acting on behalf of DTC, DTC, nor the intermediary acting as “intermédiaire inscrit” per subparagraph seven of Article L. 228-1 of the French Commercial Code are required to make the statements covered in this article, for all of the shares for which Cede & Co, DTC and such intermediary, respectively, are registered in such capacity in the books. ARTICLE 10 – MANDATORY PUBLIC OFFER Any natural or legal persons acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, who comes into possession, otherwise than following a voluntary takeover bid, directly or indirectly, of more than 30% of the equity securities or voting rights of the company, shall file a draft takeover bid on all the capital and securities granting access to the capital or voting rights, and on terms that comply with applicable U.S. Securities law, rules of the U.S. Securities and Exchange Commission (SEC) and NYSE rules. The same requirement applies to natural or legal persons, acting alone or in concert, who directly or indirectly own a number between 30% and half the total number of equity securities or voting rights of the company and who, in less than twelve consecutive months, increase the holding, in capital or voting rights, of at least 1% of the securities or voting rights of the company. When a draft offer is submitted, the price proposed must be at least equal to the highest price paid by the offeror, acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, over a period of twelve (12) months preceding the event giving rise to the obligation to submit the draft offer. In the event of a clear change in the characteristics of the company, if the market for its securities so justifies or in the absence of a transaction by the offeror, acting alone or in concert, over the company's shares during the twelve-month period mentioned in the first paragraph, the price will be fixed by an expert appointed in accordance with Article 1592 of the French Civil Code and determined according to the objective evaluation criteria usually used, the characteristics of the company and the market of its securities, it being specified that the expert will be required to take into account, in its assessment, the criteria identified by the French Commission des Opérations de Bourse, the French Autorité des Marchés Financiers ("AMF") and the French courts. The obligation to file a draft public offer does not apply if the person or persons concerned justify to the company the fulfilment of one of the conditions listed in Articles 234-7 and 234- 9 of the AMF’s Règlement Général. In the event of disagreement between the parties, an expert will be appointed, at the request of the most diligent party, by the president of the commercial court, ruling in the form of interim relief, for the purpose of determining whether or not it is necessary to file a draft public offer, it being specified that the expert will be required to apply the relevant provisions of the AMF’s Règlement Général as well as the criteria issued by the French Conseil des marchés financiers, the AMF and the French courts.


 
6 Neither Cede & Co, acting on behalf of DTC, DTC, nor the intermediary acting as “intermédiaire inscrit” per subparagraph 7 of Article L. 228-1 of the French Commercial Code are subject to the requirements covered in this article, for all of the shares for which Cede & Co, DTC and such intermediary, respectively, are registered in such capacity in the books. ARTICLE 11 – RIGHTS AND OBLIGATIONS ATTACHED TO THE SHARES The rights and obligations attached to the share follow the share, in any hand it passes, and the transfer includes all dividends accrued, unpaid, and accruing, and, as applicable, the share of reserves and provisions. Share ownership entails, ipso facto, the holder’s approval of these Articles of Association as well as of the decisions of the general meetings. The voting right attached to the company's shares shall be proportional to the percentage of the capital they represent, and each of the company's shares shall carry one vote. Each share entitles the holder, in the ownership of the company assets, profit-sharing, and liquidation surplus, to a percentage proportional to the number of existing shares, taking into account, as the case may be, the amortised and non-amortised capital, paid-up or unpaid capital, the nominal amount of the shares and the rights of the different categories of shares. Whenever it is necessary to own more than one share to exercise any right, the single shares or shares in fewer numbers than required shall confer no rights on their holders against the company, and in such cases the shareholders shall be personally responsible for pooling the required number of shares. TITLE III COMPANY ADMINISTRATION ARTICLE 12 – BOARD OF DIRECTORS 1. Composition The company shall be directed by a Board composed of natural or legal persons between three and eighteen in number, appointed by the general meeting. In the event of a merger, this number may be increased under the conditions provided by law. Any legal person shall, upon its appointment, assign a natural person as permanent representative to the Board of Directors. The permanent representative's term of office shall be the same as that of the legal person he or she is representing. If the legal person removes its permanent representative, it shall immediately provide a replacement. The same provisions apply in the event of the permanent representative's death or resignation. The general meeting may decide that the Board of Directors shall be renewed annually on a rotating basis, such that this rotation involves a given fraction of the number of directors. The directors' term of office is three (3) years renewable. By way of exception, (a) the general meeting may choose a director for a shorter term so that the renewal of the directors' terms of


 
7 office may be spread out over time, (b) the directors in office immediately before the day of registration of the Company in the registre du commerce et des sociétés of Paris shall remain in office thereafter, for a duration equal to their remaining term of office before such registration. A director's term of office ends at the close of the ordinary general meeting called to approve the financial statements for the past financial year and held in the year during which the term of office of said director expires. Directors may be reappointed at any time. They may be removed at any time by a decision of the general meeting. In the event of a vacancy through the death or resignation of one or more directorships, the Board of Directors may make temporary appointments between two general meetings. The director appointed to replace another director whose term of office has not expired remains in office only for as long as the remaining term of his or her predecessor's office. A company employee may be appointed as a director. His or her employment contract must correspond to an actual position. In such cases he or she does not lose the benefit of his or her contract of employment. The number of directors bound to the company by a contract of employment may not exceed one-third (1/3) of the directors in office. The number of directors who are more than seventy-five (75) years of age shall not exceed one- third (1/3) of the directors in office. If this limit is exceeded during the terms of office, the oldest director shall automatically be considered to have resigned at the close of the next general meeting. The Board of Directors comprises also, in accordance with the provisions of Article L. 225-27- 1 of the French Commercial Code, directors representing employees and whose status is subject to the legal and regulatory provisions in force and to these Articles of Association. The preceding subparagraphs of this article 12.1 are not applicable to the directors representing employees. The number of directors representing employees is equal to one if the number of directors appointed by the general meeting referred to in Articles L. 225-17 and L. 225-18 of the French Commercial Code is less than or equal to eight at the time of the appointment of said director and to two if this number is greater than eight. Directors representing employees are not taken into account for determining the minimum number and the maximum number of directors set forth in the first subparagraph of this article 12.1. When only one director representing employees must be appointed, he or she is designated by the Group Works Council (French Group Works Council). When two directors representing employees must be appointed, the second director is designated, in accordance with Article L. 225-27-1, III, 4 ° of the French Commercial Code, by the European Works Council (designated SE-WC). The voting procedures within the Group Works Council and the European Works Council (designated SE-WC) for the appointment of directors representing employees are those


 
8 applicable to the appointment of the secretaries of these Councils. The term of office of directors representing employees is three (3) years, renewable. The term of office of a director representing employees ends at the close of the ordinary general meeting of shareholders having approved the financial statements for the past financial year and held in the year during which the term of office said director expires. The term of office of a director representing the employees ends early under the conditions provided for by law and this article, and in particular in the event of termination of his or her employment contract (with the exception of intra-group mobility). If the conditions for applying Article L. 225-27-1 of the French Commercial Code are no longer met at the end of a financial year or if this Article is abrogated, the term of office of the director(s) representing employees ends at the close of the meeting during which the Board of Directors takes note of it. In the event of a vacancy for any reason whatsoever in a seat of a director representing employees, the vacant seat is filled in by an employee designated under the same condition as the replaced director representing employees, in accordance with Article L. 225-34 of the French Commercial Code. The term of office of a so appointed director representing employees ends at the expiry of the normal term of office of the other directors appointed in accordance with Article L. 225-27-1 of the French Commercial Code. It is specified that until the date of replacement of the director(s) representing employees, the Board of Directors may meet and validly deliberate The absence of appointment of the director(s) representing employees by the Council(s) referred to above, pursuant to law and this article, does not affect the validity of the deliberations of the Board of Directors. Directors representing employees are subject to the same obligations, particularly in terms of confidentiality, and incur the same responsibilities as other directors. 2. Chair – Bureau of the Board of Directors The Board of Directors elects a Chairman from among its members who must be a natural person. The Board of Directors sets his or her term office, which cannot exceed that of his or her directorship, and may remove him or her at any time. The Board sets his or her compensation. The Chairman organises and directs the tasks of the Board, which he or she then reports to the general meeting. He or she oversees the proper functioning of the various bodies of the company and, in particular, ensures that the directors are able to fulfil their mission. The Board Chairman may not be more than seventy-five (75) years of age. If the Chairman reaches that age during his or her term, he or she shall automatically be considered to have resigned. However, his or her term of office shall be extended until the next meeting of the Board of Directors during which his or her successor shall be appointed. Subject to this provision, the Board Chairman may be re-elected at any time. Moreover, the Board, if it sees fit, appoints a vice-chairman from among its members, whose term of office it sets within the limit of that of his or her directorship.


 
9 The Board appoints a secretary, who may be chosen from outside the directors and shareholders. ARTICLE 13 – MEETING OF THE BOARD OF DIRECTORS The Board of Directors meets as often as required by the company's interests, at the registered office or at the location indicated in the convening notice, and at least every three (3) months. Directors shall be convened to Board meetings by the Chairman. Convocation may be made through any written means. The Chairman must convene the Board of Directors within seven (7) days following a reasoned request made in this sense by the Chief Executive Officer, if the offices of Chairman and Chief Executive Officer are separate, or at least one-third (1/3) of the members of the Board of Directors. If this request goes unanswered, the requesters may themselves convene the meeting, stating the agenda. Moreover, the directors representing at least one-third (1/3) of the Board members may validly convene the meeting if the Board of Directors has not met for more than two (2) months. In this case, they must state the meeting's agenda. The Board meets either at the company's registered office or in any other location in France or outside France. An attendance record shall be kept, and the minutes drawn up after each meeting. Meetings of the Board of Directors shall be chaired by the Board Chairman. In the event of the Chairman's absence or prevention, the Board of Directors shall entrust the Chairman's duties to the vice-chairman. In the event of the absence or prevention of these latter, the Board shall appoint one of its members to chair each meeting; if there is a tied vote for this appointment, the meeting shall be chaired by the eldest candidate. For the Board's deliberations to be valid, more than half of the Board members must be present or represented. The Board of Directors' decisions shall be taken by a majority vote; if the votes are tied, the Chairman's vote shall be decisive. Decisions that are within the competence of the Board of Directors may also be taken by written consultation of the directors under the conditions and within the limits set down by French Law. These decisions currently include those provided for by the French Commercial Code in Article L. 225-24 (co-optation of directors), the last paragraph of Article L. 225-35 (authorization of security interests, endorsements and guarantees), the second paragraph of Article L. 225-36 (amendment of the articles of association to comply with legal and regulatory provisions) and I of Article L. 225-103 (convening of shareholders' meetings) and the decisions to transfer the registered office within the same department. In addition to the relevant provisions of these Articles of Association, the Board of Directors may adopt rules of procedure in order to organize its decision-making process and working method, including the rules in case of a conflict of interest. These rules of procedure may stipulate, specifically, that the directors attending the Board meeting via videoconference and


 
10 telecommunications methods shall be considered to be in attendance, in accordance with regulations in force. Each director receives the information required to perform his or her duties and, by virtue of his or her office, may obtain any and all documentation he or she deems useful. Any director may assign the power, even by letter, fax, or electronic mail, to another director to represent him or her in a Board meeting, but each director may only have one proxy during a meeting. Copies or extracts of the deliberations of the Board of Directors shall be validly certified by the Chairman of the Board of Directors, the Chief Executive Officer, the Deputy Chief Executive Officers, the director temporarily delegated to the duties of the chairman, or a proxy authorised for that purpose. ARTICLE 14 – POWERS AND DUTIES OF THE BOARD OF DIRECTORS The Board of Directors sets the guidelines for the company's activity and oversees their implementation, in accordance with its corporate interest, taking into consideration the social and environmental impact of its activity. Subject to the powers expressly assigned by law to the shareholders' meetings and within the limit of the corporate purpose, it hears any issue relevant to the company's smooth operation and, by means of its deliberations, settles the matters of concern to it. In its relations with third parties, the company shall be bound even by the decisions of the Board of Directors that do not come under the corporate purpose, unless the company can prove that the third party knew that the decision exceeded that purpose or that it could not have been unaware of this in light of the circumstances; publication of the Articles of Association alone does not constitute sufficient proof. The Board of Directors proceeds with the controls and checks that it deems advisable. Moreover, the Board of Directors exercises the special powers conferred on it by law. The Board of Directors may appoint, from within, one or more special committees, of which it sets the composition and powers and which carry out their activity under its responsibility. Each committee shall report on its missions at the next meeting of the Board of Directors. Directors, non-voting members, and any other person called to attend meetings of the Board of Directors are bound not to disclose, as applicable, even after the end of their duties, the information they have on the company and the disclosure of which could compromise the company's interests, except for cases in which such disclosure is required or allowed by law or in the public interest. ARTICLE 15 – GENERAL MANAGEMENT The company's executive management shall be assumed by a natural person appointed by the Board of Directors and given the title of Chief Executive Officer (directeur général). If the company's executive management is assumed by the Chairman (président), the laws, regulations, and statutes pertaining to the Chief Executive Officer shall be applicable to him or


 
11 her. He or she shall take the title of Chairman and Chief Executive Officer (président-directeur général). The Chief Executive Officer shall be vested with the broadest powers to act in all circumstances in the company's name. He or she shall exercise his or her powers within the scope of the corporate purpose and subject to those that the law expressly assigns to shareholders' meetings and the Board of Directors. He or she shall represent the company in its relations with third parties. The company shall be bound even by the actions of the Chief Executive Officer that do not belong to the corporate purpose, unless it can prove that the third party knew that the decision exceeded that purpose or that it could not have been unaware of this in light of the circumstances; publication of the Articles of Association alone does not constitute sufficient proof. The Chief Executive Officer shall not be more than seventy (70) years of age. If the Chief Executive Officer reaches that age limit, he or she shall be considered to have resigned. However, his or her term of office shall be extended until the next meeting of the Board of Directors during which the new Chief Executive Officer is appointed. The Board of Directors may remove the Chief Executive Officer at any time. If the removal is approved without due cause, it may give rise to damages, unless the Chief Executive Officer is taking office as the Chairman of the Board of Directors. By a simple resolution passed by a majority vote of the directors present or represented, the Board of Directors shall choose whether the general management of the company is to be assumed by the Chairman of the Board or by another natural person. Shareholders and third parties shall be informed of this choice in accordance with the laws and regulations. The Board of Directors' choice thus made shall remain in force until an opposing decision by the Board or, at the Board's discretion, throughout the Chief Executive Officer's term of office. If the company's general management is assumed by the Chairman of the Board of Directors, the provisions applicable to the Chief Executive Officer shall be applicable to him or her. On a proposal by the Chief Executive Officer, the Board of Directors may appoint one or more natural persons to assist the Chief Executive Officer as Deputy Chief Executive Officer (directeur général délégué). In agreement with the Chief Executive Officer, the Board of Directors shall set the scope and duration of the powers conferred on the Deputy Chief Executive Officers. The Board of Directors shall set their compensation. If a Deputy Chief Executive Officer is a director, his or her duties cannot outlast his or her directorship. With regard to third parties, Deputy Chief Executive Officers have the same powers as the Chief Executive Officer; Deputy Chief Executive Officers have the power to litigate. The number of Deputy Chief Executive Officers may not exceed five. The Deputy Chief Executive Officer(s) shall be removable at any time by the Board of


 
12 Directors, as proposed by the Chief Executive Officer. If the removal is approved without due cause, it may give rise to damages. A Deputy Chief Executive Officer may not be more than seventy (70) years of age. If a Deputy Chief Executive Officer in office reaches that age limit, he or she shall automatically be considered to have resigned. However, his or her term of office shall be extended until the next meeting of the Board of Directors during which a new Deputy Chief Executive Officer could potentially be appointed. If the Chief Executive Officer ceases to perform or is prevented from performing his or her duties, the Deputy Chief Executive Officer(s) shall retain all duties and powers until the appointment of the new Chief Executive Officer, unless decided otherwise by the Board of Directors. ARTICLE 16 – NON-VOTING MEMBERS The Board of Directors may appoint one or more non-voting members (censeurs) from among the shareholders, natural or legal persons, or elsewhere, but they shall not be more than two (2) in number. The non-voting members' term of office shall be set by the Board of Directors, not to exceed three (3) years. The duties of a non-voting member shall end at the close of the ordinary general meeting called to approve the financial statements for the past year and held in the year during which the term of office of said non-voting member expires. Non-voting members may be re-elected at any time. The Board of Directors may put an end to their term of office at any time. In the event of the death, resignation, or severance of a non-voting member for any other reason, the Board of Directors may replace him or her for the remainder of his or her term of office. Non-voting members shall be called upon to attend meetings of the Board of Directors as observers and may be consulted by the latter or by the Chairman and take part in the deliberations with a consultative voice only; however their absence cannot affect the validity of the deliberations. They shall be convened to Board meetings under the same conditions as directors. Non-voting members shall not be remunerated for their duties. However, the Board of Directors may authorise the reimbursement of the expenses that the non-voting members incur in the company's interest. ARTICLE 17 – INDEMNIFICATION OF DIRECTORS The members and former members of the Board of Directors shall be reimbursed for: (a) reasonable cost of conducting a defense against claims, including claims by the company (other than such claims for which such members or former members of the Board have been declared responsible for by a final court decision), based on acts or failures to act in the exercise of their duties or any other duties currently or previously performed by them at the company’s request; and (b) any damages payable by them as a result of an act or failure to act in the exercise of


 
13 their duties or any other duties currently or previously performed by them at the company’s request. There shall be no entitlement to indemnity: (a) if and to the extent the laws of France would not permit such indemnification; (b) if and to the extent a competent court has established in a final and conclusive decision that the act or failure to act of the current or former member of the Board may be characterized as willful (faute intentionnelle), intentionally reckless (faute lourde) or falling outside the exercise of its duties (faute détachable); or (c) if and to the extent the costs, damages or fines payable by the current or former member of the Board are covered by any liability insurance and the insurer has paid out the costs, damages or fines. Except if the claim is instituted by the company itself, the relevant current or former member of the Board of Directors shall follow the company’s instructions relating to the manner of his or her defense and consult with the company in advance about the manner of such defense. The person concerned shall not: (i) acknowledge any personal liability, (ii) waive any defense, or (iii) agree on a settlement, without the company’s prior written consent. The company may take out liability insurance for the benefit of current or former members of the Board. ARTICLE 18 – RELATED-PARTY AGREEMENTS Pursuant to subparagraph 6 of Article L. 229-7 of the French Commercial Code, Articles L. 225- 38 to L. 225-42 of the said Commercial Code are applicable to agreements entered into by the company. TITLE IV STATUTORY AUDITORS ARTICLE 19 – STATUTORY AUDITORS The company is audited, per the conditions set by law, by one or more statutory auditors meeting the legal conditions of eligibility. When the legal conditions are met, the company shall appoint at least two statutory auditors. Each statutory auditor shall be appointed by the ordinary general meeting. If the ordinary general meeting fails to elect a statutory auditor, any shareholder may petition the court to appoint one, with the Chairman of the Board of Directors duly summoned. The term of office of the court-appointed statutory auditors shall end when the ordinary general shareholders' meeting has duly appointed the statutory auditor(s).


 
14 TITLE V GENERAL MEETINGS ARTICLE 20 1. Convocation General meetings shall be convened and held per the conditions and deadlines set forth by the laws and regulations. Meetings shall be held at the registered office or at any other location specified in the convocation. 2. Entitlement The right to attend general meetings shall be documented by the book entry of shares in the name of the shareholder or of the intermediary registered on his or her behalf in the company registers in accordance with the deadlines and conditions set forth by law. Shareholders who do not attend the meeting in person may choose one of the following options: • be represented by the intermediary registered on their behalf; or • assign a proxy to another shareholder, to their spouse, or to the partner with whom they have entered into a civil union (pacte civil de solidarité); or • vote by mail; or • send a proxy to the company without indicating an assignment, in accordance with the conditions set forth by the laws and regulations in force. The date after which voting forms received by the Company will not be taken into account cannot be more than three days prior to a general meeting. However, the Board of Directors may decide to set a shorter period for any general meeting, and decide that voting forms must be received by the Company no later than first, second or third day preceding the general meeting in order to be taken into account. 3. Videoconference voting Under the conditions set forth by applicable laws and regulations, the Board of Directors may arrange for shareholders to attend and vote by videoconference or other means of telecommunications that allow for a person's identification. If the Board of Directors decides to exercise this option for a given meeting, the Board of Directors' decision is recorded in the meeting notice and/or convocation. Shareholders attending meetings by videoconference or any of the other means of telecommunications mentioned hereinabove, at the Board of Directors' discretion, shall be considered present for the calculation of quorum and majority. 4. Committee – Attendance sheet – minutes Meetings shall be presided over by the Chairman of the Board of Directors or, in his or her absence, by the Chief Executive Officer, by a Deputy Chief Executive Officer if he or she is a


 
15 director, or by a director specially appointed for that purpose by the Board. Failing that, the meeting shall elect its own Chairman. The committee shall include a Chairman and two scrutineers. The scrutineers' duties shall be performed by the two members of the meeting who have the highest number of votes, if they are present and accept these duties. The committee shall appoint a secretary, who need not be a shareholder. At each meeting, an attendance sheet shall be kept, with the powers assigned to authorised agents appended to it as well as any absentee ballots, and minutes shall be taken of the meeting. This attendance sheet may be regularised by the general meeting committee following the company's acceptance of the information transmitted by the registrar of the U.S. Register on the disposals made, before the second (2nd) business day preceding the meeting at zero hour, Paris time, as applicable, by shareholders who have already cast their vote before that date. Indeed, the company is obligated to invalidate or amend votes cast by shareholders who have thus disposed of their shares, pursuant to Articles R. 225-85 and R. 225-86 of the French Commercial Code. Consequently, in view of the transmission deadlines for this information, the attendance sheet prepared at the general meeting shall be a draft document until it is regularised. The outcome of voting on the resolutions shall be final after the information thus transmitted is taken into account. Copies or extracts of the meeting minutes shall be validly certified by the Chairman of the Board of Directors, by a director performing the duties of Chief Executive Officer, or by the meeting secretary. 5. Quorum and majority Shareholders' decisions shall be made at the general meeting. Only the extraordinary general meeting shall be authorised to amend any or all provisions of the Articles of Association. The ordinary general meeting shall make all other decisions falling within the competence of a general meeting. Special meetings shall be attended by holders of a given category of shares, assuming that such is created, to decide on any amendment to the rights in respect of shares of that category. The ordinary general meeting held on the date set by the first convening notice validly deliberates where the shareholders present, represented or having voted by correspondence hold at least one-fifth (1/5) of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting; no quorum is required for such second meeting. The extraordinary general meeting held on the date set by the first convening notice validly deliberates where the shareholders present, represented or having voted by correspondence hold at least a quarter (1/4) of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting. If the quorum at the second meeting is


 
16 not reached, the second meeting can be postponed to a date no later than two months after the date on which the second meeting was convened. The quorum for such second or postponed meeting, as the case may be, to be validly held is 1/5 of the voting shares. Special meetings held on the date set by the first convening notice may validly deliberate where the shareholders present, represented or having voted by correspondence hold at least one third (1/3), on first notice, and, failing which, 1/5 for the meeting held on the date set by the second convening notice or in the case of postponement of the second meeting. The ordinary general meeting's decisions shall be made by a majority of votes validly cast. Decisions of the extraordinary general meetings and special meetings shall be made by a two- thirds (2/3) majority of votes validly cast. Votes cast shall not include those attached to shares for which the shareholder has not taken part in voting or has abstained or has returned a blank or invalid vote. TITLE VI COMPANY RESULTS ARTICLE 21 – FINANCIAL YEAR Each financial year shall last one calendar year, beginning on 1 January and ending on 31 December. ARTICLE 22 – PROFITS - LEGAL RESERVE A mandatory deduction of five percent (5%) of the profit for the financial year, minus any prior losses, shall be allocated to creating a reserve fund known as the "legal reserve." This deduction shall cease to be mandatory once the amount of the legal reserve reaches one-tenth (1/10) of the capital. Distributable profit shall comprise profit for the financial year, minus any prior losses and the deduction stipulated in the preceding subparagraph, plus accumulated profit. ARTICLE 23 – DIVIDENDS If the financial statements for the year, as approved by the general meeting, show a distributable profit, the general meeting shall decide to enter it in one or more reserve accounts of which it governs the allocation or use, to carry it forward, or to distribute it as dividends. After recording the existence of reserves available to it, the general meeting may decide to distribute funds deducted from those reserves. In this case, the decision shall expressly indicate the reserve accounts from which these deductions are made. However, dividends shall first be deducted from the distributable profit for the financial year. The procedures for issuing payment of dividends shall be set by the general meeting or by the Board of Directors, as appropriate.


 
17 Distributions payable in cash shall be approved in euro and paid (i) in euro for all holders of shares held on the French Register and (ii) in U.S. dollars (USD) for all holders of shares entered in the U.S. Register. For the purposes of paying the dividend in dollars, the general meeting or, as appropriate, the Board of Directors shall set the reference date to be applied for the EUR/USD conversion price. Dividend payment shall be issued no later than nine (9) months after the close of the financial year. The general meeting approving the financial statements for the year may grant each shareholder, for some or all of the dividend being distributed, the choice of cash or shares in payment of the dividend. Likewise, each shareholder may be granted an interim distribution, and for some or all of said interim distribution, the choice of cash or shares in payment of the interim distribution. The offer of payment in shares, the price, and the conditions for issuing the shares, as well as the request for payment in shares and the conditions for the capital increase, shall be governed by the laws and regulations in force. The Board of Directors may decide to carry out interim distributions under the conditions set out by the laws and regulations in force. TITLE VII DISSOLUTION · LIQUIDATION ARTICLE 24 – EARLY DISSOLUTION The extraordinary general meeting may decide on the company's early dissolution at any point in time. ARTICLE 25 – LOSS OF ONE-HALF OF CAPITAL If, due to losses recorded in the accounting documents, the shareholders’ equity falls below one- half of the registered capital, the Board of Directors shall, within four months from approval of the financial statements showing such a loss, convene the extraordinary general meeting for the purpose of deciding whether the early dissolution of the company is justified. If the decision is not made to dissolve, the capital shall, no later than the closure of the second financial year following the one during which the losses were recorded, and subject to the laws relating to the minimum capital of sociétés anonymes, be reduced by an amount equal to or greater than any losses that could not be charged against the reserves, if, during that period, the equity capital has not been restored to a value equal to or greater than one-half of the capital. If the general meeting is not held, or if that meeting fails to validly deliberate, any interested party may petition the court for the company's dissolution.


 
18 ARTICLE 26 – EFFECTS OF DISSOLUTION The company shall be in liquidation from the moment it is dissolved for any reason whatsoever. Its legal personality shall persist for the purposes of this liquidation until the closure thereof. Throughout the liquidation period, the general meeting shall retain the same powers as it had during the company's existence. Shares shall remain tradeable until the closure of the liquidation. The company's dissolution shall only have effect with respect to third parties from the date on which said dissolution is published in the trade and corporate register. ARTICLE 27 – APPOINTMENT OF LIQUIDATORS – POWERS At the expiration of the company's duration or in the event of early dissolution, the general meeting shall govern the mode of liquidation and appoint one or more liquidators, whose powers it shall set and who shall perform their duties in compliance with the law. The appointment of liquidators puts an end to the duties of the directors, the Chairman, the Chief Executive Officer, and the Deputy Chief Executive Officers. TITLE VIII NOTIFICATIONS ARTICLE 28 All notifications provided under these Articles of Association shall be made by certified letter with acknowledgement of receipt or by extrajudicial act. Simultaneously, a duplicate of the notification shall be sent to its recipient by regular mail. TITLE IX DISPUTES ARTICLE 29 Any disputes that may arise during the life of the company or its liquidation, either among shareholders or between the company and the shareholders, as to the construal or execution of these Articles of Association or, generally, regarding company matters, shall fall within the jurisdiction of the competent courts of the location of the registered office. As such, in case of a dispute, each shareholder must elect domicile under the jurisdiction of the competent court of the location of the registered office, and all summons and notices shall be lawfully issued to this domicile. If no domicile is elected, the summons and notices shall be validly made to the Office of the Public Prosecutor (Procureur de la République) of the regional court (Tribunal de Grande Instance) of the location of the registered office.


 

1 Exhibit 2.1 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the ordinary shares and the Articles of Association of Constellium SE (“Constellium SE” or the “Company”) is a summary and does not purport to be complete. This summary is subject to, and qualified in its entirety by reference to, the complete text of the Company’s Articles of Association, which are incorporated by reference as Exhibit 1.1 of the Company’s Annual Report on Form 20-F to which this description is also an exhibit. The Company encourages you to read the Company’s Articles of Association carefully. As of December 31, 2022, Constellium SE had the following series of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act: Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Ordinary Shares, nominal value €0.02 per share CSTM New York Stock Exchange General On June 28, 2019, Constellium N.V. converted its corporate form from a Dutch public limited liability company (Naamloze Vennootschap) into a Societas Europaea (SE) and changed its name to Constellium SE, with its head office remaining in Amsterdam, the Netherlands. On December 12, 2019, Constellium SE completed its re-domicile and the relocation of its head office to Paris, France (the “Transfer”). Effective as of December 12, 2019, the Company’s existing articles of association were amended by means of a deed of amendment to reflect the Company’s re-domicile to Paris, France (as further amended from time to time, the “Articles of Association”). The Company’s number with the Paris Trade and Companies Register is 831 763 743. According to article 3 of the Articles of Association, the object of the Company, directly or indirectly, in any form, in France and in all countries, is: • to incorporate, to participate in, to finance, to collaborate with, to manage, to supervise businesses, companies and other enterprises and provide advice and other services; • to acquire, use and/or assign industrial and intellectual property rights and real property; • to finance and/or acquire companies and any businesses; • to borrow, to lend and to raise funds, including through the issue of bonds, debt instruments or other securities or evidence of indebtedness, as well as to enter into agreements in connection with the aforementioned activities; • to invest funds; • to provide guarantees and security for debts of legal persons or of other companies with which the Company is affiliated in a Group or for the debts of third parties; • to undertake all that which is connected to the foregoing or in furtherance thereof, all of the above being understood in the broadest sense of the words. Outstanding Capital Stock As of December 31, 2022, the Company’s issued and paid-up share capital amounted to €2,886,031.84 consisting of 144,301,592 ordinary shares, each with a nominal value of €0.02, all of the same class. French law does not recognize the concept of authorized capital and any capital increase will have to be decided at an extraordinary shareholders’ meeting of the Company. Each of the ordinary shares has one vote. Form of Shares Pursuant to our Articles of Association, our ordinary shares are available in the form of an entry in a share register without issuance of a share certificate, and may be registered either on the U.S. Register maintained by our transfer agent, Computershare Trust Company, N.A. (“Computershare”) or on accounts maintained in France in accordance with French requirements (such accounts being collectively referred to as the “French Register”).


 
2 The U.S. Register Shares registered on the U.S. Register are either in the name of Cede & co., acting on behalf of DTC, or in the name of holders who want to be directly recorded on the U.S. Register. Only shares registered on the U.S. Register in the name of Cede & co are eligible for direct trading on the NYSE. Shares registered on the U.S. Register are in “au porteur” form. The ordinary shares of Constellium SE are admitted to the operations of the central depositary Euroclear France. Uptevia (formerly CACEIS Corporate Trust) acts in France as a registered intermediary (“intermédiaire inscrit”) for the account of the owners of the shares registered on the U.S. Register in accordance with articles L. 228-1 et seq. of the French Code de commerce (the “French Commercial Code”). The French Register Shares registered on the French Register may be in “au nominatif” form (i.e., registered on an account maintained by or on behalf of the Company) or in “au porteur” form (i.e., registered on an account maintained by an authorized intermediary in accordance with Article L. 211-3 of the French code monétaire et financier to comply with French requirements). With respect to shares held in “au nominatif” form, each shareholder may elect to give instructions directly to the issuer or its agent (“au nominatif pur”) or through an authorized intermediary with which it has opened a securities account (“nominatif administré”). The accounts on which shares are held in any such forms (“nominatif pur,” “nominatif administré,” “au porteur”) are collectively referred to as the French Register. Each shareholder has the option to have its shares registered on the U.S. Register or on the French Register and, in the latter case, to have its shares held in “au nominatif” or in “au porteur” form. Any shareholder seeking to transfer its shares from one register to another will have to give proper instructions, at its own cost, to its broker or the Company, as the case may be. Restrictions on share transfer and ownership Our ordinary shares are freely transferable except as otherwise restricted under U.S. or other applicable laws, which may include securities laws, antitrust laws or laws restricting foreign investment. Under current French laws and regulations related to foreign investments, the acquisition, directly or indirectly, of 25% or more of the voting rights of a French company by a non-French investor, or a French investor domiciled outside of France or controlled by one of the former, is subject to prior approval of the French Ministry of the Economy, if the company is involved, even occasionally, in activities which may impact public order, public security or national defense interests. Certain activities of certain French subsidiaries of Constellium SE may qualify as such activities and, therefore, the acquisition, directly or indirectly, of 25% or more of the voting rights of Constellium SE may require such prior approval. Issuance of Ordinary Shares As indicated under “Form of Shares”, our shares may be held in either registered (“au nominatif”) or bearer (“au porteur”) form, at the shareholder’s discretion. Shares must be issued for a subscription price at least equal to their nominal value, which must be fully paid unless otherwise agreed. Shares paid in cash must be paid up to at least 25% of their nominal value and, as the case may be, the whole of any issue premium at the time of issuance. In order to be traded on the NYSE, shares must be held through a participant in the system managed by the Depositary Trust Company (“DTC”). To that end, shares that are DTC-eligible are recorded in the U.S. Register maintained by Computershare. The U.S. Register includes all shares traded on the NYSE and the shares registered directly with this U.S. Register. Shares recorded in the U.S. Register are in bearer (“au porteur”) form, meaning that a registered intermediary for the account of our beneficial owners (the “French Intermediary”) is registered in France for the account of the owners of the shares registered on the U.S. Register in accordance with articles L. 228-1 et seq. of the French Commercial Code. Shares other than those recorded in the U.S. Register shall be recorded on the French Register, which shares may not be traded on the NYSE (see “Form of Shares”). Any shareholder wishing to hold its shares on one or another register shall, at its own expense, provide instructions to this end to its account holder or to the Company, as applicable.


 
3 As of December 31, 2022, 144,291,033 shares of the Company were recorded in the U.S. Register and 10,559 shares of the Company were recorded on the French Register. As a French company that has listed securities in the United States, we are subject to U.S. securities laws and regulations regarding trading in the Company’s ordinary shares. Under U.S. securities laws and regulations, persons are prohibited from trading on the basis of material, non-public information. We apply the Company’s Insider Trading Policy consistent with U.S. laws and regulations and make this policy available to our directors and employees to whom these laws and regulations may apply. The rules on insider dealing, unlawful disclosure of inside information and market manipulation under Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014 on market abuse (and the texts adopted for its implementation) apply to the Company as issuer of debt securities that are admitted to trading on the Euro MTF market of the Luxembourg Stock Exchange. Share-Based Compensation Our share-based compensation plan is the Constellium SE 2013 Equity Incentive Plan (the “Plan”). The principal purposes of the Plan are to focus our officers and employees on business performance to help create shareholder value, to encourage innovative approaches to the business of the Group and to encourage ownership of our ordinary shares by officers and employees. The Plan is also intended to recognize and retain our key employees needed to sustain and ensure our future and business competitiveness. The Plan provides for a variety of awards, including “incentive stock options” (within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) (“ISOs”), nonqualified stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), other stock- based awards or any combination of those awards. To date, we have only awarded RSUs and PSUs under the Plan. The Plan provides that awards may be made under the Plan for 10 years following approval by the Company’s board of directors (the “Board of Directors”) of the Plan in 2013. The Company’s shareholders previously authorized a total of 14,292,291 ordinary shares to be eligible for issue or delivery under the Plan. These authorizations were confirmed at the shareholders’ meeting held on November 25, 2019 to allow for awards to be made under the Plan following the Transfer. The number of ordinary shares so authorized and available was subject to adjustment in certain circumstances to prevent dilution. This shareholders’ authorization expired on January 24, 2022. At the Company’s shareholders’ meeting held on May 11, 2021, the shareholders authorized an additional 6,800,000 ordinary shares to be eligible for issue or delivery under the Plan. This shareholders’ authorization is effective until July 10, 2024. The number of ordinary shares so authorized and available is subject to adjustment in certain circumstances to prevent dilution. Awards made following the Transfer are subject to compliance with mandatory provisions of the French Commercial Code that now apply, as further described below. Administration The Plan is administered by the Human Resources Committee of our Board of Directors. The Board of Directors or the Human Resources Committee may delegate administration to one or more members of our Board of Directors. The Human Resources Committee has the power to interpret the Plan and to adopt rules for the administration, interpretation and application of the Plan according to its terms. The Board of Directors, acting on the recommendation of our Human Resources Committee, determines the number of our ordinary shares that will be subject to each award granted under the Plan and may take into account the recommendations of our senior management in determining the award recipients and the terms and conditions of such awards. Subject to certain exceptions as may be required pursuant to Rule 16b-3 under the Exchange Act, if applicable, our Board of Directors may, at any time and from time to time, exercise any and all rights and duties of the Human Resources Committee under the Plan.


 
4 Following the Transfer, in accordance with the French Commercial Code: • the Human Resources Committee no longer has the power to make awards of any type; • the Board of Directors has exclusive power to make awards that are to be settled with shares; • the Board of Directors has exclusive power to make awards to the Company’s CEO and to any deputy chief executive officer (Directeur Général Délégué), irrespective of the form of settlement; and • the Company’s senior management has exclusive power to make awards to officers and employees that are cash-settled (other than to the Company’s CEO and any deputy chief executive officer (Directeur Général Délégué)). Eligibility Officers and employees are eligible to be granted awards under the Plan. Our Human Resources Committee makes recommendations regarding: • which officers and employees are to be granted awards; • the type of award that is granted; • the number of our ordinary shares subject to the awards; and • the terms and conditions of such awards, consistent with the Plan. Following the Transfer, the power to make new awards and set their terms are as described above under “Administration.” Furthermore, in accordance with the French Commercial Code, following the Transfer, the Company is no longer permitted to grant restricted stock, and only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share-settled awards. Except for the Chairman of the Board of Directors, non-executive members of the Board of Directors and consultants are no longer eligible to receive share-settled awards. Stock Options Subject to the terms and provisions of the Plan, stock options to purchase our ordinary shares may be granted to eligible individuals at any time and from time to time as determined by our Board of Directors. Stock options may be granted as ISOs, which are intended to qualify for favorable treatment to the recipient under U.S. federal tax law, or as nonqualified stock options, which do not qualify for this favorable tax treatment. Subject to the limits provided in the Plan, our Board of Directors has the authority to determine the number of stock options granted to each recipient. Each stock option award is evidenced by a stock option agreement that specifies the stock option exercise price, whether the stock options are intended to be incentive stock options or nonqualified stock options, the term of the stock options, the number of shares to which the stock options pertain, and such additional limitations, terms and conditions as our Board of Directors may determine. Our Board of Directors determines the exercise price for each stock option granted, except that the stock option exercise price may not be less than 100% of the fair market value of an ordinary share on the date of grant. All stock options granted under the Plan expire no later than 10 years from the date of grant. Stock options are nontransferable except by will or by the laws of descent and distribution or, in the case of nonqualified stock options, as otherwise expressly permitted by our Board of Directors. The granting of a stock option does not accord the recipient the rights of a shareholder, and such rights accrue only after the exercise of a stock option and the registration of ordinary shares in the recipient’s name. Following the Transfer, stock options may only be granted if the Company’s shareholders specifically authorize the Board of Directors to make such grants. As of the date of this document, we have not requested such shareholders’ authorization, but may do so at a future date. Stock Appreciation Rights The Company’s senior management may grant SARs under the Plan. SARs may be “tandem SARs,” which are granted in conjunction with a stock option, or “free-standing SARs,” which are not granted in conjunction with a stock option. A SAR entitles the holder to receive from us, upon exercise, an amount equal to the excess, if any, of the aggregate fair market value of a specified number of our ordinary shares to which such SAR pertains over the aggregate exercise price for the underlying


 
5 shares. The exercise price of a free-standing SAR may not be less than 100% of the fair market value of an ordinary share on the date of grant. A tandem SAR may be granted at the grant date of the related stock option. A tandem SAR may be exercised only at such time or times and to the extent that the related stock option is exercisable and has the same exercise price as the related stock option. A tandem SAR terminates or is forfeited upon the exercise or forfeiture of the related stock option, and the related stock option terminates or is forfeited upon the exercise or forfeiture of the tandem SAR. Each SAR is evidenced by an award agreement that specifies the exercise price, the number of ordinary shares to which the SAR pertains and such additional limitations, terms and conditions as the Company's senior management may determine. We may make payment of the amount to which the participant exercising the SARs is entitled by delivering ordinary shares, cash or a combination of stock and cash as set forth in the award agreement relating to the SARs. SARs are not transferable except by will or the laws of descent and distribution or, with respect to SARs that are not granted in “tandem” with a stock option, as expressly permitted by the Company’s senior management. Following the Transfer, the power to make new grants of free-standing SARs and set the terms of free-standing SARs are as described above under “Administration” with respect to cash-settled awards. No tandem SARs may be granted unless the shareholders specifically authorize the Board of Directors to make grants of stock options, as described above under “Stock Options”. Restricted Stock The Plan provides for the award of ordinary shares that are subject to forfeiture and restrictions on transferability to the extent permitted by applicable law and as set forth in the Plan, the applicable award agreement and as may be otherwise determined by our Board of Directors. Except for these restrictions and any others imposed by our Board of Directors to the extent permitted by applicable law, upon the grant of restricted stock, the recipient will have rights of a shareholder with respect to the restricted stock, including the right to vote the restricted stock and to receive all dividends and other distributions paid or made with respect to the restricted stock on such terms as set forth in the applicable award agreement. During the restriction period set by our Board of Directors, the recipient is prohibited from selling, transferring, pledging, exchanging or otherwise encumbering the restricted stock to the extent permitted by applicable law. Following the Transfer, under the terms of the French Commercial Code, the Company is no longer permitted to grant restricted stock. Restricted Stock Units (RSUs) The Plan authorizes our Board of Directors to grant RSUs. RSUs are not ordinary shares and do not entitle the recipient to the rights of a shareholder, although the award agreement may provide for rights with respect to dividend equivalents. The recipient may not sell, transfer, pledge or otherwise encumber RSUs granted under the Plan prior to their vesting. RSUs may be settled in cash, ordinary shares or a combination thereof as provided in the applicable award agreement, in an amount based on the fair market value of an ordinary share on the settlement date. Following the Transfer, the Board of Directors has exclusive power to make new grants of RSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”. Performance-Based Restricted Stock Units (PSUs) The Plan authorizes the Board of Directors to grant PSUs. The value of a PSU is conditioned upon the achievement of performance goals set by our Board of Directors in granting the PSUs and may be paid in cash, ordinary shares, other property or a combination thereof. Each PSU award is evidenced by an award agreement, which may contain terms relating to the termination of a participant’s employment.


 
6 Following the Transfer, the Board of Directors has exclusive power to make new grants of PSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”. Other Stock-Based Awards The Plan provides for the award of ordinary shares and other awards that are valued by reference to our ordinary shares, including unrestricted stock, dividend equivalents and convertible debentures. Following the Transfer, grants of other stock-based awards may only be made in accordance with the French Commercial Code. Performance Goals The Plan provides that performance goals may be established by our Board of Directors in connection with the grant of any award under the Plan. Termination without Cause following a Change in Control The Plan has a “double trigger” vesting provision in place for its awards. Upon a termination of employment by the Company without “cause” (as defined in the Plan) of a participant occurring upon or during the two years immediately following the date of a “change in control”, unless otherwise provided in the applicable award agreement, (i) all awards held by such participant will vest in full (in the case of any awards that are subject to performance goals, at target) and be free of restrictions, and (ii) any option or SAR held by the participant as of the date of the change in control that remains outstanding as of the date of such termination of employment may thereafter be exercised until (A) in the case of ISOs, the last date on which such ISOs would otherwise be exercisable or (B) in the case of nonqualified options and SARs, the later of (x) the last date on which such nonqualified option or SAR would otherwise be exercisable and (y) the earlier of (I) the second anniversary of such change in control and (II) the expiration of the term of such nonqualified option or SAR. With respect to new share-settled awards made following the Transfer, the Company’s ability to deliver shares is subject to the minimum vesting and, if applicable, holding period requirements set forth under the French Commercial Code, as described below. Application of the French Commercial Code Following the Transfer, the French Commercial Code applies to new share-settled awards and requires in particular that: • awards be made by the Board of Directors, pursuant to an authorization of the shareholders which may be valid for a maximum of up to 38 months; • the total number of shares subject to outstanding awards plus shares subject to a mandatory holding condition under French tax law (if any) may not exceed 10% of share capital, as measured on the relevant grant date; • only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share- settled awards (as described above under “Eligibility”); and • persons holding more than 10% of the Company's share capital prior to grant or as a result of the award are ineligible. Pursuant to the French Commercial Code, awards are subject to a two-year minimum vesting period, or a one-year minimum vesting period followed by a mandatory one-year holding period, subject in both cases to exceptions for death and disability. The foregoing requirement pursuant to the French Commercial Code is satisfied with respect to awards under the Plan, which are subject to a minimum 36-month vesting period. Amendments Our Board of Directors or our Human Resources Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation will be made that would materially impair the rights of a participant with respect to a previously granted award without such participant’s consent, unless such an amendment is made to comply with applicable law, including, without limitation, Section 409A of the Code, stock exchange rules or accounting rules. In addition, no such amendment will be


 
7 made without the approval of the Company’s shareholders to the extent such approval is required by applicable law or the listing standards of the applicable stock exchange. Rights of Shareholders and Shareholders’ Meetings Under French law and in general, each shareholder is entitled to one vote per share at any general shareholders’ meeting. A general shareholders’ meeting is held annually to, inter alia, approve the annual financial statements. General shareholders’ meetings (including annual meetings) can be ordinary and/or extraordinary, depending upon the resolutions submitted to the vote. At an extraordinary general shareholders’ meeting (which votes upon any proposal to change the articles of association, including any change in the rights of shareholders), majority is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/4 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting. If the quorum at the second meeting is not reached, the second meeting can be postponed to a date no later than two months after the date on which the second meeting was convened. The quorum for such second or postponed meeting, as the case may be, to be validly held is 1/5 of the voting shares. At an ordinary shareholders’ meeting (which votes upon any proposal within the competence of a general shareholders’ meeting other than an extraordinary shareholders meeting such as approval of annual financial statements or appointment of directors), majority is simple majority (more than 50%) of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/5 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting; no quorum is required for such second meeting. Special meetings bring together the holders of shares of a specified class, should it be created, to decide on an amendment to the rights relating to the shares of this class. Majority at special meetings is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/3 of the voting shares, and, failing which, 1/5 for the meeting held on the date set by the second convening notice or in the case of postponement of the second meeting. French law does not provide for cumulative voting. The right to participate in a shareholders’ meeting is granted to all the shareholders whose shares are fully paid up and for whom a right to attend shareholders’ meetings has been established by registration of their shares in their names or names of the authorized intermediary acting on their behalf on the second business day prior to the shareholders’ meeting at 0:00 (zero hour) (Paris time) (the “French Record Date”), either in the registered (“au nominatif”) shares accounts held by the company (or an agent acting on its behalf) or in the bearer (“au porteur”) shares accounts held by the authorized intermediary. Shareholders holding shares registered on the U.S. Register (which include all shares which are listed on the NYSE, held through a DTC participant and shares directly recorded in the name of their holder with Computershare) vote through a process similar to the one that was in place before the Transfer with the following main differences: • their voting instructions will be transmitted to the Company via the French Intermediary, acting as intermediary for the account of all shareholders registered on the U.S. Register, in accordance with articles L. 228-1 et seq. of the French Commercial Code; • the French Record Date will be set; • an additional record date will be fixed for all shareholders registered on the U.S. Register, which date will be the 25th day before the meeting (the “U.S. Record Date”); and • shareholders who purchase shares between the U.S. Record Date and the French Record Date will be entitled to participate and vote at the shareholders’ meeting as long as they continue to be shareholders on the French Record Date. However, given the short time between the French Record Date and the shareholders’ meeting date, shareholders as of the French Record Date may not have received the notices and information received by shareholders holding shares registered on the U.S. Register as of the U.S. Record Date. To the extent that shareholders as of the U.S. Record Date have sent voting instructions and sold or otherwise transferred their


 
8 shares as of the French Record Date, such voting instructions will be invalidated or modified by the Company, as the case may be, in accordance with articles R. 225-85 and R. 225-86 of the French Commercial Code. Shareholder Proposals and Action by Written Consent Pursuant to French law, the board of directors is required to convene an annual ordinary general meeting of shareholders for approval of the annual financial statements. This meeting must be held within six months after the end of each prior fiscal year. The board of directors may also convene an ordinary or extraordinary meeting of shareholders upon proper notice at any time during the year. If the board of directors fails to convene a shareholders’ meeting, the auditors may call the meeting. In a bankruptcy, the liquidator or court-appointed agent may also call a shareholders’ meeting in some instances. Any of the following may request the court to appoint an agent: • one or several shareholders holding at least 5% of the share capital, or •  any interested party or the workers committee in cases of urgency. Shareholders holding a majority of the capital or voting rights after a public take-over bid or exchange offer or the transfer of a controlling block of shares may also convene a shareholders’ meeting. In general, shareholders can only take action at shareholders’ meetings on matters listed on the agenda for the meeting. As an exception to this rule, shareholders may take action with respect to the dismissal and appointment of directors. Additional draft resolutions to be submitted for approval by the shareholders at any shareholders’ meeting may be proposed to the board of directors within the legal time limit (which is no later than 20 days after the publication of the convening notice (avis de réunion) and in any event no sooner than 25 days prior to the date of the shareholders’ meeting) by one or several shareholders holding a specified percentage of shares. The convening notice (avis de réunion) must be published in France with the BALO at least 35 days prior to the date of the shareholders’ meeting and can be consulted at https://www.journal- officiel.gouv.fr/balo/. As the U.S. Record Date is fixed at the 25th day before the shareholders’ meeting, shareholders wishing to submit additional resolutions will need to submit them before receiving the meeting materials sent to them on or around the U.S. Record Date, otherwise their submissions will not be considered. The percentage of shares required to be held by one or several shareholders to be able to submit additional draft resolutions depends on the amount of the share capital of the Company; based on the Company’s issued share capital of €2,886,031.84 as of December 31, 2022, this percentage would be 2.89%. Under French law, shareholders’ action by written consent is not permitted in a Societas Europaea. Shareholder Suits French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a company in the company’s interest if it fails to bring such legal action itself. If so, any damages awarded by the court are paid to the company and any legal fees relating to such action are borne by the relevant shareholder or the group of shareholders. The plaintiff must remain a shareholder throughout the duration of the legal action. There is no other case where shareholders may initiate a derivative action to enforce a right of a company. A shareholder may alternatively or cumulatively bring an individual legal action against the directors, provided he or she has suffered distinct damages from those suffered by the company. In this case, any damages awarded by the court are paid to the relevant shareholder. Repurchase of Shares; Pre-emptive Rights; Shareholder Vote on Certain Reorganizations Under French law, a private company (which our Company is for French law purposes for so long as its shares are not listed on an EU-regulated market) may not subscribe for newly issued shares in its capital but may, however, acquire its own shares,


 
9 subject to shareholders’ authorization, for the following purposes only: • With a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, restricted free share or share option plan, not to exceed 10% of the share capital; • In payment or in exchange for assets acquired by the company within two years of their repurchase, not to exceed 5% of the share capital; • To sell the relevant shares to any shareholders willing to purchase them as part of a process organized by the company within five years, not to exceed 10% of the share capital. Shares acquired but not used in accordance with the above purposes must be cancelled. As of the date of this document, the Company does not have in place such shareholders’ authorization granted to the Board of Directors to purchase its own shares. Also, under French law, a private company (which our Company is for French law purposes for so long as its shares are not listed on an EU-regulated market) may acquire its own shares, without shareholders’ authorization, with a view to distributing within one year of their repurchase the relevant shares to employees or managers under a restricted free share or share option plan, not to exceed 10% of the share capital. The Company may also acquire its own shares to decrease its share capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction. Under French law, in case of issuance of additional shares or other securities giving right, immediately or in the future, to new shares for cash or set-off against cash debts, the existing shareholders have preferential subscription rights to these securities on a pro rata basis unless such rights are waived by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the extraordinary meeting deciding or authorizing the capital increase. In case such rights are not waived by the extraordinary general meeting, each shareholder may individually either exercise, or assign or not exercise its preferential rights. Generally, under French law, completion of a legal merger (fusion), demerger (scission), dissolution, sale, lease or exchange of all or substantially all of a company’s assets, requires: •  the approval of the board of directors; and •  the approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting, or in the case of a legal merger (fusion) with a non-EU company, approval of all the shareholders of the company. Anti-Takeover Provisions and Shareholder Disclosure Thresholds Anti-Takeover Provisions French law does not contain provisions restricting or making difficult to change the composition of the board of directors following a change of control. French law allows shareholders at general meetings to delegate the authority to the board of directors to issue shares or warrants to subscribe for shares, which may make it more difficult for a shareholder to obtain control over our general meeting of shareholders. Crossing of Threshold Notifications According to the Articles of Association, any natural persons or legal entities acting alone or in concert, who come to own, directly or indirectly, a number of shares equal to or greater than 5%, 10%, 15%, 20%, 25%, 30%, 33 1/3%, 50%, 66 2/3% or 90% of the total number of shares or voting rights must, within five (5) trading days after the shareholding threshold is crossed, upwards or downwards, notify the Company, by certified letter with acknowledgment of receipt, of the total number of shares


 
10 or voting rights that they own alone, directly or indirectly, or in concert. The notification includes information on (i) the number of securities held giving deferred rights to the shares to be issued and the corresponding voting rights, and (ii) the number of shares already issued or the voting rights they may acquire. Furthermore, according to the Articles of Association, any persons or entities who hold a number of shares equal to or greater than 10%, 15%, 20% or 25% of the total number of shares or voting rights in the Company shall inform the Company of the objectives they intend to pursue over the six (6) months to come. Following a period of six (6) months, any persons or entities who continue to hold a number of shares or voting rights equal to or greater than the fractions mentioned hereinabove, shall renew their statement of intent, in compliance with the aforementioned terms, for each new period of six (6) months. This statement shall specify whether the shareholder is acting alone or in concert, if he plans to discontinue or continue his purchases, to acquire or not the control of the Company, to request his appointment or that of one or several persons as director. The Company reserves the right to share with the public and shareholders either the objectives that it has been notified of, or the relevant person’s failure to comply with the aforementioned obligation. For the application of the preceding subparagraphs, the shares or voting rights listed in paragraphs 1 to 8 of Article L. 233-9 I of the French Commercial Code shall be considered equivalent to the shares or voting rights held by a shareholder. Mandatory Takeover Bid According to the Articles of Association, any natural or legal persons, acting alone or in concert under Article L. 233-10 of the French Commercial Code, who comes into possession, otherwise than following a voluntary takeover bid, directly or indirectly, of more than 30% of the capital or voting rights of the Company, shall file a draft takeover bid on all the capital and securities granting access to the capital or voting rights, and on terms that comply with applicable United States securities law, rules of the SEC and NYSE rules. The same requirement applies to natural or legal persons, acting alone or in concert, who directly or indirectly own a number between 30% and half of the total number of equity securities or voting rights of the company and who, in less than twelve consecutive months, increase the holding, in capital or voting rights, of at least 1% of the total number of equity securities or voting rights of the Company. When a draft offer is submitted, the price proposed must be at least equal to the highest price paid by the offeror, acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, over a period of twelve (12) months preceding the event giving rise to the obligation to submit the draft offer. In the event of a clear change in the characteristics of the Company, if the market for its securities so justifies or in the absence of a transaction by the offeror, acting alone or in concert, over the Company’s shares during the twelve-month period mentioned in the first paragraph, the price will be fixed by an expert appointed in accordance with Article 1592 of the French Civil Code and determined according to objective evaluation criteria usually used, the characteristics of the Company and the market of its securities, it being specified that the expert will be required to take into account, in its assessment, the criteria identified by the Commission des Opérations de Bourse, the AMF and the French courts. The obligation to file a draft public offer does not apply if the person or persons concerned justify to the Company the fulfillment of one of the conditions listed in Articles 234-7 and 234-9 of the AMF General Regulations. In the event of disagreement between the parties, an expert will be appointed by the president of the commercial court, ruling in the form of interim relief, for the purpose of determining whether or not it is necessary to file a draft public offer, it being specified that the expert will be required to apply the relevant provisions of the AMF General Regulations as well as the criteria issued by the French Conseil des Marchés Financiers, the AMF and the French courts.


 
11 Any breach of the obligation to file a takeover bid as provided in the Articles of Association may give rise to claims for damages or, as the case may be, action for injunctive relief. Dividends Our Board of Directors periodically explores the potential adoption of a dividend program; however, no assurances can be made that any future dividends will be paid on the ordinary shares. Any proposal to declare and pay future dividends to holders of our ordinary shares will be at the discretion of our Board of Directors and will depend on many factors, including our financial condition, earnings, capital requirements, level of indebtedness, statutory future prospects and contractual restrictions applying to the payment of dividends and other considerations that our Board of Directors deems relevant. Under French law, dividends are approved by the shareholders’ meeting. All calculations to determine the amounts available for dividends or other distributions will be based on our statutory financial statements which are, as a holding company, different from our consolidated financial statements and which are prepared in accordance with French GAAP because we are a French company. Dividends may only be paid by a French Societas Europaea out of “distributable profits,” plus any distributable reserves and “distributable premium” that the shareholders decide to make available for distribution, other than those reserves that are specifically required by law. “Distributable profits” consist of the unconsolidated net profits of the relevant company for each fiscal year, as increased or reduced by any profit or loss carried forward from prior years. “Distributable premium” refers to the contribution paid by the shareholders in addition to the par value of their shares for their subscription that the shareholders decide to make available for distribution. Except in the case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the articles of association. Dividends may be paid in cash or, if the shareholders’ meeting so decides, in kind, provided that all the shareholders receive a whole number of assets of the same nature paid in lieu of cash. Our Articles of Association provide that each shareholder may be given the choice to receive his or her dividend in cash or in shares subject to a decision of the shareholders’ meeting taken by ordinary resolution. Under French law, the board of directors may distribute interim dividends before the approval by the shareholders of the financial statements for the relevant fiscal year when the interim balance sheet, established during or at the close of such year and certified by the auditors, reflects that the company has earned distributable profits since the close of the previous fiscal year, after recognizing the necessary depreciation and provisions and after deducting prior losses, if any, and the sums to be allocated to reserves, as required by French law or articles of association, and including any retained earnings. The amount of such interim dividends may not exceed the amount of the profit so defined. Generally, we rely on dividends paid to Constellium SE, or funds otherwise distributed or advanced to Constellium SE by its subsidiaries to fund the payment of dividends, if any, to our shareholders. In addition, restrictions contained in the agreements governing our outstanding indebtedness limit our ability to pay dividends on our ordinary shares and limit the ability of our subsidiaries to pay dividends to us. Future indebtedness that we may incur may contain similar restrictions. According to our Articles of Association, distributions payable in cash shall be approved in euros and paid (i) in euros for all the holders of shares under the French Register and (ii) in USD for all the holders of shares under the U.S. Register. For the purposes of the payment of the dividend in dollars, the general shareholders’ meeting or, as the case may be, our Board of Directors, shall set the reference date to be considered for the EUR/USD exchange rate. Cash dividends and other distributions that have not been collected within five years after the date on which they became due


 
12 and payable will revert to the French State. We have historically not paid dividends to our shareholders since the time that we became a publicly listed company on the NYSE. Liquidation Rights and Dissolution In the event of our dissolution and liquidation, and after we have paid all debts and liquidation expenses, all assets available for distribution shall be distributed to holders of our shares pro rata based on the amount paid upon the shares held by such holders. Our Corporate Governance As a foreign private issuer listed on the NYSE, we are subject to NYSE corporate governance listing standards. However, NYSE rules permit a foreign private issuer like us to follow the corporate governance practices of its home country. Following the Transfer, we intend to rely on the NYSE Listed Company Manual with respect to our corporate governance to the extent possible under French law. The following are the significant ways in which our corporate governance practices differ from those required for U.S. companies listed on the NYSE following the Transfer. • Audit Committee-The Board’s audit committee is responsible for selecting our statutory auditors and making a recommendation to our Board regarding the terms of their compensation. As required by French law, the actual appointment of the statutory auditors has to be made by the shareholders at a general meeting of the shareholders. • Committee Powers-While the NYSE Listed Company Manual empowers board committees with decision-making authority that can be delegated by a company’s board, under French law, committees of the Company recommend to the full Board, which will be the decision-making body (not its committees). • Executive Sessions/Communications with Independent Directors-French law does not require for our independent directors to meet regularly without management, nor does it require the independent directors to meet alone in executive session at least once a year, as required by the NYSE Listed Company Manual. However, if our independent directors decide to engage in either or both of these activities, they will be permitted to do so. In practice, our independent directors regularly meet among themselves for discussions, but we do not expect them to be under any requirement to do so under our Articles of Association or French law. In addition, French law does not require a method for interested parties to communicate with our independent directors. • Equity Compensation Plans-French law requires shareholder approval at a general meeting of the shareholders to adopt an equity compensation plan, which is consistent with the shareholder vote required by the NYSE Listed Company Manual. It is common practice after obtaining such shareholder approval for the shareholders of a French company to then delegate to such company’s board of directors the authority to decide on the specific terms of the granting of equity compensation, within the limits of the shareholders’ authorization. The shareholders of the Company at the extraordinary general meeting held on November 25, 2019 and at the annual general meeting held on May 11, 2021 approved such authorizations to delegate such authority to the Board of Directors. • Corporate Governance Guidelines-A Board Internal Charter is required by the NYSE Listed Company Manual for U.S. companies listed on the NYSE that would set forth certain corporate governance practices of a listed company’s board. Our Board Internal Charter after the Transfer covers all items required by the NYSE Listed Company Manual subject to certain differences set forth by French law, particularly with respect to Committee powers (as described above) and conflict of interest transactions (as described below). • Conflicts of Interest-Pursuant to French law and the Articles of Association, any agreement (directly or through an intermediary) between the Company and any director of the Company that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions will be subject to the prior authorization of the Board, excluding the


 
13 participation and vote of the interested director. As required by French law, any such agreement will also be subject to approval at the next ordinary shareholders’ meeting (by a simple majority, excluding the vote of interested persons). If the transaction has not been pre-approved by the Board, it can be nullified if it has prejudicial consequences for the Company. If it is not approved by the shareholders, interested directors may be held liable for any prejudicial consequences for the Company of the unapproved transaction; such transaction will nevertheless remain valid, unless it is nullified in case of fraud. The foregoing requirements also apply to agreements between the Company and another entity if one of the Company’s directors is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the Company’s directors has an indirect interest. Aside from the foregoing requirements, there are no specific provisions prohibiting conflicted directors to participate or vote at a Board meeting. However, as a general rule under French law, directors must act in the interest of the Company. Differences in Corporate Law We are incorporated under the laws of France. The following discussion summarizes material differences between the rights of holders of our ordinary shares and the rights of holders of the common stock of a typical corporation incorporated under the laws of the state of Delaware, which result from differences in governing documents and the laws of France and Delaware. This discussion does not purport to be a complete statement of the rights of holders of our ordinary shares under applicable French law and our Articles of Association or the rights of holders of the common stock of a typical corporation under applicable Delaware law and a typical certificate of incorporation and bylaws. Delaware France Duties of directors The board of directors of a Delaware corporation bears the ultimate responsibility for managing the business and affairs of a corporation. There is generally only one board of directors. In discharging this function, directors of a Delaware corporation owe fiduciary duties of care and loyalty to the corporation and to its shareholders. The duty of care generally requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. In general, but subject to certain exceptions, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Delaware courts have also imposed a heightened standard of conduct upon directors of a Delaware corporation who take any action designed to defeat a threatened change in control of the corporation. In addition, under Delaware law, when the board of directors of a Delaware corporation approves the sale or break-up of a corporation, the board of directors may, in certain circumstances, have a duty to obtain the highest value reasonably available to the shareholders. In France, a company organized as a "Societas Europaea" can have a two-tier board structure: a management board comprising managing directors (Directoire) and a supervisory board comprising the non-executive directors (Conseil de Surveillance), or a single-tier board of directors (Conseil d’Administration). The single-tier board of directors of such French company will be comprised of non- executive directors and, if any, executive directors. Under French law, the board of directors supervises the management of the executive officers, sets the guidelines for the company’s activities and oversees their implementation. Subject to the powers expressly assigned by law to the shareholders’ meetings and within the limit of the corporate purpose, the board of directors hears any issue relevant to the company’s operation and, by means of its deliberations, settles the matters of concern to it, taking into consideration the social and environmental impact of the company's activity. The board of directors proceeds with the controls and checks what it deems advisable. Moreover, the board of directors exercises the special powers conferred on it by law. As of the date of this document, we have a single-tier Board of Directors consisting of one executive director (the CEO) and eleven non-executive directors, two of which are employee directors. As required by French law, following the amendment by the


 
14 Company’s Annual General Meeting held on May 11, 2021 to our Articles of Association to allow for such appointment, two employees of the Group were appointed to our Board of Directors by, respectively, the French Group Works Council and the European Works Council. Under French law, each director has a duty towards the company to properly perform his/her duties. Furthermore, each director has a duty to act in the corporate interest of the company. The corporate interest extends to the interests of all corporate stakeholders, such as shareholders, creditors, employees, customers and suppliers. The company is bound vis-à-vis third parties by the actions of its board of directors, even if such actions are not in line with the corporate purpose, unless it can be proven that the third party knew that the action exceeded that purpose or that the third party could not have been unaware of such excess in light of the circumstances; publication of the articles of association (which, under French law, include description of the corporate purpose) does not per se constitute such proof. Any board resolution regarding a change in the company’s Articles of Association requires shareholders’ approval. The board of directors may decide in its sole discretion, within the confines of French law and the Articles of Association, to incur additional indebtedness subject to any contractual restrictions pursuant to existing financing arrangements. Under French law, there is no obligation for directors to hold shares in the company unless required by the articles of association. According to our Articles of Association, there is no such obligation. However, the Company adopted internal Share-Ownership Guidelines (SOGs) to encourage minimum levels of the Company’s share ownership by its executive director (CEO) and by those of its non-executive directors who receive compensation in such capacity. For further information on the SOGs, you may refer to “Item 6. Directors, Senior Management and Employees— B. Compensation” of our Annual Report on Form 20-F for the year ended December 31, 2022 with which this Exhibit is filed. Director terms The Delaware General Corporation Law generally provides for a one-year term for directors, but permits directorships to be divided into up to three classes with up to three-year terms, with the years for each class expiring in different years, if permitted by the certificate of Under French law, a director of a company is appointed for a maximum term of six years. In practice, the articles of association set the directors’ precise term. According to our Articles of Association, the term of office


 
15 incorporation, an initial bylaw or a bylaw adopted by the shareholders. A director elected to serve a term on a “classified” board may not be removed by shareholders without cause except as otherwise provided in the certificate of incorporation. There is no limit to the number of terms a director may serve. of a Director is of three (3) years and can be renewed without limitation. Directors may be appointed for a shorter term so that the renewal of the Directors’ terms of office may be spread out over time. According to our Articles of Association, the number of Directors who are more than seventy-five (75) years old may not exceed one third of the directors in office and, if this limit is exceeded during the terms of office, the oldest director shall automatically be considered to have resigned at the close of the next general meeting. According to our Articles of Association, the Chairman of our Board of Directors cannot be older than seventy-five (75) years. If the Chairman of our Board of Directors reaches this age limit during his or her term as Chairman, he or she is automatically deemed to have resigned from such position. His or her mandate would extend however, until the next meeting of the Board of Directors during which his or her successor is appointed. Director election and vacancies The Delaware General Corporation Law provides that vacancies and newly created directorships may be filled by a majority of the directors then in office (even though less than a quorum) or by a sole remaining director unless (a) otherwise provided in the certificate of incorporation or by-laws of the corporation or (b) the certificate of incorporation directs that a particular class of stock is to elect such director, in which case a majority of the other directors elected by such class, or a sole remaining director elected by such class, will fill such vacancy. Under French law, new members of the board of directors of a company are appointed by the general meeting of shareholders by a simple majority. The board of directors which convenes the shareholders' meeting proposes candidates; shareholders may also propose candidates under certain conditions. The shareholders at the meeting may vote for other candidates than those proposed on the agenda, by a simple majority. Vacancies on the board of directors occurring between shareholders’ meetings may be filled at a board meeting by a majority of the remaining directors, subject to ratification at the next shareholders’ meeting. According to our Articles of Association, the first employee director is appointed by the French Group Works Council and the second by the European Works Council. In the event of a vacancy in a seat of an employee director, the vacant seat is filled in by an employee designated in the same way as the replaced employee director. Conflict of interest transactions Under the Delaware General Corporation Law, transactions with directors must be approved by disinterested directors or by the shareholders, or otherwise proven to be fair to the company as of the time it is approved. Such transaction may be void or voidable, unless (1) the material facts of any interested directors’ interests are disclosed or are known to the board of directors and the board in good faith authorizes the contract or transaction by an affirmative votes of a majority of the disinterested directors, even though the disinterested directors constitute less than a quorum; (2) the material facts of any interested directors’ interests are disclosed or are known to the shareholders entitled to vote thereon, and the transaction is specifically approved in Pursuant to French law and the Articles of Association, any agreement between (directly or through an intermediary) a company and any of its directors, its executive corporate officers (“Directeur Général”or any “Directeur Général Délégué”), its shareholders holding more than 10% of its voting rights or companies controlling such shareholders, that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions, is subject to a prior authorization of the board of directors, excluding the participation and vote of the interested director. Such agreement is also subject to approval at the next ordinary shareholders’ meeting (by a simple majority), excluding the votes of any interested persons.


 
16 good faith by vote of the shareholders; or (3) the transaction is fair to the company as of the time it is approved. Interested directors may be counted in determining the presence of a quorum at a meeting of the board of directors or of a committee which authorizes the contract or transaction. The foregoing requirements also apply to agreements between the company and another entity if one of the company’s directors, or executive corporate officers (“Directeur Général”or any “Directeur Général Délégué”) is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the company’s directors, executive corporate officers (“Directeur Général”or any “Directeur Général Délégué”), shareholders holding more than 10% of its voting rights or companies controlling such shareholders has an indirect interest. If the transaction has not been pre-approved by the board of directors, it can be nullified if it has prejudicial consequences for the company. If an agreement is not then approved by the shareholders, the interested person may be held liable for any prejudicial consequences for the company of the unapproved transaction; such transaction will nevertheless remain valid unless it is nullified in case of fraud. Aside from the above rule, there are no specific provisions prohibiting conflicted directors to participate or vote at board meetings. However, as a general rule, directors must act in the interest of the company. Proxy voting by directors A director of a Delaware corporation may not issue a proxy representing the director’s voting rights as a director. According to French law and our Articles of Association, a director may grant to another director a proxy to represent him or her at a meeting of the board of directors. No director can hold more than one proxy at any meeting. Voting rights Under the Delaware General Corporation Law, each shareholder is entitled to one vote per share of stock, unless the certificate of incorporation provides otherwise. In addition, the certificate of incorporation may provide for cumulative voting at all elections of directors of the corporation, or at elections held under specified circumstances. Either the certificate of incorporation or the bylaws may specify the number of shares or the amount of other securities that must be represented at a meeting in order to constitute a quorum, but in no event will a quorum consist of less than one-third of the shares entitled to vote at a meeting, except that, where a separate vote by a class or series or classes or series is required, a quorum will consist of no less than 1/3 of the shares of such class or series or classes or series. Shareholders as of the record date for the meeting are entitled to vote at the meeting, and the board of directors may fix a record date that is no more than 60 days nor less than 10 days before the date of the meeting, and if no record date is set then the record date is the close of business on the day next preceding the day on which the meeting is held. The determination of the shareholders of record entitled to notice or to vote at a meeting of shareholders shall apply to any adjournment of the meeting, but the board of directors may fix a new record date for the adjourned meeting. Under French law and in general, each shareholder is entitled to one vote per share at any general shareholders’ meeting. A general shareholders’ meeting is held annually to, inter alia, approve the annual financial statements. General shareholders’ meetings (including annual meetings) can be ordinary and/or extraordinary, depending upon the resolutions submitted to the vote. At an extraordinary general shareholders’ meeting (which votes upon any proposal to change the articles of association, including any change in the rights of shareholders), majority is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/4 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting. If the quorum at the second meeting is not reached, the second meeting can be postponed to a date no later than two months after the date on which the second meeting was convened. The quorum for such second or postponed meeting, as the case may be, to be validly held is 1/5 of the voting shares. At an ordinary shareholders’ meeting (which votes upon any proposal within the competence of a general shareholders’ meeting other than an extraordinary shareholders meeting


 
17 such as approval of annual financial statements or appointment of directors), majority is simple majority (more than 50%) of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/5 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting; no quorum is required for such second meeting. Special meetings bring together the holders of shares of a specified class, should it be created, to decide on an amendment to the rights relating to the shares of this class. Majority at special meetings is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/3 of the voting shares, and, failing which, 1/5 for the meeting held on the date set by the second convening notice or in the case of postponement of the second meeting. French law does not provide for cumulative voting. The right to participate in a shareholders’ meeting is granted to all the shareholders whose shares are fully paid up and for whom a right to attend shareholders’ meetings has been established by registration of their shares in their names or names of the authorized intermediary acting on their behalf on the second business day prior to the shareholders’ meeting at 0:00 (zero hour) (Paris time) (the “French Record Date”), either in the registered (“au nominatif”) shares accounts held by the company (or an agent acting on its behalf) or in the bearer (“au porteur”) shares accounts held by the authorized intermediary. Shareholders holding shares registered on the U.S. Register (which include all shares which are listed on the NYSE, held through a DTC participant and shares directly recorded in the name of their holder with Computershare) vote through a process similar to the one that was in place before the Transfer with the following main differences: • their voting instructions will be transmitted to the Company via the French Intermediary, acting as intermediary for the account of all shareholders registered on the U.S. Register, in accordance with articles L. 228-1 et seq. of the French Commercial Code; • the French Record Date will be set; • an additional record date will be fixed for all shareholders registered on the U.S. Register, which date will be the 25th day before the meeting (the “U.S. Record Date”); and • shareholders who purchase shares between the U.S.


 
18 Record Date and the French Record Date will be entitled to participate and vote at the shareholders’ meeting as long as they continue to be shareholders on the French Record Date. However, given the short time between the French Record Date and the shareholders’ meeting date, shareholders as of the French Record Date may not have received the notices and information received by shareholders holding shares registered on the U.S. Register as of the U.S. Record Date. To the extent that shareholders as of the U.S. Record Date have sent voting instructions and sold or otherwise transferred their shares as of the French Record Date, such voting instructions will be invalidated or modified by the Company, as the case may be, in accordance with articles R. 225-85 and R. 225-86 of the French Commercial Code. Shareholder proposals Delaware law does not provide shareholders an express right to put any proposal before a meeting of shareholders, but it provides that a corporation’s bylaws may provide that if the corporation solicits proxies with respect to the election of directors, it may be required to include in its proxy solicitation materials one or more individuals nominated by a shareholder. In keeping with common law, Delaware corporations generally afford shareholders an opportunity to make proposals and nominations, provided that they comply with the notice provisions in the certificate of incorporation or bylaws. Pursuant to French law, the board of directors is required to convene an annual ordinary general meeting of shareholders for approval of the annual financial statements. This meeting must be held within six months after the end of each prior fiscal year. The board of directors may also convene an ordinary or extraordinary meeting of shareholders upon proper notice at any time during the year. If the board of directors fails to convene a shareholders’ meeting, the auditors may call the meeting. In a bankruptcy, the liquidator or court-appointed agent may also call a shareholders’ meeting in some instances. Any of the following may request the court to appoint an agent: • one or several shareholders holding at least 5% of the share capital, or •  any interested party or the workers committee in cases of urgency. Shareholders holding a majority of the capital or voting rights after a public take-over bid or exchange offer or the transfer of a controlling block of shares may also convene a shareholders’ meeting. In general, shareholders can only take action at shareholders’ meetings on matters listed on the agenda for the meeting. As an exception to this rule, shareholders may take action with respect to the dismissal and appointment of directors. Additional draft resolutions to be submitted for approval by the shareholders at any shareholders’ meeting may be proposed to the board of directors within the legal time limit (which is no later than 20 days after the publication of the convening notice (avis de réunion) and in any event no


 
19 sooner than 25 days prior to the date of the shareholders’ meeting) by one or several shareholders holding a specified percentage of shares. The convening notice (avis de réunion) must be published in France with the BALO at least 35 days prior to the date of the shareholders’ meeting and can be consulted at https://www.journal- officiel.gouv.fr/balo/. As the U.S. Record Date is fixed at the 25th day before the shareholders’ meeting, shareholders wishing to submit additional resolutions will need to submit them before receiving the meeting materials sent to them on or around the U.S. Record Date, otherwise their submissions will not be considered. The percentage of shares required to be held by one or several shareholders to be able to submit additional draft resolutions depends on the amount of the share capital of the Company; based on the Company’s issued share capital of €2,886,031.84 as of December 31, 2022, this percentage would be 2.89%. Action by written consent Unless otherwise provided in the corporation’s certificate of incorporation, any action required or permitted to be taken at any annual or special meeting of shareholders of a corporation may be taken without a meeting, without prior notice and without a vote, if one or more consents in writing, setting forth the action to be so taken, are signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Although permitted by Delaware law, publicly listed companies do not typically permit stockholders of a corporation to take action by written consent. Under French law, shareholders’ action by written consent is not permitted in a Societas Europaea. Shareholder suits Under the Delaware General Corporation Law, a shareholder may bring a derivative action on behalf of the corporation to enforce the rights of the corporation. An individual also may commence a class action suit on behalf of himself and other similarly situated shareholders where the requirements for maintaining a class action under Delaware law have been met. A person may institute and maintain such a suit only if that person was a shareholder at the time of the transaction which is the subject of the suit. In addition, under Delaware case law, the plaintiff normally must be a shareholder not only at the time of the transaction that is the subject of the suit, but also throughout the duration of the derivative suit. Delaware law also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff in court, unless such a demand would be futile. French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a company in the company’s interest if it fails to bring such legal action itself. If so, any damages awarded by the court are paid to the company and any legal fees relating to such action are borne by the relevant shareholder or the group of shareholders. The plaintiff must remain a shareholder throughout the duration of the legal action. There is no other case where shareholders may initiate a derivative action to enforce a right of a company. A shareholder may alternatively or cumulatively bring an individual legal action against the directors, provided he or she has suffered distinct damages from those suffered by the company. In this case, any damages awarded by the court are paid to the relevant shareholder. Repurchase of shares Under the Delaware General Corporation Law, a Under French law, a private company (which our Company


 
20 corporation may purchase or redeem its own shares unless the capital of the corporation is impaired or the purchase or redemption would cause an impairment of the capital of the corporation. A Delaware corporation may, however, purchase or redeem out of capital any of its preferred shares or, if no preferred shares are outstanding, any of its own shares if such shares will be retired upon acquisition and the capital of the corporation will be reduced in accordance with specified limitations. is for French law purposes for so long as its shares are not listed on an EU-regulated market) may not subscribe for newly issued shares in its capital but may, however, acquire its own shares, subject to shareholders’ authorization, for the following purposes only: • With a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, restricted free share or share option plan, not to exceed 10% of the share capital; • In payment or in exchange for assets acquired by the company within two years of their repurchase, not to exceed 5% of the share capital; • To sell the relevant shares to any shareholders willing to purchase them as part of a process organized by the company within five years, not to exceed 10% of the share capital. Shares acquired but not used in accordance with the above purposes must be cancelled. As of the date of this document, the Company does not have in place such shareholders’ authorization granted to the Board of Directors to purchase its own shares. Also, under French law, a private company (which our Company is for French law purposes for so long as its shares are not listed on an EU-regulated market) may acquire its own shares, without shareholders’ authorization, with a view to distributing within one year of their repurchase the relevant shares to employees or managers under a restricted free share or share option plan, not to exceed 10% of the share capital. The Company may also acquire its own shares to decrease its share capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction. Anti-takeover provisions In addition to other aspects of Delaware law governing fiduciary duties of directors during a potential takeover, the Delaware General Corporation Law also contains a business combination statute that protects Delaware companies from hostile takeovers and from actions following the takeover by prohibiting some transactions once an acquirer has gained a significant holding in the corporation. Section 203 of the Delaware General Corporation Law prohibits “business combinations,” including mergers, sales and leases of assets, issuances of securities and French law does not contain provisions restricting or making difficult to change the composition of the board of directors following a change of control. French law allows shareholders at general meetings to delegate the authority to the board of directors to issue shares or warrants to subscribe for shares, which may make it more difficult for a shareholder to obtain control over our general meeting of shareholders.


 
21 similar transactions by a corporation or a subsidiary with an interested shareholder that beneficially owns 15% or more of a corporation’s voting stock (or which is an affiliate or associate of the corporation and owned 15% or more of the corporation’s outstanding voting stock within the past three years), within three years after the person becomes an interested shareholder, unless: •  the transaction that will cause the person to become an interested shareholder is approved by the board of directors of the target prior to the transactions; •  after the completion of the transaction in which the person becomes an interested shareholder, the interested shareholder holds at least 85% of the voting stock of the corporation not including shares owned by persons who are directors and also officers of interested shareholders and shares owned by specified employee benefit plans; or •  after the person becomes an interested shareholder, the business combination is approved by the board of directors of the corporation and holders of at least 66.67% of the outstanding voting stock, excluding shares held by the interested shareholder. A Delaware corporation may elect not to be governed by Section 203 by a provision contained in the original certificate of incorporation of the corporation or an amendment to the original certificate of incorporation or to the bylaws of the company, which amendment must be approved by a majority of the shares entitled to vote and may not be further amended by the board of directors of the corporation. Such an amendment is not effective until twelve months following its adoption. Inspection of books and records Under the Delaware General Corporation Law, any shareholder may inspect for any proper purpose the corporation’s stock ledger, a list of its shareholders and its other books and records during the corporation’s usual hours of business. The board of directors must provide all required information for the shareholders’ meeting. Under French law, shareholders are entitled to review and copy the list of the shareholders (name and address) who hold their shares in nominative form during 15 days prior to any shareholders’ meeting. However, that should not apply to shares held in bearer (“au porteur”) form by U.S. shareholders. Removal of directors Under the Delaware General Corporation Law, any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except (a) unless the certificate of incorporation provides otherwise, in the case of a corporation whose board is classified, shareholders may effect such removal only for cause, or (b) in the case of a corporation having cumulative voting, if less than the entire board is to be removed, no director may be removed without cause if the Under French law, directors may be removed from office, with or without cause, at any shareholders’ meeting without notice or justification, by a simple majority vote of shareholders. Directors cannot be suspended or removed by the board of directors. Under French law, an employee director may be removed from office only in case of a fault in the performance of the directorship, by decision of the president of a French court (Tribunal Judiciaire), at request of majority of directors.


 
22 votes cast against his removal would be sufficient to elect him if then cumulatively voted at an election of the entire board of directors, or, if there are classes of directors, at an election of the class of directors of which he is a part. An executive corporate officer appointed by the board of directors (CEO (Directeur Général) or, if any, deputy chief executive officer (Directeur Général Délégué)) can have his or her executive duties suspended at any time by the board of directors. If such executive corporate officer is also a director, he or she will remain non-executive director as his or her duties as a director can only be removed by a shareholders’ meeting. Preemptive rights Under the Delaware General Corporation Law, shareholders have no preemptive rights to subscribe to additional issues of stock or to any security convertible into such stock unless, and except to the extent that, such rights are expressly provided for in the certificate of incorporation. Under French law, in case of issuance of additional shares or other securities giving right, immediately or in the future, to new shares for cash or set-off against cash debts, the existing shareholders have preferential subscription rights to these securities on a pro rata basis unless such rights are waived by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the extraordinary meeting deciding or authorizing the capital increase. In case such rights are not waived by the extraordinary general meeting, each shareholder may individually either exercise, or assign or not exercise its preferential rights. Dividends Under the Delaware General Corporation Law, a Delaware corporation may, subject to any restrictions contained in its certificate of incorporation, pay dividends out of its surplus (the excess of net assets over capital), or in case there is no surplus, out of its net profits for the fiscal year in which the dividend is declared or the preceding fiscal year (provided that the amount of the capital of the corporation is not less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets). In determining the amount of surplus of a Delaware corporation, the assets of the corporation, including stock of subsidiaries owned by the corporation, must be valued at their fair market value as determined by the board of directors, without regard to their historical book value. Dividends may be paid in the form of common stock, property or cash. Our Board of Directors periodically explores the potential adoption of a dividend program; however, no assurances can be made that any future dividends will be paid on the ordinary shares. Any proposal to declare and pay future dividends to holders of our ordinary shares will be at the discretion of our Board of Directors and will depend on many factors, including our financial condition, earnings, capital requirements, level of indebtedness, statutory future prospects and contractual restrictions applying to the payment of dividends and other considerations that our Board of Directors deems relevant. Under French law, dividends are approved by the shareholders’ meeting. All calculations to determine the amounts available for dividends or other distributions will be based on our statutory financial statements which are, as a holding company, different from our consolidated financial statements and which are prepared in accordance with French GAAP because we are a French company. Dividends may only be paid by a French Societas Europaea out of “distributable profits,” plus any distributable reserves and “distributable premium” that the shareholders decide to make available for distribution, other than those reserves that are specifically required by law. “Distributable profits” consist of the unconsolidated net profits of the relevant company for each fiscal year, as increased or reduced by any profit or loss carried forward from prior years.


 
23 “Distributable premium” refers to the contribution paid by the shareholders in addition to the par value of their shares for their subscription that the shareholders decide to make available for distribution. Except in the case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the articles of association. Dividends may be paid in cash or, if the shareholders’ meeting so decides, in kind, provided that all the shareholders receive a whole number of assets of the same nature paid in lieu of cash. Our Articles of Association provide that each shareholder may be given the choice to receive his or her dividend in cash or in shares subject to a decision of the shareholders’ meeting taken by ordinary resolution. Under French law, the board of directors may distribute interim dividends before the approval by the shareholders of the financial statements for the relevant fiscal year when the interim balance sheet, established during or at the close of such year and certified by the auditors, reflects that the company has earned distributable profits since the close of the previous fiscal year, after recognizing the necessary depreciation and provisions and after deducting prior losses, if any, and the sums to be allocated to reserves, as required by French law or articles of association, and including any retained earnings. The amount of such interim dividends may not exceed the amount of the profit so defined. Generally, we rely on dividends paid to Constellium SE, or funds otherwise distributed or advanced to Constellium SE by its subsidiaries to fund the payment of dividends, if any, to our shareholders. In addition, restrictions contained in the agreements governing our outstanding indebtedness limit our ability to pay dividends on our ordinary shares and limit the ability of our subsidiaries to pay dividends to us. Future indebtedness that we may incur may contain similar restrictions. According to our Articles of Association, distributions payable in cash shall be approved in euros and paid (i) in euros for all the holders of shares under the French Register and (ii) in USD for all the holders of shares under the U.S. Register. For the purposes of the payment of the dividend in dollars, the general shareholders’ meeting or, as the case


 
24 may be, our Board of Directors, shall set the reference date to be considered for the EUR/USD exchange rate. Cash dividends and other distributions that have not been collected within five years after the date on which they became due and payable will revert to the French State. We have historically not paid dividends to our shareholders since the time we became a publicly listed company on the NYSE. Shareholder vote on certain reorganizations Under the Delaware General Corporation Law, the vote of a majority of the outstanding shares of capital stock entitled to vote thereon generally is necessary to approve a merger or consolidation or the sale of substantially all of the assets of a corporation. The Delaware General Corporation Law permits a corporation to include in its certificate of incorporation a provision requiring for any corporate action the vote of a larger portion of the stock or of any class or series of stock than would otherwise be required. Under the Delaware General Corporation Law, no vote of the shareholders of a surviving corporation to a merger is needed; however, unless required by the certificate of incorporation, if (a) the agreement of merger does not amend in any respect the certificate of incorporation of the surviving corporation, (b) the shares of stock of the surviving corporation are not changed in the merger and (c) the number of ordinary shares of the surviving corporation into which any other shares, securities or obligations to be issued in the merger may be converted does not exceed 20% of the surviving corporation’s common shares outstanding immediately prior to the effective date of the merger. In addition, shareholders may not be entitled to vote in certain mergers with other corporations that own 90% or more of the outstanding shares of each class of stock of such corporation, but the shareholders will be entitled to appraisal rights. Generally, under French law, completion of a legal merger (fusion), demerger (scission), dissolution, sale, lease or exchange of all or substantially all of a company’s assets, requires: •  the approval of the board of directors; and •  the approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting, or in the case of a legal merger (fusion) with a non-EU company, approval of all the shareholders of the company. Compensation of board of directors Under the Delaware General Corporation Law, the shareholders do not generally have the right to approve the compensation policy for the board of directors or the senior management of the corporation, although certain aspects of the compensation policy may be subject to shareholder vote due to the provisions of federal securities and tax law, as well as stock exchange requirements. The board of directors determines the remuneration of executive directors (i.e. the CEO (“Directeur Général”) and, if any, Deputy Chief Executive Officers (“Directeurs Généraux Délégués”), who may (but are not required to) be directors). French law does not provide for any specific rules on remuneration of executive directors for French companies not listed on a EU-regulated market. Executive directors may be granted free shares and stock options of the Company. With respect to the remuneration of non-executive directors, the ordinary shareholders’ meeting votes an envelope of fixed annual fees to be allocated to directors for each year. The board of directors will then decide the allocation of


 
25 these fees among directors. These fees include all cash remunerations granted to directors in such capacity. In addition to the fixed amount of fees approved at the shareholders meeting, the board of directors may grant fees to the chairman of the board in such capacity, and may also, exceptionally, grant additional fees to certain directors in remuneration for separate, specific missions or tasks assigned to them. Non-executive directors are not eligible to receive awards that are to be settled with shares. However, the board of directors may grant share-settled awards (such as free shares or stock options) to the chairman of the board in such capacity. Action by written consent and quorum requirements at the board of directors Under the Delaware General Corporation Law, a majority of the total number of directors constitutes a quorum unless the company’s certificate of incorporation or bylaws require a greater number. Unless the certificate of incorporation says otherwise, the bylaws may provide that a number less than a majority constitutes a quorum (but no less than 1/3 of the total number of directors). The vote of the majority of the directors present at a meeting at which a quorum is present shall be the act of the board unless the certificate of incorporation or bylaws require the vote of a greater number. Unless otherwise restricted by the certificate of incorporation or bylaws, the board or any committee may take any action without a meeting if all members consent thereto in writing or by electronic transmission. According to French law and the Articles of Association, certain decisions of the Board of Directors may be adopted in writing. These decisions include interim appointment of directors, authorization of certain security interests and guarantees, amendment of the articles of association to comply with legal provisions, convening of shareholder meetings and decisions to transfer the registered office within the same department. According to French law and our Articles of Association, a director may grant to another director a proxy to represent him or her at a meeting of the board of directors. No director can hold more than one proxy at any meeting. According to French law and the Articles of Association, for the board’s deliberations to be valid, more than half of the board members must be present or represented. The board of directors’ decisions shall be taken by a majority vote; if the votes are tied, the chairman’s vote shall be decisive.


 

[Execution] 6974498.7 AMENDMENT NO. 6 TO AMENDED AND RESTATED CREDIT AGREEMENT This AMENDMENT NO. 6 TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment No. 6”), dated as of June 23, 2022, by and among Constellium Muscle Shoals LLC, a Delaware limited liability company (f/k/a Wise Alloys LLC) (“Muscle Shoals”), Constellium Rolled Products Ravenswood, LLC, a Delaware limited liability company (“Ravenswood”), Constellium Bowling Green LLC, a Delaware limited liability company (f/k/a Constellium-UACJ ABS LLC) (“Bowling Green” and together with Muscle Shoals and Ravenswood, the “Borrowers” and each, a “Borrower”), Constellium Holdings Muscle Shoals LLC, a Delaware limited liability company (f/k/a Wise Metals Group LLC) (“Muscle Shoals Holdings”), Constellium US Holdings I, LLC, a Delaware limited liability company (“CUSHI”), Constellium US Intermediate Holdings LLC, a Delaware limited liability company (“Intermediate”), Wells Fargo Bank, National Association (“Wells Fargo”), as Administrative Agent and Collateral Agent (in such capacities, the “Administrative Agent”), and the Lenders signatory hereto, amends that certain Amended and Restated Credit Agreement, dated as of February 20, 2019, as amended by Amendment No. 1 to Amended and Restated Credit Agreement, dated as of May 10, 2019, Amendment No. 2 to Amended and Restated Credit Agreement, dated as of April 24, 2020, Amendment No. 3 to Amended and Restated Credit Agreement, dated as of September 25, 2020, Amendment No. 4 to Amended and Restated Credit Agreement, dated as of April 27, 2021 and Amendment No. 5 to Amended and Restated Credit Agreement, dated as of December 3, 2021 (the “Existing Credit Agreement”, and as amended hereby, the “Credit Agreement”), by and among the Borrowers, Muscle Shoals Holdings, CUSHI, Intermediate, Constellium International S.A.S. (the “Parent Guarantor”), acting as successor by merger to Constellium Holdco II B.V., the Administrative Agent, and the Lenders from time to time party thereto. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Credit Agreement. WHEREAS, the Borrowers have requested that the Administrative Agent and the Lenders agree to make certain amendments to the Existing Credit Agreement; and WHEREAS, the Lenders party hereto and the Administrative Agent have so agreed, subject to the terms and conditions set forth herein. NOW, THEREFORE, in consideration of the premises set forth above, the terms and conditions contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree to enter into this Amendment No. 6. 1. Amendments to Credit Agreement. Subject to the satisfaction of the conditions precedent set forth in Section 3 of this Amendment No. 6, the Existing Credit Agreement is hereby amended to delete the stricken text (indicated textually in the same manner as the following example: stricken text) and to add the double-underlined text (indicated textually in the same manner as the following example: double-underlined text) as set forth in Exhibit A hereto. Exhibit C-1 to the Credit Agreement (Revolving Facility Borrowing Request) is deleted in its entirety and replaced with Exhibit C-1 (SOFR Notice) as set forth in Exhibit B hereto. Schedules 1.01(b), 2.01, 7.01 and 7.02(a) to the Credit Agreement are deleted in their entirety and replaced with Schedules 1.01(b), 2.01, 7.01 and 7.02(a) as set forth in Exhibit C hereto. All other exhibits and schedules to the Credit Agreement, as in effect immediately prior to the Amendment No. 6 Effective Date (as defined below), shall constitute schedules and exhibits to the Credit Agreement. 2. Amendment No. 6 Effective Date; Conditions Precedent to Amendments. The amendments set forth in Section 1 shall become effective as of the date (the “Amendment No. 6 Effective Date”) on which all of the conditions precedent set forth on Schedule 1 hereto have been satisfied. 2 6974498.7 3. [Reserved]. 4. Miscellaneous. (a) Headings. The various headings of this Amendment No. 6 are inserted for convenience of reference only, are not part of this Amendment No. 6 and shall not affect the meaning or interpretation of this Amendment No. 6 or any provisions hereof. (b) Counterparts. This Amendment No. 6, any documents executed in connection herewith and any notices delivered under this Amendment No. 6 or the Credit Agreement, may be executed by the parties hereto by means of (i) an electronic signature that complies with the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, or any other relevant and applicable electronic signatures law; (ii) an original manual signature; or (iii) a faxed, scanned, or photocopied manual signature. Each electronic signature or faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature. Administrative Agent reserves the right, in its reasonable discretion, to accept, deny, or condition acceptance of any electronic signature on this Amendment No. 6 or on any notice delivered to Administrative Agent under this Amendment No. 2. This Amendment No. 2 and any notices delivered hereunder and under the other Loan Documents may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of which when taken together shall be deemed to be one and the same instrument. Delivery of an executed counterpart of a signature page of this Amendment No. 6 and any notices as set forth herein will be as effective as delivery of a manually executed counterpart of Amendment No. 6 or notice. (c) Interpretation. No provision of this Amendment No. 6 shall be construed against or interpreted to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such party’s having or being deemed to have structured, drafted or dictated such provision. (d) Representations and Warranties. Each Loan Party party hereto hereby represents and warrants that, as of the date hereof and as of the Amendment No. 6 Effective Date: (i) this Amendment No. 6 and the Credit Agreement constitute the legal, valid and binding obligation of such Loan Party, enforceable against such Loan Party in accordance with their respective terms, subject to (1) the effects of bankruptcy, insolvency, moratorium, reorganization, fraudulent conveyance or other similar laws affecting creditors’ rights generally, (2) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and (3) implied covenants of good faith and fair dealing; (ii) its execution, delivery and performance of this Amendment No. 6 and its performance of the Credit Agreement have been duly authorized by all necessary corporate, stockholder, partnership or limited liability company action, and do not and will not: (1) violate (a) any provision of law, statute, rule or regulation, or of the certificate or articles of incorporation or other constitutive documents (including any partnership, limited liability company or operating agreements) or bylaws of such Loan Party, (b) any applicable order of any court or any rule, regulation or order of any Governmental Authority or (c) any provision of any indenture, certificate of designation for preferred stock, agreement or other instrument to which such Loan Party is a party or by which any of them or any of their property is or may be bound, (2) be in conflict with, result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, give rise to a right of or result in any cancellation or acceleration of any right or obligation (including any payment) or to a loss of a material benefit under any such indenture, certificate of designation for preferred stock, agreement or other instrument, where any such conflict, violation, breach or default referred to in clause (1) or (2) of this Section 4(d)(ii), would 3 6974498.7 reasonably be expected to have, individually or in the aggregate a Material Adverse Effect, or (3) result in the creation or imposition of any Lien upon or with respect to any property or assets now owned or hereafter acquired by any such Loan Party, other than the Liens created by the Loan Documents and Permitted Liens; (iii) as of the Amendment No. 6 Effective Date, the information included in the Beneficial Ownership Certification is true and correct in all respects; and (iv) after giving effect to this Amendment No. 6, (1) no Default or Event of Default has occurred and is continuing and (2) each representation and warranty of such Loan Party contained in the Credit Agreement and in each other Loan Document to which it is a party is true and correct in all material respects (without duplication of any materiality qualifier contained therein), except to the extent that such representation or warranty expressly relates to an earlier date (in which event such representation or warranty is true and correct in all material respects (without duplication of any materiality qualifier contained therein) as of such earlier date). (e) Ratification. Each Loan Party hereby (i) ratifies and reaffirms all of its payment and performance obligations, contingent or otherwise, under each of the Credit Agreement and each other Loan Document to which it is a party, (ii) ratifies and reaffirms the grant of liens or security interests over its property pursuant to the Loan Documents and confirms that such liens and security interests continue to secure the ABL Finance Obligations, (iii) agrees that such ratification and reaffirmation is not a condition to the continued effectiveness of the Loan Documents and (iv) agrees that neither such ratification and reaffirmation, nor the Administrative Agent’s nor any Lender’s solicitation of such ratification and reaffirmation, constitutes a course of dealing giving rise to any obligation or condition requiring a similar or any other ratification or reaffirmation from each party to the Credit Agreement with respect to any amendment, consent or waiver with respect to the Credit Agreement or other Loan Documents. (f) Governing Law. THE LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE CONFLICTS OF LAWS PRINCIPLES THEREOF THAT WOULD REQUIRE THE APPLICATION OF LAWS OF ANOTHER JURISDICTION) SHALL GOVERN ALL MATTERS ARISING OUT OF, IN CONNECTION WITH, OR RELATING TO, THIS AMENDMENT NO. 6. (g) Effect. Upon the occurrence of the Amendment No. 6 Effective Date, each reference in the Existing Credit Agreement to “this Agreement,” “hereunder,” “hereof” or words of like import shall mean and be a reference to the Credit Agreement and each reference in the other Loan Documents to the Existing Credit Agreement, “thereunder,” “thereof,” or words of like import shall mean and be a reference to the Credit Agreement. Except as expressly provided in this Amendment No. 6, all of the terms, conditions and provisions of the Existing Credit Agreement and the other Loan Documents shall remain the same. This Amendment No. 6 shall constitute a Loan Document for purposes of the Credit Agreement. (h) No Other Waiver. Except as specifically set forth in this Amendment No. 6, the execution, delivery and effectiveness of this Amendment No. 6 shall not (a) limit, impair, constitute a waiver by, or otherwise affect any right, power or remedy of, the Administrative Agent or any Lender under the Credit Agreement or any other Loan Document, (b) constitute a waiver of any provision in the Credit Agreement or any other Loan Document or of any Default or Event of Default that may have occurred and be continuing or (c) alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or in any of the other Loan Documents, all of which are ratified and affirmed in all respects and shall continue in full force and effect. 4 6974498.7 (i) Administrative Agent’s Expenses. The Borrowers hereby agree to promptly reimburse the Administrative Agent for all of the reasonable and documented out-of-pocket expenses and customary administrative charges incurred by the Administrative Agent in connection with the preparation, negotiation and execution of this Amendment No. 6. [SIGNATURE PAGES FOLLOW]


 


 
Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) DEUTSCHE BANK AG NEW YORK BRANCH, as Lender By: Name: Title: By: Name: Title: Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) GOLDMAN SACHS BANK USA, as Lender By: Name: Andrew B. Vernon Title: Authorized Signatory


 
Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) BARCLAYS BANK PLC, as Lender By: Name: Charlene�Saldanha Title: Vice�President Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) Bank of America N.A., as Lender By: Name: Ernesto Moran Title: Senior Vice President Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) CITIBANK, N.A., as Lender By: Name: Michelle Pratt Title: Vice President Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) CREDIT SUISSE AG, NEW YORK BRANCH as Lender By: Name: Komal Shah Title: Authorized Signatory By: Name: Michael Dieffenbacher Title: Authorized Signatory


 
Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) PNC Bank, N.A. as Lender By: Name: Nancy Rosal Bonnell Title: Managing Director Amendment No. 6 to Amended and Restated Credit Agreement (Constellium) Bank of the West as Lender 6974498.7 EXHIBIT A to Amendment No. 6 to Amended and Restated Credit Agreement Amended Credit Agreement [Attached]


 
6974492.9 [Execution] EXHIBIT A TO AMENDMENT NO. 6 TO AMENDED AND RESTATED CREDIT AGREEMENT AMENDED AND RESTATED CREDIT AGREEMENT dated as of February 20, 2019 among CONSTELLIUM INTERNATIONAL S.A.S., as the Parent Guarantor, CONSTELLIUM MUSCLE SHOALS LLC, as a Borrower, CONSTELLIUM ROLLED PRODUCTS RAVENSWOOD, LLC, as a Borrower, and CONSTELLIUM BOWLING GREEN LLC, as a BorrowerBorrowers, CONSTELLIUM HOLDINGS MUSCLE SHOALS LLC, as a Loan Party, CONSTELLIUM US HOLDINGS I, LLC and CONSTELLIUM US INTERMEDIATE HOLDINGS LLC, as a Loan PartyParties, CONSTELLIUM PROPERTY AND EQUIPMENT COMPANY, LLC, as a Loan Party, THE LENDERS FROM TIME TO TIME PARTY HERETO, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent _____________________________ WELLS FARGO BANK, NATIONAL ASSOCIATION, and DEUTSCHE BANK SECURITIES INC., as Revolving Facility Joint Lead Arrangers and Joint Bookrunners, and GOLDMAN SACHS BANK USA BARCLAYS BANK PLC, and DEUTSCHE BANK SECURITIES INC., as Revolving Facility Co-Syndication Agents And WELLS FARGO BANK, NATIONAL ASSOCIATION, DEUTSCHE BANK SECURITIES INC., and GOLDMAN SACHS BANK USA as Term Facility Joint Lead Arrangers and Joint Bookrunners As amended by: Amendment No. 1 to Amended and Restated Credit Agreement, dated as of May 10, 2019, Amendment No. 2 to Amended and Restated Credit Agreement, dated as of April 24, 2020, Amendment No. 3 to Amended and Restated Credit Agreement, dated as of September 25, 2020, Amendment No. 4 to Amended and Restated Credit Agreement, dated as of April 27, 2021, Amendment No. 5 to Amended and Restated Credit Agreement, dated as of December 3, 2021, and Amendment No. 6 to Amended and Restated Credit Agreement, dated as of June 23, 2022 i TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.01 Defined Terms .............................................................................................................. 1 Section 1.02 Terms Generally ..................................................................................................... 6461 Section 1.03 Effectuation of Transactions .................................................................................. 6462 Section 1.04 Letter of Credit Amounts ....................................................................................... 6462 Section 1.05 Amendment and Restatement of the Existing Credit Agreement. .......................... 6462 Section 1.06 Rates; LIBOR Notification ......................................................................................... 65 62 ARTICLE II THE CREDITS 6563 Section 2.01 Revolving Facility Commitments .......................................................................... 6563 Section 2.02 Revolving Facility Loans and Revolving Facility Loan Borrowings ..................... 6663 Section 2.03 Requests for Revolving Facility Borrowings ......................................................... 6764 Section 2.04 Swing Line Loans. .................................................................................................. 6865 Section 2.05 Letters of Credit ..................................................................................................... 7067 Section 2.06 Funding of Borrowings .......................................................................................... 7875 Section 2.07 Interest Elections .................................................................................................... 7976 Section 2.08 Termination and Reduction of Revolving Facility Commitments ......................... 8077 Section 2.09 Agreement to Repay Loans; Evidence of Debt ...................................................... 8178 Section 2.10 Repayment of Loans ............................................................................................... 8178 Section 2.11 Prepayment of Revolving Facility Loans ............................................................... 8279 Section 2.12 Fees......................................................................................................................... 8582 Section 2.13 Interest .................................................................................................................... 8683 Section 2.14 Payments Generally; Pro Rata Treatment; Sharing of Setoffs ............................... 8987 Section 2.15 Term Loans. ........................................................................................................... 9189 Section 2.16 Cash Collateral ....................................................................................................... 9391 Section 2.17 Defaulting Lenders ................................................................................................. 9492 Section 2.18 Agent Advances ..................................................................................................... 9694 Section 2.19 Settlement ............................................................................................................... 9695 Section 2.20 Maintenance of Loan Account; Statement of Obligations ..................................... 9896 Section 2.21 Incremental Facilities. ................................................................................................ 97 ARTICLE III TAXES, YIELD PROTECTION AND ILLEGALITY 98 Section 3.01 Taxes .......................................................................................................................... 98 Section 3.02 Illegality .................................................................................................. 103[Reserved] 102 Section 3.03 Inability to Determine Rates[Reserved] ................................................................... 103 Section 3.04 Increased Costs ................................................................................................... 104103 Section 3.05 Compensation for Losses ................................................................................... 106104 Section 3.06 Mitigation Obligations; Replacement of Lenders .............................................. 106104 Section 3.07 Survival .............................................................................................................. 107105 ARTICLE IV REPRESENTATIONS AND WARRANTIES 107105 Section 4.01 Organization; Powers ......................................................................................... 107105 Section 4.02 Authorization ...................................................................................................... 107105 Section 4.03 Enforceability ..................................................................................................... 107105 ii Section 4.04 Governmental Approvals ................................................................................... 108106 Section 4.05 Financial Statements........................................................................................... 108106 Section 4.06 No Material Adverse Effect ............................................................................... 108106 Section 4.07 Title to Properties; Possession Under Leases ..................................................... 108106 Section 4.08 Subsidiaries ........................................................................................................ 109107 Section 4.09 Litigation; Compliance with Laws ..................................................................... 109107 Section 4.10 Federal Reserve Regulations .............................................................................. 109107 Section 4.11 Investment Company Act ................................................................................... 110108 Section 4.12 Use of Proceeds .................................................................................................. 110108 Section 4.13 Taxes .................................................................................................................. 110108 Section 4.14 No Material Misstatements ................................................................................ 110108 Section 4.15 Employee Benefit Plans ..................................................................................... 111109 Section 4.16 Environmental Matters ....................................................................................... 111109 Section 4.17 Security Documents ........................................................................................... 112110 Section 4.18 Location of Real Property and Leased Premises ................................................ 113111 Section 4.19 Solvency ............................................................................................................. 113111 Section 4.20 Labor Matters ..................................................................................................... 113112 Section 4.21 Insurance ............................................................................................................ 114112 Section 4.22 No Default .......................................................................................................... 114112 Section 4.23 Intellectual Property; Licenses, Etc. ................................................................... 114112 Section 4.24 Senior Debt ......................................................................................................... 114112 Section 4.25 Anti-Money Laundering and Economic Sanction Laws .................................... 114112 Section 4.26 Anti-Corruption Laws ........................................................................................ 115113 Section 4.27 Borrowing Base Matters ..................................................................................... 115113 Section 4.28 EEA Financial Institution ................................................................................... 115114 ARTICLE V CONDITIONS OF LENDING 116114 Section 5.01 All Credit Events ................................................................................................ 116114 Section 5.02 First Credit Event ............................................................................................... 117114 ARTICLE VI AFFIRMATIVE COVENANTS 119117 Section 6.01 Existence; Businesses and Properties ................................................................. 119117 Section 6.02 Insurance ............................................................................................................ 120118 Section 6.03 Taxes .................................................................................................................. 121119 Section 6.04 Financial Statements, Reports, etc. .................................................................... 121119 Section 6.05 Litigation and Other Notices .............................................................................. 123121 Section 6.06 Compliance with Laws ....................................................................................... 124122 Section 6.07 Maintaining Records; Access to Properties and Inspections .............................. 124122 Section 6.08 Use of Proceeds .................................................................................................. 124122 Section 6.09 Compliance with Environmental Laws .............................................................. 124122 Section 6.10 Further Assurances; Additional Security............................................................ 125123 Section 6.11 Appraisals and Field Examinations .................................................................... 127125 Section 6.12 Collection of Accounts; Payments ..................................................................... 128126 Section 6.13 Collateral Reporting ........................................................................................... 128126 Section 6.14 Anti-Money Laundering and Economic Sanction Laws; Anti-Corruption Laws129127 ARTICLE VII NEGATIVE COVENANTS 129127 Section 7.01 Indebtedness ....................................................................................................... 129127 iii Section 7.02 Liens ................................................................................................................... 132130 Section 7.03 Sale and Lease Back Transactions ..................................................................... 135133 Section 7.04 Investments, Loans and Advances ..................................................................... 135133 Section 7.05 Mergers, Consolidations, Sales of Assets and Acquisitions ............................... 138136 Section 7.06 Dividends and Distributions ............................................................................... 141139 Section 7.07 Transactions with Affiliates ............................................................................... 142140 Section 7.08 Business of the Borrowers and their respective Subsidiaries ............................. 144142 Section 7.09 Limitation on Modifications of Indebtedness; Modifications of Certificate of Incorporation, By Laws and Certain Other Agreements; etc. ............................ 144142 Section 7.10 Margin Stock; Use of Proceeds .......................................................................... 146144 Section 7.11 Holdcos Covenants ............................................................................................. 146144 Section 7.12 Financial Covenants ........................................................................................... 147145 ARTICLE VIII EVENTS OF DEFAULT 147145 Section 8.01 Events of Default ................................................................................................ 147145 Section 8.02 Exclusion of Immaterial Subsidiaries ................................................................. 150148 Section 8.03 Application of Funds. ......................................................................................... 150148 ARTICLE IX THE AGENCY PROVISIONS 154152 Section 9.01 Appointment and Authority ................................................................................ 154152 Section 9.02 Rights as a Lender .............................................................................................. 155153 Section 9.03 Exculpatory Provisions....................................................................................... 155153 Section 9.04 Reliance by Administrative Agent ..................................................................... 156154 Section 9.05 Delegation of Duties ........................................................................................... 156154 Section 9.06 Resignation of Administrative Agent ................................................................. 156154 Section 9.07 Non-Reliance on Administrative Agent and Other Lenders .............................. 158156 Section 9.08 No Other Duties, Etc. ......................................................................................... 158156 Section 9.09 Administrative Agent May File Proofs of Claim ............................................... 158156 Section 9.10 Collateral and Guaranty Matters ........................................................................ 159157 Section 9.11 Secured Hedge Agreements and Secured Cash Management Agreements ........ 160158 Section 9.12 Certain ERISA Matters ...................................................................................... 160158 Section 9.13 Erroneous Payment............................................................................................. 161159 ARTICLE X MISCELLANEOUS 163161 Section 10.01 Amendments, Etc. .............................................................................................. 163161 Section 10.02 Notices; Effectiveness; Electronic Communication ........................................... 167165 Section 10.03 No Waiver; Cumulative Remedies; Enforcement .............................................. 168166 Section 10.04 Expenses; Indemnity; Damage Waiver .............................................................. 169167 Section 10.05 Payments Set Aside ............................................................................................ 172170 Section 10.06 Successors and Assigns ...................................................................................... 172170 Section 10.07 Treatment of Certain Information; Confidentiality ............................................ 176175 Section 10.08 Platform; Borrower Materials ............................................................................ 177175 Section 10.09 Right of Setoff .................................................................................................... 177175 Section 10.10 Interest Rate Limitation ...................................................................................... 178176 Section 10.11 Counterparts; Integration; Effectiveness ............................................................ 178176 Section 10.12 Survival of Representations and Warranties ...................................................... 178176 Section 10.13 Severability ......................................................................................................... 178177 Section 10.14 Replacement of Lenders ..................................................................................... 179177


 
iv Section 10.15 Governing Law; Jurisdiction Etc. ....................................................................... 179178 Section 10.16 Waiver of Jury Trial ........................................................................................... 180179 Section 10.17 No Advisory or Fiduciary Responsibility .......................................................... 181179 Section 10.18 Electronic Execution of Assignments and Certain Other Documents ................ 181179 Section 10.19 USA Patriot Act Notice ...................................................................................... 181180 Section 10.20 Intercreditor Agreements .................................................................................... 182180 Section 10.21 Field Audit and Examination Reports; Disclaimer by Lenders .......................... 182180 Section 10.22 Release of Liens and Guarantees ........................................................................ 183181 Section 10.23 Headings ............................................................................................................. 183181 Section 10.24 Acknowledgement and Consent to Bail-In of Affected Financial Institutions... 183181 Section 10.25 Power of Attorney .............................................................................................. 184182 Section 10.26 Acknowledgement Regarding Any Supported QFCs ......................................... 184182 v Exhibits: Exhibit A – Form of Assignment and Assumption Exhibit B-1 – Form of Solvency Certificate Exhibit B-2 – Form of Borrowing Base Certificate Exhibit C-1 – Form of Revolving Facility Borrowing RequestSOFR Notice Exhibit C-2 – Form of Swing Line Loan Notice Exhibit C-3 Form of Letter of Credit Request Exhibit C-4 – Form of Term Loan Request Exhibit D-1 – U.S. Tax Compliance Certificate Exhibit D-2 – U.S. Tax Compliance Certificate Exhibit D-3 – U.S. Tax Compliance Certificate Exhibit D-4 – U.S. Tax Compliance Certificate Schedules: Schedule 1.01(a) – Certain U.S. Subsidiaries Schedule 1.01(b) – Mortgaged Properties Schedule 1.01(c) – Immaterial Subsidiaries Schedule 1.01(d) – Qualified Receivables Schedule 1.01(e) – Unrestricted Subsidiaries Schedule 1.01(f) – Acceptable Appraisers Schedule 1.01(g) – Bowling Green Property Description Schedule 1.01(h) – Account Debtor Restrictions Schedule 2.01 – Revolving Facility Commitments Schedule 2.15 – Term Loan Commitments Schedule 4.01 – Organization and Good Standing Schedule 4.04 – Governmental Approvals Schedule 4.07(b) – Leased Properties Schedule 4.08(a) – Subsidiaries Schedule 4.08(b) – Subscriptions Schedule 4.13 – Taxes Schedule 4.16 – Environmental Matters Schedule 4.21 – Insurance Schedule 4.23 – Intellectual Property Schedule 5.02(b) – Local Counsel Schedule 6.10 – Post-Closing Deliveries Schedule 6.13 – Collateral Reporting Information Schedule 7.01 – Indebtedness Schedule 7.02(a) – Liens Schedule 7.04 – Investments Schedule 10.02 – Notice Information 1 This AMENDED AND RESTATED CREDIT AGREEMENT, dated as of February 20, 2019 (this “Agreement”), is entered into by and among CONSTELLIUM MUSCLE SHOALS LLC, a Delaware limited liability company (f/k/a Wise Alloys LLC) (“Muscle Shoals”), CONSTELLIUM ROLLED PRODUCTS RAVENSWOOD, LLC, a Delaware limited liability company (“Ravenswood” together with Muscle Shoals, the “Existing Borrowers”), CONSTELLIUM BOWLING GREEN LLC, a Delaware limited liability company (f/k/a Constellium-UACJ ABS LLC) (“Bowling Green”), CONSTELLIUM HOLDINGS MUSCLE SHOALS LLC, a Delaware limited liability company (f/k/a Wise Metals Group LLC) (“Muscle Shoals Holdings”), CONSTELLIUM US HOLDINGS I, LLC, a Delaware limited liability company (“CUSHI”), CONSTELLIUM PROPERTY AND EQUIPMENT COMPANY,US INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“CPECConstellium US Intermediate”), CONSTELLIUM INTERNATIONAL S.A.S., a simplified joint- stock company (société par actions simplifiée) incorporated under French law, having its registered address at 40-44 rue Washington, 75008 Paris, France, registered with the Trade and Companies Registry of Paris under number 832 509 418 (“Parent Guarantor”), acting as successor by merger to CONSTELLIUM HOLDCO II B.V., a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) incorporated under Dutch law having its corporate seat (statutaire zetel) in Amsterdam, the Netherlands, the LENDERS party hereto from time to time, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as administrative agent and collateral agent (in such capacities, the “Administrative Agent”) for the Lenders. WHEREAS, the Existing Borrowers, Muscle Shoals Holdings, CUSHI, Bowling Green, Parent Guarantor, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent thereunder, are currently party to that Credit Agreement, dated as of June 21, 2017, as amended by Amendment No. 1, dated May 10, 2019 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Existing Credit Agreement”); WHEREAS, the Borrowers, the Lenders and the Administrative Agent have entered into this Agreement in order to, among other things, (i) amend and restate the Existing Credit Agreement in its entirety; (ii) add Bowling Green as a Borrower under this Agreement; (iii) increase the aggregate amount of the Revolving Facility Commitment from $300,000,000400,000,000 to $350,000,000500,000,000; (iviii) set forth the terms and conditions under which the Lenders will, from time to time, make loans and extend other financial accommodations to or for the benefit of the Borrowers, and (viv) pursuant to Amendment No. 2, set forth the terms and conditions pursuant to which Borrowers may borrow up to $166,250,000 of Term Loans; and WHEREAS, it is the intent of the parties hereto that this Agreement not constitute a novation of the obligations and liabilities of the parties under the Existing Credit Agreement or be deemed to evidence or constitute full repayment of such obligations and liabilities, but that this Agreement amend and restate in its entirety the Existing Credit Agreement and re-evidence the obligations and liabilities of the Borrowers outstanding thereunder, which shall be payable in accordance with the terms hereof. NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, the parties hereto agree that the Existing Credit Agreement is hereby amended and restated as follows: ARTICLE I DEFINITIONS Section 1.01 Defined Terms. As used in this Agreement, the following terms have the meanings specified below: 2 “AB Receivables” means, collectively, Accounts for which the related Account Debtor is Anheuser-Busch and/or its Affiliates (other than Envases y Tapas Modelo, S. de R.L. de C.V.). “AB Receivables Financing” means any transaction or series of transactions that may be entered into by any of Muscle Shoals or its Subsidiaries pursuant to which Muscle Shoals or such Subsidiary (any such Subsidiary, the “AB Receivables Subsidiary”) may sell, convey or otherwise transfer to any other Person (other than the Administrative Agent pursuant to the Loan Documents), or may grant a security interest in, any AB Receivables (whether now existing or arising in the future) of the AB Receivables Subsidiary, including all collateral securing such AB Receivables, all contracts and all guarantees or other obligations in respect of such AB Receivables, proceeds of such AB Receivables and other assets, in each case, which are customarily transferred in or in respect of which security interests are customarily granted in connection with asset securitization transactions or factoring transactions involving accounts receivable. “AB Receivables Subsidiary” has the meaning set forth in the definition of “AB Receivables Financing”. “ABL Credit Obligations” means, with respect to each Loan Party and the Parent Guarantor, without duplication: (a) in the case of each Borrower, all principal of, premium, if any, and interest (including, without limitation, any interest which accrues after the commencement of any proceeding under any Debtor Relief Law with respect to such Borrower, whether or not allowed or allowable as a claim in any such proceeding) on, any Loan or L/C Obligation under, or any Note issued pursuant to, this Agreement or any other Loan Document; (b) all fees, expenses, indemnification obligations and other amounts of whatever nature now or hereafter payable by such Loan Party or Parent Guarantor (including, without limitation, any amounts which accrue after the commencement of any proceeding under any Debtor Relief Law with respect to such Loan Party, whether or not allowed or allowable as a claim in any such proceeding) pursuant to this Agreement or any other Loan Document; (c) all expenses of the Administrative Agent as to which the Administrative Agent has a right to reimbursement by such Loan Party or Parent Guarantor under Section 10.04(a) of this Agreement or under any other similar provision of any other Loan Document, including, without limitation, any and all sums advanced by the Collateral Agent to preserve the Collateral or preserve its security interests in the Collateral to the extent permitted under any Loan Document or applicable Law; (d) all amounts paid by any Indemnitee as to which such Indemnitee has the right to reimbursement by such Loan Party or Parent Guarantor under Section 10.04(b) of this Agreement or under any other similar provision of any other Loan Document; and (e) in the case of the Holdcos, each Borrower and each Subsidiary Loan Party, all amounts now or hereafter payable by the Holdcos, such Borrower or such Subsidiary Loan Party and all other obligations or liabilities (including all amounts charged to the Loan Account pursuant to this Agreement) now existing or hereafter arising or incurred (including, without limitation, any amounts which accrue after the commencement of any proceeding under any Debtor Relief Law with respect to any Borrower, the Holdcos or such Subsidiary Loan Party, whether or not allowed or allowable as a claim in any such proceeding) on the part of the Holdcos, such Borrower or such Subsidiary Loan Party pursuant to this Agreement, the Guaranty or any other Loan Document;


 
3 together in each case with all renewals, modifications, consolidations or extensions thereof; provided, that, notwithstanding the foregoing, the ABL Credit Obligations guaranteed by Parent Guarantor pursuant to the Collateral Agreement shall not include the Term Loan A-2 Obligations. “ABL Finance Obligations” means, at any date, (i) all ABL Credit Obligations and (ii) all Swap Obligations of any Borrower or any Material Subsidiary then owing under any Secured Hedge Agreement to any Hedge Bank and (iii) all obligations of any Borrower or any Material Subsidiary then owing under any Secured Cash Management Agreement to any Cash Management Bank. “Acceptable Appraiser” means (a) any Person listed on Schedule 1.01(f) or (b) any other experienced and reputable appraiser reasonably acceptable to the Administrative Agent. “Accepting Lenders” has the meaning assigned to such term in Section 10.01. “Account” has the meaning assigned to such term in the Collateral Agreement. “Account Debtor” has the meaning assigned to such term in the Collateral Agreement. “Accounts Availability Triggering Event” shall occur at any time that (a) Availability is less than the greater of 12.5% of the Loan Cap and $37,500,00046,900,000 for a period of five (5) consecutive Business Days or (b) an Event of Default shall have occurred and be continuing. Once occurred, an Accounts Availability Triggering Event shall be deemed to be continuing until such time as either (i) Availability exceeds the greater of 12.5% of the Loan Cap and $37,500,00046,900,000 for a period of at least 30 consecutive days or (ii) such Event of Default has been cured or waived in accordance with the terms hereof, as applicable. “Additional Mortgage” has the meaning assigned to such term in Section 6.10(c). “Adjusted Eurodollar Rate” means the quotient obtained (expressed as a decimal, carried out to five decimal places) by dividing (A) the applicable Eurodollar Base Rate by (B) 1.00 minus the Eurodollar Reserve Percentage (rounded upwards, if necessary, to the next 1/100 of 1%). “Adjusted Term SOFR” means, for purposes of any calculation, the rate per annum equal to (a) Term SOFR for such calculation plus (b) the Term SOFR Adjustment; provided that if Adjusted Term SOFR as so determined shall ever be less than the Floor, then Adjusted Term SOFR shall be deemed to be the Floor. “Administrative Agent” has the meaning assigned to such term in the preamble to this Agreement. “Administrative Agent Fees” has the meaning assigned to such term in Section 2.12(c). “Administrative Agent’s Account” means the Deposit Account of the Administrative Agent identified on Schedule 10.02 to this Agreement (or such other Deposit Account of the Administrative Agent that has been designated as such, in writing, by the Administrative Agent to Borrowers and the Lenders). “Administrative Agent’s Office” means the Administrative Agent’s address set forth on Schedule 10.02, or such other address as the Administrative Agent may from time to time notify the Borrowers and the Lenders. 4 “Administrative Questionnaire” means an Administrative Questionnaire in a form supplied by the Administrative Agent. “Affected Facility” has the meaning assigned to such term in Section 10.01. “Affected Financial Institution” means (a) any EEA Financial Institution and (b) any UK Financial Institution. “Affiliate” means, when used with respect to a specified person, another person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the person specified. “Agent Advance” shall have the meaning assigned to such term in Section 2.18. “Agreement” means, on any date, this Agreement as originally in effect on the Effective Date and as thereafter amended, supplemented, amended and restated or otherwise modified from time to time and in effect on such date. “Airbus” means Airbus Group SE and its successors and assigns. “Amendment Fee LetterNo. 1 Effective Date” means that certain fee letter dated as of May 10, 2019 among the Administrative Agent and the Borrowers. “Amendment No. 1 Effective Date” means May 10, 2019, after giving effect to the amendments to this Agreement contemplated by that certain Amendment No. 1 hereto among the Loan Parties, the Lenders and the Administrative Agent dated as of May 10, 2019. “Amendment No. 2 Effective Date” means April 24, 2020, after giving effect to the amendments to this Agreement contemplated by that certain Amendment No. 2 hereto among the Loan Parties, the Lenders and the Administrative Agent dated as of April 24, 2020. “Amendment No. 2 Fee Letter” means that certain fee letter, dated as of April 24, 2020 among the Administrative Agent and the Borrowers. “Amendment No. 3” means Amendment No. 3 to Amended and Restated Credit Agreement, dated September 25, 2020, by and among Administrative Agent, Lenders, and Loan Parties, as the same now exists or may hereafter be amended, modified, supplemented, extended, renewed, restated or replaced. “Amendment No. 3 Fees” shall have the meaning set forth in Section 5 of Amendment No. 3. “Amendment No. 3 Effective Date” means the first date on which the conditions precedent set forth in Section 3 of Amendment No. 3 are satisfied in accordance with Section 3 of Amendment No. 3. “Amendment No. 4” means Amendment No. 4 to Amended and Restated Credit Agreement, dated April 27, 2021, by and among Administrative Agent, Lenders and Loan Parties, as the same now exists or may hereafter be amended, modified, supplemented, extended, renewed, restated or replaced. “Amendment No. 4 Fee LetterEffective Date” means that certain fee letter, dated as of April 27, 2021 among the Administrative Agent and the Borrowers. 5 “Amendment No. 4 Effective Date” means the first date on which the conditions precedent set forth in Section 4 of Amendment No. 4 are satisfied in accordance with Section 4 of Amendment No. 4. “Amendment No. 56” means Amendment No. 56 to Amended and Restated Credit Agreement, dated as of December 3June 23, 20212022, by and among Administrative Agent, Lenders and Loan Parties, as the same now exists or may hereafter be amended, modified, supplemented, extended, renewed, restated or replaced. “Amendment No. 56 Effective Date” means the first date on which the conditions precedent set forth in Section 3 of Amendment No. 56 are satisfied in accordance with Section 3 of Amendment No. 56. “Anheuser-Busch” means Anheuser-Busch, LLC and its successors and assigns. “Announcements” has the meaning set forth in Section 2.13(g). “Anti-Money Laundering Laws” means any and all laws, judgments, orders, executive orders, decrees, ordinances, rules, regulations, statutes, case law or treaties applicable to a Loan Party, its subsidiaries or Affiliates related to terrorism financing or money laundering, including any applicable provision of Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act (USA PATRIOT Act) of 2001 (Title III of Pub. L. 107-56) and The Currency and Foreign Transactions Reporting Act (also known as the “Bank Secrecy Act”, 31 U.S.C. §§ 5311-5330 and 12 U.S.C. §§ 1818(s), 1820(b) and 1951-1959). “Applicable Accounting Rules” means GAAP or IFRS, as applicable to the applicable Person in the applicable context; provided, that for purposes of the definitions of “Indebtedness” and “Capital Lease Obligations”, the determination whether a lease is a capital lease or an operating lease, the capitalized amount of any lease, and whether any obligations under such lease constitute a liability on the balance sheet of any person shall, in each case, be made on the basis of GAAP or IFRS (as applicable) as in effect on the Original Closing Date, without giving effect to any subsequent change in GAAP or IFRS (including, for the avoidance of doubt, IFRS 16). “Applicable Margin” means, with respect to Revolving Facility Loans, Agent Advances, and Swing Line Loans, a percentage per annum equal to the rate set forth below opposite the then-applicable Tier for the fiscal quarter immediately preceding the fiscal quarter in which Tier Average Quarterly Excess Availability Applicable Revolving Facility LIBOR Rate MarginMargin for SOFR Loans (the “SOFR Margin”) Applicable Revolving Facility Margin for Base Rate Loans (the “Base Rate Margin”) I Greater than 66 2/3% of the Revolving Loan Limit 1.25% 0.25% 6 II Less than or equal to 66 2/3% of the Revolving Loan Limit and greater than 33 1/3% of the Revolving Loan Limit 1.50% 0.50% III Less than or equal to 33 1/3% of the Revolving Loan Limit 1.75% 0.75% For the avoidance of doubt, (i) Agent Advances and Swing Line Loans shall bear interest as Revolving Facility Loans which are Base Rate Loans, and (ii) changes in the Applicable Margin resulting from a change in the Average Quarterly Excess Availability as calculated in a compliance certificate delivered pursuant to Section 6.04(c), for any fiscal quarter of Borrowers shall become effective as to all applicable Revolving Facility Loans and Letter of Credit Fees on the first day of the next fiscal quarter following delivery of such compliance certificate except in the case of compliance certificates that are delivered pursuant to Section 6.04(c) for any fiscal quarter that ends on the last day of a fiscal year, in which case such change shall become effective on the first day of the fiscal quarter in which such compliance certificate is required to be delivered; provided, however, that if a compliance certificate is not delivered when due in accordance with such Section 6.04(c), then Pricing Level III shall apply from the first day of the next fiscal quarter following the date on which such compliance certificate was due through the date on which such compliance certificate is delivered, after which the pricing level corresponding to the Average Quarterly Excess Availability set forth in such compliance certificate shall apply. Notwithstanding the calculation of the Applicable Margin for any period as set forth above, if, as a result of any error in the calculation of the Average Quarterly Excess Availability for any quarter or for any other reason, the Borrowers or the Lenders determine that (1) the Average Quarterly Excess Availability as calculated for such quarter was inaccurate and (2) a proper calculation of the Average Quarterly Excess Availability for such quarter would have resulted in higher pricing for such period, the Borrowers shall immediately and retroactively be obligated to pay to the Administrative Agent for the account of the applicable Lenders or the L/C Issuers, as applicable, promptly on demand by the Administrative Agent (or, after the occurrence of an actual or deemed entry of an order for relief with respect to any Borrower under the Bankruptcy Code of the United States, automatically and without further action by the Administrative Agent, any Lender or any L/C Issuer), an amount equal to the excess of the amount of interest and fees that should have been paid for such period over the amount of interest and fees actually paid for such period. This paragraph shall not limit the rights of the Administrative Agent, any Lender or any L/C Issuer, as the case may be, under Section 2.13(c) or 2.05(h) or under Article VIII. “Application Event” means the occurrence of (a) a failure by Borrowers to repay all of the ABL Finance Obligations in full on the Facility Maturity Date, and (b) an Event of Default and the election by Administrative Agent or the Required Lenders to require that payments and proceeds of Collateral be applied pursuant to Section 8.03(b) and (c) of this Agreement. “Approved Fund” means any Fund that is administered or managed by (i) a Lender, (ii) an Affiliate of a Lender or (iii) an entity or an Affiliate of an entity that administers or manages a Lender. “Asset Sale” means any loss, damage, destruction or condemnation of, or any sale, transfer or other disposition (including any sale and leaseback of assets and any mortgage or lease of Real Property) to any person of any asset or assets of any Borrower or any Subsidiary (including to a Divided LLC pursuant to a Division).


 
7 “Assignment and Assumption” means an assignment and assumption entered into by a Lender and an assignee, and accepted by the Administrative Agent, the L/C Issuers, the Swing Line Lender and the Borrowers (in each case, if required by such assignment and assumption), in the form of Exhibit A or such other form as shall be approved by the Administrative Agent, the L/C Issuers, the Swing Line Lender and the Borrowers (such approval not to be unreasonably withheld or delayed). “Auto-Extension Letter of Credit” shall have the meaning specified in Section 2.05(b)(iii). “Auto-Reinstatement Letter of Credit” shall have the meaning specified in Section 2.05(b)(iv). “Available Increase Amount” means, as of any date of determination from and after the Amendment No. 6 Effective Date, an amount equal to the result of (a) $100,000,000, minus (b) the aggregate principal amount of Increases to the Revolving Facility Commitments previously made pursuant to Section 2.21 of this Agreement. “Available Tenor” means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (a ) if the then-currentsuch Benchmark is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the length of an interest period pursuant to this Agreement or (b) otherwise, any payment period for interest calculated with reference to such Benchmark, as applicable, (or component thereof) that is or may be used for determining the length of an Interest Periodany frequency of making payments of interest calculated with reference to such Benchmark pursuant to this Agreement, in each case, as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of “Interest Period” pursuant to Section 2.13(gj)(iviii)(D). “Availability” means, at any time, (a) the lesser of the Revolving Loan Limit and the Borrowing Base in effect at such time minus (b) the aggregate Outstanding Amounts under the Revolving Facility. “Availability Period” shall mean the period from and including the Closing Date to but excluding the earlier of (x) the Facility Maturity Date and (y) the date of termination of the Revolving Facility Commitments. “Availability Triggering Event” shall occur at any time that (a) Availability is less than the greater of 12.5% of the Loan Cap and $37,500,00046,900,000 or (b) a Default or an Event of Default shall have occurred and be continuing. Once occurred, an Availability Triggering Event shall be deemed to be continuing until such time as (A) in the case of an Availability Triggering Event described in clause (a), Availability exceeds the greater of 12.5% of the Loan Cap and $37,500,00046,900,000 for 30 consecutive days or (B) in the case of an Availability Triggering Event described in clause (b), the applicable Default or Event of Default has been cured or waived in accordance with the terms hereof, as applicable. “Average Quarterly Excess Availability” means, at any time, an amount (expressed as a percentage) equal to the quotient of (A) the average dailysum of the aggregate amount of Excess Availability duringfor each day in the immediately preceding quarter divided by (B) the average daily Revolving Loan Limit for the immediately preceding quarternumber of days in such period. “Bail-In Action” means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution. “Bail-In Legislation” means, (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the 8 implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act of 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings). “Bank Product Obligations” means the obligations owing to any Hedge Bank and Cash Management Bank described in clauses (ii) and (iii) of the definition of ABL Finance Obligations. “Bank Product Reserves” means, as of any date of determination, those Reserves that Administrative Agent deems necessary or appropriate to establish and maintain, in its Permitted Discretion in respect of Bank Product Obligations provided by Revolving Facility Lenders or their Affiliates (in their capacities as a Cash Management Bank or a Hedge Bank, as the case may be) then provided or outstanding based on the determination of the applicable Cash Management Bank or Hedge Bank, of the liabilities and obligations of each Loan Party and its Subsidiaries in respect of such Bank Product Obligations. “Base Rate” means, for any day, a rate per annum equal to the highestgreatest of (a) the Prime Rate for such dayFloor, (b) the sum of 0.50% plus the Federal Funds Rate forin effect on such day andplus ½%, (c) the sum of the Eurodollar Base Rate for a one-month interest period (which rate shall be determined on a daily basis) plus 1.00%.Term SOFR for a one month tenor in effect on such day, plus 1%, provided that this clause (c) shall not be applicable during any period in which Term SOFR is unavailable or unascertainable, and (d) the rate of interest announced, from time to time, within Wells Fargo at its principal office in San Francisco as its “prime rate” in effect on such day, with the understanding that the “prime rate” is one of Wells Fargo’s base rates (not necessarily the lowest of such rates) and serves as the basis upon which effective rates of interest are calculated for those loans making reference thereto and is evidenced by the recording thereof after its announcement in such internal publications as Wells Fargo may designate “Base Rate Borrowing” means either a Base Rate Revolving Facility Borrowing or a Base Rate Term Loan Facility Borrowing. “Base Rate Loan” means a Loan that bears interest based on the Base Rate. “Base Rate Margin” has the meaning set forth in the definition of Applicable Margin. “Base Rate Revolving Facility Borrowing” means a Revolving Facility Borrowing comprised of Base Rate Loans. “Base Rate Term Loan Facility Borrowing” means a Term Loan Facility Borrowing comprised of Base Rate Loans. “Benchmark” means, initially, USD LIBORthe Term SOFR Reference Rate; provided, that, if a Benchmark Transition Event, a Term SOFR Transition Event, or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date have has occurred with respect to USD LIBORthe Term SOFR Reference Rate or the then-current Benchmark, then “Benchmark” means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to Section 2.13(gj)(iiii)(A). “Benchmark Replacement” means, for any Available Tenor, 9 (a) with respect to any Benchmark Transition Event or Early Opt-in Election, the first alternative set forth in the order below that can be determined by the Administrative Agent for the applicable Benchmark Replacement Date: (i) the sum of: (A) Term SOFR and (B) the related Benchmark Replacement Adjustment; (ii) the sum of: (A) Daily Simple SOFR and (B) the related Benchmark Replacement Adjustment; (iii) “Benchmark Replacement” means, with respect to any Benchmark Transition Event, the sum of: (Aa) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrowers as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to (1i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (2ii) any evolving or then- prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for Dollar-denominated syndicated credit facilities at such time and (Bb) the related Benchmark Replacement Adjustment; orprovided that if such Benchmark Replacement as so determined would be less than the Floor, such Benchmark Replacement shall be deemed to be the Floor for the purposes of this Agreement and the other Loan Documents. (b) with respect to any Term SOFR Transition Event, the sum of (i) Term SOFR and (ii) the related Benchmark Replacement Adjustment; Provided, that, (A) in the case of clause (a)(i), if the Administrative Agent decides that Term SOFR is not administratively feasible for the Administrative Agent, then Term SOFR will be deemed unable to be determined for purposes of this definition and (B) in the case of clause (a)(i) or clause (b) of this definition, the applicable Unadjusted Benchmark Replacement is displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion. “Benchmark Replacement Adjustment” means, with respect to any replacement of the then- current Benchmark with an Unadjusted Benchmark Replacement for any applicable Interest Period and Available Tenor for any setting of such Unadjusted Benchmark Replacement: (a) for purposes of clauses (a)(i) and (a)(ii) of the definition of “Benchmark Replacement,” the first alternative set forth in the order below that can be determined by the Administrative Agent: (i) the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that has been selected or recommended by the Relevant Governmental Body for the replacement of such Available Tenor of such Benchmark with the applicable Unadjusted Benchmark Replacement; (ii) the spread adjustment (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that would apply to the fallback rate for a derivative transaction referencing the ISDA Definitions to be effective upon an index cessation event with respect to such Available Tenor of such Benchmark; 10 (b) for purposes of clause (a)(iii) of the definition of “Benchmark Replacement,” Adjustment” means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement for any applicable Available Tenor, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the BorrowersBorrower giving due consideration to (ia) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Available Tenor of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body on the applicable Benchmark Replacement Date or (iib) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Available Tenor of such Benchmark with the applicable Unadjusted Benchmark Replacement for Dollar- denominated syndicated credit facilities; and at such time. (c) for purposes of clause (b) of the definition of “Benchmark Replacement,” the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that has been selected or recommended by the Relevant Governmental Body for the replacement of such Available Tenor of USD LIBOR with a SOFR-based rate; Provided, that, (x) in the case of clause (i) above, such adjustment is displayed on a screen or other information service that publishes such Benchmark Replacement Adjustment from time to time as selected by the Administrative Agent in its reasonable discretion and (y) if the then-current Benchmark is a term rate, more than one tenor of such Benchmark is available as of the applicable Benchmark Replacement Date and the applicable Unadjusted Benchmark Replacement that will replace such Benchmark in accordance with Section 2.13(g)(i) will not be a term rate, the Available Tenor of such Benchmark for purposes of this definition of “Benchmark Replacement Adjustment” shall be deemed to be, with respect to each Unadjusted Benchmark Replacement having a payment period for interest calculated with reference thereto, the Available Tenor that has approximately the same length (disregarding business day adjustments) as such payment period. “Benchmark Replacement Conforming Changes” means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “Base Rate,” the definition of “Business Day,” the definition of “Interest Period,” timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent in consultation with the Borrowers decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines, in consultation with the Borrowers, that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent, in consultation with the Borrowers, decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents). “Benchmark Replacement Date” means the earliest to occur of the following events with respect to the then-current Benchmark: (a) in the case of clause (a) or (b) of the definition of “Benchmark Transition Event,” the later of (i) the date of the public statement or publication of information referenced therein and (ii) the date on which the administrator of such Benchmark (or the published component used in the calculation


 
11 thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof); or (b) in the case of clause (3c) of the definition of “Benchmark Transition Event,” the first date of the publicon which such Benchmark (or the published component used in the calculation thereof) has been determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be non-representative; provided that such non- representativeness will be determined by reference to the most recent statement or publication of information referenced therein;in such clause (c) and even if any Available Tenor of such Benchmark (or such component thereof) continues to be provided on such date. (c) in the case of a Term SOFR Transition Event, the date that is thirty (30) days after the Administrative Agent has provided the Term SOFR Notice to the Lenders and the Borrowers pursuant to Section 2.13(g)(i)(B); or (d) in the case of an Early Opt-in Election, the sixth (6th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the Administrative Agent has not received, by 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election from Lenders comprising the Required Lenders. For the avoidance of doubt, (i) if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination and (ii) the “Benchmark Replacement Date” will be deemed to have occurred in the case of clause (a) or (b) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof). “Benchmark Transition Event” means the occurrence of one or more of the following events with respect to the then-current Benchmark: (a) a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof); (b) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof); or 12 (c) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are no longernot, or as of a specified future date will not be, representative. For the avoidance of doubt, if the then-current Benchmark has any Available Tenors, a “Benchmark Transition Event” will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof). “Benchmark Transition Start Date” means, in the case of a Benchmark Transition Event, the earlier of (a) the applicable Benchmark Replacement Date and (b) if such Benchmark Transition Event is a public statement or publication of information of a prospective event, the 90th day prior to the expected date of such event as of such public statement or publication of information (or if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such statement or publication). “Benchmark Unavailability Period” means the period (if any) (x) beginning at the time that a Benchmark Replacement Date pursuant to clauses (a) or (b) of that definition has occurred if, at such time, no Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 2.13(gj)(iii) and (y) ending at the time that a Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 2.13(gj)(iii). “Beneficial Ownership Certification” means a certification regarding beneficial ownership as required by the Beneficial Ownership Regulation. “Beneficial Ownership Regulation” means 31 C.F.R. § 1010.230. “Benefit Plan” means any of (a) an “employee benefit plan” (as defined in ERISA) that is subject to Title I of ERISA, (b) a “plan” as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such “employee benefit plan” or “plan”. “Board” means the Board of Governors of the Federal Reserve System of the United States of America. “Board of Directors” means, as to any person, the board of directors or other governing body of such person, or if such person is owned or managed by a single entity, the board of directors or other governing body of such entity. “Borrowers” means, collectively, Bowling Green, Ravenswood and Muscle Shoals. Unless the context otherwise requires, “Borrower” shall mean one or all of the foregoing Persons, jointly, severally, and collectively. “Borrower Materials” has the meaning assigned to such term in Section 10.08. “Borrowing” means a Revolving Facility Borrowing or a Term Loan Facility Borrowing. “Borrowing Base” means, at any time, an amount equal to: 13 the result of (a) the sum of: (i) 85.0% of the Net Amount of Eligible Accounts, plus (ii) the lesser of: (A) 80.0% of the lesser of the original cost or market value of Eligible Inventory (valued at any date based on average cost method of accounting), and (B) 85.0% of the Orderly Liquidation Value of Eligible Inventory, minus (b) all Reserves which the Administrative Agent deems necessary in the exercise of its Permitted Discretion to maintain with respect to any Loan Party, including Reserves for any amounts which the Administrative Agent or any Lender may be obligated to pay in the future for the account of any Loan Party. The specified percentages set forth in this definition will not (except as otherwise specified herein) be reduced without the consent of each Borrower (not to be unreasonably withheld or delayed). Any determination by the Administrative Agent in respect of the Borrowing Base shall be based on the Administrative Agent’s Permitted Discretion. The parties understand that the exclusionary criteria in the definitions of Eligible Accounts and Eligible Inventory, any Reserves that may be imposed as provided herein, any deductions or other adjustments to determine “lesser of cost or market value” and Net Amount of Eligible Accounts and factors considered in the calculation of Orderly Liquidation Value of Eligible Inventory have the effect of reducing the Borrowing Base, and, accordingly, whether or not any provisions hereof so state, all of the foregoing shall be determined without duplication so as not to result in multiple reductions in the Borrowing Base for the same facts or circumstances. “Borrowing Base Certificate” means a certificate by a Responsible Officer of the Borrowers, substantially in the form of Exhibit B-2 (or another form acceptable to the Administrative Agent) setting forth the calculation of the Borrowing Base, including a calculation of each component thereof (including, to the extent any Borrower has received notice of any such Reserve from the Administrative Agent, any of the Reserves included in such calculation pursuant to clause (y) of the definition of the Borrowing Base), all in such detail as shall be reasonably satisfactory to the Administrative Agent. All calculations of the Borrowing Base in connection with the preparation of any Borrowing Base Certificate shall be made by the Borrowers and certified to the Administrative Agent. “Borrowing Minimum” means $1,000,000, except in the case of Swing Line Loans, in which case it means $250,000. “Borrowing Multiple” means $250,000. “Bowling Green Current Assets Access Agreement” means an agreement providing access and use rights to the Administrative Agent with respect to any Collateral located at the Bowling Green Property described on Schedule 1.01(g), on terms substantially similar to Section 9 of the Ravenswood Intercreditor Agreement, or other terms reasonably satisfactory to the Administrative Agent. 14 “Bowling Green Intercompany Indebtedness” means the Indebtedness incurred by Bowling Green pursuant to each of the CF Credit Facility Agreement, the CF Intercompany Loan Agreement and the CUSHI Intercompany Loan Agreement. “Bowling Green Property” means all Real Property owned by Bowling Green and located in Bowling Green, Kentucky, including without limitation the property described on Schedule 1.01(g). “Budget” has the meaning assigned to such term in Section 6.04(e). “Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks are authorized to close under the Laws of, or are in fact closed in, the state where the Administrative Agent’s Office is located, except that if such day relates to any Eurodollar Rate Loan, such day shall also be a London Banking Day. “Capital Expenditures” means, for any person in respect of any period, the aggregate of all expenditures incurred by such person during such period that, in accordance with Applicable Accounting Rules, are or should be included in “additions to property, plant or equipment” or similar items reflected in the statement of cash flows of such person; provided, however, that Capital Expenditures for the Ultimate Parent and its Subsidiaries shall not include: (a) expenditures to the extent they are made with proceeds of the issuance of Equity Interests of the Ultimate Parent after the Closing Date or funds that would have constituted any Net Proceeds under the definition of the term “Net Proceeds” (but for the application of the first proviso thereof); (b) expenditures with proceeds of insurance settlements, condemnation awards and other settlements in respect of lost, destroyed, damaged or condemned assets, equipment or other property to the extent such expenditures are made to replace or repair such lost, destroyed, damaged or condemned assets, equipment or other property or otherwise to acquire, maintain, develop, construct, improve, upgrade or repair assets or properties useful in the business of the Ultimate Parent and its Subsidiaries within 15 months of receipt of such proceeds (or, if not made within such period of 15 months, are committed to be made during such period); (c) interest capitalized during such period; (d) expenditures that are accounted for as capital expenditures of such person and that actually are paid for by a third party (excluding the Ultimate Parent or any Subsidiary thereof) and for which neither the Ultimate Parent nor any Subsidiary thereof has provided or is required to provide or incur, directly or indirectly, any consideration or obligation to such third party or any other person (whether before, during or after such period); (e) the book value of any asset owned by such person prior to or during such period to the extent that such book value is included as a capital expenditure during such period as a result of such person reusing or beginning to reuse such asset during such period without a corresponding expenditure actually having been made in such period; provided that (A) any expenditure necessary in order to permit such asset to be reused shall be included as a Capital Expenditure during the period that such expenditure actually is made and (B) such book value shall have been included in Capital Expenditures when such asset was originally acquired; (f) the purchase price of equipment purchased during such period to the extent the consideration therefor consists of any combination of (A) used or surplus equipment traded in at the time


 
15 of such purchase and (B) the proceeds of a concurrent sale of used or surplus equipment, in each case, in the ordinary course of business; (g) Investments in respect of a Permitted Business Acquisition; or (h) the purchase of property, plant or equipment made or contractually committed to be made within 15 months of the sale of any asset (other than inventory) to the extent purchased with the proceeds of such sale. “Capital Lease Obligations” of any person means the obligations of such person to pay rent or other amounts under any lease of (or other similar arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such person under Applicable Accounting Rules and, for purposes hereof, the amount of such obligations at any time shall be the capitalized amount thereof at such time determined in accordance with Applicable Accounting Rules. “CARES Act - Title I” means Title I of the Coronavirus Aid, Relief and Economic Security Act, as amended (including any successor thereto), and all requests, rules, guidelines, requirements and directives thereunder or issued in connection therewith or in implementation thereof, regardless of the date enacted, adopted, issued or implemented. “Cash Collateralize” means to deposit in a Controlled Account or to pledge and deposit with or deliver to the Administrative Agent, for the benefit of one or more of the L/C Issuers or the Lenders, as collateral for L/C Obligations or obligations of the Lenders to fund participations in respect of L/C Obligations, cash or deposit account balances or, if the Administrative Agent and the applicable L/C Issuers shall agree in their sole discretion, other credit support, or to provide a customary back-to-back letter of credit in support of, in each case pursuant to customary documentation in form and substance reasonably satisfactory to the Administrative Agent and the applicable L/C Issuers. “Cash Collateral” and “Cash Collateralized” have meanings correlative to the foregoing, and shall include the proceeds of such Cash Collateral and other credit support. “Cash Management Agreement” means any agreement to provide an overdraft line or other cash management services, including treasury, depository, overdraft, credit or debit card, electronic funds transfer, automated clearinghouse transactions and other cash management arrangements. “Cash Management Bank” means any Person that, at the time it enters into a Cash Management Agreement, is a Lender or an Affiliate of a Lender, in its capacity as a party to such Cash Management Agreement. “CF Credit Facility Agreement” means that certain Credit Facility Agreement dated as of January 10, 2019 between Bowling Green, as borrower, and Constellium Finance, as lender, evidencing an uncommitted revolving credit facility available to Bowling Green for advances up to a maximum principal amount at any one time of $20,000,000 (as amended, amended and restated, supplemented, replaced, or otherwise modified from time to time in compliance with Section 7.09(b)(ii)). “CF Intercompany Loan Agreement” means that certain Intragroup Loan Agreement dated as of January 10, 2019 between Bowling Green, as borrower, and Constellium Finance, as lender, evidencing a term loan to Bowling Green in an initial principal amount of $63,000,000 (as amended, amended and restated, supplemented, replaced, or otherwise modified from time to time in compliance with Section 7.09(b)(ii)). 16 “CFC” means a “controlled foreign corporation” as defined in Section 957 of the Code. “Change in Control” shall be deemed to occur if: (a) at any time (A) Ultimate Parent shall fail to own, directly or indirectly, beneficially and of record, 100% of the issued and outstanding Equity Interests of any Holdco, (B) a majority of the seats (other than vacant seats) on the Board of Directors of Ultimate Parent shall at any time be occupied by persons who were neither (i) nominated by the Board of Directors of Ultimate Parent nor (ii) appointed by directors so nominated, (C) except as permitted pursuant to Section 7.11(y), the Constellium Holding Companies (or any one or more of them) shall fail to collectively own, directly or indirectly, beneficially and of record, 100% of the issued and outstanding Equity Interests of each Borrower, (D) a majority of the seats (other than vacant seats) on the Board of Directors of any Holdco shall at any time be occupied by persons who were neither (i) nominated by the Board of Directors of such Holdco nor (ii) appointed by directors so nominated, or (E) a “change of control” (or similar event) shall occur under any Material Indebtedness; or (b) any person or “group” (within the meaning of Rules 13d-3 and 13d-5 under the Exchange Act as in effect on the Closing Date) (other than in the case of any Holdco’s Equity Interests, Ultimate Parent or any Subsidiary thereof) shall have acquired beneficial ownership of 50% or more on a fully diluted basis of the voting interest in Ultimate Parent’s Equity Interests or any Holdco’s Equity Interests. “Change in Law” means the occurrence, after the date of this Agreement, of any of the following: (ia) the adoption or taking effecteffectiveness of any law, rule, regulation, judicial ruling, judgment or treaty, (iib) any change in any law, rule, regulation, judicial ruling, judgment or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (iii) the making or issuance of any requestlaw, rule, regulation, guideline or treaty, (c) any new, or adjustment to, requirements prescribed by the Board for “Eurocurrency Liabilities” (as defined in Regulation D of the Board), requirements imposed by the Federal Deposit Insurance Corporation, or similar requirements imposed by any domestic or foreign governmental authority or resulting from compliance by Administrative Agent or any Lender with any request or directive (whether or not having the force of law) from any central bank or other Governmental Authority and related in any manner to SOFR, the Term SOFR Reference Rate, Adjusted Term SOFR or Term SOFR, or (d) the making or issuance by any Governmental Authority of any request, rule, guideline or directive, whether or not having the force of law; provided, that, notwithstanding anything hereinin this Agreement to the contrary, (xi) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith, and (yii) all requests, rules, guidelines or directives concerning capital adequacy promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities shall, in each case pursuant to Basel III, shall in each case, be deemed to be a “Change in Law”,” regardless of the date enacted, adopted or issued. “Closing Date” means the first date on or after the Effective Date when all the conditions precedent in Section 5.02 are satisfied or waived in accordance with Section 10.01. “Coca-Cola” means Coca-Cola Bottlers’ Sales and Services Company LLC, a Delaware limited liability company, and its successors and assigns. “Code” means the Internal Revenue Code of 1986, as amended from time to time. 17 “Collateral” means all the “Collateral” as defined in any Security Document and shall also include the Mortgaged Properties and all other property that is subject to any Lien in favor of the Collateral Agent or any Subagent for the benefit of the Lenders pursuant to any Security Document. “Collateral Agent” means the party acting as collateral agent for the Secured Parties under the Security Documents. On the Closing Date, the Collateral Agent is the same person as the Administrative Agent. Unless the context otherwise requires, the term “Administrative Agent” as used herein shall include the Collateral Agent, notwithstanding various specific references to the Collateral Agent herein. “Collateral Agreement” means the Amended and Restated Guarantee and Collateral Agreement, dated as of the Closing Date, by and among the Borrowers, the Guarantors, the Parent Guarantor and the Administrative Agent. “Collateral and Guarantee Requirement” means the requirement, subject to the Intercreditor Agreements, that: (a) on the Closing Date, the Collateral Agent shall have received (A) from each Borrower and each Guarantor, a counterpart of the Collateral Agreement duly executed and delivered on behalf of such person and (B) an Acknowledgment and Consent in the form attached to the Collateral Agreement, executed and delivered by each issuer of Pledged Stock (as defined in the Collateral Agreement), if any, that is a Subsidiary of any Borrower (other than any Receivables Subsidiary) but is not a Loan Party; (b) on or before the Closing Date, (A) the Collateral Agent shall have received, to the extent not previously received under the Existing Credit Agreement, a pledge of all the issued and outstanding Equity Interests of each Borrower and (B) the Collateral Agent shall have received, to the extent not previously received under the Existing Credit Agreement, all certificates or other instruments (if any) representing such Equity Interests, together with stock powers or other instruments of transfer with respect thereto endorsed in blank; (c) on or before the Closing Date, (A) all Indebtedness of each Borrower and each Subsidiary constituting Pledged Debt Securities (as defined in the Collateral Agreement) (other than (i) intercompany current liabilities incurred in the ordinary course of business in connection with the cash management operations of the Holdcos and their Subsidiaries or (ii) to the extent that a pledge of such promissory note or instrument would violate applicable law) that is owing to any Loan Party shall have been pledged pursuant to the Collateral Agreement (or other applicable Security Document as reasonably required by the Collateral Agent), and (B) the Collateral Agent shall, if any such Indebtedness is evidenced by a promissory note or an instrument, have received, to the extent not previously received under the Existing Credit Agreement, all such promissory notes or instruments, together with note powers or other instruments of transfer with respect thereto endorsed in blank; provided, however, that on and after the Amendment No. 1 Effective Date, the Industrial Revenue Bond shall no longer be required to be pledged pursuant to the Collateral Agreement and the Collateral Agent shall promptly return such Industrial Revenue Bond, together with any note powers or instruments of transfer with respect thereto endorsed in blank, to the Borrowers, and the Lenders hereby authorize such return and release of the Collateral Agent’s security interest therein; (d) in the case of any person that becomes a Subsidiary Loan Party after the Closing Date, the Collateral Agent shall have received a supplement to the Collateral Agreement, in the form specified therein, duly executed and delivered on behalf of such Subsidiary Loan Party, provided, that, (i) Administrative Agent shall not accept delivery of any joinder to any Loan Document with respect to any Subsidiary of any Loan Party that is not a Loan Party, if such Subsidiary qualifies as a “legal entity 18 customer” under the Beneficial Ownership Regulation unless such Subsidiary has delivered a Beneficial Ownership Certification in relation to such Subsidiary and Administrative Agent and each Lender, has completed its Patriot Act searches, OFAC/PEP searches and customary individual background checks for such Subsidiary, the results of which shall be satisfactory to Administrative Agent and each Lender; and (ii) no Default or Event of Default shall arise in respect of this clause (d) if such Subsidiary Loan Party has executed the applicable supplement and, if requested by the Administrative Agent or any Lender, as the case may be, delivered a Beneficial Ownership Certification and other information required for such searches and checks as contemplated hereby; (e) after the Closing Date, (A) all the outstanding Equity Interests of (i) any person that becomes a Subsidiary Loan Party after the Closing Date (and which are owned by a Borrower) and (ii) subject to Section 6.10(g), any other Person that is acquired by a Borrower after the Closing Date (other than to the extent that a pledge of such Equity Interest would violate applicable law or regulation) shall have been pledged pursuant to the Collateral Agreement; provided that (x) in no event shall more than 65% of the issued and outstanding voting Equity Interests of any FSHCO or “first tier” Foreign Subsidiary that is a CFC (other than a “first tier” Foreign Subsidiary of a FSHCO) be pledged to secure ABL Credit Obligations, (y) in no event shall any of the issued and outstanding Equity Interests of any direct or indirect Subsidiary of a FSHCO or a Foreign Subsidiary that is a CFC be pledged to secure ABL Credit Obligations and (z) in no event shall the Equity Interests of any Receivables Subsidiary be pledged, and (B) the Collateral Agent shall have received all certificates or other instruments (if any) representing such Equity Interests, together with stock powers or other instruments of transfer with respect thereto endorsed in blank; (f) except as otherwise contemplated by any Security Document and subject to Section 5.02(d), all documents and instruments, including Uniform Commercial Code financing statements, required by law or reasonably requested by the Collateral Agent to be filed, registered or recorded to create the Liens intended to be created by the Security Documents (in each case, including any supplements thereto) and perfect such Liens to the extent required by, and with the priority required by, the Security Documents, shall have been filed, registered or recorded or delivered to the Collateral Agent for filing, registration or the recording concurrently with, or promptly following, the execution and delivery of each such Security Document, and all taxes, fees, charges and costs in connection with the filing and recording of such Security Documents shall be incurred by the Borrowers; (g) (1) the Collateral Agent shall have received (A) counterparts of each Mortgage to be entered into with respect to each Mortgaged Property set forth on Schedule 1.01(b) duly executed and delivered by the record owner of such Mortgaged Property and suitable for recording or filing and, if such Mortgaged Property is an improved Real Property, no later than 15 days prior to the execution and delivery of such Mortgage (or such later date as the Collateral Agent shall determine in its sole discretion), address and other identifying information with respect to such Mortgaged Property reasonably satisfactory to the Collateral Agent and (i) if any improvements on such Mortgaged Property are located within any area designated by the Director of the Federal Emergency Management Agency as a “special flood hazard” area (as may be established by a completed Federal Emergency Management Agency Standard Flood Hazard Determination with respect to such Mortgaged Property), no later than 5 days prior to the execution and delivery of such Mortgage (or such later date as the Collateral Agent shall determine in its sole discretion), evidence of a flood insurance policy (if such insurance is required by Law and commercially reasonably available) from a company and in an amount satisfactory to the Collateral Agent for the applicable portion of the premises, naming the Collateral Agent, for the benefit of the Lenders, as mortgagee, or (ii) a certification from a registered engineer or land surveyor in a form reasonably satisfactory to the Collateral Agent or other evidence reasonably satisfactory to the Collateral Agent that none of the improvements on such Mortgaged Property is located within any area designated by the Director of the Federal Emergency Management Agency as a “special flood hazard” area and (B)


 
19 such other documents that the Collateral Agent may reasonably request, in form and substance reasonably satisfactory to the Collateral Agent, including, but not limited to, any consents, agreements, opinions and confirmations of third parties, surveys, insurance policies, and appraisals (but without duplication of the documents described in clause (h) below), as the Collateral Agent may reasonably request with respect to any such Mortgage or Mortgaged Property and (2) for the avoidance of doubt, no Real Property shall be taken as Collateral unless each Lender confirms to the Administrative Agent and the Collateral Agent that it has completed all flood due diligence, received copies of all flood insurance documentation and confirmed flood insurance compliance as required by the Flood Laws or as otherwise satisfactory to such Lender; provided, however, that the provisions of this paragraph (g) shall not apply with respect to Real Property if the Collateral Agent shall reasonably determine that the costs of obtaining or perfecting such a security interest or adhering to the provisions of this paragraph (g) are excessive in relation to the value of the security to be afforded thereby; (h) the Collateral Agent shall have received an American Land Title Association Lender’s Extend Coverage policy or policies or marked-up unconditional binder of title insurance, as applicable, paid for by the applicable Borrower, each policy in an amount not less than 100% or lesser percentage of the fair market value of the applicable Mortgaged Property as reasonably determined by the Collateral Agent, issued by a nationally recognized title insurance company approved by the Collateral Agent, insuring the Lien of each Mortgage in respect of the Mortgaged Property set forth on Schedule 1.01(b) as a valid Lien on the Mortgaged Property described therein, free of any Liens and other title defects except Permitted Liens, together with such customary endorsements (including zoning endorsements where reasonably appropriate and available), coinsurance and reinsurance as the Collateral Agent may reasonably request, including with respect to any such property located in a state in which a zoning endorsement is not available, a zoning compliance letter from the applicable municipality in a form reasonably acceptable to the Collateral Agent; (i) upon or prior to the delivery of the Mortgages, the Collateral Agent shall have received evidence of the insurance required by the terms of the Mortgages; (j) except as otherwise contemplated by any Security Document, each Loan Party shall have obtained all consents and approvals required to be obtained by it in connection with (A) the execution and delivery of all Security Documents (or supplements thereto) to which it is a party and the granting by it of the Liens thereunder and (B) the performance of its obligations thereunder; (k) except as otherwise approved in writing by the Administrative Agent, (i) each Subsidiary of any Borrower (other than any Receivables Subsidiary) that incurs Guarantees to support any Indebtedness for borrowed money in an amount in excess of $15,000,000 of any Loan Party or any Affiliate of any Loan Party shall, within 30 days (or such longer time as the Administrative Agent may agree) after incurring such Guarantees, guaranty the ABL Finance Obligations and (ii) each such Person that grants Liens to support any Indebtedness for borrowed money in an amount in excess of $15,000,000 of any Loan Party or any Affiliate of any Loan Party (including to secure Guarantees of such Person that support such Indebtedness) to grant to the Administrative Agent, for the benefit of the Secured Parties, a security interest in, subject to the limitations set forth herein and in the Security Documents, all of such Person’s property to secure the ABL Finance Obligations within 30 days (or such longer time as the Administrative Agent may agree) after granting such Liens; and (l) after the Closing Date, the Collateral Agent shall have received (A) such other Security Documents as may be required to be delivered pursuant to Section 6.10, (B) (i) Administrative Agent shall not accept delivery of any joinder to any Loan Document with respect to any Subsidiary of any Loan Party that is not a Loan Party, if such Subsidiary qualifies as a “legal entity customer” under the Beneficial Ownership Regulation unless such Subsidiary has delivered a Beneficial Ownership 20 Certification in relation to such Subsidiary and Administrative Agent and each Lender has completed its Patriot Act searches, OFAC/PEP searches and customary individual background checks for such Subsidiary, the results of which shall be satisfactory to Administrative Agent and each Lender; and (ii) no Default or Event of Default shall arise in respect of this clause (l) if the applicable Loan Party has executed the applicable Security Document and, if requested by the Administrative Agent or any Lender, as the case may be, delivered a Beneficial Ownership Certification and other information required for such searches and checks as contemplated hereby; and (C) upon reasonable request by the Collateral Agent, evidence of compliance with any other requirements of Section 6.10. Notwithstanding the foregoing provisions of this definition or anything in this Agreement or any other Loan Document to the contrary, Liens required to be granted from time to time pursuant to the term “Collateral and Guarantee Requirement” shall be subject to exceptions and limitations set forth in the Security Documents. The Administrative Agent may grant extensions of time for the creation and perfection of security interests in or the obtaining of title insurance, legal opinions or other deliverables with respect to particular assets or the provision of any Guarantee by any Subsidiary (including extensions beyond the Effective Date or in connection with assets acquired, or Subsidiaries formed or acquired, after the Effective Date) where it reasonably determines that either (i) such action cannot be accomplished without undue effort or expense by the time or times at which it would otherwise be required to be accomplished by this Agreement or the Security Documents or (ii) such extension of time is otherwise reasonable, necessary or appropriate, and each Lender hereby consents to any such extensions of time. “Commitments” means (a) with respect to any Lender, such Lender’s Revolving Facility Commitment or its Term Loan Commitment, as the context requires, and, with respect to all Lenders, their Revolving Facility Commitments or their Term Loan Commitments, as the context requires, in each case as such Dollar amounts are set forth beside such Lender’s name under the applicable heading on Schedule 2.01 to this Agreement, in respect of Revolving Facility Commitments, and Schedule 2.15, in the case of Term Loan Commitments or in the Assignment and Assumption pursuant to which such Lender became a Lender under this Agreement, as such amounts may be reduced or increased from time to time pursuant to assignments made in accordance with the provisions of Section 10.06 of this Agreement, and in the case of Term Loan and (b) with respect to the Swing Line Lender, its Swing Line Commitment. “Conforming Changes” means, with respect to either the use or administration of Term SOFR or the use, administration, adoption or implementation of any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “Base Rate,” the definition of “Business Day,” the definition of “U.S. Government Securities Business Day,” the definition of “Interest Period” or any similar or analogous definition (or the addition of a concept of “interest period”), timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of Section 2.13(h)(ii) and other technical, administrative or operational matters) that Administrative Agent reasonably decides in consultation with the Borrowers may be appropriate to reflect the adoption and implementation of any such rate or to permit the use and administration thereof by Administrative Agent in a manner substantially consistent with market practice (or, if Administrative Agent reasonably decides that adoption of any portion of such market practice is not administratively feasible or if Administrative Agent reasonably determines that no market practice for the administration of any such rate exists, in such other manner of administration as Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents in each case in consultation with the Borrowers). 21 “Connection Income Taxes” means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes. “Consolidated Adjusted EBITDA" means, for any period, an amount determined for Ultimate Parent and its Subsidiaries, on a consolidated basis, equal to EBITDA plus, to the extent reducing EBITDA, or minus, to the extent increasing EBITDA the sum, without duplication, of amounts for: (a) Unrealized non-cash gains or losses from the re-measurement of monetary assets and liabilities, and (b) Income taxes on items excluded from Consolidated Net Income pursuant to clauses (a), (e), (f), and (g) of the definition of “Consolidated Net Income.” “Consolidated Interest Expense” means, with respect to any Person for any period, the sum, without duplication, of: (a) consolidated interest expense of such Person and its Subsidiaries for such period, to the extent such expense was deducted in computing Consolidated Net Income (including amortization of original issue discount, noncash interest payments, the interest component of Capital Lease Obligations, and net payments and receipts (if any) pursuant to interest rate Swap Obligations (but excluding unrealized mark-to-market gains and losses attributable to such Swap Obligations, amortization of deferred financing fees and expensing of any bridge or other financing fees), and excluding interest expense attributable to the Factoring Facilities or any Qualified Receivables Financing or other factoring arrangements (to the extent accounted for as interest expense under Applicable Accounting Rules), amortization of deferred financing fees, debt issuance costs, commissions, fees and expenses and expensing of any bridge commitment or other financing fees); plus (b) consolidated capitalized interest of such Person and its Subsidiaries for such period, whether paid or accrued; plus (c) preferred stock dividends paid in cash in respect of Disqualified Stock of the Ultimate Parent held by persons other than the Ultimate Parent or a Subsidiary; plus (d) Commissions based on draws, discounts and yield (but excluding other fees and charges, including commitment fees) incurred in connection with any Receivables Financing which are payable to Persons other than the Ultimate Parent and its Subsidiaries; minus (e) interest income for such period. For purposes of this definition, interest on a Capital Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a responsible financial or accounting officer of the Ultimate Parent to be the rate of interest implicit in such Capital Lease Obligation in accordance with Applicable Accounting Rules. “Consolidated Net Income” means, with respect to any Person for any period, the aggregate of the Net Income of such Person and its Subsidiaries for such period, on a consolidated basis; provided, however, that: (a) any net after-tax extraordinary, nonrecurring or unusual gains or losses or income, expenses or charges, in each case, other than those which could be categorized under clause (4) of the definition of “EBITDA” (less all fees and expenses relating thereto), including, without limitation, 22 any expenses related to any reconstruction of fixed assets and any fees, expenses or charges related to any equity offering, Investment permitted hereunder, acquisition, disposition, receivables financing, recapitalization or issuance, repayment, incurrence, refinancing, amendment or modification of Indebtedness permitted to be incurred by this Agreement (in each case, whether or not successful), in each case, shall be excluded; (b) any increase in amortization or depreciation or any non-cash charges, in each case resulting from purchase accounting in connection with any acquisition that is consummated after the Closing Date shall be excluded; (c) the Net Income for such period shall not include the cumulative effect of a change in accounting principles during such period; (d) any net after-tax income or loss from disposed, abandoned, transferred, closed or discontinued operations and any net after-tax gains or losses on disposal of disposed, abandoned, transferred, closed or discontinued operations shall be excluded; (e) any net after-tax gains or losses (less all fees and expenses or charges relating thereto) attributable to business dispositions or asset dispositions other than in the ordinary course of business (as determined in good faith by the Borrowers) shall be excluded; (f) any net after-tax gains or losses (less all fees and expenses or charges relating thereto) attributable to the early extinguishment of Indebtedness or Swap Obligations or other derivative instruments shall be excluded; (g) the Net Income for such period of any Person that is not a Subsidiary of such Person, or is an Unrestricted Subsidiary, or that is accounted for by the equity method of accounting, shall be included only to the extent of the amount of dividends or distributions or other payments paid in cash (or to the extent converted into cash) to the referent Person or a Subsidiary thereof in respect of such period; (h) [Reserved]; (i) any non-cash impairment charges or asset write-offs resulting from the application of Applicable Accounting Rules and the amortization of intangibles arising pursuant to Applicable Accounting Rules shall be excluded; (j) any non-cash expense realized or resulting from stock option plans, employee benefit plans or post-employment benefit plans, grants and sales of stock, stock appreciation or similar rights, stock options or other rights of such Person or any of its Subsidiaries shall be excluded; (k) any (a) severance or relocation costs or expenses, (b) one-time non-cash compensation charges, (c) the costs and expenses related to employment of terminated employees, (d) [Reserved] or (e) costs or expenses realized in connection with or resulting from stock appreciation or similar rights, stock options or other rights existing on the Closing Date of officers, directors and employees, in each case of such Person or any of its Subsidiaries, shall be excluded; (l) accruals and reserves that are established or adjusted in accordance with Applicable Accounting Rules or changes as a result of the adoption or modification of accounting policies shall be excluded;


 
23 (m) (a)(i) the non-cash portion of “straight line” rent expense shall be excluded and (ii) the cash portion of “straight line” rent expense which exceeds the amount expensed in respect of such rent expense shall be included and (b) non-cash gains, losses, income and expenses resulting from fair value accounting shall be excluded; (n) unrealized gains and losses relating to hedging transactions and mark-to-market of Indebtedness denominated in foreign currencies shall be excluded; (o) solely for the purpose of calculating Restricted Payments, the difference, if positive, of the Consolidated Taxes of the Ultimate Parent calculated in accordance with Applicable Accounting Rules and the actual Consolidated Taxes paid in cash by the Ultimate Parent during any reference period shall be included; (p) non-cash charges for deferred tax asset valuation allowances shall be excluded; (q) an adjustment (which may be a negative number) shall be made to the extent that Net Income was calculated on an average cost basis with respect to inventory, in order to reflect the additional Net Income (or the reduction to Net Income) which would have been recognized using an approximation of last in first out inventory accounting; and (r) any loss on sale of receivables and related assets in a Factoring Facility or other Qualified Receivables Financing shall be excluded. “Consolidated Non-cash Charges” means, with respect to any Person for any period, the aggregate depreciation, amortization, accretion and other non-cash expenses of such Person and its Subsidiaries reducing Consolidated Net Income of such Person for such period on a consolidated basis and otherwise determined in accordance with Applicable Accounting Rules, but excluding any such charge which consists of or requires an accrual of, or cash reserve for, anticipated cash charges for any future period. “Consolidated Taxes” means provision for taxes based on income, profits or capital, including, without limitation, state, franchise and similar taxes. “Consolidated Total Assets” means, as of any date, the total assets of the Borrowers and their consolidated Subsidiaries, determined in accordance with the Applicable Accounting Rules, as set forth on the consolidated balance sheet of the Borrowers as of such date. “Consolidated Total Debt” means, as at any date of determination, the aggregate stated balance sheet amount of all Indebtedness of Ultimate Parent and its consolidated Subsidiaries (or, if higher, the par value or stated face amount of all such Indebtedness (other than zero coupon Indebtedness) determined on a consolidated basis in accordance with GAAP, reduced by the aggregate stated balance sheet amount of all unrestricted Cash and Cash Equivalents on such balance sheet of the Ultimate Parent and its consolidated Subsidiaries up to € 300,000,000. “Constellium Entities” means, collectively, Ultimate Parent and its Subsidiaries other than the Holdcos and the Borrowers. “Constellium Holding Company” means, any of CUSHI, Muscle Shoals Holdings and CPECConstellium US Intermediate or, in each case, any permitted successor thereto. 24 “Constellium US Intermediate” means Constellium US Intermediate Holdings LLC, a Delaware limited liability company, and any permitted successors. “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a person, whether through the ownership of voting securities, by contract or otherwise, and “Controlling” and “Controlled” have meanings correlative thereto. “Controlled Account” means each Deposit Account that is subject to a Deposit Account Control Agreement in form and substance satisfactory to the Administrative Agent and, in the event that such Deposit Account holds Cash Collateral, the L/C Issuers. “Corresponding Tenor” with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor. “Co-Syndication Agents” means each of Goldman Sachs Bank USA, Barclays Bank PLC and Deutsche Bank Securities Inc., in its capacity as a co-syndication agent. “COVID-19 Relief Laws” mean CARES Act- Title I and all other similar Laws of the United States or other applicable jurisdictions from time to time in effect together with all requests, rules, guidelines, requirements and directives thereunder or issued in connection therewith or in implementation thereof, regardless of the date enacted, adopted, issued or implemented to address the economic effects of the Coronavirus. “CPEC” has the meaning assigned to such term in the preamble hereto. “Credit Event” has the meaning assigned to such term in Article V. “Credit Facility” means the Revolving Facility. “Crown” means Crown Holdings, Inc., a Pennsylvania corporation, and its successors and assigns. “CUSHI” means Constellium US Holdings I, LLC, a Delaware limited liability company, and any permitted successors. “CUSHI Intercompany Loan Agreement” means that certain Intragroup Loan Agreement dated as of January 10, 2019 between Bowling Green, as borrower, and CUSHI, as lender, evidencing a term loan to Bowling Green in an initial principal amount of $142,521,221.25 (as amended, amended and restated, supplemented, replaced, or otherwise modified from time to time in compliance with Section 7.09(b)(ii)). “Daily Simple SOFR” means, for any day, SOFR, with the conventions for this rate (which will include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate selected or recommended by the Relevant Governmental Body for determining “Daily Simple SOFR” for syndicated business loans; provided, that, if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion. “Debtor Relief Laws” means the U.S. Bankruptcy Code, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, 25 receivership, insolvency, reorganization, or similar debtor relief Laws of the United States or other applicable jurisdictions from time to time in effect. “Default” means any event or condition that upon notice, lapse of time or both would constitute an Event of Default. “Default Rate” has the meaning assigned to such term in Section 2.13(c). “Defaulting Lender” means any Lender that (i) has failed (A) to fund all or any portion of its Loans within two Business Days of the date such Loans were required to be funded hereunder unless such Lender has notified the Administrative Agent and the Borrowers in writing that such failure is the result of such Lender’s good faith determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, or (B) to pay to the Administrative Agent, an L/C Issuer, the Swing Line Lender or any other Lender any other amount required to be paid by it hereunder (including in respect of its participation in Letters of Credit or Swing Line Loans or Agent Advances) within two Business Days of the date when due, (ii) has notified the applicable Borrower, the Administrative Agent, an L/C Issuer or the Swing Line Lender in writing that it does not intend to comply with its funding obligations hereunder, or has made a public statement to that effect (unless such writing or public statement relates to such Lender’s obligation to fund a Loan hereunder and states that such position is based on such Lender’s good faith determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (iii) has generally defaulted on its funding obligations under other loan agreements or credit agreements or other similar financing agreements, (iv) has failed, within three Business Days after written request by the Administrative Agent or the applicable Borrower, to confirm in writing to the Administrative Agent and such Borrower that it will comply with its prospective funding obligations hereunder (provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (iv) upon receipt of such written confirmation by the Administrative Agent and such Borrower), or (v) has, or has a direct or indirect parent company that has, (A) become insolvent, or become generally unable to pay its debts as they become due, or admitted in writing its inability to pay its debts as they become due, or made a general assignment for the benefit of its creditors, (B) become the subject of a proceeding under any Debtor Relief Law, (C) had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity, or (D) become the subject of a Bail-In Action; provided that a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any Equity Interest in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender. Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses (i) through (v) above, and of the effective date of such status, shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting Lender as of the date established therefor by the Administrative Agent in a written notice of such determination, which shall be delivered by the Administrative Agent to the Borrowers and, to the extent permitted by law, each L/C Issuer, the Swing Line Lender and each other Lender promptly following such determination. “Delaware LLC” means any limited liability company organized or formed under the laws of the State of Delaware. 26 “Deposit Account” means a “deposit account” (as defined in the Uniform Commercial Code) and also means and includes all demand, time, savings, passbook or similar accounts maintained by a Loan Party with a bank or other financial institution, whether or not evidenced by an instrument, all cash and other funds held therein and all passbooks related thereto and all certificates and instruments, if any, from time to time representing, evidencing or deposited into such deposit accounts. “Deposit Account Control Agreement” means a deposit account control agreement among the Collateral Agent, any Borrower or other Loan Party maintaining a Deposit Account at any bank or financial institution (an “Account Bank”) and such Account Bank, which agreement shall be on terms reasonably satisfactory to the Administrative Agent, as the same may be amended, supplemented or otherwise modified from time to time. “Designated Non-Cash Consideration” means the fair market value (as determined in good faith by the applicable Borrower) of non-cash consideration received by such Borrower or one of its Subsidiaries in connection with an Asset Sale that is so designated as Designated Non-Cash Consideration pursuant to a certificate of a Responsible Officer, setting forth the basis of such valuation, less the amount of cash or cash equivalents received in connection with a subsequent sale of such Designated Non-Cash Consideration. “Disqualified Stock” means, with respect to any person, any Equity Interests of such person that, by their terms (or by the terms of any security or other Equity Interests into which such Equity Interests are convertible or for which they are redeemable or exchangeable), or upon the happening of any event or condition (i) matures or is mandatorily redeemable (other than solely for Qualified Equity Interests), pursuant to a sinking fund obligation or otherwise (except as a result of a change of control or asset sale so long as any rights of the holders thereof upon the occurrence of a change of control or asset sale event shall be subject to the prior repayment in full of the Loans and all other ABL Credit Obligations that are accrued and payable and the termination of the Commitments), (ii) are redeemable at the option of the holder thereof (other than solely for Qualified Equity Interests), in whole or in part, (iii) provide for the scheduled payments of dividends in cash, or (iv) are or become convertible into or exchangeable for Indebtedness or any other Equity Interests that would constitute Disqualified Stock, in each case, prior to the date that is ninety-one (91) days after the earlier of (x) the Facility Maturity Date and (y) the date on which the Loans and all other ABL Credit Obligations that are accrued and payable are repaid in full and the Commitments are terminated; provided, however, that only the portion of the Equity Interests that so mature or are mandatorily redeemable, are so convertible or exchangeable or are so redeemable at the option of the holder thereof prior to such date shall be deemed to be Disqualified Stock; provided, further, however, that if such Equity Interests are issued to any employee or to any plan for the benefit of employees of the Borrowers or their respective Subsidiaries or by any such plan to such employees, such Equity Interests shall not constitute Disqualified Stock solely because they may be required to be repurchased by the applicable Borrower in order to satisfy applicable statutory or regulatory obligations or as a result of such employee’s termination, death or disability; provided, further, however, that any class of Equity Interests of such person that by its terms authorizes such person to satisfy its obligations by delivery of Equity Interests that are not Disqualified Stock shall not be deemed to be Disqualified Stock. “Divided LLC” means any Delaware LLC which has been formed as a consequence of a Division (excluding any dividing Delaware LLC that survives a Division). “Division” means the statutory division of any Delaware LLC into two or more Delaware LLCs pursuant to Section 18-217 of the Delaware Limited Liability Company Act. “Dollars” or “$” means the lawful currency of the United States of America.


 
27 “Domestic Subsidiary” means any Subsidiary that is not a Foreign Subsidiary or a subsidiary listed on Schedule 1.01(a). “Early Opt-in Election” means, if the then-current Benchmark is USD LIBOR, the occurrence of: (a) a notification by the Administrative Agent to (or the request by the Borrowers to the Administrative Agent to notify) each of the other parties hereto that at least five currently outstanding Dollar-denominated syndicated credit facilities at such time contain (as a result of amendment or as originally executed) a SOFR-based rate (including SOFR, a term SOFR or any other rate based upon SOFR) as a benchmark rate (and such syndicated credit facilities are identified in such notice and are publicly available for review), and (b) the joint election by the Administrative Agent and the Borrowers to trigger a fallback from USD LIBOR and the provision by the Administrative Agent of written notice of such election to the Lenders. “EBITDA” means, with respect to any Person for any period, the Consolidated Net Income of such Person and its Subsidiaries for such period plus, without duplication, to the extent the same was deducted in calculating Consolidated Net Income: (a) Consolidated Taxes; plus (b) Consolidated Interest Expense; plus (c) Consolidated Non-cash Charges; plus (d) business optimization expenses and other restructuring charges or expenses (which, for the avoidance of doubt, shall include, without limitation, the effect of inventory optimization programs, plant closures, facility consolidations, retention, severance, systems establishment costs, contract termination costs, future lease commitments and excess pension charges); provided that the aggregate amount of business optimization expenses and other restructuring charges or expenses added pursuant to this clause (4) shall not exceed the greater of (i) €20.0 million and (ii) 10% of EBITDA for such period; minus, without duplication, (e) non-cash items increasing Consolidated Net Income for such period (excluding the recognition of deferred revenue or any items which represent the reversal of any accrual of, or cash reserve for, anticipated cash charges in any prior period and any items for which cash was received in a prior period). “EEA Financial Institution” means (a) any institution established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent. “EEA Member Country” means any of the member states of the European Union, Iceland, Liechtenstein, and Norway. 28 “EEA Resolution Authority” means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution. “Effective Date” means the date this Agreement becomes effective in accordance with Section 10.11. “Eligible Accounts” means all Accounts of each Borrower reflected in the most recent Borrowing Base Certificate (but, with respect to each such Account, solely to the extent of the unpaid portion of the obligations stated on the respective Account invoices issued to a customer of such Borrower with respect to inventory sold and shipped or services performed in the ordinary course of business, in each case net of any credits, rebates or offsets owed by such Borrower to the respective customer, and any unapplied cash), except any Account with respect to which any of the exclusionary criteria set forth below applies: (a) Accounts of Account Debtors set forth on Schedule 1.01(h); (b) with respect to which any of the representations, warranties, covenants, and agreements contained in Section 4.05 of the Collateral Agreement are not or have ceased to be correct or have been breached; (c) with respect to which Account (or any other Account due from such Account Debtor), in whole or in part, a check, promissory note, draft, trade acceptance, or other instrument for the payment of money has been received, presented for payment, and returned uncollected for any reason; (d) (i) as to which such Borrower is not able to bring suit or otherwise enforce its remedies against the Account Debtor through judicial process or (ii) which represents a progress billing; provided that for the purposes hereof, “progress billing” means any invoice for goods sold or leased or services rendered under a contract or agreement pursuant to which the Account Debtor’s obligation to pay such invoice is conditioned upon completion of any further performance under the contract or agreement or is subject to the equitable lien of a surety bond issuer; (e) with respect to which any one or more of the following events has occurred to the Account Debtor on such Account: (i) death or judicial declaration of incompetency of an Account Debtor who is an individual; (ii) the filing by or against the Account Debtor of a request or petition for liquidation, reorganization, arrangement, adjustment of debts, adjudication as a bankrupt, winding-up, or other relief under any Debtor Relief Law; (iii) the making of any general assignment by the Account Debtor for the benefit of creditors; (iv) the appointment of a receiver or trustee for the Account Debtor or for any of the assets of the Account Debtor, including, without limitation, the appointment of or taking possession by a “custodian”, as defined in the U.S. Bankruptcy Code; (v) the institution by or against the Account Debtor of any other type of insolvency proceeding (under the U.S. Bankruptcy Code, another Debtor Relief Law or otherwise) or of any formal or informal proceeding for the dissolution or liquidation of, settlement of claims against, or winding up of affairs of, the Account Debtor; (vi) the sale, assignment, or transfer of all or substantially all of the assets of the Account Debtor; (vii) the nonpayment generally by the Account Debtor of its debts as they become due; or (viii) the cessation of the business of the Account Debtor as a going concern; (f) if fifty percent (50.0%) or more of the aggregate Dollar amount of outstanding Accounts owed at such time by the Account Debtor thereon is classified as ineligible under clause (a) preceding; 29 (g) owed by an Account Debtor which: (i) does not maintain its chief executive office in the United States or Canada; (ii) is not organized under the laws of the United States or Canada or any political subdivision, state, or province thereof; or (iii) is the government of any foreign country or sovereign state, or of any state, province, municipality, or other political subdivision thereof, or of any department, agency, public corporation, or other instrumentality thereof; except to the extent that (x) such Account is insured by the Export-Import Bank of the United States or other credit insurer acceptable to the Administrative Agent or secured or payable by a letter of credit satisfactory to the Administrative Agent as to form, amount and issuer in its reasonable discretion or (y) such Account is an Eligible Foreign Account; provided that to the extent the aggregate amount of such Eligible Foreign Accounts exceeds $30,000,000 at any time, such excess shall be excluded; (h) Intercompany Accounts or other Accounts owed by an Account Debtor which is an Affiliate or employee of any Borrower or Subsidiary; (i) except as agreed by the Administrative Agent as provided in clause (g) preceding or clause (l) following regarding political subdivisions of the United States of America but not the U.S. federal government, with respect to which either the perfection, enforceability, or validity of the Collateral Agent’s Lien in such Account, or the Collateral Agent’s right or ability to obtain direct payment to the Collateral Agent of the proceeds of such Account, is governed by any federal, state, or local statutory requirements other than those of the UCC; (j) owed by an Account Debtor to which a Loan Party or any of their respective Subsidiaries is indebted in any way, or which is subject to any right of set-off or recoupment by the Account Debtor, unless the Account Debtor has entered into an agreement that the Collateral Agent has accepted in writing in its reasonable discretion to waive set-off rights; or if the Account Debtor thereon has disputed liability or made any claim with respect to any other Account due from such Account Debtor; but in each such case only to the extent of such indebtedness, set-off, recoupment, dispute, or claim; (k) with respect to which such Borrower at the time of determination deems such Account as uncollectible; (l) owed by the United States of America, any state or county thereof or any municipality or other political subdivision, department, agency, public corporation or other instrumentality of any of the foregoing (unless such Borrower complies with any applicable assignment of claims act restricting the assignment thereof with respect to such obligation if the Collateral Agent reasonably determines that its Lien therein is not or cannot be otherwise perfected); (m) which represents a sale on a bill-and-hold, guaranteed sale, sale and return, sale on approval, consignment, or other repurchase or return basis or other terms by reason of which the payment by the Account Debtor is conditional; (n) which is evidenced by a promissory note or other instrument, by judgment or by chattel paper; (o) (i) Accounts of an Account Debtor that is Investment Grade, which when aggregated with all other Accounts owing by such Account Debtor, exceed 35% of the aggregate Eligible Accounts and (ii) Accounts of an Account Debtor that is not Investment Grade, which when aggregated with all other Accounts owing by such Account Debtor, exceed 25% of the aggregate Eligible Accounts; 30 (p) in the Administrative Agent’s Permitted Discretion upon thirty (30) days’ prior notice to the Borrowers, with respect to which the Account Debtor is located in any state requiring the filing of a “Notice of Business Activities Report” or similar report in order to permit the applicable Borrower to seek judicial enforcement in such state of payment of such Account, unless such Borrower has qualified to do business in such state or has filed a “Notice of Business Activities Report” or equivalent report for the then current year; (q) which arises out of a sale of goods or performance of services not made in the ordinary course of such Borrower’s business, including sales of equipment and bulk sales; (r) with respect to which the goods giving rise to such Account have not been shipped and delivered to, or have been rejected or objected to, by the Account Debtor or the services giving rise to such Account have not been performed by such Borrower, and, if applicable, accepted by the Account Debtor, or the Account Debtor revokes its acceptance of such goods or services, but, in each case, only to the extent of the portion of such Account applicable to goods or services in question; (s) which arises out of an enforceable contract or order which, by its terms, validly forbids, restricts, or makes void or unenforceable the granting of a Lien by such Borrower to the Collateral Agent with respect to such Account; (t) which is not subject to a first priority and perfected security interest in favor of the Collateral Agent, for the benefit of the Secured Parties, or which is subject to any other Lien other than (i) Liens securing Indebtedness that is permitted to be incurred and secured pursuant to the terms of this Agreement and that are subject to the applicable Intercreditor Agreements (or any additional intercreditor agreements, reasonably satisfactory to the Administrative Agent), providing that such Liens are subordinated in right of priority to the Liens securing the ABL Finance Obligations and (ii) Permitted Liens arising by operation of law as described in clauses (d), (e) and (k) of the definition thereof; (u) which is an Account owed to a Borrower acquired in a Permitted Business Acquisition under this Agreement, unless either (i) the Administrative Agent has been given the opportunity for a reasonable period (which shall not be required to be longer than thirty (30) days and which shall, at the request of such Borrower, be completed prior to the consummation of such Permitted Business Acquisition; provided that the Administrative Agent shall have been given, for a period of at least thirty (30) days prior to such consummation, all information and access to the properties, records, files and books of account of such Borrower as the Administrative Agent reasonably deems necessary) to complete such due diligence as the Administrative Agent deems, in the exercise of Permitted Discretion, to be necessary in the circumstances, or (ii) at the time of such Permitted Business Acquisition, the sum of the Eligible Accounts and Eligible Inventory of such Borrower then being acquired is less than $5,000,000; (v) any AB Receivables (other than AB Receivables for which an Eligible Foreign Account Debtor is the Account Debtor); (w) any Qualified Receivables subject to a Qualified Receivables Financing; (x) with respect to which an invoice has not been sent to the applicable Account Debtor; (y) that arise with respect to goods that are sold on a cash-on-delivery basis; (z) that are payable in any currency other than Dollars; and


 
31 (aa) that are not true and correct statements of bona fide indebtedness incurred in the amount of such Account for merchandise sold to or services rendered and accepted by the applicable Account Debtor. If any Account at any time ceases to be an Eligible Account, then such Account shall promptly be excluded from the calculation of the Borrowing Base; provided, however, that if any Account ceases to be an Eligible Account because of the adjustment of or imposition of new exclusionary criteria pursuant to the succeeding paragraph, the Administrative Agent will not require exclusion of such Account from the Borrowing Base until fifteen (15) days following the date on which the Administrative Agent gives notice to the Borrowers of such ineligibility, except for calculations of the Borrowing Base for purposes of Section 5.01(c)(ii)(B), in which case such exclusion shall be immediate. The Administrative Agent reserves the right, at any time and from time to time after the Closing Date, to adjust any of the exclusionary criteria set forth above and to establish new criteria, in its Permitted Discretion (based on an analysis of material facts or events first occurring, or first discovered by the Administrative Agent, after the Closing Date), subject to the approval of Supermajority Revolving Facility Lenders in the case of adjustments or new criteria which have the effect of making more credit available than would have been available based upon the criteria in effect on the Closing Date. “Eligible Equipment” shall mean the Equipment identified in, and subject to, the appraisal dated as of April 18, 2020 by Great American Appraisal and Valuation Services, L.L.C., received by Administrative Agent prior to the Amendment No. 2 Effective Date and any other Equipment acquired after the Amendment No. 2 Effective Date and identified in, and subject to, any appraisal received by to Administrative Agent thereafter pursuant to, and in accordance with Section 6.11, which satisfies the criteria below as determined by Administrative Agent. In general, Equipment shall be Eligible Equipment if: (a) such Equipment is located in-place at a location in the United States of America and is included in an appraisal of Equipment received by Administrative Agent in accordance with the requirements of Section 6.11; (b) such Equipment is in working order, repair, running and marketable condition (ordinary wear and tear excepted); (c) such Equipment is subject to the first priority, valid and perfected security interest of Administrative Agent for the benefit of the Secured Parties and is not subject to a Lien (including any lease but excluding the Equipment located at the Bowling Green Property to the extent the lessor thereof has granted to the Administrative Agent a security interest in such Equipment) in favor of any other Person unless such Lien (i) is the subject of an Intercreditor Agreement, in form and substance reasonably satisfactory to Administrative Agent, including pursuant to which such Lien is subordinated to the Lien in favor of Administrative Agent, (ii) such Lien is a subordinate Lien arising by operation of Law, or (ii) the NOLV of such Equipment used for purposes of this Agreement is reduced by the amount of the Indebtedness and other obligations secured by such other Lien; (d) such Equipment is not worn-out, obsolete, damaged or defective Equipment and such Equipment is used or usable in the ordinary course of Borrowers’ business as presently conducted; and (e) such Equipment is not computer hardware. 32 “Eligible Foreign Account” means an Account of any Borrower with respect to which an Eligible Foreign Account Debtor is the Account Debtor and that would constitute an Eligible Account but for clause (g) of the definition of “Eligible Accounts”, so long as such Account satisfies each of the following criteria: (i) such Account is at all times billed and payable in Dollars, (ii) all payments in respect of such Account are made by such Eligible Foreign Account Debtor to the applicable Borrower in the United States or to an account located in the United States that is subject to a Deposit Account Control Agreement (subject to the post-closing timing requirement specified in Section 6.10(h) of this Agreement) and (iii) such Account is subject to a first priority valid and perfected security interest of the Administrative Agent in the United States; provided that such Borrower shall, promptly upon request of the Administrative Agent, execute and deliver, or cause to be executed and delivered to the Administrative Agent such agreements, documents and instruments as may be required by the Administrative Agent to perfect the security interest of the Administrative Agent in such Account in accordance with the applicable laws of the jurisdiction of formation of such Eligible Foreign Account Debtor and take, or cause to be taken, such other and further actions as the Administrative Agent may request to enable the Administrative Agent, as secured party with respect thereto, to collect such Account under the applicable laws of such jurisdiction of formation. “Eligible Foreign Account Debtors” means Persons designated by the Administrative Agent as “Eligible Foreign Account Debtors” from time to time in its Permitted Discretion, which Persons shall initially be (i) the foreign Affiliates of Coca-Cola, (ii) the foreign Affiliates of Rexam and Ball Corporation, (iii) the foreign Affiliates of Crown (including NAFCEL), (iv) ThyssenKrupp AG and its foreign Affiliates, (v) Anheuser-Busch and its foreign Affiliates that are not subject to an AB Receivables Financing and (vi) Airbus and its foreign Affiliates for so long as the senior, unsecured, non-credit enhanced long term Indebtedness of Airbus receives a rating greater than or equal to BBB- from S&P, greater than or equal to BBB- from Fitch and greater than or equal to Baa3 from Moody’s. For purposes of clarity, the Administrative Agent may from time to time in its Permitted Discretion remove such designation with respect to any Person that was previously designated as an “Eligible Foreign Account Debtor,” after which time such Person shall no longer constitute an “Eligible Foreign Account Debtor” (unless the Administrative Agent subsequently redesignates such Person as an “Eligible Foreign Account Debtor” in its Permitted Discretion). “Eligible Inventory” means all Inventory of each Borrower reflected in the most recent Borrowing Base Certificate, except any Inventory with respect to which any of the exclusionary criteria set forth below applies: (a) Inventory that is not owned by any Borrower; (b) Inventory that is not subject to the Collateral Agent’s Liens, or is subject to any other Lien, other than (i) Liens securing Indebtedness that is permitted to be incurred and secured pursuant to the terms of this Agreement and that are subject to the applicable Intercreditor Agreements (or an additional intercreditor agreement, reasonably satisfactory to the Administrative Agent) providing that such Liens are subordinated in right of priority to the Liens securing the ABL Finance Obligations and (ii) Permitted Liens arising by operation of law as described in clauses (d), (e), (k) and (r) of the definition thereof; provided that, unless such Permitted Liens (A) are junior in priority to the Collateral Agent’s Liens (other than statutory landlord’s Liens to the extent provided otherwise by a requirement of applicable Law) and (B) do not impair directly or indirectly the ability of the Collateral Agent to realize on or obtain the full benefit of the Collateral, the Administrative Agent may, in the exercise of Permitted Discretion, establish a Reserve against Availability with respect to any Inventory subject to such Permitted Liens in an amount not to exceed (on an aggregate basis for all Inventory from time to time subject to such Permitted Liens) (1) in the case of Inventory subject to Liens described in clause (e) of the definition of Permitted Liens, the greater of (x) an amount equal to the amount which would have to be 33 paid to such Lien claimant in order to obtain a release of such Liens, and (y) with respect to landlords’ liens, an amount equal to sixty (60) days’ rent for the properties or facilities on or at which the applicable Inventory is located, (2) in the case of Inventory subject to Liens described in clause (d) or (r) of the definition of Permitted Liens, the amount of such Taxes, fees, assessments, duties or other charges, and (3) in the case of Inventory subject to Liens described in clause (k) of the definition of Permitted Liens, the amount specified in such judgments or notices; (c) Inventory that does not consist of finished goods or raw materials (except that “work-in-process” shall constitute Eligible Inventory, other than any cost relating to a conversion of “work-in-process” to finished Inventory); (d) Inventory that consists of chemicals, supplies, spare parts, packing and shipping materials, or advertising or marketing materials (including samples), other than coatings and lubricants which shall constitute Eligible Inventory; (e) Inventory that is not in good condition, is unmerchantable or fails to meet all material standards imposed by any Governmental Authority having regulatory authority over such goods, its use, or sale; (f) Inventory that is not currently either usable or salable in the normal course of any Borrower’s business; (g) Inventory that is not located within the United States, other than (x) Eligible In- Transit Inventory not exceeding $25,000,000, and (y) Inventory in which the Collateral Agent’s Liens are continuously perfected pursuant to documentation reasonably acceptable to the Collateral Agent; (h) if such Inventory is located in a public warehouse or in possession of a bailee or in a facility leased by such Borrower; provided that such Inventory will be Eligible Inventory if the warehouseman, the bailee, or the lessor has delivered to the Collateral Agent, if requested by the Collateral Agent, a subordination agreement in form and substance reasonably satisfactory to the Collateral Agent (or if such Borrower is unable to obtain any such subordination or such Borrower has notified the Administrative Agent of such warehouse, bailment or lease and such subordination has not been requested, such Inventory shall be Eligible Inventory but the Administrative Agent may, in the exercise of Permitted Discretion, establish a Reserve with respect to any Inventory so located or possessed in an amount not to exceed (on an aggregate basis for all Inventory from time to time so located or possessed) (A) in the case of Inventory located in a public warehouse or leased facility, the greater of (x) an amount equal to the amount which would have to be paid to such claimant in order to obtain a release of any Permitted Lien held by such claimant, or (y) an amount equal to sixty (60) days’ rent or storage fee for the warehouses or facilities on or at which the applicable Inventory is located and (B) in the case of Inventory otherwise in the possession of a bailee, the amount necessary to complete any work being performed on such Inventory and/or to obtain a surrender of the Inventory to the possession of such Borrower or the Collateral Agent); (i) if such Inventory contains or bears any Intellectual Property Rights licensed to such Borrower by any third party, the Collateral Agent shall not be reasonably satisfied that it may sell or otherwise dispose of such Inventory in accordance with Article VIII without infringing the rights of the licensor of such Intellectual Property Rights or violating any contract with such licensor (and without payment of any royalties other than any royalties due with respect to the sale or disposition of such Inventory pursuant to the existing license agreement), and, if the Collateral Agent deems it necessary, such Borrower shall deliver to the Collateral Agent a consent or sublicense agreement from such licensor in form and substance reasonably acceptable to the Collateral Agent; 34 (j) Inventory that is owned by a Borrower acquired in a Permitted Business Acquisition under this Agreement, unless either (i) the Administrative Agent has been given the opportunity for a reasonable period (which shall not be required to be longer than thirty (30) days and which shall, at the request of such Borrower, be completed prior to the consummation of such Permitted Business Acquisition provided that the Administrative Agent shall have been given, for a period of at least thirty (30) days prior to such consummation, all information and access to the properties, records, files, and books of account of such Borrower as the Administrative Agent reasonably deems necessary for such completion) to complete such due diligence as it deems, in the exercise of Permitted Discretion, to be necessary in the circumstances, or (ii) at the time of such Permitted Business Acquisition, the sum of the Eligible Accounts and Eligible Inventory of such Borrower then being acquired is less than $5,000,000; (k) Inventory that is unsalable, but solely to the extent the book value of such Inventory exceeds its scrap value; (l) Inventory is located at any site if the aggregate book value of Inventory at any such location is less than $100,000; (m) Inventory subject to any licensing, trademark, trade name or copyright agreements with any third parties which would require any consent of any third party for the sale or disposition of that Inventory (which consent has not been obtained) or the payment of any monies to any third party upon such sale or other disposition (to the extent of such monies); (n) Inventory that consists of packing or shipping materials, or manufacturing supplies; (o) Inventory that consists of tooling or replacement parts; (p) Inventory that consists of display items; (q) Inventory that consists of goods which have been returned by the buyer; provided that, Inventory shall not be excluded from Eligible Inventory pursuant to this clause if such Inventory has been inspected and re-valued by the applicable Borrower upon return and is able to be resold or reused in the ordinary course of business; (r) Inventory that consists of Hazardous Materials or goods that can be transported or sold only with licenses that are not readily available; or (s) Inventory that is not covered by casualty insurance reasonably acceptable to the Administrative Agent. If any Inventory at any time ceases to be Eligible Inventory, such Inventory shall promptly be excluded from the calculation of the Borrowing Base; provided that if any Inventory ceases to be Eligible Inventory because of the adjustment of or imposition of new exclusionary criteria pursuant to the succeeding paragraph, the Administrative Agent will not require exclusion of such Inventory from the Borrowing Base until fifteen (15) days following the date on which the Administrative Agent gives notice to the Borrowers of such ineligibility, except for calculations of the Borrowing Base for purposes of Section 5.01(c)(ii)(B), in which case such exclusion shall be immediate. The Administrative Agent reserves the right, at any time and from time to time after the Closing Date, to adjust any of the exclusionary criteria set forth above and to establish new criteria, in its


 
35 Permitted Discretion (based on an analysis of material facts or events first occurring, or first discovered by the Administrative Agent, after the Closing Date), subject to the approval of the Supermajority Revolving Facility Lenders in the case of adjustments or new criteria which have the effect of making more credit available than would be available based upon the criteria in effect on the Closing Date. “Eligible In-Transit Inventory” means all raw materials and finished goods Inventory owned by a Borrower, which Inventory is in transit to the United States or to an Eligible Foreign Account Debtor and (a) for which title and risk of loss has been transferred to or remains with such Borrower, (b) is fully insured as required by Section 6.02, (c) is subject to a first priority perfected security interest in and lien upon such goods in favor of the Collateral Agent (except for any possessory lien upon such goods in the possession of a freight carrier or shipping company securing only the freight charges for the transportation of such goods) pursuant to documentation reasonably acceptable to the Collateral Agent and (d) is evidenced or deliverable pursuant to documents that have been delivered to the Collateral Agent, as reasonably requested by the Collateral Agent from time to time. “Embargoed Person” means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by any Governmental Authority of the United States of America, including without limitation, OFAC or the U.S. Department of State, or by Her Majesty’s Treasury or the European Union, (b) any Person located, operating, organized or resident in a Sanctioned Country, (c) the government or an agency of the government of a Sanctioned Country or (d) any Person owned or Controlled by any Persons or agencies described in any of the preceding clauses (a) through (c). “Engagement Letter” means that certain Engagement Letter dated as of May 15, 2017 by and among Wells Fargo Capital Finance, LLC and the Existing Borrowers. “Environment” means ambient and indoor air, surface water and groundwater (including potable water, navigable water and wetlands), the land surface or subsurface strata, natural resources such as flora and fauna, the workplace or as otherwise defined in any Environmental Law. “Environmental Laws” means all applicable laws (including common law), rules, regulations, codes, ordinances, orders, decrees or judgments, promulgated or entered into by any Governmental Authority, relating in any way to the environment, preservation or reclamation of natural resources, the generation, management, Release or threatened Release of, or exposure to, any Hazardous Material or to occupational health and safety matters (to the extent relating to the environment or Hazardous Materials). “Environmental Liabilities” means all Liabilities (including costs of natural resource damages and costs and expenses of investigation and feasibility studies, including the cost of environmental consultants and the cost of attorney’s fees) that may be imposed on, incurred by or asserted against any Loan Party or any Subsidiary of any Loan Party as a result of, or related to, any claim, suit, action, investigation, proceeding or demand by any Person, whether based in contract, tort, implied or express warranty, strict liability, criminal or civil statute or common law or otherwise, arising under any Environmental Law or in connection with any environmental, health or safety condition or with any Release and resulting from the ownership, lease, sublease or other operation or occupation of property by any Loan Party or any Subsidiary of any Loan Party, whether on, prior or after the date hereof. “Equipment” means equipment (as that term is defined in the UCC). “Equity Interests” of any person means any and all shares, interests, rights to purchase or otherwise acquire, warrants, options, participations or other equivalents of or interests in (however designated) equity or ownership of such person, including any preferred stock, any limited or general 36 partnership interest and any limited liability company membership interest, and any securities or other rights or interests convertible into or exchangeable for any of the foregoing. “ERISA” means the Employee Retirement Income Security Act of 1974, as the same may be amended from time to time and any final regulations promulgated and the rulings issued thereunder. “ERISA Affiliate” means any trade or business (whether or not incorporated) that, together with the Holdcos, the Borrowers or a Subsidiary, is treated as a single employer under Section 414(b) or (c) of the Code, or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code. “ERISA Event” means (i) any Reportable Event or the requirements of Section 4043(b) of ERISA apply with respect to a Plan, other than in respect of an event for which advance notice is waived under applicable regulations; (ii) the failure to meet the minimum funding standards of Sections 412 and 430 of the Code and Sections 302 and 303 of ERISA; (iii) a determination that any Plan is, or is expected to be, in “at risk” status (as defined in Section 430 of the Code or Section 303 of ERISA); (iv) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan, the failure to make by its due date a required installment under Section 430(j) of the Code with respect to any Plan or the failure to make any required contribution to a Multiemployer Plan; (v) the incurrence by the Holdcos, a Borrower, a Subsidiary or any ERISA Affiliate of any liability under Title IV of ERISA, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA; (vi) the receipt by the Holdcos, a Borrower, a Subsidiary or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Plan or to appoint a trustee to administer any Plan under Section 4042 of ERISA; (vii) a determination that any Multiemployer Plan is, or is reasonably expected to be, in “critical” or “endangered” status under Section 432 of the Code or Section 305 of ERISA; (viii) the incurrence by the Holdcos, a Borrower, a Subsidiary or any ERISA Affiliate of any liability with respect to the withdrawal or partial withdrawal from any Plan or Multiemployer Plan; (ix) the receipt by the Holdcos, a Borrower, a Subsidiary or any ERISA Affiliate of any notice, or the receipt by any Multiemployer Plan from the Holdcos, a Borrower, a Subsidiary or any ERISA Affiliate of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent within the meaning of Title IV of ERISA; or (x) the conditions for imposition of a lien under Section 303(k) of ERISA shall have been met with respect to any Plan. “Erroneous Payment” has the meaning set forth in Section 9.13. “Erroneous Payment Deficiency Assignment” has the meaning set forth in Section 9.13. “Erroneous Payment Return Deficiency” has the meaning set forth in Section 9.13. “Erroneous Payment Subrogation Rights” has the meaning set forth in Section 9.13. “EU Bail-In Legislation Schedule” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time. “Eurodollar Base Rate” means the rate per annum as published by ICE Benchmark Administration Limited (or any successor page or, if unavailable, other commercially available source as the Administrative Agent may designate from time to time) as of 11:00 a.m., London time, two Business Days prior to the commencement of the requested Interest Period, for a term, and in an amount, comparable to the Interest Period and the amount of the Eurodollar Rate Loan requested (whether as an initial Eurodollar Rate Loan or as a continuation of a Eurodollar Rate Loan or as a conversion of a Base 37 Rate Loan to a Eurodollar Rate Loan) by a Borrower in accordance with this Agreement (and, if any such published rate is below zero, then the rate shall be deemed to be zero). Each determination of the Eurodollar Base Rate shall be made by the Administrative Agent and shall be conclusive in the absence of manifest error. “Eurodollar Rate Borrowing” means a Revolving Facility Borrowing or a Term Loan Facility Borrowing comprised of Eurodollar Rate Loans. “Eurodollar Rate Loan” means, at any date, a Loan which bears interest at a rate based on the Adjusted Eurodollar Rate. “Eurodollar Reserve Percentage” means for any day during any Interest Period, the reserve percentage (expressed as a decimal, carried out to five decimal places) in effect on such day, whether or not applicable to any Lender, under regulations issued from time to time by the Board of Governors of the Federal Reserve System (or any other entity succeeding to the functions currently performed thereby) for determining the maximum reserve requirement (including any emergency, supplemental or other marginal reserve requirement) with respect to Eurocurrency funding (currently referred to “Eurocurrency liabilities”). The Adjusted Eurodollar Rate for each outstanding Eurodollar Rate Loan shall be adjusted automatically on and as of the effective date of any change in the Eurodollar Reserve Percentage. “Event of Default” has the meaning assigned to such term in Section 8.01. “Exchange Act” means the Securities Exchange Act of 1934, as amended. “Excluded Taxes” means any of the following Taxes imposed on or with respect to any Recipient or required to be withheld or deducted from a payment to a Recipient: (i) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (A) imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in the case of any Lender, its Lending Office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (B) that are Other Connection Taxes, (ii) U.S. withholding Taxes imposed on amounts payable to or for the account of any Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date on which (A) such Lender acquires such interest in the Loan or Commitment (other than pursuant to an assignment request by the Borrowers under Section 10.04) or (B) such Lender changes its Lending Office, except in each case to the extent that, pursuant to Section 3.01(a)(ii) or Section 3.01(b), amounts with respect to such Taxes were payable either to such Lender's assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed its Lending Office, (iii) Taxes attributable to such Recipient’s failure to comply with Section 3.01(c) or Section 3.06(a) and (iv) any U.S. federal withholding Taxes imposed pursuant to FATCA. “Exempt Deposit Accounts” means (i) Deposit Accounts the balance of which consists exclusively of (A) withheld income taxes and federal, state or local employment taxes in such amounts as are required in the reasonable judgment of the applicable Borrower to be paid to the Internal Revenue Service or state or local government agencies with respect to employees of any of the Loan Parties; or (B) amounts required to be paid over to an employee benefit plan pursuant to DOL Reg. Sec. 2510.3-102 on behalf of or for the benefit of employees of one or more Loan Parties, (ii) all segregated Deposit Accounts constituting (and the balance of which consists solely of funds set aside in connection with) taxes accounts, payroll accounts, trust or similar accounts and (iii) other non-concentration accounts containing less than $1,000,000 individually and in the aggregate for all such other non-concentration accounts. “Existing Credit Agreement” has the meaning assigned to such term in the recitals hereto. 38 “Existing Factoring Agreement” means that certain Recourse Factoring Agreement, dated as of September 6, 2017, between Bowling Green and Wells Fargo, in its capacity as purchaser thereunder. “Existing Letters of Credit” means, collectively or individually as the context may require, the letters of credit outstanding as of the Closing Date under the Existing Credit Agreement. “Facility Maturity Date” means the earlier of (i) the fifth anniversary of the Amendment No. 4 Effective DateApril 27, 2026 and (ii) 90 days prior to the maturity date of any Indebtedness (other than Loans) of any Borrower or any Borrower’s Subsidiaries in an aggregate amount exceeding $50,000,000 (but excluding for this purpose the Indebtedness of Borrowers pursuant to their guarantees of the unsecured notes issued by Constellium SE). “Facility Termination Date” means the date on which (A) the Commitments have terminated, (B) all ABL Credit Obligations (other than contingent indemnification obligations) have been paid in full, (C) all ABL Finance Obligations arising under Secured Cash Management Agreements and Secured Rate Contracts that the Administrative Agent has theretofore been notified in writing by the holder of such Obligation are then due and payable, have been paid in full in cash and (D) all Letters of Credit have expired or terminated (other than Letters of Credit as to which other arrangements, including cash collateralization or backstopping, reasonably satisfactory to the Administrative Agent and the L/C Issuers shall have been made). “Factoring Facilities” means the receivables purchase facilities granted to certain Subsidiaries of Ultimate Parent pursuant to (a) the agreement dated as of December 3, 2015 between GE Factofrance S.A.S. as purchaser, Constellium Issoire S.A.S., Constellium Neuf Brisach S.A.S. and Constellium Extrusions France S.A.S. as sellers, Parent Guarantor and Constellium Switzerland AG, (b) the agreement dated as of May 27, 2016 between GE Capital Bank AG as purchaser and Constellium Rolled Products Singen GmbH as seller, (c) the agreement dated as of March 26, 2014 between GE Capital Bank AG as purchaser and Constellium Singen GmbH as seller, (d) the agreement dated as of December 16, 2010 between GE Capital Bank AG as purchaser and Constellium Extrusions Deutschland GmbH as seller, (e) the agreement dated as of December 16, 2010 between GE Capital Bank AG as purchaser and Constellium Valais AG as seller, (f) the agreement dated as of June 26, 2015 between GE Capital Bank AG as purchaser and Constellium Extrusions Decin S.R.O. as seller, (g) the agreement dated as of December 15, 2015 between Deutsche Bank Trust Company Americas as purchaser and Constellium Automotive USA, LLC as seller, in each case, as such agreement may be amended, restated, supplemented, waived, replaced (whether or not upon termination, and whether with the original parties or otherwise), restructured, or otherwise modified from time to time. On July 20, 2016, the Banque Fédérative du Crédit Mutuel purchased the Equipment Finance and Receivable Finance businesses of GE. Pursuant to this transaction, GE Factofrance S.A.S. was renamed Factofrance and GE Capital Bank AG was renamed Targo Commercial Financing AG. “FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities entered into in connection with the implementation of the foregoing. “FCA” has the meaning set forth in Section 1.06. “FCPA” means the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder.


 
39 “Federal Funds Rate” means, for any period, a fluctuating interest rate per annum equal to, for each day during such period, the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day which is a Business Day, the average of the quotations for such day on such transactions received by Administrative Agent from three Federal funds brokers of recognized standing selected by it (and, if any such rate is below zero, then the rate determined pursuant to this definition shall be deemed to be zero). “Fee Letter” means that certainthe Amendment No. 6 Fee Letter, dated as of the ClosingAmendment No. 6 Effective Date by and, among the Administrative Agent, Bowling Green, Ravenswood and Muscle Shoals and the Borrowers. “Fees” means, collectively, the Revolving Facility Commitment Fees, the Letter of Credit Fees, the L/C Issuer Fees, the Administrative Agent Fees, the Term Loan Facility Fees, and the fees set forth in the Fee Letter, the Amendment Fee Letter, the Amendment No. 2 Fee Letter. “Final Term Loan Funding Date” means the earlier of (a) the date that the Term Loan Commitments have been reduced to zero and (b) the Term Loan Commitment Expiration Date. “Financial Covenant Triggering Event” shall occur at any time Availability is less than the greater of 10.0% of the Loan Cap and $30,000,00037,500,000 and shall continue for the period until Availability has been greater than such amount for a period of at least 30 consecutive days; provided, that, (a) if Availability is less than such amount solely as the result of a reduction in the amount of the Borrowing Base (as opposed to an increase of the outstanding Revolving Facility Loans or Letters of Credit), no Event of Default shall be deemed to have occurred with respect to the breach of Section 7.12 unless Availability is less than the required amount for a period of 5 consecutive Business Days (and in any event no Loans will be made or Letters of Credit issued or increased or extended during such 5 Business Day period) and (b) a Default with respect to the breach of Section 7.12, if applicable, will occur immediately upon the occurrence of Availability being less than the specified amount and shall continue during such 5 Business Day period unless waived or cured during such period. “Financial Officer” of any person means the Chief Financial Officer, Treasurer, or Controller of such person. “Fitch” means Fitch Ratings, Inc. “Fixed Charge Coverage Ratio” means the ratio of (i) EBITDA of the Ultimate Parent and its Subsidiaries for the most recent period of four consecutive fiscal quarters for which financial statements have been delivered pursuant to Sections 6.04(a) or (b) hereof minus the income taxes paid in cash by the Ultimate Parent and its Subsidiaries and included in the determination of Consolidated Net Income for such period minus Unfinanced Capital Expenditures of the Ultimate Parent and its Subsidiaries during such period to (ii) the sum of (A) scheduled principal payments required to be made during such period in respect of Indebtedness for borrowed money of the Ultimate Parent and its Subsidiaries, including the Term Loans plus (B) the Consolidated Interest Expense (excluding amortization of any original issue discount, interest paid in kind or added to principal and other noncash interest) of the Ultimate Parent and its Subsidiaries, in each case to the extent paid in cash for such period. “Flood Laws” means, collectively, (i) the National Flood Insurance Reform Act of 1994 (which comprehensively revised the National Flood Insurance Act of 1968 and the Flood Disaster Protection Act of 1973) as now or hereafter in effect or any successor statute thereto, (ii) the Flood Insurance Reform 40 Act of 2004 as now or hereafter in effect or any successor statute thereto and (iii) the Biggert-Waters Flood Insurance Reform Act of 2012 as now or hereafter in effect or any successor statute thereto. “Floor” means a rate of interest equal to 0%. “Foreign Lender” means a Lender or L/C Issuer that is not a U.S. Person. “Foreign Subsidiary” means any Subsidiary that is incorporated or organized under the laws of any jurisdiction other than the United States of America, any State thereof or the District of Columbia. “Fronting Exposure” means, at any time there is a Defaulting Lender, (i) with respect to any L/C Issuer, such Defaulting Lender’s Revolving Facility Percentage of the outstanding L/C Obligations arising in respect of Letters of Credit issued by such L/C Issuer other than L/C Obligations as to which such Defaulting Lender’s participation obligation has been reallocated to other Lenders or Cash Collateralized in accordance with the terms hereof, and (ii) with respect to the Swing Line Lender, such Defaulting Lender’s Revolving Facility Percentage of Swing Line Loans other than Swing Line Loans as to which such Defaulting Lender’s participation obligation has been reallocated to other Lenders in accordance with the terms hereof. “FSHCO” means any Subsidiary of the Borrowers all or substantially all of the assets of which are Equity Interests (or Equity Interests and Indebtedness) in one or more CFCs and/or one or more FSHCOs, so long as such Subsidiary (i) does not conduct any material amount of business or activity other than the ownership of such Equity Interests or Indebtedness and (ii) does not incur, and is not otherwise liable for, any Indebtedness or other liabilities. “GAAP” means generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, which are in effect on the Closing Date. For purposes herein, the term “consolidated” means such Person consolidated with the Subsidiaries and shall not include any Unrestricted Subsidiary, but the interest of such Person in an Unrestricted Subsidiary will be accounted for as an Investment. “Governmental Authority” means any federal, state, provincial, territorial, municipal, local or foreign court or governmental agency, authority, instrumentality or regulatory or legislative body, including any supra-national bodies such as the European Union or the European Central Bank. “Guarantee” of or by any person (the “guarantor”) means (i) any obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (A) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation (whether arising by virtue of partnership arrangements, by agreement to keep well, to purchase assets, goods, securities or services, to take-or-pay or otherwise) or to purchase (or to advance or supply funds for the purchase of) any security for the payment of such Indebtedness or other obligation, (B) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (C) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation, (D) entered into for the purpose of assuring in any other manner the holders of such Indebtedness or other obligation of the payment thereof or to protect such holders against 41 loss in respect thereof (in whole or in part) or (E) as an account party in respect of any letter of credit, bank guarantee or other letter of guaranty issued to support such Indebtedness or other obligation, or (ii) any Lien on any assets of the guarantor securing any Indebtedness (or any existing right, contingent or otherwise, of the holder of Indebtedness to be secured by such a Lien) of any other person, whether or not such Indebtedness or other obligation is assumed by the guarantor; provided, however, the term “Guarantee” shall not include endorsements of instruments for deposit or collection in the ordinary course of business or customary and reasonable indemnity obligations in effect on the Closing Date or entered into in connection with any acquisition or disposition of assets permitted by this Agreement (other than such obligations with respect to Indebtedness). The amount of any Guarantee shall be deemed to be an amount equal to the stated or determinable amount of the Indebtedness in respect of which such Guarantee is made or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof (assuming such person is required to perform thereunder) as determined by such person in good faith. “guarantor” has the meaning assigned to such term in the definition of the term “Guarantee.” “Guarantor” means any of the Borrowers, the Holdcos and the Subsidiary Loan Parties, and “Guarantors” means two or more of them, collectively. “Guaranty” means, collectively, the guaranty made by the Guarantors under the Collateral Agreement in favor of the Secured Parties, together with each other guaranty and guaranty supplement delivered pursuant to Section 6.10; provided, that, notwithstanding anything to the contrary set forth in the Collateral Agreement, the ABL Finance Obligations guaranteed by Parent Guarantor pursuant to the Collateral Agreement shall not include the Term Loan A-2 Obligations. “Hazardous Materials” means all pollutants, contaminants, wastes, chemicals, materials, substances and constituents, including, without limitation, explosive or radioactive substances or petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls or radon gas, of any nature subject to regulation or which can give rise to liability under any Environmental Law. “Hedge Bank” means any Person that, at the time it enters into a Swap Contract permitted under Article VII, is a Lender or an Affiliate of a Lender, in its capacity as a party to such Swap Contract. “Holdcos” means, collectively or individually as the context may require, (a) the Parent Guarantor, and (b) with respect to each Borrower, any Constellium Holding Company that owns directly any of the issued and outstanding Equity Interests of such Borrower. “Honor Date” has the meaning specified in Section 2.05(c)(i). “IBA” has the meaning set forth in Section 1.06. “IFRS” means the accounting and financial reporting standards issued by the International Accounting Standards Board. “Immaterial Subsidiary” means any Subsidiary that, as of the last day of the fiscal quarter of the Borrowers most recently ended, (i) did not have assets with a value in excess of 2.5% of the Consolidated Total Assets or revenues representing in excess of 2.5% of total revenues of the Borrowers and their Subsidiaries on a consolidated basis as of such date and (ii) when taken together with all other Immaterial Subsidiaries as of such date, did not have assets with a value in excess of 5.0% of the Consolidated Total Assets or revenues representing in excess of 5.0% of total revenues of the Borrowers and their 42 Subsidiaries on a consolidated basis as of such date. Each Immaterial Subsidiary as of the Closing Date shall be set forth in Schedule 1.01(c). “Increase” has the meaning set forth in Section 2.21. “Increase Date” has the meaning set forth in Section 2.21. “Increase Joinder” has the meaning set forth in Section 2.21. “Indebtedness” of any person means, without duplication, (i) all obligations of such person for borrowed money, (ii) all obligations of such person evidenced by bonds, debentures, notes or similar instruments, (iii) all obligations of such person under conditional sale or other title retention agreements relating to property or assets purchased by such person, (iv) all obligations of such person issued or assumed as the deferred purchase price of property or services, to the extent that the same would be required to be shown as a long term liability on a balance sheet prepared in accordance with the Applicable Accounting Rules, (v) all Capital Lease Obligations of such person, (vi) all net payments that such person would have to make in the event of an early termination, on the date Indebtedness of such person is being determined, in respect of outstanding Swap Contracts, (vii) the principal component of all obligations, contingent or otherwise, of such person as an account party in respect of letters of credit and bank guarantees, (viii) the principal component of all obligations of such person in respect of bankers’ acceptances, (ix) all Guarantees by such person of Indebtedness described in clauses (i) through (viii) above and (x) the amount of all obligations of such person with respect to the redemption, repayment or other repurchase of any Disqualified Stock (excluding accrued dividends that have not increased the liquidation preference of such Disqualified Stock); provided that Indebtedness shall not include (A) trade payables, accrued expenses and intercompany liabilities arising in the ordinary course of business, (B) prepaid or deferred revenue arising in the ordinary course of business, (C) purchase price holdbacks arising in the ordinary course of business in respect of a portion of the purchase price of an asset to satisfy unperformed obligations of the seller of such asset or (D) earn-out obligations, except to the extent such obligations constitute a liability on the balance sheet of such person in accordance with the Applicable Accounting Rules. The Indebtedness of any person shall include the Indebtedness of any partnership in which such person is a general partner, other than to the extent that the instrument or agreement evidencing such Indebtedness expressly limits the liability of such person in respect thereof. “Indemnified Taxes” means (i) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of any Loan Party under any Loan Document and (ii) to the extent not otherwise described in clause (i) above, Other Taxes. “Indemnitee” has the meaning assigned to such term in Section 10.04(b). “Industrial Revenue Bond” means the industrial revenue bond identified on Schedule 7.04 hereto. “Information” has the meaning assigned to such term in Section 10.07. “Information Memorandum” means the Confidential Information Memorandum dated May 2017, as modified or supplemented prior to the Original Closing Date. “Intellectual Property Rights” has the meaning assigned to such term in Section 4.23. “Intercompany Accounts” means all obligations and liabilities, however arising, which are due to any Loan Party from, which are due from any Loan Party to, or which otherwise arise from any transaction by any Loan Party with, any Affiliate of such Loan Party.


 
43 “Intercompany Subordination Agreement” means that certain Intercompany Subordination Agreement dated as of the Closing Date made by Constellium Finance in favor of the Administrative Agent. “Intercreditor Agreement” means, collectively or individually as the context may require, the PBGC Intercreditor Agreement, the Ravenswood Intercreditor Agreement, and each other intercreditor agreement, including each Secured Debt Intercreditor Agreement, entered into after the Amendment No. 6 Effective Date by the Administrative Agent and any Loan Party in connection with the Loan Documents. “Interest Election Request” means a request by a Borrower to convert or continue a Revolving Facility Borrowing in accordance with Section 2.07. “Interest Payment Date” means (i) with respect to any Eurodollar Rate Loan, the last day of each Interest Period applicable to the Borrowing of which such Loan is a part and, in the case of a Eurodollar Rate Borrowing with an Interest Period of more than three months’ duration, each day that would have been an Interest Payment Date had successive Interest Periods of three months’ duration been applicable to such Borrowing and, in addition, the date of any refinancing or conversion of such Borrowing with or to a Borrowing of a different Type and (ii) with respect to any Base Rate Loan, the first day of each April, July, October and January. “Interest Period” means, as to any Eurodollar Rate Borrowing, thewith respect to any SOFR Loan, a period commencing on the date of such Borrowing or on the last day of the immediately preceding Interest Period applicable to such Borrowing, as applicable, and ending on the numerically corresponding day (or, if there is no numerically corresponding day, on the last day) in the calendar month that is 1, 2, 3 or 6 months thereafter (or 12 months, if at the time of the relevant Borrowing, all relevant Lenders consent to such Interest Period), as a Borrower may elect, or the date any Eurodollar Rate Borrowing is converted to a Base Rate Borrowing in accordance with Section 2.07 or repaid or prepaid in accordance with Section 2.09, 2.10 or 2.11; provided, however, that ifthe making of such SOFR Loan (or the continuation of a SOFR Loan or the conversion of a Base Rate Loan to a SOFR Loan) and ending 1 or 3 months thereafter; provided, that (a) interest shall accrue at the applicable rate based upon Adjusted Term SOFR from and including the first day of each Interest Period to, but excluding, the day on which any Interest Period expires, (b) any Interest Period that would end on a day other thanthat is not a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the nextfalls in another calendar month, in which case such Interest Period shall end on the next preceding Business Day. Interest shall accrue from and including the first day of, (c) with respect to an Interest Period to but excluding the last daythat begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period.), the Interest Period shall end on the last Business Day of the calendar month that is 1 or 3 months after the date on which the Interest Period began, as applicable, (d) Borrowers may not elect an Interest Period which will end after the Facility Maturity Date and (e) no tenor that has been removed from this definition pursuant to Section 2.13(j)(iii)(D) shall be available for specification in any SOFR Notice or conversion or continuation notice. “Inventory” has the meaning assigned to such term in the Collateral Agreement. “Investment” has the meaning assigned to such term in Section 7.04. “Investment Grade” means, for an Account Debtor, a corporate family rating by any two of S&P, Fitch or Moody’s of at least BBB- by S&P, BBB- by Fitch and Baa3 by Moody’s. 44 “ISDA Definitions” means the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. or any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time by the International Swaps and Derivatives Association, Inc. or such successor thereto. “ISP” means, with respect to any Letter of Credit, the “International Standby Practices 1998” published by the Institute of International Banking Law & Practice, Inc. (or such later version thereof as may be in effect at the time of issuance). “Issuer Documents” means with respect to any Letter of Credit, the Letter of Credit Request, and any other document, agreement and instrument entered into by the applicable L/C Issuer and the applicable Borrower (or any Subsidiary) or in favor of the L/C Issuer and relating to such Letter of Credit. “Joint Bookrunners” means Wells Fargo and Deutsche Bank Securities Inc., in their capacities as joint bookrunners. “Joint Lead Arrangers” means Wells Fargo and Deutsche Bank Securities Inc., in their capacities as joint lead arrangers. “Junior Financing” means (x) Indebtedness which by its terms is subordinated in right or payment to the ABL Credit Obligations and which Indebtedness is incurred pursuant to Section 7.01(k) and (y) the Bowling Green Intercompany Indebtedness, and, in each case, any subordinated Permitted Refinancing Indebtedness in respect thereof, any preferred Equity Interests and any Disqualified Stock. “L/C Advance” means, with respect to each Revolving Facility Lender, such Lender’s funding of its participation in any L/C Borrowing in accordance with its Revolving Facility Percentage. “L/C Borrowing” means an extension of credit resulting from a drawing under any Letter of Credit which has not been reimbursed on the date when made or refinanced as a Revolving Facility Borrowing. “L/C Credit Extension” means, with respect to any Letter of Credit, the issuance thereof or extension of the expiry date thereof, or the increase of the amount thereof. “L/C Issuer” means (i) Wells Fargo in its capacity as issuer of Letters of Credit under Section 2.05(b) and its successor or successors in such capacity and (ii) any other Lender which the Borrowers shall have designated (with such Lender’s consent) as an “L/C Issuer” by notice to the Administrative Agent (including any Lender designated as such as a replacement for any L/C Issuer who is at the time of such appointment a Defaulting Lender) that is reasonably acceptable to the Administrative Agent. “L/C Issuer Fees” has the meaning specified in Section 2.05(i). “L/C Obligations” means, as at any date of determination, the aggregate amount available to be drawn under all outstanding Letters of Credit plus the aggregate of all Unreimbursed Amounts, including all L/C Borrowings. For purposes of computing the amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with Section 1.04. For all purposes of this Agreement, if on any date of determination a Letter of Credit has expired by its terms but any amount may still be drawn thereunder by reason of the operation of Rule 3.14 of the ISP, such Letter of Credit shall be deemed to be “outstanding” in the amount so remaining available to be drawn. 45 “Laws” means, collectively, all international, foreign, Federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directives, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of Law. “Lender” means each financial institution listed on Schedule 2.01 (other than any such person that ceased to be a party hereto pursuant to an Assignment and Assumption in accordance with Section 10.06), as well as any person that becomes a “Lender” hereunder pursuant to Section 10.06; and shall include, as the context may require, the Swing Line Lender in such capacity. “Lending Office” means with respect to any Lender and for each Type of Loan, the “Lending Office” of such Lender (or of an Affiliate of such Lender) designated for such Type of Loan in such Lender’s Administrative Questionnaire or in any applicable Assignment and Assumption pursuant to which such Lender became a Lender hereunder or such other office of such Lender (or of an Affiliate of such Lender) as such Lender may from time to time specify to the Administrative Agent and the Borrowers as the office by which its Loans of such Type are to be made and maintained. “Letter of Credit” means any letter of credit issued hereunder providing for the payment of cash upon the honoring of a presentation thereunder, including, for the avoidance of doubt, any Existing Letter of Credit. A Letter of Credit may be a commercial letter of credit (including a trade letter of credit in support of trade obligations of a Borrower and its Subsidiaries) or a standby letter of credit. “Letter of Credit Request” means an application and agreement for the issuance or amendment of a Letter of Credit in the form from time to time in use by the L/C Issuer. “Letter of Credit Expiration Date” means the day that is five days prior to the Facility Maturity Date then in effect (or, if such day is not a Business Day, the next preceding Business Day). “Letter of Credit Fee” has the meaning specified in Section 2.05(h). “Letter of Credit Sublimit” means an amount equal to $35,000,000. The Letter of Credit Sublimit is part of, and not in addition to, the Revolving Facility. “Leverage Ratio” means the ratio as of the last day of any Fiscal Quarter of (i) Consolidated Total Debt as of such day to (ii) Consolidated Adjusted EBITDA for the four (4) Fiscal Quarter period ending on such date. “Lien” means, with respect to any asset, (i) any mortgage, deed of trust, lien, hypothecation, pledge, charge, security interest or similar encumbrance in or on such asset or (ii) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset, provided that in no event shall an operating lease or an agreement to sell be deemed to constitute a Lien. “Loan Account” has the meaning specified therefor in Section 2.20 of this Agreement. “Loan Cap” means, as of any date of determination, the lesser of (a) the Revolving Loan Limit, and (b) the Borrowing Base as of such date of determination. 46 “Loan Documents” means this Agreement, the Letters of Credit, the Security Documents, the Intercreditor Agreements, the Intercompany Subordination Agreement and, any Note issued under Section 2.09(e), the Fee Letter, and solely for the purposes of Sections 5.02 and 8.01 hereof, the Engagement Letter, the Fee Letter, the Amendment Fee Letter, and the Amendment No. 2 Fee Letter. “Loan Modification Agreement” has the meaning assigned to such term in Section 10.01. “Loan Modification Offer” has the meaning assigned to such term in Section 10.01. “Loan Parties” means, collectively or individually as the context may require, the Holdcos (other than the Parent Guarantor), the Borrowers and the Subsidiary Loan Parties. “Loans” means the Revolving Facility Loans, Term Loans, and the Swing Line Loans. “Local Time” means New York City time. “London Banking Day” means any day on which dealings in Dollar deposits are conducted by and between banks in the London interbank eurodollar market. “Margin Stock” has the meaning assigned to such term in Regulation U. “Material Adverse Effect” means a material adverse effect on the business, property, operations or condition of the Borrowers and their respective Subsidiaries, taken as a whole (other than resulting from any event, development or circumstance related to the COVID-19 pandemic that was disclosed in writing to the Administrative Agent and Lenders, or otherwise publicly disclosed, in each case, on or prior to April 10, 2020), or the validity or enforceability of any of the material Loan Documents or the rights and remedies of the Administrative Agent and the Lenders thereunder. “Material Indebtedness” means Indebtedness (other than Loans) of any one or more of (i) Ultimate Parent or any Subsidiary thereof (other than the Borrowers and their Subsidiaries) in an aggregate principal amount exceeding $50,000,000 and (ii) any Borrower and its Subsidiaries in an aggregate amount exceeding $15,000,000. “Material Subsidiary” means any Subsidiary other than an Immaterial Subsidiary. “Maximum Rate” has the meaning assigned to such term in Section 10.10. “Maximum Revolver Amount” means $500,000,000, decreased by the amount of reductions in the Revolving Facility Commitments made in accordance with Section 2.08 of this Agreement and increased by the amount of any Increase made in accordance with Section 2.21 of this Agreement. “Minimum Borrower EBITDA Contribution” means, for any period, the ratio (expressed as a percentage) of (x) the combined EBITDA of the Borrowers and their Subsidiaries for such period to (y) the consolidated EBITDA of the Ultimate Parent and its Subsidiaries for such period. “Minimum Collateral Amount” means, at any time, (i) with respect to Cash Collateral consisting of cash or deposit account balances provided to reduce or eliminate Fronting Exposure during the existence of a Defaulting Lender, an amount equal to 103% of the Fronting Exposure of an L/C Issuer with respect to Letters of Credit issued and outstanding at such time, (ii) with respect to Cash Collateral consisting of cash or deposit account balances provided in accordance with the provisions of Section 2.16(a)(i), (a)(ii) or (a)(iii), an amount equal to 103% of the Outstanding Amount of all L/C Obligations,


 
47 and (iii) otherwise, an amount determined by the Administrative Agent and the applicable L/C Issuer in their sole discretion. “Moody’s” means Moody’s Investors Service, Inc. “Mortgaged Properties” means the Real Properties owned in fee simple by the Loan Parties and encumbered by a Mortgage that are set forth on Schedule 1.01(b) and each additional Real Property encumbered by a Mortgage pursuant to Section 6.10. “Mortgages” means, collectively, the mortgages, trust deeds, deeds of trust, deeds to secure debt, assignments of leases and rents, and other security documents delivered with respect to Mortgaged Properties, each in a form reasonably acceptable to the Administrative Agent, as amended, supplemented or otherwise modified from time to time. “Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3) of ERISA to which any Borrower, the Holdcos or any Subsidiary or any ERISA Affiliate is making or accruing an obligation to make contributions, or has within any of the preceding six plan years made or accrued an obligation to make contributions, or otherwise has any outstanding liability. “Muscle Shoals Holdings” has the meaning assigned to such term in the preamble hereto. “NAFCEL” means National Factory for Can Ends Ltd., a limited liability company formed under the laws of Saudi Arabia. “Net Amount of Eligible Accounts” means, at any time, the gross amount of Eligible Accounts less sales, excise, or similar taxes, and less returns, discounts, claims, credits, and allowances of any nature at any time issued, owing, granted, outstanding, available, or claimed (in each case without duplication, whether of the exclusionary criteria set forth in the definition of Eligible Accounts, of any Reserve, or otherwise). “Net Income” means, with respect to any Person, the net income (loss) of such Person, determined in accordance with the Applicable Accounting Rules and before any reduction in respect of preferred stock dividends. “NOLV” means, as of any date of determination, with respect to Eligible Equipment of any Person, the value of such Eligible Equipment that is estimated to be recoverable in an orderly liquidation of such Eligible Equipment “in-place”, net of all associated costs and expenses of such liquidation, as determined based upon the most recent appraisal of Equipment received by Administrative Agent from an Acceptable Appraiser in accordance with Section 6.11, provided, that, if such appraisal does not provide the costs and expenses of such liquidation on an item by item basis, then costs and expenses of liquidation for each item of Eligible Equipment will be such amount as determined by Administrative Agent in its Permitted Discretion. “Net Proceeds” means 100% of the cash proceeds actually received by any Borrower or any Subsidiary Loan Party (including any cash payments received by way of deferred payment of principal pursuant to a note or installment receivable or purchase price adjustment receivable or otherwise and including casualty insurance settlements and condemnation awards, but only as and when received) from any Asset Sale (other than those pursuant to Section 7.05(a), (b), (c), (d), (e), (f), (h), (i), (j), (m), (n) or (o)), net of (A) attorneys’ fees, accountants’ fees, investment banking fees, survey costs, title insurance premiums, and related search and recording charges, transfer Taxes, deed or mortgage recording Taxes, required debt payments and required payments of other obligations relating to the applicable asset to the 48 extent such debt or obligations are secured by a Lien permitted hereunder (other than pursuant to the Loan Documents) on such asset, other customary expenses and brokerage, consultant and other customary fees actually incurred in connection therewith, (B) Taxes paid or payable as a result thereof, and (C) the amount of any reasonable reserve established in accordance with the Applicable Accounting Rules against any adjustment to the sale price or any liabilities (other than any Taxes deducted pursuant to clause (A) above) (x) related to any of the applicable assets and (y) retained by any Borrower or any of its Subsidiaries including, without limitation, pension and other post-employment benefit liabilities and liabilities related to environmental matters or against any indemnification obligations (however, the amount of any subsequent reduction of such reserve (other than in connection with a payment in respect of any such liability) shall be deemed to be Net Proceeds of such Asset Sale occurring on the date of such reduction); provided that, no proceeds of an Asset Sale (other than an Asset Sale of any Eligible Equipment) realized in a single transaction or a series of related transactions shall constitute Net Proceeds unless such proceeds shall exceed $10,000,000 in the aggregate in any fiscal year. For purposes of calculating the amount of Net Proceeds, fees, commissions and other costs and expenses payable to a Borrower or any Affiliate of a Borrower shall be disregarded. “Non-Consenting Lender” has the meaning assigned to such term in Section 10.01. “Non-Defaulting Lender” means, at any time, each Lender that is not a Defaulting Lender at such time. “Non-Extension Notice Date” has the meaning specified in Section 2.05(b)(iii). “Non-Reinstatement Deadline” has the meaning specified in Section 2.05(b)(iv). “Note” has the meaning assigned to such term in Section 2.09(e). “OFAC” means, the U.S. Treasury Department’s Office of Foreign Assets Control. “Orderly Liquidation Value” means an amount equal to the most recently determined Orderly Liquidation Value Factor multiplied by the book value of all Eligible Inventory of the Borrowers. “Orderly Liquidation Value Factor” means, with respect to Eligible Inventory of the Borrowers, the net orderly liquidation value thereof (expressed as a percentage of book value) as determined by an Acceptable Appraiser in accordance with Section 6.11, net of all associated costs and expenses of such liquidation. “Original Closing Date” means June 21, 2017. “Other Connection Taxes” means, with respect to any Recipient, Taxes imposed as a result of such Recipient engaging or having engaged in a trade or business in the jurisdiction imposing such Tax or any other present or former connection between such Recipient and such jurisdiction; provided that no such Recipient shall be deemed to be engaged in a trade or business in, or to have any other connection with, any jurisdiction solely as a result of such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document pursuant to an assignment request by the Borrowers under Section 10.14. “Other Taxes” means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, 49 performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to Section 3.06). Other Taxes shall not include any Taxes imposed on, or measured by reference to, gross income, net income or gain. “Outstanding Amount” means, (i) with respect to Revolving Facility Loans, and Swing Line Loans on any date, the aggregate outstanding principal amount thereof after giving effect to any borrowings and prepayments or repayments of Revolving Facility Loans and Swing Line Loans, as the case may be, occurring on such date; (ii) with respect to any L/C Obligations on any date, the amount of such L/C Obligations on such date after giving effect to any L/C Credit Extension occurring on such date and any other changes in the aggregate amount of the L/C Obligations as of such date, including as a result of any reimbursements by the applicable Borrower of Unreimbursed Amounts or any reductions in the maximum amount available for drawing under Letters of Credit taking effect on such date, and (iii) with respect to Term Loans, on any date, the aggregate outstanding principal amount thereof after giving effect to any borrowings and prepayments or repayments of Term Loans, as the case may be, occurring on such date. “Parent Entity” means any direct or indirect parent of Parent Guarantor. “Parent Guarantor” has the meaning assigned to such term in the preamble hereto. “Participant” has the meaning assigned to such term in Section 10.06(d). “Participant Register” has the meaning assigned to such term in Section 10.06(d). “Payment Conditions” means, with respect to and after giving effect to any proposed Payment Event on Pro Forma basis, (a) as of the date of any such transaction or payment, and after giving effect thereto, either: (i) the Availability shall be not less than the greater of 15.0% of the Loan Cap and $45,000,00056,300,000 on the date of, and after giving effect to, the transaction or payment, on a Pro Forma basis using the most recent calculation of the Borrowing Base immediately prior to any such payment or transaction; or (ii) both (A) the Availability shall be not less than the greater of 12.5% of the Loan Cap and $37,500,00046,900,000 and as of the date of, and after giving effect to, the transaction or payment, on a Pro Forma basis using the most recent calculation of the Borrowing Base immediately prior to any such payment or transaction, the Availability shall be not less than such amount, and (B) as of the date of any such transaction or payment, and after giving effect thereto, on a Pro Forma basis, the Fixed Charge Coverage Ratio for the immediately preceding 12 consecutive fiscal months ending on the last day of the applicable fiscal period prior to the date of such payment or transaction for which Administrative Agent has received financial statements shall be at least 1.00 to 1.00; (b) in the event that Availability is less than 5% more than the amount of Availability required under clause (a), Administrative Agent shall have received written notice of the proposed payment or transaction not less than 5 Business Days prior thereto (or such shorter period as determined by Administrative Agent) and such information with respect thereto as Administrative Agent may reasonably request. 50 “Payment Event” means a Permitted Business Acquisition, a designation of a Subsidiary or a Subsidiary Redesignation pursuant to the definition of “Unrestricted Subsidiary”, any Liens permitted pursuant to Section 7.02(u), any Investment permitted pursuant to Section 7.04(i), any Restricted Payment permitted pursuant to Section 7.06(f) or any prepayment of Indebtedness permitted pursuant to Section 7.09(b)(i)(D) or (E). “Payment Recipient” has the meaning set forth in Section 9.13. “PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA. “PBGC Intercreditor Agreement” means that certain Intercreditor Agreement, dated as of October 16, 2012, among PBGC, Wells Fargo, as successor in interest to Deutsche Bank Trust Company Americas, in its capacity thereunder as ABL collateral agent, and acknowledged and agreed to by Ravenswood. “PBGC Lien” means the Lien granted by Ravenswood to the PBGC pursuant to that certain Settlement Agreement, dated as of January 26, 2001, by and between the PBGC and Ravenswood, as in effect on the date hereof. “Perfection Certificate” means the Perfection Certificate dated as of the Effective Date with respect to the Borrowers and the other Loan Parties in a form reasonably satisfactory to the Administrative Agent. “Permitted Amendment” has the meaning assigned to such term in Section 10.01. “Permitted Business Acquisition” means any acquisition of all or substantially all the assets of, or all or substantially all the Equity Interests (other than directors’ qualifying shares) in (or that results in a Borrower or its Subsidiaries owning all or substantially all the Equity Interests in), or merger, consolidation or amalgamation with, a person or division or line of business of a person (or any subsequent investment made in a person, division or line of business previously acquired in a Permitted Business Acquisition), but only if: (i) no Event of Default shall have occurred and be continuing or would result therefrom; (ii) all transactions related thereto shall be consummated in accordance with applicable laws; (iii) with respect to any such acquisition or investment with a fair market value (as determined in good faith by the applicable Borrower) in excess of $10,000,000, the Payment Conditions shall have been satisfied; (iv) any acquired or newly formed Subsidiary shall not be liable for any Indebtedness except for Indebtedness permitted by Section 7.01; and (v) to the extent required by Section 6.10, any person acquired in such acquisition, if acquired by a Borrower or a Domestic Subsidiary, shall be merged into such Borrower or a Subsidiary Loan Party or become upon consummation of such acquisition a Subsidiary Loan Party. “Permitted Discretion” means the reasonable credit judgment of the Administrative Agent exercised in good faith and in the exercise of reasonable (from the perspective of a secured asset-based lender) business judgment, and, as it relates to the establishment of Reserves or the adjustment or imposition of exclusionary criteria, is based upon its consideration of any factor, including, without limitation, any factor that (a) it reasonably believes could adversely affect the quantity, quality, mix or value of Collateral (including any applicable Laws that may inhibit collection of an Account), the enforceability or priority of the Liens on the Collateral or the amount that the Administrative Agent and the Lenders could receive in liquidation of any Collateral; (b) suggests that any collateral report or financial information delivered by any Loan Party or the Parent Guarantor is incomplete, inaccurate or misleading in any material respect; (c) materially increases the likelihood of any bankruptcy or insolvency proceeding involving a Loan Party or the Parent Guarantor; or (d) creates or could reasonably be expected


 
51 to result in a Default or Event of Default. In exercising such judgment, the Administrative Agent may consider any factors that could increase the credit risk of lending to any Borrower on the security of the Collateral. “Permitted Investments” means: (a) direct obligations of the United States of America or any member of the European Union or any agency thereof or obligations guaranteed by the United States of America or any member of the European Union or any agency thereof, in each case with maturities not exceeding two years; (b) bank deposits, checking accounts, time deposit accounts, certificates of deposit and money market deposits maturing within 180 days of the date of acquisition thereof issued by a bank or trust company that is organized under the laws of the United States of America, any state thereof or any foreign country recognized by the United States of America having capital, surplus and undivided profits in excess of $250,000,000 and whose long term debt, or whose parent holding company’s long term debt, is rated A (or such similar equivalent rating or higher by at least one nationally recognized statistical rating organization (as defined in Rule 436 under the Securities Act)); (c) repurchase obligations with a term of not more than 180 days for underlying securities of the types described in clause (i) above entered into with a bank meeting the qualifications described in clause (ii) above; (d) commercial paper, maturing not more than one year after the date of acquisition, issued by a corporation (other than an Affiliate of any Borrower) organized and in existence under the laws of the United States of America or any foreign country recognized by the United States of America with a rating at the time as of which any investment therein is made of P-1 (or higher) according to Moody’s, or A-1 (or higher) according to S&P; (e) securities with maturities of two years or less from the date of acquisition issued or fully guaranteed by any State, commonwealth or territory of the United States of America, or by any political subdivision or taxing authority thereof, and rated at least A by S&P or A by Moody’s; (f) shares of mutual funds whose investment guidelines restrict 95% of such funds’ investments to those satisfying the provisions of clauses (i) through (v) above; (g) money market funds that (A) comply with the criteria set forth in Rule 2a-7 under the Investment Company Act of 1940, (B) are rated AAA by S&P and Aaa by Moody’s and (C) have portfolio assets of at least $5,000,000,000; (h) time deposit accounts, certificates of deposit and money market deposits (in each case with or from a bank meeting the qualifications described in clause (ii) above) in an aggregate face amount not in excess of 0.50% of the total assets of the Borrowers and their Subsidiaries, on a consolidated basis, as of the end of the Borrowers’ most recently completed fiscal year; and (i) instruments equivalent to those referred to in clauses (i) through (viii) above denominated in any foreign currency comparable in credit quality and tenor to those referred to above and commonly used by corporations for cash management purposes in any jurisdiction outside the United States to the extent reasonably required in connection with any business conducted by any Subsidiary organized in such jurisdiction. 52 “Permitted Liens” has the meaning assigned to such term in Section 7.02. “Permitted Refinancing Indebtedness” means any Indebtedness issued in exchange for, or the net proceeds of which are used to extend, refinance, renew, replace, defease or refund (collectively, to “Refinance”), the Indebtedness being Refinanced (or previous refinancings thereof constituting Permitted Refinancing Indebtedness); provided that (i) the principal amount (or accreted value, if applicable) of such Permitted Refinancing Indebtedness does not exceed the principal amount (or accreted value, if applicable) of the Indebtedness so Refinanced (plus unpaid accrued interest and premium (including tender premiums) thereon and underwriting discounts, defeasance costs, fees, commissions and expenses), (ii) the weighted average life to maturity of such Permitted Refinancing Indebtedness is greater than or equal to the earlier of (x) the weighted average life to maturity of the Indebtedness being Refinanced and (y) 90 days after the Facility Maturity Date, (iii) if the Indebtedness being Refinanced is subordinated in right of payment to the ABL Credit Obligations, such Permitted Refinancing Indebtedness shall be subordinated in right of payment to such ABL Credit Obligations on terms at least as favorable to the Lenders as those contained in the documentation governing the Indebtedness being Refinanced, (iv) no Permitted Refinancing Indebtedness shall have different obligors (other than entities that are not the Borrowers or Subsidiaries thereof), or greater guarantees or security (other than from entities that are not the Borrowers or Subsidiaries thereof), than the Indebtedness being Refinanced (provided that (x) Indebtedness (A) of any Loan Party may be Refinanced to add or substitute as an obligor another Loan Party that is reasonably satisfactory to the Administrative Agent and (B) of any Subsidiary that is not a Loan Party may be Refinanced to add or substitute as an obligor another Subsidiary that is not a Loan Party and is reasonably satisfactory to the Administrative Agent and (y) other guarantees and security may be added to the extent then independently permitted under Article VII) and (v) if the Indebtedness being Refinanced is secured by any collateral owned by CUSHI, Muscle Shoals Holdings, CPECConstellium US Intermediate, the Borrowers or a Subsidiary of the Borrowers (whether equally and ratably with, or junior to, the Secured Parties or otherwise), such Permitted Refinancing Indebtedness may be secured by such collateral (including in respect of working capital facilities of Foreign Subsidiaries otherwise permitted under this Agreement only, any collateral pursuant to after acquired property clauses to the extent any such collateral secured the Indebtedness being Refinanced) on terms no less favorable to the Secured Parties than those contained in the documentation governing the Indebtedness being Refinanced; provided, further, that, with respect to a Refinancing of subordinated Indebtedness permitted to be incurred herein, such Permitted Refinancing Indebtedness shall (x) be subordinated to the guarantee by the Holdcos and the Subsidiary Loan Parties of the Revolving Facility, and (y) be otherwise on terms not materially less favorable to the Lenders than those contained in the documentation governing the Indebtedness being refinanced. “Person” and “person” mean any natural person, corporation, business trust, joint venture, association, company, partnership, limited liability company or government, individual or family trusts, or any agency or political subdivision thereof. “Plan” shall mean any employee pension benefit plan, as such term is defined in Section 3(2) of ERISA (other than a Multiemployer Plan) (i) subject to the provisions of Title IV of ERISA, (ii) sponsored or maintained (at the time of determination or at any time within the five years prior thereto) by the Holdcos, any Borrower or any ERISA Affiliate, or (iii) in respect of which the Holdcos, any Borrower, any Subsidiary or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an “employer” as defined in Section 3(5) of ERISA. “Platform” has the meaning assigned to such term in Section 10.08. “Pledged Collateral” has the meaning assigned to such term in the Collateral Agreement. 53 “Post-Increase Revolver Lenders” has the meaning set forth in Section 2.21. “Pre-Increase Revolver Lenders” has the meaning set forth in Section 2.21. “Primary Payment Accounts” has the meaning ascribed to it in Section 6.12. “Prime Rate” means, for any day, the rate of interest in effect for such day as publicly announced from time to time within Wells Fargo at its principal office in San Francisco as its “prime rate”, with the understanding that the “prime rate” is one of Wells Fargo’s base rates (not necessarily the lowest of such rates) and serves as the basis upon which effective rates of interest are calculated for those loans making reference thereto and is evidenced by the recording thereof after its announcement in such internal publications as Wells Fargo may designate (and, if any such announced rate is below zero, then the Prime Rate shall be deemed to be zero). “Pro Forma Basis” means, for purposes of making any computation hereunder, Investments, acquisitions, dispositions, mergers, amalgamations, consolidations and discontinued operations (as determined in accordance with Applicable Accounting Rules), in each case with respect to an operating unit of a business, and any operational changes that the Ultimate Parent or any of its Subsidiaries has determined to make and/or made during the four-quarter reference period or subsequent to such reference period and on or prior to or simultaneously with the applicable calculation date (each, for purposes of this definition, a “pro forma event”) shall be calculated on a pro forma basis assuming that all such Investments, acquisitions, dispositions, mergers, amalgamations, consolidations, discontinued operations and operational changes (and the change of any associated fixed charge obligations and the change in EBITDA resulting therefrom) had occurred on the first day of the four-quarter reference period. If since the beginning of such period any Person that subsequently became a Subsidiary or was merged with or into the Borrowers or any Subsidiary since the beginning of such period shall have made any Investment, acquisition, disposition, merger, amalgamation, consolidation, discontinued operation or operational change, in each case with respect to an operating unit of a business, that would have required adjustment pursuant to this definition, then the applicable computation shall be calculated giving pro forma effect thereto for such period as if such Investment, acquisition, disposition, is continued operation, merger, amalgamation, consolidation or operational change had occurred at the beginning of the applicable four- quarter period. Pro forma calculations made pursuant to the definition of this term “Pro Forma Basis” shall be determined in good faith by a Responsible Officer of the Borrowers. Any such pro forma calculation may include adjustments appropriate, in the reasonable good faith determination of the Borrowers, to reflect operating expense reductions, other operating improvements, synergies or such operational changes or restructurings described above reasonably expected to result from the applicable pro forma event in the 18-month period following the consummation of the pro forma event. If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the applicable calculation date had been the applicable rate for the entire period (taking into account any Swap Obligations applicable to such Indebtedness if such Swap Obligation has a remaining term in excess of 12 months). Interest on a Capital Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a Responsible Officer of the Borrowers to be the rate of interest implicit in such Capital Lease Obligation in accordance with Applicable Accounting Rules. For purposes of making the computation referred to above, interest on any Indebtedness under a revolving credit facility computed on a pro forma basis shall be computed based upon the average daily balance of such Indebtedness during the applicable period. Interest on Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a eurocurrency interbank offered rate, or other rate, shall be deemed to have been 54 based upon the rate actually chosen, or, if none, then based upon such optional rate chosen as the Borrowers may designate. “Pro Rata Share” means, as of any date of determination: (a) with respect to a Revolving Facility Lender’s obligation to make all or a portion of the Revolving Facility Loans, with respect to such Lender’s right to receive payments of interest, fees, and principal with respect to the Revolving Facility Loans, and with respect to all other computations and other matters related to the Revolving Facility Commitments or the Revolving Facility Loans, a fraction (expressed as a percentage), the numerator of which is the sum of the amounts of such Lender’s Revolving Facility Commitment and the denominator of which is the sum of the amounts of all of the Lenders’ Revolving Facility Commitments, or if no Revolving Facility Commitments are outstanding, a fraction (expressed as a percentage), the numerator of which is the principal amount of Revolving Facility Credit Exposure owed to such Lender and the denominator of which is the aggregate principal amount of the Revolving Facility Credit Exposure for all Revolving Facility Lenders, in each case giving effect to a Lender’s participation in Letters of Credit, Swing Line Loans and Agent Advances, (b) with respect to a Term Loan Lender’s obligation to make all or a portion of the Term Loans, with respect to such Lender’s right to receive payments of interest, fees, and principal with respect to the Term Loans, and with respect to all other computations and other matters related to the Term Loan Commitments or the Term Loans, a fraction (expressed as a percentage), the numerator of which is the sum of the amount of such Lender’s unfunded Term Loan Commitment, if any (which are not exercised and otherwise effective pursuant to Section 2.15) plus the outstanding principal amount of the Term Loans owed to such Lender and the denominator of which is the sum of the amounts of all of the Lenders’ unfunded Term Loan Commitments, and the aggregate principal amount of Term Loans owed to all Lenders or if no Commitments are outstanding, a fraction (expressed as a percentage), the numerator of which is the principal amount of Term Loan Exposure owed to such Lender and the denominator of which is the aggregate principal amount of the Term Loan Exposure owed to the Lenders, and (c) with respect to all other matters and for all other matters as to a particular Lender (including the indemnification obligations arising under Section 10.04), the percentage obtained by dividing (i) the sum of the Revolving Facility Credit Exposure and Term Loan Exposure of such Lender, by (ii) the aggregate Revolving Facility Credit Exposure and Term Loan Exposure of all Lenders, in any such case as the applicable percentage may be adjusted by assignments permitted pursuant to Section 10.06. “Projections” means any projections and any forward looking statements (including statements with respect to booked business) of the Holdcos, the Borrowers and their respective Subsidiaries with respect to the 2019 fiscal year and each fiscal year thereafter through 2023 furnished to the Lenders or the Administrative Agent by or on behalf of the Holdcos, the Borrowers or any of their respective Subsidiaries on January 28, 2019 and February 5, 2019. “PTE” means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time. “Qualified Equity Interests” means any Equity Interests other than Disqualified Stock. “Qualified Receivables” means, collectively, Accounts for which the related Account Debtor is the entity set forth on Schedule 1.01(d) and/or its Affiliates; provided that, solely for purposes of Sections 7.02(ee) and 7.05(o), “Qualified Receivables” shall include related assets that are customarily transferred


 
55 in or in respect of which security interests are customarily granted in connection with asset securitization transactions or factoring transactions involving accounts receivable. “Qualified Receivables Financing” means (A) the Receivables Financing pursuant to the Factoring Facilities (including any increase in the amount thereof); and (B) any Receivables Financing that meets the following conditions: (a) the Ultimate Parent or the applicable Subsidiary thereof shall have determined in good faith that such Receivables Financing (including financing terms, covenants, termination events and other provisions) is in the aggregate economically fair and reasonable to the Ultimate Parent or the applicable Subsidiary thereof in question; (b) all sales of accounts receivable and related assets are made at fair market value; (c) the financing terms, covenants, termination events and other provisions thereof shall be market terms (as determined in good faith by the Ultimate Parent or the applicable Subsidiary thereof) and may include Standard Undertakings; (d) if requested by the Administrative Agent, the lender or purchaser in connection with such Qualified Receivables Financing shall have entered into an intercreditor agreement with the Administrative Agent, in form and substance reasonably acceptable to the Administrative Agent, relating to payments received in respect of the Qualified Receivables; and (e) payments received in respect of Qualified Receivables that constitute Collateral shall be deposited in accounts and otherwise handled in a manner reasonably acceptable to the Administrative Agent. “Ravenswood Intercreditor Agreement” means that certain Intercreditor Agreement, dated as of the Original Closing Date, among Ravenswood, CUSHI, Wells Fargo, in its capacity thereunder as ABL agent, and the Secured Notes Collateral AgentDeutsche Bank Trust Company Americas. “Real Property” means, collectively, all right, title and interest (including any leasehold estate) in and to any and all parcels of or interests in real property owned in fee or leased by any Loan Party, together with, in each case, all easements, hereditaments and appurtenances relating thereto, all improvements and appurtenant fixtures incidental to the ownership or lease thereof. “Receivables Financing” means any transaction or series of transactions that may be entered into by the Ultimate Parent or its respective Subsidiaries pursuant to which Ultimate Parent or any such Subsidiary may sell, convey or otherwise transfer to any other Person, or may grant a security interest in, any accounts receivable (whether now existing or arising in the future) of such Subsidiary, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts receivable and other assets, in each case, which are customarily transferred in or in respect of which security interests are customarily granted in connection with asset securitization transactions or factoring transactions involving accounts receivable. “Receivables Subsidiary” means the AB Receivables Subsidiary and any Specified Receivables Subsidiary. “Recipient” means the Administrative Agent, any Lender, any L/C Issuer or any other recipient of any payment to be made by or on account of any obligation of any Loan Party hereunder. 56 “Reference Time” with respect to any setting of the then-current Benchmark means (a) if such Benchmark is USD LIBOR, 11:00 a.m. (London time) on the day that is two (2) London Banking Days preceding the date of such setting, and (b) if such Benchmark is not USD LIBOR, the time determined by the Administrative Agent in its reasonable discretion. “Refinance” has the meaning assigned to such term in the definition of the term “Permitted Refinancing Indebtedness,” and “Refinanced” has a meaning correlative thereto. “Refinancing” means the refinancing of loans outstanding under the Existing Credit Agreements to occur on the Closing Date in accordance with the terms of this Agreement. “Register” has the meaning assigned to such term in Section 10.06(c). “Regulation U” means Regulation U of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof. “Regulation X” means Regulation X of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof. “Related Parties” means, with respect to any specified person, such person’s Affiliates and the respective directors, trustees, officers, representatives, employees, agents and advisors of such person and such person’s Affiliates. “Release” means any spilling, leaking, seepage, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, disposing, depositing, emanating or migrating in, into, onto or through the environment. “Released” has a meaning correlative to the foregoing. “Relevant Governmental Body” means the Federal Reserve Board or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board or the Federal Reserve Bank of New York, or any successor thereto. “Remaining Present Value” means, as of any date with respect to any lease, the present value as of such date of the scheduled future lease payments with respect to such lease, determined with a discount rate equal to a market rate of interest for such lease reasonably determined at the time such lease was entered into. “Replacement Rate Conforming Changes” means, with respect to any proposed Replacement Rate, any conforming changes to the definition of Applicable Margin, Eurodollar Base Rate, Interest Period, timing and frequency of determining rates and making payments of interest and other administrative matters as may be appropriate, in the reasonable discretion of the Administrative Agent, to reflect the adoption of such Replacement Rate and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such Replacement Rate exists, in such other manner of administration as the Administrative Agent reasonably determines is necessary in connection with this Agreement). “Report” has the meaning assigned to such term in Section 10.21. 57 “Reportable Event” means any reportable event as defined in Section 4043(c) of ERISA or the regulations issued thereunder, other than those events as to which the 30 day notice period referred to in Section 4043(a) of ERISA has been waived under applicable regulations, with respect to a Plan. “Required Lenders” means, at any time, the Required Revolving Facility Lenders. “Required Revolving Facility Lenders” means, at any time, Lenders having or holding more than fifty percent (50%) of the sum of the aggregate Revolving Facility Credit Exposure of all Lenders, provided, that, (i) the Revolving Facility Credit Exposure of any Defaulting Lender shall be disregarded in the determination of the Required Revolving Facility Lenders, and (ii) at any time there are three (3) or more Revolving Facility Lenders, “Required Revolving Facility Lenders” must include at least two (2) Revolving Facility Lenders (who are not Affiliates of one another). “Required Term Loan Lenders” means, at any time, Lenders having or holding more than fifty percent (50%) of the sum of the aggregate Term Loan Exposure of all Lenders, provided, that, (i) the Term Loan Exposure of any Defaulting Lender shall be disregarded in the determination of the Required Term Loan Lenders, and (ii) at any time there are three (3) or more Term Loan Lenders, “Required Term Loan Lenders” must include at least two (2) Term Loan Lenders (who are not Affiliates of one another). “Reserves” means all reserves against the Borrowing Base that the Administrative Agent has, in the exercise of its Permitted Discretion, established from time to time, provided, that, Administrative Agent shall give written notice to the Borrowers in the case of any new categories of reserves that may be established after the Closing Date or changes in methodology for a then existing reserve (except after a (i) Event of Default or (ii) for changes to any Reserves resulting solely by virtue of mathematical calculations of the amount of the Reserve in accordance with the methodology of calculation previously utilized (such as, but not limited to a rent Reserve), or (iii) for changes to Reserves or establishment of additional Reserves if a Material Adverse Effect has occurred or it would be reasonably likely that a Material Adverse Effect to the Lenders would occur were such Reserve not changed or established) and shall include the right of Administrative Agent to establish (A) a Reserve after written notice to Borrowers in the event that at any time the then outstanding aggregate principal amount of the Term Loans exceeds 50% of the NOLV of Eligible Equipment in place as set forth in the then most recent appraisal received by Administrative Agent from an Acceptable Appraiser in accordance with Section 6.11 and (B) Bank Product Reserves. “Resolution Authority” means any EEA Resolution Authority, or with respect to any UK Financial Institution, a UK Resolution Authority. “Responsible Officer” of any person means any executive officer or Financial Officer of such person and any other officer or similar official thereof responsible for the administration of the obligations of such person in respect of this Agreement. “Restricted Payments” has the meaning assigned to such term in Section 7.06. “Revolving Facility” means the Revolving Facility Commitments and the extensions of credit made hereunder by the Revolving Facility Lenders. “Revolving Facility Base Rate Margin” has the meaning set forth in the definition of Applicable Margin. 58 “Revolving Facility Borrowing” means a group of Revolving Facility Loans of a single Type under the Revolving Facility and made on a single date and, in the case of Eurodollar RateSOFR Loans, as to which a single Interest Period is in effect. “Revolving Facility Borrowing Request” means a request by a Borrower in accordance with the terms ofhas the meaning assigned to such term in Section 2.03 and substantially in the form of Exhibit C- 1 or otherwise in form and substance satisfactory to the Administrative Agent. “Revolving Facility Commitment” means, with respect to each Revolving Facility Lender, the commitment of such Revolving Facility Lender to make Revolving Facility Loans pursuant to Section 2.01, expressed as an amount representing the maximum aggregate permitted amount of such Revolving Facility Lender’s Revolving Facility Credit Exposure hereunder, as such commitment may be (i) reduced from time to time pursuant to Section 2.08, (ii) increased pursuant to Section 2.21, or (iii) reduced or increased from time to time pursuant to assignments by or to such Lender under Section 10.06. The amount of each Lender’s Revolving Facility Commitment as of the Amendment No. 46 Effective Date is set forth on Schedule 2.01. The aggregate amount of the Lenders’ Revolving Facility Commitments on the Amendment No. 46 Effective Date is $400,000,000500,000,000. “Revolving Facility Commitment Fee” has the meaning assigned to such term in Section 2.12(a). “Revolving Facility Credit Exposure” means, at any time, the sum of (a) the aggregate principal amount of the Revolving Facility Loans outstanding at such time, (b) the aggregate principal amount of the Swing Line Loans outstanding at such time and (c) the aggregate principal amount of L/C Obligations outstanding at such time. The Revolving Facility Credit Exposure of any Revolving Facility Lender at any time shall be the product of (i) such Revolving Facility Lender’s Revolving Facility Percentage and (ii) the aggregate Revolving Facility Credit Exposure of all Revolving Facility Lenders, collectively, at such time. “Revolving Facility Lender” means a Lender with a Revolving Facility Commitment and/or with outstanding Revolving Facility Loans. “Revolving Facility LIBOR Rate Margin” has the meaning set forth in the definition of Applicable Margin. “Revolving Facility Loan” means a Loan made by a Revolving Facility Lender pursuant to Section 2.01. “Revolving Loan Priority Collateral” means all Collateral other than Term Loan Priority Collateral. “Revolving Loan Limit” means, at any time, the aggregate amount of Revolving Facility Commitments in effect at such time. “Revolving Facility Percentage” means, with respect to any Revolving Facility Lender, the percentage of the total Revolving Facility Commitments represented by such Lender’s Revolving Facility Commitment, subject to adjustment as provided in Section 2.17. If the Revolving Facility Commitments have terminated or expired, the Revolving Facility Percentages shall be determined based upon the Revolving Facility Commitments most recently in effect, giving effect to any subsequent assignments pursuant to Section 10.06.


 
59 “Rexam” means Rexam Beverage Can Company, a Delaware corporation, and its successors and assigns. “S&P” means Standard & Poor’s Ratings Group, Inc. “Sanction” has the meaning assigned to such term in Section 4.25(b). “Sanctioned Country” means a country or territory which is the subject or target of any Sanctions. “Sale and Lease Back Transaction” has the meaning assigned to such term in Section 7.03. “Secured Cash Management Agreement” means any Cash Management Agreement that is entered into by and between any Borrower or any Subsidiary of a Borrower that is a Loan Party and any Cash Management Bank. “Secured Debt Intercreditor Agreement” has the meaning assigned to such term in Section 10.20. “Secured Hedge Agreement” means any Swap Contract that is entered into by and between any Borrower or any Subsidiary of a Borrower that is a Loan Party and any Hedge Bank. “Secured Notes Collateral Agent” means Deutsche Bank Trust Company Americas, in its capacity with respect to the Ravenswood Intercreditor Agreement, as notes collateral agent under the Ravenswood Intercreditor Agreement. “Secured Parties” means the “Secured Parties” as defined in the Collateral Agreement. “Securities Act” means the Securities Act of 1933, as amended. “Security Documents” means the Mortgages, the Collateral Agreement and each of the security agreements and other instruments and documents executed and delivered pursuant to any of the foregoing or pursuant to Section 6.10. “SOFR” means, with respect to any Business Day, a rate per annum equal to the secured overnight financing rate for such Business Day publishedas administered by the SOFR Administrator on the SOFR Administrator’s Website on the immediately succeeding Business Day. “SOFR Administrator” means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate). “SOFR Administrator’s Website” means the website of the Federal Reserve Bank of New York, currently at http://www.newyorkfed.org, or any successor source for the secured overnight financing rate identified as such by the SOFR Administrator from time to time. “SOFR Deadline” has the meaning specified therefor in Section 2.13(h)(i) of this Agreement. “SOFR Loan” means each portion of a Revolving Facility Loan or the Term Loan that bears interest at a rate determined by reference to Adjusted Term SOFR (other than pursuant to clause (c) of the definition of “Base Rate”). “SOFR Margin” has the meaning set forth in the definition of Applicable Margin. “SOFR Notice” means a written notice in the form of Exhibit C-1 to this Agreement. 60 “SOFR Option” has the meaning specified therefor in Section 2.13(g) of this Agreement. “Specified Person” has the meaning assigned to such term in Section 4.25(b). “Specified Receivables Subsidiary” means a Wholly Owned Subsidiary of any Borrower which engages in no activities other than in connection with the financing or sale of such Qualified Receivables of such Borrower and its Subsidiaries, all proceeds thereof and all rights (contractual or other), collateral and other assets relating thereto, and any business or activities incidental or related to such business, and which is designated by the applicable Borrower as a Specified Receivables Subsidiary and: (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (i) is guaranteed by the Borrowers or any other Subsidiary of a Borrower (excluding guarantees of obligations (other than the principal of and interest on, Indebtedness) pursuant to Standard Undertakings), (ii) is recourse to or obligates the Borrowers or any other Subsidiary of a Borrower in any way other than pursuant to Standard Undertakings, or (iii) subjects any property or asset of the Borrowers or any other Subsidiary of a Borrower, directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to Standard Undertakings; (b) with which neither the Borrowers nor any other Subsidiary of a Borrower has any material contract, agreement, arrangement or understanding other than on terms which the applicable Borrower reasonably believes to be no less favorable to the Borrowers or such Subsidiary than those that might be obtained at the time from Persons that are not Affiliates of the applicable Borrower; and (c) to which neither the Borrowers nor any other Subsidiary of a Borrower has any obligation to maintain or preserve such entity’s financial condition or cause such entity to achieve certain levels of operating results. “Standard Letter of Credit Practice” means, for any L/C Issuer, any domestic or foreign law or letter of credit practices applicable in the city in which such L/C Issuer issued the applicable Letter of Credit or, for its branch or correspondent, such laws and practices applicable in the city in which it has advised, confirmed or negotiated such Letter of Credit, as the case may be, in each case, (a) which letter of credit practices are of banks that regularly issue letters of credit in the particular city, and (b) which laws or letter of credit practices are required or permitted under ISP or UCP, as chosen in the applicable Letter of Credit. “Standard Undertakings” means representations, warranties, covenants, indemnities and guarantees of performance entered into by the Borrowers or any Subsidiary of a Borrower that are determined by the Borrowers in good faith to be customary for a Receivables Financing, including, without limitation, those relating to the servicing of assets of a Subsidiary. “subsidiary” means, with respect to any person (herein referred to as the “parent”), any corporation, partnership, association or other business entity (i) of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general partnership interests are, at the time any determination is being made, directly or indirectly, owned, controlled or held, or (ii) that is, at the time any determination is made, otherwise controlled, by the parent or one or more subsidiaries of the parent or by the parent and one or more subsidiaries of the parent. “Subsidiary” means, unless the context otherwise requires, a subsidiary of a Borrower, provided that (except for purposes of Sections 4.09, 4.13, 4.15, 4.16, 6.03, 6.09 and 8.01(k), and the definition of 61 Unrestricted Subsidiary contained herein) an Unrestricted Subsidiary shall be deemed not to be a Subsidiary of a Borrower or any of its Subsidiaries for purposes of this Agreement. “Subsidiary Loan Party” means (i) each Wholly Owned Domestic Subsidiary of any Borrower (which itself is not a Borrower), whether existing on the Closing Date or formed or acquired thereafter that, in each case, guarantees any other Indebtedness for borrowed money in excess of $15,000,000 of any Loan Party or any Affiliate of any Loan Party, and (ii) each other Subsidiary of any Borrower (which itself is not a Borrower) that, in the sole discretion of such Borrower, becomes a party to the Collateral Agreement (or a comparable agreement mutually agreed, each in their sole discretion, by such Borrower and the Administrative Agent) after the Closing Date; provided, however, that in no event shall a Receivables Subsidiary be a Subsidiary Loan Party. “Subsidiary Redesignation” has the meaning provided in the definition of “Unrestricted Subsidiary” contained in this Section 1.01. “Supermajority Revolving Facility Lenders” means, at any time, Lenders having or holding more than sixty-six and two-thirds percent (66 2/3%) of the sum of the aggregate Revolving Facility Credit Exposure of all Lenders, provided, that, (i) the Revolving Facility Credit Exposure of any Defaulting Lender shall be disregarded in the determination of the Required Revolving Facility Lenders, and (ii) at any time there are three (3) or more Revolving Facility Lenders, “Required Supermajority Revolving Facility Lenders” must include at least two (2) Revolving Facility Lenders (who are not Affiliates of one another). “Supermajority Term Loan Lenders” means, at any time, Lenders having or holding more than sixty-six and two-thirds percent (66 2/3%) of the sum of the aggregate Term Loan Exposure of all Lenders, provided, that, the Term Loan Exposure of any Defaulting Lender shall be disregarded in the determination of the Required Term Loan Lenders. “Swap Contract” means (i) any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate transactions, commodity swaps, commodity options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options or forward bond or forward bond price or forward bond index transactions, interest rate options, forward foreign exchange transactions, cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions, currency options, spot contracts, or any other similar transactions or any combination of any of the foregoing (including any options to enter into any of the foregoing), whether or not any such transaction is governed by or subject to any master agreement, and (ii) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a “Master Agreement”), including any such obligations or liabilities under any Master Agreement; provided that (i) no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of the Holdcos, the Borrowers or any of their respective Subsidiaries, and (ii) no contract for the purchase of natural gas of which any Loan Party intends to take delivery from a counterparty in the business of supplying natural gas, shall be a Swap Contract. “Swap Obligations” of any Person means all obligations (including, without limitation, any amounts which accrue after the commencement of any bankruptcy or insolvency proceeding with respect to such Person, whether or not allowed or allowable as a claim under any proceeding under any Debtor Relief Law) of such Person in respect of any Swap Contract. 62 “Swap Termination Value” means, in respect of any one or more Swap Contracts, after taking into account the effect of any legally enforceable netting agreement relating to such Swap Contracts, (i) for any date on or after the date such Swap Contracts have been closed out and termination value(s) determined in accordance therewith, such termination value(s), and (ii) for any date prior to the date referenced in clause (i), the amount(s) determined as the mark-to-market value(s) for such Swap Contracts, as determined based upon one or more mid-market or other readily available quotations provided by any recognized dealer in such Swap Contracts (which may include a Lender or any Affiliate of a Lender). “Swing Line Borrowing” means a borrowing of a Swing Line Loan pursuant to Section 2.04. “Swing Line Commitment” means the commitment of any Lender, established pursuant to Section 2.04, to make Swing Line Loans to the Borrowers. “Swing Line Lender” means Wells Fargo in its capacity as provider of Swing Line Loans, or any successor swing line lender hereunder. “Swing Line Loan” has the meaning specified in Section 2.04(a). “Swing Line Loan Notice” means a notice of a Swing Line Borrowing pursuant to Section 2.04(b), which, if in writing, shall be substantially in the form of Exhibit C-2. “Swing Line Sublimit” means $35,000,000. The Swing Line Sublimit is part of, and not in addition to, the Revolving Facility. “Taxes” means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto. “Term Loan” means, collectively, Term Loans A-1 and Term Loans A-2. As of the Amendment No. 6 Effective Date, no Term Loans are outstanding. “Term Loan Amount” means $166,250,000. “Term Loan A-2 Obligations” means all ABL Credit Obligations arising in respect of Term Loans A-2, including all principal, interest and fees owing in respect thereof. “Term Loan Commitment” means, with respect to each Term Loan Lender, its Term Loan Commitment, and, with respect to all Lenders, their Term Loan Commitments, in each case as such Dollar amounts are set forth beside such Lender’s name under the applicable heading on Schedule 2.15 to this Agreement or in the Assignment and Assumption pursuant to which such Lender became a Term Loan Lender under this Agreement, as such amounts may be reduced or increased from time to time pursuant to assignments made in accordance with the provisions of Section 10.06 of this Agreement. TheAs of the Amendment No. 6 Effective Date, the aggregate amount of the Lenders’ Term Loan Commitments on the Amendment No. 2 Effective Date is $166,250,000is zero. “Term Loan Commitment Expiration Date” means May 1, 2021. “Term Loan Facility” means the Term Loan Commitments and the extensions of credit made hereunder by the Term Loan Lenders.


 
63 “Term Loan Facility Borrowing” means a group of term loans of a single Type under the Term Loan Facility and made on a single date and, in the case of Eurodollar RateSOFR Loans, as to which a single Interest Period is in effect. “Term Loan Exposure” means, with respect to any Term Loan Lender, as of any date of determination (a) prior to the Term Loan Commitment Expiration Date, the sum of (i) the unused amount of such Term Loan Lender’s Term Loan Commitment plus (ii) the outstanding amount of all Term Loans made by such Term Loan Lender, and (b) after the Term Loan Commitment Expiration Date, the outstanding aggregate outstanding principal amount of all Term Loans made by such Term Loan Lender. “Term Loan Facility Fee” has the meaning assigned to such term in Section 2.12(d). “Term Loan Facility Percentage” means with respect to any Term Loan Lender, (i) prior to the Final Term Loan Funding Date, the percentage of aggregate Unutilized Term Loan Commitments represented by such Lender’s Term Loan Commitment and (ii) if the Term Loan Commitments have terminated or expired, the fraction (expressed as a percentage), the numerator of which is the aggregate outstanding principal amount of Term Loans owed to such Lender and the denominator of which is aggregate outstanding principal amount of Term Loans owed to all Term Loan Lenders. “Term Loan Funding Date” means the date on which Administrative Agent determines that all of the conditions set forth in Section 2.15(f) have been satisfied. “Term Loan Lender” means a Lender that has a Term Loan Commitment or that has funded any Term Loan hereunder. “Term Loan LIBOR Rate Margin” has the meaning set forth in the definition of Applicable Margin. “Term Loan Priority Collateral” means (i) the equipment of Borrowers, (ii) the Mortgaged Properties, and (iii) all collateral security and guarantees with respect to any Term Loan Priority Collateral and all cash, money, instruments, securities, financial assets and deposit accounts directly received as proceeds of any Term Loan Priority Collateral. “Term Loan Request” means a request by a Borrower for Term Loans in accordance with the terms of Section 2.15(f) and substantially in the form of Exhibit C-4 or otherwise in form and substance satisfactory to the Administrative Agent. “Term Loans A-1” means all of the term loans made pursuant to Section 2.15 of this Agreement by the Term Loan Lenders identified on Schedule 2.15 as “Term Loan A-1 Lenders.” “Term Loans A-2” means all of the term loans made pursuant to Section 2.15 of this Agreement by the Term Loan Lenders identified on Schedule 2.15 as Term Loan A-2 Lenders. “Term SOFR” means, (a) for any calculation with respect to a SOFR Loan, the Term SOFR Reference Rate for a tenor comparable to the applicable Interest Period on the day (such day, the “Periodic Term SOFR Determination Day”) that is two (2) U.S. Government Securities Business Days prior to the first day of such Interest Period, as such rate is published by the Term SOFR Administrator; provided, however, that if as of 5:00 p.m. (New York City time) on any Periodic Term SOFR Determination Day the Term SOFR Reference Rate for the applicable tenor has not been published by the Term SOFR Administrator and a 64 Benchmark Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the Term SOFR Reference Rate for such tenor as published by the Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such Periodic Term SOFR Determination Day, and (b) for any calculation with respect to a Base Rate Loan on any day, the Term SOFR Reference Rate for a tenor of one month on the day (such day, the “Base Rate Term SOFR Determination Day”) that is two (2) U.S. Government Securities Business Days prior to such day, as such rate is published by the Term SOFR Administrator; provided, however, that if as of 5:00 p.m. (New York City time) on any Base Rate Term SOFR Determination Day the Term SOFR Reference Rate for the applicable tenor has not been published by the Term SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the Term SOFR Reference Rate for such tenor as published by the Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such Base Rate Term SOFR Determination Day. “Term SOFR Adjustment” means a percentage equal to 0.10% per annum. “Term SOFR Administrator” means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term SOFR Reference Rate selected by Administrative Agent in its reasonable discretion). “Term SOFR” means, for the applicable Corresponding Tenor as of the applicable Reference Time, Reference Rate” means the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body. “Term SOFR Notice” means a notification by the Administrative Agent to the Lenders and the Borrowers of the occurrence of a Term SOFR Transition Event. “Term SOFR Transition Event” means the determination by the Administrative Agent that (a) Term SOFR has been recommended for use by the Relevant Governmental Body, (b) the administration of Term SOFR is administratively feasible for the Administrative Agent and (c) a Benchmark Transition Event or an Early Opt-in Election, as applicable, has previously occurred resulting in the replacement of the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 2.13(g) with a Benchmark Replacement the Unadjusted Benchmark Replacement component of which is not Term SOFR. “Transactions” means, collectively, the transactions to occur pursuant to the Loan Documents, including (i) the execution and delivery of the Loan Documents, the creation of the Liens pursuant to the Security Documents, and the initial borrowings hereunder; (ii) the repurchase under and termination of, or refinancing (or discharge) of Indebtedness under, the Existing Factoring Agreement, and (iii) the payment of all fees and expenses to be paid on or prior to the Closing Date and owing in connection with the foregoing. “Type” means, when used in respect of any Loan or Borrowing, the Rate by reference to which interest on such Loan or on the Loans comprising such Borrowing is determined. For purposes hereof, the term “Rate” shall include the Adjusted Eurodollar RateTerm SOFR and the Base Rate. 65 “UCP” means, with respect to any Letter of Credit, the Uniform Customs and Practice for Documentary Credits, International Chamber of Commerce (“ICC”) Publication No. 600 (or such later version thereof as may be in effect at the time of issuance). “UK Financial Institution” means any BRRD Undertaking (as defined under the PRA Rulebook (as amended from time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any Person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain financial affiliates of such credit institutions or investment firms. “UK Resolution Authority” means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution. “Ultimate Parent” means Constellium SE, a Societas Europea, domiciled in Paris, France. “Unadjusted Benchmark Replacement” means the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment. “Unfinanced Capital Expenditures” means Capital Expenditures not paid with the proceeds of Indebtedness (other than with the proceeds of Revolving Facility Loans) or with the proceeds of the sale of Equity Interests of Ultimate Parent. “Unfunded Pension Liability” means the amount by which the present value of a Plan’s obligations (based on the assumptions used for purposes of the Applicable Accounting Rules), as of the date of the most recent financial statements reflecting such amounts, exceeds the fair market value of the Plan’s assets. “Uniform Commercial Code or UCC” means the Uniform Commercial Code as the same may from time to time be in effect in the State of New York or the Uniform Commercial Code (or similar code or statute) of another jurisdiction, to the extent it may be required to apply to any item or items of Collateral. “Unreimbursed Amount” has the meaning specified in Section 2.05(c)(i). “Unrestricted Subsidiary” means (i) any subsidiary of a Borrower identified on Schedule 1.01(e) and (ii) any subsidiary of a Borrower that is itself not a Borrower and is designated by such Borrower as an Unrestricted Subsidiary hereunder by written notice to the Administrative Agent; provided that a Borrower shall only be permitted to so designate a new Unrestricted Subsidiary after the Closing Date and so long as (A) no Default or Event of Default has occurred and is continuing or would result therefrom, (B) immediately after giving effect to such designation (as well as all other such designations theretofore consummated after the first day of such reference period), the Payment Conditions shall have been satisfied, (C) such Unrestricted Subsidiary shall be capitalized (to the extent capitalized by a Borrower or any of its Subsidiaries) through Investments as permitted by, and in compliance with, Section 7.04(i), and any prior or concurrent Investments in such Subsidiary by such Borrower or any of its Subsidiaries shall be deemed to have been made under Section 7.04(i), (D) without duplication of clause (C) above, any assets owned by such Unrestricted Subsidiary at the time of the initial designation thereof shall be treated as Investments pursuant to Section 7.04(i), and (E) such Subsidiary shall have been designated an “unrestricted subsidiary” (or otherwise not be subject to the covenants and defaults) under any applicable Indebtedness permitted to be incurred hereby and all applicable Permitted Refinancing Indebtedness in respect of any of the foregoing and all applicable Disqualified Stock. A Borrower may designate any Unrestricted Subsidiary to be a Subsidiary for purposes of this Agreement (each, a “Subsidiary 66 Redesignation”); provided that (i) no Default or Event of Default has occurred and is continuing or would result therefrom, (ii) immediately after giving effect to such Subsidiary Redesignation (as well as all other Subsidiary Redesignations theretofore consummated after the first day of such reference period), the Payment Conditions shall have been satisfied, and (iii) the applicable Borrower shall have delivered to the Administrative Agent an officer’s certificate executed by a Responsible Officer of such Borrower, certifying to the best of such officer’s knowledge, compliance with the requirements of preceding clauses (i) and (ii), inclusive, and containing the calculations and information demonstrating compliance with the preceding clause (i). “Unutilized Revolving Commitments” means, at any time, the Revolving Loan Limit at such time minus the sum of (a) the aggregate principal amount of Revolving Facility Loans outstanding at such time and (b) the aggregate principal amount of L/C Obligations outstanding at such time. “Unutilized Term Loan Commitments” means, at any time, prior to the Final Term Loan Funding Date, the Term Loan Amount minus the sum of the aggregate principal amount of Term Loans outstanding at such time. “U.S. Bankruptcy Code” means Title 11 of the United States Code, as amended, or any similar federal or state law for the relief of debtors. “U.S. Government Securities Business Day” means any day except for (i) a Saturday, (ii) a Sunday or (iii) a day on which the Securities Industry and Financial Markets Association, or any successor thereto, recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities; provided, that for purposes of notice requirements in Sections 2.3(a), 2.3(c) and 2.12(b), in each case, such day is also a Business Day. “U.S. Person” means any Person that is a “United States person” as defined in Section 7701(a)(30) of the Code. “U.S. Tax Compliance Certificate” has the meaning specified in Section 3.01(c)(ii)(B)(3). “USD LIBOR” means the London interbank offered rate for Dollars. “Wells Fargo” means Wells Fargo Bank, National Association and its successors and assigns. “Wholly Owned Domestic Subsidiary” of any person means a subsidiary of such person that is both a Domestic Subsidiary and a Wholly Owned Subsidiary. “Wholly Owned Foreign Subsidiary” of any person means a subsidiary of such person that is both a Foreign Subsidiary and a Wholly Owned Subsidiary. “Wholly Owned Subsidiary” of any person means a subsidiary of such person, all of the Equity Interests of which (other than directors’ qualifying shares or nominee or other similar shares required pursuant to applicable law) are owned by such person or another Wholly Owned Subsidiary of such person. “Withdrawal Liability” means liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part 1 of Subtitle E of Title IV of ERISA.


 
67 “Write-Down and Conversion Powers” means (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that Person or any other Person, to provide that any such contract or instrument is to have effect as if a right hand had been exercised under it to or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers. Section 1.02 Terms Generally. The definitions set forth or referred to in Section 1.01 shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include,” “includes” and “including” shall be deemed to be followed by the phrase “without limitation.” All references herein to Articles, Sections, Exhibits and Schedules shall be deemed references to Articles and Sections of, and Exhibits and Schedules to, this Agreement unless the context shall otherwise require. Except as otherwise expressly provided herein, any reference in this Agreement to any Loan Document shall mean such document as amended, restated, supplemented or otherwise modified from time to time in accordance with the requirements hereof and thereof. Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be construed in accordance with the Applicable Accounting Rules, as in effect from time to time; provided that, if the Borrowers notify the Administrative Agent that the Borrowers request, or the Administrative Agent requests or the Required Lenders request, an amendment to any provision hereof to eliminate the effect of any change occurring after the Closing Date in the Applicable Accounting Rules or in the application thereof on the operation of such provision, regardless of whether any such notice is given before or after such change in the Applicable Accounting Rules or in the application thereof, then such provision shall be interpreted on the basis of the Applicable Accounting Rules as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith. Section 1.03 Effectuation of Transactions. Each of the representations and warranties of the Holdcos and the Borrowers contained in this Agreement (and all corresponding definitions) are made after giving effect to the Transactions, unless the context otherwise requires.\ Section 1.04 Letter of Credit Amounts. Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the Dollar stated amount of such Letter of Credit at such time; provided, however, that with respect to any Letter of Credit that, by its terms or the terms of any Issuer Document related thereto, provides for one or more automatic increases in the stated amount thereof, the amount of such Letter of Credit shall be deemed to be the Dollar maximum stated amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum stated amount is in effect at such time. Section 1.05 Amendment and Restatement of the Existing Credit Agreement. The parties to this Agreement agree that, on the Effective Date, the terms and provisions of the Existing Credit Agreement shall be and hereby are amended, superseded and restated in their entirety by the terms and provisions of this Agreement. This Agreement is not intended to be, and shall not constitute, a novation. All Swing Line Loans and Revolving Facility Loans made, and all ABL Finance Obligations, incurred, under the Existing Credit Agreement which are outstanding on the Effective Date shall continue as Swing Line Loans, Revolving Facility Loans and ABL Finance Obligations, respectively, under (and shall be governed by the terms of) this Agreement and the other Loan Documents. 68 (b) Without limiting the foregoing, upon the effectiveness of the amendment and restatement contemplated hereby on the Effective Date: (c) all references in the “Loan Documents” (as defined in the Existing Credit Agreement) to the “Administrative Agent”, the “Credit Agreement” and the “Loan Documents” shall be deemed to refer to the Administrative Agent, this Agreement and the Loan Documents; (i) the “Revolving Facility Commitments” (as defined in the Existing Credit Agreement) shall be redesignated as Revolving Facility Commitments hereunder as set forth on Schedule 2.01; and (ii) the Existing Letters of Credit which remain outstanding on the Closing Date shall continue as Letters of Credit under (and shall be governed by the terms of) this Agreement. Section 1.06 Rates; LIBOR Notification. The interest rate on Eurodollar Rate Loans and Base Rate Loans (when determined by reference to clause (iii) of the definition of Base Rate) is determined by reference to the Eurodollar Base Rate, which is derived from the London interbank offered rate. The London interbank offered rate is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market. On March 5, 2021, ICE Benchmark Administration (“IBA”), the administrator of the London interbank offered rate, and the Financial Conduct Authority (the “FCA”), the regulatory supervisor of IBA, announced in public statements (the “Announcements”) that the final publication or representativeness date for the London interbank offered rate for Dollars for: (a) 1-week and 2-month tenor settings will be December 31, 2021 and (b) overnight, 1-month, 3-month, 6-month and 12-month tenor settings will be June 30, 2023. No successor administrator for IBA was identified in such Announcements. As a result, it is possible that commencing for purposes of the IBA setting the London interbank offered rate. As a result, it is possible that commencing immediately after such dates, the London interbank offered rate for such tenors may no longer be available or may no longer be deemed a representative reference rate upon which to determine the interest rate on Eurodollar Rate Loans or Base Rate Loans (when determined by reference to clause (iii) of the definition of Base Rate). There is no assurance that the dates set forth in the Announcements will not change or that IBA or the FCA will not take further action that could impact the availability, composition or characteristics of any London interbank offered rate. Public and private sector industry initiatives have been and continue, as of the date hereof, to be underway to implement new or alternative reference rates to be used in place of the London interbank offered rate. In the event that the London interbank offered rate or any other then-current Benchmark is no longer available or in certain other circumstances set forth in Section 2.13(g), such Section 2.13(g) provides a mechanism for determining an alternative rate of interest. The Administrative Agent will notify the Borrowers, pursuant to Section 2.13(g), of any change to the reference rate upon which the interest rate on Eurodollar Rate Loans and Base Rate Loans (when determined by reference to clause (iii) of the definition of Base Rate) is based. However, the Administrative Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to, (ia) the continuation of, administration of, submission of, calculation of or any other matter related to the London interbank offered rate or otherTerm SOFR Reference Rate, Adjusted Term SOFR, Term SOFR or any other Benchmark, any component definition thereof or rates referred to in the definition of “Eurodollar Base Rate” orthereof, or with respect to any alternative, comparable or successor rate thereto, or replacement rate thereofthereto (including any then-current Benchmark or any Benchmark Replacement), including whether the composition or characteristics of any such alternative, successor or replacement reference rate (including any Benchmark Replacement), as it may or may not be adjusted pursuant to Section 2.13(gj)(iii), will be similar to, or produce the same value or economic equivalence of, London interbank offered rate or any other Benchmark, or have the same volume or liquidity as did, the London interbank offered rateTerm SOFR Reference Rate, Adjusted Term SOFR, Term SOFR or any other Benchmark, prior to its discontinuance or unavailability, or (iib) the 69 effect, implementation or composition of any Benchmark Replacement Conforming Changes. The parties hereto agree and acknowledge that the Announcements resulted in the occurrence of a Benchmark Transition Event with respect to the London interbank offered rate pursuant to the terms of this Agreement and that any obligation of the Administrative Agent to notify any parties of such Benchmark Transition Event pursuant to Section 2.13(g) shall be deemed satisfied.Administrative Agent and its affiliates or other related entities may engage in transactions that affect the calculation of the Term SOFR Reference Rate, Adjusted Term SOFR, Term SOFR, any alternative, successor or replacement rate (including any Benchmark Replacement) or any relevant adjustments thereto and such transactions may be adverse to a Borrower. Administrative Agent may select information sources or services in its reasonable discretion to ascertain the Term SOFR Reference Rate, Adjusted Term SOFR or Term SOFR, or any other Benchmark, any component definition thereof or rates referred to in the definition thereof, in each case pursuant to the terms of this Agreement, and shall have no liability to any Borrower, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source or service. ARTICLE II THE CREDITS Section 2.01 Revolving Facility Commitments. Prior to the Effective Date, certain “Loans” were made to the Existing Borrowers under the Existing Credit Agreement (such outstanding “Revolving Facility Loans,” the “Existing Revolving Facility Loans” and such outstanding “Swing Line Loans,” the “Existing Swing Line Loans” and together with the Existing Revolving Facility Loans, the “Existing Loans”). As of the Effective Date and prior to the funding of any Loans hereunder on the Effective Date, the outstanding principal balance of the Existing Revolving Facility Loans is $12.52 and the outstanding principal balance of the Existing Swing Line Loans is $0. Subject to the terms and conditions set forth in this Agreement, each Borrower and each of the Lenders agree that on the Effective Date the Existing Revolving Facility Loans shall be re-evidenced as Revolving Facility Loans under this Agreement and the Existing Swing Line Loans shall be re-evidenced as Swing Line Loans under this Agreement and the terms of the Existing Loans shall be restated in their entirety and shall be evidenced by this Agreement. Subject to the terms and conditions set forth herein each Revolving Facility Lender severally and not jointly agrees to make Revolving Facility Loans to the Borrowers in Dollars from time to time on any Business Day during the Availability Period in an aggregate principal amount not to exceed at any time outstanding the amount of such Lender’s Revolving Facility Commitment; provided, however, that, after giving effect to any Revolving Facility Borrowing, (i) the Revolving Facility Credit Exposure shall not exceed the lesser of the Revolving Loan Limit and the Borrowing Base and (ii) the Revolving Facility Credit Exposure of any Revolving Facility Lender shall not exceed such Lender’s Revolving Facility Commitment. Within the limits of each Lender’s Revolving Facility Commitment, and subject to the other terms and conditions hereof, each Borrower may borrow under this Section 2.01, prepay under Section 2.11 and reborrow under this Section 2.01. Revolving Facility Loans may be Base Rate Loans or Eurodollar RateSOFR Loans, as further provided herein. Section 2.02 Revolving Facility Loans and Revolving Facility Loan Borrowings. (a) Each Revolving Facility Loan shall be made as part of a Revolving Facility Borrowing consisting of Revolving Facility Loans under the Revolving Facility and of the same Type made by the Lenders ratably in accordance with their respective Commitments under the Revolving Facility (or in the case of Swing Line Loans, in accordance with their respective Swing Line Commitments); provided, however, that Revolving Facility Loans shall be made by Revolving Facility Lenders ratably in accordance with their respective Revolving Facility Percentages on the date such Revolving Facility Loans are made hereunder. The 70 failure of any Lender to make any Revolving Facility Loan required to be made by it shall not relieve any other Lender of its obligations hereunder; provided that the Revolving Facility Commitments of the Lenders are several and no Lender shall be responsible for any other Lender’s failure to make Revolving Facility Loans as required. (b) Subject to Section 3.03, each Revolving Facility Borrowing shall be comprised entirely of Base Rate Loans or Eurodollar RateSOFR Loans as a Borrower may request in accordance herewith. Each Swing Line Borrowing shall be a Base Rate Borrowing. Each Lender at its option may make any Base Rate Loan or Eurodollar RateSOFR Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan; provided that any exercise of such option shall not affect the obligation of such Borrower to repay such Revolving Facility Loan in accordance with the terms of this Agreement and such Lender shall not be entitled to any amounts payable under Section 3.01 or 3.04 solely in respect of increased costs resulting from such exercise and existing at the time of such exercise. (c) At the commencement of each Interest Period for any Eurodollar Rate BorrowingSOFR Loan, such Revolving Facility Borrowing shall be in an aggregate amount that is an integral multiple of the Borrowing Multiple and not less than the Borrowing Minimum. At the time that each Base Rate Borrowing is made, such Revolving Facility Borrowing shall be in an aggregate amount that is an integral multiple of the Borrowing Multiple and not less than the Borrowing Minimum; provided that a Base Rate Borrowing may be in an aggregate amount that is equal to the entire unused balance of the Revolving Facility Commitments or that is required to finance the reimbursement in respect of Letters of Credit as contemplated by Section 2.05(c). Each Swing Line Borrowing shall be in an amount that is an integral multiple of the Borrowing Multiple and not less than the Borrowing Minimum. Revolving Facility Borrowings of more than one Type may be outstanding at the same time; provided that there shall not at any time be more than a total of 15 Eurodollar Rate BorrowingsSOFR Loans outstanding under the Revolving Facility. (d) Notwithstanding any other provision of this Agreement, no Borrower shall be entitled to request, or to elect to convert or continue, any Revolving Facility Borrowing if the Interest Period requested with respect thereto would end after the Facility Maturity Date. Section 2.03 Requests for Revolving Facility Borrowings. To request a Revolving Facility Borrowing, the applicable Borrower shall notify the Administrative Agent of such request in writing by delivery of a borrowing request (a “Revolving Facility Borrowing Request (”) (which may be delivered through Administrative Agent’s electronic platform or portal) (a) in the case of a Eurodollar Rate Borrowing, not later than 12:00 p.m., Local Time, three Business Days before the date of the proposed Revolving Facility Borrowing or (b) in the case of a Base Rate Borrowing of Revolving Facility Loans, notnot later than 11:00 a.m. (i) on the Business Day that is the requested Funding Date in the case of a request for a Swing Loan, (ii) on the Business Day that is one Business Day prior to the requested Funding Date in the case of a request for a Base Rate Loan, and (iii) on the U.S. Government Securities Business Day that is three U.S. Government Securities Business Days prior to the requested Funding Date in the case of a request for a SOFR Loan, specifying (A) the amount of such Borrowing, and (B) the requested Funding Date (which shall be a Business Day); provided, that Administrative Agent may, in its sole discretion, elect to accept as timely requests that are received later than 11:00 a.m., Local Time, on the date of the proposed Revolving Facility Borrowing on the applicable Business Day or U.S. Government Securities Business Day, as applicable; provided that any such notice of a Base Rate Borrowing to finance the reimbursement in respect of a Letter of Credit as contemplated by Section 2.05(c) may be given not later than 10:00 a.m., Local Time, on the date of the proposed Revolving Facility Borrowing. All Revolving Facility Borrowing Requests which are not made on-line via Administrative Agent’s electronic platform or portal shall be subject to (and unless Administrative Agent elects otherwise in the exercise of its sole discretion, such Revolving Facility Borrowings shall not be


 
71 made until the completion of) a customary authentication process by the Administrative Agent (with results reasonably satisfactory to Administrative Agent) prior to the funding of any such requested Revolving Facility Loan. Each such Revolving Facility Revolving Facility Borrowing Request shall be irrevocable and shall specify the following information in compliance with Section 2.02: (i) the name of the applicable Borrower; (ii) the aggregate amount of (A) the requested Revolving Facility Borrowing and (B) the Revolving Facility Credit Exposure (after giving effect to the requested Revolving Facility Borrowing); (iii) the date of such Revolving Facility Borrowing, which shall be a Business Day; (iv) whether such Revolving Facility Borrowing is to be a Base Rate Borrowing or a Eurodollar Rate Borrowing; (v) in the case of a Eurodollar Rate Borrowing, the initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term “Interest Period”; and (vi) the location and number of such Borrower’s account to which funds are to be disbursed. If such Borrower fails to specify a Type of Revolving Facility Loan in a Revolving Facility Borrowing Request or if such Borrower fails to give a timely notice requesting a conversion or continuation, then the Revolving Facility Loans shall be made as, or converted to, Base Rate Loans. Any such automatic conversion to Base Rate Loans shall be effective as of the last day of the Interest Period then in effect with respect to the applicable Eurodollar Rate Loans. If no Interest Period is specified with respect to any requested Eurodollar Rate Borrowing, then such Borrower shall be deemed to have selected an Interest Period of one month’s duration. Promptly following receipt of a Revolving Facility Borrowing Request in accordance with this Section, the Administrative Agent shall advise each Lender of the details thereof and of the amount of such Lender’s Loan to be made as part of the requested Borrowing. Section 2.04 Swing Line Loans. (a) The Swing Line. Subject to the terms and conditions set forth herein, the Swing Line Lender, in reliance upon the agreements of the other Lenders set forth in this Section 2.04, may make loans (each such loan, a “Swing Line Loan”) to a Borrower in Dollars from time to time on any Business Day during the Availability Period in an aggregate amount not to exceed at any time outstanding the amount of the Swing Line Sublimit; provided, however, that, (x) after giving effect to any Swing Line Loan, (i) the Revolving Facility Credit Exposure shall not exceed the lesser of the Revolving Loan Limit and the Borrowing Base at such time, and (ii) the Revolving Facility Credit Exposure of any Lender (including the Swing Line Lender) shall not exceed such Lender’s Revolving Facility Commitment, (y) the applicable Borrower shall not use the proceeds of any Swing Line Loan to refinance any outstanding Swing Line Loan and (z) the Swing Line Lender may choose not to make any Swing Line Loan if it has, or by making of such Swing Line Loan may have, Fronting Exposure. Within the foregoing limits, and subject to the other terms and conditions hereof, each Borrower may borrow under this Section 2.04, prepay under Section 2.11, and reborrow under this Section 2.04. Each Swing Line Loan shall bear interest only at the Base Rate plus the Applicable Margin for Base Rate Loans. Immediately upon the making of a Swing Line Loan, each Revolving Facility Lender shall be deemed to, and hereby irrevocably 72 and unconditionally agrees to, purchase from the Swing Line Lender a risk participation in such Swing Line Loan in an amount equal to the product of such Lender’s Revolving Facility Percentage multiplied by the principal amount of such Swing Line Loan. (b) Borrowing Procedures. Each Swing Line Borrowing shall be made upon the applicable Borrower’s irrevocable written notice to the Swing Line Lender and the Administrative Agent, which may be delivered electronically. Each such notice must be in the form of a Swing Line Loan Notice and be received by the Swing Line Lender and the Administrative Agent not later than 1:00 p.m., Local Time, on the requested borrowing date or such later time on the requested borrowing date as may be approved by the Swing Line Lender in its sole discretion, and shall specify (i) the amount to be borrowed, which shall be in an aggregate amount that is an integral multiple of the Borrowing Multiple and not less than the Borrowing Minimum, and (ii) the requested borrowing date, which shall be a Business Day. Promptly after receipt by the Swing Line Lender of any Swing Line Loan Notice, the Swing Line Lender will confirm with the Administrative Agent that the Administrative Agent has also received such Swing Line Loan Notice and, if not, the Swing Line Lender will notify the Administrative Agent of the contents thereof. Unless the Swing Line Lender has received notice from the Administrative Agent (including at the request of any Revolving Facility Lender) prior to 2:00 p.m., Local Time, on the date of the proposed Swing Line Borrowing (A) directing the Swing Line Lender not to make such Swing Line Loan as a result of the limitations set forth in the proviso to the first sentence of Section 2.04(a), or (B) that one or more of the applicable conditions specified in Article V is not then satisfied or waived (and one or more such conditions are not in fact satisfied or waived), then, subject to the terms and conditions hereof, the Swing Line Lender will, not later than 3:00 p.m., Local Time, on the borrowing date specified in such Swing Line Loan Notice, make the amount of its Swing Line Loan available to such Borrower in immediately available funds either by (i) crediting the account of such Borrower on the books of the Swing Line Lender with the amount of such funds or (ii) wire transfer of such funds, in each case in accordance with instructions provided to the Swing Line Lender by such Borrower. (c) Refinancing of Swing Line Loans. (i) The Swing Line Lender at any time in its sole discretion may request, on behalf of any Borrower (which hereby irrevocably authorizes the Swing Line Lender to so request on its behalf), that each Revolving Facility Lender make a Base Rate Loan in an amount equal to such Lender’s Revolving Facility Percentage of the amount of Swing Line Loans then outstanding. Such request shall be made in writing (which written request shall be deemed to be a Revolving Facility Borrowing Request for purposes hereof) and in accordance with the requirements of Section 2.02 and 2.03, without regard to the minimum and multiples specified therein for the principal amount of Base Rate Loans, but subject to sufficient Availability, the unutilized portion of the Revolving Facility and the conditions set forth in Section 5.01. The Swing Line Lender shall furnish such Borrower with a copy of the applicable Revolving Facility Borrowing Request promptly after delivering such notice to the Administrative Agent. Each Revolving Facility Lender shall transfer an amount equal to its Revolving Facility Percentage of the amount specified in such Revolving Facility Borrowing Request to the Administrative Agent in immediately available funds (and the Administrative Agent may apply Cash Collateral available with respect to the applicable Swing Line Loan) for the account of the Swing Line Lender to the Administrative Agent’s Account not later than 1:00 p.m., Local Time, on the day specified in such Revolving Facility Borrowing Request, whereupon, subject to Section 2.04(c)(ii), each Revolving Facility Lender that so makes funds available shall be deemed to have made a Base Rate Loan to such Borrower in such amount. The Administrative Agent shall remit the funds so received to the Swing Line Lender. (ii) If for any reason any Swing Line Loan cannot be refinanced by such a Revolving Facility Borrowing in accordance with Section 2.04(c)(i), the request for Base Rate Loans submitted by the Swing Line Lender as set forth herein shall be deemed to be a request by the Swing Line 73 Lender that each of the Revolving Facility Lenders fund its risk participation in the relevant Swing Line Loan and each Revolving Facility Lender’s payment to the Administrative Agent for the account of the Swing Line Lender pursuant to Section 2.04(c)(i) shall be deemed payment in respect of such participation. (iii) If any Revolving Facility Lender fails to make available to the Administrative Agent for the account of the Swing Line Lender any amount required to be paid by such Lender pursuant to the foregoing provisions of this Section 2.04(c) by the time specified in Section 2.04(c)(i), the Swing Line Lender shall be entitled to recover from such Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to the Swing Line Lender at a rate per annum equal to the greater of the Federal Funds Rate and a rate determined by the Swing Line Lender in accordance with banking industry rules on interbank compensation, plus any administrative, processing or similar fees customarily charged by the Swing Line Lender in connection with the foregoing. If such Lender pays such amount (with interest and fees as aforesaid), the amount so paid shall constitute such Lender’s Revolving Facility Loan included in the relevant Revolving Facility Borrowing or funded participation in the relevant Swing Line Loan, as the case may be. A certificate of the Swing Line Lender submitted to any Lender (through the Administrative Agent) with respect to any amounts owing under this clause (iii) shall be conclusive absent manifest error. (iv) Each Revolving Facility Lender’s obligation to make Revolving Facility Loans or to purchase and fund risk participations in Swing Line Loans pursuant to this Section 2.04(c) shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right which such Lender may have against the Swing Line Lender, any Borrower or any other Person for any reason whatsoever, (B) the occurrence or continuance of a Default or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing; provided, however, that each Revolving Facility Lender’s obligation to make Revolving Facility Loans pursuant to this Section 2.04(c) is subject to the conditions set forth in Section 5.01. (d) Repayment of Participations. (i) At any time after any Revolving Facility Lender has purchased and funded a risk participation in a Swing Line Loan, if the Swing Line Lender receives any payment on account of such Swing Line Loan, the Swing Line Lender will distribute to such Revolving Facility Lender its Revolving Facility Percentage thereof in the same funds as those received by the Swing Line Lender. (i) If any payment received by the Swing Line Lender in respect of principal or interest on any Swing Line Loan is required to be returned by the Swing Line Lender under any of the circumstances described in Section 10.05 (including pursuant to any settlement entered into by the Swing Line Lender in its discretion), each Revolving Facility Lender shall pay to the Swing Line Lender its Revolving Facility Percentage thereof on demand of the Administrative Agent, plus interest thereon from the date of such demand to the date such amount is returned, at a rate per annum equal to the Federal Funds Rate. The Administrative Agent will make such demand upon the request of the Swing Line Lender. The obligations of the Lenders under this clause shall survive the payment in full of the ABL Credit Obligations and the termination of this Agreement. (e) Interest for Account of Swing Line Lender. The Swing Line Lender shall be responsible for invoicing the applicable Borrower for interest on the Swing Line Loans. Until each Revolving Facility Lender funds its Base Rate Loan or risk participation pursuant to this Section 2.04 to refinance such Revolving Facility Lender’s Revolving Facility Percentage of any Swing Line Loan, 74 interest in respect of such Revolving Facility Percentage shall be solely for the account of the Swing Line Lender. (f) Payments Directly to Swing Line Lender. The applicable Borrower shall make all payments of principal and interest in respect of the Swing Line Loans directly to the Swing Line Lender. (g) Defaulting Lenders. Notwithstanding anything to the contrary contained in this Section 2.04, the Swing Line Lender shall not be obligated to make any Swing Line Loan at a time when any Revolving Facility Lender is a Defaulting Lender, unless the Swing Line Lender has entered into arrangements satisfactory to it to eliminate its Fronting Exposure (after giving effect to Section 2.16) with respect to any Defaulting Lender’s risk participations in, and all other obligations in respect of, Swing Line Loans, including by cash collateralizing such Defaulting Lender’s Revolving Facility Percentage of all Swing Line Loans outstanding or to be outstanding hereunder. Section 2.05 Letters of Credit. (a) The Letter of Credit Commitment. (i) Subject to the terms and conditions set forth herein, (A) each L/C Issuer agrees, in reliance upon the agreements of the Revolving Facility Lenders set forth in this Section 2.05, (1) from time to time on any Business Day during the period from the Closing Date until the Letter of Credit Expiration Date, to issue Letters of Credit for the account of any Borrower or its Subsidiaries, and to amend or (solely in the case of standby Letters of Credit) extend Letters of Credit previously issued by it, in accordance with subsection (b) below, and (2) to honor drawings under the Letters of Credit; and (B) the Revolving Facility Lenders severally and not jointly agree to participate in Letters of Credit issued for the account of any Borrower or its Subsidiaries and any drawings thereunder; provided that after giving effect to any L/C Credit Extension with respect to any Letter of Credit, (x) the Revolving Facility Credit Exposure shall not exceed the lesser of the Revolving Loan Limit and the Borrowing Base at such time, (y) the Revolving Facility Credit Exposure of any Lender shall not exceed such Lender’s Revolving Facility Commitment, and (z) the Outstanding Amount of the L/C Obligations shall not exceed the Letter of Credit Sublimit. Each request by a Borrower for the issuance or amendment of a Letter of Credit shall be deemed to be a representation by such Borrower that the L/C Credit Extension so requested complies with the conditions set forth in the proviso to the preceding sentence. Anything contained herein to the contrary notwithstanding, each L/C Issuer may, but shall not be obligated to, issue a Letter of Credit that supports an obligation of a Borrower in respect of (x) a lease of real property or (y) an employment contract. Within the foregoing limits, and subject to the terms and conditions hereof, the Borrowers’ ability to obtain Letters of Credit shall be fully revolving, and accordingly any Borrower may, during the foregoing period, obtain Letters of Credit to replace Letters of Credit that have expired or that have been drawn upon and reimbursed. As of the Closing Date, the Existing Letters of Credit shall be deemed to have been issued under (and shall be governed by the terms of) this Agreement. (ii) No L/C Issuer shall issue any Letter of Credit if: (A) subject to Section 2.05(b)(iii), the expiry date of the requested Letter of Credit would occur, (1) with respect to each standby Letter of Credit, more than twelve months after the date of issuance or last extension or, (2) with respect to each commercial Letter of Credit, more than 180 days after the date of issuance, unless, in each case, the Required Lenders have approved such expiry date; or


 
75 (B) unless such L/C Issuer has otherwise agreed, the expiry date of the requested Letter of Credit would occur after the Letter of Credit Expiration Date; provided that if any such Letter of Credit is outstanding on the Letter of Credit Expiration Date, the applicable Borrower shall Cash Collateralize the Outstanding Amount of all L/C Obligations with respect to such Letter of Credit. (iii) No L/C Issuer shall be under any obligation to issue any Letter of Credit if: (A) any order, judgment or decree of any Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain the L/C Issuer from issuing the Letter of Credit, or any Law applicable to the L/C Issuer or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over the L/C Issuer shall prohibit, or request that the L/C Issuer refrain from, the issuance of letters of credit generally or the Letter of Credit in particular or shall impose upon the L/C Issuer with respect to the Letter of Credit any restriction, reserve or capital requirement (for which the L/C Issuer is not otherwise compensated hereunder) not in effect on the Closing Date, or shall impose upon the L/C Issuer any unreimbursed loss, cost or expense which was not applicable on the Closing Date and which the L/C Issuer in good faith deems material to it; (B) the issuance of the Letter of Credit would violate in any material respect one or more policies of the L/C Issuer applicable to letters of credit generally and customary for other issuers of letters of credit; (C) except as otherwise agreed by the Administrative Agent and the L/C Issuer, the Letter of Credit is in an initial stated amount less than $100,000, in the case of a commercial Letter of Credit, or $500,000, in the case of a standby Letter of Credit; (D) the Letter of Credit is to be denominated in a currency other than Dollars; or (E) any Lender is at that time a Defaulting Lender, unless such L/C Issuer has entered into arrangements, including the delivery of Cash Collateral, satisfactory to the L/C Issuer (in its sole discretion) with the applicable Borrower or such Lender to eliminate the L/C Issuer’s actual or reasonably determined potential Fronting Exposure (after giving effect to Section 2.16(a)(iv)) with respect to the Defaulting Lender arising from either the Letter of Credit then proposed to be issued or that Letter of Credit and all other L/C Obligations as to which the L/C Issuer has actual or reasonably determined potential Fronting Exposure. (iv) The L/C Issuer shall not amend any Letter of Credit if the L/C Issuer would not be permitted at such time to issue the Letter of Credit in its amended form under the terms hereof. (v) The L/C Issuer shall be under no obligation to amend any Letter of Credit if (A) the L/C Issuer would have no obligation at such time to issue the Letter of Credit in its amended form under the terms hereof, or (B) the beneficiary of the Letter of Credit does not accept the proposed amendment to the Letter of Credit. (vi) Each L/C Issuer shall act on behalf of the Revolving Facility Lenders with respect to any Letters of Credit issued by it and the documents associated therewith, and such L/C Issuer shall have all of the benefits and immunities (A) provided to the Administrative Agent in Article IX with respect to any acts taken or omissions suffered by such L/C Issuer in connection with Letters of Credit issued by it or proposed to be issued by it and Issuer Documents pertaining to such Letters of 76 Credit as fully as if the term “Administrative Agent” as used in Article IX included the L/C Issuer with respect to such acts or omissions, and (B) as additionally provided herein with respect to the L/C Issuer. (vii) It is agreed that, in the case of the issuance of any commercial or trade Letter of Credit, such Letter of Credit shall in no event provide for time drafts or bankers’ acceptances, unless a proper Reserve has been established with respect thereto. (b) Procedures for Issuance and Amendment of Letters of Credit; Auto-Extension Letters of Credit. (i) Each Letter of Credit shall be issued or amended, as the case may be, upon the request of the applicable Borrower delivered to the applicable L/C Issuer (with a copy to the Administrative Agent) in the form of a Letter of Credit Request, appropriately completed and signed by a Responsible Officer of such Borrower. Such Letter of Credit Request may be sent by fax or by electronic transmission using the system provided by the applicable L/C Issuer or by any other means acceptable to such L/C Issuer and shall be subject to customary authentication procedures by such L/C Issuer with results reasonably satisfactory to such L/C Issuer. Such Letter of Credit Request must be received by the L/C Issuer and the Administrative Agent not later than 2:00 p.m., Local Time, at least two Business Days (or such later date and time as the Administrative Agent and the L/C Issuer may agree in a particular instance in their sole discretion) prior to the proposed issuance date or date of amendment, as the case may be. In the case of a request for an initial issuance of a Letter of Credit, such Letter of Credit Request shall specify in form and detail reasonably satisfactory to the L/C Issuer: (A) the proposed issuance date of the requested Letter of Credit (which shall be a Business Day); (B) the amount thereof; (C) the expiry date thereof; (D) the name and address of the beneficiary thereof; (E) the documents to be presented by such beneficiary in case of any drawing thereunder; (F) the full text of any certificate to be presented by such beneficiary in case of any drawing thereunder; (G) the purpose and nature of the requested Letter of Credit; and (H) such other customary matters as the L/C Issuer may reasonably require. In the case of a request for an amendment of any outstanding Letter of Credit, such Letter of Credit Request shall specify in form and detail reasonably satisfactory to the L/C Issuer: (1) the Letter of Credit to be amended; (2) the proposed date of amendment thereof (which shall be a Business Day); (3) the nature of the proposed amendment; and (4) such other customary matters as the L/C Issuer may reasonably require. Additionally, such Borrower shall furnish to the L/C Issuer and the Administrative Agent such other customary documents and information pertaining to such requested Letter of Credit issuance or amendment, including any Issuer Documents, as the L/C Issuer or the Administrative Agent may reasonably require. (ii) Promptly after receipt of any Letter of Credit Request, the L/C Issuer will confirm with the Administrative Agent that the Administrative Agent has received a copy of such Letter of Credit Request from the applicable Borrower and, if not, the L/C Issuer will provide the Administrative Agent with a copy thereof. Unless one or more applicable conditions contained in Article V shall not then be satisfied or waived, then, subject to the terms and conditions hereof, the L/C Issuer shall, on the requested date, issue a Letter of Credit for the account of such Borrower (or the applicable Subsidiary) or enter into the applicable amendment, as the case may be, in each case in accordance with the L/C Issuer’s usual and customary business practices. Immediately upon the issuance of each Letter of Credit, each Revolving Facility Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from the L/C Issuer a risk participation in such Letter of Credit in an amount equal to the product of such Lender’s Revolving Facility Percentage times the amount of such Letter of Credit. (iii) If any Borrower so requests in any applicable standby Letter of Credit Request, the L/C Issuer may, in its sole and absolute discretion, agree to issue a standby Letter of Credit that has automatic extension provisions (each, an “Auto-Extension Letter of Credit”); provided that (x) 77 any such Auto-Extension Letter of Credit must permit the L/C Issuer to prevent any such extension at least once in each twelve-month period (commencing with the date of issuance of such Letter of Credit) by giving prior notice to the beneficiary thereof not later than a day (the “Non-Extension Notice Date”) in each such twelve-month period to be agreed upon at the time such Letter of Credit is issued and (y) such prior notice shall be deemed to have been given by the L/C Issuer on the effective date of its resignation as L/C Issuer in accordance with Section 10.06(f). Unless otherwise directed by the applicable L/C Issuer, the applicable Borrower shall not be required to make a specific request to the L/C Issuer for any such extension. Once an Auto-Extension Letter of Credit has been issued, the Revolving Facility Lenders shall be deemed to have authorized (but may not require) the L/C Issuer to permit the extension of such Letter of Credit at any time to an expiry date not later than the Letter of Credit Expiration Date (unless the applicable L/C Issuer has otherwise agreed, in which case such expiry date may be later than the Letter of Credit Expiration Date, and if any such Letter of Credit is outstanding on the Letter of Credit Expiration Date, such Borrower shall Cash Collateralize the Outstanding Amount of all L/C Obligations with respect to such Letter of Credit); provided, however, that the L/C Issuer shall not permit any such extension if (A) the L/C Issuer has determined that it would not be permitted at such time to issue such Letter of Credit in its revised form (as extended) under the terms hereof (by reason of the provisions of clause (ii) or (iii) of Section 2.05(a) or otherwise), or (B) one or more of the applicable conditions specified in Section 5.01 is not then satisfied or waived. (iv) If any Borrower so requests in any applicable Letter of Credit Request, the L/C Issuer may, in its sole and absolute discretion, agree to issue a standby Letter of Credit that permits the automatic reinstatement of all or a portion of the stated amount thereof after any drawing thereunder (each, an “Auto-Reinstatement Letter of Credit”). Unless otherwise directed by the L/C Issuer, such Borrower shall not be required to make a specific request to the L/C Issuer to permit such reinstatement. Once an Auto-Reinstatement Letter of Credit has been issued, except as provided in the following sentence, the Revolving Facility Lenders shall be deemed to have authorized (but may not require) the L/C Issuer to reinstate all or a portion of the stated amount thereof in accordance with the provisions of such Letter of Credit. Notwithstanding the foregoing, if such Auto-Reinstatement Letter of Credit permits the L/C Issuer to decline to reinstate all or any portion of the stated amount thereof after a drawing thereunder by giving notice of such non-reinstatement within a specified number of days after such drawing (the “Non-Reinstatement Deadline”), the L/C Issuer shall not permit such reinstatement if it has received a notice on or before the day that is seven Business Days before the Non-Reinstatement Deadline (A) that the Administrative Agent has reasonably determined not to permit such reinstatement or (B) from the Administrative Agent, any Lender or such Borrower that one or more of the applicable conditions specified in Section 5.01 is not then satisfied (treating such reinstatement as an L/C Credit Extension for purposes of this clause) and, in each case, directing the L/C Issuer not to permit such reinstatement. (v) Promptly after its delivery of any Letter of Credit or any amendment to a Letter of Credit to an advising bank with respect thereto or to the beneficiary thereof, the L/C Issuer will also deliver to the applicable Borrower and the Administrative Agent a true and complete copy of such Letter of Credit or amendment. (c) Drawings and Reimbursements; Funding of Participations. (i) Upon receipt from the beneficiary of any Letter of Credit of any notice of a drawing under such Letter of Credit, the L/C Issuer shall notify the applicable Borrower and the Administrative Agent thereof. Not later than 2:00 p.m., Local Time, on the Business Day (each such date, an “Honor Date”) following the date upon which such Borrower receives such notice from the L/C Issuer of a payment by the L/C Issuer under a Letter of Credit, such Borrower shall reimburse the L/C Issuer through the Administrative Agent in an amount equal to the amount of such drawing. If such 78 Borrower fails to so reimburse the L/C Issuer by such time, the L/C Issuer shall notify the Administrative Agent who shall promptly notify each Revolving Facility Lender of the Honor Date, the amount of the unreimbursed drawing (the “Unreimbursed Amount”), and the amount of such Revolving Facility Lender’s Revolving Facility Percentage thereof. In such event, such Borrower shall be deemed to have requested a Revolving Facility Borrowing of Base Rate Loans to be disbursed on the Honor Date in an amount equal to the Unreimbursed Amount, without regard to the minimum and multiples specified in Section 2.01 for the principal amount of Base Rate Loans, but subject to the amount of the unutilized portion of the Revolving Facility Commitments and the conditions set forth in Section 5.01 (other than the delivery of a Revolving Facility Borrowing Request). (ii) Each Revolving Facility Lender shall, upon any notice pursuant to Section 2.05(c)(i), make funds available (and the Administrative Agent may apply Cash Collateral provided for this purpose) for the account of the L/C Issuer at the account of the Administrative Agent most recently designated by it for such purpose by notice to the Lenders, in an amount equal to its Revolving Facility Percentage of the Unreimbursed Amount not later than 1:00 p.m., Local Time, on the Business Day specified in such notice by the Administrative Agent, whereupon, subject to the provisions of Section 2.05(c)(iii), each Revolving Facility Lender that so makes funds available shall be deemed to have made a Base Rate Loan to the applicable Borrower in such amount. The Administrative Agent shall remit the funds so received to the L/C Issuer. (iii) With respect to any Unreimbursed Amount that is not fully refinanced by a Revolving Facility Borrowing of Base Rate Loans because the conditions set forth in Section 5.01 cannot be satisfied or for any other reason, the applicable Borrower shall be deemed to have incurred from the L/C Issuer an L/C Borrowing in the amount of the Unreimbursed Amount that is not so refinanced, which L/C Borrowing shall be due and payable on demand (together with interest) and shall bear interest at the Default Rate. In such event, each Revolving Facility Lender’s payment to the Administrative Agent for the account of the L/C Issuer pursuant to Section 2.05(c)(ii) shall be deemed payment in respect of its participation in such L/C Borrowing and shall constitute an L/C Advance from such Lender in satisfaction of its participation obligation under this Section 2.05. (iv) Until each Revolving Facility Lender funds its Revolving Facility Loan or L/C Advance pursuant to this Section 2.05(c) to reimburse the L/C Issuer for any amount drawn under any Letter of Credit, interest in respect of such Lender’s Revolving Facility Percentage of such amount shall be solely for the account of the L/C Issuer. (v) Each Revolving Facility Lender’s obligation to make Revolving Facility Loans or L/C Advances to reimburse the L/C Issuer for amounts drawn under Letters of Credit, as contemplated by this Section 2.05(c), shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right which such Lender may have against the L/C Issuer, any Borrower or any other Person for any reason whatsoever; (B) the occurrence or continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing; provided, however, that each Revolving Facility Lender’s obligation to make Revolving Facility Loans pursuant to this Section 2.05(c) is subject to the conditions set forth in Article V (other than delivery by a Borrower of a Revolving Facility Borrowing Request). No such making of an L/C Advance shall relieve or otherwise impair the obligation of any Borrower to reimburse the L/C Issuer for the amount of any payment made by the L/C Issuer under any Letter of Credit, together with interest as provided herein. (vi) If any Revolving Facility Lender fails to make available to the Administrative Agent for the account of any L/C Issuer any amount required to be paid by such Lender pursuant to the foregoing provisions of this Section 2.05(c) by the time specified in Section 2.05(c)(ii),


 
79 then, without limiting the other provisions of this Agreement, the L/C Issuer shall be entitled to recover from such Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to the L/C Issuer at a rate per annum equal to the greater of the Federal Funds Rate and a rate determined by the L/C Issuer in accordance with banking industry rules on interbank compensation, plus any administrative, processing or similar fees customarily charged by the L/C Issuer in connection with the foregoing. If such Lender pays such amount (with interest and fees as aforesaid), the amount so paid shall constitute such Lender’s Revolving Facility Loan included in the relevant Revolving Facility Borrowing or L/C Advance in respect of the relevant L/C Borrowing, as the case may be. A certificate of the L/C Issuer submitted to any Revolving Facility Lender (through the Administrative Agent) with respect to any amounts owing under this Section 2.05(c)(vi) shall be conclusive absent manifest error. (d) Repayment of Participations. (i) At any time after an L/C Issuer has made a payment under any Letter of Credit and has received from any Revolving Facility Lender such Lender’s L/C Advance in respect of such payment in accordance with Section 2.05(c), if the Administrative Agent receives for the account of the L/C Issuer any payment in respect of the related Unreimbursed Amount or interest thereon (whether directly from the applicable Borrower or otherwise, including proceeds of Cash Collateral applied thereto by the Administrative Agent), the Administrative Agent will distribute to such Lender its Revolving Facility Percentage thereof in the same funds as those received by the Administrative Agent. (ii) If any payment received by the Administrative Agent for the account of the L/C Issuer pursuant to Section 2.05(c)(i) is required to be returned under any of the circumstances described in Section 10.05 (including pursuant to any settlement entered into by the L/C Issuer in its discretion), each Revolving Facility Lender shall pay to the Administrative Agent for the account of the L/C Issuer its Revolving Facility Percentage thereof on demand of the Administrative Agent, plus interest thereon from the date of such demand to the date such amount is returned by such Lender, at a rate per annum equal to the Federal Funds Rate from time to time in effect. The obligations of the Lenders under this clause shall survive the payment in full of the ABL Credit Obligations and the termination of this Agreement. (e) Obligations Absolute. The obligation of each Borrower to reimburse the L/C Issuer for each drawing under each Letter of Credit and to repay each L/C Borrowing shall be absolute, unconditional and irrevocable, and shall be paid strictly in accordance with the terms of this Agreement under all circumstances, including the following: (i) any lack of validity or enforceability of such Letter of Credit, this Agreement, any Issuer Document or any other Loan Document, or any term or provisions therein or herein; (ii) the existence of any claim, counterclaim, setoff, defense or other right that any Borrower or any Subsidiary may have at any time against any beneficiary or any transferee of such Letter of Credit (or any Person for whom any such beneficiary or any such transferee may be acting), the L/C Issuer or any other Person, whether in connection with this Agreement, the transactions contemplated hereby or by such Letter of Credit or any agreement or instrument relating thereto, or any unrelated transaction; (iii) any draft, demand, certificate or other document presented under such Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement 80 therein being untrue or inaccurate in any respect; or any loss or delay in the transmission or otherwise of any document required in order to make a drawing under such Letter of Credit; (iv) any payment by the L/C Issuer under such Letter of Credit against presentation of a draft or certificate that does not strictly comply with the terms of such Letter of Credit; or any payment made by the L/C Issuer under such Letter of Credit to any Person purporting to be a trustee in bankruptcy, debtor-in-possession, assignee for the benefit of creditors, liquidator, receiver or other representative of or successor to any beneficiary or any transferee of such Letter of Credit, including any arising in connection with any proceeding under any Debtor Relief Law; or (v) any other circumstance or happening whatsoever, whether or not similar to any of the foregoing, including any other circumstance that might otherwise constitute a defense available to, or a discharge of, any Borrower or any of its Subsidiaries. (f) Role of L/C Issuer. Each Lender and each Borrower agree that, in paying any drawing under a Letter of Credit, the L/C Issuer shall not have any responsibility to obtain any document (other than any sight draft, certificates and documents expressly required by the Letter of Credit) or to ascertain or inquire as to the validity or accuracy of any such document or the authority of the Person executing or delivering any such document. None of the L/C Issuer, the Administrative Agent, any of their respective Related Parties or any correspondent, participant or assignee of the applicable L/C Issuer shall be liable to any Lender for: (i) any action taken or omitted in connection herewith at the request or with the approval of the Revolving Facility Lenders or the Required Lenders, as applicable; (ii) any action taken or omitted in the absence of gross negligence or willful misconduct; or (iii) the due execution, effectiveness, validity or enforceability of any document or instrument related to any Letter of Credit or Issuer Document. Each Borrower hereby assumes all risks of the acts or omissions of any beneficiary or transferee with respect to its use of any Letter of Credit; provided, however, that this assumption is not intended to, and shall not, preclude such Borrower’s pursuing such rights and remedies as it may have against the beneficiary or transferee at law or under any other agreement. None of the L/C Issuers, the Administrative Agent, any of their respective Related Parties nor any correspondent, participant or assignee of any L/C Issuer shall be liable or responsible for any of the matters described in clauses (i) through (v) of Section 2.05(e); provided, however, that anything in such clauses to the contrary notwithstanding, the applicable Borrower may have a claim against an L/C Issuer, and such L/C Issuer may be liable to such Borrower, to the extent, but only to the extent, of any direct, as opposed to consequential or exemplary, damages suffered by such Borrower which such Borrower proves were caused by such L/C Issuer’s willful misconduct or gross negligence or such L/C Issuer’s willful failure to pay under any Letter of Credit after the presentation to it by the beneficiary of a sight draft and certificate(s) strictly complying with the terms and conditions of such Letter of Credit. In furtherance and not in limitation of the foregoing, the L/C Issuer may accept documents that appear on their face to be in order, without responsibility for further investigation, regardless of any notice or information to the contrary, and the L/C Issuer shall not be responsible for the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign a Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, which may prove to be invalid or ineffective for any reason. The L/C Issuer may send a Letter of Credit or conduct any communication to or from the beneficiary via the Society for Worldwide Interbank Financial Telecommunication message or overnight courier, or any other commercially reasonable means of communicating with a beneficiary. (g) Applicability of ISP and UCP. Unless otherwise expressly agreed by the L/C Issuer and the applicable Borrower when a Letter of Credit is issued, (i) the rules of the ISP shall apply to each standby Letter of Credit, and (ii) the rules of the UCP shall apply to each commercial Letter of Credit. Notwithstanding the foregoing, the L/C Issuer shall not be responsible to any Borrower for, and the L/C Issuer’s rights and remedies against any Borrower shall not be impaired by, any action or inaction 81 of the L/C Issuer required or permitted under any law, order, or practice that is required or permitted to be applied to any Letter of Credit or this Agreement, including the Law or any order of a jurisdiction where the L/C Issuer or the beneficiary is located, the practice stated in the ISP or UCP, as applicable, or in the decisions, opinions, practice statements, or official commentary of the ICC Banking Commission, the Bankers Association for Finance and Trade - International Financial Services Association (BAFT-IFSA), or the Institute of International Banking Law & Practice, whether or not any Letter of Credit chooses such law or practice. (h) Letter of Credit Fees. Each Borrower shall pay to the Administrative Agent for the account of each Revolving Facility Lender, in accordance with its Revolving Facility Percentage, a Letter of Credit fee (the “Letter of Credit Fee”) (i) for each commercial Letter of Credit issued at the request of such Borrower equal to the Revolving Facility LIBOR RateSOFR Margin for each day during any quarter times the daily amount available to be drawn under such Letter of Credit and (ii) for each standby Letter of Credit issued at the request of such Borrower equal to the Applicable Margin for Eurodollar Rate BorrowingsSOFR Loans effective for each day during any quarter times the daily amount available to be drawn under such Letter of Credit. For purposes of computing the daily amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with Section 1.04. Letter of Credit Fees shall be (i) due and payable on the first Business Day of each March, June, September and December, commencing with the first such date to occur after the issuance of such Letter of Credit, on the Letter of Credit Expiration Date and thereafter on demand, (ii) computed on a quarterly basis in arrears on the basis of a year of 360 days and (iii) payable for the actual number of days elapsed (including the first day but excluding the last day). If there is any change in the Applicable Margin during any quarter, the daily amount available to be drawn under each Letter of Credit shall be computed and multiplied by the Applicable Margin separately for each period during such quarter that such Applicable Margin was in effect. Notwithstanding anything to the contrary contained herein, upon the request of the Required Lenders, while any Event of Default exists, all Letter of Credit Fees shall accrue at the Default Rate. (i) Fronting Fee and Documentary and Processing Charges to L/C Issuers. Each Borrower shall pay directly to each L/C Issuer for its own account a fronting fee (i) with respect to each commercial Letter of Credit issued at the request of such Borrower, at the rate of 0.125 % per annum (or such lesser amount to any respective L/C Issuer as such Borrower may agree in writing with such L/C Issuer), computed on the amount of such Letter of Credit, and payable upon the issuance thereof, (ii) with respect to any amendment of a commercial Letter of Credit increasing the amount of such Letter of Credit issued at the request of such Borrower, at a rate separately agreed between such Borrower and the L/C Issuer, computed on the amount of such increase, and payable upon the effectiveness of such amendment, and (iii) with respect to each standby Letter of Credit issued at the request of such Borrower, at the rate of 0.125% per annum (or such lesser amount to any respective L/C Issuer as such Borrower may agree in writing with such L/C Issuer), computed on the daily amount available to be drawn under such Letter of Credit, and payable upon each Credit Event with respect thereto. In addition, each Borrower shall pay directly to the L/C Issuer for its own account the customary issuance, presentation, amendment and other processing fees, and other standard costs and charges, of the L/C Issuer relating to letters of credit requested by such Borrower as from time to time in effect. Such customary fees and standard costs and charges are due and payable on demand and are nonrefundable. The fees in this paragraph are referred to collectively as “L/C Issuer Fees”. (j) Conflict with Issuer Documents. In the event of any conflict between the terms hereof and the terms of any Issuer Document, the terms hereof shall control. (k) Letters of Credit Issued for Subsidiaries. Notwithstanding that a Letter of Credit issued or outstanding hereunder is in support of any obligations of, or is for the account of, a Subsidiary, 82 the applicable Borrower shall be obligated to reimburse the L/C Issuer hereunder for any and all drawings under such Letter of Credit in accordance with the terms hereof. Each Borrower hereby acknowledges that the issuance of Letters of Credit for the account of its Subsidiaries inures to the benefit of such Borrower, and that such Borrower’s business derives substantial benefits from the businesses of such Subsidiaries. (l) Reporting. Each L/C Issuer will report in writing to the Administrative Agent (i) on the first Business Day of each week, the aggregate face amount of Letters of Credit issued by it and outstanding as of the last Business Day of the preceding week, (ii) on or prior to each Business Day on which such L/C Issuer expects to issue, amend, renew or extend any Letter of Credit, the date of such issuance, amendment, renewal or extension and the aggregate face amount of Letters of Credit to be issued, amended, renewed or extended by it and outstanding after giving effect to such issuance, amendment, renewal or extension (and such L/C Issuer shall advise the Administrative Agent on such Business Day whether such issuance, amendment, renewal or extension occurred and whether the amount thereof changed), (iii) on each Business Day on which such L/C Issuer makes any L/C Borrowing, the date and amount of such L/C Borrowing and (iv) on any Business Day on which the applicable Borrower fails to reimburse an L/C Borrowing required to be reimbursed to such L/C Issuer on such day, the date and amount of such failure. (m) Standard of Care. Each L/C Issuer shall be deemed to have acted with due diligence and reasonable care if such L/C Issuer’s conduct is in accordance with Standard Letter of Credit Practice or in accordance with this Agreement. (n) Power of Attorney. Each Borrower irrevocably appoints the L/C Issuer of any commercial Letter of Credit as its attorney-in-fact and authorizes such L/C Issuer, without notice to Borrowers, to take such reasonable actions to execute and deliver ancillary documents and letters customary in the letter of credit business that may include but are not limited to advisements, indemnities, checks, bills of exchange and issuance documents. The power of attorney granted by the Borrowers is limited solely to such actions related to the issuance, confirmation or amendment of any commercial Letter of Credit and to ancillary documents or letters customary in the letter of credit business. This appointment is coupled with an interest. Section 2.06 Funding of Borrowings. (a) Each Revolving Facility Lender shall make each Revolving Facility Loan to be made by it hereunder on the proposed date thereof by wire transfer of immediately available funds by 12:00 p.m., Local Time, to the Administrative Agent’s Account; provided that Swing Line Revolving Facility Loans shall be made as provided in Section 2.04. The Administrative Agent will make such Revolving Facility Revolving Facility Loans available to the applicable Borrower by promptly crediting the amounts so received, in like funds, to an account of such Borrower as specified in the Revolving Facility Borrowing Request; provided that Revolving Facility Borrowings and Swing Line Borrowings made to finance the reimbursement in respect of Letters of Credit and Swing Line Revolving Facility Loans shall be remitted by the Administrative Agent to the applicable L/C Issuer or the Swing Line Revolving Facility Lender, as applicable. (b) Unless the Administrative Agent shall have received notice from a Revolving Facility Lender prior to the proposed date of any Borrowing that such Revolving Facility Lender will not make available to the Administrative Agent such Revolving Facility Lender’s share of such Borrowing, the Administrative Agent may assume that such Revolving Facility Lender has made such share available on such date in accordance with paragraph (a) of this Section 2.06 and may, in reliance upon such assumption, make available to the applicable Borrower a corresponding amount. In such event, if a


 
83 Revolving Facility Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Revolving Facility Lender and such Borrower severally and not jointly agree to pay to the Administrative Agent forthwith on demand (without duplication) such corresponding amount with interest thereon, for each day from and including the date such amount is made available to such Borrower to but excluding the date of payment to the Administrative Agent, at (i) in the case of such Revolving Facility Lender, the greater of (A) the Federal Funds Rate and (B) a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation or (ii) in the case of such Borrower, the interest rate applicable to Base Rate Revolving Facility Loans at such time. If such Revolving Facility Lender pays such amount to the Administrative Agent, then such amount shall constitute such Revolving Facility Lender’s Revolving Facility Loan included in such Borrowing. In the event such Borrower pays such amount to the Administrative Agent, then such amount shall reduce the principal amount of such Borrowing (but exclusive of any accrued and unpaid interest thereon). Section 2.07 Interest Elections. (a) Each Borrowing initially shall be of the Type specified in the applicable Revolving Facility Borrowing Request and, in the case of a Eurodollar Rate BorrowingSOFR Loan, shall have an initial Interest Period as specified in such Revolving Facility Borrowing Request or, if no Interest Period is specified in such Revolving Facility Borrowing Request, an initial Interest Period of one month’s duration. Thereafter, the applicable Borrower may elect to convert such Borrowing to a different Type or to continue such Borrowing and, in the case of a Eurodollar Rate BorrowingSOFR Loan, may elect Interest Periods therefor, all as provided in this Section. The applicable Borrower may elect different options with respect to different portions of the affected Borrowing, in which case each such portion shall be allocated ratably among the Lenders holding the Revolving Facility Loans comprising such Borrowing, and the Revolving Facility Loans comprising each such portion shall be considered a separate Borrowing. This Section shall not apply to Swing Line Borrowings which may not be converted or continued. (b) To make an election pursuant to this Section, the applicable Borrower shall notify the Administrative Agent of such election in writing (which may be delivered electronically) by the time that a Revolving Facility Borrowing Request would be required under Section 2.03 if such Borrower were requesting a Borrowing of the Type resulting from such election to be made on the effective date of such election. Each such Interest Election Request shall be irrevocable. (c) Each Interest Election Request shall be irrevocable and shall specify the following information in compliance with Section 2.02: (i) the name of the applicable Borrower and the Borrowing to which such Interest Election Request applies and, if different options are being elected with respect to different portions thereof, the portions thereof to be allocated to each resulting Borrowing (in which case the information to be specified pursuant to clauses (iii) and (iv) below shall be specified for each resulting Borrowing); (ii) the effective date of the election made pursuant to such Interest Election Request, which shall be a Business Day; (iii) whether the resulting Borrowing is to be a Base Rate Borrowing or a Eurodollar Rate BorrowingSOFR Loan; and 84 (iv) if the resulting Borrowing is a Eurodollar Rate BorrowingSOFR Loan, the Interest Period to be applicable thereto after giving effect to such election, which shall be a period contemplated by the definition of the term “Interest Period.” (v) If any such Interest Election Request requests a Eurodollar Rate BorrowingSOFR Loan but does not specify an Interest Period, then the applicable Borrower shall be deemed to have selected an Interest Period of one month’s duration. (d) Promptly following receipt of an Interest Election Request, the Administrative Agent shall advise each Lender to which such Interest Election Request relates of the details thereof and of such Lender’s portion of each resulting Borrowing. (e) If the applicable Borrower fails to deliver a timely Interest Election Request with respect to a Eurodollar Rate BorrowingSOFR Loan prior to the end of the Interest Period applicable thereto, then, unless such Borrowing is repaid as provided herein, at the end of such Interest Period such Borrowing shall be converted to a Base Rate Borrowing. Notwithstanding any contrary provision hereof, if an Event of Default has occurred and is continuing and the Administrative Agent, at the written request (including a request through electronic means) of the Required Lenders, so notifies the Borrowers, then, so long as an Event of Default is continuing (i) no outstanding Borrowing may be converted to or continued as a Eurodollar Rate BorrowingSOFR Loan and (ii) unless repaid, each Eurodollar Rate BorrowingSOFR Loan shall be converted to a Base Rate Borrowing at the end of the Interest Period applicable thereto. Section 2.08 Termination and Reduction of Revolving Facility Commitments. (a) Unless previously terminated, the Revolving Facility Commitments shall terminate on the Facility Maturity Date. (b) The Borrowers may at any time terminate or from time to time permanently reduce the Revolving Facility Commitments; provided that (i) each reduction of the Revolving Facility Commitments shall be in an amount that is an integral multiple of $5,000,000 and not less than $10,000,000 (or, if less, the remaining amount of the Revolving Facility Commitments), (ii) the Borrowers shall not terminate or reduce the Revolving Facility Commitments if, after giving effect to any concurrent prepayment of the Revolving Facility Loans in accordance with Section 2.11, the Revolving Facility Credit Exposure would exceed the Revolving Loan Limit, and (iii) it is after the Final Term Loan Funding Date and no Term Loans are outstanding. (c) The Borrowers shall notify the Administrative Agent of any election to terminate or permanently reduce the Revolving Facility Commitments under paragraph (b) of this Section 2.08 at least three Business Days prior to the effective date of such termination or reduction, specifying such election and the effective date thereof. Promptly following receipt of any notice, the Administrative Agent shall advise the Lenders of the contents thereof. Each notice delivered by the Borrowers pursuant to this Section shall be irrevocable; provided that, notwithstanding the foregoing, a notice of termination or reduction of the Revolving Facility Commitments delivered by the Borrowers may state that such notice is conditioned upon the happening or non-happening of one or more events, including, without limitation, the effectiveness of other credit facilities, receivables financing facilities or the consummation of a Change in Control, in which case such notice may be revoked by the Borrowers (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied. Any termination or reduction of the Commitments shall be permanent. Each reduction of the Commitments shall be made ratably among the Lenders in accordance with their respective Commitments. 85 Section 2.09 Agreement to Repay Loans; Evidence of Debt. (a) The Borrowers hereby unconditionally promise to pay (i) to the Administrative Agent for the account of each Revolving Facility Lender the then unpaid principal amount of each Revolving Facility Loan of such Lender on the Facility Maturity Date, (ii) to the Swing Line Lender the then unpaid principal amount of each Swing Line Loan on the Facility Maturity Date, and (iii) to the Administrative Agent for the account of each Term Loan Lender the then unpaid principal amount of each Term Loan of such Lender on the Facility Maturity Date. The Borrowers are jointly and severally liable for all ABL Credit Obligations. (b) Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of each Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder. (c) The Administrative Agent shall maintain accounts in which it shall record (i) the amount of each Loan made hereunder, the Type thereof and the Interest Period (if any) applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from each Borrower to each Lender hereunder and (iii) any amount received by the Administrative Agent hereunder for the account of the Lenders and each Lender’s share thereof. (d) The entries made in the accounts maintained pursuant to paragraph (b) or (c) of this Section 2.09 shall be prima facie evidence of the existence and amounts of the obligations recorded therein; provided that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of any Borrower to repay the Loans in accordance with the terms of this Agreement. (e) Any Lender may request that Loans made by it be evidenced by a promissory note (a “Note”). In such event, each Borrower shall prepare, execute and deliver to such Lender a promissory note payable to such Lender (or, if requested by such Lender, to such Lender and its registered assigns) in a form approved by the Administrative Agent and reasonably acceptable to such Borrower. Thereafter, the Loans evidenced by such promissory note and interest thereon shall at all times (including after assignment pursuant to Section 10.06) be represented by one or more promissory notes in such form payable to the order of the payee named therein (or, if such promissory note is a registered note, to such payee and its registered assigns). Section 2.10 Repayment of Loans. (a) To the extent not previously paid, outstanding Revolving Facility Loans and Term Loans shall be due and payable on the Facility Maturity Date. (b) Prior to any repayment of any Revolving Facility Loans, the Borrowers shall select the Borrowing or Borrowings under the Revolving Facility to be repaid and shall notify the Administrative Agent in writing (which may be delivered electronically) of such selection not later than 1:00 p.m., Local Time, (i) in the case of a Base Rate Borrowing, one Business Day before the scheduled date of such repayment and (ii) in the case of a Eurodollar Rate BorrowingSOFR Loan, three Business Days before the scheduled date of such repayment. Each repayment of a Borrowing shall be applied to the Revolving Facility Loans included in the repaid Borrowing such that each Revolving Facility Lender receives its ratable share of such repayment (based upon the respective Revolving Facility Credit Exposures of the Revolving Facility Lenders at the time of such repayment). Notwithstanding anything to the contrary in the immediately preceding sentence, prior to any repayment of a Swing Line Loan 86 hereunder, the Borrowers shall select the Borrowing or Borrowings to be repaid and shall notify the Administrative Agent in writing (which may be delivered electronically) of such selection not later than 1:00 p.m., Local Time, on the scheduled date of such repayment. Repayments of Eurodollar Rate BorrowingsSOFR Loans shall be accompanied by accrued interest on the amount repaid, together with any additional amounts required pursuant to Section 3.05. Section 2.11 Prepayment of Revolving Facility Loans and Term Loans. (a) Optional Prepayments. (i) The Borrowers shall have the right at any time and from time to time to prepay any Revolving Facility Loan in whole or in part, without premium or penalty (but subject to Section 3.05), in an aggregate principal amount that is an integral multiple of the Borrowing Multiple and not less than the Borrowing Minimum or, if less, the amount outstanding, subject to prior notice in accordance with Section 2.10(b), which notice shall be irrevocable except to the extent conditioned on the occurrence of one or more events, including, without limitation, a change of control or a refinancing of all or any portion of the Credit Facility. (ii) The Borrowers shall have the right at any time and from time to time, upon at least three (3) Business Days prior written notice to Administrative Agent, to prepay the aggregate outstanding principal amount of the Term Loans, in whole or in part, without premium or penalty (but subject to Section 3.05), in an aggregate principal amount of not less than $5,000,000 and increments of $1,000,000 in excess thereof, or, if less, the amount outstanding, subject to prior notice in accordance with Section 2.10(c), which notice shall be irrevocable except to the extent conditioned on the occurrence of one or more events, including, without limitation, a change of control or a refinancing of all or any portion of the Credit Facility, provided, that, with respect to, and after giving effect to, any such proposed prepayment of any principal amount of the Term Loans, on a Pro Forma basis, either (A) Availability is not less than 10.0% of Revolving Loan Limit and the Fixed Charge Coverage Ratio is not less than 1.00 to 1.00 or (B) Availability is equal to or greater than 12.5% of the Revolving Loan Limit. Each such prepayment shall be applied against the remaining installments of principal due (and including breakage or similar costs, if any) on the outstanding Term Loans as directed by Borrowers (for the avoidance of doubt, any amount that is due and payable on the Facility Maturity Date shall constitute an installment). (b) Mandatory Prepayments. (i) In the event and on each occasion that the total Revolving Facility Credit Exposure exceeds the lesser of (A) the Revolving Loan Limit and (B) the Borrowing Base in effect at such time (including any reduction of the Borrowing Base as a result of the receipt of Net Proceeds from a sale or other disposition of inventory or receivables outside the ordinary course of business as specified in clause (iii) of the last paragraph of Section 7.05; the Borrowers shall immediately prepay Revolving Facility Borrowings or Swing Line Borrowings (or, if no such Borrowings are outstanding, deposit Cash Collateral pursuant to Section 2.16) in an aggregate amount equal to such excess. (ii) In the event and on each occasion that the L/C Obligations exceed (A) the Letter of Credit Sublimit or (B) the lesser of the Revolving Loan Limit and the Borrowing Base in effect at such time (including any reduction of the Borrowing Base as a result of the receipt of Net Proceeds from a sale or other disposition of inventory or receivables outside the ordinary course of business as specified in clause (iii) of the last paragraph of Section 7.05), the Borrowers shall immediately deposit Cash Collateral pursuant to Section 2.16 in an amount equal to such excess.


 
87 (iii) In the event and on each occasion that the Swing Line Loans exceed (A) the Swing Line Sublimit or (B) the lesser of the Revolving Loan Limit and the Borrowing Base in effect at such time (including any reduction of the Borrowing Base as a result of the receipt of Net Proceeds from a sale or other disposition of inventory or receivables outside the ordinary course of business as specified in clause (iii) of the last paragraph of Section 7.05), the Borrowers shall immediately prepay Swing Line Borrowings in an aggregate amount equal to such excess. (iv) Subject to clause (v) below, in the event and on each occasion of the receipt by any Loan Party or any of its Subsidiaries of the Net Proceeds of any Asset Sale, of such Loan Party or Subsidiary, Borrowers shall promptly after such receipt, but in any event within five (5) Business Days after the receipt thereof), prepay the outstanding principal amount of the ABL Credit Obligations in an amount equal to 100% of such Net Proceeds received by such Person in connection with such sales or other dispositions; provided that, if no (A) Event of Default exists, (B) the monies are held in a Deposit Account in which Administrative Agent has a perfected first-priority security interest, and (C) the applicable Borrower shall deliver a certificate of a Responsible Officer of such Borrower to the Administrative Agent promptly following receipt of any such proceeds setting forth such Borrower’s intention to use any portion of such proceeds up to an amount not exceeding $100,000,000 in any fiscal year, to acquire, maintain, develop, construct, improve, upgrade or repair assets useful in the business of such Borrower and its Subsidiaries or to make investments in Permitted Business Acquisitions, in each case within 180 days of such receipt, such portion of such proceeds shall not constitute Net Proceeds except to the extent not, within 180 days of such receipt, so used or contractually committed to be so used (it being understood that if any portion of such proceeds are not so used within such 180 day period but within such 180 day period are contractually committed to be used, then, upon the termination of such contract, such remaining portion shall constitute Net Proceeds as of the date of such termination or expiry without giving effect to this proviso). Nothing contained in this Section 2.11(b)(iv) shall permit any Loan Party or any of its Subsidiaries to sell or otherwise dispose of any assets other than in accordance with Section 7.05. (v) Notwithstanding the foregoing, mandatory prepayments pursuant to clause (iv) above as to assets (a) constituting Eligible Equipment shall only be required to prepay ABL Credit Obligations if either (A) the fair market value of such Equipment exceeds $7,500,000 in any one case or $35,000,000 in the aggregate in any 12 month period or (B) after giving effect to such asset disposition or such casualty, the aggregate principal amount of the Term Loans is greater than 50% of the NOLV of the remaining Eligible Equipment in place as set forth in the most recent appraisal in form, scope and methodology and by an Acceptable Appraiser received by Administrative Agent pursuant to Section 6.11 in accordance with this Agreement and (b) constituting Revolving Loan Priority Collateral shall only be required to prepay ABL Credit Obligations to the extent Revolving Facility Credit Exposure exceeds the Loan Cap, including after giving effect to any reduction of the Borrowing Base as a result of the receipt of Net Proceeds from a sale or other disposition of inventory or receivables outside the ordinary course of business or from casualty event. Nothing contained in this Section 2.11(b)(v) shall limit any rights or remedies of the Collateral Agent upon the occurrence and during the continuance of an Accounts Availability Triggering Event in accordance with Section 6.12. (vi) In the event and on each occasion of the incurrence by any Loan Party or any of its Subsidiaries of any Indebtedness (other than Indebtedness permitted pursuant to Section7.01 (other than any Permitted Refinancing of the Credit Facility)), Borrowers shall immediately prepay the outstanding principal amount of the ABL Credit Obligations in an amount equal to 100% of the net proceeds received by such Person in connection with such incurrence. Nothing contained in this Section 2.11(b)(vi) shall permit any Loan Party or any of its Subsidiaries to incur any Indebtedness other than in accordance with Section 7.01. 88 (vii) In the event and on each occasion of the issuance by any Loan Party or any of its Subsidiaries of any Equity Interests upon the occurrence and during the continuance an Accounts Availability Triggering Event, (other than (A) in the event that any Borrower or any of its Subsidiaries forms any Subsidiary in accordance with the terms hereof, the issuance by such Subsidiary of Equity Interests to such Borrower or such Subsidiary, as applicable, (B) the issuance of Equity Interests by any Borrower or its Subsidiaries to any Person that is an equity holder of any Borrower or its Subsidiary prior to such issuance (a “Subject Holder”) so long as such Subject Holder did not acquire any Equity Interests of such Borrower or its Subsidiary so as to become a Subject Holder concurrently with, or in contemplation of, the issuance of such Equity Interests to such Subject Holder, (C) the issuance of Equity Interests of any Borrower or its Subsidiary to directors, officers or employees of such Borrower and its Subsidiaries pursuant to employee stock option plans (or other employee incentive plans or other compensation arrangements) approved by the Board of Directors, (D) any other issuance of Equity Interests otherwise permitted by clauses (a), (b), (c), (d), or (e) of Section 7.06 and (E) the issuance of Equity Interests by a Subsidiary of a Borrower to its parent or member in connection with the contribution by such parent or member to such Subsidiary of the proceeds of an issuance described in clauses (A) – (E) above), Borrowers shall immediately prepay the outstanding principal amount of the ABL Finance Obligations in an amount equal to 100% of the net proceeds received by such Person in connection with such issuance. Nothing contained in this Section 2.11(b)(vii) shall permit any Loan Party or any of its Subsidiaries to issue any Equity Interests otherwise prohibited by the terms of this Agreement. (c) Application of Payments. (i) Each prepayment pursuant to Section 2.11(b)(vi) and (vii) shall, (1) so long as no Application Event shall have occurred and be continuing, be applied, first, to the outstanding principal amount of the Revolving Facility Loans until paid in full, and second, to cash collateralize the Letters of Credit in an amount equal to 105% of the then outstanding Letter of Credit Usage, and (2) if an Application Event shall have occurred and be continuing, be applied in the manner set forth in Section 8.03(b) and (c). (ii) Each prepayment in respect of Net Proceeds in respect of Term Loan Priority Collateral pursuant to Sections 2.11(b)(iv) and (v), shall (A) so long as no Application Event shall have occurred and be continuing, be applied, first, to the outstanding principal amount of the Term Loan until paid in full, second, to the outstanding principal amount of the Revolving Facility Loans, until paid in full, and third, to Cash Collateralize the Letters of Credit in an amount equal to 105% of the then outstanding Letter of Credit Usage, and (B) if an Application Event shall have occurred and be continuing, be applied in the manner set forth in Section 8.03(c). Each such prepayment of the Term Loan shall be applied against the remaining installments of principal of the Term Loan in the inverse order of maturity (for the avoidance of doubt, any amount that is due and payable on the Facility Maturity Date shall constitute an installment). (iii) Each such prepayment of the Term Loan made pursuant to clauses 2.11(c) shall be applied against the remaining installments of principal of the Term Loan in the inverse order of maturity (for the avoidance of doubt, any amount that is due and payable on the Facility Maturity Date shall constitute an installment). Each such prepayment of the Revolving Facility Loans made pursuant to clause 2.11(c) shall not result in a permanent reduction of the Revolving Facility. Section 2.12 Fees. (a) The Borrowers shall pay to the Administrative Agent for the account of each Revolving Facility Lender (other than Defaulting Lenders), in accordance with each such Lender’s Revolving Facility Percentage, a quarterly commitment fee (the “Revolving Facility Commitment Fee”) 89 equal to the product of (i) the average daily Unutilized Revolving Commitments during each fiscal quarter (or, with respect to the following clause (ii)(B)(1), during the period specified therein), multiplied by (ii) (A) 0.25% per annum (with respect to each such period during which (x) the average daily Unutilized Revolving Commitments during i)such period divided by (y) the average daily Revolving Facility Commitments for such period is less than 50%) or (B) 0.375% per annum (with respect to (1) the period beginning on the Effective Date and ending on the last day of the first full fiscal quarter after the Closing Date and (2) thereafter, each such period during which (x) the average daily Unutilized Revolving Commitments during such period divided by (y) the average daily Revolving Facility Commitments for such period is greater than or equal to 50%), in each case subject to adjustment as provided in Section 2.17. For the avoidance of doubt, the Outstanding Amount of Swing Line Loans shall not be counted towards or considered usage of the aggregate Commitments for purposes of determining the Revolving Facility Commitment Fee. The Revolving Facility Commitment Fee shall accrue at all times during the Availability Period, including at any time during which one or more of the conditions in Article V is not met, and shall be due and payable quarterly in arrears on the first calendar day of each April, July, October and January, commencing with the first such date to occur after the Closing Date, and on the last day of the Availability Period. The Revolving Facility Commitment Fee shall be calculated quarterly in arrears, shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day). (b) The Borrowers from time to time agree to pay such Letter of Credit Fees and L/C Issuer Fees as specified in Section 2.05. (c) The Borrowers agree to pay to the Administrative Agent, for the account of the Administrative Agent, the agency fees set forth in the Engagement Letter, as amended, restated, supplemented or otherwise modified from time to time, at the times specified therein (the “Administrative Agent Fees”). (d) The Borrowers shall pay to the Administrative Agent for the account of each Term Loan Lender (other than Defaulting Lenders) having Term Loan Commitments in respect of the Term Loan Facility, in accordance with each such Lender’s Term Loan Facility Percentage, a monthly commitment fee (the “Term Loan Facility Fee”) equal to the product of (i) the Unutilized Term Loan Commitments multiplied by (ii) 0.50% per annum. The Term Loan Facility Fee shall accrue at all times prior to the and including the Final Term Loan Funding Date, including at any time during which one or more of the conditions in Article V is not met, and shall be due and payable monthly in arrears on the first calendar day of each month commencing with the first such date to occur after the Amendment No. 2 Effective Date, and on the effective date of the Term Loan Facility. The Term Loan Facility Fee shall be calculated monthly in arrears, shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day). (e) The Borrowers agree to pay to the Administrative Agent on the Closing Date the fees set forth in the Fee Letter. (f) All Fees shall be paid on the dates due, in immediately available funds, to the Administrative Agent for distribution, if and as applicable, among the Lenders, except that L/C Issuer Fees shall be paid directly to the applicable L/C Issuers. Once paid, none of the Fees shall be refundable under any circumstances (g) The Borrowers agree to pay to the Administrative Agent (for the benefit of Administrative Agent and the Lenders in accordance with the arrangements between them) the fees set forth in the Amendment No. 2 Fee Letter on the dates and in the amounts set forth therein. The Borrowers agree to pay (or cause to be paid) to the Administrative Agent, for the account of each of the 90 Term Loan Lenders in accordance with the agreements among them (as applicable), a funding fee equal to 0.30% of the aggregate principal amount of Term Loans funded by such Term Loan Lender on each Term Loan Funding Date (the “Term Loan Commitment Fee”), which Term Loan Commitment Fee shall be earned and due and payable in full on each such Term Loan Funding Date. Section 2.13 Interest. (a) (i) The Revolving Facility Loans comprising each Base Rate Borrowing (including each Swing Line Loan) shall bear interest at the Base Rate plus the Revolving Facility Base Rate Margin, and (ii) the Term Loans comprising each Base Rate Borrowing shall bear interest at the Base Rate plus the Term Loan Base Rate Margin. (a) Except as provided in Section 2.13(c) and Section 2.13(j), all Obligations (except for undrawn Letters of Credit) that have been charged to the Loan Account pursuant to the terms hereof shall bear interest as follows: (i) if the relevant Obligation is a SOFR Loan, at a per annum rate equal to Adjusted Term SOFR plus the SOFR Margin, and (ii) otherwise, at a per annum rate equal to the Base Rate plus the Base Rate Margin. (b) (i) The Revolving Facility Loans comprising each Eurodollar Rate Borrowing shall bear interest at the Adjusted Eurodollar Rate for the Interest Period in effect for such Revolving Facility Borrowing plus the Revolving Facility LIBOR Rate Margin, and (ii) The Revolving Facility Loans comprising each Eurodollar Rate Borrowing shall bear interest at the Adjusted Eurodollar Rate for the Interest Period in effect for such Term Loan Facility Borrowing plus the Term Loan LIBOR Rate Margin.In connection with the use or administration of Term SOFR, Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document. Administrative Agent will promptly notify Borrower and the Lenders of the effectiveness of any Conforming Changes in connection with the use or administration of Term SOFR. (c) Notwithstanding the foregoing, if any principal of or interest on any Loan or any Fees or other amount payable by any Borrower hereunder has not been paid when due, whether at stated maturity, upon acceleration or otherwise, such amount shall bear interest, after as well as before judgment, at a rate (the “Default Rate”) per annum equal to (i) in the case of overdue principal of any Loan, 2.0% plus the rate otherwise applicable to such Loan as provided in the preceding paragraphs of this Section 2.13 or (ii) in the case of any other amount, 2.0% plus the rate applicable to Base Rate Loans as provided in paragraph (a) of this Section; provided that this paragraph (c) shall not apply to any Event of Default that has been waived by the Lenders pursuant to Section 10.01. (d) Accrued interest on each Revolving Facility Loan shall be payable in arrears (i) on each Interest Payment Date for such Revolving Facility Loan(A) in the case of a SOFR Loan, on the last day of the Interest Period applicable thereto, and (B) in the case of a Base Rate Loan, the first day of each April, July, October and January, (ii) upon termination of the Revolving Facility Commitments and (iii) on the Facility Maturity Date; provided that (A) interest accrued pursuant to paragraph (c) of this Section 2.13 shall be payable on demand, (B) in the event of any repayment or prepayment of any Revolving Facility Loan (other than a prepayment of a Base Rate Revolving Facility Loan or a Swing Line Loan prior to the end of the Availability Period), accrued interest on the principal amount repaid or


 
91 prepaid shall be payable on the date of such repayment or prepayment and (C) in the event of any conversion of any Eurodollar RateSOFR Loan prior to the end of the current Interest Period therefor, accrued interest on such Loan shall be payable on the effective date of such conversion. (e) Accrued interest on each Term Loan shall be payable in arrears (i) on each Interest Payment Date for such Term Loan commencing with the first Interest Payment Date after such Term Loan is madethe last day of the Interest Period applicable thereto, and (ii) on the Facility Maturity Date; provided that (A) interest accrued pursuant to paragraph (c) of this Section 2.13 shall be payable on demand, (B) in the event of any repayment or prepayment of any Term Loan, accrued interest on the principal amount repaid or prepaid shall be payable on the date of such repayment or prepayment and (C) in the event of any conversion of any Eurodollar RateSOFR Loan prior to the end of the current Interest Period therefor, accrued interest on such Loan shall be payable on the effective date of such conversion. (f) All interest hereunder shall be computed on the basis of a year of 360 days, except that interest computed by reference to the Base Rate (including Base Rate Loans determined by reference to the Adjusted Eurodollar Rate) shall be computed on the basis of a year of 365 days (or 366 days in a leap year), and in each case shall be payable for the actual number of days elapsed (including the first day but excluding the last day). The applicable Base Rate, Adjusted Eurodollar Rate or Eurodollar Base Rate shall be determined by the Administrative Agent, and such determination shall be conclusive absent manifest error. (a) SOFR Option. In lieu of having interest charged at the rate based upon the Base Rate, Borrowers shall have the option, subject to Section 2.13(h) below (the “SOFR Option”) to have interest on all or a portion of the Revolving Facility Loans or the Term Loan be charged (whether at the time when made (unless otherwise provided herein), upon conversion from a Base Rate Loan to a SOFR Loan, or upon continuation of a SOFR Loan as a SOFR Loan) at a rate of interest based upon Adjusted Term SOFR. Interest on SOFR Loans shall be payable on the earliest of (i) the last day of the Interest Period applicable thereto; provided, that subject to the following clauses (ii) and (iii), in the case of any Interest Period greater than three months in duration, interest shall be payable at three month intervals after the commencement of the applicable Interest Period and on the last day of such Interest Period, (ii) the date on which all or any portion of the Obligations are accelerated pursuant to the terms hereof, or (iii) the date on which this Agreement is terminated pursuant to the terms hereof. On the last day of each applicable Interest Period, unless Borrowers have properly exercised the SOFR Option with respect thereto, the interest rate applicable to such SOFR Loan automatically shall convert to the rate of interest then applicable to Base Rate Loans of the same type hereunder. At any time that an Event of Default has occurred and is continuing, at the written election of Administrative Agent or the Required Lenders, Borrowers no longer shall have the option to request that Revolving Loans or any portion of the Term Loan bear interest at a rate based upon Adjusted Term SOFR. (b) SOFR Election. (i) Borrowers may, at any time and from time to time, so long as no Event of Default has occurred and is continuing, elect to exercise the SOFR Option by notifying Administrative Agent prior to 11:00 a.m. at least three U.S. Government Securities Business Days prior to the commencement of the proposed Interest Period (the “SOFR Deadline”). Notice of Borrowers’ election of the SOFR Option for a permitted portion of the Revolving Facility Loans or the Term Loan and an Interest Period pursuant to this Section shall be made by delivery to Administrative Agent of a SOFR Notice received by Administrative Agent before the SOFR Deadline. Promptly upon its receipt of each such SOFR Notice, Administrative Agent shall provide a notice thereof to each of the affected Lenders. 92 (ii) Each SOFR Notice shall be irrevocable and binding on Borrowers. In connection with each SOFR Loan, each Borrower shall indemnify, defend, and hold Administrative Agent and the Lenders harmless against any loss, cost, or expense actually incurred by Administrative Agent or any Lender as a result of (A) the payment or required assignment of any principal of any SOFR Loan other than on the last day of an Interest Period applicable thereto (including as a result of an Event of Default), (B) the conversion of any SOFR Loan other than on the last day of the Interest Period applicable thereto, or (C) the failure to borrow, convert, continue or prepay any SOFR Loan on the date specified in any SOFR Notice delivered pursuant hereto (such losses, costs, or expenses, “Funding Losses”). (iii) A certificate of Administrative Agent or a Lender delivered to Borrowers setting forth in reasonable detail any amount or amounts that Administrative Agent or such Lender is entitled to receive pursuant to this Section 2.13 shall be conclusive absent manifest error. Borrowers shall pay such amount to Administrative Agent or the Lender, as applicable, within 30 days of the date of its receipt of such certificate. If a payment of a SOFR Loan on a day other than the last day of the applicable Interest Period would result in a Funding Loss, Administrative Agent may, in its sole discretion at the request of Borrowers, hold the amount of such payment as cash collateral in support of the Obligations until the last day of such Interest Period and apply such amounts to the payment of the applicable SOFR Loan on such last day of such Interest Period, it being agreed that Administrative Agent has no obligation to so defer the application of payments to any SOFR Loan and that, in the event that Administrative Agent does not defer such application, Borrowers shall be obligated to pay any resulting Funding Losses. (iv) Unless Administrative Agent, in its sole discretion, agrees otherwise, Borrowers shall have not more than five SOFR Loans in effect at any given time. Borrowers may only exercise the SOFR Option for proposed SOFR Loans of at least $1,000,000. (c) Conversion; Prepayment. Borrowers may convert SOFR Loans to Base Rate Loans or prepay SOFR Loans at any time; provided, that in the event that SOFR Loans are converted or prepaid on any date that is not the last day of the Interest Period applicable thereto, including as a result of any prepayment through the required application by Administrative Agent of any payments or proceeds of Collateral in accordance with Section 2.4(b) or for any other reason, including early termination of the term of this Agreement or acceleration of all or any portion of the Obligations pursuant to the terms hereof, each Borrower shall indemnify, defend, and hold Administrative Agent and the Lenders and their Participants harmless against any and all Funding Losses in accordance with Section 2.13(h)(ii). (d) Special Provisions Applicable to Adjusted Term SOFR. (i) Adjusted Term SOFR may be adjusted by Administrative Agent with respect to any Lender on a prospective basis to take into account any additional or increased costs (other than Taxes which shall be governed by Section 3.01), in each case, due to changes in applicable law occurring subsequent to the commencement of the then applicable Interest Period, or pursuant to any Change in Law or change in the reserve requirements imposed by the Board, which additional or increased costs would increase the cost of funding or maintaining loans bearing interest at Adjusted Term SOFR. In any such event, the affected Lender shall give Borrowers and Administrative Agent notice of such a determination and adjustment and Administrative Agent promptly shall transmit the notice to each other Lender and, upon its receipt of the notice from the affected Lender, Borrowers may, by notice to such affected Lender (A) require such Lender to furnish to Borrowers a statement setting forth in reasonable detail the basis for adjusting Adjusted Term SOFR and the method for determining the amount of such adjustment, or (B) repay the SOFR Loans or Base Rate Loans determined with reference to Adjusted Term SOFR, in each case, of such Lender with respect to which such adjustment is made (together with any amounts due under Section 2.13(h)(ii)). 93 (ii) Subject to the provisions set forth in Section 2.13(j)(iii) below, in the event that any change in market conditions or any Change in Law shall at any time after the date hereof, in the reasonable opinion of any Lender, make it unlawful or impractical for such Lender to fund or maintain SOFR Loans (or Base Rate Loans determined with reference to Adjusted Term SOFR) or to continue such funding or maintaining, or to determine or charge interest rates at the Term SOFR Reference Rate, Adjusted Term SOFR, Term SOFR or SOFR, such Lender shall give notice of such changed circumstances to Administrative Agent and Borrowers and Administrative Agent promptly shall transmit the notice to each other Lender and (y)(i) in the case of any SOFR Loans of such Lender that are outstanding, such SOFR Loans of such Lender will be deemed to have been converted Base Rate Loans on the last day of the Interest Period of such SOFR Loans, if such Lender may lawfully continue to maintain such SOFR Loans, or immediately, if such Lender may not lawfully continue to maintain such SOFR Loans, and thereafter interest upon the SOFR Loans of such Lender thereafter shall accrue interest at the rate then applicable to Base Rate Loans (and if applicable, without reference to the Adjusted Term SOFR component thereof) and (ii) in the case of any such Base Rate Loans of such Lender that are outstanding and that are determined with reference to Adjusted Term SOFR, interest upon the Base Rate Loans of such Lender after the date specified in such Lender’s notice shall accrue interest at the rate then applicable to Base Rate Loans without reference to the Adjusted Term SOFR component thereof and (z) Borrowers shall not be entitled to elect the SOFR Option and Base Rate Loans shall not be determined with reference to the Adjusted Term SOFR component thereof, in each case, until such Lender determines that it would no longer be unlawful or impractical to do so. (iii) (g) Benchmark Replacement Setting. (A) (i) (A) Benchmark Replacement. Notwithstanding anything to the contrary herein or in any other Loan Document (and any Secured Hedge Agreement shall be deemed not to be a “Loan Document” for purposes of this Section 2.13(g)) if, upon the occurrence of a Benchmark Transition Event or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of, Administrative Agent and Borrower may amend this Agreement to replace the then-current Benchmark, then (x) if with a Benchmark Replacement is determined in accordance with clause (a)(i) or (a)(ii) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document and (y) if a Benchmark Replacement is determined in accordance with clause (a)(iii) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5:00 p.m. (New York City time). Any such amendment with respect to a Benchmark Transition Event will become effective at 5:00 p.m. on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as theAdministrative Agent has posted such proposed amendment to all affected Lenders and Borrower so long as Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacementamendment from Lenders comprising the Required Lenders. No replacement of a Benchmark with a Benchmark Replacement pursuant to this Section 2.13(j)(iii) will occur prior to the applicable Benchmark Transition Start Date. (B) Notwithstanding anything to the contrary herein or in any other Loan Document, if a Term SOFR Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then the applicable Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder or under any 94 Loan Document in respect of such Benchmark setting and subsequent Benchmark settings, without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document; provided that this clause (B) shall not be effective unless the Administrative Agent has delivered to the Lenders and the Borrowers a Term SOFR Notice. For the avoidance of doubt, the Administrative Agent shall not be required to deliver a Term SOFR Notice after a Term SOFR Transition Event and may elect or not elect to do so in its sole discretion. (B) (ii) Benchmark Replacement Conforming Changes. In connection with the use, administration, adoption or implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document. (C) (iii) Notices; Standards for Decisions and Determinations. The Administrative Agent will promptly notify the BorrowersBorrower and the Lenders of (A) any occurrence of a Benchmark Transition Event, a Term SOFR Transition Event or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date, (B1) the implementation of any Benchmark Replacement, and (C2) the effectiveness of any Benchmark Replacement Conforming Changes, (D) in connection with the use, administration, adoption or implementation of a Benchmark Replacement. Administrative Agent will notify Borrower of (x) the removal or reinstatement of any tenor of a Benchmark pursuant to Section 2.13(gj)(iviii) below(D) and (Ey) the commencement or conclusion of any Benchmark Unavailability Period. Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section 2.13(gj)(iii), including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party to this Agreement or any other Loan Document, except, in each case, as expressly required pursuant to this Section 2.13(gj)(iii). (D) (iv) Unavailability of Tenor of Benchmark. Notwithstanding anything to the contrary herein or in any other Loan Document, at any time (including in connection with the implementation of a Benchmark Replacement), (A1) if the then-current Benchmark is a term rate (including the Term SOFR or USD LIBORReference Rate) and either (1I) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (2II) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is not or will be no longernot be representative, then the Administrative Agent may in consultation with the Borrowers modify the definition of “Interest Period” (or any similar or analogous definition) for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor and (B2) if a tenor that was removed pursuant to clause (A1) above either (1I) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (2II) is not, or is no longer, subject to an announcement that it is not or will no longernot be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent may modify the definition of “Interest Period” (or any similar or analogous definition) for all Benchmark settings at or after such time to reinstate such previously removed tenor. (E) (v) Benchmark Unavailability Period. Upon the Borrowers’Borrower’s receipt of notice of the commencement of a Benchmark Unavailability Period, the Borrowers(1) Borrower may revoke any pending request for a borrowing of, conversion to or continuation of Eurodollar RateSOFR Loans to be made, converted or continued during any Benchmark


 
95 Unavailability Period and, failing that, the Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to Base Rate Loans and (2) any outstanding affected SOFR Loans will be deemed to have been converted to Base Rate Loans at the end of the applicable Interest Period. During any Benchmark Unavailability Period or at any time that a tenor for the then- current Benchmark is not an Available Tenor, the component of the Base Rate based upon the then- current Benchmark or such tenor for such Benchmark, as applicable, will not be used in any determination of the Base Rate. (e) No Requirement of Matched Funding. Anything to the contrary contained herein notwithstanding, neither Administrative Agent, nor any Lender, nor any of their Participants, is required actually to match fund any Obligation as to which interest accrues at Adjusted Term SOFR or the Term SOFR Reference Rate. Section 2.14 Payments Generally; Pro Rata Treatment; Sharing of Setoffs. (a) Unless otherwise specified, the applicable Borrower shall make each payment required to be made by it hereunder (whether of principal, interest, fees or reimbursement of L/C Obligations, or of amounts payable under Section 3.01, 3.04 or 3.05, or otherwise) prior to 2:00 p.m., Local Time, on the date when due, in immediately available funds, without condition or deduction for any defense, recoupment, set off or counterclaim. Any amounts received after such time on any date may, in the discretion of the Administrative Agent, be deemed to have been received on the next succeeding Business Day for purposes of calculating interest thereon. All such payments shall be made to the Administrative Agent to the Administrative Agent’s Account, except payments to be made directly to the applicable L/C Issuer or the Swing Line Lender as expressly provided herein and except that payments pursuant to Sections 3.01, 3.04, 3.05 and 10.04 may be made directly to the persons entitled thereto. The receipt of any payment item by the Administrative Agent shall not be required to be considered a payment on account unless such payment item is a wire transfer of immediately available funds made to the Administrative Agent’s Account or unless and until such payment item is honored when presented for payment. Should any payment item not be honored when presented for payment, then Borrowers shall be deemed not to have made such payment. The Administrative Agent shall distribute any such payments received by it for the account of any other person to the appropriate recipient promptly following receipt thereof. If any payment hereunder shall be due on a day that is not a Business Day, the date for payment shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest, interest thereon shall be payable for the period of such extension. All payments under the Loan Documents shall be made in Dollars. Any payment required to be made by the Administrative Agent hereunder shall be deemed to have been made by the time required if the Administrative Agent shall, at or before such time, have taken the necessary steps to make such payment in accordance with the regulations or operating procedures of the clearing or settlement system used by the Administrative Agent to make such payment. (b) If at any time insufficient funds are received by and available to the Administrative Agent from any Borrower to pay fully all amounts of principal, unreimbursed L/C Obligations, interest and fees then due from such Borrower hereunder, such funds shall be applied (i) first, towards payment of interest and fees then due from such Borrower hereunder, ratably among the parties entitled thereto in accordance with the amounts of interest and fees then due to such parties, (ii) second, towards payment of principal of Swing Line Loans and unreimbursed L/C Obligations then due from such Borrower hereunder, ratably among the parties entitled thereto in accordance with the amounts of principal and unreimbursed L/C Obligations then due to such parties and (iii) third, towards payment of principal of Revolving Facility Loans then due from such Borrower hereunder, ratably among the parties entitled thereto in accordance with the amounts of principal then due to such parties. 96 (c) If any Lender shall, by exercising any right of setoff or counterclaim or otherwise, obtain payment in respect of (i) ABL Credit Obligations due and payable to such Lender hereunder and under the other Loan Documents at such time in excess of its ratable share (according to the proportion of (x) the amount of such ABL Credit Obligations due and payable to such Lender at such time to (y) the aggregate amount of the ABL Credit Obligations due and payable to all Lenders hereunder and under the other Loan Documents at such time) of payments on account of the ABL Credit Obligations due and payable to all Lenders hereunder and under the other Loan Documents at such time or (ii) ABL Credit Obligations owing (but not due and payable) to such Lender hereunder and under the other Loan Documents at such time in excess of its ratable share (according to the proportion of (x) the amount of such ABL Credit Obligations owing (but not due and payable) to such Lender at such time to (y) the aggregate amount of the ABL Credit Obligations owing (but not due and payable) to all Lenders hereunder and under the other Loan Parties at such time) of payment on account of the ABL Credit Obligations owing (but not due and payable) to all Lenders hereunder and under the other Loan Documents at such time, then the Lender receiving such greater proportion shall (A) notify the Administrative Agent of such fact, and (B) purchase (for cash at face value) participations in the Loans and sub-participations in L/C Obligations and Swing Line Loans of the other Lenders, or make such other adjustments as shall be equitable, so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of ABL Credit Obligations then due and payable to the Lenders or owing (but not due and payable) to the Lenders, as the case may be, provided that: (d) if any such participations or sub-participations are purchased and all or any portion of the payment giving rise thereto is recovered, such participations or sub-participations shall be rescinded and the purchase price restored to the extent of such recovery, without interest; and (e) the provisions of this Section shall not be construed to apply to (A) any payment made by or on behalf of any Borrower pursuant to and in accordance with the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender), (B) the application of Cash Collateral provided for in Section 2.16 or (C) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or sub-participations in L/C Obligations or Swing Line Loans to any assignee or participant. (f) Each Borrower consents to this Section 2.14(c) and agrees, to the extent it may effectively do so under applicable Law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against any Loan Party rights of setoff and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of such Loan Party in the amount of such participation. (g) Unless the Administrative Agent shall have received notice from the applicable Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or the L/C Issuer hereunder that such Borrower will not make such payment, the Administrative Agent may assume that such Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders the amount due. In such event, if such Borrower has not in fact made such payment, then each of the Lenders severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender in immediately available funds with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation. (h) Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any Borrowing of Eurodollar RateSOFR Loans (or, in the case of any Borrowing 97 of Base Rate Loans, prior to 12:00 noon, Local Time, on the date of such Borrowing) that such Lender will not make available to the Administrative Agent such Lender’s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with Section 2.02 (or, in the case of a Borrowing of Base Rate Loans, that such Lender has made such share available in accordance with and at the time required by Section 2.02) and may, in reliance upon such assumption, make available to the applicable Borrower a corresponding amount. In such event, if a Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and such Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount in immediately available funds with interest thereon, for each day from and including the date such amount is made available to such Borrower to but excluding the date of payment to the Administrative Agent, at (A) in the case of a payment to be made by such Lender, the greater of the Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation, plus any administrative, processing or similar fees customarily charged by the Administrative Agent in connection with the foregoing, and (B) in the case of a payment to be made by such Borrower, the interest rate applicable to Base Rate Loans. If such Borrower and such Lender shall pay such interest to the Administrative Agent for the same or an overlapping period, the Administrative Agent shall promptly remit to such Borrower the amount of such interest paid by such Borrower for such period. If such Lender pays its share of the applicable Borrowing to the Administrative Agent, then the amount so paid shall constitute such Lender’s Loan included in such Borrowing. Any payment by a Borrower shall be without prejudice to any claim such Borrower may have against a Lender that shall have failed to make such payment to the Administrative Agent. Section 2.15 Term Loans. (a) Subject to the terms and conditions set forth herein each Term Loan Lender severally and not jointly agrees to make term loans to the Borrowers in Dollars from time to time, on any Business Day prior to and including the Final Term Loan Funding Date, subject to satisfaction (or waiver by all such Lenders having Term Loan Commitments of the conditions precedent set forth in Section 5.01 and in accordance with the procedures in Section 2.15(f), upon written request by the Borrowers; provided, that, in addition, after giving effect to the making of any Term Loan, each of the following conditions is satisfied: (i) after the making of such Term Loan, the aggregate Term Loan Exposure of all Lenders shall not exceed the Term Loan Amount, (ii) the Term Loan Exposure of any Term Loan Lender shall not exceed such Lender’s original Term Loan Commitment, (iii) such Term Loans may be made on no more than three (3) occasions on or prior to the Term Loan Commitment Expiration Date. Once repaid, whether such repayment is voluntary or required, no portion of the any Term Loans may be reborrowed. Term Loans may be Base Rate Loans or Eurodollar RateSOFR Loans, as further provided herein. Each Term Loan shall be made as part of a request received pursuant to Section 2.15(f) consisting of Term Loans under the Term Loan Facility and of the same Type made by the Term Loan Lenders ratably in accordance with their respective Term Loan Commitments; provided, however, that Term Loans shall be made by Term Loan Lenders ratably in accordance with their respective Term Loan Facility Percentages on the date such Term Loans are made hereunder. The failure of any Term Loan Lender to make any Term Loan required to be made by it shall not relieve any other Term Loan Lender of its obligations hereunder; provided that the Term Loan Commitments of the Term Loan Lenders are several and no Term Loan Lender shall be responsible for any other Term Loan Lender’s failure to make Term Loans as required. (b) Term Loans will be repaid in consecutive equal quarterly installments of principal, commencing July 1, 2021, with each installment of principal (other than the final installment) in an amount equal to the aggregate principal amount of the Term Loans outstanding on the Final Term Loan Funding Date (and after giving effect to any Term Loans made on such date) divided by 21, with the 98 first installment payable on such date and each installment thereafter payable on the first day of each fiscal quarter, with the final installment to be in the then remaining aggregate principal balance of the Term Loans (and including principal, accrued and unpaid interest and other amounts) due on the earlier of the Facility Maturity Date or the termination of the Credit Facility. (c) Subject to Section 3.03, each request of Borrower made to the Administrative Agent for Term Loans shall be comprised entirely of Base Rate Loans or Eurodollar RateSOFR Loans as a Borrower may request in accordance herewith. Each Lender at its option may make any Base Rate Loan or Eurodollar RateSOFR Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Term Loan; provided that any exercise of such option shall not affect the obligation of such Borrower to repay such Term Loan in accordance with the terms of this Agreement and such Lender shall not be entitled to any amounts payable under Section 3.01 or 3.04 solely in respect of increased costs resulting from such exercise and existing at the time of such exercise. (d) At the commencement of each Interest Period for any Term Loan denominated as Eurodollar RateSOFR Loan, such Term Loan shall be in an aggregate amount that is an integral multiple of the $5,000,000 and multiples of $1,000,000. At the time that each Base Rate Borrowing is made, such Borrowing shall be in an aggregate minimum of $5,000,000 and multiples of $1,000,000 in excess thereof; provided that Term Loans of more than one Type may be outstanding at the same time; provided that there shall not at any time be more than a total of three (3) Term Loans which Eurodollar Rate BorrowingsSOFR Loans outstanding under the Term Loan Facility. (e) Notwithstanding any other provision of this Agreement, no Borrower shall be entitled to request, or to elect to convert or continue, any Term Loan if the Interest Period requested with respect thereto would end after the Facility Maturity Date. (f) To request a Term Loan Facility Borrowing, the applicable Borrower shall notify the Administrative Agent of such request in writing by delivery of a Term Loan Request (which may be delivered through Administrative Agent’s electronic platform or portal) not less than five (5) Business Days prior to the requested borrowing date. All Term Loan Requests which are not made on-line via Administrative Agent’s electronic platform or portal shall be subject to (and unless Administrative Agent elects otherwise in the exercise of its sole discretion, such Borrowings shall not be made until the completion of) a customary authentication process by the Administrative Agent (with results reasonably satisfactory to Administrative Agent) prior to the funding of any such requested Term Loan. Each such Term Loan Request shall be irrevocable and shall specify the following information in compliance with Section 2.02: (i) the name of the applicable Borrower; (ii) the aggregate amount of (A) the requested Term Loans (the principal amount of Term Loans requested may not be less than $50,000,000 in the aggregate) and (B) the aggregate Term Loan Exposure (after giving effect to the requested Term Loans); (iii) the date of such Term Loans are to be made, which shall be a Business Day; (iv) whether such Term Loans are to be a Base Rate Borrowing or a Eurodollar Rate BorrowingSOFR Loan;


 
99 (v) in the case of a Eurodollar RateSOFR Loans, the initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term “Interest Period”; and (vi) the location and number of such Borrower’s account to which funds are to be disbursed. If such Borrower fails to specify a Type of Term Loan in a Term Loan Request or if such Borrower fails to give a timely notice requesting a conversion or continuation, then the Term Loans shall be made as, or converted to, Base Rate Loans. Any such automatic conversion to Base Rate Loans shall be effective as of the last day of the Interest Period then in effect with respect to the applicable Eurodollar RateSOFR Loans. If no Interest Period is specified with respect to any requested Eurodollar Rate BorrowingSOFR Loan, then such Borrower shall be deemed to have selected an Interest Period of one month’s duration. Promptly following receipt of a Term Loan Request in accordance with this Section, the Administrative Agent shall advise each Term Loan Lender of the details thereof and of the amount of such Lender’s Term Loan to be made as part of the request. Section 2.16 Cash Collateral. (a) Certain Credit Support Events. If (i) an L/C Issuer has honored any full or partial drawing request under any Letter of Credit and such drawing has resulted in an L/C Borrowing, (ii) as of the Letter of Credit Expiration Date, any L/C Obligation for any reason remains outstanding, (iii) the Borrowers shall be required to provide Cash Collateral pursuant to Section 8.01, or (iv) there shall exist a Defaulting Lender, the Borrowers shall immediately (in the case of clause (iii) above) or within one Business Day (in all other cases) following any request by the Administrative Agent or the L/C Issuer, provide Cash Collateral in an amount not less than the applicable Minimum Collateral Amount (determined in the case of Cash Collateral provided pursuant to clause (iv) above, after giving effect to Section 2.17(a)(iv) and any Cash Collateral provided by the Defaulting Lender). (b) Grant of Security Interest. Each Borrower, and to the extent provided by any Defaulting Lender, such Defaulting Lender, hereby grants to (and subjects to the control of) the Administrative Agent, for the benefit of the Administrative Agent, the L/C Issuers and the Lenders, and agrees to maintain, a first priority security interest in all such cash, deposit accounts and all balances therein, and all other property so provided as collateral pursuant hereto, and in all proceeds of the foregoing, all as security for the obligations to which such Cash Collateral may be applied pursuant to subsection (c) below. If at any time the Administrative Agent determines that Cash Collateral is subject to any right or claim of any Person other than the Administrative Agent or an L/C Issuer as herein provided, or that the total amount of such Cash Collateral is less than the Minimum Collateral Amount, the Borrowers will, promptly upon demand by the Administrative Agent, pay or provide to the Administrative Agent additional Cash Collateral in an amount sufficient to eliminate such deficiency. All Cash Collateral (other than credit support not constituting funds subject to deposit) shall be maintained in one or more Controlled Accounts held with Wells Fargo. The Borrowers shall pay on demand therefor from time to time all customary account opening, activity and other administrative fees and charges in connection with the maintenance and disbursement of Cash Collateral. (c) Application. Notwithstanding anything to the contrary contained in this Agreement, Cash Collateral provided under any of this Section 2.16 or Sections 2.04, 2.05, 2.17 or Section 8.01 in respect of Letters of Credit shall be held and applied to the satisfaction of the specific L/C Obligations, obligations to fund participations therein (including, as to Cash Collateral provided by a Defaulting Lender, any interest accrued on such obligation) and other obligations for which the Cash 100 Collateral was so provided, prior to any other application of such property as may otherwise be provided for herein. (d) Release. Cash Collateral (or the appropriate portion thereof) provided to reduce Fronting Exposure or to secure other obligations shall be released promptly following (i) the elimination of the applicable Fronting Exposure or other obligations giving rise thereto (including by the termination of Defaulting Lender status of the applicable Lender (or, as appropriate, its assignee following compliance with Section 10.06(b)(vi))) or (ii) the determination by the Administrative Agent and the applicable L/C Issuer that there exists excess Cash Collateral; provided, however, (x) any such release shall be without prejudice to, and any disbursement or other transfer of Cash Collateral shall be and remain subject to, any other Lien conferred under the Loan Documents and the other applicable provisions of the Loan Documents, and (y) the Person providing Cash Collateral and the applicable L/C Issuer may agree that Cash Collateral shall not be released but instead held to support future anticipated Fronting Exposure or other obligations. Section 2.17 Defaulting Lenders. (a) Adjustments. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as that Lender is no longer a Defaulting Lender, to the extent permitted by applicable Law: (i) Waivers and Amendments. Such Defaulting Lender’s right to approve or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as set forth in the definition of “Required Lenders” and Section 10.01. (ii) Defaulting Lender Waterfall. Any payment of principal, interest, fees, indemnity payments or other amounts received by the Administrative Agent for the account of such Defaulting Lender (whether voluntary or mandatory, at maturity, pursuant to Article VIII or otherwise) or received by the Administrative Agent from a Defaulting Lender pursuant to Section 10.09 shall be applied at such time or times as may be determined by the Administrative Agent as follows: first, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder; second, to the payment on a pro rata basis of any amounts owing by such Defaulting Lender to any L/C Issuer or Swing Line Lender hereunder; third, to Cash Collateralize the L/C Issuer’s Fronting Exposure with respect to such Defaulting Lender in accordance with Section 2.16; fourth, as the Borrowers may request (so long as no Default or Event of Default exists), to the funding of any Loan in respect of which such Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent; fifth, if so determined by the Administrative Agent and the Borrowers, to be held in a deposit account and released pro-rata in order to (x) satisfy such Defaulting Lender’s potential future funding obligations with respect to Loans under this Agreement and (y) Cash Collateralize the L/C Issuer’s future Fronting Exposure with respect to such Defaulting Lender with respect to future Letters of Credit issued under this Agreement, in accordance with Section 2.16; sixth, to the payment of any amounts owing to the Lenders, the L/C Issuers or the Swing Line Lender as a result of any judgment of a court of competent jurisdiction obtained by any Lender, any L/C Issuer or the Swing Line Lender against such Defaulting Lender as a result of such Defaulting Lender’s breach of its obligations under this Agreement; seventh, so long as no Default or Event of Default exists, to the payment of any amounts owing to any Borrower as a result of any final, non-appealable judgment of a court of competent jurisdiction obtained by such Borrower against such Defaulting Lender as a result of such Defaulting Lender's breach of its obligations under this Agreement; and eighth, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction; provided that if (x) such payment is a payment of the principal amount of any Loans or L/C Borrowings in respect of which such Defaulting Lender has not fully funded its appropriate share, and (y) such Loans were made or the related Letters of Credit were 101 issued at a time when the conditions set forth in Section 5.01 were satisfied or waived, such payment shall be applied solely to pay the Loans of, and L/C Obligations owed to, all Non-Defaulting Lenders on a pro rata basis prior to being applied to the payment of any Loans of, or L/C Obligations owed to, such Defaulting Lender until such time as all Loans and funded and unfunded participations in L/C Obligations and Swing Line Loans are held by the Lenders pro-rata in accordance with the Commitments hereunder without giving effect to Section 2.17(a)(iv). Any payments, prepayments or other amounts paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender or to post Cash Collateral pursuant to this Section 2.17(a)(ii) shall be deemed paid to and redirected by such Defaulting Lender, and each Lender irrevocably consents hereto. (iii) Certain Fees. (A) No Defaulting Lender shall be entitled to any Revolving Facility Commitment Fee for any period during which that Lender is a Defaulting Lender (and no Borrower shall be required to pay any such fee that otherwise would have been required to have been paid to that Defaulting Lender). (B) Each Defaulting Lender shall be entitled to receive Letter of Credit Fees for any period during which that Lender is a Defaulting Lender only to the extent allocable to its Revolving Facility Percentage of the stated amount of Letters of Credit for which it has provided Cash Collateral pursuant to Section 2.16. (C) With respect to any fee payable under Section 2.12(a) or any Letter of Credit Fee not required to be paid to any Defaulting Lender pursuant to clause (A) or (B) above, the applicable Borrower shall (x) pay to each Non-Defaulting Lender that portion of any such fee otherwise payable to such Defaulting Lender with respect to such Defaulting Lender’s participation in L/C Obligations or Swing Line Loans that has been reallocated to such Non-Defaulting Lender pursuant to clause (iv) below, (y) pay to the applicable L/C Issuers and Swing Line Lender, as applicable, the amount of any such fee otherwise payable to such Defaulting Lender to the extent allocable to such L/C Issuers’ or Swing Line Lender’s Fronting Exposure to such Defaulting Lender and (z) not be required to pay the remaining amount of any such fee. (iv) Reallocation of Revolving Facility Percentages to Reduce Fronting Exposure. All or any part of such Defaulting Lender’s participation in L/C Obligations and Swing Line Loans shall be reallocated among the Non-Defaulting Lenders in accordance with their respective Revolving Facility Percentages (calculated without regard to such Defaulting Lender’s Revolving Facility Commitment) but only to the extent that (x) the conditions set forth in Section 5.01 are satisfied at the time of such reallocation (and, unless the applicable Borrower shall have otherwise notified the Administrative Agent at such time, such Borrower shall be deemed to have represented and warranted that such conditions are satisfied at such time), and (y) such reallocation does not cause the aggregate Revolving Facility Credit Exposure of any Non-Defaulting Lender to exceed such Non-Defaulting Lender’s Revolving Facility Commitment. Subject to Section 10.24, no reallocation hereunder shall constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender arising from that Lender having become a Defaulting Lender, including any claim of a Non-Defaulting Lender as a result of such Non-Defaulting Lender’s increased exposure following such reallocation. (v) Cash Collateral, Repayment of Swing Line Loans. If the reallocation described in clause (a)(iv) above cannot, or can only partially, be effected, the applicable Borrower shall, without prejudice to any right or remedy available to it hereunder or under applicable Law, (x) first, prepay Swing Line Loans in an amount equal to the Swing Line Lender’s Fronting Exposure and (y) 102 second, Cash Collateralize the L/C Issuers’ Fronting Exposure in accordance with the procedures set forth in Section 2.16. (b) Defaulting Lender Cure. If each Borrower, the Administrative Agent, the Swing Line Lender and one or more applicable L/C Issuers, in their sole discretion, agree in writing that a Lender is no longer a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any Cash Collateral), that Lender will, to the extent applicable, purchase that portion of outstanding Loans of the other Lenders or take such other actions as the Administrative Agent may determine to be necessary to cause the Loans and funded and unfunded participations in Letters of Credit and Swing Line Loans to be held on a pro-rata basis by the Lenders in accordance with their Revolving Facility Percentages (carried out to the ninth decimal place) (without giving effect to Section 2.17(a)(iv), whereupon such Lender will cease to be a Defaulting Lender; provided that no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of any Borrower while that Lender was a Defaulting Lender; provided, further, that except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Non-Defaulting Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender’s having been a Defaulting Lender. Section 2.18 Agent Advances. (a) Subject to the limitations set forth in the provisos contained in this Section 2.18, the Administrative Agent is hereby authorized by the Borrowers and the Lenders, from time to time in the Administrative Agent’s sole discretion, (A) after the occurrence of a Default or an Event of Default, or (B) at any time that any of the other applicable conditions precedent set forth in Article V have not been satisfied, to make Revolving Facility Loans to the Borrowers on behalf of the Lenders which the Administrative Agent, (1) in its Permitted Discretion, deems necessary or desirable to preserve or protect the Collateral, or any portion thereof, (2) in its Permitted Discretion, deems necessary or desirable to enhance the likelihood of, or maximize the amount of, repayment of the Revolving Facility Loans and other ABL Credit Obligations, or (3) in its reasonable business judgment, deems necessary or desirable to pay any other amount chargeable to the Borrowers pursuant to the terms of this Agreement, including costs, fees, and expenses as described in Section 10.04 (any of the advances described in the foregoing clauses (1) and (2) being hereinafter referred to as “Protective Advances”; any of the advances described in the foregoing clause (3) being hereinafter referred to as “Overadvances”, and such Overadvances together with any Protective Advances, collectively, “Agent Advances”); provided that (x) the Revolving Facility Credit Exposure (except for and excluding amounts charged to the Loan Account for interest, fees, or other expenses of the Lenders) after giving effect to any Agent Advance shall not exceed the Revolving Loan Limit and (y) Agent Advances outstanding and unpaid at no time will exceed 10% of the Borrowing Base then in effect in the aggregate; provided, further, that the Required Revolving Facility Lenders may revoke the Administrative Agent’s authorization contained in this Section 2.18 to make additional Overadvances at any time after any Overadvances have been outstanding for thirty (30) consecutive days, any such revocation to be in writing and to become effective upon the Administrative Agent’s receipt thereof provided further that no Protective Advances shall be revocable. (b) The Agent Advances shall be repayable on demand and secured by the Collateral Agent’s Liens in and to the Collateral, shall constitute Revolving Facility Loans and ABL Credit Obligations hereunder, and shall bear interest at the rate applicable to Base Rate Loans from time to time. The Administrative Agent shall notify each Lender in writing of each Agent Advance; provided that any delay or failure of the Administrative Agent in providing any such notice to any Lender shall not result in any liability or constitute the breach of any duty or obligation of the Administrative Agent hereunder.


 
103 Section 2.19 Settlement. Except as may be specifically provided otherwise herein, it is agreed that each Lender’s funded portion of the Revolving Facility Loans is intended by the Lenders to be equal at all times to such Lender’s applicable Pro Rata Share of the outstanding Revolving Facility Loans of such Type. Notwithstanding such agreement, the Administrative Agent, the Swing Line Lender, and the Lenders agree (which agreement shall not be for the benefit of or enforceable by any Borrower) that in order to facilitate the administration of this Agreement and the other Loan Documents, settlement among them as to the Revolving Facility Loans, including the Swing Line Loans and the Agent Advances, shall take place on a periodic basis in accordance with the following provisions: (a) The Administrative Agent shall request settlement (a “Settlement”) with the Lenders on at least a weekly basis, or on a more frequent basis if so determined by the Administrative Agent, (A) on behalf of the Swing Line Lender, with respect to each outstanding Swing Line Loan, (B) for itself, with respect to each Agent Advance, and (C) with respect to collections received, in each case, by notifying the Lenders of such requested Settlement by fax, telephone, or other means of written electronic communication, no later than 12:00 noon, Local Time, on the date of such requested Settlement (the “Settlement Date”). Each Revolving Facility Lender (other than the Swing Line Lender, in the case of Swing Line Loans, and the Administrative Agent, in the case of Agent Advances) shall transfer the amount of such Lender’s Pro Rata Share of the outstanding principal amount of the Swing Line Loans and Agent Advances with respect to which Settlement is requested to the Administrative Agent’s Account not later than 3:00 p.m., Local Time, on the Settlement Date applicable thereto, which may occur before or after the occurrence or during the continuation of a Default or an Event of Default and whether or not the applicable conditions precedent set forth in Article V have then been satisfied. Such amounts made available to the Administrative Agent shall be applied against the amounts of the applicable Swing Line Loan or Agent Advance and, together with the portion of such Swing Line Loan or Agent Advance representing the Swing Line Lender’s Pro Rata Share thereof, shall constitute Revolving Facility Loans of the Lenders, respectively. If any such amount is not made available to the Administrative Agent by any Lender on the Settlement Date applicable thereto, the Administrative Agent shall, on behalf of the Swing Line Lender with respect to each outstanding Swing Line Loan and for itself with respect to each Agent Advance, be entitled to recover such amount on demand from such Lender together with interest thereon at the Federal Funds Rate for the first three (3) days from and after the Settlement Date and thereafter at the interest rate then applicable to Revolving Facility Loans that are Base Rate Loans. (b) Notwithstanding the foregoing, not more than one (1) Business Day after demand is made by the Administrative Agent (whether before or after the occurrence of a Default or an Event of Default and regardless of whether the Administrative Agent has requested a Settlement with respect to a Swing Line Loan or Agent Advance), each Lender (A) shall irrevocably and unconditionally purchase and receive from the Swing Line Lender or the Administrative Agent, as applicable, without recourse or warranty, an undivided interest and participation in such Swing Line Loan or Agent Advance equal to such Lender’s Pro Rata Share of such Swing Line Loan or Agent Advance and (B) if Settlement has not previously occurred with respect to such Swing Line Loans or Agent Advances, upon demand by the Swing Line Lender or the Administrative Agent, as applicable, shall pay to the Swing Line Lender or the Administrative Agent, as applicable, as the purchase price of such participation an amount equal to one- hundred percent (100%) of such Lender’s Pro Rata Share of such Swing Line Loans or Agent Advances. If such amount is not in fact made available to the Administrative Agent by any Lender, the Administrative Agent shall be entitled to recover such amount on demand from such Lender together with interest thereon at the Federal Funds Rate for the first three (3) days from and after such demand and thereafter at the interest rate then applicable to Base Rate Loans. (c) From and after the date, if any, on which any Lender purchases an undivided interest and participation in any Swing Line Loan or Agent Advance pursuant to clause (ii) preceding, the Administrative Agent shall promptly distribute to such Lender such Lender’s Pro Rata Share of all 104 payments of principal and interest and all proceeds of Collateral received by the Administrative Agent in respect of such Swing Line Loan or Agent Advance. (d) Between Settlement Dates, to the extent no Agent Advances are outstanding, the Administrative Agent may pay over to the Swing Line Lender any payments received by the Administrative Agent, which in accordance with the terms of this Agreement would be applied to the reduction of the Revolving Facility Loans, for application to the Swing Line Lender’s Revolving Facility Loans including Swing Line Loans. If, as of any Settlement Date, collections received since the then immediately preceding Settlement Date have been applied to the Swing Line Lender’s Revolving Facility Loans (other than to Swing Line Loans or Agent Advances in which a Lender has not yet funded its purchase of a participation, as provided for in the previous sentence), the Swing Line Lender shall pay to the Administrative Agent for the accounts of the Lenders, to be applied to the outstanding Revolving Facility Loans of such Lenders, an amount such that each Lender shall, upon receipt of such amount, have, as of such Settlement Date, its Pro Rata Share of the Revolving Facility Loans. During the period between Settlement Dates, the Swing Line Lender with respect to Swing Line Loans, the Administrative Agent with respect to Agent Advances, and each Lender with respect to the Revolving Facility Loans other than Swing Line Loans and Agent Advances, shall be entitled to interest at the applicable rate or rates payable under this Agreement on the actual average daily amount of funds employed by the Swing Line Lender, the Administrative Agent, and the Lenders. (e) Unless the Administrative Agent has received written notice from a Lender to the contrary, the Administrative Agent may assume that the applicable conditions precedent set forth in Article V have been satisfied and the requested Borrowing will not exceed Availability on any date for funding a Revolving Facility Loan or Swing Line Loan. If any Lender makes available to the Administrative Agent funds for any Revolving Facility Loan to be made by such Lender as provided in the provisions of this Article II, and such funds are not made available to the applicable Borrower by the Administrative Agent because the conditions set forth in Article V are not satisfied or waived in accordance with the terms hereof, the Administrative Agent shall return such funds (in like funds as received from such Lender) to such Lender, without interest. Section 2.20 Maintenance of Loan Account; Statement of Obligations. The Administrative Agent shall maintain an account on its books in the name of the Borrowers (the “Loan Account”) on which Borrowers will be charged with all Revolving Facility Loans (including Agent Advances and Swing Line Loans) made by Administrative Agent, Swing Line Lender, or the Lenders to Borrowers or for Borrowers’ account, the Letters of Credit issued or arranged by the L/C Issuer for Borrowers’ account, and with all other ABL Credit Obligations that are payment obligations hereunder or under the other Loan Documents, including, accrued interest, fees and expenses. In accordance with Section 2.14(a), the Loan Account will be credited with all payments received by the Administrative Agent from Borrowers or for Borrowers’ account. The Administrative Agent shall make available to Borrowers monthly statements regarding the Loan Account, including the principal amount of the Revolving Facility Loans, interest accrued hereunder, fees accrued or charged hereunder or under the other Loan Documents, and a summary itemization of all charges and expenses accrued hereunder or under the other Loan Documents, and each such statement, absent manifest error, shall be conclusively presumed to be correct and accurate and constitute an account stated between Borrowers and the Lenders unless, within 30 days after the Administrative Agent first makes such a statement available to Borrowers, Borrowers shall deliver to the Administrative Agent written objection thereto describing the error or errors contained in such statement. Section 2.21 Incremental Facilities. (a) At any time from and after the Amendment No. 6 Effective Date, at the option of Borrowers (but subject to the conditions set forth in clause (b) below), the Revolving Facility 105 Commitments and the Maximum Revolver Amount may be increased by an amount in the aggregate for all such increases of the Revolving Facility Commitments not to exceed the Available Increase Amount (each such increase, an “Increase”). The Borrowers shall invite each Lender to increase its Revolving Facility Commitments (it being understood that no Lender shall be obligated to increase its Revolving Facility Commitments), and if any Lenders do not agree to increase their Revolving Facility Commitments in connection with such proposed Increase, then Borrowers may invite any prospective lender who is reasonably satisfactory to Administrative Agent and Borrowers to become a Lender in connection with a proposed Increase. Any Increase shall be in an amount of at least $30,000,000 and integral multiples of $10,000,000 in excess thereof. In no event may the Revolving Facility Commitments and the Maximum Revolver Amount be increased pursuant to this Section 2.21 on more than three (3) occasions in the aggregate for all such Increases. Additionally, for the avoidance of doubt, it is understood and agreed that in no event shall the aggregate amount of the Increases to the Revolving Facility Commitments exceed $100,000,000. (b) Each of the following shall be conditions precedent to any Increase: (i) Administrative Agent or Borrowers have obtained the commitment of one or more Lenders (or other prospective lenders) reasonably satisfactory to Administrative Agent and Borrowers to provide the applicable Increase and any such Lenders (or prospective lenders), Borrowers, and Administrative Agent have signed a joinder agreement to this Agreement (an “Increase Joinder”), in form and substance reasonably satisfactory to Administrative Agent, to which such Lenders (or prospective lenders), Borrowers, and Administrative Agent are party, (ii) each of the conditions precedent set forth in Section 5.01(b) and (c) are satisfied, (iii) the interest rate margins with respect to the Revolving Facility Loans to be made pursuant to the increased Revolving Facility Commitments shall be the same as the interest rate margin applicable to Revolving Facility Loans hereunder immediately prior to the applicable Increase Date (as defined below) (the date of the effectiveness of the increased Revolving Facility Commitments and the Maximum Revolver Amount, the “Increase Date”), provided, that nothing in this Section 2.21 shall prohibit the payment of commitment fees or other fees to Lenders participating in an Increase, and (iv) Administrative Agent and Lenders shall have received mortgage amendments, title policy endorsements, flood certifications, legal opinions and such other documents as Administrative Agent may reasonable request in connection with any Mortgage. (c) Any Increase Joinder may, with the consent of Administrative Agent, Borrowers and the Lenders or prospective lenders agreeing to the proposed Increase, effect such amendments to this Agreement and the other Loan Documents as may be necessary to effectuate the provisions of this Section 2.21. (d) Unless otherwise specifically provided herein, all references in this Agreement and any other Loan Document to Revolving Facility Loans shall be deemed, unless the context otherwise requires, to include Revolving Facility Loans made pursuant to the increased Revolving Facility Commitments and Maximum Revolver Amount pursuant to this Section 2.21. (e) Each of the Lenders having a Revolving Facility Commitment prior to the Increase Date (the “Pre-Increase Revolver Lenders”) shall assign to any Lender which is acquiring a new or additional Revolving Facility Commitment on the Increase Date (the “Post-Increase Revolver Lenders”), and such Post-Increase Revolver Lenders shall purchase from each Pre-Increase Revolver 106 Lender, at the principal amount thereof, such interests in the Revolving Facility Loans and participation interests in Letters of Credit on such Increase Date as shall be necessary in order that, after giving effect to all such assignments and purchases, such Revolving Facility Loans and participation interests in Letters of Credit will be held by Pre-Increase Revolver Lenders and Post-Increase Revolver Lenders ratably in accordance with their Pro Rata Share after giving effect to such increased Revolving Facility Commitments. (f) The Revolving Facility Loans, Revolving Facility Commitments, and Maximum Revolver Amount established pursuant to this Section 2.21 shall constitute Revolving Facility Loans, Revolving Facility Commitments, and Maximum Revolver Amount under, and shall be entitled to all the benefits afforded by, this Agreement and the other Loan Documents, and shall, without limiting the foregoing, benefit equally and ratably from any guarantees and the security interests created by the Loan Documents. Borrowers shall take any actions reasonably required by Administrative Agent to ensure and demonstrate that the Liens and security interests granted by the Loan Documents continue to be perfected under the Code or otherwise after giving effect to the establishment of any such new Revolving Facility Commitments and Maximum Revolver Amount. ARTICLE III TAXES, YIELD PROTECTION AND ILLEGALITY Section 3.01 Taxes. (a) Payments Free of Taxes; Obligation to Withhold; Payments on Account of Taxes. (i) Any and all payments by or on account of any obligation of any Loan Party or the Parent Guarantor under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by applicable Laws. If any applicable Laws (as determined in the good faith discretion of the Administrative Agent, Loan Party or the Parent Guarantor) require the deduction or withholding of any Tax from any such payment by the Administrative Agent, a Loan Party or the Parent Guarantor, then the Administrative Agent, such Loan Party or the Parent Guarantor shall be entitled to make such deduction or withholding, upon the basis of the information and documentation to be delivered pursuant to Section 3.01(a)(ii) below. (ii) If any Loan Party, the Parent Guarantor or the Administrative Agent shall be required by any applicable Laws to withhold or deduct any Taxes from any payment under any Loan Documents, then (A) such Loan Party, the Parent Guarantor or the Administrative Agent shall withhold or make such deductions as are determined by such Loan Party, the Parent Guarantor or the Administrative Agent to be required based upon the information and documentation it has received pursuant to Section 3.01(c) below, (B) such Loan Party, the Parent Guarantor or the Administrative Agent shall timely pay the full amount withheld or deducted to the relevant Governmental Authority in accordance with the applicable Law and (C) to the extent that the withholding or deduction is made on account of Indemnified Taxes, the sum payable by the applicable Loan Party or the Parent Guarantor shall be increased as necessary so that after any required withholding or the making of all required deductions for Indemnified Taxes (including deductions for Indemnified Taxes applicable to additional sums payable under this Section 3.01(a)) the applicable Recipient receives an amount equal to the sum it would have received had no such withholding or deduction of Indemnified Taxes been made. (iii) Payment of Other Taxes by the Loan Parties. Without limiting the provisions of Section 3.01(a)(i) and Section 3.01(a)(ii) above, the Loan Parties or the Parent Guarantor shall timely pay to the relevant Governmental Authority in accordance with applicable law, or at the option of the Administrative Agent timely reimburse it for the payment of, any Other Taxes.


 
107 (b) Tax Indemnifications. (i) Without duplication of any additional amounts paid pursuant to Section 3.01(a), each of the Loan Parties and the Parent Guarantor shall, and does hereby, jointly and severally indemnify each Recipient, and shall make payment in respect thereof within 10 Business Days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section 3.01) payable or paid by such Recipient or required to be withheld or deducted from a payment to such Recipient, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to the Borrowers by a Lender or an L/C Issuer (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender or an L/C Issuer, shall be conclusive absent manifest error. (ii) Each Lender and L/C Issuer shall, and does hereby, severally indemnify, and shall make payment in respect thereof within 10 days after demand therefor, (x) the Administrative Agent against any Indemnified Taxes attributable to such Lender or L/C Issuer (but only to the extent that any Loan Party or the Parent Guarantor has not already indemnified the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Loan Parties or the Parent Guarantor to do so), (y) the Administrative Agent against any Taxes attributable to such Lender’s failure to comply with the provisions of Section 10.06(d) relating to the maintenance of a Participant Register and (z) the Administrative Agent against any Excluded Taxes attributable to such Lender or L/C Issuer, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender or L/C Issuer by the Administrative Agent shall be conclusive absent manifest error. Each Lender and L/C Issuer hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender or L/C Issuer, as the case may be, under this Agreement or any other Loan Document against any amount due to the Administrative Agent under Section 3.01(b)(ii). (iii) Evidence of Payments. Upon request by a Borrower or the Administrative Agent, as the case may be, after any payment of Taxes by any Loan Party, the Parent Guarantor or the Administrative Agent to a Governmental Authority as provided in this Section 3.01, such Borrower shall deliver to the Administrative Agent or the Administrative Agent shall deliver to such Borrower, as the case may be, the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of any return required by Laws to report such payment or other evidence of such payment reasonably satisfactory to such Borrower or the Administrative Agent, as the case may be. (c) Status of Lenders; Tax Documentation. (i) Each Lender and L/C Issuer that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrowers and the Administrative Agent, at the time or times reasonably requested by the Borrowers or the Administrative Agent, such properly completed and executed documentation reasonably requested by the Borrowers or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, each Lender and L/C Issuer, if reasonably requested by the Borrowers or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrowers or the Administrative Agent as will enable the Borrowers or the Administrative Agent to determine whether or not such Lender or L/C 108 Issuer is subject to backup withholding or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in Error! Reference source not found., Error! Reference source not found., Error! Reference source not found. and Error! Reference source not found. below) shall not be required if in the Lender’s, L/C Issuer’s or Swing Line Lender’s reasonable judgment such completion, execution or submission would subject such Lender or L/C Issuer to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender or L/C Issuer. (ii) Without limiting the generality of the foregoing: (A) each Lender or L/C Issuer that is a U.S. Person (or, if such Lender or L/C Issuer is disregarded as an entity separate from its owner for U.S. federal income tax purposes, is owned by a U.S. Person) shall deliver to the Borrowers and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Lender or L/C Issuer becomes a party to this Agreement (and from time to time thereafter upon the reasonable request of the Borrowers or the Administrative Agent), duly completed and executed originals of IRS Form W-9 certifying that such Lender or L/C Issuer or such U.S. Person, as applicable, is exempt from U.S. federal backup withholding Tax; (B) any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrowers and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a party to this Agreement (and from time to time thereafter upon the reasonable request of the Borrowers or the Administrative Agent), whichever of the following is applicable: (1) in the case of a Foreign Lender (or, if such Foreign Lender is disregarded as an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) relying on the benefits of an income tax treaty to which the United States is a party (x) with respect to payments of interest under any Loan Document, duly completed and executed originals of IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “interest” article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, duly completed and executed originals of IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other income” article of such tax treaty; (2) duly completed and executed originals of IRS Form W- 8ECI with respect to such Foreign Lender (or, if such Foreign Lender is disregarded as an entity separate from its owner for U.S. federal income tax purposes, with respect to the Person treated as its owner for U.S. federal income tax purposes); (3) in the case of a Foreign Lender (or, if such Foreign Lender is disregarded as an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) relying on the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate substantially in the form of Exhibit D-1 to the effect that such Foreign Lender is not a “bank” within the meaning of Section 881(c)(3)(A) of the Code, a “10 percent shareholder” of any Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a “controlled foreign corporation” described in Section 881(c)(3)(C) of the Code (a “U.S. Tax Compliance Certificate”) and (y) duly completed and executed originals of IRS Form W-8BEN or IRS Form W- 8BEN-E, as applicable; or 109 (4) to the extent a Foreign Lender (or, if such Foreign Lender is disregarded as an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) is not the beneficial owner, duly completed and executed originals of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN, IRS Form W-8BEN-E, a U.S. Tax Compliance Certificate substantially in the form of Exhibit D-2 or Exhibit D-3, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that if the Foreign Lender (or, if such Foreign Lender is disregarded as an entity separate from its owner for U.S. federal income tax purposes, the Person treated as its owner for U.S. federal income tax purposes) is a partnership and one or more direct or indirect partners of such Foreign Lender (or owner) are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate substantially in the form of Exhibit D-4 on behalf of each such direct and indirect partner; provided that, for the absence of doubt, in the event a Foreign Lender is eligible for more than one benefit or exemption described in the above clauses, such Foreign Lender shall deliver to the Borrowers and the Administrative Agent properly completed and executed documentation described in whichever of the clause above would establish an exemption from or the greatest reduction of withholding Tax with respect to payments made under any Loan Document; (C) any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrowers and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a party to this Agreement (and from time to time thereafter upon the reasonable request of the Borrowers or the Administrative Agent), executed originals of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Borrowers or the Administrative Agent to determine the withholding or deduction required to be made; and (D) if a payment made to any Lender or L/C Issuer under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender or L/C Issuer were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender or L/C Issuer shall deliver to the Borrowers and the Administrative Agent at the time or times prescribed by applicable Law and at such time or times reasonably requested by the Borrowers or the Administrative Agent such documentation prescribed by applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrowers or the Administrative Agent as may be necessary for the Borrowers and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender or L/C Issuer has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this Section 3.01(c)(ii)(D), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. (iii) Each Lender or L/C Issuer agrees that if any form or certification it previously delivered pursuant to this Section 3.01 expires or becomes obsolete or inaccurate in any respect, it shall promptly (x) update such form or certification or (y) notify the Borrowers and the Administrative Agent in writing of its legal inability to do so. (iv) Each Lender, L/C Issuer and Swing Line Lender shall promptly (A) notify the Borrowers, the Holdcos and the Administrative Agent of any change in circumstances which would modify or render invalid any claimed exemption or reduction, and (B) take such steps as shall not be materially disadvantageous to it, in the reasonable judgment of such Lender or L/C Issuer, and as may 110 be reasonably necessary (including the re-designation of its Lending Office) to avoid any requirement of applicable Laws of any jurisdiction that the Borrowers, the Holdcos or the Administrative Agent make any withholding or deduction for Taxes from amounts payable to such Lender or L/C Issuer. (d) If any party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section 3.01 (including by the payment of additional amounts pursuant to this Section 3.01), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this Section 3.01 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Such indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this Error! Reference source not found.Section 3.01(d) (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this Error! Reference source not found.Section 3.01(d), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this Error! Reference source not found.Section 3.01(d) the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This Error! Reference source not found.Section 3.01(d) shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the indemnifying party or any other Person. (e) FATCA. For purposes of determining withholding Taxes imposed under FATCA, from and after the Closing Date, each Borrower and the Administrative Agent shall treat (and the Lenders and the L/C Issuer hereby authorize the Administrative Agent to treat) the obligations under the Loan Documents as not qualifying as a “grandfathered obligation” within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i). (f) Survival. Each party’s obligations under this Section 3.01 shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender or an L/C Issuer, the termination of the Commitments and the repayment, satisfaction or discharge of all other ABL Credit Obligations. Section 3.02 Illegality[Reserved]. If any Lender determines that any Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Office to make, maintain or fund Loans whose interest is determined by reference to the Eurodollar Base Rate, or to determine or charge interest rates based upon the Eurodollar Base Rate, or any Governmental Authority has imposed material restrictions on the authority of such Lender to purchase or sell, or to take deposits of, Dollars in the London interbank market, then, on notice thereof by such Lender to the Borrowers through the Administrative Agent, (i) any obligation of such Lender to make or continue Eurodollar Rate Loans or to convert Base Rate Loans to Eurodollar Rate Loans shall be suspended, and (ii) if such notice asserts the illegality of such Lender making or maintaining Base Rate Loans the interest rate on which is determined by reference to the Eurodollar Base Rate component of the Base Rate, the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Eurodollar Base Rate component of the Base Rate, in each case until such Lender notifies the Administrative Agent and the Borrowers that the circumstances giving rise to such determination no longer exist. Upon receipt of such notice, (x) the Borrowers shall, upon demand from such Lender (with a copy to the Administrative


 
111 Agent), prepay or, if applicable, convert all Eurodollar Rate Loans of such Lender to Base Rate Loans (the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Eurodollar Base Rate component of the Base Rate), either on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such Eurodollar Rate Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Eurodollar Rate Loans and (y) if such notice asserts the illegality of such Lender determining or charging interest rates based upon the Eurodollar Base Rate, the Administrative Agent shall during the period of such suspension compute the Base Rate applicable to such Lender without reference to the Eurodollar Base Rate component thereof until the Administrative Agent is advised in writing by such Lender that it is no longer illegal for such Lender to determine or charge interest rates based upon the Eurodollar Base Rate. Each Lender agrees to notify the Administrative Agent and the Borrowers in writing promptly upon becoming aware that it is no longer illegal for such Lender to determine or charge interest rates based upon the Eurodollar Base Rate. Upon any such prepayment or conversion, the Borrowers shall also pay accrued interest on the amount so prepaid or converted. . Section 3.03 Inability to Determine Rates[Reserved]. Subject in all respects to Section 2.13(g), if the Required Lenders advise the Administrative Agent prior to a Eurodollar Rate Borrowing or a conversion of a Base Rate Loan to a Eurodollar Rate Loan or a continuation of a Eurodollar Rate Loan that (a) Dollar deposits are not being offered to banks in the London interbank eurodollar market for the applicable amount and Interest Period of such Eurodollar Rate Loan, (b) adequate and reasonable means do not exist for determining the Eurodollar Base Rate for any requested Interest Period with respect to a proposed Eurodollar Rate Loan or in connection with an existing or proposed Base Rate Loan or (c) the Eurodollar Base Rate for any requested Interest Period with respect to a proposed Eurodollar Rate Loan does not adequately and fairly reflect the cost to such Lenders of funding such Loan, the Administrative Agent will as promptly as practicable notify the applicable Borrower (by telephone and/or fax) and each Lender. Thereafter, (x) any Interest Election Request that requests the conversion of any Base Rate Loan to a Eurodollar Rate Loan or the continuation of a Eurodollar Rate Loan shall be ineffective, (y) if any Borrowing Request requests a Eurodollar Rate Borrowing, then such Borrowing shall be made as a Base Rate Borrowing and (z) in the event of a determination described in the preceding sentence with respect to the Eurodollar Base Rate component of the Base Rate, the utilization of the Eurodollar Base Rate component in determining the Base Rate shall be suspended, in each case until the Administrative Agent (upon the instruction of the Required Lenders) revokes such notice. Notwithstanding anything to the contrary herein, upon receipt of such notice, such Borrower may revoke any pending request for a Eurodollar Rate Borrowing, conversion of a Base Rate Loan to a Eurodollar Rate Loan or a continuation of Eurodollar Rate Loans or, failing that, will be deemed to have converted such request into a request for a Borrowing of Base Rate Loans in the amount specified therein.. . Section 3.04 Increased Costs. (a) Increased Costs Generally. If any Change in Law shall: (i) impose, modify or deem applicable any reserve, special deposit, liquidity or similar requirement, including any compulsory loan, insurance charge or similar requirement against assets held by, deposits with or for the account of, or credit extended or participated in by, any Lender (or its applicable Lending Office) (except any reserve requirement which is reflected in the determination of the Adjusted Eurodollar Rate hereunder) or any L/C Issuer; 112 (ii) subject any Recipient to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes and (C) Connection Income Taxes) on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto; or (iii) impose on any Lender (or its applicable Lending Office) or L/C Issuer or the London interbank market any other condition, cost or expense affecting this Agreement or Eurodollar RateSOFR Loans made by such Lender or any Letter of Credit or participation therein; and the result of any of the foregoing shall be to increase the cost to such Lender or such other Recipient (or its applicable Lending Office) of making, converting to, continuing or maintaining any Loan (or of maintaining its obligation to make any such Loan), or to increase the cost to such Lender, any L/C Issuer or such other Recipient of participating in, issuing or maintaining any Letter of Credit (or of maintaining its obligation to participate in or to issue any Letter of Credit), or to reduce the amount of any sum received or receivable by such Lender, L/C Issuer or such other Recipient hereunder (whether of principal, interest or any other amount) then, upon request of such Lender, L/C Issuer or such other Recipient, the applicable Borrower will pay to such Lender, L/C Issuer or such other Recipient, as the case may be, such additional amount or amounts as will compensate such Lender, L/C Issuer or such other Recipient, as the case may be, for such additional costs incurred or reduction suffered. (b) Capital Requirements. If any Lender or an L/C Issuer determines that any Change in Law affecting such Lender or an L/C Issuer or its applicable Lending Office or such Lender’s or an L/C Issuer’s holding company, if any, regarding capital requirements has or would have the effect of reducing the rate of return on such Lender’s or an L/C Issuer’s capital or on the capital of such Lender’s or an L/C Issuer’s holding company, if any, as a consequence of this Agreement, the Commitments of such Lender or the Loans made by or participations in Letters of Credit or Swing Line Loans held by, such Lender, or the Letters of Credit issued by such L/C Issuer, to a level below that which such Lender or L/C Issuer or such Lender’s or L/C Issuer’s holding company could have achieved but for such Change in Law (taking into consideration such Lender’s or L/C Issuer’s policies and the policies of such Lender’s or L/C Issuer’s holding company with respect to capital adequacy and liquidity requirements), then from time to time the Borrowers will pay to such Lender or L/C Issuer, as the case may be, such additional amount or amounts as will compensate such Lender or L/C Issuer or such Lender’s or L/C Issuer’s holding company for any such reduction suffered. (c) Certificates for Reimbursement. A certificate of a Lender or L/C Issuer setting forth the amount or amounts necessary to compensate such Lender or L/C Issuer or its holding company, as the case may be, as specified in subsection (a) or (b) of this Section and delivered to the Borrowers shall be conclusive absent manifest error. The Borrowers shall pay such Lender or L/C Issuer, as the case may be, the amount shown as due on any such certificate within 10 days after receipt thereof. (d) Delays in Requests. Failure or delay on the part of any Lender or L/C Issuer to demand compensation pursuant to the foregoing provisions of this Section 3.04 shall not constitute a waiver of such Lender’s or L/C Issuer’s right to demand such compensation; provided that the Borrowers shall not be required to compensate a Lender or L/C Issuer pursuant to the foregoing provisions of this Section for any increased costs incurred or reductions suffered more than 180 days prior to the date that such Lender or L/C Issuer, as the case may be, notifies the Borrowers of the Change in Law giving rise to such increased costs or reductions and of such Lender’s or L/C Issuer’s intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect thereof). 113 Section 3.05 Compensation for Losses. Upon demand of any Lender (with a copy to the Administrative Agent) from time to time, the applicable Borrower shall promptly compensate such Lender for and hold such Lender harmless from any loss, cost or expense incurred by it as a result of: (a) any continuation, conversion, payment or prepayment of any Loan other than a Base Rate Loan on a day other than the last day of the Interest Period for such Loan (whether voluntary, mandatory, automatic, by reason of acceleration, or otherwise); (b) any failure by such Borrower (for a reason other than the failure of such Lender to make a Loan) to prepay, borrow, continue or convert any Loan other than a Base Rate Loan on the date or in the amount notified by such Borrower pursuant to this Agreement; or (c) any assignment of a Eurodollar RateSOFR Loan on a day other than the last day of the Interest Period therefor as a result of a request by such Borrower pursuant to Section 2.15 or Section 10.14; including any loss or expense arising from the liquidation or reemployment of funds obtained by it to maintain such Loan or from fees payable to terminate the deposits from which such funds were obtained. Such Borrower shall also pay any customary administrative fees charged by such Lender in connection with the foregoing. For purposes of calculating amounts payable by the Borrowers to the Lenders under this Section 3.05, each Lender shall be deemed to have funded each Eurodollar Rate Loan made by it at the Eurodollar Base Rate for such Loan by a matching deposit or, other borrowing in the London interbank eurodollar market for a comparable amount and for a comparable period, whether or not such Eurodollar Rate Loan was in fact so funded. Section 3.06 Mitigation Obligations; Replacement of Lenders. (a) Designation of a Different Lending Office. If any Lender requests compensation under Section 3.04, or if any Borrower is required to pay any Indemnified Taxes or additional amounts to any Lender, any L/C Issuer or any Governmental Authority for the account of any Lender or L/C Issuer pursuant to Section 3.01, or if any event gives rise to the operation of Section 3.02, such Lender or L/C Issuer shall use reasonable efforts to designate a different Lending Office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or Affiliates, if, in the judgment of such Lender or L/C Issuer, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to Section 3.01 or 3.04, as the case may be, in the future, or eliminate the need for the notice pursuant to Section 3.02, as applicable, and (ii) would not subject such Lender or L/C Issuer to any material unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender or L/C Issuer, as the case may be, in any material respect. The Borrowers hereby agree to pay all reasonable costs and expenses incurred by any Lender or L/C Issuer in connection with any such designation or assignment. (b) Replacement of Lenders. If any Lender requests compensation under Section 3.04, or if any Borrower is required to pay any Indemnified Taxes or additional amounts to any Lender or any Governmental Authority for the account of any Lender or L/C Issuer pursuant to Section 3.01 and, in each case, such Lender or L/C Issuer has declined or is unable to designate a different Lending Office in accordance with Section 3.06(a), such Borrower may replace such Lender or L/C Issuer in accordance with Section 10.14. 114 Section 3.07 Survival. All of each Borrower’s obligations under this Article III shall survive repayment of all other ABL Credit Obligations hereunder and resignation of the Administrative Agent. ARTICLE IV REPRESENTATIONS AND WARRANTIES On the date of each Credit Event as provided in Section 5.01, each Holdco and each Borrower represents and warrants to each of the Lenders that: Section 4.01 Organization; Powers. Except as set forth on Schedule 4.01, each Holdco, each Borrower and each of the Material Subsidiaries (a) is a partnership, limited liability company or corporation duly organized, validly existing and in good standing (or, if applicable in a foreign jurisdiction, enjoys the equivalent status under the laws of any jurisdiction of organization outside the United States) under the laws of the jurisdiction of its organization, (b) has all requisite power and authority to own its property and assets and to carry on its business as now conducted, (c) is qualified to do business in each jurisdiction where such qualification is required, except where the failure so to qualify would not reasonably be expected to have a Material Adverse Effect, and (d) has the power and authority to execute, deliver and perform its obligations under each of the Loan Documents and each other agreement or instrument contemplated thereby to which it is or will be a party and, in the case of each Borrower, to borrow and otherwise obtain credit hereunder. Section 4.02 Authorization. The execution, delivery and performance by the Holdcos, each Borrower and each of the Subsidiary Loan Parties of each of the Loan Documents to which it is a party, and the borrowings hereunder and the transactions forming a part of the Transactions (a) have been duly authorized by all corporate, stockholder, partnership or limited liability company action required to be obtained by the Holdcos, such Borrower and such Subsidiary Loan Parties and (b) will not (i) violate (A) any provision of law, statute, rule or regulation, or of the certificate or articles of incorporation or other constitutive documents (including any partnership, limited liability company or operating agreements) or bylaws of the Holdcos, any such Borrower or any such Subsidiary Loan Party, (B) any applicable order of any court or any rule, regulation or order of any Governmental Authority or (C) any provision of any indenture, certificate of designation for preferred stock, agreement or other instrument to which the Holdcos, any such Borrower or any such Subsidiary Loan Party is a party or by which any of them or any of their property is or may be bound, (ii) be in conflict with, result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, give rise to a right of or result in any cancellation or acceleration of any right or obligation (including any payment) or to a loss of a material benefit under any such indenture, certificate of designation for preferred stock, agreement or other instrument, where any such conflict, violation, breach or default referred to in clause (i) or (ii) of this Section 4.02(b), would reasonably be expected to have, individually or in the aggregate a Material Adverse Effect, or (iii) result in the creation or imposition of any Lien upon or with respect to any property or assets now owned or hereafter acquired by any such Borrower or any such Subsidiary Loan Party, other than the Liens created by the Loan Documents and Permitted Liens. Section 4.03 Enforceability. This Agreement has been duly executed and delivered by the Holdcos and each Borrower and constitutes, and each other Loan Document when executed and delivered by each Loan Party and the Parent Guarantor that is party thereto will constitute, a legal, valid and binding obligation of such Loan Party and the Parent Guarantor enforceable against each such Loan Party and the Parent Guarantor in accordance with its terms, subject to (i) the effects of bankruptcy, insolvency, moratorium, reorganization, fraudulent conveyance or other similar laws affecting creditors’ rights generally, (ii) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and (iii) implied covenants of good faith and fair dealing.


 
115 Section 4.04 Governmental Approvals. No action, consent, exemption or approval of, registration or filing with or any other action by, or notice to, any Governmental Authority is or will be required in connection with the Transactions, the perfection or maintenance of the Liens created under the Security Documents or the exercise by the Administrative Agent, any L/C Issuer or any Lender of its rights under the Loan Documents or the remedies in respect of the Collateral, except for (a) the filing of Uniform Commercial Code financing statements and equivalent filings, registrations or other notifications in foreign jurisdictions, (b) filings with the United States Patent and Trademark Office and the United States Copyright Office and comparable offices in foreign jurisdictions and equivalent filings in foreign jurisdictions, (c) recordation of the Mortgages, (d) such as have been made or obtained and are in full force and effect, (e) such actions, consents and approvals the failure of which to be obtained or made would not reasonably be expected to have a Material Adverse Effect and (f) filings or other actions listed on Schedule 4.04. Section 4.05 Financial Statements. The audited combined balance sheets of Ultimate Parent and its consolidated Subsidiaries as at the end of the 2016 and 2017 fiscal years, and the related audited combined statements of income, stockholders’ equity, and cash flows for such fiscal years, reported on by and accompanied by a report from the auditors thereof, copies of which have heretofore been furnished to each Lender, (i) present fairly in all material respects the combined financial position of Ultimate Parent and its consolidated Subsidiaries as at such date and the combined results of operations, stockholders’ equity, and cash flows of the Ultimate Parent and its Subsidiaries for the years then ended and (ii) were prepared in accordance with the Applicable Accounting Rules consistently applied throughout the respective periods covered thereby, except as otherwise expressly noted therein. Section 4.06 No Material Adverse Effect. Since December 31, 2017, there has been no event, development or circumstance that has had or could reasonably be expected to have a Material Adverse Effect. Section 4.07 Title to Properties; Possession Under Leases. (a) Each Borrower and each of its Subsidiaries has good record and marketable title in fee simple to, or valid leasehold interests in, or easements or other limited property interests in, all its Real Properties (including all Mortgaged Properties) and has good and valid title to its personal property and assets, in each case, except for Permitted Liens and except for defects in title that do not materially interfere with its ability to conduct its business as currently conducted or to utilize such properties and assets for their intended purposes and except where the failure to have such title would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. All such properties and assets are free and clear of Liens, other than Permitted Liens. As of the Closing Date, all material permits required to have been issued or appropriate to enable the Real Properties to be lawfully occupied and used for all of the purposes for which it is currently occupied and used have been lawfully issued and are in full force and effect. (b) Each Borrower and each of its Subsidiaries has complied with all obligations under all leases to which it is a party, except where the failure to comply would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, and all such leases are in full force and effect, except leases in respect of which the failure to be in full force and effect would not reasonably be expected to have a Material Adverse Effect. Except as set forth on Schedule 4.07(b), each Borrower and each of its Subsidiaries enjoys peaceful and undisturbed possession under all such leases, other than leases in respect of which the failure to enjoy peaceful and undisturbed possession would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 116 (c) As of the Closing Date, no Borrower nor any of their respective Subsidiaries has received any notice of any pending or contemplated condemnation proceeding affecting any material portion of the Mortgaged Properties or any sale or disposition thereof in lieu of condemnation that remains unresolved as of the Closing Date. (d) No Borrower nor any of their respective Subsidiaries is obligated on the Closing Date under any right of first refusal, option or other contractual right to sell, assign or otherwise dispose of any Mortgaged Property or any interest therein, except as permitted by Section 7.02 or 7.05. Section 4.08 Subsidiaries. (a) Schedule 4.08(a) sets forth as of the Closing Date the name and jurisdiction of incorporation, formation or organization of each direct and indirect subsidiary of the Holdcos (other than the Parent Guarantor) and, as to each such subsidiary, the percentage of each class of Equity Interests owned by Holdcos (other than the Parent Guarantor) or by any such subsidiary. (b) As of the Closing Date, there are no outstanding subscriptions, options, warrants, calls, rights or other agreements or commitments (other than stock options granted to employees or directors and directors’ qualifying shares) of any nature relating to any Equity Interests of any Borrower or any of its Subsidiaries, except as set forth on Schedule 4.08(b). Section 4.09 Litigation; Compliance with Laws. (a) There are no actions, suits or proceedings at law or in equity or, to the knowledge of any Borrower, investigations by or on behalf of any Governmental Authority or in arbitration now pending, or, to the knowledge of the Holdcos or any Borrower, threatened in writing against or affecting the Ultimate Parent, the Holdcos or the Borrowers or any of their respective Subsidiaries or any business, property or rights of any such person which would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. (b) No Borrower nor any of their respective Subsidiaries and their respective properties or assets is in violation of (nor will the continued operation of their material properties and assets as currently conducted violate) any law, rule or regulation (including any zoning, building, ordinance, code or approval or any building permit, but excluding any Environmental Laws, which are subject to Section 4.16) or any restriction of record or agreement affecting any Mortgaged Property, or is in default with respect to any judgment, writ, injunction or decree of any Governmental Authority, where such violation or default would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. (c) No injunction, writ, temporary restraining order or any order of any nature has been issued by any court or other Governmental Authority purporting to enjoin or restrain the execution, delivery or performance of this Agreement or any other Loan Document, or directing that the transactions provided for herein or therein not be consummated as herein or therein provided. Section 4.10 Federal Reserve Regulations. (a) None of the Holdcos, the Borrowers or the Borrowers’ Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying Margin Stock. 117 (b) No part of the proceeds of any Loan will be used, whether directly or indirectly, and whether immediately, incidentally or ultimately, (i) to purchase or carry Margin Stock or to extend credit to others for the purpose of purchasing or carrying Margin Stock or to refund indebtedness originally incurred for such purpose, or (ii) for any purpose that entails a violation of, or that is inconsistent with, the provisions of the Regulations of the Board, including Regulation U or Regulation X. Section 4.11 Investment Company Act. None of the Holdcos, the Borrowers and the Borrowers’ Subsidiaries is an “investment company” as defined in, or subject to regulation under, the Investment Company Act of 1940, as amended. Section 4.12 Use of Proceeds. The Borrowers will use the proceeds of each Credit Event for general corporate purposes and to effect the repurchase under and termination of or, refinancing (or discharge) of Indebtedness under, the Existing Factoring Agreement. Section 4.13 Taxes. Except as set forth on Schedule 4.13: (a) except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (x) each of the Holdcos, each Borrower and its Subsidiaries has filed or caused to be filed all federal, state, local and non-U.S. Tax returns required to have been filed by it and (y) each such Tax return is true and correct; (b) each of the Holdcos, each Borrower and its Subsidiaries has timely paid or caused to be timely paid all Taxes shown to be due and payable by it on the returns referred to in clause (a)(i) above and all other Taxes or assessments (or made adequate provision (in accordance with the Applicable Accounting Rules) for the payment of all Taxes due) with respect to all periods or portions thereof ending on or before the Closing Date (except Taxes or assessments that are being contested in good faith by appropriate proceedings in accordance with Section 6.03 and for which the Holdcos, any Borrower or any of its Subsidiaries (as the case may be) has set aside on its books adequate reserves in accordance with the Applicable Accounting Rules), which Taxes, if not paid or adequately provided for, would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (c) other than as would not be, individually or in the aggregate, reasonably expected to have a Material Adverse Effect as of the Closing Date, with respect to each of the Holdcos, each Borrower and its Subsidiaries, there are no claims being asserted in writing by any Governmental Authority with respect to any Taxes. Section 4.14 No Material Misstatements. (a) All written information (other than the Projections, estimates and information of a general economic nature or general industry nature) (the “Information”) concerning the Holdcos, the Borrowers, their respective Subsidiaries, the Transactions and any other transactions contemplated hereby included in the Information Memorandum or otherwise prepared by or on behalf of the foregoing or their representatives and made available to any Lenders or the Administrative Agent in connection with the Transactions or the other transactions contemplated hereby, when taken as a whole, was true and correct in all material respects, as of the date such Information was furnished to the Lenders and, if delivered after the Original Closing Date and prior to the Closing Date, as of the Closing Date and did not, taken as a whole, contain any untrue statement of a material fact as of any such date or omit to state a material fact necessary in order to make the statements contained therein, taken as a whole, not materially misleading in light of the circumstances under which such statements were made. 118 (b) The Projections and estimates and information of a general economic nature prepared by or on behalf of any Borrower or any of its representatives and that have been made available to any Lenders or the Administrative Agent in connection with the Transactions or the other transactions contemplated hereby (i) have been prepared in good faith based upon assumptions believed by such Borrower to be reasonable as of the date thereof (it being understood that actual results may vary materially from the Projections), as of the date such Projections and estimates were furnished to the Lenders and as of the Closing Date, and (ii) as of the Closing Date, have not been modified in any material respect by such Borrower. Section 4.15 Employee Benefit Plans. (a) Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect:(i) each Plan is in compliance in all respects with the applicable provisions of ERISA and the Code; (ii) no Reportable Event has occurred during the past five years; (iii) no Plan has any Unfunded Pension Liability; (iv) no ERISA Event has occurred or is reasonably expected to occur; and (v) none of the Holdcos, the Borrowers, their respective Subsidiaries and the ERISA Affiliates (A) has received any written notification that any Multiemployer Plan is insolvent or has been terminated within the meaning of Title IV of ERISA, or has knowledge that any Multiemployer Plan is reasonably expected to be insolvent or to be terminated or (B) has incurred or is reasonably expected to incur any Withdrawal Liability to any Multiemployer Plan. (b) Each of the Holdcos, the Borrowers and their respective Subsidiaries is in compliance (i) with all applicable provisions of law and all applicable regulations and published interpretations thereunder with respect to any employee pension benefit plan or other employee benefit plan governed by the laws of a jurisdiction other than the United States and (ii) with the terms of any such plan, except, in each case, for such noncompliance that would not reasonably be expected to have a Material Adverse Effect. (c) Within the last five years, no Plan of the Holdcos, Borrowers, any Subsidiaries or the ERISA Affiliates has been terminated, whether or not in a “standard termination” as that term is used in Section 4041(b)(1) of ERISA, that would reasonably be expected to result in liability to the Holdcos, Borrowers, any Subsidiaries or the ERISA Affiliates in excess of $1,000,000, nor has any Plan of the Holdcos, Borrowers, any Subsidiaries or the ERISA Affiliates (determined at any time within the past five years) with Unfunded Pension Liabilities been transferred outside of the “controlled group” (with the meaning of Section 4001(a)(14) of ERISA) of the Holdcos, Borrowers, any Subsidiaries or the ERISA Affiliates, in either case, that has or would reasonably be expected to result in a Material Adverse Effect. Section 4.16 Environmental Matters. Except as set forth in Schedule 4.16 and except as to matters that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect: (i) no written notice, request for information, order, complaint or penalty has been received by any Borrower or any of its Subsidiaries, and there are no judicial, administrative or other actions, suits or proceedings pending or, to such Borrower’s knowledge, threatened, which allege a violation of or liability under any Environmental Laws, in each case relating to such Borrower or any of its Subsidiaries, (ii) each Borrower and each of its Subsidiaries has all environmental permits, licenses and other approvals necessary for its operations to comply with all applicable Environmental Laws and is, and during the term of all applicable statutes of limitation, has been, in compliance with the terms of such permits, licenses and other approvals and with all other applicable Environmental Laws, (iii) to any Borrower’s knowledge, no Hazardous Material is located at, on or under any property currently owned, operated or leased by such Borrower or any of its Subsidiaries that would reasonably be expected to give rise to any cost, liability or obligation of such Borrower or any of its Subsidiaries under any Environmental Laws, and no Hazardous Material has been generated, owned, treated, stored, handled or


 
119 controlled by such Borrower or any of its Subsidiaries and transported to or Released at any location in a manner that would reasonably be expected to give rise to any cost, liability or obligation of such Borrower or any of its Subsidiaries under any Environmental Laws, (iv) there are no agreements in which any Borrower or any of its Subsidiaries has expressly assumed or undertaken responsibility for any known or reasonably likely liability or obligation of any other person arising under or relating to Environmental Laws, which in any such case has not been made available to the Administrative Agent prior to the date hereof and (v) no Lien in favor of any Governmental Authority securing, in whole or in part, Environmental Liabilities has attached to any Property of any Borrower or any Subsidiary of any Borrower and, to the knowledge of the Borrowers, no facts, circumstances or conditions exist that would reasonably be expected to result in any such Lien attaching to any such Property. Section 4.17 Security Documents. (a) The Collateral Agreement is effective to create in favor of the Collateral Agent (for the benefit of the Secured Parties) a legal, valid and enforceable security interest in the Collateral described therein and proceeds thereof. In the case of the Pledged Collateral described in the Collateral Agreement, when certificates or promissory notes, as applicable, representing such Pledged Collateral, together with stock powers or other instruments of transfer with respect thereto endorsed in blank, are delivered to the Collateral Agent, and in the case of the other Collateral described in the Collateral Agreement (other than the Intellectual Property (as defined in the Collateral Agreement)), when financing statements and other filings specified in the Perfection Certificate are filed in the offices specified in the Perfection Certificate, the Collateral Agent (for the benefit of the Secured Parties) shall have a perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Collateral and, subject to Section 9-315 of the New York Uniform Commercial Code, the proceeds thereof, as security for the ABL Finance Obligations to the extent perfection can be obtained by filing Uniform Commercial Code financing statements, in each case prior and superior in right to any other Person (except for Permitted Liens and subject to the Intercreditor Agreements). (b) When the Collateral Agreement, a summary thereof or one or more intellectual property security agreements in form and substance satisfactory to the Administrative Agent is properly filed in the United States Patent and Trademark Office and the United States Copyright Office, and, with respect to Collateral in which a security interest cannot be perfected by such filings, upon the proper filing of the financing statements referred to in paragraph (a) above, the Collateral Agent (for the benefit of the Secured Parties) shall have a perfected Lien on, and security interest in, all right, title and interest of the Loan Parties thereunder in all domestic Intellectual Property, in each case prior and superior in right to any other person (except Permitted Liens and subject to the Intercreditor Agreements), it being understood that subsequent recordings in the United States Patent and Trademark Office and the United States Copyright Office may be necessary to perfect a lien on registered trademarks and patents, trademark and patent applications and registered copyrights acquired by the Loan Parties after the Closing Date. (c) The Mortgages (including those to be executed and delivered after the Closing Date pursuant to Section 6.10) shall be effective to create in favor of the Collateral Agent (for the benefit of the Secured Parties) a valid Lien on all of the Loan Parties’ right, title and interest in and to the Mortgaged Property thereunder and the proceeds thereof, and when such Mortgages are filed or recorded in the proper real estate filing or recording offices, the Collateral Agent (for the benefit of the Secured Parties) shall have a perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Mortgaged Property and, to the extent applicable, subject to Section 9-315 of the Uniform Commercial Code, the proceeds thereof, in each case prior and superior in right to any other person, subject to the Intercreditor Agreements and except with respect to the rights of a person pursuant to Permitted Liens. 120 (d) Notwithstanding anything herein (including this Section 4.17) or in any other Loan Document to the contrary, neither any Borrower nor any other Loan Party makes any representation or warranty as to the effects of perfection or non-perfection, the priority or the enforceability of any pledge of or security interest in any Equity Interests of any Foreign Subsidiary that is not a Loan Party, or as to the rights and remedies of the Administrative Agent, the Collateral Agent or any Lender with respect thereto, under foreign law. Section 4.18 Location of Real Property and Leased Premises. (a) The Perfection Certificate correctly sets forth and identifies, in all material respects, as of the Closing Date all material Real Property owned by the Holdcos (other than the Parent Guarantor), the Borrowers and the Subsidiary Loan Parties and the addresses thereof. As of the Closing Date, the Holdcos (other than the Parent Guarantor), the Borrowers and the Subsidiary Loan Parties own in fee simple all the Real Property set forth as being owned by them on the Perfection Certificate. (b) The Perfection Certificate completely and correctly sets forth and identifies, in all material respects, as of the Closing Date, all material Real Property leased by the Holdcos (other than the Parent Guarantor), the Borrowers and the Subsidiary Loan Parties and the addresses thereof and the leases pursuant to which the Real Property is leased. Section 4.19 Solvency. (a) Immediately after giving effect to the Transactions on the Closing Date or prior to the date this representation and warranty is made or remade, (i) the fair value of the assets of each Borrower (individually) and the Holdcos, the Borrowers and their respective Subsidiaries on a consolidated basis, at a fair valuation, will exceed the debts and liabilities, direct, subordinated, unmatured, unliquidated, contingent or otherwise, of such Borrower (individually) and the Holdcos, the Borrowers and their respective Subsidiaries on a consolidated basis, respectively; (ii) the present fair saleable value of the property of each Borrower (individually) and the Holdcos, the Borrowers and their respective Subsidiaries on a consolidated basis will be greater than the amount that will be required to pay the probable liability of such Borrower (individually) and the Holdcos, the Borrowers and their respective Subsidiaries on a consolidated basis, respectively, on their debts and other liabilities, direct, subordinated, unmatured, unliquidated, contingent or otherwise, as such debts and other liabilities become absolute and matured; (iii) each Borrower (individually) and the Holdcos, the Borrowers and their respective Subsidiaries on a consolidated basis will be able to pay their debts and liabilities, direct, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured; and (iv) each Borrower (individually) and the Holdcos, the Borrowers and their respective Subsidiaries on a consolidated basis will not have unreasonably small capital with which to conduct the businesses in which they are engaged as such businesses are now conducted and are proposed to be conducted following the Closing Date. (b) On the Closing Date, neither the Holdcos nor any Borrower intends to, and neither the Holdcos nor any Borrower believes that it or any of its subsidiaries will, incur debts beyond its ability to pay such debts as they mature, taking into account the timing and amounts of cash to be received by it or any such subsidiary and the timing and amounts of cash to be payable on or in respect of its Indebtedness or the Indebtedness of any such subsidiary. Section 4.20 Labor Matters. Except as, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect: (a) there are no strikes or other labor disputes pending or threatened against any Holdco (other than the Parent Guarantor), any Borrower or any of their respective Subsidiaries; (b) the hours worked by and payments made to employees of each Holdco (other than the 121 Parent Guarantor), each Borrower and their respective Subsidiaries have not been in violation of the Fair Labor Standards Act or any other applicable law dealing with such matters; and (c) all payments due from any Holdco (other than the Parent Guarantor), any Borrower or any of their respective Subsidiaries or for which any claim may be made against any Holdco (other than the Parent Guarantor), any Borrower or any of their respective Subsidiaries, on account of wages and employee health and welfare insurance and other benefits have been paid or accrued as a liability on the books of such Holdco, such Borrower or such Subsidiary to the extent required by the Applicable Accounting Rules. Except as, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect, the consummation of the Transactions will not give rise to a right of termination or right of renegotiation on the part of any union under any material collective bargaining agreement to which any Holdco (other than the Parent Guarantor), any Borrower or any of their respective Subsidiaries (or any predecessor) is a party or by which any Holdco (other than the Parent Guarantor), any Borrower or any of their respective Subsidiaries (or any predecessor) is bound. Section 4.21 Insurance. Schedule 4.21 sets forth a true, complete and correct description, in all material respects, of all material insurance maintained by or on behalf of the Holdcos (other than the Parent Guarantor), the Borrowers and their respective Subsidiaries as of the Closing Date. As of such date, such insurance is in full force and effect. Section 4.22 No Default. No Default or Event of Default has occurred and is continuing or would result from the consummation of the transactions contemplated by this Agreement or any other Loan Document. Section 4.23 Intellectual Property; Licenses, Etc. Except as would not reasonably be expected to have a Material Adverse Effect and as set forth in Schedule 4.23, (a) each Borrower and each of its Subsidiaries owns, or possesses the right to use, all of the patents, patent rights, trademarks, service marks, trade names, copyrights, mask works, domain names, and any and all applications or registrations for any of the foregoing (collectively, “Intellectual Property Rights”) that are reasonably necessary for the operation of their respective businesses, without conflict with the rights of any other person, (b) to the best knowledge of each Borrower, neither such Borrower nor its Subsidiaries nor any Intellectual Property Right, proprietary right, product, process, method, substance, part, or other material now employed, sold or offered by or contemplated to be employed, sold or offered by such Borrower or its Subsidiaries infringes upon Intellectual Property Rights of any other person, and (c) no claim or litigation regarding any of the foregoing is pending or, to the best knowledge of each Borrower, threatened. Section 4.24 Senior Debt. The ABL Credit Obligations constitute “Senior Debt” (or the equivalent thereof) and “Designated Senior Debt” (or the equivalent thereof) under the documentation governing any outstanding Indebtedness, if any, permitted to be incurred hereunder constituting Indebtedness that, by its terms, is expressly subordinated in right of payment to the ABL Credit Obligations pursuant to written agreement. Section 4.25 Anti-Money Laundering and Economic Sanction Laws. (a) To its reasonable knowledge, no Loan Party or any of its subsidiaries or its Affiliates and none of the respective officers, directors or agents of such Loan Party, subsidiary or Affiliate has violated or is in violation of any applicable Anti-Money Laundering Laws in any material respect. (b) No Loan Party nor any of its subsidiaries or its Affiliates nor, to its knowledge, any director, officer, employee, agent, Affiliate or representative of such Loan Party or Subsidiary (each, a “Specified Person”) is an individual or entity that is, or is owned or controlled by individuals or entities 122 that are currently the subject of any sanctions or trade embargoes imposed, administered or enforced by OFAC, the U.S. Department of State, or any other Governmental Authority of the United States of America, including without limitation, OFAC or the U.S. Department of State, or by Her Majesty’s Treasury, the United Kingdom or the European Union (collectively, “Sanctions”), nor is any Loan Party or any of its subsidiaries or its Affiliates or any individuals or entities that own or control such person located, organized or resident in a Sanctioned Country. To its knowledge, each Borrower, its Subsidiaries and their respective Affiliates maintains reasonable policies and procedures designed to promote and achieve compliance with Sanctions and Anti-Money Laundering Laws and with the representation and warranty contained herein. (c) Except to the extent permitted for a Person required to comply with Sanctions, no Specified Person will, directly or indirectly, use any proceeds of the Loans or any Letter of Credit or lend, contribute or otherwise make available such proceeds to any Person (i) for the purpose of financing the activities or business of or with any Person or in any country or territory that, at the time of financing, is an Embargoed Person or a Sanctioned Country or (ii) in any other manner that would result in a violation of Sanctions by any Loan Party or any other Lender party to this Agreement. (d) Except to the extent conducted in accordance with applicable Law, no Loan Party, nor any of its subsidiaries and Affiliates and, to its knowledge, none of the respective officers, directors, brokers or agents of such Loan Party, such subsidiary or such Affiliate acting or benefiting in any capacity in connection with the Loans (i) conducts any business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any Embargoed Person, (ii) deals in, or otherwise engages in any transaction related to, any property or interests in property blocked pursuant to any Sanctions or (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the applicable prohibitions set forth under Sanctions. Section 4.26 Anti-Corruption Laws. None of the Holdcos, any Borrower or any of their respective Subsidiaries nor, to their knowledge, any director, officer, agent, employee or Affiliate of the Holdcos, any Borrower or any of their respective Subsidiaries is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the FCPA or any other applicable anti- corruption laws, including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization or approval of the payment of any money, or other property, gift, promise to give or authorization of the giving of anything of value, directly or indirectly, to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office in contravention of the FCPA or any other applicable anti-corruption laws. Each Borrower, its Subsidiaries and their respective Affiliates have conducted their businesses in compliance with applicable anti- corruption laws and the FCPA and will maintain policies and procedures designed to promote and achieve compliance with such laws and with the representation and warranty contained herein. Section 4.27 Borrowing Base Matters. The calculation by the Borrowers of the Borrowing Base in each Borrowing Base Certificate delivered hereunder is complete and accurate in all material respects as of the time such calculation was made. The Administrative Agent may rely, in determining which Accounts are Eligible Accounts, and which Inventory is Eligible Inventory, on all statements and representations by the Borrowers and their respective Subsidiaries with respect thereto, as contained in the Borrowing Base Certificate, and in any other Loan Document. Section 4.28 EEA Financial Institution. None of the Holdcos or any Borrower is an EEA Financial Institution.


 
123 ARTICLE V CONDITIONS OF LENDING The obligations of (a) the Lenders to make Loans and (b) any L/C Issuer to issue Letters of Credit or increase the stated amounts of Letters of Credit hereunder (each, a “Credit Event”) are subject to the satisfaction or waiver (in accordance with Section 10.01 hereof) of the following conditions: Section 5.01 All Credit Events. On the date of each Credit Event: (a) The Administrative Agent shall have received (i) in the case of a Revolving Facility Borrowing, a Revolving Facility Borrowing Request as required by Section 2.03 (or a Revolving Facility Borrowing Request shall have been deemed given in accordance with the last paragraph of Section 2.03 or with Section 2.04(c)(i)) or, in the case of the issuance of a Letter of Credit, the applicable L/C Issuer and the Administrative Agent shall have received a notice requesting the issuance of such Letter of Credit as required by Section 2.05 and/or (ii) in the case of a Term Loan Facility Borrowing, a Term Loan Request as required by Section 2.15. (b) The representations and warranties set forth in the Loan Documents shall be true and correct in all material respects (or, to the extent that any such representations and warranties are qualified by materiality, in all respects) as of such date (other than an amendment, extension or renewal of a Letter of Credit without any increase in the stated amount of such Letter of Credit), as applicable, with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date (in which case such representations and warranties shall be true and correct in all material respects (or, to the extent that any such representations and warranties are qualified by materiality, in all respects) as of such earlier date). (c) At the time of and immediately after such Revolving Facility Borrowing or issuance, amendment, extension or renewal of a Letter of Credit (other than an amendment, extension or renewal of a Letter of Credit without any increase in the stated amount of such Letter of Credit), as applicable, (i) no Event of Default or Default shall have occurred and be continuing or would result therefrom and (ii) the Revolving Facility Credit Exposure shall not exceed the lesser of (A) the Revolving Loan Limit and (B) Borrowing Base. (d) Prior to the funding of the first Term Loan Facility Borrowing, Administrative Agent shall have received satisfactory confirmation that the modifications to Mortgages in Alabama and West Virginia, more particularly specified in Schedule 1 clauses (i)(F) and (G) to Amendment No. 2 have been executed, acknowledged and delivered to the title insurer and the title insurer has submitted such modifications to Mortgages in Alabama and West Virginia for recording. (e) The Administrative Agent and the Term Loan Lenders shall have received, in respect of any Term Loan Facility Borrowing, the applicable Term Loan Facility Fee and all other fees due and payable on the date of such Credit Event in respect to any Term Loan Facility Borrowing in accordance with the Amendment No. 2 Fee Letter. (f) Each Lender requesting a Note, no later than three (3) Business Days prior to the funding of any Term Loan Facility Borrowing, shall have received a fully executed Note in the principal amount of its Term Loan contemporaneously with the funding of such Term Loan. Each such Credit Event shall be deemed to constitute a representation and warranty by the Borrowers on the date of such Borrowing, issuance, amendment, extension or renewal, as applicable, as to the matters specified in paragraphs (b) and (c) of this Section 5.01. 124 Section 5.02 First Credit Event. On or prior to the Closing Date. (a) The Administrative Agent (or its counsel) shall have received from each party thereto either (i) a counterpart of this Agreement and each other Loan Document to be executed on or prior to the Closing Date, signed on behalf of such party or (ii) written evidence satisfactory to the Administrative Agent (which may include electronic transmission of a signed signature page of this Agreement) that such party has signed a counterpart of this Agreement and such other applicable Loan Documents. (b) The Administrative Agent shall have received, on behalf of itself, the Lenders and the L/C Issuer on the Closing Date, a favorable written opinion of Wachtell, Lipton, Rosen & Katz, Clifford Chance Europe LLP and other counsel set forth on Schedule 5.02(b), in each case addressed to the Administrative Agent, the Lenders and the L/C Issuer, which shall be in form and substance reasonably satisfactory to the Administrative Agent and covering such matters as the Administrative Agent shall reasonably request. (c) The Administrative Agent shall have received in the case of each Loan Party and the Parent Guarantor each of the items referred to in clauses (i), (ii), (iii) and (iv) below, to the extent applicable: (i) a copy of the certificate or articles of incorporation, certificate of limited partnership or certificate of formation, as applicable, including all amendments thereto, of each Loan Party, certified as of a recent date by the Secretary of State (or other similar official) of the jurisdiction of its organization, a certificate as to the good standing (to the extent such concept or a similar concept exists under the laws of such jurisdiction) of each such Loan Party as of a recent date from such Secretary of State (or other similar official), a copy of the articles of association (statuts) of the Parent Guarantor and a recent extract from the commercial and companies registry (register du commerce et des sociétés) of Paris relating to the Parent Guarantor; (ii) a certificate of the Secretary or Assistant Secretary or similar officer of each Loan Party and the Parent Guarantor dated the Closing Date and certifying; (A) that attached thereto is a true and complete copy of the by-laws (or partnership agreement, limited liability company agreement or other equivalent governing documents) of such Loan Party and the articles of association of the Parent Guarantor as in effect on the Closing Date and at all times since a date prior to the date of the resolutions described in clause (B) below; (B) that attached thereto is a true and complete copy of resolutions duly adopted by the Board of Directors (or equivalent governing body) of such Loan Party and the Parent Guarantor (or its managing general partner or managing member) authorizing the execution, delivery and performance of the Loan Documents to which such person is a party and, in the case of each Borrower, the borrowings hereunder, and that such resolutions have not been modified, rescinded or amended and are in full force and effect on the Closing Date; (C) that the certificate or articles of incorporation, certificate of limited partnership or certificate of formation of such Loan Party has not been amended since the date of the last amendment thereto disclosed pursuant to clause (i) above; (D) as to the incumbency and specimen signature of each officer executing any Loan Document or any other document delivered in connection herewith on behalf of such Loan Party (other than the Parent Guarantor); and 125 (E) as to the absence of any pending proceeding for the dissolution or liquidation of such Loan Party and the Parent Guarantor or, to the knowledge of such person, threatening the existence of such Loan Party and the Parent Guarantor; (iii) a certificate of a director or another officer as to the incumbency and specimen signature of the Secretary or Assistant Secretary or similar officer executing the certificate pursuant to clause (ii) above (other than the certificate with respect to the Parent Guarantor); and (iv) such other documents as the Administrative Agent, the Lenders and any L/C Issuer on the Closing Date may reasonably request (including without limitation, tax identification numbers and addresses). (d) The Administrative Agent shall have received evidence that the elements of the Collateral and Guarantee Requirement required to be satisfied on the Closing Date have been satisfied and the results of a search of the Uniform Commercial Code (or equivalent) filings made with respect to the Loan Parties in the jurisdictions contemplated by the Perfection Certificate and copies of the financing statements (or similar documents) disclosed by such search and evidence reasonably satisfactory to the Administrative Agent that the Liens indicated by such financing statements (or similar documents) are Permitted Liens or have been released. (e) The Administrative Agent and the Lenders shall have received a solvency certificate substantially in the form of Exhibit B-1 and signed by the Chief Financial Officer or Treasurer, as applicable, of each Borrower. (f) The Administrative Agent shall have received a certificate signed by a Responsible Officer of each Borrower certifying as to the matters set forth in Section 5.01 and Section 5.02(i) and (j). (g) The Administrative Agent shall have received evidence reasonably satisfactory to it that the Existing Factoring Agreement shall have been terminated and all amounts due or outstanding thereunder shall have been (or substantially with the closing under this Agreement shall be) paid in full and satisfactory arrangements shall have been made for the termination of any Liens granted in connection therewith. (h) The Administrative Agent and the Lenders shall have received the financial information (i) referred to in Section 4.05 and (ii) constituting the Projections, in each case, the results and assumptions set forth therein in form and substance reasonably satisfactory to the Administrative Agent. (i) On the Closing Date, after giving effect to the Transactions and the other transactions contemplated hereby, (x) no Borrower shall have outstanding any Indebtedness and each Borrower and its Subsidiaries shall have outstanding no Indebtedness other than (i) the extensions of credit under this Agreement and (ii) other Indebtedness permitted pursuant to Section 7.01 and (y) the Holdcos (other than the Parent Guarantor) shall have no Indebtedness for borrowed money (other than intercompany loans owed to Ultimate Parent or any of its Subsidiaries) for which they are liable as primary obligor. (j) Since December 31, 2017 there shall not have been any event, development or circumstance that, individually or in the aggregate, has, had or would reasonably be expected to have a Material Adverse Effect. 126 (k) All fees and expenses due and payable on or prior to the Closing Date, pursuant to the Fee Letter or as may otherwise be agreed between the Borrowers and the Joint Lead Arrangers shall have been paid (which amounts, at the option of the Borrowers, may be offset against the proceeds of the Revolving Facility), including, to the extent invoiced, reimbursement or payment of all reasonable out of pocket expenses (including reasonable fees, charges and disbursements of Sidley Austin LLP) required to be reimbursed or paid by the Loan Parties hereunder or under any Loan Document. (l) The Administrative Agent shall have received all insurance certificates satisfying the requirements of Section 6.02(a) of this Agreement. (m) The Administrative Agent and each Lender shall have received all documentation and other information required by regulatory authorities under applicable “know your customer” and anti- money laundering rules and regulations, including without limitation, the USA PATRIOT Act to the extent requested not less than seven (7) Business Days prior to the Closing Date. (n) Bowling Green shall have delivered, or cause to be delivered, to the Administrative Agent an inventory appraisal and a field examination from an Acceptable Appraiser for Bowling Green, in each case that are reasonably satisfactory in form and substance to the Administrative Agent on or prior to the Closing Date, and the Administrative Agent shall have received a Borrowing Base Certificate effective as of the last day of the month immediately preceding the Closing Date. For purposes of determining compliance with the conditions specified in this Section 5.02, each Lender shall be deemed to have consented to, approved or accepted or to be satisfied with each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to the Lenders unless an officer of the Administrative Agent responsible for the transactions contemplated by the Loan Documents shall have received notice from such Lender prior to the Closing Date specifying its objection thereto and such Lender shall not have made available to the Administrative Agent such Lender’s ratable portion of the initial Borrowing. ARTICLE VI AFFIRMATIVE COVENANTS Each Borrower covenants and agrees with each Lender that unless and until (i) all Commitments shall have been terminated, (ii) all ABL Credit Obligations arising under the Loan Documents (other than contingent obligations for unasserted claims) shall have been repaid and (iii) all Letters of Credit have been canceled or have expired (or shall have been Cash Collateralized or backstopped on terms reasonably satisfactory to the Administrative Agent) and all amounts drawn or paid thereunder have been reimbursed in full, unless the Required Lenders shall otherwise consent in writing, each Borrower will, and will cause each of the Material Subsidiaries to: Section 6.01 Existence; Businesses and Properties. (a) Do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence, except, in the case of a Subsidiary of a Borrower, where the failure to do so would not reasonably be expected to have a Material Adverse Effect, and except as otherwise expressly permitted under Section 7.05, and except for the liquidation or dissolution of Subsidiaries if the assets of such Subsidiaries, to the extent they exceed estimated liabilities, are acquired by a Borrower or a Wholly Owned Subsidiary of a Borrower in such liquidation or dissolution; provided that Subsidiary Loan Parties may not be liquidated into Subsidiaries that are not Loan Parties and Domestic Subsidiaries may not be liquidated into Foreign Subsidiaries.


 
127 (b) Except where the failure to do so would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, do or cause to be done all things necessary to (i) lawfully obtain, preserve, renew, extend and keep in full force and effect the rights, privileges, qualifications, permits, franchises, authorizations, patents, trademarks, service marks, trade names, copyrights, licenses and rights with respect thereto necessary in the normal conduct of its business, (ii) at all times maintain and preserve all property necessary in the normal conduct of its business and keep such property in good repair, working order and condition and from time to time make, or cause to be made, all needful and proper repairs, renewals, additions, improvements and replacements thereto necessary in order that the business carried on in connection therewith, if any, may be properly conducted at all times, and (iii) conduct its business and affairs without infringement of or interference with any Intellectual Property Right of any other Person in any respect (in each case except as expressly permitted by this Agreement). Section 6.02 Insurance. (a) Maintain, with financially sound and reputable insurance companies (that are not Affiliates of any Loan Party), insurance in such amounts, providing such coverage as is sufficient and against such risks as are customarily maintained by similarly situated companies engaged in the same or similar businesses operating in the same or similar locations and cause, subject to the time periods set forth in clause (i) of the definition of “Collateral and Guarantee Requirement” and Schedule 6.10, if applicable, the Administrative Agent to be listed as a loss payee on property policies and as an additional insured on liability policies. All such policies of insurance will contain an endorsement, in form and substance acceptable to the Administrative Agent, showing loss payable to the Administrative Agent (Form CP 1218 or equivalent and naming the Administrative Agent as lenders loss payee as agent for the Lenders) and extra expense and business interruption endorsements. Such endorsement, or an independent instrument furnished to the Administrative Agent, will provide that the insurance companies will give the Administrative Agent at least 30 days’ prior written notice before any such policy or policies of insurance shall be altered or canceled and that no act or default of the Loan Parties or any other Person shall affect the right of the Administrative Agent to recover under such policy or policies of insurance in case of loss or damage. Each Loan Party shall direct all present and future insurers under its “All Risk” policies of property insurance to pay all proceeds payable thereunder directly to the Administrative Agent. Subject to the terms of the Intercreditor Agreements, if any insurance proceeds are paid by check, draft or other instrument payable to any Loan Party and the Administrative Agent jointly, the Administrative Agent may endorse such Loan Party’s name thereon and do such other things as the Administrative Agent may deem advisable to reduce the same to cash. The Administrative Agent reserves the right at any time, upon review of each Loan Party’s risk profile, to reasonably require additional forms and limits of insurance. All flood insurance on Mortgaged Properties (including all related diligence, documentation and coverage) shall comply with the Flood Laws, or otherwise shall be reasonably satisfactory to all Lenders. (b) With respect to any Mortgaged Properties, if at any time the area in which the Premises (as defined in the Mortgages) are located is designated a “flood hazard area” in any Flood Insurance Rate Map published by the Federal Emergency Management Agency (or any successor agency), maintain, subject to the time periods and other requirements regarding flood insurance set forth in clause (g) of the definition of “Collateral and Guarantee Requirement” to the extent commercially reasonably available flood insurance from such providers, on such terms, and in amounts no less than that maintained by the Borrowers and the Material Subsidiaries as of the Closing Date or in such other total amount as the Administrative Agent may from time to time reasonably require or as otherwise required by the Lenders, and otherwise comply with Flood Laws, and in addition, the applicable Loan Party shall name the Administrative Agent, as a loss payee and mortgagee with respect to all such flood insurance policies. 128 (c) In connection with the covenants set forth in this Section 6.02, it is understood and agreed that: (i) none of the Administrative Agent, the Lenders and their respective agents or employees shall be liable for any loss or damage insured by the insurance policies required to be maintained under this Section 6.02, it being understood that (A) the Loan Parties shall look solely to their insurance companies or any other parties other than the aforesaid parties for the recovery of such loss or damage and (B) such insurance companies shall have no rights of subrogation against the Administrative Agent, the Lenders or their agents or employees. If, however, the insurance policies, as a matter of the internal policy of such insurer, do not provide waiver of subrogation rights against such parties, as required above, then each of the Holdcos and the Borrowers, on behalf of itself and behalf of each of its Subsidiaries, hereby agrees, to the extent permitted by law, to waive, and further agrees to cause each of their Subsidiaries to waive, its right of recovery, if any, against the Administrative Agent, the Lenders and their agents and employees; and (ii) the designation of any form, type or amount of insurance coverage by the Administrative Agent under this Section 6.02 shall in no event be deemed a representation, warranty or advice by the Administrative Agent or the Lenders that such insurance is adequate for the purposes of the business of the Holdcos, the Borrowers and their respective Subsidiaries or the protection of their properties. (d) Unless the Loan Parties provide the Administrative Agent with evidence of the insurance coverage required by this Agreement (including, without limitation, flood insurance), the Administrative Agent may purchase insurance (including, without limitation, flood insurance) at the Loan Parties’ expense to protect the Administrative Agent’s and Lenders’ interests in the Loan Parties’ and their Subsidiaries’ properties with ten (10) days’ prior written notice to the Loan Parties. This insurance may, but need not, protect the Loan Parties’ and their Subsidiaries’ interests. The coverage that the Administrative Agent purchases may not pay any claim that any Loan Party or any Subsidiary of any Loan Party makes or any claim that is made against such Loan Party or any Subsidiary in connection with said Property. The Loan Parties may later cancel any insurance purchased by the Administrative Agent, but only after providing the Administrative Agent with evidence that there has been obtained insurance as required by this Agreement. If the Administrative Agent purchases insurance, the Loan Parties will be responsible for the costs of that insurance, including interest and any other charges the Administrative Agent may impose in connection with the placement of insurance, until the effective date of the cancellation or expiration of the insurance. The costs of the insurance shall be added to the ABL Credit Obligations. The costs of the insurance may be more than the cost of insurance the Loan Parties may be able to obtain on their own. Section 6.03 Taxes. Pay and discharge promptly when due all Taxes imposed upon it or upon its income or profits or in respect of its property, before the same shall become delinquent or in default, as well as all lawful claims which, if unpaid, might give rise to a Lien (other than a Permitted Lien) upon such properties or any part thereof, except to the extent the validity or amount thereof shall be contested in good faith by appropriate proceedings, and the Holdcos, the Borrowers or the affected Subsidiary, as applicable, shall have set aside on its books reserves in accordance with the Applicable Accounting Rules with respect thereto and except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect. Section 6.04 Financial Statements, Reports, etc. Furnish to the Administrative Agent (which will promptly furnish such information to the Lenders): 129 (a) Within 120 days after the end of each fiscal year, a consolidated balance sheet and related statements of operations, cash flows and owners’ equity showing the financial position of the Ultimate Parent and its Subsidiaries as of the close of such fiscal year and the consolidated results of its operations during such year and setting forth in comparative form the corresponding figures for the prior fiscal year, which consolidated balance sheet and related statements of operations, cash flows and owners’ equity shall be audited by independent public accountants of recognized national (in the United States of America) or international standing and accompanied by an opinion of such accountants (which opinion shall not be qualified as to scope of audit or as to the status of the Ultimate Parent as a going concern) to the effect that such consolidated financial statements fairly present, in all material respects, the financial position and results of operations of the Ultimate Parent and its Subsidiaries on a consolidated basis in accordance with the Applicable Accounting Rules; (b) within 65 days after the end of each of the first three fiscal quarters of each fiscal year beginning with the fiscal quarter ending March 31, 2019, a consolidated balance sheet and related statements of operations and cash flows showing the financial position of the Ultimate Parent and its Subsidiaries as of the close of such fiscal quarter and the consolidated results of its operations during such fiscal quarter and the then elapsed portion of the fiscal year and setting forth in comparative form the corresponding figures for the corresponding periods of the prior fiscal year, and which consolidated balance sheet and related statements of operations and cash flows shall be certified by a Financial Officer of the Ultimate Parent on behalf of the Ultimate Parent as fairly presenting, in all material respects, the financial position and results of operations of the Ultimate Parent and its Subsidiaries on a consolidated basis in accordance with the Applicable Accounting Rules (subject to normal year-end audit adjustments and the absence of footnotes); (c) within 35 days after the end of each fiscal quarter of each fiscal year (including the last fiscal quarter of each fiscal year), a consolidated balance sheet and related statements of operations and cash flows showing the financial position of each Borrower and its Subsidiaries as of the close of such fiscal quarter and the consolidated results of its operations during such fiscal quarter and the then elapsed portion of the fiscal year (and if at any time in any fiscal month of Borrowers, Availability is less than or equal to the greater of 20% of the Loan Cap and $60,000,000 for any five (5) consecutive Business Days during such fiscal month, then, within 35 days after the end of such fiscal month, a consolidated balance sheet and related statements of operations and cash flows showing the financial position of each Borrower and its Subsidiaries as of the close of such fiscal month and the consolidated results of its operations during such fiscal month and the then elapsed portion of the fiscal year), and in each case which consolidated balance sheet and related statements of operations and cash flows (whether for fiscal quarter end or fiscal month end, as the case may be) shall be certified by a Financial Officer of each Borrower on behalf of such Borrower as fairly presenting, in all material respects, the financial position and results of operations of such Borrower and its Subsidiaries on a consolidated basis in accordance with the Applicable Accounting Rules (subject to normal year-end audit adjustments and the absence of footnotes); (d) concurrently with any delivery of financial statements under paragraphs (a) or (b) above, a certificate of a Financial Officer of each Borrower (i) certifying that no Event of Default or Default has occurred or, if such an Event of Default or Default has occurred, specifying the nature and extent thereof and any corrective action taken or proposed to be taken with respect thereto, (ii) solely with respect to any fiscal period for which the average daily Availability during such fiscal period is less than 25% of the Revolving Loan Limit, setting forth computations in reasonable detail satisfactory to the Administrative Agent of the Fixed Charge Coverage Ratio and the Minimum Borrower EBITDA Contribution, (iii) setting forth computations in reasonable detail satisfactory to the Administrative Agent of the Average Quarterly Excess Availability, (iv) certifying a list of names of all Immaterial Subsidiaries, that each Subsidiary set forth on such list individually qualifies as an Immaterial Subsidiary 130 and that all such Subsidiaries in the aggregate do not exceed the limitation set forth in clause (ii) of the definition of the term Immaterial Subsidiary and (v) certifying a list of names of all Unrestricted Subsidiaries, that each Subsidiary set forth on such list individually qualifies as an Unrestricted Subsidiary; (e) within 90 days after the beginning of each fiscal year, a reasonably detailed consolidated annual budget for each fiscal quarter during such fiscal year (including a projected consolidated balance sheet of each Borrower and its Subsidiaries as of the end of the following fiscal year, and the related consolidated statements of projected cash flow and projected income), including a description of underlying assumptions with respect thereto (collectively, the “Budget”), which Budget shall in each case be accompanied by the statement of a Financial Officer of each Borrower to the effect that the Budget is based on assumptions believed by such Financial Officer to be reasonable as of the date of delivery thereof; (f) upon the reasonable request of the Administrative Agent, an updated Perfection Certificate (or, to the extent such request relates to specified information contained in the Perfection Certificate, such information) reflecting all changes since the date of the information most recently received pursuant to this paragraph (f) or Section 6.10(f); (g) (i) promptly, from time to time, such other information regarding the operations, collateral, business affairs and financial condition of the Holdcos, the Borrowers or any of the Borrowers’ respective Subsidiaries, or compliance with the terms of any Loan Document, or such consolidating financial statements as in each case the Administrative Agent may reasonably request (for itself or on behalf of any Lender) and (ii) prior written notice in the event that any Borrower changes its fiscal year end or any other material change in accounting policies or financial reporting practices by any Loan Party or any Subsidiary thereof; (h) promptly upon request by the Administrative Agent, copies of: (i) each Schedule SB or MB (Actuarial Information) to the most recent annual report (Form 5500 Series) filed with the Internal Revenue Service with respect to a Plan; (ii) the most recent actuarial valuation report for any Plan; (iii) all notices received from a Multiemployer Plan sponsor, a plan administrator or any governmental agency, or provided to any Multiemployer Plan by the Holdcos, the Borrowers, a Subsidiary or any ERISA Affiliate, concerning an ERISA Event; and (iv) such other documents or governmental reports or filings relating to any Plan or Multiemployer Plan as the Administrative Agent shall reasonably request; and (i) Borrowing Base Certificates, at the times specified in Section 6.13. Section 6.05 Litigation and Other Notices. Furnish to the Administrative Agent (which will promptly thereafter furnish to the Lenders) written notice of the following promptly after any Responsible Officer of the Holdcos or any Borrower obtains actual knowledge thereof: (a) any Event of Default or Default, specifying the nature and extent thereof and the corrective action (if any) proposed to be taken with respect thereto; (b) the filing or commencement of, or any written threat or notice of intention of any person to file or commence, any action, suit or proceeding, whether at law or in equity or by or before any Governmental Authority or in arbitration, against the Holdcos, any Borrower or any of the Borrowers’ respective Subsidiaries as to which an adverse determination is reasonably probable and which, if adversely determined, would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect;


 
131 (c) any other development (including, without limitation, any development related to litigation or labor controversies) specific to the Holdcos, any Borrower or any of its Subsidiaries that is not a matter of general public knowledge and that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; (d) the development or occurrence of any ERISA Event that, together with all other ERISA Events that have developed or occurred, would reasonably be expected to have a Material Adverse Effect; and (e) the creation, establishment or acquisition of any direct or indirect Subsidiary of a Borrower. Section 6.06 Compliance with Laws. Comply with all laws, rules, regulations and orders of any Governmental Authority applicable to it or its property, except where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; provided that this Section 6.06 shall not apply to Environmental Laws, which are the subject of Section 6.09, or to laws related to Taxes, which are the subject of Section 6.03. Section 6.07 Maintaining Records; Access to Properties and Inspections. Maintain all financial records in accordance with the Applicable Accounting Rules and permit the Administrative Agent (and its consultants or agents), accompanied by any Lender which so elects, upon reasonable advance notice and at reasonable times during regular business hours, and at any time when an Event of Default exists, to have access to, examine, audit, make extracts from or copies of, and inspect any or all of the Loan Parties’ records, files, and books of account and the Collateral, and discuss the Loan Parties’ affairs with the Loan Parties’ officers and senior management; provided that, (i) unless an Event of Default is continuing, such access, examinations, audits and inspections shall be limited to two instances in any calendar year and (ii) all such access, examinations, audits and inspections will be at the Loan Parties’ expense. The Loan Parties will deliver to the Administrative Agent any instrument necessary for the Administrative Agent to obtain records from any service bureau maintaining records for the Loan Parties. The Administrative Agent may, and at the direction of the Required Lenders shall, at any time when an Event of Default exists, and at the Loan Parties’ expense, make copies of all of the Loan Parties’ books and records, or require the Loan Parties to deliver such copies to the Administrative Agent. Upon reasonable request to senior management of the applicable Borrower, the Administrative Agent may, without expense to the Administrative Agent, use such of the Loan Parties’ respective personnel, supplies, and premises as may be reasonably necessary for maintaining or enforcing the Collateral Agent’s Liens. The Administrative Agent shall have the right, at any time, in the Administrative Agent’s name or in the name of a nominee of the Administrative Agent, to verify the validity, amount, or any other matter relating to the Accounts, Inventory, or other Collateral, by mail, telephone, or otherwise; provided, however, in the absence of an Event of Default, the Collateral Agent agrees that it will not attempt to verify more than ten (10) Accounts each month. Section 6.08 Use of Proceeds. Use the proceeds of each Credit Event solely for (a) working capital, capital expenditures, Permitted Business Acquisitions and other general corporate purposes not in violation of this Agreement or the other Loan Documents, (b) to effect the repurchase under and termination of or, refinancing (or discharge) of Indebtedness under, the Existing Factoring Agreement, and (c) costs, expenses and fees in connection with the Credit Facility. Section 6.09 Compliance with Environmental Laws. Comply, and make reasonable efforts to cause all lessees and other persons occupying its properties to comply, with all Environmental Laws applicable to its operations and properties; obtain and renew all material authorizations and permits required pursuant to Environmental Law for its operations and properties, in each case in accordance with 132 Environmental Laws, complete any investigation, study, sampling and testing and undertake any clean up, removal, remediation or other response necessary to remove and clean up Hazardous Materials, to the extent such actions are required under any applicable Environmental Laws, and make an appropriate response to any notice, request for information, order, or complaint that alleges a violation of or liability under any Environmental Laws, except, in each case with respect to this Section 6.09, to the extent the failure to do so would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Section 6.10 Further Assurances; Additional Security. (a) Promptly execute any and all further documents, financing statements, agreements and instruments, and take all such further actions (including the filing and recording of financing statements, fixture filings, Mortgages and other documents and recordings of Liens in stock registries), that may be required under any applicable law or to carry out more effectively the purposes of this Agreement or any other Loan Document, including, for the avoidance of doubt, the post-closing items set forth on Schedule 6.10, or that the Collateral Agent may reasonably request to satisfy the Collateral and Guarantee Requirement and to cause the Collateral and Guarantee Requirement to be and remain satisfied, all at the expense of the Loan Parties and provide to the Collateral Agent, from time to time upon reasonable request, evidence reasonably satisfactory to the Collateral Agent as to the perfection and priority of the Liens created or intended to be created by the Security Documents. (b) If any asset (including any Real Property (other than Real Property covered by paragraph (c) below) or improvements thereto or any interest therein) that has an individual fair market value (as determined in good faith by the applicable Borrower) in an amount greater than $1,000,000 is acquired by a Borrower or any other Loan Party after the Closing Date or owned by an entity at the time it becomes a Subsidiary Loan Party (in each case other than (x) assets constituting Collateral under a Security Document that become subject to the Lien of such Security Document upon acquisition thereof and (y) assets that are not required to become subject to Liens in favor of the Collateral Agent pursuant to Section 6.10(g) or the Security Documents) (i) notify the Collateral Agent thereof, and (ii) cause such asset to be subjected to a Lien securing the ABL Finance Obligations (subject, as the case may be, to the Intercreditor Agreements and Permitted Liens) and take, and cause the Subsidiary Loan Parties to take, such actions as shall be necessary or reasonably requested by the Collateral Agent to grant and perfect such Liens, (subject, as the case may be, to the Intercreditor Agreements and Permitted Liens), including actions described in paragraph (a) of this Section 6.10, all at the expense of the Loan Parties, subject to paragraph (g) below. (c) Promptly notify the Collateral Agent of the acquisition of, and grant and cause each of the Subsidiary Loan Parties to grant to the Collateral Agent security interests and mortgages in, such Real Property of such Borrower or any such Subsidiary Loan Parties as are not covered by the original Mortgages, to the extent acquired after the Closing Date and having a value at the time of acquisition in excess of $25,000,000 in the aggregate, and, to the extent requested by the Collateral Agent, pursuant to documentation substantially in the form of the Mortgages delivered to the Collateral Agent pursuant to the post-closing timing requirement specified in the definition of “Collateral and Guarantee Requirement” or in such other form as is reasonably satisfactory to the Collateral Agent (each, an “Additional Mortgage”) and constituting valid and enforceable Liens subject to no other Liens except Permitted Liens and subject to the Intercreditor Agreements, at the time of perfection thereof, record or file, and cause each such Subsidiary to record or file, the Additional Mortgage or instruments related thereto in such manner and in such places as is required by law to establish, perfect, preserve and protect the Liens in favor of the Collateral Agent required to be granted pursuant to the Additional Mortgages and pay, and cause each such Subsidiary to pay, in full, all Taxes, fees and other charges payable in connection therewith, in each case subject to paragraph (g) below. Unless otherwise waived by the 133 Collateral Agent, with respect to each such Additional Mortgage, the applicable Borrower shall deliver to the Collateral Agent (i) if such Real Property is an improved Real Property, prior to the execution and delivery of such Additional Mortgage, (x)(1) address and other identifying information with respect to such Real Property reasonably satisfactory to the Collateral Agent and (2) if any improvements on such Mortgaged Property are located within any area designated by the Director of the Federal Emergency Management Agency as a “special flood hazard” area (as may be established by a completed Federal Emergency Management Agency Standard Flood Hazard Determination with respect to such Mortgaged Property), evidence of a flood insurance policy (if such insurance is required by applicable Law and commercially reasonably available) from a company and in an amount satisfactory to the Collateral Agent for the applicable portion of the premises, naming the Collateral Agent, for the benefit of the Lenders, as mortgagee or (y) a certification from a registered engineer or land surveyor in a form reasonably satisfactory to the Collateral Agent or other evidence reasonably satisfactory to the Collateral Agent that none of the improvements on such Mortgaged Property is located within any area designated by the Director of the Federal Emergency Management Agency as a “special flood hazard” area and (ii) contemporaneously therewith a title insurance policy and a copy of any survey obtained by such Borrower with respect to each Real Property subject to an Additional Mortgage. (d) If any additional direct or indirect Subsidiary of any Borrower is formed (including pursuant to a Division) or acquired after the Closing Date (with any Subsidiary Redesignation resulting in an Unrestricted Subsidiary becoming a Subsidiary being deemed to constitute the acquisition of a Subsidiary), and if such Subsidiary is a Subsidiary Loan Party, within ten Business Days after the date such Subsidiary is formed or acquired, notify the Collateral Agent and the Lenders thereof and, within 20 Business Days after the date such Subsidiary is formed or acquired or such longer period as the Collateral Agent shall agree, cause the Collateral and Guarantee Requirement to be satisfied with respect to such Subsidiary and with respect to any Equity Interest in or Indebtedness of such Subsidiary owned by or on behalf of any Loan Party, subject to paragraph (g) below. (e) If any additional Foreign Subsidiary of any Borrower is formed or acquired after the Closing Date (with any Subsidiary Redesignation resulting in an Unrestricted Subsidiary becoming a Subsidiary being deemed to constitute the acquisition of a Subsidiary), and if such Subsidiary is a “first tier” Foreign Subsidiary, within five Business Days after the date such Foreign Subsidiary is formed or acquired, notify the Collateral Agent and the Lenders thereof and, within 20 Business Days after the date such Foreign Subsidiary is formed or acquired or such longer period as the Collateral Agent shall agree, cause the Collateral and Guarantee Requirement to be satisfied with respect to any Equity Interest in such Foreign Subsidiary owned by or on behalf of any Loan Party, subject to the Intercreditor Agreements and paragraph (g) below. (f) (i) Furnish to the Collateral Agent prompt written notice of any change (A) in any Loan Party’s or the Parent Guarantor’s corporate or organization name or jurisdiction of organization or formation, (B) in any Loan Party’s or the Parent Guarantor’s identity or organizational structure or (C) in any Loan Party’s or the Parent Guarantor’s organizational identification number; provided that no Borrower shall effect or permit any such change unless all filings have been made, or will have been made within any statutory period, under the Uniform Commercial Code or otherwise that are required in order for the Collateral Agent to continue at all times following such change to have a valid, legal and perfected security interest in all the Collateral for the benefit of the Secured Parties and (ii) promptly notify the Collateral Agent if any material portion of the Collateral is damaged or destroyed. (g) The Collateral and Guarantee Requirement and the other provisions of this Section 6.10 need not be satisfied with respect to (i) any motor vehicle, (ii) Exempt Deposit Accounts, (iii) any Equity Interests issued or acquired after the Closing Date (other than Equity Interests in each Borrower or, in the case of any person which is a Subsidiary, Equity Interests in such person issued or 134 acquired after such person became a Subsidiary) in accordance with this Agreement if, and to the extent that, and for so long as (A) such Equity Interests constitute less than 100% of all applicable Equity Interests of such person and the person holding the remainder of such Equity Interests are not Affiliates, (B) doing so would violate applicable law or a contractual obligation binding on or with respect to such Equity Interests or such Subsidiary and (C) with respect to such contractual obligations, such obligation existed at the time of the acquisition thereof and was not created or made binding on or with respect to such Equity Interests or such Subsidiary in contemplation of or in connection with the acquisition of such Equity Interests or Subsidiary, (iv) any assets acquired after the Closing Date, to the extent that, and for so long as, taking such actions would violate an enforceable contractual obligation binding on such assets that existed at the time of the acquisition thereof and was not created or made binding on such assets in contemplation or in connection with the acquisition of such assets (except in the case of assets acquired with Indebtedness permitted pursuant to Section 7.01(i) that is secured by a Permitted Lien) or (v) those assets as to which the Collateral Agent shall reasonably determine that the costs of obtaining or perfecting such a security interest are excessive in relation to the value of the security to be afforded thereby; provided that, upon the reasonable request of the Collateral Agent, the applicable Borrower shall, and shall cause any applicable Subsidiary to, use commercially reasonable efforts to have waived or eliminated any contractual obligation of the types described in clauses (iii) and (iv) above. (h) Within 60 days after the Closing Date (or such later date as may be agreed by the Administrative Agent in its discretion), Bowling Green shall execute and deliver to the Collateral Agent a Deposit Account Control Agreement with respect to each Deposit Account of such Borrower and the Loan Parties in existence as of the Closing Date, other than any Exempt Deposit Account. (i) Prior to any Loan Party establishing and funding a Deposit Account following the Closing Date, the applicable Borrower shall notify the Collateral Agent thereof and execute and deliver to the Collateral Agent a Deposit Account Control Agreement with respect to each such Deposit Account, other than any Exempt Deposit Account. (j) Following the Closing Date (and subject to the time period provided for in Section 6.10(h)), the Loan Parties shall maintain effective Deposit Account Control Agreements with respect to each Deposit Account, other than Exempt Deposit Accounts, of the Loan Parties, at all times unless and until the Security Interest (as defined in the Collateral Agreement) with respect to such Deposit Account is released in accordance with this Agreement. Section 6.11 Appraisals and Field Examinations. Whenever an Event of Default exists, and at other times not more frequently than once per consecutive 12-month period so long as Availability during such period is at all times not less than the greater of 12.5% of the Loan Cap and $37,500,00046,900,000, the Loan Parties shall, at their expense and upon the Administrative Agent’s request, provide the Administrative Agent with appraisals of inventory and field examinations or updates thereof of any or all of the Collateral from one or more Acceptable Appraisers, and prepared in a form and on a basis reasonably satisfactory to the Administrative Agent, such appraisals and updates to include, without limitation, information required by requirements of Law and by the internal policies of the Lenders; provided, that, (a) the Loan Parties shall provide, at the expense of the Loan Parties, during any time within a consecutive 12-month period that the Availability is less than the greater of 12.5% of the Loan Cap and $37,500,00046,900,000, a second such appraisal of inventory or field examination or update during such period and (b) upon the request of the Administrative Agent, the Loan Parties shall provide, at the expense of the Administrative Agent and the Lenders, any other or additional appraisals of Collateral or field examination or update. In addition, the Loan Parties shall have the right (but not the obligation), at their expense, at any time and from time to time (but not more than once per year) to provide the Administrative Agent with additional appraisals or updates thereof of any or all of the Collateral from one or more Acceptable Appraisers, and prepared in a form and on a basis reasonably


 
135 satisfactory to the Administrative Agent, in which case such appraisals or field examinations or updates shall be used in connection with the determination of the Orderly Liquidation Value and the calculation of the Borrowing Base hereunder.. Section 6.12 Collection of Accounts; Payments. Subject to the post-closing timing requirement specified in Section 6.10 of this Agreement, establish a payment account for each Borrower, or designate an existing deposit account for each Borrower in form and substance reasonably satisfactory to the Administrative Agent (in either case, collectively, the “Primary Payment Accounts”), which shall each be a Controlled Account and into which all Account collections (other than Qualified Receivables to the extent subject to a Qualified Receivables Financing) and other proceeds of Collateral with respect to the applicable Borrower will be deposited (it being understood that the Loan Parties shall promptly transfer to the applicable Primary Payment Account any such collections or proceeds on deposit in or credited to any other payment account or other account, or received directly by any Loan Party), and the Loan Parties hereby agree that, during an Accounts Availability Triggering Event, the Collateral Agent will have exclusive control over each Primary Payment Account; provided, however, that, in the absence of an Accounts Availability Triggering Event, the Loan Parties will have exclusive right to make withdrawals from the Primary Payment Accounts. Section 6.13 Collateral Reporting. (a) Provide, or cause to be provided, to the Administrative Agent, a Borrowing Base Certificate (i) so long as the Revolving Extensions of Credit do not exceed 35% of the Loan Cap for any three (3) consecutive Business Days and no Availability Triggering Event has occurred during a calendar quarter, on or before the twelfth (12th) Business Day of the next calendar quarter as of the immediately preceding calendar quarter-end, (ii) to the extent that the Revolving Extensions of Credit equal or exceed 35% of the Loan Cap for any three (3) consecutive Business Days during a calendar quarter and no Availability Triggering Event has occurred, on or before the twelfth (12th) Business Day of the calendar month after the Revolving Extensions of Credit equal or exceed such amount, as of the immediately preceding calendar month-end, and thereafter on or before the twelfth (12th) Business day of the next two (2) consecutive months, as of the immediately preceding calendar month-end and (iii) notwithstanding anything to the contrary contained herein, during the continuance of an Availability Triggering Event, on each Friday, as of the Friday of the immediately preceding week or any later date approved by the Administrative Agent in its sole discretion. If any of the Loan Parties’ records or reports of the Collateral required to be delivered pursuant to this Agreement or any other Loan Document are prepared by an accounting service or other agent, each Loan Party hereby authorizes such service or agent to deliver such records or reports to the Administrative Agent, for distribution to the Lenders. Without limiting the foregoing, a Borrower may, at or prior to the closing of a Permitted Business Acquisition (but subject to any review of the acquired company’s Eligible Accounts and Eligible Inventory as required by the definitions of such terms), deliver a revised Borrowing Base Certificate showing the Borrowing Base on a Pro Forma Basis after giving effect to such acquisition, which would be effective for purposes of Borrowing as of the time of the closing of such Permitted Business Acquisition and, for the avoidance of doubt, demonstrating compliance with the requirements of clause (iii) of the definition thereof. The applicable Borrower shall be permitted upon notice of such election to the Administrative Agent to deliver an updated Borrowing Base Certificate more frequently than quarterly or monthly (as specified in such notice); provided, that, in such case, such Borrower shall, for the immediately following 90 days, deliver an updated Borrowing Base Certificate with the same frequency as the frequency specified in such notice. (b) Deliver to the Administrative Agent (i) concurrently with the delivery of each Borrowing Base Certificate, a summary of Inventory by location and type with a supporting perpetual Inventory report consistent with past practice; (ii) concurrently with the delivery of each Borrowing Base 136 Certificate, a monthly trial balance showing Accounts outstanding aged from due date as follows: current, 1 to 30 days, 31 to 60 days and 61 days or more, (iii) from time to time, such other information with respect to the Borrowing Base or any other reports delivered under this Section 6.13 as shall be requested by the Administrative Agent in its reasonable discretion; and (iv) at the time of delivery of each of the monthly financial statements delivered pursuant to Section 6.04(c): (A) a reconciliation of the most recent Borrowing Base and month-end Inventory reports by location each Borrower’s general ledger and monthly financial statements delivered pursuant to Section 6.04(c); (B) a reconciliation of the accounts receivable aging to the Borrowers’ most recent Borrowing Base Certificate, general ledger and monthly financial statements delivered pursuant to Section 6.04(c); (C) an aging of accounts payable and a reconciliation of such accounts payable aging to each Borrower’s general ledger and monthly financial statements delivered pursuant to Section 6.04(c); and (D) in the case of any monthly financial statements delivered for the last month of a fiscal quarter, a listing of government contracts, including those that are subject to the Federal Assignment of Claims Act of 1940 or any similar state or municipal law. Section 6.14 Anti-Money Laundering and Economic Sanction Laws; Anti-Corruption Laws. Each Loan Party shall comply, and each Loan Party shall cause each of its Subsidiaries to comply, in all material respects, with all laws, regulations and executive orders referred to in Sections 4.25 and 4.26 so as to make such representations and warranties true and correct in all material respects. ARTICLE VII NEGATIVE COVENANTS Each Borrower (and for purposes of Section 7.11, each Holdco) covenants and agrees with each Lender that unless and until (i) all Commitments shall have been terminated and (ii) all ABL Credit Obligations arising under the Loan Documents (other than contingent obligations for unasserted claims) shall have been paid and (iii) all Letters of Credit have been canceled or have expired (or have been Cash Collateralized or backstopped on terms reasonably satisfactory to the Administrative Agent) and all amounts drawn or paid thereunder have been reimbursed in full, unless the Required Lenders shall otherwise consent in writing, each Borrower will not, and will not permit any of the Material Subsidiaries to: Section 7.01 Indebtedness. Incur, create, assume or permit to exist any Indebtedness, except: (a) Indebtedness existing on the Amendment No. 26 Effective Date and set forth on Schedule 7.01 and any Permitted Refinancing Indebtedness incurred to Refinance such Indebtedness (other than intercompany indebtedness Refinanced with Indebtedness owed to a person not affiliated with such Borrower or any Subsidiary); (b) (i) Indebtedness created hereunder and under the other Loan Documents and any Permitted Refinancing Indebtedness incurred to Refinance such Indebtedness; and (ii) Guarantees by the Borrowers and the Material Subsidiaries of Indebtedness of Ultimate Parent, Parent Guarantor or any Subsidiary thereof; (c) obligations (contingent or otherwise) arising under a Swap Contract if such obligations are (or were) entered into by such Person in the ordinary course of business for the purpose of directly mitigating risks associated with fluctuations in interest rates, commodity prices or foreign exchange rates (or to allow any customer to do so); provided, however, to the extent that such Indebtedness is incurred under a Secured Hedge Agreement, such Secured Hedge Agreement was entered into in connection with the execution of customer contracts to hedge currency and commodity risk thereunder; 137 (d) Indebtedness owed to (including obligations in respect of letters of credit or bank guarantees or similar instruments for the benefit of) any person providing workers’ compensation, health, disability or other employee benefits or property, casualty or liability insurance to any Borrower or any Subsidiary, pursuant to reimbursement or indemnification obligations to such person, in each case in the ordinary course of business; provided that upon the incurrence of Indebtedness with respect to reimbursement obligations regarding workers’ compensation claims, such obligations are reimbursed not later than 30 days following such incurrence; (e) unsecured Indebtedness of any Borrower to the Ultimate Parent, any Subsidiary of Ultimate Parent or any Subsidiary and of any Subsidiary to Ultimate Parent, any Subsidiary of Ultimate Parent, the Borrowers or any other Subsidiary; provided that, except in respect of intercompany current liabilities incurred in the ordinary course of business in connection with the cash management operations among Ultimate Parent and its subsidiaries, Indebtedness of any Loan Party to any Person incurred under this clause (e) shall be subordinated to the ABL Credit Obligations on terms reasonably satisfactory to the Administrative Agent; (f) Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety bonds and completion guarantees and similar obligations, in each case provided in the ordinary course of business, including those incurred to secure health, safety and environmental obligations in the ordinary course of business; (g) Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business or other cash management services in the ordinary course of business; provided that (x) such Indebtedness (other than credit or purchase cards) is extinguished within ten Business Days of notification to the applicable Borrower of its incurrence and (y) such Indebtedness in respect of credit or purchase cards is extinguished within 60 days from its incurrence; (h) (i)(x) Indebtedness of a Subsidiary acquired after the Closing Date or an entity merged into or consolidated or amalgamated with any Borrower or any Subsidiary after the Closing Date and Indebtedness assumed in connection with the acquisition of assets, which Indebtedness in each case exists at the time of such acquisition, merger, consolidation or amalgamation and is not created in contemplation of such event and where such acquisition, merger, consolidation or amalgamation is permitted by this Agreement and (y) Indebtedness incurred to finance Permitted Business Acquisitions permitted pursuant to Section 7.04(j) and (ii) any Permitted Refinancing Indebtedness incurred to Refinance such Indebtedness; provided that no Default or Event of Default shall have occurred and be continuing or would result therefrom; (i) Capital Lease Obligations, mortgage financings and purchase money Indebtedness incurred by any Borrower or any Subsidiary prior to or within 270 days after the acquisition, lease, construction, repair, replacement or improvement of the respective property (real or personal, and whether through the direct purchase of property or the Equity Interests of any person owning such property) permitted under this Agreement in order to finance such acquisition, lease, construction, repair, replacement or improvement, and any Permitted Refinancing Indebtedness in respect thereof, in an aggregate principal amount that at the time of, and after giving effect to, the incurrence thereof, together with the Remaining Present Value of outstanding leases permitted under Section 7.03(a), would not exceed $125,000,000 at any time outstanding; (j) Capital Lease Obligations incurred by any Borrower or any Subsidiary in respect of any Sale and Lease Back Transaction that is permitted under Section 7.03 and any Permitted Refinancing Indebtedness in respect thereof; 138 (k) other Indebtedness of any Borrower or any Subsidiary, in an aggregate principal amount outstanding that at the time of, and after giving effect to, the incurrence thereof, would not exceed $25,000,000 at any time outstanding; provided that any Indebtedness incurred pursuant to this clause (k) that by its terms is subordinated in right of payment to the ABL Credit Obligations shall not, pursuant to the terms thereof, be required to be repaid (other than pursuant to customary change of control, asset sale proceeds and similar provisions), in whole or in part, prior to the date that is 91 days following the Facility Maturity Date; (l) Indebtedness arising from agreements of any Borrower or any Subsidiary providing for indemnification, adjustment of purchase or acquisition price or similar obligations, in each case, incurred or assumed in connection with the Transactions and any Permitted Business Acquisition or the disposition of any business, assets or a Subsidiary not prohibited by this Agreement, other than Guarantees of Indebtedness incurred by any person acquiring all or any portion of such business, assets or a Subsidiary for the purpose of financing such acquisition; (m) Indebtedness in respect of letters of credit, bank guarantees, warehouse receipts or similar instruments issued to support performance obligations and trade letters of credit (other than obligations in respect of other Indebtedness) in the ordinary course of business; (n) Indebtedness supported by a Letter of Credit in a principal amount not in excess of the stated amount of such Letter of Credit; (o) Indebtedness consisting of (i) the financing of insurance premiums or (ii) take-or- pay obligations contained in supply arrangements, in each case, in the ordinary course of business; (p) Indebtedness of Subsidiaries that are not Subsidiary Loan Parties; provided that the aggregate amount of Indebtedness incurred under this clause (p), when aggregated with all other Indebtedness incurred and outstanding pursuant to this clause (p), shall not exceed $10,000,000 at the time of such incurrence; (q) Indebtedness representing deferred compensation to employees and directors of any Borrower or any Subsidiary incurred in the ordinary course of business; (r) Indebtedness consisting of obligations of any Borrower or any Subsidiary under deferred compensation or other similar arrangements incurred by such Person in connection with Permitted Business Acquisitions or any other Investment permitted hereunder; (s) Indebtedness incurred under any Qualified Receivables Financing; (t) Indebtedness of any Borrower and its respective Subsidiaries arising pursuant to an unsecured loan made to such Borrower or Subsidiary by a United States Governmental Authority (including the United States Small Business Administration) or any other Person to the extent such Indebtedness is subject to a participation therein by a United States Governmental Authority or is guaranteed by a United States Governmental Authority, in each case under this clause (t), pursuant to the CARES Act or other COVID-19 Relief Laws, provided, that, as to any such Indebtedness (i) the aggregate principal amount of all such Indebtedness shall not exceed $50,000,000, (ii) Borrowers are at all times in compliance with the terms of the CARES Act or other applicable COVID-19 Relief Laws pursuant to which such Indebtedness is incurred, (iii) the proceeds of any such loans shall only be used for the purposes permitted by the terms of the applicable COVID-19 Relief Laws, and (iv) such Indebtedness shall be on terms and conditions approved by Administrative Agent in its Permitted Discretion; and


 
139 (u) all premiums (if any), interest (including post-petition interest), fees, expenses, charges and additional or contingent interest on obligations described in paragraphs (a) through (t) above. Section 7.02 Liens. Create, incur, assume or permit to exist any Lien on any property or assets (including stock or other securities of any person, including any Borrower and any Subsidiary) at the time owned by it or on any income or revenues or rights in respect of any thereof, except the following (collectively, “Permitted Liens”): (a) Liens on property or assets of any Borrower and its Subsidiaries existing on the Amendment No. 26 Effective Date and set forth on Schedule 7.02(a) and any modifications, replacements, renewals or extensions thereof; provided that such Liens shall secure only those obligations that they secure on the Amendment No. 26 Effective Date (and any Permitted Refinancing Indebtedness in respect of such obligations permitted by Section 7.01(a)) and shall not subsequently apply to any other property or assets of any Borrower or any Subsidiary other than (A) after-acquired property that is affixed or incorporated into the property covered by such Lien, and (B) proceeds and products thereof; (b) (i) Liens created under the Loan Documents (including, without limitation, Liens created under the Security Documents securing obligations under Secured Hedge Agreements incurred pursuant to Section 7.01(c) and securing obligations under Cash Management Agreements) or permitted in respect of any Mortgaged Property by the terms of the applicable Mortgage and (ii) Liens securing Indebtedness incurred pursuant to Section 7.01(b)(ii) (including Liens securing Swap Obligations secured under the documents governing such Indebtedness), which Liens are subject to the applicable Intercreditor Agreements or any other intercreditor agreement substantially consistent with and no less favorable to the Revolving Facility Lenders in any material respect than the applicable Intercreditor Agreements; (c) Liens on any property or asset of any Borrower or any Subsidiary securing Indebtedness permitted under Section 7.01(h)(i)(x) or Permitted Refinancing Indebtedness in respect thereof if permitted by Section 7.01(h)(ii), in each case, subject to the applicable Intercreditor Agreements; provided that such Lien (i) does not apply to any other property or assets of any Borrower or any of its Subsidiaries not securing such Indebtedness at the date of the acquisition of such property or asset (other than after acquired property subjected to a Lien securing Indebtedness and other obligations incurred prior to such date and which Indebtedness and other obligations are permitted hereunder that require a pledge of after acquired property, it being understood that such requirement shall not be permitted to apply to any property to which such requirement would not have applied but for such acquisition), (ii) such Lien is not created in contemplation of or in connection with such acquisition, and (iii) in the case of a Lien securing Permitted Refinancing Indebtedness, subject to compliance with clause (iv) of the definition of the term “Permitted Refinancing Indebtedness”; (d) Liens for Taxes, assessments or other governmental charges or levies not yet due or that are being contested in compliance with Section 6.03; (e) Liens imposed by law, such as landlord’s, carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s, construction or other like Liens arising in the ordinary course of business and securing obligations that are not overdue by more than 30 days or that are being contested in good faith by appropriate proceedings and in respect of which, if applicable, any Borrower or any Subsidiary shall have set aside on its books reserves in accordance with Applicable Accounting Rules; (f) (i) pledges and deposits and other Liens made in the ordinary course of business in compliance with the Federal Employers Liability Act or any other workers’ compensation, unemployment insurance and other social security laws or regulations and deposits securing liability to 140 insurance carriers under insurance or self-insurance arrangements in respect of such obligations and (ii) pledges and deposits and other Liens securing liability for reimbursement or indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing property, casualty or liability insurance to any Borrower or any Subsidiary; (g) deposits and other customary Liens to secure the performance of bids, trade contracts (other than for Indebtedness), leases (other than Capital Lease Obligations), statutory and regulatory obligations, surety and appeal bonds, performance and return of money bonds, bids, leases, government contracts, trade contracts, agreements with utilities, and other obligations of a like nature (including letters of credit in lieu of any such bonds or to support the issuance thereof) incurred in the ordinary course of business, including those incurred to secure health, safety and environmental obligations in the ordinary course of business; (h) zoning restrictions, survey exceptions and such matters as an accurate survey would disclose, easements, trackage rights, leases (other than Capital Lease Obligations), licenses, special assessments, rights of way, covenants, conditions, restrictions and declaration on or with respect to the use of Real Property, servicing agreements, development agreements, site plan agreements and other similar encumbrances incurred in the ordinary course of business and title defects or irregularities that are of a minor nature and that, in the aggregate, do not interfere in any material respect with the ordinary conduct of the business of any Borrower or any Subsidiary; (i) Liens securing Indebtedness permitted by Section 7.01(i) or (j) (in each case, limited to the assets subject to such Indebtedness); (j) Liens arising out of sale and lease-back transactions permitted under Section 7.03, so long as such Liens attach only to the property sold and being leased in such transaction and any accessions thereto or proceeds thereof and related property (k) Liens securing judgments that do not constitute an Event of Default under Section 8.01(j) and notices of lis pendens and associated rights related to litigation being contested in good faith by appropriate proceedings and for which adequate reserves have been made; (l) Liens disclosed by the title insurance policies delivered on or subsequent to the Closing Date and pursuant to Section 6.10 and any replacement, extension or renewal of any such Lien; provided that such replacement, extension or renewal Lien shall not cover any property other than the property that was subject to such Lien prior to such replacement, extension or renewal; provided, further, that the Indebtedness and other obligations secured by such replacement, extension or renewal Lien are permitted by this Agreement; (m) any interest or title of a lessor or sublessor under any leases or subleases entered into by any Borrower or any Subsidiary in the ordinary course of business; (n) Liens that are contractual rights of set off (i) relating to the establishment of depository relations with banks not given in connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts of any Borrower or any Subsidiary to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business of any Borrower or any Subsidiary or (iii) relating to purchase orders and other agreements entered into with customers of any Borrower or any Subsidiary in the ordinary course of business; (o) Liens arising solely by virtue of any statutory or common law provision relating to banker’s liens, rights of set off or similar rights; 141 (p) Liens securing obligations in respect of trade related letters of credit or bank guarantees permitted under Section 7.01(g) or (m) and covering the goods (or the documents of title in respect of such goods) financed by such letters of credit or bank guarantees and the proceeds and products thereof; (q) leases or subleases, licenses or sublicenses (including with respect to intellectual property and software) granted to others in the ordinary course of business not interfering in any material respect with the business of any Borrower and its Subsidiaries, taken as a whole; (r) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods; (s) Liens solely on any cash earnest money deposits made by any Borrower or any of its Subsidiaries in connection with any letter of intent or purchase agreement in respect of any Investment permitted hereunder; (t) Liens with respect to property or assets of any Subsidiary that is not a Subsidiary Loan Party securing Indebtedness permitted under Section 7.01(p); (u) other Liens with respect to property or assets of any Borrower or any Subsidiary provided that either (i) the obligations secured by any such Liens shall not exceed $50,000,000 at any time outstanding or (ii) the Payment Conditions shall have been met; provided further that (A) no such Lien shall secure any Swap Obligation, (B) at the time of the incurrence of such Lien no Default or Event of Default shall have occurred and be continuing or would result therefrom, (C) the Indebtedness or other obligations secured by such Lien are otherwise permitted by this Agreement, (D) to the extent such Liens extend to Collateral (including Revolving Loan Priority Collateral and Term Loan Priority Collateral), such Liens shall be subordinated to the Liens securing the ABL Finance Obligations pursuant to the applicable Intercreditor Agreements (or an additional intercreditor agreement reasonably satisfactory to the Administrative Agent), and (E) such Liens shall not secure Indebtedness permitted to be incurred pursuant to Section 7.01(t); (v) the prior rights of consignees and their lenders under consignment arrangements entered into in the ordinary course of business; (w) Liens arising from precautionary Uniform Commercial Code financing statements or consignments entered into in connection with any transaction otherwise permitted under this Agreement; (x) Liens on Equity Interests in joint ventures securing obligations of such joint venture; (y) Liens on securities that are the subject of repurchase agreements constituting Permitted Investments under clause (iii) of the definition thereof; (z) the PBGC Lien; (aa) Liens on goods or inventory the purchase, shipment or storage price of which is financed by a documentary letter of credit, bank guarantee or bankers’ acceptance issued or created for the account of any Borrower or any Subsidiary in the ordinary course of business; provided that such Lien secures only the obligations of such Borrower or such Subsidiaries in respect of such letter of credit or bank guarantee to the extent permitted under Section 7.01; 142 (bb) Liens securing insurance premiums financing arrangements, provided that such Liens are limited to the applicable unearned insurance premiums; (cc) Liens on deposits securing Swap Contracts permitted under Section 7.01(c) not to exceed $1,000,000 in the aggregate; (dd) Reserved; and (ee) Liens on AB Receivables and other Qualified Receivables in connection with Qualified Receivables Financings permitted hereunder. (ff) Liens on Equipment and Mortgages on Real Property securing Indebtedness permitted under Section 7.01 that is incurred after the Amendment No. 4 Effective Date, provided, that, upon Borrowers’ request, the Lien of Administrative Agent shall be subordinated to the Lien on the applicable Equipment or Mortgages on Real Property that secures such Indebtedness on customary terms for the type of Indebtedness that is secured by such Liens and otherwise on terms and conditions reasonably satisfactory to Administrative Agent and subject to an intercreditor agreement between Administrative Agent and the holder of such Lien in form and substance reasonably satisfactory to Administrative Agent. Section 7.03 Sale and Lease Back Transactions. Enter into any arrangement, directly or indirectly, with any person whereby it shall sell or transfer any property, real or personal, used or useful in its business, whether now owned or hereafter acquired, and thereafter rent or lease such property or other property that it intends to use for substantially the same purpose or purposes as the property being sold or transferred (a “Sale and Lease Back Transaction”); provided that Sale and Lease Back Transactions shall be permitted so long as the aggregate fair market value (as determined in good faith by the applicable Borrower at the time of the applicable Sale and Lease Back Transaction) of all property subject to Sale and Lease Back Transactions permitted pursuant to this clause (a) does not exceed $25,000,000 in the aggregate at any time during the term of this Agreement. Section 7.04 Investments, Loans and Advances. Purchase, hold or acquire (including pursuant to any merger, consolidation or amalgamation with a person that is not a Wholly Owned Subsidiary immediately prior to such merger, consolidation or amalgamation) any Equity Interests, evidences of Indebtedness or other securities of, make or permit to exist any loans or advances to or Guarantees of the obligations of, or make or permit to exist any investment or any other interest in (each, an “Investment”), any other person, except: (a) (i) Investments by any Borrower or any Subsidiary in the Equity Interests of any Borrower or any Subsidiary; (ii) intercompany loans from any Borrower or any Subsidiary to any Borrower or any Subsidiary; and (iii) Guarantees by any Borrower or any Subsidiary Loan Party of Indebtedness otherwise expressly permitted hereunder of any Borrower or any Subsidiary, provided that the sum of (A) Investments (valued at the time of the making thereof and without giving effect to any write downs or write offs thereof) made after the Amendment No. 2 Effective Date by the Loan Parties pursuant to clause (i) in Subsidiaries that are not Subsidiary Loan Parties, plus (B) net intercompany loans made after the Amendment No. 2 Effective Date by Loan Parties to Subsidiaries that are not Subsidiary Loan Parties pursuant to clause (ii), plus (C) Guarantees after the Amendment No. 2 Effective Date by Loan Parties of Indebtedness of Subsidiaries that are not Subsidiary Loan Parties pursuant to clause (iii), shall not exceed an aggregate net amount equal to $5,000,000 (plus any return of capital actually received by the respective investors in respect of Investments theretofore made by them pursuant to this paragraph (b));


 
143 (b) Permitted Investments and Investments that were Permitted Investments when made; (c) Investments arising out of the receipt by any Borrower or any Subsidiary of non- cash consideration for the sale of assets permitted under Section 7.05; (d) loans and advances to officers, directors, employees or consultants of any Borrower or any Subsidiary (i) in the ordinary course of business not to exceed $1,000,000 at any time outstanding (calculated without regard to write downs or write offs thereof), (ii) in respect of payroll payments and expenses in the ordinary course of business and (iii) in connection with such person’s purchase of Equity Interests of the Holdcos (or any Parent Entity) solely to the extent that the amount of such loans and advances shall be contributed to such Borrower in cash as common equity; (e) accounts receivable, security deposits and prepayments arising and trade credit granted in the ordinary course of business and any assets or securities received in satisfaction or partial satisfaction thereof from financially troubled account debtors to the extent reasonably necessary in order to prevent or limit loss and any prepayments and other credits to suppliers made in the ordinary course of business; (f) Swap Contracts permitted hereunder; (g) Investments existing on, or contractually committed as of, the Amendment No. 2 Effective Date and set forth on Schedule 7.04 and any extensions, renewals or reinvestments thereof, so long as the aggregate amount of all Investments pursuant to this clause (g) is not increased at any time above the amount of such Investment existing or contractually committed to on the Amendment No. 2 Effective Date; (h) Investments resulting from pledges and deposits under Sections 7.02(f), (g), (k), (r), (s) and (u); (i) other Investments by any Borrower or any Subsidiary if (i) the Payment Conditions shall have been met and (ii) no Event of Default shall have occurred and be continuing or would result therefrom; (j) Investments constituting Permitted Business Acquisitions; (k) intercompany loans between Subsidiaries that are not Subsidiary Loan Parties and Guarantees by such Subsidiaries to the extent permitted by Section 7.01(l); (l) Investments received in connection with the bankruptcy or reorganization of, or settlement of delinquent accounts and disputes with or judgments against, customers and suppliers, in each case in the ordinary course of business or Investments acquired by any Borrower as a result of a foreclosure by such Borrower or any of its Subsidiaries with respect to any secured Investments or other transfer of title with respect to any secured Investment in default; (m) Investments of a Subsidiary acquired after the Closing Date or of an entity merged into any Borrower or merged into or consolidated with a Subsidiary after the Closing Date, in each case, to the extent permitted under this Section 7.04 and, in the case of any acquisition, merger, consolidation or amalgamation, in accordance with Section 7.05 to the extent that such Investments were not made in contemplation of or in connection with such acquisition, merger, consolidation or 144 amalgamation and were in existence on the date of such acquisition, merger, consolidation or amalgamation; (n) acquisitions by any Borrower of obligations of one or more current or former officers, directors or other employees of the Holdcos, any Parent Entity, such Borrower or its Subsidiaries and their respective estates, spouses or former spouses in connection with such person’s acquisition of Equity Interests of the Holdcos or any Parent Entity, so long as no cash is actually advanced by such Borrower or any of its Subsidiaries to such persons in connection with the acquisition of any such obligations; (o) Guarantees by any Borrower or any Subsidiary of operating leases (other than Capital Lease Obligations) or of other obligations that do not constitute Indebtedness, in each case entered into by any Borrower or any Subsidiary in the ordinary course of business; (p) Investments to the extent that payment for such Investments is made with Equity Interests of the Holdcos (or any Parent Entity); (q) Investments in the Equity Interests of one or more newly formed persons that are received in consideration of the contribution by the Holdcos, the applicable Borrower or the applicable Subsidiary of assets (including Equity Interests and cash) to such person or persons; provided that (i) the fair market value (as determined in good faith by such Borrower) of such assets, determined on an arms’- length basis, so contributed pursuant to this paragraph (q) shall not in the aggregate exceed $1,000,000 and (ii) in respect of each such contribution, a Responsible Officer of the applicable Borrower shall certify (x) no Default or Event of Default shall have occurred and be continuing or would result from such contribution, (y) the fair market value (as determined in good faith by such Borrower) of the assets so contributed and (z) that the requirements of clause (i) of this proviso remain satisfied; (r) Investments consisting of Restricted Payments permitted under Section 7.06; (s) Investments in the ordinary course of business consisting of Uniform Commercial Code Article 3 endorsements for collection or deposit and Uniform Commercial Code Article 4 customary trade arrangements with customers consistent with past practices; (t) Investments in Subsidiaries that are not Loan Parties not to exceed $1,000,000 at any time outstanding (plus any return of capital actually received by the respective investors in respect of Investments theretofore made by them pursuant to this paragraph (u)), as valued at the fair market value (as determined in good faith by the applicable Borrower) of such Investment at the time such Investment is made; (u) Investments consisting of the licensing or contribution of intellectual property licenses pursuant to joint marketing arrangements with other persons; (v) Guarantees permitted under Section 7.01 (except to the extent such Guarantee is expressly subject to Section 7.04); (w) advances in the form of a prepayment of expenses, so long as such expenses are being paid in accordance with customary trade terms of the applicable Borrower or Subsidiary; (x) Investments by any Borrower and its Subsidiaries, including loans and advances, to any direct or indirect parent of such Borrower, if such Borrower or any other Subsidiary would otherwise be permitted to make a Restricted Payment in such amount (provided that the amount of any 145 such Investment shall also be deemed to be a Restricted Payment under the appropriate clause of Section 7.06 for all purposes of this Agreement); (y) Investments received substantially contemporaneously in exchange for Equity Interests of the Holdcos or any Parent Entity; (z) Investments in joint ventures not in excess of $5,000,000 in the aggregate (plus any return of capital actually received by the respective investors in respect of Investments theretofore made by them pursuant to this clause (z)); provided that if any Investment pursuant to this clause (z) is made in any person that is not a Subsidiary of any Borrower at the date of the making of such Investment and such person becomes a Subsidiary of any Borrower after such date, such Investment shall thereafter be deemed to have been made pursuant to Section 7.04(a) and shall cease to have been made pursuant to this clause (z) for so long as such person continues to be a Subsidiary of a Borrower; (aa) Reasonable and customary Investments (including, to the extent reasonable and customary, capital contributions, intercompany debt or other extensions of credit) in any Receivables Subsidiary in connection with any Qualified Receivables Financing; and (bb) Industrial revenue bonds or other similar municipal bonds issued to any Borrower or any Subsidiary pursuant to arrangements of the type pursuant to which the Industrial Revenue Bond was issued, provided that any consideration paid by any Borrower or any Subsidiary for such bonds is applied solely for the acquisition, lease, construction, repair, replacement or improvement of property owned or leased (or to be owned or leased) by any Borrower or any Subsidiary and to pay costs and expenses in connection with such arrangements. Section 7.05 Mergers, Consolidations, Sales of Assets and Acquisitions. Merge into or consolidate or amalgamate with any other person, or permit any other person to merge into or consolidate or amalgamate with it, or otherwise sell, transfer, lease or otherwise dispose (including to a Divided LLC pursuant to a Division) of (in one transaction or in a series of transactions) all or any part of its assets (whether now owned or hereafter acquired), or issue, sell, transfer or otherwise dispose of any Equity Interests of any Borrower or any Subsidiary, or purchase, lease or otherwise acquire (in one transaction or a series of transactions) all or substantially all of the assets of any other person or any division, unit or business of any person, except that this Section shall not prohibit: (a) (i) the purchase and sale of inventory in the ordinary course of business by any Borrower or any Subsidiary, (ii) the acquisition or lease (pursuant to an operating lease) of any other asset in the ordinary course of business by any Borrower or any Subsidiary, (iii) the sale of surplus, obsolete or worn out equipment or other property in the ordinary course of business by any Borrower or any Subsidiary or (iv) the sale of Permitted Investments in the ordinary course of business; (b) if at the time thereof and immediately after giving effect thereto no Default or Event of Default shall have occurred and be continuing or would result therefrom, (i) the merger, consolidation or amalgamation of any Subsidiary with or into any Borrower or any Subsidiary Loan Party in a transaction in which the surviving or resulting entity is such Borrower or, if a Borrower is not a party to such transaction, a Subsidiary Loan Party, and no person other than a Borrower or Subsidiary Loan Party receives any consideration;, (ii) the merger, consolidation or amalgamation of any Subsidiary that is not a Subsidiary Loan Party into or with any Subsidiary that is not a Subsidiary Loan Party, 146 (iii) the liquidation or dissolution or change in form of entity of any Subsidiary if the applicable Borrower determines in good faith that such liquidation, dissolution or change in form is in the best interests of such Borrower and is not materially disadvantageous to the Lenders, (iv) any Subsidiary may merge, consolidate or amalgamate with or into any other person in order to effect an Investment permitted pursuant to Section 7.04 so long as the continuing or surviving person shall be a Subsidiary, which shall be a Loan Party if the merging, consolidating or amalgamating Subsidiary was a Loan Party and which together with each of its Subsidiaries shall have complied with the requirements of Section 6.10, or (v) the merger, consolidation or amalgamation of any Constellium Holding Company with or into any Borrower or any Subsidiary Loan Party in a transaction in which the surviving or resulting entity is such Borrower or, if a Borrower is not a party to such transaction, a Subsidiary Loan Party, and no person other than a Borrower or Subsidiary Loan Party receives any consideration. (c) sales, transfers, leases or other dispositions to a Borrower or a Subsidiary (upon voluntary liquidation or otherwise); provided that any sales, transfers, leases or other dispositions by a Loan Party to a Subsidiary that is not a Subsidiary Loan Party in reliance on this paragraph (c) shall be made in compliance with Section 7.07 and the aggregate gross proceeds of any such sales, transfers, leases or other dispositions plus the aggregate fair market value of any or all assets sold, transferred, leased, licensed or otherwise disposed of in reliance on clause (g) below, shall not exceed, in any fiscal year of the Borrowers, $5,000,000; (d) Sale and Lease Back Transactions permitted by Section 7.03; (e) Investments permitted by Section 7.04 and Permitted Liens and Restricted Payments permitted by Section 7.06; (f) the sale or other disposition of defaulted receivables and the compromise, settlement and collection of receivables in the ordinary course of business or in bankruptcy or other proceedings concerning the other account party thereon and not as part of an accounts receivables financing transaction; (g) sales, transfers, leases, licenses or other dispositions of assets not otherwise permitted by this Section 7.05 (or required to be included in this clause (g) pursuant to Section 7.05(c)); provided that (i) the aggregate gross proceeds (including non-cash proceeds) of any or all assets sold, transferred, leased, licensed or otherwise disposed of in reliance upon this clause (g) shall not exceed, in any fiscal year of the Borrowers, $10,000,000 and (ii) no Default or Event of Default exists or would result therefrom; (h) Permitted Business Acquisitions (including any merger, consolidation or amalgamation in order to effect a Permitted Business Acquisition); provided that following any such merger, consolidation or amalgamation (i) involving a Borrower, such Borrower is the surviving corporation or such merger, consolidation or amalgamation shall otherwise satisfy the requirements of subsection (b)(i) above and (ii) involving a Subsidiary Loan Party, the surviving or resulting entity shall be a Subsidiary Loan Party that is a Wholly Owned Subsidiary; (i) leases, licenses (on a non-exclusive basis with respect to intellectual property), or subleases or sublicenses (on a non-exclusive basis with respect to intellectual property) of any real or personal property in the ordinary course of business;


 
147 (j) sales, leases or other dispositions of inventory of any Borrower and its Subsidiaries determined by the management of such Borrower to be no longer useful or necessary in the operation of the business of such Borrower or any of its Subsidiaries; (k) any surrender or waiver of contract rights or the settlement, release, recovery on or surrender of contract tort or other claims of any kind to the extent that any of the foregoing could not reasonably be expected to have a Material Adverse Effect; (l) any exchange of assets for services and/or other assets of comparable or greater value; provided that (i) at least 90% of the consideration received by the transferor consists of assets that will be used in a business or business activity permitted hereunder, (ii) in the event of a swap with a fair market value (as determined in good faith by the applicable Borrower) in excess of $2,000,000, the Administrative Agent shall have received a certificate from a Responsible Officer of such Borrower with respect to such fair market value and (iii) in the event of a swap with a fair market value (as determined in good faith by the applicable Borrower) in excess of $5,000,000, such exchange shall have been approved by at least a majority of the Board of Directors of the applicable Holdco or such Borrower; provided that (A) the aggregate gross consideration (including exchange assets, other non-cash consideration and cash proceeds) of any or all assets exchanged in reliance upon this paragraph (n) shall not exceed, in any fiscal year of the Borrowers, $10,000,000 and (B) no Default or Event of Default exists or would result therefrom; (m) any disposition of Equity Interests of a Subsidiary pursuant to an agreement or other obligation with or to a person (other than each Borrower and its Subsidiaries) from whom such Subsidiary was acquired or from whom such Subsidiary acquired its business and assets (having been newly formed in connection with such acquisition) in a Permitted Business Acquisition, made as part of such acquisition and in each case comprising all or a portion of the consideration in respect of such sale or acquisition; (n) any merger, consolidation, conveyance, transfer, lease or other disposition of the Equity Interests of, or undertaken by, Wise Alloys Finance Corporation or Listerhill Total Maintenance Center, LLC, so long as the assets attributable to such entities do not have a book value or fair market value in an aggregate amount in excess of $4,000,000 measured at the time of each such disposition; and (o) (i) with respect to any Borrower, the sale of all or substantially all of the Accounts of such Borrower which are Qualified Receivables to a Receivables Subsidiary in one or more transactions, and (ii) with respect to any Receivables Subsidiary, the sale of all or substantially all of the applicable receivables of such Receivables Subsidiary in one or more transactions pursuant to any Qualified Receivables Financing. Notwithstanding anything to the contrary contained in Section 7.05 above, (i) no sale, transfer or other disposition of assets shall be permitted by this Section 7.05 (other than sales, transfers, leases, licenses or other dispositions to Loan Parties pursuant to paragraph (c) of this Section 7.05 or any Sale and Lease Back Transaction permitted by Section 7.03(b)) unless such disposition is for fair market value (as determined in good faith by the applicable Borrower), or if not fair market value, the shortfall is permitted as an Investment under Section 7.04, (ii) no sale, transfer or other disposition of assets in excess of $1,000,000 shall be permitted by paragraph (g) of this Section 7.05 unless such disposition is for at least 75% cash consideration; provided that, for purposes of this clause (ii), (a) the amount of any liabilities (as shown on any Borrower’s or any Subsidiary’s most recent balance sheet delivered pursuant to Section 6.04(c)) of any Borrower or any Subsidiary of any Borrower (other than liabilities that are by their terms subordinated to the ABL Credit Obligations) that are assumed by the transferee of any such assets, (b) any notes or other obligations or other securities or assets received by such Borrower or such Subsidiary of 148 such Borrower from such transferee that are converted by such Borrower or such Subsidiary of such Borrower into cash within 180 days of the receipt thereof (to the extent of the cash received) and (c) any Designated Non-Cash Consideration received by such Borrower or any of its Subsidiaries in such Asset Sale having an aggregate fair market value, taken together with all other Designated Non-Cash Consideration received pursuant to this clause (c) that is at that time outstanding, not to exceed $5,000,000 at the time of the receipt of such Designated Non-Cash Consideration (with the fair market value (as determined in good faith by the applicable Borrower) of each item of Designated Non-Cash Consideration being measured at the time received and without giving effect to subsequent changes in value) shall be deemed to be cash and (iii) in respect of any sale, transfer or other disposition of Accounts and/or Inventory made in any case outside of the ordinary course of business of any Borrower or any other applicable Loan Party, such Borrower shall notify the Administrative Agent thereof in writing and the amount set forth in clause (x) of the definition of “Borrowing Base” shall be reduced by the Net Proceeds thereof until receipt by the Administrative Agent of the next Borrowing Base Certificate delivered pursuant to Section 6.13 hereof. To the extent any Collateral is disposed of in a transaction expressly permitted by this Section 7.05 to any Person other than the Holdcos, the Borrowers or any Subsidiary, such Collateral shall be sold free and clear of the Liens created by the Loan Documents, and the Administrative Agent shall take, and shall be authorized by each Lender to take, any actions reasonably requested by the applicable Borrower in order to evidence the foregoing. Section 7.06 Dividends and Distributions. Declare or pay any dividend or make any other distribution (by reduction of capital or otherwise), whether in cash, property, securities or a combination thereof, with respect to any of its Equity Interests (other than dividends and distributions on Equity Interests payable solely by the issuance of additional Equity Interests (other than Disqualified Stock) of the person paying such dividends or distributions) or directly or indirectly redeem, purchase, retire or otherwise acquire for value (or permit any Subsidiary to purchase or acquire) any of its Equity Interests or set aside any amount for any such purpose (other than through the issuance of additional Equity Interests (other than Disqualified Stock) of the person redeeming, purchasing, retiring or acquiring such shares) (the foregoing, “Restricted Payments”); provided, however, that: (a) any Subsidiary of any Borrower may make Restricted Payments to such Borrower or to any Wholly Owned Subsidiary of such Borrower (or, in the case of non-Wholly Owned Subsidiaries, to such Borrower or any Subsidiary that is a direct or indirect parent of such Subsidiary and to each other owner of Equity Interests of such Subsidiary on a pro rata basis (or more favorable basis from the perspective of such Borrower or such Subsidiary) based on their relative ownership interests so long as any repurchase of its Equity Interests from a person that is not such Borrower or a Subsidiary is permitted under Section 7.04); (b) each Borrower may make Restricted Payments to any Holdco in respect of (i) overhead, legal, accounting and other professional fees and expenses of such Holdco, (ii) fees and expenses related to any public offering or private placement of debt or equity securities of such Holdco whether or not consummated, (iii) franchise Taxes or similar Taxes and fees and expenses in connection with the maintenance of such Holdco’s existence and such Holdco’s ownership of such Borrower, (iv) payments permitted by Section 7.07(b), (v) the portion (which shall be 100% for so long as such Holdco owns no assets other than the Equity Interests in such Borrower) of the tax liability to each relevant jurisdiction in respect of consolidated, combined, unitary or affiliated returns for the relevant jurisdiction of such Holdco attributable to such Borrower or its Subsidiaries, (vi) tax liabilities of such Holdco incurred as a result of transactions occurring prior to the Amendment No. 2 Effective Date, and (vii) customary salary, bonus and other benefits payable to, and indemnities provided on behalf of, officers and employees of such Holdco, in each case in order to permit such Holdco to make such payments; provided that, in the case of clauses (i), (ii) and (iii), the amount of such Restricted Payments shall not exceed the portion of any amounts referred to in such clauses (i), (ii) and (iii) that are allocable to such Borrower and 149 its Subsidiaries (which shall be 100% for so long as such Holdco, owns no assets other than the Equity Interests in such Borrower); (c) non-cash repurchases of Equity Interests deemed to occur upon exercise of stock options or warrants if such Equity Interests represent a portion of the exercise price of such options or warrants; (d) each Borrower may make Restricted Payments to any Holdco or any Parent Entity to finance any Investment permitted to be made pursuant to Section 7.04; provided that (i) such Restricted Payment shall be made substantially concurrently with the closing of such Investment and (ii) such parent shall, immediately following the closing thereof, cause (A) all property acquired (whether assets or Equity Interests) to be contributed to such Borrower or a Subsidiary or (B) the merger, consolidation or amalgamation (to the extent permitted in Section 7.05) of the Person formed or acquired into such Borrower or a Subsidiary in order to consummate such Permitted Business Acquisition or Investment, in each case, in accordance with the requirements of Section 6.10; (e) Restricted Payments made within 60 days after the date of declaration thereof, if at the date of declaration such payment would have been permitted under (and was counted against any applicable basket under) this Agreement; and (f) each Borrower may make any Restricted Payment; provided that (x) no Event of Default shall have occurred and be continuing or would result therefrom and (y) the Payment Conditions shall have been satisfied. Section 7.07 Transactions with Affiliates. (a) Sell or transfer any property or assets to, or purchase or acquire any property or assets from, or otherwise engage in any other transaction with, any of its Affiliates or any known direct or indirect holder of 10% or more of any class of capital stock of the Holdcos or any Borrower in a transaction involving aggregate consideration in excess of $1,000,000, unless such transaction is (i) otherwise permitted (or required) under this Agreement or (ii) upon terms no less favorable to such Borrower or such Subsidiary, as applicable, than would be obtained in a comparable arm’s length transaction with a person that is not an Affiliate. For purposes of this Section 7.07, any transaction with any Affiliate or any such 10% holder shall be deemed to have satisfied the standard set forth in clause (ii) of the immediately preceding sentence if such transaction is approved by a majority of the disinterested members of the Board of Directors of the Holdcos or such Borrower. (b) The foregoing paragraph (a) shall not prohibit, to the extent otherwise permitted under this Agreement, (i) any issuance of securities, or other payments, loans (or cancellation of loans), awards or grants in cash, securities or otherwise pursuant to, or the funding of, employment arrangements, equity purchase agreements, stock options and stock ownership plans or similar employee benefit plans approved by the Board of Directors of the Holdcos or of any Borrower, (ii) loans or advances to employees or consultants of the Holdcos (or any Parent Entity), any Borrower or any of its Subsidiaries in accordance with Section 7.04(d), (iii) transactions among any Borrower or any Subsidiary or any entity that becomes a Loan Party as a result of such transaction (including via merger, consolidation or amalgamation in which a Subsidiary is the surviving entity), 150 (iv) the payment of fees, reasonable out-of-pocket costs and indemnities to directors, officers, consultants and employees of the Holdcos, any Parent Entity, any Borrower and its Subsidiaries in the ordinary course of business (limited, in the case of the Holdcos or any Parent Entity, to the portion of such fees and expenses that are allocable to the applicable Borrower and its Subsidiaries), (v) (A) any employment agreements entered into by any Borrower or any of its Subsidiaries in the ordinary course of business, (B) any subscription agreement or similar agreement pertaining to the repurchase of Equity Interests pursuant to put/call rights or similar rights with employees, officers or directors, and (C) any employee compensation, benefit plan or arrangement, any health, disability or similar insurance plan which covers employees, and any reasonable employment contract and transactions pursuant thereto, (vi) Restricted Payments permitted under Section 7.06, including payments to the Holdcos (and any Parent Entity), (vii) any purchase by a Holdco of the Equity Interests of the applicable Borrower, or contributions by a Holdco to the capital of the applicable Borrower; provided that any Equity Interests of such Borrower purchased by such Holdco shall be pledged to the Administrative Agent on behalf of the Lenders pursuant to the Collateral Agreement, (viii) transactions with Wholly Owned Subsidiaries for the purchase or sale of goods, products, parts and services entered into in the ordinary course of business in a manner consistent with past practice, (ix) any transaction in respect of which any Borrower delivers to the Administrative Agent (for delivery to the Lenders) a letter addressed to the Board of Directors of such Borrower from an accounting, appraisal or investment banking firm, in each case of nationally recognized standing that is (A) in the good faith determination of such Borrower qualified to render such letter and (B) reasonably satisfactory to the Administrative Agent, which letter states that such transaction is on terms that are no less favorable to such Borrower or such Subsidiary, as applicable, than would be obtained in a comparable arm’s length transaction with a person that is not an Affiliate, (x) transactions with joint ventures for the purchase or sale of goods, equipment and services entered into in the ordinary course of business, (xi) without duplication of any amounts otherwise paid with respect to Taxes, payments by the Holdcos (and any Parent Entity), any Borrower and its Subsidiaries pursuant to tax sharing agreements among the Holdcos (and any such Parent Entity), such Borrower and its Subsidiaries on customary terms that require each party to make payments when such Taxes are due or refunds received of amounts equal to the income tax liabilities and refunds generated by each such party calculated on a separate return basis and payments to the party generating tax benefits and credits of amounts equal to the value of such tax benefits and credits made available to the group by such party, (xii) the provision to subsidiaries, or by Affiliates, of cash management, accounting and other overhead services in the ordinary course of business undertaken in good faith (as certified in an officer’s certificate executed by a Responsible Officer of the applicable Borrower) and not for the purpose of circumventing any covenant set forth in this Agreement, (xiii) intercompany transactions undertaken in good faith (as certified in an officer’s certificate executed by a Responsible Officer of the applicable Borrower) for the purpose of


 
151 improving the consolidated tax efficiency of such Borrower and its Subsidiaries and not for the purpose of circumventing any covenant set forth in this Agreement, or (xiv) any transactions between or among any Holdco, Borrower or any of its Subsidiaries and any other Constellium Entity. Section 7.08 Business of the Borrowers and their respective Subsidiaries. Notwithstanding any other provisions hereof, engage at any time in any business or business activity other than any business or business activity conducted by any of them on the Amendment No. 2 Effective Date and any business or business activities incidental or related thereto, or any business or activity that is reasonably similar or complementary thereto or a reasonable extension, development or expansion thereof or ancillary thereto. Section 7.09 Limitation on Modifications of Indebtedness; Modifications of Certificate of Incorporation, By Laws and Certain Other Agreements; etc. (a) Amend or modify in any manner materially adverse to the Lenders (as determined in good faith by the Administrative Agent), or grant any waiver or release under or terminate in any manner (if such granting or termination shall be materially adverse to the Lenders taken as a whole (as determined in good faith by the Administrative Agent)), the articles or certificate of incorporation, by laws, limited liability company operating agreement, partnership agreement or other organizational documents of any Borrower or any of its Subsidiaries. (b) (1)Make, or agree or offer to pay or make, directly or indirectly, any payment or other distribution (whether in cash, securities or other property) of or in respect of principal of or interest (x) on any Indebtedness for borrowed money on which a Borrower or a Subsidiary of a Borrower is a primary obligor, prior to its scheduled maturity or scheduled payment date, except for (A) the ABL Finance Obligations, (B) Refinancings with the proceeds of Permitted Refinancing Indebtedness, (C) prepayments of other Indebtedness (excluding any Indebtedness which by its terms is subordinated in right of payment to the ABL Credit Obligations) in amounts not to exceed $1,000,000 in the aggregate, (D) prepayments of intercompany Indebtedness of the Loan Parties owed to Ultimate Parent or any of its Subsidiaries, provided, that (I) no Event of Default has occurred and is continuing or would result therefrom and (II) the Payment Conditions shall have been satisfied, (E) other prepayments of Indebtedness in amounts not to exceed $10,000,000 in the aggregate, provided, that (I) no Event of Default has occurred and is continuing or would result therefrom and (II) the Payment Conditions shall have been satisfied, (F) Refinancings of the Indebtedness evidenced by or arising under the CF Intercompany Loan Agreement with the proceeds from any Sale and Lease Back Transaction permitted by Section 7.03(b) and (G) prepayments of Indebtedness owed by any Borrower or any Subsidiary of a Borrower to any other Borrower or Subsidiary of any Borrower or (y) on any Indebtedness permitted by Section 7.01(e) (other than intercompany current liabilities incurred in the ordinary course of business in connection with the cash management operations among Ultimate Parent and its subsidiaries), on its scheduled maturity date, other than (A) any Refinancing of the Indebtedness evidenced by or arising under the CF Intercompany Loan Agreement with the proceeds from any Sale and Lease Back Transaction permitted by Section 7.03(b), and (B) any other payment if, in the case of this clause (B), (I) no Event of Default has occurred and is continuing or would result therefrom and (II) the Payment Conditions shall have been satisfied; or (i) Amend or modify, or permit the amendment or modification of any provision of Junior Financing, or any agreement, document or instrument evidencing or relating thereto, other than amendments or modifications that (A) are not in any manner materially adverse to the Revolving Facility Lenders and that do not affect the subordination or payment provisions thereof (if any) 152 in a manner adverse to the Revolving Facility Lenders and (B) otherwise comply with the definition of “Permitted Refinancing Indebtedness”; provided, that any refusal of Bowling Green to elect to pay interest “in kind” under the CUSHI Intercompany Loan Agreement on or before January 15, 2021, and any other notice under or amendment or modification of the CUSHI Intercompany Loan Agreement permitting or requiring Bowling Green to make any payment in cash in respect of interest accrued thereunder on or before January 15, 2021, in each case, shall be deemed materially adverse to the Revolving Facility Lenders and shall be prohibited by this Section 7.09(b)(ii) notwithstanding the foregoing clauses (A) and (B). (c) Permit any Material Subsidiary to enter into any agreement or instrument that by its terms restricts (i) the payment of dividends or distributions or the making of cash advances to any Borrower or any Subsidiary that is a direct or indirect parent of such Subsidiary or (ii) the granting of Liens by any Borrower or such Material Subsidiary pursuant to the Security Documents, in each case other than those arising under any Loan Document, except, in each case, restrictions existing by reason of: (A) restrictions imposed by applicable law; (B) contractual encumbrances or restrictions in effect on the Amendment No. 2 Effective Date under Indebtedness existing on the Amendment No. 2 Effective Date and set forth on Schedule 7.01 or any agreements related to any Permitted Refinancing Indebtedness in respect of any such Indebtedness that does not expand the scope of any such encumbrance or restriction; (C) any restriction on a Subsidiary imposed pursuant to an agreement entered into for the sale or disposition of the Equity Interests or assets of a Subsidiary pending the closing of such sale or disposition; (D) customary provisions in joint venture agreements and other similar agreements applicable to joint ventures entered into in the ordinary course of business; (E) any restrictions imposed by any agreement relating to secured Indebtedness permitted by this Agreement to the extent that such restrictions apply only to the property or assets securing such Indebtedness; (F) customary provisions contained in leases or licenses of intellectual property and other similar agreements entered into in the ordinary course of business; (G) customary provisions restricting subletting or assignment of any lease governing a leasehold interest; (H) customary provisions restricting assignment of any agreement entered into in the ordinary course of business; (I) customary restrictions and conditions contained in the document relating to any Lien, so long as (1) such Lien is a Permitted Lien in an amount less than $5,000,000 and such restrictions or conditions relate only to the specific asset subject to such Lien, and (2) such restrictions and conditions are not created for the purpose of avoiding the restrictions imposed by this Section 7.09; (J) customary net worth provisions contained in Real Property leases entered into by Subsidiaries of any Borrower, so long as such Borrower has determined in good 153 faith that such net worth provisions would not reasonably be expected to impair the ability of such Borrower and its Subsidiaries to meet their ongoing obligations; (K) any agreement in effect at the time such subsidiary becomes a Subsidiary, so long as such agreement was not entered into in contemplation of such person becoming a Subsidiary other than Subsidiaries of such new Subsidiary; (L) restrictions in agreements representing Indebtedness permitted under Section 7.01 of a Subsidiary of any Borrower that is not a Subsidiary Loan Party; (M) customary restrictions on leases, subleases, licenses or Equity Interests or asset sale agreements otherwise permitted hereby as long as such restrictions relate to the Equity Interests and assets subject thereto; (N) restrictions on cash or other deposits imposed by customers under contracts entered into in the ordinary course of business; or (O) any encumbrances or restrictions of the type referred to in Sections 7.09(c)(i) and 7.09(c)(ii) above imposed by any amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings of the contracts, instruments or obligations referred to in clauses (A) through (N) above; provided that such amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings are, in the good faith judgment of the applicable Borrower, no more restrictive with respect to such dividend and other payment restrictions than those contained in the dividend or other payment restrictions prior to such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing. Section 7.10 Margin Stock; Use of Proceeds. (a) No Loan Party shall, and no Loan Party shall suffer or permit any of its Subsidiaries to, use any portion of the Loan proceeds, directly or indirectly, to purchase or carry Margin Stock or repay or otherwise refinance Indebtedness of any Loan Party or others incurred to purchase or carry Margin Stock, or otherwise in any manner which is in contravention of any applicable Law or in violation of this Agreement. (b) No Borrower shall, nor shall it permit any other Loan Party or any other Subsidiary to, use any proceeds of the Loans or any Letter of Credit in a manner that would make the representations and warranties referred to in Sections 4.25 and 4.26 fail to be true and correct in all material respects at any time. Section 7.11 Holdcos Covenants. Each Holdco covenants and agrees with each Lender that unless and until (i) all Commitments shall have been terminated and (ii) all ABL Credit Obligations arising under the Loan Documents (other than contingent obligations for unasserted claims) shall have been repaid, unless the Required Lenders shall otherwise consent in writing, no Holdco (x) will create, incur, assume or permit to exist any Lien (other than Liens of a type described in Section 7.02(b), (d), (e) or (k)) on any of the Equity Interests issued by the applicable Borrower other than the Liens created under the Loan Documents or (y) will merge into or consolidate or amalgamate with any other person, or permit any other person to merge into or consolidate or amalgamate with it, or otherwise sell, transfer, lease or otherwise dispose (including to a Divided LLC pursuant to a Division) of (in one transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired), or issue, sell, transfer or otherwise dispose of any Equity Interests of any Borrower, except that (1) each 154 Constellium Holding Company shall be permitted to merge into or consolidate or amalgamate with any other Subsidiary of Ultimate Parent that is organized under the laws of the United States or any political subdivision, state, or province thereof, in a transaction in which any Constellium Holding Company or such Subsidiary is the surviving or resulting entity, (2) Parent Guarantor shall be permitted to merge into, or convert its jurisdiction of formation to, any Subsidiary of Ultimate Parent organized under the laws of the European Union, Switzerland, or United States or any political subdivision, state, or province thereof, and (3) each Constellium Holding Company shall be permitted to issue, sell, transfer or otherwise dispose of the Equity Interests of any Borrower to any other Constellium Holding Company, provided that, in the case of clauses (1) and (2), the applicable surviving Person (if other than the applicable Holdco) shall promptly reaffirm its obligations, and, as applicable, its grant of security interests, under the Guaranty and the Collateral Agreement, as applicable, and otherwise comply with Section 6.10 to ensure that such Person remains a Loan Party or the Parent Guarantor hereunder, as applicable, and in the case of clause (2), shall promptly deliver to the Administrative Agent a favorable written opinion of its legal counsel qualified in its jurisdiction of organization addressed to the Administrative Agent, the Lenders and the L/C Issuer, which shall be in form and substance reasonably satisfactory to the Administrative Agent and covering such matters as the Administrative Agent shall reasonably request. Section 7.12 Financial Covenants. If a Financial Covenant Triggering Event has occurred and is continuing: (a) permit the Fixed Charge Coverage Ratio to be less than 1.0 to 1.0 for the most recently ended four fiscal quarters for which the Administrative Agent has received financial statements pursuant to Section 6.04(a) or (b); or (b) Reserved. ARTICLE VIII EVENTS OF DEFAULT Section 8.01 Events of Default. In case of the happening of any of the following events (each, an “Event of Default”): (a) any representation or warranty made or deemed made by the Holdcos, any Borrower or any other Loan Party herein or in any other Loan Document or any certificate or document delivered pursuant hereto or thereto shall prove to have been false or misleading in any material respect (without duplication of other materiality qualifiers contained therein) when so made or deemed made; (b) default shall be made in the payment of any principal of any Loan or any L/C Obligation or the deposit of any funds as Cash Collateral in respect of L/C Obligations when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or by acceleration thereof or otherwise; (c) default shall be made in the payment of any interest on any Loan or any L/C Obligation or in the payment of any Fee or any other amount (other than an amount referred to in (b) above) due under any Loan Document, when and as the same shall become due and payable, and such default shall continue unremedied for a period of five Business Days; (d) default shall be made in the due observance or performance by the Holdcos, any Borrower or any of its Subsidiaries of any covenant, condition or agreement contained in any of Section 6.01(a), 6.05(i), 6.08 or 6.10(h), 6.12 or in Article VII;


 
155 (e) default shall be made in the due observance or performance by the Holdcos, any Borrower or any of its Subsidiaries of any covenant, condition or agreement contained in any Loan Document (other than those specified in paragraphs (b), (c) and (d) above) and such default shall continue unremedied for a period of 30 days (or (i) 60 days if such default results solely from a Foreign Subsidiary’s failure to duly observe or perform any such covenant, condition or agreement; (ii) 5 Business Days in the case of any covenant, condition or agreement contained in Section 6.07, 6.11 or 6.13 or (iii) 10 Business Days in the case of any covenant, condition or agreement contained in Section 6.04) after notice thereof from the Administrative Agent to any Borrower; (f) (i) any Loan Party, the Parent Guarantor or any Subsidiary of any thereof (A) fails to make payment when due (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise) and beyond any applicable grace period, regardless of amount, in respect of any Material Indebtedness (other than in respect of Swap Contracts), (B) fails to perform or observe any other condition or covenant, or any other event shall occur or condition shall exist, under any agreement or instrument relating to any Material Indebtedness, if the effect of such failure, event or condition (giving effect to any applicable grace period) is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such Material Indebtedness (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, such Material Indebtedness to be declared to be due and payable prior to its stated maturity or (C) shall be required by the terms of such Material Indebtedness to offer to prepay or repurchase such Material Indebtedness (or any portion thereof) prior to the stated maturity thereof; or (ii) there occurs under any Swap Contract or Swap Obligation an Early Termination Date (as defined in such Swap Contract) resulting from any event of default under such Swap Contract as to which any Loan Party, the Parent Guarantor or any Subsidiary thereof is the Defaulting Party (as defined in such Swap Contract) and the Swap Termination Value owed by a Loan Party, the Parent Guarantor or any Subsidiary thereof as a result thereof is greater than $15,000,000 (in the case of Borrower and its Subsidiaries) or $50,000,000 (in the case of any other Loan Party, the Parent Guarantor or Subsidiary thereof); provided that this clause (f) shall not apply to secured Indebtedness that becomes due, or which any Loan Party or the Parent Guarantor shall be required to prepay or repurchase, as a result of the sale or transfer (including by way of condemnation or casualty) of the property or assets securing such Indebtedness if such sale or transfer is permitted hereunder and under the documents providing for such Indebtedness; (g) there shall have occurred a Change in Control; (h) an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking (i) relief in respect of the Holdcos, any Borrower or any of its Subsidiaries, or of a substantial part of the property or assets of the Holdcos, any Borrower or any Subsidiary, under the U.S. Bankruptcy Code or any other Debtor Relief Law, as now constituted or hereafter amended, or any other federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Holdcos, any Borrower or any of its Subsidiaries or for a substantial part of the property or assets of the Holdcos, any Borrower or any of its Subsidiaries or (iii) the winding up or liquidation of the Holdcos, any Borrower or any Subsidiary (except, in the case of any Subsidiary, in a transaction permitted by Section 7.05); and, in each case, such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered; (i) the Holdcos, any Borrower or any Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking relief under the U.S. Bankruptcy Code or any other Debtor Relief Law, as now constituted or hereafter amended, or any other federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or the filing of any petition described in paragraph (h) above, (iii) 156 apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Holdcos, any Borrower or any of its Subsidiaries or for a substantial part of the property or assets of the Holdcos, any Borrower or any Subsidiary, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) become unable or admit in writing its inability or fail generally to pay its debts as they become due; (j) the failure by the Holdcos, any Borrower or any Subsidiary to pay one or more final judgments aggregating in excess of $15,000,000 (in the case of a Borrower and its Subsidiaries) or $50,000,000 (in the case of any other Loan Party, the Parent Guarantor or Subsidiary of any thereof) (in each case to the extent not covered by insurance), which judgments are not discharged or effectively waived or stayed for a period of 45 consecutive days; (k) (i) a trustee shall be appointed by a United States district court to administer any Plan, (ii) an ERISA Event or ERISA Events shall have occurred, (iii) the PBGC shall institute proceedings (including giving notice of intent thereof) to terminate any Plan or Plans, (iv) the Holdcos, any Borrower or any Subsidiary or any ERISA Affiliate shall have been notified by the sponsor of a Multiemployer Plan that such Multiemployer Plan is insolvent or is being terminated, within the meaning of Title IV of ERISA, (v) the Holdcos, any Borrower or any Subsidiary shall engage in any “prohibited transaction” (as defined in Section 406 of ERISA or Section 4975 of the Code) involving any Plan; and in each case in clauses (i) through (v)above, such event or condition, together with all other such events or conditions, if any, would reasonably be expected to have a Material Adverse Effect; (l) (i) any Loan Document shall for any reason be asserted in writing by the Holdcos, any Borrower or any Subsidiary not to be a legal, valid and binding obligation of any party thereto, (ii) any security interest purported to be created by any Security Document and to extend to assets that are not immaterial to the Holdcos, any Borrower and its Subsidiaries on a consolidated basis shall cease to be, or shall be asserted in writing by any Borrower or any other Loan Party not to be, a valid and perfected security interest (perfected as or having the priority required by this Agreement or the relevant Security Document and subject to such limitations and restrictions as are set forth herein and therein) in the securities, assets or properties covered thereby, except to the extent that any such loss of perfection or priority results from the limitations of foreign laws, rules and regulations as they apply to pledges of Equity Interests in Foreign Subsidiaries or the application thereof, or from the failure of the Administrative Agent to maintain possession of certificates actually delivered to it representing securities pledged under the Collateral Agreement or to file Uniform Commercial Code continuation statements or take the actions described on Schedule 4.04 and except to the extent that such loss is covered by a lender’s title insurance policy and the Administrative Agent shall be reasonably satisfied with the credit of such insurer, or (iii) the Guarantees pursuant to the Security Documents by the Holdcos, the Borrowers or the Subsidiary Loan Parties of any of the ABL Finance Obligations shall cease to be in full force and effect (other than in accordance with the terms thereof), or shall be asserted in writing by the Holdcos or any Borrower or any Subsidiary Loan Party not to be in effect or not to be legal, valid and binding obligations; or (m) the PBGC Intercreditor Agreement, or Bowling Green Current Assets Access Agreement or the Ravenswood Intercreditor Agreement, or any provision thereof, shall cease to be in full force and effect (except in accordance with its terms), or any of the Loan Parties or the Parent Guarantor party thereto shall deny or disaffirm their respective obligations thereunder or default in the due performance or observance of any term, covenant or agreement on their part to be performed or observed pursuant to the terms thereof; 157 (n) then, and in every such event (other than an event with respect to any Borrower described in paragraph (h) or (i) above), and at any time thereafter during the continuance of such event, the Administrative Agent, at the request of the Required Lenders, shall, by notice to the Borrowers, take any or all of the following actions, at the same or different times: (i) terminate forthwith the Commitments (and any obligations to make L/C Credit Extensions), (ii) declare the Loans and L/C Obligations then outstanding to be forthwith due and payable in whole or in part, whereupon the principal of the Loans and the L/C Obligations so declared to be due and payable, together with accrued interest thereon and any unpaid accrued Fees and all other liabilities of the Borrowers accrued hereunder and under any other Loan Document, shall become forthwith due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by each Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding, (iii) require that the Borrowers Cash Collateralize the L/C Obligations (in an amount equal to the Minimum Collateral Amount with respect thereto), and (iv) exercise all rights and remedies granted to it under any Loan Document and all its rights under any other applicable law or in equity; and in any event with respect to the applicable Borrower described in paragraph (h) or (i) above, the Commitments (and any obligations to make L/C Credit Extensions) shall automatically terminate, the principal of the Loans then outstanding, together with accrued interest thereon and any unpaid accrued Fees and all other liabilities of the Borrowers accrued hereunder and under any other Loan Document, shall automatically become due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by each Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding. Section 8.02 Exclusion of Immaterial Subsidiaries. Solely for the purposes of determining whether an Event of Default has occurred under clause (h), (i), (j) or (l) of Section 8.01, any reference in any such clause to any Subsidiary shall be deemed not to include any Immaterial Subsidiary affected by any event or circumstance referred to in any such clause. Section 8.03 Application of Funds. (a) (i) So long as no Application Event has occurred and is continuing and except as otherwise provided herein with respect to Defaulting Lenders, all principal and interest payments received by Administrative Agent shall be apportioned ratably among the Lenders (according to the unpaid principal balance of the Obligations to which such payments relate held by each Lender) and all payments of fees and expenses received by Agent (other than fees or expenses that are for Agent's separate account or for the separate account of Issuing Bank) shall be apportioned ratably among the Lenders having a Pro Rata Share of the type of Commitment or ABL Finance Obligation to which a particular fee or expense relates. (ii) Subject to Section 8.03(e), Section 2.11(a)(ii), and Section 2.11(b), all payments to be made hereunder by Borrowers shall be remitted to Administrative Agent and all such payments, and all proceeds of Collateral received by Administrative Agent (including during an Accounts Availability Triggering Event which is not commenced as a result of an Event of Default), shall be applied, so long as no Application Event has occurred and is continuing and except as otherwise provided herein with respect to Defaulting Lenders, first, to reduce the balance of the Revolving Facility Loans outstanding, and second, to the Term Loans, as the case, may be and, thereafter, to Borrowers (to be wired to the Designated Account) or such other Person entitled thereto under applicable law. (b) At any time that an Application Event has occurred and is continuing any all payments remitted to Administrative Agent (other than those in respect of Term Loan Priority Collateral) and all amounts received on account of Revolving Loan Priority Collateral shall, subject to the provisions 158 of Section 2.17 and the Intercreditor Agreements, be applied by the Administrative Agent in the following order: first, to payment of that portion of the ABL Finance Obligations constituting fees, indemnities, expenses and other amounts (including fees, charges and disbursements of counsel to the Administrative Agent and amounts payable under Article III) payable to the Administrative Agent in its capacity as such, until paid in full; second, to payment of that portion of the ABL Finance Obligations constituting accrued and unpaid interest and unpaid principal of the Swing Line Loans payable to the Swing Line Lender and Agent Advances payable to the Administrative Agent, ratably among the Swing Line Lender and Administrative Agent in proportion to the respective amounts described in this clause Second held by them, until paid in full; third, to payment of that portion of the ABL Finance Obligations constituting accrued and unpaid Letter of Credit Fees and unpaid principal of the L/C Borrowings, ratably among the L/C Issuers in proportion to the respective amounts described in this clause Third held by them, until paid in full; fourth, to payment of that portion of the ABL Finance Obligations constituting fees, and indemnities payable to the Revolving Facility Lenders and the L/C Issuers arising under the Loan Documents and amounts payable under Article III (other than amounts paid under the preceding clauses), ratably among them in proportion to the respective amounts described in this clause Fourth payable to them, until paid in full; fifth, to payment to the Administrative Agent for the account of the L/C Issuers, to Cash Collateralize that portion of L/C Obligations comprised of the aggregate undrawn amount of Letters of Credit to the extent not otherwise Cash Collateralized by the Borrowers pursuant to Sections 2.05 and 2.16, until paid in full; sixth, to payment of that portion of the ABL Finance Obligations, other than amounts paid under preceding clauses, constituting accrued and unpaid interest on the Revolving Facility Loans until paid in full; seventh, ratably to payment of that portion of the ABL Finance Obligations, other than amounts paid to Revolving Facility Lenders under preceding clauses, constituting (i) unpaid principal of Revolving Facility Loans and (ii) Bank Product Obligations up to the amount of the Bank Product Reserves then in effect in respect of such Bank Product Obligations, in proportion to the respective amounts described in this clause Seventh held by them, until paid in full (provided, that, if a Lender or its Affiliates is both a Revolving Facility Lender and a Term Loan Lender, then for purposes of any Bank Product Obligations owing to it, such Lender shall be deemed only a Revolving Facility Lender); eighth, payment to other ABL Credit Obligations in respect of Revolving Facility other than amounts paid to Revolving Facility Lenders under preceding clauses (and other than Bank Product Obligations owing to Revolving Facility referred to in clause Twelfth), ratably among the Revolving Facility Lenders in proportion to the respective amounts in this clause Eighth held by them until paid in full; ninth, to payment of that portion of the ABL Finance Obligations constituting fees, indemnities payable to the Term Loan Lenders arising under the Loan Documents and amounts payable under Article III, ratably among them in proportion to the respective amounts described in this clause Ninth payable to them, until paid in full;


 
159 tenth, to payment of that portion of the ABL Finance Obligations, other than amounts paid to Term Loan Lenders under preceding clauses, constituting accrued and unpaid interest on the Term Loans, ratably among the Term Loan Lenders in proportion to the respective amounts described in this clause Tenth held by them, until paid in full; eleventh, to payment of that portion of the ABL Finance Obligations, other than amounts paid under preceding clauses, constituting unpaid principal of the Term Loans and other ABL Credit Obligations in respect of the Term Facility (other than Bank Product Obligations), ratably among the Term Loan Lenders in proportion to the respective amounts described in this clause Eleventh held by them, until paid in full; twelfth, to payment of that portion of the ABL Finance Obligations constituting unpaid Bank Product Obligations then owing to Revolving Facility Lenders or their Affiliates (that have not been paid pursuant to clause Seventh above), ratably among the relevant Hedge Banks and the Cash Management Banks in proportion to the respective amounts described in this clause Twelfth held by them, until paid in full; thirteenth, to payment of that portion of the ABL Finance Obligations constituting unpaid Bank Product Obligations then owing to Term Loan Lenders and their Affiliates, ratably among the relevant Hedge Banks and the Cash Management Banks in proportion to the respective amounts described in this clause Thirteenth held by them, until paid in full; fourteenth, to payment of any remaining ABL Finance Obligations ratably among the relevant Lenders in proportion to the respective amounts described in this clause Fourteenth held by them, until paid in full; and last, the balance, if any, after all of the ABL Finance Obligations have been indefeasibly paid in full, to the Borrowers or as otherwise required by Law. Subject to Sections 2.05(c) and 2.16, amounts used to Cash Collateralize the aggregate undrawn amount of Letters of Credit pursuant to clause Fifth above shall be applied to satisfy drawings under such Letters of Credit as they occur. If any amount remains on deposit as Cash Collateral after all Letters of Credit have either been fully drawn or expired, such remaining amount shall be applied to the other ABL Finance Obligations, if any, in the order set forth above. (c) At any time that an Application Event has occurred and is continuing any amounts received on account of Term Loan Priority Collateral shall, subject to the provisions of Section 2.17 and the Intercreditor Agreements, be applied by the Administrative Agent in the following order: first, to payment of that portion of the ABL Finance Obligations constituting fees, indemnities, expenses and other amounts (including fees, charges and disbursements of counsel to the Administrative Agent and amounts payable under Article III) payable to the Administrative Agent in its capacity as such, until paid in full; second, to payment of that portion of the ABL Finance Obligations constituting fees, and indemnities (other than amounts paid under preceding clauses) payable to the Term Loan Lenders arising under the Loan Documents and amounts payable under Article III, ratably among them in proportion to the respective amounts described in this clause Second payable to them, until paid in full; third, to payment of that portion of the ABL Finance Obligations, other than amounts paid under preceding clauses, constituting accrued and unpaid interest on the Term Loans, ratably among the Term 160 Loan Lenders in proportion to the respective amounts described in this clause Third held by them, until paid in full; fourth, ratably to payment of that portion of the ABL Finance Obligations, other than amounts paid under preceding clauses, constituting unpaid principal of the Term Loans and other ABL Credit Obligations in respect of Term Facility, in proportion to the respective amounts described in this clause Fourth held by them, until paid in full; fifth, to payment of that portion of the ABL Finance Obligations constituting accrued and unpaid interest and unpaid principal of the Swing Line Loans payable to the Swing Line Lender and Agent Advances payable to the Administrative Agent, ratably among the Swing Line Lender and Administrative Agent in proportion to the respective amounts described in this clause Fifth held by them, until paid in full; sixth, to payment of that portion of the ABL Finance Obligations constituting accrued and unpaid Letter of Credit Fees and unpaid principal of the L/C Borrowings, ratably among the L/C Issuers in proportion to the respective amounts described in this clause Sixth held by them, until paid in full; seventh, to payment of that portion of the ABL Finance Obligations constituting fees, and indemnities (other than amounts paid under preceding clauses) payable to the Revolving Facility Lenders and the L/C Issuers arising under the Loan Documents and amounts payable under Article III, ratably among them in proportion to the respective amounts described in this clause Seventh payable to them, until paid in full; eighth, to payment to the Administrative Agent for the account of the L/C Issuers, to Cash Collateralize that portion of L/C Obligations comprised of the aggregate undrawn amount of Letters of Credit to the extent not otherwise Cash Collateralized by the Borrowers pursuant to Sections 2.05 and 2.16, until paid in full; ninth, to payment of that portion of the ABL Finance Obligations, other than amounts paid under preceding clauses, constituting accrued and unpaid interest on the Revolving Facility Loans, ratably among the Revolving Facility Lenders in proportion to the respective amounts described in this clause Ninth held by them, until paid in full; tenth, ratably to payment of that portion of the ABL Finance Obligations, other than amounts paid to Revolving Facility Lenders under preceding clauses, constituting unpaid principal of Revolving Facility Loans and other ABL Credit Obligations owing to Revolving Facility Lenders, in proportion to the respective amounts described in this clause Tenth held by them, until paid in full; eleventh, to payment of that portion of the ABL Finance Obligations constituting unpaid Bank Product Obligations owing to Term Loan Lenders ratably among the relevant Hedge Banks and the Cash Management Banks in proportion to the respective amounts described in this clause Eleventh held by them, until paid in full; twelfth, to payment of that portion of the ABL Finance Obligations constituting unpaid Bank Product Obligations owing to Revolving Facility Lenders or their Affiliates ratably among the relevant Hedge Banks and the Cash Management Banks in proportion to the respective amounts described in this clause Twelfth held by them, until paid in full; 161 thirteenth, to payment of any remaining ABL Finance Obligations ratably among the relevant Lenders in proportion to the respective amounts described in this clause Thirteenth held by them, until paid in full; and last, the balance, if any, after all of the ABL Finance Obligations have been indefeasibly paid in full, to the Borrowers or as otherwise required by Law. (d) Notwithstanding the foregoing, ABL Finance Obligations arising under Secured Cash Management Agreements and Secured Hedge Agreements shall be excluded from the application described in Sections 8.03(b) and (c) above if the Administrative Agent has not received written notice thereof, together with such supporting documentation as the Administrative Agent may request, from the applicable Cash Management Bank or Hedge Bank, as the case may be. Each Cash Management Bank or Hedge Bank not a party to this Agreement that has given the notice contemplated by the preceding sentence shall, by such notice, be deemed to have acknowledged and accepted the appointment of the Administrative Agent pursuant to the terms of Article IX hereof for itself and its Affiliates as if a “Lender” party hereto. (e) In each instance, so long as no Application Event has occurred and is continuing, Sections 8.03 (a)(ii) shall not apply to any payment made by Borrowers to Agent and specified by Borrowers to be for the payment of specific ABL Finance Obligations then due and payable (or prepayable) under any provision of this Agreement or any other Loan Document. (f) For purposes of Sections 8.03(b) and (c), “paid in full” of a type of ABL Finance Obligation means payment in cash or immediately available funds of all amounts owing on account of such type of ABL Finance Obligation, including interest accrued after the commencement of any proceeding under the U.S. Bankruptcy Code or any other Debtor Relief Law, default interest, interest on interest, indemnities and expense reimbursements, irrespective of whether any of the foregoing would be or is allowed or disallowed in whole or in part in any proceeding under the U.S. Bankruptcy Proceeding or any other Debtor Relief Law. (g) Notwithstanding anything to the contrary (i) no payment received by Administrative Agent from the Parent Guarantor in respect of its Guarantee of the ABL Finance Obligations shall be applied against any Term Loan A-2 Obligations, (ii) all payments received pursuant to Section 8.03(b) clause Fourteenth shall be allocated to the Lenders base on their Pro Rata Share as defined in clause (c) of the definition of Pro Rata Share, (iii) all payments received pursuant to Section 8.03(c) Thirteenth shall be allocated to the Lenders base on their Pro Rata Share as defined in clause (c) of the definition of Pro Rata Share, and (iv) with respect to Bank Product Obligations, if a Hedge Bank or a Cash Management Bank is both a Revolving Facility Lender and a Term Loan Lender, then its Bank Product Obligations shall be treated as owing to a Revolving Facility Lender. ARTICLE IX THE AGENCY PROVISIONS Section 9.01 Appointment and Authority. (a) Administrative Agent. Each of the Lenders (in its capacities as a Lender and on behalf of itself and its Affiliates as a potential Hedge Bank and a potential Cash Management Bank) and L/C Issuers hereby irrevocably appoints Wells Fargo to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto 162 (including, without limitation, the making of one or more Agent Advances). The provisions of this Article are solely for the benefit of the Administrative Agent, the Lenders and L/C Issuers. No Borrower shall have rights as a third party beneficiary of any of such provisions (except as expressly provided in Section 9.06). It is understood and agreed that the use of the term “agent” herein or in any other Loan Documents (or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable Law. Instead such term is used as a matter of market custom, and is intended to create or reflect only an administrative relationship between contracting parties. (b) Collateral Agent. The Administrative Agent shall also act as the “collateral agent” under the Loan Documents, and each of the Lenders (in its capacities as a Lender on behalf of itself and its Affiliates and as a potential Hedge Bank and a potential Cash Management Bank) and L/C Issuers hereby irrevocably appoints and authorizes the Administrative Agent to act as the agent of such Lender and L/C Issuers for purposes of acquiring, holding and enforcing any and all Liens on Collateral granted by any of the Loan Parties to secure any of the ABL Finance Obligations, together with such powers and discretion as are reasonably incidental thereto. In this connection, the Administrative Agent, as “collateral agent” and any co-agents, sub-agents and attorneys-in-fact appointed by the Administrative Agent pursuant to Section 9.05 for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under the Security Documents (and subject to the Intercreditor Agreements), or for exercising any rights and remedies thereunder at the direction of the Administrative Agent, shall be entitled to the benefits of all provisions of this Article IX and Article X (including Section 10.04(c), as though such co-agents, sub-agents and attorneys-in-fact were the “collateral agent” under the Loan Documents) as if set forth in full herein with respect thereto. Section 9.02 Rights as a Lender. The Person serving as the Administrative Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent and the term “Lender” or “Lenders” shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with any Borrower or any Subsidiary or other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders. Section 9.03 Exculpatory Provisions. The Administrative Agent shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents, and its duties hereunder shall be administrative in nature. Without limiting the generality of the foregoing, the Administrative Agent: (a) shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing; (b) shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents); provided that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law, including for the avoidance of doubt any action that may be in violation of the automatic stay under any Debtor Relief Law or that may effect a


 
163 forfeiture, modification or termination of property of a Defaulting Lender in violation of any Debtor Relief Law; and (c) shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to any Borrower or any of its Affiliates that is communicated to or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity. The Administrative Agent shall not be liable for any action taken or not taken by it (i) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in Sections 10.01 and 8.01) or (ii) in the absence of its own gross negligence or willful misconduct, as determined by a court of competent jurisdiction by a final and non-appealable judgment. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until notice describing such Default is given in writing to the Administrative Agent by a Borrower, a Lender or an L/C Issuer. The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document, (v) the value or the sufficiency of any Collateral or (vi) the satisfaction of any condition set forth in Article V or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent. Section 9.04 Reliance by Administrative Agent. The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan, or the issuance, extension, renewal or increase of a Letter of Credit, that by its terms must be fulfilled to the satisfaction of a Lender or an L/C Issuer, the Administrative Agent may presume that such condition is satisfactory to such Lender or L/C Issuer unless the Administrative Agent shall have received notice to the contrary from such Lender or L/C Issuer prior to the making of such Loan or the issuance, extension, renewal or increase of such Letter of Credit. The Administrative Agent may consult with legal counsel (who may be counsel for a Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts. Section 9.05 Delegation of Duties. The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent. The Administrative Agent shall not be responsible for the 164 negligence or misconduct of any sub-agents except to the extent that a court of competent jurisdiction determines in a final and non-appealable judgment that the Administrative Agent acted with gross negligence or willful misconduct in the selection of such sub-agents. Section 9.06 Resignation of Administrative Agent. (a) The Administrative Agent may at any time give notice of its resignation to the Lenders, the L/C Issuers and the Borrowers. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, in consultation with the Borrowers, to appoint a successor, which shall be a bank with an office in the United States, or an Affiliate of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the retiring Administrative Agent gives notice of its resignation (or such earlier day as shall be agreed by the Required Lenders) (the “Resignation Effective Date”), then the retiring Administrative Agent may (but shall not be obligated to) on behalf of the Lenders and the L/C Issuers, appoint a successor Administrative Agent meeting the qualifications set forth above. Whether or not a successor has been appointed, such resignation shall become effective in accordance with such notice on the Resignation Effective Date. (b) If the Person serving as Administrative Agent is a Defaulting Lender pursuant to clause (iv) of the definition thereof, the Required Lenders may, to the extent permitted by applicable law, by notice in writing to the Borrowers and such Person remove such Person as Administrative Agent and, in consultation with the Borrowers, appoint a successor. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days (or such earlier day as shall be agreed by the Required Lenders) (the “Removal Effective Date”), then such removal shall nonetheless become effective in accordance with such notice on the Removal Effective Date. (c) With effect from the Resignation Effective Date or the Removal Effective Date (as applicable) (1) the retiring or removed Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and (2) except for any indemnity payments or other amounts then owed to the retiring or removed Administrative Agent, all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender and each L/C Issuer directly, until such time, if any, as the Required Lenders appoint a successor Administrative Agent as provided for above. Upon the acceptance of a successor’s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or removed) Administrative Agent (other than as provided in Section 3.01(f) and other than any rights to indemnity payments or other amounts owed to the retiring or removed Administrative Agent as of the Resignation Effective Date or the Removal Effective Date, as applicable), and the retiring or removed Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrowers to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrowers and such successor. After the retiring or removed Administrative Agent’s resignation or removal hereunder and under the other Loan Documents, the provisions of this Article and Section 10.04 shall continue in effect for the benefit of such retiring or removed Administrative Agent, its sub agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring or removed Administrative Agent was acting as Administrative Agent. (d) Any resignation by Wells Fargo as Administrative Agent pursuant to this Section shall also constitute its resignation as L/C Issuer and Swing Line Lender. If Wells Fargo resigns as an L/C Issuer, it shall retain all the rights, powers, privileges and duties of an L/C Issuer hereunder with 165 respect to all Letters of Credit issued by it which are outstanding as of the effective date of its resignation as an L/C Issuer and all L/C Obligations with respect thereto, including the right to require the Lenders to make Base Rate Loans or fund risk participations in Unreimbursed Amounts pursuant to Section 2.05(c). If Wells Fargo resigns as Swing Line Lender, it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make Base Rate Loans or fund risk participations in outstanding Swing Line Loans pursuant to Section 2.04(c). Upon the appointment by the Borrowers of a successor L/C Issuer or Swing Line Lender hereunder (which successor shall in all cases be a Lender other than a Defaulting Lender), (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring L/C Issuer or Swing Line Lender, as applicable, (b) the retiring L/C Issuer and Swing Line Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents, and (c) the successor L/C Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, issued by the retiring L/C Issuer which are outstanding at the time of such succession or make other arrangements satisfactory to Wells Fargo to effectively assume the obligations of Wells Fargo with respect to such Letters of Credit. Section 9.07 Non-Reliance on Administrative Agent and Other Lenders. Each Lender and L/C Issuer acknowledges that it has, independently and without reliance upon the Administrative Agent, any arranger of this credit facility or any amendment thereto or any other Lender or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender and L/C Issuer also acknowledges that it will, independently and without reliance upon the Administrative Agent, any arranger of this credit facility or any amendment thereto or any other Lender or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder. Section 9.08 No Other Duties, Etc. Anything herein to the contrary notwithstanding, none of the Joint Bookrunners, Joint Lead Arrangers or Co-Syndication Agents listed on the cover page hereof shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, a Lender or an L/C Issuer hereunder, but all such parties shall be entitled to the benefits of this Article IX. Section 9.09 Administrative Agent May File Proofs of Claim. In case of the pendency of any proceeding under any Debtor Relief Law or any other judicial proceeding relative to any Loan Party or the Parent Guarantor, the Administrative Agent (irrespective of whether the principal of any Loan or L/C Obligation shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrowers) shall be entitled and empowered, by intervention in such proceeding or otherwise: (a) to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans, L/C Obligations and all other ABL Credit Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders, the L/C Issuers and the Administrative Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders, the L/C Issuers and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders, the L/C Issuers and the Administrative Agent under Sections 2.05(h) and (i), 2.12 and 10.04) allowed in such judicial proceeding; and (b) to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same; 166 and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under Sections 2.12 and 10.04. Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender any plan of reorganization, arrangement, adjustment or composition affecting the ABL Finance Obligations or the rights of any Lender or to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding. Section 9.10 Collateral and Guaranty Matters. Without limiting the provisions of Section 9.09 each of the Lenders (in its capacities as a Lender and as a potential Cash Management Bank and a potential Hedge Bank) and the L/C Issuers irrevocably authorizes the Administrative Agent, at its option and in its discretion, to: (a) release any Lien on any property granted to or held by the Administrative Agent under any Loan Document (A) upon the Facility Termination Date, (B) with respect to any property that is sold or otherwise disposed of or to be sold or otherwise disposed of as part of or in connection with any sale or other disposition permitted hereunder or under any other Loan Document or (C) if approved, authorized or ratified in writing in accordance with Section 10.01; (b) release any Guarantor from its obligations under the Guaranty if such Person ceases to be a Subsidiary as a result of a transaction permitted under the Loan Documents; (c) subordinate any Lien on any property granted to or held by the Administrative Agent under any Loan Document to the holder of any Lien on such property that is permitted by Section 7.02(a), (b), (c), (i) or (j); and (d) execute and deliver the Intercreditor Agreements and any amendments, supplements or joinders thereto, including any intercreditor agreement necessary or desirable to permit the incurrence by the Loan Parties of secured indebtedness permitted to be incurred hereunder with the priority permitted hereunder and perform its obligations and duties, and exercise its rights and remedies, thereunder. Upon request by the Administrative Agent at any time, the Required Lenders will confirm in writing the Administrative Agent’s authority to release or subordinate its interest in particular types or items of property, or to release any Guarantor from its obligations under the Guaranty pursuant to this Section 9.10. In each case as specified in this Section 9.10, the Administrative Agent will, at the Borrowers’ expense, execute and deliver to the applicable Loan Party such documents as such Loan Party may reasonably request to evidence the release of such item of Collateral from the assignment and security interest granted under the Collateral Agreement and the other Loan Documents or to subordinate its interest in such item, or to release such Subsidiary Loan Party from its obligations under the Guaranty, in each case in accordance with the terms of the Loan Documents and this Section 9.10. In addition, the Administrative Agent and the Secured Parties agree to release all Liens over any accounts receivable in connection with their transfer to a Receivables Subsidiary or their sale, transfer or pledge under any Qualified Receivables Financing permitted to be entered into pursuant to the Loan Documents, and will execute any documents and prepare and make any filings reasonably requested by


 
167 the Borrowers (at the sole cost and expense of the Borrowers), and in form and substance approved by Agent in its reasonable discretion, as may be necessary to evidence such release. The Administrative Agent shall not be responsible for or have a duty to ascertain or inquire into any representation or warranty regarding the existence, value or collectability of the Collateral, the existence, priority or perfection of the Administrative Agent’s Lien thereon, or any certificate prepared by any Loan Party in connection therewith, nor shall the Administrative Agent be responsible or liable to the Lenders for any failure to monitor or maintain any portion of the Collateral. Without limiting the foregoing, no Secured Party shall have any right individually to realize upon any of the Collateral or to enforce any Guarantee of the ABL Finance Obligations, it being understood and agreed that all powers, rights and remedies under the Loan Documents may be exercised solely by the Administrative Agent or Collateral Agent on behalf of the Secured Parties in accordance with the terms thereof. In the event of a foreclosure by the Collateral Agent on any of the Collateral pursuant to a public or private sale or other disposition (including any sale or disposition conducted under a plan of reorganization), any Secured Party may be the purchaser of any or all of such Collateral at any such sale or other disposition, and the Collateral Agent, as agent for and representative of the Secured Parties (but not any Lender, Hedge Bank or Cash Management Bank in its or their respective individual capacities) shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale, to use and apply any of the ABL Finance Obligations as a credit on account of the purchase price for any Collateral payable by the Collateral Agent on behalf of the Secured Parties at such sale or other disposition. Each Secured Party, whether or not a party hereto, will be deemed, by its acceptance of the benefits of the Collateral and of the Guarantees of the ABL Finance Obligations provided under the Loan Documents, to have agreed to the foregoing provisions. The provisions of this paragraph are for the sole benefit of the Secured Parties and shall not afford any right to, or constitute a defense available to, any Loan Party. The Administrative Agent, in its capacity as “ABL Collateral Agent” under the PBGC Intercreditor Agreement, and in its capacity as “ABL Agent” under the Ravenswood Intercreditor Agreement shall be entitled to all rights, privileges, protections, immunities, benefits and indemnities provided to the Administrative Agent under this Article IX and under Section 10.04. Section 9.11 Secured Hedge Agreements and Secured Cash Management Agreements. Except as otherwise expressly set forth herein or in any Guaranty or any Security Document, no Hedge Bank or Cash Management Bank that obtains the benefits of Section 8.01, the Guaranty or any Collateral by virtue of the provisions hereof or of the Guaranty or any Security Document shall have any right to notice of any action or to consent to, direct or object to any action hereunder or under any other Loan Document or otherwise in respect of the Collateral (including the release or impairment of any Collateral) other than in its capacity as a Lender and, in such case, only to the extent expressly provided in the Loan Documents. Notwithstanding any other provision of this Article IX to the contrary, the Administrative Agent shall not be required to verify the payment of, or that other satisfactory arrangements have been made with respect to, ABL Finance Obligations arising under Secured Hedge Agreements and Secured Cash Management Agreements unless the Administrative Agent has received written notice of such ABL Finance Obligations, together with such supporting documentation as the Administrative Agent may request, from the applicable Hedge Bank or Cash Management Bank, as the case may be. Section 9.12 Certain ERISA Matters. (a) Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and not, 168 for the avoidance of doubt, to or for the benefit of any Borrower or any other Loan Party, that at least one of the following is and will be true: (i) such Lender is not using “plan assets” (within the meaning of the Section 3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments or this Agreement, (ii) the transaction exemption set forth in one or more PTEs, such as PTE 84- 14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement, (iii) (A) such Lender is an investment fund managed by a “Qualified Professional Asset Manager” (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement, or (iv) such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender. (b) In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and not, for the avoidance of doubt, to or for the benefit of any Borrower or any other Loan Party, that the Administrative Agent is not a fiduciary with respect to the assets of such Lender involved in such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto). Section 9.13 Erroneous Payment. (a) If Administrative Agent notifies a Lender, L/C Issuer or other Secured Party, or any Person who has received funds on behalf of a Lender, L/C Issuer or other Secured Party such Lender or L/C Issuer (any such Lender, L/C Issuer, other Secured Party or other recipient, a “Payment Recipient”) that Administrative Agent has determined in its sole discretion (whether or not after receipt of any notice under immediately succeeding clause (b)) that any funds received by such Payment Recipient from Administrative Agent or any of its Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Payment Recipient (whether or not known to such Lender, L/C Issuer, other Secured Party or other Payment Recipient on its behalf) (any such funds, whether 169 received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise, individually and collectively, an “Erroneous Payment”) and demands the return of such Erroneous Payment (or a portion thereof), such Erroneous Payment shall at all times remain the property of Administrative Agent and shall be segregated by the Payment Recipient and held in trust for the benefit of Administrative Agent, and such Lender, L/C Issuer or other Secured Party shall (or, with respect to any Payment Recipient who received such funds on its behalf, shall cause such Payment Recipient to) promptly, but in no event later than two (2) Business Days thereafter, return to Administrative Agent the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received by such Payment Recipient to the date such amount is repaid to Administrative Agent in same day funds at the greater of the Federal Funds Rate and a rate determined by Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect. A notice of Administrative Agent to any Payment Recipient under this clause (a) shall be conclusive, absent manifest error. (b) Without limiting the immediately preceding clause (a), each Lender, L/C Issuer or other Secured Party, or any Person who has received funds on behalf of a Lender, L/C Issuer or other Secured Party such Lender or L/C Issuer, hereby further agrees that if it receives a payment, prepayment or repayment (whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise) from Administrative Agent (or any of its Affiliates) (i) that is in a different amount than, or on a different date from, that specified in a notice of payment, prepayment or repayment sent by Administrative Agent (or any of its Affiliates) with respect to such payment, prepayment or repayment, (ii) that was not preceded or accompanied by a notice of payment, prepayment or repayment sent by Administrative Agent (or any of its Affiliates), or (iii) that such Lender, L/C Issuer or other Secured Party, or other such recipient, otherwise becomes aware was transmitted, or received, in error or by mistake (in whole or in part) in each case: (A) in the case of immediately preceding clauses (i) or (ii), an error shall be presumed to have been made (absent written confirmation from Administrative Agent to the contrary) or (B) an error has been made (in the case of immediately preceding clause (iii)), in each case, with respect to such payment, prepayment or repayment; and (B) such Lender, L/C Issuer or other Secured Party shall (and shall cause any other recipient that receives funds on its respective behalf to) promptly (and, in all events, within one (1) Business Day of its knowledge of such error) notify Administrative Agent of its receipt of such payment, prepayment or repayment, the details thereof (in reasonable detail) and that it is so notifying Administrative Agent pursuant to this Section 9.13. (c) Each Lender, L/C Issuer or other Secured Party hereby authorizes Administrative Agent to set off, net and apply any and all amounts at any time owing to such Lender, L/C Issuer or other Secured Party under any Loan Document, or otherwise payable or distributable by Administrative Agent to such Lender, L/C Issuer or other Secured Party from any source, against any amount due to Administrative Agent under immediately preceding clause (a) or under the indemnification provisions of this Agreement. (d) In the event that an Erroneous Payment (or portion thereof) is not recovered by Administrative Agent for any reason, after demand therefor by Administrative Agent in accordance with immediately preceding clause (a), from any Lender or L/C Issuer that has received such Erroneous Payment (or portion thereof) (and/or from any Payment Recipient who received such Erroneous Payment (or portion thereof) on its respective behalf) (such unrecovered amount, an “Erroneous Payment Return Deficiency”), upon Administrative Agent's notice to such Lender or Issuing Lender at any time, (i) such 170 Lender or L/C Issuer shall be deemed to have assigned its Loans (but not its Commitments) with respect to which such Erroneous Payment was made in an amount equal to the Erroneous Payment Return Deficiency (or such lesser amount as Administrative Agent may specify) (such assignment of the Loans (but not Commitments), the “Erroneous Payment Deficiency Assignment”) at par plus any accrued and unpaid interest (with the assignment fee to be waived by Administrative Agent in such instance), and is hereby (together with Borrowers) deemed to execute and deliver an Assignment and Assumption with respect to such Erroneous Payment Deficiency Assignment, and such Lender or L/C Issuer shall deliver any Notes evidencing such Loans to Administrative Agent, (ii) Administrative Agent as the assignee Lender shall be deemed to acquire the Erroneous Payment Deficiency Assignment, (iii) upon such deemed acquisition, Administrative Agent as the assignee Lender shall become a Lender or L/C Issuer, as applicable, hereunder with respect to such Erroneous Payment Deficiency Assignment and the assigning Lender or assigning L/C Issuer shall cease to be a Lender or L/C Issuer, as applicable, hereunder with respect to such Erroneous Payment Deficiency Assignment, excluding, for the avoidance of doubt, its obligations under the indemnification provisions of this Agreement and its applicable Commitments which shall survive as to such assigning Lender or assigning L/C Issuer and (iv) Administrative Agent may reflect in the Register its ownership interest in the Loans subject to the Erroneous Payment Deficiency Assignment. Administrative Agent may, in its discretion, sell any Loans acquired pursuant to an Erroneous Payment Deficiency Assignment and upon receipt of the proceeds of such sale, the Erroneous Payment Return Deficiency owing by the applicable Lender or L/C Issuer shall be reduced by the net proceeds of the sale of such Loan (or portion thereof), and Administrative Agent shall retain all other rights, remedies and claims against such Lender or L/C Issuer (and/or against any recipient that receives funds on its respective behalf). For the avoidance of doubt, no Erroneous Payment Deficiency Assignment will reduce the Commitments of any Lender or L/C Issuer and such Commitments shall remain available in accordance with the terms of this Agreement. In addition, each party hereto agrees that, except to the extent that Administrative Agent has sold a Loan (or portion thereof) acquired pursuant to an Erroneous Payment Deficiency Assignment, and irrespective of whether Administrative Agent may be equitably subrogated, Administrative Agent shall be contractually subrogated to all the rights and interests of the applicable Lender, L/C Issuer or other Secured Party under the Loan Documents with respect to each Erroneous Payment Return Deficiency (the “Erroneous Payment Subrogation Rights”). (e) The parties hereto agree that an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any ABL Credit Obligations or L/C Obligations, except, in each case, to the extent such Erroneous Payment is, and solely with respect to the amount of such Erroneous Payment that is, comprised of funds received by Administrative Agent from a Loan Party for the purpose of making such Erroneous Payment. (f) To the extent permitted by applicable law, no Payment Recipient shall assert any right or claim to an Erroneous Payment, and hereby waives, and is deemed to waive, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by Administrative Agent for the return of any Erroneous Payment received, including without limitation waiver of any defense based on “discharge for value” or any similar doctrine (g) Each party's obligations, agreements and waivers under this Section 9.13 shall survive the resignation or replacement of Administrative Agent, any transfer of rights or obligations by, or the replacement of, a Lender or L/C Issuer, the termination of the Commitments and/or the repayment, satisfaction or discharge of all ABL Credit Obligations (or any portion thereof) under any Loan Document.


 
171 ARTICLE X MISCELLANEOUS Section 10.01 Amendments, Etc. Except as otherwise set forth in this Agreement, no amendment or waiver of any provision of this Agreement or any other Loan Document, and no consent to any departure by any Borrower or any other Loan Party therefrom, shall be effective unless in writing signed by the Required Lenders (or by the Administrative Agent with the consent or ratification of the Required Lenders or such other number or percentage of Lenders as may be specified herein) and the applicable Borrower or the applicable Loan Party, as the case may be, and acknowledged by the Administrative Agent, and each such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given; provided that (x) the Administrative Agent and each Borrower may, with the consent of the Administrative Agent and each Borrower, amend, modify or supplement this Agreement and any other Loan Document to cure any ambiguity, omission, typographical error, mistake, defect or inconsistency if such amendment, modification or supplement does not adversely affect the rights of the Administrative Agent, any Lender or any L/C Issuer, to comply with local law or the advice of local counsel or to cause one or more Loan Documents to be consistent with other Loan Documents and (y) no such amendment, waiver or consent shall: (a) without the written consent of each Lender, (A) waive any condition set forth in Section 5.02 or (B) without limiting the generality of the preceding clause (A), waive any condition set forth in Section 5.01 as to any Credit Event under the Revolving Facility (it being understood that the waiver of any Default or Event of Default or the amendment or waiver of any covenant or representation contained herein shall not constitute a waiver of any condition set forth in Section 5.01 or Section 5.02); (b) extend or increase (other than pursuant to Section 2.15) the Commitment of any Lender (or reinstate any Commitment terminated pursuant to Section 8.01) without the written consent of such Lender directly and adversely affected thereby; (c) postpone any date fixed by this Agreement or any other Loan Document for any payment (excluding mandatory prepayments) of principal, interest or fees due to the Lenders (or any of them) hereunder or under any other Loan Document without the written consent of each Lender directly and adversely affected thereby; (d) reduce the principal of, or the rate of interest specified herein on, any Loan or L/C Borrowing, or any fees payable hereunder or under any other Loan Document, without the written consent of each Lender directly and adversely affected thereby; (e) change Section 2.11(c) in a manner that would alter the order of payments required thereby or Section 8.03 in a manner that would alter the pro rata sharing of or the order of payments required thereby, in each case, without the written consent of each Lender directly and adversely affected thereby; (f) change any provision of this Section 10.01, the definition of “Required Lenders” “Required Revolving Facility Lenders,” “Required Term Loan Lenders” “Supermajority Revolving Facility Lenders” “Supermajority Term Loan Lenders” or any other provision hereof specifying the number or percentage of Lenders required to amend, waive or otherwise modify any rights hereunder or make any determination or grant any consent hereunder, without the written consent of each Lender; (g) modify the definition of “Pro Rata Share” or amend or otherwise modify the provisions of Section 2.14(c) without the written consent of each Lender; 172 (h) release the Collateral Agent’s Liens on all or substantially all of the Collateral in any transaction or series of related transactions, without the written consent of each Lender, except to the extent the release of such Liens is permitted pursuant to Section 9.10 (in which case such release may be made by the Administrative Agent acting alone); (i) except as otherwise permitted under this Agreement, permit any Loan Party or the Parent Guarantor to assign its rights under this Agreement or any other Loan Document to which it is a party; (j) release all or substantially all of the value of the Guaranties, without the written consent of each Lender, except to the extent the release of any Subsidiary from the Guaranty is permitted pursuant to Section 9.10 (in which case such release may be made by the Administrative Agent acting alone); (k) subordinate the Collateral Agent’s Liens on the Collateral (other than with respect to Permitted Liens) or subordinate the payment of the ABL Finance Obligations, in each case, without the written consent of each Lender; (l) increase the advance rates set forth in the definition of Borrowing Base or otherwise modify the definition thereof without the written consent of the Supermajority Revolving Facility Lenders; (m) no waiver, amendment, or consent shall, unless in writing and signed by Supermajority Term Loan Lenders, waive any condition set forth in Section 5.01 in connection with the obligation to make any Term Loans (it being understood and agreed that any amendment or waiver of, or any consent with respect to, any provision of this Agreement (other than any waiver expressly relating to Section 5.01) or any other Loan Document, including any amendment of any affirmative or negative covenant set forth herein or in any other Loan Document or any waiver of a Default or an Event of Default, shall not be deemed to be a waiver of a condition set forth in Section 5.01); or (n) except as otherwise set forth in the definitions of Eligible Accounts and Eligible Inventory, add new asset categories to the Borrowing Base, or otherwise cause the Borrowing Base availability under the Revolving Facility to be increased beyond the level permissible under this Agreement as then in effect, in each case without the written consent of the Supermajority Revolving Facility Lenders (it being understood and agreed that the Administrative Agent’s release or reduction of a Reserve shall not constitute an amendment, waiver or consent under this Section 10.01); provided, further, that: (i) no amendment, waiver or consent shall, unless in writing and signed by each applicable L/C Issuer in addition to the Lenders required above, affect the rights or duties of such L/C Issuer under this Agreement or any Issuer Document relating to any Letter of Credit issued or to be issued by it; (ii) no amendment, waiver or consent shall, unless in writing and signed by the Swing Line Lender in addition to the Lenders required above, affect the rights or duties of the Swing Line Lender under this Agreement; (iii) no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent in addition to the Lenders required above, affect the rights or duties of the Administrative Agent under this Agreement or any other Loan Document; (iv) no amendment, waiver or consent which would require the consent of a Lender but for the fact that it is a Defaulting Lender shall be enforced against it without its consent; and (iv) the Engagement Letter, the Fee Letter, and the Amendment No. 2 Fee Letter may be amended, or rights or privileges thereunder waived, in a writing executed only by the parties thereto. Notwithstanding anything to the contrary herein, no Defaulting Lender shall have any right to approve or disapprove any amendment, waiver or consent hereunder (and any amendment, waiver or consent which by its terms requires the consent of all Lenders or each affected 173 Lender may be effected with the consent of the applicable Lenders other than Defaulting Lenders), except that (x) the Commitment of any Defaulting Lender may not be increased or extended without the consent of such Lender and (y) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender that by its terms affects any Defaulting Lender disproportionately more adversely relative to other affected Lenders shall require the consent of such Defaulting Lender. Notwithstanding any provision herein to the contrary, the Borrowers may, by written notice to the Administrative Agent from time to time, make one or more offers (each, a “Loan Modification Offer”) to all the Lenders under the Revolving Facility (as subject to such a Loan Modification Offer, an “Affected Facility”) to make one or more Permitted Amendments (as defined below) pursuant to procedures reasonably specified by the Administrative Agent and reasonably acceptable to the Borrowers. Such notice shall set forth (i) the terms and conditions of the requested Permitted Amendment and (ii) the date on which such Permitted Amendment is requested to become effective (which shall not be less than 10 Business Days nor more than 30 Business Days after the date of such notice) (or such shorter periods as are acceptable to the Administrative Agent). Permitted Amendments shall become effective only with respect to the Loans of the Lenders under the Affected Facility that accept the applicable Loan Modification Offer (such Lenders, the “Accepting Lenders”) and, in the case of any Accepting Lender, only with respect to such Lender’s Loans under such Affected Facility as to which such Lender’s acceptance has been made. Each Borrower and each Accepting Lender shall execute and deliver to the Administrative Agent an agreement in form and substance satisfactory to the Administrative Agent giving effect to the Permitted Amendment (a “Loan Modification Agreement”) and such other documentation as the Administrative Agent shall reasonably specify to evidence the acceptance of the Permitted Amendments and the terms and conditions thereof. The Administrative Agent shall promptly notify each Lender as to the effectiveness of each Loan Modification Agreement. Each of the parties hereto hereby agrees that, upon the effectiveness of any Loan Modification Agreement, this Agreement shall be deemed amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Permitted Amendment evidenced thereby and only with respect to the Loans and Commitments of the Accepting Lenders under the Affected Facility. Notwithstanding the foregoing, no Permitted Amendment shall become effective under this paragraph unless the Administrative Agent shall have received any corporate documents, officers’ certificates or legal opinions consistent with those delivered on the Closing Date under Section 5.02 reasonably requested by the Administrative Agent. As used in this paragraph, “Permitted Amendments” shall be limited to (i) an extension of the final maturity date of the applicable Loans of the Accepting Lenders (provided that such extension may not result in having more than two additional final maturity dates in any year, or more than three additional final maturity dates at any time, under this Agreement without the consent of the Administrative Agent), (ii) a reduction, elimination or extension, of the scheduled amortization of the applicable Loans of the Accepting Lenders, (iii) a change in rate of interest (including a change to the Base Rate or Eurodollar Base RateTerm SOFR and any provision establishing a minimum rate), premium, or other amount with respect to the applicable Loans of the Accepting Lenders and/or a change in the payment of fees to the Accepting Lenders and/or a change in the payment of fees to the Accepting Lenders (such change and/or payments to be in the form of cash, Equity Interests or other property to the extent not prohibited by this Agreement) and (iv) any other amendment to a Loan Document required to give effect to the Permitted Amendments described in clauses (i) through (iii) of this sentence. If any Lender (a “Non-Consenting Lender”) does not consent to a proposed amendment, waiver, consent, release, discharge or termination with respect to any Loan Document that, pursuant to the terms of this Section 10.01, requires the consent of each Lender (or each affected Lender) and that has been approved by the Required Lenders, the Borrowers may replace such Non-Consenting Lender in accordance with Section 10.14. 174 No Real Property shall be taken as Collateral unless the Lenders receive 45 days prior written notice and each Lender confirms to the Administrative Agent and the Collateral Agent that it has completed all flood due diligence, received copies of all flood insurance documentation and confirmed flood insurance compliance as required by the Flood Laws or as otherwise satisfactory to such Lender. Notwithstanding anything to the contrary in any of the Loan Documents, any grace or cure period or other time period for the creation of Liens on such Real Property shall be tolled from the giving of such written notice until each Lender has provided such confirmation to the Administrative Agent and the Collateral Agent, and no Default or Event of Default shall be deemed to result from the occurrence of any date on which any such period would otherwise have expired. At any time that any Real Property constitutes Collateral, no modification of a Loan Document shall add, increase, renew or extend any Loan, Commitment or other Credit Event hereunder (other than pursuant to Section 2.15) until the completion of flood due diligence, documentation and coverage as confirmed to the Administrative Agent and the Collateral Agent by all Lenders and as required by the Flood Laws or as otherwise satisfactory to all Lenders. Section 10.02 Notices; Effectiveness; Electronic Communication. (a) Notices Generally. Except in the case of notices and other communications expressly permitted to be given by telephone (and except as provided in subsection (b) below), all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by fax as follows, and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable telephone number, as follows: (i) if to any Borrower, the Holdcos or any other Loan Party, the Administrative Agent, an L/C Issuer or the Swing Line Lender to the address, fax number, electronic mail address or telephone number specified for such Person on Schedule 10.02; and (ii) if to any other Lender, to the address, fax number, electronic mail address or telephone number specified in its Administrative Questionnaire. Notices and other communications sent by hand or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received; notices and other communications sent by fax shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business on the next Business Day for the recipient).Notices and other communications delivered through electronic communications to the extent provided in subsection (b) below, shall be effective as provided in such subsection (b). (b) Electronic Communications. Notices and other communications to the Lenders and the L/C Issuers hereunder may be delivered or furnished by electronic communication (including e- mail and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to notices to any Lender or L/C Issuer pursuant to Article II if such Lender or L/C Issuer, as applicable, has notified the Administrative Agent that it is incapable of receiving notices under such Article by electronic communication. The Administrative Agent, the Swing Line Lender and L/C Issuers or the Borrowers may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it; provided that approval of such procedures may be limited to particular notices or communications. Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender’s receipt of an acknowledgement from the


 
175 intended recipient (such as by the “return receipt requested” function, as available, return e-mail or other written acknowledgement), and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor; provided that, for both clauses (i) and (ii), if such notice, email or other communication is not sent during the normal business hours of the recipient, such notice, email or communication shall be deemed to have been sent at the opening of business on the next Business Day for the recipient. (c) The Platform. THE PLATFORM IS PROVIDED “AS IS” AND “AS AVAILABLE.” THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no event shall the Administrative Agent, the Joint Bookrunners, the Co-Syndications Agents or any of their respective Related Parties (collectively, “Agent Parties”) have any liability to the Holdcos, any Borrower, any Lender, any L/C Issuer or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of any Loan Party’s or the Administrative Agent’s transmission of Borrower Materials through the Internet. (d) Change of Address, Etc. Each of the Holdcos, each Borrower, the Administrative Agent, each L/C Issuer and the Swing Line Lender may change its address, fax or telephone number for notices and other communications hereunder by notice to the other parties hereto. Each other Lender may change its address, fax or telephone number for notices and other communications hereunder by notice to each Borrower, the Administrative Agent, each L/C Issuer and the Swing Line Lender. In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, fax number and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender. (e) Reliance by Administrative Agent, L/C Issuers and Lenders. The Administrative Agent, the L/C Issuers and the Lenders shall be entitled to rely and act upon any notices (including telephonic or electronic Revolving Facility Borrowing Requests, Term Loan Requests, Letter of Credit Requests and Swing Line Loan Notices) purportedly given by or on behalf of any Borrower or any other Loan Party even if (i) such notices were not made in a manner specified herein, were incomplete or were not preceded or followed by any other form of notice specified herein or (ii) the terms thereof, as understood by the recipient, varied from any confirmation thereof. Each Borrower shall indemnify the Administrative Agent, each L/C Issuer, each Lender and the Related Parties of each of them from all losses, costs, expenses and liabilities resulting from the reliance by such Person on any notice purportedly given by or on behalf of such Borrower in the absence of gross negligence or willful misconduct by the Administrative Agent in relying on any notice purportedly given by or on behalf of such Borrower, such Lender or Related Party, as applicable, as determined in a final and non-appealable judgment by a court of competent jurisdiction. All telephonic notices to and other telephonic communications with the Administrative Agent may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording. 176 Section 10.03 No Waiver; Cumulative Remedies; Enforcement. No failure by any Lender or L/C Issuer or by the Administrative Agent to exercise, and no delay by any such Person in exercising, any right, remedy, power or privilege hereunder or under any other Loan Document shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided and provided under each other Loan Document are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law. Notwithstanding anything to the contrary contained herein or in any other Loan Document, but subject to the Intercreditor Agreements, the authority to enforce rights and remedies hereunder and under the other Loan Documents against the Loan Parties or any of them shall be vested exclusively in, and all actions and proceedings at law in connection with such enforcement shall be instituted and maintained exclusively by, the Administrative Agent in accordance with Section 8.01 for the benefit of all the Lenders and the L/C Issuers; provided, however, that the foregoing shall not prohibit (i) the Administrative Agent from exercising on its own behalf the rights and remedies that inure to its benefit (solely in its capacity as Administrative Agent) hereunder and under the other Loan Documents, (ii) any L/C Issuer and the Swing Line Lender from exercising the rights and remedies that inure to its benefit solely in its capacity as L/C Issuer or Swing Line Lender, as the case may be, hereunder and under the other Loan Documents, (iii) any Lender from exercising setoff rights in accordance with Section 10.09 (subject to the terms of Section 2.14) or (iv) any Lender from filing proofs of claim or appearing and filing pleadings on its own behalf during the pendency of a proceeding relative to any Loan Party under any Debtor Relief Law; provided, further, that if at any time there is no Person acting as Administrative Agent hereunder and under the other Loan Documents, then (x) the Required Lenders shall have the rights otherwise ascribed to the Administrative Agent pursuant to Section 8.01 and (y) in addition to the matters set forth in clauses (ii), (iii) and (iv) of the preceding proviso and subject to Section 2.14, any Lender may, with the consent of the Required Lenders, enforce any rights and remedies available to it and as authorized by the Required Lenders. Section 10.04 Expenses; Indemnity; Damage Waiver. (a) Costs and Expenses. The Loan Parties and the Parent Guarantor, jointly and severally, agree to pay, upon the Administrative Agent’s demand, (i) all reasonable and documented out- of-pocket expenses and customary administrative charges incurred by the Administrative Agent, the Joint Lead Arrangers, the Joint Bookrunners and their respective Affiliates (including the reasonable and invoiced fees, charges and disbursements of Sidley Austin LLP, as counsel for the Administrative Agent, and, if necessary, the reasonable fees, charges and disbursements of one local counsel per jurisdiction), in connection with the syndication and arrangement of the credit facilities provided for herein, the preparation, negotiation, execution, delivery and administration of this Agreement and the other Loan Documents (including expenses incurred in connection with due diligence and initial ongoing Collateral examination to the extent incurred in compliance with this Agreement, filing and search charges, recording taxes, appraisals, environmental assessments and field examination charges and expenses (including a charge at the then-standard rate of the Administrative Agent per person per day for the examiners of the Administrative Agent in the field and in the office, which, as of the Closing Date, is not to exceed $1,000 per person per day for examinations with respect to Loan Parties) or any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the Transactions contemplated hereby or thereby shall be consummated), (ii) all reasonable and documented out-of-pocket expenses and customary administrative charges incurred by any L/C Issuer in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and, (iii) all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent, any Lender or any L/C Issuer (including the reasonable and invoiced fees, charges and disbursements of 177 any special counsel (limited to one firm for the Administrative Agent, the Lenders and the L/C Issuers unless, in the reasonable opinion of the Administrative Agent or any such Lender or L/C Issuer seeking reimbursement, such joint representation would be inappropriate due to the existence of any actual or potential conflict of interest, in which case the Administrative Agent or any such Lender or L/C Issuer, as the case may be, shall inform the Borrowers of such conflict and the Borrowers shall reimburse the legal fees and expenses of no more than such number of additional outside counsel for the Administrative Agent, the Lenders and the L/C Issuers as is necessary to avoid any actual or potential conflict of interest)) and local counsel (limited to one firm for the Administrative Agent, the Lenders and the L/C Issuers in each relevant jurisdiction unless, in the reasonable opinion of the Administrative Agent or any such Lender or L/C Issuer seeking reimbursement, such joint representation would be inappropriate due to the existence of any actual or potential conflict of interest, in which case the Administrative Agent or any such Lender or L/C Issuer, as the case may be, shall inform the Borrowers of such conflict and the Borrowers shall reimburse the legal fees and expenses of no more than such number of additional outside counsel for the Administrative Agent, the Lenders and the L/C Issuers as is necessary to avoid any actual or potential conflict of interest for the Administrative Agent, the Lenders and the L/C Issuer), in connection with the enforcement, collection or protection of its rights (A) in connection with this Agreement and the other Loan Documents, including its rights under this Section, or (B) in connection with the Loans made or Letters of Credit issued hereunder, including all such reasonable and documented out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit. (b) Indemnification. The Loan Parties and the Parent Guarantor, jointly and severally, shall indemnify the Administrative Agent (and any sub-agent thereof), the Collateral Agent, the Joint Lead Arrangers, the Joint Bookrunners, the Co-Syndication Agents, each Lender, each L/C Issuer, and each of its respective Affiliates and their respective Related Parties (each such Person being called an “Indemnitee”) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses (including the reasonable legal counsel fees, charges and disbursements of not more than one counsel, plus, if necessary, one local counsel per jurisdiction (except the allocated costs of in-house counsel) unless, in the reasonable opinion of any such Indemnitee seeking indemnity, such joint representation would be inappropriate due to the existence of any actual or potential conflict of interest, in which case such Indemnitee or Indemnitees, as the case may be, shall inform the Borrowers of such conflict and the Borrowers shall reimburse the legal fees and expenses of no more than such number of additional outside counsel for the Indemnitees as is necessary to avoid any actual or potential conflict of interest), incurred by any Indemnitee or asserted against any Indemnitee by any Person (including any Borrower or any other Loan Party or the Parent Guarantor) other than such Indemnitee and its Related Parties arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the Transactions and the other transactions contemplated hereby or thereby (including, in the case of the Administrative Agent (and any sub-agent thereof) and its Related Parties, the administration of this Agreement and the other Loan Documents (including in respect of any matters addressed in Section 3.01)), (ii) any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by an L/C Issuer to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit) or (iii) any claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by any Borrower or any other Loan Party, and regardless of whether any Indemnitee is a party thereto; provided that, with respect to clauses (i), (ii) and (iii) above, such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and non-appealable judgment to have resulted from (x) the gross negligence, bad faith or willful misconduct of such Indemnitee (for purposes of this proviso only, each of 178 the Administrative Agent, any Joint Lead Arranger, any Joint Bookrunner, any L/C Issuer, the Swing Line Lender or any Lender shall be treated as several and separate Indemnitees, but each of them, together with its respective directors, trustees, officers and employees, shall be treated as a single Indemnitee) or (y) any material breach of any Loan Document by such Indemnitee. Subject to and without limiting the generality of the foregoing sentence, each Loan Party and the Parent Guarantor agrees to indemnify each Indemnitee against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including reasonable counsel or consultant fees, charges and disbursements (limited to not more than one counsel, plus, if necessary, one local counsel per jurisdiction) (except the allocated costs of in-house counsel), incurred by or asserted against any Indemnitee arising out of, in any way connected with, or as a result of (A) any claim related in any way to Environmental Laws and Loan Parties or any of their Subsidiaries, or (B) any actual or alleged presence, Release or threatened Release of Hazardous Materials at, under, on or from any Real Property; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and non-appealable judgment to have resulted from the (1) gross negligence, bad faith or willful misconduct of such Indemnitee or (2) any material breach of any Loan Document by such Indemnitee (for purposes of this proviso only, each of the Administrative Agent, any Joint Lead Arranger, any Joint Bookrunner, any L/C Issuer, the Swing Line Lender or any Lender shall be treated as several and separate Indemnitees, but each of them together, together with its respective directors, trustees, officers and employees, shall be treated as a single Indemnitee). None of the Indemnitees (or any of their respective Affiliates) shall be responsible or liable to the Loan Parties or any of their respective subsidiaries, Affiliates or stockholders or any other person or entity for any special, indirect, consequential or punitive damages, which may be alleged as a result of the Revolving Facility or the Transactions. Without limiting the provisions of Section 3.01(b), this Section 10.04(b) shall not apply with respect to Taxes (other than any Taxes that represent losses, claims, damages, etc. arising from any non-Tax claim). The provisions of this Section 10.04 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the ABL Credit Obligations, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent or any Lender or L/C Issuer. All amounts due under this Section 10.04 shall be payable on written demand therefor accompanied by reasonable documentation with respect to any reimbursement, indemnification or other amount requested. (c) Reimbursement by Lenders. To the extent that the Loan Parties or the Parent Guarantor for any reason fail indefeasibly to pay any amount required under subsection (a) or (b) of this Section to be paid by it or them to the Administrative Agent (or any sub-agent thereof), any L/C Issuer or the Swing Line Lender or any Related Party of any of the foregoing, each Lender severally agrees to pay to the Administrative Agent (or any such sub-agent), each L/C Issuer or the Swing Line Lender or such Related Party, as the case may be, such Lender’s pro rata share (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought based on each Lender’s outstanding Loans and unused Commitments at such time) of such unpaid amount (including any such unpaid amount in respect of a claim asserted by such Lender), such payment to be made severally among them based on such Lenders’ percentage (carried out to the ninth decimal place) of the Credit Facility (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought), provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent (or any such sub-agent), an L/C Issuer or the Swing Line Lender in its capacity as such, or against any Related Party of any of the foregoing acting for the Administrative Agent (or any such sub-agent) an L/C Issuer or the Swing Line Lender in connection with such capacity. The obligations of the Lenders under this subsection (c) are subject to the provisions of Section 2.02(a).


 
179 (d) Waiver of Consequential Damages. To the fullest extent permitted by applicable Law, no Borrower shall assert, and each Borrower hereby waives, and acknowledges that no other Loan Party or the Parent Guarantor shall have, any claim against any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof. No Indemnitee referred to in subsection (b) above shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby other than for direct or actual damages resulting from the gross negligence or willful misconduct of such Indemnitee as determined by a final and non-appealable judgment of a court of competent jurisdiction. (e) Payments. All amounts due under this Section shall be payable not later than ten Business Days after demand therefor; provided, however, any Indemnitee shall promptly refund an indemnification payment received hereunder to the extent that there is a final judicial determination that such Indemnitee was not entitled to indemnification with respect to such payment pursuant to this Section 10.04. (f) Survival. The agreements in this Section and the indemnity provisions of Section 10.02(e)shall survive the resignation of the Administrative Agent, any L/C Issuer and the Swing Line Lender, the replacement of any Lender, the termination of the Commitments of all the Lenders and the repayment, satisfaction or discharge of all the other ABL Credit Obligations. Section 10.05 Payments Set Aside. To the extent that any payment by or on behalf of any Borrower or any other Loan Party or the Parent Guarantor is made to the Administrative Agent, any L/C Issuer or any Lender, or the Administrative Agent, any L/C Lender or any Lender exercises its right of set-off, and such payment or the proceeds of such set-off or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by the Administrative Agent, such L/C Issuer or such Lender in its discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any Debtor Relief Law or otherwise, then (i) to the extent of such recovery, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such set-off had not occurred, and (ii) each Lender and L/C Issuer severally agrees to pay to the Administrative Agent upon demand its applicable share of any amount so recovered from or repaid by the Administrative Agent, plus interest thereon from the date of such demand to the date such payment is made at a rate per annum equal to the Federal Funds Rate from time to time in effect. The obligations of the Lenders and the L/C Issuers under clause (ii) of the preceding sentence shall survive the payment in full of the ABL Credit Obligations and the termination of this Agreement. Section 10.06 Successors and Assigns. (a) Successors and Assigns Generally. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby, except that neither any Borrower nor any other Loan Party nor the Parent Guarantor (except as otherwise permitted by this Agreement) may assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee in accordance with the provisions of Section 10.06(b), (ii) by way of participation in accordance with the provisions of Section 10.06(d), or (iii) by way of pledge or assignment of a security interest 180 subject to the restrictions of Section 10.06(e). Nothing in this Agreement, expressed or implied, is intended to confer, shall be construed to confer, or shall confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Participants to the extent provided in subsection (d) of this Section and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement. (b) Assignments by Lenders. Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment(s) and the Loans (including for purposes of this Section 10.06(b), participations in L/C Obligations and in Swing Line Loans) at the time owing to it); provided that any such assignment shall be subject to the following conditions: (i) Minimum Amounts. (A) (1) in the case of an assignment of the entire remaining amount of the assigning Lender’s Revolving Facility Commitment and/or the Revolving Facility Loans at the time owing to it or contemporaneous assignments to related Approved Funds that equal at least the amount specified in subsection (b)(i)(B) of this Section in the aggregate or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned and (2) in the case of an assignment of the entire remaining amount of the assigning Lender’s Term Loan Commitment and/or the Term Loans at the time owing to it or contemporaneous assignments to related Approved Funds that equal at least the amount specified in subsection (b)(i)(B) of this Section in the aggregate or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned; and (B) in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the Commitment (which for this purpose includes Loans outstanding thereunder) or, if the applicable Commitment is not then in effect, the principal outstanding balance of the Loans of the assigning Lender subject to each such assignment, determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if “Trade Date” is specified in the Assignment and Assumption, as of the Trade Date, shall not be less than $5,000,000 in the case of the Revolving Facility and not less than $1,000,000 in the case of the Term Loan Facility, unless each of the Administrative Agent and, so long as no Event of Default has occurred and is continuing, each Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed). (ii) Proportionate Amounts. Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender’s rights and obligations under this Agreement with respect to the Loans or the Commitment(s) assigned, except that this clause (ii) shall not apply to the Swing Line Lender’s rights and obligations in respect of Swing Line Loans. (iii) Required Consents. No consent shall be required for any assignment except to the extent required by subsection (b)(i)(B) of this Section and, in addition: (A) the consent of each Borrower (such consent not to be unreasonably withheld, conditioned or delayed) shall be required unless (1) an Event of Default has occurred and is continuing at the time of such assignment or (2) such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund; provided that the Borrowers shall be deemed to have consented to any such assignment unless they shall object thereto by written notice to the Administrative 181 Agent within ten Business Days after having received notice thereof; provided, further, that the Borrowers’ consent shall not be required during the primary syndication of the Revolving Facility; (B) the consent of the Administrative Agent (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for assignments in respect of (i) any unfunded Commitment if such assignment is to a Person that is not a Lender with a Commitment, an Affiliate of such Lender or an Approved Fund with respect to such Lender or (ii) any Loan to a Person that is not a Lender, an Affiliate of a Lender or an Approved Fund; and (C) the consent of each L/C Issuer and the Swing Line Lender (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for any assignment in respect of the Revolving Facility. (iv) Assignment and Assumption. The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption via an electronic settlement system acceptable to the Administrative Agent (or, if previously agreed with the Administrative Agent, manually), and shall pay to the Administrative Agent a processing and recordation fee of $3,500 (which fee may be waived or reduced in the sole discretion of the Administrative Agent). The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire and all applicable tax forms. (v) No Assignment to Certain Persons. No such assignment shall be made (A) to any Loan Party or any Affiliates or Subsidiaries of any Loan Party, (B) to any Defaulting Lender or any of its Subsidiaries, or (C) to any natural person. (vi) Certain Additional Payments. In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be outright payment, purchases by the assignee of participations or sub-participations, or other compensating actions, including funding, with the consent of the Borrowers and the Administrative Agent, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent, any L/C Issuer or any Lender hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full pro rata share of all Loans and participations in Letters of Credit and Swing Line Loans in accordance with its Revolving Facility Percentage. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable Law without compliance with the provisions of this paragraph, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs. Subject to acceptance and recording thereof by the Administrative Agent pursuant to subsection (c) of this Section, from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 3.01, 3.04, 3.05 and 10.04 with respect to facts and circumstances occurring prior to the effective date of such 182 assignment); provided that, except to the extent otherwise expressly agreed by the affected parties, no assignment by a Defaulting Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender’s having been a Defaulting Lender. Upon request, each Borrower (at its expense) shall execute and deliver a Note to the assignee Lender. Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this subsection shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with subsection (d) of this Section 10.06. Notwithstanding the foregoing, no assignee, which as of the date of any assignment to it pursuant to this Section 10.06 would be entitled to any payments under Sections 3.01, 3.04 or 3.05 in an amount greater than the assignor would have been entitled to as of such date with respect to the rights assigned, shall be entitled to such greater payments. (c) Register. (2)The Administrative Agent, acting solely for this purpose as a non- fiduciary agent of the Borrowers (and such agency being solely for Tax purposes), shall maintain at the Administrative Agent’s Office a copy of each Assignment and Assumption delivered to it (or the equivalent thereof in electronic form) and a register for the recordation of the names and addresses of the Lenders and L/C Issuers, and the Commitments of, and principal amounts (and stated interest) of the Loans, L/C Borrowings and Swing Line Loans owing to, each Lender and L/C Issuer pursuant to the terms hereof from time to time (the “Register”).The entries in the Register shall be conclusive absent manifest error, and the Borrowers, the Administrative Agent, the Lenders and L/C Issuers shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender, L/C Issuer or Swing Line Lender hereunder for all purposes of this Agreement. The Register shall be available for inspection by any Borrower and any Lender, at any reasonable time and from time to time upon reasonable prior notice. In addition, at any time that a request for a consent for a material or other substantive change to the Loan Documents is pending, any Lender or L/C Issuer may request and receive from the Administrative Agent a copy of the Register. (i) Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an assignee, the assignee’s completed Administrative Questionnaire (unless the assignee shall already be a Lender hereunder), all applicable tax forms, the processing and recordation fee referred to in paragraph (b)(iv) of this Section 10.06 (unless waived in accordance with such paragraph) and any written consent to such assignment required by paragraph (b)(iii) of this Section 10.06, the Administrative Agent shall promptly accept such Assignment and Assumption and record the information contained therein in the Register. No assignment, whether or not evidenced by a promissory note, shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph (c)(ii). (d) Participations. Any Lender may at any time, without the consent of, or notice to, any Borrower or the Administrative Agent, sell participations to any Person (other than a natural Person, a known Defaulting Lender or a Loan Party or any Affiliates or Subsidiaries of a Loan Party) (each, a “Participant”) in all or a portion of such Lender’s rights and/or obligations under this Agreement (including all or a portion of its Commitment and/or the Loans (including such Lender’s participations in L/C Obligations and/or Swing Line Loans) owing to it); provided that (i) such Lender’s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii) the Borrowers, the Administrative Agent, the L/C Issuers and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement. For the avoidance of doubt, each Lender shall be responsible for the indemnity under Section 10.04(c) without regard to the existence of any participation. Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and the other Loan Documents and


 
183 to approve any amendment, modification or waiver of any provision of this Agreement or any of the other Loan Documents; provided that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, waiver or other modification described in clause (y) of the first proviso to Section 10.01 that affects such Participant and requires the consent of each Lender directly affected thereby. Each Borrower agrees that each Participant shall be entitled to the benefits of Sections 3.01, 3.04 and 3.05 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to subsection (b) of this Section (it being understood that the documentation required under Section 3.01(c) shall be delivered to the Lender who sells the participation); provided that such Participant (A) agrees to be subject to the provisions of Sections 3.06 and 10.14 as if it were an assignee under paragraph (b) of this Section and (B) shall not be entitled to receive any greater payment under Sections 3.01, 3.04 or 3.05, with respect to any participation, than the Lender from whom it acquired the applicable participation would have been entitled to receive, unless the sale of the participation to such Participant is made with the Borrowers’ prior written consent. A participant shall not be entitled to the benefits of Section 3.01 to the extent such Participant fails to comply with Section 3.01(c) as though it were a Lender. Each Lender that sells a participation agrees, at a Borrower’s request and expense, to use reasonable efforts to cooperate with such Borrower to effectuate the provisions of Section 3.06 with respect to any Participant. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 10.09 as though it were a Lender; provided that such Participant agrees to be subject to Section 2.14 as though it were a Lender. Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrowers, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other obligations under the Loan Documents (the “Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s interest in any Commitments, Loans, L/C Borrowings, Swing Line Loans or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such Commitment, Loan, L/C Borrowing, Swing Line Loan or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register. (e) Certain Pledges. Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement (including under its Note, if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank; provided that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto. (f) Resignation as an L/C Issuer or Swing Line Lender after Assignment. Notwithstanding anything to the contrary contained herein, if at any time Wells Fargo assigns all of its Revolving Facility Commitment and Revolving Facility Loans pursuant to Section 10.06(b), Wells Fargo may, (i) upon 30 days’ notice to the Borrowers and the Lenders, resign as an L/C Issuer and/or (ii) upon 30 days’ notice to the Borrowers, resign as Swing Line Lender. In the event of any such resignation as an L/C Issuer or the Swing Line Lender, the Borrowers shall be entitled to appoint from among the Lenders a successor L/C Issuer or Swing Line Lender hereunder; provided, however, that no failure by the Borrowers to appoint any such successor shall affect the resignation of Wells Fargo as an L/C Issuer or the Swing Line Lender, as the case may be. If Wells Fargo resigns as an L/C Issuer, it shall retain all the rights, powers, privileges and duties of an L/C Issuer hereunder with respect to all Letters of Credit issued by it which remain outstanding as of the effective date of its resignation as an L/C Issuer and all L/C 184 Obligations with respect thereto (including the right to require the Lenders to make Base Rate Loans or fund risk participations in Unreimbursed Amounts pursuant to Section 2.05(c)). If Wells Fargo resigns as the Swing Line Lender, it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make Base Rate Loans or fund risk participations in outstanding Swing Line Loans pursuant to Section 2.04(c). Upon the appointment of a successor L/C Issuer and/or Swing Line Lender, (i) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring L/C Issuer or Swing Line Lender, as the case may be, and (ii) the successor L/C Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, issued by the retiring L/C Issuer and remaining outstanding at the time of such succession or make other arrangements satisfactory to Wells Fargo to effectively assume the obligations of Wells Fargo with respect to such Letters of Credit. Section 10.07 Treatment of Certain Information; Confidentiality. Each of the Administrative Agent, the L/C Issuers and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed: (i) to its Related Parties (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential); (ii) to the extent required or requested by any applicable regulatory authority having jurisdiction over such Person or its Related Parties (including any self-regulatory authority, such as the National Association of Insurance Commissioners); (iii) to the extent required by applicable Laws or regulations or by any subpoena or similar legal process; (iv) to any other party hereto; (v) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (vi) subject to an agreement containing confidentiality provisions substantially the same (and at least as restrictive) as those of this Section, to (A) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights and obligations under this Agreement or any assignee invited to be a Lender pursuant to Section 2.15 or (B) any actual or prospective party (or its Related Parties) to any swap, derivative or other transaction under which payments are to be made by reference to the obligations under this Agreement, (vii) to (A) any rating agency in connection with rating any Borrower or its Subsidiaries or the credit facilities provided hereunder or (B) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers or other market identifiers with respect to the credit facilities provided hereunder, in each case on a confidential basis, (viii) with the consent of the Borrowers or (ix) to the extent such Information (A) becomes publicly available other than as a result of a breach of this Section or (B) becomes available to the Administrative Agent, any L/C Issuer or any Lender or any of their respective Affiliates on a non-confidential basis from a source other than the Holdcos, any Borrower or any Subsidiary. For purposes of this Section, “Information” means all information received from the Holdcos, any Borrower or any Subsidiary relating to the Holdcos, any Borrower or any Subsidiary or any of their respective businesses, other than any such information that is available to the Administrative Agent, any L/C Issuer or any Lender on a non-confidential basis prior to disclosure by the Holdcos, any Borrower or any Subsidiary. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information. Notwithstanding any other provision of this Agreement, any other Loan Document or any Assignment and Assumption, the provisions of this Section 10.07 shall survive with respect to the Administrative Agent and each Lender and L/C Issuer until the second anniversary of the Administrative Agent or Lender ceasing to be the Administrative Agent or a Lender or an L/C Issuer, respectively. Section 10.08 Platform; Borrower Materials. Each of the Holdcos and each Borrower hereby acknowledges that the Administrative Agent may, but shall not be obligated to, make available to 185 the Lenders and the L/C Issuers materials and/or information provided by or on behalf of the Holdcos and any Borrower hereunder (collectively, “Borrower Materials”) by posting the Borrower Materials on Debt Domain, IntraLinks, Syndtrak or another similar electronic system (the “Platform”). Section 10.09 Right of Setoff. If an Event of Default shall have occurred and be continuing, each Lender and each L/C Issuer and each of their respective Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by applicable Law, to set off and apply any and all deposits (general or special, time or demand, provisional or final, in whatever currency) at any time held and other obligations (in whatever currency) at any time owing by such Lender or L/C Issuer or any such Affiliate to or for the credit or the account of any Borrower, any other Loan Party or the Parent Guarantor against any and all of the obligations of such Borrower, such Loan Party or the Parent Guarantor now or hereafter existing under this Agreement or any other Loan Document to such Lender or an L/C Issuer or such Affiliate, irrespective of whether or not such Lender, L/C Issuer or Affiliate shall have made any demand under this Agreement or any other Loan Document and although such obligations of such Borrower, such Loan Party or the Parent Guarantor may be contingent or unmatured or are owed to a branch or office of such Lender or L/C Issuer or such Affiliate different from the branch or office holding such deposit or obligated on such indebtedness; provided that, in the event that any Defaulting Lender shall exercise any such right of setoff, (x) all amounts so set off shall be paid over immediately to the Administrative Agent for further application in accordance with the provisions of Section 2.17 and, pending such payment, shall be segregated by such Defaulting Lender from its other funds and deemed held in trust for the benefit of the Administrative Agent, L/C Issuers and the Lenders, and (y) the Defaulting Lender shall provide promptly to the Administrative Agent a statement describing in reasonable detail the ABL Finance Obligations owing to such Defaulting Lender as to which it exercised such right of setoff. The rights of each Lender, L/C Issuer and their respective Affiliates under this Section are in addition to other rights and remedies (including other rights of setoff) that such Lender, L/C Issuer or their respective Affiliates may have. Each Lender and L/C Issuer agrees to notify the Borrowers and the Administrative Agent promptly after any such setoff and application; provided that the failure to give such notice shall not affect the validity of such setoff and application. Section 10.10 Interest Rate Limitation. Notwithstanding anything to the contrary contained in any Loan Document, the interest paid or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable Law (the “Maximum Rate”). If the Administrative Agent or any Lender shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal, refunded to the applicable Borrower. In determining whether the interest contracted for, charged, or received by the Administrative Agent or a Lender exceeds the Maximum Rate, such Person may, to the extent permitted by applicable Law, (i) characterize any payment that is not principal as an expense, fee, or premium rather than interest, (ii) exclude voluntary prepayments and the effects thereof and (iii) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of the ABL Credit Obligations hereunder. Section 10.11 Counterparts; Integration; Effectiveness. This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement, the other Loan Documents, and any separate letter agreements with respect to fees payable to the Administrative Agent or an L/C Issuer, constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 5.02, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by fax or 186 other electronic imaging means (e.g. “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart of this Agreement. Section 10.12 Survival of Representations and Warranties. All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof. Such representations and warranties have been or will be relied upon by the Administrative Agent and each Lender and L/C Issuer, regardless of any investigation made by the Administrative Agent or any Lender or L/C Issuer or on their behalf and notwithstanding that the Administrative Agent or any Lender or L/C Issuer may have had notice or knowledge of any Default or Event of Default at the time of any credit extension, and shall continue in full force and effect as long as any Loan or any other ABL Credit Obligation shall remain unpaid or unsatisfied or any Letter of Credit shall remain outstanding. Section 10.13 Severability. If any provision of this Agreement or the other Loan Documents is held to be illegal, invalid or unenforceable, (i) the legality, validity and enforceability of the remaining provisions of this Agreement and the other Loan Documents shall not be affected or impaired thereby and (ii) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. Without limiting the foregoing provisions of this Section 10.13, if and to the extent that the enforceability of any provisions in this Agreement relating to Defaulting Lenders shall be limited by Debtor Relief Laws, as determined in good faith by the Administrative Agent, the L/C Issuer or the Swing Line Lender, as applicable, then such provisions shall be deemed to be in effect only to the extent not so limited. Section 10.14 Replacement of Lenders. If any Lender is a Defaulting Lender or a Non- Consenting Lender or if any other circumstance exists hereunder that gives the Borrowers the right to replace a Lender as a party hereto, then the Borrowers may, at their sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in Section 10.06), all of its interests, rights and obligations under this Agreement and the related Loan Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment); provided that: (a) unless waived, the Borrowers or such assignee shall have paid to the Administrative Agent the assignment fee specified in Section 10.06(b); (b) such Lender shall have received payment of an amount equal to the outstanding par principal of its Loans and L/C Advances, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents (including any amounts under Section 3.05) from such assignee (to the extent of such outstanding principal and accrued interest and fees) or the Borrowers (in the case of all other amounts); (c) in the case of any assignment resulting from a claim for compensation under Section 3.04 or payments required to be made pursuant to Section 3.01, such assignment will result in a reduction in such compensation or payments thereafter; and (d) such assignment does not conflict with applicable Laws. A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver or consent, as applicable, by such Lender or otherwise, the circumstances entitling the


 
187 Borrowers to require such assignment and delegation cease to apply. Each party hereto agrees that an assignment required pursuant to this Section 10.14 may be effected pursuant to, and recorded on the Register after execution of, an Assignment and Assumption executed by each Borrower, the Administrative Agent and the assignee and the Lender required to make such assignment need not be a party thereto. Each Lender agrees that, if the Borrowers elect to replace such Lender in accordance with this Section, it shall promptly deliver to the Administrative Agent any Note (if Notes have been issued in respect of such Lender’s Loans) subject to such Assignment and Assumption. Nothing in this Section 10.14 shall be deemed to prejudice any rights that the Borrowers may have against any Lender that is a Defaulting Lender. Section 10.15 Governing Law; Jurisdiction Etc. (a) Governing Law. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT (EXCEPT, AS TO ANY OTHER LOAN DOCUMENT, AS EXPRESSLY SET FORTH THEREIN) AND THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK WITHOUT REGARD TO THE CONFLICTS OF LAWS PRINCIPLES THEREOF THAT WOULD REQUIRE THE APPLICATION OF LAWS OF ANOTHER JURISDICTION. (b) Submission to Jurisdiction. EACH BORROWER, EACH OTHER LOAN PARTY AND THE PARENT GUARANTOR IRREVOCABLY AND UNCONDITIONALLY AGREES THAT IT WILL NOT COMMENCE ANY ACTION, LITIGATION OR PROCEEDING OF ANY KIND OR DESCRIPTION, WHETHER IN LAW OR EQUITY, WHETHER IN CONTRACT OR IN TORT OR OTHERWISE, AGAINST THE ADMINISTRATIVE AGENT, ANY LENDER, ANY L/C ISSUER OR ANY RELATED PARTY OF THE FOREGOING IN ANY WAY RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS RELATING HERETO OR THERETO, IN ANY FORUM OTHER THAN THE COURTS OF THE STATE OF NEW YORK SITTING IN NEW YORK COUNTY AND OF THE UNITED STATES DISTRICT COURT OF THE SOUTHERN DISTRICT OF NEW YORK, AND ANY APPELLATE COURT FROM ANY THEREOF, AND EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY SUBMITS TO THE JURISDICTION OF SUCH COURTS AND AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION, LITIGATION OR PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION, LITIGATION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT OR IN ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT THE ADMINISTRATIVE AGENT OR ANY LENDER OR ANY L/C ISSUER MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST ANY BORROWER, THE PARENT GUARANTOR OR ANY OTHER LOAN PARTY OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION. (c) Waiver of Venue. EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS 188 AGREEMENT OR ANY OTHER LOAN DOCUMENT IN ANY COURT REFERRED TO IN PARAGRAPH (B) OF THIS SECTION. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT. (d) Service of Process. EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN SECTION 10.02. NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY APPLICABLE LAW. Section 10.16 Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. Section 10.17 No Advisory or Fiduciary Responsibility. In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), each Borrower acknowledges and agrees, and acknowledges its Affiliates’ understanding, that: (i)(A) the arranging and other services regarding this Agreement provided by the Administrative Agent, the Joint Lead Arrangers, the Joint Bookrunners, the Co-Syndication Agents and the Lenders are arm’s-length commercial transactions between each Borrower and its Affiliates, on the one hand, and the Administrative Agent, the Joint Lead Arrangers, the Joint Bookrunners, the Co-Syndication Agents and the Lenders, on the other hand, (B) each Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (C) each Borrower is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents; (ii)(A) the Administrative Agent, each Joint Lead Arranger, each Joint Bookrunner, each Co-Syndication Agent and each Lender is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for any Borrower or any of its Affiliates, or any other Person and (B) neither the Administrative Agent, any Joint Lead Arranger, any Joint Bookrunner, any Co-Syndication Agent nor any Lender has any obligation to any Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents; and (iii) the Administrative Agent, the Joint Lead Arrangers, the Joint Bookrunners, the Co-Syndication Agents and the Lenders and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrowers and their respective Affiliates, and neither the Administrative Agent, any Joint Lead Arranger, any Joint Bookrunner, any Co-Syndication Agent nor any Lender has any obligation to disclose any of such interests to any Borrower or its Affiliates. To the fullest extent permitted by law, each Borrower hereby waives and releases any claims that it may have against the Administrative Agent, the Joint Lead Arrangers, the Joint Bookrunners or any Lender with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby. 189 Section 10.18 Electronic Execution of Assignments and Certain Other Documents. The words “execute,” “execution,” “signed,” “signature,” and words of like import in any Assignment and Assumption or in any amendment or other modification hereof (including waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. Section 10.19 USA Patriot Act Notice. Each Lender that is subject to the Patriot Act (as hereinafter defined) and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Loan Parties and the Parent Guarantor that pursuant to the requirements of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Title III of Pub. L. 107-56 (signed into Law October 26, 2001) (the “Patriot Act”)), it is required to obtain, verify and record information that identifies each Loan Party and the Parent Guarantor, which information includes the name and address of each Loan Party and the Parent Guarantor and other information that will allow such Lender or the Administrative Agent, as applicable, to identify each Loan Party and the Parent Guarantor in accordance with the Patriot Act. Each Borrower shall, and shall cause each other Loan Party and the Parent Guarantor to, promptly following a request by the Administrative Agent or any Lender, provide all documentation and other information that the Administrative Agent or such Lender requests in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act. Section 10.20 Intercreditor Agreements. Each Lender agrees that it will be bound by, and will take no actions contrary to, the provisions of each Intercreditor Agreement. Each Lender authorizes and instructs the Administrative Agent and the Collateral Agent to enter into the Security Documents and the Intercreditor Agreements on behalf of such Lender and to take all actions (and execute all documents) required (or deemed advisable) by the Administrative Agent or the Collateral Agent in accordance with the terms of the Security Documents and the Intercreditor Agreements. The provisions of this Section 10.20 are not intended to summarize all relevant provisions of the Intercreditor Agreements. Reference must be made to each Intercreditor Agreement itself to understand all terms and conditions thereof. Each Lender is responsible for making its own analysis and review of each Intercreditor Agreement and the terms and provisions thereof, and neither the Administrative Agent nor the Collateral Agent or any of their respective affiliates, representatives, advisors, attorneys or other Person makes any representation to any Lender as to the sufficiency or advisability of the provisions contained in any Intercreditor Agreement. Notwithstanding anything to the contrary set forth herein or in any other Loan Document, this Agreement is subject to the terms and provisions of each Intercreditor Agreement. In the event of an inconsistency between the provisions of this Agreement and any Intercreditor Agreement, the provisions of such Intercreditor Agreement shall prevail. Each Lender further agrees that it will be bound by, and will take no actions contrary to, the provisions of any intercreditor agreement contemplated by Section 7.02(b) and (u) (each, a “Secured Debt Intercreditor Agreement”). Each Lender authorizes and instructs the Administrative Agent and the Collateral Agent to enter into any Secured Debt Intercreditor Agreement on behalf of such Lender and to take all actions (and execute all documents) required (or deemed advisable) by the Administrative Agent or the Collateral Agent in accordance with the terms of such Secured Debt Intercreditor Agreement. 190 Section 10.21 Field Audit and Examination Reports; Disclaimer by Lenders. By signing this Agreement, each Lender: (i) is deemed to have requested that the Administrative Agent furnish such Lender, promptly after it becomes available, a copy of each field audit or examination report (each a “Report” and collectively, “Reports”) prepared by or on behalf of the Administrative Agent; (ii) expressly agrees and acknowledges that neither Wells Fargo nor the Administrative Agent (A) makes any representation or warranty as to the accuracy of any Report, or (B) shall be liable for any information contained in any Report; (iii) expressly agrees and acknowledges that the Reports are not comprehensive audits or examinations, that the Administrative Agent, Wells Fargo, or other party performing any audit or examination will inspect only specific information regarding the Borrowers and will rely significantly upon the Borrowers’ books and records, as well as on representations of the Borrowers’ personnel; (iv) agrees to keep all Reports confidential and strictly for its internal use, and not to distribute except to its participants, or use any Report in any other manner; and (v) without limiting the generality of any other indemnification provision contained in this Agreement, agrees: (A) to hold the Administrative Agent and any such other Lender preparing a Report harmless from any action the indemnifying Lender may take or conclusion the indemnifying Lender may reach or draw from any Report in connection with any loans or other credit accommodations that the indemnifying Lender has made or may make to any Borrower, or the indemnifying Lender’s participation in, or the indemnifying Lender’s purchase of, a loan or loans of any Borrower; and (B) to pay and protect, and indemnify, defend, and hold the Administrative Agent and any such other Lender preparing a Report harmless from and against, the claims, actions, proceedings, damages, costs, expenses, and other amounts incurred by or on behalf of the Administrative Agent and any such other Lender preparing a Report as the direct or indirect result of any third parties who might obtain all or part of any Report through the indemnifying Lender. Section 10.22 Release of Liens and Guarantees. In the event that any Loan Party conveys, sells, leases, assigns, transfers or otherwise disposes of all or any portion of any of the Equity Interests or assets of any Subsidiary Loan Party to a person that is not (and is not required to become) a Loan Party in a transaction not prohibited by Section 7.05, any Liens created by any Loan Document in respect of such Equity Interests or assets shall be automatically released and the Administrative Agent shall promptly (and the Lenders hereby authorize the Administrative Agent to) take such action and execute any such documents as may be reasonably requested by the Holdcos or any Borrower and at the Borrowers’ expense to release or evidence the release of any Liens created by any Loan Document in respect of such Equity Interests or assets. In the event of (x) a disposition of the Equity Interests of any Subsidiary Loan Party in a transaction permitted by Section 7.05 (including through merger, consolidation, amalgamation or otherwise) and as a result of which such Subsidiary Loan Party would cease to be a Subsidiary, or (y) the designation of any Subsidiary Loan Party as an Unrestricted Subsidiary, in each case, such Subsidiary Loan Party’s obligations under the Loan Documents shall be automatically terminated and the Administrative Agent shall promptly (and the Lender hereby authorizes the Administrative Agent to) take such action and execute such documents at the Borrowers’ expense as may be reasonably requested by the Holdcos or any Borrower to terminate such Subsidiary Loan Party’s obligations under the Loan Documents. In addition, the Administrative Agent agrees (a) to take such actions as are reasonably requested by any Borrower and at the Borrowers’ expense to terminate the Liens and security interests created by the Loan Documents when all the ABL Credit Obligations (other than contingent indemnification obligations) are paid in full, all Commitments to lend hereunder are terminated and all Letters of Credit have been either cancelled or cash collateralized as required hereunder and (b) to enter into any Secured Debt Intercreditor Agreement (in each case in the circumstances and on those terms contemplated by this Agreement) and to take such actions (and execute all documents) as are reasonably requested by the Holdcos or any Borrower in connection with such Secured Debt Intercreditor Agreement.


 
191 Section 10.23 Headings. Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement. Section 10.24 Acknowledgement and Consent to Bail-In of Affected Financial Institutions. (a) Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties to the Loan Documents, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Loan Document, to the extent that such liability is unsecured, may be subject to the Write-Down and Conversion Powers of a Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by: (i) the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution; and (ii) the effects of any Bail-In Action on any such liability, including, if applicable: (A) a reduction in full or in part or cancellation of any such liability; (B) a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or (C) the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of any Resolution Authority. (b) Each party hereto agrees that it will notify the Borrowers and the Administrative Agent, as soon as practicable, of such party becoming the subject of a Bail-In Action unless notification is prohibited by law, regulation or order. Section 10.25 Power of Attorney (a) A party may appoint an attorney to represent it for purposes of signing this Agreement or any agreement or document it enters into in connection with this Agreement. Section 10.26 Acknowledgement Regarding Any Supported QFCs. To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Swap Contract or any other agreement or instrument that is a QFC (such support, “QFC Credit Support”, and each such QFC, a “Supported QFC”), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the “U.S. Special Resolution Regimes”) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and/or of the United States or any other state of the United States): 192 (a) In the event a Covered Entity that is party to a Supported QFC (each, a “Covered Party”) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support. (b) As used in this Section 10.26, the following terms have the following meanings: “BHC Act Affiliate” of a party means an “affiliate” (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party. “Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). “Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable. “QFC” has the meaning assigned to the term “qualified financial contract” in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D). [Signature Pages Follow] 6974498.7 EXHIBIT B to Amendment No. 6 to Amended and Restated Credit Agreement Exhibit C-1 to Amended and Restated Credit Agreement SOFR Notice [Attached] Exhibit C-1 FORM OF SOFR NOTICE Wells Fargo Bank, National Association, as Administrative Agent under the below referenced Credit Agreement 100 Park Avenue, 14th Floor New York, NY 10017 Ladies and Gentlemen: Reference is hereby made to that certain Amended and Restated Credit Agreement, dated as of February 20, 2019 (as amended, restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”), by and among Constellium Muscle Shoals LLC, a Delaware limited liability company (f/k/a Wise Alloys LLC) (“Muscle SHOALS”), Constellium Rolled Products Ravenswood, LLC, a Delaware limited liability company (“Ravenswood”), Constellium Bowling Green LLC, a Delaware limited liability company (“Bowling Green” and together with Muscle Shoals and Ravenswood, the “Borrowers” and each, a “Borrower”), Constellium Holdings Muscle Shoals LLC, a Delaware limited liability company (f/k/a Wise Metals Group LLC) (“Muscle Shoals Holdings”), Constellium US Holdings I, LLC, a Delaware limited liability company (“CUSHI”), Constellium US Intermediate Holdings LLC, a Delaware limited liability company (“Intermediate”), Wells Fargo Bank, National Association (“Wells Fargo”), as Administrative Agent and Collateral Agent (in such capacities, the “Administrative Agent”), and the Lenders signatory thereto. Capitalized terms used herein, but not specifically defined herein, shall have the meanings ascribed to them in the Credit Agreement. This SOFR Notice represents Borrowers’ request to elect the SOFR Option with respect to outstanding Revolving Facility Loans and the Term Loan in the amount of $________ (the “SOFR Advance”)[, and is a written confirmation of the telephonic notice of such election given to Agent]. The SOFR Advance will have an Interest Period of [1 or 3] month(s). Such Interest Period is requested to commence on . This SOFR Notice further confirms Borrowers’ acceptance, for purposes of determining the rate of interest based on SOFR as determined pursuant to the Credit Agreement. Borrower represents and warrants that (i) as of the date hereof, the representations and warranties of the Loan Parties contained in the Credit Agreement and in the other Loan Documents are true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof) on and as of the date hereof, as though made on and as of such date (except to the extent that such representations and warranties relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof) as of such earlier date)), (ii) each of the covenants and agreements contained in any Loan Document have been performed (to the extent required to be performed on or before the date hereof or


 
2 each such effective date), and (iii) no Default or Event of Default has occurred and is continuing on the date hereof, nor will any thereof occur after giving effect to the request above. [signature page follows] Dated: ______________________, a ________ _________________, as Borrower By Name: Title: Acknowledged by: WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as Administrative Agent By: Name: Title: [_______________, a _____________, as a Lender By: Name: Title: ] 6974498.7 EXHIBIT C to Amendment No. 6 to Amended and Restated Credit Agreement Schedules to Amended and Restated Credit Agreement [Attached] 7017802.3 Schedule 1.01(b) Mortgaged Properties Name of Borrower/Guarantor Address/City/State/Zip Code County Constellium Rolled Products Ravenswood, LLC 859 Century Road Ravenswood, WV 26164 Jackson Constellium Muscle Shoals LLC 4805 Second Street Muscle Shoals, AL 35661 Colbert Constellium Muscle Shoals LLC 1009 Ford Rd Muscle Shoals, AL 35661 Colbert Constellium Muscle Shoals LLC 501 West 20th Avenue Sheffield, AL 35660 Colbert Constellium Bowling Green LLC 714 Commonwealth Boulevard Bowling Green, KY 42101 Warren 7017802.3 Schedule 2.01 Revolving Facility Commitments Lender Revolving Facility Commitment as of the Amendment No. 6 Effective Date Wells Fargo Bank, National Association $180,000,000 Deutsche Bank AG New York Branch $60,000,000 Goldman Sachs Bank USA $43,750,000 Barclays Bank PLC $43,750,000 Bank of America, N.A. $37,500,000 Citibank, N.A. $28,125,000 Credit Suisse AG, New York Branch $28,125,000 Fifth Third Bank, National Association $28,125,000 PNC Bank, National Association $28,125,000 Bank of the West $22,500,000 Total $500,000,000


 
7017802.3 Schedule 7.01 Indebtedness 1. Capital Lease Obligations of Constellium Muscle Shoals LLC in the amount of $5,974,214 as of May 31, 2022. 2. Capital Lease Obligations of Constellium Rolled Products Ravenswood, LLC in the amount of $538,251.97 as of May 31, 2022. 3. Capital Lease Obligations of Constellium Bowling Green, LLC in the amount of $414,252 as of May 31, 2022. 7017802.3 Schedule 7.02(a) Liens 1. Trust Agreement between Constellium Rolled Products Ravenswood, LLC and United Bank, Inc. to secured liabilities of Constellium Rolled Products Ravenswood, LLC in respect of a hazardous waste management facility (storage ponds). The trust is to be funded in an amount of $472,616 with annual payments over a ten-year period, commencing on January 17, 2008. The environmental escrow account has a balance of $499,282.10 as of June 7, 2022. 2. Mechanic’s lien filed on April 21, 2022 with the clerk’s office of Jackson County, WV, by Admar PA, LLC (DBA Admar Construction Equipment & Supplies) against Constellium Ravenswood Rolled Products, LLC to secure the payment of $22,192.34. 3. Other Liens (provided that the Lien described below in favor of McKesson Corporation shall secure only the debtor’s obligations in respect of accounts payable): Debtor Secured Party Jurisdiction of filing Type of filing Initial File # Initial File Date Description of Collateral Constellium Muscle Shoals LLC Constellium Muscle Shoals Funding III LLC DE Secretary of State Financing Statement 20217820005 09/30/2021 Certain receivables Constellium Muscle Shoals LLC McKesson Corporation, for itself and as Collateral Agent for each of its affiliates DE Secretary of State Financing Statement 20221138718 02/09.2022 All assets 6974498.7 EXHIBIT D Consent and Reaffirmation Constellium International S.A.S. (the “Parent Guarantor”) hereby acknowledges receipt of a copy of the foregoing Amendment No. 6 dated as of the date hereof (the “Amendment No. 6”) by and among Constellium Muscle Shoals LLC (f/k/a Wise Alloys LLC) (“Muscle Shoals”), Constellium Rolled Products Ravenswood, LLC (“Ravenswood”), Constellium Bowling Green LLC (f/k/a Constellium-UACJ ABS LLC) (“Bowling Green” and together with Muscle Shoals and Ravenswood, the “Borrowers” and each, a “Borrower”), Constellium Holdings Muscle Shoals LLC (f/k/a Wise Metals Group LLC) (“Muscle Shoals Holdings”), Constellium US Holdings I, LLC (“CUSHI”), Constellium US Intermediate Holdings LLC (“Intermediate”), Wells Fargo Bank, National Association, as Administrative Agent and Collateral Agent (in such capacities, the “Administrative Agent”), and the Lenders signatory thereto, amending that certain Amended and Restated Credit Agreement, dated as of February 20, 2019 and as amended by Amendment No. 1 to Amended and Restated Credit Agreement, dated May 10, 2019, Amendment No. 2 to Amended and Restated Credit Agreement, dated April 24, 2020, Amendment No. 3 to Amended and Restated Credit Agreement, dated September 25, 2020, Amendment No. 4 to Amended and Restated Credit Agreement, dated as of April 27, 2021 and Amendment No. 5 to Amended and Restated Credit Agreement, dated as of December 3, 2021 (the “Existing Credit Agreement”; the Existing Credit Agreement as amended by the Amendment No. 6, and as further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Borrowers, Muscle Shoals Holdings, CUSHI, Intermediate, the Administrative Agent, and the Lenders from time to time party thereto. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Credit Agreement. The Parent Guarantor hereby (1) ratifies and reaffirms all of its obligations and covenants, including, without limitation, the ABL Credit Obligations applicable to it, under the Credit Agreement, provided, that, notwithstanding anything to the contrary set forth in the Credit Agreement, the “ABL Credit Obligations” of Parent Guarantor under the Credit Agreement shall not include Term Loan A-2 Obligations, (2) ratifies and reaffirms all of its obligations and covenants under that certain Amended and Restated Guarantee and Collateral Agreement, dated as of February 20, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Guarantee and Collateral Agreement”), by and among the Borrowers, Muscle Shoals Holdings, CUSHI, Intermediate, the Parent Guarantor, the Administrative Agent and each subsidiary of a Borrower identified therein, provided, that, notwithstanding anything to the contrary set forth in the Guarantee and Collateral Agreement, the “Obligations” and “Guaranteed Obligations” of Parent Guarantor thereunder shall not include Term Loan A-2 Obligations, (3) agrees that neither such ratification and reaffirmation provided for in clauses (1) and (2), nor the Administrative Agent’s or any Lender’s solicitation of such ratification and reaffirmation, constitutes a course of dealing giving rise to any obligation or condition requiring a similar or any other ratification or reaffirmation from the Parent Guarantor with respect to any subsequent modifications to the Credit Agreement or the other Loan Documents, (4) agrees that none of the terms and conditions of the Amendment No. 6 shall limit or diminish its payment and performance obligations, contingent or otherwise, under the Credit Agreement and the Guarantee and Collateral Agreement and (5) agrees that both the Credit Agreement and the Guarantee and Collateral Agreement, as modified by the provisos in clauses (1) and (2) above, remain in full force and effect and each is hereby reaffirmed, ratified and confirmed. Dated: _______, 2022 [Signature Page Follows] Signature Page to Consent and Reaffirmation (Amendment No. 6 to Amended and Restated Credit Agreement) 6974498.7 CONSTELLIUM INTERNATIONAL S.A.S., as Parent Guarantor By:_____________________________________ Name: Title:


 
Schedule 1-1 (Amendment No. 6 to Amended and Restated Credit Agreement) 6974498.7 SCHEDULE 1 Conditions Precedent (i) Administrative Agent shall have received each of the following documents, in form and substance reasonably satisfactory to Administrative Agent, duly executed and delivered, and each such document shall be in full force and effect: (A) this Amendment No. 6 executed and delivered by duly authorized officers of each Loan Party, the Lenders and the Administrative Agent; (B) the consent and reaffirmation agreement, substantially in the form of Exhibit D attached hereto (the “Consent and Reaffirmation”), executed and delivered by the Parent Guarantor; (C) the Amendment No. 6 Fee Letter executed and delivered by the Borrowers; (D) an updated Perfection Certificate executed and delivered by the Borrowers and the other Loan Parties; (E) a solvency certificate signed by the Chief Financial Officer or Treasurer, as applicable, of each Borrower; (F) a certificate from a secretary or assistant secretary of each Loan Party, in each case certifying as to and attaching (a) such Loan Party’s certificate or articles of incorporation, certificate of limited partnership or certificate of formation, as applicable, and all amendments thereto, certified as of a recent date by the Secretary of State (or other similar official) of the jurisdiction of its organization (or confirmation that there have been no changes to any organizational document since Amendment No. 2 Effective Date), (b) such Loan Party’s bylaws, partnership agreement, limited liability company agreement or other equivalent governing documents and all amendments thereto (or confirmation that there have been no changes to any such document since Amendment No. 2 Effective Date), (c) resolutions duly adopted by the Board of Directors or equivalent governing body of such Loan Party (or its managing general partner or managing member), (d) the incumbency and signatures of the officers or representatives executing this Amendment No. 6 and the other Loan Documents and (e) the absence of any pending proceeding for the dissolution or liquidation of such entity or, to the knowledge of such person, threatening the existence of such entity; (G) a certificate from an officer of the Parent Guarantor certifying as to and attaching (a) its by-laws (statuts) (or confirmation that there have been no changes to any organizational document since Amendment No. 2 Effective Date), (b) an electronic copy of a k-bis extract (extrait k-bis) (or confirmation that there have been no changes to any organizational document since Amendment No. 2 Effective Date), (c) resolutions duly adopted by its sole shareholder or equivalent governing body and (d) the incumbency and signatures of the officers or representatives executing the Consent and Reaffirmation; (H) a certificate of good standing of each Loan Party from the Secretary of State (or other similar official) of the jurisdiction of its organization if applicable, dated as of a recent date not more than thirty (30) days prior to the Amendment No. 6 Effective Date; (I) a certificate of a Responsible Officer of the Borrowers, certifying that, as of the Amendment No. 6 Effective Date, the representations and warranties set forth in Section 4(d) of this Amendment No. 6 are true and correct in all material respects (without duplication of any materiality qualifier contained therein), except to the extent that such representation or warranty expressly relates to an earlier date Schedule 1-2 (Amendment No. 6 to Amended and Restated Credit Agreement) 6974498.7 (in which event such representation or warranty is true and correct in all material respects (without duplication of any materiality qualifier contained therein) as of such earlier date); (J) a favorable written opinion of (a) Wachtell, Lipton, Rosen & Katz, as counsel for the Borrowers and the other Loan Parties, and (b) Clifford Chance Europe LLP, as counsel for the Parent Guarantor, in each case addressed to the Administrative Agent, the Lenders and the L/C Issuer, which shall be in form and substance reasonably satisfactory to the Administrative Agent and covering such matters as the Administrative Agent shall reasonably request; and (K) the results of a search of the UCC filings (or equivalent filings) made with respect to each Loan Party, each in the state of Delaware, together with copies of the financing statements (or similar documents) disclosed by such search; (ii) Borrowers shall have Availability in an aggregate amount in excess of $100,000,000 after giving effect to the initial extensions of credit under this Agreement and the payment of all fees and expenses required to be paid by Borrowers on or prior to the Amendment No. 6 Effective Date; (iii) Administrative Agent and each Lender shall have received required internal FDPA compliance approval; (iv) No Default or Event of Default under any of the Loan Documents shall exist or have occurred on the Amendment No. 6 Effective Date; and (v) Borrowers shall have paid, or shall concurrently pay, costs, Fees (including all of the Fees referred to in the Amendment No. 6 Fee Letter which are due and payable on the Amendment No. 6 Effective Date) and expenses due and payable on the Amendment No. 6 Effective Date, provided, that for costs and expenses, invoices shall have been delivered to Borrowers not less than three (3) Business Days prior to the Amendment No. 6 Effective Date.


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 
Paris 17846958.7 166 SIGNATORIES Made in Paris on 21 July 2022, In six (6) originals CONSTELLIUM INTERNATIONAL as Parent Company /s/ Arina Yemelyanova CONSTELLIUM NEUF BRISACH as Seller /s/ Arina Yemelyanova By: Arina Yemelyanova Title: Authorized signatory By: Arina Yemelyanova Title: Authorized signatory CONSTELLIUM ISSOIRE as Seller /s/ Arina Yemelyanova CONSTELLIUM EXTRUSIONS FRANCE as Seller /s/ Arina Yemelyanova By: Arina Yemelyanova Title: Authorized signatory By: Arina Yemelyanova Title: Authorized signatory CONSTELLIUM SWITZERLAND AG as Sellers’ Agent /s/ Arina Yemelyanova FACTOFRANCE as Factor /s/ Nicolas Morgant By: Arina Yemelyanova Title: Authorized signatory By: Nicolas Morgant Title: Head of International


 

2022 Long Term Incentive Award Agreement Terms and Conditions Effective as from March 10, 2022


 
2022 Award Agreement 2 1. BACKGROUND This Award Agreement is adopted under the Constellium SE 2013 Equity Incentive Plan, as amended and restated from time to time (the “Plan”). The Units awarded under this Award Agreement entitle the Participant to receive Constellium Shares or a cash equivalent, subject to the terms and conditions of the Plan, this Award Agreement and the Award Letter. The Company’s shareholders have authorized the issuance of up to 21,092,291 Shares under the Plan (pursuant to corporate decisions taken on May 16, 2013, June 11, 2014, May 24, 2018 and May 11, 2021). This Award Agreement has been adopted by the Board of Directors of the Company pursuant to such authorization. 2. DEFINITIONS The terms and conditions set forth in the Plan are incorporated by reference. Terms used herein shall have the meaning ascribed thereto in the Plan unless otherwise defined herein. Section references in this Award Agreement are to the respective section herein unless otherwise noted. Award Agreement: This Long Term Incentive Award Agreement of the Company, as amended and restated from time to time. Award Letter: A letter provided by the Company to the Participant in respect of each Grant, specifying the number of RSUs and/or PSUs granted, the Grant Date, the Index or Indices (if applicable), the Vesting Period and/or Performance Period (if applicable), the Vesting Date and any other terms and conditions applicable. Award Letters will be subject to modifications and additional provisions decided by the Board or the Committee in its discretion. Base Amount: One Share for each Unit, unless otherwise specified in the Award Letter. Board: The Board of Directors of the Company or, if delegated by the Board, the Human Resources and Remuneration Committee of the Board, any successor committee thereto, or any other committee or body appointed from time to time by the Board to administer awards under this Award Agreement. Change in Control: Change in Control has the meaning defined in Section 10(b) of the Plan, except that for purposes of this Award Agreement to the extent permitted by applicable law: (a) the 50% threshold in Section 10(b)(i) of the Plan shall be replaced by 35%, (b) the 50% threshold in Section 10(b)(iii)(A) of the Plan shall be replaced by 65%, (c) the 50% threshold in Section 10(b)(iii)(B) of the Plan shall be replaced by 35%, (d) the majority threshold in Section 10(b)(iii)(C) of the Plan shall be replaced by 65%, and (e) and a new Section 10(b)(v) of the Plan shall be added: (v) any Person with beneficial ownership of 5% or more of either the Outstanding Company Shares or Outstanding Company Voting Securities shall have nominated for election by the Company’s stockholders directors representing 35% or more of the Board and such persons shall have been elected, without the approval of at least a majority of the Incumbent Board. Company: Constellium SE or any successor thereto.


 
2022 Award Agreement 3 Constellium Group: The Company together with the companies in which the Company holds directly or indirectly more the 50% of the outstanding shares and which are included in the consolidated financial statements of the Company. References to the Constellium Group shall be to all such companies or any one or group of them, as the context requires. Continued Service Condition: The condition referred to in Section 5. Converted RSUs: Has the meaning set forth in Section 13. Converted PSUs: Has the meaning set forth in Section 13. Converted Units: Has the meaning set forth in Section 13. Delivery Date: A day that is both a trading day on the New York Stock Exchange and a banking day in the city in which the Company has its headquarters, falling as soon as practicable after the Vesting Date, as determined by the Company, unless otherwise specified in this Award Agreement or the Award Letter. Grant: The award of Units to a Participant in accordance with this Award Agreement. Grant Date: The date on which a Grant of Units is made by the relevant corporate body of Constellium. The Grant Date applicable to each Unit will be specified in the Award Letter. Index or Indices: The Index or Indices will be specified in the Award Letter. Participant: An employee of the Constellium Group who has received a Grant of Units under this Award Agreement. Performance Condition: Such performance condition or conditions as shall be specified in the Award Letter. Performance Period: The period over which the Performance Condition shall be measured. For each PSU, this period will be specified in the Award Letter. The period will be of three years, unless otherwise specified in the Award Letter. The Performance Period is subject to earlier termination in the event of a Change in Control or the Participant’s Disaffiliation. Performance Share Unit or PSU: Each PSU shall be a “Performance Share Unit” within the meaning of Section 8 of the Plan and represents a conditional right to receive a certain number of Shares or, in the Company’s discretion, their cash equivalent upon settlement, subject to the fulfillment of the Performance Condition, the Continued Service Condition and the other terms and conditions of this Award Agreement. Permanent Disability: (i) For Participants covered by the long term disability plan of the Constellium Group, disability as defined in such plan, (ii) for French-resident Participants, a disability falling within the second and third categories of article L. 341-4 of the French Social Security Code and, (iii) for all other Participants, a physical or mental condition of the Participant resulting from bodily injury, disease or mental disorder which renders the Participant incapable of continuing the Participant’s usual or customary employment with the Participant’s employer for a period of not less than six consecutive months, as determined by the Board in its discretion. Notwithstanding the foregoing, for U.S. taxpayers, such occurrence must also constitute a disability within the meaning of Section 409A of the Internal Revenue Code (“Section 409A”). Plan: Has the meaning set forth in Section 1. Restricted Stock Unit or RSU: Each RSU shall be a “Restricted Stock Unit” within the meaning of Section 7 of the Plan and represents a conditional right to receive a certain number


 
2022 Award Agreement 4 of Shares or, in the Company’s discretion, their cash equivalent upon settlement, subject to the fulfillment of the Continued Service Condition and the other terms and conditions of this Award Agreement. Retirement: Defined by the Participant’s employer in accordance with applicable local law or, in the absence of such law, under the conditions provided for in the employer’s retirement or early retirement plan, or in the absence of such a plan, at the minimum age of 65 (to the extent permitted by law). Termination: A “Termination of Employment” as defined in the Plan which, for the avoidance of doubt, shall include any voluntary or involuntary ending of services (including garden leave or other periods of non-work / interruption of employment as defined in the discretion of the Company) with the Company or a Subsidiary. Total Shareholder Return or TSR: With respect to any share or Index, the variation in stock price of such share or the value of such Index, as the case may be, measured by comparing the price or value at the beginning of the relevant Performance Period with the price or value at the end of such period plus, in the case of a share, dividends and distributions paid, declared or made in respect of such share during the Performance Period, which shall be deemed to have been reinvested, expressed as a percentage return, in each case expressed as a percentage of the beginning point. TSR will be measured as of the first and last day of the relevant Performance Period, in each case by reference to an average of the closing price of the relevant share or index on each of the 20 trading days immediately preceding, as applicable, the first day of the relevant Performance Period (the Grant Date unless otherwise provided in the Award Letter) and the last day of the relevant Performance Period (the Vesting Date unless otherwise provided in the Award Letter, or, if earlier, the occurrence of a Change in Control or the Participant’s Disaffiliation). Units: Performance Share Units and Restricted Stock Units. Vesting Date: The Vesting Date of each Unit will be the third anniversary of the Grant Date, unless otherwise specified in this Award Agreement or in the Award Letter, subject to the satisfaction of the Continued Service Condition and, in respect of the PSUs, the Performance Condition. On the Vesting Date, Participants become entitled to the delivery of Shares (or a cash payment) with respect to such Units. Vesting Period: The period from the Grant Date through and including the Vesting Date. The period will be of three years, unless otherwise specified in this Award Agreement or in the Award Letter. Voluntary Termination for Good Reason: Has the meaning set forth in Section 13. 3. GRANT OF UNITS Grants of Units will be made by decision of the Board or, to the extent permitted by applicable law, by the Committee acting under the authority granted to it under Section 2 of the Plan. An Award Letter will be entered into with each Participant setting forth the specific terms and conditions of the Participant’s Grant. As a precondition for a valid Grant, the Participant must be employed by a company of the Constellium Group on the Grant Date. The Participant will be required to accept the terms and conditions of the Grant and to provide such information as may be required by the Company and its service providers for the administration of the Grant.


 
2022 Award Agreement 5 4. VESTING OF UNITS The level of vesting of the Units and the resulting Share entitlement shall be determined as soon as practicable after the Vesting Date subject to the achievement of the Continued Service Condition as set forth under Section 5 and, in respect of the PSUs, based on the level of achievement of the Performance Condition as set forth under Section 6. To the extent that vesting is achieved under these conditions, the Participant will be entitled to receive Shares in the numbers determined according to such conditions. Any Units that do not vest will be cancelled without further notice, entitlement or right of indemnity. Prior to the Delivery Date, the Participant does not have any legal ownership or any other rights relating to the Shares. The Participant shall not be entitled to any dividend or have any voting rights or any other rights as a shareholder to the Shares until and unless the Shares have been transferred to the Participant or, in certain limited cases, upon vesting of the Units. If at any time any Participant forfeits any or all of such Participant’s Units, due to the Continued Service Condition or the Performance Condition not being met or otherwise, all of such Participant’s rights and interests in such Units and in Shares issuable thereunder shall terminate upon forfeiture without payment of any indemnity or consideration. 5. CONTINUED SERVICE CONDITION As a condition to the vesting of the Units, the Participant must remain an active employee of the Constellium Group from the Grant Date through the Vesting Date, without Termination, unless one of the exceptions listed below shall apply. A Termination that does not result from such an exception shall result in the immediate cancellation and forfeiture of any Units of such Participant that have not previously vested, without further notice, entitlement or right of indemnity. The Continued Service Condition shall not be deemed to be breached if the Participant’s termination of employment within the Constellium Group results from one of the following exceptional events: (a) Permanent Disability, in which case the Participant retains the right to settlement and the original Vesting Date and conditions will continue to apply; (b) Death of the Participant, in which case outstanding Units will be settled with the Participant’s heirs or representatives (for PSUs, at the Base Amount) as soon as practicable after the date of death, constituting full and final settlement of such Units; or (c) Retirement, in which case the Participant retains the right to settlement and the original Vesting Date and conditions will continue to apply, and the number of Shares to be delivered will be prorated by multiplying (i) the number of Shares the Participant would otherwise have received for the Vesting Period by (ii) a fraction, the numerator of which is the number of full months in the period that begins with the month that contains the Grant Date and ends with (and includes) the month in which the Participant’s employment with the Constellium Group terminates due to the Participant’s Retirement, and the denominator of which is the total number of full months in the period that begins with the month that contains the Grant Date and ends with the month that contains the Vesting Date.


 
2022 Award Agreement 6 If the Participant’s last day of employment with the Constellium Group occurs before the last day of the Vesting Period for any reason other than those mentioned above, then, unless the Board or Committee determines otherwise in its sole discretion, any Units of such Participant that have not previously vested shall be immediately cancelled and forfeited without further notice, entitlement or right of indemnity. 6. PERFORMANCE CONDITION The vesting of the PSUs and the delivery of the related Shares shall be subject to the level of achievement of the Performance Condition in respect of the relevant Performance Period, as specified in the Award Letter. 7. MEASUREMENT AND CALCULATION OF ACHIEVEMENT The measurement of the achievement of the Performance Condition shall be made as soon as practicable after the end of the relevant Performance Period. The number of PSUs to be settled as Shares or the equivalent amount of cash, in case applicable, shall be calculated by the Company based on this measurement. The Company shall carry out the measurement and calculation in its discretion. The Board may in its discretion decide to amend the targets initially set and/or the composition of the list of companies referred to if it reasonably believes that changes in the business of the Company and/or any of the listed companies have had an adverse effect on their comparability for purposes of measuring the Company’s relative performance. Such changes may include a change in accounting method, a change in scope of consolidation following a merger, sale, acquisition, or the creation of a material new business entity or the discontinuation of an existing material business entity, or any other changes in circumstances that it shall deem material and pertinent. The calculation of the number of Shares to be settled shall not result in fractional Shares. The number of Shares shall be rounded to the nearest whole Share. 8. SETTLEMENT Following the Vesting Date, the Company will complete the settlement by transferring the applicable number of Shares or, in its discretion, their cash equivalent to the Participant’s brokerage or other bank account, as applicable, on the Delivery Date. Completion of settlement is dependent on the Participant’s compliance with the terms and conditions of the Plan, this Award Agreement and the relevant Award Letter and providing all necessary instructions and actions to enable the Company to facilitate the settlement. If the Participant has not performed all necessary actions to enable the Company to complete the settlement, the Company may, in its sole discretion, sell the Shares on behalf of the Participant and remit the proceeds to the Participant. The Company may, in its sole discretion, use one or more of the following instruments to settle Units: newly issued Shares, treasury Shares held by the Company, Shares purchased from the open market, or, in lieu of Shares, cash (without adjustment for change in tax or social treatment). On each Delivery Date, the Company shall pay to the Participant a cash amount equal to the product of (x) any cash dividends or other distributions (other than cash dividends or other distributions pursuant to which the Units were adjusted pursuant to Section 3(c) of the Plan or Section 13(a)), if any, paid on a Share from the Grant Date to such Delivery Date and (y) the number of Shares delivered to the Participant on such Delivery Date (including for this purpose


 
2022 Award Agreement 7 any Shares that would have been delivered on such Delivery Date but for being withheld to satisfy tax withholding obligations). 9. NO EFFECT ON TERMS OF EMPLOYMENT The Grant or settlement of Units and/or Shares does not constitute a term or a condition of the Participant’s employment with any company of the Constellium Group under applicable local laws and the rights and obligations arising from a Participant’s employment with the Group are separate from, and are not affected by, the Participant’s participation in this Award Agreement. The Units, the Shares or their cash equivalent do not form a part of the Participant’s salary or benefit of any kind. Nothing in this Award Agreement, any Award Letter or the Plan shall interfere with or limit in any way the right of the Company, its Subsidiaries or its Affiliates to terminate a Participant’s employment or service at any time, nor confer upon any Participant the right to continue in the employment of the Company, its Subsidiaries or its Affiliates. The Grant or settlement of Units and/or Shares does not create any right for that Participant to be offered participation in the Plan in the future or to be granted any additional Units or Shares on any particular terms or in any particular amounts. By participating in the Plan, a Participant waives all rights to compensation for any loss in relation to and in accordance with such participation, including: (a) any loss or reduction of any rights or expectations under this Award Agreement and the Award Letter in any circumstances or for any reason; (b) any exercise of a discretion or a decision taken in relation to any Units or Shares, and/or to this Award Agreement or the Award Letter, or any failure to exercise a discretion or take a decision; and (c) the operation, suspension, termination or amendment of the Plan, this Award Agreement or the Award Letter. 10. TAXES AND OTHER OBLIGATIONS The Participant is responsible for paying all personal taxes and personal social security charges associated with the Units and the Shares related thereto. This includes responsibility for any and all personal tax and personal social security charge liabilities in multiple countries, if the Participant has resided in more than one country during any period in which tax liabilities arise with respect to this Grant. Participants are advised to consult their own financial and tax advisers (at their own expense) before accepting the Grant in order to verify their tax position. Units and Shares before delivery must not be used as security for any liability, be transferred or otherwise disposed of (except in the event of the Participant’s death, to the Participant’s personal representatives) and will lapse immediately on any attempt to do so. Pursuant to applicable laws, the Constellium Group is or may be required or may deem it appropriate to withhold taxes, social security charges or fulfill employment related and other obligations upon Grant, vesting or settlement of Shares, or payment of any cash-equivalent, or when the Shares are disposed of by a Participant. The Constellium Group shall have the right to determine how such collection, withholding or other measures will be arranged or carried out, including but not limited to salary withholding, a settlement of a net amount remaining after the completion of such measures or a sale of the Shares on behalf of a Participant for the completion of such measures.


 
2022 Award Agreement 8 11. BREACH OF THESE TERMS AND CONDITIONS The Participant shall comply with the terms and conditions set forth in this Award Agreement and in the Award Letter, as well as any administrative instructions given by the Company regarding the same from time to time. If the Participant breaches the terms and conditions set forth in the Plan, this Award Agreement and/or in the Award Letter and/or any administrative instructions given by the Company, the Company may in its discretion, at any time prior to the Delivery Date, cancel the Grant of Units. 12. AMENDMENTS Amendments of this Award Agreement and of any Grant made hereunder shall be governed by Section 12 of the Plan. 13. RIGHTS OF PARTICIPANTS IN CORPORATE EVENTS (a) The Board may in its discretion choose to adjust the number of Shares underlying each Unit in accordance with applicable law in the event that it shall deem such adjustment to be necessary and equitable to protect the interests of the Participants following certain corporate transactions affecting the share capital of the Company. These events may include, and are not limited to, (i) capital reduction, (ii) modification of the means of sharing of profits, (iii) grants of free shares to all existing holders, (iv) a capital increase by incorporation of reserves, profits or issuance premiums, (v) distribution of reserves and (vi) any issuance of capital securities or financial instruments that give a right to the allocation of capital securities with preferential subscription rights reserved to shareholders. For the avoidance of doubt, the Company’s decision to cancel existing shares held by the Company, to grant stock or stock options to employees or to issue shares to selected investors prior to the settlement of the Units will not give rise to such adjustments. (b) Subject to Section 13(d) and Section 409A, should the Company, during the Vesting Period, resolve to merge with another existing company or merge with a company to be formed, or should the Company resolve to be demerged, the Board may determine, in its sole discretion, whether the Units may be settled prior to the merger or demerger. Any settlement will be within such period as resolved by the Board. The Board may determine, in its sole discretion, whether the Units should be converted into similar equity rights issued by the other company. In such circumstances, the Board shall determine the terms and the period applicable to the vesting of such new rights. (c) This Award Agreement and the Grants made hereunder shall not in any way infringe or limit the ability of the Company to register in or transfer to another member state in the European Economic Area or to register a transfer of its domicile into another member state. Such registration or transfer shall not have any impact on the rights and obligations of the Participants under this Award Agreement and in respect of any Grant, except to the extent resulting from a change in applicable law and/or as decided by the Board in its sole discretion. (d) In the event of a Change in Control occurring before the Vesting Date, in accordance with the provisions of Section 10(b) of the Plan, as well as the definition of Change in Control under Section 2: (i) any RSUs that have not previously vested or lapsed will be converted into a cash-denominated right equal in value to (A) the number of Shares underlying such RSU immediately prior to such Change in Control multiplied by (B) the


 
2022 Award Agreement 9 closing price of a Share on the date immediately preceding the date of such Change in Control (“Converted RSUs”); (ii) any PSUs that have not previously vested or lapsed will be converted into a cash-denominated right equal in value to (A) the higher of (I) the Base Amount and (II) the number of Shares determined on the basis of the actual TSR, measured for such purposes as of the date immediately preceding the date of such Change in Control, which, for such purposes, will become the last day of the Performance Period multiplied by (B) the closing price of a Share on the date immediately preceding the date of such Change in Control (“Converted PSUs” and together with the Converted RSUs, the “Converted Units”); and (iii) the Converted Units will vest subject to the terms of, and at the same time as, the RSUs or PSUs from which the Converted Unit originated, provided that upon a Termination without Cause or Voluntary Termination for Good Reason of a Participant occurring upon such Change in Control or during any period thereafter that is prior to the last Vesting Date under this Award Agreement: 1. the date of such Termination will become the Vesting Date of any then outstanding Converted Units held by such Participant, and all outstanding Converted Units held by such Participant will fully vest and settle upon such Termination 2. to the extent permitted by applicable law, the Delivery Date of the Converted Units that have vested in accordance with the foregoing will be accelerated to occur on or as soon as practicable after the occurrence of the Termination, provided that (A) for French-resident Participants and for Grants that are subject to Article L. 225-197-1 of the French Commercial Code, if the Termination occurs (x) before the first anniversary of the Grant Date, the Board may defer the Delivery Date until such first anniversary and thereafter impose a mandatory holding period until the second anniversary of the Grant Date and (y) after the first anniversary of the Grant Date but before the second anniversary of the Grant Date, the Board may impose a mandatory holding period from the Delivery Date until the second anniversary of the Grant Date and (B) for Participants who are U.S. taxpayers, the originally scheduled Delivery Date will be maintained unless (x) a Change in Control occurs at the 50% threshold originally provided in Section 10(b) of the Plan or (y) the Board determines that the acceleration of the Delivery Date provided for above would be permissible under Section 409A and would not result in the imposition of any additional tax, penalty or surcharge on Participants under such Section 409A. For the avoidance of doubt, any limitation on the acceleration of delivery resulting from the foregoing clauses (A) or (B) shall have no effect on the acceleration of vesting provided for under clauses (i), (ii) and (iii) above, and 3. for purposes of the foregoing, “Voluntary Termination for Good Reason” shall mean a termination of the Participant’s employment at the Participant’s initiative following the occurrence, without prior written consent, of one or more of the following events: i. a material reduction in the Participant’s base salary and/or the Participant’s target bonus or long-term


 
2022 Award Agreement 10 incentive target from that in place immediately prior to the Change in Control (but not including any diminution related to an across-the-board reduction that is not related to a particular employee occurring prior to such Change in Control); ii. a material reduction in the Participant’s duties or responsibilities or the assignment to the Participant of duties or responsibilities inconsistent with the Participant’s position, in each case as in effect immediately prior to the Change in Control; iii. a material adverse change in the Participant’s titles or positions or the reporting structure applicable to the Participant from those in effect immediately prior to the Change in Control; iv. the relocation of the Participant’s office location as assigned to the Participant by the Company or its successor, to a location more than 75 kilometers from the location immediately prior to the Change in Control; or v. the failure of the Company to obtain the assumption in writing of the Company’s obligations to the Participant under this Agreement by any successor prior to or at the time of the merger, consolidation, disposition of all or substantially all of the assets of the Company or similar transaction, unless such assumption in writing was not legally required to maintain the effectiveness of such obligation. For the avoidance of doubt, the Change in Control provisions described above shall apply only to Grants that are subject to this Award Agreement and shall not apply to any grants or awards made under earlier award agreements. (e) In the event of a Disaffiliation (as defined in Section 1 of the Plan) of a Subsidiary occurring before the Vesting Date, with respect to the Participants who are employees of the disaffiliated Subsidiary at the time of such occurrence: (i) the date of such occurrence will become the Vesting Date of any then outstanding Units, (ii) any RSUs that have not previously vested or lapsed will fully vest upon such occurrence, (iii) any PSUs that have not previously vested or lapsed will vest (A) if such Disaffiliation is on or after a Change in Control, at the level determined in accordance with Section 13(d)(ii), or (B) if such Disaffiliation is before a Change in Control, at the higher of (I) the Base Amount and (II) the amount determined on the basis of the actual TSR, measured for such purposes as of the date of occurrence of such Disaffiliation which, for such purposes, will become the last day of the Performance Period, and (iv) to the extent permitted by applicable law, including Section 409A, the Delivery Date of the Units that have vested in accordance with the foregoing will be accelerated to occur on or as soon as practicable after the occurrence of the Disaffiliation, provided that if such Disaffiliation occurs before the second


 
2022 Award Agreement 11 anniversary of the Grant Date, the Board shall convert the affected Units to cash settlement in the manner described in Sections 13(d)(i) and (ii) above, on the basis of the closing price of a Share and actual TSR measured on the date immediately preceding the date of such Disaffiliation. (f) In any situation described above providing for the delivery of Shares, the Board may in its discretion choose to cause Shares from other sources to be delivered or shall cause the Company to pay an equivalent value in cash (without adjustment for change in tax or social treatment). The amount to be paid out would be determined based on the number of Shares to be delivered to Participants concerned, valued on a given date or according to an average of share prices calculated over the course of a period preceding the payment date retained by the Board. 14. GOVERNING LAW AND INTERPRETATION With respect to each Unit granted, the Plan, this Award Agreement and the Award Letter are governed by the corporate laws applicable to the Company on the Grant Date of such Unit. To the extent that any discretionary action or interpretation of the Plan, this Award Agreement and the Award Letter is taken or made by the Company or the Board, such action or interpretation shall be taken or made in good faith after consideration of the best interests of the affected Participants. For Participants who are U.S. taxpayers, it is intended that the Grant meets the requirements of Section 409A and shall be interpreted accordingly. The Participants recognize that it may be necessary to modify the Plan and/or this Award Agreement to reflect guidance under Section 409A issued by the Internal Revenue Service. The Participant agrees that the Company shall have sole discretion in determining (i) whether any such modification is desirable or appropriate and (ii) the terms of any such modification. For Participants who are French taxpayers, it is intended that the Grant meets the requirements of Article L. 225-197-1 et seq. of the French Commercial Code and related tax and social regulations and shall be interpreted accordingly. The Participants recognize that it may be necessary to modify the Plan and/or this Award Agreement to reflect guidance under such provision issued by the French tax and social administration. The Participant agrees that the Company shall have sole discretion in determining (i) whether any such modification is desirable or appropriate and (ii) the terms of any such modification. 15. COLLECTING, PROCESSING AND TRANSFERRING OF PERSONAL DATA Personal data required for the administration of Plan, this Award Agreement, the Award Letter and the settlement of the Units shall be collected, processed and transferred by the Constellium Group or its authorized agent(s) fairly and in accordance with the governing applicable data protection principles and conditions. The Participant is entitled to request access, rectification and objection of the personal data concerning the Participant as per applicable laws, statutes or regulation. In order to exercise this right, the Participant must contact the local data privacy/human resources contact in the Participant’s location.


 

FORM 2022 LTIP Award Letter Last Name, First Name March 10, 2022 FORM 2022 Long Term Incentive Award Letter Dear First Name, I am pleased to inform you that you have received a Grant of Units in the amounts set forth below. These Units entitle you to receive Constellium Shares (or a cash equivalent, at Constellium’s discretion), subject to the terms and conditions set forth in this Award Letter, in the Constellium 2022 Long Term Incentive Award Agreement (the “2022 Award Agreement”) and the Constellium SE 2013 Equity Incentive Plan, as may be amended from time to time (the “Plan”). Capitalized Terms used in this Award Letter, unless so defined herein, shall have the meanings found in the 2022 Award Agreement or the Plan. Grant Date March 10, 2022 Grant Date Award Value $XX,XXX Restricted Stock Units (RSUs) Y,YYY Vesting Date March 10, 2025 Vesting Period From the Grant Date through the Vesting Date Please note that, except as otherwise set forth in the 2022 Award Agreement, the vesting of the RSUs and the delivery of Shares (or a cash equivalent in respect of such RSUs) is subject to the satisfaction of the Continued Service Condition. By electronic acceptance of this award, you acknowledge that you have received a copy of, or have online access to, the 2022 Award Agreement and the Plan, and hereby accept the Units granted, subject to all the terms and provisions of this Award Letter, the 2022 Award Agreement and the Plan. The Board or the Committee shall determine whether an event has occurred resulting in the forfeiture of your Units and any Shares issuable thereunder and all such determinations shall be final and conclusive. You also acknowledge that this award and similar awards are made on a selective basis and are, therefore, to be kept confidential. Ryan Jurkovic Senior Vice President Chief Human Resources Officer


 

FORM 2022 LTIP Award Letter Last Name, First Name March 10, 2022 FORM 2022 Long Term Incentive Award Letter Dear First Name, I am pleased to inform you that you have received a Grant of Units in the amounts set forth below. These Units entitle you to receive Constellium Shares (or a cash equivalent, at Constellium’s discretion), subject to the terms and conditions set forth in this Award Letter, in the Constellium 2022 Long Term Incentive Award Agreement (the “2022 Award Agreement”) and the Constellium SE 2013 Equity Incentive Plan, as may be amended from time to time (the “Plan”). Capitalized Terms used in this Award Letter, unless so defined herein, shall have the meanings found in the 2022 Award Agreement or the Plan. Grant Date March 10, 2022 Grant Date Award Value $X,XXX,XXX Total Units Granted TOTAL (= YYY,YYY + ZZZ,ZZZ) Restricted Stock Units (RSUs) YYY,YYY Performance Share Units (PSUs) – Base Amount ZZZ,ZZZ Indices/Comparator Group S&P MidCap 400 Materials Index; S&P SmallCap 600 Materials Index Initial price on the Grant Date CSTM share price: $18.64 (20-day average) Vesting Date March 10, 2025 Vesting Period / Performance Period From the Grant Date through the Vesting Date Please note that, except as otherwise set forth in the 2022 Award Agreement, the vesting of the RSUs and PSUs and the delivery of Shares (or a cash equivalent in respect of such RSUs and PSUs) is subject to the satisfaction of the Continued Service Condition. The vesting of the PSUs is, in addition, subject to the satisfaction of the Performance Condition. The level of achievement of the Performance Condition shall be determined by comparing the Constellium TSR to the average of the TSRs of the two Indices (i.e., the Comparator Group) at the end of the relevant Performance Period as follows: Performance Condition Achievement Level Number of Shares underlying PSUs Constellium TSR is below the average of the two 25th percentile TSRs of the Comparator Group PSU Base Amount x 0% Constellium TSR is at the average of the two 25th percentile TSRs of the Comparator Group PSU Base Amount x 25% Constellium TSR is between the average of the two 25th percentile TSRs & the average of the two median TSRs of the Comparator Group PSU Base Amount x (linear interpolation between 25% and 100%) Constellium TSR is at the average of the two median TSRs of the Comparator Group PSU Base Amount x 100% Constellium TSR is between the average of the two median TSRs & the average of the two 75th percentile TSRs of the Comparator Group PSU Base Amount x (linear interpolation between 100% and 200%) Constellium TSR is at or above the average of the two 75th percentile TSRs of the Comparator Group PSU Base Amount x 200%


 
FORM 2022 LTIP Award Letter Last Name, First Name Notwithstanding the foregoing, if the Constellium TSR is negative, the number of Shares (or a cash equivalent) eligible to be delivered in respect of the PSUs shall be capped at 100% of the Base Amount. By electronic acceptance of this award, you acknowledge that you have received a copy of, or have online access to, the 2022 Award Agreement and the Plan, and hereby accept the Units granted, subject to all the terms and provisions of this Award Letter, the 2022 Award Agreement and the Plan. The Board or the Committee shall determine whether an event has occurred resulting in the forfeiture of your Units and any Shares issuable thereunder and all such determinations shall be final and conclusive. You also acknowledge that this award and similar awards are made on a selective basis and are, therefore, to be kept confidential. Very truly yours Ryan Jurkovic Senior Vice President Chief Human Resources Officer


 

EXECUTION VERSION Constellium: Second Omnibus Amendment 748283241 SECOND OMNIBUS AMENDMENT This SECOND OMNIBUS AMENDMENT, dated as of June 28, 2022 (this “Amendment”) is: (1) THE SECOND AMENDMENT to the RECEIVABLES SALE AGREEMENT, between Constellium Muscle Shoals LLC, as seller (the “RSA Seller”) and Constellium Muscle Shoals Funding III LLC, as purchaser; and (2) THE SECOND AMENDMENT to the RECEIVABLES PURCHASE AGREEMENT, among Constellium Muscle Shoals Funding III LLC, as seller (the “RPA Seller”), the RSA Seller as servicer (the “Servicer”), Deutsche Bank Trust Company Americas, Deutsche Bank AG New York Branch, and each other subsidiary or affiliate of either such party who may from time to time become a party thereto (collectively, “DB”), in such capacity as a purchaser hereunder (each, a “RPA Purchaser”), and Intesa Sanpaolo S.p.A., New York Branch and each subsidiary or affiliate who may from time to time become a party thereto (collectively, “Intesa”), in its capacity as a purchaser thereunder (each, a “Purchaser” and, together with DB, and each of their permitted successors and assigns, collectively, the “Purchasers”), and in its capacity as purchaser representative hereunder (together with its successors and permitted assigns in such capacity, the “Purchaser Representative”). RECITALS WHEREAS, the RSA Seller and the RPA Seller have heretofore entered into the RECEIVABLES SALE AGREEMENT, dated as of September 30, 2021 (as amended, restated, supplemented, assigned or otherwise modified from time to time, the “Receivables Sale Agreement”); WHEREAS, Constellium International SAS (the “Parent”) has heretofore entered into a PERFORMANCE UNDERTAKING, dated as of September 30, 2021, in favor of the RPA Seller with respect to obligations under the Receivables Sale Agreement (the “First Tier Parent Guarantee”); WHEREAS, the RPA Seller, the Servicer, Intesa (in its capacity as Purchaser and Purchaser Representative) and DB (in its capacity as Purchaser) heretofore entered into the RECEIVABLES PURCHASE AGREEMENT, dated as of September 30, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the “Receivables Purchase Agreement”; together with the Receivables Sale Agreement, each an “Agreement” and collectively, the “Agreements”); WHEREAS, the Parent has heretofore entered into a PERFORMANCE UNDERTAKING, dated as of September 30, 2021, in favor of the Purchasers with respect to obligations under the Receivables Purchase Agreement (the “Second Tier Parent Guarantee,” and together with the First Tier Parent Guarantee, the “Guarantees”); WHEREAS, the parties hereto seek to modify each of the Agreements upon the terms hereof.


 
2 Constellium: Second Omnibus Amendment 748283241 NOW, THEREFORE, in exchange for good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged and confirmed), the parties hereto agree as follows: SECTION 1. Definitions. Unless otherwise defined or provided herein, capitalized terms used herein have the meanings attributed thereto in (or by reference in) the Agreements, as applicable. SECTION 2. Amendment to the Receivables Sale Agreement. The Receivables Sale Agreement is hereby amended as follows: (a) SECTION 17 of the Receivables Sale Agreement is hereby amended and restated to read in its entirety as follows: “TERM SOFR CESSATION. If, on any date of determination, the Purchaser reasonably determines in good faith that the Term SOFR Reference Rate (for purposes of calculating the Discount Rate and Purchase Price, and any other calculations between such parties based on the Term SOFR Reference Rate) is not ascertainable and the inability to ascertain the Term SOFR Reference Rate is unlikely to be temporary, each such Person shall notify the Seller and the Purchaser Representative under the Receivables Purchase Agreement (as defined therein) in writing (the occurrence of the foregoing conditions, a “Benchmark Discontinuation Event”) and the Term SOFR Reference Rate shall, for any related period thereafter, be an alternate benchmark floating term rate of interest established by the Purchaser Representative that is generally accepted as the then prevailing market convention for determining a rate of interest for similar transactions or interest or discount rate calculations in the United States at such time and shall include (i) the spread or method for determining a spread or other adjustment or modification that is generally accepted as the then prevailing market convention for determining such spread, method, adjustment or modification and (ii)other adjustments to such alternate rate and this Agreement (A) to not increase or decrease pricing in effect for any related Purchase Price calculation on the Business Day immediately preceding the Business Day on which such alternate rate is selected pursuant to this provision(but for the avoidance of doubt which would not reduce the applicable Discount Rate) and (B) other changes necessary to reflect the available interest periods for such alternate rate for similar transactions of this type in the United States at such time (any such rate, the “Successor Benchmark Rate”), and the Purchaser and the Seller shall, if necessary or reasonably requested by the Purchaser, enter into an amendment to this Agreement to reflect such alternate rate of interest and such other related changes to this Agreement as may be applicable and, notwithstanding anything to the contrary in Section 15 hereof, such amendment shall become effective without any further action or consent of any other party to this Agreement; provided, further that if a Successor Benchmark Rate has not


 
3 Constellium: Second Omnibus Amendment 748283241 been established pursuant to the immediately preceding proviso after the Purchaser has reached such a determination that the Term SOFR Reference Rate is not or no longer ascertainable, the Purchaser Representative may select a different alternate rate as long as it is reasonably practicable for the Purchaser to administer such different rate and, upon not less than 15 Business Days’ prior written notice to the Purchaser, the Seller and the parties to the Receivables Purchase Agreement, shall enter into an amendment to this Agreement, if necessary or reasonably requested by the Purchaser, to reflect such alternate rate of interest and such other related changes to this Agreement as may be applicable and, notwithstanding anything to the contrary in Section 15 hereof, such amendment shall become effective without any further action or consent of any other party to this Agreement. For the avoidance of doubt, if a Benchmark Discontinuation Event occurs, the applicable Discount Rate for any previously purchased Receivables hereunder shall remain the rate used in the calculation of Purchase Price for such Proposed Receivable when originally calculated pursuant to Section 2(d), above. Notwithstanding anything to the contrary contained herein, if at any time there placement index is less than zero, at such times, such index shall be deemed to be zero for purposes of this Agreement.” (b) Schedule 3 of the Receivable Sale Agreement, is hereby amended by amending and restating the grid of Applicable Credit Spreads therein as follows: Account Debtor Applicable Credit Spread Anheuser-Busch, LLC 1.675% Crown Cork and Seal USA, Inc. 2.05% (c) Exhibit A of the Receivables Sale Agreement, is hereby amended by deleting the definition “LIBOR” in its entirety. (d) Exhibit A to the Receivables Sale Agreement, is hereby amended by inserting the following definitions in alphabetical order: “SOFR” means, the secured overnight financing rate administered by the Federal Reserve Bank of New York (or any other person which takes over the administration of that rate) published by the Federal Reserve Bank of New York (or any other person which takes over the publication of that rate). “SOFR Administrator” means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).


 
4 Constellium: Second Omnibus Amendment 748283241 “Term SOFR Reference Rate” means, for any Discount Period or other period: (a) The forward looking term SOFR reference rate based on SOFR as administered by CME Group Benchmark Administration Ltd and/ or CME Group Inc. and published from time to time on its official website (“CME Term SOFR Reference Rate”) or as displayed through an authorized redistributor of such CME Term SOFR Reference Rate, e.g. Refinitiv or Bloomberg as determined by the Buyer from time to time for such Discount Period or other period. If the applicable CME Term SOFR Reference Rate as so determined would be less than zero in any calculation, such rate shall be deemed to be zero for the purposes of this Agreement; or (b) if no CME Term SOFR Reference Rate is available in respect of the applicable Discount Period or other period, the rate per annum as determined by Buyer (which determination shall be conclusive and binding, absent manifest error) to be equal to the rate (“Interpolated Term SOFR Reference Rate”) which results from interpolating on a linear basis between: (i) the sum of Term SOFR Reference Rate for the longest period (for which CME Term SOFR Reference Rate is available) which is less than such applicable Discount Period or other period; (ii) the sum of Term SOFR Reference Rate for the shortest period (for which CME Term SOFR Reference Rate is available) which exceeds such applicable Discount Period or other period. If the applicable Interpolated Term SOFR Reference Rate as so determined would be less than zero in any calculation, such rate shall be deemed to be zero for the purposes of this Agreement. (e) Exhibit A to the Receivables Sale Agreement is hereby amended by amending and restating the definition of “Discount Rate” as follows: “Discount Rate”: On any date of determination, a rate equal to the Term SOFR Reference Rate plus a per annum rate equal to the Applicable Credit Spread at such time. SECTION 3. Amendment to the Receivables Purchase Agreement. The Receivables Purchase Agreement is hereby amended as follows: (a) SECTION 17 of the Receivables Purchase Agreement is hereby amended and restated in its entirety as follows: “TERM SOFR CESSATION. If, on any date of determination, the Purchaser reasonably determines in good faith that the Term SOFR


 
5 Constellium: Second Omnibus Amendment 748283241 Reference Rate (for purposes of calculating the Discount Rate and Purchase Price, and any other calculations between such parties based on the Term SOFR Reference Rate) is not ascertainable and the inability to ascertain the Term SOFR Reference Rate is unlikely to be temporary, each such Person shall notify the Seller and the Purchaser Representative in writing (the occurrence of the foregoing conditions, a “Benchmark Discontinuation Event”) and the Term SOFR Reference Rate shall, for any related period thereafter, be an alternate benchmark floating term rate of interest established by the Purchaser Representative that is generally accepted as the then prevailing market convention for determining a rate of interest for similar transactions or interest or discount rate calculations in the United States at such time and shall include (i) the spread or method for determining a spread or other adjustment or modification that is generally accepted as the then prevailing market convention for determining such spread, method, adjustment or modification and (ii) other adjustments to such alternate rate and this Agreement (A) to not increase or decrease pricing in effect for any related Purchase Price calculation on the Business Day immediately preceding the Business Day on which such alternate rate is selected pursuant to this provision(but for the avoidance of doubt which would not reduce the applicable Discount Rate) and (B) other changes necessary to reflect the available interest periods for such alternate rate for similar transactions of this type in the United States at such time (any such rate, the “Successor Benchmark Rate”), and the Purchasers and the Seller shall, if necessary or reasonably requested by the Purchaser Representative, enter into an amendment to this Agreement to reflect such alternate rate of interest and such other related changes to this Agreement as may be applicable and, notwithstanding anything to the contrary in Section 15 hereof, such amendment shall become effective without any further action or consent of any other party to this Agreement; provided, further that if a Successor Benchmark Rate has not been established pursuant to the immediately preceding proviso after the Purchaser has reached such a determination that the Term SOFR Reference Rate is not or no longer ascertainable, the Purchaser Representative may select a different alternate rate as long as it is reasonably practicable for the Purchasers to administer such different rate and, upon not less than 15 Business Days’ prior written notice to the Purchasers, the Seller and the parties to the Receivables Purchase Agreement, shall enter into an amendment to this Agreement, if necessary or reasonably requested by the Purchaser Representative, to reflect such alternate rate of interest and such other related changes to this Agreement as may be applicable and, notwithstanding anything to the contrary in Section 15 hereof, such amendment shall become effective without any further action or consent of any other party to this Agreement. For the avoidance of doubt, if a Benchmark Discontinuation Event occurs, the applicable Discount Rate for any previously purchased Receivables hereunder shall remain the rate used in the calculation of Purchase Price for such Proposed Receivable when originally calculated pursuant to Section 2(d), above. Notwithstanding


 
6 Constellium: Second Omnibus Amendment 748283241 anything to the contrary contained herein, if at any time there placement index is less than zero, at such times, such index shall be deemed to be zero for purposes of this Agreement.” (b) Schedule 3 of the Receivable Sale Agreement, is hereby amended by amending and restating the grid of Applicable Credit Spreads therein as follows: Account Debtor Applicable Credit Spread Anheuser-Busch, LLC 1.675% Crown Cork and Seal USA, Inc. 2.05% (c) Exhibit A of the Receivables Purchase Agreement, is hereby amended by deleting the definition “LIBOR” in its entirety. (d) Exhibit A to the Receivables Purchase Agreement, is hereby amended by inserting the following definitions in alphabetical order: “SOFR” means, the secured overnight financing rate administered by the Federal Reserve Bank of New York (or any other person which takes over the administration of that rate) published by the Federal Reserve Bank of New York (or any other person which takes over the publication of that rate). “SOFR Administrator” means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate). “Term SOFR Reference Rate” means, for any Discount Period or other period: (a) The forward looking term SOFR reference rate based on SOFR as administered by CME Group Benchmark Administration Ltd and/ or CME Group Inc. and published from time to time on its official website (“CME Term SOFR Reference Rate”) or as displayed through an authorized redistributor of such CME Term SOFR Reference Rate, e.g. Refinitiv or Bloomberg as determined by the Buyer from time to time for such Discount Period or other period. If the applicable CME Term SOFR Reference Rate as so determined would be less than zero in any calculation, such rate shall be deemed to be zero for the purposes of this Agreement; or (b) if no CME Term SOFR Reference Rate is available in respect of the applicable Discount Period or other period, the rate per annum as determined by Buyer (which determination shall be conclusive and binding, absent manifest error) to be equal to the rate (“Interpolated Term SOFR Reference Rate”) which results


 
7 Constellium: Second Omnibus Amendment 748283241 from interpolating on a linear basis between: (i) the sum of Term SOFR Reference Rate for the longest period (for which CME Term SOFR Reference Rate is available) which is less than such applicable Discount Period or other period; (ii) the sum of Term SOFR Reference Rate for the shortest period (for which CME Term SOFR Reference Rate is available) which exceeds such applicable Discount Period or other period. If the applicable Interpolated Term SOFR Reference Rate as so determined would be less than zero in any calculation, such rate shall be deemed to be zero for the purposes of this Agreement. (e) Exhibit A to the Receivables Purchase Agreement is hereby amended by amending and restating the definition of “Discount Rate” as follows: “Discount Rate”: On any date of determination, a rate equal to the Term SOFR Reference Rate plus a per annum rate equal to the Applicable Credit Spread at such time. (f) Each Purchaser’s Commitment limits and Commitment sub-limit by Account Debtor in the Receivables Purchase Agreement are hereby amended and restated as set forth on the signature pages to this Second Omnibus Amendment. SECTION 4. Consent. The Parent hereby (a) consents to the RSA Seller and the RPA Seller entering into this Amendment, (b) confirms and restates its obligations under the First Tier Parent Guarantee and the Second Tier Parent Guarantee with respect to (i) the effectiveness of the Receivables Sale Agreement and the Receivables Purchase Agreement, respectively, each of which may be amended from time to time. The Parent further confirms and agrees that the First Tier Parent Guarantee and the Second Tier Parent Guarantee have not been annulled, revoked, rescinded or terminated prior to the date hereof. SECTION 5. Condition to Effectiveness. This Amendment shall become effective on the later of the date hereof or the date on which all of the following conditions have been satisfied (the “Effective Date”): (a) each of the parties hereto shall have received counterparts of this Amendment executed by each of the other parties hereto (including facsimile or e-mail signature pages); and (b) the representations and warranties contained in each of the Agreements and in this Amendment shall be true and correct both as of the date hereof and immediately after giving effect to this Amendment.


 
8 Constellium: Second Omnibus Amendment 748283241 SECTION 6. Representations and Warranties. Each of the RSA Seller, RPA Seller and the Parent, on and as of the date hereof, make the following representations and warranties: (a) Authority. Each such party has the requisite corporate power and authority to execute and deliver this Amendment and to perform its obligations hereunder and under the Agreements (as amended hereby) and the Guarantees, as the case may be. The execution, delivery and performance by such party of this Amendment and the performance of the Agreements (as amended hereby) and the Guarantees, as the case may be, have been duly approved by all necessary corporate action, and no other corporate proceedings are necessary to consummate such transactions; (b) Enforceability. This Amendment has been duly executed and delivered by it. Each of the Agreements (as amended hereby) and the Guarantees, as the case may be, is a legal, valid and binding obligation enforceable against such party in accordance with its terms, subject to applicable bankruptcy, insolvency, moratorium or other similar laws affecting the rights of creditors and to general principles of equity, and is in full force and effect; (c) Representations, Warranties and Covenants. Each such party’s representations, warranties and covenants contained in the Agreements and the Guarantees, as the case may be (other than any such representations or warranties that, by their terms, are specifically made as of a date other than the date hereof), are correct on and as of the date hereof as though made on and as of the date hereof; and (d) No Termination Event. No Termination Event has occurred and is continuing. SECTION 7. Effect of Amendment; Ratification. (a) Upon the effectiveness of this Amendment, (i) all references in the Receivables Sale Agreement or in any other Transaction Document to “the Receivables Sale Agreement,” “this Agreement,” “hereof,” “herein” or words of similar effect, in each case referring to the Receivables Sale Agreement, shall be deemed to be references to the Receivables Sale Agreement as amended by this Amendment and (ii) all references in the Receivables Purchase Agreement or in any other Transaction Document to “the Receivables Purchase Agreement,” “this Agreement,” “hereof,” “herein” or words of similar effect, in each case referring to the Receivables Purchase Agreement, shall be deemed to be references to the Receivables Purchase Agreement as amended by this Amendment. (b) Except as specifically amended hereby, the Agreements and all other Transaction Documents, instruments and agreements executed and/or delivered in connection therewith shall remain in full force and effect and are hereby ratified and confirmed in all respects.


 
9 Constellium: Second Omnibus Amendment 748283241 (c) The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Purchaser or any of its assignees under the Agreements or any other Transaction Document, instrument, or agreement executed in connection therewith, nor constitute a waiver of any provision contained therein. (d) All reasonable costs and expenses of the Purchaser Representative related to the preparation, negotiation and delivery of this Amendment shall be for the account of and promptly paid by the RSA Seller. SECTION 8. Counterparts. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. SECTION 9. Governing Law. This Amendment shall be governed by the laws of the State of New York, without giving effect to conflict of laws principles that would require the application of the law of any other jurisdiction. SECTION 10. Transaction Document. This Amendment shall be a Transaction Document under each of the Agreements. SECTION 11. Section Headings. The various headings of the Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the Agreements or any provision hereof or thereof. SECTION 12. Severability. If any one or more of the agreements, provisions or terms of this Amendment shall for any reason whatsoever be held invalid or unenforceable, then such agreements, provisions or terms shall be deemed severable from the remaining agreements, provisions and terms of this Amendment and shall in no way affect the validity or enforceability of the provisions of this Amendment. [Signatures follow]


 


 
S-2 Constellium: Second Omnibus Amendment 748283241 INTESA SANPAOLO S.P.A., NEW YORK BRANCH, as a Purchaser and as Purchaser Representative By:______________________________________ Name:____________________________________ Title:_____________________________________ By:______________________________________ Name:____________________________________ Title:_____________________________________ Intesa’s Aggregate Commitment: $120,000,000.00 Intesa’s Sublimit Commitment for Crown Cork and Seal USA, Inc.: $85,000,000.00 Intesa’s Sublimit Commitment for Anheuser-Busch LLC: $35,000,000.00 Marco Fracchia Head of FI - SEF & TEF Vamsi Potukuchi Business Director


 
S-3 Constellium: Second Omnibus Amendment 748283241 DEUTSCHE BANK TRUST COMPANY AMERICAS, as a Purchaser By:______________________________________ Name:____________________________________ Title:_____________________________________ By:______________________________________ Name:____________________________________ Title:_____________________________________ DEUTSCHE BANK AG NEW YORK BRANCH, as a Purchaser By:______________________________________ Name:____________________________________ Title:_____________________________________ By:______________________________________ Name:____________________________________ Title:_____________________________________ DB’s Aggregate Commitment: $80,000,000.00 DB’s Sublimit Commitment for Crown Cork and Seal USA, Inc.: $70,000,000.00 DB’s Sublimit Commitment for Anheuser-Busch LLC: $10,000,000.00 DocuSign Envelope ID: 8740204E-36B1-4467-89DD-57613C42E775 Abdellah Agouzoul Abdellah Agouzoul Vice President Vice President Michael Arrizurieta Assistant Vice President Gaurav Mathur Director


 


 

Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jean-Marc Germain, certify that: 1. I have reviewed this annual report on Form 20-F of Constellium SE (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4. The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; 5. The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. Date: March 14, 2023 By: /s/ Jean-Marc Germain Name: Jean-Marc Germain Title: Chief Executive Officer      


 

Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Peter R. Matt, certify that: 1. I have reviewed this annual report on Form 20-F of Constellium SE (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4. The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; 5. The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. Date: March 14, 2023 By: /s/ Peter R. Matt Name: Peter R. Matt Title: Executive Vice President and Chief Financial Officer      


 

Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Constellium SE (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jean-Marc Germain, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 14, 2023 By: /s/ Jean-Marc Germain Name: Jean-Marc Germain Title: Chief Executive Officer      


 

Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Constellium SE (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter R. Matt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 14, 2023 By: /s/ Peter R. Matt Name: Peter R. Matt Title: Executive Vice President and Chief Financial Officer    


 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333- 256148, 333-191905, 333-201141, 333-225926) and Form F-3 (No. 333-250089) of Constellium SE of our report dated March 14, 2023 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. /s/ PricewaterhouseCoopers Audit Neuilly-sur-Seine, France March 14, 2023


 

Exhibit 21.1 Subsidiaries of Constellium SE as of December 31, 2022 Subsidiary Jurisdiction Alcan International Network México S.A. de C.V. Mexico AluInfra Services SA Switzerland Astrex Inc. Canada Constellium Automotive México, S. DE R.L. DE C.V Mexico Constellium Automotive México Trading, S. DE R.L. DE C.V. Mexico Constellium Automotive (Nanjing) Co., Ltd. China Constellium Automotive Spain, S.L. Spain Constellium Automotive USA, LLC Delaware Constellium Automotive Žilina, s.r.o. Slovak Republic Constellium Bowling Green LLC Delaware Constellium China China Constellium Deutschland GmbH Germany Constellium Engley (Changchun) Automotive Structures Co Ltd. China Constellium Extrusions Burg GmbH Germany Constellium Extrusions Decin s.r.o. Czech Republic Constellium Extrusions Deutschland GmbH Germany Constellium Extrusions France France Constellium Extrusions Landau GmbH Germany Constellium Extrusions Levice S.r.o. Slovak Republic Constellium Finance France Constellium France III France Constellium France Holdco France Constellium Germany Holdco GmbH & Co. KG Germany Constellium Germany Verwaltungs GmbH Germany Constellium Holdings Muscle Shoals LLC Delaware Constellium International France Constellium Issoire France Constellium Japan KK Japan Constellium Metal Procurement LLC Constellium Montreuil Juigné Delaware France Constellium Muscle Shoals LLC Delaware Constellium Muscle Shoals Funding II LLC Delaware Constellium Muscle Shoals Funding III LLC Constellium Neuf Brisach France Constellium Paris France Constellium Rolled Products Ravenswood, LLC Delaware Constellium Rolled Products Singen GmbH & Co. KG Germany Constellium Singen GmbH Germany Constellium Switzerland AG Switzerland Constellium Treuhand UG (haftunsgbeschränkt) Germany Constellium UK Limited United Kingdom Constellium US Holdings I, LLC Delaware Constellium US Intermediate Holdings LLC Delaware Constellium Ussel France Constellium Valais SA Switzerland C-TEC Constellium Technology Center France Engineered Products International SAS France


 

v3.22.4
COVER
12 Months Ended
Dec. 31, 2022
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Period End Date Dec. 31, 2022
Current Fiscal Year End Date --12-31
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-35931
Entity Registrant Name Constellium SE
Entity Incorporation, State or Country Code I0
Entity Address, Address Line One Washington Plaza,
Entity Address, Address Line Two 40-44 rue Washington
Entity Address, Postal Zip Code 75008
Entity Address, City or Town Paris
Entity Address, Country FR
Title of 12(b) Security Ordinary Shares
Trading Symbol CSTM
Security Exchange Name NYSE
Entity Common Stock, Shares Outstanding 144,301,592
Entity Well-known Seasoned Issuer Yes
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
ICFR Auditor Attestation Flag true
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Amendment Flag false
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Entity Central Index Key 0001563411
Other Address  
Document Information [Line Items]  
Entity Address, Address Line One 300 East Lombard Street
Entity Address, Address Line Two Suite 1710
Entity Address, Postal Zip Code 21202
Entity Address, City or Town Baltimore
Entity Address, State or Province MD
Entity Address, Country US
Chief Securities Counsel  
Document Information [Line Items]  
Entity Address, Address Line One 300 East Lombard Street
Entity Address, Address Line Two Suite 1710
Entity Address, Postal Zip Code 21202
Entity Address, City or Town Baltimore
Entity Address, State or Province MD
Entity Address, Country US
Local Phone Number 420-7861
City Area Code 443
Contact Personnel Name Rina E. Teran
Contact Personnel Email Address E-mail: rina.teran@constellium.com

v3.22.4
Audit Information
12 Months Ended
Dec. 31, 2022
Audit Information [Abstract]  
PCAOB ID 1347
Auditor Name PricewaterhouseCoopers Audit
Auditor Location Neuilly-sur-Seine, France

v3.22.4
CONSOLIDATED INCOME STATEMENT - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Profit or loss [abstract]      
Revenue € 8,120 € 6,152 € 4,883
Cost of sales (7,448) (5,488) (4,393)
Gross profit 672 664 490
Selling and administrative expenses (282) (258) (237)
Research and development expenses (48) (39) (39)
Other gains and losses - net (8) 117 (89)
Income from operations 334 484 125
Finance costs - net (131) (167) (159)
Income / (loss) before tax 203 317 (34)
Income tax benefit / (expense) 105 (55) 17
Net income / (loss) 308 262 (17)
Net income / (loss) attributable to:      
Equity holders of Constellium 301 257 (21)
Non-controlling interests 7 5 4
Net income / (loss) € 308 € 262 € (17)
Earnings per share attributable to the equity holders of Constellium (in Euros)      
Basic (in EUR per share) € 2.10 € 1.82 € (0.15)
Diluted (in EUR per share) € 2.06 € 1.75 € (0.15)
Weighted average number of shares      
Basic (in shares) 143,625,764 140,995,106 138,739,635
Diluted (in shares) 146,605,716 147,169,971 138,739,635

v3.22.4
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of comprehensive income [abstract]      
Net income / (loss) € 308 € 262 € (17)
Items that will not be reclassified subsequently to the consolidated income statement      
Remeasurement on post-employment benefit obligations 157 114 (20)
Income tax on remeasurement on post-employment benefit obligations (35) (16) 5
Items that may be reclassified subsequently to the consolidated income statement      
Cash flow hedges (8) (17) 26
Income tax on cash flow hedges 2 4 (7)
Currency translation differences 21 34 (18)
Other comprehensive income / (loss) 137 119 (14)
Total comprehensive income / (loss) 445 381 (31)
Attributable to:      
Equity holders of Constellium 439 374 (34)
Non-controlling interests 6 7 3
Total comprehensive income / (loss) € 445 € 381 € (31)

v3.22.4
CONSOLIDATED STATEMENT OF FINANCIAL POSITION - EUR (€)
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents € 166,000,000 € 147,000,000
Trade receivables and other 539,000,000 683,000,000
Inventories 1,320,000,000 1,050,000,000
Other financial assets 31,000,000 58,000,000
Total current assets 2,056,000,000 1,938,000,000
Non-current assets    
Property, plant and equipment 2,017,000,000 1,948,000,000
Goodwill 478,000,000 451,000,000
Intangible assets 54,000,000 58,000,000
Deferred tax assets 271,000,000 162,000,000
Trade receivables and other 43,000,000 55,000,000
Other financial assets 8,000,000 12,000,000
Total non-current assets 2,871,000,000 2,686,000,000
Assets of disposal group classified as held for sale 14,000,000 0
Total Assets 4,941,000,000 4,624,000,000
Current liabilities    
Trade payables and other 1,467,000,000 1,377,000,000
Borrowings 148,000,000 258,000,000
Other financial liabilities 41,000,000 25,000,000
Income tax payable 16,000,000 34,000,000
Provisions 21,000,000 20,000,000
Total current liabilities 1,693,000,000 1,714,000,000
Non-current liabilities    
Trade payables and other 43,000,000 32,000,000
Borrowings 1,908,000,000 1,871,000,000
Other financial liabilities 14,000,000 6,000,000
Pension and other post-employment benefit obligations 403,000,000 599,000,000
Provisions 90,000,000 97,000,000
Deferred tax liabilities 28,000,000 14,000,000
Total non-current liabilities 2,486,000,000 2,619,000,000
Liabilities of disposal group classified as held for sale 10,000,000 0
Total Liabilities 4,189,000,000 4,333,000,000
Equity    
Share capital 2,886,031.84 3,000,000
Share premium 420,000,000 420,000,000
Retained earnings / (deficit) and other reserves 308,000,000 (149,000,000)
Equity attributable to equity holders of Constellium 731,000,000 274,000,000
Non-controlling interests 21,000,000 17,000,000
Total Equity 752,000,000 291,000,000
Total Equity and Liabilities € 4,941,000,000 € 4,624,000,000

v3.22.4
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - EUR (€)
€ in Millions
Total
Share capital
Share premium
Re- measurement
Cash flow hedges
Foreign currency translation reserve
Other reserves
Retained (deficit) / earnings
Total
Non-controlling interests
Beginning balance at Dec. 31, 2019 € (85) € 3 € 420 € (177) € (10) € 4 € 53 € (389) € (96) € 11
Net income / (loss) (17)             (21) (21) 4
Other comprehensive income / (loss) (14)     (15) 19 (17)     (13) (1)
Total comprehensive income / (loss) (31)     (15) 19 (17)   (21) (34) 3
Share-based compensation 15           15   15  
Transactions with non-controlling interests 0                 0
Ending balance at Dec. 31, 2020 (101) 3 420 (192) 9 (13) 68 (410) (115) 14
Net income / (loss) 262             257 257 5
Other comprehensive income / (loss) 119     98 (13) 32     117 2
Total comprehensive income / (loss) 381     98 (13) 32   257 374 7
Share-based compensation 15           15   15  
Transactions with non-controlling interests (4)                 (4)
Ending balance at Dec. 31, 2021 291 3 420 (94) (4) 19 83 (153) 274 17
Net income / (loss) 308             301 301 7
Other comprehensive income / (loss) 137     122 (6) 22     138 (1)
Total comprehensive income / (loss) 445     122 (6) 22   301 439 6
Share-based compensation 18           18   18  
Transactions with non-controlling interests (2)                 (2)
Ending balance at Dec. 31, 2022 € 752 € 3 € 420 € 28 € (10) € 41 € 101 € 148 € 731 € 21

v3.22.4
CONSOLIDATED STATEMENT OF CASH FLOWS - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of cash flows [abstract]      
Net income / (loss) € 308 € 262 € (17)
Adjustments      
Depreciation and amortization 287 267 259
Impairment of assets 0 0 43
Pension and other post-employment benefits service costs (22) 64 34
Finance costs - net 131 167 159
Income tax (benefit) / expense (105) 55 (17)
Unrealized losses / (gains) on derivatives - net and from remeasurement of monetary assets and liabilities - net 47 (36) (18)
Losses on disposal 4 3 4
Other - net 17 11 19
Change in working capital      
Inventories (241) (435) 63
Trade receivables 155 (227) 36
Trade payables 41 396 (38)
Other 13 5 (10)
Change in provisions (10) (7) 1
Pension and other post-employment benefits paid (44) (43) (53)
Interest paid (113) (128) (140)
Income tax (paid) / refunded (17) 3 9
Net cash flows from operating activities 451 357 334
Purchases of property, plant and equipment (273) (232) (182)
Property, plant and equipment grants received 4 10 5
Proceeds from disposals, net of cash 0 1 1
Other investing activities (1) 0 0
Net cash flows used in investing activities (270) (221) (176)
Proceeds from issuance of long-term borrowings 0 712 472
Repayments of long-term borrowings (192) (1,052) (209)
Net change in revolving credit facilities and short-term borrowings 72 (5) (110)
Lease repayments (37) (32) (35)
Payment of financing costs and redemption fees (1) (30) (9)
Transactions with non-controlling interests (2) (2) 0
Other financing activities (3) (26) (8)
Net cash flows (used in) / from financing activities (163) (435) 101
Net increase / (decrease) in cash and cash equivalents 18 (299) 259
Cash and cash equivalents - beginning of period 147 439 184
Reclassification as assets of disposal group classified as held for sale (1) 0 0
Effect of exchange rate changes on cash and cash equivalents 2 7 (4)
Cash and cash equivalents - end of year € 166 € 147 € 439

v3.22.4
GENERAL INFORMATION
12 Months Ended
Dec. 31, 2022
Disclosure of general information [abstract]  
GENERAL INFORMATION
NOTE 1 - GENERAL INFORMATION
Constellium is a global leader in the design and manufacture of a broad range of innovative specialty rolled and extruded aluminium products, serving primarily the packaging, aerospace and automotive end-markets. The Group has a strategic footprint of 29 manufacturing facilities located in North America, Europe and China, 3 R&D centers and 3 administrative centers. The Group has approximately 12,500 employees.
Constellium SE, a French Societas Europaea (SE), is the parent company of the Group. The business address (head office) of Constellium SE is located at Washington Plaza, 40-44 rue Washington, 75008 Paris, France.
Unless the context indicates otherwise, when we refer to “we”, “our”, “us”, “Constellium”, the “Group” and the “Company” in this document, we are referring to Constellium SE and its subsidiaries.

v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2022
Disclosure of summary of significant accounting policies [abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.1 Statement of compliance
The Consolidated Financial Statements of Constellium SE and its subsidiaries have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and as endorsed by the European Union (EU). The Group’s application of IFRS results in no difference between IFRS as issued by the IASB and IFRS as endorsed by the EU (https://ec.europa.eu/info/law/international-accounting-standards-regulation-ec-no-1606-2002_en).
The Consolidated Financial Statements were authorized for issue on March 9, 2023 by the Board of Directors.
2.2 New and amended standards and interpretations
Several amendments to IFRS standards and interpretations applied for the first time in 2022, but had no impact on the Consolidated Financial Statements of the Group.
Amendments to IAS 16: Property, Plant and Equipment: Proceeds before Intended Use
Amendments to IFRS 3: Reference to the Conceptual Framework
Amendments to IAS 37: Onerous Contracts – Costs of Fulfilling a Contract
Annual Improvements to IFRS Standards 2018-2020
IFRS 9 Financial Instruments: Fees in the ‘10 per cent’ test for derecognition of financial liabilities
2.3 New standards and interpretations not yet mandatorily applicable
The Group has not early adopted the following new standards, amendments and interpretations which have been issued, but are not yet effective. The Group plans to adopt these new standards, amendments and interpretations on their required effective dates and does not expect any material impact as a result of their adoption.
Amendments to IAS 1: Classification of Liabilities as Current or Non-current
Amendment to IAS 1 and IFRS Practice Statement 2: Disclosure of Accounting Policies
Amendment to IAS 8: Definition of Accounting Estimates
Amendment to IAS 12: Deferred Tax related to Assets and Liabilities arising from a Single Transaction
2.4 Basis of preparation
In accordance with IAS 1- Presentation of Financial Statements, the Consolidated Financial Statements are prepared on the assumption that Constellium is a going concern and will continue in operation for the foreseeable future.
The Group’s financial position, its cash flows, liquidity position and borrowing facilities are described in the Consolidated Financial Statements in NOTE 12 - Cash and Cash Equivalents, NOTE 20 - Borrowings and NOTE 22 - Financial Risk Management.
The Group’s forecasts and projections, taking account of reasonably possible changes in operating performance, including an assessment of the current macroeconomic environment, indicate that the Group should be able to operate within the level of its current facilities and related covenants.
Accordingly, the Group continues to adopt the going concern basis in preparing the Consolidated Financial Statements. This assessment was confirmed by the Board of Directors on March 9, 2023.
2.5 Presentation of the operating performance of each operating segment and of the Group
In accordance with IFRS 8 - Operating Segments, operating segments are based upon the product lines, markets and industries served, and are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The Chief Executive Officer, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the chief operating decision-maker.
The accounting principles used to prepare the Group’s operating segment information are the same as those used to prepare the Group’s Consolidated Financial Statements.
2.6 Principles governing the preparation of the Consolidated Financial Statements
Presentation of financial statements
The Consolidated Financial Statements are presented in millions of Euros, except as otherwise stated. Certain reclassifications may have been made to prior year amounts to conform to the current year presentation.
Basis of consolidation
These Consolidated Financial Statements include all the assets, liabilities, equity, revenues, expenses and cash flows of the Group's subsidiaries. All intercompany transactions and balances are eliminated.
Subsidiaries are entities over which the Group has control. The Group controls an entity when the Group has power over the entity, is exposed to, or has rights to variable returns from its involvement in the entity and has the ability to affect those returns through its power over the entity.
Subsidiaries are consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.
Investments over which the Group has joint control are accounted for either as joint ventures under the equity method or as joint arrangements in relation to its interest in the joint operation. Investments over which the Group has significant influence are accounted for under the equity method.
Joint venture investments are initially recorded at cost. They are subsequently increased or decreased by the Group’s share in the profit or loss, or by other movements reflected directly in the equity of the entity.
Business combinations
The Group applies the acquisition method to account for business combinations.
The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities assumed and the equity interests issued by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. The amount of non-controlling interests is determined for each business combination and is either based on the fair value (full goodwill method) or the present ownership instruments’ proportionate share in the recognized amounts of the acquiree’s identifiable net assets, resulting in recognition of only the share of goodwill attributable to equity holders of the parent (partial goodwill method).
Goodwill is initially measured as the excess of the aggregate of the consideration transferred and the amount of non-controlling interest over the net identifiable assets acquired and liabilities assumed. If this consideration is lower than the fair
value of the net assets of the subsidiary acquired, the difference is recognized as a gain in Other gains and losses - net in the Consolidated Income Statement.
At the acquisition date, the Group recognizes the identifiable acquired assets, liabilities and contingent liabilities (identifiable net assets) of the subsidiaries on the basis of fair value at the acquisition date. Recognized assets and liabilities may be adjusted during a maximum of 12 months from the acquisition date, depending on new information obtained about the facts and circumstances existing at the acquisition date.
Acquisition-related costs are expensed as incurred and are included in Other gains and losses - net in the Consolidated Income Statement.
Non-current Assets (and disposal groups) Held for Sale and Discontinued Operations
IFRS 5 “Non-current Assets Held For Sale and Discontinued Operations” defines a discontinued operation as a component of an entity that (i) generates cash flows that are largely independent from cash flows generated by other components, (ii) is held for sale or has been sold, and (iii) represents a separate major line of business or geographic areas of operations.
Assets and liabilities are classified as held for sale when their carrying amount will be recovered principally through a sale transaction rather than through continuing use. This condition is regarded as met only when the sale is highly probable and the non-current asset (or disposal group) is available for immediate sale in its present condition.
Assets and liabilities are stated at the lower of carrying amount and fair value less costs to sell if their carrying amount is to be recovered principally through a sale transaction rather than through continuing use.
Assets and liabilities held for sale are reflected in separate line items in the Consolidated Statement of Financial Position of the period during which the decision to sell is made.
The results of discontinued operations are shown separately in the Consolidated Income Statement.
Foreign currency transactions and foreign operations
Functional currency
Items included in the Consolidated Financial Statements of each of the entities and businesses of Constellium are measured using their functional currency, which is the currency of the primary economic environment in which they operate.
Foreign currency transactions
Transactions denominated in currencies other than the functional currency are recorded in the functional currency at the exchange rate in effect at the date of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the Consolidated Income Statement, except when deferred in Other Comprehensive Income ("OCI") as qualifying cash flow hedges or qualifying net investment hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in Finance costs - net. Realized foreign exchange gains and losses that relate to commercial transactions are presented in Cost of sales. All other foreign exchange gains and losses, including those that relate to foreign currency derivatives hedging commercial transactions where hedge accounting has not been applied, are presented within Other gains and losses - net.
Foreign operations: presentation currency and foreign currency translation
In the preparation of the Consolidated Financial Statements, the year-end balances of assets, liabilities and components of equity of Constellium’s entities and businesses are translated from their functional currencies into Euros, the presentation currency of the Group, at their respective year-end exchange rates. Revenue, expenses and cash flows of Constellium’s entities and businesses are translated from their functional currencies into Euros using their respective average exchange rates for the year. The net differences arising from exchange rate translation are recognized in OCI.
The following table summarizes the main exchange rates used for the preparation of the Consolidated Financial Statements:
Average ratesClosing rates
Foreign exchange rate for 1 EuroYear ended December 31,At December 31,
202220212020202220212020
U.S. DollarsUSD1.05071.18211.14051.06661.13261.2271
Swiss FrancsCHF1.00381.08081.07040.98471.03311.0802
Czech KorunaCZK24.563325.636626.433724.116024.858026.2420
Revenue from contracts with customers
Revenue is recognized in an amount that reflects the consideration to which the Group expects to be entitled in exchange for transferring goods or services to a customer.
The Group primarily contracts with customers for the sale of rolled or extruded aluminium products. For the majority of our business, performance obligations with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near-term. These purchase orders are short-term in nature, although they may be governed by multi-year frame agreements.
Revenue from product sales, measured at the fair value of the consideration received or receivable, is recognized at a point in time when control of the asset is transferred to the customer, generally upon delivery. In certain limited circumstances, the Group may be required to recognize revenue over time for products that have no alternative use and for which the Group has an enforceable right to payment for production completed to date.
Revenue from product sales, net of trade discounts, allowances and volume-based incentives, is recognized for the amount the Group expects to be entitled to, generally upon delivery, and provided that control has transferred.
Contract liabilities consist of expected volume discounts, rebates, incentives, refunds, penalties and price concessions. Contract liabilities are presented in Trade payables and other.
The Group applies the practical expedient for disclosures on performance obligations that are part of contracts that have an original duration of one year or less.
The Group elected the practical expedient on significant financing components when the period of transfer of the product and the payment is one year or less.
Research and development costs
Costs incurred on development projects are recognized as intangible assets when the following criteria are met:
It is technically feasible to complete the intangible asset so that it will be available for use;
Management intends to complete and use the intangible asset;
There is an ability to use the intangible asset;
It can be demonstrated how the intangible asset will generate probable future economic benefits;
Adequate technical, financial and other resources to complete the development and use or sell the intangible asset are available; and
The expenditure attributable to the intangible asset during its development can be reliably measured.
Development expenditures that do not meet these criteria are expensed as incurred. Development costs previously recognized as expenses cannot be recognized as an asset in a subsequent period.
Other gains and losses - net
Other gains and losses - net includes: (i) realized and unrealized gains and losses for commodity derivatives and foreign exchange derivatives contracted for commercial purposes to which hedge accounting is not applied (ii) unrealized exchange gains and losses from the remeasurement of monetary assets and liabilities, (iii) the ineffective portion of changes in the fair value of derivatives designated for hedge accounting and (iv) impairment charges on assets.
Other gains and losses - net also includes other unusual, infrequent or non-recurring items. Such items are disclosed by virtue of their size, nature or incidence. In determining whether an event or transaction is unusual, infrequent or non-recurring, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence.
Interest income and expense
Interest expense on short and long-term financing is recorded at the relevant rates on the various borrowing agreements using the effective interest rate method.
Borrowing costs, including interest, incurred for the construction of any qualifying asset are capitalized during the period of time required to complete and prepare the asset for its intended use.
Cash and cash equivalents
Cash and cash equivalents are comprised of cash in bank accounts and on hand, short-term deposits held on call with banks and other short-term highly liquid investments with original maturities of three months or less that are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value, less bank overdrafts that are repayable on demand, provided there is an offset right.
Trade account receivables
Recognition and measurement
Trade account receivables are recognized at fair value through OCI since they are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to factors. The group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables and contract assets.
Factoring arrangements
In factoring arrangements under which the Group has transferred substantially all the risks and rewards of ownership of the receivables, the receivables are derecognized from the Consolidated Statement of Financial Position. In determining whether the Group has transferred substantially all the risks and rewards of ownership, it considers credit risk, late-payment risk, dilution risk, foreign exchange risk and tax risk. Arrangements in which the Group derecognizes receivables result in changes in trade receivables, which are reflected as cash flows from operating activities. When trade account receivables are sold with limited recourse and substantially all the risks and rewards associated with these receivables are not transferred, receivables are not derecognized. Where the Group does not derecognize the receivables, the cash received from the factor is classified as a financing cash inflow, the settlement of the receivables as an operating cash inflow and the repayment to the factor as a financing cash outflow.
Inventories
Inventories are valued at the lower of cost and net realizable value, primarily on a weighted-average cost basis.
Weighted-average cost for raw materials, stores, work in progress and finished goods is calculated using the costs experienced in the current period based on normal operating capacity and includes the purchase price of materials, freight, duties and customs, and the costs of production, which includes labor, materials and other costs that are directly attributable to the production process and production overheads.
Financial Instruments
i.Classification and measurement
Financial assets
At initial recognition, financial assets are classified either: (a) at amortized cost, (b) at fair value through other comprehensive income (FVOCI), or (c) at fair value through profit or loss (FVPL). The classification depends on the financial asset’s contractual cash flow characteristics and the Group’s business model for managing the financial assets.
i.Assets at amortized cost are comprised of other receivables, non-current loans receivable and current loans receivable in the Consolidated Statement of Financial Position. The business model objective is to hold assets in order to collect contractual cash flows provided they give rise to cash flows that are ‘solely payments of principal and interest’ on the principal amount outstanding. They are carried at amortized cost using the effective interest rate method, less any impairment. They are classified as current or non-current assets based on their maturity date.
ii.Assets at fair value through OCI are comprised of trade receivables in the Consolidated Statement of Financial Position. The business model objective is to maintain liquidity for the Group, should the need arise, which leads to sales through factoring agreements that are more than infrequent and significant in value. Trade receivables are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to the factors. The portfolio of trade receivables is therefore classified as measured at fair value through OCI. Upon derecognition, the cumulative fair value change recognized in OCI is reclassified to profit or loss. Foreign exchange revaluation and impairment losses or reversals are recognized in profit or loss and computed in the same manner as for financial assets measured at amortized cost. The remaining fair value changes are recognized in OCI. These assets are classified as current or non-current assets based on their maturity date.
iii.Assets at fair value through profit or loss are comprised of derivatives except those designated as hedging instruments that qualify for hedge accounting in accordance with IAS 39 - Financial Instruments which are classified as assets at fair value through OCI. Financial assets carried at fair value through profit or loss are initially recognized at fair value and transaction costs are expensed in the Consolidated Income Statement.
Financial liabilities
Borrowings and other financial liabilities, excluding derivative liabilities, are recognized initially at fair value, net of transaction costs incurred and directly attributable to the issuance of the liability. These financial liabilities are subsequently measured at amortized cost using the effective interest rate method. Any difference between the amounts originally received, net of transaction costs, and the redemption value is recognized in the Consolidated Income Statement using the effective interest rate method.
ii.Impairment of financial assets
Financial assets subject to IFRS 9’s expected credit loss model are cash and cash equivalents, trade receivables and other and loans to joint ventures.
iii.Offsetting financial instruments
Financial assets and liabilities are offset and the net amount is reported in the Consolidated Statement of Financial Position when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously.
Derivative financial instruments
Derivatives
The Group uses derivative financial instruments, such as forward currency contracts, interest rate swaps and forward commodity contracts, to hedge its foreign currency risks, interest rate risks and commodity price risks, respectively.
Derivatives are carried as financial assets when the fair value is positive and as financial liabilities when the fair value is negative.
Fair value is the price expected to be received in selling an asset or paid in transferring a liability in an orderly transaction between market participants at the measurement date. Where available, relevant market prices are used to determine fair values. The Group periodically estimates the impact of credit risk on its derivative instruments aggregated by counterparties and takes this into account when estimating the fair value of its derivatives.
Credit Value Adjustments are calculated for asset derivatives based on the counterparties’ credit risk. Debit Value Adjustments are calculated for credit derivatives based on Constellium’s own credit risk. The fair value method used is based on the historical probability of default, provided by leading rating agencies.
Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently re-measured to their fair value at the end of each reporting period.
The accounting for subsequent changes in fair value depends on whether the derivative qualifies for hedge accounting treatment. For derivative instruments that do not qualify for hedge accounting, changes in the fair value are recognized immediately in profit or loss and are included in Other gains and losses - net or Finance costs, net depending on the nature of the underlying exposure. For derivatives that qualify for hedge accounting, changes in the fair value are recognized in OCI.
Hedge accounting
The Group did not adopt the disposition of IFRS 9 - Financial Instruments on hedging and will therefore continue to apply the provisions of IAS 39 - Financial Instruments. For derivative instruments that are designated for hedge accounting, at the inception of the hedging transaction, the group documents the relationship between hedging instruments and hedged items, the risk management objective and the strategy for undertaking the hedge transaction. The group also documents its assessment, both at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions have been and will continue to be highly effective in offsetting changes in cash flows of hedged items.
The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized in OCI and accumulated in equity. The gain or loss relating to the ineffective portion is recognized immediately in the Consolidated Income Statement in Other gains and losses - net.
Amounts accumulated in equity are reclassified to the Consolidated Income Statement when the hedged item affects the Consolidated Income Statement. The gain or loss relating to the effective portion of derivative instruments hedging forecasted cash flows under customer agreements is recognized in Revenue. When the forecasted transaction that is hedged results in the recognition of a non-financial asset, the gains and losses previously deferred in equity are reclassified from equity and included in the initial measurement of the cost of the asset. The deferred amounts would ultimately be recognized in the Consolidated Income Statement upon the sale, depreciation or impairment of the asset.
When a hedging instrument expires or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, any cumulative gain or loss existing in equity at that time remains in equity and is recognized when the forecasted transaction is ultimately recognized in the Consolidated Income Statement. When a forecasted transaction is no longer expected to occur, the cumulative gain or loss that was recognized in equity is immediately reclassified to the Consolidated Income Statement.
Property, plant and equipment
Recognition and measurement
Property, plant and equipment acquired by the Company are recorded at cost, which comprises the purchase price, including import duties and non-refundable purchase taxes, any costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management and the estimated close down and restoration costs associated with the asset. Borrowing costs, including interest, directly attributable to the acquisition or construction of property, plant and equipment are included in the cost. Subsequent to the initial recognition, Property, plant and equipment are measured at cost less accumulated depreciation and impairment, if any. Costs are capitalized into construction work-in-progress until projects are completed and the assets are available for use.
Subsequent costs
Enhancements and replacements are capitalized as additions to Property, plant and equipment only when it is probable that future economic benefits associated with them will flow to the Company and their cost can be measured with reliability. Ongoing regular maintenance costs related to Property, plant and equipment are expensed as incurred.
Depreciation
Land is not depreciated. Property, plant and equipment are depreciated over the estimated useful lives of the related assets using the straight-line method as follows:
Buildings: 10 – 50 years;
Machinery and equipment: 3 – 40 years;
Vehicles: 5 – 8 years.
Government Grants
Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions are complied with.
Government grants relating to the purchase of property, plant and equipment reduce the carrying amount of the asset. They are credited to profit or loss on a straight-line basis over the expected useful lives of the related assets. Government grants relating to costs offset the corresponding expense and are deferred and recognized in profit or loss over the period necessary to match them with the costs that they are intended to compensate.
Intangible assets
Recognition and measurement
Technology and customer relationships acquired in a business combination are recognized at fair value at the acquisition date. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and impairment losses. The useful lives of the Group intangible assets are assessed to be finite.
Amortization
Intangible assets are amortized over the estimated useful lives of the related assets using the straight-line method as follows:
Technology: 20 years;
Customer relationships: 25 years;
Software: 3 – 5 years.
Goodwill
Goodwill arising from a business combination is carried at cost as established at the date of the business combination less accumulated impairment losses, if any.
Goodwill is allocated at the operating segment levels, which are the groups of cash-generating units that are expected to benefit from the synergies of the combination. The operating segments represent the lowest level within the Group at which goodwill is monitored for internal management purposes.
Gains and losses on the disposal of a cash-generating unit include the carrying amount of goodwill relating to the cash-generating unit sold.
Impairment
Impairment of property, plant and equipment and intangible assets
Property, plant and equipment and intangible assets subject to amortization are reviewed for impairment if there is any indication that the carrying amount of the asset, or cash-generating unit to which it belongs, may not be recoverable. The recoverable amount is based on the higher of fair value less cost of disposal and value in use, as determined using estimates of discounted future net cash flows of the asset or group of assets to which it belongs.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement.
Impairment of goodwill
Groups of cash-generating units to which goodwill is allocated are tested for impairment annually, or more frequently when there is an indication that allocated goodwill may be impaired.
The net carrying value of a group of cash-generating units is compared to their recoverable amounts, which is the higher of the value in use and the fair value less costs of disposal.
Value in use calculations use cash flow projections based on financial budgets approved by management and usually covering a 5-year period. Cash flows beyond this period are estimated using a perpetual long-term growth rate for the subsequent years.
The value in use is the sum of the discounted cash flows over the projected period and the terminal value. Discount rates are determined based on the weighted-average cost of capital of each operating segment.
The fair value is the price that would be received for the group of cash-generating units, in an orderly transaction, from a market participant. This value is estimated on the basis of available and relevant market data or a discounted cash flow model reflecting market participant assumptions.
An impairment loss is recognized for the amount by which the group of units carrying amount exceeds its recoverable amount.
Any impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the group of cash-generating units and then to the other assets of the group of units pro rata on the basis of the carrying amount of each asset in the group of units.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement. An impairment loss recognized for goodwill cannot be reversed in subsequent years.
Cash-generating units
The reporting units, which generally correspond to industrial sites, are the lowest level of independent cash flows and have been identified as cash-generating units.
Taxation
Income tax (expense) / benefit is calculated on the basis of the tax laws enacted or substantively enacted at the Consolidated Statement of Financial Position date in the countries where the Company and its subsidiaries operate and generate taxable income.
The Group is subject to income taxes in France, the United States, Germany and numerous other jurisdictions. Certain of Constellium’s businesses may be included in tax returns in some jurisdictions. In certain circumstances, these businesses may be jointly and severally liable with the entity filing the consolidated return, for additional taxes that may be assessed.
Deferred income tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the Consolidated Financial Statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income tax assets are also recognized for operating loss carryforwards and tax credit carryforwards.
Deferred income tax assets and liabilities are measured using tax rates that are expected to apply in the year when the asset is realized or the liability is settled. Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.
Trade payables
Trade payables are initially recorded at fair value and are subsequently measured at amortized cost. Trade payables are classified as current liabilities if payment is due in one year or less.
Leases
Right-of-use assets
The Group recognizes right-of-use assets at the commencement date of the lease. Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and are adjusted for remeasurement of lease liabilities resulting from a change in future lease payments arising from a change in an index or a rate, or a change in the assessment of whether the purchase, extension or termination options will be exercised.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are recorded in the asset category to which they relate in Property, plant and equipment. Unless the Group is reasonably certain to obtain ownership of the leased assets at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of their estimated useful life and the lease term. Right-of-use assets are subject to impairment.
Lease liabilities
At the commencement date of the lease, the Group recognizes a lease liability measured at the present value of lease payments to be made over the lease term.
In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension or termination option. Extension options or periods after termination options are only included in the lease term if the lease is reasonably certain to be extended or not terminated.
The lease payments include fixed payments less any lease incentive receivables, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating a lease, if the lease term reflects the Group exercising the option to terminate. Lease liabilities are presented within Borrowings. Variable lease payments that do not depend on an index or a rate are recognized as expense in the period in which the event or condition that triggers the payment occurs.
In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the implicit interest rate in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced by the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, or a change in the assessment to purchase the underlying asset.
Short-term leases and leases of low-value assets
The Group applies the short-term lease recognition exemption to leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option. The Group also applies the low-value asset recognition exemption to leases of assets with a value below €5,000. Lease payments on short-term leases and low-value asset leases are recognized as expense on a straight-line basis over the lease term.
The Group also applies the practical expedients for lease and non-lease components as a single component for vehicles.
Provisions
Provisions are recorded at the best estimate of expenditures required to settle liabilities of uncertain timing or amount when management determines that i) a legal or constructive obligation exists as a result of past events, ii) it is probable that an outflow of resources will be required to settle the obligation and iii) such amounts can be reasonably estimated. Provisions are measured at the present value of the expected expenditures required to settle the obligation.
The ultimate cost to settle such liabilities is uncertain, and cost estimates can vary in response to many factors. The settlement of these liabilities could materially differ from recorded amounts or the expected timing of expenditure could change. As a result, there could be significant adjustments to provisions, which could result in additional charges or recoveries.
Close down and restoration costs
Estimated close down and restoration costs are accounted for in the year when the legal or constructive obligation arising from the related disturbance occurs and it is probable that an outflow of resources will be required to settle the obligation. These costs are based on the net present value of estimated future costs. Provisions for close down and restoration costs do not include any additional obligations expected to arise from future disturbance. The costs are estimated on the basis of a closure plan including feasibility and engineering studies, are updated annually during the life of the operation to reflect known developments (e.g. revisions to cost estimates and to the estimated lives of operations) and are subject to formal review at regular intervals each year.
The initial closure provision together with subsequent movements in the provisions for close down and restoration costs, including those resulting from new disturbance, updated cost estimates, changes to the estimated lives of operations and revisions to discount rates, are capitalized in Property, plant and equipment. These costs are depreciated over the remaining useful lives of the related assets. The amortization or unwinding of the discount applied in establishing the net present value of the provisions is recorded in the Consolidated Income Statement as a finance cost.
Environmental remediation costs
Environmental remediation costs are accounted for based on the estimated present value of the costs of the Group’s environmental clean-up obligations. Changes in the environmental remediation provisions are recorded in Cost of sales.
Restructuring costs
Provisions for restructuring are recorded when Constellium’s management is demonstrably committed to the restructuring plan and the liabilities can be reasonably estimated. The Group recognizes liabilities that primarily include one-time termination benefits, severance, and contract termination costs, primarily related to equipment and facility lease obligations. These amounts are based on the remaining amounts due under various contractual agreements and are periodically adjusted for changes in circumstances that would reduce or increase these obligations.
Legal, tax and other potential claims
Provisions for legal claims are made when it is probable that liabilities will be incurred and when such liabilities can be reasonably estimated. For asserted claims and assessments, liabilities are recorded when an unfavorable outcome of a matter is deemed to be probable and the loss is reasonably estimable. Management determines the likelihood of an unfavorable outcome based on many factors such as the nature of the matter, available defenses and case strategy, progress of the matter, views and opinions of legal counsel and other advisors, applicability and success of appeals, process and outcomes of similar historical matters, amongst others. Once an unfavorable outcome is considered probable, management weighs the probability of possible outcomes and the most likely loss is recorded. Legal matters are reviewed on a regular basis to determine if there have been changes in management’s judgment regarding the likelihood of an unfavorable outcome or the estimate of a potential loss. Depending on their nature, these costs may be recorded in Cost of sales or Other gains and losses - net in the Consolidated Income Statement. Included in other potential claims are provisions for product warranties and guarantees to settle the net present value portion of any settlement costs for potential future legal actions, claims and other assertions that may be brought by Constellium’s customers or the end-users of products. Provisions for product warranty and guarantees are recorded in Cost of sales in the Consolidated Income Statement.
Management establishes tax reserves and accrues interest thereon, if deemed appropriate, in expectation that certain tax positions other than income tax may be challenged and that the Group might not succeed in defending such positions.
Pension, other post-employment plans and other long-term employee benefits
For defined contribution plans, the contribution paid in respect of service rendered over the service year is recognized in the Consolidated Income Statement. This expense is included in Income / (loss) from operations.
For defined benefit plans, the retirement benefit obligation recognized in the Consolidated Statement of Financial Position represents the present value of the defined benefit obligation less the fair value of plan assets. The defined benefit obligations are assessed using the projected unit credit method. The most significant assumption is the discount rate. The amount recorded in the Consolidated Income Statement in respect of these plans is included within Income / (loss) from operations except for net interest costs, which are included in Finance costs - net. The effects of changes in actuarial assumptions and experience adjustments are presented in the Consolidated Statement of Comprehensive Income.
Other post-employment benefit plans mainly relate to health and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents. Eligibility for coverage is dependent upon certain age and service criteria. These benefit plans are unfunded and are accounted for as defined benefit obligations, as described above.
Other long-term employee benefits mainly include jubilees and other long-term disability benefits. For these plans, actuarial gains and losses are recognized immediately in the Consolidated Income Statement.
Share capital
Ordinary shares are classified as equity. Costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Share-based payment arrangements
Equity-settled share-based payments to employees and Board members are measured at the fair value of the equity instruments at the grant date.
The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the Group’s estimate of equity instruments that will eventually vest, with a corresponding increase in equity. At the end of each reporting period, the Group revises its estimate of the number of equity instruments expected to vest.
2.7 Judgments in applying accounting policies and key sources of estimation uncertainty
The preparation of the Group’s consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures, and the disclosure of contingent liabilities. These judgments, estimates and assumptions are based on management’s best knowledge of the relevant facts and circumstances, giving consideration to previous experience. However, actual results may differ from the amounts included in the Consolidated Financial Statements. Key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year include the items presented below. The Group continuously reviews its significant assumptions and estimates in light of the uncertainty associated with the global geopolitical and macroeconomic conditions, including the ongoing armed conflict in Ukraine and the COVID-19 pandemic and their potential direct and indirect impacts on its business and its financial statements, as detailed in NOTE 4 - Operating Segment Information, NOTE 15 - Property, Plant and Equipment, NOTE 20 - Borrowings, NOTE 22 - Financial Risk Management, NOTE 24 - Provisions and NOTE 27 - COVID-19-related Government assistance. However, there remains significant uncertainty with respect to the duration and severity of these crises and their potential impacts on the global economy and our business, and there can be no guarantee that our assumptions will materialize or that actual results will not differ materially from estimates.
Impairment tests for goodwill, intangible assets and property, plant and equipment
The determination of fair value and value in use of cash-generating units or groups of cash-generating units depends on a number of assumptions, in particular market data, estimated future cash flows and discount rates.
The Group assesses where climate risks could have a significant impact, such as the introduction of emission-reduction legislation that may increase manufacturing costs. The Group constantly monitors the latest government legislation in relation to climate-related matters. At the current time, no legislation has been passed that will impact the Group. The Group will adjust the assumptions used in value-in-use calculations and sensitivity to changes in assumptions should a change be required.
These assumptions are subject to risk and uncertainty. Any material changes in these assumptions could result in a significant change in a cash-generating units’ recoverable value or in a goodwill impairment. Details of the key assumptions made and judgments applied are set out in NOTE 15 - Property, Plant and Equipment and in NOTE 16 - Intangible Assets and Goodwill.
Income Taxes
Significant judgment is sometimes required in determining the accrual for income taxes as there are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Group recognizes liabilities based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were recorded, such differences will impact the current and deferred income tax provisions, results of operations and possibly cash flows in the year in which such determination is made.
Significant judgment is also required to determine the extent to which deferred tax assets can be recognized. In assessing the recognition of deferred tax assets, management considers whether it is more likely than not that the deferred tax assets will be utilized. The deferred tax assets will be ultimately utilized to the extent that sufficient taxable profits will be available in the years in which the temporary differences become deductible. This assessment is conducted through a detailed review of deferred tax assets by jurisdiction and takes into account the scheduled reversals of taxable and deductible temporary
differences, past, current and expected future performance deriving from the budget, the business plan and tax planning strategies. Deferred tax assets are not recognized in the jurisdictions where it is less likely than not that sufficient taxable profits will be available against which the deductible temporary differences can be utilized. Details of the key assumptions made and judgments applied are set out in NOTE 17 - Deferred Income Taxes.
Provisions
Provisions have been recorded for: (i) close down and restoration costs; (ii) environmental remediation and monitoring costs; (iii) restructuring plans; (iv) legal and other potential claims including provisions for tax risks other than income tax, product warranty and guarantees. These provisions are recorded at amounts which represent management’s best estimates of the expenditure required to settle the obligation at the date of the Consolidated Statement of Financial Position. Expectations are revised each year until the actual liability is settled, with any difference accounted for in the Consolidated Income Statement in the year in which the revision is made. Details of the key assumptions made and judgments applied are described in NOTE 24 - Provisions.
Pension, other post-employment benefits and other long-term employee benefits
The present value of the defined benefit obligations depends on a number of factors that are determined on an actuarial basis using a number of assumptions and its determination requires the application of judgment. Assumptions used and judgments made in determining the defined benefit obligations and net pension costs include discount rates, rates of future compensation increase, and the criteria considered to determine when a plan amendment has occurred.
Any material changes in these assumptions could result in a significant change in Pensions and other post-employment benefit obligations and in employee benefit expenses recognized in the Consolidated Income Statement or actuarial gains and losses recognized in OCI. Details of the key assumptions made and judgments applied are set out in NOTE 23 - Pensions and Other Post-Employment Benefit Obligations.

v3.22.4
REVENUE
12 Months Ended
Dec. 31, 2022
Revenue [abstract]  
REVENUE
NOTE 3 - REVENUE
Year ended December 31,
(in millions of Euros)202220212020
Packaging rolled products3,3262,6731,960
Automotive rolled products1,154854663
Specialty and other thin-rolled products175161102
Aerospace rolled products728389560
Transportation, industry, defense and other rolled products916713442
Automotive extruded products949735665
Other extruded products872627491
Total Revenue by product line8,1206,1524,883
Year ended December 31,
(in millions of Euros)202220212020
Germany2,0361,4811,014
France691466362
United Kingdom221179192
Switzerland876352
Spain302252185
Czech Republic237172119
Other Europe1,110809619
Total Europe4,6843,4222,543
United States2,8232,3351,941
Asia and Other Pacific252171211
All Other361224188
Total Revenue by destination of shipment8,1206,1524,883
Revenue is recognized at a point in time, except for certain products with no alternative use for which we have a right to payment, which represent less than 1% of total revenue.

v3.22.4
OPERATING SEGMENT INFORMATION
12 Months Ended
Dec. 31, 2022
Disclosure of operating segments [abstract]  
OPERATING SEGMENT INFORMATION
NOTE 4 - OPERATING SEGMENT INFORMATION
Packaging and Automotive Rolled Products (P&ARP)
P&ARP supplies thin-gauge rolled aluminium products to the packaging market with canstock and closure stock for the beverage and food industry, foil stock for the flexible packaging market and to the automotive market with a number of technically sophisticated applications, such as automotive body sheet and heat exchanger materials. P&ARP operates four facilities in three countries and had approximately 4,100 employees at December 31, 2022.
Aerospace and Transportation (A&T)
A&T supplies thick-gauge rolled aluminium products and very limited volumes of extruded products to the aerospace market, as well as thick-gauge rolled products for transportation, industry and defense end-uses. A&T operates six facilities in three countries and had approximately 3,500 employees at December 31, 2022.
Automotive Structures and Industry (AS&I)
AS&I supplies hard and soft aluminium alloy extruded profiles for a range of high demand industry applications in the automotive, engineering, rail and other transportation end markets, and technologically advanced structural components to the automotive industry. AS&I operates nineteen facilities in ten countries and had approximately 4,500 employees at December 31, 2022.
Holdings & Corporate (H&C)
Holdings & Corporate includes the costs of our corporate support functions and our technology centers.
Intersegment elimination
Intersegment transactions are conducted on an arm’s length basis and reflect market prices.
4.1 Segment Revenue
Year ended December 31,
202220212020
(in millions of Euros)Segment revenueInter-segment eliminationExternal revenueSegment revenueInter-segment eliminationExternal revenueSegment revenueInter-segment eliminationExternal revenue
P&ARP4,664(9)4,6553,698(10)3,6882,734(9)2,725
A&T1,700(55)1,6451,142(40)1,1021,025(23)1,002
AS&I1,861(41)1,8201,383(21)1,3621,167(11)1,156
Total8,225(105)8,1206,223(71)6,1524,926(43)4,883
4.2 Segment Adjusted EBITDA and reconciliation of Adjusted EBITDA to Net Income
Constellium’s chief operating decision-maker measures the profitability and financial performance of its operating segments based on Adjusted EBITDA. Adjusted EBITDA is defined as income / (loss) from continuing operations before income taxes, results from joint ventures, net finance costs, other expenses and depreciation, amortization as adjusted to exclude restructuring costs, impairment charges, unrealized gains or losses on derivatives and on foreign exchange differences on transactions that do not qualify for hedge accounting, metal price lag, share-based compensation expense, effects of certain purchase accounting adjustments, start-up and development costs or acquisition, integration and separation costs, certain incremental costs and other exceptional, unusual or generally non-recurring items.
Year ended December 31,
(in millions of Euros)Notes202220212020
P&ARP 326344291
A&T 217111106
AS&I 14914288
H&C (19)(16)(20)
Adjusted EBITDA 673581465
Metal price lag (A)(29)187(8)
Start-up and development costs (B)(5)
Share based compensation costs 30(18)(15)(15)
Gains / (losses) on pension plan amendments (C)2347(32)(2)
Depreciation and amortization 15, 16(287)(267)(259)
Impairment of assets 15, 16(43)
Restructuring costs 8(1)(3)(13)
Unrealized (losses) / gains on derivatives (46)3516
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net 8(1)11
Losses on disposal 8(4)(3)(4)
Other (D)(8)
Income from operations334484125
Finance costs - net10(131)(167)(159)
Income / (loss) before tax203317(34)
Income tax benefit / (expense)11105(55)17
Net income / (loss)308262(17)
(A)Metal price lag represents the financial impact of the timing difference between when aluminium prices included within Constellium's Revenue are established and when aluminium purchase prices included in Cost of sales are established. The Group accounts for inventory using a weighted average price basis and this adjustment aims to remove the effect of volatility in LME prices. The calculation of the Group metal price lag adjustment is based on an internal standardized methodology calculated at each of Constellium’s manufacturing sites and is primarily calculated as the average value of product recorded in inventory, which approximates the spot price in the market, less the average value transferred out of inventory, which is the weighted average of the metal element of cost of sales, based on the quantity sold in the year.
(B)Start-up and development costs, for the year ended December 31, 2020, was related to new projects in our AS&I operating segment.
(C)In the year ended December 31, 2022 the group recognized a net gain of €47 million from past service cost as a result from a new 3-year collective bargaining agreement between Constellium Rolled Products Ravenswood and the United Steelworkers Local Union 5668 entered in October 2022. The agreement resulted in changes in OPEB and pension benefits that were accounted for as a plan amendment in the year ended December 31, 2022. (see Note 23.6 Ravenswood plan amendment).
In the year ended December 31, 2021, the group recognized a loss of €31 million from past service cost following an adverse decision of the Fourth Circuit Court in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network. (see Note 23.7 Ravenswood OPEB dispute).
(D)Other, for the year ended December 31, 2020, included €2 million of procurement penalties and termination fees incurred because of the Groups inability to fulfill certain commitments due to the COVID-19 pandemic and a €6 million loss resulting from the discontinuation of hedge accounting for certain forecasted sales that were determined to be no longer expected to occur in light of the COVID-19 pandemic effects.
4.3 Segment capital expenditures
Year ended December 31,
(in millions of Euros)202220212020
P&ARP(127)(94)(73)
A&T(78)(70)(45)
AS&I(62)(62)(61)
H&C(6)(6)(3)
Capital expenditures(273)(232)(182)
4.4 Segment assets
At December 31,
(in millions of Euros)20222021
P&ARP2,1872,108
A&T1,081948
AS&I727738
H&C456451
Segment assets4,4514,245
Deferred income tax assets271162
Cash and cash equivalents166147
Other financial assets3970
Assets of disposal group classified as held for sale14
Total Assets4,9414,624
4.5 Information about major customers
Revenue in the P&ARP segment from sales to the Group’s largest customer, which we serve through a number of contracts across our sites, was €839 million, €692 million and €492 million for the years ended December 31, 2022, 2021 and 2020, respectively. No other single customer contributed 10% or more to the Group’s revenue for 2022, 2021 and 2020.

v3.22.4
INFORMATION BY GEOGRAPHIC AREA
12 Months Ended
Dec. 31, 2022
Disclosure of geographical areas [abstract]  
INFORMATION BY GEOGRAPHIC AREA
NOTE 5 - INFORMATION BY GEOGRAPHIC AREA
Property, plant and equipment are reported based on the physical location of the assets:
At December 31,
(in millions of Euros)20222021
United States832811
France699653
Germany269266
Czech Republic9799
Other120119
Total2,0171,948

v3.22.4
EXPENSES BY NATURE
12 Months Ended
Dec. 31, 2022
Disclosure of attribution of expenses by nature to their function [abstract]  
EXPENSES BY NATURE
NOTE 6 - EXPENSES BY NATURE
Year ended December 31,
(in millions of Euros)202220212020
Raw materials and consumables used(5,545)(3,885)(2,832)
Employee benefit expenses(1,110)(967)(902)
Energy costs(274)(149)(141)
Sub-contractors(125)(102)(89)
Freight out costs(163)(143)(122)
Professional fees(81)(63)(73)
Lease expenses(15)(12)(11)
Depreciation and amortization(287)(267)(259)
Other operating expenses(178)(197)(240)
Other gains and losses - net(8)117(89)
Total operating expenses(7,786)(5,668)(4,758)

v3.22.4
EMPLOYEE BENEFIT EXPENSES
12 Months Ended
Dec. 31, 2022
Classes of employee benefits expense [abstract]  
EMPLOYEE BENEFIT EXPENSES
NOTE 7 - EMPLOYEE BENEFIT EXPENSES
Year ended December 31,
(in millions of Euros)Notes202220212020
Wages and salaries(1,067)(920)(855)
Pension costs - defined benefit plans23(22)(24)(23)
Other post-employment benefits23(3)(8)(9)
Share-based compensation30(18)(15)(15)
Total employee benefit expenses(1,110)(967)(902)
NOTE 23 - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS
The Group has a number of pensions, other post-employment benefits and other long-term employee benefit plans. Some of these plans are defined contribution plans and some are defined benefit plans, with assets held in separate trustee-administered funds. Benefits paid through pension trusts are sufficiently funded to ensure the payment of benefits to retirees when they become due.
Actuarial valuations are reflected in the Consolidated Financial Statements as described in NOTE 2.6 - Principles governing the preparation of the Consolidated Financial Statements.
23.1 Description of the plans
Pension plans
Constellium’s pension obligations are in the U.S., Switzerland, Germany and France. Pension benefits are generally based on the employee’s service and highest average eligible compensation before retirement and are periodically adjusted for cost of living increases, either by company practice, collective agreement or statutory requirement. Benefit plans in the U.S., Switzerland and France are funded through long-term employee benefit funds.
Other post-employment benefits (OPEB)
The Group provides healthcare and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents, mainly in the U.S. Eligibility for coverage depends on certain age and service criteria. These benefit plans are unfunded.
Other long-term employee benefits
Other long-term employee benefits mainly include jubilees in France, Germany and Switzerland and other long-term disability benefits in the U.S. These benefit plans are unfunded.
23.2 Description of risks
The defined benefit obligations expose the Group to a number of risks, including longevity, inflation, interest rate, medical cost inflation, investment performance, and change in law governing the employee benefit obligations. These risks are mitigated when possible by applying an investment strategy for the funded schemes that aims to reduce the volatility of returns and achieve a matching of the underlying liabilities to minimize the long-term costs. This is achieved by investing in a diversified selection of asset classes.
Investment performance risk
Our pension plan assets consist primarily of funds invested in listed stocks and bonds.
The present value of funded defined benefit obligations is calculated using a discount rate determined by reference to high-quality corporate bond yields. If the return on plan assets is below this rate, it will increase the plan deficit.
Interest rate risk
A decrease in the discount rate will increase the defined benefit obligation. At December 31, 2022, impacts of the change on the defined benefit obligation of a 50 basis points increase / decrease in the discount rates are calculated by using a proxy based on the duration of each scheme:
(in millions of Euros)50 bp increase in
discount rates
50 bp decrease in
discount rates
France (6)7
Germany(5)5
Switzerland(16)17
United States(19)23
Total sensitivity on Defined Benefit Obligations(46)52
Longevity risk
The present value of the defined benefit obligation is calculated by reference to the best estimate of the mortality of plan participants. An increase in the life expectancy of the plan participants will increase the plan’s liability.
23.3 Actuarial assumptions
Pension and other post-employment benefit obligations were updated based on the discount rates applicable at December 31, 2022.
At December 31,
20222021
Rate of increase in salariesRate of increase in pensionsDiscount rateRate of increase in salariesRate of increase in pensionsDiscount rate
Switzerland1.75%2.05%1.50%0.15%
U.S.
Hourly pension3.00%
5.00% - 5.05%
2.20%
2.80% - 2.95%
Salaried pension—%5.05%—%2.85%
OPEB (A)4.00%
5.00% - 5.05%
3.80%
2.85% - 2.95%
Other benefits3.80%
4.95% - 5.00%
3.80%
2.60% - 2.85%
France
2.20%
2.00%
1.80% - 3.80%
2.00%
Retirements3.80%1.00%
Other benefits3.80%0.90%
Germany2.50%2.00%3.75%2.50%1.80%1.05%
(A)The other main financial assumptions used for the OPEB healthcare plans, which are predominantly in the U.S. were:
Medical trend rate: i) pre-65: 6.75% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards and ii) post-65: 6.00% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards,
Claims costs based on Company experience.
For both pension and healthcare plans, the post-employment mortality assumptions allow for future improvements in life expectancy.
23.4 Amounts recognized in the Consolidated Statement of Financial Position
At December 31,
20222021
(in millions of Euros)Pension BenefitsOther BenefitsTotalPension BenefitsOther BenefitsTotal
Present value of funded obligation614614766766
Fair value of plan assets(461)(461)(544)(544)
Deficit of funded plans153153222222
Present value of unfunded obligation96154250128249377
Net liability / (asset) arising from defined benefit obligation249154403350249599
23.5 Movement in net defined benefit obligations
Year ended December 31, 2022
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20228942491,143(544)599
Included in the Consolidated Income Statement
Current service cost2082828
Interest cost / (income)13720(9)11
Past service cost2(49)(47)(47)
Immediate recognition of gains arising over the year(5)(5)(5)
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets107107
—changes in financial assumptions(211)(43)(254)(254)
—changes in demographic assumptions(1)(1)(1)
—experience losses(3)(9)(12)(12)
Effects of changes in foreign exchange rates341650(30)20
Included in the Consolidated Statement of Cash Flows
Benefits paid(42)(21)(63)57(6)
Contributions by the Group(38)(38)
Contributions by the plan participants426(6)
Reclassification as liabilities of disposal group classified as held for sale (1)(1)(1)
At December 31, 2022710154864(461)403
Year ended December 31, 2021
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20219062161,122(458)664
Included the Consolidated Income Statement
Current service cost2283030
Interest cost / (income)10515(6)9
Past service cost1313232
Immediate recognition of gains arising over the year
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets(56)(56)
—changes in financial assumptions(29)(9)(38)(38)
—changes in demographic assumptions(13)(13)(13)
—experience losses(9)(2)(11)(11)
Effects of changes in foreign exchange rates381755(32)23
Included in the Consolidated Statement of Cash Flows
Benefits paid(36)(18)(54)32(22)
Contributions by the Group(21)(21)
Contributions by the plan participants415(5)
At December 31, 20218942491,143(544)599
Movements in net defined benefit obligations reported in Other Comprehensive Income in the years ended December 31, 2022 and 2021, primarily reflected the impact of changes in discount rates (see note 23.3), the difference between actual returns and interest on plan assets and the impact of changes in foreign exchanges rates.
23.6 Ravenswood plan amendment
In October 2022, Constellium Rolled Products Ravenswood and United Steelworkers Local Union 5668 entered into a new three-year collective bargaining agreement. The agreement included changes in OPEB and pension benefits that are accounted for as a plan amendment in the year ended December 31, 2022. The changes resulted in a reduction of the OPEB obligation recorded as a gain from negative past service cost for €49 million and an increase of the pension obligation recorded as an additional past service costs for €2 million.
23.7 Ravenswood OPEB dispute
In 2018, the Group announced a plan to transfer certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan (“the Plan”) from a company-sponsored program to a third-party health network providing similar benefits at a lower cost. The United Steelworkers Local Union 5668 (the “Union”) contested this change in benefits and filed a lawsuit against Constellium Rolled Products Ravenswood, LLC ("Ravenswood") in a federal district court in West Virginia (the “District Court”) seeking to enjoin the Plan changes and to compel arbitration. The District Court issued an order in December 2018, enjoining Ravenswood from implementing the Plan amendments pending resolution in arbitration. In September 2019, the arbitrator issued a decision ruling against Ravenswood and sustaining the Union’s grievance. Ravenswood filed a motion in the District Court to vacate this decision, which was denied in June 2020. In July 2020, Ravenswood appealed that denial to the Fourth Circuit Court of Appeals. In November 2021, the Fourth Circuit Court issued an opinion in favor of the Union, and the Group elected not to further pursue legal action on this matter.
The Group recognized a gain of €36 million from negative past service cost in the year ended December 31, 2018, reflecting its decision to amend the plan benefits and its determination at the time that it was probable that it would ultimately prevail in the dispute with the Union. This gain was partially reversed in the years ended December 31, 2019 and 2020, to reflect delays in the estimated implementation timetable as a result of the dispute with the Union. The Group recognized a loss
of €31 million from past service cost in the year ended December 31, 2021, following the Fourth Circuit Court's ruling in favor of the Union.
23.8 Net defined benefit obligations by country
At December 31,
20222021
(in millions of Euros)Defined benefit obligationsPlan assetsNet defined benefit liabilityDefined benefit obligationsPlan assetsNet defined benefit liability
France117(6)111158(5)153
Germany100(1)99134(2)132
Switzerland249(236)13306(268)38
United States398(218)180545(269)276
Total864(461)4031,143(544)599
23.9 Plan asset categories
At December 31,
20222021
(in millions of Euros)Quoted in an active marketNot quoted in an active marketTotalQuoted in an active marketNot quoted in an active marketTotal
Cash & cash equivalents4444
Equities873612311561176
Bonds14680226149110259
Property146074165571
Other34343434
Total fair value of plan assets251210461284260544
23.10 Cash flows
Expected contributions to pension and other benefit plans amount to €23 million and €16 million, respectively, for the year ending December 31, 2023.
Future benefit payments expected to be paid either by pension funds or directly by the Company to beneficiaries are as follows:
(in millions of Euros)Estimated benefits payments
Year ended December 31,
202356
202456
202557
202657
202760
2028 to 2032328
The weighted-average maturity of the defined benefit obligations was 11.2 and 14.2, respectively, for the years ended December 31, 2022 and 2021.

v3.22.4
OTHER GAINS AND LOSSES—NET
12 Months Ended
Dec. 31, 2022
Analysis of income and expense [abstract]  
OTHER GAINS AND LOSSES—NET
NOTE 8 - OTHER GAINS AND LOSSES - NET
Year ended December 31,
(in millions of Euros)Notes202220212020
Realized (losses) / gains on derivatives (A)(6)113(35)
Losses reclassified from OCI as a result of hedge accounting discontinuation (B)(6)
Unrealized (losses) / gains on derivatives at fair value through profit and loss - net (A)(47)3916
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net (1)11
Impairment of assets (C)15, 16(43)
Restructuring costs (D)24(1)(3)(13)
Gains / (losses) on pension plan amendments (E)2347(32)(2)
Losses on disposal (4)(3)(4)
Other 42(3)
Total other gains and losses - net (8)117(89)
(A)Realized and unrealized gains and losses are related to derivatives entered into with the purpose of mitigating exposure to volatility in foreign currencies and commodity prices and that do not qualify for hedge accounting.
(B)In the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for 2020 and 2021, to which hedge accounting was applied, were no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted in a €6 million loss.
(C)In the year ended December 31, 2020, an impairment charge of €43 million was recognized for certain A&T cash-generating units due to the downturn in the aerospace industry resulting from the COVID-19 pandemic and for certain AS&I cash-generating units as a result of the review of their long-term business perspectives.
(D)For the years ended December 31, 2021 and 2020, restructuring costs amounted to €3 million and €13 million, respectively, and related to headcount reductions in Europe and in the U.S.
(E)In the year ended December 31, 2022 the group recognized a net gain of €47 million from past service cost as a result from a new 3-year collective bargaining agreement between Constellium Rolled Products Ravenswood and the United Steelworkers Local Union 5668 entered in October 2022. The agreement resulted in changes in OPEB and pension benefits that were accounted for as a plan amendment in the year ended December 31, 2022 (see Note 23.6 Ravenswood plan amendment).
In the year ended December 31, 2021, the group recognized a loss of €31 million from past service cost following an adverse decision of the Fourth Circuit Court in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network (see Note 23.7 Ravenswood OPEB dispute)

v3.22.4
CURRENCY GAINS / (LOSSES)
12 Months Ended
Dec. 31, 2022
Analysis of income and expense [abstract]  
CURRENCY GAINS / (LOSSES)
NOTE 9 - CURRENCY GAINS / (LOSSES)
Year ended December 31,
(in millions of Euros)Notes202220212020
Included in Revenue22(8)(4)(6)
Included in Cost of sales21(2)
Included in Other gains and losses - net516(19)
Total(1)13(27)
Realized exchange losses on foreign currency derivatives - net22(8)(1)(11)
Losses reclassified from OCI as a result of hedge accounting discontinuation22(6)
Unrealized gains / (losses) on foreign currency derivatives - net22613(8)
Exchange gains / (losses) from the remeasurement of monetary assets and liabilities - net11(2)
Total(1)13(27)
See NOTE 21 - Financial Instruments and NOTE 22 - Financial Risk Management for further information regarding the Company’s foreign currency derivatives and hedging activities.
Foreign currency translation reserve
At December 31,
(in millions of Euros)20222021
Foreign currency translation reserve at January 1,19(13)
Effect of currency translation differences2232
Foreign currency translation reserve at December 31,4119

v3.22.4
FINANCE COSTS—NET
12 Months Ended
Dec. 31, 2022
Analysis of income and expense [abstract]  
FINANCE COSTS—NET
NOTE 10 - FINANCE COSTS - NET
Year ended December 31,
(in millions of Euros)202220212020
Interest expense on borrowings (A)(91)(103)(122)
Interest expense on leases (10)(14)(10)
Interest cost on pension and other benefits (11)(9)(11)
Expenses on factoring arrangements (15)(9)(10)
Net loss on settlement of debt (B)(27)
Realized and unrealized gains / (losses) on debt derivatives at fair value (C)110(32)
Realized and unrealized exchange (losses) / gains on financing activities - net (C)(1)(10)37
Other finance expenses (5)(6)(12)
Capitalized borrowing costs (D)111
Finance expenses (131)(167)(159)
Finance costs - net (131)(167)(159)
(A)For the year ended December 31, 2022, interest expense on borrowings included €79 million of interest and €4 million of amortization of arrangement fees related to Constellium SE Senior Notes. For the year ended December 31, 2021, it included €92 million of interest and €4 million of amortization of arrangement fees related to Constellium SE Senior Notes.
(B)In February 2021, Constellium SE tendered and redeemed its $650 million 6.625% Senior Notes due 2025. The net loss on the settlement of debt included redemption fees of €9 million and the write-off of the outstanding deferred arrangement fees at the date of redemption of €8 million.
In June 2021, Constellium SE redeemed its $400 million 5.750% Senior Notes due 2024. The net loss on the settlement of debt included redemption fees of €3 million and the write-off of the outstanding deferred arrangement fees at the date of redemption of €3 million.
In November 2021, Constellium SE redeemed $200 million of the $500 million outstanding aggregate principal amount of the 5.875% Senior Notes due 2026. The net loss on the settlement of debt included redemption fees of €3 million and the write-off of the deferred arrangement fees attributable to the portion redeemed at the date of redemption of €1 million.
(C)     The Group hedges the dollar exposure, relating to the principal of its Constellium SE U.S. Dollar Senior Notes, for the portion that has not been used to finance directly or indirectly U.S. Dollar functional currency entities. Changes in the fair value of these hedging derivatives are recognized within Finance costs – net in the Consolidated Income Statement.
(D)     Borrowing costs directly attributable to the construction of assets are capitalized. The capitalization rate was 5% for the years ended December 31, 2022 and 2021 and 6% for the year ended December 31, 2020

v3.22.4
INCOME TAX
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
INCOME TAX
NOTE 11 - INCOME TAX
Year ended December 31,
(in millions of Euros)202220212020
Current tax expense (22)(26)(14)
Deferred tax benefit / (expense) 127(29)31
Income tax benefit / (expense)105(55)17
The Group’s effective tax rate reconciliation is as follows:
Year ended December 31,
(in millions of Euros)202220212020
Income / (loss) before tax 203317(34)
Statutory tax rate applicable to the parent company 25.8%28.4%32.0%
Income tax (expense) / benefit calculated at statutory tax rate (52)(90)11
Effect of foreign tax rate (A)3152
Changes in recognized and unrecognized deferred tax assets (B)1542415
Other (4)(11)
Income tax benefit / (expense) 105(55)17
Effective income tax rate (52)%17%49%
(A)For the years ended December 31, 2022, 2021 and 2020, the Effect of foreign tax rate resulted from the geographical mix of our pre-tax results.
(B)For the year ended December 31, 2022, the changes in recognized and unrecognized deferred tax assets mainly related to the recognition of previously unrecognized deferred tax assets at one of our main operating entities in the United States for €154 million (see NOTE 17 - Deferred Income Taxes). For the year ended December 31, 2021, the changes mainly related to the recognition of deferred tax assets on temporary differences at one of our main operating entities in the United States. For the year ended December 31, 2020, the changes mainly related to recognized deferred tax assets on prior-year losses carried forward at one of our main operating entities in the United States, following some clarification on U.S. interest limitation rules and the CARES Act.
NOTE 17 - DEFERRED INCOME TAXES
Recognized Deferred Tax Assets
At December 31,
(in millions of Euros)20222021
Deferred income tax assets 271162
Deferred income tax liabilities (28)(14)
Net deferred income tax assets 243148
At January 1, 2022Reclassified as held for saleRecognized inFXAt December 31, 2022
(in millions of Euros)Profit or lossOCI
Long-term assets (124)(2)31(7)(102)
Inventories 3(4)(1)(2)
Pensions 119(10)(35)478
Derivative valuation (6)824
Tax losses carried forward 117676190
Other (A)3935175
Net deferred income tax assets 148(2)127(33)3243
(A)At December 31, 2022, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.
At January 1, 2021Recognized inFXAt December 31,
2021
(in millions of Euros)Profit or lossOCI
Long-term assets (106)(10)(8)(124)
Inventories 5(2)3
Pensions 1265(17)5119
Derivative valuation (5)(5)4(6)
Tax losses carried forward 116(7)8117
Other (A)47(10)239
Net deferred income tax assets 183(29)(13)7148
(A)At December 31, 2021, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.
Unrecognized Deferred Tax Assets
Based on the expected taxable income of the entities, the Group believed that it was more likely than not that a total of €199 million and €805 million at December 31, 2022 and 2021, respectively, of unused tax losses and deductible temporary differences, would not be used. Consequently, the corresponding net deferred tax assets were not recognized. The related tax impact of €48 million and €191 million at December 31, 2022 and 2021, respectively, was attributable to the following:
At December 31,
(in millions of Euros)20222021
Expiring within 5 years (5)(3)
Expiring after 5 years and limited (5)(55)
Unlimited (21)(27)
Tax losses (31)(85)
Long-term assets (2)(65)
Pensions (3)(7)
Other (12)(34)
Deductible temporary differences (17)(106)
Total (48)(191)
Recognition of Deferred Tax Assets
Some deferred tax assets in respect of temporary differences and unused tax losses were recognized without being offset by deferred tax liabilities.
In accordance with the accounting policies described in note 2.6 of the Consolidated Financial Statements, a detailed assessment was performed on net deferred tax asset recovery at December 31, 2022, with specific focus on tax jurisdictions with unused tax losses carried forward.
At December 31, 2021, most of the the tax loss carryforwards as well as the deductible temporary differences on long-term assets and other differences resided at one of our main operating entities in the United States. An assessment was performed on the recoverability of the deferred tax assets associated with the deductible temporary differences and tax losses. Management concluded that it was more likely than not that the entity would not be able to use the tax benefits associated with the deductible temporary differences and tax losses. Consequently, the related deferred tax assets were not recognized.
In the year ended December 31, 2022, management determined that it is more likely than not that future earnings will be sufficient to realize these previously unrecognized deferred tax assets. In making this determination management considered all available positive and negative evidence including historical results as well as forecasted profitability supported by revised projections from the Group’s latest long-term plan. Accordingly, the Group recognized a deferred tax asset and a corresponding income tax benefit of €154 million in the year ended December 31, 2022.
Management considered that the tax losses related to the other tax jurisdictions that generated the deferred tax assets were not expected to be recurring and did not challenge the profitable long-term structure of its business model. In addition, tax planning opportunities are available to increase the taxable profit and the use the long-term limited and unlimited tax losses.
Management concluded that it was more likely than not that the net deferred tax asset balance of €243 million and €148 million at December 31, 2022 and 2021, respectively, would be recoverable.

v3.22.4
CASH AND CASH EQUIVALENTS
12 Months Ended
Dec. 31, 2022
Cash and cash equivalents [abstract]  
CASH AND CASH EQUIVALENTS
NOTE 12 - CASH AND CASH EQUIVALENTS
Cash at bank and on hand at December 31, 2022 amounted to €166 million and included €24 million held by subsidiaries that operate in countries where capital control restrictions prevent these balances from being immediately available for general use by the other entities within the Group. At December 31, 2021, the amount subject to these restrictions was €29 million.

v3.22.4
TRADE RECEIVABLES AND OTHER
12 Months Ended
Dec. 31, 2022
Trade and other receivables [abstract]  
TRADE RECEIVABLES AND OTHER
NOTE 13 - TRADE RECEIVABLES AND OTHER
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Trade receivables - gross467607
Impairment(2)(4)
Total trade receivables - net465603
Income tax receivables14162420
Other tax receivables3840
Contract assets152192
Prepaid expenses1819
Other1310119
Total other receivables43745580
Total trade receivables and other4353955683
13.1 Contract assets
Contract assets included €4 million and €6 million of unbilled tooling costs at December 31, 2022 and 2021, respectively.
13.2 Aging
At December 31,
(in millions of Euros)20222021
Not past due453596
1 – 30 days past due106
31 – 60 days past due21
Total trade receivables - net465603
The maximum exposure to credit risk at the reporting date is the carrying value of each class of receivable shown above. The Group does not hold any collateral from its customers or debtors as security.
13.3 Currency concentration
At December 31,
(in millions of Euros)20222021
Euro225277
U.S. Dollar213305
Swiss franc84
Other currencies1917
Total trade receivables - net465603
13.4 Factoring arrangements
The Group factors trade receivables under committed factoring agreements in the United States, France, Germany, Switzerland and the Czech Republic:
In the United States, Constellium Muscle Shoals LLC is party to a factoring agreement with a capacity of $200 million and a maturity date in September 2023 and Constellium Automotive USA LLC is party to a factoring agreement with a maximum capacity of $25 million and a maturity date in December 2023.
The factoring agreement in place for our entities in France has a maximum capacity of €250 million (including a €20 million recourse line) and a maturity date in January 2026.
Factoring agreements in place for our entities in Germany, Switzerland and the Czech Republic have a combined maximum capacity of €200 million and maturity dates in December 2027.
In addition, the Group sells receivables from one of its German customers under an uncommitted factoring facility whereby receivables sold are confirmed by the customer.
These factoring agreements contain certain customary affirmative and negative covenants, including some relating to the administration and collection of the assigned receivables, the terms of the invoices and the exchange of information, but do not contain maintenance financial covenants. In addition, the commitment of the factor to buy receivables under the Muscle Shoals factoring agreement is subject to certain credit ratings being maintained. The Group was in compliance with all applicable covenants at and for the years ended December 31, 2022 and 2021.
Under the Group’s factoring agreements, most of the trade receivables are sold without recourse. Where the Group has transferred substantially all the risks and rewards of ownership of the receivables, the receivables are derecognized. Some remaining receivables do not qualify for derecognition, as the Group retains substantially all the associated risks and rewards. At December 31, 2022, the total carrying amount of the original assets factored was €574 million of which €368 million were derecognized. At December 31, 2021, the total carrying amount of the original assets factored was €639 million of which €345 million were derecognized.
The amounts due to the factors in respect to trade receivables sold were €6 million and zero at December 31, 2022 and 2021, respectively.

v3.22.4
INVENTORIES
12 Months Ended
Dec. 31, 2022
Subclassifications of assets, liabilities and equities [abstract]  
INVENTORIES
NOTE 14 - INVENTORIES
At December 31,
(in millions of Euros)20222021
Finished goods315225
Work in progress638551
Raw materials 308226
Stores and supplies11295
Inventories write down(53)(47)
Total inventories1,3201,050

v3.22.4
PROPERTY, PLANT AND EQUIPMENT
12 Months Ended
Dec. 31, 2022
Property, plant and equipment [abstract]  
PROPERTY, PLANT AND EQUIPMENT
NOTE 15 - PROPERTY, PLANT AND EQUIPMENT
(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2022213741,411127151,948
Additions14901885297
Disposals(4)(1)(5)
Depreciation expense(1)(32)(230)(2)(12)(277)
Transfer and other changes21876(103)7
Effect of changes in foreign exchange rates17441154
Net balance at December 31, 2022233811,387211152,017
Cost426372,957224633,923
Less accumulated depreciation and impairment(19)(256)(1,570)(13)(48)(1,906)
Net balance at December 31, 2022233811,387211152,017
(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2021203791,361132141,906
Additions6521696233
Disposals(1)(2)(1)(4)
Depreciation expense(1)(27)(210)(3)(12)(253)
Transfer and other changes15153(174)8(7)
Effect of changes in foreign exchange rates11257373
Net balance at December 31, 2021213741,411127151,948
Cost385902,750142573,577
Less accumulated depreciation and impairment(17)(216)(1,339)(15)(42)(1,629)
Net balance at December 31, 2021213741,411127151,948
Right-of-use assets
Right-of-use assets have been included in the same line item as that in which a corresponding owned asset would be presented.
(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2022108651174
Additions11718
Disposals(1)(1)
Depreciation expense(12)(20)(1)(33)
Effect of changes in foreign exchange rates33
Net balance at December 31, 202210754161
Cost1611461308
Less accumulated depreciation and impairment(54)(92)(1)(147)
Net balance at December 31, 202210754161
(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2021112722186
Additions5712
Depreciation expense(11)(16)(1)(28)
Transfer and other changes(1)(1)
Effect of changes in foreign exchange rates235
Net balance at December 31, 2021108651174
Cost1501443297
Less accumulated depreciation and impairment(42)(79)(2)(123)
Net balance at December 31, 2021108651174
The total expense relating to short-term leases, low value asset leases and variable lease payments that are still recognized as operating expenses was €15 million, €12 million and €11 million for the years ended December 31, 2022, 2021 and 2020 respectively.
Depreciation expense
Total depreciation expense relating to property, plant and equipment and intangible assets are presented in the Consolidated Income Statement as follows:
Year ended December 31,
(in millions of Euros)202220212020
Cost of sales(270)(245)(240)
Selling and administrative expenses(12)(17)(14)
Research and development expenses(5)(5)(5)
Total depreciation expense(287)(267)(259)
The amount of contractual commitments for the acquisition of property, plant and equipment is disclosed in NOTE 28 - Commitments.
Impairment tests for property, plant and equipment and intangibles assets
Impairment tests at December 31, 2022 and 2021
No triggering events were identified at December 31, 2022 and 2021 for our Cash Generating Units (“CGUs”).
Impairment tests at December 31, 2020
At December 31, 2020, the downturn in the aerospace industry resulting from the COVID-19 pandemic was identified as an indicator of impairment for all the CGUs in the A&T segment.
As a result, these CGUs were tested for impairment and their value in use was calculated using discounted cash flows based on a financial forecast for the period 2021-2025 prepared by management and reflecting its best estimates at the time. Based on this analysis, the conclusion to fully impair these two CGUs for €16 million (€9 million for the Montreuil-Juigné plant and €7 million for the Ussel plant) was reached in the year ended December 31, 2020.
The Group also tested the sensitivity of two other A&T CGUs to changes in cash flows, in discount rates, and in perpetuity growth rates, and determined that no impairment was appropriate.
At December 31, 2020, management also reviewed the CGUs in the AS&I segment and identified an indicator of impairment for two Automotive Structures plants - Nanjing, China and White, Georgia, U.S. The two CGUs were tested for impairment and their values in use were calculated using discounted cash flows and a discount rate of 9%. Based on this analysis, the conclusion to fully impair the Nanjing plant for €12 million was reached in the year ended December 31, 2020. The White Georgia plant was partially impaired for €13 million, leading to a carrying value of €11 million at December 31, 2020.
There were no other impairment indicators identified for our other CGUs at December 31, 2020.

v3.22.4
INTANGIBLE ASSETS AND GOODWILL
12 Months Ended
Dec. 31, 2022
Intangible assets and goodwill [abstract]  
INTANGIBLE ASSETS AND GOODWILL
NOTE 16 - INTANGIBLE ASSETS AND GOODWILL
(in millions of Euros)TechnologyComputer SoftwareCustomer relationshipsWork in ProgressOtherTotal Intangible AssetsGoodwill
Net balance at January 1, 20221821132458451
Additions33
Amortization expense(2)(7)(1)(10)
Transfer2(2)
Effect of changes in foreign exchange rates21327
Net balance at December 31, 20221816133454478
Cost92944244236478
Less accumulated depreciation and impairment(74)(78)(29)(1)(182)
Net balance at December 31, 20221816133454478
(in millions of Euros)TechnologyComputer SoftwareCustomer relationshipsWork in ProgressOtherTotal Intangible Assets Goodwill
Net balance at January 1, 202118151313261417
Additions44
Amortization expense(1)(12)(1)(14)
Transfer 17(15)24
Effect of changes in foreign exchange rates111334
Net balance at December 31, 20211821132458451
Cost86914034224451
Less accumulated depreciation and impairment(68)(70)(27)(1)(166)
Net balance at December 31, 20211821132458451
Impairment tests for goodwill
Goodwill in the amount of €478 million was allocated to our operating segments: €471 million to P&ARP, €5 million to A&T and €2 million to AS&I.
At December 31, 2022, the recoverable amount of our operating segments was determined based on value in use calculations, using discounted cash-flows.
The recoverable amount of the A&T and AS&I operating segments significantly exceeded their carrying value. No reasonable change in the assumptions used could have led to a potential impairment charge.
For the P&ARP operating segment, the analysis was based on forecasted cash flows that grow to management’s estimate of a normalized level by 2027 and then at a long term growth rate of 1.5% thereafter. The discount rate applied to the cash-flow projections was 9%. Based on this analysis, the carrying value of €1.6 billion remained below the recoverable value which was in excess of €2 billion at December 31, 2022 and therefore there was no goodwill impairment at the P&ARP operating segment.
With cash-flows 40% lower from 2023 to 2027 including the terminal year cash flow, the recoverable value still exceeded the carrying value.

v3.22.4
DEFERRED INCOME TAXES
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
DEFERRED INCOME TAXES
NOTE 11 - INCOME TAX
Year ended December 31,
(in millions of Euros)202220212020
Current tax expense (22)(26)(14)
Deferred tax benefit / (expense) 127(29)31
Income tax benefit / (expense)105(55)17
The Group’s effective tax rate reconciliation is as follows:
Year ended December 31,
(in millions of Euros)202220212020
Income / (loss) before tax 203317(34)
Statutory tax rate applicable to the parent company 25.8%28.4%32.0%
Income tax (expense) / benefit calculated at statutory tax rate (52)(90)11
Effect of foreign tax rate (A)3152
Changes in recognized and unrecognized deferred tax assets (B)1542415
Other (4)(11)
Income tax benefit / (expense) 105(55)17
Effective income tax rate (52)%17%49%
(A)For the years ended December 31, 2022, 2021 and 2020, the Effect of foreign tax rate resulted from the geographical mix of our pre-tax results.
(B)For the year ended December 31, 2022, the changes in recognized and unrecognized deferred tax assets mainly related to the recognition of previously unrecognized deferred tax assets at one of our main operating entities in the United States for €154 million (see NOTE 17 - Deferred Income Taxes). For the year ended December 31, 2021, the changes mainly related to the recognition of deferred tax assets on temporary differences at one of our main operating entities in the United States. For the year ended December 31, 2020, the changes mainly related to recognized deferred tax assets on prior-year losses carried forward at one of our main operating entities in the United States, following some clarification on U.S. interest limitation rules and the CARES Act.
NOTE 17 - DEFERRED INCOME TAXES
Recognized Deferred Tax Assets
At December 31,
(in millions of Euros)20222021
Deferred income tax assets 271162
Deferred income tax liabilities (28)(14)
Net deferred income tax assets 243148
At January 1, 2022Reclassified as held for saleRecognized inFXAt December 31, 2022
(in millions of Euros)Profit or lossOCI
Long-term assets (124)(2)31(7)(102)
Inventories 3(4)(1)(2)
Pensions 119(10)(35)478
Derivative valuation (6)824
Tax losses carried forward 117676190
Other (A)3935175
Net deferred income tax assets 148(2)127(33)3243
(A)At December 31, 2022, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.
At January 1, 2021Recognized inFXAt December 31,
2021
(in millions of Euros)Profit or lossOCI
Long-term assets (106)(10)(8)(124)
Inventories 5(2)3
Pensions 1265(17)5119
Derivative valuation (5)(5)4(6)
Tax losses carried forward 116(7)8117
Other (A)47(10)239
Net deferred income tax assets 183(29)(13)7148
(A)At December 31, 2021, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.
Unrecognized Deferred Tax Assets
Based on the expected taxable income of the entities, the Group believed that it was more likely than not that a total of €199 million and €805 million at December 31, 2022 and 2021, respectively, of unused tax losses and deductible temporary differences, would not be used. Consequently, the corresponding net deferred tax assets were not recognized. The related tax impact of €48 million and €191 million at December 31, 2022 and 2021, respectively, was attributable to the following:
At December 31,
(in millions of Euros)20222021
Expiring within 5 years (5)(3)
Expiring after 5 years and limited (5)(55)
Unlimited (21)(27)
Tax losses (31)(85)
Long-term assets (2)(65)
Pensions (3)(7)
Other (12)(34)
Deductible temporary differences (17)(106)
Total (48)(191)
Recognition of Deferred Tax Assets
Some deferred tax assets in respect of temporary differences and unused tax losses were recognized without being offset by deferred tax liabilities.
In accordance with the accounting policies described in note 2.6 of the Consolidated Financial Statements, a detailed assessment was performed on net deferred tax asset recovery at December 31, 2022, with specific focus on tax jurisdictions with unused tax losses carried forward.
At December 31, 2021, most of the the tax loss carryforwards as well as the deductible temporary differences on long-term assets and other differences resided at one of our main operating entities in the United States. An assessment was performed on the recoverability of the deferred tax assets associated with the deductible temporary differences and tax losses. Management concluded that it was more likely than not that the entity would not be able to use the tax benefits associated with the deductible temporary differences and tax losses. Consequently, the related deferred tax assets were not recognized.
In the year ended December 31, 2022, management determined that it is more likely than not that future earnings will be sufficient to realize these previously unrecognized deferred tax assets. In making this determination management considered all available positive and negative evidence including historical results as well as forecasted profitability supported by revised projections from the Group’s latest long-term plan. Accordingly, the Group recognized a deferred tax asset and a corresponding income tax benefit of €154 million in the year ended December 31, 2022.
Management considered that the tax losses related to the other tax jurisdictions that generated the deferred tax assets were not expected to be recurring and did not challenge the profitable long-term structure of its business model. In addition, tax planning opportunities are available to increase the taxable profit and the use the long-term limited and unlimited tax losses.
Management concluded that it was more likely than not that the net deferred tax asset balance of €243 million and €148 million at December 31, 2022 and 2021, respectively, would be recoverable.

v3.22.4
DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE
12 Months Ended
Dec. 31, 2022
Non-Current Assets Held For Sale And Discontinued Operations [Abstract]  
DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE
NOTE 18 - DISPOSAL GROUPS CLASSIFIED AS HELD FOR SALE
In the quarter ended December 31, 2022, the Group determined that Constellium Ussel, one of the entities in the Aerospace and Transportation operating segment, met the criteria to be classified as a disposal group held for sale. As a result, the related assets and liabilities were presented as held for sale at December 31, 2022. The sale of this entity was completed in February 2023 (see NOTE 32 - Subsequent Events).
No impairment loss was recognized on the reclassification as held for sale.
At December 31,
(in millions of Euros)2022
Assets of disposal group classified as held for sale
Cash and cash equivalents1
Trade receivables and other6
Inventories5
Deferred tax assets2
Total assets of disposal group classified as held for sale14
Liabilities of disposal group classified as held for sale
Trade payables and other8
Pensions and other post-employment benefit obligations2
Total liabilities of disposal group classified as held for sale10

v3.22.4
TRADE PAYABLES AND OTHER
12 Months Ended
Dec. 31, 2022
Trade and other payables [abstract]  
TRADE PAYABLES AND OTHER
NOTE 19 - TRADE PAYABLES AND OTHER
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Trade payables1,1551,065
Fixed assets payables3622
Employees' entitlements195185
Taxes payable other than income tax1716
Contract liabilities and other liabilities to customers2055477
Other payables2392812
Total other4331232312
Total trade payables and other431,467321,377
Contract liabilities and other liabilities to customers
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Deferred tooling revenue193
Advance payment from customers67
Unrecognized variable consideration (A)149167
Other3
Total contract liabilities and other liabilities to customers2055477
(A)Unrecognized variable consideration consists of expected volume rebates, discounts, incentives, refunds penalties and price concessions.
Revenue of €58 million that related to contract liabilities at at January 1, 2022 was recognized in the year ended December 31, 2022. Revenue of €60 million generated in the year ended December 31, 2022 was deferred.
Revenue of €33 million that related to contract liabilities at January 1, 2021 was recognized in the year ended December 31, 2021. Revenue of €36 million generated in the year ended December 31, 2021 was deferred.

v3.22.4
BORROWINGS
12 Months Ended
Dec. 31, 2022
Borrowings [abstract]  
BORROWINGS
NOTE 20 - BORROWINGS
20.1 Analysis by nature
At December 31,
20222021
(in millions of Euros)Nominal Value in CurrencyNominal rateNominal Value in Euros(Arrange-ment fees) Accrued interestsCarrying valueCarrying
value
Secured Pan-U.S. ABL
(due 2026) (A)
$85 Floating80181
Secured PGE French Facility
(repaid in May 2022) (B)
180 Floating180
Senior Unsecured Notes (C)
Issued November 2017 anddue 2026 $300 5.875 %281(2)6285268
Issued November 2017 anddue 2026 400 4.250 %400(3)6403402
Issued June 2020 anddue 2028 $325 5.625 %305(5)1301284
Issued February 2021 anddue 2029 (D)$500 3.750 %469(6)4467438
Issued June 2021 anddue 2029 (D)300 3.125 %300(4)4300300
Unsecured Swiss Facility
(repaid in June 2022)
CHF15 1.175 %14
Lease liabilities 1671168183
Other loans (E)515160
Total Borrowings2,053(20)232,0562,129
Of which non-current1,9081,871
Of which current148258
(A)In June 2022, the Pan-U.S. ABL was amended to, among other things, increase the commitment to $500 million, provide an incremental revolving credit facility accordion of up to $100 million, and replace the LIBOR reference rate by the SOFR reference rate.
(B)The initial maturity date of the PGE was May 2021 with an option for Constellium to extend for up to 5 years. In May 2021, the maturity date was extended to May 2022. In May 2022, the PGE was repaid accordingly.
(C)The Senior Unsecured Notes were issued by Constellium SE and are guaranteed by certain subsidiaries.
(D)For the $500 million Sustainability-Linked Senior Notes issued in February 2021 and the €300 million Sustainability-Linked Senior Notes issued in June 2021, Constellium has established two sustainability performance targets (greenhouse gas emissions intensity and recycled metal input). If Constellium does not satisfy the first target for the year ended December 31, 2025, the interest rates for both Notes will be increased by 0.125% starting April 15, 2026 and July 15, 2026 respectively. If Constellium does not satisfy the second target for the year ended December 31, 2026, the interest rates will be increased by 0.125% starting April 15, 2027 and July 15, 2027, respectively (in addition to any increase arising from failure to meet the first target). At December 31, 2022, the Group expects to satisfy these targets.
(E)At December 31, 2022 Other loans included €36 million of financial liabilities relating to the sale and leaseback of assets that were considered to be financing arrangements in substance.
20.2 Undrawn credit facilities and overdraft arrangements
At December 31, 2022, the Group had a €100 million Secured Inventory facility in place. This committed asset-based credit facility matures in April 2023 and was undrawn at December 31, 2022. The Group also uses a €50 million Money Market facility, as well as overdraft agreements with its commercial banks for cash management purposes. These arrangements are uncommitted and were undrawn at December 31, 2022.
20.3 Securities against borrowings and covenants
Assets pledged as security
Constellium has pledged assets and financial instruments as collateral against certain of its borrowings.
Pan-U.S. ABL
Obligations under this facility are, subject to certain permitted liens, secured by substantially all assets of Ravenswood, Muscle Shoals, and Bowling Green.
French Inventory Facility
Obligations under the Secured Inventory Facility of Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S. (the “French Inventory Facility”) are secured by possessory and non-possessory pledges of the eligible inventory of Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S.
Lease liabilities
Lease liabilities are generally secured as the rights to the leased assets recognized in the financial statements revert to the lessor in the event of default.
Covenants
The Group was in compliance with all applicable debt covenants at and for the years ended December 31, 2022 and 2021.
Constellium SE Senior Notes
The indentures for our outstanding Senior Notes contain customary terms and conditions, including amongst other things, limitations on incurring or guaranteeing additional indebtedness, on paying dividends, on making other restricted payments, on creating restrictions on dividends and other payments to us from certain of our subsidiaries, on incurring certain liens, on selling assets and subsidiary stock, and on merging.
Pan-U.S. ABL
This facility contains a fixed charge coverage ratio covenant along with customary affirmative and negative covenants. Evaluation of compliance with the maintenance covenants is only required if the excess availability falls below 10% of the aggregate revolving loan commitment.
20.4 Movements in borrowings
(in millions of Euros)20222021
At January 1, 2,1292,391
Cash flows
Proceeds from issuance of long-term borrowings (A)712
Repayments of long-term borrowings (B)(192)(1,052)
Net change in revolving credit facilities and short-term borrowings (C)72(5)
Lease repayments(37)(32)
Payment of deferred financing costs(13)
Non-cash changes
Movement in accrued interest(1)(11)
Changes in leases and other loans1818
Deferred arrangement fees 316
Effects of changes in foreign exchange rates64105
At December 31,2,0562,129
(A)In February 2021, Constellium SE issued $500 million 3.750% Sustainability-Linked Senior Notes (€412 million converted at the issuance date exchange rate). In June 2021, Constellium SE issued €300 million 3.125% Sustainability-Linked Senior Notes.
(B)For the twelve months ended December 31, 2022, repayments of long-term borrowings included the repayment of the PGE.
In February 2021, Constellium SE tendered and redeemed the $650 million 6.625% Senior Notes due 2025 (€536 million converted at the redemption date exchange rate). In June 2021, Constellium SE redeemed the $400 million 5.750% Senior Notes due 2024 (€328 million converted at the redemption date exchange rate). In November 2021, Constellium SE partially redeemed $200 million ( €177 million converted at the repayment date exchange rate) of the $500 million outstanding aggregate principal amount of the 5.875% Senior Notes due 2026.
(C)For the twelve months ended December 31, 2022, the net change in revolving credit facilities and short-term borrowings included the net proceeds from the Pan-U.S. ABL and the repayment of the Swiss facility.
20.5 Currency concentration
At December 31,
(in millions of Euros)20222021
U.S. Dollar1,1881,055
Euro8611,048
Other currencies726
Total borrowings2,0562,129

v3.22.4
FINANCIAL INSTRUMENTS
12 Months Ended
Dec. 31, 2022
Disclosure of detailed information about financial instruments [abstract]  
FINANCIAL INSTRUMENTS
NOTE 21 - FINANCIAL INSTRUMENTS
21.1 Financial assets and liabilities by categories
At December 31,
20222021
(in millions of Euros)NotesAt amortized costAt fair value through profit and lossAt fair value through OCITotalAt amortized costAt fair value through profit and lossAt fair value through OCITotal
Cash and cash equivalents12166166147147
Trade receivables 13465465603603
Other financial assets372397070
Total1663746767014770603820
At December 31,
20222021
(in millions of Euros)NotesAt amortized costAt fair value through profit and lossAt fair value through OCITotalAt amortized costAt fair value through profit and lossAt fair value through OCITotal
Trade payables and fixed asset payables191,1911,1911,0871,087
Borrowings202,0562,0562,1292,129
Other financial liabilities40155526531
Total3,24740153,3023,2162653,247
21.2 Fair values
The carrying value of the Group’s borrowings at maturity is the redemption value.
The fair value of Constellium SE Senior Notes issued in November 2017, June 2020, February 2021 and June 2021 account for 97%, 92%, 82% and 80% respectively of the nominal value and amount to €657 million, €282 million, €385 million and €239 million, respectively, at December 31, 2022.
All derivatives are presented at fair value in the Consolidated Statement of Financial Position. The fair values of trade receivables, other financial assets and liabilities approximate their carrying values, as a result of their liquidity or short maturity.
At December 31,
20222021
(in millions of Euros)Non-currentCurrentTotalNon-currentCurrentTotal
Aluminium and premium derivatives27993847
Energy derivatives325112
Other commodity derivatives2244
Currency commercial derivatives3202321416
Currency net debt derivatives11
Other financial assets - derivatives83139125870
Aluminium and premium derivatives19191414
Energy derivatives3710
Other commodity derivatives11
Currency commercial derivatives11142561117
Other financial liabilities - derivatives14415562531
In the year ended December 31, 2021, forward purchases of $565 million versus the Euro using cross currency basis swaps were not renewed when they reached their maturity or were bought out before their initial maturity in connection with the refinancing of the Senior Notes. This transaction generated a cash outflow of €32 million which is presented in Other financing activities within the Consolidated Statement of Cash Flows in the year ended December 31, 2021.
21.3 Valuation hierarchy
The following table provides an analysis of financial instruments measured at fair value, grouped into levels based on the degree to which the fair value is observable:
Level 1 is based on a quoted price (unadjusted) in active markets for identical financial instruments. Level 1 includes aluminium, copper and zinc futures that are traded on the LME.
Level 2 is based on inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly (i.e. prices) or indirectly (i.e. derived from prices). Level 2 includes foreign exchange derivatives and natural gas derivatives. The present value of future cash flows based on the forward or on the spot exchange rates at the balance sheet date is used to value foreign exchange derivatives.
Level 3 is based on inputs for the asset or liability that are not based on observable market data (unobservable inputs). Trade receivables are classified as a Level 3 measurement under the fair value hierarchy.
At December 31,
20222021
(in millions of Euros)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Other financial assets - derivatives63339412970
Other financial liabilities - derivatives173855131831
There was no material transfer of asset and liability categories into or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2022 and 2021.

v3.22.4
FINANCIAL RISK MANAGEMENT
12 Months Ended
Dec. 31, 2022
Disclosure of financial risk management [Abstract]  
FINANCIAL RISK MANAGEMENT
NOTE 22 - FINANCIAL RISK MANAGEMENT
The Group’s financial risk management strategy focuses on minimizing the cash flow impacts of volatility in foreign currency exchange rates and metal prices, while maintaining the financial flexibility the Group requires in order to successfully execute its business strategy.
Due to Constellium’s capital structure and the nature of its operations, the Group is exposed to the following financial risks: (i) market risk including foreign exchange, commodity price and interest rate risks; (ii) credit risk and (iii) liquidity risk.
22.1 Foreign exchange risk
Foreign exchange risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates.
Net assets, earnings and cash flows are influenced by multiple currencies due to the geographic diversity of sales and the countries in which the Group operates.
Constellium has the following foreign exchange risk: i) transaction exposures, which include commercial transactions related to forecasted sales and purchases and on-balance sheet receivables/payables resulting from such transactions and financing transactions related to external and internal net debt, and ii) translation exposures, which relate to net investments in foreign entities that are converted in Euros in the Consolidated Financial Statements.
i. Commercial transaction exposures
The Group policy is to hedge committed and highly probable forecasted foreign currency operational transactions. The Group uses foreign exchange forwards and foreign exchange swaps for this purpose.
The following tables outline the nominal value (converted to millions of Euros at the closing rate) of forward derivatives for Constellium’s most significant foreign exchange exposures at December 31, 2022.
Sold currenciesMaturity YearLess than 1 yearOver 1 year
USD2023-2025409186
CHF2023-20268229
CZK20233
Other currencies202310
Purchased currenciesMaturity YearLess than 1 yearOver 1 year
USD2023-202610925
CHF2023-202513416
CZK2023-20247820
Other currencies20231
The Group has agreed to supply a major customer with fabricated metal products from a Euro functional currency entity and invoices in U.S. Dollars. The Group has entered into significant foreign exchange derivatives that matched related highly probable future conversion sales. The Group designates these derivatives for hedge accounting, with a total nominal amount of $248 million and $274 million at December 31, 2022 and December 31, 2021 respectively, with maturities ranging from 2023 to 2025.
The table below details the effect of foreign currency derivatives in the Consolidated Income Statement and the Consolidated Statement of Comprehensive Income:
Year ended December 31,
(in millions of Euros)Notes202220212020
Derivatives that do not qualify for hedge accounting
Included in Other gains and losses - net
Realized gains / (losses) on foreign currency derivatives - net91(4)
Unrealized gains / (losses) on foreign currency derivatives - net (A)9615(9)
Derivatives that qualify for hedge accounting
Included in Other comprehensive income
Unrealized (losses) / gains on foreign currency derivatives - net(16)(21)20
Gains reclassified from cash flow hedge reserve to the Consolidated Income Statement846
Included in Revenue (B)
Realized losses on foreign currency derivatives - net
9(8)(2)(7)
Unrealized (losses) / gains on foreign currency derivatives - net9(2)1
Derivatives discontinued from hedge accounting
Included in Other gains and losses - net
Losses reclassified from OCI as a result of hedge accounting discontinuation (C)9(6)
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized.
(B)Changes in fair value of derivatives that qualify for hedge accounting are included in Revenue when the related customer invoices are issued.
(C)In the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for 2020 and 2021, to which hedge accounting was applied, was no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted a €6 million loss.
ii. Financing transaction exposures
When the Group enters into intercompany loans and deposits, the financing is generally provided in the functional currency of the subsidiary. The foreign currency exposure of the Group’s external funding and liquid assets is systematically hedged either naturally through intercompany foreign currency loans and deposits or through foreign currency derivatives.
At December 31, 2022, the net hedged position related to long-term and short-term loans and deposits in U.S. dollars included a forward sale of $115 million versus the Euro using simple foreign exchange forward contracts.
Year ended December 31,
(in millions of Euros)202220212020
Derivatives
Included in Finance costs - net
Realized gains / (losses) on foreign currency derivatives - net2(36)7
Unrealized (losses) / gains on foreign currency derivatives - net(1)46(39)
Total110(32)
In accordance with the Group policy, total realized and unrealized gains or losses on foreign currency derivatives are expected to offset the net foreign exchange result related to financing activities, both included in Finance costs - net.
Net debt derivatives settled during the year are presented in Other financing activities in the Consolidated Statement of Cash Flows.
Foreign exchange sensitivity on commercial and financing transaction exposures
The largest exposures of the Group are related to the Euro/U.S. Dollar exchange rate. The table below summarizes the impact on income and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro for non U.S. Dollar functional currency entities.
(in millions of Euros)Effect on income before taxEffect on pretax equity
Trade receivables3
Trade payables(1)
Derivatives on commercial transactions (A)(25)(24)
Net commercial transaction exposure(23)(24)
Cash in Bank and intercompany loans105
Borrowings(117)
Derivatives on financing transactions12
Net financing transaction exposure
Total(23)(24)
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized. The impact on pretax equity of €24 million relates to derivatives hedging the future sales spread from 2023 to 2025 which are designated as cash flow hedges.
The amounts shown in the table above may not be indicative of future results since the balances of financial assets and liabilities may change.
iii. Translation exposures
Foreign exchange impacts related to the translation of net investments in foreign subsidiaries from functional currency to Euro, and of the related revenue and expenses, are not hedged as the Group operates in these various countries on permanent basis except as described below.
Foreign exchange sensitivity on translation exposures
The exposure relates to foreign currency translation of net investments in foreign subsidiaries and arises mainly from operations conducted by U.S. Dollar functional currency subsidiaries.
The table below summarizes the impact on income and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro (on average rate for income before tax and closing rate for pretax equity) for U.S. Dollar functional currency entities.
(in millions of Euros)Effect on income before taxEffect on pretax equity
10% strengthening U.S. Dollar/Euro23182
The amounts shown in the table above may not be indicative of future results since the balances of financial assets and liabilities may change.
22.2 Commodity price risk
The Group is subject to the effects of market fluctuations in the price of aluminium, which is the Group’s primary metal input and a significant component of its output. The Group is also exposed to variation in regional premiums and in the price of zinc, natural gas, silver and copper and other alloying metals but in a less significant way.
The Group policy is to minimize exposure to aluminium price volatility by passing through the aluminium price risk to customers and using derivatives where necessary. For most of its aluminium price exposure, sales and purchases of aluminium are converted to be on the same floating basis and then the same quantities are bought and sold at the same market price.
Temporary increases in inventory, to the extent material, are sold forward to the expected sales date to ensure the price paid for the metal will be redeemed when it is sold.
The Group also purchases fixed price copper, aluminium premium, silver and zinc derivatives to offset the commodity exposure where sales contracts have embedded fixed price agreements for these commodities.
In addition, the Group purchases natural gas fixed price derivatives to lock in energy costs where a fixed price purchase contract is not possible.
At December 31, 2022, the nominal amount of commodity derivatives is as follows:
(in millions of Euros)MaturityLess than 1 yearOver 1 year
Aluminium 2023-20242905
Premium 2023-2025185
Copper 202312
Silver 2023-202418
Natural gas2023-20263129
Zinc20238
The value of the contracts will fluctuate due to changes in market prices but our hedging strategy helps protect the Group’s margin on future conversion and fabrication activities. At December 31, 2022, these contracts were directly entered into with external counterparties.
The Group does not apply hedge accounting on commodity derivatives and therefore mark-to-market movements are recognized in Other gains and losses - net.
Year ended December 31,
(in millions of Euros)202220212020
Derivatives
Included in Other gains and losses - net
Realized (losses) / gains on commodity derivatives - net
(6)112(31)
Unrealized (losses) / gains on commodity derivatives - net(53)2425
Commodity price sensitivity: risks associated with derivatives
The net impact on earnings and equity of a 10% increase in the market price of aluminium, based on the aluminium derivatives held by the Group at December 31, 2022 (before tax), with all other variables held constant, was estimated to be a €28 million gain. The balances of these financial instruments may change in future years, and therefore these amounts may not be indicative of future results.
22.3 Interest rate risk
Interest rate risk is the risk that the fair value or future cash flows of financial instruments will fluctuate because of changes in market interest rates. The Group’s interest rate risk arises principally from borrowings. Borrowings issued at variable rates expose the Group to cash flow interest rate risk, which is partially offset by cash and cash equivalent deposits earning interest at variable interest rates. Borrowings issued at fixed rates expose the Group to fair value interest rate risk. At December 31, 2022, the Group’s borrowings were mainly at fixed rates.
Interest rate sensitivity: risks associated with variable-rate financial instruments
The impact on income before income tax of a 50 basis point increase or decrease in the LIBOR, EURIBOR or SOFR interest rates as applicable, based on the variable rate financial instruments held by the Group at December 31, 2022 and 2021, with all other variables held constant, was estimated to be approximately €3 million for the year ended December 31, 2022, and approximately €1 million for the year ended December 31, 2021. However, the balances of such financial instruments may not remain constant in future years, and therefore these amounts may not be indicative of future results.
22.4 Credit risk
Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Group is exposed to credit risk with financial institutions and other parties as a result of cash-in-bank, cash deposits, mark-to-market on derivative transactions and customer trade receivables arising from the Group’s operating activities. The maximum exposure to credit risk for the year ended December 31, 2022 is the carrying value of each class of financial asset as described in NOTE 21 - Financial Instruments. The Group does not generally hold any collateral as security.
i. Credit risk related to transactions with financial institutions
Credit risk with financial institutions is managed by the Group’s Treasury department in accordance with a Board approved policy. Management is not aware of any significant risks associated with financial institutions as a result of cash and cash equivalent deposits, including short-term investments and financial derivative transactions.
The number of financial counterparties tabulated below shows our exposure to the counterparty by rating type (Parent company ratings from Moody’s Investor Services):
At December 31,
20222021
Number of financial counterparties (A)Exposure (in millions of Euros)Number of financial counterparties (A)Exposure (in millions of Euros)
Rated Aa or better251354
Rated A61121398
Rated Baa13333
Total 916619185
(A)Financial counterparties for which the Group’s exposure is below €0.25 million have been excluded from the analysis.
ii. Credit risks related to customer trade receivables
The Group has a diverse customer base geographically and by industry. The responsibility for customer credit risk management rests with management. Payment terms vary and are set in accordance with practices in the different geographies and end-markets served. Credit limits are typically established based on internal or external rating criteria, which take into account such factors as the financial condition of the customers, their credit history and the risk associated with their industry segment.
Trade receivables are actively monitored and managed, at the business unit or site level. Business units report credit exposure information to Constellium management on a regular basis. Over 76% of the Group’s trade account receivables are insured by insurance companies rated A3 or better or sold to a factor on a non-recourse basis. In situations where collection risk is considered to be above acceptable levels, risk is mitigated through the use of advance payments, bank guarantees or letters of credit.
Historically, we have a very low level of customer default as a result of long history of dealing with our customer base and an active credit monitoring function. See NOTE 13 - Trade Receivables and Other for the aging of trade receivables.
22.5 Liquidity risk management
The Group’s capital structure includes shareholder’s equity, borrowings and various third-party financing arrangements. Constellium’s total capital is defined as total equity plus net debt. Net debt includes borrowings due to third parties less cash and cash equivalents.
Constellium’s overriding objectives when managing capital are to safeguard the business as a going concern, to maintain an optimal capital structure in order to minimize the weighted cost of capital, and to maximize returns for its owners.
All activities around cash funding, borrowings and financial instruments are centralized within Constellium’s Treasury department.
The liquidity requirements of the overall Company are funded by cash and drawings on available credit facilities, while the internal management of liquidity is optimized by means of cash pooling agreements and/or intercompany loans and deposits between the Company’s operating entities and central Treasury.
At December 31, 2022, the borrowing base for the Pan-U.S. ABL and the French Inventory Facility were €469 million and €100 million, respectively. After deduction of amounts drawn and letters of credit, the Group had €480 million outstanding availability under these revolving credit facilities.
At December 31, 2022, liquidity was €709 million, comprised of €166 million of cash and cash equivalents and €543 million of available undrawn facilities, including the €480 million described above.
At December 31, 2021, liquidity was €773 million, comprised of €147 million of cash and cash equivalents and €626 million of available undrawn facilities.
Margin calls
The Group’s financial institution counterparties may require margin calls should the mark-to-market of our derivatives hedging foreign exchange and commodity price risks exceed a pre-agreed contractual limit. In order to protect from potential margin calls for significant market movements, the Group enters into derivatives with a large number of financial counterparties and monitors margin requirements on a daily basis. In addition, the Group (i) ensures that financial counterparts hedging transactional exposure are also hedging foreign currency loan and deposit exposures and (ii) holds a significant liquidity buffer in cash or in availability under its various borrowing facilities.
At December 31, 2022 and 2021, there was no margin requirement paid as collateral to counterparties related to foreign exchange hedges nor related to aluminium or any other commodity hedges.
Undiscounted contractual financial assets and liabilities
The tables below show undiscounted contractual financial assets and financial liabilities values by relevant maturity groupings based on the remaining periods from December 31, 2022 and 2021, respectively, to the contractual maturity date.
At December 31,
20222021
(in millions of Euros)Less than 1 yearBetween 1- 5 yearsOver 5 yearsLess than 1 yearBetween 1 - 5 yearsOver 5 years
Financial assets
Net cash flows from derivative assets related to currencies and commodities3196012
Trade receivables 465603
Total496966312
At December 31,
20222021
(in millions of Euros)NotesLess than 1 yearBetween 1 - 5 yearsAfter 5 yearsLess than 1 yearBetween 1 - 5 YearsAfter 5 years
Financial liabilities
Borrowings56981,0871957101,046
Leases359886379985
Interest (A)78260547928596
Net cash flows from derivative liabilities related to currencies and commodities42192612
Trade payables and fixed asset payables191,1911,087
Total1,3511,0751,2271,4241,1061,227
(A)Interest disclosed is an undiscounted forecasted interest amount that excludes interest on leases.

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS
12 Months Ended
Dec. 31, 2022
Disclosure of employee benefits [Abstract]  
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS
NOTE 7 - EMPLOYEE BENEFIT EXPENSES
Year ended December 31,
(in millions of Euros)Notes202220212020
Wages and salaries(1,067)(920)(855)
Pension costs - defined benefit plans23(22)(24)(23)
Other post-employment benefits23(3)(8)(9)
Share-based compensation30(18)(15)(15)
Total employee benefit expenses(1,110)(967)(902)
NOTE 23 - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS
The Group has a number of pensions, other post-employment benefits and other long-term employee benefit plans. Some of these plans are defined contribution plans and some are defined benefit plans, with assets held in separate trustee-administered funds. Benefits paid through pension trusts are sufficiently funded to ensure the payment of benefits to retirees when they become due.
Actuarial valuations are reflected in the Consolidated Financial Statements as described in NOTE 2.6 - Principles governing the preparation of the Consolidated Financial Statements.
23.1 Description of the plans
Pension plans
Constellium’s pension obligations are in the U.S., Switzerland, Germany and France. Pension benefits are generally based on the employee’s service and highest average eligible compensation before retirement and are periodically adjusted for cost of living increases, either by company practice, collective agreement or statutory requirement. Benefit plans in the U.S., Switzerland and France are funded through long-term employee benefit funds.
Other post-employment benefits (OPEB)
The Group provides healthcare and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents, mainly in the U.S. Eligibility for coverage depends on certain age and service criteria. These benefit plans are unfunded.
Other long-term employee benefits
Other long-term employee benefits mainly include jubilees in France, Germany and Switzerland and other long-term disability benefits in the U.S. These benefit plans are unfunded.
23.2 Description of risks
The defined benefit obligations expose the Group to a number of risks, including longevity, inflation, interest rate, medical cost inflation, investment performance, and change in law governing the employee benefit obligations. These risks are mitigated when possible by applying an investment strategy for the funded schemes that aims to reduce the volatility of returns and achieve a matching of the underlying liabilities to minimize the long-term costs. This is achieved by investing in a diversified selection of asset classes.
Investment performance risk
Our pension plan assets consist primarily of funds invested in listed stocks and bonds.
The present value of funded defined benefit obligations is calculated using a discount rate determined by reference to high-quality corporate bond yields. If the return on plan assets is below this rate, it will increase the plan deficit.
Interest rate risk
A decrease in the discount rate will increase the defined benefit obligation. At December 31, 2022, impacts of the change on the defined benefit obligation of a 50 basis points increase / decrease in the discount rates are calculated by using a proxy based on the duration of each scheme:
(in millions of Euros)50 bp increase in
discount rates
50 bp decrease in
discount rates
France (6)7
Germany(5)5
Switzerland(16)17
United States(19)23
Total sensitivity on Defined Benefit Obligations(46)52
Longevity risk
The present value of the defined benefit obligation is calculated by reference to the best estimate of the mortality of plan participants. An increase in the life expectancy of the plan participants will increase the plan’s liability.
23.3 Actuarial assumptions
Pension and other post-employment benefit obligations were updated based on the discount rates applicable at December 31, 2022.
At December 31,
20222021
Rate of increase in salariesRate of increase in pensionsDiscount rateRate of increase in salariesRate of increase in pensionsDiscount rate
Switzerland1.75%2.05%1.50%0.15%
U.S.
Hourly pension3.00%
5.00% - 5.05%
2.20%
2.80% - 2.95%
Salaried pension—%5.05%—%2.85%
OPEB (A)4.00%
5.00% - 5.05%
3.80%
2.85% - 2.95%
Other benefits3.80%
4.95% - 5.00%
3.80%
2.60% - 2.85%
France
2.20%
2.00%
1.80% - 3.80%
2.00%
Retirements3.80%1.00%
Other benefits3.80%0.90%
Germany2.50%2.00%3.75%2.50%1.80%1.05%
(A)The other main financial assumptions used for the OPEB healthcare plans, which are predominantly in the U.S. were:
Medical trend rate: i) pre-65: 6.75% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards and ii) post-65: 6.00% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards,
Claims costs based on Company experience.
For both pension and healthcare plans, the post-employment mortality assumptions allow for future improvements in life expectancy.
23.4 Amounts recognized in the Consolidated Statement of Financial Position
At December 31,
20222021
(in millions of Euros)Pension BenefitsOther BenefitsTotalPension BenefitsOther BenefitsTotal
Present value of funded obligation614614766766
Fair value of plan assets(461)(461)(544)(544)
Deficit of funded plans153153222222
Present value of unfunded obligation96154250128249377
Net liability / (asset) arising from defined benefit obligation249154403350249599
23.5 Movement in net defined benefit obligations
Year ended December 31, 2022
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20228942491,143(544)599
Included in the Consolidated Income Statement
Current service cost2082828
Interest cost / (income)13720(9)11
Past service cost2(49)(47)(47)
Immediate recognition of gains arising over the year(5)(5)(5)
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets107107
—changes in financial assumptions(211)(43)(254)(254)
—changes in demographic assumptions(1)(1)(1)
—experience losses(3)(9)(12)(12)
Effects of changes in foreign exchange rates341650(30)20
Included in the Consolidated Statement of Cash Flows
Benefits paid(42)(21)(63)57(6)
Contributions by the Group(38)(38)
Contributions by the plan participants426(6)
Reclassification as liabilities of disposal group classified as held for sale (1)(1)(1)
At December 31, 2022710154864(461)403
Year ended December 31, 2021
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20219062161,122(458)664
Included the Consolidated Income Statement
Current service cost2283030
Interest cost / (income)10515(6)9
Past service cost1313232
Immediate recognition of gains arising over the year
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets(56)(56)
—changes in financial assumptions(29)(9)(38)(38)
—changes in demographic assumptions(13)(13)(13)
—experience losses(9)(2)(11)(11)
Effects of changes in foreign exchange rates381755(32)23
Included in the Consolidated Statement of Cash Flows
Benefits paid(36)(18)(54)32(22)
Contributions by the Group(21)(21)
Contributions by the plan participants415(5)
At December 31, 20218942491,143(544)599
Movements in net defined benefit obligations reported in Other Comprehensive Income in the years ended December 31, 2022 and 2021, primarily reflected the impact of changes in discount rates (see note 23.3), the difference between actual returns and interest on plan assets and the impact of changes in foreign exchanges rates.
23.6 Ravenswood plan amendment
In October 2022, Constellium Rolled Products Ravenswood and United Steelworkers Local Union 5668 entered into a new three-year collective bargaining agreement. The agreement included changes in OPEB and pension benefits that are accounted for as a plan amendment in the year ended December 31, 2022. The changes resulted in a reduction of the OPEB obligation recorded as a gain from negative past service cost for €49 million and an increase of the pension obligation recorded as an additional past service costs for €2 million.
23.7 Ravenswood OPEB dispute
In 2018, the Group announced a plan to transfer certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan (“the Plan”) from a company-sponsored program to a third-party health network providing similar benefits at a lower cost. The United Steelworkers Local Union 5668 (the “Union”) contested this change in benefits and filed a lawsuit against Constellium Rolled Products Ravenswood, LLC ("Ravenswood") in a federal district court in West Virginia (the “District Court”) seeking to enjoin the Plan changes and to compel arbitration. The District Court issued an order in December 2018, enjoining Ravenswood from implementing the Plan amendments pending resolution in arbitration. In September 2019, the arbitrator issued a decision ruling against Ravenswood and sustaining the Union’s grievance. Ravenswood filed a motion in the District Court to vacate this decision, which was denied in June 2020. In July 2020, Ravenswood appealed that denial to the Fourth Circuit Court of Appeals. In November 2021, the Fourth Circuit Court issued an opinion in favor of the Union, and the Group elected not to further pursue legal action on this matter.
The Group recognized a gain of €36 million from negative past service cost in the year ended December 31, 2018, reflecting its decision to amend the plan benefits and its determination at the time that it was probable that it would ultimately prevail in the dispute with the Union. This gain was partially reversed in the years ended December 31, 2019 and 2020, to reflect delays in the estimated implementation timetable as a result of the dispute with the Union. The Group recognized a loss
of €31 million from past service cost in the year ended December 31, 2021, following the Fourth Circuit Court's ruling in favor of the Union.
23.8 Net defined benefit obligations by country
At December 31,
20222021
(in millions of Euros)Defined benefit obligationsPlan assetsNet defined benefit liabilityDefined benefit obligationsPlan assetsNet defined benefit liability
France117(6)111158(5)153
Germany100(1)99134(2)132
Switzerland249(236)13306(268)38
United States398(218)180545(269)276
Total864(461)4031,143(544)599
23.9 Plan asset categories
At December 31,
20222021
(in millions of Euros)Quoted in an active marketNot quoted in an active marketTotalQuoted in an active marketNot quoted in an active marketTotal
Cash & cash equivalents4444
Equities873612311561176
Bonds14680226149110259
Property146074165571
Other34343434
Total fair value of plan assets251210461284260544
23.10 Cash flows
Expected contributions to pension and other benefit plans amount to €23 million and €16 million, respectively, for the year ending December 31, 2023.
Future benefit payments expected to be paid either by pension funds or directly by the Company to beneficiaries are as follows:
(in millions of Euros)Estimated benefits payments
Year ended December 31,
202356
202456
202557
202657
202760
2028 to 2032328
The weighted-average maturity of the defined benefit obligations was 11.2 and 14.2, respectively, for the years ended December 31, 2022 and 2021.

v3.22.4
PROVISIONS
12 Months Ended
Dec. 31, 2022
Disclosure of other provisions [abstract]  
PROVISIONS
NOTE 24 - PROVISIONS
(in millions of Euros)Close down and environmental remediation costsRestructuring
 costs
Legal claims
and other costs
Total
At January 1, 202288227117
Allowance336
Amounts used(3)(2)(2)(7)
Unused amounts reversed(4)(4)
Unwinding of discounts and change in discount rates(5)(5)
Effects of changes in foreign exchange rates314
At December 31, 20228625111
Of which current12921
Of which non-current741690
Total provisions8625111
(in millions of Euros)Close down and environmental remediation costsRestructuring
 costs
Legal claims
and other costs
Total
At January 1, 202188627121
Allowance43411
Amounts used(1)(6)(2)(9)
Unused amounts reversed(2)(1)(6)(9)
Unwinding of discounts and change in discount rates(1)(1)
Effects of changes in foreign exchange rates44
Transfer(4)4
At December 31, 202188227117
Current711220
Non-Current8111597
Total Provisions88227117
Close down, environmental and remediation costs
The Group records provisions for the estimated present value of the costs of its environmental clean-up obligations and close down and restoration efforts based on the net present value of estimated future costs of the dismantling and demolition of infrastructure and the removal of residual material of disturbed areas.
These provisions are expected to be settled over the next 40 years depending on the nature of the disturbance and the technical remediation plans.
Legal claims and other costs
At December 31,
(in millions of Euros)20222021
Litigation1516
Disease claims (A)109
Other2
Total provisions for legal claims and other costs2527
(A)Since the early 1990s, certain activities of the Group’s businesses have been subject to claims and lawsuits in France relating to occupational diseases resulting from alleged asbestos exposure, such as mesothelioma and asbestosis. It is not uncommon for the investigation and resolution of such claims to go on over many years as the latency period for developing such diseases is typically
between 25 and 40 years. For any such claim, it is up to the social security authorities in each jurisdiction to determine if a claim qualifies as an occupational illness claim. If so determined, the Group must settle the case or defend its position in court. At December 31, 2022, six cases in which gross negligence is alleged (“faute inexcusable”) are outstanding (five at December 31, 2021), the average amount per claim being around €0.4 million. The average settlement amount per claim over the past five years was less than €0.5 million. It is not anticipated that the resolution of such litigation and proceedings will have a material effect on the future results from continuing operations, financial position, or cash flows of the Group.
Contingencies
The Group is involved, and may become involved, in various lawsuits, claims and proceedings relating to customer claims, product liability, employee and retiree benefit matters and other commercial matters. The Group records provisions for pending litigation matters when it determines that it is probable that an outflow of resources will be required to settle the obligation, and such amounts can be reasonably estimated. In some proceedings, the issues raised are or can be highly complex and subject to significant uncertainties and amounts claimed are and can be substantial. As a result, the probability of loss and an estimation of damages are and can be difficult to ascertain. In exceptional cases, when the Group considers that disclosures relating to provisions and contingencies may prejudice its position, disclosures are limited to the general nature of the dispute.

v3.22.4
NON-CASH INVESTING AND FINANCING TRANSACTIONS
12 Months Ended
Dec. 31, 2022
Disclosure of cash flow statement [Abstract]  
NON-CASH INVESTING AND FINANCING TRANSACTIONS
NOTE 25 - NON-CASH INVESTING AND FINANCING TRANSACTIONS
Property, plant and equipment acquired through leases or financed by third parties amounted to €18 million, €18 million and €66 million for the years ended December 31, 2022, 2021 and 2020, respectively. These leases and financings are excluded from the Statement of Cash Flow as they are non-cash investing transactions.
Fair values of vested Restricted Stock Units and Performance Stock Units amounted to €15 million for the years ended December 31, 2022 and 2021, and €14 million for the year ended December 31, 2020, respectively. They are excluded from the Statement of Cash flows as non-cash financing activities.

v3.22.4
SHARE CAPITAL
12 Months Ended
Dec. 31, 2022
Disclosure of share capital, reserves and other equity interest [Abstract]  
SHARE CAPITAL
NOTE 26 - SHARE CAPITAL
Share capital amounted to €2,886,031.84 at December 31, 2022, divided into 144,301,592 ordinary shares, each with a nominal value of two cents and fully paid-up. All shares are of the same class and have the right to one vote.
(in millions of Euros)
Number of sharesShare capitalShare premium
At January 1, 2022141,677,3663420
New shares issued (A)2,624,226
At December 31, 2022144,301,5923420
(A)In the year ended December 31, 2022, Constellium SE issued and delivered 2,624,226 ordinary shares to certain employees and directors related to share-based compensation plans.

v3.22.4
COVID-19-RELATED GOVERNMENT ASSISTANCE
12 Months Ended
Dec. 31, 2022
Government Grants [Abstract]  
COVID-19-RELATED GOVERNMENT ASSISTANCE
NOTE 27 - COVID-19-RELATED GOVERNMENT ASSISTANCE
In the year ended December 31, 2020, the Group received government assistance in various forms, including government-guaranteed credit facilities in France, Germany, and Switzerland (see NOTE 20 - Borrowings), as well as subsidies to compensate for the cost of employees furloughed as a result of the COVID-19 pandemic in various jurisdictions. These subsidies were recognized where there was reasonable assurance that they would be received and the Company was able to meet all of the associated conditions. For the year ended December 31, 2020, COVID-19-related subsidies in the amount of €22 million were accounted for as a deduction of employee benefit expenses.

v3.22.4
COMMITMENTS
12 Months Ended
Dec. 31, 2022
Disclosures of commitments [Abstract]  
COMMITMENTS
NOTE 28 - COMMITMENTS
Non-cancellable lease commitments
Non-cancellable lease commitments relating to the future aggregate minimum lease payments under non-cancellable leases still recognized as expense are presented below:
At December 31,
(in millions of Euros)20222021
Less than 1 year33
1 to 5 years93
More than 5 years2
Total non-cancellable minimum lease payments128
Tangible and intangible asset commitments
Contractual commitments for the acquisition of Property, Plant and Equipment are presented below:
At December 31,
(in millions of Euros)20222021
Property, plant and equipment16665
Total tangible and intangible asset commitments16665

v3.22.4
RELATED PARTIES
12 Months Ended
Dec. 31, 2022
Disclosure of transactions between related parties [abstract]  
RELATED PARTIES
NOTE 29 - RELATED PARTIES
Subsidiaries and affiliates
A list of the principal companies controlled by the Group or over which the Group has significant influence is presented in NOTE 31 - Subsidiaries and Affiliates. Transactions between consolidated companies are eliminated when preparing the Consolidated Financial Statements.
Shareholders
One of our French entities entered into a fully committed term loan facility with a syndicate of banks (the “PGE French Facility”) on May 13, 2020 for an aggregate amount of up to €180 million, of which 80% is guaranteed by the French State. Bpifrance Financement, an affiliate of one of the shareholders of Constellium SE, Bpifrance Participations S.A., provided €30 million of the PGE French Facility. The initial maturity date of the PGE was May 2021 with an option for Constellium to extend for up to 5 years. In May 2021, the maturity date was extended to May 2022. In May 2022, the PGE was repaid accordingly.
Key management remuneration
The Group’s key management comprises the Board members and the Executive committee members effectively present in 2022.
Executive officers who are members of the Executive committee are those persons having authority and responsibility for planning, directing and controlling the activities of the Company, and typically directly reporting to the CEO.
The costs reported below are compensation and benefits for key management:
Short term employee benefits include their base salary plus bonus and other in-kind benefits;
Directors’ fees include annual retainers fees, committee membership fees, chair fees and cash paid in lieu of RSU grant for 2022;
Share-based compensation includes the portion of the IFRS 2 expense as allocated to key management;
Post-employment benefits mainly include pension costs;
Termination benefits include departure costs.
As a result, the aggregate compensation for the Group’s key management is comprised of the following:
Year ended December 31,
(in millions of Euros)202220212020
Short-term employee benefits1289
Directors' fees211
Share-based compensation10910
Post-employments benefits
Termination benefits
Employer social contribution211
Total261921

v3.22.4
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2022
Share-based payment arrangements [Abstract]  
SHARE-BASED COMPENSATION
NOTE 30 - SHARE-BASED COMPENSATION
Description of the plans
Performance-Based Restricted Stock Units Award Agreements (equity-settled)
The Company has periodically granted Performance Stock Units (PSUs) to selected employees and to the CEO. These units vest after three years from the grant date if the following conditions are met:
A vesting condition under which the beneficiaries must be continuously employed by or at the service of the Company through the end of the vesting period; and
A performance condition, contingent on the TSR performance of Constellium shares over the vesting period compared to the TSR of specified indices. PSUs will ultimately vest based on a vesting multiplier which ranges from 0% to 200%.
The PSUs granted in July 2017 achieved a TSR performance of 186.8%. These PSUs vested in July 2020 and 1,458,985 shares were granted to beneficiaries.
The PSUs granted in May 2018 achieved a TSR performance of 182.9%. These PSUs vested in May 2021 and 1,161,718 shares were granted to beneficiaries.
The PSUs granted in April 2019 achieved a TSR performance of 200.0%. These PSUs vested in April 2022 and 1,849,268 shares were granted to beneficiaries.
In March 2022, the Company granted Performance Stock Units (PSUs) to selected employees and to the CEO. The following table lists the inputs to the valuation model used for the PSUs granted in 2022 and 2021:
March 2022 PSUsMay 2021 PSUs
Fair value at grant date (in euros)23.7021.84
Share price at grant date (in euros)17.1113.90
Dividend yield
Expected volatility (A)70%71%
Risk-free interest rate (US government bond yield)1.88%0.31%
Model usedMonte CarloMonte Carlo
(A)Volatilities for the Company and companies included in indices were estimated based on observed historical volatilities over a period equal to the PSU vesting period.
Restricted Stock Units Award Agreements (equity-settled)
During the year ended December 31, 2022, the Company granted Restricted Stock Units (RSUs) to a certain number of employees and to the CEO subject to the beneficiaries remaining continuously employed within or at the service of the Group
from the grant date through the end of the vesting period. The vesting period is three years. The fair value of the RSUs awarded is €17.11, being the euro equivalent of the quoted market price at grant date.
Equity Awards Plans (equity-settled)
In 2019, our non-executive Company Board members were granted two RSU awards. These RSUs vest in equal installments on the earlier of (i) the first anniversary or (ii) the date of the annual general meeting of shareholders of that year, and on the earlier of (i) the second anniversary or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service. The fair value of RSUs awarded under the plan was the the euro equivalent of the quoted market price at grant date.
In 2022, 2021 and 2020, no RSU awards were granted to our non-executive Company Board members.
Expense recognized during the year
In accordance with IFRS 2, share-based compensation is recognized as an expense over the vesting period. The estimate of this expense is based upon the fair value of a potential ordinary share at the grant date. The total share-based compensation for the year ended December 31, 2022, 2021 and 2020 amounted to €18 million, €15 million and €15 million, respectively.
Movement of potential shares
Performance-Based RSURestricted Stock UnitsEquity Award Plans
Potential SharesWeighted-Average Grant-Date Fair Value per Share Potential SharesWeighted-Average Grant-Date Fair Value per Share Potential SharesWeighted-Average Grant-Date Fair Value per Share
At January 1, 20212,594,32710.172,231,9116.8832,9128.39
Granted614,55521.84534,49913.90
Over-performance526,55115.31
Vested(1,161,718)15.31(520,064)10.27(32,912)8.39
Forfeited(47,188)10.29(97,347)7.17
At December 31, 20212,526,52711.712,148,9997.79
Granted (A)603,02323.70556,36017.11
Over-performance (B)924,63410.44
Vested(1,849,268)10.44(774,958)7.10
Forfeited (C)(19,082)11.65(54,955)9.04
At December 31, 20222,185,83415.561,875,44610.80
(A)For PSUs, the number of potential shares granted is presented using a vesting multiplier of 100%.
(B)When the achievement of TSR performance exceeds the vesting multiplier of 100%, the additional potential shares are presented as over-performance shares.
(C)For potential shares related to PSUs, 19,082 were forfeited following the departure of certain beneficiaries and none were forfeited in relation to the non-fulfilment of performance conditions.
Antidilutive potential ordinary shares
For the year ended December 31, 2020, there were 6,402,289 potential ordinary shares that could have had a dilutive impact but were considered antidilutive due to negative earnings.

v3.22.4
SUBSIDIARIES AND AFFILIATES
12 Months Ended
Dec. 31, 2022
Disclosure of subsidiaries [abstract]  
SUBSIDIARIES AND AFFILIATES
NOTE 31 - SUBSIDIARIES AND AFFILIATES
The following Group’s affiliates are legal entities included in the Consolidated Financial Statements of the Group at December 31, 2022. All entities are consolidated except for Rhenaroll which is accounted for under the equity method.
EntityCountry% Group Interest
Cross Operating Segment
Constellium Singen GmbH (AS&I and P&ARP)Germany100%
Constellium Valais S.A. (AS&I and A&T)Switzerland100%
AS&I
Constellium Automotive USA, LLCU.S.100%
Constellium Engley (Changchun) Automotive Structures Co Ltd.China54%
Constellium Extrusions Decin S.r.o.Czech Republic100%
Constellium Extrusions Deutschland GmbHGermany100%
Constellium Extrusions Landau GmbHGermany100%
Constellium Extrusions Burg GmbHGermany100%
Constellium Extrusions France S.A.S.France100%
Constellium Extrusions Levice S.r.o.Slovakia100%
Constellium Automotive Mexico, S. DE R.L. DE C.V.Mexico100%
Constellium Automotive Mexico Trading, S. DE R.L. DE C.V.Mexico100%
Astrex IncCanada50%
Constellium Automotive Zilina S.r.o.Slovakia100%
Constellium Automotive (Nanjing) Co. Ltd.China100%
Constellium Automotive Spain SLSpain100%
Constellium UK LimitedUnited Kingdom100%
A&T
Constellium Issoire S.A.S.France100%
Constellium Montreuil Juigné S.A.S.France100%
Constellium China Co. Ltd.China100%
Constellium Japan KKJapan100%
Constellium Rolled Products Ravenswood, LLCU.S.100%
Constellium Ussel S.A.S.France100%
AluInfra Services SA (A)Switzerland50%
P&ARP
Constellium Deutschland GmbHGermany100%
Constellium Rolled Products Singen GmbH & Co. KGGermany100%
Constellium Neuf Brisach S.A.S.France100%
Constellium Muscle Shoals LLCU.S.100%
Constellium Holdings Muscle Shoals LLCU.S.100%
Constellium Muscle Shoals Funding II LLCU.S.100%
Constellium Muscle Shoals Funding III LLCU.S.100%
Constellium Metal Procurement LLCU.S.100%
Constellium Bowling Green LLCU.S.100%
Rhenaroll SAFrance50%
Holdings & Corporate
C-TEC Constellium Technology Center S.A.S.France100%
Constellium Finance S.A.S.France100%
Constellium France III S.A.S.France100%
Constellium France Holdco S.A.S.France100%
Constellium International S.A.S.France100%
Constellium Paris S.A.S.France100%
Constellium Germany Holdco GmbH & Co. KGGermany100%
Constellium Germany Verwaltungs GmbHGermany100%
Constellium US Holdings I, LLCU.S.100%
Constellium US Intermediate Holdings LLCU.S.100%
Constellium Switzerland AGSwitzerland100%
Constellium Treuhand UG (haftunsgbeschränkt)Germany100%
Engineered Products International S.A.S.France100%
(A)AluInfra Services SA, the joint venture created with Novelis in July 2018, is consolidated as a joint operation and is immaterial to the Group Consolidated Financial Statements.

v3.22.4
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2022
Disclosure of non-adjusting events after reporting period [abstract]  
SUBSEQUENT EVENTS
NOTE 32 - SUBSEQUENT EVENTS
On February 2, 2023, the Group completed the sale of Constellium Ussel in exchange for cash consideration of €1.6 million.

v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2022
Disclosure of summary of significant accounting policies [abstract]  
Statement of compliance Statement of compliance
The Consolidated Financial Statements of Constellium SE and its subsidiaries have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and as endorsed by the European Union (EU). The Group’s application of IFRS results in no difference between IFRS as issued by the IASB and IFRS as endorsed by the EU (https://ec.europa.eu/info/law/international-accounting-standards-regulation-ec-no-1606-2002_en).
The Consolidated Financial Statements were authorized for issue on March 9, 2023 by the Board of Directors.
New and amended standards and interpretations New and amended standards and interpretations
Several amendments to IFRS standards and interpretations applied for the first time in 2022, but had no impact on the Consolidated Financial Statements of the Group.
Amendments to IAS 16: Property, Plant and Equipment: Proceeds before Intended Use
Amendments to IFRS 3: Reference to the Conceptual Framework
Amendments to IAS 37: Onerous Contracts – Costs of Fulfilling a Contract
Annual Improvements to IFRS Standards 2018-2020
IFRS 9 Financial Instruments: Fees in the ‘10 per cent’ test for derecognition of financial liabilities
New standards and interpretations not yet mandatorily applicable New standards and interpretations not yet mandatorily applicable
The Group has not early adopted the following new standards, amendments and interpretations which have been issued, but are not yet effective. The Group plans to adopt these new standards, amendments and interpretations on their required effective dates and does not expect any material impact as a result of their adoption.
Amendments to IAS 1: Classification of Liabilities as Current or Non-current
Amendment to IAS 1 and IFRS Practice Statement 2: Disclosure of Accounting Policies
Amendment to IAS 8: Definition of Accounting Estimates
Amendment to IAS 12: Deferred Tax related to Assets and Liabilities arising from a Single Transaction
Basis of preparation Basis of preparation
In accordance with IAS 1- Presentation of Financial Statements, the Consolidated Financial Statements are prepared on the assumption that Constellium is a going concern and will continue in operation for the foreseeable future.
The Group’s financial position, its cash flows, liquidity position and borrowing facilities are described in the Consolidated Financial Statements in NOTE 12 - Cash and Cash Equivalents, NOTE 20 - Borrowings and NOTE 22 - Financial Risk Management.
The Group’s forecasts and projections, taking account of reasonably possible changes in operating performance, including an assessment of the current macroeconomic environment, indicate that the Group should be able to operate within the level of its current facilities and related covenants.
Accordingly, the Group continues to adopt the going concern basis in preparing the Consolidated Financial Statements. This assessment was confirmed by the Board of Directors on March 9, 2023.
Presentation of the operating performance of each operating segment and of the Group Presentation of the operating performance of each operating segment and of the Group
In accordance with IFRS 8 - Operating Segments, operating segments are based upon the product lines, markets and industries served, and are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The Chief Executive Officer, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the chief operating decision-maker.
The accounting principles used to prepare the Group’s operating segment information are the same as those used to prepare the Group’s Consolidated Financial Statements.
Presentation of financial statements
Presentation of financial statements
The Consolidated Financial Statements are presented in millions of Euros, except as otherwise stated. Certain reclassifications may have been made to prior year amounts to conform to the current year presentation.
Basis of consolidation
Basis of consolidation
These Consolidated Financial Statements include all the assets, liabilities, equity, revenues, expenses and cash flows of the Group's subsidiaries. All intercompany transactions and balances are eliminated.
Subsidiaries are entities over which the Group has control. The Group controls an entity when the Group has power over the entity, is exposed to, or has rights to variable returns from its involvement in the entity and has the ability to affect those returns through its power over the entity.
Subsidiaries are consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.
Investments over which the Group has joint control are accounted for either as joint ventures under the equity method or as joint arrangements in relation to its interest in the joint operation. Investments over which the Group has significant influence are accounted for under the equity method.
Joint venture investments are initially recorded at cost. They are subsequently increased or decreased by the Group’s share in the profit or loss, or by other movements reflected directly in the equity of the entity.
Business combinations
Business combinations
The Group applies the acquisition method to account for business combinations.
The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities assumed and the equity interests issued by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. The amount of non-controlling interests is determined for each business combination and is either based on the fair value (full goodwill method) or the present ownership instruments’ proportionate share in the recognized amounts of the acquiree’s identifiable net assets, resulting in recognition of only the share of goodwill attributable to equity holders of the parent (partial goodwill method).
Goodwill is initially measured as the excess of the aggregate of the consideration transferred and the amount of non-controlling interest over the net identifiable assets acquired and liabilities assumed. If this consideration is lower than the fair
value of the net assets of the subsidiary acquired, the difference is recognized as a gain in Other gains and losses - net in the Consolidated Income Statement.
At the acquisition date, the Group recognizes the identifiable acquired assets, liabilities and contingent liabilities (identifiable net assets) of the subsidiaries on the basis of fair value at the acquisition date. Recognized assets and liabilities may be adjusted during a maximum of 12 months from the acquisition date, depending on new information obtained about the facts and circumstances existing at the acquisition date.
Acquisition-related costs are expensed as incurred and are included in Other gains and losses - net in the Consolidated Income Statement.
Non-current Assets (and disposal groups) Held for Sale and Discontinued Operations
Non-current Assets (and disposal groups) Held for Sale and Discontinued Operations
IFRS 5 “Non-current Assets Held For Sale and Discontinued Operations” defines a discontinued operation as a component of an entity that (i) generates cash flows that are largely independent from cash flows generated by other components, (ii) is held for sale or has been sold, and (iii) represents a separate major line of business or geographic areas of operations.
Assets and liabilities are classified as held for sale when their carrying amount will be recovered principally through a sale transaction rather than through continuing use. This condition is regarded as met only when the sale is highly probable and the non-current asset (or disposal group) is available for immediate sale in its present condition.
Assets and liabilities are stated at the lower of carrying amount and fair value less costs to sell if their carrying amount is to be recovered principally through a sale transaction rather than through continuing use.
Assets and liabilities held for sale are reflected in separate line items in the Consolidated Statement of Financial Position of the period during which the decision to sell is made.
The results of discontinued operations are shown separately in the Consolidated Income Statement.
Foreign currency transactions and foreign operations
Foreign currency transactions and foreign operations
Functional currency
Items included in the Consolidated Financial Statements of each of the entities and businesses of Constellium are measured using their functional currency, which is the currency of the primary economic environment in which they operate.
Foreign currency transactions
Transactions denominated in currencies other than the functional currency are recorded in the functional currency at the exchange rate in effect at the date of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the Consolidated Income Statement, except when deferred in Other Comprehensive Income ("OCI") as qualifying cash flow hedges or qualifying net investment hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in Finance costs - net. Realized foreign exchange gains and losses that relate to commercial transactions are presented in Cost of sales. All other foreign exchange gains and losses, including those that relate to foreign currency derivatives hedging commercial transactions where hedge accounting has not been applied, are presented within Other gains and losses - net.
Foreign operations: presentation currency and foreign currency translation
In the preparation of the Consolidated Financial Statements, the year-end balances of assets, liabilities and components of equity of Constellium’s entities and businesses are translated from their functional currencies into Euros, the presentation currency of the Group, at their respective year-end exchange rates. Revenue, expenses and cash flows of Constellium’s entities and businesses are translated from their functional currencies into Euros using their respective average exchange rates for the year. The net differences arising from exchange rate translation are recognized in OCI.
Revenue from contracts with customers
Revenue from contracts with customers
Revenue is recognized in an amount that reflects the consideration to which the Group expects to be entitled in exchange for transferring goods or services to a customer.
The Group primarily contracts with customers for the sale of rolled or extruded aluminium products. For the majority of our business, performance obligations with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near-term. These purchase orders are short-term in nature, although they may be governed by multi-year frame agreements.
Revenue from product sales, measured at the fair value of the consideration received or receivable, is recognized at a point in time when control of the asset is transferred to the customer, generally upon delivery. In certain limited circumstances, the Group may be required to recognize revenue over time for products that have no alternative use and for which the Group has an enforceable right to payment for production completed to date.
Revenue from product sales, net of trade discounts, allowances and volume-based incentives, is recognized for the amount the Group expects to be entitled to, generally upon delivery, and provided that control has transferred.
Contract liabilities consist of expected volume discounts, rebates, incentives, refunds, penalties and price concessions. Contract liabilities are presented in Trade payables and other.
The Group applies the practical expedient for disclosures on performance obligations that are part of contracts that have an original duration of one year or less.
The Group elected the practical expedient on significant financing components when the period of transfer of the product and the payment is one year or less.
Research and development costs
Research and development costs
Costs incurred on development projects are recognized as intangible assets when the following criteria are met:
It is technically feasible to complete the intangible asset so that it will be available for use;
Management intends to complete and use the intangible asset;
There is an ability to use the intangible asset;
It can be demonstrated how the intangible asset will generate probable future economic benefits;
Adequate technical, financial and other resources to complete the development and use or sell the intangible asset are available; and
The expenditure attributable to the intangible asset during its development can be reliably measured.
Development expenditures that do not meet these criteria are expensed as incurred. Development costs previously recognized as expenses cannot be recognized as an asset in a subsequent period.
Other gains and losses - net
Other gains and losses - net
Other gains and losses - net includes: (i) realized and unrealized gains and losses for commodity derivatives and foreign exchange derivatives contracted for commercial purposes to which hedge accounting is not applied (ii) unrealized exchange gains and losses from the remeasurement of monetary assets and liabilities, (iii) the ineffective portion of changes in the fair value of derivatives designated for hedge accounting and (iv) impairment charges on assets.
Other gains and losses - net also includes other unusual, infrequent or non-recurring items. Such items are disclosed by virtue of their size, nature or incidence. In determining whether an event or transaction is unusual, infrequent or non-recurring, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence.
Interest income and expense
Interest income and expense
Interest expense on short and long-term financing is recorded at the relevant rates on the various borrowing agreements using the effective interest rate method.
Borrowing costs, including interest, incurred for the construction of any qualifying asset are capitalized during the period of time required to complete and prepare the asset for its intended use.
Cash and cash equivalents
Cash and cash equivalents
Cash and cash equivalents are comprised of cash in bank accounts and on hand, short-term deposits held on call with banks and other short-term highly liquid investments with original maturities of three months or less that are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value, less bank overdrafts that are repayable on demand, provided there is an offset right.
Trade account receivables
Trade account receivables
Recognition and measurement
Trade account receivables are recognized at fair value through OCI since they are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to factors. The group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables and contract assets.
Factoring arrangements
In factoring arrangements under which the Group has transferred substantially all the risks and rewards of ownership of the receivables, the receivables are derecognized from the Consolidated Statement of Financial Position. In determining whether the Group has transferred substantially all the risks and rewards of ownership, it considers credit risk, late-payment risk, dilution risk, foreign exchange risk and tax risk. Arrangements in which the Group derecognizes receivables result in changes in trade receivables, which are reflected as cash flows from operating activities. When trade account receivables are sold with limited recourse and substantially all the risks and rewards associated with these receivables are not transferred, receivables are not derecognized. Where the Group does not derecognize the receivables, the cash received from the factor is classified as a financing cash inflow, the settlement of the receivables as an operating cash inflow and the repayment to the factor as a financing cash outflow.
Inventories
Inventories
Inventories are valued at the lower of cost and net realizable value, primarily on a weighted-average cost basis.
Weighted-average cost for raw materials, stores, work in progress and finished goods is calculated using the costs experienced in the current period based on normal operating capacity and includes the purchase price of materials, freight, duties and customs, and the costs of production, which includes labor, materials and other costs that are directly attributable to the production process and production overheads.
Financial Instruments
Financial Instruments
i.Classification and measurement
Financial assets
At initial recognition, financial assets are classified either: (a) at amortized cost, (b) at fair value through other comprehensive income (FVOCI), or (c) at fair value through profit or loss (FVPL). The classification depends on the financial asset’s contractual cash flow characteristics and the Group’s business model for managing the financial assets.
i.Assets at amortized cost are comprised of other receivables, non-current loans receivable and current loans receivable in the Consolidated Statement of Financial Position. The business model objective is to hold assets in order to collect contractual cash flows provided they give rise to cash flows that are ‘solely payments of principal and interest’ on the principal amount outstanding. They are carried at amortized cost using the effective interest rate method, less any impairment. They are classified as current or non-current assets based on their maturity date.
ii.Assets at fair value through OCI are comprised of trade receivables in the Consolidated Statement of Financial Position. The business model objective is to maintain liquidity for the Group, should the need arise, which leads to sales through factoring agreements that are more than infrequent and significant in value. Trade receivables are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to the factors. The portfolio of trade receivables is therefore classified as measured at fair value through OCI. Upon derecognition, the cumulative fair value change recognized in OCI is reclassified to profit or loss. Foreign exchange revaluation and impairment losses or reversals are recognized in profit or loss and computed in the same manner as for financial assets measured at amortized cost. The remaining fair value changes are recognized in OCI. These assets are classified as current or non-current assets based on their maturity date.
iii.Assets at fair value through profit or loss are comprised of derivatives except those designated as hedging instruments that qualify for hedge accounting in accordance with IAS 39 - Financial Instruments which are classified as assets at fair value through OCI. Financial assets carried at fair value through profit or loss are initially recognized at fair value and transaction costs are expensed in the Consolidated Income Statement.
Financial liabilities
Borrowings and other financial liabilities, excluding derivative liabilities, are recognized initially at fair value, net of transaction costs incurred and directly attributable to the issuance of the liability. These financial liabilities are subsequently measured at amortized cost using the effective interest rate method. Any difference between the amounts originally received, net of transaction costs, and the redemption value is recognized in the Consolidated Income Statement using the effective interest rate method.
ii.Impairment of financial assets
Financial assets subject to IFRS 9’s expected credit loss model are cash and cash equivalents, trade receivables and other and loans to joint ventures.
iii.Offsetting financial instruments
Financial assets and liabilities are offset and the net amount is reported in the Consolidated Statement of Financial Position when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously.
Derivatives financial instruments
Derivative financial instruments
Derivatives
The Group uses derivative financial instruments, such as forward currency contracts, interest rate swaps and forward commodity contracts, to hedge its foreign currency risks, interest rate risks and commodity price risks, respectively.
Derivatives are carried as financial assets when the fair value is positive and as financial liabilities when the fair value is negative.
Fair value is the price expected to be received in selling an asset or paid in transferring a liability in an orderly transaction between market participants at the measurement date. Where available, relevant market prices are used to determine fair values. The Group periodically estimates the impact of credit risk on its derivative instruments aggregated by counterparties and takes this into account when estimating the fair value of its derivatives.
Credit Value Adjustments are calculated for asset derivatives based on the counterparties’ credit risk. Debit Value Adjustments are calculated for credit derivatives based on Constellium’s own credit risk. The fair value method used is based on the historical probability of default, provided by leading rating agencies.
Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently re-measured to their fair value at the end of each reporting period.
The accounting for subsequent changes in fair value depends on whether the derivative qualifies for hedge accounting treatment. For derivative instruments that do not qualify for hedge accounting, changes in the fair value are recognized immediately in profit or loss and are included in Other gains and losses - net or Finance costs, net depending on the nature of the underlying exposure. For derivatives that qualify for hedge accounting, changes in the fair value are recognized in OCI.
Hedge accounting
The Group did not adopt the disposition of IFRS 9 - Financial Instruments on hedging and will therefore continue to apply the provisions of IAS 39 - Financial Instruments. For derivative instruments that are designated for hedge accounting, at the inception of the hedging transaction, the group documents the relationship between hedging instruments and hedged items, the risk management objective and the strategy for undertaking the hedge transaction. The group also documents its assessment, both at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions have been and will continue to be highly effective in offsetting changes in cash flows of hedged items.
The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized in OCI and accumulated in equity. The gain or loss relating to the ineffective portion is recognized immediately in the Consolidated Income Statement in Other gains and losses - net.
Amounts accumulated in equity are reclassified to the Consolidated Income Statement when the hedged item affects the Consolidated Income Statement. The gain or loss relating to the effective portion of derivative instruments hedging forecasted cash flows under customer agreements is recognized in Revenue. When the forecasted transaction that is hedged results in the recognition of a non-financial asset, the gains and losses previously deferred in equity are reclassified from equity and included in the initial measurement of the cost of the asset. The deferred amounts would ultimately be recognized in the Consolidated Income Statement upon the sale, depreciation or impairment of the asset.
When a hedging instrument expires or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, any cumulative gain or loss existing in equity at that time remains in equity and is recognized when the forecasted transaction is ultimately recognized in the Consolidated Income Statement. When a forecasted transaction is no longer expected to occur, the cumulative gain or loss that was recognized in equity is immediately reclassified to the Consolidated Income Statement.
Property, plant and equipment
Property, plant and equipment
Recognition and measurement
Property, plant and equipment acquired by the Company are recorded at cost, which comprises the purchase price, including import duties and non-refundable purchase taxes, any costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management and the estimated close down and restoration costs associated with the asset. Borrowing costs, including interest, directly attributable to the acquisition or construction of property, plant and equipment are included in the cost. Subsequent to the initial recognition, Property, plant and equipment are measured at cost less accumulated depreciation and impairment, if any. Costs are capitalized into construction work-in-progress until projects are completed and the assets are available for use.
Subsequent costs
Enhancements and replacements are capitalized as additions to Property, plant and equipment only when it is probable that future economic benefits associated with them will flow to the Company and their cost can be measured with reliability. Ongoing regular maintenance costs related to Property, plant and equipment are expensed as incurred.
Depreciation
Land is not depreciated. Property, plant and equipment are depreciated over the estimated useful lives of the related assets using the straight-line method as follows:
Buildings: 10 – 50 years;
Machinery and equipment: 3 – 40 years;
Vehicles: 5 – 8 years.
Government Grants
Government Grants
Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions are complied with.
Government grants relating to the purchase of property, plant and equipment reduce the carrying amount of the asset. They are credited to profit or loss on a straight-line basis over the expected useful lives of the related assets. Government grants relating to costs offset the corresponding expense and are deferred and recognized in profit or loss over the period necessary to match them with the costs that they are intended to compensate.
Intangible assets
Intangible assets
Recognition and measurement
Technology and customer relationships acquired in a business combination are recognized at fair value at the acquisition date. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and impairment losses. The useful lives of the Group intangible assets are assessed to be finite.
Amortization
Intangible assets are amortized over the estimated useful lives of the related assets using the straight-line method as follows:
Technology: 20 years;
Customer relationships: 25 years;
Software: 3 – 5 years.
Goodwill
Goodwill
Goodwill arising from a business combination is carried at cost as established at the date of the business combination less accumulated impairment losses, if any.
Goodwill is allocated at the operating segment levels, which are the groups of cash-generating units that are expected to benefit from the synergies of the combination. The operating segments represent the lowest level within the Group at which goodwill is monitored for internal management purposes.
Gains and losses on the disposal of a cash-generating unit include the carrying amount of goodwill relating to the cash-generating unit sold.
Impairment of property, plant and equipment and intangible assets
Impairment
Impairment of property, plant and equipment and intangible assets
Property, plant and equipment and intangible assets subject to amortization are reviewed for impairment if there is any indication that the carrying amount of the asset, or cash-generating unit to which it belongs, may not be recoverable. The recoverable amount is based on the higher of fair value less cost of disposal and value in use, as determined using estimates of discounted future net cash flows of the asset or group of assets to which it belongs.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement.
Impairment of goodwill
Impairment of goodwill
Groups of cash-generating units to which goodwill is allocated are tested for impairment annually, or more frequently when there is an indication that allocated goodwill may be impaired.
The net carrying value of a group of cash-generating units is compared to their recoverable amounts, which is the higher of the value in use and the fair value less costs of disposal.
Value in use calculations use cash flow projections based on financial budgets approved by management and usually covering a 5-year period. Cash flows beyond this period are estimated using a perpetual long-term growth rate for the subsequent years.
The value in use is the sum of the discounted cash flows over the projected period and the terminal value. Discount rates are determined based on the weighted-average cost of capital of each operating segment.
The fair value is the price that would be received for the group of cash-generating units, in an orderly transaction, from a market participant. This value is estimated on the basis of available and relevant market data or a discounted cash flow model reflecting market participant assumptions.
An impairment loss is recognized for the amount by which the group of units carrying amount exceeds its recoverable amount.
Any impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the group of cash-generating units and then to the other assets of the group of units pro rata on the basis of the carrying amount of each asset in the group of units.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement. An impairment loss recognized for goodwill cannot be reversed in subsequent years.
Cash-generating units
Cash-generating units
The reporting units, which generally correspond to industrial sites, are the lowest level of independent cash flows and have been identified as cash-generating units.
Taxation
Taxation
Income tax (expense) / benefit is calculated on the basis of the tax laws enacted or substantively enacted at the Consolidated Statement of Financial Position date in the countries where the Company and its subsidiaries operate and generate taxable income.
The Group is subject to income taxes in France, the United States, Germany and numerous other jurisdictions. Certain of Constellium’s businesses may be included in tax returns in some jurisdictions. In certain circumstances, these businesses may be jointly and severally liable with the entity filing the consolidated return, for additional taxes that may be assessed.
Deferred income tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the Consolidated Financial Statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income tax assets are also recognized for operating loss carryforwards and tax credit carryforwards.
Deferred income tax assets and liabilities are measured using tax rates that are expected to apply in the year when the asset is realized or the liability is settled. Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.
Trade payables
Trade payables
Trade payables are initially recorded at fair value and are subsequently measured at amortized cost. Trade payables are classified as current liabilities if payment is due in one year or less.
Leases
Leases
Right-of-use assets
The Group recognizes right-of-use assets at the commencement date of the lease. Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and are adjusted for remeasurement of lease liabilities resulting from a change in future lease payments arising from a change in an index or a rate, or a change in the assessment of whether the purchase, extension or termination options will be exercised.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are recorded in the asset category to which they relate in Property, plant and equipment. Unless the Group is reasonably certain to obtain ownership of the leased assets at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of their estimated useful life and the lease term. Right-of-use assets are subject to impairment.
Lease liabilities
At the commencement date of the lease, the Group recognizes a lease liability measured at the present value of lease payments to be made over the lease term.
In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension or termination option. Extension options or periods after termination options are only included in the lease term if the lease is reasonably certain to be extended or not terminated.
The lease payments include fixed payments less any lease incentive receivables, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating a lease, if the lease term reflects the Group exercising the option to terminate. Lease liabilities are presented within Borrowings. Variable lease payments that do not depend on an index or a rate are recognized as expense in the period in which the event or condition that triggers the payment occurs.
In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the implicit interest rate in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced by the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, or a change in the assessment to purchase the underlying asset.
Short-term leases and leases of low-value assets
The Group applies the short-term lease recognition exemption to leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option. The Group also applies the low-value asset recognition exemption to leases of assets with a value below €5,000. Lease payments on short-term leases and low-value asset leases are recognized as expense on a straight-line basis over the lease term.
The Group also applies the practical expedients for lease and non-lease components as a single component for vehicles.
Provisions
Provisions
Provisions are recorded at the best estimate of expenditures required to settle liabilities of uncertain timing or amount when management determines that i) a legal or constructive obligation exists as a result of past events, ii) it is probable that an outflow of resources will be required to settle the obligation and iii) such amounts can be reasonably estimated. Provisions are measured at the present value of the expected expenditures required to settle the obligation.
The ultimate cost to settle such liabilities is uncertain, and cost estimates can vary in response to many factors. The settlement of these liabilities could materially differ from recorded amounts or the expected timing of expenditure could change. As a result, there could be significant adjustments to provisions, which could result in additional charges or recoveries.
Close down and restoration costs
Estimated close down and restoration costs are accounted for in the year when the legal or constructive obligation arising from the related disturbance occurs and it is probable that an outflow of resources will be required to settle the obligation. These costs are based on the net present value of estimated future costs. Provisions for close down and restoration costs do not include any additional obligations expected to arise from future disturbance. The costs are estimated on the basis of a closure plan including feasibility and engineering studies, are updated annually during the life of the operation to reflect known developments (e.g. revisions to cost estimates and to the estimated lives of operations) and are subject to formal review at regular intervals each year.
The initial closure provision together with subsequent movements in the provisions for close down and restoration costs, including those resulting from new disturbance, updated cost estimates, changes to the estimated lives of operations and revisions to discount rates, are capitalized in Property, plant and equipment. These costs are depreciated over the remaining useful lives of the related assets. The amortization or unwinding of the discount applied in establishing the net present value of the provisions is recorded in the Consolidated Income Statement as a finance cost.
Environmental remediation costs
Environmental remediation costs are accounted for based on the estimated present value of the costs of the Group’s environmental clean-up obligations. Changes in the environmental remediation provisions are recorded in Cost of sales.
Restructuring costs
Provisions for restructuring are recorded when Constellium’s management is demonstrably committed to the restructuring plan and the liabilities can be reasonably estimated. The Group recognizes liabilities that primarily include one-time termination benefits, severance, and contract termination costs, primarily related to equipment and facility lease obligations. These amounts are based on the remaining amounts due under various contractual agreements and are periodically adjusted for changes in circumstances that would reduce or increase these obligations.
Legal, tax and other potential claims
Provisions for legal claims are made when it is probable that liabilities will be incurred and when such liabilities can be reasonably estimated. For asserted claims and assessments, liabilities are recorded when an unfavorable outcome of a matter is deemed to be probable and the loss is reasonably estimable. Management determines the likelihood of an unfavorable outcome based on many factors such as the nature of the matter, available defenses and case strategy, progress of the matter, views and opinions of legal counsel and other advisors, applicability and success of appeals, process and outcomes of similar historical matters, amongst others. Once an unfavorable outcome is considered probable, management weighs the probability of possible outcomes and the most likely loss is recorded. Legal matters are reviewed on a regular basis to determine if there have been changes in management’s judgment regarding the likelihood of an unfavorable outcome or the estimate of a potential loss. Depending on their nature, these costs may be recorded in Cost of sales or Other gains and losses - net in the Consolidated Income Statement. Included in other potential claims are provisions for product warranties and guarantees to settle the net present value portion of any settlement costs for potential future legal actions, claims and other assertions that may be brought by Constellium’s customers or the end-users of products. Provisions for product warranty and guarantees are recorded in Cost of sales in the Consolidated Income Statement.
Management establishes tax reserves and accrues interest thereon, if deemed appropriate, in expectation that certain tax positions other than income tax may be challenged and that the Group might not succeed in defending such positions.
Pension, other post-employment benefits and other long-term employee benefits
Pension, other post-employment plans and other long-term employee benefits
For defined contribution plans, the contribution paid in respect of service rendered over the service year is recognized in the Consolidated Income Statement. This expense is included in Income / (loss) from operations.
For defined benefit plans, the retirement benefit obligation recognized in the Consolidated Statement of Financial Position represents the present value of the defined benefit obligation less the fair value of plan assets. The defined benefit obligations are assessed using the projected unit credit method. The most significant assumption is the discount rate. The amount recorded in the Consolidated Income Statement in respect of these plans is included within Income / (loss) from operations except for net interest costs, which are included in Finance costs - net. The effects of changes in actuarial assumptions and experience adjustments are presented in the Consolidated Statement of Comprehensive Income.
Other post-employment benefit plans mainly relate to health and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents. Eligibility for coverage is dependent upon certain age and service criteria. These benefit plans are unfunded and are accounted for as defined benefit obligations, as described above.
Other long-term employee benefits mainly include jubilees and other long-term disability benefits. For these plans, actuarial gains and losses are recognized immediately in the Consolidated Income Statement.
Share capital
Share capital
Ordinary shares are classified as equity. Costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Share-based payment arrangements
Share-based payment arrangements
Equity-settled share-based payments to employees and Board members are measured at the fair value of the equity instruments at the grant date.
The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the Group’s estimate of equity instruments that will eventually vest, with a corresponding increase in equity. At the end of each reporting period, the Group revises its estimate of the number of equity instruments expected to vest.
Judgments in applying accounting policies and key sources of estimation uncertainty Judgments in applying accounting policies and key sources of estimation uncertainty
The preparation of the Group’s consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures, and the disclosure of contingent liabilities. These judgments, estimates and assumptions are based on management’s best knowledge of the relevant facts and circumstances, giving consideration to previous experience. However, actual results may differ from the amounts included in the Consolidated Financial Statements. Key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year include the items presented below. The Group continuously reviews its significant assumptions and estimates in light of the uncertainty associated with the global geopolitical and macroeconomic conditions, including the ongoing armed conflict in Ukraine and the COVID-19 pandemic and their potential direct and indirect impacts on its business and its financial statements, as detailed in NOTE 4 - Operating Segment Information, NOTE 15 - Property, Plant and Equipment, NOTE 20 - Borrowings, NOTE 22 - Financial Risk Management, NOTE 24 - Provisions and NOTE 27 - COVID-19-related Government assistance. However, there remains significant uncertainty with respect to the duration and severity of these crises and their potential impacts on the global economy and our business, and there can be no guarantee that our assumptions will materialize or that actual results will not differ materially from estimates.
Impairment tests for goodwill, intangible assets and property, plant and equipment
The determination of fair value and value in use of cash-generating units or groups of cash-generating units depends on a number of assumptions, in particular market data, estimated future cash flows and discount rates.
The Group assesses where climate risks could have a significant impact, such as the introduction of emission-reduction legislation that may increase manufacturing costs. The Group constantly monitors the latest government legislation in relation to climate-related matters. At the current time, no legislation has been passed that will impact the Group. The Group will adjust the assumptions used in value-in-use calculations and sensitivity to changes in assumptions should a change be required.
These assumptions are subject to risk and uncertainty. Any material changes in these assumptions could result in a significant change in a cash-generating units’ recoverable value or in a goodwill impairment. Details of the key assumptions made and judgments applied are set out in NOTE 15 - Property, Plant and Equipment and in NOTE 16 - Intangible Assets and Goodwill.
Income Taxes
Significant judgment is sometimes required in determining the accrual for income taxes as there are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Group recognizes liabilities based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were recorded, such differences will impact the current and deferred income tax provisions, results of operations and possibly cash flows in the year in which such determination is made.
Significant judgment is also required to determine the extent to which deferred tax assets can be recognized. In assessing the recognition of deferred tax assets, management considers whether it is more likely than not that the deferred tax assets will be utilized. The deferred tax assets will be ultimately utilized to the extent that sufficient taxable profits will be available in the years in which the temporary differences become deductible. This assessment is conducted through a detailed review of deferred tax assets by jurisdiction and takes into account the scheduled reversals of taxable and deductible temporary
differences, past, current and expected future performance deriving from the budget, the business plan and tax planning strategies. Deferred tax assets are not recognized in the jurisdictions where it is less likely than not that sufficient taxable profits will be available against which the deductible temporary differences can be utilized. Details of the key assumptions made and judgments applied are set out in NOTE 17 - Deferred Income Taxes.
Provisions
Provisions have been recorded for: (i) close down and restoration costs; (ii) environmental remediation and monitoring costs; (iii) restructuring plans; (iv) legal and other potential claims including provisions for tax risks other than income tax, product warranty and guarantees. These provisions are recorded at amounts which represent management’s best estimates of the expenditure required to settle the obligation at the date of the Consolidated Statement of Financial Position. Expectations are revised each year until the actual liability is settled, with any difference accounted for in the Consolidated Income Statement in the year in which the revision is made. Details of the key assumptions made and judgments applied are described in NOTE 24 - Provisions.
Pension, other post-employment benefits and other long-term employee benefits
The present value of the defined benefit obligations depends on a number of factors that are determined on an actuarial basis using a number of assumptions and its determination requires the application of judgment. Assumptions used and judgments made in determining the defined benefit obligations and net pension costs include discount rates, rates of future compensation increase, and the criteria considered to determine when a plan amendment has occurred.
Any material changes in these assumptions could result in a significant change in Pensions and other post-employment benefit obligations and in employee benefit expenses recognized in the Consolidated Income Statement or actuarial gains and losses recognized in OCI. Details of the key assumptions made and judgments applied are set out in NOTE 23 - Pensions and Other Post-Employment Benefit Obligations.

v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of summary of significant accounting policies [abstract]  
Schedule of Main Exchange Rates Used for Preparation of Financial Statements The following table summarizes the main exchange rates used for the preparation of the Consolidated Financial Statements:
Average ratesClosing rates
Foreign exchange rate for 1 EuroYear ended December 31,At December 31,
202220212020202220212020
U.S. DollarsUSD1.05071.18211.14051.06661.13261.2271
Swiss FrancsCHF1.00381.08081.07040.98471.03311.0802
Czech KorunaCZK24.563325.636626.433724.116024.858026.2420

v3.22.4
REVENUE (Tables)
12 Months Ended
Dec. 31, 2022
Revenue [abstract]  
Schedule of Disaggregation Revenue
Year ended December 31,
(in millions of Euros)202220212020
Packaging rolled products3,3262,6731,960
Automotive rolled products1,154854663
Specialty and other thin-rolled products175161102
Aerospace rolled products728389560
Transportation, industry, defense and other rolled products916713442
Automotive extruded products949735665
Other extruded products872627491
Total Revenue by product line8,1206,1524,883
Year ended December 31,
(in millions of Euros)202220212020
Germany2,0361,4811,014
France691466362
United Kingdom221179192
Switzerland876352
Spain302252185
Czech Republic237172119
Other Europe1,110809619
Total Europe4,6843,4222,543
United States2,8232,3351,941
Asia and Other Pacific252171211
All Other361224188
Total Revenue by destination of shipment8,1206,1524,883

v3.22.4
OPERATING SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of operating segments [abstract]  
Schedule of Segment Revenue
Year ended December 31,
202220212020
(in millions of Euros)Segment revenueInter-segment eliminationExternal revenueSegment revenueInter-segment eliminationExternal revenueSegment revenueInter-segment eliminationExternal revenue
P&ARP4,664(9)4,6553,698(10)3,6882,734(9)2,725
A&T1,700(55)1,6451,142(40)1,1021,025(23)1,002
AS&I1,861(41)1,8201,383(21)1,3621,167(11)1,156
Total8,225(105)8,1206,223(71)6,1524,926(43)4,883
Schedule of Segment Capital Expenditures
Year ended December 31,
(in millions of Euros)202220212020
P&ARP(127)(94)(73)
A&T(78)(70)(45)
AS&I(62)(62)(61)
H&C(6)(6)(3)
Capital expenditures(273)(232)(182)
Schedule of Segment Assets
At December 31,
(in millions of Euros)20222021
P&ARP2,1872,108
A&T1,081948
AS&I727738
H&C456451
Segment assets4,4514,245
Deferred income tax assets271162
Cash and cash equivalents166147
Other financial assets3970
Assets of disposal group classified as held for sale14
Total Assets4,9414,624

v3.22.4
INFORMATION BY GEOGRAPHIC AREA (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of geographical areas [abstract]  
Schedule of Property, Plant and Equipment Reported Based on Physical Location of Assets
Property, plant and equipment are reported based on the physical location of the assets:
At December 31,
(in millions of Euros)20222021
United States832811
France699653
Germany269266
Czech Republic9799
Other120119
Total2,0171,948

v3.22.4
EXPENSES BY NATURE (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of attribution of expenses by nature to their function [abstract]  
Schedule of Total Operating Expenses by Nature
Year ended December 31,
(in millions of Euros)202220212020
Raw materials and consumables used(5,545)(3,885)(2,832)
Employee benefit expenses(1,110)(967)(902)
Energy costs(274)(149)(141)
Sub-contractors(125)(102)(89)
Freight out costs(163)(143)(122)
Professional fees(81)(63)(73)
Lease expenses(15)(12)(11)
Depreciation and amortization(287)(267)(259)
Other operating expenses(178)(197)(240)
Other gains and losses - net(8)117(89)
Total operating expenses(7,786)(5,668)(4,758)

v3.22.4
EMPLOYEE BENEFIT EXPENSES (Tables)
12 Months Ended
Dec. 31, 2022
Classes of employee benefits expense [abstract]  
Schedule of Total Employee Benefit Expenses
Year ended December 31,
(in millions of Euros)Notes202220212020
Wages and salaries(1,067)(920)(855)
Pension costs - defined benefit plans23(22)(24)(23)
Other post-employment benefits23(3)(8)(9)
Share-based compensation30(18)(15)(15)
Total employee benefit expenses(1,110)(967)(902)

v3.22.4
OTHER GAINS AND LOSSES—NET (Tables)
12 Months Ended
Dec. 31, 2022
Analysis of income and expense [abstract]  
Schedule of Other Gains and Losses—Net
Year ended December 31,
(in millions of Euros)Notes202220212020
Realized (losses) / gains on derivatives (A)(6)113(35)
Losses reclassified from OCI as a result of hedge accounting discontinuation (B)(6)
Unrealized (losses) / gains on derivatives at fair value through profit and loss - net (A)(47)3916
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net (1)11
Impairment of assets (C)15, 16(43)
Restructuring costs (D)24(1)(3)(13)
Gains / (losses) on pension plan amendments (E)2347(32)(2)
Losses on disposal (4)(3)(4)
Other 42(3)
Total other gains and losses - net (8)117(89)
(A)Realized and unrealized gains and losses are related to derivatives entered into with the purpose of mitigating exposure to volatility in foreign currencies and commodity prices and that do not qualify for hedge accounting.
(B)In the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for 2020 and 2021, to which hedge accounting was applied, were no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted in a €6 million loss.
(C)In the year ended December 31, 2020, an impairment charge of €43 million was recognized for certain A&T cash-generating units due to the downturn in the aerospace industry resulting from the COVID-19 pandemic and for certain AS&I cash-generating units as a result of the review of their long-term business perspectives.
(D)For the years ended December 31, 2021 and 2020, restructuring costs amounted to €3 million and €13 million, respectively, and related to headcount reductions in Europe and in the U.S.
(E)In the year ended December 31, 2022 the group recognized a net gain of €47 million from past service cost as a result from a new 3-year collective bargaining agreement between Constellium Rolled Products Ravenswood and the United Steelworkers Local Union 5668 entered in October 2022. The agreement resulted in changes in OPEB and pension benefits that were accounted for as a plan amendment in the year ended December 31, 2022 (see Note 23.6 Ravenswood plan amendment).
In the year ended December 31, 2021, the group recognized a loss of €31 million from past service cost following an adverse decision of the Fourth Circuit Court in the dispute between Constellium Rolled Products Ravenswood, LLC and the United Steelworkers Local Union 5668 over the transfer of certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan to a third-party health network (see Note 23.7 Ravenswood OPEB dispute)

v3.22.4
CURRENCY GAINS / (LOSSES) (Tables)
12 Months Ended
Dec. 31, 2022
Analysis of income and expense [abstract]  
Schedule of Currency Gains and Losses Included in Income from Operations
Year ended December 31,
(in millions of Euros)Notes202220212020
Included in Revenue22(8)(4)(6)
Included in Cost of sales21(2)
Included in Other gains and losses - net516(19)
Total(1)13(27)
Realized exchange losses on foreign currency derivatives - net22(8)(1)(11)
Losses reclassified from OCI as a result of hedge accounting discontinuation22(6)
Unrealized gains / (losses) on foreign currency derivatives - net22613(8)
Exchange gains / (losses) from the remeasurement of monetary assets and liabilities - net11(2)
Total(1)13(27)
Schedule of Foreign Currency Translation Reserve
At December 31,
(in millions of Euros)20222021
Foreign currency translation reserve at January 1,19(13)
Effect of currency translation differences2232
Foreign currency translation reserve at December 31,4119

v3.22.4
FINANCE COSTS—NET (Tables)
12 Months Ended
Dec. 31, 2022
Analysis of income and expense [abstract]  
Schedule of Finance Costs—Net
Year ended December 31,
(in millions of Euros)202220212020
Interest expense on borrowings (A)(91)(103)(122)
Interest expense on leases (10)(14)(10)
Interest cost on pension and other benefits (11)(9)(11)
Expenses on factoring arrangements (15)(9)(10)
Net loss on settlement of debt (B)(27)
Realized and unrealized gains / (losses) on debt derivatives at fair value (C)110(32)
Realized and unrealized exchange (losses) / gains on financing activities - net (C)(1)(10)37
Other finance expenses (5)(6)(12)
Capitalized borrowing costs (D)111
Finance expenses (131)(167)(159)
Finance costs - net (131)(167)(159)
(A)For the year ended December 31, 2022, interest expense on borrowings included €79 million of interest and €4 million of amortization of arrangement fees related to Constellium SE Senior Notes. For the year ended December 31, 2021, it included €92 million of interest and €4 million of amortization of arrangement fees related to Constellium SE Senior Notes.
(B)In February 2021, Constellium SE tendered and redeemed its $650 million 6.625% Senior Notes due 2025. The net loss on the settlement of debt included redemption fees of €9 million and the write-off of the outstanding deferred arrangement fees at the date of redemption of €8 million.
In June 2021, Constellium SE redeemed its $400 million 5.750% Senior Notes due 2024. The net loss on the settlement of debt included redemption fees of €3 million and the write-off of the outstanding deferred arrangement fees at the date of redemption of €3 million.
In November 2021, Constellium SE redeemed $200 million of the $500 million outstanding aggregate principal amount of the 5.875% Senior Notes due 2026. The net loss on the settlement of debt included redemption fees of €3 million and the write-off of the deferred arrangement fees attributable to the portion redeemed at the date of redemption of €1 million.
(C)     The Group hedges the dollar exposure, relating to the principal of its Constellium SE U.S. Dollar Senior Notes, for the portion that has not been used to finance directly or indirectly U.S. Dollar functional currency entities. Changes in the fair value of these hedging derivatives are recognized within Finance costs – net in the Consolidated Income Statement.
(D)     Borrowing costs directly attributable to the construction of assets are capitalized. The capitalization rate was 5% for the years ended December 31, 2022 and 2021 and 6% for the year ended December 31, 2020.

v3.22.4
INCOME TAX (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
Schedule of Current and Deferred Components of Income Tax
Year ended December 31,
(in millions of Euros)202220212020
Current tax expense (22)(26)(14)
Deferred tax benefit / (expense) 127(29)31
Income tax benefit / (expense)105(55)17
Schedule of Income Tax Reconciliation Using Composite Statutory Income Tax Rate Applicable by Tax Jurisdiction
The Group’s effective tax rate reconciliation is as follows:
Year ended December 31,
(in millions of Euros)202220212020
Income / (loss) before tax 203317(34)
Statutory tax rate applicable to the parent company 25.8%28.4%32.0%
Income tax (expense) / benefit calculated at statutory tax rate (52)(90)11
Effect of foreign tax rate (A)3152
Changes in recognized and unrecognized deferred tax assets (B)1542415
Other (4)(11)
Income tax benefit / (expense) 105(55)17
Effective income tax rate (52)%17%49%
(A)For the years ended December 31, 2022, 2021 and 2020, the Effect of foreign tax rate resulted from the geographical mix of our pre-tax results.
(B)For the year ended December 31, 2022, the changes in recognized and unrecognized deferred tax assets mainly related to the recognition of previously unrecognized deferred tax assets at one of our main operating entities in the United States for €154 million (see NOTE 17 - Deferred Income Taxes). For the year ended December 31, 2021, the changes mainly related to the recognition of deferred tax assets on temporary differences at one of our main operating entities in the United States. For the year ended December 31, 2020, the changes mainly related to recognized deferred tax assets on prior-year losses carried forward at one of our main operating entities in the United States, following some clarification on U.S. interest limitation rules and the CARES Act.

v3.22.4
TRADE RECEIVABLES AND OTHER (Tables)
12 Months Ended
Dec. 31, 2022
Trade and other receivables [abstract]  
Schedule of Trade Receivables and Other
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Trade receivables - gross467607
Impairment(2)(4)
Total trade receivables - net465603
Income tax receivables14162420
Other tax receivables3840
Contract assets152192
Prepaid expenses1819
Other1310119
Total other receivables43745580
Total trade receivables and other4353955683
Schedule of Aging of Total Trade Receivables—Net
At December 31,
(in millions of Euros)20222021
Not past due453596
1 – 30 days past due106
31 – 60 days past due21
Total trade receivables - net465603
Schedule of Currency Concentration of Total Trade Receivables
At December 31,
(in millions of Euros)20222021
Euro225277
U.S. Dollar213305
Swiss franc84
Other currencies1917
Total trade receivables - net465603

v3.22.4
INVENTORIES (Tables)
12 Months Ended
Dec. 31, 2022
Subclassifications of assets, liabilities and equities [abstract]  
Schedule of Inventories
At December 31,
(in millions of Euros)20222021
Finished goods315225
Work in progress638551
Raw materials 308226
Stores and supplies11295
Inventories write down(53)(47)
Total inventories1,3201,050

v3.22.4
PROPERTY, PLANT AND EQUIPMENT (Tables)
12 Months Ended
Dec. 31, 2022
Property, plant and equipment [abstract]  
Schedule of Property, Plant and Equipment
(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2022213741,411127151,948
Additions14901885297
Disposals(4)(1)(5)
Depreciation expense(1)(32)(230)(2)(12)(277)
Transfer and other changes21876(103)7
Effect of changes in foreign exchange rates17441154
Net balance at December 31, 2022233811,387211152,017
Cost426372,957224633,923
Less accumulated depreciation and impairment(19)(256)(1,570)(13)(48)(1,906)
Net balance at December 31, 2022233811,387211152,017
(in millions of Euros)Land and Property RightsBuildingsMachinery and EquipmentConstruction Work in ProgressOtherTotal
Net balance at January 1, 2021203791,361132141,906
Additions6521696233
Disposals(1)(2)(1)(4)
Depreciation expense(1)(27)(210)(3)(12)(253)
Transfer and other changes15153(174)8(7)
Effect of changes in foreign exchange rates11257373
Net balance at December 31, 2021213741,411127151,948
Cost385902,750142573,577
Less accumulated depreciation and impairment(17)(216)(1,339)(15)(42)(1,629)
Net balance at December 31, 2021213741,411127151,948
Schedule of Right of Use Assets Right-of-use assets have been included in the same line item as that in which a corresponding owned asset would be presented.
(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2022108651174
Additions11718
Disposals(1)(1)
Depreciation expense(12)(20)(1)(33)
Effect of changes in foreign exchange rates33
Net balance at December 31, 202210754161
Cost1611461308
Less accumulated depreciation and impairment(54)(92)(1)(147)
Net balance at December 31, 202210754161
(in millions of Euros)BuildingsMachinery and EquipmentOtherTotal
Net balance at January 1, 2021112722186
Additions5712
Depreciation expense(11)(16)(1)(28)
Transfer and other changes(1)(1)
Effect of changes in foreign exchange rates235
Net balance at December 31, 2021108651174
Cost1501443297
Less accumulated depreciation and impairment(42)(79)(2)(123)
Net balance at December 31, 2021108651174
Schedule of Depreciation Expense and Impairment Losses Relating to Property, Plant and Equipment
Total depreciation expense relating to property, plant and equipment and intangible assets are presented in the Consolidated Income Statement as follows:
Year ended December 31,
(in millions of Euros)202220212020
Cost of sales(270)(245)(240)
Selling and administrative expenses(12)(17)(14)
Research and development expenses(5)(5)(5)
Total depreciation expense(287)(267)(259)

v3.22.4
INTANGIBLE ASSETS AND GOODWILL (Tables)
12 Months Ended
Dec. 31, 2022
Intangible assets and goodwill [abstract]  
Schedule of Changes in Intangible Assets and Goodwill
(in millions of Euros)TechnologyComputer SoftwareCustomer relationshipsWork in ProgressOtherTotal Intangible AssetsGoodwill
Net balance at January 1, 20221821132458451
Additions33
Amortization expense(2)(7)(1)(10)
Transfer2(2)
Effect of changes in foreign exchange rates21327
Net balance at December 31, 20221816133454478
Cost92944244236478
Less accumulated depreciation and impairment(74)(78)(29)(1)(182)
Net balance at December 31, 20221816133454478
(in millions of Euros)TechnologyComputer SoftwareCustomer relationshipsWork in ProgressOtherTotal Intangible Assets Goodwill
Net balance at January 1, 202118151313261417
Additions44
Amortization expense(1)(12)(1)(14)
Transfer 17(15)24
Effect of changes in foreign exchange rates111334
Net balance at December 31, 20211821132458451
Cost86914034224451
Less accumulated depreciation and impairment(68)(70)(27)(1)(166)
Net balance at December 31, 20211821132458451

v3.22.4
DEFERRED INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
Schedule or Net Deferred Income Tax Assets
At December 31,
(in millions of Euros)20222021
Deferred income tax assets 271162
Deferred income tax liabilities (28)(14)
Net deferred income tax assets 243148
Schedule of Significant Changes in Net Deferred Income Tax Assets / (Liabilities)
At January 1, 2022Reclassified as held for saleRecognized inFXAt December 31, 2022
(in millions of Euros)Profit or lossOCI
Long-term assets (124)(2)31(7)(102)
Inventories 3(4)(1)(2)
Pensions 119(10)(35)478
Derivative valuation (6)824
Tax losses carried forward 117676190
Other (A)3935175
Net deferred income tax assets 148(2)127(33)3243
(A)At December 31, 2022, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.
At January 1, 2021Recognized inFXAt December 31,
2021
(in millions of Euros)Profit or lossOCI
Long-term assets (106)(10)(8)(124)
Inventories 5(2)3
Pensions 1265(17)5119
Derivative valuation (5)(5)4(6)
Tax losses carried forward 116(7)8117
Other (A)47(10)239
Net deferred income tax assets 183(29)(13)7148
(A)At December 31, 2021, Other primarily related to temporary differences arising from provisions and interest expense which will become tax-deductible in future periods.
Schedule of Unrecognized Deferred Tax Assets The related tax impact of €48 million and €191 million at December 31, 2022 and 2021, respectively, was attributable to the following:
At December 31,
(in millions of Euros)20222021
Expiring within 5 years (5)(3)
Expiring after 5 years and limited (5)(55)
Unlimited (21)(27)
Tax losses (31)(85)
Long-term assets (2)(65)
Pensions (3)(7)
Other (12)(34)
Deductible temporary differences (17)(106)
Total (48)(191)

v3.22.4
DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE (Tables)
12 Months Ended
Dec. 31, 2022
Non-Current Assets Held For Sale And Discontinued Operations [Abstract]  
Disclosure of analysis of single amount of discontinued operations
At December 31,
(in millions of Euros)2022
Assets of disposal group classified as held for sale
Cash and cash equivalents1
Trade receivables and other6
Inventories5
Deferred tax assets2
Total assets of disposal group classified as held for sale14
Liabilities of disposal group classified as held for sale
Trade payables and other8
Pensions and other post-employment benefit obligations2
Total liabilities of disposal group classified as held for sale10

v3.22.4
TRADE PAYABLES AND OTHER (Tables)
12 Months Ended
Dec. 31, 2022
Trade and other payables [abstract]  
Schedule of Trade Payables and Other
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Trade payables1,1551,065
Fixed assets payables3622
Employees' entitlements195185
Taxes payable other than income tax1716
Contract liabilities and other liabilities to customers2055477
Other payables2392812
Total other4331232312
Total trade payables and other431,467321,377
Schedule of Contract Liabilities and Other Liabilities to Customers
At December 31,
20222021
(in millions of Euros)Non-currentCurrentNon-currentCurrent
Deferred tooling revenue193
Advance payment from customers67
Unrecognized variable consideration (A)149167
Other3
Total contract liabilities and other liabilities to customers2055477
(A)Unrecognized variable consideration consists of expected volume rebates, discounts, incentives, refunds penalties and price concessions.

v3.22.4
BORROWINGS (Tables)
12 Months Ended
Dec. 31, 2022
Borrowings [abstract]  
Schedule of Borrowings by Nature
At December 31,
20222021
(in millions of Euros)Nominal Value in CurrencyNominal rateNominal Value in Euros(Arrange-ment fees) Accrued interestsCarrying valueCarrying
value
Secured Pan-U.S. ABL
(due 2026) (A)
$85 Floating80181
Secured PGE French Facility
(repaid in May 2022) (B)
180 Floating180
Senior Unsecured Notes (C)
Issued November 2017 anddue 2026 $300 5.875 %281(2)6285268
Issued November 2017 anddue 2026 400 4.250 %400(3)6403402
Issued June 2020 anddue 2028 $325 5.625 %305(5)1301284
Issued February 2021 anddue 2029 (D)$500 3.750 %469(6)4467438
Issued June 2021 anddue 2029 (D)300 3.125 %300(4)4300300
Unsecured Swiss Facility
(repaid in June 2022)
CHF15 1.175 %14
Lease liabilities 1671168183
Other loans (E)515160
Total Borrowings2,053(20)232,0562,129
Of which non-current1,9081,871
Of which current148258
(A)In June 2022, the Pan-U.S. ABL was amended to, among other things, increase the commitment to $500 million, provide an incremental revolving credit facility accordion of up to $100 million, and replace the LIBOR reference rate by the SOFR reference rate.
(B)The initial maturity date of the PGE was May 2021 with an option for Constellium to extend for up to 5 years. In May 2021, the maturity date was extended to May 2022. In May 2022, the PGE was repaid accordingly.
(C)The Senior Unsecured Notes were issued by Constellium SE and are guaranteed by certain subsidiaries.
(D)For the $500 million Sustainability-Linked Senior Notes issued in February 2021 and the €300 million Sustainability-Linked Senior Notes issued in June 2021, Constellium has established two sustainability performance targets (greenhouse gas emissions intensity and recycled metal input). If Constellium does not satisfy the first target for the year ended December 31, 2025, the interest rates for both Notes will be increased by 0.125% starting April 15, 2026 and July 15, 2026 respectively. If Constellium does not satisfy the second target for the year ended December 31, 2026, the interest rates will be increased by 0.125% starting April 15, 2027 and July 15, 2027, respectively (in addition to any increase arising from failure to meet the first target). At December 31, 2022, the Group expects to satisfy these targets.
(E)At December 31, 2022 Other loans included €36 million of financial liabilities relating to the sale and leaseback of assets that were considered to be financing arrangements in substance.
Schedule of Movement in Borrowings
(in millions of Euros)20222021
At January 1, 2,1292,391
Cash flows
Proceeds from issuance of long-term borrowings (A)712
Repayments of long-term borrowings (B)(192)(1,052)
Net change in revolving credit facilities and short-term borrowings (C)72(5)
Lease repayments(37)(32)
Payment of deferred financing costs(13)
Non-cash changes
Movement in accrued interest(1)(11)
Changes in leases and other loans1818
Deferred arrangement fees 316
Effects of changes in foreign exchange rates64105
At December 31,2,0562,129
(A)In February 2021, Constellium SE issued $500 million 3.750% Sustainability-Linked Senior Notes (€412 million converted at the issuance date exchange rate). In June 2021, Constellium SE issued €300 million 3.125% Sustainability-Linked Senior Notes.
(B)For the twelve months ended December 31, 2022, repayments of long-term borrowings included the repayment of the PGE.
In February 2021, Constellium SE tendered and redeemed the $650 million 6.625% Senior Notes due 2025 (€536 million converted at the redemption date exchange rate). In June 2021, Constellium SE redeemed the $400 million 5.750% Senior Notes due 2024 (€328 million converted at the redemption date exchange rate). In November 2021, Constellium SE partially redeemed $200 million ( €177 million converted at the repayment date exchange rate) of the $500 million outstanding aggregate principal amount of the 5.875% Senior Notes due 2026.
(C)For the twelve months ended December 31, 2022, the net change in revolving credit facilities and short-term borrowings included the net proceeds from the Pan-U.S. ABL and the repayment of the Swiss facility.
Schedule of Currency Concentration of Total Borrowings
At December 31,
(in millions of Euros)20222021
U.S. Dollar1,1881,055
Euro8611,048
Other currencies726
Total borrowings2,0562,129

v3.22.4
FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of detailed information about financial instruments [abstract]  
Schedule of Financial Assets and Liabilities by Categories
At December 31,
20222021
(in millions of Euros)NotesAt amortized costAt fair value through profit and lossAt fair value through OCITotalAt amortized costAt fair value through profit and lossAt fair value through OCITotal
Cash and cash equivalents12166166147147
Trade receivables 13465465603603
Other financial assets372397070
Total1663746767014770603820
At December 31,
20222021
(in millions of Euros)NotesAt amortized costAt fair value through profit and lossAt fair value through OCITotalAt amortized costAt fair value through profit and lossAt fair value through OCITotal
Trade payables and fixed asset payables191,1911,1911,0871,087
Borrowings202,0562,0562,1292,129
Other financial liabilities40155526531
Total3,24740153,3023,2162653,247
Schedule of Other Financial Assets and Other Financial Liabilities Positions
At December 31,
20222021
(in millions of Euros)Non-currentCurrentTotalNon-currentCurrentTotal
Aluminium and premium derivatives27993847
Energy derivatives325112
Other commodity derivatives2244
Currency commercial derivatives3202321416
Currency net debt derivatives11
Other financial assets - derivatives83139125870
Aluminium and premium derivatives19191414
Energy derivatives3710
Other commodity derivatives11
Currency commercial derivatives11142561117
Other financial liabilities - derivatives14415562531
In the year ended December 31, 2021, forward purchases of $565 million versus the Euro using cross currency basis swaps were not renewed when they reached their maturity or were bought out before their initial maturity in connection with the refinancing of the Senior Notes. This transaction generated a cash outflow of €32 million which is presented in Other financing activities within the Consolidated Statement of Cash Flows in the year ended December 31, 2021.
Schedule of Derivatives Measured at Fair Value
At December 31,
20222021
(in millions of Euros)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Other financial assets - derivatives63339412970
Other financial liabilities - derivatives173855131831

v3.22.4
FINANCIAL RISK MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of detailed information about hedging instruments [line items]  
Schedule of Effect of Foreign Currency Derivatives Impacts in Consolidated Income Statement and Statement of Comprehensive Income
The table below details the effect of foreign currency derivatives in the Consolidated Income Statement and the Consolidated Statement of Comprehensive Income:
Year ended December 31,
(in millions of Euros)Notes202220212020
Derivatives that do not qualify for hedge accounting
Included in Other gains and losses - net
Realized gains / (losses) on foreign currency derivatives - net91(4)
Unrealized gains / (losses) on foreign currency derivatives - net (A)9615(9)
Derivatives that qualify for hedge accounting
Included in Other comprehensive income
Unrealized (losses) / gains on foreign currency derivatives - net(16)(21)20
Gains reclassified from cash flow hedge reserve to the Consolidated Income Statement846
Included in Revenue (B)
Realized losses on foreign currency derivatives - net
9(8)(2)(7)
Unrealized (losses) / gains on foreign currency derivatives - net9(2)1
Derivatives discontinued from hedge accounting
Included in Other gains and losses - net
Losses reclassified from OCI as a result of hedge accounting discontinuation (C)9(6)
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized.
(B)Changes in fair value of derivatives that qualify for hedge accounting are included in Revenue when the related customer invoices are issued.
(C)In the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for 2020 and 2021, to which hedge accounting was applied, was no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted a €6 million loss.
Schedule of Exposure to Financial Counterparties by Rating Type
The number of financial counterparties tabulated below shows our exposure to the counterparty by rating type (Parent company ratings from Moody’s Investor Services):
At December 31,
20222021
Number of financial counterparties (A)Exposure (in millions of Euros)Number of financial counterparties (A)Exposure (in millions of Euros)
Rated Aa or better251354
Rated A61121398
Rated Baa13333
Total 916619185
(A)Financial counterparties for which the Group’s exposure is below €0.25 million have been excluded from the analysis.
Schedule of Undiscounted Contractual Financial Assets and Financial Liabilities Values by Relevant Maturity Groupings
The tables below show undiscounted contractual financial assets and financial liabilities values by relevant maturity groupings based on the remaining periods from December 31, 2022 and 2021, respectively, to the contractual maturity date.
At December 31,
20222021
(in millions of Euros)Less than 1 yearBetween 1- 5 yearsOver 5 yearsLess than 1 yearBetween 1 - 5 yearsOver 5 years
Financial assets
Net cash flows from derivative assets related to currencies and commodities3196012
Trade receivables 465603
Total496966312
At December 31,
20222021
(in millions of Euros)NotesLess than 1 yearBetween 1 - 5 yearsAfter 5 yearsLess than 1 yearBetween 1 - 5 YearsAfter 5 years
Financial liabilities
Borrowings56981,0871957101,046
Leases359886379985
Interest (A)78260547928596
Net cash flows from derivative liabilities related to currencies and commodities42192612
Trade payables and fixed asset payables191,1911,087
Total1,3511,0751,2271,4241,1061,227
(A)Interest disclosed is an undiscounted forecasted interest amount that excludes interest on leases.
Currency risk  
Disclosure of detailed information about hedging instruments [line items]  
Schedule of Nominal Value of Derivatives
The following tables outline the nominal value (converted to millions of Euros at the closing rate) of forward derivatives for Constellium’s most significant foreign exchange exposures at December 31, 2022.
Sold currenciesMaturity YearLess than 1 yearOver 1 year
USD2023-2025409186
CHF2023-20268229
CZK20233
Other currencies202310
Purchased currenciesMaturity YearLess than 1 yearOver 1 year
USD2023-202610925
CHF2023-202513416
CZK2023-20247820
Other currencies20231
Schedule of Effect of Foreign Currency Derivatives Impacts in Consolidated Income Statement
Year ended December 31,
(in millions of Euros)202220212020
Derivatives
Included in Finance costs - net
Realized gains / (losses) on foreign currency derivatives - net2(36)7
Unrealized (losses) / gains on foreign currency derivatives - net(1)46(39)
Total110(32)
Commodity price risk  
Disclosure of detailed information about hedging instruments [line items]  
Schedule of Nominal Value of Derivatives
At December 31, 2022, the nominal amount of commodity derivatives is as follows:
(in millions of Euros)MaturityLess than 1 yearOver 1 year
Aluminium 2023-20242905
Premium 2023-2025185
Copper 202312
Silver 2023-202418
Natural gas2023-20263129
Zinc20238
Schedule of Effect of Foreign Currency Derivatives Impacts in Consolidated Income Statement
Year ended December 31,
(in millions of Euros)202220212020
Derivatives
Included in Other gains and losses - net
Realized (losses) / gains on commodity derivatives - net
(6)112(31)
Unrealized (losses) / gains on commodity derivatives - net(53)2425
Other currencies  
Disclosure of detailed information about hedging instruments [line items]  
Schedule of Impact on Profit and Equity (before tax effect) of a 10% strengthening of the US Dollar versus the Euro The table below summarizes the impact on income and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro for non U.S. Dollar functional currency entities.
(in millions of Euros)Effect on income before taxEffect on pretax equity
Trade receivables3
Trade payables(1)
Derivatives on commercial transactions (A)(25)(24)
Net commercial transaction exposure(23)(24)
Cash in Bank and intercompany loans105
Borrowings(117)
Derivatives on financing transactions12
Net financing transaction exposure
Total(23)(24)
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized. The impact on pretax equity of €24 million relates to derivatives hedging the future sales spread from 2023 to 2025 which are designated as cash flow hedges.
U.S. Dollars  
Disclosure of detailed information about hedging instruments [line items]  
Schedule of Impact on Profit and Equity (before tax effect) of a 10% strengthening of the US Dollar versus the Euro
The table below summarizes the impact on income and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro (on average rate for income before tax and closing rate for pretax equity) for U.S. Dollar functional currency entities.
(in millions of Euros)Effect on income before taxEffect on pretax equity
10% strengthening U.S. Dollar/Euro23182

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of defined benefit plans [line items]  
Schedule of Sensitivity Analysis and Actuarial Assumptions
At December 31,
20222021
Rate of increase in salariesRate of increase in pensionsDiscount rateRate of increase in salariesRate of increase in pensionsDiscount rate
Switzerland1.75%2.05%1.50%0.15%
U.S.
Hourly pension3.00%
5.00% - 5.05%
2.20%
2.80% - 2.95%
Salaried pension—%5.05%—%2.85%
OPEB (A)4.00%
5.00% - 5.05%
3.80%
2.85% - 2.95%
Other benefits3.80%
4.95% - 5.00%
3.80%
2.60% - 2.85%
France
2.20%
2.00%
1.80% - 3.80%
2.00%
Retirements3.80%1.00%
Other benefits3.80%0.90%
Germany2.50%2.00%3.75%2.50%1.80%1.05%
(A)The other main financial assumptions used for the OPEB healthcare plans, which are predominantly in the U.S. were:
Medical trend rate: i) pre-65: 6.75% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards and ii) post-65: 6.00% starting in 2022 decreasing gradually to 4.50% in 2031 and stable onwards,
Claims costs based on Company experience.
Schedule of Amounts Recognized in the Consolidated Statement of Financial Position
At December 31,
20222021
(in millions of Euros)Pension BenefitsOther BenefitsTotalPension BenefitsOther BenefitsTotal
Present value of funded obligation614614766766
Fair value of plan assets(461)(461)(544)(544)
Deficit of funded plans153153222222
Present value of unfunded obligation96154250128249377
Net liability / (asset) arising from defined benefit obligation249154403350249599
Schedule of Movement in Net Defined Benefit Obligations
Year ended December 31, 2022
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20228942491,143(544)599
Included in the Consolidated Income Statement
Current service cost2082828
Interest cost / (income)13720(9)11
Past service cost2(49)(47)(47)
Immediate recognition of gains arising over the year(5)(5)(5)
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets107107
—changes in financial assumptions(211)(43)(254)(254)
—changes in demographic assumptions(1)(1)(1)
—experience losses(3)(9)(12)(12)
Effects of changes in foreign exchange rates341650(30)20
Included in the Consolidated Statement of Cash Flows
Benefits paid(42)(21)(63)57(6)
Contributions by the Group(38)(38)
Contributions by the plan participants426(6)
Reclassification as liabilities of disposal group classified as held for sale (1)(1)(1)
At December 31, 2022710154864(461)403
Year ended December 31, 2021
Defined benefit obligationsPlan AssetsNet defined benefit liability
(in millions of Euros)Pension benefitsOther benefitsTotal
At January 1, 20219062161,122(458)664
Included the Consolidated Income Statement
Current service cost2283030
Interest cost / (income)10515(6)9
Past service cost1313232
Immediate recognition of gains arising over the year
Administration expenses22
Included in the Statement of Comprehensive Income
Remeasurements due to:
—actual return less interest on plan assets(56)(56)
—changes in financial assumptions(29)(9)(38)(38)
—changes in demographic assumptions(13)(13)(13)
—experience losses(9)(2)(11)(11)
Effects of changes in foreign exchange rates381755(32)23
Included in the Consolidated Statement of Cash Flows
Benefits paid(36)(18)(54)32(22)
Contributions by the Group(21)(21)
Contributions by the plan participants415(5)
At December 31, 20218942491,143(544)599
Schedule of Net Defined Benefit Obligations by Country
At December 31,
20222021
(in millions of Euros)Defined benefit obligationsPlan assetsNet defined benefit liabilityDefined benefit obligationsPlan assetsNet defined benefit liability
France117(6)111158(5)153
Germany100(1)99134(2)132
Switzerland249(236)13306(268)38
United States398(218)180545(269)276
Total864(461)4031,143(544)599
Schedule of Plan Asset Categories
At December 31,
20222021
(in millions of Euros)Quoted in an active marketNot quoted in an active marketTotalQuoted in an active marketNot quoted in an active marketTotal
Cash & cash equivalents4444
Equities873612311561176
Bonds14680226149110259
Property146074165571
Other34343434
Total fair value of plan assets251210461284260544
Schedule of Benefit Payments Expected to be Paid Either by Pension Funds or Directly to Beneficiaries
Future benefit payments expected to be paid either by pension funds or directly by the Company to beneficiaries are as follows:
(in millions of Euros)Estimated benefits payments
Year ended December 31,
202356
202456
202557
202657
202760
2028 to 2032328
Actuarial assumption of discount rates  
Disclosure of defined benefit plans [line items]  
Schedule of Sensitivity Analysis and Actuarial Assumptions At December 31, 2022, impacts of the change on the defined benefit obligation of a 50 basis points increase / decrease in the discount rates are calculated by using a proxy based on the duration of each scheme:
(in millions of Euros)50 bp increase in
discount rates
50 bp decrease in
discount rates
France (6)7
Germany(5)5
Switzerland(16)17
United States(19)23
Total sensitivity on Defined Benefit Obligations(46)52

v3.22.4
PROVISIONS (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of other provisions [abstract]  
Schedule of Changes in Provisions
(in millions of Euros)Close down and environmental remediation costsRestructuring
 costs
Legal claims
and other costs
Total
At January 1, 202288227117
Allowance336
Amounts used(3)(2)(2)(7)
Unused amounts reversed(4)(4)
Unwinding of discounts and change in discount rates(5)(5)
Effects of changes in foreign exchange rates314
At December 31, 20228625111
Of which current12921
Of which non-current741690
Total provisions8625111
(in millions of Euros)Close down and environmental remediation costsRestructuring
 costs
Legal claims
and other costs
Total
At January 1, 202188627121
Allowance43411
Amounts used(1)(6)(2)(9)
Unused amounts reversed(2)(1)(6)(9)
Unwinding of discounts and change in discount rates(1)(1)
Effects of changes in foreign exchange rates44
Transfer(4)4
At December 31, 202188227117
Current711220
Non-Current8111597
Total Provisions88227117
Schedule of Legal Claims and Other Costs
At December 31,
(in millions of Euros)20222021
Litigation1516
Disease claims (A)109
Other2
Total provisions for legal claims and other costs2527
(A)Since the early 1990s, certain activities of the Group’s businesses have been subject to claims and lawsuits in France relating to occupational diseases resulting from alleged asbestos exposure, such as mesothelioma and asbestosis. It is not uncommon for the investigation and resolution of such claims to go on over many years as the latency period for developing such diseases is typically
between 25 and 40 years. For any such claim, it is up to the social security authorities in each jurisdiction to determine if a claim qualifies as an occupational illness claim. If so determined, the Group must settle the case or defend its position in court. At December 31, 2022, six cases in which gross negligence is alleged (“faute inexcusable”) are outstanding (five at December 31, 2021), the average amount per claim being around €0.4 million. The average settlement amount per claim over the past five years was less than €0.5 million. It is not anticipated that the resolution of such litigation and proceedings will have a material effect on the future results from continuing operations, financial position, or cash flows of the Group.

v3.22.4
SHARE CAPITAL (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of share capital, reserves and other equity interest [Abstract]  
Schedule of Share Capital
(in millions of Euros)
Number of sharesShare capitalShare premium
At January 1, 2022141,677,3663420
New shares issued (A)2,624,226
At December 31, 2022144,301,5923420
(A)In the year ended December 31, 2022, Constellium SE issued and delivered 2,624,226 ordinary shares to certain employees and directors related to share-based compensation plans.

v3.22.4
COMMITMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Disclosures of commitments [Abstract]  
Schedule of Non-cancellable Lease Commitments Not Capitalized
Non-cancellable lease commitments relating to the future aggregate minimum lease payments under non-cancellable leases still recognized as expense are presented below:
At December 31,
(in millions of Euros)20222021
Less than 1 year33
1 to 5 years93
More than 5 years2
Total non-cancellable minimum lease payments128
Schedule of Tangible and Intangible Assets Commitments
Contractual commitments for the acquisition of Property, Plant and Equipment are presented below:
At December 31,
(in millions of Euros)20222021
Property, plant and equipment16665
Total tangible and intangible asset commitments16665

v3.22.4
RELATED PARTIES (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of transactions between related parties [abstract]  
Schedule of Key Management Personnel Compensation
As a result, the aggregate compensation for the Group’s key management is comprised of the following:
Year ended December 31,
(in millions of Euros)202220212020
Short-term employee benefits1289
Directors' fees211
Share-based compensation10910
Post-employments benefits
Termination benefits
Employer social contribution211
Total261921

v3.22.4
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-based payment arrangements [Abstract]  
Schedule of Inputs to the Model Used for PSUs Granted The following table lists the inputs to the valuation model used for the PSUs granted in 2022 and 2021:
March 2022 PSUsMay 2021 PSUs
Fair value at grant date (in euros)23.7021.84
Share price at grant date (in euros)17.1113.90
Dividend yield
Expected volatility (A)70%71%
Risk-free interest rate (US government bond yield)1.88%0.31%
Model usedMonte CarloMonte Carlo
(A)Volatilities for the Company and companies included in indices were estimated based on observed historical volatilities over a period equal to the PSU vesting period.
Schedule of Number and Movement of Potential Shares
Performance-Based RSURestricted Stock UnitsEquity Award Plans
Potential SharesWeighted-Average Grant-Date Fair Value per Share Potential SharesWeighted-Average Grant-Date Fair Value per Share Potential SharesWeighted-Average Grant-Date Fair Value per Share
At January 1, 20212,594,32710.172,231,9116.8832,9128.39
Granted614,55521.84534,49913.90
Over-performance526,55115.31
Vested(1,161,718)15.31(520,064)10.27(32,912)8.39
Forfeited(47,188)10.29(97,347)7.17
At December 31, 20212,526,52711.712,148,9997.79
Granted (A)603,02323.70556,36017.11
Over-performance (B)924,63410.44
Vested(1,849,268)10.44(774,958)7.10
Forfeited (C)(19,082)11.65(54,955)9.04
At December 31, 20222,185,83415.561,875,44610.80
(A)For PSUs, the number of potential shares granted is presented using a vesting multiplier of 100%.
(B)When the achievement of TSR performance exceeds the vesting multiplier of 100%, the additional potential shares are presented as over-performance shares.
(C)For potential shares related to PSUs, 19,082 were forfeited following the departure of certain beneficiaries and none were forfeited in relation to the non-fulfilment of performance conditions.

v3.22.4
SUBSIDIARIES AND AFFILIATES (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of subsidiaries [abstract]  
Schedule of Group's Affiliates and Legal Entities Included in Consolidated Financial Statements
The following Group’s affiliates are legal entities included in the Consolidated Financial Statements of the Group at December 31, 2022. All entities are consolidated except for Rhenaroll which is accounted for under the equity method.
EntityCountry% Group Interest
Cross Operating Segment
Constellium Singen GmbH (AS&I and P&ARP)Germany100%
Constellium Valais S.A. (AS&I and A&T)Switzerland100%
AS&I
Constellium Automotive USA, LLCU.S.100%
Constellium Engley (Changchun) Automotive Structures Co Ltd.China54%
Constellium Extrusions Decin S.r.o.Czech Republic100%
Constellium Extrusions Deutschland GmbHGermany100%
Constellium Extrusions Landau GmbHGermany100%
Constellium Extrusions Burg GmbHGermany100%
Constellium Extrusions France S.A.S.France100%
Constellium Extrusions Levice S.r.o.Slovakia100%
Constellium Automotive Mexico, S. DE R.L. DE C.V.Mexico100%
Constellium Automotive Mexico Trading, S. DE R.L. DE C.V.Mexico100%
Astrex IncCanada50%
Constellium Automotive Zilina S.r.o.Slovakia100%
Constellium Automotive (Nanjing) Co. Ltd.China100%
Constellium Automotive Spain SLSpain100%
Constellium UK LimitedUnited Kingdom100%
A&T
Constellium Issoire S.A.S.France100%
Constellium Montreuil Juigné S.A.S.France100%
Constellium China Co. Ltd.China100%
Constellium Japan KKJapan100%
Constellium Rolled Products Ravenswood, LLCU.S.100%
Constellium Ussel S.A.S.France100%
AluInfra Services SA (A)Switzerland50%
P&ARP
Constellium Deutschland GmbHGermany100%
Constellium Rolled Products Singen GmbH & Co. KGGermany100%
Constellium Neuf Brisach S.A.S.France100%
Constellium Muscle Shoals LLCU.S.100%
Constellium Holdings Muscle Shoals LLCU.S.100%
Constellium Muscle Shoals Funding II LLCU.S.100%
Constellium Muscle Shoals Funding III LLCU.S.100%
Constellium Metal Procurement LLCU.S.100%
Constellium Bowling Green LLCU.S.100%
Rhenaroll SAFrance50%
Holdings & Corporate
C-TEC Constellium Technology Center S.A.S.France100%
Constellium Finance S.A.S.France100%
Constellium France III S.A.S.France100%
Constellium France Holdco S.A.S.France100%
Constellium International S.A.S.France100%
Constellium Paris S.A.S.France100%
Constellium Germany Holdco GmbH & Co. KGGermany100%
Constellium Germany Verwaltungs GmbHGermany100%
Constellium US Holdings I, LLCU.S.100%
Constellium US Intermediate Holdings LLCU.S.100%
Constellium Switzerland AGSwitzerland100%
Constellium Treuhand UG (haftunsgbeschränkt)Germany100%
Engineered Products International S.A.S.France100%
(A)AluInfra Services SA, the joint venture created with Novelis in July 2018, is consolidated as a joint operation and is immaterial to the Group Consolidated Financial Statements.

v3.22.4
GENERAL INFORMATION (Details)
Dec. 31, 2022
employee
center
site
facility
Disclosure of general information [abstract]  
Number of production facilities | facility 29
Number of R&D centers | center 3
Number of administrative centers | site 3
Number of employees | employee 12,500

v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Disclosure of Foreign Exchange Rates (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
U.S. Dollars      
Disclosure of foreign exchange rates [line items]      
Average rates 1.0507 1.1821 1.1405
Closing rates 1.0666 1.1326 1.2271
Swiss Francs      
Disclosure of foreign exchange rates [line items]      
Average rates 1.0038 1.0808 1.0704
Closing rates 0.9847 1.0331 1.0802
Czech Koruna      
Disclosure of foreign exchange rates [line items]      
Average rates 24.5633 25.6366 26.4337
Closing rates 24.1160 24.8580 26.2420

v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
12 Months Ended
Dec. 31, 2022
EUR (€)
Summary of significant accounting policies [line items]  
Cash flow projection period used in impairment of goodwill 5 years
Low-value asset recognition exemption to leased assets € 5,000
Technology  
Summary of significant accounting policies [line items]  
Intangible assets amortized estimated useful life 20 years
Customer relationships  
Summary of significant accounting policies [line items]  
Intangible assets amortized estimated useful life 25 years
Bottom of range | Computer Software  
Summary of significant accounting policies [line items]  
Intangible assets amortized estimated useful life 3 years
Bottom of range | Buildings  
Summary of significant accounting policies [line items]  
Property, plant and equipment, useful life 10 years
Bottom of range | Machinery and Equipment  
Summary of significant accounting policies [line items]  
Property, plant and equipment, useful life 3 years
Bottom of range | Vehicles  
Summary of significant accounting policies [line items]  
Property, plant and equipment, useful life 5 years
Top of range | Computer Software  
Summary of significant accounting policies [line items]  
Intangible assets amortized estimated useful life 5 years
Top of range | Buildings  
Summary of significant accounting policies [line items]  
Property, plant and equipment, useful life 50 years
Top of range | Machinery and Equipment  
Summary of significant accounting policies [line items]  
Property, plant and equipment, useful life 40 years
Top of range | Vehicles  
Summary of significant accounting policies [line items]  
Property, plant and equipment, useful life 8 years

v3.22.4
REVENUE - Disaggregation of Revenue by Product Line (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of products and services [line items]      
Total Revenue by product line € 8,120 € 6,152 € 4,883
Packaging rolled products      
Disclosure of products and services [line items]      
Total Revenue by product line 3,326 2,673 1,960
Automotive rolled products      
Disclosure of products and services [line items]      
Total Revenue by product line 1,154 854 663
Specialty and other thin-rolled products      
Disclosure of products and services [line items]      
Total Revenue by product line 175 161 102
Aerospace rolled products      
Disclosure of products and services [line items]      
Total Revenue by product line 728 389 560
Transportation, industry, defense and other rolled products      
Disclosure of products and services [line items]      
Total Revenue by product line 916 713 442
Automotive extruded products      
Disclosure of products and services [line items]      
Total Revenue by product line 949 735 665
Other extruded products      
Disclosure of products and services [line items]      
Total Revenue by product line € 872 € 627 € 491

v3.22.4
REVENUE - Disaggregation of Revenue by Destination of Shipment (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of geographical areas [line items]      
Total Revenue by product line € 8,120 € 6,152 € 4,883
Germany      
Disclosure of geographical areas [line items]      
Total Revenue by product line 2,036 1,481 1,014
France      
Disclosure of geographical areas [line items]      
Total Revenue by product line 691 466 362
United Kingdom      
Disclosure of geographical areas [line items]      
Total Revenue by product line 221 179 192
Switzerland      
Disclosure of geographical areas [line items]      
Total Revenue by product line 87 63 52
Spain      
Disclosure of geographical areas [line items]      
Total Revenue by product line 302 252 185
Czech Republic      
Disclosure of geographical areas [line items]      
Total Revenue by product line 237 172 119
Other Europe      
Disclosure of geographical areas [line items]      
Total Revenue by product line 1,110 809 619
Total Europe      
Disclosure of geographical areas [line items]      
Total Revenue by product line 4,684 3,422 2,543
United States      
Disclosure of geographical areas [line items]      
Total Revenue by product line 2,823 2,335 1,941
Asia and Other Pacific      
Disclosure of geographical areas [line items]      
Total Revenue by product line 252 171 211
All Other      
Disclosure of geographical areas [line items]      
Total Revenue by product line € 361 € 224 € 188

v3.22.4
REVENUE - Narrative (Details)
12 Months Ended
Dec. 31, 2022
Revenue recognized over time  
Disclosure of geographical areas [line items]  
Percentage of payment option over total revenue 1.00%

v3.22.4
OPERATING SEGMENT INFORMATION - Narrative (Details)
€ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
employee
country
facility
Dec. 31, 2021
EUR (€)
Dec. 31, 2020
EUR (€)
Disclosure of operating segments [line items]      
Number of employees | employee 12,500    
Revenue € 8,120 € 6,152 € 4,883
P&ARP      
Disclosure of operating segments [line items]      
Number of facilities | facility 4    
Number of countries in which entity operates | country 3    
Number of employees | employee 4,100    
Revenue € 4,655 3,688 2,725
P&ARP | Group's largest customer      
Disclosure of operating segments [line items]      
Revenue € 839 692 492
A&T      
Disclosure of operating segments [line items]      
Number of facilities | facility 6    
Number of countries in which entity operates | country 3    
Number of employees | employee 3,500    
Revenue € 1,645 1,102 1,002
AS&I      
Disclosure of operating segments [line items]      
Number of facilities | facility 19    
Number of countries in which entity operates | country 10    
Number of employees | employee 4,500    
Revenue € 1,820 € 1,362 € 1,156

v3.22.4
OPERATING SEGMENT INFORMATION - Segment Revenue (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of operating segments [line items]      
Revenue € 8,120 € 6,152 € 4,883
P&ARP      
Disclosure of operating segments [line items]      
Revenue 4,655 3,688 2,725
A&T      
Disclosure of operating segments [line items]      
Revenue 1,645 1,102 1,002
AS&I      
Disclosure of operating segments [line items]      
Revenue 1,820 1,362 1,156
Segment revenue      
Disclosure of operating segments [line items]      
Revenue 8,225 6,223 4,926
Segment revenue | P&ARP      
Disclosure of operating segments [line items]      
Revenue 4,664 3,698 2,734
Segment revenue | A&T      
Disclosure of operating segments [line items]      
Revenue 1,700 1,142 1,025
Segment revenue | AS&I      
Disclosure of operating segments [line items]      
Revenue 1,861 1,383 1,167
Inter-segment elimination      
Disclosure of operating segments [line items]      
Revenue (105) (71) (43)
Inter-segment elimination | P&ARP      
Disclosure of operating segments [line items]      
Revenue (9) (10) (9)
Inter-segment elimination | A&T      
Disclosure of operating segments [line items]      
Revenue (55) (40) (23)
Inter-segment elimination | AS&I      
Disclosure of operating segments [line items]      
Revenue € (41) € (21) € (11)

v3.22.4
OPERATING SEGMENT INFORMATION - Segment Adjusted EBITDA and reconciliation of Adjusted EBITDA to Net Income (Details) - EUR (€)
€ in Millions
1 Months Ended 12 Months Ended
Oct. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]        
Adjusted EBITDA   € 673 € 581 € 465
Metal price lag   (29) 187 (8)
Start-up and development costs   0 0 (5)
Share based compensation costs   (18) (15) (15)
(Losses) / gains on pension plan amendments   47 (32) (2)
Depreciation and amortization   (287) (267) (259)
Impairment of assets   0 0 (43)
Restructuring costs   (1) (3) (13)
Unrealized (losses) / gains on derivatives   (46) 35 16
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net   (1) 1 1
Losses on disposal   (4) (3) (4)
Other   0 0 (8)
Income from operations   334 484 125
Finance costs - net   (131) (167) (159)
Income / (loss) before tax   203 317 (34)
Income tax benefit / (expense)   105 (55) 17
Net income / (loss)   308 262 (17)
Collective bargaining agreement, period 3 years      
Losses reclassified from OCI as a result of hedge accounting discontinuation   0 0 6
OPEB        
Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]        
(Losses) / gains on pension plan amendments   49    
Negative past service cost recorded to cancel gain originally recognized     31  
COVID-19        
Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]        
Procurement penalties and termination fees       2
Losses reclassified from OCI as a result of hedge accounting discontinuation       6
P&ARP        
Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]        
Adjusted EBITDA   326 344 291
A&T        
Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]        
Adjusted EBITDA   217 111 106
AS&I        
Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]        
Adjusted EBITDA   149 142 88
H&C        
Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]        
Adjusted EBITDA   € (19) € (16) € (20)

v3.22.4
OPERATING SEGMENT INFORMATION - Segment Capital Expenditures (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of operating segments [line items]      
Capital expenditures € (273) € (232) € (182)
P&ARP      
Disclosure of operating segments [line items]      
Capital expenditures (127) (94) (73)
A&T      
Disclosure of operating segments [line items]      
Capital expenditures (78) (70) (45)
AS&I      
Disclosure of operating segments [line items]      
Capital expenditures (62) (62) (61)
H&C      
Disclosure of operating segments [line items]      
Capital expenditures € (6) € (6) € (3)

v3.22.4
OPERATING SEGMENT INFORMATION - Segment Assets (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of operating segments [line items]        
Total Assets € 4,941 € 4,624    
Deferred income tax assets 271 162    
Cash and cash equivalents 166 147 € 439 € 184
Assets of disposal group classified as held for sale 14 0    
Segment revenue        
Disclosure of operating segments [line items]        
Total Assets 4,451 4,245    
Segment revenue | P&ARP        
Disclosure of operating segments [line items]        
Total Assets 2,187 2,108    
Segment revenue | A&T        
Disclosure of operating segments [line items]        
Total Assets 1,081 948    
Segment revenue | AS&I        
Disclosure of operating segments [line items]        
Total Assets 727 738    
Segment revenue | H&C        
Disclosure of operating segments [line items]        
Total Assets 456 451    
Unallocated        
Disclosure of operating segments [line items]        
Deferred income tax assets 271 162    
Cash and cash equivalents 166 147    
Other financial assets 39 70    
Assets of disposal group classified as held for sale € 14 € 0    

v3.22.4
INFORMATION BY GEOGRAPHIC AREA (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of detailed information about property, plant and equipment [line items]      
Property, plant and equipment € 2,017 € 1,948 € 1,906
United States      
Disclosure of detailed information about property, plant and equipment [line items]      
Property, plant and equipment 832 811  
France      
Disclosure of detailed information about property, plant and equipment [line items]      
Property, plant and equipment 699 653  
Germany      
Disclosure of detailed information about property, plant and equipment [line items]      
Property, plant and equipment 269 266  
Czech Republic      
Disclosure of detailed information about property, plant and equipment [line items]      
Property, plant and equipment 97 99  
Other      
Disclosure of detailed information about property, plant and equipment [line items]      
Property, plant and equipment € 120 € 119  

v3.22.4
EXPENSES BY NATURE (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of attribution of expenses by nature to their function [line items]      
Employee benefit expenses € (1,110) € (967) € (902)
Depreciation and amortization (287) (267) (259)
Other gains and losses - net (8) 117 (89)
Total operating expenses (7,786) (5,668) (4,758)
Total Operating Expenses      
Disclosure of attribution of expenses by nature to their function [line items]      
Raw materials and consumables used (5,545) (3,885) (2,832)
Employee benefit expenses (1,110) (967) (902)
Energy costs (274) (149) (141)
Sub-contractors (125) (102) (89)
Freight out costs (163) (143) (122)
Professional fees (81) (63) (73)
Lease expenses (15) (12) (11)
Depreciation and amortization (287) (267) (259)
Other operating expenses (178) (197) (240)
Other gains and losses - net € (8) € 117 € (89)

v3.22.4
EMPLOYEE BENEFIT EXPENSES (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Classes of employee benefits expense [abstract]      
Wages and salaries € (1,067) € (920) € (855)
Pension costs - defined benefit plans (22) (24) (23)
Other post-employment benefits (3) (8) (9)
Share-based compensation (18) (15) (15)
Total employee benefit expenses € (1,110) € (967) € (902)

v3.22.4
OTHER GAINS AND LOSSES—NET (Details) - EUR (€)
€ in Millions
1 Months Ended 12 Months Ended
Oct. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Analysis of income and expense [abstract]        
Realized gains / (losses) on derivatives   € (6) € 113 € (35)
Losses reclassified from OCI as a result of hedge accounting discontinuation   0 0 (6)
Realized and unrealized (losses) / gains on debt derivatives at fair value   (47) 39 16
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net   (1) 1 1
Impairment of assets   0 0 (43)
Restructuring costs   (1) (3) (13)
(Losses) / gains on pension plan amendments   47 (32) (2)
Losses on disposal   (4) (3) (4)
Other   4 2 (3)
Total other gains and losses - net   (8) 117 (89)
Disclosure of income tax expense [line Items]        
Impairment charge   0 0 43
(Losses) / gains on pension plan amendments   47 (32) (2)
Collective bargaining agreement, period 3 years      
OPEB        
Analysis of income and expense [abstract]        
(Losses) / gains on pension plan amendments   49    
Disclosure of income tax expense [line Items]        
Negative past service cost recorded to cancel gain originally recognized     € 31  
(Losses) / gains on pension plan amendments   € 49    
COVID-19        
Analysis of income and expense [abstract]        
Losses reclassified from OCI as a result of hedge accounting discontinuation       (6)
COVID-19 | A&T and AC&I        
Analysis of income and expense [abstract]        
Impairment of assets       (43)
Disclosure of income tax expense [line Items]        
Impairment charge       € 43

v3.22.4
CURRENCY GAINS / (LOSSES) - Currency Gains and Losses Included in Income from Operations (Details)
€ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
EUR (€)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
EUR (€)
Dec. 31, 2020
USD ($)
Analysis of income and expense [line items]            
Total currency gains / (losses) - net € (1) $ (1) € 13 $ 13 € (27) $ (27)
Realized gains / (losses) on foreign currency derivatives - net (8)   (1)   (11)  
Losses reclassified from OCI as a result of hedge accounting discontinuation 0   0   (6)  
Unrealized gains / (losses) on foreign currency derivatives - net 6   13   (8)  
Exchange gains / (losses) from the remeasurement of monetary assets and liabilities - net 1   1   (2)  
Included in Revenue            
Analysis of income and expense [line items]            
Total currency gains / (losses) - net (8)   (4)   (6)  
Included in Cost of sales            
Analysis of income and expense [line items]            
Total currency gains / (losses) - net 2   1   (2)  
Included in Other gains and losses - net            
Analysis of income and expense [line items]            
Total currency gains / (losses) - net € 5   € 16   € (19)  

v3.22.4
CURRENCY GAINS / (LOSSES) - Foreign Currency Translation Reserve (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Movement in foreign currency translation reserve [abstract]    
Foreign currency translation reserve at January 1, € 19 € (13)
Effect of currency translation differences 22 32
Foreign currency translation reserve at December 31, € 41 € 19

v3.22.4
FINANCE COSTS—NET (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2021
EUR (€)
Nov. 30, 2021
USD ($)
Jun. 30, 2021
EUR (€)
Jun. 30, 2021
USD ($)
Feb. 28, 2021
EUR (€)
Feb. 28, 2021
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2020
EUR (€)
Dec. 31, 2022
USD ($)
Analysis of income and expense [line items]                    
Interest expense on borrowings             € (91,000,000) € (103,000,000) € (122,000,000)  
Interest expense on leases             (10,000,000) (14,000,000) (10,000,000)  
Interest cost on pension and other benefits             (11,000,000) (9,000,000) (11,000,000)  
Expenses on factoring arrangements             (15,000,000) (9,000,000) (10,000,000)  
Net loss on settlement of debt             0 (27,000,000) 0  
Realized and unrealized (losses) / gains on debt derivatives at fair value             1,000,000 10,000,000 (32,000,000)  
Realized and unrealized exchange (losses) / gains on financing activities - net             (1,000,000) (10,000,000) 37,000,000  
Other finance expenses             (5,000,000) (6,000,000) (12,000,000)  
Capitalized borrowing costs             1,000,000 1,000,000 1,000,000  
Finance expenses             (131,000,000) (167,000,000) (159,000,000)  
Finance costs - net             (131,000,000) (167,000,000) (159,000,000)  
Redemption of senior notes             192,000,000 € 1,052,000,000 € 209,000,000  
Nominal value             € 2,053,000,000      
Capitalization rate             5.00% 5.00% 6.00%  
Constellium SE Senior Notes                    
Analysis of income and expense [line items]                    
Interest expense on debt instruments issued             € 79,000,000 € 92,000,000    
Borrowing costs recognised as expense             € 4,000,000 € 4,000,000    
Senior Unsecured Notes Issued February 2017 and due 2025                    
Analysis of income and expense [line items]                    
Redemption of senior notes         € 536,000,000 $ 650,000,000        
Nominal rate         6.625% 6.625%        
Borrowing redemption fees         € 9,000,000          
Write off borrowing costs         € 8,000,000          
Senior Unsecured Notes Issued May 2014 and due 2024                    
Analysis of income and expense [line items]                    
Redemption of senior notes     € 328,000,000 $ 400,000,000            
Nominal rate     5.75% 5.75%            
Borrowing redemption fees     € 3,000,000              
Write off borrowing costs     € 3,000,000              
Senior Unsecured Notes Issued November 2017 and due 2026                    
Analysis of income and expense [line items]                    
Redemption of senior notes € 177,000,000 $ 200,000,000                
Nominal rate 5.875% 5.875%         5.875%      
Borrowing redemption fees € 3,000,000                  
Write off borrowing costs € 1,000,000                  
Nominal value   $ 500,000,000         € 281,000,000     $ 300,000,000

v3.22.4
INCOME TAX - Current and Deferred Components of Income Tax (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Taxes [Abstract]      
Current tax expense € (22) € (26) € (14)
Deferred tax benefit / (expense) 127 (29) 31
Income tax benefit / (expense) € 105 € (55) € 17

v3.22.4
INCOME TAX - Income Tax Reconciliation Using Composite Statutory Income Tax Rate Applicable by Tax Jurisdiction (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Reconciliation of average effective tax rate and applicable tax rate [abstract]      
Income / (loss) before tax € 203 € 317 € (34)
Statutory tax rate applicable to the parent company 25.80% 28.40% 32.00%
Income tax (expense) / benefit calculated at statutory tax rate € (52) € (90) € 11
Effect of foreign tax rate 3 15 2
Changes in recognized and unrecognized deferred tax assets 154 24 15
Other 0 (4) (11)
Income tax benefit / (expense) € 105 € (55) € 17
Effective income tax rate (52.00%) 17.00% 49.00%
Deferred tax assets € 271 € 162  

v3.22.4
CASH AND CASH EQUIVALENTS (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of cash and cash equivalents [line Items]        
Cash in bank and on hand € 166 € 147 € 439 € 184
Cash subject to restrictions   € 29    
Subsidiaries in capital control restrictions countries        
Disclosure of cash and cash equivalents [line Items]        
Cash subject to restrictions € 24      

v3.22.4
TRADE RECEIVABLES AND OTHER - Schedule of Trade Receivables and Other (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Non-current    
Trade receivables € 0 € 0
Income tax receivables 14 24
Other tax receivables 0 0
Contract assets 15 19
Prepaid expenses 1 1
Other 13 11
Total other receivables 43 55
Total trade receivables and other 43 55
Current    
Trade receivables 465 603
Income tax receivables 16 20
Other tax receivables 38 40
Contract assets 2 2
Prepaid expenses 8 9
Other 10 9
Total other receivables 74 80
Total trade receivables and other 539 683
Total factored assets 574 639
Cost    
Non-current    
Trade receivables 0 0
Current    
Trade receivables 467 607
Impairment    
Non-current    
Trade receivables 0 0
Current    
Trade receivables € (2) € (4)

v3.22.4
TRADE RECEIVABLES AND OTHER - Narrative (Details)
12 Months Ended
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
EUR (€)
Disclosure of trade and other receivables [line items]      
Contract assets € 15,000,000   € 19,000,000
Total factored assets 574,000,000   639,000,000
Factored assets derecognized 368,000,000   345,000,000
Debt due factor 6,000,000   0
Unbilled Tooling Costs      
Disclosure of trade and other receivables [line items]      
Contract assets 4,000,000   € 6,000,000
United States | Factoring of receivables | Muscle Shoals factoring facility      
Disclosure of trade and other receivables [line items]      
Factoring maximum capacity | $   $ 200,000,000  
United States | Factoring of receivables | Constellium automotive      
Disclosure of trade and other receivables [line items]      
Factoring maximum capacity | $   $ 25,000,000  
France | Factoring of receivables      
Disclosure of trade and other receivables [line items]      
Factoring maximum capacity 250,000,000    
France | Factoring Receivable, Recourse Line      
Disclosure of trade and other receivables [line items]      
Factoring maximum capacity 20,000,000    
Germany, Switzerland and Czech Republic | Factoring of receivables      
Disclosure of trade and other receivables [line items]      
Factoring maximum capacity € 200,000,000    

v3.22.4
TRADE RECEIVABLES AND OTHER - Aging of Total Trade Receivables - Net (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Trade receivables [line items]    
Trade receivables € 465 € 603
Not past due    
Trade receivables [line items]    
Trade receivables 453 596
1 – 30 days past due    
Trade receivables [line items]    
Trade receivables 10 6
31 – 60 days past due    
Trade receivables [line items]    
Trade receivables € 2 € 1

v3.22.4
TRADE RECEIVABLES AND OTHER - Currency Concentration of Total Trade Receivables (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Trade receivables [line items]    
Trade receivables € 465 € 603
Euro    
Trade receivables [line items]    
Trade receivables 225 277
U.S. Dollars    
Trade receivables [line items]    
Trade receivables 213 305
Swiss Francs    
Trade receivables [line items]    
Trade receivables 8 4
Other currencies    
Trade receivables [line items]    
Trade receivables € 19 € 17

v3.22.4
INVENTORIES (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Subclassifications of assets, liabilities and equities [abstract]    
Finished goods € 315 € 225
Work in progress 638 551
Raw materials 308 226
Stores and supplies 112 95
Inventories write down (53) (47)
Total inventories € 1,320 € 1,050

v3.22.4
PROPERTY, PLANT AND EQUIPMENT - Schedule of Property, Plant and Equipment (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance € 1,948 € 1,906
Additions 297 233
Disposals (5) (4)
Depreciation expense (277) (253)
Transfer and other changes 0 (7)
Effect of changes in foreign exchange rates 54 73
Ending balance 2,017 1,948
Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 3,577  
Ending balance 3,923 3,577
Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (1,629)  
Ending balance (1,906) (1,629)
Land and Property Rights    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 21 20
Additions 0 0
Disposals 0 0
Depreciation expense (1) (1)
Transfer and other changes 2 1
Effect of changes in foreign exchange rates 1 1
Ending balance 23 21
Land and Property Rights | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 38  
Ending balance 42 38
Land and Property Rights | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (17)  
Ending balance (19) (17)
Buildings    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 374 379
Additions 14 6
Disposals 0 (1)
Depreciation expense (32) (27)
Transfer and other changes 18 5
Effect of changes in foreign exchange rates 7 12
Ending balance 381 374
Buildings | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 590  
Ending balance 637 590
Buildings | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (216)  
Ending balance (256) (216)
Machinery and Equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 1,411 1,361
Additions 90 52
Disposals (4) (2)
Depreciation expense (230) (210)
Transfer and other changes 76 153
Effect of changes in foreign exchange rates 44 57
Ending balance 1,387 1,411
Machinery and Equipment | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 2,750  
Ending balance 2,957 2,750
Machinery and Equipment | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (1,339)  
Ending balance (1,570) (1,339)
Construction Work in Progress    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 127 132
Additions 188 169
Disposals 0 0
Depreciation expense (2) (3)
Transfer and other changes (103) (174)
Effect of changes in foreign exchange rates 1 3
Ending balance 211 127
Construction Work in Progress | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 142  
Ending balance 224 142
Construction Work in Progress | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (15)  
Ending balance (13) (15)
Other    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 15 14
Additions 5 6
Disposals (1) (1)
Depreciation expense (12) (12)
Transfer and other changes 7 8
Effect of changes in foreign exchange rates 1 0
Ending balance 15 15
Other | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 57  
Ending balance 63 57
Other | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (42)  
Ending balance € (48) € (42)

v3.22.4
PROPERTY, PLANT AND EQUIPMENT - Right of Use Assets (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance € 1,948 € 1,906
Additions 297 233
Disposals (5) (4)
Depreciation expense (277) (253)
Transfer and other changes 0 (7)
Effect of changes in foreign exchange rates 54 73
Ending balance 2,017 1,948
Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 3,577  
Ending balance 3,923 3,577
Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (1,629)  
Ending balance (1,906) (1,629)
Buildings    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 374 379
Additions 14 6
Disposals 0 (1)
Depreciation expense (32) (27)
Transfer and other changes 18 5
Effect of changes in foreign exchange rates 7 12
Ending balance 381 374
Buildings | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 590  
Ending balance 637 590
Buildings | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (216)  
Ending balance (256) (216)
Machinery and Equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 1,411 1,361
Additions 90 52
Disposals (4) (2)
Depreciation expense (230) (210)
Transfer and other changes 76 153
Effect of changes in foreign exchange rates 44 57
Ending balance 1,387 1,411
Machinery and Equipment | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 2,750  
Ending balance 2,957 2,750
Machinery and Equipment | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (1,339)  
Ending balance (1,570) (1,339)
Other    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 15 14
Additions 5 6
Disposals (1) (1)
Depreciation expense (12) (12)
Transfer and other changes 7 8
Effect of changes in foreign exchange rates 1 0
Ending balance 15 15
Other | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 57  
Ending balance 63 57
Other | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (42)  
Ending balance (48) (42)
Right-of-use assets    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 174 186
Additions 18 12
Disposals (1)  
Depreciation expense (33) (28)
Transfer and other changes   (1)
Effect of changes in foreign exchange rates 3 5
Ending balance 161 174
Right-of-use assets | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 297  
Ending balance 308 297
Right-of-use assets | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (123)  
Ending balance (147) (123)
Right-of-use assets | Buildings    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 108 112
Additions 11 5
Disposals 0  
Depreciation expense (12) (11)
Transfer and other changes   0
Effect of changes in foreign exchange rates 0 2
Ending balance 107 108
Right-of-use assets | Buildings | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 150  
Ending balance 161 150
Right-of-use assets | Buildings | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (42)  
Ending balance (54) (42)
Right-of-use assets | Machinery and Equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 65 72
Additions 7 7
Disposals (1)  
Depreciation expense (20) (16)
Transfer and other changes   (1)
Effect of changes in foreign exchange rates 3 3
Ending balance 54 65
Right-of-use assets | Machinery and Equipment | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 144  
Ending balance 146 144
Right-of-use assets | Machinery and Equipment | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (79)  
Ending balance (92) (79)
Right-of-use assets | Other    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 1 2
Additions 0 0
Disposals 0  
Depreciation expense (1) (1)
Transfer and other changes   0
Effect of changes in foreign exchange rates 0 0
Ending balance 0 1
Right-of-use assets | Other | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance 3  
Ending balance 1 3
Right-of-use assets | Other | Less accumulated depreciation and impairment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning balance (2)  
Ending balance € (1) € (2)

v3.22.4
PROPERTY, PLANT AND EQUIPMENT - Depreciation Expense (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense and impairment losses € (287) € (267) € (259)
Cost of sales      
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense and impairment losses (270) (245) (240)
Selling and administrative expenses      
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense and impairment losses (12) (17) (14)
Research and development expenses      
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense and impairment losses € (5) € (5) € (5)

v3.22.4
PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)
€ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2020
EUR (€)
cash_generating_unit
Disclosure of detailed information about property, plant and equipment [line items]      
Expense related to short-term leases, low value asset leases and variable lease still recognized as operating expenses € 15 € 12 € 11
Property, plant and equipment € 2,017 € 1,948 € 1,906
A&T      
Disclosure of detailed information about property, plant and equipment [line items]      
Number of cash generating units impaired | cash_generating_unit     2
Impairment charges related to cash-generating units     € 16
A&T | Montreuil Juigné      
Disclosure of detailed information about property, plant and equipment [line items]      
Impairment charges related to cash-generating units     9
A&T | Ussel      
Disclosure of detailed information about property, plant and equipment [line items]      
Impairment charges related to cash-generating units     € 7
AS&I      
Disclosure of detailed information about property, plant and equipment [line items]      
Number of cash generating units impaired | cash_generating_unit     2
Discount rate to estimate normative cash flows     9.00%
AS&I | Nanjing Plant      
Disclosure of detailed information about property, plant and equipment [line items]      
Impairment charges related to cash-generating units     € 12
AS&I | White Georgia      
Disclosure of detailed information about property, plant and equipment [line items]      
Impairment charges related to cash-generating units     13
Property, plant and equipment     € 11

v3.22.4
INTANGIBLE ASSETS AND GOODWILL (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance € 58 € 61
Additions 3 4
Amortization expense (10) (14)
Transfer 0 4
Effect of changes in foreign exchange rates 3 3
Intangible assets (excluding goodwill), ending balance 54 58
Changes in goodwill [abstract]    
Goodwill, beginning balance 451 417
Effect of changes in foreign exchange rates 27 34
Goodwill, ending balance 478 451
Cost    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 224  
Intangible assets (excluding goodwill), ending balance 236 224
Changes in goodwill [abstract]    
Goodwill, beginning balance 451  
Goodwill, ending balance 478 451
Less accumulated depreciation and impairment    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance (166)  
Intangible assets (excluding goodwill), ending balance (182) (166)
Technology    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 18 18
Additions 0 0
Amortization expense (2) (1)
Transfer 0 0
Effect of changes in foreign exchange rates 2 1
Intangible assets (excluding goodwill), ending balance 18 18
Technology | Cost    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 86  
Intangible assets (excluding goodwill), ending balance 92 86
Technology | Less accumulated depreciation and impairment    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance (68)  
Intangible assets (excluding goodwill), ending balance (74) (68)
Computer Software    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 21 15
Additions 0 0
Amortization expense (7) (12)
Transfer 2 17
Effect of changes in foreign exchange rates 0 1
Intangible assets (excluding goodwill), ending balance 16 21
Computer Software | Cost    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 91  
Intangible assets (excluding goodwill), ending balance 94 91
Computer Software | Less accumulated depreciation and impairment    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance (70)  
Intangible assets (excluding goodwill), ending balance (78) (70)
Customer relationships    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 13 13
Additions 0 0
Amortization expense (1) (1)
Transfer 0 0
Effect of changes in foreign exchange rates 1 1
Intangible assets (excluding goodwill), ending balance 13 13
Customer relationships | Cost    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 40  
Intangible assets (excluding goodwill), ending balance 42 40
Customer relationships | Less accumulated depreciation and impairment    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance (27)  
Intangible assets (excluding goodwill), ending balance (29) (27)
Work in Progress    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 2 13
Additions 3 4
Amortization expense 0 0
Transfer (2) (15)
Effect of changes in foreign exchange rates 0 0
Intangible assets (excluding goodwill), ending balance 3 2
Work in Progress | Cost    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 3  
Intangible assets (excluding goodwill), ending balance 4 3
Work in Progress | Less accumulated depreciation and impairment    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance (1)  
Intangible assets (excluding goodwill), ending balance (1) (1)
Other    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 4 2
Additions 0 0
Amortization expense 0 0
Transfer 0 2
Effect of changes in foreign exchange rates 0 0
Intangible assets (excluding goodwill), ending balance 4 4
Other | Cost    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 4  
Intangible assets (excluding goodwill), ending balance 4 4
Other | Less accumulated depreciation and impairment    
Changes in intangible assets other than goodwill [abstract]    
Intangible assets (excluding goodwill), beginning balance 0  
Intangible assets (excluding goodwill), ending balance € 0 € 0

v3.22.4
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details) - EUR (€)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]      
Goodwill € 478,000,000 € 451,000,000 € 417,000,000
P&ARP      
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]      
Goodwill 471,000,000    
Carrying value 1,600,000,000    
Recoverable value 2,000,000,000    
Goodwill impairment € 0    
Cash flow rates 40.00%    
P&ARP | Bottom of range      
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]      
Discount rate to estimate normative cash flows 9.00%    
P&ARP | Top of range      
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]      
Long term growth rate used to estimate normative cash flow 1.50%    
A&T      
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]      
Goodwill € 5,000,000    
AS&I      
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]      
Goodwill € 2,000,000    
Discount rate to estimate normative cash flows     9.00%

v3.22.4
DEFERRED INCOME TAXES - Net Deferred Income Tax Assets (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Income Taxes [Abstract]    
Deferred income tax assets € 271 € 162
Deferred income tax liabilities (28) (14)
Net deferred income tax assets € 243 € 148

v3.22.4
DEFERRED INCOME TAXES - Changes in Net Deferred Income Tax Assets / (Liabilities) (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Significant components of deferred tax assets and liabilities [line items]    
At January 1 € 148 € 183
Reclassified as held for sale (2)  
Recognized in Profit or loss 127 (29)
Recognized in OCI (33) (13)
FX 3 7
At December 31 243 148
Long-term assets    
Significant components of deferred tax assets and liabilities [line items]    
At January 1 (124) (106)
Reclassified as held for sale (2)  
Recognized in Profit or loss 31 (10)
Recognized in OCI 0 0
FX (7) (8)
At December 31 (102) (124)
Inventories    
Significant components of deferred tax assets and liabilities [line items]    
At January 1 3 5
Reclassified as held for sale 0  
Recognized in Profit or loss (4) (2)
Recognized in OCI 0 0
FX (1) 0
At December 31 (2) 3
Pensions    
Significant components of deferred tax assets and liabilities [line items]    
At January 1 119 126
Reclassified as held for sale 0  
Recognized in Profit or loss (10) 5
Recognized in OCI (35) (17)
FX 4 5
At December 31 78 119
Derivative valuation    
Significant components of deferred tax assets and liabilities [line items]    
At January 1 (6) (5)
Reclassified as held for sale 0  
Recognized in Profit or loss 8 (5)
Recognized in OCI 2 4
FX 0 0
At December 31 4 (6)
Tax losses carried forward    
Significant components of deferred tax assets and liabilities [line items]    
At January 1 117 116
Reclassified as held for sale 0  
Recognized in Profit or loss 67 (7)
Recognized in OCI 0 0
FX 6 8
At December 31 190 117
Other    
Significant components of deferred tax assets and liabilities [line items]    
At January 1 39 47
Reclassified as held for sale 0  
Recognized in Profit or loss 35 (10)
Recognized in OCI 0 0
FX 1 2
At December 31 € 75 € 39

v3.22.4
DEFERRED INCOME TAXES - Narrative (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Taxes [Abstract]      
Deductible temporary differences and unused tax losses for which no deferred tax asset recognized € 199 € 805  
Deferred tax assets 271 162  
Net deferred tax asset balance 243 148 € 183
Adjustments for deferred tax expense € 154 € 24 € 15

v3.22.4
DEFERRED INCOME TAXES - Components of Unrecognized Deferred Tax Assets (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact € (48) € (191)
Tax losses    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact (31) (85)
Long-term assets    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact (2) (65)
Pensions    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact (3) (7)
Other    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact (12) (34)
Deductible temporary differences    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact (17) (106)
Between 1- 5 years | Tax losses    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact (5) (3)
Expiring after 5 years and limited | Tax losses    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact (5) (55)
Unlimited | Tax losses    
Significant components of deferred tax assets and liabilities [line items]    
Related tax impact € (21) € (27)

v3.22.4
DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure Of Analysis Of Single Amount Of Discontinued Operations [Line Items]        
Cash and cash equivalents € 166 € 147 € 439 € 184
Trade receivables and other 539 683    
Inventories 1,320 1,050    
Deferred tax assets 271 162    
Non-current assets or disposal groups classified as held for sale 14 0    
Trade payables and other 1,467 1,377    
Pension and other post-employment benefit obligations 403 599    
Liabilities of disposal group classified as held for sale 10 € 0    
Disposal groups classified as held for sale [member]        
Disclosure Of Analysis Of Single Amount Of Discontinued Operations [Line Items]        
Cash and cash equivalents 1      
Trade receivables and other 6      
Inventories 5      
Deferred tax assets 2      
Non-current assets or disposal groups classified as held for sale 14      
Trade payables and other 8      
Pension and other post-employment benefit obligations 2      
Liabilities of disposal group classified as held for sale € 10      

v3.22.4
TRADE PAYABLES AND OTHER - Schedule of Trade Payables and Other (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Non-current    
Trade payables € 0 € 0
Fixed assets payables 0 0
Employees' entitlements 0 0
Taxes payable other than income tax 0 0
Contract liabilities and other liabilities to customers 20 4
Other payables 23 28
Total other 43 32
Total trade payables and other 43 32
Current    
Trade payables 1,155 1,065
Fixed assets payables 36 22
Employees' entitlements 195 185
Taxes payable other than income tax 17 16
Contract liabilities and other liabilities to customers 55 77
Other payables 9 12
Total other 312 312
Total trade payables and other € 1,467 € 1,377

v3.22.4
TRADE PAYABLES AND OTHER - Contract Liabilities and Other Liabilities to Customers (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of disaggregation of contract liabilities with customers [line items]    
Non-current € 20 € 4
Current 55 77
Deferred tooling revenue    
Disclosure of disaggregation of contract liabilities with customers [line items]    
Non-current 19 3
Current 0 0
Advance payment from customers    
Disclosure of disaggregation of contract liabilities with customers [line items]    
Non-current 0 0
Current 6 7
Unrecognized variable consideration    
Disclosure of disaggregation of contract liabilities with customers [line items]    
Non-current 1 1
Current 49 67
Other    
Disclosure of disaggregation of contract liabilities with customers [line items]    
Non-current 0 0
Current € 0 € 3

v3.22.4
TRADE PAYABLES AND OTHER - Narrative (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Trade and other payables [abstract]    
Revenue recognized related to contract liabilities € 58 € 33
Deferred revenue related to contract liabilities € 60 € 36

v3.22.4
BORROWINGS - Borrowings by Nature (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
May 31, 2021
Feb. 28, 2021
EUR (€)
target
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
CHF (SFr)
Jun. 30, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Feb. 28, 2021
USD ($)
target
Dec. 31, 2020
EUR (€)
Disclosure of detailed information about borrowings [line items]                      
Nominal value         € 2,053,000,000            
Gross lease liabilities         167,000,000            
Arrangement fees         (20,000,000)            
Accrued interests         23,000,000            
Accrued interest lease liabilities         1,000,000            
Borrowings         2,056,000,000       € 2,129,000,000   € 2,391,000,000
Leases         168,000,000       183,000,000    
Non-current borrowings         1,908,000,000       1,871,000,000    
Current borrowings         148,000,000       258,000,000    
Secured Pan-U.S. ABL (due 2026)                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value         80,000,000 $ 85,000,000          
Arrangement fees         0            
Accrued interests         1,000,000            
Borrowings         81,000,000       0    
Maximum borrowing capacity               € 500,000,000      
Accordion feature, higher borrowing capacity option               € 100,000,000      
Secured French PGE French Facility (due 2022)                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value         0 180,000,000          
Arrangement fees         0            
Accrued interests         0            
Borrowings         0       180,000,000    
Extension period     5 years                
Senior Unsecured Notes Issued November 2017 and due 2026                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value $ 500,000,000       € 281,000,000 300,000,000          
Nominal rate 5.875%       5.875%            
Arrangement fees         € (2,000,000)            
Accrued interests         6,000,000            
Borrowings         285,000,000       268,000,000    
Senior Unsecured Note Issued November 2017 and due 2026                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value         € 400,000,000            
Nominal rate         4.25%            
Arrangement fees         € (3,000,000)            
Accrued interests         6,000,000            
Borrowings         403,000,000       402,000,000    
Senior Unsecured Notes Issued June 2020 and due 2028                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value         € 305,000,000 325,000,000          
Nominal rate         5.625%            
Arrangement fees         € (5,000,000)            
Accrued interests         1,000,000            
Borrowings         301,000,000       284,000,000    
Senior Unsecured Notes Issued February 2021 and due 2029                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value       € 412,000,000 € 469,000,000 $ 500,000,000       $ 500,000,000  
Nominal rate       3.75% 3.75%            
Arrangement fees         € (6,000,000)            
Accrued interests         4,000,000            
Borrowings         467,000,000       438,000,000    
Number of sustainability performance targets | target       2           2  
Senior Unsecured Notes Issued February 2021 and due 2029 | Starting in April and July 2026                      
Disclosure of detailed information about borrowings [line items]                      
Increase in borrowing nominal rate       0.125%              
Senior Unsecured Notes Issued February 2021 and due 2029 | Starting in April and July 2027                      
Disclosure of detailed information about borrowings [line items]                      
Increase in borrowing nominal rate       0.125%              
Senior Unsecured Notes Issued June 2021 and due 2029                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value   $ 300,000,000     € 300,000,000            
Nominal rate   3.125%     3.125%            
Arrangement fees         € (4,000,000)            
Accrued interests         4,000,000            
Borrowings         300,000,000       300,000,000    
Unsecured Swiss Facility                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value         € 0   SFr 15,000,000        
Nominal rate         1.175%            
Arrangement fees         € 0            
Accrued interests         0            
Borrowings         0       14,000,000    
Other loans                      
Disclosure of detailed information about borrowings [line items]                      
Nominal value         51,000,000            
Arrangement fees         0            
Accrued interests         0            
Borrowings         51,000,000       € 60,000,000    
Financing Arrangements                      
Disclosure of detailed information about borrowings [line items]                      
Borrowings         € 36,000,000            

v3.22.4
BORROWINGS - Narrative (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about borrowings [line items]    
Undrawn facilities € 543 € 626
Secured Inventory Facility    
Disclosure of detailed information about borrowings [line items]    
Undrawn facilities 100  
Money Market Facility    
Disclosure of detailed information about borrowings [line items]    
Undrawn facilities € 50  
Secured Pan-U.S. ABL (due 2026)    
Disclosure of detailed information about borrowings [line items]    
Debt covenant, percentage of aggregate revolving loan commitments 10.00%  

v3.22.4
BORROWINGS - Movement in Borrowings (Details)
1 Months Ended 6 Months Ended 12 Months Ended
Nov. 30, 2021
EUR (€)
Nov. 30, 2021
USD ($)
Jun. 30, 2021
EUR (€)
Jun. 30, 2021
USD ($)
Feb. 28, 2021
EUR (€)
Feb. 28, 2021
USD ($)
Jun. 30, 2021
EUR (€)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2020
EUR (€)
Dec. 31, 2022
USD ($)
Feb. 28, 2021
USD ($)
Disclosure of detailed information about borrowings [line items]                        
Beginning Balance             € 2,391,000,000 € 2,129,000,000 € 2,391,000,000      
Cash flows                        
Proceeds from issuance of long-term borrowings             € 712,000,000 0 712,000,000 € 472,000,000    
Repayments of long-term borrowings               (192,000,000) (1,052,000,000) (209,000,000)    
Net change in revolving credit facilities and short-term borrowings               72,000,000 (5,000,000) (110,000,000)    
Lease repayments               (37,000,000) (32,000,000)      
Payment of deferred financing costs               0 (13,000,000)      
Non-cash changes                        
Movement in accrued interest               (1,000,000) (11,000,000)      
Changes in leases and other loans               18,000,000 18,000,000      
Deferred arrangement fees               3,000,000 16,000,000      
Effects of changes in foreign exchange rates               64,000,000 105,000,000      
Ending Balance               2,056,000,000 2,129,000,000 € 2,391,000,000    
Debt issued               2,053,000,000        
Senior Unsecured Notes Issued February 2021 and due 2029                        
Disclosure of detailed information about borrowings [line items]                        
Beginning Balance               438,000,000        
Non-cash changes                        
Ending Balance               467,000,000 438,000,000      
Debt issued         € 412,000,000     € 469,000,000     $ 500,000,000 $ 500,000,000
Nominal rate         3.75% 3.75%   3.75%        
Constellium SE Senior Sustainability-Linked Notes Issued June 2021 Due June 2029                        
Disclosure of detailed information about borrowings [line items]                        
Beginning Balance               € 300,000,000        
Non-cash changes                        
Ending Balance               300,000,000 300,000,000      
Debt issued       $ 300,000,000       € 300,000,000        
Nominal rate     3.125% 3.125%       3.125%        
Senior Unsecured Notes Issued February 2017 and due 2025                        
Cash flows                        
Repayments of long-term borrowings         € (536,000,000) $ (650,000,000)            
Non-cash changes                        
Nominal rate         6.625% 6.625%            
Senior Unsecured Notes Issued May 2014 and due 2024                        
Cash flows                        
Repayments of long-term borrowings     € (328,000,000) $ (400,000,000)                
Non-cash changes                        
Nominal rate     5.75% 5.75%                
Senior Unsecured Notes Issued November 2017 and due 2026                        
Disclosure of detailed information about borrowings [line items]                        
Beginning Balance               € 268,000,000        
Cash flows                        
Repayments of long-term borrowings € (177,000,000) $ (200,000,000)                    
Non-cash changes                        
Ending Balance               285,000,000 € 268,000,000      
Debt issued   $ 500,000,000           € 281,000,000     $ 300,000,000  
Nominal rate 5.875% 5.875%           5.875%        

v3.22.4
BORROWINGS - Currency Concentration of Total Borrowings (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of detailed information about borrowings [line items]      
Borrowings € 2,056 € 2,129 € 2,391
U.S. Dollar      
Disclosure of detailed information about borrowings [line items]      
Borrowings 1,188 1,055  
Euro      
Disclosure of detailed information about borrowings [line items]      
Borrowings 861 1,048  
Other currencies      
Disclosure of detailed information about borrowings [line items]      
Borrowings € 7 € 26  

v3.22.4
FINANCIAL INSTRUMENTS - Financial Assets and Liabilities by Categories (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about financial instruments [line items]    
Financial assets € 670 € 820
Financial liabilities 3,302 3,247
Trade payables and fixed asset payables    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 1,191 1,087
Borrowings    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 2,056 2,129
Other financial liabilities    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 55 31
At amortized cost    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 3,247 3,216
At amortized cost | Trade payables and fixed asset payables    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 1,191 1,087
At amortized cost | Borrowings    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 2,056 2,129
At amortized cost | Other financial liabilities    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 0 0
At fair value through profit and loss    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 40 26
At fair value through profit and loss | Trade payables and fixed asset payables    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 0 0
At fair value through profit and loss | Borrowings    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 0 0
At fair value through profit and loss | Other financial liabilities    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 40 26
At fair value through OCI    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 15 5
At fair value through OCI | Trade payables and fixed asset payables    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 0 0
At fair value through OCI | Borrowings    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 0 0
At fair value through OCI | Other financial liabilities    
Disclosure of detailed information about financial instruments [line items]    
Financial liabilities 15 5
Cash and cash equivalents    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 166 147
Trade receivables    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 465 603
Other financial assets    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 39 70
At amortized cost    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 166 147
At amortized cost | Cash and cash equivalents    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 166 147
At amortized cost | Trade receivables    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 0 0
At amortized cost | Other financial assets    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 0 0
At fair value through profit and loss    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 37 70
At fair value through profit and loss | Cash and cash equivalents    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 0 0
At fair value through profit and loss | Trade receivables    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 0 0
At fair value through profit and loss | Other financial assets    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 37 70
At fair value through OCI    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 467 603
At fair value through OCI | Cash and cash equivalents    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 0 0
At fair value through OCI | Trade receivables    
Disclosure of detailed information about financial instruments [line items]    
Financial assets 465 603
At fair value through OCI | Other financial assets    
Disclosure of detailed information about financial instruments [line items]    
Financial assets € 2 € 0

v3.22.4
FINANCIAL INSTRUMENTS - Narrative (Details) - Fair value - Level 1
€ in Millions
Dec. 31, 2022
EUR (€)
Constellium SE Senior Notes Due 2024  
Disclosure of detailed information about financial instruments [line items]  
Percentage of fair value senior notes issued 97.00%
Senior notes issued € 657
Senior Unsecured Notes Issued February 2017 and due 2025  
Disclosure of detailed information about financial instruments [line items]  
Percentage of fair value senior notes issued 92.00%
Senior notes issued € 282
Constellium SE Senior Notes Due 2026  
Disclosure of detailed information about financial instruments [line items]  
Percentage of fair value senior notes issued 82.00%
Senior notes issued € 385
Constellium SE Senir Notes Due 2028  
Disclosure of detailed information about financial instruments [line items]  
Percentage of fair value senior notes issued 80.00%
Senior notes issued € 239

v3.22.4
FINANCIAL INSTRUMENTS - Other Financial Assets and Other Financial Liabilities Positions (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives assets € 8 € 12  
Current derivatives assets 31 58  
Derivative financial assets 39 70  
Non-current derivatives liabilities 14 6  
Current derivative liabilities 41 25  
Derivatives liabilities 55 31  
Other financing activities (3) (26) € (8)
Aluminium and premium derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives liabilities 0 0  
Current derivative liabilities 19 14  
Derivatives liabilities 19 14  
Energy derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives liabilities 3 0  
Current derivative liabilities 7 0  
Derivatives liabilities 10 0  
Other commodity derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives liabilities 0 0  
Current derivative liabilities 1 0  
Derivatives liabilities 1 0  
Currency commercial derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives liabilities 11 6  
Current derivative liabilities 14 11  
Derivatives liabilities 25 17  
Currency net debt derivatives | Forward purchase contracts versus EURO      
Disclosure of detailed information about financial instruments [line items]      
Nominal amount   565  
Other financing activities   (32)  
Aluminium and premium derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives assets 2 9  
Current derivatives assets 7 38  
Derivative financial assets 9 47  
Energy derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives assets 3 1  
Current derivatives assets 2 1  
Derivative financial assets 5 2  
Other commodity derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives assets 0 0  
Current derivatives assets 2 4  
Derivative financial assets 2 4  
Currency commercial derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives assets 3 2  
Current derivatives assets 20 14  
Derivative financial assets 23 16  
Currency net debt derivatives      
Disclosure of detailed information about financial instruments [line items]      
Non-current derivatives assets 0 0  
Current derivatives assets 0 1  
Derivative financial assets € 0 € 1  

v3.22.4
FINANCIAL INSTRUMENTS - Derivatives Measured at Fair Value (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of financial instruments measured at fair value [line items]    
Other financial assets - derivatives € 39 € 70
Other financial liabilities - derivatives 55 31
Level 1    
Disclosure of financial instruments measured at fair value [line items]    
Other financial assets - derivatives 6 41
Other financial liabilities - derivatives 17 13
Level 2    
Disclosure of financial instruments measured at fair value [line items]    
Other financial assets - derivatives 33 29
Other financial liabilities - derivatives 38 18
Level 3    
Disclosure of financial instruments measured at fair value [line items]    
Other financial assets - derivatives 0 0
Other financial liabilities - derivatives € 0 € 0

v3.22.4
FINANCIAL RISK MANAGEMENT - Nominal Value of Currency Derivatives (Details) - Currency risk
EUR_ in Millions
Dec. 31, 2022
EUR_
Less than 1 year | Sold currencies USD  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 409
Less than 1 year | Sold currencies CHF  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 82
Less than 1 year | Sold currencies CZK  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 3
Less than 1 year | Sold currencies - Other currencies  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 10
Less than 1 year | Purchased currencies USD  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 109
Less than 1 year | Purchased currencies CHF  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 134
Less than 1 year | Purchased currencies EUR  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 78
Less than 1 year | Purchased currencies - Other currencies  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 1
Over 1 year | Sold currencies USD  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 186
Over 1 year | Sold currencies CHF  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 29
Over 1 year | Sold currencies CZK  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 0
Over 1 year | Sold currencies - Other currencies  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 0
Over 1 year | Purchased currencies USD  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 25
Over 1 year | Purchased currencies CHF  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 16
Over 1 year | Purchased currencies EUR  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 20
Over 1 year | Purchased currencies - Other currencies  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal value 0

v3.22.4
FINANCIAL RISK MANAGEMENT - Narrative (Details)
€ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
EUR (€)
Dec. 31, 2019
EUR (€)
Disclosure of liquidity risk [line items]              
Percentage of trade account receivables insured 76.00%     76.00%      
Revolving credit facilities outstanding availability € 480            
Liquidity value 709   € 773        
Cash and cash equivalents 166   147     € 439 € 184
Undrawn facilities 543   626        
Derivative classified as cash flow hedge              
Disclosure of liquidity risk [line items]              
Nominal amount hedging instrument | $       $ 248 $ 274    
Forward purchase contracts versus EURO | Foreign exchange forward contracts              
Disclosure of liquidity risk [line items]              
Net position hedges related to loans and deposits | $   $ 115          
U.S. Revolving Facility              
Disclosure of liquidity risk [line items]              
Borrowing base | $       $ 469      
French Inventory Based Facility              
Disclosure of liquidity risk [line items]              
Borrowing base 100            
Currency risk              
Disclosure of liquidity risk [line items]              
Margin requirement paid as collateral to counterparties     0        
10% increase or decrease in the market price | Aluminium              
Disclosure of liquidity risk [line items]              
Impact of increase or decrease in market price in gain or loss from derivatives 28            
Top of range | 50 basis point increase or decrease in the LIBOR or EURIBOR interest rates              
Disclosure of liquidity risk [line items]              
Impact of increase or decrease in interest rate in income before income tax € 3   € 1        

v3.22.4
FINANCIAL RISK MANAGEMENT - Effect of Foreign Currency Derivatives Impacts and Commercial Transactions Exposures (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Realized gains / (losses) on foreign currency derivatives - net € (8) € (1) € (11)
Unrealized (losses) / gains on foreign currency derivatives - net 6 13 (8)
Losses reclassified from OCI as a result of hedge accounting discontinuation 0 0 6
Derivatives that do not qualify for hedge accounting | At fair value through profit and loss      
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Realized gains / (losses) on foreign currency derivatives - net 0 1 (4)
Unrealized (losses) / gains on foreign currency derivatives - net 6 15 (9)
Derivatives that qualify for hedge accounting | At fair value through profit and loss      
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Realized gains / (losses) on foreign currency derivatives - net (8) (2) (7)
Unrealized (losses) / gains on foreign currency derivatives - net 0 (2) 1
Losses reclassified from OCI as result of hedge accounting discontinuation 0 0 (6)
Losses reclassified from OCI as a result of hedge accounting discontinuation     6
Derivatives that qualify for hedge accounting | At fair value through OCI      
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Unrealized (losses) / gains on foreign currency derivatives - net (16) (21) 20
Gains reclassified from cash flow hedge reserve to the Consolidated Income Statement € 8 € 4 € 6

v3.22.4
FINANCIAL RISK MANAGEMENT - Effect of Foreign Currency Derivatives Impacts and Financing Transaction Exposures (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Realized gains / (losses) on foreign currency derivatives - net € (8) € (1) € (11)
Unrealized (losses) / gains on foreign currency derivatives - net 6 13 (8)
Total 1 10 (32)
Currency risk | At fair value through profit and loss      
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Realized gains / (losses) on foreign currency derivatives - net 2 (36) 7
Unrealized (losses) / gains on foreign currency derivatives - net (1) 46 (39)
Total € 1 € 10 € (32)

v3.22.4
FINANCIAL RISK MANAGEMENT - Impact on Profit and Equity (Before Tax Effect) of a 10% Strengthening of US Dollar Versus Euro for Non-US Dollar Functional Currency Entities (Details) - 10% strengthening U.S. Dollar/Euro
€ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax € (23)
Effect on pretax equity (24)
Net commercial transaction exposure  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax (23)
Effect on pretax equity (24)
Net financing transaction exposure  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax 0
Effect on pretax equity 0
Trade receivables  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax 3
Effect on pretax equity 0
Trade payables  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax (1)
Effect on pretax equity 0
Derivatives on commercial transactions  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax (25)
Effect on pretax equity (24)
Cash in Bank and intercompany loans  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax 105
Effect on pretax equity 0
Borrowings  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax (117)
Effect on pretax equity 0
Derivatives on financing transactions  
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax 12
Effect on pretax equity € 0

v3.22.4
FINANCIAL RISK MANAGEMENT - Impact on Profit and Equity (Before Tax Effect) of a 10% Strengthening of US Dollar Versus Euro for US Dollar Functional Currency Entities (Details) - 10% strengthening U.S. Dollar/Euro
€ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Disclosure of nature and extent of risks arising from financial instruments [line items]  
Effect on income before tax € 23
Effect on pretax equity € 182

v3.22.4
FINANCIAL RISK MANAGEMENT - Nominal Value of Commodity Derivatives (Details) - Commodity price risk
€ in Millions
Dec. 31, 2022
EUR (€)
Less than 1 year | Aluminium  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount € 290
Less than 1 year | Premium  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 18
Less than 1 year | Copper  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 12
Less than 1 year | Silver  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 18
Less than 1 year | Natural gas  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 31
Less than 1 year | Zinc  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 8
Over 1 year | Aluminium  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 5
Over 1 year | Premium  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 5
Over 1 year | Copper  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 0
Over 1 year | Silver  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 0
Over 1 year | Natural gas  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount 29
Over 1 year | Zinc  
Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]  
Nominal amount € 0

v3.22.4
FINANCIAL RISK MANAGEMENT - Mark-to-market Movements Recognized in Other Gains (Losses) - Net (Details) - Commodity price risk - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Realized (losses) / gains on commodity derivatives - net € (6) € 112 € (31)
Unrealized (losses) / gains on commodity derivatives - net € (53) € 24 € 25

v3.22.4
FINANCIAL RISK MANAGEMENT - Exposure to Financial Counterparties by Rating Type (Details)
€ in Thousands
Dec. 31, 2022
EUR (€)
counterparty
Dec. 31, 2021
EUR (€)
counterparty
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Number of financial counterparties | counterparty 9 19
Exposure € 166,000 € 185,000
Credit exposure threshold amount € 250 € 250
Rated Aa or better    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Number of financial counterparties | counterparty 2 3
Exposure € 51,000 € 54,000
Rated A    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Number of financial counterparties | counterparty 6 13
Exposure € 112,000 € 98,000
Rated Baa    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Number of financial counterparties | counterparty 1 3
Exposure € 3,000 € 33,000

v3.22.4
FINANCIAL RISK MANAGEMENT - Undiscounted Contractual Financial Assets and Financial Liabilities Values by Relevant Maturity Groupings (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Leases € 168 € 183
Less than 1 year    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 496 663
Financial liabilities 1,351 1,424
Leases 35 37
Less than 1 year | Borrowings    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 5 195
Less than 1 year | Interest    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 78 79
Less than 1 year | Net cash flows from derivative liabilities related to currencies and commodities    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 42 26
Less than 1 year | Trade payables and fixed asset payables    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 1,191 1,087
Less than 1 year | Net cash flows from derivative assets related to currencies and commodities    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 31 60
Less than 1 year | Trade receivables    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 465 603
Between 1- 5 years    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 9 12
Financial liabilities 1,075 1,106
Leases 98 99
Between 1- 5 years | Borrowings    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 698 710
Between 1- 5 years | Interest    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 260 285
Between 1- 5 years | Net cash flows from derivative liabilities related to currencies and commodities    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 19 12
Between 1- 5 years | Trade payables and fixed asset payables    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 0 0
Between 1- 5 years | Net cash flows from derivative assets related to currencies and commodities    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 9 12
Between 1- 5 years | Trade receivables    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 0 0
Over 5 years    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 0 0
Financial liabilities 1,227 1,227
Leases 86 85
Over 5 years | Borrowings    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 1,087 1,046
Over 5 years | Interest    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 54 96
Over 5 years | Net cash flows from derivative liabilities related to currencies and commodities    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 0 0
Over 5 years | Trade payables and fixed asset payables    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial liabilities 0 0
Over 5 years | Net cash flows from derivative assets related to currencies and commodities    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets 0 0
Over 5 years | Trade receivables    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Financial assets € 0 € 0

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Narrative (Details) - EUR (€)
€ in Millions
1 Months Ended 12 Months Ended
Oct. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Disclosure of defined benefit plans [line items]          
Collective bargaining agreement, period 3 years        
Increase (reduction) in pension obligation   € (47) € 32    
Gains on pension plan amendments   € 47 € (32) € (2)  
Weighted-average maturity of defined benefit obligations   11 years 2 months 12 days 14 years 2 months 12 days    
Defined benefit obligations          
Disclosure of defined benefit plans [line items]          
Increase (reduction) in pension obligation   € (47) € 32    
Other Benefits          
Disclosure of defined benefit plans [line items]          
Gains on pension plan amendments         € 36
Expected contributions to pension and other benefits for next year   16      
Other Benefits | Defined benefit obligations          
Disclosure of defined benefit plans [line items]          
Increase (reduction) in pension obligation   (49) 31    
OPEB          
Disclosure of defined benefit plans [line items]          
Gains on pension plan amendments   49      
Loss recognized on disputes about plan changes     31    
Pension Benefits          
Disclosure of defined benefit plans [line items]          
Expected contributions to pension and other benefits for next year   23      
Pension Benefits | Defined benefit obligations          
Disclosure of defined benefit plans [line items]          
Increase (reduction) in pension obligation   € 2 € 1    

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Sensitivity Analysis on Defined Benefit Obligations (Details) - Actuarial assumption of discount rates
€ in Millions
Dec. 31, 2022
EUR (€)
Disclosure of sensitivity analysis for actuarial assumptions [line items]  
Increase in actuarial assumption 0.50%
50 bp increase in discount rates € (46)
50 bp decrease in discount rates 52
France  
Disclosure of sensitivity analysis for actuarial assumptions [line items]  
50 bp increase in discount rates (6)
50 bp decrease in discount rates 7
Germany  
Disclosure of sensitivity analysis for actuarial assumptions [line items]  
50 bp increase in discount rates (5)
50 bp decrease in discount rates 5
Switzerland  
Disclosure of sensitivity analysis for actuarial assumptions [line items]  
50 bp increase in discount rates (16)
50 bp decrease in discount rates 17
United States  
Disclosure of sensitivity analysis for actuarial assumptions [line items]  
50 bp increase in discount rates (19)
50 bp decrease in discount rates € 23

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Actuarial Assumptions (Details)
Dec. 31, 2022
Dec. 31, 2021
OPEB | Pre 65 | 2021    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Medical trend rate 6.75%  
OPEB | Pre 65 | 2029    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Medical trend rate 4.50%  
OPEB | Post 65 | 2021    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Medical trend rate 6.00%  
OPEB | Post 65 | 2029    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Medical trend rate 4.50%  
Switzerland    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 1.75% 1.50%
Rate of increase in pensions 0.00% 0.00%
Discount rate 2.05% 0.15%
U.S.    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries
Rate of increase in pensions
Discount rate
U.S. | Hourly pension    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 3.00% 2.20%
Rate of increase in pensions 0.00% 0.00%
U.S. | Hourly pension | Bottom of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Discount rate 5.00% 2.80%
U.S. | Hourly pension | Top of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Discount rate 5.05% 2.95%
U.S. | Salaried pension    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 0.00% 0.00%
Rate of increase in pensions 0.00% 0.00%
Discount rate 5.05% 2.85%
U.S. | OPEB    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 4.00% 3.80%
Rate of increase in pensions 0.00% 0.00%
U.S. | OPEB | Bottom of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Discount rate 5.00% 2.85%
U.S. | OPEB | Top of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Discount rate 5.05% 2.95%
U.S. | Other benefits    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 3.80% 3.80%
Rate of increase in pensions 0.00% 0.00%
U.S. | Other benefits | Bottom of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Discount rate 4.95% 2.60%
U.S. | Other benefits | Top of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Discount rate 5.00% 2.85%
France    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in pensions 2.00% 2.00%
Discount rate
France | Bottom of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 2.20% 1.80%
France | Top of range    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries   3.80%
France | Retirements    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 0.00% 0.00%
Rate of increase in pensions 0.00% 0.00%
Discount rate 3.80% 1.00%
France | Other benefits    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 0.00% 0.00%
Rate of increase in pensions 0.00% 0.00%
Discount rate 3.80% 0.90%
Germany    
Disclosure of sensitivity analysis for actuarial assumptions [line items]    
Rate of increase in salaries 2.50% 2.50%
Rate of increase in pensions 2.00% 1.80%
Discount rate 3.75% 1.05%

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Amounts Recognized in the Consolidated Statement of Financial Position (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of net defined benefit liability (asset) [line items]    
Present value of funded obligation € 614 € 766
Fair value of plan assets (461) (544)
Deficit of funded plans 153 222
Present value of unfunded obligation 250 377
Net liability / (asset) arising from defined benefit obligation 403 599
Pension Benefits    
Disclosure of net defined benefit liability (asset) [line items]    
Present value of funded obligation 614 766
Fair value of plan assets (461) (544)
Deficit of funded plans 153 222
Present value of unfunded obligation 96 128
Net liability / (asset) arising from defined benefit obligation 249 350
Other Benefits    
Disclosure of net defined benefit liability (asset) [line items]    
Present value of funded obligation 0 0
Fair value of plan assets 0 0
Deficit of funded plans 0 0
Present value of unfunded obligation 154 249
Net liability / (asset) arising from defined benefit obligation € 154 € 249

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Movement in Net Defined Benefit Obligations (Details)
€ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
EUR (€)
Disclosure of net defined benefit liability (asset) [line items]      
Beginning balance € 599 $ 599 € 664
Current service cost 28   30
Interest cost / (income) 11   9
Past service cost (47)   32
Immediate recognition of gains arising over the year (5)   0
Administration expenses 2   2
Remeasurements due to:      
—actual return less interest on plan assets 107   (56)
—changes in financial assumptions (254)   (38)
—changes in demographic assumptions (1)   (13)
—experience losses (12)   (11)
Effects of changes in foreign exchange rates 20   23
Benefits paid (6)   (22)
Contributions by the Group (38)   (21)
Contributions by the plan participants 0   0
Reclassification as liabilities of disposal group classified as held for sale (1)    
Closing balance 403   599
Defined benefit obligations      
Disclosure of net defined benefit liability (asset) [line items]      
Beginning balance 1,143   1,122
Current service cost 28   30
Interest cost / (income) 20   15
Past service cost (47)   32
Immediate recognition of gains arising over the year (5)   0
Administration expenses 0   0
Remeasurements due to:      
—actual return less interest on plan assets 0   0
—changes in financial assumptions (254)   (38)
—changes in demographic assumptions (1)   (13)
—experience losses (12)   (11)
Effects of changes in foreign exchange rates 50   55
Benefits paid (63)   (54)
Contributions by the Group 0   0
Contributions by the plan participants 6   5
Reclassification as liabilities of disposal group classified as held for sale (1)    
Closing balance 864   1,143
Defined benefit obligations | Pension Benefits      
Disclosure of net defined benefit liability (asset) [line items]      
Beginning balance 894   906
Current service cost 20   22
Interest cost / (income) 13   10
Past service cost 2   1
Immediate recognition of gains arising over the year 0   0
Administration expenses 0   0
Remeasurements due to:      
—actual return less interest on plan assets 0   0
—changes in financial assumptions (211)   (29)
—changes in demographic assumptions 0   (13)
—experience losses (3)   (9)
Effects of changes in foreign exchange rates 34   38
Benefits paid (42)   (36)
Contributions by the Group 0   0
Contributions by the plan participants 4   4
Reclassification as liabilities of disposal group classified as held for sale (1)    
Closing balance 710   894
Defined benefit obligations | Other Benefits      
Disclosure of net defined benefit liability (asset) [line items]      
Beginning balance 249   216
Current service cost 8   8
Interest cost / (income) 7   5
Past service cost (49)   31
Immediate recognition of gains arising over the year (5)   0
Administration expenses 0   0
Remeasurements due to:      
—actual return less interest on plan assets 0   0
—changes in financial assumptions (43)   (9)
—changes in demographic assumptions (1)   0
—experience losses (9)   (2)
Effects of changes in foreign exchange rates 16   17
Benefits paid (21)   (18)
Contributions by the Group 0   0
Contributions by the plan participants 2   1
Reclassification as liabilities of disposal group classified as held for sale 0    
Closing balance 154   249
Plan Assets      
Disclosure of net defined benefit liability (asset) [line items]      
Beginning balance (544)   (458)
Current service cost 0   0
Interest cost / (income) (9)   (6)
Past service cost 0   0
Immediate recognition of gains arising over the year 0   0
Administration expenses 2   2
Remeasurements due to:      
—actual return less interest on plan assets 107   (56)
—changes in financial assumptions 0   0
—changes in demographic assumptions 0   0
—experience losses 0   0
Effects of changes in foreign exchange rates (30)   (32)
Benefits paid 57   32
Contributions by the Group (38)   (21)
Contributions by the plan participants (6)   (5)
Reclassification as liabilities of disposal group classified as held for sale 0    
Closing balance € (461)   € (544)

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Net Defined Benefit Obligations by Country (Details)
€ in Millions, $ in Millions
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
EUR (€)
Disclosure of net defined benefit liability (asset) [line items]        
Defined benefit obligations € 864 € 1,143    
Plan assets (461) (544)    
Net defined benefit liability 403 599 $ 599 € 664
France        
Disclosure of net defined benefit liability (asset) [line items]        
Defined benefit obligations 117 158    
Plan assets (6) (5)    
Net defined benefit liability 111 153    
Germany        
Disclosure of net defined benefit liability (asset) [line items]        
Defined benefit obligations 100 134    
Plan assets (1) (2)    
Net defined benefit liability 99 132    
Switzerland        
Disclosure of net defined benefit liability (asset) [line items]        
Defined benefit obligations 249 306    
Plan assets (236) (268)    
Net defined benefit liability 13 38    
United States        
Disclosure of net defined benefit liability (asset) [line items]        
Defined benefit obligations 398 545    
Plan assets (218) (269)    
Net defined benefit liability € 180 € 276    

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Plan Asset Categories (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of changes in financial position [line items]    
Cash & cash equivalents € 4 € 4
Equities 123 176
Bonds 226 259
Property 74 71
Other 34 34
Total fair value of plan assets 461 544
Quoted in an active market    
Disclosure of changes in financial position [line items]    
Cash & cash equivalents 4 4
Equities 87 115
Bonds 146 149
Property 14 16
Other 0 0
Total fair value of plan assets 251 284
Not quoted in an active market    
Disclosure of changes in financial position [line items]    
Cash & cash equivalents 0 0
Equities 36 61
Bonds 80 110
Property 60 55
Other 34 34
Total fair value of plan assets € 210 € 260

v3.22.4
PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Benefit Payments Expected to be Paid Either by Pension Funds or Directly to Beneficiaries (Details)
€ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Disclosure of employee benefits [Abstract]  
2023 € 56
2024 56
2025 57
2026 57
2027 60
2028 to 2032 € 328

v3.22.4
PROVISIONS - Changes in Provisions (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Changes in other provisions [abstract]    
Beginning balance € 117 € 121
Allowance 6 11
Amounts used (7) (9)
Unused amounts reversed (4) (9)
Unwinding of discounts and change in discount rates (5) (1)
Effects of changes in foreign exchange rates 4 4
Transfer   0
Ending balance 111 117
Current 21 20
Non-Current 90 97
Total Provisions 111 117
Close down and environmental remediation costs    
Changes in other provisions [abstract]    
Beginning balance 88 88
Allowance 3 4
Amounts used (3) (1)
Unused amounts reversed 0 (2)
Unwinding of discounts and change in discount rates (5) (1)
Effects of changes in foreign exchange rates 3 4
Transfer   (4)
Ending balance 86 88
Current 12 7
Non-Current 74 81
Total Provisions 86 88
Restructuring costs    
Changes in other provisions [abstract]    
Beginning balance 2 6
Allowance 0 3
Amounts used (2) (6)
Unused amounts reversed 0 (1)
Unwinding of discounts and change in discount rates 0 0
Effects of changes in foreign exchange rates 0 0
Transfer   0
Ending balance 0 2
Current 0 1
Non-Current 0 1
Total Provisions 0 2
Legal claims and other costs    
Changes in other provisions [abstract]    
Beginning balance 27 27
Allowance 3 4
Amounts used (2) (2)
Unused amounts reversed (4) (6)
Unwinding of discounts and change in discount rates 0 0
Effects of changes in foreign exchange rates 1 0
Transfer   4
Ending balance 25 27
Current 9 12
Non-Current 16 15
Total Provisions € 25 € 27

v3.22.4
PROVISIONS - Narrative (Details)
12 Months Ended
Dec. 31, 2022
Disclosure of other provisions [abstract]  
Expected provisions settlement period 40 years

v3.22.4
PROVISIONS - Legal Claims and Other Costs (Details) - Legal claims and other costs
€ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
claim
Dec. 31, 2021
EUR (€)
claim
Disclosure of other provisions [line items]    
Litigation € 15.0 € 16.0
Disease claims 10.0 9.0
Other 0.0 2.0
Total provisions for legal claims and other costs € 25.0 € 27.0
Disease claims    
Disclosure of other provisions [line items]    
Number of cases outstanding for disease claims | claim 6 5
Disease claims | Bottom of range    
Disclosure of other provisions [line items]    
Latency period for acquiring diseases 25 years  
Disease claims | Top of range    
Disclosure of other provisions [line items]    
Latency period for acquiring diseases 40 years  
Average amount per claim outstanding (less than) € 0.4 € 0.4
Average settlement amount per disease claim (less than) € 0.5  

v3.22.4
NON-CASH INVESTING AND FINANCING TRANSACTIONS (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of cash flow statement [Abstract]      
Property, plant and equipment acquired by finance lease € 18 € 18 € 66
Fair value of vested PSUs and RSUs € 15 € 15 € 14

v3.22.4
SHARE CAPITAL - Narrative (Details)
Dec. 31, 2022
EUR (€)
vote
€ / shares
shares
Dec. 31, 2021
EUR (€)
shares
Disclosure of classes of share capital [line items]    
Share capital | € € 2,886,031.84 € 3,000,000
Nominal value of ordinary fully-paid shares (in EUR per share) | € / shares € 0.02  
Number of vote rights per share | vote 1  
Ordinary shares    
Disclosure of classes of share capital [line items]    
Number of ordinary shares (in shares) | shares 144,301,592 141,677,366

v3.22.4
SHARE CAPITAL (Details)
€ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
shares
Disclosure of classes of share capital [line items]  
Beginning balance € 291
Ending balance 752
Share capital  
Disclosure of classes of share capital [line items]  
Beginning balance 3
New shares issued 0
Ending balance 3
Share premium  
Disclosure of classes of share capital [line items]  
Beginning balance 420
New shares issued 0
Ending balance € 420
Ordinary shares  
Disclosure of classes of share capital [line items]  
Beginning balance (in shares) | shares 141,677,366
Ending balance (in shares) | shares 144,301,592
Ordinary shares | Employees  
Disclosure of classes of share capital [line items]  
New shares issued (in shares) | shares 2,624,226

v3.22.4
COVID-19-RELATED GOVERNMENT ASSISTANCE (Details)
€ in Millions
12 Months Ended
Dec. 31, 2020
EUR (€)
COVID-19  
Government Assistance [Line Items]  
Proceeds from government grants deducted from employee benefit expenses € 22

v3.22.4
COMMITMENTS - Non-cancellable Lease Commitments Not Capitalized (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of non-cancellable operating leases commitments [line items]    
Total non-cancellable minimum lease payments € 12 € 8
Less than 1 year    
Disclosure of non-cancellable operating leases commitments [line items]    
Total non-cancellable minimum lease payments 3 3
1 to 5 years    
Disclosure of non-cancellable operating leases commitments [line items]    
Total non-cancellable minimum lease payments 9 3
Over 5 years    
Disclosure of non-cancellable operating leases commitments [line items]    
Total non-cancellable minimum lease payments € 0 € 2

v3.22.4
COMMITMENTS - Tangible and Intangible Asset Commitments (Details) - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Disclosure of capital expenditures commitments [line items]    
Total tangible and intangible asset commitments € 166 € 65
Property, plant and equipment    
Disclosure of capital expenditures commitments [line items]    
Total tangible and intangible asset commitments € 166 € 65

v3.22.4
RELATED PARTIES - Narrative (Details) - EUR (€)
€ in Millions
1 Months Ended
May 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
May 13, 2020
Disclosure of detailed information about borrowings [line items]          
Borrowings   € 2,056 € 2,129 € 2,391  
Secured French PGE French Facility (due 2022)          
Disclosure of detailed information about borrowings [line items]          
Borrowings   € 0 € 180    
Extension period 5 years        
Secured French PGE French Facility (due 2022) | French Government          
Disclosure of detailed information about borrowings [line items]          
Borrowings         € 180
Percentage of borrowings guaranteed         80.00%
Secured French PGE French Facility (due 2022) | French Government | BPI France          
Disclosure of detailed information about borrowings [line items]          
Borrowings         € 30

v3.22.4
RELATED PARTIES - Key Management Personnel Compensation (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of transactions between related parties [abstract]      
Short-term employee benefits € 12 € 8 € 9
Directors' fees 2 1 1
Share-based compensation 10 9 10
Post-employments benefits 0 0 0
Termination benefits 0 0 0
Employer social contribution 2 1 1
Total € 26 € 19 € 21

v3.22.4
SHARE-BASED COMPENSATION - Narrative (Details)
€ / shares in Units, € in Millions
1 Months Ended 12 Months Ended
Apr. 30, 2022
shares
Jul. 31, 2020
shares
May 31, 2020
shares
Apr. 30, 2019
May 31, 2018
Jul. 31, 2017
Dec. 31, 2022
EUR (€)
shares
€ / shares
Dec. 31, 2021
EUR (€)
shares
€ / shares
Dec. 31, 2020
EUR (€)
shares
Dec. 31, 2019
shares
Share Based Payment Plans [line items]                    
Expense from share-based payment transactions with employees | €             € 18 € 15 € 15  
Antidilutive securities (in shares)                 6,402,289  
PSUs                    
Share Based Payment Plans [line items]                    
Share based compensation, vesting period             3 years      
Total shareholder return (TSR) percentage achieved       200.00% 182.90% 186.80%        
Potential additional shares granted (in shares) 1,849,268 1,458,985 1,161,718              
Share price at grant date (in EUR per share) | € / shares             € 17.11 € 13.90    
PSUs | Bottom of range                    
Share Based Payment Plans [line items]                    
Percentage of vesting multiplier             0.00%      
PSUs | Top of range                    
Share Based Payment Plans [line items]                    
Percentage of vesting multiplier             200.00%      
RSUs                    
Share Based Payment Plans [line items]                    
Potential additional shares granted (in shares)             556,360 534,499    
RSUs | Certain Employees And Chief Financial Officer                    
Share Based Payment Plans [line items]                    
Vesting period on the grant date             3 years      
Share price at grant date (in EUR per share) | € / shares             € 17.11      
RSUs | Board Members                    
Share Based Payment Plans [line items]                    
Potential additional shares granted (in shares)             0 0 0 2

v3.22.4
SHARE-BASED COMPENSATION - Inputs to the Model Used for PSUs Granted (Details) - PSUs - € / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disclosure of Input of Model Used for Performance-Based RSU [Line Items]    
Fair value at grant date (in euros) (in EUR per share) € 23.70 € 21.84
Share price at grant date (in EUR per share) € 17.11 € 13.90
Dividend yield 0.00% 0.00%
Expected volatility 70.00% 71.00%
Risk-free interest rate (US government bond yield) 1.88% 0.31%

v3.22.4
SHARE-BASED COMPENSATION - Number and Movement of Potential Shares (Details)
12 Months Ended
Dec. 31, 2022
EUR (€)
shares
Dec. 31, 2021
EUR (€)
shares
Performance-Based RSU    
Disclosure of movement of potential shares [line items]    
Potential Shares, Beginning balance (in shares) 2,526,527 2,594,327
Potential Shares, Granted (in shares) 603,023 614,555
Potential Shares, Over-performance (in shares) 924,634 526,551
Potential Shares, Vested (in shares) (1,849,268) (1,161,718)
Potential Shares, Forfeited (in shares) (19,082) (47,188)
Potential Shares, Ending balance (in shares) 2,185,834 2,526,527
Weighted- Average Grant-Date Fair Value per Share, Beginning balance | € € 11.71 € 10.17
Weighted- Average Grant-Date Fair Value per Share, Granted | € 23.70 21.84
Weighted- Average Grant-Date Fair Value per Share, Over-performance | € 10.44 15.31
Weighted- Average Grant-Date Fair Value per Share, Vested | € 10.44 15.31
Weighted- Average Grant-Date Fair Value per Share, Forfeited | € 11.65 10.29
Weighted- Average Grant-Date Fair Value per Share, Ending balance | € € 15.56 € 11.71
Percentage of vesting multiplier 100.00%  
Performance based shares forfeited upon departure of certain beneficiaries (in shares) 19,082  
Performance based shares forfeited upon non-fulfillment of performance conditions (in shares) 0  
Restricted Stock Units    
Disclosure of movement of potential shares [line items]    
Potential Shares, Beginning balance (in shares) 2,148,999 2,231,911
Potential Shares, Granted (in shares) 556,360 534,499
Potential Shares, Over-performance (in shares) 0 0
Potential Shares, Vested (in shares) (774,958) (520,064)
Potential Shares, Forfeited (in shares) (54,955) (97,347)
Potential Shares, Ending balance (in shares) 1,875,446 2,148,999
Weighted- Average Grant-Date Fair Value per Share, Beginning balance | € € 7.79 € 6.88
Weighted- Average Grant-Date Fair Value per Share, Granted | € 17.11 13.90
Weighted- Average Grant-Date Fair Value per Share, Over-performance | € 0 0
Weighted- Average Grant-Date Fair Value per Share, Vested | € 7.10 10.27
Weighted- Average Grant-Date Fair Value per Share, Forfeited | € 9.04 7.17
Weighted- Average Grant-Date Fair Value per Share, Ending balance | € € 10.80 € 7.79
Equity Award Plans    
Disclosure of movement of potential shares [line items]    
Potential Shares, Beginning balance (in shares) 0 32,912
Potential Shares, Granted (in shares) 0 0
Potential Shares, Over-performance (in shares) 0 0
Potential Shares, Vested (in shares) 0 (32,912)
Potential Shares, Forfeited (in shares) 0 0
Potential Shares, Ending balance (in shares) 0 0
Weighted- Average Grant-Date Fair Value per Share, Beginning balance | € € 0 € 8.39
Weighted- Average Grant-Date Fair Value per Share, Granted | € 0 0
Weighted- Average Grant-Date Fair Value per Share, Over-performance | € 0 0
Weighted- Average Grant-Date Fair Value per Share, Vested | € 0 8.39
Weighted- Average Grant-Date Fair Value per Share, Forfeited | € 0 0
Weighted- Average Grant-Date Fair Value per Share, Ending balance | € € 0 € 0

v3.22.4
SUBSIDIARIES AND AFFILIATES (Details)
12 Months Ended
Dec. 31, 2022
Cross Operating Segment | Constellium Singen GmbH (AS&I and P&ARP)  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
Cross Operating Segment | Constellium Valais S.A. (AS&I and A&T)  
Disclosure of subsidiaries [line items]  
Country Switzerland
% Group Interest 100.00%
AS&I | Constellium Automotive USA, LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
AS&I | Constellium Engley (Changchun) Automotive Structures Co Ltd.  
Disclosure of subsidiaries [line items]  
Country China
% Group Interest 54.00%
AS&I | Constellium Extrusions Decin S.r.o.  
Disclosure of subsidiaries [line items]  
Country Czech Republic
% Group Interest 100.00%
AS&I | Constellium Extrusions Deutschland GmbH  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
AS&I | Constellium Extrusions Landau GmbH  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
AS&I | Constellium Extrusions Burg GmbH  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
AS&I | Constellium Extrusions France S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
AS&I | Constellium Extrusions Levice S.r.o.  
Disclosure of subsidiaries [line items]  
Country Slovakia
% Group Interest 100.00%
AS&I | Constellium Automotive Mexico, S. DE R.L. DE C.V.  
Disclosure of subsidiaries [line items]  
Country Mexico
% Group Interest 100.00%
AS&I | Constellium Automotive Mexico Trading, S. DE R.L. DE C.V.  
Disclosure of subsidiaries [line items]  
Country Mexico
% Group Interest 100.00%
AS&I | Astrex Inc  
Disclosure of subsidiaries [line items]  
Country Canada
% Group Interest 50.00%
AS&I | Constellium Automotive Zilina S.r.o.  
Disclosure of subsidiaries [line items]  
Country Slovakia
% Group Interest 100.00%
AS&I | Constellium Automotive (Nanjing) Co. Ltd.  
Disclosure of subsidiaries [line items]  
Country China
% Group Interest 100.00%
AS&I | Constellium Automotive Spain SL  
Disclosure of subsidiaries [line items]  
Country Spain
% Group Interest 100.00%
AS&I | Constellium UK Limited  
Disclosure of subsidiaries [line items]  
Country United Kingdom
% Group Interest 100.00%
A&T | Constellium Issoire S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
A&T | Constellium Montreuil Juigné S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
A&T | Constellium China Co. Ltd.  
Disclosure of subsidiaries [line items]  
Country China
% Group Interest 100.00%
A&T | Constellium Japan KK  
Disclosure of subsidiaries [line items]  
Country Japan
% Group Interest 100.00%
A&T | Constellium Rolled Products Ravenswood, LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
A&T | Constellium Ussel S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
A&T | AluInfra Services SA  
Disclosure of subsidiaries [line items]  
Country Switzerland
% Group Interest 50.00%
P&ARP | Constellium Deutschland GmbH  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
P&ARP | Constellium Rolled Products Singen GmbH & Co. KG  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
P&ARP | Constellium Neuf Brisach S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
P&ARP | Constellium Muscle Shoals LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
P&ARP | Constellium Holdings Muscle Shoals LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
P&ARP | Constellium Muscle Shoals Funding II LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
P&ARP | Constellium Muscle Shoals Funding III LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
P&ARP | Constellium Metal Procurement LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
P&ARP | Constellium Bowling Green LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
P&ARP | Rhenaroll SA  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 50.00%
Holdings & Corporate | C-TEC Constellium Technology Center S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
Holdings & Corporate | Constellium Finance S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
Holdings & Corporate | Constellium France III S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
Holdings & Corporate | Constellium France Holdco S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
Holdings & Corporate | Constellium International S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
Holdings & Corporate | Constellium Paris S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%
Holdings & Corporate | Constellium Germany Holdco GmbH & Co. KG  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
Holdings & Corporate | Constellium Germany Verwaltungs GmbH  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
Holdings & Corporate | Constellium US Holdings I, LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
Holdings & Corporate | Constellium US Intermediate Holdings LLC  
Disclosure of subsidiaries [line items]  
Country U.S.
% Group Interest 100.00%
Holdings & Corporate | Constellium Switzerland AG  
Disclosure of subsidiaries [line items]  
Country Switzerland
% Group Interest 100.00%
Holdings & Corporate | Constellium Treuhand UG (haftunsgbeschränkt)  
Disclosure of subsidiaries [line items]  
Country Germany
% Group Interest 100.00%
Holdings & Corporate | Engineered Products International S.A.S.  
Disclosure of subsidiaries [line items]  
Country France
% Group Interest 100.00%

v3.22.4
SUBSEQUENT EVENTS (Details)
€ in Millions
Feb. 02, 2023
EUR (€)
Disposal of major subsidiary [member]  
Disclosure of non-adjusting events after reporting period [line items]  
Cash consideration received on sale of business € 1.6

{
 "instance": {
  "cstm-20221231.htm": {
   "axisCustom": 7,
   "axisStandard": 47,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 51,
    "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 2227
   },
   "contextCount": 877,
   "dts": {
    "calculationLink": {
     "local": [
      "cstm-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cstm-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cstm-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cstm-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cstm-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cstm-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 1080,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 178,
   "keyStandard": 378,
   "memberCustom": 184,
   "memberStandard": 74,
   "nsprefix": "cstm",
   "nsuri": "http://www.constellium.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - COVER",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.constellium.com/role/COVER",
     "shortName": "COVER",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - REVENUE",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.constellium.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DeferredTaxAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - DEFERRED INCOME TAXES - Net Deferred Income Tax Assets (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.constellium.com/role/DEFERREDINCOMETAXESNetDeferredIncomeTaxAssetsDetails",
     "shortName": "DEFERRED INCOME TAXES - Net Deferred Income Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDeferredIncomeTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:NetDeferredTaxAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - DEFERRED INCOME TAXES - Changes in Net Deferred Income Tax Assets / (Liabilities) (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails",
     "shortName": "DEFERRED INCOME TAXES - Changes in Net Deferred Income Tax Assets / (Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cstm:IncreaseDecreaseThroughClassifiedAsHeldForSaleDeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:DeductibleTemporaryDifferencesAndUnusedTaxLossesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - DEFERRED INCOME TAXES - Narrative (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.constellium.com/role/DEFERREDINCOMETAXESNarrativeDetails",
     "shortName": "DEFERRED INCOME TAXES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:DeductibleTemporaryDifferencesAndUnusedTaxLossesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - DEFERRED INCOME TAXES - Components of Unrecognized Deferred Tax Assets (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails",
     "shortName": "DEFERRED INCOME TAXES - Components of Unrecognized Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
     "shortName": "DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i0811f64b103a425bb82c734d8b4185bf_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfTradePayablesAndOtherExplanatoryTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentPayablesToTradeSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - TRADE PAYABLES AND OTHER - Schedule of Trade Payables and Other (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails",
     "shortName": "TRADE PAYABLES AND OTHER - Schedule of Trade Payables and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfTradePayablesAndOtherExplanatoryTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentPayablesToTradeSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfTradePayablesAndOtherExplanatoryTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentContractLiabilities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - TRADE PAYABLES AND OTHER - Contract Liabilities and Other Liabilities to Customers (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails",
     "shortName": "TRADE PAYABLES AND OTHER - Contract Liabilities and Other Liabilities to Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfContractLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i2edd2ec6eae740b398e62f94c4133975_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentContractLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000107 - Disclosure - TRADE PAYABLES AND OTHER - Narrative (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.constellium.com/role/TRADEPAYABLESANDOTHERNarrativeDetails",
     "shortName": "TRADE PAYABLES AND OTHER - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NotionalAmount",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - BORROWINGS - Borrowings by Nature (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
     "shortName": "BORROWINGS - Borrowings by Nature (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ifrs-full:GrossLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UndrawnBorrowingFacilities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000109 - Disclosure - BORROWINGS - Narrative (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.constellium.com/role/BORROWINGSNarrativeDetails",
     "shortName": "BORROWINGS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i26e5c03ffa854409990e168bb737a401_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:UndrawnBorrowingFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - OPERATING SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATION",
     "shortName": "OPERATING SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:ScheduleOfReconciliationOfMovementsInNetBorrowingsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i1ff4ca0105c54302a6a8d7d9b553f0dd_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - BORROWINGS - Movement in Borrowings (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
     "shortName": "BORROWINGS - Movement in Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:ScheduleOfReconciliationOfMovementsInNetBorrowingsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ia867cf07fb6f4264b089b5911ffe3d7d_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:ScheduleOfReconciliationOfMovementsInNetBorrowingsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - BORROWINGS - Currency Concentration of Total Borrowings (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
     "shortName": "BORROWINGS - Currency Concentration of Total Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDetailedInformationAboutCarryingAmountsAndMarketValuesOfBorrowingsExplanatoryTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ic33365beb35446beb4e936138f41c080_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - FINANCIAL INSTRUMENTS - Financial Assets and Liabilities by Categories (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Financial Assets and Liabilities by Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ic08540aa872f4fbb96c7044d19ca23f1_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "cstm:PercentageOfFairValueSeniorNotesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ic08540aa872f4fbb96c7044d19ca23f1_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "cstm:PercentageOfFairValueSeniorNotesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfFinancialDerivativeInstrumentAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentDerivativeFinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - FINANCIAL INSTRUMENTS - Other Financial Assets and Other Financial Liabilities Positions (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Other Financial Assets and Other Financial Liabilities Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfFinancialDerivativeInstrumentAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentDerivativeFinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DerivativeFinancialAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000115 - Disclosure - FINANCIAL INSTRUMENTS - Derivatives Measured at Fair Value (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Derivatives Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i98ce13cb193a49aea4b77e610f0396b7_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:DerivativeFinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i0f75dd245135406592db8539aa1e7f72_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NominalAmountOfHedgingInstrument",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur_",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000116 - Disclosure - FINANCIAL RISK MANAGEMENT - Nominal Value of Currency Derivatives (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Nominal Value of Currency Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i0f75dd245135406592db8539aa1e7f72_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NominalAmountOfHedgingInstrument",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur_",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cstm:PercentageOfTradeAccountReceivablesInsured",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000117 - Disclosure - FINANCIAL RISK MANAGEMENT - Narrative (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cstm:RevolvingCreditFacilityOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock",
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:RealizedGainsLossesOnForeignCurrencyDerivativesNet",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000118 - Disclosure - FINANCIAL RISK MANAGEMENT - Effect of Foreign Currency Derivatives Impacts and Commercial Transactions Exposures (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Effect of Foreign Currency Derivatives Impacts and Commercial Transactions Exposures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i22bd7c7727e24639a2154d80e488319f_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cstm:RealizedGainsLossesOnForeignCurrencyDerivativesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock",
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:RealizedGainsLossesOnForeignCurrencyDerivativesNet",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000119 - Disclosure - FINANCIAL RISK MANAGEMENT - Effect of Foreign Currency Derivatives Impacts and Financing Transaction Exposures (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Effect of Foreign Currency Derivatives Impacts and Financing Transaction Exposures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i0698dd749571452ba61de895208f697e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cstm:RealizedGainsLossesOnForeignCurrencyDerivativesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - INFORMATION BY GEOGRAPHIC AREA",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREA",
     "shortName": "INFORMATION BY GEOGRAPHIC AREA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4d0bf1f9b49b477fb7226f9463bc29f3_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ForeignExchangeSensitivityOnCommercialAndFinancingTransactionsExposuresEffectOnProfitBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000120 - Disclosure - FINANCIAL RISK MANAGEMENT - Impact on Profit and Equity (Before Tax Effect) of a 10% Strengthening of US Dollar Versus Euro for Non-US Dollar Functional Currency Entities (Details)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Impact on Profit and Equity (Before Tax Effect) of a 10% Strengthening of US Dollar Versus Euro for Non-US Dollar Functional Currency Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4d0bf1f9b49b477fb7226f9463bc29f3_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ForeignExchangeSensitivityOnCommercialAndFinancingTransactionsExposuresEffectOnProfitBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfForeignExchangeSensitivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4d0bf1f9b49b477fb7226f9463bc29f3_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ForeignExchangeSensitivityEffectOnProfitBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000121 - Disclosure - FINANCIAL RISK MANAGEMENT - Impact on Profit and Equity (Before Tax Effect) of a 10% Strengthening of US Dollar Versus Euro for US Dollar Functional Currency Entities (Details)",
     "menuCat": "Details",
     "order": "121",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Impact on Profit and Equity (Before Tax Effect) of a 10% Strengthening of US Dollar Versus Euro for US Dollar Functional Currency Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfForeignExchangeSensitivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4d0bf1f9b49b477fb7226f9463bc29f3_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ForeignExchangeSensitivityEffectOnProfitBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3fba2a0f086344aaad9b64b71eb25ae3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CreditDerivativeNominalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000122 - Disclosure - FINANCIAL RISK MANAGEMENT - Nominal Value of Commodity Derivatives (Details)",
     "menuCat": "Details",
     "order": "122",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Nominal Value of Commodity Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3fba2a0f086344aaad9b64b71eb25ae3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CreditDerivativeNominalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4ddaf3ed3c85414fbaee43aee34c4f7e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:RealizedGainsLossesOnCommodityDerivativesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000123 - Disclosure - FINANCIAL RISK MANAGEMENT - Mark-to-market Movements Recognized in Other Gains (Losses) - Net (Details)",
     "menuCat": "Details",
     "order": "123",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Mark-to-market Movements Recognized in Other Gains (Losses) - Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4ddaf3ed3c85414fbaee43aee34c4f7e_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:RealizedGainsLossesOnCommodityDerivativesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfExternalCreditExposuresExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cstm:NumberOfFinancialCounterparties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "counterparty",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000124 - Disclosure - FINANCIAL RISK MANAGEMENT - Exposure to Financial Counterparties by Rating Type (Details)",
     "menuCat": "Details",
     "order": "124",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Exposure to Financial Counterparties by Rating Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfExternalCreditExposuresExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cstm:NumberOfFinancialCounterparties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "counterparty",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000125 - Disclosure - FINANCIAL RISK MANAGEMENT - Undiscounted Contractual Financial Assets and Financial Liabilities Values by Relevant Maturity Groupings (Details)",
     "menuCat": "Details",
     "order": "125",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails",
     "shortName": "FINANCIAL RISK MANAGEMENT - Undiscounted Contractual Financial Assets and Financial Liabilities Values by Relevant Maturity Groupings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfUndiscountedContractualValuesOfByRelevantMaturityGroupingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i083a40a202af4b2abdce3e595cdb4e9d_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:FinancialAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib52ce22f53ef4c76b177ee6108f78daa_D20221001-20221031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:CollectiveBargainingAgreementPeriod",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000126 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Narrative (Details)",
     "menuCat": "Details",
     "order": "126",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "cstm:WeightedAverageMaturityOfDefinedBenefitObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i946dc57b15e1451587b219c8ec9f6582_I20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000127 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Sensitivity Analysis on Defined Benefit Obligations (Details)",
     "menuCat": "Details",
     "order": "127",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Sensitivity Analysis on Defined Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i946dc57b15e1451587b219c8ec9f6582_I20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ie3817b03e7204274bd11d34e7d3d39a7_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000128 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Actuarial Assumptions (Details)",
     "menuCat": "Details",
     "order": "128",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Actuarial Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ie3817b03e7204274bd11d34e7d3d39a7_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDefinedBenefitPlansRecognizedInConsolidatedStatementsOfFinancialPositionTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:PresentValueOfFundedObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000129 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Amounts Recognized in the Consolidated Statement of Financial Position (Details)",
     "menuCat": "Details",
     "order": "129",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Amounts Recognized in the Consolidated Statement of Financial Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDefinedBenefitPlansRecognizedInConsolidatedStatementsOfFinancialPositionTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:PresentValueOfFundedObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - EXPENSES BY NATURE",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.constellium.com/role/EXPENSESBYNATURE",
     "shortName": "EXPENSES BY NATURE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000130 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Movement in Net Defined Benefit Obligations (Details)",
     "menuCat": "Details",
     "order": "130",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Movement in Net Defined Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R131": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfGeographicalDistributionOfDefinedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:DefinedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000131 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Net Defined Benefit Obligations by Country (Details)",
     "menuCat": "Details",
     "order": "131",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Net Defined Benefit Obligations by Country (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfGeographicalDistributionOfDefinedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:DefinedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R132": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000132 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Plan Asset Categories (Details)",
     "menuCat": "Details",
     "order": "132",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Plan Asset Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R133": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfEstimatedFutureBenefitPaymentsOfDefinedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:EstimatedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000133 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Benefit Payments Expected to be Paid Either by Pension Funds or Directly to Beneficiaries (Details)",
     "menuCat": "Details",
     "order": "133",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSBenefitPaymentsExpectedtobePaidEitherbyPensionFundsorDirectlytoBeneficiariesDetails",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS - Benefit Payments Expected to be Paid Either by Pension Funds or Directly to Beneficiaries (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfEstimatedFutureBenefitPaymentsOfDefinedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:EstimatedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R134": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfProvisionsByTypeExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:OtherProvisions",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000134 - Disclosure - PROVISIONS - Changes in Provisions (Details)",
     "menuCat": "Details",
     "order": "134",
     "role": "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails",
     "shortName": "PROVISIONS - Changes in Provisions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfProvisionsByTypeExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i1ff4ca0105c54302a6a8d7d9b553f0dd_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OtherProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R135": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:ProvisionsExpectedSettlementPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000135 - Disclosure - PROVISIONS - Narrative (Details)",
     "menuCat": "Details",
     "order": "135",
     "role": "http://www.constellium.com/role/PROVISIONSNarrativeDetails",
     "shortName": "PROVISIONS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:ProvisionsExpectedSettlementPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R136": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i2071ad1498bb44839a9af81abd93ccdc_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ProvisionForLitigation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000136 - Disclosure - PROVISIONS - Legal Claims and Other Costs (Details)",
     "menuCat": "Details",
     "order": "136",
     "role": "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails",
     "shortName": "PROVISIONS - Legal Claims and Other Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i2071ad1498bb44839a9af81abd93ccdc_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ProvisionForLitigation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R137": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:AdditionsThroughNoncashFinanceLeasePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000137 - Disclosure - NON-CASH INVESTING AND FINANCING TRANSACTIONS (Details)",
     "menuCat": "Details",
     "order": "137",
     "role": "http://www.constellium.com/role/NONCASHINVESTINGANDFINANCINGTRANSACTIONSDetails",
     "shortName": "NON-CASH INVESTING AND FINANCING TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:AdditionsThroughNoncashFinanceLeasePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R138": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000138 - Disclosure - SHARE CAPITAL - Narrative (Details)",
     "menuCat": "Details",
     "order": "138",
     "role": "http://www.constellium.com/role/SHARECAPITALNarrativeDetails",
     "shortName": "SHARE CAPITAL - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R139": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000139 - Disclosure - SHARE CAPITAL (Details)",
     "menuCat": "Details",
     "order": "139",
     "role": "http://www.constellium.com/role/SHARECAPITALDetails",
     "shortName": "SHARE CAPITAL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i8b690fe46aae4b418e569666894d523d_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:IssueOfEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - EMPLOYEE BENEFIT EXPENSES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSES",
     "shortName": "EMPLOYEE BENEFIT EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R140": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i02835822531641eeab3faf6fed253568_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000140 - Disclosure - COVID-19-RELATED GOVERNMENT ASSISTANCE (Details)",
     "menuCat": "Details",
     "order": "140",
     "role": "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCEDetails",
     "shortName": "COVID-19-RELATED GOVERNMENT ASSISTANCE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i02835822531641eeab3faf6fed253568_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R141": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfMinimumOperatingLeasePaymentsExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:MinimumLeasePaymentsPayableUnderNonCancellableOperatingLease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000141 - Disclosure - COMMITMENTS - Non-cancellable Lease Commitments Not Capitalized (Details)",
     "menuCat": "Details",
     "order": "141",
     "role": "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails",
     "shortName": "COMMITMENTS - Non-cancellable Lease Commitments Not Capitalized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfMinimumOperatingLeasePaymentsExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:MinimumLeasePaymentsPayableUnderNonCancellableOperatingLease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R142": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfCapitalExpendituresCommitmentsExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CapitalCommitments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000142 - Disclosure - COMMITMENTS - Tangible and Intangible Asset Commitments (Details)",
     "menuCat": "Details",
     "order": "142",
     "role": "http://www.constellium.com/role/COMMITMENTSTangibleandIntangibleAssetCommitmentsDetails",
     "shortName": "COMMITMENTS - Tangible and Intangible Asset Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfCapitalExpendituresCommitmentsExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CapitalCommitments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R143": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:ScheduleOfReconciliationOfMovementsInNetBorrowingsExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000143 - Disclosure - RELATED PARTIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "143",
     "role": "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails",
     "shortName": "RELATED PARTIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ic4b17d21f2414594942b754d2f02a583_I20200513",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R144": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000144 - Disclosure - RELATED PARTIES - Key Management Personnel Compensation (Details)",
     "menuCat": "Details",
     "order": "144",
     "role": "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails",
     "shortName": "RELATED PARTIES - Key Management Personnel Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R145": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000145 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "145",
     "role": "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i12eda20ce9f24cfc86fe8e78abeb05f9_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cstm:InstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R146": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ia991de671b9540ecae3e11afca569c73_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cstm:FairValueAtMeasurementDateOtherEquityInstrumentsGrantedPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000146 - Disclosure - SHARE-BASED COMPENSATION - Inputs to the Model Used for PSUs Granted (Details)",
     "menuCat": "Details",
     "order": "146",
     "role": "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails",
     "shortName": "SHARE-BASED COMPENSATION - Inputs to the Model Used for PSUs Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ia991de671b9540ecae3e11afca569c73_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cstm:FairValueAtMeasurementDateOtherEquityInstrumentsGrantedPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R147": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfNumberOfOtherEquityInstrumentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4d85ed93d1344613bb61ff5081f5d08d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000147 - Disclosure - SHARE-BASED COMPENSATION - Number and Movement of Potential Shares (Details)",
     "menuCat": "Details",
     "order": "147",
     "role": "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails",
     "shortName": "SHARE-BASED COMPENSATION - Number and Movement of Potential Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfNumberOfOtherEquityInstrumentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i7a0ddb22a8294f198c015e580324e889_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R148": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "id2323a9b0bd14f5986bdf2429c86a679_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000148 - Disclosure - SUBSIDIARIES AND AFFILIATES (Details)",
     "menuCat": "Details",
     "order": "148",
     "role": "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails",
     "shortName": "SUBSIDIARIES AND AFFILIATES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "id2323a9b0bd14f5986bdf2429c86a679_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R149": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ia2cba8fca2a041238a8ff3a72ce106e9_D20230202-20230202",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000149 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "menuCat": "Details",
     "order": "149",
     "role": "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ia2cba8fca2a041238a8ff3a72ce106e9_D20230202-20230202",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfOtherGainsNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - OTHER GAINS AND LOSSES\u2014NET",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.constellium.com/role/OTHERGAINSANDLOSSESNET",
     "shortName": "OTHER GAINS AND LOSSES\u2014NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfOtherGainsNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - CURRENCY GAINS / (LOSSES)",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.constellium.com/role/CURRENCYGAINSLOSSES",
     "shortName": "CURRENCY GAINS / (LOSSES)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceCostExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - FINANCE COSTS\u2014NET",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.constellium.com/role/FINANCECOSTSNET",
     "shortName": "FINANCE COSTS\u2014NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceCostExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - INCOME TAX",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.constellium.com/role/INCOMETAX",
     "shortName": "INCOME TAX",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - CASH AND CASH EQUIVALENTS",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.constellium.com/role/CASHANDCASHEQUIVALENTS",
     "shortName": "CASH AND CASH EQUIVALENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.constellium.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - TRADE RECEIVABLES AND OTHER",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.constellium.com/role/TRADERECEIVABLESANDOTHER",
     "shortName": "TRADE RECEIVABLES AND OTHER",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.constellium.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - INTANGIBLE ASSETS AND GOODWILL",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILL",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - DEFERRED INCOME TAXES",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.constellium.com/role/DEFERREDINCOMETAXES",
     "shortName": "DEFERRED INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALE",
     "shortName": "DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - TRADE PAYABLES AND OTHER",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.constellium.com/role/TRADEPAYABLESANDOTHER",
     "shortName": "TRADE PAYABLES AND OTHER",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - BORROWINGS",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.constellium.com/role/BORROWINGS",
     "shortName": "BORROWINGS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - FINANCIAL INSTRUMENTS",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.constellium.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - FINANCIAL RISK MANAGEMENT",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENT",
     "shortName": "FINANCIAL RISK MANAGEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED INCOME STATEMENT",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
     "shortName": "CONSOLIDATED INCOME STATEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONS",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfProvisionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - PROVISIONS",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://www.constellium.com/role/PROVISIONS",
     "shortName": "PROVISIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfProvisionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - NON-CASH INVESTING AND FINANCING TRANSACTIONS",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://www.constellium.com/role/NONCASHINVESTINGANDFINANCINGTRANSACTIONS",
     "shortName": "NON-CASH INVESTING AND FINANCING TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - SHARE CAPITAL",
     "menuCat": "Notes",
     "order": "33",
     "role": "http://www.constellium.com/role/SHARECAPITAL",
     "shortName": "SHARE CAPITAL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - COVID-19-RELATED GOVERNMENT ASSISTANCE",
     "menuCat": "Notes",
     "order": "34",
     "role": "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCE",
     "shortName": "COVID-19-RELATED GOVERNMENT ASSISTANCE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - COMMITMENTS",
     "menuCat": "Notes",
     "order": "35",
     "role": "http://www.constellium.com/role/COMMITMENTS",
     "shortName": "COMMITMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - RELATED PARTIES",
     "menuCat": "Notes",
     "order": "36",
     "role": "http://www.constellium.com/role/RELATEDPARTIES",
     "shortName": "RELATED PARTIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - SHARE-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "37",
     "role": "http://www.constellium.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - SUBSIDIARIES AND AFFILIATES",
     "menuCat": "Notes",
     "order": "38",
     "role": "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATES",
     "shortName": "SUBSIDIARIES AND AFFILIATES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "39",
     "role": "http://www.constellium.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfStatementOfCompliancePolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "40",
     "role": "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfStatementOfCompliancePolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - REVENUE (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.constellium.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - OPERATING SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONTables",
     "shortName": "OPERATING SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfPropertyPlantAndEquipmentReportedBasedOnPhysicalLocationOfAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - INFORMATION BY GEOGRAPHIC AREA (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREATables",
     "shortName": "INFORMATION BY GEOGRAPHIC AREA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfPropertyPlantAndEquipmentReportedBasedOnPhysicalLocationOfAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDetailedInformationAboutExpensesByNatureToTheirFunctionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - EXPENSES BY NATURE (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.constellium.com/role/EXPENSESBYNATURETables",
     "shortName": "EXPENSES BY NATURE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDetailedInformationAboutExpensesByNatureToTheirFunctionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - EMPLOYEE BENEFIT EXPENSES (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESTables",
     "shortName": "EMPLOYEE BENEFIT EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "cstm:DisclosureOfOtherGainsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDetailedInformationOtherGainsAndLossesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - OTHER GAINS AND LOSSES\u2014NET (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETTables",
     "shortName": "OTHER GAINS AND LOSSES\u2014NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cstm:DisclosureOfOtherGainsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDetailedInformationOtherGainsAndLossesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - CURRENCY GAINS / (LOSSES) (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://www.constellium.com/role/CURRENCYGAINSLOSSESTables",
     "shortName": "CURRENCY GAINS / (LOSSES) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceCostExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - FINANCE COSTS\u2014NET (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://www.constellium.com/role/FINANCECOSTSNETTables",
     "shortName": "FINANCE COSTS\u2014NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceCostExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENT OF FINANCIAL POSITION",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
     "shortName": "CONSOLIDATED STATEMENT OF FINANCIAL POSITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OtherCurrentFinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - INCOME TAX (Tables)",
     "menuCat": "Tables",
     "order": "50",
     "role": "http://www.constellium.com/role/INCOMETAXTables",
     "shortName": "INCOME TAX (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - TRADE RECEIVABLES AND OTHER (Tables)",
     "menuCat": "Tables",
     "order": "51",
     "role": "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERTables",
     "shortName": "TRADE RECEIVABLES AND OTHER (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfInformationAboutInventoriesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "52",
     "role": "http://www.constellium.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfInformationAboutInventoriesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "menuCat": "Tables",
     "order": "53",
     "role": "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)",
     "menuCat": "Tables",
     "order": "54",
     "role": "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLTables",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDeferredIncomeTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - DEFERRED INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "55",
     "role": "http://www.constellium.com/role/DEFERREDINCOMETAXESTables",
     "shortName": "DEFERRED INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfDeferredIncomeTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE (Tables)",
     "menuCat": "Tables",
     "order": "56",
     "role": "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALETables",
     "shortName": "DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfTradePayablesAndOtherExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - TRADE PAYABLES AND OTHER (Tables)",
     "menuCat": "Tables",
     "order": "57",
     "role": "http://www.constellium.com/role/TRADEPAYABLESANDOTHERTables",
     "shortName": "TRADE PAYABLES AND OTHER (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfTradePayablesAndOtherExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - BORROWINGS (Tables)",
     "menuCat": "Tables",
     "order": "58",
     "role": "http://www.constellium.com/role/BORROWINGSTables",
     "shortName": "BORROWINGS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "menuCat": "Tables",
     "order": "59",
     "role": "http://www.constellium.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib07194ccff714c2a8fd768574113a308_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF CHANGES IN EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib07194ccff714c2a8fd768574113a308_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - FINANCIAL RISK MANAGEMENT (Tables)",
     "menuCat": "Tables",
     "order": "60",
     "role": "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables",
     "shortName": "FINANCIAL RISK MANAGEMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS (Tables)",
     "menuCat": "Tables",
     "order": "61",
     "role": "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables",
     "shortName": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfProvisionsByTypeExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - PROVISIONS (Tables)",
     "menuCat": "Tables",
     "order": "62",
     "role": "http://www.constellium.com/role/PROVISIONSTables",
     "shortName": "PROVISIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfProvisionsByTypeExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - SHARE CAPITAL (Tables)",
     "menuCat": "Tables",
     "order": "63",
     "role": "http://www.constellium.com/role/SHARECAPITALTables",
     "shortName": "SHARE CAPITAL (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfMinimumOperatingLeasePaymentsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - COMMITMENTS (Tables)",
     "menuCat": "Tables",
     "order": "64",
     "role": "http://www.constellium.com/role/COMMITMENTSTables",
     "shortName": "COMMITMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:DisclosureOfMinimumOperatingLeasePaymentsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - RELATED PARTIES (Tables)",
     "menuCat": "Tables",
     "order": "65",
     "role": "http://www.constellium.com/role/RELATEDPARTIESTables",
     "shortName": "RELATED PARTIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "66",
     "role": "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - SUBSIDIARIES AND AFFILIATES (Tables)",
     "menuCat": "Tables",
     "order": "67",
     "role": "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESTables",
     "shortName": "SUBSIDIARIES AND AFFILIATES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cstm:NumberOfProductionFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - GENERAL INFORMATION (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.constellium.com/role/GENERALINFORMATIONDetails",
     "shortName": "GENERAL INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cstm:NumberOfProductionFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i9797391a5b6846d7918fd349192f4ccb_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:AverageForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Disclosure of Foreign Exchange Rates (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Disclosure of Foreign Exchange Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i9797391a5b6846d7918fd349192f4ccb_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:AverageForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENT OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:ImpairmentLossRecognisedInProfitOrLossGoodwillCashFlowProjectionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cstm:ImpairmentLossRecognisedInProfitOrLossGoodwillCashFlowProjectionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - REVENUE - Disaggregation of Revenue by Product Line (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails",
     "shortName": "REVENUE - Disaggregation of Revenue by Product Line (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "div",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i1acf9d96b71942bd8eb805bbc0a5ffb6_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - REVENUE - Disaggregation of Revenue by Destination of Shipment (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
     "shortName": "REVENUE - Disaggregation of Revenue by Destination of Shipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "if50bda0221ed466a857341c8f07a8f9e_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "iff7843d9f9c54352a1d664bb0150ed33_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - REVENUE - Narrative (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.constellium.com/role/REVENUENarrativeDetails",
     "shortName": "REVENUE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "iff7843d9f9c54352a1d664bb0150ed33_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NumberOfEmployees",
      "reportCount": 1,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - OPERATING SEGMENT INFORMATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
     "shortName": "OPERATING SEGMENT INFORMATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i08c22628e68945e18f71e56741be0062_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cstm:NumberOfFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - OPERATING SEGMENT INFORMATION - Segment Revenue (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails",
     "shortName": "OPERATING SEGMENT INFORMATION - Segment Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i83714dd0213043718c4b275ec9239afb_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:AdjustedEBITDA",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - OPERATING SEGMENT INFORMATION - Segment Adjusted EBITDA and reconciliation of Adjusted EBITDA to Net Income (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
     "shortName": "OPERATING SEGMENT INFORMATION - Segment Adjusted EBITDA and reconciliation of Adjusted EBITDA to Net Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:AdjustedEBITDA",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - OPERATING SEGMENT INFORMATION - Segment Capital Expenditures (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
     "shortName": "OPERATING SEGMENT INFORMATION - Segment Capital Expenditures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfSegmentCapitalExpendituresTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i4a8c1c861c5446f0bdd8866ba4097062_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfSegmentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Assets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - OPERATING SEGMENT INFORMATION - Segment Assets (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
     "shortName": "OPERATING SEGMENT INFORMATION - Segment Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfSegmentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i29d1988779764d90b50a5e7582b9bc54_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - INFORMATION BY GEOGRAPHIC AREA (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
     "shortName": "INFORMATION BY GEOGRAPHIC AREA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfPropertyPlantAndEquipmentReportedBasedOnPhysicalLocationOfAssetsTableTextBlock",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ie93d0c14c0e740a9b0348762f2dc84f6_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - GENERAL INFORMATION",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.constellium.com/role/GENERALINFORMATION",
     "shortName": "GENERAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EmployeeBenefitsExpense",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - EXPENSES BY NATURE (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.constellium.com/role/EXPENSESBYNATUREDetails",
     "shortName": "EXPENSES BY NATURE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDetailedInformationAboutExpensesByNatureToTheirFunctionTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:OperatingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - EMPLOYEE BENEFIT EXPENSES (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails",
     "shortName": "EMPLOYEE BENEFIT EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfDetailedInformationOtherGainsAndLossesTableTextBlock",
       "cstm:DisclosureOfOtherGainsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:RealizedGainLossesOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - OTHER GAINS AND LOSSES\u2014NET (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
     "shortName": "OTHER GAINS AND LOSSES\u2014NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfDetailedInformationOtherGainsAndLossesTableTextBlock",
       "cstm:DisclosureOfOtherGainsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:RealizedGainLossesOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock",
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - CURRENCY GAINS / (LOSSES) - Currency Gains and Losses Included in Income from Operations (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
     "shortName": "CURRENCY GAINS / (LOSSES) - Currency Gains and Losses Included in Income from Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock",
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfCurrencyTranslationReserveTableTextBlock",
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ReserveOfExchangeDifferencesOnTranslation",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - CURRENCY GAINS / (LOSSES) - Foreign Currency Translation Reserve (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.constellium.com/role/CURRENCYGAINSLOSSESForeignCurrencyTranslationReserveDetails",
     "shortName": "CURRENCY GAINS / (LOSSES) - Foreign Currency Translation Reserve (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfCurrencyTranslationReserveTableTextBlock",
       "div",
       "cstm:DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i1ff4ca0105c54302a6a8d7d9b553f0dd_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:ReserveOfExchangeDifferencesOnTranslation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "ifrs-full:DisclosureOfFinanceCostExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - FINANCE COSTS\u2014NET (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.constellium.com/role/FINANCECOSTSNETDetails",
     "shortName": "FINANCE COSTS\u2014NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "ifrs-full:DisclosureOfFinanceCostExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - INCOME TAX - Current and Deferred Components of Income Tax (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.constellium.com/role/INCOMETAXCurrentandDeferredComponentsofIncomeTaxDetails",
     "shortName": "INCOME TAX - Current and Deferred Components of Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - INCOME TAX - Income Tax Reconciliation Using Composite Statutory Income Tax Rate Applicable by Tax Jurisdiction (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails",
     "shortName": "INCOME TAX - Income Tax Reconciliation Using Composite Statutory Income Tax Rate Applicable by Tax Jurisdiction (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - CASH AND CASH EQUIVALENTS (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails",
     "shortName": "CASH AND CASH EQUIVALENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - TRADE RECEIVABLES AND OTHER - Schedule of Trade Receivables and Other (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails",
     "shortName": "TRADE RECEIVABLES AND OTHER - Schedule of Trade Receivables and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NoncurrentContractAssets",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - TRADE RECEIVABLES AND OTHER - Narrative (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails",
     "shortName": "TRADE RECEIVABLES AND OTHER - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cstm:DerecognizedFactoredAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfTradeReceivablesNetDenominatedInMajorCurrenciesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:TradeReceivables",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - TRADE RECEIVABLES AND OTHER - Aging of Total Trade Receivables - Net (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails",
     "shortName": "TRADE RECEIVABLES AND OTHER - Aging of Total Trade Receivables - Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib23195d9e86e48028ea48ca3cb9a32e1_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:TradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfTradeReceivablesNetDenominatedInMajorCurrenciesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:TradeReceivables",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - TRADE RECEIVABLES AND OTHER - Currency Concentration of Total Trade Receivables (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails",
     "shortName": "TRADE RECEIVABLES AND OTHER - Currency Concentration of Total Trade Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfTradeReceivablesNetDenominatedInMajorCurrenciesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i8875db6ab27745f1899548d8f8972504_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:TradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfInformationAboutInventoriesExplanatoryTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:FinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - INVENTORIES (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.constellium.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cstm:DisclosureOfInformationAboutInventoriesExplanatoryTableTextBlock",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:FinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Schedule of Property, Plant and Equipment (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT - Schedule of Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "id08c451f6bc345aa9e8fff4d4141f38f_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Right of Use Assets (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT - Right of Use Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i972f0a36b6784549819ab13a60d858d8_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfDepreciationExpenseAndImpairmentLossesRelatingToPropertyPlantAndEquipmentAndIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Depreciation Expense (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT - Depreciation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cstm:DisclosureOfDepreciationExpenseAndImpairmentLossesRelatingToPropertyPlantAndEquipmentAndIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ExpenseRelatingToShortTermLeasesLeasesOfLowValueAssetsAndVariableLeasePaymentsForWhichRecognitionExemptionHasBeenUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i3336d3475f73438da1a6697df8934ede_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cstm:ExpenseRelatingToShortTermLeasesLeasesOfLowValueAssetsAndVariableLeasePaymentsForWhichRecognitionExemptionHasBeenUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i89c9ca7f82f6484481a719cfecb57149_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i1ff4ca0105c54302a6a8d7d9b553f0dd_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "ib02d19c11ab24e85b07a9e35b77ccb3e_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:Goodwill",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cstm-20221231.htm",
      "contextRef": "i08c22628e68945e18f71e56741be0062_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ifrs-full:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 276,
   "tag": {
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CZ": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CZECHIA",
        "terseLabel": "Czech Republic"
       }
      }
     },
     "localname": "CZ",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_ES": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SPAIN",
        "terseLabel": "Spain"
       }
      }
     },
     "localname": "ES",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "United Kingdom"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AccruedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest accrued but is not yet paid.",
        "label": "Accrued interest",
        "terseLabel": "Accrued interests"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_AdditionsThroughNoncashFinanceLeasePropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions through noncash finance lease, property, plant and equipment.",
        "label": "Additions through noncash finance lease, property, plant and equipment",
        "terseLabel": "Property, plant and equipment acquired by finance lease"
       }
      }
     },
     "localname": "AdditionsThroughNoncashFinanceLeasePropertyPlantAndEquipment",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/NONCASHINVESTINGANDFINANCINGTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_AdjustedEBITDA": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted earnings before interest taxes depreciation and amortization.",
        "label": "Adjusted EBITDA",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "AdjustedEBITDA",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_AdjustmentsForMetalPriceLag": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for metal price lag.",
        "label": "Adjustments For Metal Price Lag",
        "negatedLabel": "Metal price lag"
       }
      }
     },
     "localname": "AdjustmentsForMetalPriceLag",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_AdjustmentsForRestructuringCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for restructuring costs.",
        "label": "Adjustments For Restructuring Costs",
        "negatedLabel": "Restructuring costs"
       }
      }
     },
     "localname": "AdjustmentsForRestructuringCosts",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_AdvancePaymentFromCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance payment from customers.",
        "label": "Advance Payment From Customers [member]",
        "terseLabel": "Advance payment from customers"
       }
      }
     },
     "localname": "AdvancePaymentFromCustomersMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AerospaceAndTransportationAndAutomotiveStructuresAndIndustryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aerospace And Transportation And Automotive Structures And Industry",
        "label": "Aerospace And Transportation And Automotive Structures And Industry [Member]",
        "terseLabel": "A&T and AC&I"
       }
      }
     },
     "localname": "AerospaceAndTransportationAndAutomotiveStructuresAndIndustryMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AerospaceAndTransportationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aerospace and transportation.",
        "label": "Aerospace and Transportation [Member]",
        "terseLabel": "A&T"
       }
      }
     },
     "localname": "AerospaceAndTransportationMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AerospaceRolledProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aerospace rolled products.",
        "label": "Aerospace rolled products [member]",
        "terseLabel": "Aerospace rolled products"
       }
      }
     },
     "localname": "AerospaceRolledProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AgingOfTradeReceivablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aging of trade receivables.",
        "label": "Aging Of Trade Receivables [table]",
        "terseLabel": "Aging of trade receivables [table]"
       }
      }
     },
     "localname": "AgingOfTradeReceivablesTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_AluinfraServicesSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AluInfra Services SA.",
        "label": "AluInfra Services SA [member]",
        "terseLabel": "AluInfra Services SA"
       }
      }
     },
     "localname": "AluinfraServicesSAMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AluminiumAndPremiumFutureContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aluminium and premium future contract.",
        "label": "Aluminium and premium future contract [member]",
        "terseLabel": "Aluminium and premium derivatives"
       }
      }
     },
     "localname": "AluminiumAndPremiumFutureContractMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AluminiumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aluminium.",
        "label": "Aluminium [member]",
        "terseLabel": "Aluminium"
       }
      }
     },
     "localname": "AluminiumMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AnalysisOfIncomeAndExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Analysis of income and expense.",
        "label": "Analysis Of Income And Expense [line items]",
        "terseLabel": "Analysis of income and expense [line items]"
       }
      }
     },
     "localname": "AnalysisOfIncomeAndExpenseLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_AnalysisOfIncomeAndExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Analysis Of Income And Expense [table]",
        "label": "Analysis Of Income And Expense [table]",
        "terseLabel": "Analysis Of Income And Expense [table]"
       }
      }
     },
     "localname": "AnalysisOfIncomeAndExpenseTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_ArrangementFeesPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement fees payment.",
        "label": "Arrangement fees payment",
        "negatedLabel": "Payment of deferred financing costs"
       }
      }
     },
     "localname": "ArrangementFeesPayment",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_AsiaAndOtherPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia and other pacific.",
        "label": "Asia And Other Pacific [member]",
        "terseLabel": "Asia and Other Pacific"
       }
      }
     },
     "localname": "AsiaAndOtherPacificMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AstrexIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Astrex Inc.",
        "label": "Astrex Inc [member]",
        "terseLabel": "Astrex Inc"
       }
      }
     },
     "localname": "AstrexIncMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_AutomotiveExtrudedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Automotive extruded products.",
        "label": "Automotive extruded products [member]",
        "terseLabel": "Automotive extruded products"
       }
      }
     },
     "localname": "AutomotiveExtrudedProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AutomotiveRolledProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Automotive rolled products.",
        "label": "Automotive Rolled Products [member]",
        "terseLabel": "Automotive rolled products"
       }
      }
     },
     "localname": "AutomotiveRolledProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AutomotiveStructuresAndIndustryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Automotive structures and industry.",
        "label": "Automotive Structures And Industry [Member]",
        "terseLabel": "AS&I"
       }
      }
     },
     "localname": "AutomotiveStructuresAndIndustryMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_AverageClaimSettlementValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average claim settlement value.",
        "label": "Average Claim Settlement Value",
        "terseLabel": "Average settlement amount per disease claim (less than)"
       }
      }
     },
     "localname": "AverageClaimSettlementValue",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_AverageClaimsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average claims outstanding.",
        "label": "Average Claims Outstanding",
        "terseLabel": "Average amount per claim outstanding (less than)"
       }
      }
     },
     "localname": "AverageClaimsOutstanding",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingCapacityUnderRevolvingCreditFacility": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing capacity under revolving credit facility.",
        "label": "Borrowing Capacity Under Revolving Credit Facility",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "BorrowingCapacityUnderRevolvingCreditFacility",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingCostsCapitalizedCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing costs capitalised credit.",
        "label": "Borrowing Costs Capitalized Credit",
        "terseLabel": "Capitalized borrowing costs"
       }
      }
     },
     "localname": "BorrowingCostsCapitalizedCredit",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingCovenantPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Covenant Period",
        "label": "Borrowing Covenant Period [Axis]",
        "terseLabel": "Borrowing Covenant Period [Axis]"
       }
      }
     },
     "localname": "BorrowingCovenantPeriodAxis",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_BorrowingCovenantPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Covenant Period [Domain]",
        "label": "Borrowing Covenant Period [Domain]",
        "terseLabel": "Borrowing Covenant Period [Domain]"
       }
      }
     },
     "localname": "BorrowingCovenantPeriodDomain",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_BorrowingCovenantPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Covenant Period One",
        "label": "Borrowing Covenant Period One [Member]",
        "terseLabel": "Starting in April and July 2026"
       }
      }
     },
     "localname": "BorrowingCovenantPeriodOneMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_BorrowingCovenantPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Covenant Period Two",
        "label": "Borrowing Covenant Period Two [Member]",
        "terseLabel": "Starting in April and July 2027"
       }
      }
     },
     "localname": "BorrowingCovenantPeriodTwoMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_BorrowingFacilitiesAccordionFeatureHigherBorrowingCapacityOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Facilities, Accordion Feature, Higher Borrowing Capacity Option",
        "label": "Borrowing Facilities, Accordion Feature, Higher Borrowing Capacity Option",
        "terseLabel": "Accordion feature, higher borrowing capacity option"
       }
      }
     },
     "localname": "BorrowingFacilitiesAccordionFeatureHigherBorrowingCapacityOption",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingFacilitiesMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Facilities, Maximum Borrowing Capacity",
        "label": "Borrowing Facilities, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "BorrowingFacilitiesMaximumBorrowingCapacity",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available borrowings under credit facility.",
        "label": "Borrowing Facility",
        "terseLabel": "Borrowing base"
       }
      }
     },
     "localname": "BorrowingFacility",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingRedemptionFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Redemption Fees",
        "label": "Borrowing Redemption Fees",
        "terseLabel": "Borrowing redemption fees"
       }
      }
     },
     "localname": "BorrowingRedemptionFees",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_Borrowings1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings.",
        "label": "Borrowings 1 [member]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "Borrowings1Member",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_BorrowingsArrangementFeesStepUp": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings arrangement fees or (step up).",
        "label": "Borrowings Arrangement Fees Step Up",
        "negatedLabel": "Arrangement fees"
       }
      }
     },
     "localname": "BorrowingsArrangementFeesStepUp",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingsEffectOfChangesInForeignExchangeRates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effect of changes in foreign exchange rates on borrowings.",
        "label": "Borrowings, Effect Of Changes In Foreign Exchange Rates",
        "terseLabel": "Effects of changes in foreign exchange rates"
       }
      }
     },
     "localname": "BorrowingsEffectOfChangesInForeignExchangeRates",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_BorrowingsExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings Extension Period",
        "label": "Borrowings Extension Period",
        "terseLabel": "Extension period"
       }
      }
     },
     "localname": "BorrowingsExtensionPeriod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_BorrowingsIncreaseInNominalInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings Increase In Nominal Interest Rate",
        "label": "Borrowings Increase In Nominal Interest Rate",
        "terseLabel": "Increase in borrowing nominal rate"
       }
      }
     },
     "localname": "BorrowingsIncreaseInNominalInterestRate",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_BorrowingsNominalInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings nominal interest rate.",
        "label": "Borrowings Nominal Interest Rate",
        "terseLabel": "Nominal rate"
       }
      }
     },
     "localname": "BorrowingsNominalInterestRate",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_BorrowingsPercentageOfOutstandingBalanceGuaranteed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings Percentage Of Outstanding Balance Guaranteed",
        "label": "Borrowings Percentage Of Outstanding Balance Guaranteed",
        "terseLabel": "Percentage of borrowings guaranteed"
       }
      }
     },
     "localname": "BorrowingsPercentageOfOutstandingBalanceGuaranteed",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_COVID19PandemicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID 19 Pandemic",
        "label": "COVID 19 Pandemic [Member]",
        "terseLabel": "COVID-19"
       }
      }
     },
     "localname": "COVID19PandemicMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCEDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CarryingAmountOfAssetOrCashGeneratingUnit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying Amount Of Asset Or Cash-generating Unit",
        "label": "Carrying Amount Of Asset Or Cash-generating Unit",
        "terseLabel": "Carrying value"
       }
      }
     },
     "localname": "CarryingAmountOfAssetOrCashGeneratingUnit",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_CashInBankAndIntercompanyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash in Bank and intercompany loans.",
        "label": "Cash in Bank and intercompany loans [member]",
        "terseLabel": "Cash in Bank and intercompany loans"
       }
      }
     },
     "localname": "CashInBankAndIntercompanyLoansMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CashandCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashandCashEquivalentsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CertainEmployeesAndChiefFinancialOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Employees And Chief Financial Officer",
        "label": "Certain Employees And Chief Financial Officer [Member]",
        "terseLabel": "Certain Employees And Chief Financial Officer"
       }
      }
     },
     "localname": "CertainEmployeesAndChiefFinancialOfficerMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CollectiveBargainingAgreementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collective Bargaining Agreement, Period",
        "label": "Collective Bargaining Agreement, Period",
        "terseLabel": "Collective bargaining agreement, period"
       }
      }
     },
     "localname": "CollectiveBargainingAgreementPeriod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_CommercialTransactionExposureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial transaction exposure.",
        "label": "Commercial transaction exposure [member]",
        "terseLabel": "Net commercial transaction exposure"
       }
      }
     },
     "localname": "CommercialTransactionExposureMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumAutomotiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Automotive.",
        "label": "Constellium Automotive [member]",
        "terseLabel": "Constellium automotive"
       }
      }
     },
     "localname": "ConstelliumAutomotiveMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumAutomotiveMexicoSDERLDECVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Automotive Mexico, S. DE R.L. DE C.V.",
        "label": "Constellium Automotive Mexico, S. DE R.L. DE C.V. [member]",
        "terseLabel": "Constellium Automotive Mexico, S. DE R.L. DE C.V."
       }
      }
     },
     "localname": "ConstelliumAutomotiveMexicoSDERLDECVMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumAutomotiveMexicoTradingSDERLDECVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Automotive Mexico Trading, S. DE R.L. DE C.V.",
        "label": "Constellium Automotive Mexico Trading, S. DE R.L. DE C.V [member]",
        "terseLabel": "Constellium Automotive Mexico Trading, S. DE R.L. DE C.V."
       }
      }
     },
     "localname": "ConstelliumAutomotiveMexicoTradingSDERLDECVMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumAutomotiveNanjingCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Automotive Nanjing Co Ltd.",
        "label": "Constellium Automotive Nanjing Co Ltd [member]",
        "terseLabel": "Constellium Automotive (Nanjing) Co. Ltd."
       }
      }
     },
     "localname": "ConstelliumAutomotiveNanjingCoLtdMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumAutomotiveSpainSLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Automotive Spain SL.",
        "label": "Constellium Automotive Spain SL [member]",
        "terseLabel": "Constellium Automotive Spain SL"
       }
      }
     },
     "localname": "ConstelliumAutomotiveSpainSLMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumAutomotiveUSALLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Automotive USA LLC.",
        "label": "Constellium Automotive USA LLC [member]",
        "terseLabel": "Constellium Automotive USA, LLC"
       }
      }
     },
     "localname": "ConstelliumAutomotiveUSALLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumAutomotiveZilinaSroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Automotive Zilina S.r.o.",
        "label": "Constellium Automotive zilina sro [member]",
        "terseLabel": "Constellium Automotive Zilina S.r.o."
       }
      }
     },
     "localname": "ConstelliumAutomotiveZilinaSroMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumChinaCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium China Co. Ltd.",
        "label": "Constellium China Co. Ltd. [Member]",
        "terseLabel": "Constellium China Co. Ltd."
       }
      }
     },
     "localname": "ConstelliumChinaCoLtdMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumDeutschlandGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Deutschland GmbH.",
        "label": "Constellium Deutschland GmbH [member]",
        "terseLabel": "Constellium Deutschland GmbH"
       }
      }
     },
     "localname": "ConstelliumDeutschlandGmbHMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumEngleyChangchunAutomotiveStructuresCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Engley Changchun Automotive Structures Co Ltd.",
        "label": "Constellium Engley Changchun Automotive Structures Co Ltd [member]",
        "terseLabel": "Constellium Engley (Changchun) Automotive Structures Co Ltd."
       }
      }
     },
     "localname": "ConstelliumEngleyChangchunAutomotiveStructuresCoLtdMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumExtrusionsBurgGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Extrusions Burg GmbH.",
        "label": "Constellium Extrusions Burg GmbH [member]",
        "terseLabel": "Constellium Extrusions Burg GmbH"
       }
      }
     },
     "localname": "ConstelliumExtrusionsBurgGmbHMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumExtrusionsDecinSroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Extrusions Decin S.r.o.",
        "label": "Constellium Extrusions Decin Sro [member]",
        "terseLabel": "Constellium Extrusions Decin S.r.o."
       }
      }
     },
     "localname": "ConstelliumExtrusionsDecinSroMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumExtrusionsDeutschlandGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Extrusions Deutschland GmbH.",
        "label": "Constellium Extrusions Deutschland GmbH [member]",
        "terseLabel": "Constellium Extrusions Deutschland GmbH"
       }
      }
     },
     "localname": "ConstelliumExtrusionsDeutschlandGmbHMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumExtrusionsFranceSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Extrusions France S.A.S.",
        "label": "Constellium Extrusions France S.A.S. [member]",
        "terseLabel": "Constellium Extrusions France S.A.S."
       }
      }
     },
     "localname": "ConstelliumExtrusionsFranceSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumExtrusionsLandauGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Extrusions Landau GmbH.",
        "label": "Constellium Extrusions Landau GmbH [member]",
        "terseLabel": "Constellium Extrusions Landau GmbH"
       }
      }
     },
     "localname": "ConstelliumExtrusionsLandauGmbHMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumExtrusionsLeviceSroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Extrusions Levice S.r.o.",
        "label": "Constellium Extrusions Levice S.r.o [member]",
        "terseLabel": "Constellium Extrusions Levice S.r.o."
       }
      }
     },
     "localname": "ConstelliumExtrusionsLeviceSroMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumFinanceSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Finance S.A.S.",
        "label": "Constellium Finance S.A.S [member]",
        "terseLabel": "Constellium Finance S.A.S."
       }
      }
     },
     "localname": "ConstelliumFinanceSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumFranceHoldcoSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium France Holdco S.A.S.",
        "label": "Constellium France Holdco S.A.S. [member]",
        "terseLabel": "Constellium France Holdco S.A.S."
       }
      }
     },
     "localname": "ConstelliumFranceHoldcoSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumFranceIIISASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium France III S.A.S.",
        "label": "Constellium France III S.A.S. [Member]",
        "terseLabel": "Constellium France III S.A.S."
       }
      }
     },
     "localname": "ConstelliumFranceIIISASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumGermanyHoldcoGmbHAndCoKGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Germany Holdco GmbH And Co KG.",
        "label": "Constellium Germany Holdco GmbH And Co KG [member]",
        "terseLabel": "Constellium Germany Holdco GmbH\u00a0& Co. KG"
       }
      }
     },
     "localname": "ConstelliumGermanyHoldcoGmbHAndCoKGMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumGermanyVerwaltungsGmbhMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Germany Verwaltungs GmbH.",
        "label": "Constellium Germany Verwaltungs GmbH [member]",
        "terseLabel": "Constellium Germany Verwaltungs GmbH"
       }
      }
     },
     "localname": "ConstelliumGermanyVerwaltungsGmbhMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumHoldingMuscleShoalsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Holding Muscle Shoals LLC.",
        "label": "Constellium Holding Muscle Shoals LLC [member]",
        "terseLabel": "Constellium Holdings Muscle Shoals LLC"
       }
      }
     },
     "localname": "ConstelliumHoldingMuscleShoalsLLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumInternationalSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium International S.A.S.",
        "label": "Constellium International S.A.S. [Member]",
        "terseLabel": "Constellium International S.A.S."
       }
      }
     },
     "localname": "ConstelliumInternationalSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumIssoireSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Issoire S.A.S.",
        "label": "Constellium Issoire S.A.S. [member]",
        "terseLabel": "Constellium Issoire S.A.S."
       }
      }
     },
     "localname": "ConstelliumIssoireSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumJapanKKMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Japan KK.",
        "label": "Constellium Japan KK [member]",
        "terseLabel": "Constellium Japan KK"
       }
      }
     },
     "localname": "ConstelliumJapanKKMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumMetalProcurementLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Metal Procurement LLC.",
        "label": "Constellium Metal Procurement LLC [member]",
        "terseLabel": "Constellium Metal Procurement LLC"
       }
      }
     },
     "localname": "ConstelliumMetalProcurementLLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumMontreuilJuigneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Montreuil Juigne S.A.S.",
        "label": "Constellium Montreuil Juigne [member]",
        "terseLabel": "Constellium Montreuil Juign\u00e9 S.A.S."
       }
      }
     },
     "localname": "ConstelliumMontreuilJuigneMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumMuscleShoalsFundingIIILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Muscle Shoals Funding III LLC",
        "label": "Constellium Muscle Shoals Funding III LLC [Member]",
        "terseLabel": "Constellium Muscle Shoals Funding III LLC"
       }
      }
     },
     "localname": "ConstelliumMuscleShoalsFundingIIILLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumMuscleShoalsFundingTwoLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Muscle Shoals Funding II LLC.",
        "label": "Constellium Muscle Shoals Funding II LLC [member]",
        "terseLabel": "Constellium Muscle Shoals Funding II LLC"
       }
      }
     },
     "localname": "ConstelliumMuscleShoalsFundingTwoLLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumMuscleShoalsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Muscle Shoals LLC.",
        "label": "Constellium Muscle Shoals LLC [member]",
        "terseLabel": "Constellium Muscle Shoals LLC"
       }
      }
     },
     "localname": "ConstelliumMuscleShoalsLLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumNeufBrisachMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Neuf Brisach.",
        "label": "Constellium Neuf Brisach [member]",
        "terseLabel": "Constellium Neuf Brisach S.A.S."
       }
      }
     },
     "localname": "ConstelliumNeufBrisachMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumParisSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Paris S.A.S.",
        "label": "Constellium Paris S.A.S [member]",
        "terseLabel": "Constellium Paris S.A.S."
       }
      }
     },
     "localname": "ConstelliumParisSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumRolledProductsRavenswoodLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Rolled Products Ravenswood LLC.",
        "label": "Constellium Rolled Products Ravenswood LLC [member]",
        "terseLabel": "Constellium Rolled Products Ravenswood, LLC"
       }
      }
     },
     "localname": "ConstelliumRolledProductsRavenswoodLLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumRolledProductsSingenGmbHKGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Rolled Products Singen GmbH KG.",
        "label": "Constellium Rolled Products Singen GmbH KG [member]",
        "terseLabel": "Constellium Rolled Products Singen GmbH & Co. KG"
       }
      }
     },
     "localname": "ConstelliumRolledProductsSingenGmbHKGMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSEEURandUSDseniorunsecurednotesissuedNovembertwothousandseventeenDueTwoThousandTwentySixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE EUR and USD senior unsecured notes issued November two thousand seventeen Due Two Thousand Twenty Six",
        "label": "Constellium SE EUR and USD senior unsecured notes issued November two thousand seventeen Due Two Thousand Twenty Six [Member]",
        "terseLabel": "Constellium SE Senior Notes Due 2026"
       }
      }
     },
     "localname": "ConstelliumSEEURandUSDseniorunsecurednotesissuedNovembertwothousandseventeenDueTwoThousandTwentySixMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Notes",
        "label": "Constellium SE Senior Notes [Member]",
        "terseLabel": "Constellium SE Senior Notes"
       }
      }
     },
     "localname": "ConstelliumSESeniorNotesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Sustainability-Linked Notes issued February 2021 due February 2029",
        "label": "Constellium SE Senior Sustainability-Linked Notes issued February 2021 due February 2029 [Member]",
        "verboseLabel": "Senior Unsecured Notes Issued February 2021 and due 2029"
       }
      }
     },
     "localname": "ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Member",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorSustainabilityLinkedNotesIssuedJune2021DueJune2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Sustainability-Linked Notes Issued June 2021 Due June 2029",
        "label": "Constellium SE Senior Sustainability-Linked Notes Issued June 2021 Due June 2029 [Member]",
        "terseLabel": "Constellium SE Senior Sustainability-Linked Notes Issued June 2021 Due June 2029",
        "verboseLabel": "Senior Unsecured Notes Issued June 2021 and due 2029"
       }
      }
     },
     "localname": "ConstelliumSESeniorSustainabilityLinkedNotesIssuedJune2021DueJune2029Member",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Unsecured Notes Issued February Two Thousand Seventeen Due Two Thousand Twenty Five",
        "label": "Constellium SE Senior Unsecured Notes Issued February Two Thousand Seventeen Due Two Thousand Twenty Five [Member]",
        "terseLabel": "Senior Unsecured Notes Issued February 2017 and due 2025"
       }
      }
     },
     "localname": "ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Unsecured Notes Issued June Two Thousand Twenty Due Two Thousand Twenty Eight",
        "label": "Constellium SE Senior Unsecured Notes Issued June Two Thousand Twenty Due Two Thousand Twenty Eight [Member]",
        "terseLabel": "Senior Unsecured Notes Issued June 2020 and due 2028",
        "verboseLabel": "Constellium SE Senir Notes Due 2028"
       }
      }
     },
     "localname": "ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Unsecured Notes Issued May Two Thousand Fourteen Due Two Thousand Twenty Four",
        "label": "Constellium SE Senior Unsecured Notes Issued May Two Thousand Fourteen Due Two Thousand Twenty Four [Member]",
        "terseLabel": "Senior Unsecured Notes Issued May 2014 and due 2024",
        "verboseLabel": "Constellium SE Senior Notes Due 2024"
       }
      }
     },
     "localname": "ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Unsecured Notes Issued November Two Thousand Seventeen Due Two Thousand Twenty Six",
        "label": "Constellium SE Senior Unsecured Notes Issued November Two Thousand Seventeen Due Two Thousand Twenty Six [Member]",
        "terseLabel": "Senior Unsecured Notes Issued November 2017 and due 2026"
       }
      }
     },
     "localname": "ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium SE Senior Unsecured Notes Issued November Two Thousand Seventeen Due Two Thousand Twenty Six One",
        "label": "Constellium SE Senior Unsecured Notes Issued November Two Thousand Seventeen Due Two Thousand Twenty Six One [Member]",
        "terseLabel": "Senior Unsecured Note Issued November 2017 and due 2026"
       }
      }
     },
     "localname": "ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSingenGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Singen GmbH.",
        "label": "Constellium Singen GmbH [member]",
        "terseLabel": "Constellium Singen GmbH (AS&I and P&ARP)"
       }
      }
     },
     "localname": "ConstelliumSingenGmbHMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumSwitzerlandAGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Switzerland AG.",
        "label": "Constellium Switzerland AG [member]",
        "terseLabel": "Constellium Switzerland AG"
       }
      }
     },
     "localname": "ConstelliumSwitzerlandAGMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumTreuhandUGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Treuhand UG.",
        "label": "Constellium Treuhand UG [member]",
        "terseLabel": "Constellium Treuhand UG (haftunsgbeschr\u00e4nkt)"
       }
      }
     },
     "localname": "ConstelliumTreuhandUGMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumUACJABSLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium-Bowling Green.",
        "label": "Constellium UACJ ABS LLC [member]",
        "terseLabel": "Constellium Bowling Green LLC"
       }
      }
     },
     "localname": "ConstelliumUACJABSLLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumUKLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium UK Limited.",
        "label": "Constellium UK Limited [member]",
        "terseLabel": "Constellium UK Limited"
       }
      }
     },
     "localname": "ConstelliumUKLimitedMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumUSHoldingsILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium U.S. Holdings I, LLC.",
        "label": "Constellium U.S. Holdings I, LLC [member]",
        "terseLabel": "Constellium US Holdings I, LLC"
       }
      }
     },
     "localname": "ConstelliumUSHoldingsILLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumUSIntermediateHoldingsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium U.S. Intermediate Holdings, LLC",
        "label": "Constellium U.S. Intermediate Holdings, LLC [Member]",
        "terseLabel": "Constellium US Intermediate Holdings LLC"
       }
      }
     },
     "localname": "ConstelliumUSIntermediateHoldingsLLCMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumUsselSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Ussel S.A.S.",
        "label": "Constellium Ussel SAS [member]",
        "terseLabel": "Constellium Ussel S.A.S."
       }
      }
     },
     "localname": "ConstelliumUsselSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ConstelliumValaisSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constellium Valais S A.",
        "label": "Constellium Valais S A [member]",
        "terseLabel": "Constellium Valais S.A. (AS&I and A&T)"
       }
      }
     },
     "localname": "ConstelliumValaisSAMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CopperMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Copper.",
        "label": "Copper [member]",
        "terseLabel": "Copper"
       }
      }
     },
     "localname": "CopperMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CorporateBondsAmountContributedToFairValueOfPlanAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_PlanAssetsAtFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount that instruments representing government or corporate bonds constitute of the fair value of defined benefit plan assets.",
        "label": "Corporate Bonds, Amount Contributed to Fair Value of Plan Assets",
        "terseLabel": "Bonds"
       }
      }
     },
     "localname": "CorporateBondsAmountContributedToFairValueOfPlanAssets",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_CostOfSales1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of sales.",
        "label": "Cost of sales [member]",
        "terseLabel": "Included in Cost of sales",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSales1Member",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CountryNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Country Name [axis]",
        "label": "Country Name [axis]",
        "terseLabel": "Country Name [axis]"
       }
      }
     },
     "localname": "CountryNameAxis",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_CountryNameMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Country Name [member]",
        "label": "Country Name [member]",
        "terseLabel": "Country Name [member]"
       }
      }
     },
     "localname": "CountryNameMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CreditExposureThresholdAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit exposure threshold amount.",
        "label": "Credit exposure threshold amount",
        "terseLabel": "Credit exposure threshold amount"
       }
      }
     },
     "localname": "CreditExposureThresholdAmount",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_CrossOperatingSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross operating segment.",
        "label": "Cross Operating Segment [member]",
        "terseLabel": "Cross Operating Segment"
       }
      }
     },
     "localname": "CrossOperatingSegmentMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CtecConstelliumTechnologyCenterSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C-TEC Constellium Technology Center S.A.S.",
        "label": "C-TEC Constellium Technology Center S.A.S. [member]",
        "terseLabel": "C-TEC Constellium Technology Center S.A.S."
       }
      }
     },
     "localname": "CtecConstelliumTechnologyCenterSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CurrencyCommercialContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency Commercial Contracts [member]",
        "label": "Currency Commercial Contracts [member]",
        "terseLabel": "Currency commercial derivatives"
       }
      }
     },
     "localname": "CurrencyCommercialContractsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CurrencyNetDebtDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency Net Debt Derivatives [member]",
        "label": "Currency Net Debt Derivatives [member]",
        "terseLabel": "Currency net debt derivatives"
       }
      }
     },
     "localname": "CurrencyNetDebtDerivativesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_CustomerRelationships1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationships.",
        "label": "Customer Relationships 1 [member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationships1Member",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DecreaseThroughClassifiedAsHeldForSaleNonCurrentAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease Through Classified As Held For Sale, Non-Current Assets",
        "label": "Decrease Through Classified As Held For Sale, Non-Current Assets",
        "negatedTerseLabel": "Reclassification as assets of disposal group classified as held for sale"
       }
      }
     },
     "localname": "DecreaseThroughClassifiedAsHeldForSaleNonCurrentAssets",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_DecreaseThroughClassifiedHeldForSaleLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease Through Classified Held For Sale, Liabilities",
        "label": "Decrease Through Classified Held For Sale, Liabilities",
        "negatedTerseLabel": "Reclassification as liabilities of disposal group classified as held for sale"
       }
      }
     },
     "localname": "DecreaseThroughClassifiedHeldForSaleLiabilities",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_DeductibleTemporaryDifferencesAndUnusedTaxLossesForWhichNoDeferredTaxAssetIsRecognised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductible Temporary Differences And Unused Tax Losses For Which No Deferred Tax Asset Is Recognised",
        "label": "Deductible Temporary Differences And Unused Tax Losses For Which No Deferred Tax Asset Is Recognised",
        "verboseLabel": "Deductible temporary differences and unused tax losses for which no deferred tax asset recognized"
       }
      }
     },
     "localname": "DeductibleTemporaryDifferencesAndUnusedTaxLossesForWhichNoDeferredTaxAssetIsRecognised",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_DeferredArrangementFeesStepUpAmortizationAndOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred arrangement fees, step-up amortization and other.",
        "label": "Deferred Arrangement Fees Step-Up Amortization And Other",
        "terseLabel": "Deferred arrangement fees"
       }
      }
     },
     "localname": "DeferredArrangementFeesStepUpAmortizationAndOther",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_DeferredRevenueRelatedToContractLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue related to contract liabilities.",
        "label": "Deferred revenue related to contract liabilities",
        "terseLabel": "Deferred revenue related to contract liabilities"
       }
      }
     },
     "localname": "DeferredRevenueRelatedToContractLiabilities",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_DeferredToolingRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tooling revenue.",
        "label": "Deferred Tooling Revenue [member]",
        "terseLabel": "Deferred tooling revenue"
       }
      }
     },
     "localname": "DeferredToolingRevenueMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DefinedBenefitObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_LiabilityAssetOfDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit obligation.",
        "label": "Defined Benefit Obligation",
        "terseLabel": "Defined benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitObligation",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_DerecognizedFactoredAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derecognized factored assets.",
        "label": "Derecognized Factored Assets",
        "terseLabel": "Factored assets derecognized"
       }
      }
     },
     "localname": "DerecognizedFactoredAssets",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_DerivativeClassifiedAsCashFlowHedgeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative classified as Cash flow Hedge.",
        "label": "Derivative classified as Cash flow Hedge [member]",
        "terseLabel": "Derivative classified as cash flow hedge"
       }
      }
     },
     "localname": "DerivativeClassifiedAsCashFlowHedgeMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DerivativeInstrumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument.",
        "label": "Derivative Instrument [axis]",
        "terseLabel": "Derivative Instrument [axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentAxis",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DerivativeInstrumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of derivative instrument.",
        "label": "Derivative Instrument [domain]",
        "terseLabel": "Derivative Instrument [domain]"
       }
      }
     },
     "localname": "DerivativeInstrumentDomain",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DerivativeValuationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative valuation.",
        "label": "Derivative Valuation [member]",
        "terseLabel": "Derivative valuation"
       }
      }
     },
     "localname": "DerivativeValuationMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DerivativesOnCommercialTransactionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivatives on commercial transaction.",
        "label": "Derivatives on commercial transaction [member]",
        "terseLabel": "Derivatives on commercial transactions"
       }
      }
     },
     "localname": "DerivativesOnCommercialTransactionMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DerivativesOnFinancingTransactionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivatives on financing transaction.",
        "label": "Derivatives on financing transaction [member]",
        "terseLabel": "Derivatives on financing transactions"
       }
      }
     },
     "localname": "DerivativesOnFinancingTransactionMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for basis of consolidation.",
        "label": "Description of accounting policy for basis of consolidation [Policy Text Block]",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationPolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DescriptionOfAccountingPolicyForBasisOfPreparationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for basis of preparation.",
        "label": "Description of accounting policy for Basis of preparation [Policy Text Block]",
        "terseLabel": "Basis of preparation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBasisOfPreparationPolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DescriptionOfAccountingPolicyForCashGeneratingUnitsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for cash generating units.",
        "label": "Description Of Accounting Policy For Cash Generating Units [Policy Text Block]",
        "terseLabel": "Cash-generating units"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForCashGeneratingUnitsPolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DescriptionOfAccountingPolicyForNewAccountingStandardsAndInterpretationsNotYetMandatoryOrEarlyAdoptedPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for new Accounting Standards and Interpretations not yet mandatory or early adopted.",
        "label": "Description of accounting policy for new Accounting Standards and Interpretations not yet mandatory or early adopted [Policy Text Block]",
        "terseLabel": "New and amended standards and interpretations"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForNewAccountingStandardsAndInterpretationsNotYetMandatoryOrEarlyAdoptedPolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DescriptionOfAccountingPolicyForOtherGainsLossesNetPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for other gains losses net.",
        "label": "Description of accounting policy for other gains losses net [Policy Text Block]",
        "terseLabel": "Other gains and losses - net"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForOtherGainsLossesNetPolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DescriptionOfAccountingPolicyForPresentationOfFinancialStatementsExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for presentation of financial statements.",
        "label": "Description Of Accounting Policy For Presentation Of Financial Statements Explanatory [Policy Text Block]",
        "terseLabel": "Presentation of financial statements"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPresentationOfFinancialStatementsExplanatoryPolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DescriptionOfAccountingPolicyForUseOfJudgementsAndEstimatesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for use of judgements and estimates.",
        "label": "Description of accounting policy for use of judgements and estimates [Policy Text Block]",
        "terseLabel": "Judgments in applying accounting policies and key sources of estimation uncertainty"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForUseOfJudgementsAndEstimatesPolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DescriptionOfConsolidationMethod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of consolidation method.",
        "label": "Description of Consolidation Method",
        "terseLabel": "Consolidation Method"
       }
      }
     },
     "localname": "DescriptionOfConsolidationMethod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfCapitalExpendituresCommitmentsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of capital expenditures commitments explanatory.",
        "label": "Disclosure Of Capital Expenditures Commitments Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Tangible and Intangible Assets Commitments"
       }
      }
     },
     "localname": "DisclosureOfCapitalExpendituresCommitmentsExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfCapitalExpendituresCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Capital Expenditures Commitments [line items]",
        "label": "Disclosure Of Capital Expenditures Commitments [line items]",
        "terseLabel": "Disclosure of capital expenditures commitments [line items]"
       }
      }
     },
     "localname": "DisclosureOfCapitalExpendituresCommitmentsLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTangibleandIntangibleAssetCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfCapitalExpendituresCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to commitments.",
        "label": "Disclosure Of Capital Expenditures Commitments [table]",
        "terseLabel": "Disclosure Of Capital Expenditures Commitments [table]"
       }
      }
     },
     "localname": "DisclosureOfCapitalExpendituresCommitmentsTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTangibleandIntangibleAssetCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfCashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of cash and cash equivalents.",
        "label": "Disclosure of cash and cash equivalents [line items]",
        "terseLabel": "Disclosure of cash and cash equivalents [line Items]"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of cash and cash equivalents [table]",
        "label": "Disclosure Of Cash And Cash Equivalents [table]",
        "terseLabel": "Disclosure of cash and cash equivalents [table]"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfChangesInFinancialPositionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of changes in financial position [line items]",
        "label": "Disclosure of changes in financial position [line items]",
        "terseLabel": "Disclosure of changes in financial position [line items]"
       }
      }
     },
     "localname": "DisclosureOfChangesInFinancialPositionLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfChangesInFinancialPositionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of changes in financial position [table]",
        "label": "Disclosure of changes in financial position [table]",
        "terseLabel": "Disclosure of changes in financial position [table]"
       }
      }
     },
     "localname": "DisclosureOfChangesInFinancialPositionTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfContractLiabilitiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of contract liabilities.",
        "label": "Disclosure of contract liabilities [Table Text Block]",
        "terseLabel": "Schedule of Contract Liabilities and Other Liabilities to Customers"
       }
      }
     },
     "localname": "DisclosureOfContractLiabilitiesExplanatory",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of currency gains and losses explanatory.",
        "label": "Disclosure of Currency Gains and (Losses) Explanatory [Text Block]",
        "terseLabel": "CURRENCY GAINS / (LOSSES)"
       }
      }
     },
     "localname": "DisclosureOfCurrencyGainsAndLossesExplanatoryTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Currency Gains and Losses Included in Income / (Loss) From Operations Explanatory",
        "label": "Disclosure of Currency Gains and Losses Included in Income / (Loss) From Operations Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Currency Gains and Losses Included in Income from Operations"
       }
      }
     },
     "localname": "DisclosureOfCurrencyGainsAndLossesIncludedInIncomeLossFromOperationsExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfCurrencyTranslationReserveTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of currency translation reserve.",
        "label": "Disclosure Of Currency Translation Reserve [Table Text Block]",
        "terseLabel": "Schedule of Foreign Currency Translation Reserve"
       }
      }
     },
     "localname": "DisclosureOfCurrencyTranslationReserveTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDeferredIncomeTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of deferred income tax assets and liabilities.",
        "label": "Disclosure Of Deferred Income Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule or Net Deferred Income Tax Assets"
       }
      }
     },
     "localname": "DisclosureOfDeferredIncomeTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDefinedBenefitPlansRecognizedInConsolidatedStatementsOfFinancialPositionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of defined benefit plans recognized in Consolidated Statements of Financial Position.",
        "label": "Disclosure of defined benefit plans recognized in Consolidated Statements of Financial Position [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in the Consolidated Statement of Financial Position"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansRecognizedInConsolidatedStatementsOfFinancialPositionTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDepreciationExpenseAndImpairmentLossesRelatingToPropertyPlantAndEquipmentAndIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of depreciation expense and impairment losses relating to property plant and equipment and intangible assets.",
        "label": "Disclosure of Depreciation Expense and Impairment Losses Relating to Property Plant and Equipment and Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Depreciation Expense and Impairment Losses Relating to Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisclosureOfDepreciationExpenseAndImpairmentLossesRelatingToPropertyPlantAndEquipmentAndIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDetailedInformationAboutCarryingAmountsAndMarketValuesOfBorrowingsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about carrying amounts and market values of borrowings explanatory.",
        "label": "Disclosure of detailed information about carrying amounts and market values of borrowings explanatory [Table Text Block]",
        "terseLabel": "Schedule of Currency Concentration of Total Borrowings"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutCarryingAmountsAndMarketValuesOfBorrowingsExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDetailedInformationAboutExpensesByNatureToTheirFunctionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about expenses by nature.",
        "label": "Disclosure Of Detailed Information About Expenses By Nature To Their Function [Table Text Block]",
        "terseLabel": "Schedule of Total Operating Expenses by Nature"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutExpensesByNatureToTheirFunctionTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATURETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about trade and other receivables.",
        "label": "Disclosure of detailed information about trade and other receivables [Table Text Block]",
        "terseLabel": "Schedule of Trade Receivables and Other"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDetailedInformationOtherGainsAndLossesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information other gains and losses.",
        "label": "Disclosure of detailed information other gains and losses [Table Text Block]",
        "terseLabel": "Schedule of Other Gains and Losses\u2014Net"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationOtherGainsAndLossesTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfDisaggregationOfContractLiabilitiesWithCustomersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items representing disaggregation of contract liabilities with customers.",
        "label": "disclosure of disaggregation of contract liabilities with customers [line items]",
        "terseLabel": "Disclosure of disaggregation of contract liabilities with customers [line items]"
       }
      }
     },
     "localname": "DisclosureOfDisaggregationOfContractLiabilitiesWithCustomersLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfEstimatedFutureBenefitPaymentsOfDefinedBenefitObligationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of estimated future benefit payments of defined benefit obligations.",
        "label": "Disclosure Of Estimated Future Benefit Payments Of Defined Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Benefit Payments Expected to be Paid Either by Pension Funds or Directly to Beneficiaries"
       }
      }
     },
     "localname": "DisclosureOfEstimatedFutureBenefitPaymentsOfDefinedBenefitObligationsTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfFinancialDerivativeInstrumentAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of financial derivative instrument assets and liabilities.",
        "label": "Disclosure Of Financial Derivative Instrument Assets And Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Financial Assets and Other Financial Liabilities Positions"
       }
      }
     },
     "localname": "DisclosureOfFinancialDerivativeInstrumentAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfFinancialInstrumentsMeasuredAtFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of financial instruments measured at fair value.",
        "label": "Disclosure of financial instruments measured at fair value [line items]",
        "terseLabel": "Disclosure of financial instruments measured at fair value [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsMeasuredAtFairValueLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfFinancialInstrumentsMeasuredAtFairValueTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of financial instruments measured at fair value [table]",
        "label": "Disclosure of financial instruments measured at fair value [table]",
        "terseLabel": "Disclosure of financial instruments measured at fair value [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsMeasuredAtFairValueTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfForeignExchangeRatesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of foreign exchange rates.",
        "label": "Disclosure of foreign exchange rates [line items]",
        "terseLabel": "Disclosure of foreign exchange rates [line items]"
       }
      }
     },
     "localname": "DisclosureOfForeignExchangeRatesLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfForeignExchangeRatesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Foreign Exchange Rates [table]",
        "label": "Disclosure Of Foreign Exchange Rates [table]",
        "terseLabel": "Disclosure Of Foreign Exchange Rates [table]"
       }
      }
     },
     "localname": "DisclosureOfForeignExchangeRatesTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfForeignExchangeSensitivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of foreign exchange sensitivity",
        "label": "Disclosure of foreign exchange sensitivity [Table Text Block]",
        "terseLabel": "Schedule of Impact on Profit and Equity (before tax effect) of a 10% strengthening of the US Dollar versus the Euro"
       }
      }
     },
     "localname": "DisclosureOfForeignExchangeSensitivityTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfGeneralInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of general information.",
        "label": "Disclosure of general information [abstract]",
        "terseLabel": "Disclosure of general information [abstract]"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfGeographicalDistributionOfDefinedBenefitObligationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of geographical distribution of defined benefit obligations.",
        "label": "Disclosure of geographical distribution of defined benefit obligations [Table Text Block]",
        "terseLabel": "Schedule of Net Defined Benefit Obligations by Country"
       }
      }
     },
     "localname": "DisclosureOfGeographicalDistributionOfDefinedBenefitObligationsTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfIncomeTaxExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of income tax expense.",
        "label": "Disclosure Of Income Tax Expense [line items]",
        "terseLabel": "Disclosure of income tax expense [line Items]"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExpenseLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfIncomeTaxExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of income tax expense table.",
        "label": "Disclosure Of Income Tax Expense [table]",
        "terseLabel": "Disclosure of income tax expense [table]"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExpenseTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfInformationAboutInventoriesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventories explanatory.",
        "label": "Disclosure Of Information About Inventories Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutInventoriesExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfInputOfModelUsedForPerformancebasedRSULineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of input of model used for performance-based RSU.",
        "label": "Disclosure Of Input Of Model Used For Performance-Based RSU [line items]",
        "terseLabel": "Disclosure of Input of Model Used for Performance-Based RSU [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfInputOfModelUsedForPerformancebasedRSULineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfInputOfModelUsedForPerformancebasedRSUTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Input Of Model Used For Performance-Based RSU [table]",
        "label": "Disclosure Of Input Of Model Used For Performance-Based RSU [table]",
        "terseLabel": "Disclosure Of Input Of Model Used For Performance-Based RSU [table]"
       }
      }
     },
     "localname": "DisclosureOfInputOfModelUsedForPerformancebasedRSUTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfLiquidityRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of liquidity risk.",
        "label": "Disclosure Of Liquidity Risk [line items]",
        "terseLabel": "Disclosure of liquidity risk [line items]"
       }
      }
     },
     "localname": "DisclosureOfLiquidityRiskLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfMinimumOperatingLeasePaymentsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of minimum operating lease payments explanatory.",
        "label": "Disclosure Of Minimum Operating Lease Payments Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Non-cancellable Lease Commitments Not Capitalized"
       }
      }
     },
     "localname": "DisclosureOfMinimumOperatingLeasePaymentsExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfMovementOfPotentialSharesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of movement of potential shares.",
        "label": "Disclosure of Movement of Potential Shares [line items]",
        "terseLabel": "Disclosure of movement of potential shares [line items]"
       }
      }
     },
     "localname": "DisclosureOfMovementOfPotentialSharesLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfMovementOfPotentialSharesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Movement Of Potential Shares [table]",
        "label": "Disclosure Of Movement Of Potential Shares [table]",
        "terseLabel": "Disclosure Of Movement Of Potential Shares [table]"
       }
      }
     },
     "localname": "DisclosureOfMovementOfPotentialSharesTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfNoncancellableOperatingLeasesCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Non-cancellable Operating Leases Commitments [line items]",
        "label": "Disclosure Of Non-cancellable Operating Leases Commitments [line items]",
        "terseLabel": "Disclosure of non-cancellable operating leases commitments [line items]"
       }
      }
     },
     "localname": "DisclosureOfNoncancellableOperatingLeasesCommitmentsLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfNoncancellableOperatingLeasesCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Non-cancellable Operating Leases Commitments [table]",
        "label": "Disclosure Of Non-cancellable Operating Leases Commitments [table]",
        "terseLabel": "Disclosure Of Non-cancellable Operating Leases Commitments [table]"
       }
      }
     },
     "localname": "DisclosureOfNoncancellableOperatingLeasesCommitmentsTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfNumberOfOtherEquityInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of number of other equity instruments.",
        "label": "Disclosure of number of other equity instruments [Table Text Block]",
        "terseLabel": "Schedule of Number and Movement of Potential Shares"
       }
      }
     },
     "localname": "DisclosureOfNumberOfOtherEquityInstrumentsTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfOtherGainsNetTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of information about other gains.",
        "label": "Disclosure of other gains net [Text Block]",
        "terseLabel": "OTHER GAINS AND LOSSES\u2014NET"
       }
      }
     },
     "localname": "DisclosureOfOtherGainsNetTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfPropertyPlantAndEquipmentReportedBasedOnPhysicalLocationOfAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of property plant and equipment reported based on physical location of assets.",
        "label": "Disclosure of Property Plant And Equipment Reported Based On Physical Location Of Assets [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment Reported Based on Physical Location of Assets"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentReportedBasedOnPhysicalLocationOfAssetsTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfProvisionsByTypeExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of provisions by type.",
        "label": "Disclosure of provisions by type explanatory [Table Text Block]",
        "terseLabel": "Schedule of Changes in Provisions"
       }
      }
     },
     "localname": "DisclosureOfProvisionsByTypeExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfReconciliationOfSegmentProfitBeforeTaxAndProfitLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reconciliation of segment profit before tax and profit loss.",
        "label": "Disclosure of reconciliation of segment profit before tax and profit loss [Table Text Block]",
        "terseLabel": "Schedule of Segment Adjusted EBITDA and reconciliation of Adjusted EBITDA to Net Income"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfSegmentProfitBeforeTaxAndProfitLossTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfRestatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Restatement [abstract]",
        "label": "Disclosure Of Restatement [abstract]",
        "terseLabel": "Disclosure Of Restatement [abstract]"
       }
      }
     },
     "localname": "DisclosureOfRestatementAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfSegmentAdjustedEbitdaAndReconciliationOfAdjustedEbitdaToNetIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income.",
        "label": "Disclosure Of Segment Adjusted EBITDA And Reconciliation Of Adjusted EBITDA To Net Income [line items]",
        "terseLabel": "Disclosure of segment adjusted EBITDA and reconciliation of adjusted EBITDA to net income [line items]"
       }
      }
     },
     "localname": "DisclosureOfSegmentAdjustedEbitdaAndReconciliationOfAdjustedEbitdaToNetIncomeLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfSegmentAdjustedEbitdaAndReconciliationOfAdjustedEbitdaToNetIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Segment Adjusted EBITDA And Reconciliation Of Adjusted EBITDA To Net Income [table]",
        "label": "Disclosure Of Segment Adjusted EBITDA And Reconciliation Of Adjusted EBITDA To Net Income [table]",
        "terseLabel": "Disclosure Of Segment Adjusted EBITDA And Reconciliation Of Adjusted EBITDA To Net Income [table]"
       }
      }
     },
     "localname": "DisclosureOfSegmentAdjustedEbitdaAndReconciliationOfAdjustedEbitdaToNetIncomeTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfSegmentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of segment assets.",
        "label": "Disclosure Of Segment Assets [Table Text Block]",
        "terseLabel": "Schedule of Segment Assets"
       }
      }
     },
     "localname": "DisclosureOfSegmentAssetsTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfSegmentCapitalExpendituresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of segment capital expenditures.",
        "label": "Disclosure Of Segment Capital Expenditures [Table Text Block]",
        "terseLabel": "Schedule of Segment Capital Expenditures"
       }
      }
     },
     "localname": "DisclosureOfSegmentCapitalExpendituresTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of significant components of deferred tax assets and liabilities.",
        "label": "Disclosure of significant components of deferred tax assets and liabilities [Table Text Block]",
        "terseLabel": "Schedule of Significant Changes in Net Deferred Income Tax Assets / (Liabilities)"
       }
      }
     },
     "localname": "DisclosureOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfStatementOfCompliancePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of statement of compliance.",
        "label": "Disclosure of statement of compliance [Policy Text Block]",
        "terseLabel": "Statement of compliance"
       }
      }
     },
     "localname": "DisclosureOfStatementOfCompliancePolicyTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of summary of significant accounting policies [abstract]",
        "label": "Disclosure of summary of significant accounting policies [abstract]",
        "terseLabel": "Disclosure of summary of significant accounting policies [abstract]"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfTradeAndOtherReceivablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of trade and other receivables.",
        "label": "Disclosure of trade and other receivables [line items]",
        "terseLabel": "Disclosure of trade and other receivables [line items]"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfTradeAndOtherReceivablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of trade and other receivables.",
        "label": "Disclosure of Trade and Other Receivables [table]",
        "terseLabel": "Disclosure of trade and other receivables [table]"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureOfTradePayablesAndOtherExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of trade payables and other.",
        "label": "Disclosure of Trade Payables and Other Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Trade Payables and Other"
       }
      }
     },
     "localname": "DisclosureOfTradePayablesAndOtherExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfTradeReceivablesNetDenominatedInMajorCurrenciesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Trade Receivables Net Denominated in Major Currencies",
        "label": "Disclosure of Trade Receivables Net Denominated in Major Currencies [Table Text Block]",
        "terseLabel": "Schedule of Currency Concentration of Total Trade Receivables"
       }
      }
     },
     "localname": "DisclosureOfTradeReceivablesNetDenominatedInMajorCurrenciesTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfUndiscountedContractualValuesOfByRelevantMaturityGroupingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of undiscounted contractual values of by relevant maturity groupings.",
        "label": "Disclosure of undiscounted contractual values of by relevant maturity groupings [Table Text Block]",
        "terseLabel": "Schedule of Undiscounted Contractual Financial Assets and Financial Liabilities Values by Relevant Maturity Groupings"
       }
      }
     },
     "localname": "DisclosureOfUndiscountedContractualValuesOfByRelevantMaturityGroupingsTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureOfUnusedTaxLossesForWhichNoDeferredTaxAssetRecognisedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of unused tax losses for which no deferred tax assets recognised.",
        "label": "Disclosure of Unused Tax Losses For Which No Deferred Tax Asset Recognised [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Deferred Tax Assets"
       }
      }
     },
     "localname": "DisclosureOfUnusedTaxLossesForWhichNoDeferredTaxAssetRecognisedTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_DisclosureofcashflowstatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of cash flow statement",
        "label": "Disclosure of cash flow statement [Abstract]",
        "terseLabel": "Disclosure of cash flow statement [Abstract]"
       }
      }
     },
     "localname": "DisclosureofcashflowstatementAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureofemployeebenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of employee benefits",
        "label": "Disclosure of employee benefits [Abstract]",
        "terseLabel": "Disclosure of employee benefits [Abstract]"
       }
      }
     },
     "localname": "DisclosureofemployeebenefitsAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureoffinancialriskmanagementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of financial risk management",
        "label": "Disclosure of financial risk management [Abstract]",
        "terseLabel": "Disclosure of financial risk management [Abstract]"
       }
      }
     },
     "localname": "DisclosureoffinancialriskmanagementAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosureofsharecapitalreservesandotherequityinterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of share capital, reserves and other equity interest",
        "label": "Disclosure of share capital, reserves and other equity interest [Abstract]",
        "terseLabel": "Disclosure of share capital, reserves and other equity interest [Abstract]"
       }
      }
     },
     "localname": "DisclosureofsharecapitalreservesandotherequityinterestAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DisclosuresofcommitmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures of commitments",
        "label": "Disclosures of commitments [Abstract]",
        "terseLabel": "Disclosures of commitments [Abstract]"
       }
      }
     },
     "localname": "DisclosuresofcommitmentsAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_DiseaseClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disease claims.",
        "label": "Disease claims [member]",
        "terseLabel": "Disease claims"
       }
      }
     },
     "localname": "DiseaseClaimsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_DueToFactorRelatedToTradeAccountReceivablesSold": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due to Factor Related To Trade Account Receivables Sold",
        "label": "Due to Factor Related To Trade Account Receivables Sold",
        "terseLabel": "Debt due factor"
       }
      }
     },
     "localname": "DueToFactorRelatedToTradeAccountReceivablesSold",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_EURCZKForwardDerivativesSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EUR/CZK Forward derivatives sales",
        "label": "EUR/CZK Forward derivatives sales [Member]",
        "terseLabel": "Sold currencies CZK"
       }
      }
     },
     "localname": "EURCZKForwardDerivativesSalesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees.",
        "label": "Employees [member]",
        "terseLabel": "Employees"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_EnergyFutureContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Energy Future Contract",
        "label": "Energy Future Contract [Member]",
        "terseLabel": "Energy derivatives"
       }
      }
     },
     "localname": "EnergyFutureContractMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_EngineeredProductsInternationalSASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engineered Products International S.A.S.",
        "label": "Engineered Products International S A S [member]",
        "terseLabel": "Engineered Products International S.A.S."
       }
      }
     },
     "localname": "EngineeredProductsInternationalSASMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_EquityAwardsPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity awards plans.",
        "label": "Equity Awards Plan [member]",
        "terseLabel": "Equity Award Plans"
       }
      }
     },
     "localname": "EquityAwardsPlanMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_EstimatedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated future benefit payments Five Fiscal Years Thereafter",
        "label": "Estimated future benefit payments Five Fiscal Years Thereafter",
        "terseLabel": "2028 to 2032"
       }
      }
     },
     "localname": "EstimatedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSBenefitPaymentsExpectedtobePaidEitherbyPensionFundsorDirectlytoBeneficiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_EstimatedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated future benefit payments next twelve months",
        "label": "Estimated future benefit payments next twelve months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "EstimatedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSBenefitPaymentsExpectedtobePaidEitherbyPensionFundsorDirectlytoBeneficiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_EstimatedFutureBenefitPaymentsYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated future benefit payments Year Five",
        "label": "Estimated future benefit payments Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "EstimatedFutureBenefitPaymentsYearFive",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSBenefitPaymentsExpectedtobePaidEitherbyPensionFundsorDirectlytoBeneficiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_EstimatedFutureBenefitPaymentsYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated future benefit payments Year Four",
        "label": "Estimated future benefit payments Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "EstimatedFutureBenefitPaymentsYearFour",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSBenefitPaymentsExpectedtobePaidEitherbyPensionFundsorDirectlytoBeneficiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_EstimatedFutureBenefitPaymentsYearThree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated future benefit payments Year Three",
        "label": "Estimated future benefit payments Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "EstimatedFutureBenefitPaymentsYearThree",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSBenefitPaymentsExpectedtobePaidEitherbyPensionFundsorDirectlytoBeneficiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_EstimatedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated future benefit payments Year Two",
        "label": "Estimated future benefit payments Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "EstimatedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSBenefitPaymentsExpectedtobePaidEitherbyPensionFundsorDirectlytoBeneficiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_EurChfForwardDerivativesPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EUR/CHF Forward derivatives purchases.",
        "label": "EUR/CHF Forward derivatives purchases [member]",
        "terseLabel": "Purchased currencies CHF"
       }
      }
     },
     "localname": "EurChfForwardDerivativesPurchasesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_EurChfForwardDerivativesSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EUR/CHF Forward derivatives sales.",
        "label": "EUR/CHF Forward derivatives sales [member]",
        "terseLabel": "Sold currencies CHF"
       }
      }
     },
     "localname": "EurChfForwardDerivativesSalesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ExchangesGainsLossesFromReMeasurementOfMonetaryAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchanges gains / (losses) from remeasurement of monetary assets and liabilities - net.",
        "label": "Exchanges Gains / (Losses) From Re-Measurement Of Monetary Assets And Liabilities - Net",
        "terseLabel": "Exchange gains / (losses) from the remeasurement of monetary assets and liabilities - net"
       }
      }
     },
     "localname": "ExchangesGainsLossesFromReMeasurementOfMonetaryAssetsAndLiabilitiesNet",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected dividend as percentage, other equity instruments granted.",
        "label": "Expected dividend as percentage, other equity instruments granted",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ExpectedDividendAsPercentageOtherEquityInstrumentsGranted",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_ExpectedVolatilityOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected volatility, other equity instruments granted.",
        "label": "Expected volatility, other equity instruments granted",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ExpectedVolatilityOtherEquityInstrumentsGranted",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_ExpenseRelatingToShortTermLeasesLeasesOfLowValueAssetsAndVariableLeasePaymentsForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense Relating To Short-Term Leases, Leases Of Low-Value Assets And Variable Lease Payments For Which Recognition Exemption Has Been Used",
        "label": "Expense Relating To Short-Term Leases, Leases Of Low-Value Assets And Variable Lease Payments For Which Recognition Exemption Has Been Used",
        "terseLabel": "Expense related to short-term leases, low value asset leases and variable lease still recognized as operating expenses"
       }
      }
     },
     "localname": "ExpenseRelatingToShortTermLeasesLeasesOfLowValueAssetsAndVariableLeasePaymentsForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ExpensesOnFactoringArrangementsPaidOrPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses on factoring arrangements paid or payable.",
        "label": "Expenses on Factoring Arrangements Paid or Payable",
        "negatedLabel": "Expenses on factoring arrangements"
       }
      }
     },
     "localname": "ExpensesOnFactoringArrangementsPaidOrPayable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_FactoredAssetsDerecognizedAndRecognizedInConsolidatedStatementOfFinancialPosition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Factored assets derecognized and recognized in consolidated statement of financial position.",
        "label": "Factored Assets Derecognized and Recognized In Consolidated Statement Of Financial Position",
        "terseLabel": "Total factored assets"
       }
      }
     },
     "localname": "FactoredAssetsDerecognizedAndRecognizedInConsolidatedStatementOfFinancialPosition",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_FactoringMaximumCapacity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum capacity according the factoring agreement.",
        "label": "Factoring Maximum Capacity",
        "terseLabel": "Factoring maximum capacity"
       }
      }
     },
     "localname": "FactoringMaximumCapacity",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_FactoringReceivableRecourseLineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Factoring Receivable, Recourse Line",
        "label": "Factoring Receivable, Recourse Line [Member]",
        "terseLabel": "Factoring Receivable, Recourse Line"
       }
      }
     },
     "localname": "FactoringReceivableRecourseLineMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_FairValueAtMeasurementDateOtherEquityInstrumentsGrantedPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at measurement date other equity instruments granted per share.",
        "label": "Fair Value At Measurement Date Other Equity Instruments Granted Per Share",
        "terseLabel": "Fair value at grant date (in euros) (in EUR per share)"
       }
      }
     },
     "localname": "FairValueAtMeasurementDateOtherEquityInstrumentsGrantedPerShare",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cstm_FairValueOfPerformanceStockUnitsAndRestrictedStockUnitsVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of performance stock units and restricted stock units vested.",
        "label": "Fair value of performance stock units and restricted stock units vested",
        "terseLabel": "Fair value of vested PSUs and RSUs"
       }
      }
     },
     "localname": "FairValueOfPerformanceStockUnitsAndRestrictedStockUnitsVested",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/NONCASHINVESTINGANDFINANCINGTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_FiftyBasisPointIncreaseOrDecreaseInTheLiborOrEuriborInterestRatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "50 basis point increase or decrease in the LIBOR or EURIBOR interest rates.",
        "label": "Fifty basis point increase or decrease in the LIBOR or EURIBOR interest rates [member]",
        "terseLabel": "50 basis point increase or decrease in the LIBOR or EURIBOR interest rates"
       }
      }
     },
     "localname": "FiftyBasisPointIncreaseOrDecreaseInTheLiborOrEuriborInterestRatesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_FinanceLeasesAndOtherLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Leases And Other Loans",
        "label": "Finance Leases And Other Loans",
        "terseLabel": "Changes in leases and other loans"
       }
      }
     },
     "localname": "FinanceLeasesAndOtherLoans",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Liabilities At Fair Value Through Other Comprehensive Income Category",
        "label": "Financial Liabilities At Fair Value Through Other Comprehensive Income Category [Member]",
        "terseLabel": "At fair value through OCI"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_FinancialLiabilitiesDesignatedAsNotMeasuredAtFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial liabilities designated as not measured at fair value.",
        "label": "Financial liabilities designated as not measured at fair value [abstract]",
        "terseLabel": "Financial liabilities designated as not measured at fair value [abstract]"
       }
      }
     },
     "localname": "FinancialLiabilitiesDesignatedAsNotMeasuredAtFairValueAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_FinancingArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Arrangements",
        "label": "Financing Arrangements [Member]",
        "terseLabel": "Financing Arrangements"
       }
      }
     },
     "localname": "FinancingArrangementsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_FinancingTransactionExposureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Transaction Exposure",
        "label": "Financing Transaction Exposure [Member]",
        "terseLabel": "Net financing transaction exposure"
       }
      }
     },
     "localname": "FinancingTransactionExposureMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ForeignExchangeForwardContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward contracts.",
        "label": "Foreign Exchange Forward Contracts [member]",
        "terseLabel": "Foreign exchange forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardContractsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ForeignExchangeSensitivityEffectOnPretaxEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange sensitivity effect on pretax equity.",
        "label": "Foreign exchange sensitivity effect on pretax equity",
        "terseLabel": "Effect on pretax equity"
       }
      }
     },
     "localname": "ForeignExchangeSensitivityEffectOnPretaxEquity",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ForeignExchangeSensitivityEffectOnProfitBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange sensitivity effect on profit before tax.",
        "label": "Foreign exchange sensitivity effect on profit before tax",
        "terseLabel": "Effect on income before tax"
       }
      }
     },
     "localname": "ForeignExchangeSensitivityEffectOnProfitBeforeTax",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ForeignExchangeSensitivityOnCommercialAndFinancingTransactionsExposuresEffectOnPretaxEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange sensitivity on commercial and financing transactions exposures effect on pretax equity.",
        "label": "Foreign exchange sensitivity on commercial and financing transactions exposures effect on pretax equity",
        "terseLabel": "Effect on pretax equity"
       }
      }
     },
     "localname": "ForeignExchangeSensitivityOnCommercialAndFinancingTransactionsExposuresEffectOnPretaxEquity",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ForeignExchangeSensitivityOnCommercialAndFinancingTransactionsExposuresEffectOnProfitBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange sensitivity on commercial and financing transactions exposures effect on profit before tax.",
        "label": "Foreign exchange sensitivity on commercial and financing transactions exposures effect on profit before tax",
        "terseLabel": "Effect on income before tax"
       }
      }
     },
     "localname": "ForeignExchangeSensitivityOnCommercialAndFinancingTransactionsExposuresEffectOnProfitBeforeTax",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ForwardDerivativesPurchasesEurCzkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EUR/CZK Forward derivatives purchases.",
        "label": "Forward derivatives purchases - EUR\\CZK [member]",
        "terseLabel": "Purchased currencies EUR"
       }
      }
     },
     "localname": "ForwardDerivativesPurchasesEurCzkMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ForwardPurchaseContractsVersusEuroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward purchase contracts versus EURO.",
        "label": "Forward purchase contracts versus EURO [member]",
        "terseLabel": "Forward purchase contracts versus EURO"
       }
      }
     },
     "localname": "ForwardPurchaseContractsVersusEuroMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_FrenchGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "French Government",
        "label": "French Government [Member]",
        "terseLabel": "French Government"
       }
      }
     },
     "localname": "FrenchGovernmentMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_FrenchPGEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "French PGE",
        "label": "French PGE [Member]",
        "terseLabel": "Secured French PGE French Facility (due 2022)",
        "verboseLabel": "French Inventory Based Facility"
       }
      }
     },
     "localname": "FrenchPGEMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_FullNominalAmountOfHedgingInstrument": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total nominal amount of hedging instrument.",
        "label": "Full Nominal Amount Of Hedging Instrument",
        "terseLabel": "Nominal amount hedging instrument"
       }
      }
     },
     "localname": "FullNominalAmountOfHedgingInstrument",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_GainsLossesOnPensionPlanAmendments": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains (losses) on pension plan amendments.",
        "label": "Gains (losses) on pension plan amendments",
        "terseLabel": "(Losses) / gains on pension plan amendments",
        "verboseLabel": "Gains on pension plan amendments"
       }
      }
     },
     "localname": "GainsLossesOnPensionPlanAmendments",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_GainsLossesRecognisedInProfitOrLossAttributableToChangeInFairValueDerivatives": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains (Losses) Recognised In Profit Or Loss Attributable To Change In Fair Value Derivatives",
        "label": "Gains (Losses) Recognised In Profit Or Loss Attributable To Change In Fair Value Derivatives",
        "verboseLabel": "Realized and unrealized (losses) / gains on debt derivatives at fair value"
       }
      }
     },
     "localname": "GainsLossesRecognisedInProfitOrLossAttributableToChangeInFairValueDerivatives",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_GainsLossesRecognizedOnReclassificationAdjustmentsOnCashFlowHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "(Gains) Losses recognized on reclassification adjustments on cash flow hedges.",
        "label": "(Gains) Losses recognized on reclassification adjustments on cash flow hedges",
        "terseLabel": "Gains reclassified from cash flow hedge reserve to the Consolidated Income Statement"
       }
      }
     },
     "localname": "GainsLossesRecognizedOnReclassificationAdjustmentsOnCashFlowHedges",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_GermanySwitzerlandAndCzechRepublicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Germany Switzerland And Czech Republic.",
        "label": "Germany Switzerland And Czech Republic [member]",
        "terseLabel": "Germany, Switzerland and Czech Republic"
       }
      }
     },
     "localname": "GermanySwitzerlandAndCzechRepublicMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_GovernmentAssistanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance",
        "label": "Government Assistance [Line Items]",
        "terseLabel": "Government Assistance [Line Items]"
       }
      }
     },
     "localname": "GovernmentAssistanceLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_GovernmentAssistanceTableTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance Table [Table]",
        "label": "Government Assistance Table [Table]",
        "terseLabel": "Government Assistance Table [Table]"
       }
      }
     },
     "localname": "GovernmentAssistanceTableTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_GovernmentGrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance",
        "label": "Government Grants [Abstract]"
       }
      }
     },
     "localname": "GovernmentGrantsAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_GuarantorAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor",
        "label": "Guarantor [Axis]",
        "terseLabel": "Guarantor [Axis]"
       }
      }
     },
     "localname": "GuarantorAxis",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_GuarantorDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor",
        "label": "Guarantor [Domain]",
        "terseLabel": "Guarantor [Domain]"
       }
      }
     },
     "localname": "GuarantorDomain",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_HoldingsAndCorporateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holdings and corporate.",
        "label": "Holdings And Corporate [Member]",
        "terseLabel": "H&C",
        "verboseLabel": "Holdings\u00a0& Corporate"
       }
      }
     },
     "localname": "HoldingsAndCorporateMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_HourlyPensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hourly pension.",
        "label": "Hourly Pension [member]",
        "terseLabel": "Hourly pension"
       }
      }
     },
     "localname": "HourlyPensionMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ImmediateRecognitionActuarialGainsLossesArisingFromChangeInAssumptionRecognizedInProfitLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immediate recognition actuarial gains (losses) arising from change in assumption recognized in profit (loss).",
        "label": "Immediate recognition Actuarial Gains Losses Arising From Change in Assumption Recognized In Profit Loss",
        "terseLabel": "Immediate recognition of gains arising over the year"
       }
      }
     },
     "localname": "ImmediateRecognitionActuarialGainsLossesArisingFromChangeInAssumptionRecognizedInProfitLoss",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ImpactOfIncreaseOrDecreaseInInterestRateInIncomeLossBeforeIncomeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of increase or decrease in interest rate in income loss before income tax.",
        "label": "Impact of increase or decrease in interest rate in income/loss before income tax",
        "terseLabel": "Impact of increase or decrease in interest rate in income before income tax"
       }
      }
     },
     "localname": "ImpactOfIncreaseOrDecreaseInInterestRateInIncomeLossBeforeIncomeTax",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ImpactOfIncreaseOrDecreaseInMarketPriceInGainOrLossFromDerivatives": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of increase or decrease in market price in gain or loss from derivatives.",
        "label": "Impact of increase or decrease in market price in gain or loss from derivatives",
        "terseLabel": "Impact of increase or decrease in market price in gain or loss from derivatives"
       }
      }
     },
     "localname": "ImpactOfIncreaseOrDecreaseInMarketPriceInGainOrLossFromDerivatives",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ImpairmentLossRecognisedInProfitOrLossGoodwillCashFlowProjectionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Loss Recognised In Profit Or Loss, Goodwill, Cash Flow Projection Period",
        "label": "Impairment Loss Recognised In Profit Or Loss, Goodwill, Cash Flow Projection Period",
        "terseLabel": "Cash flow projection period used in impairment of goodwill"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwillCashFlowProjectionPeriod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_ImpairmentLossRecognizedInProfitAndLossPropertyPlantAndEquipmentAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 12.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Loss Recognized In Profit And Loss , Property, Plant And Equipment And Intangible Assets",
        "label": "Impairment Loss Recognized In Profit And Loss , Property, Plant And Equipment And Intangible Assets",
        "negatedLabel": "Impairment of assets",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "ImpairmentLossRecognizedInProfitAndLossPropertyPlantAndEquipmentAndIntangibleAssets",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_IncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Abstract]",
        "label": "Income Taxes [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxesAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_IncreaseDecreaseInTradeWorkingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in trade working capital.",
        "label": "Increase Decrease In Trade Working Capital [abstract]",
        "terseLabel": "Change in working capital"
       }
      }
     },
     "localname": "IncreaseDecreaseInTradeWorkingCapitalAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_IncreaseDecreaseThroughClassifiedAsHeldForSaleDeferredTaxLiabilityAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Through Classified As Held For Sale, Deferred Tax Liability (Asset)",
        "label": "Increase (Decrease) Through Classified As Held For Sale, Deferred Tax Liability (Asset)",
        "terseLabel": "Reclassified as held for sale"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughClassifiedAsHeldForSaleDeferredTaxLiabilityAsset",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_IncreaseDecreaseThroughTransfersProvisions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease through transfers provisions.",
        "label": "Increase decrease through transfers provisions",
        "terseLabel": "Transfer"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersProvisions",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_InstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments With Potential Future Dilutive Effect Not Included In Calculation Of Diluted Earnings Per Share",
        "label": "Instruments With Potential Future Dilutive Effect Not Included In Calculation Of Diluted Earnings Per Share",
        "terseLabel": "Antidilutive securities (in shares)"
       }
      }
     },
     "localname": "InstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShare",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cstm_IntangibleAssetsAmortizedEstimatedUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets amortized estimated useful life.",
        "label": "Intangible Assets Amortized Estimated Useful Life",
        "terseLabel": "Intangible assets amortized estimated useful life"
       }
      }
     },
     "localname": "IntangibleAssetsAmortizedEstimatedUsefulLife",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_InterestAccruedOnLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Accrued On Lease Liabilities",
        "label": "Interest Accrued On Lease Liabilities",
        "terseLabel": "Accrued interest lease liabilities"
       }
      }
     },
     "localname": "InterestAccruedOnLeaseLiabilities",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_InterestCostOnPensionAndEmployeeBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest cost on pension and employee benefits.",
        "label": "Interest cost on pension and employee benefits",
        "negatedLabel": "Interest cost on pension and other benefits"
       }
      }
     },
     "localname": "InterestCostOnPensionAndEmployeeBenefits",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_InterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interests.",
        "label": "Interests [member]",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_InventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories.",
        "label": "Inventory [member]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_InventoryWriteDownAllowance": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/INVENTORIESDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_InventoriesAtNetRealisableValue",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Write-Down, Allowance",
        "label": "Inventory Write-Down, Allowance",
        "negatedTerseLabel": "Inventories write down"
       }
      }
     },
     "localname": "InventoryWriteDownAllowance",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_KeyManagementPersonnelCompensationEmployerSocialContribution": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key management personnel compensation employer social contribution.",
        "label": "Key Management Personnel Compensation Employer Social Contribution",
        "terseLabel": "Employer social contribution"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationEmployerSocialContribution",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_LandAndPropertyRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land and property rights.",
        "label": "Land and Property Rights [member]",
        "terseLabel": "Land and Property Rights"
       }
      }
     },
     "localname": "LandAndPropertyRightsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_LatencyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latency period.",
        "label": "Latency Period",
        "terseLabel": "Latency period for acquiring diseases"
       }
      }
     },
     "localname": "LatencyPeriod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_LaterThanFiveYearsAndLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Later than five years and limited.",
        "label": "Later than five years and limited [member]",
        "terseLabel": "Expiring after 5 years and limited"
       }
      }
     },
     "localname": "LaterThanFiveYearsAndLimitedMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_LongTermAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term assets.",
        "label": "Long Term Assets [member]",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "LongTermAssetsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_MachineryAndEquipment1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Machinery and equipment.",
        "label": "Machinery And Equipment1 [member]",
        "terseLabel": "Machinery and Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipment1Member",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_MarginRequirementPaidAsCollateralToCounterparty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Margin Requirement Paid As Collateral To Counterparty",
        "label": "Margin Requirement Paid As Collateral To Counterparty",
        "terseLabel": "Margin requirement paid as collateral to counterparties"
       }
      }
     },
     "localname": "MarginRequirementPaidAsCollateralToCounterparty",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_MinimumLeasePaymentsPayableUnderNonCancellableOperatingLease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Lease Payments Payable Under Non-Cancellable Operating Lease",
        "label": "Minimum Lease Payments Payable Under Non-Cancellable Operating Lease",
        "verboseLabel": "Total non-cancellable minimum lease payments"
       }
      }
     },
     "localname": "MinimumLeasePaymentsPayableUnderNonCancellableOperatingLease",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_MiscellaneousOtherGainsLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Miscellaneous other gains (losses)",
        "label": "Miscellaneous other gains (losses)",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "MiscellaneousOtherGainsLosses",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_MoneyMarketFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money Market Facility",
        "label": "Money Market Facility [Member]",
        "terseLabel": "Money Market Facility"
       }
      }
     },
     "localname": "MoneyMarketFacilityMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_MontreuilJuignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Montreuil Juign\u00e9",
        "label": "Montreuil Juign\u00e9 [Member]",
        "terseLabel": "Montreuil Juign\u00e9"
       }
      }
     },
     "localname": "MontreuilJuignMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_MovementInAccruedInterestAndInterestCostCapitalised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Movement in accrued interest and interest cost capitalized.",
        "label": "Movement in Accrued Interest and Interest Cost Capitalised",
        "terseLabel": "Movement in accrued interest"
       }
      }
     },
     "localname": "MovementInAccruedInterestAndInterestCostCapitalised",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_MovementInForeignCurrencyTranslationReserveAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Movement in foreign currency translation reserve.",
        "label": "Movement in foreign currency translation reserve [abstract]",
        "terseLabel": "Movement in foreign currency translation reserve [abstract]"
       }
      }
     },
     "localname": "MovementInForeignCurrencyTranslationReserveAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESForeignCurrencyTranslationReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_MovementsInBorrowingsFinancingActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Movements In Borrowings, Financing Activity",
        "label": "Movements In Borrowings, Financing Activity [Abstract]",
        "terseLabel": "Cash flows"
       }
      }
     },
     "localname": "MovementsInBorrowingsFinancingActivityAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_MovementsInBorrowingsNoncashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Movements In Borrowings, Noncash",
        "label": "Movements In Borrowings, Noncash [Abstract]",
        "terseLabel": "Non-cash changes"
       }
      }
     },
     "localname": "MovementsInBorrowingsNoncashAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_MuscleShoalsFactoringFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Muscle Shoals factoring facility.",
        "label": "Muscle Shoals Factoring Facility [member]",
        "terseLabel": "Muscle Shoals factoring facility"
       }
      }
     },
     "localname": "MuscleShoalsFactoringFacilityMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_NanjingPlantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nanjing Plant",
        "label": "Nanjing Plant [Member]",
        "terseLabel": "Nanjing Plant"
       }
      }
     },
     "localname": "NanjingPlantMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_NaturalGasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natural gas.",
        "label": "Natural Gas [member]",
        "terseLabel": "Natural gas"
       }
      }
     },
     "localname": "NaturalGasMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net cash flows from derivative assets related to currencies and commodities.",
        "label": "Net cash flows from derivative assets related to currencies and commodities [member]",
        "terseLabel": "Net cash flows from derivative assets related to currencies and commodities"
       }
      }
     },
     "localname": "NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net cash flows from derivatives liabilities related to currencies and commodities [member]",
        "label": "Net cash flows from derivatives liabilities related to currencies and commodities [member]",
        "terseLabel": "Net cash flows from derivative liabilities related to currencies and commodities"
       }
      }
     },
     "localname": "NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_NetPositionHedgesRelatedToLoansAndDeposits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net position hedges related to loans and deposits.",
        "label": "Net position hedges related to loans and deposits",
        "terseLabel": "Net position hedges related to loans and deposits"
       }
      }
     },
     "localname": "NetPositionHedgesRelatedToLoansAndDeposits",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_NonCurrentAssetsHeldForSaleAndDiscontinuedOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Current Assets Held For Sale And Discontinued Operations [Abstract]",
        "label": "Non-Current Assets Held For Sale And Discontinued Operations [Abstract]"
       }
      }
     },
     "localname": "NonCurrentAssetsHeldForSaleAndDiscontinuedOperationsAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_NoncurrentPayablesToEmployees": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "cstm_OtherNoncurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent payables to employees.",
        "label": "Noncurrent payables to employees",
        "terseLabel": "Employees' entitlements"
       }
      }
     },
     "localname": "NoncurrentPayablesToEmployees",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_NoncurrentPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 4.0,
       "parentTag": "cstm_OtherReceivablesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current prepaid expenses",
        "label": "Non-current prepaid expenses",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "NoncurrentPrepaidExpenses",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_NonqualifyingHedgesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-qualifying hedges.",
        "label": "Non-qualifying hedges [member]",
        "terseLabel": "Derivatives that do not qualify for hedge accounting"
       }
      }
     },
     "localname": "NonqualifyingHedgesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_NumberOfAdministrativeAndCommercialSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of administrative and commercial sites.",
        "label": "Number Of Administrative And Commercial Sites",
        "terseLabel": "Number of administrative centers"
       }
      }
     },
     "localname": "NumberOfAdministrativeAndCommercialSites",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/GENERALINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_NumberOfCasesOutstandingForDiseaseClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of cases outstanding for disease claims.",
        "label": "Number of cases outstanding for disease claims",
        "terseLabel": "Number of cases outstanding for disease claims"
       }
      }
     },
     "localname": "NumberOfCasesOutstandingForDiseaseClaims",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "cstm_NumberOfCountriesInWhichEntityOperates1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Countries In Which Entity Operates1",
        "label": "Number Of Countries In Which Entity Operates1",
        "terseLabel": "Number of countries in which entity operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates1",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_NumberOfFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of facilities.",
        "label": "Number Of Facilities",
        "terseLabel": "Number of facilities"
       }
      }
     },
     "localname": "NumberOfFacilities",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_NumberOfFinancialCounterparties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of financial counterparties.",
        "label": "Number of financial counterparties",
        "terseLabel": "Number of financial counterparties"
       }
      }
     },
     "localname": "NumberOfFinancialCounterparties",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_NumberOfImpairedCashGeneratingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Impaired Cash-generating Units",
        "label": "Number Of Impaired Cash-generating Units",
        "terseLabel": "Number of cash generating units impaired"
       }
      }
     },
     "localname": "NumberOfImpairedCashGeneratingUnits",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "cstm_NumberOfInstrumentsOtherEquityInstrumentsOverPerformance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of instruments other equity instruments over performance.",
        "label": "Number Of Instruments Other Equity Instruments Over Performance",
        "terseLabel": "Potential Shares, Over-performance (in shares)"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsOverPerformance",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "cstm_NumberOfInstrumentsOtherEquityInstrumentsVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of instruments other equity instruments vested.",
        "label": "Number of instruments other equity instruments vested",
        "negatedLabel": "Potential Shares, Vested (in shares)"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsVested",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cstm_NumberOfOtherEquityInstrumentsForfeitedOnDepartureOfCertainBeneficiariesInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of other equity instruments forfeited on departure of certain beneficiaries in share based payment arrangement.",
        "label": "Number Of Other Equity Instruments Forfeited On Departure Of Certain Beneficiaries In Sharebased Payment Arrangement",
        "terseLabel": "Performance based shares forfeited upon departure of certain beneficiaries (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsForfeitedOnDepartureOfCertainBeneficiariesInSharebasedPaymentArrangement",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cstm_NumberOfOtherEquityInstrumentsForfeitedOnNonFulfillmentOfPerformanceConditionsInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of other equity instruments forfeited on non fulfillment of performance conditions in share based payment arrangement.",
        "label": "Number Of Other Equity Instruments Forfeited On Non Fulfillment Of Performance Conditions In Sharebased Payment Arrangement",
        "terseLabel": "Performance based shares forfeited upon non-fulfillment of performance conditions (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsForfeitedOnNonFulfillmentOfPerformanceConditionsInSharebasedPaymentArrangement",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cstm_NumberOfProductionFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of production facilities.",
        "label": "Number Of Production Facilities",
        "terseLabel": "Number of production facilities"
       }
      }
     },
     "localname": "NumberOfProductionFacilities",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/GENERALINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_NumberOfSustainabilityPerformanceTargets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Sustainability Performance Targets",
        "label": "Number Of Sustainability Performance Targets",
        "terseLabel": "Number of sustainability performance targets"
       }
      }
     },
     "localname": "NumberOfSustainabilityPerformanceTargets",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_NumberOfVotingRightsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Voting Rights Per Share",
        "label": "Number Of Voting Rights Per Share",
        "terseLabel": "Number of vote rights per share"
       }
      }
     },
     "localname": "NumberOfVotingRightsPerShare",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_NumberOfWorldClassTechnologyCenter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of world class technology center.",
        "label": "Number Of World Class Technology Center",
        "terseLabel": "Number of R&D centers"
       }
      }
     },
     "localname": "NumberOfWorldClassTechnologyCenter",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/GENERALINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cstm_OfferingOfSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering Of Senior Notes",
        "label": "Offering Of Senior Notes [Member]",
        "terseLabel": "Offering of Senior Notes"
       }
      }
     },
     "localname": "OfferingOfSeniorNotesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OneLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Largest Customer",
        "label": "One Largest Customer [Member]",
        "terseLabel": "Group's largest customer"
       }
      }
     },
     "localname": "OneLargestCustomerMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 11.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other adjustments.",
        "label": "Other Adjustments",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherAdjustments",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_OtherBenefitPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other benefits.",
        "label": "Other Benefit Plans [member]",
        "terseLabel": "Other Benefits"
       }
      }
     },
     "localname": "OtherBenefitPlansMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherCommodityDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Commodity Derivatives",
        "label": "Other Commodity Derivatives [Member]",
        "terseLabel": "Other commodity derivatives"
       }
      }
     },
     "localname": "OtherCommodityDerivativesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherContractLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other contract liabilities.",
        "label": "Other contract liabilities [member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherContractLiabilitiesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other countries.",
        "label": "Other Countries [member]",
        "terseLabel": "All Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherCurrenciesForwardDerivativesPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other currencies forward derivatives purchases.",
        "label": "Other currencies forward derivatives purchases [member]",
        "terseLabel": "Purchased currencies - Other currencies"
       }
      }
     },
     "localname": "OtherCurrenciesForwardDerivativesPurchasesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherCurrenciesForwardDerivativesSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other currencies forward derivatives sales.",
        "label": "Other currencies forward derivatives sales [member]",
        "terseLabel": "Sold currencies - Other currencies"
       }
      }
     },
     "localname": "OtherCurrenciesForwardDerivativesSalesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherCurrenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other currencies.",
        "label": "Other Currencies [member]",
        "terseLabel": "Other currencies"
       }
      }
     },
     "localname": "OtherCurrenciesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherCurrentAssetsReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets Receivables",
        "label": "Other Current Assets Receivables",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCurrentAssetsReceivables",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_OtherCurrentPayablesOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other current payables other.",
        "label": "Other current payables Other",
        "totalLabel": "Total other"
       }
      }
     },
     "localname": "OtherCurrentPayablesOther",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_OtherDeferredTaxAssetsAndLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other.",
        "label": "Other deferred tax assets and liabilities [member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDeferredTaxAssetsAndLiabilitiesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherEmployeeBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other benefits.",
        "label": "Other employee benefits [member]",
        "terseLabel": "Other benefits"
       }
      }
     },
     "localname": "OtherEmployeeBenefitsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Europe.",
        "label": "Other Europe [member]",
        "terseLabel": "Other Europe"
       }
      }
     },
     "localname": "OtherEuropeMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherExtrudedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other extruded products.",
        "label": "Other extruded products [member]",
        "terseLabel": "Other extruded products"
       }
      }
     },
     "localname": "OtherExtrudedProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Financial Assets",
        "label": "Other Financial Assets [Member]",
        "terseLabel": "Other financial assets"
       }
      }
     },
     "localname": "OtherFinancialAssetsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherFinancialLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Financial Liabilities",
        "label": "Other Financial Liabilities [Member]",
        "terseLabel": "Other financial liabilities"
       }
      }
     },
     "localname": "OtherFinancialLiabilitiesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherGainsAndLossesNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Gains and Losses Net [member]",
        "label": "Other Gains and Losses Net [member]",
        "terseLabel": "Included in Other gains and losses - net"
       }
      }
     },
     "localname": "OtherGainsAndLossesNetMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other loans.",
        "label": "Other loans [member]",
        "terseLabel": "Other loans"
       }
      }
     },
     "localname": "OtherLoansMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherNoncurrentAssetsReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 5.0,
       "parentTag": "cstm_OtherReceivablesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other noncurrent assets receivables.",
        "label": "Other Noncurrent Assets Receivables",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsReceivables",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_OtherNoncurrentPayablesOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other non-current payables, other.",
        "label": "Other non-current payables, other",
        "totalLabel": "Total other"
       }
      }
     },
     "localname": "OtherNoncurrentPayablesOther",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_OtherPostEmploymentBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other benefits.",
        "label": "Other post employment benefit [member]",
        "terseLabel": "OPEB"
       }
      }
     },
     "localname": "OtherPostEmploymentBenefitMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherPostRetirementBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other benefits.",
        "label": "Other Post Retirement Benefits[member]",
        "terseLabel": "Other benefits"
       }
      }
     },
     "localname": "OtherPostRetirementBenefitsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_OtherReceivablesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other receivables noncurrent.",
        "label": "Other receivables noncurrent",
        "totalLabel": "Total other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNoncurrent",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_PackagingAndAutomotiveRolledProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packaging and automotive rolled products.",
        "label": "Packaging And Automotive Rolled Products [Member]",
        "terseLabel": "P&ARP"
       }
      }
     },
     "localname": "PackagingAndAutomotiveRolledProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PackagingRolledProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packaging rolled products.",
        "label": "Packaging Rolled Products [member]",
        "terseLabel": "Packaging rolled products"
       }
      }
     },
     "localname": "PackagingRolledProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PastDueOneToThirtyDaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Past due 1-30 days.",
        "label": "Past Due One to Thirty Days [member]",
        "terseLabel": "1 \u2013 30 days past due"
       }
      }
     },
     "localname": "PastDueOneToThirtyDaysMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PaymentsOfDeferredFinancingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Of Deferred Financing Costs",
        "label": "Payments Of Deferred Financing Costs",
        "negatedLabel": "Payment of financing costs and redemption fees"
       }
      }
     },
     "localname": "PaymentsOfDeferredFinancingCosts",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_PensionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pensions.",
        "label": "Pensions [member]",
        "terseLabel": "Pensions"
       }
      }
     },
     "localname": "PensionsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PercentageDecreaseInCashFlowsInDeterminingAmountByWhichUnitsRecoverableAmountExceedsItsCarryingValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Decrease In Cash Flows In Determining Amount By Which Units Recoverable Amount Exceeds Its Carrying Value",
        "label": "Percentage Decrease In Cash Flows In Determining Amount By Which Units Recoverable Amount Exceeds Its Carrying Value",
        "terseLabel": "Cash flow rates"
       }
      }
     },
     "localname": "PercentageDecreaseInCashFlowsInDeterminingAmountByWhichUnitsRecoverableAmountExceedsItsCarryingValue",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_PercentageOfFairValueSeniorNotesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fair value senior notes issued.",
        "label": "Percentage of fair value senior notes issued",
        "terseLabel": "Percentage of fair value senior notes issued"
       }
      }
     },
     "localname": "PercentageOfFairValueSeniorNotesIssued",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_PercentageOfRevolvingLoanCommitments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of excess availability vs. aggregate revolving commitment that require an evaluation of compliance.",
        "label": "Percentage Of Revolving Loan Commitments",
        "terseLabel": "Debt covenant, percentage of aggregate revolving loan commitments"
       }
      }
     },
     "localname": "PercentageOfRevolvingLoanCommitments",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_PercentageOfSharebasedPaymentsVestingMultiplier": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of sharebased payments vesting multiplier.",
        "label": "Percentage of sharebased payments vesting multiplier",
        "terseLabel": "Percentage of vesting multiplier"
       }
      }
     },
     "localname": "PercentageOfSharebasedPaymentsVestingMultiplier",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_PercentageOfTradeAccountReceivablesInsured": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of trade account receivables insured.",
        "label": "Percentage of trade account receivables insured",
        "terseLabel": "Percentage of trade account receivables insured"
       }
      }
     },
     "localname": "PercentageOfTradeAccountReceivablesInsured",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_PerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance based restricted stock units.",
        "label": "Performance Based Restricted Stock Units [member]",
        "terseLabel": "Performance-Based RSU"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance share units (PSUs) .",
        "label": "Performance share units (PSUs) [member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "PerformanceShareUnitsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PlanAssetCategoriesNotQuotedInAnActiveMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan Asset Categories Not Quoted In An Active Market",
        "label": "Plan Asset Categories Not Quoted In An Active Market [Member]",
        "terseLabel": "Not quoted in an active market"
       }
      }
     },
     "localname": "PlanAssetCategoriesNotQuotedInAnActiveMarketMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PlanAssetCategoriesQuotedInAnActiveMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan asset categories quoted in an active market.",
        "label": "Plan asset categories quoted in an active market [member]",
        "terseLabel": "Quoted in an active market"
       }
      }
     },
     "localname": "PlanAssetCategoriesQuotedInAnActiveMarketMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PostSixtyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post sixty five.",
        "label": "Post Sixty Five [member]",
        "terseLabel": "Post 65"
       }
      }
     },
     "localname": "PostSixtyFiveMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PotentialAdditionalSharesToBeVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential additional shares to be vested.",
        "label": "potential Additional Shares To Be Vested",
        "terseLabel": "Potential additional shares to be vested (in shares)"
       }
      }
     },
     "localname": "PotentialAdditionalSharesToBeVested",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cstm_PreSixtyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre sixty five.",
        "label": "Pre Sixty Five [member]",
        "terseLabel": "Pre 65"
       }
      }
     },
     "localname": "PreSixtyFiveMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums.",
        "label": "Premiums [member]",
        "terseLabel": "Premium"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PresentValueOfFundedObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present Value Of Funded Obligation",
        "label": "Present Value Of Funded Obligation",
        "terseLabel": "Present value of funded obligation"
       }
      }
     },
     "localname": "PresentValueOfFundedObligation",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_PresentValueOfUnfundedObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of unfunded obligation.",
        "label": "Present value of unfunded obligation",
        "terseLabel": "Present value of unfunded obligation"
       }
      }
     },
     "localname": "PresentValueOfUnfundedObligation",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ProceedsFromRepaymentsOfLinesOfCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From (Repayments Of) Lines Of Credit",
        "label": "Proceeds From (Repayments Of) Lines Of Credit",
        "terseLabel": "Net change in revolving credit facilities and short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfLinesOfCredit",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ProcurementPenaltiesAndTerminationFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Procurement Penalties And Termination Fees",
        "label": "Procurement Penalties And Termination Fees",
        "terseLabel": "Procurement penalties and termination fees"
       }
      }
     },
     "localname": "ProcurementPenaltiesAndTerminationFees",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ProfitAndLossStatementLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Profit And Loss Statement Location",
        "label": "Profit And Loss Statement Location [Axis]",
        "terseLabel": "Profit and Loss Statement Location [axis]"
       }
      }
     },
     "localname": "ProfitAndLossStatementLocationAxis",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_ProfitAndLossStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Profit And Loss Statement Location",
        "label": "Profit And Loss Statement Location [Domain]",
        "terseLabel": "Profit and Loss Statement Location [Domain]"
       }
      }
     },
     "localname": "ProfitAndLossStatementLocationDomain",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_PropertyPlantAndEquipmentGrantReceived": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant And Equipment, Grant Received",
        "label": "Property, Plant And Equipment, Grant Received",
        "terseLabel": "Property, plant and equipment grants received"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGrantReceived",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_PropertyPlantAndEquipmentUsefulLife1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment useful life.",
        "label": "Property Plant And Equipment Useful Life1",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife1",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_ProvisionForDiseaseClaims": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_LegalProceedingsProvision",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for disease claims.",
        "label": "Provision For Disease Claims",
        "terseLabel": "Disease claims"
       }
      }
     },
     "localname": "ProvisionForDiseaseClaims",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ProvisionForLitigation": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_LegalProceedingsProvision",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for litigation.",
        "label": "Provision For Litigation",
        "terseLabel": "Litigation"
       }
      }
     },
     "localname": "ProvisionForLitigation",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ProvisionsExpectedSettlementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisions Expected Settlement Period",
        "label": "Provisions Expected Settlement Period",
        "terseLabel": "Expected provisions settlement period"
       }
      }
     },
     "localname": "ProvisionsExpectedSettlementPeriod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_QualifyingHedgesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualifying hedges.",
        "label": "Qualifying hedges [member]",
        "terseLabel": "Derivatives that qualify for hedge accounting"
       }
      }
     },
     "localname": "QualifyingHedgesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RatedAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rated A.",
        "label": "Rated A [member]",
        "terseLabel": "Rated A"
       }
      }
     },
     "localname": "RatedAMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RatedAaOrBetterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rated Aa or better.",
        "label": "Rated Aa or better [member]",
        "terseLabel": "Rated Aa or better"
       }
      }
     },
     "localname": "RatedAaOrBetterMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RatedBaaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rated Baa.",
        "label": "Rated Baa [member]",
        "terseLabel": "Rated Baa"
       }
      }
     },
     "localname": "RatedBaaMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RealizedAndUnrealizedExchangeGainsLossesOnFinancingActivitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized and Unrealized Exchange Gains (Losses) on Financing Activities - Net",
        "label": "Realized and Unrealized Exchange Gains (Losses) on Financing Activities - Net",
        "terseLabel": "Realized and unrealized exchange (losses) / gains on financing activities - net"
       }
      }
     },
     "localname": "RealizedAndUnrealizedExchangeGainsLossesOnFinancingActivitiesNet",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_RealizedGainLossInIneffectivePortionOfDerivatives": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized gain/(loss) in ineffective portion of derivatives.",
        "label": "Realized gain/(loss) in ineffective portion of derivatives",
        "terseLabel": "Losses reclassified from OCI as result of hedge accounting discontinuation"
       }
      }
     },
     "localname": "RealizedGainLossInIneffectivePortionOfDerivatives",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_RealizedGainLossesOnDerivatives": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized gain (losses) on derivatives.",
        "label": "Realized Gain (Losses) on Derivatives",
        "terseLabel": "Realized gains / (losses) on derivatives"
       }
      }
     },
     "localname": "RealizedGainLossesOnDerivatives",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_RealizedGainsLossesOnCommodityDerivativesNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized gains losses on commodity derivatives net.",
        "label": "Realized gains losses on commodity derivatives net.",
        "terseLabel": "Realized (losses) / gains on commodity derivatives - net"
       }
      }
     },
     "localname": "RealizedGainsLossesOnCommodityDerivativesNet",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_RealizedGainsLossesOnForeignCurrencyDerivativesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized gains (losses) on foreign currency derivatives - net.",
        "label": "Realized Gains / (Losses) on Foreign Currency Derivatives - Net",
        "terseLabel": "Realized gains / (losses) on foreign currency derivatives - net",
        "verboseLabel": "Realized gains / (losses) on foreign currency derivatives - net"
       }
      }
     },
     "localname": "RealizedGainsLossesOnForeignCurrencyDerivativesNet",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_RedemptionOfSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption of Senior Notes",
        "label": "Redemption of Senior Notes [Member]",
        "terseLabel": "Redemption of Senior Notes"
       }
      }
     },
     "localname": "RedemptionOfSeniorNotesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RepaymentOfObligationsUnderFinanceLeasesAndOtherDebts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of obligations under finance leases and other debts.",
        "label": "Repayment Of Obligations Under Finance Leases and Other Debts",
        "negatedLabel": "Lease repayments"
       }
      }
     },
     "localname": "RepaymentOfObligationsUnderFinanceLeasesAndOtherDebts",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ResearchAndDevelopmentExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development expenses [member]",
        "label": "Research and development expenses [member]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve of cash flow hedges and net investment hedges.",
        "label": "Reserve of cash flow hedges and net investment hedges [member]",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units.",
        "label": "Restricted stock units [member]",
        "terseLabel": "Restricted Stock Units",
        "verboseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RetainedEarningsAndOtherReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 3.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retained Earnings And Other Reserves",
        "label": "Retained Earnings And Other Reserves",
        "verboseLabel": "Retained earnings / (deficit) and other reserves"
       }
      }
     },
     "localname": "RetainedEarningsAndOtherReserves",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_RetirementBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirements.",
        "label": "Retirement Benefits [member]",
        "terseLabel": "Retirements"
       }
      }
     },
     "localname": "RetirementBenefitsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RevenueFromContractWithCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customers",
        "label": "Revenue From Contract With Customers [Member]",
        "terseLabel": "Included in Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomersMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RevolvingCreditFacilityOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving credit facility outstanding.",
        "label": "Revolving Credit Facility Outstanding",
        "terseLabel": "Revolving credit facilities outstanding availability"
       }
      }
     },
     "localname": "RevolvingCreditFacilityOutstanding",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_RhenarollSaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rhenaroll S.A.",
        "label": "Rhenaroll SA [member]",
        "terseLabel": "Rhenaroll SA"
       }
      }
     },
     "localname": "RhenarollSaMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_RiskFreeInterestRateOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk free interest rate, other equity instruments granted.",
        "label": "Risk free interest rate, other equity instruments granted",
        "terseLabel": "Risk-free interest rate (US government bond yield)"
       }
      }
     },
     "localname": "RiskFreeInterestRateOtherEquityInstrumentsGranted",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_SalariedPensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Salaried pension.",
        "label": "Salaried Pension [member]",
        "terseLabel": "Salaried pension"
       }
      }
     },
     "localname": "SalariedPensionMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ScheduleOfReconciliationOfMovementsInNetBorrowingsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of reconciliation of movements in net borrowings explanatory.",
        "label": "Schedule of Reconciliation of Movements in Net Borrowings Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Movement in Borrowings"
       }
      }
     },
     "localname": "ScheduleOfReconciliationOfMovementsInNetBorrowingsExplanatoryTableTextBlock",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cstm_SecuredInventoryFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Inventory Facility",
        "label": "Secured Inventory Facility [Member]",
        "terseLabel": "Secured Inventory Facility"
       }
      }
     },
     "localname": "SecuredInventoryFacilityMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_SecuredPanUSABLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Pan-U.S. ABL",
        "label": "Secured Pan-U.S. ABL [Member]",
        "terseLabel": "Secured Pan-U.S. ABL (due 2026)",
        "verboseLabel": "U.S. Revolving Facility"
       }
      }
     },
     "localname": "SecuredPanUSABLMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_SellingAndAdministrativeExpenses1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling and administrative expenses.",
        "label": "Selling and administrative expenses [member]",
        "terseLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingAndAdministrativeExpenses1Member",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_SeniorNotesFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes fair value.",
        "label": "Senior Notes Fair value",
        "terseLabel": "Senior notes issued"
       }
      }
     },
     "localname": "SeniorNotesFairValue",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_SensitivityAnalysisAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis axis.",
        "label": "Sensitivity Analysis [axis]",
        "terseLabel": "Sensitivity Analysis [axis]"
       }
      }
     },
     "localname": "SensitivityAnalysisAxis",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_SensitivityAnalysisDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity analysis domain.",
        "label": "Sensitivity Analysis [domain]",
        "terseLabel": "Sensitivity Analysis [domain]"
       }
      }
     },
     "localname": "SensitivityAnalysisDomain",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_ShareBasedCompensationCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation costs.",
        "label": "Share based compensation costs",
        "negatedLabel": "Share based compensation costs"
       }
      }
     },
     "localname": "ShareBasedCompensationCosts",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ShareBasedCompensationVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation vesting period.",
        "label": "Share based compensation vesting period",
        "terseLabel": "Share based compensation, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationVestingPeriod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_ShareBasedPaymentArrangementVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based Payment Arrangement Vesting Period",
        "label": "Share based Payment Arrangement Vesting Period",
        "terseLabel": "Vesting period on the grant date"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementVestingPeriod",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_ShareBasedPaymentPlansLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment plans.",
        "label": "Share Based Payment Plans [line items]",
        "terseLabel": "Share Based Payment Plans [line items]"
       }
      }
     },
     "localname": "ShareBasedPaymentPlansLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_ShareBasedPaymentPlansTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment plans.",
        "label": "Share Based Payment Plans [table]",
        "terseLabel": "Share Based Payment Plans [table]"
       }
      }
     },
     "localname": "ShareBasedPaymentPlansTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_ShareBasedPaymentsClassifiedAsOperatingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payments, Classified As Operating Activities",
        "label": "Share-based Payments, Classified As Operating Activities",
        "negatedLabel": "Pension and other post-employment benefits paid"
       }
      }
     },
     "localname": "ShareBasedPaymentsClassifiedAsOperatingActivities",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_SharePriceAtGrantedDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share price at granted date.",
        "label": "Share Price At Granted Date",
        "terseLabel": "Share price at grant date (in EUR per share)"
       }
      }
     },
     "localname": "SharePriceAtGrantedDate",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cstm_SharebasedCompensationStockholdersReturnPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased Compensation stockholders return percentage.",
        "label": "Sharebased Compensation Stockholders Return Percentage",
        "terseLabel": "Total shareholder return (TSR) percentage achieved"
       }
      }
     },
     "localname": "SharebasedCompensationStockholdersReturnPercentage",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cstm_SharebasedpaymentarrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangements",
        "label": "Share-based payment arrangements [Abstract]",
        "terseLabel": "Share-based payment arrangements [Abstract]"
       }
      }
     },
     "localname": "SharebasedpaymentarrangementsAbstract",
     "nsuri": "http://www.constellium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cstm_SignificantComponentsOfDeferredTaxAssetsAndLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant components of deferred tax assets and liabilities line items.",
        "label": "Significant components of deferred tax assets and liabilities [line items]",
        "terseLabel": "Significant components of deferred tax assets and liabilities [line items]"
       }
      }
     },
     "localname": "SignificantComponentsOfDeferredTaxAssetsAndLiabilitiesLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_SignificantComponentsOfDeferredTaxAssetsAndLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant components of deferred tax assets and liabilities.",
        "label": "Significant components of deferred tax assets and liabilities [table]",
        "terseLabel": "Significant components of deferred tax assets and liabilities [table]"
       }
      }
     },
     "localname": "SignificantComponentsOfDeferredTaxAssetsAndLiabilitiesTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_SilverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Silver.",
        "label": "Silver [member]",
        "terseLabel": "Silver"
       }
      }
     },
     "localname": "SilverMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_SpecialtyAndOtherThinrolledProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty and other thin-rolled products.",
        "label": "Specialty And Other Thin-rolled Products [member]",
        "terseLabel": "Specialty and other thin-rolled products"
       }
      }
     },
     "localname": "SpecialtyAndOtherThinrolledProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_StartupAndDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Startup and development costs.",
        "label": "Startup And Development Costs",
        "negatedLabel": "Start-up and development costs"
       }
      }
     },
     "localname": "StartupAndDevelopmentCosts",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_SubcontractorsExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subcontractors expense.",
        "label": "Subcontractors Expense",
        "negatedLabel": "Sub-contractors"
       }
      }
     },
     "localname": "SubcontractorsExpense",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_SubsidiariesInCapitalControlRestrictionsCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for entities in countries where capital control restrictions prevent the balances from being immediately available for general use by the other entities within the Group.",
        "label": "Subsidiaries In Capital Control Restrictions Countries [member]",
        "terseLabel": "Subsidiaries in capital control restrictions countries"
       }
      }
     },
     "localname": "SubsidiariesInCapitalControlRestrictionsCountriesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items representing the summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line items]",
        "terseLabel": "Summary of significant accounting policies [line items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [table]",
        "label": "Summary Of Significant Accounting Policies [table]",
        "terseLabel": "Summary of Significant Accounting Policies [table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_TaxLossesCarriedForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax losses carried forward.",
        "label": "Tax losses carried forward [member]",
        "terseLabel": "Tax losses carried forward"
       }
      }
     },
     "localname": "TaxLossesCarriedForwardMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TenPercentageIncreaseOrDecreaseInTheMarketPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "10% increase or decrease in the market price.",
        "label": "Ten percentage increase or decrease in the market price [member]",
        "terseLabel": "10% increase or decrease in the market price"
       }
      }
     },
     "localname": "TenPercentageIncreaseOrDecreaseInTheMarketPriceMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TenPercentageStrengtheningUsDollarEuroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ten percentage strengthening US Dollar/Euro.",
        "label": "Ten percentage strengthening US Dollar/Euro [member]",
        "terseLabel": "10% strengthening U.S. Dollar/Euro"
       }
      }
     },
     "localname": "TenPercentageStrengtheningUsDollarEuroMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TotalOperatingExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Operating Expenses",
        "label": "Total Operating Expenses [Member]",
        "terseLabel": "Total Operating Expenses"
       }
      }
     },
     "localname": "TotalOperatingExpensesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TradePayablesAndOtherFixedAssetPayabalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Payables And Other Fixed Asset Payabales",
        "label": "Trade Payables And Other Fixed Asset Payabales [Member]",
        "terseLabel": "Trade payables and fixed asset payables"
       }
      }
     },
     "localname": "TradePayablesAndOtherFixedAssetPayabalesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TradePayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade payables.",
        "label": "Trade Payables [member]",
        "terseLabel": "Trade payables",
        "verboseLabel": "Trade payables and fixed asset payables"
       }
      }
     },
     "localname": "TradePayablesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TradeReceivablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade receivables [line items]",
        "label": "Trade Receivables [line items]",
        "terseLabel": "Trade receivables [line items]"
       }
      }
     },
     "localname": "TradeReceivablesLineItems",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_TradeReceivablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Receivables [table]",
        "label": "Trade Receivables [table]",
        "terseLabel": "Trade receivables [table]"
       }
      }
     },
     "localname": "TradeReceivablesTable",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_TransportationIndustryAndOtherRolledProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transportation Industry and other rolled products.",
        "label": "Transportation Industry and other rolled products [member]",
        "terseLabel": "Transportation, industry, defense and other rolled products"
       }
      }
     },
     "localname": "TransportationIndustryAndOtherRolledProductsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TwoThousandTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty",
        "label": "Two Thousand Twenty [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "TwoThousandTwentyMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_TwoThousandTwentyNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Nine",
        "label": "Two Thousand Twenty Nine [Member]",
        "terseLabel": "2029"
       }
      }
     },
     "localname": "TwoThousandTwentyNineMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UnbilledToolingCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled tooling costs.",
        "label": "Unbilled Tooling Costs [member]",
        "terseLabel": "Unbilled Tooling Costs"
       }
      }
     },
     "localname": "UnbilledToolingCostsMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UnlimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unlimited [member]",
        "label": "Unlimited [member]",
        "terseLabel": "Unlimited"
       }
      }
     },
     "localname": "UnlimitedMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UnrealizedExchangeGainsLossesFromReMeasurementOfMonetaryAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized Exchange Gains (Losses) From Re-measurement of Monetary Assets and Liabilities, Net",
        "label": "Unrealized Exchange Gains (Losses) From Re-measurement of Monetary Assets and Liabilities, Net",
        "terseLabel": "Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities \u2013 net"
       }
      }
     },
     "localname": "UnrealizedExchangeGainsLossesFromReMeasurementOfMonetaryAssetsAndLiabilitiesNet",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_UnrealizedGainsLossesOnChangeInFairValueOfDerivatives": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized gains (losses) on change in fair value of derivatives.",
        "label": "Unrealized Gains Losses On Change In Fair Value Of Derivatives",
        "terseLabel": "Unrealized (losses) / gains on derivatives"
       }
      }
     },
     "localname": "UnrealizedGainsLossesOnChangeInFairValueOfDerivatives",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_UnrealizedGainsLossesOnCommodityDerivativesNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized gains losses on commodity derivatives net.",
        "label": "Unrealized gains losses on commodity derivatives net.",
        "terseLabel": "Unrealized (losses) / gains on commodity derivatives - net"
       }
      }
     },
     "localname": "UnrealizedGainsLossesOnCommodityDerivativesNet",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_UnrealizedGainsLossesOnForeignCurrencyDerivativesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized gains (losses) on foreign currency derivatives - net.",
        "label": "Unrealized Gains / (Losses) on Foreign Currency Derivatives - Net",
        "terseLabel": "Unrealized (losses) / gains on foreign currency derivatives - net",
        "verboseLabel": "Unrealized gains / (losses) on foreign currency derivatives - net"
       }
      }
     },
     "localname": "UnrealizedGainsLossesOnForeignCurrencyDerivativesNet",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_UnrecognizedVariableConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized variable consideration.",
        "label": "Unrecognized Variable Consideration [member]",
        "terseLabel": "Unrecognized variable consideration"
       }
      }
     },
     "localname": "UnrecognizedVariableConsiderationMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UnsecuredCreditFacilitySwitzerlandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Credit Facility Switzerland",
        "label": "Unsecured Credit Facility Switzerland [Member]",
        "terseLabel": "Unsecured Swiss Facility"
       }
      }
     },
     "localname": "UnsecuredCreditFacilitySwitzerlandMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UnsecuredRevolvingCreditFacilitiesDueInTwoThousandTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Revolving Credit Facilities Due In Two Thousand Twenty One [member]",
        "label": "Unsecured Revolving Credit Facilities Due In Two Thousand Twenty One [member]",
        "terseLabel": "Unsecured Revolving Credit Facility (expired in 2021)"
       }
      }
     },
     "localname": "UnsecuredRevolvingCreditFacilitiesDueInTwoThousandTwentyOneMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UnusualOrInfrequentItemOrBoth1Axis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unusual or Infrequent Item, or Both1",
        "label": "Unusual or Infrequent Item, or Both1 [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both1 [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemOrBoth1Axis",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCEDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cstm_UnusualOrInfrequentItemOrBoth1Domain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unusual or Infrequent Item, or Both1",
        "label": "Unusual or Infrequent Item, or Both1 [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both1 [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemOrBoth1Domain",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCEDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UsdEurForwardDerivativesPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD/EUR Forward derivatives purchases.",
        "label": "USD/EUR Forward derivatives purchases [member]",
        "terseLabel": "Purchased currencies USD"
       }
      }
     },
     "localname": "UsdEurForwardDerivativesPurchasesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UsdEurForwardDerivativesSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD/EUR Forward derivatives sales.",
        "label": "USD/EUR Forward derivatives sales [member]",
        "terseLabel": "Sold currencies USD"
       }
      }
     },
     "localname": "UsdEurForwardDerivativesSalesMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_UsselMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ussel",
        "label": "Ussel [Member]",
        "terseLabel": "Ussel"
       }
      }
     },
     "localname": "UsselMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_WeightedAverageFairValueOnMeasurementDateOtherEquityInstrumentsGrantedPerShare": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Fair Value On Measurement Date Other Equity Instruments Granted Per Share",
        "label": "Weighted Average Fair Value On Measurement Date Other Equity Instruments Granted Per Share",
        "periodEndLabel": "Weighted- Average Grant-Date Fair Value per Share, Ending balance",
        "periodStartLabel": "Weighted- Average Grant-Date Fair Value per Share, Beginning balance"
       }
      }
     },
     "localname": "WeightedAverageFairValueOnMeasurementDateOtherEquityInstrumentsGrantedPerShare",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value per share other equity instruments forfeited.",
        "label": "Weighted Average Grant Date Fair Value per Share Other Equity Instruments Forfeited",
        "terseLabel": "Weighted- Average Grant-Date Fair Value per Share, Forfeited"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsForfeited",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value per share other equity instruments, granted.",
        "label": "Weighted Average Grant Date Fair Value Per Share Other Equity Instruments, Granted",
        "terseLabel": "Weighted- Average Grant-Date Fair Value per Share, Granted"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsGranted",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsOverPerformance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value per share other equity instruments over performance.",
        "label": "Weighted Average Grant Date Fair Value per Share Other Equity Instruments Over Performance",
        "terseLabel": "Weighted- Average Grant-Date Fair Value per Share, Over-performance"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsOverPerformance",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value per share other equity instruments vested.",
        "label": "Weighted Average Grant Date Fair Value per Share Other Equity Instruments Vested",
        "terseLabel": "Weighted- Average Grant-Date Fair Value per Share, Vested"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValuePerShareOtherEquityInstrumentsVested",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_WeightedAverageMaturityOfDefinedBenefitObligations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average maturity of defined benefit obligations.",
        "label": "Weighted-Average Maturity Of Defined Benefit Obligations",
        "terseLabel": "Weighted-average maturity of defined benefit obligations"
       }
      }
     },
     "localname": "WeightedAverageMaturityOfDefinedBenefitObligations",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cstm_WhiteGeorgiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "White, Georgia",
        "label": "White, Georgia [Member]",
        "terseLabel": "White Georgia"
       }
      }
     },
     "localname": "WhiteGeorgiaMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_WorkInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Work-in progress.",
        "label": "Work In Progress [member]",
        "terseLabel": "Work in Progress"
       }
      }
     },
     "localname": "WorkInProgressMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cstm_WriteOffBorrowingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write Off Borrowing Costs",
        "label": "Write Off Borrowing Costs",
        "terseLabel": "Write off borrowing costs"
       }
      }
     },
     "localname": "WriteOffBorrowingCosts",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cstm_ZincMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zinc.",
        "label": "Zinc [member]",
        "terseLabel": "Zinc"
       }
      }
     },
     "localname": "ZincMember",
     "nsuri": "http://www.constellium.com/20221231",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CHF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Switzerland, Francs",
        "terseLabel": "Swiss Francs"
       }
      }
     },
     "localname": "CHF",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CZK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Czech Republic, Koruny",
        "terseLabel": "Czech Koruna"
       }
      }
     },
     "localname": "CZK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "U.S. Dollars",
        "verboseLabel": "U.S. Dollar"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "PCAOB ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Chief Securities Counsel"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address",
        "terseLabel": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "verboseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_OtherAddressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other address for entity",
        "label": "Other Address [Member]",
        "terseLabel": "Other Address"
       }
      }
     },
     "localname": "OtherAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.constellium.com/role/COVER"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": {
     "auth_ref": [
      "r63",
      "r71",
      "r140",
      "r149",
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated depreciation, amortisation and impairment [member]",
        "verboseLabel": "Less accumulated depreciation and impairment"
       }
      }
     },
     "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AccumulatedImpairmentMember": {
     "auth_ref": [
      "r218",
      "r240",
      "r326",
      "r349",
      "r354",
      "r381",
      "r397",
      "r401",
      "r402"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated impairment. [Refer: Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated impairment [member]",
        "terseLabel": "Impairment"
       }
      }
     },
     "localname": "AccumulatedImpairmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates [member]",
        "terseLabel": "Actuarial assumption of discount rates"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRatesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases",
        "terseLabel": "Rate of increase in pensions"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreases",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of salary increases",
        "terseLabel": "Rate of increase in salaries"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Medical cost trend rate used as significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of medical cost trend rates",
        "terseLabel": "Medical trend rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfMedicalCostTrendRates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionsAxis": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [axis]",
        "terseLabel": "Actuarial assumptions [axis]"
       }
      }
     },
     "localname": "ActuarialAssumptionsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ActuarialAssumptionsMember": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [member]",
        "terseLabel": "Actuarial assumptions [member]"
       }
      }
     },
     "localname": "ActuarialAssumptionsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions",
        "terseLabel": "\u2014changes in demographic assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions",
        "terseLabel": "\u2014changes in financial assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments",
        "terseLabel": "\u2014experience losses"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionalProvisionsOtherProvisions": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additional other provisions made. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additional provisions, other provisions",
        "terseLabel": "Allowance"
       }
      }
     },
     "localname": "AdditionalProvisionsOtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade and other receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDeferredTaxExpense": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for deferred tax expense",
        "negatedLabel": "Changes in recognized and unrecognized deferred tax assets",
        "negatedTerseLabel": "Adjustments for deferred tax expense"
       }
      }
     },
     "localname": "AdjustmentsForDeferredTaxExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNarrativeDetails",
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation and amortisation expense",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForFinanceIncomeCost": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for finance income (cost)",
        "negatedTerseLabel": "Finance costs - net"
       }
      }
     },
     "localname": "AdjustmentsForFinanceIncomeCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gains (losses) on change in fair value of derivatives",
        "negatedLabel": "Unrealized losses / (gains) on derivatives - net and from remeasurement of monetary assets and liabilities - net"
       }
      }
     },
     "localname": "AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) on inventories recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Impairment loss; Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories",
        "terseLabel": "Impairment of assets"
       }
      }
     },
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for income tax expense",
        "verboseLabel": "Income tax (benefit) / expense"
       }
      }
     },
     "localname": "AdjustmentsForIncomeTaxExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade and other payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for losses (gains) on disposal of non-current assets",
        "terseLabel": "Losses on disposal"
       }
      }
     },
     "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForProvisions": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for provisions",
        "verboseLabel": "Change in provisions"
       }
      }
     },
     "localname": "AdjustmentsForProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Pension and other post-employment benefits service costs"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdministrativeExpense": {
     "auth_ref": [
      "r51",
      "r110",
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity classifies as being administrative."
       }
      },
      "en-us": {
       "role": {
        "label": "Administrative expenses",
        "terseLabel": "Administration expenses"
       }
      }
     },
     "localname": "AdministrativeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedMeasurementMember": {
     "auth_ref": [
      "r147",
      "r151",
      "r188"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated measurement [member]",
        "terseLabel": "Aggregated measurement [member]"
       }
      }
     },
     "localname": "AggregatedMeasurementMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r26",
      "r199",
      "r209",
      "r210",
      "r226",
      "r272",
      "r273",
      "r274",
      "r280",
      "r305",
      "r329",
      "r333"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]",
        "terseLabel": "Aggregated time bands [member]"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "auth_ref": [
      "r84",
      "r189"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "All levels of fair value hierarchy [member]",
        "terseLabel": "All levels of fair value hierarchy [member]"
       }
      }
     },
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation, intangible assets other than goodwill",
        "negatedLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Analysis of income and expense [abstract]",
        "terseLabel": "Analysis of income and expense [abstract]"
       }
      }
     },
     "localname": "AnalysisOfIncomeAndExpenseAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "verboseLabel": "Statutory tax rate applicable to the parent company"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r22",
      "r188",
      "r189",
      "r190",
      "r261",
      "r263"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssetsAndLiabilitiesAxis": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets and liabilities [axis]",
        "terseLabel": "Assets and liabilities [axis]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssetsAndLiabilitiesMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets and liabilities. It also represents the standard value for the 'Assets and liabilities' axis if no other member is used. [Refer: Assets; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Assets and liabilities [member]",
        "terseLabel": "Assets and liabilities [member]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AtFairValueMember": {
     "auth_ref": [
      "r147",
      "r151",
      "r188"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."
       }
      },
      "en-us": {
       "role": {
        "label": "At fair value [member]",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "AtFairValueMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "auth_ref": [
      "r368",
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [axis]",
        "terseLabel": "Attribution of expenses by nature to their function [axis]"
       }
      }
     },
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AverageEffectiveTaxRate": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Average effective tax rate",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "AverageEffectiveTaxRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_AverageForeignExchangeRate": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies."
       }
      },
      "en-us": {
       "role": {
        "label": "Average foreign exchange rate",
        "verboseLabel": "Average rates"
       }
      }
     },
     "localname": "AverageForeignExchangeRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r118",
      "r119"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic (in EUR per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BenefitsPaidOrPayable": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of benefits paid or payable for retirement benefit plans."
       }
      },
      "en-us": {
       "role": {
        "label": "Benefits paid or payable",
        "terseLabel": "Benefits paid"
       }
      }
     },
     "localname": "BenefitsPaidOrPayable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BorrowingCostsRecognisedAsExpense": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are recognised as an expense."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowing costs recognised as expense",
        "terseLabel": "Borrowing costs recognised as expense"
       }
      }
     },
     "localname": "BorrowingCostsRecognisedAsExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Borrowings": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Borrowings",
        "totalLabel": "Borrowings"
       }
      }
     },
     "localname": "Borrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings [abstract]",
        "terseLabel": "Borrowings [abstract]"
       }
      }
     },
     "localname": "BorrowingsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]",
        "terseLabel": "Borrowings by name [axis]"
       }
      }
     },
     "localname": "BorrowingsByNameAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [member]",
        "terseLabel": "Borrowings by name [member]"
       }
      }
     },
     "localname": "BorrowingsByNameMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r192",
      "r212",
      "r274",
      "r318",
      "r319",
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings [member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CapitalCommitments": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of future capital expenditures that the entity is committed to make."
       }
      },
      "en-us": {
       "role": {
        "label": "Capital commitments",
        "terseLabel": "Total tangible and intangible asset commitments"
       }
      }
     },
     "localname": "CapitalCommitments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTangibleandIntangibleAssetCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average of interest and other costs that an entity incurs in connection with the borrowing of funds applicable to the borrowings of the entity that are outstanding during the period, other than borrowings made specifically for the purpose of obtaining a qualifying asset. [Refer: Weighted average [member]; Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Capitalisation rate of borrowing costs eligible for capitalisation",
        "terseLabel": "Capitalization rate"
       }
      }
     },
     "localname": "CapitalisationRateOfBorrowingCostsEligibleForCapitalisation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "auth_ref": [
      "r63",
      "r68",
      "r140",
      "r144",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r218",
      "r240",
      "r241",
      "r415",
      "r417"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]",
        "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      }
     },
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountMember": {
     "auth_ref": [
      "r68",
      "r144",
      "r148",
      "r150",
      "r151",
      "r218",
      "r240",
      "r241",
      "r349",
      "r353"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount [member]",
        "terseLabel": "Carrying amount [member]"
       }
      }
     },
     "localname": "CarryingAmountMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r14",
      "r162",
      "r182"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of year",
        "periodStartLabel": "Cash and cash equivalents - beginning of period",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash in bank and on hand"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents [abstract]",
        "terseLabel": "Cash and cash equivalents [abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets": {
     "auth_ref": [
      "r302"
     ],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_PlanAssetsAtFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount cash and cash equivalents contribute to the fair value of defined benefit plan assets. [Refer: Cash and cash equivalents; Plan assets, at fair value; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents, amount contributed to fair value of plan assets",
        "terseLabel": "Cash & cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from losing control of subsidiaries or other businesses, classified as investing activities",
        "terseLabel": "Proceeds from disposals, net of cash"
       }
      }
     },
     "localname": "CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r153",
      "r163"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash flows (used in) / from financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r153",
      "r163"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash flows used in investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r153",
      "r163"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash flows from operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfAssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomersAxis": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of assets recognised from costs to obtain or fulfil contracts with customers [axis]",
        "terseLabel": "Categories of assets recognised from costs to obtain or fulfil contracts with customers [axis]"
       }
      }
     },
     "localname": "CategoriesOfAssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomersAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfAssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomersMember": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all categories of assets recognised from the costs to obtain or fulfil contracts with customers. It also represents the standard value for the 'Categories of assets recognised from costs to obtain or fulfil contracts with customers' axis if no other member is used. [Refer: Assets recognised from costs to obtain or fulfil contracts with customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of assets recognised from costs to obtain or fulfil contracts with customers [member]",
        "terseLabel": "Categories of assets recognised from costs to obtain or fulfil contracts with customers [member]"
       }
      }
     },
     "localname": "CategoriesOfAssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomersMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CategoriesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of financial assets [axis]",
        "terseLabel": "Categories of financial assets [axis]"
       }
      }
     },
     "localname": "CategoriesOfFinancialAssetsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of financial liabilities [axis]",
        "terseLabel": "Categories of financial liabilities [axis]"
       }
      }
     },
     "localname": "CategoriesOfFinancialLiabilitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]",
        "terseLabel": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in goodwill [abstract]",
        "terseLabel": "Changes in goodwill [abstract]"
       }
      }
     },
     "localname": "ChangesInGoodwillAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in intangible assets other than goodwill [abstract]",
        "terseLabel": "Changes in intangible assets other than goodwill [abstract]"
       }
      }
     },
     "localname": "ChangesInIntangibleAssetsOtherThanGoodwillAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInOtherProvisionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in other provisions [abstract]",
        "terseLabel": "Changes in other provisions [abstract]"
       }
      }
     },
     "localname": "ChangesInOtherProvisionsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r121",
      "r123",
      "r191",
      "r207"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]",
        "terseLabel": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTangibleandIntangibleAssetCommitmentsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r121",
      "r191",
      "r207"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]",
        "terseLabel": "Assets [member]"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTangibleandIntangibleAssetCommitmentsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "auth_ref": [
      "r138",
      "r215"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]",
        "terseLabel": "Classes of contingent liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of employee benefits expense [abstract]",
        "terseLabel": "Classes of employee benefits expense [abstract]"
       }
      }
     },
     "localname": "ClassesOfEmployeeBenefitsExpenseAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r271",
      "r281",
      "r282",
      "r283"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]",
        "terseLabel": "Classes of financial assets [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialAssetsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "auth_ref": [
      "r240",
      "r243",
      "r245",
      "r246"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]",
        "terseLabel": "Classes of financial instruments [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsMember": {
     "auth_ref": [
      "r240",
      "r243",
      "r245",
      "r246"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments, class [member]",
        "terseLabel": "Financial instruments, class [member]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r271",
      "r282"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]",
        "terseLabel": "Classes of financial liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [axis]",
        "terseLabel": "Classes of intangible assets and goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]",
        "terseLabel": "Classes of intangible assets other than goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]",
        "terseLabel": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]",
        "terseLabel": "Classes of other provisions [axis]"
       }
      }
     },
     "localname": "ClassesOfProvisionsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]",
        "terseLabel": "Classes of share capital [axis]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails",
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share capital [member]",
        "terseLabel": "Share capital [member]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails",
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      },
      "en-us": {
       "role": {
        "label": "Closing foreign exchange rate",
        "verboseLabel": "Closing rates"
       }
      }
     },
     "localname": "ClosingForeignExchangeRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_CommodityPriceRiskMember": {
     "auth_ref": [
      "r327",
      "r337"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of other price risk that represents the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in commodity prices. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Commodity price risk [member]",
        "terseLabel": "Commodity price risk"
       }
      }
     },
     "localname": "CommodityPriceRiskMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]",
        "terseLabel": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]",
        "terseLabel": "Items that may be reclassified subsequently to the consolidated income statement"
       }
      }
     },
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]",
        "terseLabel": "Items that will not be reclassified subsequently to the consolidated income statement"
       }
      }
     },
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r2",
      "r40",
      "r168",
      "r170",
      "r180",
      "r317"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Total comprehensive income / (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income attributable to [abstract]",
        "terseLabel": "Attributable to:"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r2",
      "r43"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME_1": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r2",
      "r44"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME_1": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "terseLabel": "Equity holders of Constellium"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComputerSoftwareMember": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Computer software [member]",
        "terseLabel": "Computer Software"
       }
      }
     },
     "localname": "ComputerSoftwareMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ConstructionInProgressMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Construction in progress [member]",
        "terseLabel": "Construction Work in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContingentLiabilitiesMember": {
     "auth_ref": [
      "r139",
      "r215"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent liabilities [member]",
        "terseLabel": "Contingent liabilities [member]"
       }
      }
     },
     "localname": "ContingentLiabilitiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContinuingAndDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Continuing and discontinued operations [axis]",
        "terseLabel": "Continuing and discontinued operations [axis]"
       }
      }
     },
     "localname": "ContinuingAndDiscontinuedOperationsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfTransferAxis": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Continuing involvement in derecognised financial assets by type of transfer [axis]",
        "terseLabel": "Continuing involvement in derecognised financial assets by type of transfer [axis]"
       }
      }
     },
     "localname": "ContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfTransferAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ContinuingOperationsMember": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for components of the entity that are not discontinued operations. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. This member also represents the standard value for the 'Continuing and discontinued operations' axis if no other member is used. [Refer: Discontinued operations [member]; Aggregate continuing and discontinued operations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Continuing operations [member]",
        "terseLabel": "Continuing operations [member]"
       }
      }
     },
     "localname": "ContinuingOperationsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants",
        "terseLabel": "Contributions by the plan participants"
       }
      }
     },
     "localname": "ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r0",
      "r51"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 2.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": {
     "auth_ref": [
      "r112",
      "r115",
      "r172",
      "r175"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Country of incorporation of subsidiary",
        "terseLabel": "Country"
       }
      }
     },
     "localname": "CountryOfIncorporationOrResidenceOfSubsidiary",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CreditDerivativeNominalAmount": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal amount of a credit derivative. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Credit derivative, nominal amount",
        "terseLabel": "Nominal amount"
       }
      }
     },
     "localname": "CreditDerivativeNominalAmount",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrencyRiskMember": {
     "auth_ref": [
      "r257",
      "r275",
      "r276",
      "r277",
      "r278"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Currency risk [member]",
        "terseLabel": "Currency risk"
       }
      }
     },
     "localname": "CurrencyRiskMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 3.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails_1": {
       "order": 2.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current borrowings and current portion of non-current borrowings",
        "terseLabel": "Current borrowings"
       }
      }
     },
     "localname": "CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentContractAssets": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current contract assets. [Refer: Contract assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current contract assets",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "CurrentContractAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentContractLiabilities": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 4.0,
       "parentTag": "cstm_OtherCurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current contract liabilities",
        "terseLabel": "Contract liabilities and other liabilities to customers",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentContractLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails",
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialAssets": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_DerivativeFinancialAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial assets. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current derivative financial assets",
        "terseLabel": "Current derivatives assets"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_DerivativeFinancialLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current derivative financial liabilities",
        "terseLabel": "Current derivative liabilities"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities other than liabilities included in disposal groups classified as held for sale. [Refer: Current liabilities; Disposal groups classified as held for sale [member]; Liabilities included in disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities other than liabilities included in disposal groups classified as held for sale",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLoansAndReceivables": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_LoansAndReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current loans and receivables. [Refer: Loans and receivables]"
       }
      }
     },
     "localname": "CurrentLoansAndReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentMember": {
     "auth_ref": [
      "r326",
      "r335",
      "r416"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a current time band."
       }
      },
      "en-us": {
       "role": {
        "label": "Current [member]",
        "terseLabel": "Not past due"
       }
      }
     },
     "localname": "CurrentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentPayablesForPurchaseOfNoncurrentAssets": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 1.0,
       "parentTag": "cstm_OtherCurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables for the purchase of non-current assets. [Refer: Payables for purchase of non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current payables for purchase of non-current assets",
        "terseLabel": "Fixed assets payables"
       }
      }
     },
     "localname": "CurrentPayablesForPurchaseOfNoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 3.0,
       "parentTag": "cstm_OtherCurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current payables on social security and taxes other than income tax",
        "terseLabel": "Taxes payable other than income tax"
       }
      }
     },
     "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": {
     "auth_ref": [
      "r372"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current receivables from taxes other than income tax",
        "terseLabel": "Other tax receivables"
       }
      }
     },
     "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase in net defined benefit liability (asset) resulting from current service cost",
        "terseLabel": "Current service cost"
       }
      }
     },
     "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxAssetsCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of current tax assets. [Refer: Current tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax assets, current",
        "terseLabel": "Income tax receivables"
       }
      }
     },
     "localname": "CurrentTaxAssetsCurrent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxAssetsNoncurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "cstm_OtherReceivablesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current amount of current tax assets. [Refer: Current tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax assets, non-current",
        "terseLabel": "Income tax receivables"
       }
      }
     },
     "localname": "CurrentTaxAssetsNoncurrent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://www.constellium.com/role/INCOMETAXCurrentandDeferredComponentsofIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax expense (income)",
        "negatedLabel": "Current tax expense"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXCurrentandDeferredComponentsofIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilities": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax liabilities",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "CurrentTaxLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTradeReceivables": {
     "auth_ref": [
      "r293",
      "r295"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "CurrentTradeReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deductible temporary differences for which no deferred tax asset is recognised",
        "negatedTerseLabel": "Related tax impact"
       }
      }
     },
     "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r18",
      "r23",
      "r59"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNetDeferredIncomeTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_NetDeferredTaxAssets",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Deferred tax assets",
        "verboseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNarrativeDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNetDeferredIncomeTaxAssetsDetails",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.constellium.com/role/INCOMETAXCurrentandDeferredComponentsofIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income)",
        "negatedLabel": "Deferred tax benefit / (expense)"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXCurrentandDeferredComponentsofIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income) recognised in profit or loss",
        "terseLabel": "Recognized in Profit or loss"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r18",
      "r23",
      "r59"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNetDeferredIncomeTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_NetDeferredTaxAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "negatedLabel": "Deferred income tax liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNetDeferredIncomeTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liability (asset)",
        "periodEndLabel": "At December 31",
        "periodStartLabel": "At January 1",
        "terseLabel": "Net deferred tax asset balance"
       }
      }
     },
     "localname": "DeferredTaxLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit plans [axis]",
        "terseLabel": "Defined benefit plans [axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DefinedBenefitPlansMember": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit plans [member]",
        "terseLabel": "Defined benefit plans [member]"
       }
      }
     },
     "localname": "DefinedBenefitPlansMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense, amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss. [Refer: Depreciation and amortisation expense; Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss",
        "negatedLabel": "Depreciation expense and impairment losses"
       }
      }
     },
     "localname": "DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r1",
      "r51",
      "r185",
      "r259",
      "r265",
      "r290"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      },
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation and amortisation expense",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r66",
      "r70"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "negatedLabel": "Depreciation expense"
       }
      }
     },
     "localname": "DepreciationPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialAssets": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial assets",
        "terseLabel": "Other financial assets - derivatives",
        "totalLabel": "Derivative financial assets"
       }
      }
     },
     "localname": "DerivativeFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialLiabilities": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial liabilities",
        "terseLabel": "Other financial liabilities - derivatives",
        "totalLabel": "Derivatives liabilities"
       }
      }
     },
     "localname": "DerivativeFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for business combinations. [Refer: Business combinations [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for business combinations [text block]",
        "terseLabel": "Business combinations"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for derivative financial instruments. [Refer: Financial instruments, class [member]; Derivatives [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for derivative financial instruments. [Refer: Financial instruments, class [member]; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for derivative financial instruments [text block]",
        "terseLabel": "Derivatives financial instruments"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.\nEffective 2023-01-01: The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for employee benefits [text block]",
        "terseLabel": "Pension, other post-employment benefits and other long-term employee benefits"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for financial instruments [text block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for foreign currency translation.\nEffective 2023-01-01: The description of the entity's material accounting policy information for foreign currency translation."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for foreign currency translation [text block]",
        "terseLabel": "Foreign currency transactions and foreign operations"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for goodwill. [Refer: Goodwill]\nEffective 2023-01-01: The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for goodwill [text block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForGoodwillExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for government grants [text block]",
        "terseLabel": "Government Grants"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the impairment of assets.\nEffective 2023-01-01: The description of the entity's material accounting policy information for the impairment of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of assets [text block]",
        "terseLabel": "Impairment of property, plant and equipment and intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]\nEffective 2023-01-01: The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of non-financial assets [text block]",
        "terseLabel": "Impairment of goodwill"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for income tax.\nEffective 2023-01-01: The description of the entity's material accounting policy information for income tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Taxation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]\nEffective 2023-01-01: The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for income and expense arising from interest.\nEffective 2023-01-01: The description of the entity's material accounting policy information for income and expense arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for interest income and expense [text block]",
        "terseLabel": "Interest income and expense"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for issued capital. [Refer: Issued capital]\nEffective 2023-01-01: The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for issued capital [text block]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.\nEffective 2023-01-01: The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for leases [text block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Non-current assets or disposal groups classified as held for sale]\nEffective 2023-01-01: The description of the entity's material accounting policy information for non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Non-current assets or disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for non-current assets or disposal groups classified as held for sale and discontinued operations [text block]",
        "terseLabel": "Non-current Assets (and disposal groups) Held for Sale and Discontinued Operations"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]\nEffective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for provisions. [Refer: Provisions]\nEffective 2023-01-01: The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]\nEffective 2023-01-01: The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue from contracts with customers"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]\nEffective 2023-01-01: The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]\nEffective 2023-01-01: The description of the entity's material accounting policy information for restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for restricted cash and cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for segment reporting.\nEffective 2023-01-01: The description of the entity's material accounting policy information for segment reporting."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for segment reporting [text block]",
        "terseLabel": "Presentation of the operating performance of each operating segment and of the Group"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for share-based payment transactions [text block]",
        "terseLabel": "Share-based payment arrangements"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for trade and other payables. [Refer: Trade and other payables]\nEffective 2023-01-01: The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for trade and other payables [text block]",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for trade and other receivables. [Refer: Trade and other receivables]\nEffective 2023-01-01: The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for trade and other receivables [text block]",
        "terseLabel": "Trade account receivables"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "auth_ref": [
      "r128",
      "r130"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Discount rate applied to cash flow projections",
        "terseLabel": "Discount rate to estimate normative cash flows"
       }
      }
     },
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]",
        "terseLabel": "New standards and interpretations not yet mandatorily applicable"
       }
      }
     },
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": {
     "auth_ref": [
      "r127",
      "r129"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Growth rate used to extrapolate cash flow projections",
        "verboseLabel": "Long term growth rate used to estimate normative cash flow"
       }
      }
     },
     "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r118",
      "r119"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted (in EUR per share)"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DirectorsRemunerationExpense": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of remuneration paid or payable to the entity's directors."
       }
      },
      "en-us": {
       "role": {
        "label": "Directors' remuneration expense",
        "terseLabel": "Directors' fees"
       }
      }
     },
     "localname": "DirectorsRemunerationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the analysis of the single amount of discontinued operations. [Refer: Discontinued operations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of single amount of discontinued operations [text block]",
        "terseLabel": "Disclosure of analysis of single amount of discontinued operations"
       }
      }
     },
     "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of single amount of discontinued operations [line items]",
        "terseLabel": "Disclosure Of Analysis Of Single Amount Of Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the analysis of the single amount of discontinued operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of single amount of discontinued operations [table]",
        "terseLabel": "Disclosure of analysis of single amount of discontinued operations [table]"
       }
      }
     },
     "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [abstract]"
       }
      }
     },
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory": {
     "auth_ref": [
      "r368",
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of attribution of expenses by nature to line items by function in the statement of profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [text block]",
        "terseLabel": "EXPENSES BY NATURE"
       }
      }
     },
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATURE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [line items]",
        "terseLabel": "Disclosure of attribution of expenses by nature to their function [line items]"
       }
      }
     },
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": {
     "auth_ref": [
      "r368",
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [table]",
        "terseLabel": "Disclosure of attribution of expenses by nature to their function [table]"
       }
      }
     },
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfBorrowingsExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of borrowings [text block]",
        "terseLabel": "BORROWINGS"
       }
      }
     },
     "localname": "DisclosureOfBorrowingsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cash and cash equivalents [text block]",
        "terseLabel": "CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCashFlowStatementExplanatory": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for a statement of cash flows."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cash flow statement [text block]",
        "terseLabel": "NON-CASH INVESTING AND FINANCING TRANSACTIONS"
       }
      }
     },
     "localname": "DisclosureOfCashFlowStatementExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/NONCASHINVESTINGANDFINANCINGTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]",
        "terseLabel": "Disclosure of classes of share capital [line items]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails",
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]",
        "terseLabel": "Disclosure of classes of share capital [table]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails",
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of commitments [text block]",
        "terseLabel": "COMMITMENTS"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [text block]",
        "terseLabel": "Schedule of Legal Claims and Other Costs"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCreditRiskExposureTable": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the credit risk exposure."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of credit risk exposure [table]",
        "terseLabel": "Disclosure of credit risk exposure [table]"
       }
      }
     },
     "localname": "DisclosureOfCreditRiskExposureTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of deferred taxes [text block]",
        "terseLabel": "Schedule of Current and Deferred Components of Income Tax"
       }
      }
     },
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [text block]",
        "terseLabel": "Schedule of Total Employee Benefit Expenses"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [line items]",
        "terseLabel": "Disclosure of defined benefit plans [line items]"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [table]",
        "terseLabel": "Disclosure of defined benefit plans [table]"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of derivative financial instruments [text block]",
        "terseLabel": "Schedule of Effect of Foreign Currency Derivatives Impacts in Consolidated Income Statement"
       }
      }
     },
     "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [text block]",
        "terseLabel": "Schedule of Borrowings by Nature"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [line items]",
        "terseLabel": "Disclosure of detailed information about borrowings [line items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails",
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]",
        "terseLabel": "Disclosure of detailed information about borrowings [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails",
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutHedgingInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about hedging instruments [line items]",
        "terseLabel": "Disclosure of detailed information about hedging instruments [line items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutHedgingInstrumentsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutHedgingInstrumentsTable": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of hedging instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about hedging instruments [table]",
        "terseLabel": "Disclosure of detailed information about hedging instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutHedgingInstrumentsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]",
        "terseLabel": "Schedule of Disaggregation Revenue"
       }
      }
     },
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]",
        "terseLabel": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      }
     },
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for the effect of changes in foreign exchange rates."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of effect of changes in foreign exchange rates [text block]",
        "terseLabel": "Schedule of Main Exchange Rates Used for Preparation of Financial Statements"
       }
      }
     },
     "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of employee benefits [text block]",
        "terseLabel": "EMPLOYEE BENEFIT EXPENSES",
        "verboseLabel": "PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSES",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of entity's operating segments [text block]",
        "terseLabel": "OPERATING SEGMENT INFORMATION"
       }
      }
     },
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfExternalCreditExposuresExplanatory": {
     "auth_ref": [
      "r347",
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of external credit grades. [Refer: External credit grades [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of external credit grades [text block]",
        "terseLabel": "Schedule of Exposure to Financial Counterparties by Rating Type"
       }
      }
     },
     "localname": "DisclosureOfExternalCreditExposuresExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [text block]",
        "terseLabel": "Schedule of Derivatives Measured at Fair Value"
       }
      }
     },
     "localname": "DisclosureOfFairValueMeasurementOfAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of defined benefit plan assets. [Refer: Plan assets [member]; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value of plan assets [text block]",
        "terseLabel": "Schedule of Plan Asset Categories"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfPlanAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinanceCostExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of finance cost. [Refer: Finance costs]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of finance cost [text block]",
        "terseLabel": "FINANCE COSTS\u2014NET"
       }
      }
     },
     "localname": "DisclosureOfFinanceCostExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of finance income (cost) [text block]",
        "terseLabel": "Schedule of Finance Costs\u2014Net"
       }
      }
     },
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets that are either past due or impaired. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [text block]",
        "terseLabel": "Schedule of Aging of Total Trade Receivables\u2014Net"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [abstract]",
        "terseLabel": "Disclosure of detailed information about financial instruments [abstract]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial instruments measured at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments at fair value through profit or loss [text block]",
        "terseLabel": "Schedule of Financial Assets and Liabilities by Categories"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments [text block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [line items]",
        "terseLabel": "Disclosure of detailed information about financial instruments [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "auth_ref": [
      "r236",
      "r243",
      "r250"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [table]",
        "terseLabel": "Disclosure of detailed information about financial instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial risk management [text block]",
        "terseLabel": "FINANCIAL RISK MANAGEMENT"
       }
      }
     },
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "GENERAL INFORMATION"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/GENERALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [abstract]",
        "terseLabel": "Disclosure of geographical areas [abstract]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [text block]",
        "verboseLabel": "INFORMATION BY GEOGRAPHIC AREA"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [line items]",
        "terseLabel": "Disclosure of geographical areas [line items]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
      "http://www.constellium.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasTable": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to geographical areas."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [table]",
        "terseLabel": "Disclosure of geographical areas [table]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
      "http://www.constellium.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for government grants."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of government grants [text block]",
        "terseLabel": "COVID-19-RELATED GOVERNMENT ASSISTANCE"
       }
      }
     },
     "localname": "DisclosureOfGovernmentGrantsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "INCOME TAX",
        "verboseLabel": "DEFERRED INCOME TAXES"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXES",
      "http://www.constellium.com/role/INCOMETAX"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options)."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of indirect measurement of fair value of goods or services received, other equity instruments granted during period [text block]",
        "terseLabel": "Schedule of Inputs to the Model Used for PSUs Granted"
       }
      }
     },
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsExplanatory": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about the terms and conditions of hedging instruments and how they affect future cash flows. [Refer: Hedging instruments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [text block]",
        "terseLabel": "Schedule of Nominal Value of Derivatives"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]",
        "terseLabel": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the terms and conditions of hedging instruments and how they affect future cash flows."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]",
        "terseLabel": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets and goodwill [text block]",
        "terseLabel": "INTANGIBLE ASSETS AND GOODWILL"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILL"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of interests in subsidiaries [text block]",
        "terseLabel": "SUBSIDIARIES AND AFFILIATES"
       }
      }
     },
     "localname": "DisclosureOfInterestsInSubsidiariesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of inventories [text block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "DisclosureOfInventoriesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIssuedCapitalExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of issued capital [text block]",
        "terseLabel": "Schedule of Share Capital"
       }
      }
     },
     "localname": "DisclosureOfIssuedCapitalExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]",
        "terseLabel": "Disclosure of nature and extent of risks arising from financial instruments [line items]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [table]",
        "terseLabel": "Disclosure of nature and extent of risks arising from financial instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [text block]",
        "terseLabel": "Schedule of Movement in Net Defined Benefit Obligations"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [line items]",
        "terseLabel": "Disclosure of net defined benefit liability (asset) [line items]"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [table]",
        "terseLabel": "Disclosure of net defined benefit liability (asset) [table]"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [abstract]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [table]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-current assets or disposal groups classified as held for sale [text block]",
        "terseLabel": "DISPOSAL GROUP CLASSIFIED AS HELD FOR SALE"
       }
      }
     },
     "localname": "DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]",
        "terseLabel": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [text block]",
        "terseLabel": "Schedule of Segment Revenue"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [line items]",
        "terseLabel": "Disclosure of operating segments [line items]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]",
        "terseLabel": "Disclosure of operating segments [table]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherProvisionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [abstract]",
        "terseLabel": "Disclosure of other provisions [abstract]"
       }
      }
     },
     "localname": "DisclosureOfOtherProvisionsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherProvisionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [line items]",
        "terseLabel": "Disclosure of other provisions [line items]"
       }
      }
     },
     "localname": "DisclosureOfOtherProvisionsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherProvisionsTable": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to other provisions."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [table]",
        "terseLabel": "Disclosure of other provisions [table]"
       }
      }
     },
     "localname": "DisclosureOfOtherProvisionsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfProductsAndServicesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of products and services [line items]",
        "terseLabel": "Disclosure of products and services [line items]"
       }
      }
     },
     "localname": "DisclosureOfProductsAndServicesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfProductsAndServicesTable": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the entity's products and services."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of products and services [table]",
        "terseLabel": "Disclosure of products and services [table]"
       }
      }
     },
     "localname": "DisclosureOfProductsAndServicesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]",
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]",
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTDepreciationExpenseDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfProvisionsExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of provisions [text block]",
        "terseLabel": "PROVISIONS"
       }
      }
     },
     "localname": "DisclosureOfProvisionsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Schedule of Right of Use Assets"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [text block]",
        "terseLabel": "Schedule of Changes in Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [line items]",
        "terseLabel": "Disclosure of reconciliation of changes in intangible assets and goodwill [line items]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]",
        "terseLabel": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "RELATED PARTIES"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "auth_ref": [
      "r201",
      "r202"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of revenue from contracts with customers [text block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingExplanatory": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of risk management strategy related to hedge accounting."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of risk management strategy related to hedge accounting [text block]",
        "terseLabel": "Schedule of Effect of Foreign Currency Derivatives Impacts in Consolidated Income Statement and Statement of Comprehensive Income"
       }
      }
     },
     "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]",
        "terseLabel": "Schedule of Sensitivity Analysis and Actuarial Assumptions"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [line items]",
        "terseLabel": "Disclosure of sensitivity analysis for actuarial assumptions [line items]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]",
        "terseLabel": "Disclosure of sensitivity analysis for actuarial assumptions [table]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "SHARE CAPITAL"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITAL"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share-based payment arrangements [text block]",
        "terseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [abstract]",
        "terseLabel": "Disclosure of subsidiaries [abstract]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r114",
      "r117",
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "Schedule of Group's Affiliates and Legal Entities Included in Consolidated Financial Statements"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [line items]",
        "terseLabel": "Disclosure of subsidiaries [line items]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "auth_ref": [
      "r114",
      "r117",
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]",
        "terseLabel": "Disclosure of subsidiaries [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]",
        "terseLabel": "Schedule of Income Tax Reconciliation Using Composite Statutory Income Tax Rate Applicable by Tax Jurisdiction"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other payables [text block]",
        "terseLabel": "TRADE PAYABLES AND OTHER"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHER"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other receivables [text block]",
        "terseLabel": "TRADE RECEIVABLES AND OTHER"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHER"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [abstract]",
        "terseLabel": "Disclosure of transactions between related parties [abstract]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [text block]",
        "terseLabel": "Schedule of Key Management Personnel Compensation"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember": {
     "auth_ref": [
      "r222",
      "r410"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for groups of assets, which are to be disposed of together as a group in a single transaction, and the liabilities directly associated with those assets that will be transferred in the transaction."
       }
      },
      "en-us": {
       "role": {
        "label": "Disposal groups classified as held for sale [member]",
        "terseLabel": "Disposal groups classified as held for sale [member]"
       }
      }
     },
     "localname": "DisposalGroupsClassifiedAsHeldForSaleMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DisposalOfMajorSubsidiaryMember": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the disposal of a major subsidiary. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposal of major subsidiary [member]",
        "terseLabel": "Disposal of major subsidiary [member]"
       }
      }
     },
     "localname": "DisposalOfMajorSubsidiaryMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, property, plant and equipment",
        "negatedLabel": "Disposals",
        "negatedTerseLabel": "Disposals"
       }
      }
     },
     "localname": "DisposalsPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests, classified as financing activities",
        "negatedLabel": "Transactions with non-controlling interests"
       }
      }
     },
     "localname": "DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to non-controlling interests",
        "negatedTerseLabel": "Transactions with non-controlling interests"
       }
      }
     },
     "localname": "DividendsRecognisedAsDistributionsToNoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [abstract]",
        "terseLabel": "Earnings per share attributable to the equity holders of Constellium (in Euros)"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r157",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EliminationOfIntersegmentAmountsMember": {
     "auth_ref": [
      "r340",
      "r341"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the elimination of intersegment amounts in the reconciliations of total segment amounts to amounts recognised in the entity's financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Elimination of intersegment amounts [member]",
        "terseLabel": "Inter-segment elimination"
       }
      }
     },
     "localname": "EliminationOfIntersegmentAmountsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "auth_ref": [
      "r1",
      "r51",
      "r290"
     ],
     "calculation": {
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Employee benefits expense",
        "negatedLabel": "Employee benefit expenses",
        "negatedTotalLabel": "Total employee benefit expenses"
       }
      }
     },
     "localname": "EmployeeBenefitsExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails",
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EmployerContributions": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of employer contributions to retirement benefit plans."
       }
      },
      "en-us": {
       "role": {
        "label": "Employer contributions",
        "negatedTerseLabel": "Contributions by the Group"
       }
      }
     },
     "localname": "EmployerContributions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EnergyExpense": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from the consumption of energy."
       }
      },
      "en-us": {
       "role": {
        "label": "Energy expense",
        "negatedLabel": "Energy costs"
       }
      }
     },
     "localname": "EnergyExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForExternalCreditGradesMember": {
     "auth_ref": [
      "r285",
      "r325",
      "r334",
      "r347",
      "r350"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'External credit grades' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for external credit grades [member]",
        "terseLabel": "Entity's total for external credit grades [member]"
       }
      }
     },
     "localname": "EntitysTotalForExternalCreditGradesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForIndividualAssetsOrCashgeneratingUnitsMember": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Individual assets or cash-generating units' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for individual assets or cash-generating units [member]",
        "terseLabel": "Entity's total for individual assets or cash-generating units [member]"
       }
      }
     },
     "localname": "EntitysTotalForIndividualAssetsOrCashgeneratingUnitsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]",
        "terseLabel": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for segment consolidation items [member]",
        "terseLabel": "Entity's total for segment consolidation items [member]"
       }
      }
     },
     "localname": "EntitysTotalForSegmentConsolidationItemsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSubsidiariesMember": {
     "auth_ref": [
      "r114",
      "r117",
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for subsidiaries [member]",
        "terseLabel": "Entity's total for subsidiaries [member]"
       }
      }
     },
     "localname": "EntitysTotalForSubsidiariesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r22",
      "r32",
      "r167",
      "r169",
      "r188",
      "r189",
      "r190"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [abstract]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total Equity and Liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent",
        "totalLabel": "Equity attributable to equity holders of Constellium"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityInstrumentsAmountContributedToFairValueOfPlanAssets": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_PlanAssetsAtFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount instruments representing equity (rather than debt) contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity instruments, amount contributed to fair value of plan assets",
        "terseLabel": "Equities"
       }
      }
     },
     "localname": "EquityInstrumentsAmountContributedToFairValueOfPlanAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]",
        "terseLabel": "Equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan": {
     "auth_ref": [
      "r87",
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimate of contributions expected to be paid to plan for next annual reporting period",
        "terseLabel": "Expected contributions to pension and other benefits for next year"
       }
      }
     },
     "localname": "EstimateOfContributionsExpectedToBePaidToPlan",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "negatedLabel": "Share-based compensation",
        "terseLabel": "Expense from share-based payment transactions with employees"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseOfRestructuringActivities": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense of restructuring activities",
        "negatedLabel": "Restructuring costs"
       }
      }
     },
     "localname": "ExpenseOfRestructuringActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [
      "r206"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense relating to leases of low-value assets for which recognition exemption has been used",
        "verboseLabel": "Low-value asset recognition exemption to leased assets"
       }
      }
     },
     "localname": "ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExternalCreditGradesAxis": {
     "auth_ref": [
      "r285",
      "r325",
      "r334",
      "r347",
      "r350"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "External credit grades [axis]",
        "terseLabel": "External credit grades [axis]"
       }
      }
     },
     "localname": "ExternalCreditGradesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_FactoringOfReceivablesMember": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for transactions in which an entity transfers its receivables to another party (the factor)."
       }
      },
      "en-us": {
       "role": {
        "label": "Factoring of receivables [member]",
        "terseLabel": "Factoring of receivables"
       }
      }
     },
     "localname": "FactoringOfReceivablesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedTotalLabel": "Finance expenses"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeCost": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      },
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "terseLabel": "Finance costs - net",
        "totalLabel": "Finance costs - net"
       }
      }
     },
     "localname": "FinanceIncomeCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r235",
      "r240",
      "r241",
      "r245",
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets",
        "terseLabel": "Financial assets"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtAmortisedCostMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets measured at amortised cost class. [Refer: Financial assets at amortised cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at amortised cost, class [member]",
        "terseLabel": "At amortized cost"
       }
      }
     },
     "localname": "FinancialAssetsAtAmortisedCostMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, at fair value",
        "terseLabel": "Financial assets"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets at fair value through other comprehensive income category. [Refer: Financial assets at fair value through other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at fair value through other comprehensive income, category [member]",
        "terseLabel": "At fair value through OCI"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets at fair value through profit or loss category. [Refer: Financial assets at fair value through profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at fair value through profit or loss, category [member]",
        "terseLabel": "At fair value through profit and loss"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsCategoryMember": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, category [member]",
        "terseLabel": "Financial assets, category [member]"
       }
      }
     },
     "localname": "FinancialAssetsCategoryMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets held for managing liquidity risk (for example, financial assets that are readily saleable or expected to generate cash inflows to meet cash outflows on financial liabilities). [Refer: Liquidity risk [member]; Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets held for managing liquidity risk",
        "terseLabel": "Liquidity value"
       }
      }
     },
     "localname": "FinancialAssetsHeldForManagingLiquidityRisk",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsMember": {
     "auth_ref": [
      "r248",
      "r249",
      "r271",
      "r281",
      "r282",
      "r283"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]",
        "terseLabel": "Financial assets, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis]",
        "terseLabel": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis]"
       }
      }
     },
     "localname": "FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for financial instruments measured at fair value through profit or loss, because a credit derivative is used to manage the credit risk of these instruments. It also represents the standard value for the 'Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk' axis if no other member is used. [Refer: Financial instruments, class [member]; Credit risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [member]",
        "terseLabel": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [member]"
       }
      }
     },
     "localname": "FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities",
        "terseLabel": "Financial liabilities"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities at amortised cost, class [member]",
        "terseLabel": "At amortized cost"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtAmortisedCostMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, at fair value",
        "terseLabel": "Financial liabilities"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtFairValue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities at fair value through profit or loss category. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities at fair value through profit or loss, category [member]",
        "terseLabel": "At fair value through profit and loss"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilitiesCategoryMember": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, category [member]",
        "terseLabel": "Financial liabilities, category [member]"
       }
      }
     },
     "localname": "FinancialLiabilitiesCategoryMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilitiesMember": {
     "auth_ref": [
      "r248",
      "r249",
      "r271",
      "r282"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, class [member]",
        "terseLabel": "Financial liabilities, class [member]"
       }
      }
     },
     "localname": "FinancialLiabilitiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinishedGoods": {
     "auth_ref": [
      "r296",
      "r394"
     ],
     "calculation": {
      "http://www.constellium.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_InventoriesAtNetRealisableValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current finished goods",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "FinishedGoods",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gain (loss) arising from the difference between the carrying amount of the financial liability extinguished and the measurement of the consideration paid (equity instruments issued) to the creditor. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gain (loss) arising from difference between carrying amount of financial liability extinguished and consideration paid",
        "terseLabel": "Net loss on settlement of debt"
       }
      }
     },
     "localname": "GainLossArisingFromDifferenceBetweenCarryingAmountOfFinancialLiabilityExtinguishedAndConsiderationPaid",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r230",
      "r231"
     ],
     "calculation": {
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
       "weight": 1.0
      },
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gain (loss) recognised in profit or loss on hedge ineffectiveness. [Refer: Gain (loss) on hedge ineffectiveness]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gain (loss) on hedge ineffectiveness recognised in profit or loss",
        "negatedLabel": "Losses reclassified from OCI as a result of hedge accounting discontinuation",
        "terseLabel": "Losses reclassified from OCI as a result of hedge accounting discontinuation"
       }
      }
     },
     "localname": "GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandCommercialTransactionsExposuresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income [abstract]",
        "terseLabel": "Remeasurements due to:"
       }
      }
     },
     "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAssetAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on change in fair value of derivatives",
        "terseLabel": "Total",
        "verboseLabel": "Realized and unrealized (losses) / gains on debt derivatives at fair value"
       }
      }
     },
     "localname": "GainsLossesOnChangeInFairValueOfDerivatives",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnDisposalsOfNoncurrentAssets": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) on disposals of non-current assets. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on disposals of non-current assets",
        "terseLabel": "Losses on disposal"
       }
      }
     },
     "localname": "GainsLossesOnDisposalsOfNoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, before tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on exchange differences on translation of foreign operations, before tax",
        "negatedLabel": "Effect of currency translation differences"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationBeforeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESForeignCurrencyTranslationReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r8",
      "r94"
     ],
     "calculation": {
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Foreign exchange gain (loss)",
        "totalLabel": "Total currency gains / (losses) - net"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESCurrencyGainsandLossesIncludedinIncomefromOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r268",
      "r300",
      "r321",
      "r344"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]",
        "terseLabel": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r268",
      "r300",
      "r321",
      "r344"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]",
        "terseLabel": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GoodsOrServicesTransferredOverTimeMember": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goods or services transferred to customers over time. [Refer: Performance obligations satisfied over time [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goods or services transferred over time [member]",
        "terseLabel": "Revenue recognized over time"
       }
      }
     },
     "localname": "GoodsOrServicesTransferredOverTimeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Goodwill": {
     "auth_ref": [
      "r11",
      "r126",
      "r131",
      "r218"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r63",
      "r140",
      "r149",
      "r152",
      "r218",
      "r241",
      "r245",
      "r326",
      "r415",
      "r417"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "auth_ref": [
      "r208",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross lease liabilities",
        "terseLabel": "Gross lease liabilities"
       }
      }
     },
     "localname": "GrossLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_HedgingInstrumentsAxis": {
     "auth_ref": [
      "r225",
      "r228"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedging instruments [axis]",
        "terseLabel": "Hedging instruments [axis]"
       }
      }
     },
     "localname": "HedgingInstrumentsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_HedgingInstrumentsMember": {
     "auth_ref": [
      "r225",
      "r228"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedging instruments [member]",
        "terseLabel": "Hedging instruments [member]"
       }
      }
     },
     "localname": "HedgingInstrumentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ImpairmentLoss": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss",
        "terseLabel": "Impairment charges related to cash-generating units"
       }
      }
     },
     "localname": "ImpairmentLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, goodwill",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]",
        "terseLabel": "Profit or loss [abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r46",
      "r54",
      "r56",
      "r57",
      "r111",
      "r186",
      "r260"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT_1": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      },
      "http://www.constellium.com/role/INCOMETAXCurrentandDeferredComponentsofIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "negatedLabel": "Income tax benefit / (expense)",
        "negatedTotalLabel": "Income tax benefit / (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
      "http://www.constellium.com/role/INCOMETAXCurrentandDeferredComponentsofIncomeTaxDetails",
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome": {
     "auth_ref": [
      "r47",
      "r55"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to cash flow hedges included in other comprehensive income",
        "negatedLabel": "Income tax on cash flow hedges"
       }
      }
     },
     "localname": "IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome": {
     "auth_ref": [
      "r47",
      "r55"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to components of other comprehensive income",
        "terseLabel": "Recognized in OCI"
       }
      }
     },
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome": {
     "auth_ref": [
      "r47",
      "r55"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to remeasurements of defined benefit plans. [Refer: Other comprehensive income; Reserve of remeasurements of defined benefit plans; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to remeasurements of defined benefit plans included in other comprehensive income",
        "negatedLabel": "Income tax on remeasurement on post-employment benefit obligations"
       }
      }
     },
     "localname": "IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r160",
      "r313"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund), classified as operating activities",
        "negatedLabel": "Income tax (paid) / refunded"
       }
      }
     },
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes",
        "totalLabel": "Net increase / (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption",
        "terseLabel": "50 bp decrease in discount rates"
       }
      }
     },
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption",
        "terseLabel": "50 bp increase in discount rates"
       }
      }
     },
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of ordinary shares issued",
        "terseLabel": "New shares issued (in shares)"
       }
      }
     },
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_IncreaseDecreaseInWorkingCapital": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in working capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in working capital",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInWorkingCapital",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from a change in discount rate. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through change in discount rate, other provisions",
        "terseLabel": "Unwinding of discounts and change in discount rates"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangeInDiscountRateOtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)",
        "terseLabel": "Effects of changes in foreign exchange rates"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, deferred tax liability (asset)",
        "terseLabel": "FX"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESChangesinNetDeferredIncomeTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, goodwill",
        "terseLabel": "Effect of changes in foreign exchange rates"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill",
        "terseLabel": "Effect of changes in foreign exchange rates"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, other provisions",
        "terseLabel": "Effects of changes in foreign exchange rates"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment",
        "terseLabel": "Effect of changes in foreign exchange rates"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets and goodwill resulting from transfers. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers, intangible assets and goodwill",
        "terseLabel": "Transfer"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers, property, plant and equipment",
        "terseLabel": "Transfer and other changes"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IndividualAssetsOrCashgeneratingUnitsAxis": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Individual assets or cash-generating units [axis]",
        "terseLabel": "Individual assets or cash-generating units [axis]"
       }
      }
     },
     "localname": "IndividualAssetsOrCashgeneratingUnitsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [abstract]",
        "terseLabel": "Intangible assets and goodwill [abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwillMember": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [member]",
        "terseLabel": "Intangible assets and goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r11",
      "r144"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill",
        "periodEndLabel": "Intangible assets (excluding goodwill), ending balance",
        "periodStartLabel": "Intangible assets (excluding goodwill), beginning balance",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r145",
      "r307",
      "r324"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]",
        "terseLabel": "Intangible assets other than goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestExpenseOnBorrowings": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on borrowings",
        "negatedLabel": "Interest expense on borrowings"
       }
      }
     },
     "localname": "InterestExpenseOnBorrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnDebtInstrumentsIssued": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on debt instruments issued. [Refer: Interest expense; Debt instruments issued]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on debt instruments issued",
        "terseLabel": "Interest expense on debt instruments issued"
       }
      }
     },
     "localname": "InterestExpenseOnDebtInstrumentsIssued",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "negatedLabel": "Interest expense on leases"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as operating activities",
        "negatedLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRevenueExpense": {
     "auth_ref": [
      "r261",
      "r265",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or expense arising from interest. [Refer: Interest expense; Interest income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest income (expense)",
        "terseLabel": "Interest cost / (income)"
       }
      }
     },
     "localname": "InterestRevenueExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoriesAtNetRealisableValue": {
     "auth_ref": [
      "r393"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.constellium.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of inventories carried at net realisable value. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventories, at net realisable value",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoriesAtNetRealisableValue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
      "http://www.constellium.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfEquity": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "terseLabel": "New shares issued"
       }
      }
     },
     "localname": "IssueOfEquity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, post-employment benefits",
        "terseLabel": "Post-employments benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, share-based payment",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, short-term employee benefits",
        "terseLabel": "Short-term employee benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, termination benefits",
        "terseLabel": "Termination benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationTerminationBenefits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESKeyManagementPersonnelCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel of entity or parent [member]",
        "terseLabel": "Board Members"
       }
      }
     },
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r280",
      "r329",
      "r332",
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than five years [member]",
        "terseLabel": "Over 5 years"
       }
      }
     },
     "localname": "LaterThanFiveYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember": {
     "auth_ref": [
      "r326",
      "r335",
      "r370",
      "r416"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one month and not later than two months."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one month and not later than two months [member]",
        "terseLabel": "31 \u2013 60 days past due"
       }
      }
     },
     "localname": "LaterThanOneMonthAndNotLaterThanTwoMonthsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r328",
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year and not later than five years [member]",
        "terseLabel": "Between 1- 5 years",
        "verboseLabel": "1 to 5 years"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearMember": {
     "auth_ref": [
      "r25",
      "r348",
      "r352"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year [member]",
        "terseLabel": "Over 1 year"
       }
      }
     },
     "localname": "LaterThanOneYearMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LegalProceedingsProvision": {
     "auth_ref": [
      "r309",
      "r311"
     ],
     "calculation": {
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of provision for legal proceedings. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Legal proceedings provision",
        "totalLabel": "Total provisions for legal claims and other costs"
       }
      }
     },
     "localname": "LegalProceedingsProvision",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LegalProceedingsProvisionMember": {
     "auth_ref": [
      "r309",
      "r311"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a provision for legal proceedings. [Refer: Other provisions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Legal proceedings provision [member]",
        "terseLabel": "Legal claims and other costs"
       }
      }
     },
     "localname": "LegalProceedingsProvisionMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "auth_ref": [
      "r84",
      "r189"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 1 of fair value hierarchy [member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "Level1OfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "Level2OfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "Level3OfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "auth_ref": [
      "r84",
      "r189"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]",
        "terseLabel": "Levels of fair value hierarchy [axis]"
       }
      }
     },
     "localname": "LevelsOfFairValueHierarchyAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSDerivativesMeasuredatFairValueDetails",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r22",
      "r188",
      "r189",
      "r190",
      "r261",
      "r264"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": {
     "auth_ref": [
      "r19",
      "r221"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 3.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities included in disposal groups classified as held for sale",
        "terseLabel": "Liabilities of disposal group classified as held for sale",
        "totalLabel": "Liabilities of disposal group classified as held for sale"
       }
      }
     },
     "localname": "LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset)",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Net defined benefit liability"
       }
      }
     },
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LineItemsByFunctionMember": {
     "auth_ref": [
      "r368",
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Line items by function [member]",
        "terseLabel": "Line items by function [member]"
       }
      }
     },
     "localname": "LineItemsByFunctionMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LoansAndReceivables": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]"
       }
      }
     },
     "localname": "LoansAndReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermBorrowings": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails_1": {
       "order": 1.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      },
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current portion of non-current borrowings",
        "terseLabel": "Borrowings",
        "verboseLabel": "Non-current borrowings"
       }
      }
     },
     "localname": "LongtermBorrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MajorCustomersAxis": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Major customers [axis]",
        "terseLabel": "Major customers [axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersMember": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Customers [member]",
        "terseLabel": "Major customers [member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r26",
      "r199",
      "r209",
      "r210",
      "r226",
      "r247",
      "r272",
      "r273",
      "r274",
      "r280",
      "r305",
      "r329"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]",
        "terseLabel": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails",
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MaximumExposureToCreditRisk": {
     "auth_ref": [
      "r242",
      "r287"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Maximum exposure to credit risk",
        "terseLabel": "Exposure"
       }
      }
     },
     "localname": "MaximumExposureToCreditRisk",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTExposuretoFinancialCounterpartiesbyRatingTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MeasurementAxis": {
     "auth_ref": [
      "r147",
      "r151",
      "r188"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Measurement [axis]",
        "terseLabel": "Measurement [axis]"
       }
      }
     },
     "localname": "MeasurementAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating expense",
        "negatedLabel": "Other operating expenses"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MiscellaneousOtherProvisions": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_LegalProceedingsProvision",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other provisions. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other provisions",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "MiscellaneousOtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetDeferredTaxAssets": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNetDeferredIncomeTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net deferred tax assets",
        "totalLabel": "Net deferred income tax assets"
       }
      }
     },
     "localname": "NetDeferredTaxAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESNetDeferredIncomeTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [axis]",
        "terseLabel": "Net defined benefit liability (asset) [axis]"
       }
      }
     },
     "localname": "NetDefinedBenefitLiabilityAssetAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [member]",
        "terseLabel": "Net defined benefit liability (asset) [member]"
       }
      }
     },
     "localname": "NetDefinedBenefitLiabilityAssetMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NominalAmountOfHedgingInstrument": {
     "auth_ref": [
      "r226",
      "r227"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal amount of a hedging instrument. [Refer: Hedging instruments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Nominal amount of hedging instrument",
        "terseLabel": "Nominal value"
       }
      }
     },
     "localname": "NominalAmountOfHedgingInstrument",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]",
        "terseLabel": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsMember": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]",
        "terseLabel": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "NonadjustingEventsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncontrollingInterests": {
     "auth_ref": [
      "r20",
      "r171",
      "r174"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r27",
      "r178",
      "r317"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets or disposal groups classified as held for sale",
        "terseLabel": "Assets of disposal group classified as held for sale",
        "totalLabel": "Non-current assets or disposal groups classified as held for sale"
       }
      }
     },
     "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentContractAssets": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 3.0,
       "parentTag": "cstm_OtherReceivablesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current contract assets. [Refer: Contract assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current contract assets",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "NoncurrentContractAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentContractLiabilities": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 4.0,
       "parentTag": "cstm_OtherNoncurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current contract liabilities",
        "terseLabel": "Contract liabilities and other liabilities to customers",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentContractLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERContractLiabilitiesandOtherLiabilitiestoCustomersDetails",
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentDerivativeFinancialAssets": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_DerivativeFinancialAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial assets. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current derivative financial assets",
        "terseLabel": "Non-current derivatives assets"
       }
      }
     },
     "localname": "NoncurrentDerivativeFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_DerivativeFinancialLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current derivative financial liabilities",
        "terseLabel": "Non-current derivatives liabilities"
       }
      }
     },
     "localname": "NoncurrentDerivativeFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r28",
      "r179",
      "r317"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentLoansAndReceivables": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_LoansAndReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current loans and receivables. [Refer: Loans and receivables]"
       }
      }
     },
     "localname": "NoncurrentLoansAndReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentPayables": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other non-current payables",
        "terseLabel": "Trade payables and other",
        "totalLabel": "Total trade payables and other"
       }
      }
     },
     "localname": "NoncurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other non-current payables [abstract]",
        "terseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentPayablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 1.0,
       "parentTag": "cstm_OtherNoncurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current payables for the purchase of non-current assets. [Refer: Payables for purchase of non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current payables for purchase of non-current assets",
        "terseLabel": "Fixed assets payables"
       }
      }
     },
     "localname": "NoncurrentPayablesForPurchaseOfNoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 3.0,
       "parentTag": "cstm_OtherNoncurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current payables on social security and taxes other than income tax",
        "terseLabel": "Taxes payable other than income tax"
       }
      }
     },
     "localname": "NoncurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentPayablesToTradeSuppliers": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current amount of payment due to suppliers for goods and services used in the entity's business. [Refer: Trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current trade payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "NoncurrentPayablesToTradeSuppliers",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentReceivables": {
     "auth_ref": [
      "r13",
      "r30"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      },
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other non-current receivables",
        "totalLabel": "Total trade receivables and other",
        "verboseLabel": "Trade receivables and other"
       }
      }
     },
     "localname": "NoncurrentReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other non-current receivables [abstract]",
        "terseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentReceivablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax": {
     "auth_ref": [
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current receivables from taxes other than income tax",
        "terseLabel": "Other tax receivables"
       }
      }
     },
     "localname": "NoncurrentReceivablesFromTaxesOtherThanIncomeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current net defined benefit liability",
        "terseLabel": "Pension and other post-employment benefit obligations",
        "totalLabel": "Net liability / (asset) arising from defined benefit obligation"
       }
      }
     },
     "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentTradeReceivables": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current trade receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "NoncurrentTradeReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r24",
      "r209",
      "r210",
      "r280",
      "r329",
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than one year [member]",
        "terseLabel": "Less than 1 year"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSNoncancellableLeaseCommitmentsNotCapitalizedDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotionalAmount": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      },
      "en-us": {
       "role": {
        "label": "Notional amount",
        "terseLabel": "Nominal value",
        "verboseLabel": "Debt issued"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSBorrowingsbyNatureDetails",
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NumberOfEmployees": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of personnel employed by the entity at a date."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of employees",
        "terseLabel": "Number of employees"
       }
      }
     },
     "localname": "NumberOfEmployees",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/GENERALINFORMATIONDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "auth_ref": [
      "r214",
      "r409"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Potential Shares, Granted (in shares)",
        "verboseLabel": "Potential additional shares granted (in shares)"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments forfeited in share-based payment arrangement",
        "negatedLabel": "Potential Shares, Forfeited (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments outstanding in share-based payment arrangement",
        "periodEndLabel": "Potential Shares, Ending balance (in shares)",
        "periodStartLabel": "Potential Shares, Beginning balance (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesIssuedAndFullyPaid": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity, for which full payment has been received."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued and fully paid",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Number of ordinary shares (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssuedAndFullyPaid",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails",
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OperatingExpense": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      },
      "en-us": {
       "role": {
        "label": "Operating expense",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OperatingSegmentsMember": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Operating segments [member]",
        "terseLabel": "Segment revenue"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OrdinarySharesMember": {
     "auth_ref": [
      "r118",
      "r375"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]",
        "terseLabel": "Ordinary shares"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALDetails",
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherAssetsAmountContributedToFairValueOfPlanAssets": {
     "auth_ref": [
      "r386"
     ],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_PlanAssetsAtFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount other types of assets not separately disclosed contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets, amount contributed to fair value of plan assets",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsAmountContributedToFairValueOfPlanAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r4",
      "r39",
      "r48",
      "r181"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive income / (loss)",
        "totalLabel": "Other comprehensive income / (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income [abstract]",
        "terseLabel": "Other comprehensive income / (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTaxCashFlowHedges": {
     "auth_ref": [
      "r29",
      "r49"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income, before tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, before tax, cash flow hedges",
        "terseLabel": "Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": {
     "auth_ref": [
      "r29",
      "r49",
      "r383"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans",
        "terseLabel": "Remeasurement on post-employment benefit obligations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r29",
      "r48"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentFinancialAssets": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current financial assets",
        "verboseLabel": "Other financial assets"
       }
      }
     },
     "localname": "OtherCurrentFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentFinancialLiabilities": {
     "auth_ref": [
      "r16",
      "r183"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current financial liabilities",
        "verboseLabel": "Other financial liabilities"
       }
      }
     },
     "localname": "OtherCurrentFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentPayables": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 5.0,
       "parentTag": "cstm_OtherCurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other current payables",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherCurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentReceivables": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "totalLabel": "Total other receivables"
       }
      }
     },
     "localname": "OtherCurrentReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherFinanceIncomeCost": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://www.constellium.com/role/FINANCECOSTSNETDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other finance income (cost)",
        "terseLabel": "Other finance expenses"
       }
      }
     },
     "localname": "OtherFinanceIncomeCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherFinancialAssets": {
     "auth_ref": [
      "r12"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other financial assets",
        "terseLabel": "Other financial assets"
       }
      }
     },
     "localname": "OtherFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherGainsLosses": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": -1.0
      },
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other gains (losses)",
        "terseLabel": "Other gains and losses - net",
        "totalLabel": "Total other gains and losses - net"
       }
      }
     },
     "localname": "OtherGainsLosses",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other inflows (outflows) of cash, classified as financing activities",
        "terseLabel": "Other financing activities",
        "verboseLabel": "Other financing activities"
       }
      }
     },
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSOtherFinancialAssetsandOtherFinancialLiabilitiesPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as investing activities, that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other inflows (outflows) of cash, classified as investing activities",
        "terseLabel": "Other investing activities"
       }
      }
     },
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as operating activities, that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other inflows (outflows) of cash, classified as operating activities",
        "terseLabel": "Other - net"
       }
      }
     },
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other intangible assets [member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherLongtermBenefits": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of long-term employee benefits other than post-employment benefits and termination benefits. Such benefits may include long-term paid absences, jubilee or other long-service benefits, long-term disability benefits, long-term profit-sharing and bonuses and long-term deferred remuneration. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other long-term employee benefits",
        "negatedLabel": "Other post-employment benefits"
       }
      }
     },
     "localname": "OtherLongtermBenefits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherLongtermProvisions": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherProvisions",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current provisions",
        "terseLabel": "Non-Current",
        "verboseLabel": "Provisions"
       }
      }
     },
     "localname": "OtherLongtermProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentFinancialAssets": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current financial assets",
        "terseLabel": "Other financial assets"
       }
      }
     },
     "localname": "OtherNoncurrentFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentFinancialLiabilities": {
     "auth_ref": [
      "r16",
      "r184"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current financial liabilities",
        "terseLabel": "Other financial liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentPayables": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 5.0,
       "parentTag": "cstm_OtherNoncurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current payables",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherNoncurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherPropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other property, plant and equipment [member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPropertyPlantAndEquipmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherProvisions": {
     "auth_ref": [
      "r31",
      "r132"
     ],
     "calculation": {
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other provisions",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Provisions"
       }
      }
     },
     "localname": "OtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherProvisionsMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other provisions [member]",
        "terseLabel": "Other provisions [member]"
       }
      }
     },
     "localname": "OtherProvisionsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherReservesMember": {
     "auth_ref": [
      "r6",
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. It also represents the standard value for the 'Reserves within equity' axis if no other member is used. [Refer: Retained earnings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other reserves [member]",
        "terseLabel": "Other reserves"
       }
      }
     },
     "localname": "OtherReservesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherShorttermProvisions": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherProvisions",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current provisions",
        "terseLabel": "Current",
        "verboseLabel": "Provisions"
       }
      }
     },
     "localname": "OtherShorttermProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherTemporaryDifferencesMember": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences that the entity does not separately disclose in the same statement or note. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other temporary differences [member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTemporaryDifferencesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Nominal value of ordinary fully-paid shares (in EUR per share)"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHARECAPITALNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PastDueStatusAxis": {
     "auth_ref": [
      "r326",
      "r416"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Past due status [axis]",
        "terseLabel": "Past due status [axis]"
       }
      }
     },
     "localname": "PastDueStatusAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PastDueStatusMember": {
     "auth_ref": [
      "r326",
      "r416"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Past due status [member]",
        "terseLabel": "Past due status [member]"
       }
      }
     },
     "localname": "PastDueStatusMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from past service cost and losses (gains) arising from settlements. [Refer: Decrease (increase) in net defined benefit liability (asset) resulting from gains (losses) arising from settlements; Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from past service cost and losses (gains) arising from settlements",
        "negatedLabel": "Loss recognized on disputes about plan changes",
        "negatedTerseLabel": "Negative past service cost recorded to cancel gain originally recognized"
       }
      }
     },
     "localname": "PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OTHERGAINSANDLOSSESNETDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from past service cost. Past service cost is the change in the present value of the defined benefit obligation for employee service in prior periods, resulting from a plan amendment (the introduction or withdrawal of, or changes to, a defined benefit plan) or a curtailment (a significant reduction by the entity in the number of employees covered by a plan). [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from past service cost",
        "terseLabel": "Past service cost",
        "verboseLabel": "Increase (reduction) in pension obligation"
       }
      }
     },
     "localname": "PastServiceCostNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r315"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedTerseLabel": "Lease repayments"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PensionDefinedBenefitPlansMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for pension defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Pension defined benefit plans [member]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionDefinedBenefitPlansMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of entity's revenue",
        "terseLabel": "Percentage of payment option over total revenue"
       }
      }
     },
     "localname": "PercentageOfEntitysRevenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible increase in actuarial assumption",
        "terseLabel": "Increase in actuarial assumption"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSSensitivityAnalysisonDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PerformanceObligationsAxis": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Performance obligations [axis]",
        "terseLabel": "Performance obligations [axis]"
       }
      }
     },
     "localname": "PerformanceObligationsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PerformanceObligationsMember": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all performance obligations. A performance obligation is a promise in a contract with a customer to transfer to the customer either: (a) a good or service (or a bundle of goods or services) that is distinct; or (b) a series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer. This member also represents the standard value for the 'Performance obligations' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Performance obligations [member]",
        "terseLabel": "Performance obligations [member]"
       }
      }
     },
     "localname": "PerformanceObligationsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PlanAssetsAtFairValue": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": 1.0
      },
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_LiabilityAssetOfDefinedBenefitPlans",
       "weight": -1.0
      },
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets, at fair value",
        "negatedLabel": "Fair value of plan assets",
        "negatedTerseLabel": "Plan assets",
        "totalLabel": "Total fair value of plan assets"
       }
      }
     },
     "localname": "PlanAssetsAtFairValue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNetDefinedBenefitObligationsbyCountryDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PlanAssetsMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for defined benefit plan assets. Plan assets comprise: (a) assets held by a long-term employee benefit fund; and (b) qualifying insurance policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets [member]",
        "terseLabel": "Plan Assets"
       }
      }
     },
     "localname": "PlanAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": {
     "auth_ref": [
      "r383",
      "r390"
     ],
     "calculation": {
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Post-employment benefit expense in profit or loss, defined benefit plans",
        "negatedLabel": "Pension costs - defined benefit plans"
       }
      }
     },
     "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PresentValueOfDefinedBenefitObligationMember": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the present value of a defined benefit obligation. The present value of a defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Present value of defined benefit obligation [member]",
        "terseLabel": "Defined benefit obligations"
       }
      }
     },
     "localname": "PresentValueOfDefinedBenefitObligationMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the disposal of non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations",
        "terseLabel": "Cash consideration received on sale of business"
       }
      }
     },
     "localname": "ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of bonds, notes and debentures."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issue of bonds, notes and debentures",
        "terseLabel": "Proceeds from issuance of long-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssueOfBondsNotesAndDebentures",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProductionSupplies": {
     "auth_ref": [
      "r296",
      "r394"
     ],
     "calculation": {
      "http://www.constellium.com/role/INVENTORIESDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_InventoriesAtNetRealisableValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of supplies to be used for the production process. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current production supplies",
        "terseLabel": "Stores and supplies"
       }
      }
     },
     "localname": "ProductionSupplies",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "auth_ref": [
      "r267",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [axis]",
        "terseLabel": "Products and services [axis]"
       }
      }
     },
     "localname": "ProductsAndServicesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProductsAndServicesMember": {
     "auth_ref": [
      "r267",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [member]",
        "terseLabel": "Products and services [member]"
       }
      }
     },
     "localname": "ProductsAndServicesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      },
      "en-us": {
       "role": {
        "label": "Professional fees expense",
        "negatedLabel": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFeesExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r38",
      "r155",
      "r168",
      "r170",
      "r261",
      "r262",
      "r317",
      "r342",
      "r346"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Net income / (loss)",
        "totalLabel": "Net income / (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOME",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to [abstract]",
        "terseLabel": "Net income / (loss) attributable to:"
       }
      }
     },
     "localname": "ProfitLossAttributableToAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r41",
      "r173"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to owners of parent",
        "terseLabel": "Equity holders of Constellium"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r219",
      "r290",
      "r291",
      "r338",
      "r339"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT_1": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "terseLabel": "Income / (loss) before tax",
        "totalLabel": "Income / (loss) before tax"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r306",
      "r376"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      },
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_PlanAssetsAtFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount real estate contributes to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Real estate, amount contributed to fair value of plan assets",
        "terseLabel": "Property"
       }
      }
     },
     "localname": "PropertyAmountContributedToFairValueOfPlanAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSPlanAssetCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r10",
      "r68"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/INFORMATIONBYGEOGRAPHICAREADetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [abstract]",
        "terseLabel": "Property, plant and equipment [abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r69",
      "r307",
      "r324"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]",
        "terseLabel": "Property, plant and equipment [member]",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COMMITMENTSTangibleandIntangibleAssetCommitmentsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r113",
      "r116",
      "r176"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "%\u00a0Group\u00a0Interest"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProvisionForDecommissioningRestorationAndRehabilitationCostsMember": {
     "auth_ref": [
      "r309",
      "r310"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a provision relating to decommissioning, restoration and rehabilitation costs. [Refer: Other provisions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Provision for decommissioning, restoration and rehabilitation costs [member]",
        "terseLabel": "Close down and environmental remediation costs"
       }
      }
     },
     "localname": "ProvisionForDecommissioningRestorationAndRehabilitationCostsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProvisionUsedOtherProvisions": {
     "auth_ref": [
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Provision used, other provisions",
        "negatedLabel": "Amounts used"
       }
      }
     },
     "localname": "ProvisionUsedOtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r314"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Purchases of property, plant and equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r192",
      "r212",
      "r274",
      "r318",
      "r319",
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]",
        "terseLabel": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r192",
      "r212",
      "r274",
      "r318",
      "r319",
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]",
        "terseLabel": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RawMaterials": {
     "auth_ref": [
      "r296",
      "r394"
     ],
     "calculation": {
      "http://www.constellium.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_InventoriesAtNetRealisableValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current raw materials",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "RawMaterials",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RawMaterialsAndConsumablesUsed": {
     "auth_ref": [
      "r51",
      "r290"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of raw materials and consumables used in the production process or in the rendering of services. [Refer: Current raw materials]"
       }
      },
      "en-us": {
       "role": {
        "label": "Raw materials and consumables used",
        "negatedLabel": "Raw materials and consumables used"
       }
      }
     },
     "localname": "RawMaterialsAndConsumablesUsed",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of average effective tax rate and applicable tax rate [abstract]",
        "terseLabel": "Reconciliation of average effective tax rate and applicable tax rate [abstract]"
       }
      }
     },
     "localname": "ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in property, plant and equipment [abstract]",
        "terseLabel": "Reconciliation of changes in property, plant and equipment [abstract]"
       }
      }
     },
     "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RecoverableAmountOfAssetOrCashgeneratingUnit": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The higher of an asset\u2019s (or cash-generating unit\u2019s) fair value less costs of disposal and its value in use. [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Recoverable amount of asset or cash-generating unit",
        "terseLabel": "Recoverable value"
       }
      }
     },
     "localname": "RecoverableAmountOfAssetOrCashgeneratingUnit",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RentalExpense": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense recognised on rental activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Rental expense",
        "negatedLabel": "Lease expenses"
       }
      }
     },
     "localname": "RentalExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RepaymentsOfBondsNotesAndDebentures": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of bonds, notes and debentures."
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of bonds, notes and debentures",
        "negatedTerseLabel": "Repayments of long-term borrowings",
        "terseLabel": "Redemption of senior notes"
       }
      }
     },
     "localname": "RepaymentsOfBondsNotesAndDebentures",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSMovementinBorrowingsDetails",
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCASHFLOWS",
      "http://www.constellium.com/role/FINANCECOSTSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "negatedLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation",
        "periodEndLabel": "Foreign currency translation reserve at December 31,",
        "periodStartLabel": "Foreign currency translation reserve at January 1,"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CURRENCYGAINSLOSSESForeignCurrencyTranslationReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "auth_ref": [
      "r95",
      "r292"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]",
        "terseLabel": "Foreign currency translation reserve"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReserveOfRemeasurementsOfDefinedBenefitPlansMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from remeasurements of defined benefit plans. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of remeasurements of defined benefit plans [member]",
        "terseLabel": "Re- measurement"
       }
      }
     },
     "localname": "ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Restricted cash and cash equivalents",
        "terseLabel": "Cash subject to restrictions"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RestructuringProvisionMember": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Restructuring provision [member]",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringProvisionMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r6",
      "r292"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Retained (deficit) / earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense",
        "terseLabel": "\u2014actual return less interest on plan assets"
       }
      }
     },
     "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSMovementinNetDefinedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [abstract]",
        "terseLabel": "Revenue [abstract]"
       }
      }
     },
     "localname": "RevenueAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "auth_ref": [
      "r194",
      "r195"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 1.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers",
        "terseLabel": "Revenue",
        "verboseLabel": "Total Revenue by product line"
       }
      }
     },
     "localname": "RevenueFromContractsWithCustomers",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails",
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyProductLineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromGovernmentGrants": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income from government grants",
        "terseLabel": "Proceeds from government grants deducted from employee benefit expenses"
       }
      }
     },
     "localname": "RevenueFromGovernmentGrants",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/COVID19RELATEDGOVERNMENTASSISTANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue that was included in contract liability balance at beginning of period",
        "terseLabel": "Revenue recognized related to contract liabilities"
       }
      }
     },
     "localname": "RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssetsMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets [member]",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTRightofUseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]",
        "terseLabel": "Segment consolidation items [axis]"
       }
      }
     },
     "localname": "SegmentConsolidationItemsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsAxis": {
     "auth_ref": [
      "r123",
      "r196",
      "r261",
      "r301",
      "r345"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [axis]",
        "terseLabel": "Segments [axis]"
       }
      }
     },
     "localname": "SegmentsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsMember": {
     "auth_ref": [
      "r123",
      "r196",
      "r266",
      "r301",
      "r345"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [member]",
        "terseLabel": "Segments [member]"
       }
      }
     },
     "localname": "SegmentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONNarrativeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAdjustedEBITDAandreconciliationofAdjustedEBITDAtoNetIncomeDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentCapitalExpendituresDetails",
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentRevenueDetails",
      "http://www.constellium.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense",
        "negatedLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremium": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium",
        "terseLabel": "Share premium"
       }
      }
     },
     "localname": "SharePremium",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremiumMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium [member]",
        "terseLabel": "Share premium"
       }
      }
     },
     "localname": "SharePremiumMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY",
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]",
        "terseLabel": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails",
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShorttermBorrowings": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current borrowings",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ShorttermBorrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 2.0,
       "parentTag": "cstm_OtherCurrentPayablesOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term employee benefits accruals",
        "terseLabel": "Employees' entitlements"
       }
      }
     },
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "auth_ref": [
      "r114",
      "r117",
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]",
        "terseLabel": "Subsidiaries [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CASHANDCASHEQUIVALENTSDetails",
      "http://www.constellium.com/role/SUBSIDIARIESANDAFFILIATESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]",
        "terseLabel": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]",
        "terseLabel": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]",
        "terseLabel": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFCHANGESINEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]",
        "terseLabel": "Statement of comprehensive income [abstract]"
       }
      }
     },
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]",
        "terseLabel": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subclassifications of assets, liabilities and equities [abstract]",
        "terseLabel": "Subclassifications of assets, liabilities and equities [abstract]"
       }
      }
     },
     "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SubsidiariesMember": {
     "auth_ref": [
      "r104",
      "r114",
      "r117",
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for entities that are controlled by another entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsidiaries [member]",
        "terseLabel": "BPI France"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SurplusDeficitInPlan": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Surplus (deficit) in plan",
        "negatedTotalLabel": "Deficit of funded plans"
       }
      }
     },
     "localname": "SurplusDeficitInPlan",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSAmountsRecognizedintheConsolidatedStatementofFinancialPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfForeignTaxRates": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of foreign tax rates",
        "negatedTerseLabel": "Effect of foreign tax rate"
       }
      }
     },
     "localname": "TaxEffectOfForeignTaxRates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income) at applicable tax rate",
        "negatedLabel": "Income tax (expense) / benefit calculated at statutory tax rate"
       }
      }
     },
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INCOMETAXIncomeTaxReconciliationUsingCompositeStatutoryIncomeTaxRateApplicablebyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TechnologybasedIntangibleAssetsMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Technology-based intangible assets [member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologybasedIntangibleAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TemporaryDifferenceMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for differences between the carrying amount of an asset or liability in the statement of financial position and its tax base. Temporary differences may be either: (a) taxable temporary differences; or (b) deductible temporary differences. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary differences [member]",
        "terseLabel": "Deductible temporary differences"
       }
      }
     },
     "localname": "TemporaryDifferenceMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]",
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [member]",
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [member]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r192",
      "r212",
      "r274",
      "r318",
      "r319",
      "r411"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "terseLabel": "Top of range"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.constellium.com/role/PENSIONSANDOTHERPOSTEMPLOYMENTBENEFITOBLIGATIONSActuarialAssumptionsDetails",
      "http://www.constellium.com/role/PROVISIONSLegalClaimsandOtherCostsDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current payables",
        "terseLabel": "Trade payables and other",
        "totalLabel": "Total trade payables and other"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current payables [abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "auth_ref": [
      "r294",
      "r374"
     ],
     "calculation": {
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADEPAYABLESANDOTHERScheduleofTradePayablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "auth_ref": [
      "r13",
      "r30"
     ],
     "calculation": {
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0
      },
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
       "weight": 1.0
      },
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current receivables",
        "terseLabel": "Trade receivables and other",
        "totalLabel": "Total trade receivables and other"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDSTATEMENTOFFINANCIALPOSITION",
      "http://www.constellium.com/role/DISPOSALGROUPCLASSIFIEDASHELDFORSALEDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current receivables [abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERScheduleofTradeReceivablesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other payables [abstract]",
        "terseLabel": "Trade and other payables [abstract]"
       }
      }
     },
     "localname": "TradeAndOtherPayablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]",
        "terseLabel": "Trade and other receivables [abstract]"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeReceivables": {
     "auth_ref": [
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "TradeReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERAgingofTotalTradeReceivablesNetDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeReceivablesMember": {
     "auth_ref": [
      "r239",
      "r244",
      "r326",
      "r370"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables [member]",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "TradeReceivablesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALINSTRUMENTSFinancialAssetsandLiabilitiesbyCategoriesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTUndiscountedContractualFinancialAssetsandFinancialLiabilitiesValuesbyRelevantMaturityGroupingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TransportationExpense": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from transportation services."
       }
      },
      "en-us": {
       "role": {
        "label": "Transportation expense",
        "negatedLabel": "Freight out costs"
       }
      }
     },
     "localname": "TransportationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EXPENSESBYNATUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TypesOfContractsAxis": {
     "auth_ref": [
      "r322",
      "r343"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of contracts [axis]",
        "terseLabel": "Types of contracts [axis]"
       }
      }
     },
     "localname": "TypesOfContractsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfContractsMember": {
     "auth_ref": [
      "r322",
      "r343"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of contracts [member]",
        "terseLabel": "Types of contracts [member]"
       }
      }
     },
     "localname": "TypesOfContractsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfHedgesAxis": {
     "auth_ref": [
      "r228",
      "r229",
      "r232",
      "r286"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of hedges [axis]",
        "terseLabel": "Types of hedges [axis]"
       }
      }
     },
     "localname": "TypesOfHedgesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfHedgesMember": {
     "auth_ref": [
      "r228",
      "r229",
      "r232",
      "r286"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedges [member]",
        "terseLabel": "Hedges [member]"
       }
      }
     },
     "localname": "TypesOfHedgesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTImpactonProfitandEquityBeforeTaxEffectofa10StrengtheningofUSDollarVersusEuroforNonUSDollarFunctionalCurrencyEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfRisksAxis": {
     "auth_ref": [
      "r223",
      "r237",
      "r238",
      "r275",
      "r276",
      "r277",
      "r279"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of risks [axis]",
        "terseLabel": "Types of risks [axis]"
       }
      }
     },
     "localname": "TypesOfRisksAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksMember": {
     "auth_ref": [
      "r223",
      "r237",
      "r238",
      "r275",
      "r276",
      "r277",
      "r279"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Risks [member]",
        "terseLabel": "Risks [member]"
       }
      }
     },
     "localname": "TypesOfRisksMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTEffectofForeignCurrencyDerivativesImpactsandFinancingTransactionExposuresDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTMarktomarketMovementsRecognizedinOtherGainsLossesNetDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCommodityDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNominalValueofCurrencyDerivativesDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]",
        "terseLabel": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONInputstotheModelUsedforPSUsGrantedDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.constellium.com/role/SHAREBASEDCOMPENSATIONNumberandMovementofPotentialSharesDetails",
      "http://www.constellium.com/role/SHARECAPITALDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfTransferMember": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of transfers of financial instruments. It also represents the standard value for the 'Continuing involvement in derecognised financial assets by type of transfer' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of transfer [member]",
        "terseLabel": "Types of transfer [member]"
       }
      }
     },
     "localname": "TypesOfTransferMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UnallocatedAmountsMember": {
     "auth_ref": [
      "r340",
      "r341"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items that have not been allocated to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Unallocated amounts [member]",
        "terseLabel": "Unallocated"
       }
      }
     },
     "localname": "UnallocatedAmountsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/OPERATINGSEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UndrawnBorrowingFacilities": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Undrawn borrowing facilities",
        "terseLabel": "Undrawn facilities"
       }
      }
     },
     "localname": "UndrawnBorrowingFacilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSNarrativeDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedProvisionReversedOtherProvisions": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount reversed for unused other provisions. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Unused provision reversed, other provisions",
        "negatedLabel": "Unused amounts reversed"
       }
      }
     },
     "localname": "UnusedProvisionReversedOtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/PROVISIONSChangesinProvisionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses [member]",
        "terseLabel": "Tax losses"
       }
      }
     },
     "localname": "UnusedTaxLossesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/DEFERREDINCOMETAXESComponentsofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_VehiclesMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Vehicles [member]",
        "terseLabel": "Vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WagesAndSalaries": {
     "auth_ref": [
      "r392"
     ],
     "calculation": {
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wages and salaries",
        "negatedLabel": "Wages and salaries"
       }
      }
     },
     "localname": "WagesAndSalaries",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/EMPLOYEEBENEFITEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]",
        "terseLabel": "Weighted average number of shares"
       }
      }
     },
     "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/CONSOLIDATEDINCOMESTATEMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_WorkInProgress": {
     "auth_ref": [
      "r296",
      "r394"
     ],
     "calculation": {
      "http://www.constellium.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_InventoriesAtNetRealisableValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current work in progress",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "WorkInProgress",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.constellium.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.constellium.com/role/BORROWINGSCurrencyConcentrationofTotalBorrowingsDetails",
      "http://www.constellium.com/role/FINANCIALRISKMANAGEMENTTables",
      "http://www.constellium.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDisclosureofForeignExchangeRatesDetails",
      "http://www.constellium.com/role/TRADERECEIVABLESANDOTHERCurrencyConcentrationofTotalTradeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Total Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.constellium.com/role/REVENUEDisaggregationofRevenuebyDestinationofShipmentDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 17
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r10": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS24_g13-24__IAS24_g13-24_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "Clause": "vi",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_vi&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Clause": "viii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_d_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r130": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "88",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r140": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Clause": "vi",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Clause": "vii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r150": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_m&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r160": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Section": "Presentation of a statement of cash flows",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS07_g10-17__IAS07_g10-17_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "IssueDate": "2022-03-24",
   "Name": "IFRIC",
   "Number": "19",
   "Paragraph": "11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&num=19&code=ifrs-tx-2022-en-r&anchor=para_11&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r170": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "10",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2022-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "2",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_2_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r180": {
   "Clause": "ix",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Clause": "viii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_c&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "p",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_p&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r190": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "105",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_116_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r20": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r200": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFR15_g110-129_IFRS15_g110-129_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS15_g105-109__IFRS15_g105-109_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "58",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r210": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Clause": "vi",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_d_vi&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r220": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "38",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_38&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Section": "Presentation and disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS05_g30-42__IFRS05_g30-42_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "22A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_22A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24A",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24A_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24B&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r230": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24C",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24C_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24C",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24C_b_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24C&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24G",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24G_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24G",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24G&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r240": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35K",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35K_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r250": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11E",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11E&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B2",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA__IFRS07_APPA_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A__IFRS07_g3-5A_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r260": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r270": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS08_g20-24__IFRS08_g20-24_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r280": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "9",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39G",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39G_a&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_22&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_36_a&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r290": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r291": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r292": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r293": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r294": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r295": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r296": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r297": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r298": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "22",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_22_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r299": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r3": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r30": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r300": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r301": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r302": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_142_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r303": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_142_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r304": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_142_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r305": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r306": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r307": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r308": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r309": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "87",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r31": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r310": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Section": "D Examples: disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_D__IAS37_IE_D_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r311": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Section": "Example 10 A court case",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10__IAS37_IE_C_ex10_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r312": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r313": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r314": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r315": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r316": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r317": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r318": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r319": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r32": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r320": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r321": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r322": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r323": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_f&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r324": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r325": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r326": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r327": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r328": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r329": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r33": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r330": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r331": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B33&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r332": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r333": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r334": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG20C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG20C&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r335": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG20D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r336": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r337": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG32&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r338": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r339": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r340": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r341": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "IG4",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_IG4&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r342": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r343": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r344": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r345": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r346": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r347": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "36",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_36_c&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r348": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r349": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r35": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r350": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG24_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r351": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG24",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG24&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r352": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r353": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r354": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_b&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r355": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r356": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r357": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r358": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r359": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r360": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r361": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r362": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r363": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r364": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r365": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r366": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r367": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r368": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r369": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r37": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r370": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r371": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r372": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r373": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r374": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r375": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r376": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r377": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r378": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r379": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r38": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r380": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r381": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r382": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r383": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r384": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r385": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r386": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r387": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "144",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r388": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r389": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "158",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_158&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r39": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r390": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "5",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r391": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r392": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r393": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r394": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r395": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r396": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r397": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r398": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r399": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r4": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r400": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r401": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r402": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r403": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r404": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r405": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r406": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r407": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r408": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r409": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r41": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r410": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "38",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_38&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r411": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r412": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r413": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Effective 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r414": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r415": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r416": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r417": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r42": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "90",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_90&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS10_g17-22_IAS10_g17-22_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "ab",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_ab&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS12_g79-88__IAS12_g79-88_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Clause": "vii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Clause": "viii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS16_g73-79__IAS16_g73-79_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_140_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_140_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_c_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_c_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_c_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_145_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_147_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "148",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_148_d_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS19_g2-7__IAS19_g2-7_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "20",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS20_g39-39__IAS20_g39-39_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "21",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS21_g51-57__IAS21_g51-57_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "23",
   "Paragraph": "26",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=23&code=ifrs-tx-2022-en-r&anchor=para_26_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}